Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"lymphoid tissue: 462.4"	"Group enriched"	"Detected in some"	110	"MOLT-4: 65.8;REH: 62.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043939			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.7	2.3	0.5	0.5	0.5	7.4	0.7	0.5	0.5	0.5	0.6	0.5	0.5	1.2	0.5	1.3	0.5	0.6	0.5	0.6	0.5	0.2	2.4	1.2	0.8	0.5	0.5	0.5	0.6	1.1	1.9	0.5	0.8	0.5	0.5	0.4	0.5	1.5	0.5	0.5	0.2	1.5	0.5	0.5	4.4	0.8	0.9	0.5	462.4	4.5	0.5	0.8	0.7	0.5	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	65.8	0.0	0.5	0.0	62.9	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5
OR5AK2		ENSG00000181273	"Olfactory receptor family 5 subfamily AK member 2"	Q8NH90	11	56988872-56989867	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"lymphoid tissue: 11.0"	"Cell line enhanced"	"Detected in single"		"AF22: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.2	11.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 64.7;lymphoid tissue: 28.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;LHCN-M2: 2.1;NTERA-2: 3.0;RH-30: 4.2;U-2 OS: 1.7"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.1	0.0	0.1	28.6	0.1	0.0	0.1	0.1	0.1	0.1	57.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	64.7	0.1	0.1	0.1	0.1	0.0	0.2	1.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580308	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8"	"Cell line enriched"	"Detected in some"	34	"REH: 126.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 11.6;naive B-cell: 9.8"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.6"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	100000000000	100000000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.1	0.1	0.2	37.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.0	29.4	0.0	0.0	1.1	0.0	0.0	11.6	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	126.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380908-2432753	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	34	"lymphoid tissue: 5.7;skin 1: 3.3;tongue: 4.2"	"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	34	"cerebellum: 1.8"	HPA059196	Uncertain									"HPA059196: AB_2683943"						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST1H3J	"H3/j, H3FJ"	ENSG00000197153	"Histone cluster 1 H3 family member j"	P68431	6	27890382-27893106	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"lymphoid tissue: 290.9"	"Cell line enhanced"	"Detected in many"		"U-266/84: 15.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (1.15e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.91e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.37e-3)"	"unprognostic (6.67e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-8)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.04e-2)"	0.9	0.4	0.2	25.1	0.3	5.7	1.1	0.5	0.4	1.2	5.5	0.0	0.0	0.3	0.4	0.5	9.4	0.4	1.2	0.9	0.4	0.4	0.3	1.2	1.5	8.8	0.4	0.0	0.3	0.4	0.3	0.3	4.7	0.0	0.6	0.3	0.0	0.4	0.6	0.3	1.6	3.7	0.3	1.1	15.1	0.6	2.4	0.0	290.9	0.9	7.8	14.6	1.1	1.1	2.1	2.5	0.0	0.7	0.6	2.5	0.7	1.0	0.7	1.6	0.3	0.5	0.5	0.9	0.0	0.0	1.5	0.2	0.0	0.4	4.7	0.9	0.4	0.2	1.3	0.4	0.0	0.2	0.9	1.1	1.9	0.0	0.4	0.2	0.3	0.0	0.0	0.7	0.0	0.7	2.6	1.1	0.0	1.1	3.6	4.3	2.5	0.4	1.6	0.5	0.5	0.0	0.0	2.8	1.6	1.8	1.2	0.0	0.4	0.8	0.0	0.4	0.0	0.2	0.4	3.5	15.1	1.1	0.8	0.6	2.4	0.0	0.0	0.0	1.4	0.3	0.0	0.0	2.3	2.5	2.5	2.1	0.5	1.0	0.0	0.6	0.7	0.0	2.2	0.7	0.2	0.3	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 9.5;lymphoid tissue: 2.9;retina: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	95	"hypothalamus: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"hypothalamus: 7.2"	"Region enriched"	"Detected in some"	4	"hypothalamus: 3.8"	HPA041733	Enhanced				"Secreted in other tissues"					"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0
HIST1H3G	"H3/h, H3FH"	ENSG00000273983	"Histone cluster 1 H3 family member g"	P68431	6	26269405-26271815	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"lymphoid tissue: 247.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;SiHa: 10.1;U-266/70: 9.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (1.88e-1)"	"prognostic favourable (8.75e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.23e-2)"	0.7	0.4	0.0	14.6	0.0	1.9	1.7	0.0	0.0	0.5	5.2	0.0	0.0	2.1	0.1	2.2	9.1	1.5	0.8	1.1	0.0		0.2	0.0	1.0	7.3	0.0	0.0	0.1	0.0	0.3	0.0	4.8	0.0	0.1	1.6	0.0	0.4	0.4	0.0	0.3	4.7	0.4	0.0	13.6	1.0	5.0	0.0	247.1	1.0	8.0	15.9	0.7	0.0	1.6	0.4	0.6	0.4	0.2	1.5	0.7	1.1	0.2	1.1	0.0	0.1	0.2	0.5	0.4	0.2	1.2	0.4	3.9	0.0	0.0	0.6	0.1	3.3	1.3	0.6	0.8	0.9	0.0	0.1	2.5	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.3	0.3	0.0	2.3	0.0	2.4	1.1	0.4	2.0	0.0	0.8	0.0	1.4	0.7	0.7	0.3	0.6	10.1	3.1	0.0	0.1	0.5	0.3	0.5	0.0	0.0	0.2	9.6	0.3	0.0	0.5	0.0	1.2	0.0	0.0	0.3	0.3	0.1	0.4	1.1	1.5	1.0	0.4	1.6	0.0	0.5	0.6	0.2	0.4	0.0	1.5	0.7										
HIST1H2BE	"H2B.h, H2B/h, H2BFH"	ENSG00000274290	"Histone cluster 1 H2B family member e"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	26	"lymphoid tissue: 165.1"	"Cell line enhanced"	"Detected in many"		"NB-4: 8.0;REH: 7.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.7	1.1	0.4	12.2	0.8	5.9	1.8	0.6	1.7	2.5	2.9	0.1	1.8	1.1	1.5	2.9	5.5	1.6	1.6	1.9	0.5		1.7	0.3	1.5	6.7	0.0	1.2	2.1	1.2	0.7	0.0	2.4	0.2	5.2	1.5	0.7	4.0	2.2	2.1	1.9	2.0	1.8	1.6	4.5	2.5	5.4	0.0	165.1	1.2	6.4	7.1	1.8	0.0	3.6	3.1	5.5	1.7	1.6	2.9	0.8	0.5	3.6	2.9	0.9	2.9	0.4	0.4	3.0	1.0	0.5	0.3	0.8	2.1	0.6	1.4	0.5	4.2	0.5	1.1	0.6	1.5	0.9	0.5	1.4	0.1	0.2	0.3	2.4	0.6	0.2	0.6	0.2	0.3	2.3	1.8	0.1	1.6	4.5	8.0	2.4	0.9	7.8	0.2	2.5	1.4	1.8	2.7	3.6	3.9	1.4	0.9	2.7	1.6	0.8	1.5	2.6	1.0	1.9	2.3	4.4	0.6	0.6	1.4	0.5	5.2	1.7	2.4	2.0	1.3	1.6	2.1	2.0	2.5	0.7	3.6	1.8	1.7	5.5	1.6	1.5	3.1	2.9	0.8										
HIST1H2BF	"H2B/g, H2BFG"	ENSG00000277224	"Histone cluster 1 H2B family member f"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"lymphoid tissue: 252.2"	"Group enriched"	"Detected in some"	4	"U-266/70: 21.3;U-266/84: 15.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.4	1.2	0.0	17.3	0.1	3.8	5.7	0.3	0.7	2.7	3.3	0.4	1.0	0.5	1.6	1.3	9.9	1.3	1.2	0.6	0.0		0.5	0.4	2.5	7.0	0.0	0.2	0.8	0.6	0.4	0.0	3.2	0.2	5.4	1.1	0.5	1.4	1.3	0.2	0.4	3.0	0.3	0.9	8.3	1.3	2.2	0.1	252.2	0.4	3.3	14.6	2.4	0.0	3.0	0.7	6.2	0.7	0.4	1.5	1.2	0.4	0.2	0.2	0.4	0.2	0.0	0.2	0.1	0.1	0.6	0.1	0.5	0.0	0.5	0.9	0.0	0.8	0.4	0.1	0.3	0.6	0.2	0.3	1.4	0.1	0.1	0.1	0.7	0.2	0.0	0.1	0.1	0.1	1.6	3.8	0.0	0.1	3.2	1.3	0.5	0.5	1.2	0.6	2.4	0.1	0.1	2.1	0.3	4.1	0.8	0.0	3.7	0.2	0.1	0.3	1.9	0.0	0.5	21.3	15.0	1.2	0.1	0.9	0.4	0.0	0.2	1.4	0.7	0.3	1.5	0.7	0.7	0.8	0.4	3.0	0.6	1.2	6.2	0.4	0.7	0.7	0.6	1.2										
CCL25	"Ckb15, SCYA25, TECK"	ENSG00000131142	"C-C motif chemokine ligand 25"	O15444	19	8052767-8062650	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	23	"intestine: 136.8;lymphoid tissue: 185.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;HEL: 4.9;NB-4: 3.8;REH: 10.1;RPMI-8226: 2.9;SH-SY5Y: 3.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 25.4;stomach cancer: 33.5;testis cancer: 6.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 1.8;NK-cell: 7.0"	"Group enriched"	"Detected in many"	12	"B-cells: 1.8;NK-cells: 7.0"									HPA055883	Approved				"Secreted to blood"					"HPA055883: AB_2682955"	"unprognostic (9.22e-3)"	"unprognostic (3.13e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.17e-1)"	0.1	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.2	0.1	64.9	0.0	0.0	91.9	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	136.8	0.0	0.2	0.4	0.1	0.4	0.0	185.2	0.1	0.0	0.0	0.1	0.1	1.8	0.1	0.0	0.0	7.0	0.3	0.4	0.0	0.0	0.1	0.8	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	3.8	0.2	0.5	10.1	0.0	2.9	0.0	0.0	0.8	3.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.3	0.2	0.0	7.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.3	0.0	0.0	0.0
HIST1H2AI	"H2A/c, H2AFC"	ENSG00000196747	"Histone cluster 1 H2A family member i"	P0C0S8	6	27808199-27808701	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 349.3"	"Cell line enhanced"	"Detected in many"		"K-562: 17.3;U-266/84: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.54e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.50e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.24e-2)"	1.7	1.2	0.7	36.2	0.9	10.7	2.8	0.6	0.7	1.5	6.3	0.0	0.5	2.3	1.1	1.4	14.2	1.4	2.8	4.8	1.1	1.1	1.0	1.3	3.5	25.8	0.6	0.0	1.2	0.4	1.4	0.6	5.4	0.0	1.3	5.8	0.0	1.3	0.3	0.5	1.1	7.1	0.5	4.3	21.9	2.2	4.3	0.0	349.3	1.0	15.2	26.8	2.3	2.0	3.0	2.6	4.8	0.8	2.5	4.0	2.0	0.9	3.6	0.8	0.6	0.4	0.2	0.3	0.7	0.1	1.1	0.9	1.1	0.6	1.0	2.2	0.3	0.7	0.0	0.6	0.5	3.5	4.7	1.5	5.8	3.0	0.4	0.4	0.8	1.6	0.2	0.4	0.1	0.2	17.3	4.1	0.0	4.5	2.5	2.7	0.9	1.3	1.2	0.0	6.7	1.3	0.6	5.1	1.0	10.1	1.5	0.3	6.1	0.4	0.2	0.5	1.9	0.4	0.4	3.8	47.5	2.0	0.4	4.0	0.3	0.0	0.5	3.6	0.9	0.8	0.7	2.1	3.2	0.9	2.3	3.0	0.7	0.4	4.8	2.5	0.8	2.6	4.0	2.0	0.7	0.9	0.6	0.7	1.1	1.1	0.6	0.0	0.0	0.0
HIST1H2BH	"H2B/j, H2BFJ"	ENSG00000275713	"Histone cluster 1 H2B family member h"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 220.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 17.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.9	0.6	0.0	25.6	0.0	3.1	2.1	0.0	0.0	0.9	5.5	0.0	0.9	7.8	1.0	2.4	8.4	1.5	4.0	1.8	0.0		0.7	0.0	2.2	11.3	0.0	0.0	0.4	0.1	0.0	0.0	4.9	0.0	1.2	2.2	0.0	1.8	0.1	0.0	0.6	8.1	0.1	0.0	9.6	1.6	3.3	0.0	220.5	0.4	9.5	23.3	1.4	0.0	1.0	0.9	4.7	0.4	1.0	0.7	9.3	1.8	0.1	7.3	0.0	0.0	0.1	1.2	0.9	0.4	1.3	0.6	2.4	1.1	0.0	1.8	0.1	3.6	0.0	0.6	1.8	0.9	0.1	1.3	5.5	0.4	0.0	0.0	4.2	0.3	0.3	0.5	0.5	0.3	2.6	6.5	0.1	2.0	3.8	2.7	1.7	1.9	4.0	0.0	0.9	0.0	2.8	3.4	3.0	4.3	1.4	0.6	2.1	3.3	0.0	0.6	0.0	0.8	3.2	17.7	4.4	0.0	0.5	1.5	3.9	3.5	0.4	0.7	0.5	0.0	0.2	1.0	0.3	0.7	0.9	0.6	0.1	0.2	4.7	1.0	0.2	0.4	0.7	9.3										
LCE3B	LEP14	ENSG00000187238	"Late cornified envelope 3B"	Q5TA77	1	152613811-152614098	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	23	"lymphoid tissue: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HIST1H2AJ	"H2A/E, H2AFE"	ENSG00000276368	"Histone cluster 1 H2A family member j"	Q99878	6	27814354-27814740	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	22	"lymphoid tissue: 357.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.8;Karpas-707: 11.9;MCF7: 16.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"			HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.6	0.1	0.0	7.2	0.0	16.5	0.2	0.0	0.2	1.0	5.2	0.0	0.0	0.3	0.3	0.6	6.6	0.3	0.8	0.2	0.0		0.3	0.4	2.2	3.1	0.0	0.0	0.1	0.1	0.1	0.0	3.6	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.4	3.9	0.1	0.0	10.5	0.8	5.2	0.0	357.7	0.1	7.9	23.1	1.5	0.0	4.2	2.7	2.5	0.5	0.4	5.9	5.0	3.9	0.0	1.2	0.0	0.0	0.0	0.9	1.2	1.1	1.0	2.5	2.1	0.1	3.9	0.4	0.7	1.1	0.0	1.1	0.6	1.8	0.6	5.5	0.5	9.8	0.3	0.0	2.1	0.0	0.3	0.5	0.3	1.4	0.0	11.9	0.3	16.5	6.6	6.0	1.9	3.5	5.8	0.0	2.3	0.2	2.4	0.5	0.8	1.1	1.1	0.5	0.4	4.0	0.0	0.0	2.3	0.4	0.2	6.1	3.9	3.7	1.3	4.4	2.8	0.0	0.1	0.0	0.7	0.5	0.9	0.7	3.4	3.1	2.7	4.2	1.1	0.4	2.5	0.4	0.2	0.3	5.9	5.0										
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145568-19170289	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"lymphoid tissue: 81.2"	"Group enriched"	"Detected in some"	12	"Daudi: 49.8;U-266/70: 50.0;U-698: 65.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	2.0	1.0	0.8	81.2	1.2	1.4	1.9	0.6	1.4	2.7	3.0	0.9	0.6	1.5	2.2	1.1	1.5	2.3	2.2	1.9	1.0	0.6	1.8	2.9	2.0	32.3	1.1	0.9	3.7	0.8	0.8	2.1	0.8	1.0	3.7	1.0	1.8	3.5	1.1	1.4	2.3	3.1	1.1	1.2	6.7	1.7	1.7	0.8	1.6	3.0	3.5	58.7	1.9	2.9	0.1	0.2	1.1	0.9	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	49.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.3	0.0	0.9	0.4	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.4	0.5	0.1	50.0	4.6	65.8	0.1	0.3	0.0	0.0	0.9	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.4	1.0	0.6	1.1	0.9	1.0	0.8
AC064853.2		ENSG00000284622			2	227608784-227608927	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	20	"lymphoid tissue: 1.3;testis: 2.6"	"Group enriched"	"Detected in some"	44	"HeLa: 3.8;hTCEpi: 4.9"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.6			0.0		1.3	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HIST1H2BM	"dJ160A22.3, H2B/e, H2BFE"	ENSG00000273703	"Histone cluster 1 H2B family member m"	Q99879	6	27815044-27815424	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"lymphoid tissue: 232.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.3;NB-4: 11.1;REH: 7.2;U-266/70: 13.4;U-698: 6.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.1	0.1	0.0	19.9	0.0	11.6	0.1	0.0	0.2	1.6	3.4	0.0	0.0	0.1	0.7	0.9	8.4	0.1	1.4	0.3	0.0		0.1	0.3	1.8	7.3	0.0	0.0	0.3	0.1	0.1	0.0	1.5	0.0	0.5	1.1	0.0	0.3	0.1	0.1	0.8	3.8	0.1	0.5	13.9	0.5	3.5	0.0	232.2	0.1	9.4	27.6	0.1	0.0	2.6	0.4	0.3	0.3	1.5	1.7	0.0	1.5	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.5	2.1	0.4	0.3	2.2	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.8	0.2	0.8	0.0	0.0	2.0	0.0	0.0	0.8	0.0	0.0	0.2	17.3	0.0	0.5	4.5	11.1	3.3	0.8	7.2	0.0	0.4	0.0	0.0	0.1	1.9	0.7	1.1	0.0	1.0	3.3	0.0	0.0	2.0	1.2	0.1	13.4	0.5	6.8	1.1	1.2	0.9	0.0	0.1	0.1	1.5	0.3	1.7	1.9	1.7	1.5	0.4	2.6	0.1	1.2	0.3	1.5	0.0	0.2	0.6	0.0										
PTCRA	"PT-ALPHA, PTA"	ENSG00000171611	"Pre T cell antigen receptor alpha"	Q6ISU1	6	42915989-42925835	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	20	"blood: 74.1;lymphoid tissue: 129.5"	"Group enriched"	"Detected in some"	12	"MOLT-4: 28.8;SK-MEL-30: 9.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	39	"plasmacytoid DC: 74.1"	"Lineage enriched"	"Detected in many"	39	"dendritic cells: 74.1"																				"unprognostic (5.50e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.83e-2)"	"unprognostic (6.57e-4)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.89e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.45e-1)"	0.5	0.2	0.1	0.5	0.1	2.9	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.4	5.0	5.2	0.5	0.1	0.1	0.1	0.0	0.1	1.1	0.1	0.3	0.1	0.1	0.5	0.1	0.1	0.0	0.3	0.1	0.8	9.7	0.0	0.1	0.1	129.5	0.1	0.1	4.4	0.1	0.1	0.0	74.1	1.8	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	74.1	0.0	6.6	0.1	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.1	0.1
HIST1H1B	"H1.5, H1b, H1F5, H1s-3"	ENSG00000184357	"Histone cluster 1 H1 family member b"	P16401	6	27866849-27867529	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 342.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.7;NB-4: 7.5;U-698: 5.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4"									"CAB012241, HPA055907"	Approved		Supported	Nucleoplasm		510000	510000	Nucleoplasm	Nucleoplasm	"CAB012241: , HPA055907: AB_2682966"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.4	0.4	22.9	0.5	18.2	2.1	0.5	0.4	1.7	7.3	0.0	0.0	0.3	0.5	1.0	10.2	0.3	1.9	0.6	0.5	0.5	0.4	0.6	3.9	10.7	0.5	0.0	0.4	0.4	0.3	0.4	6.4	0.0	0.4	0.5	0.0	0.8	0.3	0.4	1.4	7.0	0.3	1.7	14.4	1.3	1.7	0.0	342.6	0.6	10.5	26.0	2.0	0.7	13.0	12.7	0.7	1.1	1.8	3.4	2.1	2.2	0.0	0.8	0.0	0.0	0.0	1.7	0.7	0.6	1.0	0.6	0.7	1.5	2.6	0.4	0.8	0.8	0.0	0.0	0.1	0.8	0.9	3.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.9	2.6	1.9	0.1	0.4	13.7	7.5	2.1	0.0	4.2	0.0	0.0	0.4	0.0	1.9	1.1	2.3	0.3	0.0	1.0	2.4	0.8	1.4	0.1	1.3	1.0	2.8	0.0	5.8	1.9	0.9	1.3	0.0	0.9	0.0	3.3	0.9	1.7	4.8	3.1	3.4	5.1	13.0	1.7	1.8	0.7	1.8	1.1	12.7	3.4	2.1	0.4	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.0
HIST1H2AG	"H2A.1b, H2A/p, H2AFP, pH2A/f"	ENSG00000196787	"Histone cluster 1 H2A family member g"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 305.4"	"Cell line enhanced"	"Detected in many"		"K-562: 9.7;SiHa: 11.2;U-266/84: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 9.7"	"Group enriched"	"Detected in many"	4	"B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8"									HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	2.4	1.6	1.1	25.1	1.2	6.3	8.7	0.7	1.0	3.3	9.7	0.0	1.0	3.8	2.0	3.7	15.7	1.0	3.2	2.7	1.3	1.6	1.1	2.6	6.0	13.5	2.3	0.0	1.4	0.9	0.3	1.0	8.7	0.3	2.5	2.3	0.3	2.1	1.5	1.1	1.4	7.1	0.9	2.3	20.2	1.8	16.1	0.0	305.4	1.5	12.3	28.9	2.4	2.0	4.4	1.3	9.7	0.8	1.1	3.8	7.7	1.3	1.8	1.5	1.4	4.8	1.0	1.0	0.5	0.7	1.6	0.2	0.7	1.4	0.4	2.0	0.5	2.7	1.8	0.8	1.1	2.4	1.0	0.7	3.5	0.0	1.0	0.7	1.4	1.8	0.3	0.5	0.5	0.5	9.7	4.6	0.1	1.7	1.8	1.1	0.9	1.2	1.2	1.5	4.9	0.3	0.3	6.0	1.4	11.2	1.8	0.6	0.0	0.4	0.5	1.8	3.9	1.4	0.7	8.2	30.5	3.1	0.3	1.1	1.1	9.7	0.4	0.7	0.6	0.3	1.3	3.0	2.3	1.6	0.6	4.4	2.2	1.8	3.5	1.1	0.8	1.3	3.8	7.7	1.1	1.2	0.7	0.9	1.3	1.6	2.3	0.0	0.3	0.0
HIST1H2AK	"H2A/d, H2AFD"	ENSG00000275221	"Histone cluster 1 H2A family member k"	P0C0S8	6	27837947-27838339	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 115.7"	"Cell line enhanced"	"Detected in some"		"A549: 4.2;AN3-CA: 4.8;HeLa: 4.9;SCLC-21H: 4.7;U-266/84: 7.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA041189	Supported									"HPA041189: AB_2677357"																		1.5	4.1	0.0	11.1	0.5	3.2	3.5	0.9	1.3	2.8	2.3	0.2	0.5	1.0	1.7	1.6	4.4	2.7	4.1	2.5	0.0		0.2	0.4	4.4	8.4	0.8	0.0	3.3	0.0	0.0	0.1	1.7	0.3	2.3	0.4	0.9	1.7	1.1	0.7	0.0	1.5	0.3	1.6	7.0	1.3	3.9	0.5	115.7	1.6	2.8	12.3	2.1	0.0	6.0	1.2	0.0	0.6	1.1	3.8	5.1	0.0	4.2	0.0	4.8	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.4	0.0	0.2	0.2	0.8	2.1	1.0	0.0	0.5	1.3	1.2	1.7	4.9	0.6	0.7	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.6	0.4	0.0	0.9	0.3	4.7	0.8	0.0	0.0	0.0	0.5	0.0	0.2	0.5	0.5	0.0	0.3	1.8	7.0	1.0	0.0	0.3	0.5	0.0	0.1	0.0	2.3	0.0	1.8	5.8	2.6	2.4	0.0	6.0	3.8	2.8	0.0	1.1	0.6	1.2	2.7	5.1										
HIST1H3I	"H3.f, H3/f, H3FF"	ENSG00000275379	"Histone cluster 1 H3 family member i"	P68431	6	27871905-27872315	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 236.8"	"Cell line enhanced"	"Detected in some"		"HEL: 4.5;MOLT-4: 8.2;NB-4: 5.5;REH: 8.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0"					"Cell type enhanced"	"Detected in many"		"NK-cell: 12.4"	"Low lineage specificity"	"Detected in all"											HPA042570	Approved									"HPA042570: AB_2678056"		"unprognostic (1.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.48e-2)"		"unprognostic (2.39e-1)"		"unprognostic (1.18e-1)"				"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.29e-2)"	1.0	0.8	0.0	16.7	0.0	7.9	2.4	0.0	0.4	0.9	2.9	0.0	1.6	0.4	0.4	1.4	7.1	0.5	2.9	1.8	0.0		0.4	0.4	1.9	9.2	0.0	0.0	0.4	5.0	0.4	0.0	2.4	0.0	0.5	0.4	0.0	1.0	0.7	0.4	0.4	3.6	0.4	0.0	10.2	0.8	1.8	0.0	236.8	0.6	11.6	14.5	0.4	0.0	4.1	4.7	1.0	1.2	12.4	2.4	2.2	1.2	1.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.2	2.9	0.4	0.0	0.9	0.0	0.0	0.5	1.3	1.7	4.5	0.0	0.0	1.0	2.7	0.6	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	5.5	1.2	0.0	8.6	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.2	0.5	2.4	0.6	2.0	0.8	2.0	1.5	3.3	4.1	1.7	2.2	1.0	12.4	0.5	4.7	1.9	2.2										
NXPE4	"C11orf33, FAM55D, FLJ20127"	ENSG00000137634	"Neurexophilin and PC-esterase domain family member 4"	Q6UWF7	11	114570591-114595762	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 44.3;lymphoid tissue: 21.7;salivary gland: 71.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042801	Approved				"Secreted to digestive system"					"HPA042801: AB_10793986"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.27e-1)"		"unprognostic (3.51e-3)"		"unprognostic (1.06e-1)"		"unprognostic (1.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.36e-2)"		"unprognostic (2.05e-1)"		0.2	0.2	0.2	21.7	0.2	0.0	0.2	0.2	0.2	0.2	41.5	0.1	0.1	0.0	0.2	2.4	0.3	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	2.1	44.3	0.1	71.7	0.1	0.2	0.2	0.5	1.9	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.3	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
CAPN14		ENSG00000214711	"Calpain 14"	A8MX76	2	31173056-31233858	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"esophagus: 92.6;lymphoid tissue: 25.0"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 7.7"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.9;head and neck cancer: 2.3;lung cancer: 0.8;stomach cancer: 1.4;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"					"Not detected"	"Not detected"														"unprognostic (5.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.71e-4)"	"unprognostic (8.42e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.47e-4)"	0.1	0.1	0.2	0.0	0.3	0.0	0.2	0.5	0.3	1.1	0.1	0.0	0.0	0.0	0.4	0.0	92.6	0.1	0.0	0.2	0.2	0.3	0.1	0.4	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	3.2	25.0	0.2	0.4	1.3	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.1	0.4	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.4	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.3	0.5	0.3	0.2	0.3	0.2	0.0	0.0	0.0
ADAMDEC1	M12.219	ENSG00000134028	"ADAM like decysin 1"	O15204	8	24384285-24406013	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"intestine: 126.7;lymphoid tissue: 46.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 15.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.5"	"Group enriched"	"Detected in many"	7	"B-cells: 2.7;granulocytes: 4.5;monocytes: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	22000000	22000000				"unprognostic (1.17e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.15e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.23e-2)"	0.6	0.6	0.3	46.3	0.3	0.0	0.4	0.3	0.3	0.4	57.4	0.1	0.1	30.4	0.3	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.5	0.4	1.4	30.0	0.3	0.1	0.4	0.4	0.0	0.4	0.9	0.1	0.4	52.2	0.2	0.8	0.1	0.3	0.5	126.7	1.7	0.4	5.2	0.8	0.4	0.1	1.9	0.5	0.5	5.4	5.0	0.4	2.7	0.4	4.5	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	15.2	3.6	0.0	0.0	0.0	0.0	0.0	2.0	4.5	0.0	2.1	0.0	2.7	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
HIST1H2AL	"dJ193B12.9, H2A/i, H2AFI"	ENSG00000276903	"Histone cluster 1 H2A family member l"	P0C0S8	6	27865355-27865747	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 288.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.1;MOLT-4: 8.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (2.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"		"unprognostic (2.41e-2)"	"unprognostic (2.12e-1)"		"unprognostic (6.21e-2)"	1.1	0.5	0.0	24.8	0.0	16.4	1.3	0.0	0.5	1.1	4.5	0.0	0.0	1.1	0.8	1.7	7.6	0.3	1.8	1.5	0.0		0.4	0.4	3.4	10.2	0.0	0.0	0.3	0.3	1.5	0.0	5.2	0.0	0.3	0.3	0.0	0.7	0.3	0.3	0.5	4.4	0.3	0.0	12.9	0.7	13.1	0.0	288.3	0.3	9.6	26.4	0.5	0.0	9.6	4.7	8.8	3.6	0.1	2.0	1.1	4.1	1.7	0.8	0.0	0.0	0.0	1.1	1.7	0.7	1.4	1.6	0.0	1.4	3.1	1.1	0.0	1.2	0.0	0.0	0.4	3.1	7.1	1.2	0.0	1.1	0.0	0.8	1.5	0.0	0.0	0.4	0.0	0.0	5.4	3.2	0.4	3.7	8.7	6.3	2.9	1.3	4.5	0.0	0.4	0.6	2.6	2.0	2.0	1.2	0.0	0.8	0.4	1.2	0.0	0.2	0.0	1.4	2.9	5.5	0.0	6.3	1.4	4.0	1.3	2.4	2.0	1.3	0.1	1.7	0.0	3.3	1.7	2.0	4.7	9.6	0.7	1.0	8.8	0.1	3.6	3.4	1.7	1.1										
HIST1H2BI	"H2B/k, H2BFK"	ENSG00000278588	"Histone cluster 1 H2B family member i"	P62807	6	26272976-26273356	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 150.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 5.3;MOLT-4: 14.8;THP-1: 6.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.5	0.1	0.0	19.0	0.0	8.9	1.2	0.4	0.1	1.3	3.1	0.0	0.5	0.1	0.7	2.1	6.6	0.4	2.0	1.3	0.0		0.3	0.1	2.0	6.3	0.0	0.0	0.7	0.1	0.1	0.0	2.8	0.0	0.1	0.3	0.0	1.3	0.3	0.1	1.2	1.9	0.1	0.1	11.1	0.4	1.9	0.0	150.8	0.4	8.2	14.5	2.2	0.0	4.7	0.7	0.9	1.3	0.4	4.6	0.2	1.8	0.8	1.2	0.0	0.0	0.0	0.2	0.7	0.7	2.0	5.3	0.8	0.0	0.9	0.4	0.4	0.9	1.8	0.5	0.8	2.6	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.8	0.0	3.8	0.0	0.7	14.8	2.5	2.8	0.0	4.0	0.0	4.9	0.0	0.4	0.3	0.9	1.1	1.0	0.0	0.0	6.2	0.9	0.8	0.0	0.6	3.0	3.1	0.4	0.0	1.1	0.5	2.2	0.2	0.5	0.0	3.4	1.3	2.2	2.2	3.2	4.6	0.7	4.7	1.4	0.8	0.9	0.4	0.1	0.3	1.5	0.2										
HIST1H2BO	"H2B.2, H2B/n, H2BFN"	ENSG00000274641	"Histone cluster 1 H2B family member o"	P23527	6	27893463-27893843	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 164.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 28.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favourable (4.89e-4)"	1.9	0.4	0.0	14.9	0.0	8.1	1.5	0.0	0.0	0.9	3.9	0.0	0.0	0.9	0.6	1.6	9.9	0.0	0.7	1.5	0.0		0.3	0.5	2.6	7.4	0.0	0.0	0.0	0.0	0.7	0.0	4.4	0.1	0.3	1.5	0.0	1.2	0.0	0.3	1.5	2.1	0.1	0.5	8.1	0.7	1.4	0.0	164.5	0.0	7.1	15.4	1.1	0.0	2.6	2.2	6.5	0.8	1.3	1.7	5.5	2.2	2.9	1.4	4.3	0.7	0.0	2.6	0.8	0.1	5.3	5.3	1.1	1.3	2.5	1.9	0.2	2.2	2.4	0.5	0.7	1.7	1.9	1.6	4.4	1.7	0.0	0.2	1.0	0.3	0.0	0.4	0.5	1.4	6.4	7.2	0.2	0.5	10.9	9.3	1.6	2.1	6.4	1.5	4.8	0.9	0.3	6.1	1.3	4.6	1.2	0.7	2.0	0.2	0.0	1.5	0.3	1.7	2.0	8.0	28.8	7.4	0.9	9.3	0.7	1.3	0.3	3.8	0.8	0.6	1.1	1.4	0.8	1.7	2.2	2.6	0.5	0.5	6.5	1.3	0.8	1.7	1.4	5.5										
HIST1H3F	"H3/i, H3FI"	ENSG00000277775	"Histone cluster 1 H3 family member f"	P68431	6	26250195-26250605	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 198.6"	"Cell line enhanced"	"Detected in many"		"NB-4: 8.3;U-266/84: 9.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"											"HPA042570, CAB070190"	Approved									"CAB070190: AB_10001790, HPA042570: AB_2678056"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.91e-6)"		"unprognostic (9.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"		"unprognostic (2.14e-1)"		"unprognostic (1.00e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-4)"	1.1	0.9	0.0	26.8	0.0	8.0	3.9	0.0	0.2	0.5	4.5	0.0	0.2	1.5	0.7	2.4	8.6	0.4	2.2	4.2	0.0		0.3	0.2	2.5	17.0	0.0	0.0	0.2	0.2	0.2	0.0	3.8	0.0	0.4	0.4	0.0	0.8	0.2	0.7	0.7	4.6	0.5	0.0	10.8	1.1	2.8	0.0	198.6	0.4	11.5	25.3	0.9	0.0	4.5	1.3	0.0	0.6	0.0	0.9	0.4	1.4	0.0	2.2	0.0	0.0	0.0	1.6	1.3	0.0	2.5	0.7	0.0	0.0	0.2	1.1	0.0	0.9	0.0	1.1	0.0	1.4	0.5	1.6	4.5	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	1.3	2.4	1.8	0.0	1.8	3.4	8.3	0.0	2.4	3.8	0.0	1.2	0.0	0.3	4.3	1.0	1.6	0.8	0.0	3.2	2.8	0.0	0.4	0.0	0.2	1.9	2.2	9.4	0.0	2.5	3.0	1.0	0.0	0.5	0.0	0.5	0.0	0.1	4.5	0.1	0.0	1.3	1.3	0.3	0.0	0.0	0.0	0.6	0.0	0.9	0.4										
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822698-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"blood: 57.9;lymphoid tissue: 128.9"	"Cell line enriched"	"Detected in some"	33	"MOLT-4: 39.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 57.9"	"Group enriched"	"Detected in many"	160	"granulocytes: 53.1;T-cells: 57.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130"	Enhanced									"CAB026130: , HPA002356: AB_1080375"	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	2.6	0.3	0.2	8.2	0.2	1.8	1.3	0.2	0.3	0.8	1.0	0.1	0.1	0.9	0.7	0.3	0.9	0.8	1.9	0.7	0.2	0.2	1.1	1.0	4.0	17.8	0.2	0.2	0.5	0.5	0.0	0.4	0.3	0.3	1.1	1.0	0.1	1.9	0.3	0.4	1.0	5.5	0.2	0.3	9.0	1.6	0.5	0.1	128.9	1.1	1.0	9.8	2.8	1.1	0.1	0.1	53.1	0.1	0.3	57.9	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	39.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.1	0.0	10.5	0.0	21.2	0.1	42.1	21.6	0.0	0.0	57.9	14.2	0.6	0.3	0.1	0.1	17.9	22.9	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.1
HIST1H2BL	"dJ97D16.4, H2B/c, H2BFC"	ENSG00000185130	"Histone cluster 1 H2B family member l"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 217.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.9;U-266/84: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	1.2	1.0	0.2	13.9	1.0	13.7	1.6	1.4	0.6	1.8	5.1	0.0	0.3	0.6	0.8	0.6	7.4	0.9	0.9	1.3	0.9	0.7	0.3	0.6	1.5	3.5	0.5	0.0	1.3	1.2	1.2	0.2	1.9	0.0	1.2	1.1	0.0	0.7	0.2	0.2	0.9	3.9	0.7	2.8	4.8	0.8	1.5	0.0	217.6	1.2	5.9	15.6	1.1	1.2	1.9	1.2	7.7	0.6	0.4	2.0	0.9	2.4	2.2	0.7	2.3	0.0	0.0	0.1	1.4	0.4	1.2	3.2	1.0	1.7	0.9	0.5	0.3	1.5	0.0	0.2	0.4	1.1	3.2	1.7	3.1	3.8	0.0	2.8	2.3	1.0	0.0	0.0	0.0	0.7	2.2	5.7	0.0	6.0	12.9	4.8	2.1	3.3	3.0	0.0	1.4	0.0	2.2	3.0	1.1	3.9	1.6	0.2	1.4	0.9	0.5	0.1	1.6	1.3	1.0	3.3	12.7	4.2	0.4	5.0	0.5	0.6	0.5	4.0	1.1	0.2	1.3	1.9	0.6	1.1	1.2	1.3	0.4	0.6	7.7	0.4	0.6	0.7	2.0	0.9	0.2	1.0	1.4	0.5	0.9	0.7	0.5	0.0	0.0	0.0
HIST1H4L	"H4.k, H4/k, H4FK"	ENSG00000275126	"Histone cluster 1 H4 family member l"	P62805	6	27873199-27873510	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 133.0"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 10.0;NB-4: 5.4;REH: 2.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.2"					"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.7"	"Low lineage specificity"	"Detected in many"											HPA042201	Approved					30000000	30000000			"HPA042201: AB_2677898"										"unprognostic (1.15e-1)"				"unprognostic (6.05e-4)"				0.4	0.3	0.0	23.6	0.0	4.6	2.8	0.0	0.3	0.4	3.0	0.0	0.5	0.3	0.3	0.3	3.4	0.3	1.2	0.5	0.0		0.3	0.3	1.2	4.2	0.0	0.0	0.3	8.4	0.3	0.0	2.5	0.0	0.3	1.0	0.0	0.5	0.3	0.3	0.3	2.2	0.3	0.0	11.5	0.8	4.0	0.0	133.0	0.3	7.6	16.4	0.3	0.0	7.7	3.8	0.0	1.8	1.7	1.9	0.6	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.0	5.4	0.0	0.0	2.6	0.7	0.0	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	1.0	0.0	1.3	0.8	0.3	1.8	1.1	1.9	2.6	7.7	0.5	1.4	0.0	1.7	1.8	3.8	1.3	0.6										
LYPD8		ENSG00000259823	"LY6/PLAUR domain containing 8"	Q6UX82	1	248718649-248755739	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 60.0;lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.1;THP-1: 2.5"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 15.2"					"Group enriched"	"Detected in some"	6	"classical monocyte: 1.0;intermediate monocyte: 1.1;MAIT T-cell: 1.7;neutrophil: 2.3;plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"								"Secreted to digestive system"						"unprognostic (6.69e-3)"		"unprognostic (3.53e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-4)"	"unprognostic (8.62e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.89e-1)"		"unprognostic (1.07e-1)"	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.1	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	36.8	0.0	0.0	0.0	0.0	0.0	8.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.1	2.3	1.1	0.0	1.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.1	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	3.1	0.0	0.2										
SPIC	"MGC40611, SPI-C"	ENSG00000166211	"Spi-C transcription factor"	Q8N5J4	12	101475421-101486997	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 74.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.1;non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.1"	"Not detected"	"Not detected"																		"unprognostic (9.82e-2)"	"unprognostic (2.43e-2)"					"unprognostic (9.03e-3)"	"unprognostic (2.51e-1)"		"unprognostic (4.85e-2)"			"unprognostic (5.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.77e-1)"			0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.1	4.7	0.1	16.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.3	0.0	0.1	74.6	0.1	0.1	0.0	3.1	0.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	4.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564604	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 43.0;REH: 11.6;RPMI-8226: 14.2;U-698: 21.0;U-87 MG: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 47.8;naive B-cell: 33.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005093, HPA069571"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.2	0.1	32.3	0.1	1.7	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.0	1.9	0.2	0.4	0.3	0.1	0.1	1.3	0.5	0.6	27.6	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.3	2.4	0.0	0.1	0.1	23.5	0.0	0.1	31.9	1.4	0.2	0.0	3.9	0.7	0.4	39.8	2.5	0.4	47.8	4.3	0.1	0.0	0.0	9.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.6	0.0	14.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	3.7	21.0	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.8	47.8	0.3	1.1	0.0	33.9	0.2	0.1	0.1	0.0	0.0	4.3	0.4	1.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
HIST2H3A	"H3/n, H3/o"	ENSG00000203852	"Histone cluster 2 H3 family member a"	Q71DI3	1	149852619-149854274	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 126.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5;SiHa: 8.3;U-266/70: 7.3;U-266/84: 7.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"											HPA042570	Approved									"HPA042570: AB_2678056"					"unprognostic (1.15e-1)"					"unprognostic (1.30e-1)"				"unprognostic (3.99e-2)"				1.3	0.9	1.3	22.4	2.0	4.6	2.1	5.0	3.6	0.5	4.4	0.0	0.0	1.2	0.5	1.5	6.6	0.9	1.3	1.9	1.3	0.6	0.4	1.0	1.6	5.9	0.7	0.0	0.3	2.4	0.2	0.7	4.5	0.0	2.4	0.3	0.0	1.3	0.3	0.6	0.9	2.9	0.2	1.1	6.1	1.5	2.1	0.0	126.9	0.4	8.5	12.6	0.7	0.7	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.2	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	2.6	0.0	0.1	0.2	0.8	5.5	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.1	2.5	3.1	0.1	2.2	1.5	2.0	1.7	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.3	2.3	0.4	1.4	1.8	0.0	0.6	4.7	0.3	0.4	7.3	7.2	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2	1.3	2.0	5.0	1.1	1.3	0.6	0.7	0.0	0.0	0.0
IL36A	"FIL1, FIL1E, IL-1F6, IL1(EPSILON), IL1F6, MGC129552, MGC129553"	ENSG00000136694	"Interleukin 36 alpha"	Q9UHA7	2	113005461-113008044	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"esophagus: 106.0;lymphoid tissue: 87.9;tongue: 90.7"	"Group enriched"	"Detected in some"	5	"MOLT-4: 4.1;REH: 1.6;U-266/70: 4.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 8.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"	"Not detected"	"Not detected"												"Secreted to blood"							"unprognostic (1.37e-1)"				"unprognostic (9.66e-3)"		"unprognostic (5.46e-1)"										0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	106.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	87.9	0.0	4.8	0.0	0.0	0.0	0.0	0.1	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	4.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.3	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAX1		ENSG00000125813	"Paired box 1"	P15863	20	21705659-21718486	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"lymphoid tissue: 70.7;parathyroid gland: 56.0"	"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 5.6"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (9.74e-2)"				"unprognostic (3.45e-2)"	"unprognostic (3.01e-1)"		"unprognostic (2.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.12e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.08e-2)"		0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	56.0	4.2	0.9	70.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"blood: 82.2;lymphoid tissue: 262.3"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8"	"Lineage enriched"	"Detected in many"	20	"T-cells: 82.2"					"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	500000	500000	"Plasma membrane"	"Plasma membrane"	"CAB000012: AB_2075537, CAB075722: , HPA037756: AB_2675648"	"unprognostic (1.29e-3)"	"prognostic favourable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favourable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"	2.4	1.4	1.4	7.4	2.8	6.8	1.5	1.4	1.2	2.1	5.3	0.8	0.8	4.2	1.5	2.1	2.0	2.1	4.5	1.6	1.2	1.6	1.3	2.1	6.0	23.8	1.0	0.5	1.7	1.2	0.0	0.9	0.6	0.7	2.3	1.9	1.8	3.0	1.1	0.8	0.7	12.2	0.7	1.7	46.4	5.4	1.0	0.5	262.3	2.2	1.6	8.1	3.8	1.9	0.0	0.1	0.6	0.1	4.0	82.2	17.4	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.8	17.4	1.1	0.6	0.3	0.1	0.9	3.9	0.0	0.4	0.9	2.4	0.2	0.1	0.0	0.4	0.5	0.0	0.0	0.6	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.1	0.1	0.1	0.0	4.8	0.0	36.7	0.0	0.3	82.2	0.0	0.0	0.3	77.8	0.6	4.0	0.1	0.1	0.1	17.4	1.4	2.8	1.4	1.2	1.2	1.6	1.0	0.5	0.7	0.5
HIST1H2AB	"H2A/m, H2AFM"	ENSG00000278463	"Histone cluster 1 H2A family member b"	P04908	6	26033176-26033568	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 133.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.1"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.7	0.3	0.2	7.6	0.0	9.6	2.6	0.2	0.6	0.5	1.7	0.0	0.0	0.3	0.5	0.3	5.0	0.3	0.7	2.6	0.0		0.6	0.3	1.7	5.9	0.0	0.0	0.3	0.3	0.3	0.0	2.6	0.0	0.5	0.3	0.2	0.3	0.3	0.3	0.3	2.2	0.3	0.1	8.2	0.7	8.3	0.0	133.2	0.3	1.5	12.2	0.3	0.0	4.2	1.8	3.4	1.5	1.4	2.4	0.3	0.2	1.0	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.3	1.8	0.9	0.0	0.6	0.5	0.0	0.6	0.9	2.2	1.0	0.5	9.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.4	1.0	0.0	1.4	2.0	1.9	3.6	3.4	1.1	0.7	1.5	0.0	3.0	0.4	0.1	2.1	0.0	0.1	0.6	1.0	0.0	0.3	3.9	0.3	0.2	1.4	2.4	0.0	0.6	3.7	0.3	0.0	0.1	3.4	0.8	1.5	0.0	4.2	1.5	2.4	1.8	3.1	0.6	0.8	0.7	1.4	0.1	0.2	0.6	0.3										
HIST1H2AD	"H2A.3, H2A/g, H2AFG"	ENSG00000196866	"Histone cluster 1 H2A family member d"	P20671	6	26198851-26199243	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	14	"lymphoid tissue: 225.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 20.7;U-266/84: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.0"	"Low lineage specificity"	"Detected in all"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	2.6	1.8	0.9	13.8	1.1	14.7	6.3	0.8	1.3	8.0	4.6	0.0	3.2	1.5	2.0	3.1	9.2	1.3	2.8	5.5	1.2	1.3	2.3	3.6	4.8	15.9	1.1	0.5	3.4	1.9	1.1	1.5	4.6	1.0	6.8	2.2	1.5	2.5	4.3	1.2	3.2	4.3	2.3	3.6	10.8	1.8	5.7	0.6	225.6	1.4	5.1	14.3	5.3	8.6	7.0	5.7	16.0	1.8	1.1	3.8	0.8	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.3	1.9	0.0	2.4	0.3	0.0	1.6	0.3	0.4	0.0	0.3	0.2	0.1	1.3	0.2	1.5	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.4	1.6	0.0	0.1	2.9	1.3	1.6	0.3	1.5	0.5	1.5	0.3	0.1	1.5	0.3	0.7	1.4	0.1	0.5	0.5	0.0	1.5	4.0	0.0	1.1	20.7	6.7	2.5	0.8	1.8	0.7	2.2	0.2	3.2	1.1	1.8	1.1	2.0	1.5	3.8	1.0	7.0	1.4	1.1	16.0	1.1	1.3	5.7	2.0	0.8	0.9	1.1	0.8	1.3	1.2	1.3	1.1	0.5	1.0	0.6
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 242.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 19.5;RPMI-8226: 10.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4"	"Group enriched"	"Detected in many"	39	"B-cells: 5.4;T-cells: 2.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favourable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.9	0.5	0.9	0.9	0.9	0.0	3.6	0.9	0.9	2.0	3.3	0.9	0.9	2.3	0.9	9.3	3.6	3.3	2.1	0.9	0.9	0.0	1.4	0.9	2.4	0.9	0.9	0.9	1.2	17.1	6.4	1.8	2.1	0.9	1.8	4.1	0.9	4.3	2.5	0.9	2.9	2.8	0.9	0.9	0.9	3.9	0.9	0.9	242.8	8.7	0.9	0.9	2.0	1.1	5.4	0.0	0.0	0.0	0.0	2.3	0.4	2.9	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	3.4	4.5	0.0	0.7	0.0	1.5	2.5	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.9	0.5	0.0	19.5	0.0	4.0	0.0	2.2	1.8	0.0	1.1	0.4	0.0	0.6	0.5	0.0	0.0	10.5	2.3	3.4	0.0	0.0	1.3	3.0	0.0	1.9	0.8	0.0	0.0	0.7	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	2.0	5.4	2.3	1.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
Z82206.1		ENSG00000225528			22	39960397-39964718	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	14	"blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.0;K-562: 15.9;MOLT-4: 2.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047397			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"				Nucleoli	Nucleoli	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.0	0.0		0.5		4.1	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.3	2.3			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1		1.0	0.1	0.0			0.0		1.1	0.3		3.6	3.0	5.7	2.2	2.2	8.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.8	4.4	5.2	2.2	4.5	3.6	6.5	5.7	2.7	3.2	6.7	8.1	4.3	2.2	1.9	3.0	4.2	7.6										
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609533-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"blood: 75.5;lymphoid tissue: 59.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;Karpas-707: 8.0;REH: 5.2;U-698: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 34.3;naive B-cell: 75.5"	"Lineage enriched"	"Detected in many"	22	"B-cells: 75.5"	"Region enriched"	"Detected in single"	7	"basal ganglia: 3.6"	"Low region specificity"	"Detected in all"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	1.9	1.2	0.8	16.6	1.1	2.6	1.3	0.6	0.6	0.7	0.9	0.2	0.5	0.3	0.8	2.1	0.8	0.7	1.6	0.6	0.8	0.7	1.5	2.3	2.2	26.8	0.8	0.1	0.5	1.4	0.5	1.6	1.5	1.1	0.9	0.3	1.1	3.4	0.1	0.5	0.8	5.2	0.6	1.8	59.7	0.8	0.8	0.2	1.5	1.4	0.3	22.2	4.9	0.6	75.5	3.4	0.2	0.6	1.7	0.7	2.5	0.1	0.0	0.4	0.2	0.7	3.8	0.1	0.2	0.1	0.3	0.5	0.0	0.1	12.4	0.0	0.2	0.0	0.0	0.1	0.4	1.2	0.3	0.4	0.0	0.0	0.4	0.2	2.8	1.1	0.0	0.2	0.3	0.0	0.0	8.0	0.7	0.0	0.2	1.6	0.1	0.1	5.2	0.0	3.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.1	0.2	27.7	0.5	0.4	0.0	0.0	0.3	0.0	0.5	0.6	0.7	34.3	0.2	0.3	3.4	75.5	0.1	0.4	0.2	1.7	0.0	1.8	0.3	2.5	0.8	1.1	0.6	0.6	0.8	0.7	0.8	0.1	1.1	0.2
HIST1H2AH	"dJ86C11.1, H2A/S, H2AFALii"	ENSG00000274997	"Histone cluster 1 H2A family member h"	Q96KK5	6	27147129-27147515	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 301.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 8.9;MOLT-4: 9.2;NB-4: 10.0"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"naive B-cell: 16.2"	"Low lineage specificity"	"Detected in many"											"CAB004030, HPA041189"	Supported									"CAB004030: AB_2118804, HPA041189: AB_2677357"	"unprognostic (4.07e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.35e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.74e-3)"	"unprognostic (1.87e-1)"		"unprognostic (1.26e-4)"	0.8	0.7	0.0	26.0	0.0	20.2	1.5	0.0	0.4	3.1	6.6	0.0	0.6	1.0	1.8	2.6	6.4	1.0	2.7	1.3	0.0		0.5	0.4	4.1	5.4	0.0	0.0	2.4	0.5	0.4	0.0	9.0	0.0	0.6	0.9	0.1	1.7	0.6	0.4	0.6	6.5	0.9	0.0	13.9	0.7	23.5	0.0	301.1	0.6	9.0	27.3	1.9	0.0	16.2	2.2	0.0	2.4	5.1	4.7	2.3	2.5	3.4	1.1	4.8	0.0	0.0	0.7	0.3	0.6	0.6	0.0	2.6	1.0	3.7	0.9	0.0	0.3	1.0	0.0	0.0	2.1	8.9	4.6	3.0	0.0	0.0	3.2	1.7	0.0	0.0	1.1	0.0	0.8	4.7	2.4	0.9	0.4	9.2	10.0	3.1	1.2	3.4	3.0	4.9	0.0	0.3	2.4	0.6	1.4	0.5	0.2	0.9	1.5	0.0	0.8	2.7	0.2	2.7	2.9	2.9	6.0	1.3	4.5	0.8	0.0	0.9	0.0	2.6	2.4	1.2	3.8	4.7	4.2	2.2	16.2	2.4	1.6	0.0	5.1	1.5	1.5	0.8	2.3										
HIST1H2BN	"H2B/d, H2BFD"	ENSG00000233822	"Histone cluster 1 H2B family member n"	Q99877	6	27837760-27865798	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	13	"lymphoid tissue: 193.3"	"Cell line enhanced"	"Detected in many"		"K-562: 8.7;SCLC-21H: 9.6;U-266/84: 9.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	2.4	7.2	2.3	14.0	3.3	9.3	3.1	4.9	6.2	3.4	4.5	1.0	4.4	1.8	3.4	3.7	7.6	3.2	3.7	6.4	3.7	2.4	2.3	5.3	5.4	8.0	4.1	4.2	5.0	8.3	4.2	3.8	4.5	1.4	4.0	2.5	1.7	3.3	4.7	4.6	2.3	4.3	2.5	9.4	7.0	2.4	6.8	0.5	193.3	6.1	6.2	10.9	3.6	2.2	6.0	6.2	14.6	2.6	1.0	2.8	1.4	1.4	0.2	1.5	1.5	1.2	1.9	0.9	0.7	1.1	0.7	0.8	0.5	0.8	0.7	3.0	0.7	2.1	1.3	0.4	0.3	1.5	4.4	0.7	3.6	1.3	1.4	0.9	3.6	1.2	0.3	0.1	1.3	0.2	8.7	6.8	0.8	1.8	2.9	4.4	1.3	1.0	2.0	0.9	5.1	0.4	0.9	9.6	1.9	3.5	1.3	2.9	2.4	0.8	1.5	2.1	2.1	1.1	0.6	6.0	9.0	3.5	0.7	1.7	0.7	2.3	2.6	1.7	2.6	2.4	1.8	5.8	2.0	1.9	5.0	6.0	1.3	1.2	14.6	1.0	1.8	6.2	2.8	1.4	2.3	3.3	4.9	6.2	3.7	2.4	4.1	4.2	1.4	0.5
HIST1H3B	"H3/l, H3FL"	ENSG00000274267	"Histone cluster 1 H3 family member b"	P68431	6	26031650-26032060	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 343.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 11.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (2.82e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-7)"	"unprognostic (8.52e-2)"	"unprognostic (2.78e-1)"		"unprognostic (1.90e-3)"	1.7	0.7	0.0	36.1	0.0	18.1	3.6	0.0	0.3	0.8	6.9	0.0	0.0	0.3	0.8	2.5	11.8	0.5	1.9	2.4	0.0		0.6	0.3	3.4	10.4	0.0	0.0	0.3	0.3	0.3	0.0	7.8	0.0	0.3	0.8	0.0	1.0	0.3	0.3	0.3	6.3	0.8	0.0	14.7	0.5	26.9	0.0	343.5	0.8	18.2	27.7	0.3	0.0	0.8	0.1	1.2	0.0	0.0	1.4	3.1	1.8	4.6	1.3	4.0	0.0	0.4	0.0	0.2	0.8	0.7	0.7	1.1	1.0	3.0	2.0	0.3	0.7	1.6	1.2	1.7	2.0	4.4	3.2	5.9	1.3	0.0	2.4	2.1	2.9	0.0	0.6	0.0	1.0	6.5	5.9	1.1	0.9	7.3	7.4	3.1	3.2	4.3	2.9	8.4	0.5	0.0	2.0	1.7	5.1	1.6	0.5	2.8	1.5	1.4	1.3	4.1	0.7	1.7	9.5	11.9	3.9	3.4	4.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.1	0.5	0.0	0.2	1.2	0.0	0.0	0.0	1.4	3.1										
LILRA4	"CD85g, ILT7"	ENSG00000239961	"Leukocyte immunoglobulin like receptor A4"	P59901	19	54333185-54339150	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"blood: 49.7;brain: 12.5;lymphoid tissue: 16.8"	"Cell line enriched"	"Detected in single"	30	"RPMI-8226: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	21	"plasmacytoid DC: 49.7"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 49.7"									HPA049418	Approved									"HPA049418: AB_2680756"	"unprognostic (5.11e-2)"	"unprognostic (1.21e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.28e-7)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.86e-2)"	0.7	0.4	2.1	2.3	2.5	0.6	0.7	1.1	4.3	0.4	0.9	12.5	0.0	0.7	0.4	0.4	0.6	0.4	0.8	0.4	3.5	1.4	0.4	0.7	1.4	5.3	12.2	1.2	0.4	0.4	0.4	0.3	0.4	7.6	0.5	0.5	0.0	0.7	0.5	0.4	0.6	2.0	0.6	7.4	16.8	0.5	0.5	6.7	2.3	0.4	0.0	10.1	0.7	0.2	2.4	49.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	49.7	0.0	0.1	2.1	2.5	1.1	4.3	3.5	1.4	12.2	1.2	7.6	6.7
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.0;HBEC3-KT: 8.0;HDLM-2: 30.0;PC-3: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016239, HPA038462"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB016239: AB_2159984, HPA038462: AB_10672594"	"unprognostic (3.09e-1)"	"prognostic favourable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.1	3.7	0.4	0.0	0.0	0.0	0.2	0.1	58.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.0	0.1	0.1	34.6	1.4	0.0	0.1	2.7	0.0	0.1	86.1	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.2	0.2	0.0	11.8	0.5	27.1	33.2	0.4	3.4	0.1	0.0	0.0	0.0	0.0	2.7	0.1	3.4	0.9	0.0	1.7	1.4	2.3	1.2	0.0	0.1	0.0	0.0	0.7	1.1	0.7	0.4	0.0	8.0	1.2	8.0	0.0	30.0	5.3	0.5	0.5	0.0	0.0	0.0	2.7	0.5	3.7	0.0	1.2	0.0	2.0	0.8	0.1	4.5	0.5	0.0	0.1	12.9	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.8	4.0	0.9	3.4	0.0	0.0	0.0	0.5	1.3	0.6	0.0	0.0	3.0	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PHGR1		ENSG00000233041	"Proline, histidine and glycine rich 1"	C9JFL3	15	40351033-40356434	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 308.0;lymphoid tissue: 83.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.3;HaCaT: 10.3;NB-4: 6.1;RPMI-8226: 5.7;SCLC-21H: 35.7"	"Group enriched"	"Detected in many"	16	"colorectal cancer: 248.3;stomach cancer: 94.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA068787	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA068787: AB_2686035"	"prognostic favourable (2.05e-4)"		"unprognostic (1.73e-1)"				"unprognostic (5.18e-2)"				"unprognostic (1.18e-1)"	"unprognostic (2.80e-1)"		"unprognostic (1.20e-1)"			"unprognostic (1.27e-2)"	0.3	0.1	0.3	83.6	0.3	0.0	0.6	0.3	0.3	0.3	245.3	0.3	0.3	77.9	0.3	0.3	0.4	0.5	4.1	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.4	32.9	0.3	0.4	0.3	0.3	0.3	308.0	1.3	0.3	0.3	15.1	0.3	0.3	0.3	0.3	0.3	0.3	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	5.7	0.0	0.8	35.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3
PSMB11	beta5t	ENSG00000222028	"Proteasome subunit beta 11"	A5LHX3	14	23042167-23044276	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 32.7"	"Cell line enriched"	"Detected in single"	4	"PC-3: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Region enriched"	"Detected in single"	7	"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA028967, HPA056970"	Enhanced									"HPA028967: AB_2732444, HPA056970: AB_2683293"				"unprognostic (7.96e-2)"	"unprognostic (2.77e-1)"													0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	32.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 188.8"	"Cell line enriched"	"Detected in single"	1104	"MOLT-4: 110.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"myeloid DC: 16.3"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 16.3"									HPA021824	Approved									"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.8	0.1	0.2	1.9	0.2	0.0	0.6	0.2	0.2	0.8	0.6	0.3	0.2	0.0	0.3	0.2	0.9	0.7	1.3	0.2	0.2	0.0	0.6	0.3	1.7	4.0	0.2	0.2	0.3	0.3	0.0	0.2	0.2	0.2	0.2	5.6	0.2	0.6	0.2	0.2	6.2	0.8	0.3	0.2	1.9	0.9	0.2	0.2	188.8	0.4	0.4	2.4	0.5	0.8	0.0	16.3	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
HIST1H3H	"H3/k, H3F1K, H3FK"	ENSG00000278828	"Histone cluster 1 H3 family member h"	P68431	6	27810064-27811300	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 55.3;lymphoid tissue: 204.8"	"Cell line enhanced"	"Detected in many"		"K-562: 17.5;SiHa: 15.2;U-266/70: 13.0;U-266/84: 31.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	6	"basophil: 15.9;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.9"									HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (1.61e-1)"	"prognostic favourable (4.35e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavourable (9.25e-6)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (5.73e-5)"	"unprognostic (4.09e-1)"	"unprognostic (4.94e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.82e-2)"	1.2	2.6	0.0	25.2	0.0	7.5	1.7	0.2	0.3	1.7	4.7	0.0	2.5	2.3	1.6	2.5	9.0	0.6	3.0	1.3	0.0		0.4	3.1	4.4	8.1	0.0	0.0	2.2	1.5	1.4	0.0	3.4	0.1	2.7	5.3	0.5	0.9	2.8	0.8	0.3	3.9	1.0	0.2	11.0	3.1	3.4	0.0	204.8	1.3	10.6	22.6	1.7	0.9	1.1	1.8	15.9	1.1	0.3	2.0	55.3	1.0	3.8	1.6	1.3	2.3	0.3	0.2	0.5	0.3	1.9	0.7	1.1	1.1	0.7	3.6	0.4	2.1	0.6	0.9	1.2	4.8	2.4	0.9	3.5	4.9	0.6	0.8	1.5	3.2	0.3	0.4	0.4	0.7	17.5	8.4	0.3	7.6	1.5	1.8	0.8	1.5	0.8	0.0	8.7	1.9	0.4	5.1	1.0	15.2	3.1	0.6	7.3	0.2	0.8	0.8	2.5	0.4	0.2	13.0	31.5	2.6	0.0	4.1	0.1	15.9	1.1	2.1	0.3	0.3	0.4	0.3	0.6	0.5	0.8	1.1	0.4	0.3	10.3	0.3	0.3	1.8	2.0	55.3										
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium voltage-gated channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"lymphoid tissue: 3.5;skin 1: 8.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enhanced"	"Detected in many"		"cerebellum: 75.1"	HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	8.1	0.0	0.0		0.0	0.0	0.3			0.0		3.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TCL1A	TCL1	ENSG00000100721	"T cell leukemia/lymphoma 1A"	P56279	14	95709967-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"blood: 179.4;lymphoid tissue: 63.7"	"Group enriched"	"Detected in some"	157	"Daudi: 69.4;REH: 90.3;U-698: 92.2"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	381	"memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8"	"Group enriched"	"Detected in many"	487	"B-cells: 179.4;dendritic cells: 79.8"					"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	0.4	0.2	0.2	53.4	0.2	4.8	0.3	0.2	0.2	0.2	0.9	0.0	0.2	0.0	0.3	0.0	0.8	0.3	0.6	0.3	0.2	0.2	1.1	0.4	3.2	63.7	0.2	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.4	0.2	0.1	2.9	0.0	0.2	0.2	10.4	0.1	0.2	33.5	0.5	5.3	0.0	4.7	0.8	1.2	53.6	3.6	0.3	179.4	79.8	0.2	0.1	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.5	92.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	45.6	0.0	0.0	0.1	179.4	0.1	0.0	0.2	0.0	0.1	79.8	0.0	6.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6"	"Cell line enriched"	"Detected in some"	14	"SiHa: 49.4"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"																							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	49.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"blood: 252.3;lymphoid tissue: 110.6"	"Cell line enriched"	"Detected in some"	79	"HDLM-2: 171.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 252.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 252.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003796, HPA031383, HPA074467"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: "	"prognostic favourable (3.84e-4)"	"prognostic favourable (8.03e-6)"	"unprognostic (2.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.35e-3)"	"prognostic favourable (7.61e-7)"	"unprognostic (2.71e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.68e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-2)"	2.8	0.4	0.2	26.0	0.2	5.2	1.7	0.2	0.3	2.2	1.2	0.3	0.8	0.3	1.2	0.5	1.4	2.3	2.0	1.9	0.2	0.2	1.5	1.7	3.4	110.6	0.3	0.2	1.5	0.3	0.0	1.0	1.0	0.4	1.3	2.1	0.7	8.4	0.2	0.2	1.1	16.2	0.2	0.4	20.3	1.8	1.2	0.3	57.1	2.0	1.2	53.8	4.2	1.3	58.8	2.9	2.3	0.3	44.1	252.3	109.3	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	171.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.9	0.1	1.1	0.2	0.0	0.0	1.1	0.3	0.2	3.1	0.1	3.6	37.2	53.3	15.3	0.2	58.8	252.3	133.9	2.3	44.1	0.2	2.9	30.3	109.3	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.3
FBXO43	Fbx43	ENSG00000156509	"F-box protein 43"	Q4G163	8	100133360-100145800	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"lymphoid tissue: 17.1;testis: 12.4"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 4.7;Karpas-707: 5.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024292, HPA024295, HPA024824"	Uncertain									"HPA024292: AB_1848462, HPA024295: AB_1848463, HPA024824: AB_1848464"	"unprognostic (4.94e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.07e-5)"	"unprognostic (4.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.09e-2)"	0.1	0.1	0.3	4.9	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.6	0.3	0.2	0.0	0.7	0.3	0.2	0.1	0.2	0.4	0.7	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.7	0.2	0.0	0.3	0.2	0.3	0.8	0.5	0.2	12.4	0.1	17.1	0.1	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	1.1	3.8	0.0	0.4	0.0	0.0	1.8	3.3	4.2	0.0	0.3	1.8	0.1	0.5	0.0	0.0	0.0	4.7	3.9	0.0	1.0	0.5	0.4	0.0	0.5	0.7	0.0	0.2	1.7	1.5	0.9	0.0	5.3	1.6	0.0	0.6	4.4	0.2	0.7	3.6	0.0	0.7	1.7	0.0	0.5	0.0	0.0	0.0	1.7	0.1	0.9	0.0	0.0	0.0	0.7	0.0	0.7	1.0	1.4	1.3	3.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.1
HIST1H2AM	"H2A.1, H2A/n, H2AFN"	ENSG00000278677	"Histone cluster 1 H2A family member m"	P0C0S8	6	27892757-27893149	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 315.3"	"Cell line enhanced"	"Detected in many"		"U-266/84: 24.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (6.05e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.24e-1)"	"unprognostic (8.85e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.30e-1)"	1.2	1.5	0.0	30.7	0.0	9.3	2.3	0.2	0.2	2.1	6.1	0.1	2.3	1.4	1.3	2.6	10.7	0.3	3.9	2.2	0.0		0.6	1.7	4.7	12.7	0.0	0.0	0.4	1.2	0.0	0.0	10.4	0.3	0.9	1.8	0.0	1.3	2.2	0.7	1.0	6.5	0.0	1.1	15.3	1.7	4.8	0.0	315.3	1.3	11.4	28.9	2.5	0.0	10.3	14.7	28.7	6.2	4.8	8.5	7.0	3.1	2.7	2.1	5.0	0.3	0.3	4.4	0.9	0.7	2.6	3.4	1.0	1.3	5.3	3.6	0.7	2.2	1.6	1.7	1.6	3.4	1.3	2.7	3.4	3.5	0.0	1.6	2.2	1.3	0.0	1.8	0.0	2.5	11.4	7.3	0.4	5.2	10.7	7.7	3.7	1.2	6.6	3.5	9.4	1.3	0.7	8.0	1.4	5.5	0.6	0.6	4.8	1.6	0.0	1.1	0.1	1.2	1.6	7.9	24.7	12.3	1.5	9.3	0.9	28.7	3.4	12.5	6.8	3.8	4.1	8.9	5.9	5.7	11.4	10.3	2.5	2.8	11.5	4.8	6.2	14.7	8.5	7.0										
NXPE1	"FAM55A, MGC34290"	ENSG00000095110	"Neurexophilin and PC-esterase domain family member 1"	Q8N323	11	114521645-114559895	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 44.0;lymphoid tissue: 20.4"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.0"	"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049133	Enhanced				"Intracellular and membrane"					"HPA049133: AB_2680647"	"unprognostic (2.81e-1)"		"unprognostic (2.19e-3)"		"unprognostic (3.40e-3)"			"unprognostic (4.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.76e-1)"				0.1	0.0	0.1	20.4	0.1	0.0	0.1	0.1	0.1	0.1	44.0	0.1	0.1	0.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	36.9	0.1	0.3	0.1	0.1	0.0	4.4	1.0	0.1	0.1	0.0	2.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
PITPNM2	"NIR3, RDGB2, RDGBA2"	ENSG00000090975	"Phosphatidylinositol transfer protein membrane associated 2"	Q9BZ72	12	122983480-123150015	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"lymphoid tissue: 169.5"	"Cell line enhanced"	"Detected in many"		"HEL: 16.5;MOLT-4: 30.5;WM-115: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 4.7;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003414, HPA003978"	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA003414: AB_1855410, HPA003978: AB_1855411"	"unprognostic (2.43e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.99e-2)"	3.4	5.9	3.3	3.2	7.9	3.5	3.1	9.3	8.0	3.9	3.5	2.4	3.2	3.5	3.6	5.2	3.7	2.5	2.2	4.6	2.8	2.2	3.7	4.3	5.1	6.1	2.4	2.6	14.0	2.5	5.3	4.2	3.0	2.3	2.7	1.6	3.7	2.7	3.1	3.3	3.0	3.6	4.5	2.5	3.3	2.7	14.8	2.2	169.5	2.3	2.2	4.3	4.7	2.7	0.8	0.0	0.1	0.1	4.7	2.3	1.6	2.5	5.0	1.6	2.3	1.2	2.2	9.8	0.4	0.6	1.3	0.7	2.2	2.1	0.0	2.2	0.8	7.3	1.3	1.2	0.5	0.1	1.6	16.5	2.9	5.9	0.8	0.6	3.5	1.1	2.2	1.7	1.4	2.6	3.7	0.2	1.6	1.6	30.5	3.4	1.9	2.2	8.8	0.1	6.3	2.4	2.7	1.5	0.5	3.6	3.0	2.4	0.6	1.8	7.6	1.9	2.2	3.1	2.8	0.5	0.5	11.7	4.8	1.2	14.7	0.0	0.0	0.1	2.3	0.0	0.2	0.4	0.6	1.7	0.0	0.8	1.5	1.4	0.0	4.7	0.1	0.0	1.1	1.6	3.3	7.9	9.3	8.0	2.8	2.2	2.4	2.6	2.3	2.2
SEPT1	"DIFF6, PNUTL3"	ENSG00000180096	"Septin 1"		16	30378133-30395991	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	11	"blood: 54.4;lymphoid tissue: 89.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.3;Karpas-707: 8.2;MOLT-4: 31.1;REH: 18.5;U-266/70: 10.7;U-266/84: 15.6;U-698: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041566, HPA060339"	Enhanced		Uncertain	"Actin filaments"				"Actin filaments"	"Actin filaments"	"HPA041566: AB_10794671, HPA060339: "	"unprognostic (3.65e-3)"	"prognostic favourable (9.72e-5)"	"unprognostic (5.06e-2)"	"prognostic favourable (3.04e-5)"	"unprognostic (3.32e-4)"	"prognostic favourable (6.63e-4)"	"unprognostic (2.08e-1)"	"prognostic favourable (7.24e-5)"	"unprognostic (1.24e-2)"	"unprognostic (6.52e-3)"	"prognostic favourable (2.22e-4)"	"unprognostic (3.46e-2)"	"prognostic unfavourable (2.40e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.72e-2)"	1.1	0.8	0.8	20.1	1.6	0.3	0.7	1.1	0.6	1.5	2.8	0.2	0.1	3.9	1.2	0.8	2.0	1.4	1.4	0.8	0.7	0.6	1.2	0.9	3.7	16.0	0.9	0.1	1.5	1.0	0.2	0.5	0.4	0.3	0.8	0.0	0.9	6.6	0.6	0.4	0.9	6.2	0.4	0.7	16.7	3.6	0.4	0.2	89.8	0.9	1.7	32.9	0.9	0.9	28.2	43.5	16.1	0.4	34.4	54.4	38.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.4	0.0	0.0	0.1	0.0	2.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	0.0	0.0	31.1	0.6	0.0	0.3	18.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.7	15.6	10.8	0.2	3.4	0.0	16.1	0.4	15.3	54.4	0.3	41.9	28.2	49.5	49.3	1.5	27.6	46.6	46.9	1.4	34.4	0.2	43.5	50.7	38.1	0.8	1.6	1.1	0.6	0.7	0.6	0.9	0.1	0.3	0.2
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Cell line enriched"	"Detected in single"	7	"HEL: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"									HPA065044	Uncertain				"Secreted - unknown location"					"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0
ADGRE1	"EMR1, TM7LN3"	ENSG00000174837	"Adhesion G protein-coupled receptor E1"	Q14246	19	6887566-6940459	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 64.1;lymphoid tissue: 50.0"	"Cell line enhanced"	"Detected in some"		"A549: 5.8;BJ hTERT+: 7.8;HDLM-2: 19.0;HMC-1: 13.6;Karpas-707: 16.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 64.1"	"Group enriched"	"Detected in many"	17	"granulocytes: 64.1;monocytes: 20.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA052809	Uncertain					9100	9100			"HPA052809: AB_2681959"	"unprognostic (2.06e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.93e-5)"	"unprognostic (6.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-7)"	"unprognostic (6.69e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.35e-1)"	1.8	0.5	0.7	7.2	2.4	5.9	0.5	0.3	1.7	0.5	0.6	0.3	0.0	2.8	0.4	0.9	0.4	0.6	0.7	1.3	1.5	0.7	0.7	4.1	4.6	6.6	1.7	0.0	0.3	0.4	0.0	1.0	1.8	0.9	0.5	0.5	0.5	0.5	0.0	0.4	0.3	2.8	1.7	1.9	50.0	0.7	1.2	1.0	6.9	0.5	0.0	1.7	2.8	0.4	0.0	2.4	64.1	20.2	0.1	2.0	1.9	2.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.4	13.6	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.5	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.2	0.3	0.1	0.8	3.0	0.1	3.9	3.6	0.0	27.2	4.3	64.1	0.0	12.0	0.0	0.0	1.5	0.2	2.4	0.0	2.0	0.1	1.6	0.1	20.2	0.1	0.4	1.9	0.7	2.4	0.3	1.7	1.5	0.7	1.7	0.0	0.9	1.0
AL031777.3		ENSG00000282988			6	26195595-26199293	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 184.8"	"Cell line enhanced"	"Detected in some"		"K-562: 7.8;SiHa: 7.4;U-2 OS: 5.6;U-266/70: 9.4;U-266/84: 6.1"									"Cell type enriched"	"Detected in many"	4	"neutrophil: 18.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.7"									HPA041189	Uncertain									"HPA041189: AB_2677357"																		1.3	1.3	0.1	10.9	0.2	13.1	4.8	0.3	0.7	3.9	3.4	0.0	2.2	0.7	1.0	2.2	7.1	1.2	1.9	4.2	0.0		1.0	1.1	3.5	12.7	0.0	0.1	2.4	1.2	0.7	0.0	3.4	0.4	2.9	0.9	0.9	1.1	3.2	0.7	0.7	3.2	1.5	2.6	8.5	1.7	4.3	0.1	184.8	0.9	3.9	11.4	4.0	0.0	2.7	1.1	18.7	1.0	0.6	1.1	0.7	0.8	0.5	0.2	0.7	0.2	0.1	0.0	0.7	0.1	1.4	0.4	0.6	0.9	0.8	2.4	0.0	1.2	0.3	0.0	0.0	2.6	0.3	0.7	2.4	1.5	0.0	0.2	0.8	1.1	0.0	0.8	0.5	0.2	7.8	1.6	0.0	1.1	2.8	1.7	0.2	2.3	0.7	0.2	4.3	0.0	0.0	0.9	0.2	7.4	0.0	0.5	4.7	0.0	0.8	0.8	5.6	0.0	0.2	9.4	6.1	0.9	0.5	2.2	0.3	4.3	0.0	1.2	0.3	0.3	0.4	0.9	0.6	0.6	0.4	2.7	0.5	0.8	18.7	0.6	1.0	1.1	1.1	0.7										
CCL19	"CKb11, ELC, exodus-3, MIP-3b, SCYA19"	ENSG00000172724	"C-C motif chemokine ligand 19"	Q99731	9	34689567-34691277	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 418.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;Daudi: 2.5;HDLM-2: 7.5;HL-60: 1.9;TIME: 3.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 118.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"intermediate monocyte: 2.3"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.3"					"Low region specificity"	"Detected in many"			HPA067758	Enhanced				"Secreted to blood"					"HPA067758: AB_2685897"	"prognostic favourable (2.88e-5)"	"prognostic favourable (9.91e-6)"	"unprognostic (8.25e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (8.63e-7)"	"unprognostic (7.98e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	22.5	0.6	1.2	82.3	1.1	0.0	10.2	0.8	1.3	5.8	4.7	1.5	1.5	1.0	1.5	5.9	16.3	3.4	10.4	16.5	0.8	0.7	11.8	12.8	13.6	418.9	2.1	1.0	3.4	1.7	0.0	2.0	0.6	1.5	7.0	11.0	7.4	23.1	1.0	0.7	8.7	40.2	4.5	2.2	8.2	9.0	2.8	0.6	73.1	14.9	9.9	90.9	13.4	2.3	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	7.5	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.7	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	1.1	0.8	1.3	0.8	0.7	2.1	1.0	1.5	0.6
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 308.0"	"Cell line enriched"	"Detected in single"	1338	"MOLT-4: 167.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"myeloid DC: 29.7"	"Lineage enriched"	"Detected in many"	13	"dendritic cells: 29.7"					"Low region specificity"	"Detected in all"			HPA057769	Uncertain				"Intracellular and membrane"					"HPA057769: AB_2683522"	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	1.0	0.2	0.7	2.8	0.7	0.0	1.1	0.7	0.7	1.5	1.0	0.7	0.7	1.2	0.9	0.7	7.0	1.9	3.9	0.7	0.7	0.2	2.0	0.7	2.4	4.7	0.7	0.7	0.7	0.8	0.0	0.7	0.7	0.7	1.8	4.8	0.8	1.9	0.8	0.8	11.5	2.1	0.8	0.7	3.8	3.1	0.9	0.7	308.0	1.0	1.3	8.1	2.4	2.7	0.0	29.7	0.0	2.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.1	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.7	0.7	0.7	0.7	0.2	0.7	0.7	0.7	0.7
CD8B2	CD8BP	ENSG00000254126	"CD8b2 molecule"		2	106487364-106544297	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"blood: 20.6;lymphoid tissue: 35.1"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 91.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	9	"memory CD8 T-cell: 12.0;naive CD8 T-cell: 20.6"	"Lineage enriched"	"Detected in many"	15	"T-cells: 20.6"																				"unprognostic (9.34e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.54e-2)"		"unprognostic (1.18e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.67e-3)"	0.1	0.0	0.1	1.1	0.4	0.2	0.0	0.6	0.6	1.9	0.3	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.2	0.0	0.7		2.8	0.4	0.4	5.3	0.0	0.0	0.2	0.0	2.8	0.8	0.1	0.7	1.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.9	1.6	0.0	0.0	35.1	0.0	0.3	9.0	0.3	0.0	0.0	0.0	1.3	0.0	0.2	20.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	9.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.0	1.7	0.0	0.0	12.0	0.0	0.0	0.0	20.6	0.1	0.2	0.0	0.0	0.0	5.8										
CYP2U1	SPG49	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931369-107953457	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 122.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favourable (2.75e-5)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.6	7.9	7.7	4.4	9.1	0.4	7.3	11.3	9.2	7.8	7.3	7.0	4.1	4.0	9.5	4.6	6.3	9.8	6.6	8.8	7.1	7.9	6.4	6.8	6.6	6.7	8.3	5.2	12.0	2.6	10.3	8.1	2.7	7.8	12.4	4.7	8.6	4.5	11.0	4.3	3.1	6.0	12.3	7.0	8.5	4.6	3.9	7.4	122.7	4.7	3.5	5.4	7.3	5.3	2.6	2.7	0.7	5.9	1.6	1.7	0.4	2.5	1.2	3.4	6.3	18.8	9.0	0.5	10.8	16.3	6.6	10.5	0.0	1.7	6.9	0.8	6.4	0.1	5.3	4.0	10.4	1.9	1.6	1.4	2.4	0.3	7.5	2.0	0.0	10.1	3.4	3.1	2.1	2.5	0.1	3.3	5.5	1.8	7.4	0.0	3.5	3.0	4.2	4.1	0.0	2.1	4.3	6.7	5.0	2.7	4.7	11.5	2.3	1.0	6.8	4.3	0.5	6.1	4.3	14.0	13.2	2.2	3.5	0.0	4.8	0.0	0.3	0.7	1.2	1.1	0.9	2.0	0.9	1.0	2.2	2.6	1.7	1.3	0.0	1.6	5.9	2.7	0.0	0.4	7.7	9.1	11.3	6.9	7.1	7.9	8.3	5.2	7.8	7.4
HIST1H3C	"H3.1, H3/c, H3FC"	ENSG00000278272	"Histone cluster 1 H3 family member c"	P68431	6	26045411-26045821	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 306.0"	"Cell line enhanced"	"Detected in many"		"U-937: 10.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.27e-2)"	1.7	0.2	0.0	23.3	0.0	12.8	1.8	0.0	0.7	1.0	5.1	0.0	0.0	1.2	0.5	1.5	10.1	0.4	1.6	1.8	0.0		2.8	0.6	3.0	10.9	0.0	0.0	0.2	0.4	0.2	0.0	6.6	0.0	0.6	1.1	0.0	1.0	0.2	0.2	0.7	5.4	0.2	0.0	18.8	1.0	29.9	0.0	306.0	0.2	9.9	25.2	2.3	0.0	2.2	1.0	0.3	0.2	3.3	3.7	1.9	2.6	0.6	1.3	0.0	0.6	0.0	0.0	2.0	0.9	5.0	5.1	0.0	0.4	0.0	0.1	0.5	1.2	0.0	0.5	3.5	3.6	0.4	4.1	0.5	3.6	0.4	2.6	1.7	0.0	0.4	1.4	0.0	1.6	0.0	0.0	0.0	0.0	4.0	5.1	2.3	5.0	4.6	0.0	0.0	0.6	5.5	0.1	1.6	5.0	3.2	0.5	1.3	1.5	0.0	0.0	0.0	2.1	3.4	2.3	0.1	0.0	1.5	10.9	3.5	0.0	0.2	0.0	1.5	0.1	0.0	1.5	0.6	1.1	1.0	2.2	0.6	2.2	0.3	3.3	0.0	0.9	3.7	1.9										
KRT9	"CK-9, EPPK, K9"	ENSG00000171403	"Keratin 9"	P35527	17	41565841-41572058	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"lymphoid tissue: 25.7;skin 1: 7.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.6;HaCaT: 18.0;U-2197: 3.2;U-937: 5.6"	"Cancer enriched"	"Detected in some"	6	"melanoma: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA007261, CAB037322"	Supported					42000000000	42000000000			"CAB037322: , HPA007261: AB_1079182"	"unprognostic (2.13e-2)"	"unprognostic (5.08e-2)"		"unprognostic (4.97e-2)"		"unprognostic (3.65e-2)"		"unprognostic (2.89e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.92e-7)"	"unprognostic (1.28e-1)"		"unprognostic (3.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (4.15e-2)"	0.1	1.7	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.9	0.1	7.6	0.5	0.2	0.1	0.1	0.0	0.7	0.1	25.7	0.1	0.1	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990783	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"blood: 58.1;lymphoid tissue: 193.6"	"Cell line enhanced"	"Detected in some"		"HEL: 30.3;HMC-1: 128.1;MOLT-4: 43.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"basophil: 38.2;gdTCR: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1"	"Group enriched"	"Detected in many"	134	"granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002223, HPA011157, CAB012978"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	75000	75000	"Plasma membrane"	"Plasma membrane"	"CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	4.8	1.8	1.6	27.6	3.0	8.5	2.5	6.6	2.3	3.9	10.8	2.0	2.0	4.9	7.7	3.1	4.3	4.2	5.8	3.1	1.9	1.9	6.0	3.3	7.8	33.2	1.7	1.7	3.0	2.7	1.4	6.0	2.8	1.8	8.5	2.8	3.1	12.2	5.4	2.0	5.8	9.0	3.1	1.9	13.9	5.1	2.3	1.7	193.6	7.3	4.6	50.3	6.4	5.4	0.2	0.2	38.2	0.2	15.7	58.1	26.8	0.1	0.3	0.2	0.3	0.6	0.3	0.7	0.8	0.2	0.2	0.3	0.3	0.4	0.1	1.1	0.3	0.4	0.4	0.2	0.1	0.2	0.5	30.3	0.7	0.5	0.1	0.9	128.1	0.3	0.6	0.2	0.1	0.1	0.3	3.6	0.1	0.8	43.6	6.0	0.5	0.4	0.4	0.1	3.8	0.3	0.2	0.8	0.1	0.1	0.3	0.3	0.4	5.0	0.5	0.6	2.9	0.6	0.2	1.2	1.0	0.4	7.7	0.4	0.5	38.2	0.2	0.1	47.9	0.2	33.5	0.2	46.9	47.9	0.1	0.2	44.6	42.6	2.3	15.7	0.1	0.2	58.1	26.8	1.6	3.0	6.6	2.3	1.9	1.9	1.7	1.7	1.8	1.7
LMAN1L	"ERGIC-53L, ERGL"	ENSG00000140506	"Lectin, mannose binding 1 like"	Q9HAT1	15	74812716-74825758	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"brain: 45.5;heart muscle: 18.0;lymphoid tissue: 13.5;prostate: 37.0;salivary gland: 17.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;Daudi: 3.7;HEK 293: 2.3;SCLC-21H: 2.4;SK-BR-3: 2.4"	"Cancer enriched"	"Detected in single"	45	"prostate cancer: 2.2"	"Region enriched"	"Detected in some"	22	"cerebellum: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (4.51e-1)"							"unprognostic (2.44e-1)"		"unprognostic (4.26e-2)"	"unprognostic (3.09e-1)"			0.1	1.1	0.2	4.8	0.2	0.0	0.1	45.5	0.9	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.5	18.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	2.0	37.0	0.0	0.1	17.3	0.1	0.1	0.0	0.2	0.1	0.3	13.5	2.5	0.7	0.1	0.1	0.1	0.3	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.8	0.3	0.0	1.1	0.0	0.5	2.4	0.1	0.0	2.4	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	45.5	0.9	0.1	0.0	0.1	0.3	2.0	0.1
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"lymphoid tissue: 7.7;skin 1: 3.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.2;CAPAN-2: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.2			0.0		7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL22	"A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1"	ENSG00000102962	"C-C motif chemokine ligand 22"	O00626	16	57358772-57366190	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 89.8"	"Cell line enriched"	"Detected in some"	18	"HDLM-2: 32.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (2.67e-2)"	"unprognostic (7.68e-3)"	"prognostic favourable (2.98e-4)"	"prognostic favourable (2.23e-6)"	"unprognostic (8.87e-2)"	"prognostic favourable (9.17e-5)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.88e-2)"	10.5	0.6	0.3	27.7	0.5	0.3	1.9	0.2	0.3	1.6	1.3	0.0	0.4	1.0	0.6	0.5	4.6	0.4	2.6	0.4	0.3	0.3	0.6	0.5	4.6	11.9	0.3	0.0	0.3	0.9	0.0	0.3	0.2	0.1	0.7	5.4	0.1	5.9	0.2	0.3	7.1	7.4	0.7	0.3	5.5	1.1	0.3	0.0	89.8	0.7	5.9	31.8	3.6	1.6	3.1	2.6	3.7	0.8	1.4	0.7	0.5	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.9	0.0	0.0	0.1	32.4	0.1	0.1	0.2	0.3	0.0	0.1	1.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.1	1.2	0.0	1.8	0.2	0.1	0.1	1.4	0.0	0.2	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	3.6	0.8	0.6	0.6	0.4	0.4	3.1	0.5	0.4	2.6	1.6	0.6	0.7	3.7	1.4	0.4	1.0	0.4	0.5	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.0	0.1	0.0
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	9	"blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	5	"HEL: 15.7;Karpas-707: 21.7;U-698: 55.5;U-937: 30.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 42.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 42.4"									HPA063928			Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"	"Plasma membrane, Centriolar satellite"	"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	2.7	1.0	0.8	9.8	1.1	0.9	1.1	0.3	0.9	0.6	1.7	1.3	0.1	1.6	0.7	1.3	2.6	0.9	1.5	2.7	1.0	0.9	1.6	1.4	1.9	15.5	1.3	0.7	0.5	1.7	0.0	0.9	0.5	0.9	0.8	2.8	0.8	1.5	0.1	0.5	0.5	11.5	0.9	2.5	20.5	2.6	0.6	0.3	2.2	0.9	0.5	20.6	2.8	2.4	42.4	8.6	0.7	4.6	0.0	3.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	55.5	0.0	30.5	0.0	0.7	2.6	0.1	1.7	4.6	0.0	42.4	1.4	3.5	6.1	14.5	0.0	0.5	0.1	0.0	4.6	8.6	0.1	2.1	0.8	1.1	0.3	0.9	1.0	0.9	1.3	0.7	0.9	0.3
FDCSP	"C4orf7, FDC-SP"	ENSG00000181617	"Follicular dendritic cell secreted protein"	Q8NFU4	4	70226071-70235252	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 176.5;salivary gland: 452.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.6;HL-60: 2.4;K-562: 2.2;RH-30: 3.6;U-87 MG: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 336.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA014326, CAB014890"	Enhanced				"Secreted in other tissues"					"CAB014890: , HPA014326: AB_1845719"	"unprognostic (1.26e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.73e-3)"	"unprognostic (9.62e-2)"		"prognostic favourable (2.38e-4)"	"unprognostic (5.99e-3)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.79e-1)"		"unprognostic (1.96e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.83e-2)"	0.4	0.4	0.4	95.4	0.4	0.0	9.7	0.4	0.4	0.4	1.0	0.0	0.0	0.0	0.4	0.0	1.9	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.5	124.7	0.4	0.0	0.4	0.4	0.0	0.4	0.0	0.0	0.4	0.7	0.0	452.5	0.0	0.5	0.4	3.7	0.0	0.4	12.1	0.4	0.4	0.0	0.4	0.5	35.9	176.5	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.2	0.0	0.0	0.0	0.2	9.6	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
HIST2H4A	"H4/n, H4F2, H4FN, HIST2H4"	ENSG00000270882	"Histone cluster 2 H4 family member a"	P62805	1	149832659-149839767	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 56.4"	"Cell line enhanced"	"Detected in many"		"SiHa: 27.0;U-2 OS: 24.1;U-266/70: 22.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042201	Approved					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (1.90e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.78e-4)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.99e-2)"	1.5	2.3	0.8	10.5	1.9	4.6	1.7	3.8	2.0	3.7	2.9	0.8	0.6	1.9	2.0	1.5	4.1	5.9	4.3	3.5	1.0		1.9	0.2	1.8	4.7	0.8	1.2	3.0	5.5	0.0	1.4	2.5	1.9	6.4	0.0	0.9	2.9	3.4	0.4	0.0	3.2	1.8	0.7	4.9	1.7	3.5	0.5	56.4	4.8	5.1	7.0	5.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	18.2	1.0	3.2	3.8	1.2	1.4	1.4	1.2	4.9	2.3	3.6	4.8	1.1	5.3	0.5	8.6	0.0	3.2	0.1	6.8	10.2	1.2	13.7	1.3	3.5	1.2	1.1	5.6	4.2	1.6	2.5	0.8	5.5	12.3	0.2	16.4	4.4	2.9	4.3	6.9	3.8	2.5	10.1	0.5	1.2	17.6	5.1	27.0	2.6	4.1	11.3	2.3	0.0	2.3	24.1	3.1	2.5	22.5	19.0	6.5	2.3	3.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL1F10	"FKSG75, IL-1F10, IL-1HY2, IL1-theta, MGC11983, MGC119832, MGC119833"	ENSG00000136697	"Interleukin 1 family member 10"	Q8WWZ1	2	113067970-113075850	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 5.9;skin 1: 14.8"	"Group enriched"	"Detected in some"	7	"BEWO: 3.3;HaCaT: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"							"unprognostic (3.89e-1)"				"unprognostic (6.25e-2)"		"unprognostic (1.48e-1)"	"unprognostic (1.18e-1)"			"unprognostic (2.42e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ITGAD	"ADB2, CD11d"	ENSG00000156886	"Integrin subunit alpha D"	Q13349	16	31393312-31426505	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 25.4"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.1;NK-cell: 2.6"	"Group enriched"	"Detected in many"	19	"NK-cells: 2.6;T-cells: 1.1"	"Low region specificity"	"Detected in many"							HPA026786	Uncertain									"HPA026786: AB_10603773"	"unprognostic (2.79e-2)"	"unprognostic (2.39e-4)"	"unprognostic (2.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.44e-4)"	"unprognostic (6.99e-3)"	"unprognostic (6.89e-3)"	"unprognostic (5.02e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.51e-2)"	0.3	0.1	0.1	1.0	0.1	2.5	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.2	0.0	0.4	0.2	0.2	0.2	0.1	0.1	0.1	1.2	0.7	4.0	0.1	0.0	1.6	0.1	0.0	0.1	1.2	0.0	0.1	0.0	0.2	1.5	0.0	1.3	0.1	0.3	0.0	0.2	25.4	0.1	0.2	0.0	0.4	0.1	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	2.6	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38813364	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"gallbladder: 157.1;intestine: 326.8;lymphoid tissue: 83.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;NB-4: 2.6;RT4: 6.9;SH-SY5Y: 2.5"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"		92000	92000	"Plasma membrane"	"Plasma membrane"	"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favourable (3.21e-4)"	0.3	0.2	0.2	83.5	0.2	0.0	0.3	0.3	0.2	0.3	190.6	0.3	0.3	65.5	0.3	0.5	0.6	0.5	157.1	0.2	0.2	0.2	0.4	20.3	1.5	0.2	0.2	0.2	0.3	8.3	0.0	0.2	0.2	0.2	0.8	75.8	0.3	0.3	0.4	0.3	0.3	326.8	4.9	0.2	0.6	10.5	0.2	0.2	0.3	0.4	0.3	0.2	2.7	0.3	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.1	0.6	0.2	0.0	0.7	0.1	2.1	0.0	0.0	0.1	0.1	3.0	0.5	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.3	0.0	0.3	0.0	0.3	0.0	2.1	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.3	2.6	0.0	0.0	0.3	0.2	2.1	0.2	6.9	0.3	2.5	0.2	0.2	0.1	0.4	2.3	0.0	0.0	0.6	1.7	0.1	0.7	0.4	0.2	0.0	0.2	0.3	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2
LILRA1	"CD85i, LIR-6, LIR6"	ENSG00000104974	"Leukocyte immunoglobulin like receptor A1"	O75019	19	54593582-54602090	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"blood: 22.2;lymphoid tissue: 21.0"	"Cell line enhanced"	"Detected in some"		"REH: 1.2;THP-1: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 17.9;non-classical monocyte: 22.2"	"Low lineage specificity"	"Detected in many"																						"unprognostic (4.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.28e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.79e-4)"	"unprognostic (2.53e-1)"	"unprognostic (9.83e-2)"	0.7	0.9	1.0	3.7	1.7	1.0	0.6	0.2	1.3	0.5	0.3	1.1	0.0	0.4	0.2	1.7	0.6	0.5	1.0	0.6	0.9	0.8	0.5	2.1	2.4	18.8	1.5	0.5	0.4	0.4	0.6	0.3	0.8	1.6	0.4	0.7	0.8	1.0	0.3	0.5	0.3	1.0	0.5	2.2	21.0	0.5	0.3	1.1	0.1	0.4	0.4	0.9	0.9	0.2	0.0	5.4	6.1	22.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	7.4	6.1	0.0	17.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	5.3	0.0	22.2	0.7	0.0	4.2	1.0	1.7	0.2	1.3	0.9	0.8	1.5	0.5	1.6	1.1
LY6G6C	"C6orf24, G6c, NG24"	ENSG00000204421	"Lymphocyte antigen 6 family member G6C"	O95867	6	31718648-31721845	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 24.8;placenta: 26.5;skin 1: 89.7;tongue: 56.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;HaCaT: 1.9;MCF7: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.35e-1)"		"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.85e-1)"	"unprognostic (8.80e-7)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.38e-2)"	0.1	0.1	0.0	0.1	0.1	0.1	1.9	0.0	0.1	2.5	0.1	0.0	0.0	0.1	0.4	0.1	5.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.5	0.0	0.1	0.1	0.0	2.4	0.1	0.2	89.7	0.0	0.1	0.0	0.1	0.1	0.2	0.0	1.8	0.1	56.1	24.8	0.1	4.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.8	0.4	0.1	0.0	0.1	1.9	0.0	0.2	0.1	0.0	0.2	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PRG3	"MBP2, MBPH"	ENSG00000156575	"Proteoglycan 3, pro eosinophil major basic protein 2"	Q9Y2Y8	11	57376769-57381150	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 31.6;lymphoid tissue: 8.7"	"Cell line enriched"	"Detected in some"	48	"HMC-1: 66.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA064183	Enhanced				"Secreted in other tissues"	240000	240000			"HPA064183: AB_2685205"																		0.1	0.0	0.0	0.0	0.0	31.6	0.1	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345387-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"lymphoid tissue: 331.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 92.0;MOLT-4: 21.5;REH: 25.7;T-47d: 20.6;THP-1: 39.3;U-937: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 37.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 18.6;T-cells: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"CAB056144: AB_10584780, HPA051769: AB_2681600"	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favourable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	6.7	5.3	11.8	11.7	11.0	16.4	5.9	10.1	22.7	5.6	15.1	3.6	16.1	6.8	5.9	11.1	5.3	8.0	7.7	10.9	10.8	8.1	5.4	7.2	7.6	25.9	10.0	15.6	6.2	14.8	22.4	12.9	1.8	6.6	10.1	8.2	5.9	17.9	26.2	35.7	9.2	11.3	12.1	8.1	11.5	10.4	2.9	4.5	331.6	11.3	4.6	11.8	18.7	11.0	4.7	1.2	4.7	0.6	18.6	37.9	7.9	0.4	0.0	2.6	0.0	3.7	3.6	0.3	0.7	2.5	0.6	2.1	0.1	4.7	0.9	0.0	0.8	0.0	9.6	1.1	1.2	92.0	5.8	0.0	0.2	0.0	0.5	5.3	0.8	1.6	0.8	0.0	0.1	0.6	0.1	5.1	0.4	0.0	21.5	6.8	3.9	0.3	25.7	1.3	0.9	1.0	3.2	1.2	7.3	0.0	0.8	0.0	20.6	39.3	0.3	2.7	1.7	1.2	0.7	0.2	0.0	2.0	2.2	20.7	1.2	4.7	0.5	1.3	14.3	0.6	25.8	0.5	9.7	7.4	1.0	4.7	37.9	22.6	1.2	18.6	0.3	1.2	1.7	7.9	11.8	11.0	10.1	22.7	10.8	8.1	10.0	15.6	6.6	4.5
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410021-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 99.9;lymphoid tissue: 74.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.8;HEL: 10.6;HMC-1: 8.5;NB-4: 6.5;U-698: 15.3;U-937: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 99.9;monocytes: 66.7"									"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"			Cytosol	Cytosol	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	2.6	6.2	4.5	24.6	9.8	9.1	1.4	0.7	4.9	2.7	3.7	5.7	0.0	5.3	1.3	0.7	2.2	2.7	2.7	1.6	3.3	3.0	2.6	7.2	7.7	74.6	6.6	1.8	1.2	2.4	0.2	2.5	1.1	7.7	2.6	3.3	0.7	2.3	0.7	0.6	0.9	9.6	3.2	7.4	37.0	3.1	0.9	4.8	2.0	1.2	0.2	13.2	4.8	1.3	5.8	5.1	99.9	66.7	0.0	0.1	4.4	0.1	0.0	0.4	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	20.8	0.6	0.0	0.4	0.0	0.1	0.0	6.4	1.5	10.6	0.2	0.1	0.0	4.8	8.5	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.0	0.4	0.1	6.5	0.6	0.3	1.3	0.1	0.4	0.0	0.2	0.3	0.3	0.3	0.1	0.2	0.1	3.9	0.5	0.5	1.0	0.4	0.2	1.0	0.2	15.3	0.4	8.8	0.3	1.5	5.6	99.9	0.1	33.9	0.0	5.8	0.0	0.0	5.1	3.6	0.0	0.0	11.5	0.0	66.7	0.2	0.1	4.4	4.5	9.8	0.7	4.9	3.3	3.0	6.6	1.8	7.7	4.8
SMIM28		ENSG00000262543	"Small integral membrane protein 28"	A0A1B0GU29	6	138377905-138383075	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"intestine: 6.2;lymphoid tissue: 2.4;smooth muscle: 1.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.1;SCLC-21H: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																	"unprognostic (2.50e-2)"		"unprognostic (5.48e-2)"				0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	6.2			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.0		0.3	3.1		0.0	0.0	0.0	0.0	1.5	1.9	0.0	0.0	0.3	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TCF7	TCF-1	ENSG00000081059	"Transcription factor 7"	P36402	5	134114711-134151865	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 326.1"	"Cell line enriched"	"Detected in many"	15	"MOLT-4: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2"	"Group enriched"	"Detected in many"	19	"NK-cells: 14.2;T-cells: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019403, HPA058863, HPA070505"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB019403: AB_2199302, HPA058863: , HPA070505: AB_2686275"	"unprognostic (3.63e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.10e-2)"	1.8	3.6	1.3	21.8	1.5	5.2	3.1	0.9	1.2	2.1	3.3	2.5	2.2	5.6	1.4	16.3	2.7	16.1	2.6	1.6	1.5	1.2	2.7	3.7	4.0	41.8	1.3	1.0	2.5	7.2	0.2	6.1	1.4	4.7	2.9	2.3	3.6	7.9	1.8	0.9	2.9	15.1	0.9	3.3	14.4	3.7	2.4	1.1	326.1	4.4	2.2	32.5	3.3	1.5	1.2	0.1	1.0	0.1	14.2	35.8	6.9	0.0	1.0	1.1	3.8	0.5	2.1	1.5	0.3	0.5	0.1	0.1	7.9	2.5	0.0	1.9	1.7	0.1	1.7	0.4	0.0	0.3	1.6	0.0	1.0	5.9	0.0	0.0	0.2	0.1	0.0	1.6	0.0	0.2	1.0	0.0	0.1	0.0	166.9	0.1	1.2	1.4	0.2	0.0	0.1	0.4	0.1	0.4	3.3	0.8	0.2	0.2	0.2	0.9	0.2	10.8	0.0	4.9	0.3	0.1	0.0	0.0	5.7	0.0	0.5	0.7	0.1	1.0	4.4	0.0	10.3	1.2	17.8	10.4	0.0	0.4	35.8	21.8	0.7	14.2	0.0	0.1	2.1	6.9	1.3	1.5	0.9	1.2	1.5	1.2	1.3	1.0	4.7	1.1
TIMD4		ENSG00000145850	"T cell immunoglobulin and mucin domain containing 4"	Q96H15	5	156919282-156963255	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 32.0;lymphoid tissue: 83.9;testis: 58.9"	"Group enriched"	"Detected in some"	18	"U-266/70: 45.7;U-266/84: 12.4"	"Cancer enriched"	"Detected in some"	10	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 6.4"									"HPA015625, CAB026027"	Approved					18000000	18000000			"CAB026027: , HPA015625: AB_1858018"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.90e-2)"	"prognostic favourable (3.37e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.08e-2)"	6.7	0.4	0.4	3.5	0.4	5.3	0.5	0.4	0.4	0.4	1.3	0.0	0.0	0.0	0.4	1.0	1.5	0.4	0.3	0.8	0.4	0.4	1.7	32.0	0.6	83.9	0.5	0.0	0.4	0.4	0.0	0.4	2.8	0.0	1.1	0.1	0.0	6.5	0.0	0.7	0.4	1.1	0.2	0.5	12.5	0.4	58.9	0.0	21.7	0.8	0.2	8.5	5.3	0.4	0.4	0.0	0.0	0.0	0.0	6.4	1.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	45.7	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	2.3	4.5	0.0	0.0	3.0	3.0	0.0	0.0	0.0	0.0	6.4	1.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.0
AMTN	"RSTI689, UNQ689"	ENSG00000187689	Amelotin	Q6UX39	4	70518540-70532742	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 24.6;salivary gland: 12.9;stomach 1: 6.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.0;hTERT-HME1: 9.0;MCF7: 6.6"	"Group enriched"	"Detected in many"	11	"cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036136, HPA036137"	Uncertain				"Secreted in other tissues"					"HPA036136: AB_2674963, HPA036137: AB_10673614"	"unprognostic (1.72e-1)"	"unprognostic (2.47e-1)"				"unprognostic (2.04e-1)"		"unprognostic (2.36e-1)"			"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.86e-2)"		"unprognostic (7.35e-2)"	"unprognostic (2.55e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.8	12.9	0.0	0.0	0.5	0.0	0.0	0.6	0.0	6.7	0.2	0.0	0.0	0.9	0.9	24.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	9.0	0.3	0.2	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289786-158293630	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 70.8;lymphoid tissue: 111.4"	"Cell line enriched"	"Detected in some"	14	"MOLT-4: 34.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 18.6;myeloid DC: 70.8"	"Group enriched"	"Detected in many"	8	"B-cells: 18.6;dendritic cells: 70.8"															240000	240000				"unprognostic (2.55e-3)"	"prognostic favourable (1.79e-5)"	"unprognostic (1.75e-5)"	"unprognostic (3.09e-5)"	"unprognostic (3.12e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.80e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.99e-1)"	1.8	0.4	0.5	8.2	0.6	0.0	2.2	0.5	0.5	1.1	1.2	0.5	1.3	0.4	1.4	1.2	1.8	1.6	5.1	0.6	0.5	0.3	1.6	1.5	2.8	13.2	0.6	0.5	0.7	0.7	0.0	0.6	0.7	0.6	1.0	4.8	0.9	3.0	1.0	0.6	5.5	11.7	1.3	0.5	24.6	1.2	0.8	0.5	111.4	1.0	2.4	20.5	1.4	1.3	18.6	70.8	0.2	5.9	0.9	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.6	0.0	0.1	5.9	0.0	0.0	5.1	0.0	18.6	0.0	0.0	70.8	9.3	0.0	0.0	0.2	0.9	0.6	0.3	0.1	3.3	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.5	0.6	0.5
CD3D	T3D	ENSG00000167286	"CD3d molecule"	P04234	11	118338954-118342744	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 108.7;lymphoid tissue: 181.4"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 152.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	53	"gdTCR: 105.6;MAIT T-cell: 68.6;memory CD4 T-cell: 88.1;memory CD8 T-cell: 97.6;naive CD4 T-cell: 78.8;naive CD8 T-cell: 98.6;T-reg: 108.7"	"Lineage enriched"	"Detected in many"	63	"T-cells: 108.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB013055	Enhanced									"CAB013055: "	"prognostic favourable (3.00e-4)"	"prognostic favourable (8.46e-5)"	"unprognostic (1.05e-2)"	"prognostic favourable (1.73e-7)"	"unprognostic (6.00e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (9.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.66e-2)"	"prognostic favourable (6.16e-4)"	2.6	0.8	0.5	17.4	0.7	4.8	1.7	0.5	0.7	1.3	4.1	0.7	0.8	4.1	1.2	1.6	3.2	1.9	2.9	1.0	0.7	0.4	2.6	1.9	6.1	40.8	0.9	0.5	1.0	1.2	0.0	0.7	0.8	0.7	2.2	4.3	1.1	9.0	0.8	0.7	1.3	19.3	1.0	1.5	28.6	4.4	0.8	0.5	181.4	2.7	2.8	32.6	5.7	2.4	0.5	0.3	1.7	0.3	0.2	108.7	64.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	152.7	28.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.2	105.6	0.2	68.6	0.5	88.1	97.6	0.3	0.2	78.8	98.6	1.7	0.2	0.3	0.3	108.7	64.9	0.5	0.7	0.5	0.7	0.7	0.4	0.9	0.5	0.7	0.5
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830914-157898256	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 178.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;Karpas-707: 1.9;REH: 2.0;RH-30: 1.2;U-266/70: 3.5"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"							"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	6800000000	6800000000			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		0.2	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	21.3	0.2	2.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	178.3	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.8	0.0	2.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1
CLEC12A	"CD371, CLL-1, DCAL-2, MICL"	ENSG00000172322	"C-type lectin domain family 12 member A"	Q5QGZ9	12	9951316-9995694	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 46.5;bone marrow: 35.4;lung: 36.2;lymphoid tissue: 22.4"	"Group enriched"	"Detected in some"	6	"HL-60: 11.8;U-937: 36.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 46.5"	"Group enriched"	"Detected in many"	38	"dendritic cells: 17.1;granulocytes: 46.5;monocytes: 32.8"									HPA048515	Enhanced									"HPA048515: AB_2680425"	"unprognostic (4.74e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.67e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.78e-2)"	"prognostic favourable (9.33e-4)"	4.2	1.2	0.3	6.4	1.2	35.4	1.2	0.6	1.1	0.9	1.5	0.3	0.1	0.2	1.9	3.7	0.9	1.3	2.8	3.5	0.3	0.3	1.9	3.4	36.2	9.6	0.5	0.8	1.0	1.4	0.0	0.6	3.4	1.2	1.3	1.3	1.4	1.5	0.1	0.7	1.1	1.9	3.5	1.5	22.4	1.3	0.9	0.3	2.8	0.7	0.1	1.2	2.1	1.0	0.0	17.1	46.5	32.8	0.8	0.1	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	11.8	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	36.9	0.0	4.1	32.8	46.5	0.0	26.4	0.1	0.0	0.0	0.0	17.1	0.0	0.0	0.1	10.2	0.8	28.4	1.5	0.0	12.5	0.3	1.2	0.6	1.1	0.3	0.3	0.5	0.8	1.2	0.3
CLEC9A	"CD370, DNGR-1, HEEE9341, UNQ9341"	ENSG00000197992	"C-type lectin domain containing 9A"	Q6UXN8	12	10030677-10066027	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 17.3;brain: 7.8;lymphoid tissue: 8.9;testis: 21.1"	"Group enriched"	"Detected in some"	6	"Karpas-707: 1.3;U-266/84: 3.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	103	"myeloid DC: 17.3;neutrophil: 6.1"	"Group enriched"	"Detected in many"	103	"dendritic cells: 17.3;granulocytes: 6.1"	"Not detected"	"Not detected"																		"unprognostic (1.13e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.00e-3)"	"unprognostic (7.85e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.56e-5)"	"unprognostic (6.58e-4)"	"unprognostic (4.73e-3)"	"unprognostic (9.65e-2)"	"unprognostic (7.45e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-5)"	"unprognostic (2.17e-1)"	0.6	0.0	3.3	1.7	2.5	0.3	0.6	0.6	1.1	0.6	0.6	0.6	0.6	0.9	0.6	0.6	0.6	0.0	1.0	0.6	3.2	3.1	0.6	0.8	0.6	8.9	5.0	0.6	0.8	0.6	0.0	0.6	1.0	0.6	0.6	0.6	0.6	1.2	0.6	0.6	0.0	1.8	0.8	7.8	6.4	0.2	21.1	0.6	0.6	0.6	0.6	2.8	0.8	0.6	0.0	17.3	6.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.3	3.3	2.5	0.6	1.0	3.2	3.1	5.0	0.6	0.6	0.6
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HMC-1: 1.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056505	Enhanced					3600000	3600000			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.1	0.1	0.1	23.0	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	23.9	7.6	0.1	8.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.4	0.1	0.1	0.1	1.0	0.1	0.5	0.6	0.1	0.2	0.1	0.2	0.2	0.1	9.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.9	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
FCER2	"CD23, CD23A, CLEC4J, FCE2"	ENSG00000104921	"Fc fragment of IgE receptor II"	P06734	19	7688758-7702146	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 87.2;lymphoid tissue: 38.4"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 97.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"memory B-cell: 28.2;naive B-cell: 87.2"	"Lineage enriched"	"Detected in many"	34	"B-cells: 87.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002624, HPA008928"	Enhanced				"Secreted to blood"	59000	59000			"CAB002624: , HPA008928: AB_1846285"	"unprognostic (3.20e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.17e-2)"	2.4	0.3	0.5	17.1	0.5	2.3	1.2	0.3	1.1	0.3	1.0	0.1	0.4	1.3	0.3	2.3	1.0	0.4	0.5	0.8	0.3	0.3	0.6	0.6	0.8	21.1	0.3	0.0	0.4	0.3	0.0	0.3	0.3	0.1	0.3	0.8	0.0	7.5	0.7	0.4	0.6	7.7	0.4	0.3	38.4	0.8	0.5	0.0	6.3	0.7	0.0	33.8	2.0	0.5	87.2	0.7	0.2	2.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	97.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.5	0.0	0.0	2.5	0.0	28.2	0.0	0.0	0.7	87.2	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.0	0.5	0.5	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144663-79175315	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 73.8"	"Cell line enriched"	"Detected in some"	7	"MOLT-4: 41.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA041025	Enhanced		Uncertain	Vesicles				Vesicles	Vesicles	"HPA041025: AB_10794260"	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	2.2	0.5	0.4	20.3	0.4	2.6	1.3	0.3	0.4	2.4	5.1	0.0	0.5	2.1	1.6	0.9	2.6	0.9	1.9	1.0	0.4	0.4	1.9	1.7	8.2	16.6	0.5	0.0	1.0	0.7	0.0	1.1	0.3	0.2	1.7	2.0	1.6	3.8	0.1	0.5	0.7	9.1	0.2	1.0	21.0	2.2	0.5	0.0	73.8	2.5	1.6	28.1	5.1	1.8	4.0	1.8	6.0	9.1	6.5	8.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	41.8	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	6.0	0.0	4.7	5.7	3.4	1.7	4.0	7.5	8.6	0.1	3.9	6.1	6.8	0.4	6.5	9.1	1.8	7.6	2.7	0.4	0.4	0.3	0.4	0.4	0.4	0.5	0.0	0.2	0.0
H1FX	"H1X, MGC15959, MGC8350"	ENSG00000184897	"H1 histone family member X"	Q92522	3	129314771-129316277	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"bone marrow: 381.6;lymphoid tissue: 238.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012235, HPA040099"	Supported		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB012235: , HPA040099: AB_2676846"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	23.1	13.1	11.9	19.0	14.5	381.6	33.7	29.0	22.9	30.9	21.0	9.6	13.4	21.1	26.0	19.6	34.5	25.1	24.0	27.5	11.3	11.2	12.9	24.9	30.9	44.2	6.7	16.3	39.0	22.4	18.4	20.5	15.0	6.9	26.2	7.8	18.4	32.3	16.3	30.8	40.5	26.0	19.1	9.6	29.9	29.0	14.2	6.3	238.6	21.9	18.1	20.5	35.6	25.0	5.7	10.8	15.9	5.3	4.8	8.3	2.2	19.6	10.4	19.8	8.5	2.0	2.4	18.8	8.6	6.3	10.3	10.9	6.2	10.8	2.5	9.6	3.0	19.8	8.3	5.5	1.6	18.0	16.1	7.5	8.1	8.5	8.5	8.6	2.0	4.8	7.6	4.1	9.5	5.9	11.5	44.8	1.4	20.6	40.1	17.2	18.5	11.8	28.9	8.4	23.4	3.1	4.1	31.6	36.6	9.1	4.6	26.2	17.9	17.6	5.8	8.0	41.9	7.8	7.2	137.4	52.5	21.2	6.5	8.2	8.7	0.4	5.3	15.9	4.3	3.7	4.0	4.4	6.7	5.1	7.4	5.7	8.3	4.3	1.2	4.8	3.3	10.8	5.1	2.2	11.9	14.5	29.0	22.9	11.3	11.2	6.7	16.3	6.9	6.3
HIST1H3D	"H3/b, H3FB"	ENSG00000197409	"Histone cluster 1 H3 family member d"	P68431	6	26196840-26197250	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 185.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 7.9;U-266/70: 11.2;U-266/84: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (8.64e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (1.78e-6)"	"unprognostic (2.44e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	1.2	2.7	0.6	18.3	0.6	24.3	1.5	2.0	1.3	4.4	4.1	0.0	3.0	2.9	1.0	3.0	8.0	1.2	2.3	1.3	1.2	0.9	2.3	3.1	2.5	8.0	0.8	0.7	4.3	1.0	1.0	1.6	2.6	0.3	6.4	1.2	0.7	3.3	4.3	1.0	1.6	3.8	1.4	2.4	9.2	2.2	12.4	0.0	185.6	1.4	5.9	19.9	3.2	6.8	8.9	3.4	15.3	1.8	1.6	6.6	0.5	0.9	0.2	0.0	2.1	0.0	0.5	0.9	0.0	0.5	0.3	2.5	3.5	0.2	2.1	2.1	0.3	0.6	0.2	0.5	0.0	2.9	0.8	0.0	1.7	0.0	0.1	0.7	1.1	0.4	0.4	0.0	0.0	0.3	0.3	7.9	0.0	1.6	2.2	4.0	0.3	1.1	2.5	0.0	1.2	0.0	0.3	0.1	0.0	0.0	2.0	1.0	0.4	2.9	0.0	0.0	3.9	0.0	1.6	11.2	6.1	0.7	2.0	1.7	0.9	8.9	1.4	3.3	2.5	0.8	6.6	5.5	1.6	2.0	3.0	8.9	1.5	2.6	15.3	1.6	1.8	3.4	1.9	0.5	0.6	0.6	2.0	0.6	1.2	0.9	0.8	0.7	0.3	0.0
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"lymphoid tissue: 54.7;testis: 35.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.7	0.5	0.3	7.1	0.4	5.4	0.7	0.3	0.3	0.6	4.0	0.1	0.0	1.5	0.4	0.8	3.9	0.4	0.9	0.5	0.4	0.4	0.9	1.0	1.3	4.7	0.3	0.0	0.5	0.5	0.0	0.4	2.8	0.1	0.5	1.5	0.0	0.8	0.0	0.4	0.8	3.9	0.5	0.4	3.3	0.8	35.6	0.0	54.7	0.5	4.1	3.7	0.7	0.9	2.9	1.2	0.7	0.5	0.7	2.5	0.0	10.8	5.6	11.4	8.2	0.3	1.7	5.1	12.7	5.1	10.0	8.4	6.8	4.4	7.2	4.0	5.5	13.6	10.8	5.9	10.6	12.5	2.9	21.2	9.6	2.0	0.0	16.2	10.7	0.3	0.2	6.7	4.2	8.5	13.5	12.1	11.6	3.7	13.8	3.2	5.6	5.9	12.6	16.3	3.6	1.5	9.6	9.9	4.6	11.0	6.2	1.3	6.7	4.9	7.8	11.6	10.3	13.3	7.0	4.6	15.8	14.1	4.7	11.0	11.0	0.4	0.2	0.1	0.1	0.1	0.0	2.9	1.1	0.1	1.2	2.2	0.0	0.7	0.7	0.7	0.5	0.1	2.5	0.0	0.3	0.4	0.3	0.3	0.4	0.4	0.3	0.0	0.1	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814551	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6"	"Group enriched"	"Detected in some"	30	"HaCaT: 94.2;SK-BR-3: 38.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		540000000	540000000	"Intermediate filaments"	"Intermediate filaments"	"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (6.26e-4)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	25.5	0.1	0.0	0.0	0.1	2.5	0.1	637.8	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	48.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	174.6	403.6	0.2	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 112.2;lymphoid tissue: 153.0"	"Group enriched"	"Detected in some"	6	"MOLT-4: 98.9;U-698: 57.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"gdTCR: 83.4;MAIT T-cell: 77.5;memory CD4 T-cell: 86.1;memory CD8 T-cell: 90.2;naive CD4 T-cell: 97.0;naive CD8 T-cell: 91.3;NK-cell: 42.8;T-reg: 112.2"	"Group enriched"	"Detected in many"	13	"NK-cells: 42.8;T-cells: 112.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favourable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favourable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favourable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	2.6	0.7	0.4	28.2	0.5	3.8	1.3	0.3	0.5	1.7	3.9	0.5	0.9	2.2	1.1	4.5	2.3	1.6	3.8	1.0	0.4	0.4	3.0	2.3	6.6	34.9	0.9	0.5	1.2	0.8	0.0	0.8	0.7	0.6	2.2	1.9	1.3	8.4	1.3	0.9	1.0	16.5	0.7	1.0	28.9	3.5	0.7	0.5	153.0	2.9	1.5	27.1	5.8	2.1	6.1	0.5	2.5	0.3	42.8	112.2	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	0.0	1.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	57.0	0.0	0.0	0.0	0.6	0.3	0.4	83.4	0.3	77.5	4.0	86.1	90.2	0.3	6.1	97.0	91.3	2.5	42.8	0.3	0.5	112.2	109.3	0.4	0.5	0.3	0.5	0.4	0.4	0.9	0.5	0.6	0.5
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2"	"Group enriched"	"Detected in some"	6	"THP-1: 18.8;U-937: 58.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 2.9"	"Group enriched"	"Detected in some"	5	"classical monocyte: 36.5;neutrophil: 16.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.6;monocytes: 36.5"									HPA014731	Enhanced									"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	2.2	0.3	0.3	10.0	0.5	30.9	0.5	0.4	0.9	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.3	1.2	0.2	4.8	0.2	0.2	0.6	1.3	66.4	11.8	2.9	0.0	0.4	0.4	0.0	0.1	0.8	0.6	0.4	0.0	0.1	0.6	0.0	0.2	0.1	0.3	2.4	0.9	24.2	0.6	0.7	0.3	0.3	0.7	0.0	0.1	0.5	2.9	0.0	5.3	16.6	36.5	0.2	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	36.5	0.9	0.1	2.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.1	16.6	0.2	0.1	0.3	0.1	11.6	0.3	0.5	0.4	0.9	0.2	0.2	2.9	0.0	0.6	0.3
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309836-177362943	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 70.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.5;HL-60: 28.8;Karpas-707: 37.9;MOLT-4: 29.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065761			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.5	0.4	0.2	7.4	0.2	9.3	0.7	0.1	0.2	0.8	1.5	0.1	0.1	1.5	0.5	0.1	5.6	0.2	0.3	0.5	0.2	0.2	0.4	0.4	0.9	5.1	0.2	0.1	0.3	0.2	0.0	0.2	1.6	0.2	0.2	2.1	0.2	0.8	0.1	0.2	3.4	1.7	0.5	0.7	1.5	0.8	3.5	0.3	70.8	0.2	1.1	5.0	0.7	1.3	0.2	0.3	0.8	0.0	1.6	1.6	0.2	7.0	5.9	6.3	3.1	0.7	1.3	3.1	8.8	3.2	9.8	5.8	2.1	6.2	7.8	1.3	2.3	3.3	6.6	3.5	14.2	26.5	4.3	5.4	4.6	5.6	0.2	28.8	3.7	0.1	0.2	10.1	2.2	3.7	5.5	37.9	6.3	3.1	29.2	11.1	2.9	4.3	5.9	4.3	2.5	2.5	0.9	4.9	3.4	4.4	5.1	2.4	4.1	7.5	1.7	5.9	4.6	3.0	8.8	2.6	1.7	12.4	3.9	10.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.2	0.0	1.1	0.8	1.6	0.0	0.3	1.6	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.3
SPIB	SPI-B	ENSG00000269404	"Spi-B transcription factor"	Q01892	19	50418938-50431313	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 83.3;intestine: 22.3;lymphoid tissue: 73.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 44.3;HDLM-2: 28.3;Karpas-707: 14.2;U-698: 61.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	57	"memory B-cell: 47.4;naive B-cell: 39.9;plasmacytoid DC: 83.3"	"Group enriched"	"Detected in many"	105	"B-cells: 47.4;dendritic cells: 83.3"									HPA018523	Uncertain									"HPA018523: AB_1857443"	"prognostic favourable (4.76e-5)"	"unprognostic (1.06e-5)"	"unprognostic (9.15e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.72e-3)"	"prognostic favourable (2.14e-5)"	"unprognostic (2.33e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.96e-8)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	0.6	0.4	0.4	73.2	0.4	1.9	0.5	0.4	0.4	0.4	18.9	0.1	0.1	4.6	0.4	0.0	2.3	0.5	0.7	0.6	0.4	0.4	1.1	0.5	3.7	33.0	0.4	0.0	0.4	1.5	0.0	0.5	0.2	0.3	1.1	6.7	0.4	7.7	0.0	0.6	0.4	22.3	0.0	1.2	26.9	2.4	0.6	0.0	9.3	1.0	1.5	53.7	2.2	0.6	47.4	83.3	0.4	0.0	0.6	0.0	2.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	44.3	0.0	0.0	0.0	0.3	0.0	0.0	28.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	14.2	0.0	0.1	0.0	0.1	0.4	0.0	3.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.2	0.0	0.8	0.0	0.0	1.3	0.9	61.6	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	47.4	0.0	0.0	1.0	39.9	0.0	0.0	0.4	0.6	0.0	83.3	0.0	2.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.3	0.0
TAC1	"NKNA, NPK, TAC2"	ENSG00000006128	"Tachykinin precursor 1"	P20366	7	97731908-97740472	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 61.3;lymphoid tissue: 62.9"	"Cell line enriched"	"Detected in some"	19	"U-266/70: 22.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 557.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 312.7"	HPA014429	Enhanced				"Secreted to blood"					"HPA014429: AB_1857722"	"unprognostic (9.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"					"unprognostic (2.08e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.86e-2)"	1.8	6.5	4.1	7.7	61.3	0.3	1.7	0.3	39.8	0.7	3.7	0.1	0.0	6.0	0.9	1.6	0.3	0.7	4.9	0.5	9.3	21.5	1.6	0.6	0.3	0.3	8.0	4.5	0.3	0.7	0.3	0.3	0.3	24.5	1.0	2.9	0.3	4.5	2.0	0.4	1.2	7.6	5.3	6.7	62.9	0.9	0.6	9.4	0.0	1.6	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	61.3	0.3	9.2	9.3	21.5	8.0	4.5	24.5	9.4
TAS2R40	GPR60	ENSG00000221937	"Taste 2 receptor member 40"	P59535	7	143222037-143223079	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"blood: 6.3;lymphoid tissue: 4.1"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																															0.1	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0										
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341078	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5"	"Cell line enriched"	"Detected in some"	6	"EFO-21: 11.6"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	205	"neutrophil: 20.4"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 20.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA004728	Enhanced					14000000	14000000			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	195.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	24.5	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	206.5	152.6	0.0	2.8	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TLX1	"HOX11, TCL3"	ENSG00000107807	"T cell leukemia homeobox 1"	P31314	10	101130505-101137789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 59.5;salivary gland: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;HEK 293: 3.0;K-562: 15.0;SCLC-21H: 2.5;SH-SY5Y: 3.7;SiHa: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"pons and medulla: 0.5"	"Region enriched"	"Detected in single"	20	"pons and medulla: 0.5"	HPA053185			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053185: "	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (1.06e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.06e-1)"	"unprognostic (7.35e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	19.5	0.0	0.1	0.0	0.6	0.0	0.0	59.5	0.0	0.1	0.1	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	3.7	2.5	0.0	0.0	0.1	0.4	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 31.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.3	0.3	1.6	0.3	5.5	0.3	1.0	15.2	5.4	0.9	0.3	4.2	0.3	0.4	0.4	1.4	1.1	0.3	0.9	0.3	2.5	1.2	0.3	0.3	0.4	0.3	6.5	0.7	0.3	0.3	0.3	0.0	0.3	5.2	1.2	0.3	0.0	0.6	0.3	0.3	14.1	0.3	0.3	4.1	0.3	0.6	0.4	5.3	0.0	0.3	5.5	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.4	0.5	0.3	3.5	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.2	0.8	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	15.2	5.4	2.5	1.2	6.5	0.7	5.2	5.3
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442360	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.0;Karpas-707: 20.7;RPMI-8226: 14.6;SK-BR-3: 29.7;U-266/70: 20.8;U-266/84: 27.1;U-698: 21.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 43.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	10	"basal ganglia: 357.5"	"Region enriched"	"Detected in single"	95	"basal ganglia: 166.0"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported								"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	1.0	2.4	1.9	10.4	43.9	28.1	1.5	3.4	3.8	0.8	2.0	1.7	0.3	5.4	1.4	1.4	1.0	0.9	2.4	3.5	2.4	1.8	3.5	4.3	5.1	14.8	2.6	1.6	1.2	0.8	0.0	2.1	1.4	2.3	1.6	0.8	3.3	2.7	1.5	1.2	0.9	2.6	0.7	1.3	7.5	2.8	2.0	5.7	59.0	1.3	0.9	8.6	3.8	1.3	17.7	1.1	13.7	9.0	2.2	22.8	11.2	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.2	9.3	0.5	0.9	1.7	0.1	15.0	1.0	0.2	0.3	0.9	0.0	0.0	1.8	2.6	0.2	0.0	2.1	0.1	0.3	7.5	0.1	0.0	2.8	0.0	3.3	0.1	20.7	0.0	0.2	5.2	1.6	0.6	0.0	0.1	0.7	14.6	0.0	0.1	1.5	8.7	0.4	29.7	0.1	0.3	1.4	0.2	0.9	1.4	0.2	0.1	20.8	27.1	21.2	4.7	5.1	0.1	3.0	0.8	4.8	8.6	2.6	20.1	9.6	16.1	16.9	1.1	17.7	22.8	18.3	13.7	2.2	9.0	1.1	21.4	11.2	1.9	43.9	3.4	3.8	2.4	1.8	2.6	1.6	2.3	5.7
ARL5C	ARL12	ENSG00000141748	"ADP ribosylation factor like GTPase 5C"	A6NH57	17	39156894-39167484	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 21.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;MOLT-4: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.7"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.7"	"Low region specificity"	"Detected in many"							HPA069849	Uncertain									"HPA069849: AB_2686213"	"unprognostic (2.57e-1)"				"unprognostic (2.34e-1)"								"unprognostic (1.60e-7)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-2)"			0.2	0.2	0.2	0.2	0.6	0.0	0.6	0.2	0.5	1.3	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.6	0.2	0.1	0.4	0.1	1.5	0.2	0.0	0.1	3.0	0.0	0.1	0.7	0.4	0.1	0.2	0.8	0.1	1.1	0.3	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	21.1	0.1	0.0	1.3	1.2	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.6	0.2	0.5	0.6	0.2	0.2	0.0	0.4	0.0
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007600-33023709	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 218.0;salivary gland: 191.2"	"Cell line enriched"	"Detected in single"	552	"Hep G2: 67.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	68000	68000	Vesicles	Vesicles	"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favourable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	191.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.6	218.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CASP5	ICE(rel)III	ENSG00000137757	"Caspase 5"	P51878	11	104994235-105023168	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 22.3;intestine: 31.0;lymphoid tissue: 12.3"	"Cell line enriched"	"Detected in some"	7	"HHSteC: 9.1"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 3.9;stomach cancer: 1.3"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 10.5;neutrophil: 7.8;non-classical monocyte: 22.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 7.8;monocytes: 22.3"																				"unprognostic (4.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.38e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.82e-9)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-1)"	0.6	0.3	0.3	11.8	1.0	0.0	0.3	0.2	0.8	0.2	13.3	0.2	0.0	8.2	0.2	0.2	0.3	0.5	0.1	0.4	2.9	0.3	0.4	1.2	2.7	10.5	0.4	0.2	0.2	0.3	0.0	0.9	0.5	2.0	0.4	11.3	0.2	0.3	0.0	0.8	0.2	31.0	1.4	2.1	12.3	0.4	0.3	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.0	1.0	7.8	22.3	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	10.5	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.8	0.0	22.3	0.3	0.0	0.6	0.3	1.0	0.2	0.8	2.9	0.3	0.4	0.2	2.0	0.3
CCR8	"CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1"	ENSG00000179934	"C-C motif chemokine receptor 8"	P51685	3	39329706-39333511	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"blood: 19.8;lymphoid tissue: 19.3;urinary bladder: 5.3"	"Cell line enriched"	"Detected in some"	22	"HDLM-2: 48.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 19.8"	"Lineage enriched"	"Detected in single"	30	"T-cells: 19.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042383	Enhanced									"HPA042383: AB_2732497"	"unprognostic (2.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.63e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.37e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.65e-8)"	"unprognostic (7.96e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.14e-1)"	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	0.2	0.3	0.5	0.1	0.1	0.0	0.3	0.1	0.8	0.1	2.1	0.2	0.2	0.2	0.5	0.3	1.4	2.8	0.1	0.1	0.2	0.3	0.0	0.2	0.1	0.1	0.4	1.3	0.1	0.5	0.1	0.2	1.0	1.2	0.1	0.4	1.7	0.8	0.3	0.1	19.3	0.4	1.2	3.5	5.3	0.3	0.0	0.0	0.0	0.0	0.6	19.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	19.8	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1
CCR9	"CDw199, GPR-9-6, GPR28"	ENSG00000173585	"C-C motif chemokine receptor 9"	P51686	3	45886504-45903177	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 130.2"	"Cell line enriched"	"Detected in single"	324	"MOLT-4: 48.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 17.5;naive B-cell: 9.2;T-reg: 5.7"	"Group enriched"	"Detected in many"	42	"B-cells: 17.5;T-cells: 5.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB006839	Uncertain									"CAB006839: "	"unprognostic (3.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.65e-3)"	"unprognostic (7.88e-3)"	"unprognostic (4.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-3)"	0.1	0.1	0.1	1.8	0.1	0.7	0.1	0.1	0.3	0.1	2.2	0.1	0.1	7.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.2	0.1	10.7	0.1	0.2	2.2	0.3	0.1	0.1	130.2	0.1	0.1	0.7	0.1	0.1	17.5	0.2	0.0	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.5	2.2	1.8	0.2	9.2	0.3	0.1	0.0	0.0	0.0	0.2	5.7	1.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754385-116769228	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 101.7;lymphoid tissue: 164.4"	"Group enriched"	"Detected in some"	25	"HDLM-2: 61.1;MOLT-4: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdTCR: 44.4;MAIT T-cell: 42.5;memory CD4 T-cell: 65.3;memory CD8 T-cell: 74.2;naive CD4 T-cell: 34.2;naive CD8 T-cell: 52.4;NK-cell: 101.7;T-reg: 62.3"	"Group enriched"	"Detected in many"	9	"NK-cells: 101.7;T-cells: 74.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.3"	"Low region specificity"	"Detected in many"			"CAB002430, HPA003883"	Enhanced									"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favourable (4.36e-4)"	"prognostic favourable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favourable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favourable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favourable (3.97e-5)"	"prognostic favourable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	3.0	1.1	0.6	14.5	0.5	2.4	1.7	0.5	0.6	2.9	6.0	0.6	0.6	4.8	1.7	2.1	3.8	3.1	4.8	1.4	0.6	0.6	3.3	2.5	8.1	33.0	1.2	0.6	1.9	1.6	0.0	1.0	1.0	1.0	2.9	4.7	2.3	4.1	1.3	1.0	1.2	18.8	0.9	1.8	28.8	6.5	1.1	0.8	164.4	3.5	3.4	30.8	7.7	2.7	0.3	9.3	1.4	0.5	101.7	74.2	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.1	0.0	0.1	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.5	0.1	44.4	0.3	42.5	0.3	65.3	74.2	9.3	0.2	34.2	52.4	1.4	101.7	0.2	2.0	62.3	45.9	0.6	0.5	0.5	0.6	0.6	0.6	1.2	0.6	1.0	0.8
CD79A	"IGA, MB-1"	ENSG00000105369	"CD79a molecule"	P11912	19	41877120-41881372	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 125.3;intestine: 43.5;lymphoid tissue: 119.2"	"Group enriched"	"Detected in some"	24	"Daudi: 155.5;REH: 48.3;U-698: 135.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 106.4;naive B-cell: 125.3"	"Lineage enriched"	"Detected in many"	41	"B-cells: 125.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB000019	Enhanced									"CAB000019: AB_2244527"	"prognostic favourable (8.45e-5)"	"unprognostic (1.63e-3)"	"unprognostic (4.13e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.23e-2)"	"unprognostic (8.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (6.08e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	1.3	0.6	0.5	103.8	0.5	5.4	1.3	0.5	0.5	1.8	6.3	0.1	0.1	4.9	0.6	0.2	4.4	1.0	2.3	0.8	0.5	0.5	2.3	0.9	4.3	114.9	0.5	0.1	0.6	0.6	0.0	0.5	0.5	0.1	1.0	3.4	1.8	13.6	1.2	0.5	0.5	43.5	0.2	0.5	108.1	9.7	0.8	0.1	32.0	2.4	1.9	119.2	6.8	1.0	125.3	3.0	0.7	0.3	0.2	2.3	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	0.0	0.0	48.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.7	0.1	135.4	0.0	4.6	0.0	0.7	0.1	0.5	0.1	0.1	0.0	106.4	0.3	0.1	0.2	125.3	0.4	2.3	0.4	0.2	0.3	3.0	0.8	4.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.1	0.1
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 33.6;lymphoid tissue: 57.2;retina: 74.1"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 84.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Approved									"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.4	33.6	0.8	4.0	2.4	0.1	0.3	6.0	0.4	0.5	8.2	0.7	0.2	1.2	0.5	0.1	0.5	0.1	0.8	0.4	0.2	0.8	0.1	0.1	0.3	2.8	0.4	0.0	0.1	0.2	0.1	1.5	0.2	1.2	0.6	3.4	74.1	0.2	0.6	0.1	0.6	2.9	2.8	0.2	0.2	3.6	0.9	0.5	57.2	0.2	0.2	0.7	0.8	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	16.0	84.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.4	6.0	0.4	0.2	0.8	0.4	0.0	1.2	0.5
CLEC4M	"CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN"	ENSG00000104938	"C-type lectin domain family 4 member M"	Q9H2X3	19	7763149-7769605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"liver: 38.5;lymphoid tissue: 30.1"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 2.5;K-562: 3.4;Karpas-707: 1.3;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.7"									"CAB033689, CAB033691, HPA042661"	Supported				"Intracellular and membrane"	890000	890000			"CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101"	"unprognostic (1.56e-1)"				"unprognostic (3.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"		"unprognostic (1.27e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.15e-2)"		"unprognostic (1.43e-1)"	0.9	0.9	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.3	0.1	1.2	0.6	0.1	0.1	0.1	0.0	0.1	38.5	2.5	30.1	0.1	0.1	2.7	0.1	0.0	0.1	4.8	0.2	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.5	0.1	0.1	0.2	0.0	1.4	0.1	0.1	0.2	0.1	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	3.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 49.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.5"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.6	1.2	2.0	13.7	2.4	7.0	3.0	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3.0	1.8	3.2	1.0	2.4	2.0	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5.0	1.9	2.4	1.1	2.3	4.0	1.7	3.0	5.0	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3.0	5.2	2.6	7.0	1.4	49.1	1.5	5.1	10.8	2.3	2.0	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.7	7.1	16.3	11.5	1.8	1.3	11.5	6.8	5.7	9.8	12.1	17.0	9.0	14.1	2.6	2.1	8.5	9.3	3.6	11.8	8.7	7.0	8.6	4.4	6.5	0.5	14.7	9.3	1.0	1.4	7.0	2.0	4.4	12.5	12.8	5.6	4.8	22.7	10.7	11.5	13.4	17.8	11.3	4.5	4.2	6.4	7.4	8.9	9.4	11.9	2.2	9.2	6.3	1.8	3.8	11.7	4.8	12.9	6.5	7.3	21.1	3.2	14.1	4.9	0.0	0.0	0.9	0.2	0.0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0.0	0.4	0.1	2.0	2.4	6.2	3.8	2.5	2.2	2.9	5.0	1.7	1.4
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304396-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 171.0"	"Group enriched"	"Detected in some"	420	"MOLT-4: 48.7;REH: 168.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"naive B-cell: 1.2;naive CD4 T-cell: 4.5"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036532: , HPA044194: "								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.1	0.1	0.3	24.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.7	0.0	171.0	0.6	0.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	168.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0
FAM129C	"BCNP1, FLJ39802"	ENSG00000167483	"Family with sequence similarity 129 member C"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9"	"Group enriched"	"Detected in some"	22	"Daudi: 29.1;REH: 14.6;U-698: 18.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	226	"memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2"	"Group enriched"	"Detected in many"	284	"B-cells: 19.5;dendritic cells: 37.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043277	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.5	0.2	0.2	37.9	0.2	12.1	0.2	0.3	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.6	0.2	0.2	0.5	0.3	0.9	17.4	0.2	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.4	9.9	0.2	0.1	0.2	12.3	0.0	0.3	28.5	0.4	0.5	0.0	2.5	0.5	0.4	35.4	3.0	0.4	19.5	37.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.7	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FAM25C	bA164N7.4	ENSG00000276430	"Family with sequence similarity 25 member C"	B3EWG5	10	47995355-47999791	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"breast: 5.7;esophagus: 4.9;intestine: 5.0;lymphoid tissue: 2.8;skin 1: 10.3"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 18.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"		"unprognostic (2.93e-1)"				"unprognostic (2.21e-1)"												0.0	0.0		0.0		0.0	5.7		0.0	0.0	0.0			0.0	0.0	0.0	4.9	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	10.3	5.0	0.0		0.0	0.0	0.0			0.0		2.8	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FCRL2	"CD307b, FCRH2, IRTA4, SPAP1"	ENSG00000132704	"Fc receptor like 2"	Q96LA5	1	157745733-157777132	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 20.2;intestine: 14.9;lymphoid tissue: 27.0"	"Group enriched"	"Detected in some"	4	"Daudi: 14.7;U-698: 11.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	50	"memory B-cell: 20.2;naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	65	"B-cells: 20.2"																				"unprognostic (3.94e-3)"	"unprognostic (1.47e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.69e-3)"		"unprognostic (5.11e-5)"	"unprognostic (1.67e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.19e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.60e-7)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.48e-1)"	0.4	0.2	0.2	22.6	0.2	1.5	0.2	0.1	0.2	0.2	1.3	0.1	0.1	1.2	0.3	0.1	1.4	0.2	0.4	0.2	0.2	0.2	0.5	0.9	0.7	15.6	0.3	0.1	0.5	0.2	0.0	0.2	0.1	0.2	0.4	1.7	0.6	2.8	0.7	0.1	0.2	14.9	0.1	0.2	27.0	0.8	0.2	0.1	0.3	0.5	0.1	23.3	1.4	0.2	20.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.1	0.0	11.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.2	0.1
GLYATL1B	GLYATL1P3	ENSG00000255151	"Glycine-N-acyltransferase like 1B"		11	59086307-59094786	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	7	"blood: 4.9;breast: 12.5;lymphoid tissue: 4.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.8;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 4.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"					"Group enriched"	"Detected in some"	17	"memory B-cell: 1.9;naive B-cell: 4.9"	"Lineage enriched"	"Detected in single"	24	"B-cells: 4.9"									HPA039501	Uncertain		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA039501: AB_2676545"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"						"unprognostic (1.44e-1)"			"unprognostic (1.25e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.21e-4)"	"unprognostic (3.45e-1)"		0.0	0.0		1.0		0.0	12.5		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	4.1			0.0	0.0	0.0		0.0		0.9	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.6	0.0	0.0			0.0		0.0	0.0		4.9	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	0.0	0.3	0.4	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.5	2.5	0.2	4.9	1.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HIST1H2BB	"H2B/f, H2BFF"	ENSG00000276410	"Histone cluster 1 H2B family member b"	P33778	6	26043277-26043657	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 104.9"	"Cell line enhanced"	"Detected in some"		"K-562: 3.6;Karpas-707: 3.5;MOLT-4: 4.4;NB-4: 4.8;THP-1: 5.4;U-266/84: 5.9"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.4	0.3	1.0	6.4	0.3	6.6	0.6	0.5	1.0	0.5	1.0	0.0	0.0	1.1	0.4	0.5	4.1	0.6	0.3	1.0	0.2		0.8	0.3	1.7	3.0	0.1	0.4	0.3	0.5	0.3	0.0	0.9	1.0	0.3	0.3	0.2	0.3	0.3	1.3	1.0	0.8	0.3	0.8	5.8	0.5	15.8	0.1	104.9	0.3	4.8	7.4	0.3	0.0	2.1	10.5	4.2	1.1	0.2	3.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	1.1	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	1.3	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.6	0.0	1.4	3.6	3.5	0.0	0.0	4.4	4.8	2.1	2.0	2.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.3	5.4	0.0	0.3	0.3	0.3	0.9	0.8	5.9	0.0	0.7	1.7	1.3	4.2	1.1	0.8	1.5	0.1	3.9	2.1	3.9	1.6	3.3	1.6	2.0	0.8	3.6	0.2	0.4	10.5	2.9	0.6										
HIST1H4D	"H4/b, H4FB"	ENSG00000277157	"Histone cluster 1 H4 family member d"	P62805	6	26188765-26189076	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 71.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 9.7;RT4: 15.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.8"	"Low lineage specificity"	"Detected in many"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.77e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.11e-3)"	1.4	4.7	1.9	10.1	5.2	6.5	5.6	1.2	4.5	3.9	3.1	0.0	4.5	0.9	3.3	3.5	8.3	6.5	2.0	4.6	1.4		1.6	1.8	1.6	3.5	0.0	4.4	6.5	5.8	0.9	1.3	4.2	1.6	6.0	2.1	1.4	1.4	2.7	0.9	0.9	2.3	2.2	1.6	4.1	2.2	9.8	0.8	71.3	5.3	4.8	9.5	5.5	0.0	6.8	0.6	1.3	0.9	0.2	2.3	0.7	1.3	2.1	1.5	0.0	2.7	0.0	0.8	1.3	0.4	3.6	1.8	3.4	0.8	6.7	0.4	0.0	0.9	4.4	0.7	1.1	0.5	9.7	0.9	6.6	2.4	0.0	0.7	0.2	0.0	0.0	0.5	1.4	3.1	1.7	1.2	0.0	3.4	2.4	3.9	2.3	0.7	0.7	0.0	0.8	0.9	15.6	0.7	0.4	1.4	0.6	0.9	1.2	0.5	0.0	0.5	4.3	0.5	1.7	1.5	1.8	0.0	1.0	1.6	1.0	0.1	0.9	0.0	0.9	0.1	0.6	1.4	2.3	0.5	0.6	6.8	0.3	0.6	1.3	0.2	0.5	0.1	0.1	0.7										
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 19.3;THP-1: 9.8;U-937: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"				"Nuclear speckles, Plasma membrane"	"Nuclear speckles, Plasma membrane"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	1.0	0.4	0.2	0.2	0.5	0.9	2.1	0.3	0.3	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.2	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9
KHDC3L	"C6orf221, ECAT1"	ENSG00000203908	"KH domain containing 3 like, subcortical maternal complex member"	Q587J8	6	73362677-73364171	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.1;epididymis: 1.5;lung: 3.0;lymphoid tissue: 4.4;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;HMC-1: 1.5;NTERA-2: 2.1"	"Cancer enriched"	"Detected in single"	3155	"testis cancer: 254.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043699	Uncertain									"HPA043699: AB_10960564"					"unprognostic (1.39e-2)"					"unprognostic (1.37e-1)"					"unprognostic (1.67e-1)"	"unprognostic (4.36e-1)"		0.2	0.5	1.2	0.2	2.1	0.0	0.2	4.1	0.9	0.2	0.2	0.2	0.2	0.1	0.2	1.5	0.3	0.1	0.2	0.2	2.1	0.6	0.2	0.2	3.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.6	0.3	4.9	0.2	4.4	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	2.1	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.8	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	4.1	0.9	2.1	0.6	0.4	0.2	0.2	0.2
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 64.3;lymphoid tissue: 22.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 9.3;Karpas-707: 3.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdTCR: 45.7;NK-cell: 64.3"	"Group enriched"	"Detected in many"	42	"NK-cells: 64.3;T-cells: 45.7"									HPA058052			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA058052: AB_2683589"	"unprognostic (8.17e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.58e-7)"	"unprognostic (3.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-3)"	2.4	0.5	1.2	5.8	1.4	5.6	2.3	1.0	2.7	1.7	3.3	0.7	1.2	1.5	5.5	3.9	1.7	2.5	2.4	2.6	1.6	1.3	1.9	2.0	5.9	10.3	2.3	0.6	1.2	1.4	0.3	1.3	3.6	1.5	1.9	2.5	2.0	3.1	0.3	0.5	1.0	5.0	2.1	2.6	22.1	5.2	1.4	0.5	3.5	1.9	3.0	2.9	2.9	1.8	0.1	0.0	1.2	0.1	64.3	45.7	5.1	0.4	1.6	0.1	0.1	0.6	0.4	0.8	0.0	0.0	0.8	1.7	0.0	1.3	0.2	0.1	0.4	0.3	0.6	2.8	1.1	0.9	0.4	2.1	9.3	0.0	0.1	0.6	0.4	1.0	0.0	0.3	0.0	0.8	1.3	3.8	0.8	0.0	0.2	2.8	0.0	0.0	0.9	0.2	0.3	0.2	0.0	0.5	0.1	0.8	0.0	0.3	0.3	0.0	2.6	0.4	0.0	0.0	0.3	0.0	0.0	0.7	2.2	0.8	0.0	0.2	0.0	0.0	45.7	0.0	5.8	0.1	0.0	7.9	0.0	0.0	0.0	6.9	1.2	64.3	0.1	0.0	0.0	5.1	1.2	1.4	1.0	0.9	1.6	1.3	2.3	0.6	1.5	0.5
LILRB1	"CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB"	ENSG00000104972	"Leukocyte immunoglobulin like receptor B1"		19	54617158-54637528	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"blood: 26.7;lymphoid tissue: 52.5"	"Group enriched"	"Detected in some"	19	"Daudi: 10.3;THP-1: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"intermediate monocyte: 19.1;non-classical monocyte: 26.7"	"Lineage enriched"	"Detected in many"	10	"monocytes: 26.7"														"Intracellular and membrane"						"unprognostic (9.23e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (6.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.03e-2)"	2.6	1.5	2.5	11.9	4.5	2.5	0.9	0.4	2.5	1.1	1.8	3.1	0.5	0.6	0.5	1.8	0.8	1.4	0.7	2.5	2.2	1.6	1.5	3.2	5.6	18.7	4.7	0.9	1.7	0.7	0.3	1.1	2.7	3.7	1.4	1.1	0.8	1.2	0.8	0.3	0.3	4.8	5.4	5.8	52.5	1.0	0.5	4.6	0.8	0.8	0.1	3.0	4.9	0.6	1.2	2.5	0.1	26.7	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.1	0.0	0.6	19.1	0.0	1.2	0.0	0.5	2.5	1.1	0.0	0.4	0.1	0.0	26.7	1.0	0.0	1.7	2.5	4.5	0.4	2.5	2.2	1.6	4.7	0.9	3.7	4.6
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 19.4;testis: 67.9"	"Cell line enhanced"	"Detected in many"		"A-431: 60.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 1.6"	"Group enriched"	"Detected in many"	10	"NK-cells: 2.1;T-cells: 1.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol				Cytosol	Cytosol	"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0.0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0.0	0.0	0.0	2.1	1.6	0.5	60.7	19.8	19.5	12.3	1.9	3.4	8.2	27.9	13.3	28.8	24.3	6.9	11.3	32.4	9.9	10.7	16.1	18.7	9.4	31.6	7.9	10.2	7.8	14.1	10.0	0.1	5.0	11.6	0.9	7.7	13.3	7.1	14.5	11.4	21.8	33.9	6.9	19.2	5.9	3.5	17.2	12.0	27.2	8.7	10.8	9.4	7.7	12.1	10.4	12.2	15.6	12.9	7.7	8.4	18.9	45.6	23.9	29.6	3.1	8.6	15.0	11.5	8.9	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2
RAG2		ENSG00000175097	"Recombination activating 2"	P55895	11	36575574-36598279	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 165.8"	"Group enriched"	"Detected in some"	90	"MOLT-4: 15.4;REH: 61.7"	"Cancer enriched"	"Detected in single"	21	"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA065704			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065704: AB_2732737"				"unprognostic (4.30e-2)"					"unprognostic (9.09e-2)"	"unprognostic (1.21e-1)"		"unprognostic (1.77e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.68e-3)"		0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	165.8	24.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	61.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0
SBK1	Sbk	ENSG00000188322	"SH3 domain binding kinase 1"	Q52WX2	16	28292519-28323849	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6"	"Cell line enhanced"	"Detected in some"		"AF22: 15.0;AN3-CA: 10.8;NTERA-2: 15.4;REH: 16.3;SCLC-21H: 23.8;SH-SY5Y: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdTCR: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4"	"Group enriched"	"Detected in many"	10	"NK-cells: 1.4;T-cells: 4.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 306.7"																"unprognostic (5.15e-2)"	"prognostic favourable (6.88e-4)"	"unprognostic (2.08e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.87e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.03e-3)"	0.9	2.0	8.0	1.8	7.3	2.0	1.7	31.1	17.5	1.7	1.2	1.5	0.0	1.1	1.9	1.3	1.5	1.6	1.0	1.8	9.9	5.6	1.6	0.9	1.8	2.7	6.0	4.0	1.1	2.7	4.2	4.1	0.8	8.3	2.6	1.2	1.4	3.8	1.0	39.6	1.4	1.1	0.9	3.1	2.8	1.6	2.3	3.1	22.1	2.6	0.0	1.7	1.2	0.3	0.2	0.2	0.2	0.1	1.4	4.3	0.4	0.1	0.2	15.0	10.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.3	4.5	0.1	0.0	1.5	0.5	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	1.8	6.9	0.1	15.4	0.1	16.3	0.8	0.1	0.1	0.9	23.8	22.4	0.3	1.4	0.2	1.7	0.0	0.4	0.0	2.3	0.2	0.1	0.2	0.0	0.2	0.1	0.2	0.8	0.2	0.1	0.1	4.3	0.0	1.4	0.0	1.2	2.4	0.0	0.2	1.4	3.0	0.1	1.4	0.1	0.2	1.4	0.4	8.0	7.3	31.1	17.5	9.9	5.6	6.0	4.0	8.3	3.1
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"lymphoid tissue: 11.3;ovary: 36.6"	"Cell line enriched"	"Detected in some"	15	"HEL: 15.0"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	0.4	3.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.1		36.6	1.1	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.3	0.1	11.3	1.8	0.5			0.0		0.0	0.3	0.0	0.6	0.5	2.6	3.3	0.8	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.2	15.0	0.2	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.4	0.2	0.1	0.3	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.2	0.5	1.0	2.6	0.1	3.3	0.1	0.5	0.2	0.1	0.5	0.6	0.1	0.2	1.4	0.8	3.3	0.3	0.0	0.3										
SMIM35	TMPRSS4-AS1	ENSG00000255274	"Small integral membrane protein 35"		11	118003634-118088299	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	7	"blood: 4.6;bone marrow: 3.1;kidney: 3.4;lymphoid tissue: 1.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 14.3;RPMI-8226: 8.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.1;olfactory region: 4.3"																	"unprognostic (8.83e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.64e-1)"		"unprognostic (1.58e-1)"		"unprognostic (3.04e-4)"		"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"			"unprognostic (1.64e-1)"			"unprognostic (1.88e-1)"	0.0	0.0		1.2		3.1	0.4		0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.4	0.0			3.4	0.1	0.0	1.7			0.0	0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		1.4	0.0	0.0			0.0		1.5	0.0		1.7	0.8	0.1	0.5	1.2	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.9	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.7	0.7	1.1	0.7	0.4	0.0	0.6	0.1	1.2	0.5	0.8	4.6	0.4										
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7"	"Cell line enhanced"	"Detected in some"		"HEL: 54.9;HL-60: 48.8;HMC-1: 27.5;MOLT-4: 18.9;THP-1: 26.4;U-937: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 52.1"	"Low lineage specificity"	"Detected in all"											"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB002666: , HPA055244: AB_2682756"	"prognostic favourable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favourable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	5.7	1.0	1.2	12.9	2.7	33.1	1.6	0.7	1.5	1.3	2.8	2.6	0.0	2.3	1.5	0.6	1.9	1.7	2.8	3.9	1.2	1.4	1.8	1.9	25.0	18.3	3.7	0.2	1.0	1.6	0.2	1.0	0.8	2.3	1.6	2.6	1.6	5.0	0.6	0.8	1.6	6.8	1.0	4.6	15.9	2.0	0.6	1.9	79.7	1.6	1.7	17.4	2.6	1.4	1.0	8.8	3.5	52.1	17.5	26.5	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	0.0	0.4	0.0	48.8	27.5	0.0	0.0	0.0	0.0	0.0	17.1	13.4	0.1	0.0	18.9	12.2	0.0	0.0	17.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.1	0.0	0.0	0.0	0.0	0.0	0.9	7.2	0.0	34.8	0.0	2.4	5.5	3.5	26.5	24.3	14.5	1.0	10.7	18.1	8.8	0.3	7.6	13.2	0.9	17.5	52.1	7.0	9.1	10.7	1.2	2.7	0.7	1.5	1.2	1.4	3.7	0.2	2.3	1.9
SPNS3	MGC29671	ENSG00000182557	"Sphingolipid transporter 3 (putative)"	Q6ZMD2	17	4433688-4488208	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 51.8;bone marrow: 23.1;lymphoid tissue: 15.1"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.7;NB-4: 16.0;THP-1: 17.3;U-698: 4.2;U-937: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 51.8;plasmacytoid DC: 25.1"	"Group enriched"	"Detected in many"	24	"dendritic cells: 25.1;granulocytes: 51.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023928	Uncertain									"HPA023928: AB_1844393"	"unprognostic (4.39e-2)"	"unprognostic (8.10e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (8.09e-4)"	"unprognostic (6.18e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.69e-2)"	0.3	0.5	1.1	2.0	0.9	23.1	0.3	0.5	1.6	0.4	1.3	3.7	0.0	0.6	0.5	0.1	0.4	0.7	0.7	0.7	1.2	1.6	0.4	0.3	1.2	1.3	2.4	0.1	0.2	0.3	0.1	0.5	0.1	2.0	0.5	0.2	0.0	1.3	0.5	0.1	0.5	0.8	0.2	4.2	2.9	0.3	1.3	2.2	15.1	0.2	0.0	1.6	0.3	0.3	0.0	25.1	51.8	1.5	0.0	0.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	4.7	16.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	13.3	0.0	0.0	1.5	51.8	0.1	0.3	0.1	0.0	0.0	0.2	11.5	0.0	0.0	0.2	0.2	0.0	0.0	25.1	0.0	1.0	1.1	0.9	0.5	1.6	1.2	1.6	2.4	0.1	2.0	2.2
TNFRSF9	"4-1BB, CD137, ILA"	ENSG00000049249	"TNF receptor superfamily member 9"	Q07011	1	7915894-7943165	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 13.5;lymphoid tissue: 18.3"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071425			Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071425: AB_2686394"	"unprognostic (7.23e-2)"	"unprognostic (1.72e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-4)"	"unprognostic (9.47e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (2.69e-8)"	"unprognostic (1.64e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.55e-2)"	0.8	1.0	0.3	11.0	0.3	1.9	0.5	0.2	0.3	0.4	0.5	0.1	0.1	0.6	0.3	0.1	0.6	0.8	1.6	1.8	0.3	1.0	0.7	0.7	2.1	10.8	0.3	0.1	0.3	0.6	0.0	0.5	0.2	0.5	0.4	0.7	0.3	2.1	0.1	0.3	0.5	2.3	0.1	0.3	7.9	0.7	0.5	0.1	18.3	0.7	0.9	17.5	1.4	0.4	0.5	1.1	6.6	1.5	4.1	13.5	1.1	1.2	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.0	0.1	0.0	0.2	0.4	45.9	0.1	0.2	0.2	0.0	0.9	0.0	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	1.5	0.1	0.2	0.1	0.1	0.1	5.7	0.2	0.0	1.1	1.5	0.2	1.5	0.4	0.2	0.2	1.0	8.0	1.1	0.5	0.3	1.6	6.6	4.1	0.1	0.3	13.5	1.1	0.3	0.3	0.2	0.3	0.3	1.0	0.3	0.1	0.5	0.1
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447681	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 17.6;lymphoid tissue: 62.3"	"Group enriched"	"Detected in some"	6	"HEL: 14.6;MOLT-4: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"gdTCR: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6"	"Lineage enriched"	"Detected in many"	15	"T-cells: 17.6"	"Region enriched"	"Detected in single"	13	"hippocampal formation: 0.5"	"Low region specificity"	"Detected in all"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	1.1	0.7	0.3	19.7	0.3	2.6	0.8	0.3	0.3	0.9	2.8	0.1	0.0	1.9	0.8	0.8	1.2	1.3	3.2	1.1	0.3	0.4	1.4	1.1	6.0	23.1	0.4	0.0	0.7	0.6	0.0	0.6	0.4	0.3	1.2	1.0	1.1	5.0	0.2	0.3	0.5	5.9	0.6	0.7	10.8	2.2	0.4	0.0	62.3	1.4	1.1	14.1	2.6	1.1	0.0	0.0	0.3	0.0	1.1	17.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	14.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	12.1	0.0	15.1	13.1	0.0	0.0	17.6	12.8	0.3	1.1	0.0	0.0	13.6	5.1	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.0
AC243967.1		ENSG00000267881			19	41708612-41761282	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"esophagus: 79.7;intestine: 34.3;lymphoid tissue: 77.4;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HaCaT: 1.8;MCF7: 1.9;RT4: 4.1;U-2 OS: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA011041	Approved									"HPA011041: AB_1078481"			"unprognostic (1.55e-2)"								"unprognostic (1.15e-2)"			"unprognostic (9.59e-3)"				0.4	0.3	0.3	60.6	0.4	0.2	0.5	0.6	0.4	9.2	34.3	0.0	0.0	0.5	0.3	0.1	79.7	0.3	0.5	0.5	0.4	0.3	0.4	0.7	1.4	0.1	0.3	0.0	0.5	0.6	0.3	0.5	0.1	0.0	0.5	0.4	0.0	0.7	0.1	0.4	0.5	6.1	0.7	0.3	0.6	0.8	0.6	0.0	0.0	0.4	22.3	77.4	1.0	8.0	0.1	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.3	0.3	0.0	0.0	0.0
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	7	"ASC TERT1: 3.9;HaCaT: 4.4"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APLNR	"AGTRL1, APJ, APJR, FLJ90771"	ENSG00000134817	"Apelin receptor"	P35414	11	57233577-57237314	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 63.8;lymphoid tissue: 44.1;placenta: 40.4"	"Group enriched"	"Detected in some"	19	"AF22: 10.1;HEL: 8.7;K-562: 2.6;NTERA-2: 3.0"	"Cancer enhanced"	"Detected in all"		"glioma: 50.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB025842	Approved									"CAB025842: "	"unprognostic (5.06e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	8.4	2.1	26.1	3.8	14.2	0.0	3.3	3.8	21.0	1.2	2.3	30.8	0.0	1.8	1.6	0.0	1.8	1.2	5.7	7.2	24.8	9.3	2.5	8.0	3.5	4.0	17.3	10.2	1.2	1.4	1.9	1.5	40.4	32.8	1.2	2.8	0.2	1.7	0.8	5.8	3.0	1.7	4.7	63.8	44.1	1.5	1.2	18.2	0.1	3.1	0.6	1.8	3.8	1.5	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	26.1	14.2	3.8	16.3	24.8	9.3	17.3	10.2	32.8	18.2
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942017-14961728	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4"	"Cell line enhanced"	"Detected in many"		"HEL: 101.6;HL-60: 118.9;HMC-1: 134.6;MOLT-4: 140.7;REH: 118.4;U-698: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol		120000000	120000000	Cytosol	Cytosol	"CAB018584: AB_647972, HPA051235: AB_2681398"	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favourable (3.42e-4)"	40.3	13.4	9.0	66.1	18.4	150.7	27.9	1.8	8.9	14.6	14.5	13.9	3.6	8.5	14.7	13.2	16.9	18.2	18.3	20.5	8.3	7.8	24.5	20.0	41.3	93.9	17.0	3.9	11.7	7.1	3.9	8.1	35.6	11.4	18.0	16.1	20.4	22.4	7.6	13.3	14.7	38.3	15.7	17.9	157.8	11.1	11.2	15.8	221.4	22.7	12.4	108.1	31.2	13.5	114.0	95.5	267.1	151.9	96.3	231.1	333.1	9.3	0.3	0.3	20.8	1.4	1.1	0.1	0.3	0.1	0.1	0.1	1.2	10.3	75.4	4.8	1.7	10.3	0.0	16.7	1.1	0.1	0.0	101.6	0.2	0.0	0.3	118.9	134.6	0.1	2.1	0.0	1.5	58.5	0.5	28.9	1.8	0.0	140.7	85.6	0.4	0.1	118.4	1.3	33.7	3.3	52.2	0.1	0.0	0.1	13.5	0.1	0.7	86.6	74.1	0.3	0.7	0.1	2.2	4.8	0.7	108.9	0.3	83.4	0.1	206.0	109.9	267.1	125.6	130.8	123.3	114.0	144.4	140.7	95.5	103.2	141.1	146.5	237.7	96.3	151.9	41.4	231.1	333.1	9.0	18.4	1.8	8.9	8.3	7.8	17.0	3.9	11.4	15.8
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6"	"Group enriched"	"Detected in some"	8	"MOLT-4: 34.9;REH: 19.4;RH-30: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 146.9"	"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017303	Enhanced		Approved	Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		1.2	1.3	12.3	1.5	146.9	4.6	1.1	27.8	67.9	1.1	1.4	0.3	0.0	1.3	1.1	1.1	3.2	1.1	1.1	1.1	6.8	2.8	2.0	2.9	1.2	1.2	3.9	11.5	1.1	1.1	1.1	1.9	1.1	6.7	2.0	1.5	0.0	1.1	1.3	43.6	1.1	1.4	1.1	0.8	1.2	1.1	1.1	14.8	41.2	1.5	3.5	1.5	1.1	0.1	0.1	12.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	34.9	0.0	0.0	1.4	19.4	11.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	12.3	146.9	27.8	14.7	6.8	2.8	3.9	11.5	6.7	14.8
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.2;HEL: 8.0;HL-60: 7.1;U-266/70: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	15	"memory B-cell: 61.4;naive B-cell: 46.2"	"Lineage enriched"	"Detected in many"	17	"B-cells: 61.4"	"Low region specificity"	"Detected in many"							HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	3.3	2.9	0.7	45.4	0.9	2.0	1.9	2.1	0.7	0.7	1.3	0.7	1.4	0.7	0.4	1.2	6.0	1.0	1.6	0.9	0.8	0.7	2.0	0.5	4.9	30.3	0.7	0.2	0.9	0.6	0.0	3.7	0.5	0.6	2.2	1.1	0.5	7.7	1.8	0.4	0.6	18.0	0.3	0.8	67.0	2.5	1.3	0.7	4.8	5.5	0.4	42.3	6.5	1.1	61.4	2.0	3.6	0.3	0.2	0.0	2.1	0.0	2.2	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.3	0.5	0.0	3.5	10.2	1.0	0.0	0.1	0.1	1.1	0.3	0.0	0.0	8.0	2.1	0.0	0.1	7.1	0.0	0.5	0.3	0.0	0.0	0.1	0.0	3.1	0.4	0.4	0.0	0.4	0.0	4.3	0.1	0.4	0.0	0.3	4.7	2.0	0.0	0.2	0.1	0.0	0.4	1.8	1.0	0.0	0.4	0.0	0.0	24.5	0.0	1.6	0.1	4.1	0.0	1.5	0.3	3.6	0.0	0.1	0.0	61.4	0.0	0.0	2.0	46.2	0.0	0.0	0.1	0.2	0.0	1.0	0.0	2.1	0.7	0.9	2.1	0.7	0.8	0.7	0.7	0.2	0.6	0.7
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"		12	51281038-51324668	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	6	"blood: 85.3;bone marrow: 38.0;lymphoid tissue: 24.8"	"Cell line enhanced"	"Detected in some"		"HEL: 23.3;HMC-1: 39.7;Karpas-707: 17.3;NB-4: 39.5;RPMI-8226: 15.5;THP-1: 33.5;U-937: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favourable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	4.6	1.8	3.5	12.3	4.7	38.0	1.7	1.8	2.0	2.3	3.3	3.6	0.7	2.2	1.4	2.8	2.2	1.4	3.6	2.2	3.1	2.1	2.5	3.1	7.7	23.9	4.4	0.9	1.8	2.3	0.0	1.7	8.4	3.2	1.8	3.6	1.5	4.7	0.6	1.9	2.0	3.3	2.3	4.1	18.3	2.6	3.5	3.9	24.8	1.9	0.7	17.5	4.4	1.9	10.5	17.1	85.3	59.9	35.8	47.7	61.4	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	23.3	0.0	0.0	0.0	9.7	39.7	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.1	6.7	39.5	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	9.3	0.0	2.3	0.0	21.9	0.0	85.3	30.9	37.4	47.7	49.0	38.5	8.1	32.4	39.8	17.1	10.5	25.3	33.5	61.0	35.8	59.9	6.3	40.9	61.4	3.5	4.7	1.8	2.0	3.1	2.1	4.4	0.9	3.2	3.9
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463968-112499561	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.2;lymphoid tissue: 30.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 2.4;Daudi: 1.9;U-698: 6.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.6;naive B-cell: 37.2"	"Lineage enriched"	"Detected in many"	4	"B-cells: 37.2"	"Not detected"	"Not detected"							"HPA047211, HPA062029"	Enhanced									"HPA047211: AB_2679983, HPA062029: AB_2684665"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (5.79e-4)"	"unprognostic (1.01e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.74e-6)"	"unprognostic (6.20e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-2)"	0.6	0.3	0.3	20.3	0.4	1.2	1.1	0.4	0.3	0.5	1.2	0.1	0.0	0.9	0.4	0.1	2.3	0.5	1.0	0.4	0.3	0.3	1.0	0.5	1.2	30.9	0.3	0.0	0.4	0.3	0.0	0.4	0.3	0.1	0.5	0.9	0.2	5.7	0.4	0.3	0.5	6.0	0.2	0.4	18.6	1.7	0.6	0.0	14.6	0.9	1.1	19.4	2.8	0.5	37.2	8.6	0.1	0.0	0.1	5.1	2.4	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.9	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.1	22.6	5.1	2.4	1.5	37.2	4.8	4.7	0.1	0.1	0.0	8.6	1.1	2.4	0.3	0.4	0.4	0.3	0.3	0.3	0.3	0.0	0.1	0.0
C20orf204	"DKFZp434G015, FLJ27267, LINC00176, NCRNA00176, PRR17"	ENSG00000196421	"Chromosome 20 open reading frame 204"		20	64034344-64039962	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	6	"blood: 8.2;brain: 11.2;lymphoid tissue: 19.1"	"Cell line enriched"	"Detected in some"	6	"Hep G2: 32.0"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 7.2"					"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.2;naive CD8 T-cell: 6.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 8.2"	"Low region specificity"	"Detected in many"																		"unprognostic (2.84e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.43e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.49e-6)"	"unprognostic (5.83e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.79e-4)"	1.3	0.0	0.0	0.7	0.0	0.2	0.0	11.2	0.0	0.7	1.2	0.0	0.3	0.6	0.1	2.0	0.2	0.7	1.0	1.1	0.0		0.0	0.8	1.2	9.8	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.6	0.0	2.3	0.1	0.0	1.2	0.4	0.8	0.0	19.1	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.8	8.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.7	1.1	0.0	0.0	8.2	6.6	0.4	0.8	0.0	0.0	1.7	0.4										
CACNG5		ENSG00000075429	"Calcium voltage-gated channel auxiliary subunit gamma 5"	Q9UF02	17	66835117-66885486	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 6.5;lymphoid tissue: 3.3;retina: 8.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.5;THP-1: 1.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"olfactory region: 152.3"	"Low region specificity"	"Detected in all"			HPA050115	Uncertain									"HPA050115: AB_2681022"					"unprognostic (1.85e-3)"					"unprognostic (3.84e-2)"	"unprognostic (1.44e-1)"		"unprognostic (2.46e-6)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-1)"			0.3	0.3	2.7	0.7	2.6	0.3	0.3	1.7	6.5	0.4	0.7	6.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.4	2.1	2.0	1.0	0.3	0.3	3.3	1.1	2.3	0.3	0.7	0.3	0.8	0.3	0.7	0.5	0.5	8.8	0.3	0.3	0.3	0.4	0.7	0.3	1.7	1.3	0.3	0.7	3.8	0.0	0.3	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.6	1.7	6.5	2.1	2.0	1.1	2.3	0.7	3.8
CALHM6	"C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5"	ENSG00000188820	"Calcium homeostasis modulator family member 6"	Q5R3K3	6	116461370-116463779	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.3;lymphoid tissue: 58.7"	"Cell line enhanced"	"Detected in some"		"HEL: 9.8;Karpas-707: 16.3;RPMI-8226: 55.4;U-937: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 83.9;non-classical monocyte: 95.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (1.14e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.46e-3)"	"unprognostic (7.15e-3)"	"unprognostic (9.53e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (9.31e-10)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.25e-3)"	3.0	2.7	2.8	19.6	5.2	12.9	3.1	1.1	2.1	1.5	3.4	1.5	1.7	3.9	1.1	1.3	2.0	1.5	3.9	4.3	3.1	3.2	2.9	8.1	4.2	30.6	2.6	1.8	2.8	1.0	0.4	2.5	4.6	3.4	3.1	2.2	2.7	4.2	0.7	1.0	0.9	8.1	3.7	5.1	58.7	2.2	3.3	1.7	7.3	2.1	1.9	7.5	3.5	1.4	39.6	23.3	13.8	95.3	3.1	3.8	17.8	2.2	0.0	0.2	0.1	0.2	0.7	4.2	0.0	0.4	0.7	0.4	0.0	0.3	0.0	1.3	0.5	0.0	0.1	0.0	1.5	0.2	0.1	9.8	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	16.3	1.9	0.0	0.9	1.6	1.3	0.0	0.8	0.0	55.4	0.8	0.1	1.0	0.0	5.3	0.0	4.0	0.1	2.6	0.0	0.0	0.0	0.0	0.3	4.2	0.0	0.0	0.1	21.0	1.4	1.8	24.7	5.5	2.1	83.9	2.1	27.0	2.9	1.9	23.3	39.6	3.8	1.9	13.8	3.1	95.3	10.2	0.3	17.8	2.8	5.2	1.1	2.1	3.1	3.2	2.6	1.8	3.4	1.7
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823933	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 122.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 6.8"	"Low region specificity"	"Detected in single"							"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (9.17e-5)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	3.2	1.5	1.3	18.6	1.7	21.6	1.8	5.1	1.2	2.5	6.3	1.0	0.8	6.6	2.2	2.1	11.7	1.7	2.4	3.2	1.8	1.8	1.7	1.6	3.4	15.6	1.6	0.8	4.5	0.9	0.5	3.2	12.0	1.3	2.2	7.8	1.0	2.1	0.8	1.1	4.2	7.4	2.4	1.8	8.9	2.9	8.4	0.8	122.3	1.4	18.8	18.4	2.5	5.1	0.3	0.9	0.6	0.3	1.7	6.8	1.9	38.1	9.9	27.3	11.6	1.4	3.8	22.3	26.6	11.7	35.5	26.4	21.6	23.7	35.1	7.2	14.0	12.9	34.3	15.7	29.2	16.8	15.8	28.2	13.2	21.0	0.3	42.4	20.0	0.9	1.2	14.6	8.8	21.2	40.0	35.3	28.1	13.7	54.0	24.6	21.5	11.1	24.8	52.8	17.1	10.0	7.6	11.6	12.3	14.0	17.1	7.4	14.3	18.0	12.4	16.6	25.2	17.5	25.4	22.4	23.7	40.2	9.5	43.2	18.4	0.0	0.3	0.6	0.2	0.1	0.1	0.3	2.0	1.4	0.9	0.1	0.0	0.5	0.3	1.7	0.3	0.1	6.8	1.9	1.3	1.7	5.1	1.2	1.8	1.8	1.6	0.8	1.3	0.8
CCR2	"CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R"	ENSG00000121807	"C-C motif chemokine receptor 2"	P41597	3	46353734-46360928	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 96.3;lymphoid tissue: 36.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 47.4;THP-1: 22.5;U-266/70: 109.2;U-266/84: 43.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 96.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB003793	Approved									"CAB003793: AB_344889"	"unprognostic (1.09e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.49e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.16e-4)"	"unprognostic (8.06e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.19e-1)"	2.5	1.3	0.6	20.7	0.8	0.9	1.9	0.5	0.8	4.3	5.8	0.5	1.5	5.6	2.6	2.4	6.1	2.2	2.5	1.8	0.6	0.6	3.7	1.8	8.6	30.1	1.6	0.1	1.7	1.7	0.0	0.8	2.1	1.8	3.7	4.0	2.6	10.2	3.5	0.8	1.3	7.3	5.6	1.5	36.1	3.7	1.5	0.5	3.6	2.0	3.5	5.9	5.8	1.7	1.6	29.0	96.3	28.4	2.5	19.3	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	109.2	43.5	0.0	0.0	0.8	0.0	96.3	28.4	0.4	2.5	2.6	19.3	1.6	5.2	4.2	29.0	0.3	0.1	0.1	0.7	2.5	0.0	23.0	2.3	13.5	0.6	0.8	0.5	0.8	0.6	0.6	1.6	0.1	1.8	0.5
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931939-28939346	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 47.6;intestine: 16.7;lymphoid tissue: 40.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 52.1;REH: 27.6;U-698: 11.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	93	"memory B-cell: 36.0;naive B-cell: 47.6"	"Lineage enriched"	"Detected in single"	106	"B-cells: 47.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB016110	Enhanced									"CAB016110: AB_626952"	"unprognostic (3.27e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.11e-5)"	"unprognostic (2.61e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-1)"	0.4	0.2	0.2	37.0	0.2	2.3	0.2	0.1	0.2	0.2	0.9	0.1	0.0	0.2	0.2	0.1	1.4	0.3	0.2	0.2	0.2	0.2	0.7	0.3	1.4	32.0	0.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.4	0.5	0.1	5.9	0.0	0.1	0.1	16.7	0.0	0.2	40.3	1.3	1.9	0.0	2.4	0.7	0.2	38.7	1.8	0.3	47.6	0.0	0.4	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	47.6	0.1	0.0	0.3	0.0	0.1	0.0	0.0	1.8	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862855	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 75.8;lymphoid tissue: 22.1"	"Cell line enhanced"	"Detected in some"		"HEL: 10.6;HMC-1: 37.4;NB-4: 7.4;U-937: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 75.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 75.8"					"Not detected"	"Not detected"														"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.9	0.4	0.5	3.3	0.5	8.6	0.6	0.3	0.7	0.9	3.1	0.4	1.6	2.8	1.4	0.7	1.0	0.7	1.7	2.0	0.5	0.5	0.7	4.1	5.3	7.4	1.7	0.0	1.6	0.5	0.0	0.5	1.8	1.1	1.6	1.2	1.0	1.6	0.9	1.1	0.5	6.0	2.6	1.5	22.1	0.8	2.8	0.6	0.7	0.6	0.0	4.0	1.5	0.8	0.0	7.9	75.8	13.2	14.0	14.8	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	3.4	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	14.9	0.0	75.8	8.2	20.1	14.8	11.2	7.3	0.0	0.8	8.1	7.9	0.0	1.1	7.8	0.6	14.0	13.2	0.4	0.0	11.3	0.5	0.5	0.3	0.7	0.5	0.5	1.7	0.0	1.1	0.6
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853230	"Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 94.9;seminal vesicle: 104.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 49.8;Karpas-707: 13.9;MOLT-4: 12.6;REH: 10.0;U-266/70: 10.8;U-698: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.3"	"Group enriched"	"Detected in all"	4	"B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3"	"Low region specificity"	"Detected in all"							"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favourable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	4.1	3.3	3.8	17.6	8.5	9.3	2.6	0.7	12.0	1.0	3.2	10.4	14.6	4.3	0.7	0.9	2.3	2.4	1.5	5.0	4.0	4.2	1.2	5.4	4.7	16.1	4.9	3.1	0.6	0.7	0.0	2.5	0.6	3.1	10.8	2.7	4.4	2.8	104.1	14.2	0.5	6.2	0.9	1.8	20.6	2.0	0.7	2.5	94.9	2.8	2.0	13.2	7.6	0.9	9.0	5.1	1.3	2.2	15.3	2.3	3.7	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.9	0.0	0.0	12.6	3.0	0.0	0.0	10.0	0.0	7.8	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	2.2	0.2	0.0	0.0	0.0	0.0	10.8	0.1	9.4	0.1	2.4	0.1	0.0	1.7	0.0	1.1	2.2	0.3	9.0	1.4	1.2	4.1	6.6	2.3	1.8	1.3	15.3	1.4	5.1	2.1	3.7	3.8	8.5	0.7	6.2	4.0	4.2	4.9	3.1	3.1	2.5
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 53.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.6"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (2.88e-8)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	1.2	0.9	0.2	12.1	0.2	3.5	3.0	0.2	0.2	1.3	3.5	0.4	0.3	5.3	0.9	1.5	8.5	0.1	1.2	1.5	0.2	0.3	0.8	0.7	1.4	8.2	0.3	0.0	0.5	0.7	0.0	0.3	3.1	0.3	0.5	3.2	0.1	1.7	0.0	0.3	4.5	3.6	0.8	0.3	4.9	1.8	7.8	0.0	53.7	0.4	9.2	10.0	1.3	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	30.8	7.1	11.1	6.1	0.8	1.8	9.2	9.6	7.3	13.0	11.1	5.1	10.1	9.3	6.2	3.4	9.1	9.9	5.1	12.8	27.5	9.6	15.7	3.2	8.6	0.2	9.1	17.5	0.1	0.6	5.1	7.1	6.7	12.7	19.2	10.2	10.4	13.1	14.0	9.9	13.1	15.6	19.8	10.2	5.7	1.4	9.5	9.5	9.2	10.2	7.5	6.1	9.7	4.7	8.0	20.3	9.5	15.8	19.2	19.0	37.9	3.9	18.8	15.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.0	0.3	0.0
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 97.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.1;MOLT-4: 11.5;RPMI-8226: 4.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 13.3;naive B-cell: 16.2"	"Lineage enriched"	"Detected in many"	9	"B-cells: 16.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB002659, HPA052942, HPA060715"	Enhanced					150000000	150000000			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favourable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"	0.5	0.3	0.4	97.2	0.3	0.0	0.4	0.3	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.0	2.8	0.3	0.3	0.3	0.4	0.4	1.4	0.4	2.0	72.8	0.4	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.0	6.0	0.0	0.4	0.3	11.5	0.0	0.4	63.4	1.4	0.5	0.0	6.5	0.7	0.3	56.3	0.6	0.3	16.2	0.0	0.2	0.0	0.0	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	11.5	0.0	1.9	0.2	0.0	0.2	4.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	13.3	0.7	0.5	0.0	16.2	1.8	1.6	0.2	0.0	0.0	0.0	0.0	1.1	0.4	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.0	0.0
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909541	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11.8;testis: 34.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA042923			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavourable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	1.1	1.2	1.4	5.9	2.0	1.8	3.0	1.9	1.9	1.4	2.1	0.0	0.6	1.2	1.2	1.4	1.7	1.1	1.5	1.0	1.5	1.4	1.2	1.1	2.4	5.0	1.3	1.0	3.4	1.3	1.2	1.8	1.4	0.8	1.2	1.2	0.0	1.2	1.1	1.9	1.3	1.5	0.9	1.2	4.6	1.1	34.2	0.7	11.8	1.4	1.9	2.7	1.6	1.1	1.3	0.9	4.0	0.4	0.9	1.6	0.5	1.3	1.4	2.9	3.8	0.7	0.6	0.9	1.4	0.3	1.5	2.9	2.2	0.9	3.1	1.1	0.8	1.3	3.0	0.8	1.6	2.2	2.0	1.9	1.7	0.5	0.2	2.4	1.6	0.7	0.8	1.7	1.6	1.3	1.7	6.4	2.0	2.3	4.1	2.9	3.0	2.8	1.1	4.6	3.6	1.2	0.2	4.3	2.8	1.9	3.2	1.5	1.3	2.5	0.5	1.8	2.1	4.6	3.0	3.7	7.6	3.0	1.2	4.3	3.8	4.0	0.4	0.4	1.2	0.3	0.3	0.8	1.1	0.6	0.2	1.3	1.1	1.3	1.1	0.9	0.4	0.9	1.6	0.5	1.4	2.0	1.9	1.9	1.5	1.4	1.3	1.0	0.8	0.7
DEFB4B	DEFB4P	ENSG00000177257	"Defensin beta 4B"	O15263	8	7414860-7416863	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 14.3;lymphoid tissue: 8.8"	"Cell line enriched"	"Detected in single"	16	"CAPAN-2: 1.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"											"unprognostic (1.35e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0			0.0		8.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DRD5	"DRD1B, DRD1L2"	ENSG00000169676	"Dopamine receptor D5"	P21918	4	9781680-9784009	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 8.4;lymphoid tissue: 3.5;stomach 1: 10.9"	"Cell line enhanced"	"Detected in some"		"REH: 3.6;THP-1: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048930	Supported									"HPA048930: AB_2680562"		"unprognostic (2.03e-2)"			"unprognostic (2.63e-1)"	"unprognostic (9.73e-2)"		"unprognostic (4.27e-2)"		"unprognostic (4.44e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-4)"	"unprognostic (5.09e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.36e-3)"	0.2	0.2	2.8	3.5	4.1	0.1	0.2	0.0	8.4	0.1	0.9	0.0	0.0	0.9	0.1	0.1	0.3	0.3	0.1	0.1	3.2	3.2	0.2	0.1	0.4	0.2	1.9	0.8	0.1	0.2	0.1	1.0	0.1	7.4	0.6	0.2	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.6	0.1	10.9	1.3	1.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	3.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.1	0.0	8.4	3.2	3.2	1.9	0.8	7.4	1.0
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 29.3;lymphoid tissue: 69.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favourable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	4.2	2.9	2.7	13.7	3.1	29.3	3.5	6.6	3.3	5.3	6.1	1.8	1.8	3.5	5.8	3.7	6.1	4.4	3.0	2.4	2.8	2.3	3.0	4.1	3.8	10.8	4.4	1.6	5.1	3.1	2.0	3.4	8.2	3.5	3.9	4.1	1.6	6.9	2.4	1.6	3.3	5.0	3.9	2.4	10.6	3.5	4.2	3.9	69.0	5.6	4.8	11.2	3.5	4.5	6.8	5.3	0.0	3.5	8.8	7.9	3.2	11.0	5.7	24.2	16.3	1.8	3.8	7.7	26.8	12.1	20.2	22.8	11.8	6.6	27.0	8.2	7.1	10.6	19.1	8.9	24.3	14.4	17.1	27.1	8.5	12.7	3.6	24.1	16.7	2.7	1.7	13.6	10.7	9.2	28.5	25.4	18.3	8.4	27.5	15.6	14.1	8.5	23.3	19.4	17.4	7.1	6.0	15.9	16.5	19.0	10.3	5.0	7.4	22.7	6.9	15.2	19.8	17.5	31.2	8.5	9.4	39.9	11.0	18.0	18.3	0.0	2.4	0.0	3.8	3.0	5.4	6.8	6.3	6.9	4.6	6.0	6.2	6.4	0.0	8.8	3.5	5.3	7.9	3.2	2.7	3.1	6.6	3.3	2.8	2.3	4.4	1.6	3.5	3.9
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Group enriched"	"Detected in some"	4	"Daudi: 29.4;U-266/70: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"				"Plasma membrane"	"Plasma membrane"	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	54.6	0.7	2.2	0.0	6.7	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1
GALR2	GALNR2	ENSG00000182687	"Galanin receptor 2"	O43603	17	76074794-76077541	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.5;intestine: 13.1;lymphoid tissue: 9.8;smooth muscle: 6.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.1;NTERA-2: 4.6;THP-1: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044513	Approved									"HPA044513: AB_10962510"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.32e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.14e-2)"	0.3	0.1	0.0	9.8	0.1	3.5	0.0	0.0	0.3	0.3	13.1	0.0	0.0	0.6	0.0	0.0	1.1	0.1	0.5	0.1	1.4	0.8	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.1	0.4	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	9.0	6.4	1.4	0.2	0.4	0.3	0.0	0.0	0.0	1.1	1.2	1.0	0.2	0.0	1.1	1.4	0.9	0.5	0.4	0.7	0.2	1.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.0	2.1	0.4	0.6	0.3	0.0	3.1	0.0	0.1	0.0	0.3	2.5	0.0	1.5	2.8	0.3	0.6	0.5	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.1	1.1	0.2	0.3	4.6	2.9	0.1	0.6	0.8	0.0	0.2	0.2	0.1	1.7	0.7	0.3	0.6	6.8	0.2	0.2	0.6	0.2	0.4	0.7	0.4	2.6	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.4	1.1	0.0	0.7	0.0	0.1	0.0	0.3	1.4	0.8	0.2	0.0	0.6	0.0
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024253-55034570	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.8;lymphoid tissue: 37.3"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 95.8;memory CD8 T-cell: 59.0"	"Group enriched"	"Detected in many"	191	"NK-cells: 56.9;T-cells: 95.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA063181	Enhanced				"Secreted to blood"					"HPA063181: AB_2684955"	"prognostic favourable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	3.5	1.6	0.6	10.5	0.6	3.6	3.1	0.5	0.5	4.1	3.7	0.2	1.7	0.4	3.2	2.6	2.8	1.8	7.4	1.6	0.6	0.7	4.3	4.1	10.2	37.3	0.7	0.2	2.1	1.5	0.0	1.0	0.9	0.5	6.6	1.9	2.9	5.7	2.1	0.8	0.8	7.4	0.8	1.6	36.4	2.4	2.1	0.3	3.3	3.1	2.7	28.2	4.9	2.6	0.0	0.1	0.4	0.1	56.9	95.8	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	21.1	0.1	95.8	0.0	13.2	59.0	0.0	0.0	0.6	10.5	0.4	56.9	0.1	0.1	0.8	9.9	0.6	0.6	0.5	0.5	0.6	0.7	0.7	0.2	0.5	0.3
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	1.2	0.3	0.3	11.8	0.6	7.5	1.8	0.5	0.3	0.5	1.5	0.2	0.0	2.2	0.3	0.4	2.8	0.6	1.3	0.6	0.2	0.2	0.8	0.4	2.6	5.8	0.4	0.0	0.4	0.5	0.0	0.3	1.3	0.2	0.7	1.5	0.2	1.0	0.0	1.2	0.9	3.6	0.4	1.2	4.9	1.7	26.7	0.3	26.7	0.7	1.7	7.3	0.8	1.0	2.8	1.5	2.1	0.6	0.0	1.2	0.4	7.5	8.2	7.6	8.6	0.5	1.0	6.4	6.9	5.3	13.7	13.5	6.4	3.1	18.5	4.0	3.8	12.3	13.7	6.7	13.1	0.1	11.5	9.2	6.7	3.8	0.3	5.3	9.5	0.6	0.5	10.3	6.4	6.2	8.1	16.3	6.9	3.9	10.7	3.1	6.7	5.7	11.1	9.6	5.0	2.0	5.3	3.1	4.5	6.1	4.2	2.4	4.2	5.0	3.2	6.1	7.0	6.8	12.1	3.1	3.5	9.0	3.6	7.7	7.3	0.4	0.6	2.1	0.2	0.5	0.2	0.7	0.8	0.0	1.1	2.8	1.2	0.2	0.2	0.0	0.0	1.5	0.1	0.4	0.3	0.6	0.5	0.3	0.2	0.2	0.4	0.0	0.2	0.3
HIST1H4F	"H4, H4/c, H4FC"	ENSG00000274618	"Histone cluster 1 H4 family member f"	P62805	6	26240426-26240737	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 118.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.8;MOLT-4: 11.0;REH: 5.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"										"unprognostic (1.47e-1)"				"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"			1.2	0.5	0.0	8.8	0.0	7.1	0.5	0.0	1.7	0.9	1.3	0.0	1.8	0.5	1.2	2.2	5.9	0.5	1.4	1.8	0.0		1.2	0.5	2.1	4.5	0.0	0.0	0.6	0.5	0.5	0.0	4.1	0.0	0.6	1.0	0.1	0.5	0.5	0.5	0.5	1.3	0.5	0.0	9.3	0.8	18.9	0.0	118.4	3.1	3.7	19.1	2.4	0.0	7.9	7.9	14.8	3.6	2.2	5.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.8	11.0	1.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	4.3	3.9	2.8	3.2	6.2	4.9	5.1	4.6	7.9	4.3	2.7	14.8	2.2	2.4	7.9	1.3	2.0										
HIST2H2AA4	H2A/r	ENSG00000272196	"Histone cluster 2 H2A family member a4"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 164.8;lymphoid tissue: 101.1"	"Cell line enhanced"	"Detected in many"		"SiHa: 26.8;U-266/70: 66.9;U-266/84: 59.4"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Cell type enriched"	"Detected in all"	5	"neutrophil: 164.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 164.8"									HPA041189	Supported									"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				4.5	6.5	0.0	9.8	1.2	9.0	2.5	0.3	2.6	5.2	5.7	1.5	2.5	5.7	5.5	3.4	9.1	2.4	4.2	4.0	0.7		3.0	2.5	8.8	7.1	0.1	0.0	4.3	5.0	0.0	0.5	6.5	1.6	9.5	0.0	2.1	4.2	2.6	3.5	5.8	5.4	0.9	0.8	8.4	4.2	21.6	0.1	101.1	1.9	4.8	11.5	5.8	2.3	9.3	17.2	164.8	17.9	3.5	4.2	18.8	3.8	9.6	1.2	2.2	0.0	1.2	3.1	8.1	0.0	0.0	0.0	6.4	3.9	0.0	9.1	0.0	5.2	0.0	0.0	0.0	5.2	12.6	1.2	7.9	4.3	0.0	1.1	7.4	0.0	0.0	0.0	0.0	0.0	8.2	19.3	0.0	24.3	4.1	1.2	3.6	10.0	3.7	1.5	6.6	0.0	2.0	9.7	4.1	26.8	7.4	2.1	12.7	2.6	0.0	2.7	20.5	3.7	1.0	66.9	59.4	4.5	0.0	6.1	3.1	24.2	17.9	32.8	3.2	10.5	3.3	5.9	2.8	3.0	12.0	9.3	2.2	2.0	164.8	3.5	12.4	17.2	4.2	18.8										
HIST2H2AB		ENSG00000184270	"Histone cluster 2 H2A family member b"	Q8IUE6	1	149887524-149887916	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 126.3"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.8;U-266/70: 4.8;U-266/84: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011483, HPA041189"	Supported		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB011483: AB_732909, HPA041189: AB_2677357"	"unprognostic (6.31e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"		"unprognostic (9.97e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.36e-2)"	2.4	1.6	1.2	6.4	1.6	21.1	2.9	2.6	2.4	6.8	2.6	0.6	0.6	1.2	1.9	1.6	5.1	1.5	2.2	1.5	1.4	1.3	1.6	1.8	4.2	3.0	1.2	1.9	7.4	3.0	2.2	1.4	2.3	0.0	4.2	2.0	3.9	1.9	1.9	2.5	4.7	2.9	4.0	2.7	4.8	1.9	2.1	0.1	126.3	1.7	2.1	9.0	7.1	2.4	10.2	4.3	11.6	2.0	4.3	4.5	0.8	1.3	0.0	0.7	0.7	0.0	0.0	1.1	0.9	0.0	0.0	1.4	0.0	0.9	0.8	0.5	0.0	1.0	1.0	0.0	0.0	0.3	1.5	0.0	0.8	0.7	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	1.0	1.1	0.7	0.0	7.8	3.3	0.9	1.7	1.6	0.5	1.3	0.0	0.5	2.3	1.0	2.2	0.0	0.1	0.2	3.4	0.0	0.9	3.3	0.0	0.7	4.8	5.2	1.4	2.0	0.3	0.6	1.3	1.6	0.8	2.7	2.0	2.7	3.8	4.5	4.0	2.3	10.2	2.7	2.7	11.6	4.3	1.9	4.3	2.6	0.8	1.2	1.6	2.6	2.4	1.4	1.3	1.2	1.9	0.0	0.1
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186387-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 7.6;tongue: 12.2;urinary bladder: 4.4"	"Group enriched"	"Detected in some"	37	"Karpas-707: 7.2;U-266/84: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"					"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.5	0.6	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	12.2	7.6	4.4	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52244537	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"esophagus: 2.2;lymphoid tissue: 6.4;urinary bladder: 2.4"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"											"unprognostic (3.02e-1)"	"unprognostic (2.52e-1)"			0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.6	0.2	0.1	0.0			0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2			0.0		6.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3										
IL21R	CD360	ENSG00000103522	"Interleukin 21 receptor"	Q9HBE5	16	27402162-27452042	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 17.9;lymphoid tissue: 47.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.1;HDLM-2: 42.9;Karpas-707: 19.9;RH-30: 15.1;RPMI-8226: 24.0;U-266/70: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042296	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA042296: AB_10806236"	"unprognostic (2.91e-2)"	"unprognostic (2.65e-3)"	"unprognostic (6.64e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.14e-1)"	"prognostic favourable (7.29e-4)"	"unprognostic (8.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.50e-6)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-10)"	"unprognostic (8.79e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.58e-2)"	0.8	0.6	0.6	33.6	3.7	5.7	0.6	0.5	1.6	0.5	0.9	0.3	0.0	0.5	0.5	1.3	1.0	0.8	1.1	1.8	0.6	2.3	1.6	1.3	5.6	20.9	1.3	0.0	0.5	0.5	0.0	0.9	0.9	1.9	0.9	0.9	1.8	3.7	0.3	0.7	0.7	4.0	0.6	1.7	11.2	1.3	1.0	1.4	47.8	1.3	0.8	31.7	2.7	0.8	11.5	1.6	0.7	17.9	6.3	10.3	4.2	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.3	0.0	0.0	0.9	0.0	0.0	10.1	0.1	0.8	0.0	0.0	0.0	0.0	42.9	0.0	2.1	0.0	0.2	1.4	0.0	0.6	1.5	0.0	2.7	0.0	0.0	0.1	19.9	1.5	0.0	0.0	0.2	0.3	0.0	0.1	15.1	24.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	1.1	0.8	0.2	0.2	0.0	10.0	3.5	2.3	2.1	0.5	0.0	0.2	0.3	0.0	9.8	5.8	3.6	1.0	6.3	10.3	1.6	11.5	6.9	6.7	0.7	6.3	17.9	0.7	7.6	4.2	0.6	3.7	0.5	1.6	0.6	2.3	1.3	0.0	1.9	1.4
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947711	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 12.3;lymphoid tissue: 34.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"				"Nucleoplasm, Microtubule ends"	"Nucleoplasm, Microtubule ends"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.7	0.6	0.5	8.2	0.4	12.3	0.4	0.4	0.5	0.9	1.6	0.3	0.7	2.9	0.5	0.6	3.2	0.3	1.3	1.5	0.5	0.5	0.5	0.7	0.8	5.9	0.6	0.1	0.6	0.4	0.0	0.4	1.9	0.2	0.5	1.5	0.1	0.7	0.1	0.4	2.9	2.5	0.8	0.4	1.7	1.5	3.8	0.1	34.7	0.4	2.7	7.6	0.7	1.1	1.1	0.8	2.0	0.6	1.0	1.4	0.4	14.2	18.6	15.9	14.9	0.3	1.3	13.4	12.2	4.6	15.4	12.1	15.4	12.3	12.6	5.3	4.6	15.7	11.0	4.9	7.8	26.0	16.4	16.3	20.9	9.5	0.0	13.4	14.3	0.3	0.2	13.3	5.3	7.8	12.2	21.5	7.9	11.1	24.9	13.3	11.7	12.8	19.1	24.3	8.4	2.5	7.7	12.0	11.7	8.2	7.4	4.5	13.9	9.6	5.1	23.0	22.8	13.6	25.6	6.9	6.8	15.5	7.4	10.2	14.8	1.8	0.6	0.4	0.5	0.3	0.4	0.8	0.7	0.5	0.3	1.1	0.4	0.5	2.0	1.0	0.3	0.8	1.4	0.4	0.5	0.4	0.4	0.4	0.5	0.5	0.6	0.1	0.2	0.1
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391536-33409924	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 60.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	0.9	0.8	0.0	18.0	0.3	9.6	1.5	0.0	0.5	1.7	5.7	0.1	0.3	3.0	0.9	1.6	10.1	0.5	2.2	0.8	0.0	0.0	0.7	0.7	2.2	6.3	0.1	0.2	1.5	0.3	0.2	0.2	3.6	0.4	0.6	2.5	0.6	1.7	0.1	0.4	3.3	4.2	0.7	0.4	4.7	2.5	9.7	0.2	60.9	0.4	7.4	14.6	0.6	2.8	0.8	0.3	0.0	0.1	0.2	1.4	0.7	10.6	1.8	10.2	10.7	0.2	0.4	6.2	7.7	1.9	6.1	5.2	3.7	4.7	7.0	3.0	1.6	5.8	2.6	3.6	6.7	4.1	5.8	5.7	8.6	5.4	0.0	4.6	6.3	0.0	0.9	5.1	1.5	0.5	1.7	17.4	4.6	2.7	2.7	9.3	4.7	2.2	7.0	5.7	2.4	0.9	2.4	9.3	4.1	2.8	5.9	1.4	6.2	4.8	1.4	3.2	10.0	5.4	11.4	5.7	10.9	6.8	0.0	6.9	5.7	0.0	0.1	0.0	0.4	0.0	0.6	0.8	0.3	1.4	0.3	0.8	0.3	0.3	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.2	0.4	0.2
KLRF1	"CLEC5C, NKp80"	ENSG00000150045	"Killer cell lectin like receptor F1"	Q9NZS2	12	9827481-9845007	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.2;lymphoid tissue: 24.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.2;CAPAN-2: 1.9;HAP1: 3.0;U-937: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 95.2"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 95.2"					"Low region specificity"	"Detected in some"														"unprognostic (2.96e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.95e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.89e-3)"	3.3	0.7	0.9	3.0	1.2	8.8	1.4	0.6	0.8	1.0	0.6	0.3	0.1	0.0	0.7	3.3	0.8	1.1	0.9	1.0	1.0	0.8	0.8	5.8	10.0	4.0	0.9	0.7	0.7	1.1	0.0	0.9	1.7	0.4	1.5	0.5	0.9	1.5	0.8	1.3	0.8	1.0	0.5	1.0	24.7	0.7	1.0	0.4	2.0	0.8	0.5	2.8	1.0	0.7	0.4	0.3	0.9	0.2	95.2	14.9	11.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	3.2	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.1	0.0	0.0	1.0	0.1	1.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.3	1.3	0.0	0.1	0.1	11.6	0.2	14.9	0.4	0.6	5.5	0.2	0.1	0.2	5.8	0.9	95.2	0.1	0.3	0.1	11.1	0.9	1.2	0.6	0.8	1.0	0.8	0.9	0.7	0.4	0.4
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Low region specificity"	"Detected in all"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"	"Intermediate filaments, Cytosol"	"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
LCE3C	"LEP15, SPRL3A"	ENSG00000244057	"Late cornified envelope 3C"	Q5T5A8	1	152600662-152601086	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"lymphoid tissue: 24.2;tongue: 17.3"	"Group enriched"	"Detected in some"	31	"hTCEpi: 1.3;hTERT-HME1: 4.7"	"Group enriched"	"Detected in some"	31	"head and neck cancer: 3.8;melanoma: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	17.3	24.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYPD2	"LYPDC2, RGTR430, UNQ430"	ENSG00000197353	"LY6/PLAUR domain containing 2"	Q6UXB3	8	142750150-142752534	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9"	"Group enriched"	"Detected in some"	18	"EFO-21: 14.8;HaCaT: 4.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"non-classical monocyte: 76.5"	"Lineage enriched"	"Detected in many"	20	"monocytes: 76.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028599	Uncertain				"Intracellular and membrane"					"HPA028599: AB_10603777"		"prognostic favourable (2.00e-4)"		"unprognostic (3.10e-2)"		"prognostic favourable (2.63e-4)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.11e-3)"		"unprognostic (1.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.3	0.0	77.5	0.2	0.1	1.2	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	7.7	0.0	0.5	6.5	0.0	0.0	0.0	0.1	11.6	0.0	0.0	5.7	0.0	37.9	69.2	0.0	10.1	0.2	3.7	0.0	76.5	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.8	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	76.5	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell line enriched"	"Detected in some"	12	"NB-4: 87.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	57000000	57000000	Cytosol	Cytosol	"CAB000348: , CAB068199: , CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	87.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	2.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455752-60470760	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1"	"Group enriched"	"Detected in some"	25	"Daudi: 120.0;U-698: 60.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	105	"memory B-cell: 77.7;naive B-cell: 77.7"	"Lineage enriched"	"Detected in single"	105	"B-cells: 77.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favourable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	1.6	0.3	0.3	79.0	0.3	3.6	0.6	0.3	0.3	0.5	2.0	0.0	0.0	0.2	0.4	0.5	7.0	0.4	1.3	0.7	0.3	0.3	2.0	0.9	2.7	81.2	0.3	0.1	0.3	0.4	0.0	0.4	0.4	0.1	1.1	1.7	0.6	14.5	0.2	0.3	0.3	46.1	0.1	0.4	90.7	2.6	0.6	0.0	15.7	2.5	2.7	134.1	6.4	0.8	77.7	0.0	0.2	0.0	0.7	0.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	77.7	0.3	0.6	0.0	77.7	0.0	0.2	0.2	0.7	0.0	0.0	0.0	3.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.0
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell line enhanced"	"Detected in many"		"HL-60: 38.9;MOLT-4: 70.8;NB-4: 36.9;REH: 43.7;THP-1: 61.8;U-937: 33.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favourable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favourable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.8	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	24.8	0.1	0.0	0.0	38.9	19.6	0.0	0.0	0.1	0.0	0.0	20.1	3.7	0.2	2.0	70.8	36.9	0.2	0.3	43.7	1.0	6.0	0.0	0.2	1.9	1.2	0.0	1.9	0.0	1.4	61.8	0.0	0.0	0.3	1.4	0.4	4.7	1.2	12.0	0.0	33.7	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6
OTOA	"CT108, DFNB22"	ENSG00000155719	Otoancorin	Q7RTW8	16	21663971-21761935	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 4.1;lymphoid tissue: 4.5;testis: 7.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.2;THP-1: 1.6"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	10	"myeloid DC: 1.7;plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041405	Approved				"Secreted in other tissues"	44000	44000			"HPA041405: AB_10796344"	"unprognostic (7.96e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.71e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.18e-2)"	0.2	0.3	0.2	0.0	0.1	0.4	0.1	0.0	0.7	0.0	0.1			0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.3	0.3	0.1		0.0	0.0	0.0	0.8	0.0		0.1	0.1		0.1	0.0	0.0	0.0	0.0	0.0	0.9	4.5	0.0	7.8			0.0		0.1	0.0	0.0	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0										
P2RY6	P2Y6	ENSG00000171631	"Pyrimidinergic receptor P2Y6"	Q15077	11	73264505-73298617	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 36.4;lymphoid tissue: 31.1;placenta: 38.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 32.9;EFO-21: 10.4;MCF7: 15.3;SK-BR-3: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 10.9;plasmacytoid DC: 36.4"	"Lineage enriched"	"Detected in many"	20	"dendritic cells: 36.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022740, HPA074751"	Enhanced									"CAB022740: , HPA074751: "	"unprognostic (2.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.93e-3)"	"unprognostic (4.00e-3)"	"unprognostic (1.86e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (2.50e-7)"	"unprognostic (1.48e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.05e-1)"	2.5	1.8	2.7	8.3	3.5	0.8	1.5	0.5	3.2	2.5	2.1	3.1	0.0	3.0	1.2	2.6	2.9	1.6	2.4	2.7	1.8	1.0	6.2	3.7	3.0	4.8	2.3	1.7	2.1	1.7	0.5	2.7	38.0	2.8	2.1	2.2	5.9	2.0	0.9	2.9	0.9	4.9	3.4	3.8	31.1	1.9	0.8	3.5	3.3	5.0	1.8	3.1	4.1	1.6	0.0	36.4	0.1	1.8	1.5	0.1	1.0	0.7	7.8	0.0	32.9	0.0	0.0	6.8	0.1	0.0	0.1	0.1	7.1	0.1	0.0	10.4	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.7	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.1	15.3	0.1	1.3	0.1	0.0	0.0	0.0	0.9	5.4	0.0	0.1	0.5	1.4	26.6	0.0	6.3	1.4	0.1	1.3	0.1	1.0	0.1	0.3	0.0	0.0	1.3	2.1	0.0	0.0	1.1	0.0	0.0	1.8	0.1	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.1	1.5	0.6	36.4	0.0	1.0	2.7	3.5	0.5	3.2	1.8	1.0	2.3	1.7	2.8	3.5
PSD4	"EFA6B, TIC"	ENSG00000125637	"Pleckstrin and Sec7 domain containing 4"	Q8NDX1	2	113157325-113209396	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"lymphoid tissue: 98.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.5;HMC-1: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA034722, HPA034723"	Approved									"HPA034722: AB_10669730, HPA034723: AB_2674299"	"unprognostic (1.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.13e-3)"	"prognostic favourable (9.91e-5)"	"unprognostic (6.56e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-2)"	"prognostic favourable (4.00e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.60e-3)"	5.2	11.7	2.6	53.9	3.7	6.2	5.5	0.8	2.1	2.3	5.6	2.9	2.3	5.9	2.6	4.7	8.5	1.9	8.1	3.6	2.6	1.6	3.9	16.2	14.1	25.9	3.1	1.9	2.2	9.5	11.1	3.0	2.9	2.8	6.9	4.4	3.0	11.6	2.5	1.6	6.7	13.6	2.1	2.4	29.3	8.4	1.5	3.4	98.7	8.4	2.5	40.4	4.7	3.1	4.8	7.0	14.2	3.7	7.1	6.4	5.2	7.7	0.5	0.5	0.0	0.0	0.0	14.6	1.0	3.2	0.5	0.4	0.7	9.8	20.5	1.5	0.5	6.9	0.0	2.4	0.1	14.1	0.0	13.3	0.3	4.6	0.3	16.8	25.7	0.0	2.4	0.3	0.4	0.0	9.9	8.7	0.0	5.9	16.6	16.6	0.3	1.3	0.2	0.0	11.1	0.2	3.4	0.6	0.0	0.6	10.3	0.0	3.4	15.2	0.0	0.1	0.2	0.1	2.4	9.2	5.4	8.1	0.4	11.7	0.0	1.7	3.3	3.6	6.3	2.6	6.2	4.8	3.4	6.4	3.9	4.6	3.8	4.3	14.2	7.1	3.7	7.0	3.3	5.2	2.6	3.7	0.8	2.1	2.6	1.6	3.1	1.9	2.8	3.4
PTPRCAP	"CD45-AP, LPAP"	ENSG00000213402	"Protein tyrosine phosphatase, receptor type C associated protein"	Q14761	11	67435510-67438067	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 104.7;lymphoid tissue: 149.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.1;HDLM-2: 27.3;MOLT-4: 23.2;NB-4: 110.8;U-698: 27.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Low region specificity"	"Detected in many"			HPA043734	Enhanced				"Intracellular and membrane"					"HPA043734: AB_10962214"																		1.8	1.2	1.0	79.2	1.3	8.5	1.6	1.8	0.6	2.6	10.1	0.4	0.4	5.5	1.9	1.8	5.9	3.0	6.2	1.5	1.0	0.8	3.9	2.3	6.9	71.4	1.2	0.3	1.9	1.4	0.2	1.7	1.1	0.4	3.8	1.0	1.5	14.6	0.9	1.3	1.1	21.5	0.6	1.8	56.5	8.4	2.5	0.3	149.8	5.0	4.2	67.1	3.0	2.1	104.7	50.3	4.1	0.4	45.5	97.2	58.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.0	0.1	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	16.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.4	23.2	110.8	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	27.5	0.0	0.0	0.0	1.2	0.3	4.1	97.2	0.3	82.7	80.5	60.5	85.6	0.7	104.7	44.9	68.9	2.0	45.5	0.4	50.3	78.4	58.1	1.0	1.3	1.8	0.6	1.0	0.8	1.2	0.3	0.4	0.3
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7123684-7128942	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3"	"Cell line enhanced"	"Detected in many"		"HEL: 6.8;Hep G2: 15.2;K-562: 31.3"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 1.3;T-cells: 2.4"					"Low region specificity"	"Detected in all"			HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favourable (3.68e-4)"	1.5	2.6	0.3	18.2	0.3	0.7	1.3	0.6	0.3	2.8	1.7	0.1	2.3	1.4	5.3	13.3	2.3	1.5	3.6	2.3	0.3	0.3	99.9	74.2	3.6	54.3	0.2	0.0	3.5	1.3	0.2	1.6	0.1	0.1	2.6	1.6	0.7	5.9	3.3	0.4	0.7	4.4	1.8	0.2	44.3	1.2	1.2	0.0	6.2	2.0	0.7	10.1	2.3	1.4	0.1	0.0	1.3	0.0	0.0	2.4	0.1	1.8	3.1	0.0	1.0	0.0	0.0	0.7	1.1	0.0	0.0	0.2	1.7	1.9	1.1	0.5	0.0	2.2	0.1	0.0	0.0	2.7	0.0	6.8	4.9	15.2	0.0	0.4	2.0	0.3	0.1	0.0	0.0	0.0	31.3	1.4	0.0	0.0	0.1	0.4	0.4	0.1	0.4	0.0	0.1	0.1	2.6	0.1	0.3	2.7	1.1	0.0	0.6	1.1	1.1	1.3	1.3	3.7	0.5	0.6	0.2	0.2	0.9	1.4	0.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.4	0.1	0.3	0.3	0.6	0.3	0.3	0.3	0.2	0.0	0.1	0.0
SCIMP	"C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783"	ENSG00000161929	"SLP adaptor and CSK interacting membrane protein"	Q6UWF3	17	5208961-5234860	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 49.6;lymphoid tissue: 84.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 6.8;U-698: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 22.3;intermediate monocyte: 47.8;memory B-cell: 30.6;myeloid DC: 16.8;naive B-cell: 23.0;non-classical monocyte: 49.6"	"Group enriched"	"Detected in many"	8	"B-cells: 30.6;dendritic cells: 16.8;monocytes: 49.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006117	Enhanced									"HPA006117: AB_1858633"	"unprognostic (2.53e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.95e-2)"	6.1	2.8	1.3	19.5	1.5	1.7	1.7	0.9	1.1	1.5	2.3	3.2	0.2	2.0	1.4	2.2	3.8	2.0	3.1	2.5	1.3	1.5	3.2	10.0	10.8	55.1	2.1	0.2	2.4	1.6	0.0	1.5	2.2	3.6	1.9	1.8	2.2	4.5	0.2	1.4	1.1	9.9	2.3	3.9	84.9	1.8	1.0	1.0	3.0	1.5	0.7	31.9	3.6	1.3	30.6	16.8	4.0	49.6	1.1	0.4	11.1	1.2	2.0	3.1	4.6	0.1	0.0	3.4	1.4	0.0	0.0	0.0	0.9	2.7	6.3	1.3	0.0	1.5	0.0	0.0	0.0	0.8	2.8	2.4	6.8	0.8	0.0	0.4	1.0	0.0	0.3	0.0	0.3	0.0	0.1	1.7	0.0	2.0	3.0	1.0	1.4	2.0	2.7	0.7	0.7	0.0	0.8	2.4	1.1	2.4	0.8	1.7	3.4	3.1	0.4	0.5	1.7	1.9	0.8	1.0	0.5	14.0	1.9	0.7	0.9	2.5	22.3	0.5	0.3	47.8	0.3	30.6	0.2	0.2	16.8	23.0	0.4	0.3	4.0	1.1	49.6	0.7	0.2	11.1	1.3	1.5	0.9	1.1	1.3	1.5	2.1	0.2	3.6	1.0
SERPINA9	"CENTERIN, GCET1, SERPINA11b"	ENSG00000170054	"Serpin family A member 9"	Q86WD7	14	94462717-94479689	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 37.6"	"Cell line enriched"	"Detected in single"	64	"Daudi: 38.8"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.2"	"Region enriched"	"Detected in single"	18	"basal ganglia: 64.3"										"Secreted to blood"						"unprognostic (1.32e-2)"	"unprognostic (1.05e-1)"				"unprognostic (1.94e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.67e-2)"		"unprognostic (1.38e-2)"			"unprognostic (1.16e-1)"				0.1	0.1	0.1	37.6	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	1.8	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.6	0.2	20.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	6.0	2.7	0.0	0.1	0.6	0.1	0.1	0.0	0.4	0.3	0.3	36.0	0.1	0.2	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SERPINB11	EPIPIN	ENSG00000206072	"Serpin family B member 11 (gene/pseudogene)"	Q96P15	18	63647579-63726432	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 19.5;lymphoid tissue: 19.1;prostate: 23.7;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;BEWO: 2.0;hTCEpi: 1.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"															"unprognostic (5.04e-3)"				"unprognostic (4.76e-2)"		"unprognostic (4.05e-2)"				"unprognostic (3.44e-1)"					"unprognostic (2.62e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0		0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	23.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	19.1	2.0	2.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0										
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1"	"Group enriched"	"Detected in some"	132	"HaCaT: 64.1;hTCEpi: 24.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		59000	59000	"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.1	37.7	0.1	0.0	0.0	0.1	3.1	0.1	70.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	10.9	0.1	0.2	5.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.0	0.1	107.2	54.2	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIRPG	"bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma"	ENSG00000089012	"Signal regulatory protein gamma"	Q9P1W8	20	1629152-1657779	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 60.1;lymphoid tissue: 44.0"	"Cell line enhanced"	"Detected in some"		"NB-4: 16.7;RT4: 4.5;THP-1: 2.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 60.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 60.1"																				"unprognostic (3.35e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.32e-3)"	"prognostic favourable (1.05e-6)"	"unprognostic (4.23e-3)"	"prognostic favourable (2.24e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-2)"	"prognostic favourable (7.36e-7)"	"unprognostic (1.62e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (1.47e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.95e-3)"	0.8	0.4	0.3	11.7	0.3	1.5	0.5	0.3	0.4	0.7	2.3	0.1	0.4	0.9	0.5	0.6	1.4	0.7	2.1	0.4	0.3	0.3	1.1	1.1	1.4	20.5	0.3	0.1	0.7	0.4	0.0	0.3	0.4	0.2	0.9	1.8	0.6	4.6	0.9	0.4	0.4	8.8	0.6	0.4	14.0	1.6	0.4	0.1	44.0	1.3	0.7	21.3	2.9	0.8	0.1	1.1	1.0	0.2	9.5	60.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.1	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.2	0.1	12.3	0.1	34.1	0.1	38.4	29.0	0.1	0.1	40.5	33.3	1.0	9.5	0.1	1.1	60.1	16.7	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.2	0.1
SIT1	SIT	ENSG00000137078	"Signaling threshold regulating transmembrane adaptor 1"	Q9Y3P8	9	35649295-35650950	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 56.9;lymphoid tissue: 80.9"	"Group enriched"	"Detected in some"	5	"Daudi: 40.5;HDLM-2: 25.0;U-698: 36.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	42	"gdTCR: 21.3;MAIT T-cell: 36.3;memory B-cell: 37.1;memory CD4 T-cell: 45.0;memory CD8 T-cell: 39.8;naive B-cell: 30.9;naive CD4 T-cell: 31.5;naive CD8 T-cell: 31.0;plasmacytoid DC: 33.9;T-reg: 56.9"	"Group enriched"	"Detected in many"	50	"B-cells: 37.1;dendritic cells: 33.9;T-cells: 56.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA018506	Enhanced									"HPA018506: AB_2669896"	"unprognostic (4.28e-3)"	"prognostic favourable (6.56e-4)"	"unprognostic (8.01e-3)"	"prognostic favourable (1.94e-6)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (1.75e-2)"	"unprognostic (9.34e-3)"	"prognostic favourable (8.17e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.34e-2)"	0.8	0.4	0.2	13.8	0.2	0.7	0.6	0.2	0.2	0.6	1.3	0.3	0.5	1.3	0.8	0.4	1.8	0.5	1.3	0.9	0.2	0.2	1.2	0.5	1.6	25.4	0.2	0.2	0.4	0.4	0.0	0.3	0.2	0.3	0.7	1.0	0.4	2.3	0.3	0.4	0.4	11.9	0.2	0.4	23.5	2.1	0.3	0.1	80.9	0.9	0.7	17.9	2.6	0.7	37.1	33.9	0.8	0.2	0.1	56.9	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	0.1	0.2	0.1	21.3	0.1	36.3	37.1	45.0	39.8	0.3	30.9	31.5	31.0	0.8	0.1	0.1	33.9	56.9	19.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766727	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 71.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.7;HaCaT: 4.3;RH-30: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA026871	Enhanced		Supported	Cytosol		210000	210000	Cytosol	Cytosol	"HPA026871: AB_1857536"	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.6	0.2	0.1	0.5	0.1	0.4	0.5	0.1	0.1	0.7	1.4	0.1	0.1	0.1	1.1	1.1	2.5	0.9	0.6	0.4	0.1	0.1	0.1	11.7	0.5	19.9	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.2	0.5	0.2	0.1	2.1	0.3	0.1	0.2	0.3	0.2	0.1	71.3	0.3	1.5	0.1	0.2	0.7	0.5	0.4	0.3	0.4	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.7	0.2	0.0	0.0	15.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	4.3	0.0	0.0	0.0	0.0	1.1	0.4	0.7	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.1	2.5	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.6	0.8	0.4	0.0	1.1	0.2	0.2	0.0	0.3	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Centriolar satellite, Cytosol"	"Mitotic spindle, Centriolar satellite, Cytosol"	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.2	21.0	32.2	18.5	1.7	3.6	18.2	28.6	15.3	32.9	21.8	23.2	30.5	32.2	12.2	15.6	17.1	34.0	20.8	33.5	14.1	18.4	27.3	17.4	21.4	1.6	36.9	23.2	1.5	1.4	20.7	12.0	24.9	24.6	25.5	31.2	20.6	48.6	52.8	34.8	27.6	34.4	22.8	12.9	18.7	38.2	25.1	15.8	17.2	10.9	8.0	21.4	21.4	14.6	19.2	23.0	17.3	43.1	17.9	23.6	51.6	11.1	35.7	27.1	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 55.4;bone marrow: 16.0;intestine: 14.5;lymphoid tissue: 35.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;HEL: 6.2;MOLT-4: 23.1;NB-4: 27.8;U-937: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069743	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA069743: AB_2686186"	"prognostic favourable (3.83e-4)"	"prognostic favourable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favourable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	1.3	0.4	0.7	20.8	0.8	16.0	0.7	0.4	0.4	0.9	3.0	0.4	0.7	2.4	0.5	0.6	1.6	1.3	1.5	0.8	1.1	0.3	1.9	1.5	5.2	22.4	0.5	0.8	0.6	0.5	0.0	0.4	0.7	0.4	1.1	0.4	1.4	3.6	0.2	0.4	0.4	14.5	0.2	0.8	35.0	3.1	0.7	0.9	27.1	4.6	1.0	27.8	1.8	1.8	39.1	13.1	52.5	30.6	25.9	55.4	49.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.4	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	23.1	27.8	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	5.0	0.0	11.5	0.0	33.2	10.0	52.5	51.1	23.7	36.2	37.6	44.5	44.7	13.1	39.1	46.8	42.3	49.1	25.9	30.6	11.0	55.4	49.2	0.7	0.8	0.4	0.4	1.1	0.3	0.5	0.8	0.4	0.9
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295069	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA054641: AB_2682554, HPA065897: AB_2685576"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	7.1	0.9	3.4	0.0	0.0	0.2	0.1	1.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.4	5.0	0.0	12.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	30.6	61.2	0.5	0.0	23.3	4.2	7.9	0.1	0.1	0.7	0.0	58.1	0.0	0.2	118.1	5.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.0	3.0	74.6	0.8	0.2	0.6	0.1	33.7	0.0	0.2	1.6	0.4	0.2	0.8	0.0	0.8	3.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	96.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Group enriched"	"Detected in some"	55	"Daudi: 37.3;REH: 12.5;U-698: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol				Cytosol	Cytosol	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4
TMIGD2	"CD28H, IGPR-1, MGC23244"	ENSG00000167664	"Transmembrane and immunoglobulin domain containing 2"	Q96BF3	19	4292232-4302431	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 34.0;lymphoid tissue: 43.8"	"Group enriched"	"Detected in some"	4	"BEWO: 9.3;HEL: 21.4;MOLT-4: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 34.0"	"Group enriched"	"Detected in many"	37	"dendritic cells: 30.8;NK-cells: 23.0;T-cells: 34.0"					"Low region specificity"	"Detected in many"			HPA011081	Approved									"HPA011081: AB_1079372"	"unprognostic (1.08e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-4)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.78e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.10e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.12e-4)"	"unprognostic (8.89e-4)"	0.4	0.2	2.8	6.0	1.6	6.4	0.2	0.4	1.8	0.4	3.4	2.2	0.2	2.1	0.7	0.2	0.7	0.6	1.0	0.2	2.1	1.9	0.4	1.0	1.4	9.2	3.4	0.8	0.4	0.2	0.1	0.2	0.9	1.0	0.5	0.6	0.3	0.7	0.2	0.2	0.2	6.1	0.2	2.4	9.7	1.0	0.7	1.2	43.8	0.6	0.5	5.3	1.0	0.3	0.1	30.8	0.7	0.1	23.0	34.0	7.3	0.0	0.1	0.2	0.2	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	21.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.1	0.2	0.0	3.7	1.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.7	0.0	34.0	0.0	4.4	6.6	0.1	0.1	25.5	12.9	0.7	23.0	0.1	30.8	0.4	7.3	2.8	1.6	0.4	1.5	2.1	1.9	3.4	0.8	1.0	1.2
TNFAIP8L2	FLJ23467	ENSG00000163154	"TNF alpha induced protein 8 like 2"	Q6P589	1	151156629-151159749	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 63.1;lymphoid tissue: 38.7"	"Cell line enhanced"	"Detected in some"		"HEL: 12.5;HL-60: 7.3;HMC-1: 19.5;NB-4: 10.6;THP-1: 40.5;U-937: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062742			Approved	Vesicles				Vesicles	Vesicles	"HPA062742: "	"unprognostic (3.19e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.15e-3)"	"prognostic favourable (3.64e-4)"	"unprognostic (9.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.03e-2)"	"prognostic unfavourable (3.53e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.23e-1)"	8.5	4.2	5.7	13.8	8.8	4.1	2.7	1.3	4.5	2.0	3.2	4.0	0.0	3.9	2.0	2.6	2.1	3.0	4.1	2.8	4.1	3.3	2.9	6.0	8.2	20.9	8.2	2.2	1.8	2.0	0.3	1.9	7.0	7.2	2.6	4.6	1.8	6.4	1.4	1.0	2.7	6.9	3.9	8.0	38.7	2.5	1.0	6.9	21.0	1.8	1.2	12.8	7.2	1.9	17.7	56.4	63.1	50.6	47.1	43.9	44.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.5	0.1	0.0	0.0	7.3	19.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	10.6	0.0	0.0	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	40.5	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.8	0.0	16.0	0.0	53.4	50.6	50.0	23.3	45.4	22.9	15.6	28.8	23.5	56.4	17.7	43.9	31.5	63.1	47.1	41.2	13.3	31.6	44.8	5.7	8.8	1.3	4.5	4.1	3.3	8.2	2.2	7.2	6.9
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754468	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 90.4;epididymis: 27.9;intestine: 32.7;lymphoid tissue: 77.9"	"Group enriched"	"Detected in some"	45	"Daudi: 56.9;REH: 67.3;U-698: 17.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	730	"memory B-cell: 79.9;naive B-cell: 90.4"	"Lineage enriched"	"Detected in single"	775	"B-cells: 90.4"	"Not detected"	"Not detected"							HPA003041	Supported				"Intracellular and membrane"					"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"	0.5	9.2	0.7	62.6	0.9	7.5	0.3	0.7	0.8	0.3	1.3	0.3	0.2	0.2	0.3	27.9	2.3	0.1	0.7	0.4	0.6	0.7	1.1	0.9	1.2	77.9	0.8	0.2	0.3	0.3	0.1	1.4	0.3	0.2	0.6	0.9	0.4	4.8	0.2	0.8	0.4	32.7	0.2	0.5	31.6	1.4	1.4	0.2	1.6	0.8	1.0	36.0	3.1	0.2	90.4	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.2	67.3	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.1	0.8	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.3	0.0	17.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.9	0.0	0.0	0.0	90.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.7	0.9	0.7	0.8	0.6	0.7	0.8	0.2	0.2	0.2
XCL1	"ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1"	ENSG00000143184	"X-C motif chemokine ligand 1"	P47992	1	168576473-168582077	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 33.8;lymphoid tissue: 29.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CACO-2: 4.8;Hep G2: 6.1;SCLC-21H: 5.8;U-266/70: 8.3;U-266/84: 3.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 33.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 33.8"									HPA057725	Approved				"Secreted to blood"					"HPA057725: AB_2683511"	"unprognostic (5.38e-3)"	"unprognostic (5.72e-2)"	"unprognostic (8.23e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.34e-10)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.15e-2)"	1.7	0.4	0.6	8.8	0.6	5.0	1.3	0.7	0.5	1.5	1.1	0.2	0.0	1.4	4.8	2.8	1.4	1.8	1.6	2.6	0.6	0.9	1.8	3.9	4.1	10.7	0.8	0.0	1.0	2.4	0.0	0.7	3.7	0.3	1.6	1.5	1.6	3.7	0.6	0.4	0.6	2.6	1.0	1.1	10.6	1.7	0.5	0.1	29.6	1.3	2.2	5.9	2.9	1.3	0.0	0.0	0.8	0.0	33.8	3.3	0.7	1.6	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	5.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	8.3	3.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.2	0.0	0.1	0.0	0.5	3.3	0.0	0.0	0.1	2.5	0.1	33.8	0.0	0.0	0.0	0.7	0.6	0.6	0.7	0.5	0.6	0.9	0.8	0.0	0.3	0.1
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713560-97739862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.4;lymphoid tissue: 107.1"	"Cell line enriched"	"Detected in some"	13	"MOLT-4: 61.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	41	"gdTCR: 37.4;MAIT T-cell: 25.4;memory CD4 T-cell: 19.6;memory CD8 T-cell: 29.2;naive CD4 T-cell: 14.3;naive CD8 T-cell: 21.9;NK-cell: 26.4;T-reg: 19.9"	"Group enriched"	"Detected in many"	53	"NK-cells: 26.4;T-cells: 37.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002625, HPA003134"	Enhanced									"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favourable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favourable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favourable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	2.2	0.5	0.3	18.1	0.6	11.2	1.5	0.7	0.6	1.2	3.7	0.7	0.3	2.9	1.2	1.1	1.7	1.5	2.8	0.9	0.4	0.8	2.2	2.3	5.8	28.1	0.8	0.6	0.9	1.3	0.0	0.7	0.9	0.6	2.1	0.6	1.0	5.5	1.0	0.7	1.0	12.3	0.7	0.7	24.8	3.2	1.4	0.6	107.1	2.5	1.1	20.8	3.0	1.7	0.4	0.2	0.5	0.2	26.4	37.4	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	61.5	0.1	0.0	0.0	2.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	37.4	0.1	25.4	0.0	19.6	29.2	0.0	0.4	14.3	21.9	0.5	26.4	0.2	0.2	19.9	14.3	0.3	0.6	0.7	0.6	0.4	0.8	0.8	0.6	0.6	0.6
AC010616.1		ENSG00000268041			19	41907705-41928516	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 5.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 9.5;HMC-1: 7.0;U-2 OS: 4.3;U-266/70: 3.8;U-698: 5.8;U-937: 4.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (1.97e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.88e-4)"	"unprognostic (3.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.21e-14)"	"unprognostic (5.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.98e-3)"	0.0	0.0		2.4		1.2	0.0		0.2	0.0	0.4			0.2	0.2	0.0	0.0	0.0	1.0	0.0			0.0	0.0	0.0	5.9			0.0	0.0	0.5		0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.6	0.0		2.2	0.8	0.7			0.0		2.4	0.0		0.1	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.1	0.7	0.3	0.0	0.3	0.2	0.3	0.2	0.0	0.8	9.5	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.4	7.0	0.1	0.4	0.4	0.2	0.0	0.3	0.5	0.0	1.0	0.0	0.0	0.0	0.3	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	4.3	0.2	0.0	3.8	0.2	5.8	0.2	4.1	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0										
AC012476.1		ENSG00000285396			15	40695129-40732158	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	5	"lymphoid tissue: 19.5;testis: 16.7"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA039310	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA039310: AB_2676434"																		0.4	0.8	0.0	4.2	0.0	0.9	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.8	2.1	0.2	1.4	0.9	0.0		0.2	0.3	0.8	0.9	0.0	0.0	0.3	0.5	0.9	0.0	3.9	0.0	0.1	0.0	0.0	0.3	0.0	1.8	0.9	1.2	0.0	0.2	3.0	1.6	16.7	0.0	19.5	0.1	2.1	6.1	0.0	0.0	1.3	1.0	2.3	0.4	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.5	1.2	0.2	1.0	0.2	1.1	0.3	0.4	1.3	0.2	0.3	2.3	1.2	0.1	1.0	0.3	0.1										
ADA		ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0"	"Cell line enriched"	"Detected in many"	8	"MOLT-4: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 64.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		650000	650000	"Plasma membrane"	"Plasma membrane"	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (6.77e-5)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	8.1	3.2	2.5	5.4	6.5	5.3	5.1	0.9	5.0	2.8	7.4	5.0	1.8	142.2	1.7	3.4	4.6	2.4	3.0	9.2	2.7	0.8	1.3	2.1	2.8	8.9	3.6	2.3	1.2	2.4	0.8	0.3	1.8	3.9	1.8	1.5	0.7	2.6	1.3	2.0	2.8	5.0	2.1	1.3	9.5	19.7	1.6	6.1	99.0	2.8	2.1	7.6	3.6	2.6	1.3	41.6	0.5	64.0	16.9	10.3	9.6	1.4	3.9	2.0	1.3	3.9	5.4	3.3	1.4	0.8	1.4	1.0	1.8	1.5	4.0	1.7	1.8	0.2	1.4	5.8	0.8	0.3	1.8	0.8	0.7	1.4	1.6	0.6	2.1	26.1	2.5	0.5	0.9	5.4	2.0	3.3	0.6	3.4	197.1	2.9	0.5	1.4	10.6	2.8	9.8	0.2	0.0	0.0	0.9	2.1	0.4	2.5	0.4	1.9	1.7	1.0	2.0	2.2	0.2	4.3	2.7	8.3	0.3	3.3	0.9	0.0	1.8	0.2	8.7	30.7	5.7	1.3	7.3	10.3	6.8	1.0	5.7	8.1	0.5	16.9	64.0	41.6	5.3	9.6	2.5	6.5	0.9	5.0	2.7	0.8	3.6	2.3	3.9	6.1
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099678-56233359	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7"	"Group enriched"	"Detected in some"	6	"HEL: 23.9;HMC-1: 12.4;NB-4: 15.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3"	"Group enriched"	"Detected in many"	67	"granulocytes: 13.1;T-cells: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	"Nucleoplasm, Nuclear speckles"	"HPA051049: AB_2681326, HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.9	0.5	3.3	1.3	20.0	1.4	0.5	0.5	6.7	0.3	0.5	1.5	0.0	0.5	0.3	0.2	0.6	0.6	0.8	0.4	4.3	7.8	1.1	5.7	0.6	6.1	2.3	3.5	0.5	0.3	0.2	0.5	1.4	9.9	0.3	0.7	0.7	2.1	0.3	0.3	0.9	2.4	0.5	4.1	3.0	0.7	16.7	1.8	0.0	0.4	0.0	3.8	1.0	0.3	0.0	0.0	13.1	0.2	0.0	14.3	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.1	0.9	0.0	1.1	12.4	0.0	0.0	0.0	0.0	3.0	1.9	0.8	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.3	12.6	0.2	13.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	14.3	0.5	1.2	0.0	0.0	0.0	0.6	2.1	3.3	20.0	0.5	6.7	4.3	7.8	2.3	3.5	9.9	1.8
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;HEL: 25.0;HL-60: 35.3;MOLT-4: 23.3;NB-4: 27.3;THP-1: 37.2;U-698: 28.0;U-937: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	5.5	2.7	3.6	36.6	4.6	33.5	3.7	0.6	2.9	2.4	4.3	1.5	2.1	2.7	2.1	4.3	3.6	2.4	4.9	5.0	3.8	2.1	4.5	4.8	9.1	36.9	7.8	1.7	1.5	1.2	0.4	1.3	1.6	4.6	3.9	3.3	1.0	8.1	2.2	1.1	1.7	12.2	1.6	11.3	51.8	3.0	3.5	5.9	94.4	4.2	2.2	21.7	6.0	3.9	25.2	14.5	52.0	9.6	28.7	46.0	23.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	25.0	0.1	0.0	0.0	35.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	23.3	27.3	0.1	0.0	13.1	0.1	6.6	0.0	0.0	0.1	0.1	0.1	0.0	0.2	1.2	37.2	0.1	0.1	0.8	0.0	0.0	0.3	0.1	28.0	0.2	18.7	1.0	38.6	8.6	34.9	26.6	8.8	42.3	25.2	46.0	33.3	14.5	22.5	33.9	28.4	52.0	28.7	9.6	14.4	36.5	23.2	3.6	4.6	0.6	2.9	3.8	2.1	7.8	1.7	4.6	5.9
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 94.2;lymphoid tissue: 48.7"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 94.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4"	"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favourable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	7.4	3.5	2.6	33.1	3.6	14.6	5.7	0.9	3.2	3.1	4.9	6.7	1.6	2.5	4.0	10.5	3.5	3.5	7.2	4.3	2.8	2.3	5.7	4.6	12.9	39.0	5.9	1.9	8.1	2.2	0.6	3.1	4.5	4.2	3.7	4.2	3.1	5.7	1.5	2.0	3.3	14.3	3.5	6.3	48.7	3.4	2.2	3.3	20.9	4.0	2.3	40.6	6.1	4.7	23.6	7.5	94.2	12.5	22.8	26.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.7	0.0	5.7	0.0	0.6	0.0	18.3	0.0	0.0	0.2	4.0	73.6	0.0	0.7	0.1	2.3	0.0	0.1	6.7	0.0	0.0	4.6	12.9	0.3	0.0	5.1	1.2	0.2	0.0	1.5	1.1	0.1	0.0	0.0	0.4	0.0	3.4	0.9	0.0	0.2	0.0	0.1	14.5	7.7	4.6	0.0	9.1	0.1	27.5	8.7	72.8	26.3	10.9	16.4	23.6	11.8	22.7	5.3	14.5	8.5	15.0	94.2	22.8	12.5	7.5	14.2	15.7	2.6	3.6	0.9	3.2	2.8	2.3	5.9	1.9	4.2	3.3
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 32.1;bone marrow: 35.2;intestine: 23.4;lung: 17.5;lymphoid tissue: 50.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.7;THP-1: 27.4;U-266/70: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019816	Enhanced					2200000	2200000			"HPA019816: AB_1853923"	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favourable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	4.9	2.8	2.8	28.3	3.8	35.2	4.3	0.9	2.2	2.1	4.8	3.8	0.6	4.4	2.1	2.6	3.2	3.3	5.4	2.7	3.0	2.2	4.6	3.5	17.5	42.2	5.4	1.2	1.2	1.5	0.5	2.5	5.8	3.9	3.2	1.7	3.2	6.7	1.5	1.2	2.0	23.4	2.0	4.9	50.4	6.1	1.7	4.6	45.0	4.3	1.8	38.4	4.3	4.3	9.3	9.4	15.7	9.2	11.3	32.1	21.0	3.2	0.6	0.0	3.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	8.7	4.2	21.9	0.9	0.0	2.9	0.6	0.1	0.0	16.0	0.3	2.9	6.0	1.0	0.1	14.2	17.3	0.0	0.9	0.0	0.0	0.0	1.9	30.7	0.0	0.2	15.8	12.7	2.3	1.6	15.3	0.1	21.7	0.0	0.0	0.1	0.0	5.0	0.0	1.3	1.0	27.4	1.4	0.0	0.6	0.0	0.0	40.4	17.3	17.5	0.1	21.4	1.6	2.7	9.2	9.8	20.4	9.0	17.8	7.3	23.2	24.2	9.4	9.3	32.1	23.3	15.7	11.3	8.4	5.6	18.2	21.0	2.8	3.8	0.9	2.2	3.0	2.2	5.4	1.2	3.9	4.6
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Abnormal spindle microtubule assembly"	Q8IZT6	1	197084128-197146694	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 62.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"plasmacytoid DC: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB017816			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (1.25e-4)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.7	0.7	0.2	12.4	0.4	13.8	1.5	0.2	0.4	1.2	2.8	0.2	0.2	2.8	0.3	1.5	8.7	0.2	0.4	0.6	0.2	0.2	0.5	1.3	1.9	7.0	0.3	0.2	0.5	0.3	0.0	0.2	1.8	0.5	0.4	2.8	0.3	1.5	0.2	0.5	4.6	3.1	0.8	0.5	4.3	1.7	6.3	0.2	62.8	0.3	5.0	6.9	1.2	2.3	0.0	1.5	0.0	0.0	0.3	2.4	0.0	19.8	11.1	18.1	11.0	1.0	2.5	6.8	15.9	11.2	15.8	12.5	7.7	15.5	20.3	5.7	12.4	20.1	15.5	6.3	19.7	18.2	11.8	14.2	26.2	7.4	0.2	21.2	10.1	0.2	0.6	12.7	8.9	16.6	17.8	24.1	16.2	7.8	17.0	9.9	8.2	3.0	13.0	24.8	14.9	5.7	5.5	9.5	13.5	22.6	11.7	5.1	13.0	8.8	12.6	9.8	9.5	16.8	28.9	6.9	9.4	11.7	7.7	5.8	19.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	2.4	0.0	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.5	0.2
B3GNT6	B3Gn-T6	ENSG00000198488	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6"	Q6ZMB0	11	77034398-77041973	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 15.8;lymphoid tissue: 17.5;stomach 1: 17.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.0;RPMI-8226: 1.5"	"Group enriched"	"Detected in some"	14	"colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3;neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039805	Enhanced				"Intracellular and membrane"					"HPA039805: AB_2676690"		"unprognostic (1.71e-1)"	"prognostic favourable (2.31e-4)"	"unprognostic (4.79e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.64e-2)"		"unprognostic (1.95e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.77e-2)"		"unprognostic (2.19e-1)"		"unprognostic (9.30e-2)"	"unprognostic (1.71e-1)"	0.2	0.2	0.3	6.6	0.4	0.0	0.2	0.3	0.4	0.5	15.8	0.0	0.0	3.7	0.2	0.0	2.5	0.2	0.9	0.2	0.3	0.3	0.2	0.2	1.4	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	12.4	0.0	1.6	0.0	0.2	0.2	9.4	0.0	0.2	0.2	17.9	0.6	0.0	0.0	0.2	3.4	17.5	0.2	0.3	0.4	0.3	2.3	0.2	0.8	0.5	0.2	0.1	0.0	0.5	0.5	0.0	0.2	0.2	0.1	0.2	0.5	0.1	1.1	0.2	0.7	0.3	0.0	0.0	0.1	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.6	0.2	0.5	0.4	0.0	0.0	0.0	0.2	0.6	0.0	2.0	0.2	0.5	0.7	0.0	0.0	0.1	1.5	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.5	0.3	0.1	0.2	0.2	2.3	0.2	0.3	0.4	0.2	0.5	0.2	0.2	0.2	0.0	0.4	0.3	0.3	2.2	0.8	0.0	0.3	0.1	0.2	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.0	0.0	0.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.4	7.8	8.7	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.8	3.8	14.1	2.6	1.1	9.1	13.4	3.7	6.1	8.5	9.9	14.7	8.4	2.2	0.0	14.1	7.3	0.0	0.0	4.7	2.4	3.3	12.7	4.4	4.9	3.4	10.6	7.8	9.3	1.7	10.8	16.4	5.4	1.1	9.8	6.5	6.1	3.3	4.4	2.6	3.1	11.6	1.8	3.4	6.3	3.5	8.7	3.2	13.1	14.7	1.9	10.0	5.8	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 56.5;testis: 30.9"	"Cell line enhanced"	"Detected in many"		"HEL: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA006123			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA006123: "	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavourable (1.03e-5)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	1.1	0.9	0.5	15.8	1.0	8.9	0.6	0.3	1.0	1.2	2.8	0.4	0.0	2.4	0.7	2.3	5.8	0.5	1.0	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1.0	0.7	0.0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0.0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2.0	1.8	2.4	3.0	0.2	1.4	6.1	1.1	29.9	8.8	23.1	14.5	1.0	1.7	12.3	15.6	10.3	27.2	20.5	18.4	17.2	20.3	9.7	9.0	13.1	29.5	11.3	33.8	16.1	14.4	67.2	9.4	14.7	0.2	19.3	19.0	0.4	0.7	20.9	10.4	15.8	29.4	42.4	22.2	9.8	32.3	16.2	22.3	16.6	21.5	19.8	31.0	5.5	9.5	15.5	6.7	11.1	9.4	8.4	7.4	16.4	6.5	12.4	20.2	9.3	21.6	22.2	20.8	25.0	8.3	15.0	21.7	3.0	0.0	0.7	0.6	0.2	0.9	1.8	2.5	1.0	0.8	1.4	1.6	1.5	0.0	1.4	0.1	2.4	6.1	1.1	0.5	1.0	0.3	1.0	0.5	0.5	0.6	0.2	0.5	0.1
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Group enriched"	"Detected in some"	11	"RH-30: 8.1;U-2 OS: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0
CABP4	CSNB2B	ENSG00000175544	"Calcium binding protein 4"	P57796	11	67452406-67460313	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 12.6;lymphoid tissue: 12.3;retina: 26.9"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 12.6"	"Lineage enriched"	"Detected in single"	15	"monocytes: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.57e-1)"	"unprognostic (7.10e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.44e-3)"	2.2	1.0	2.0	0.6	0.8	0.3	2.2	0.4	1.0	2.5	0.8	1.3	3.0	1.1	0.9	3.6	0.6	0.9	1.3	1.7	0.9	0.7	1.1	1.4	2.6	4.9	1.6	1.0	0.4	0.9	0.1	0.3	2.9	1.4	2.3	0.8	26.9	1.5	1.6	3.0	0.8	1.6	0.6	1.2	12.3	2.7	0.5	0.4	0.4	1.6	0.5	0.6	1.0	0.5	0.3	0.5	0.8	12.6	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	3.7	0.1	0.0	0.0	21.6	0.0	0.0	0.1	0.0	0.6	0.0	0.3	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.6	0.1	0.1	0.2	0.9	0.3	0.1	0.1	0.2	0.5	0.3	0.1	0.1	0.8	0.2	12.6	0.1	0.0	0.1	2.0	0.8	0.4	1.0	0.9	0.7	1.6	1.0	1.4	0.4
CARMIL2	"LRRC16C, RLTPR"	ENSG00000159753	"Capping protein regulator and myosin 1 linker 2"	Q6F5E8	16	67644919-67657569	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 47.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 22.1;MOLT-4: 21.6;REH: 36.4;RPMI-8226: 19.8;U-698: 36.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA041402	Approved									"HPA041402: AB_10795591"	"unprognostic (1.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.07e-2)"	"unprognostic (5.14e-10)"	"unprognostic (2.25e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.57e-2)"	0.7	0.6	5.8	23.0	6.4	5.5	0.3	5.9	7.4	0.6	2.0	0.4	0.3	1.9	0.6	1.0	1.9	0.3	2.4	0.5	10.0	3.9	0.9	0.3	1.8	24.4	2.3	0.4	0.4	3.0	0.1	2.8	0.5	0.6	0.5	0.8	0.5	6.1	0.7	0.5	0.4	8.0	0.5	0.7	12.9	1.9	0.7	0.4	47.7	0.4	0.5	21.6	2.5	0.3	1.5	1.1	0.0	0.0	1.7	2.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.5	0.2	0.0	0.2	0.0	3.3	0.2	22.1	0.4	0.0	0.0	2.1	0.0	0.0	4.9	2.8	1.3	0.1	0.4	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	21.6	10.9	3.8	0.1	36.4	0.0	19.8	0.0	0.0	5.6	0.6	0.0	0.0	0.1	0.1	0.6	0.0	0.3	0.7	0.0	0.1	6.4	11.1	36.8	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.7	0.9	2.7	0.7	0.1	1.5	0.8	0.5	0.0	1.7	0.0	1.1	2.5	0.4	5.8	6.4	5.9	7.4	10.0	3.9	2.3	0.4	0.6	0.4
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951574-32956349	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 28.9;lymphoid tissue: 57.1"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 65.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 28.9"	"Lineage enriched"	"Detected in single"	48	"T-cells: 28.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031613	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"	1.5	0.6	0.3	12.6	0.4	1.5	1.1	0.3	0.3	1.1	1.1	0.1	0.7	0.4	1.0	0.6	1.6	0.8	3.8	0.8	0.3	0.3	1.8	0.9	6.0	24.1	0.3	0.0	0.5	0.5	0.5	0.5	0.1	0.1	1.5	1.2	0.8	4.3	0.2	1.8	2.2	5.0	0.4	0.4	10.2	1.3	2.7	0.0	57.1	1.3	2.8	29.7	8.6	1.1	0.2	0.2	0.5	0.1	0.1	28.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	65.5	0.0	3.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.2	0.1	0.2	0.1	6.0	1.8	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.2	28.9	0.8	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0
CCR6	"BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22"	ENSG00000112486	"C-C motif chemokine receptor 6"	P51684	6	167111807-167139696	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 30.7;intestine: 9.9;lymphoid tissue: 33.7"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 30.7;memory B-cell: 23.8;memory CD4 T-cell: 11.9;naive B-cell: 28.2;T-reg: 20.9"	"Group enriched"	"Detected in many"	5	"B-cells: 28.2;T-cells: 30.7"	"Region enriched"	"Detected in single"	8	"basal ganglia: 0.9"	"Not detected"	"Not detected"			"CAB006820, HPA014488"	Approved									"CAB006820: , HPA014488: AB_1846639"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.39e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.74e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	0.5	0.3	1.0	24.4	1.5	1.3	1.1	0.3	1.1	0.6	3.0	0.1	0.0	1.4	0.3	0.8	2.1	0.5	3.1	0.3	0.9	0.9	1.0	0.5	3.3	27.3	0.6	0.0	0.3	0.3	0.0	0.4	0.5	0.2	0.5	1.2	0.3	5.0	0.8	0.3	1.1	9.9	0.0	0.4	23.4	2.2	2.7	0.1	3.7	0.6	2.1	33.7	4.8	0.4	28.2	5.4	0.2	0.0	0.4	30.7	2.5	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.2	1.3	0.3	0.0	0.0	0.3	0.2	0.1	2.6	0.7	0.1	0.3	14.1	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.2	0.2	0.4	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.3	0.5	0.3	0.4	0.0	0.2	0.6	0.0	0.0	0.1	1.6	0.0	30.7	23.8	11.9	4.7	5.4	28.2	0.1	0.0	0.2	0.4	0.0	0.6	20.9	2.5	1.0	1.5	0.3	1.1	0.9	0.9	0.6	0.0	0.2	0.1
CD1A	CD1	ENSG00000158477	"CD1a molecule"	P06126	1	158254137-158258269	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 105.1"	"Cell line enriched"	"Detected in single"	106	"MOLT-4: 35.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"classical monocyte: 5.9;intermediate monocyte: 3.7;memory B-cell: 6.8;myeloid DC: 10.2;naive B-cell: 5.4"	"Group enriched"	"Detected in many"	35	"B-cells: 6.8;dendritic cells: 10.2;monocytes: 5.9"									"CAB000009, HPA010734"	Enhanced									"CAB000009: AB_2073290, HPA010734: AB_1078452"	"unprognostic (7.21e-5)"	"prognostic favourable (6.37e-4)"	"unprognostic (1.37e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.49e-5)"	"unprognostic (5.58e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.81e-2)"	0.1	0.0	0.1	0.9	0.1	0.0	1.0	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.2	0.1	8.0	0.0	0.6	0.1	0.1	0.0	0.2	0.1	1.8	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.2	0.1	0.9	0.1	0.1	20.9	0.3	0.1	0.1	1.4	0.3	0.2	0.1	105.1	0.1	1.0	2.7	0.4	1.1	6.8	10.2	0.0	5.9	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.7	0.2	6.8	0.0	0.0	10.2	5.4	0.1	0.0	0.0	0.0	0.2	0.2	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CD247	"CD3H, CD3Q, CD3Z"	ENSG00000198821	"CD247 molecule"	P20963	1	167430640-167518610	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 62.8;lymphoid tissue: 129.5"	"Group enriched"	"Detected in some"	28	"HDLM-2: 47.8;MOLT-4: 50.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	26	"gdTCR: 62.8;MAIT T-cell: 35.4;memory CD4 T-cell: 32.4;memory CD8 T-cell: 36.7;naive CD4 T-cell: 41.3;naive CD8 T-cell: 33.5;NK-cell: 33.4;T-reg: 39.0"	"Group enriched"	"Detected in many"	31	"NK-cells: 33.4;T-cells: 62.8"	"Region enhanced"	"Detected in single"		"thalamus: 0.7"	"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced									"CAB004651: AB_425347, HPA008750: AB_1857863"	"prognostic favourable (9.12e-4)"	"unprognostic (3.21e-3)"	"unprognostic (7.09e-3)"	"prognostic favourable (8.63e-6)"	"unprognostic (1.99e-2)"	"prognostic favourable (3.98e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.46e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (9.94e-6)"	"unprognostic (1.60e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.94e-3)"	2.3	0.5	0.9	13.5	2.1	17.8	1.3	1.2	1.1	1.4	4.4	0.7	0.7	2.9	1.5	1.6	1.4	1.2	2.9	1.0	0.8	1.4	1.9	3.2	7.3	24.3	1.0	0.5	1.0	0.5	0.0	0.6	1.3	0.7	2.0	1.8	1.7	3.3	0.4	1.4	0.6	9.8	0.8	0.9	28.6	2.7	0.9	0.5	129.5	1.8	0.9	18.1	3.5	1.4	1.5	0.4	1.4	0.2	33.4	62.8	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.1	0.0	62.8	0.2	35.4	1.5	32.4	36.7	0.2	0.5	41.3	33.5	1.4	33.4	0.1	0.4	39.0	31.4	0.9	2.1	1.2	1.1	0.8	1.4	1.0	0.5	0.7	0.5
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466416-74484796	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 81.1;brain: 28.7;lymphoid tissue: 57.8"	"Group enriched"	"Detected in some"	5	"HMC-1: 41.3;NB-4: 16.8;RPMI-8226: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA011645	Approved				"Intracellular and membrane"	2800000	2800000			"HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	8.6	4.5	9.8	16.0	17.7	11.9	4.4	2.2	11.5	2.0	4.8	3.7	0.0	6.0	1.9	1.3	2.1	2.1	7.7	3.4	7.3	4.2	3.0	7.5	10.6	19.0	20.1	0.3	1.5	2.1	0.3	3.0	6.9	12.6	2.8	4.7	2.3	3.0	1.3	1.1	2.3	7.4	6.0	28.7	57.8	2.4	1.5	17.4	4.1	1.9	0.5	6.0	5.4	2.1	2.2	19.4	81.1	45.7	52.1	29.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.9	41.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	16.8	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	81.1	20.4	57.3	29.5	45.7	6.2	2.2	6.1	8.7	19.4	0.6	2.3	7.1	71.6	52.1	44.2	18.1	0.3	19.2	9.8	17.7	2.2	11.5	7.3	4.2	20.1	0.3	12.6	17.4
CD300LF	"CD300f, CLM1, IGSF13, IREM1, NKIR"	ENSG00000186074	"CD300 molecule like family member f"	Q8TDQ1	17	74694311-74712978	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.8;bone marrow: 18.2;lung: 24.1;lymphoid tissue: 29.1"	"Group enriched"	"Detected in some"	6	"THP-1: 15.6;U-937: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 47.8"	"Group enriched"	"Detected in many"	46	"dendritic cells: 13.5;granulocytes: 47.8;monocytes: 38.1"									HPA013712	Supported									"HPA013712: AB_2668874"	"unprognostic (6.51e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-2)"	"unprognostic (8.51e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.79e-2)"	3.3	1.0	1.2	9.8	3.1	18.2	0.9	1.5	1.3	0.8	2.3	3.1	0.0	2.7	0.7	0.7	0.9	1.1	1.9	2.4	1.3	1.2	1.1	1.5	24.1	15.6	3.8	0.5	0.9	0.9	0.0	1.0	2.1	2.6	1.4	2.6	0.8	1.9	0.3	0.5	0.5	3.4	2.3	5.8	29.1	1.0	0.7	2.4	1.1	0.8	0.0	4.2	2.8	0.8	0.0	13.5	47.8	38.1	0.7	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	30.2	0.0	8.4	20.2	47.8	0.0	34.4	0.1	0.0	0.0	0.0	13.5	0.0	0.0	0.0	15.9	0.7	38.1	1.4	0.0	8.2	1.2	3.1	1.5	1.3	1.3	1.2	3.8	0.5	2.6	2.4
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304545-118316175	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 294.2"	"Cell line enriched"	"Detected in some"	77	"MOLT-4: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	36	"gdTCR: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8"	"Group enriched"	"Detected in many"	29	"NK-cells: 21.8;T-cells: 62.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced									"CAB000010: AB_2631163, CAB072863: , CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favourable (1.72e-4)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favourable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favourable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	3.9	1.0	0.5	16.7	0.7	6.8	1.9	0.5	0.7	2.1	4.7	0.9	0.7	4.4	2.0	1.4	3.3	3.0	4.0	1.4	0.5	0.5	3.3	2.6	7.3	40.9	1.3	0.6	1.5	1.3	0.0	0.9	1.2	0.9	2.6	3.9	1.9	6.4	1.1	0.8	1.3	21.1	1.1	1.9	34.5	4.6	1.2	0.5	294.2	3.4	2.1	37.8	6.3	3.0	0.2	0.9	1.4	0.2	21.8	62.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	118.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.5	0.0	0.1	0.0	1.3	0.2	0.2	59.5	0.1	50.2	0.1	50.7	55.7	0.1	0.2	61.3	62.0	1.4	21.8	0.2	0.9	46.8	32.9	0.5	0.7	0.5	0.7	0.5	0.5	1.3	0.6	0.9	0.5
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648193-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7"	"Cell line enriched"	"Detected in single"	72	"MOLT-4: 22.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1"	"Lineage enriched"	"Detected in single"	58	"T-cells: 29.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045827	Enhanced				"Secreted to blood"					"HPA045827: AB_10959606"	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	2.0	0.5	0.3	22.4	0.3	1.4	1.2	0.3	0.3	2.0	3.3	0.1	0.0	1.7	1.5	1.3	1.6	1.6	2.6	1.1	0.4	0.4	1.6	1.1	4.0	14.6	0.4	0.0	0.7	0.6	0.0	0.4	0.2	0.3	1.0	3.1	1.0	4.9	1.3	0.4	1.1	8.7	0.5	0.6	9.9	1.7	0.6	0.1	33.7	1.4	2.0	26.1	3.0	1.4	0.0	0.0	0.5	0.0	0.2	29.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	9.4	0.0	22.9	0.0	29.2	4.1	0.0	0.0	28.1	0.2	0.5	0.2	0.0	0.0	3.3	4.7	0.3	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.3	0.1
CD7	"GP40, LEU-9, Tp40, TP41"	ENSG00000173762	"CD7 molecule"	P09564	17	82314868-82317602	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 54.1;lymphoid tissue: 127.6"	"Group enriched"	"Detected in some"	6	"Hep G2: 21.1;MOLT-4: 48.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 54.1"	"Group enriched"	"Detected in many"	21	"NK-cells: 54.1;T-cells: 19.0"									"CAB002594, HPA039079"	Enhanced									"CAB002594: , HPA039079: AB_2676337"	"unprognostic (3.14e-3)"	"prognostic favourable (5.51e-4)"	"unprognostic (1.89e-2)"	"prognostic favourable (2.03e-5)"	"unprognostic (7.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.69e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (7.75e-11)"	"unprognostic (4.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.55e-3)"	4.7	0.7	0.5	23.4	0.4	14.5	1.7	0.4	0.3	1.9	8.0	0.3	0.5	7.7	1.8	1.9	3.4	2.4	3.5	1.4	0.5	0.6	2.8	4.1	9.5	50.2	0.9	0.0	1.6	1.0	0.0	1.0	4.0	0.4	2.7	1.0	1.8	6.0	1.1	0.5	1.0	17.5	0.5	1.6	33.0	4.6	0.9	0.1	127.6	2.2	1.0	33.3	4.6	2.2	0.1	1.7	0.6	0.1	54.1	19.0	7.1	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	21.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.1	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	17.6	0.0	15.1	0.1	7.9	12.8	0.0	0.0	19.0	18.9	0.6	54.1	0.1	1.7	6.8	7.1	0.5	0.4	0.4	0.3	0.5	0.6	0.9	0.0	0.4	0.1
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 132.1;lymphoid tissue: 61.5"	"Cell line enriched"	"Detected in some"	55	"RPMI-8226: 154.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1"	"Lineage enriched"	"Detected in many"	40	"T-cells: 132.1"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favourable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavourable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"	1.2	0.7	1.0	5.3	1.0	3.9	1.0	1.3	1.3	21.2	1.1	1.0	1.0	2.5	1.2	1.0	1.0	1.1	1.8	1.0	1.0	1.8	1.0	1.0	2.7	14.4	1.7	1.0	1.3	1.0	6.4	7.4	1.0	2.2	1.3	1.3	1.0	1.0	1.0	1.0	0.9	11.4	1.0	1.5	12.7	2.3	1.0	1.0	61.5	1.5	1.0	8.1	1.8	1.3	0.1	0.1	3.2	0.1	0.1	132.1	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	154.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.1	10.0	0.0	0.2	73.5	0.0	0.1	0.5	132.1	0.7	0.1	0.1	0.1	0.2	36.3	1.0	1.0	1.3	1.3	1.0	1.8	1.7	1.0	2.2	1.0
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25458997-25507920	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 38.8;testis: 17.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.6;T-reg: 1.9"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favourable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.8	0.5	0.3	11.3	0.5	5.5	0.6	0.3	0.3	0.7	3.3	0.2	0.0	1.3	0.5	0.2	2.8	0.3	0.1	0.6	0.3	0.3	0.5	0.5	0.6	4.4	0.4	0.2	0.4	0.3	0.0	0.4	3.3	0.3	0.5	2.0	0.1	0.7	0.0	0.4	1.0	3.3	0.6	1.0	3.9	0.8	17.7	0.4	38.8	0.4	3.5	5.9	0.6	1.0	0.7	0.0	0.0	0.0	2.6	1.9	0.8	14.7	13.9	13.0	10.8	1.1	2.0	8.6	16.5	9.8	14.5	14.5	11.9	6.8	17.5	7.1	6.8	13.5	18.0	8.4	21.4	6.5	5.2	17.9	10.1	6.4	0.2	7.9	8.7	1.1	0.5	10.1	6.9	10.4	14.0	20.2	13.2	5.8	22.2	3.7	13.3	6.2	11.4	14.4	6.4	4.1	8.0	5.5	5.9	14.0	6.8	6.5	7.5	3.9	7.2	10.8	17.3	20.3	15.2	3.4	6.9	18.5	7.7	10.4	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.6	0.0	0.0	1.9	0.8	0.3	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.4
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (1.10e-6)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.2	18.4	48.9	19.3	3.2	4.9	20.1	36.5	26.6	44.5	42.9	43.0	42.7	44.2	14.2	10.0	30.0	33.2	21.2	46.4	31.4	24.2	23.2	18.1	24.9	0.5	35.5	24.0	0.9	2.1	28.8	28.1	26.7	35.3	54.5	49.5	12.8	44.6	25.5	21.5	38.7	38.8	45.5	21.7	17.0	16.0	22.9	20.1	24.5	37.3	18.9	40.2	21.8	11.0	19.0	40.6	20.0	49.8	21.4	34.3	39.9	16.4	39.8	23.6	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2
CEACAM4	CGM7	ENSG00000105352	"Carcinoembryonic antigen related cell adhesion molecule 4"	O75871	19	41618971-41627074	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 41.5;bone marrow: 22.5;lymphoid tissue: 30.2"	"Cell line enriched"	"Detected in some"	6	"U-937: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 41.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 41.5"																				"unprognostic (1.10e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-9)"	"unprognostic (3.65e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.34e-1)"	1.8	0.5	0.2	5.5	0.5	22.5	0.5	0.1	1.0	0.4	0.5	0.1	0.2	0.4	0.4	3.3	1.0	1.0	1.6	3.4	0.9	0.3	2.2	1.2	6.4	30.2	1.7	0.1	0.5	1.5	0.0	0.7	1.1	0.9	0.9	0.3	1.6	0.9	0.2	0.3	0.3	1.4	1.2	1.2	27.5	0.8	0.6	0.3	1.0	0.4	0.0	1.4	0.9	0.5	0.1	7.9	41.5	10.3	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	10.3	1.8	0.0	7.5	0.0	0.1	0.4	0.0	7.9	0.0	0.2	0.0	41.5	0.0	3.2	0.0	3.5	3.5	0.2	0.5	0.1	1.0	0.9	0.3	1.7	0.1	0.9	0.3
CEMIP	"HYBID, IR2155535, KIAA1199, TMEM2L"	ENSG00000103888	"Cell migration inducing hyaluronan binding protein"	Q8WUJ3	15	80779343-80951776	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 33.9;lymphoid tissue: 116.9"	"Group enriched"	"Detected in some"	5	"BJ: 43.3;BJ hTERT+: 68.5;fHDF/TERT166: 54.4;HSkMC: 37.4;U-138 MG: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	560000	560000				"unprognostic (1.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.27e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (2.65e-4)"	6.7	2.1	1.7	11.6	5.0	1.7	1.0	6.8	8.9	2.4	6.9	6.4	2.6	1.2	33.9	7.8	7.1	7.0	2.8	6.4	2.2	2.8	1.1	1.0	16.6	116.9	14.1	9.4	5.3	1.4	0.7	9.1	2.9	15.6	2.5	2.4	15.4	5.9	3.2	4.3	6.2	1.6	0.9	13.6	2.0	1.3	3.3	1.1	0.0	4.4	0.7	5.0	6.5	3.1	0.9	1.5	0.6	0.5	0.2	1.3	0.2	0.1	1.6	0.3	0.2	0.1	0.6	0.2	43.3	68.5	1.1	0.9	0.5	0.2	0.2	0.1	54.4	1.0	0.0	0.1	0.2	0.1	0.4	0.1	0.2	3.5	0.4	0.1	0.2	37.4	0.0	8.5	0.0	0.0	0.2	0.1	1.0	0.9	0.1	0.1	0.2	1.9	0.2	0.0	0.1	0.0	0.7	2.7	0.1	0.7	0.1	3.6	0.2	0.0	0.2	19.8	0.2	1.4	0.7	0.1	0.1	0.2	2.1	0.3	1.3	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.2	0.0	0.9	0.0	0.7	0.6	0.2	0.5	1.5	1.3	0.2	1.7	5.0	6.8	8.9	2.2	2.8	14.1	9.4	15.6	1.1
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664588	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 19.5;lymphoid tissue: 67.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	1.6	1.5	1.0	10.7	1.3	19.5	1.1	0.4	0.9	2.1	5.6	0.3	0.0	4.6	1.2	1.7	9.4	0.8	0.4	1.7	0.6	0.6	1.0	0.8	3.2	6.2	0.6	0.5	1.4	0.6	0.0	0.4	6.4	0.8	0.7	4.5	0.4	1.9	0.0	0.5	4.7	6.4	1.6	1.5	3.8	2.3	9.4	0.6	67.5	0.6	7.6	7.6	1.4	2.9	0.3	0.3	0.0	0.0	0.7	1.9	0.2	32.2	18.3	39.5	20.6	1.5	2.0	15.4	20.0	8.2	12.0	11.9	14.5	20.0	30.8	11.9	11.1	20.1	24.3	13.1	20.5	26.8	15.3	25.3	28.1	20.7	0.2	35.7	13.8	0.7	1.0	17.3	20.0	12.6	22.7	18.4	21.5	12.3	21.1	14.3	35.0	8.1	22.5	55.8	10.1	11.8	8.0	18.5	25.2	27.0	18.0	10.4	21.5	13.7	16.5	21.9	25.8	18.1	41.3	14.2	15.3	29.6	9.5	25.8	19.3	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1.4	0.4	0.3	0.3	1.9	0.8	0.0	0.7	0.0	0.3	1.7	0.2	1.0	1.3	0.4	0.9	0.6	0.6	0.6	0.5	0.8	0.6
CLEC17A	FLJ45910	ENSG00000187912	"C-type lectin domain containing 17A"	Q6ZS10	19	14583084-14611157	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 30.9;intestine: 8.5;lymphoid tissue: 25.1"	"Group enriched"	"Detected in some"	10	"Daudi: 9.9;U-698: 18.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"memory B-cell: 14.7;naive B-cell: 30.9"	"Lineage enriched"	"Detected in many"	16	"B-cells: 30.9"					"Low region specificity"	"Detected in all"														"unprognostic (4.71e-5)"	"unprognostic (1.34e-2)"	"unprognostic (9.64e-4)"	"unprognostic (5.02e-3)"	"unprognostic (3.90e-1)"	"unprognostic (9.00e-4)"	"unprognostic (3.18e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	0.4	0.3	0.8	23.2	2.2	1.3	0.3	0.3	1.3	0.3	0.6	3.3	0.0	0.4	0.3	0.0	0.4	0.3	0.6	0.3	2.2	1.1	0.6	0.3	0.4	18.7	1.3	0.0	0.3	0.3	0.1	0.5	0.1	1.7	0.4	0.6	0.4	4.7	0.0	0.3	0.3	8.5	0.0	3.7	17.0	0.7	1.4	2.0	1.0	0.5	0.0	25.1	1.5	0.3	30.9	1.8	0.7	0.3	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	14.7	0.0	0.0	1.8	30.9	0.0	0.0	0.7	0.1	0.1	0.2	0.0	1.3	0.8	2.2	0.3	1.3	2.2	1.1	1.3	0.0	1.7	2.0
CLEC6A	"CLECSF10, dectin-2"	ENSG00000205846	"C-type lectin domain containing 6A"	Q6EIG7	12	8455926-8478330	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 8.4;heart muscle: 2.3;lung: 6.2;lymphoid tissue: 5.0"	"Cell line enriched"	"Detected in some"	4	"NTERA-2: 8.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 8.4;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.5;monocytes: 8.4"	"Low region specificity"	"Detected in many"																		"unprognostic (1.44e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.27e-4)"		"unprognostic (6.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"		"unprognostic (7.30e-4)"	"unprognostic (8.89e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-2)"	0.2	0.2	0.1	4.9	0.2	0.5	0.2	0.1	0.1	0.8	0.2	0.0	0.0	0.0	0.2	0.8	0.2	0.3	0.2	2.3	0.5	0.2	0.4	0.8	6.2	5.0	0.2	0.0	0.1	0.3	0.0	0.2	0.9	0.4	0.1	0.0	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.4	0.9	0.1	0.5	0.0	0.7	0.2	0.0	1.7	1.1	0.2	0.0	3.5	0.5	8.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.2	0.1	0.1	0.5	0.2	0.2	0.0	0.4	0.0
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870526-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 19.2;lymphoid tissue: 31.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;HEL: 4.1;HMC-1: 18.9;U-698: 12.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 19.2;eosinophil: 16.2;memory B-cell: 14.9;naive B-cell: 15.1;NK-cell: 8.7"	"Group enriched"	"Detected in many"	7	"B-cells: 15.1;granulocytes: 19.2;NK-cells: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain									"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"	0.3	0.2	0.2	18.5	0.2	1.8	0.2	0.2	0.2	0.2	0.4	0.0	0.0	0.1	0.2	0.1	1.8	0.2	0.3	0.3	0.2	0.2	0.4	0.3	0.6	27.7	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.4	0.3	0.3	3.1	0.0	1.8	0.2	5.5	0.0	0.2	29.7	0.4	0.4	0.0	3.0	0.6	0.6	31.1	1.5	0.3	15.1	0.8	19.2	0.1	8.7	2.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.1	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	12.7	0.0	0.1	0.0	19.2	0.1	16.2	1.7	0.0	2.0	14.9	0.1	1.5	0.2	15.1	0.1	0.9	0.6	8.7	0.1	0.8	0.1	0.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;HL-60: 59.6;HMC-1: 103.1;MOLT-4: 57.6;NB-4: 68.1;RPMI-8226: 89.9;U-698: 55.7;U-937: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		130000000	130000000	Cytosol	Cytosol	"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favourable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favourable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	6.4	4.9	12.7	58.9	10.8	94.9	4.4	7.8	13.6	2.9	5.0	6.0	0.2	8.3	3.0	3.0	4.7	5.9	8.6	4.8	10.4	7.8	4.9	3.8	13.7	99.8	9.6	8.2	2.2	2.7	0.6	3.0	4.8	7.3	3.3	2.9	2.2	12.3	1.6	1.3	3.4	28.7	4.1	9.0	92.0	8.5	1.1	7.5	86.0	3.6	3.2	64.8	15.8	3.1	41.6	67.7	204.4	67.5	39.1	66.4	101.2	0.2	0.3	1.0	2.0	0.0	0.0	0.5	0.2	0.0	0.5	0.2	0.0	0.6	85.3	0.5	0.0	0.4	0.4	1.0	0.1	27.3	0.2	9.0	0.0	1.3	0.1	59.6	103.1	0.3	0.0	0.4	0.0	0.1	0.1	43.9	0.3	7.2	57.6	68.1	0.4	0.6	31.3	1.6	89.9	0.1	0.4	1.6	1.2	0.2	10.3	0.2	0.1	34.7	0.1	0.4	0.8	0.2	0.2	34.1	45.0	55.7	0.3	75.5	0.6	52.5	58.3	204.4	53.7	67.5	50.5	41.6	48.4	52.2	67.7	41.6	46.6	48.1	105.8	39.1	66.3	38.2	66.4	101.2	12.7	10.8	7.8	13.6	10.4	7.8	9.6	8.2	7.3	7.5
CSAG1	"CSAGE, CT24.1"	ENSG00000198930	"Chondrosarcoma associated gene 1"	Q6PB30	X	152727484-152733735	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 4.2;lymphoid tissue: 3.3;testis: 6.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 25.7;K-562: 16.4;PC-3: 23.3;SH-SY5Y: 14.5;U-266/70: 40.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.83e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.68e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.70e-3)"	0.2	0.2	3.3	1.1	4.2	0.2	0.2	1.6	4.1	0.2	0.3	1.5	0.0	0.2	0.8	0.2	0.2	0.4	0.2	0.2	3.2	1.8	0.3	0.4	0.3	3.3	3.0	0.9	0.2	0.2	0.2	0.0	0.3	2.0	0.4	0.3	0.0	0.5	0.5	0.2	0.5	0.6	0.7	1.3	0.5	0.4	6.3	2.7	0.1	0.9	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.2	0.0	0.0	0.0	25.7	0.0	0.1	0.0	0.0	0.0	16.4	0.2	0.0	0.0	0.1	0.0	0.0	23.3	0.0	0.0	0.1	0.0	0.0	2.6	14.5	0.0	8.6	6.8	0.4	0.0	0.1	1.6	0.3	8.3	2.7	40.8	0.6	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.2	1.6	4.1	3.2	1.8	3.0	0.9	2.0	2.7
CSAG3	CSAG3A	ENSG00000268916	"CSAG family member 3"	Q9Y5P2	X	152753921-152760222	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 3.4;skin 1: 2.4;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.1;HMC-1: 11.9;Karpas-707: 9.5;SH-SY5Y: 15.4;SK-BR-3: 14.2;U-2 OS: 11.2;U-266/70: 36.8;U-266/84: 18.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.56e-1)"			"unprognostic (9.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.12e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-2)"		"unprognostic (7.06e-2)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"		"unprognostic (2.91e-2)"	0.2	0.0		0.0		0.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	3.4			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0	2.4	0.0	0.0		3.3	0.0	5.5			0.0		0.2	0.0		0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	5.6	9.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.2	15.4	0.0	14.2	0.5	0.0	0.6	0.0	0.0	11.2	0.0	0.0	36.8	18.6	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949230-24959928	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 120.9;bone marrow: 160.2;lymphoid tissue: 51.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 15.7;HMC-1: 44.0;NB-4: 43.2;U-937: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdTCR: 120.9"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 2.3"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	12000	12000			"HPA040442: AB_2676988"	"prognostic favourable (6.55e-4)"	"prognostic favourable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favourable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favourable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	4.9	0.9	0.8	9.7	0.9	160.2	1.4	0.9	1.0	2.5	1.9	0.1	0.5	1.1	2.2	1.8	2.4	4.6	10.7	6.2	0.9	0.8	1.6	3.5	23.0	30.4	4.0	0.0	2.2	1.1	0.2	0.9	1.6	0.7	3.5	1.0	3.2	1.3	0.7	1.9	1.2	3.7	1.0	1.2	51.3	1.6	1.7	0.2	6.6	1.6	2.5	15.4	6.0	11.8	0.3	2.5	29.8	0.2	53.9	120.9	42.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	15.7	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	43.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	77.6	0.0	5.0	0.2	0.8	120.9	0.2	67.5	0.3	18.3	84.3	2.5	0.3	4.0	52.3	29.8	53.9	0.2	0.6	10.5	42.2	0.8	0.9	0.9	1.0	0.9	0.8	4.0	0.0	0.7	0.2
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell line enriched"	"Detected in many"	8	"BEWO: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	260000	260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoli fibrillar center, Cytosol"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavourable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	7.3	2.2	2.5	6.5	0.1	0.0	113.4	0.0	0.0	1.6	1.3	14.9	7.3	0.1	0.6	0.1	14.0	12.1	8.9	2.3	0.0	1.6	0.3	0.7	2.3	0.0	0.0	1.0	0.0	3.0	0.4	0.3	0.5	0.2	0.0	2.9	2.7	0.2	0.1	15.0	2.1	0.0	5.4	0.1	2.2	0.9	0.6	1.1	7.4	2.6	2.6	4.6	0.8	0.0	0.4	7.4	0.1	0.8	1.5	4.0	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 82.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.4;RH-30: 1.2;U-266/70: 5.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.0"									HPA052613	Uncertain				"Secreted to blood"					"HPA052613: AB_2681885"	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favourable (9.12e-4)"	"prognostic favourable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	0.2	0.1	0.0	15.3	0.2	0.0	1.5	0.3	0.0	0.1	1.1			0.0	0.8	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.3	4.3	0.2	65.1	0.0		0.2	0.0	0.0	0.8	0.0		3.8	1.8		0.8	0.0	0.0	0.1	15.5	0.0	0.0	82.5	3.7	0.3			0.5		57.5	6.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
CXCR3	"CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR"	ENSG00000186810	"C-X-C motif chemokine receptor 3"	P49682	X	71615916-71618517	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 61.7;lymphoid tissue: 24.5"	"Cell line enriched"	"Detected in some"	15	"RPMI-8226: 31.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 61.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 61.7;NK-cells: 38.1;T-cells: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045942	Enhanced									"HPA045942: AB_2679507"	"unprognostic (4.84e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.61e-1)"	"prognostic favourable (3.44e-6)"	"unprognostic (3.93e-2)"	"prognostic favourable (3.35e-4)"	"unprognostic (1.01e-2)"	"unprognostic (5.24e-2)"	"prognostic favourable (2.90e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.67e-6)"	"unprognostic (4.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.76e-2)"	0.9	0.9	0.4	9.0	0.4	6.0	0.6	0.3	0.3	1.9	2.4	0.4	0.5	5.4	3.3	1.4	1.3	1.1	2.6	2.4	0.3	0.4	1.9	0.8	4.5	19.0	0.4	0.1	1.6	0.8	0.0	0.6	0.7	0.5	2.9	0.8	1.5	3.9	1.0	0.4	0.5	9.1	0.3	0.7	13.9	2.6	0.6	0.0	14.0	1.9	1.7	24.5	1.7	1.8	9.8	61.7	0.4	0.0	38.1	26.6	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	17.3	0.0	8.9	9.8	19.6	26.6	1.6	1.8	1.2	11.1	0.4	38.1	0.0	61.7	17.8	6.3	0.4	0.4	0.3	0.3	0.3	0.4	0.4	0.1	0.5	0.0
CXCR5	"BLR1, CD185, MDR15"	ENSG00000160683	"C-X-C motif chemokine receptor 5"	P32302	11	118883766-118897799	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 35.5;lymphoid tissue: 45.6"	"Group enriched"	"Detected in some"	10	"Daudi: 10.3;U-698: 36.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 4.0"	"Group enriched"	"Detected in some"	8	"memory B-cell: 24.2;naive B-cell: 35.5"	"Lineage enriched"	"Detected in many"	9	"B-cells: 35.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB026149, HPA042432"	Enhanced									"CAB026149: , HPA042432: AB_2677995"	"unprognostic (8.51e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-1)"		"unprognostic (4.02e-5)"		"unprognostic (2.08e-2)"	"unprognostic (3.23e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-5)"	"unprognostic (4.21e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	0.4	0.8	0.6	31.8	0.6	7.3	0.1	4.0	0.9	0.1	3.6	0.2	0.1	0.1	0.2	0.1	2.6	0.0	0.5	0.9	0.7	0.5	0.8	1.0	0.9	31.5	0.3	0.1	0.3	0.5	0.0	0.9	0.1	0.2	2.9	0.3	0.3	3.6	0.1	1.3	0.9	8.6	0.1	0.3	45.6	1.3	0.1	0.1	1.9	0.7	1.3	41.8	3.9	0.9	35.5	0.0	0.0	0.0	0.0	3.9	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	10.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.5	0.0	0.2	0.4	0.0	0.0	0.2	0.0	36.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	24.2	3.9	1.0	0.0	35.5	0.4	0.3	0.0	0.0	0.0	0.0	0.5	1.9	0.6	0.6	4.0	0.9	0.7	0.5	0.3	0.1	0.2	0.1
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501907-177511274	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.5;bone marrow: 51.8;lymphoid tissue: 50.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 40.5;HMC-1: 33.0;REH: 50.0;U-698: 40.1;U-937: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	6	"B-cells: 12.7;granulocytes: 47.5;monocytes: 23.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077312	Enhanced					750000	750000			"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	6.9	2.4	2.7	22.6	7.1	51.8	4.7	2.7	3.3	1.4	2.4	1.5	0.4	3.6	1.4	2.5	2.4	3.3	2.4	2.2	3.6	2.2	2.3	4.0	10.9	26.3	6.1	0.7	2.0	1.8	0.4	1.4	4.0	4.1	2.1	1.8	2.3	4.1	1.0	1.3	1.0	10.8	2.4	7.6	50.0	2.9	3.1	2.9	1.9	1.7	0.6	21.7	4.8	1.5	12.7	4.8	47.5	23.2	0.1	0.1	7.8	1.4	2.2	1.5	1.8	0.9	0.1	3.9	1.2	0.2	3.9	3.6	3.3	0.6	40.5	0.9	1.0	2.5	3.3	2.1	1.9	7.3	4.4	6.6	5.1	0.6	0.3	15.2	33.0	0.5	1.3	4.4	0.4	0.6	4.5	17.8	1.4	3.7	0.7	19.3	3.8	3.9	50.0	3.0	0.3	1.2	1.5	2.1	1.4	0.5	0.6	1.8	3.5	21.7	0.9	3.7	3.5	1.9	1.4	3.6	3.9	40.1	0.7	28.9	0.6	4.7	20.6	19.9	0.1	20.4	0.1	12.7	0.0	0.1	4.8	6.7	0.0	0.0	47.5	0.1	23.2	0.3	0.0	7.8	2.7	7.1	2.7	3.3	3.6	2.2	6.1	0.7	4.1	2.9
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Not detected"	"Not detected"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		2700000	2700000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB037328: , HPA049265: AB_2680695, HPA073937: "	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.4	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.4	0.0	16.0	0.0	0.0	3.8	0.2	1.3	0.1	2.6	0.0	0.0	2.7	41.1	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.7	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	Nucleoplasm	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: "	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.5	10.7	18.4	9.2	1.1	2.3	9.0	15.8	9.8	14.9	22.3	6.6	11.1	9.5	5.9	6.0	9.8	24.2	13.3	21.6	11.5	11.6	15.2	14.1	8.1	0.0	19.9	9.5	1.0	0.4	24.2	12.9	6.8	18.1	19.4	17.2	5.0	26.6	9.1	21.2	12.4	21.1	32.4	18.4	4.2	8.7	11.5	18.0	15.0	14.4	6.5	12.2	9.1	3.7	15.0	11.2	15.4	17.7	7.1	11.1	22.0	7.6	13.2	14.5	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021247-77065580	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 42.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 5.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"midbrain: 7.6;pons and medulla: 7.4;thalamus: 12.1"	HPA064866			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA064866: AB_2685374"	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	1.3	0.4	0.6	4.7	0.7	8.4	0.4	0.5	0.8	1.1	1.7	1.2	0.5	1.3	1.2	1.4	5.0	1.2	1.3	0.8	0.7	0.6	0.5	0.5	1.4	2.7	0.5	0.0	0.7	0.7	0.5	1.8	2.1	0.6	0.7	3.0	0.4	0.9	1.0	0.3	2.1	2.3	0.9	0.6	2.4	1.2	6.1	0.2	42.0	0.4	2.3	6.3	1.4	1.7	0.6	5.0	1.2	0.0	0.2	1.0	0.0	9.5	4.5	12.8	5.0	0.4	1.3	15.5	13.4	14.6	7.1	8.6	6.2	3.2	5.3	2.7	2.6	7.4	7.6	14.5	13.7	2.1	5.1	4.7	13.2	3.5	3.0	4.0	4.4	0.4	3.8	18.6	11.5	6.9	4.8	4.4	14.5	4.8	15.0	0.0	9.0	10.8	10.9	11.1	3.0	1.7	8.1	8.1	5.3	11.1	3.9	3.2	6.2	4.2	19.1	26.9	13.6	11.4	17.6	4.7	2.6	3.4	9.7	1.8	16.7	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	5.0	1.0	0.0	0.6	0.7	0.5	0.8	0.7	0.6	0.5	0.0	0.6	0.2
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127410	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 43.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.7;naive B-cell: 5.7"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	1.3	1.3	0.4	8.9	0.8	3.5	1.9	0.3	1.1	1.8	4.7	0.4	0.3	2.5	0.8	2.0	9.3	0.7	1.8	1.0	0.4	0.4	1.8	2.6	2.1	9.9	0.5	0.3	1.0	0.8	1.4	0.9	2.8	0.8	1.2	5.0	0.3	2.6	0.3	0.5	3.5	4.1	1.3	0.6	5.4	2.8	1.0	0.6	43.9	0.7	9.2	11.1	1.5	2.6	5.7	0.3	3.1	0.2	0.1	1.4	0.3	24.0	6.2	9.3	0.1	1.0	1.8	0.1	18.3	9.2	10.9	16.2	13.1	9.6	30.0	12.4	5.3	18.7	13.5	12.3	19.5	15.6	3.3	3.2	11.8	5.7	0.0	0.1	3.9	0.4	0.4	10.5	0.8	5.8	0.9	28.3	12.8	9.1	18.9	0.2	0.1	7.3	20.0	13.8	11.7	5.8	20.8	1.8	5.9	15.1	17.5	3.0	19.4	1.7	3.2	8.5	18.5	25.5	16.6	21.8	15.7	0.2	12.3	0.1	12.1	0.5	0.2	0.2	0.3	0.1	0.2	5.7	0.4	0.7	0.3	5.7	0.2	0.2	3.1	0.1	0.2	0.3	1.4	0.3	0.4	0.8	0.3	1.1	0.4	0.4	0.5	0.3	0.8	0.6
FAM9C	TEX39C	ENSG00000187268	"Family with sequence similarity 9 member C"	Q8IZT9	X	13035618-13044682	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 29.8;testis: 12.0"	"Cell line enriched"	"Detected in some"	55	"AN3-CA: 63.6"	"Cancer enriched"	"Detected in single"	22	"testis cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 3.0"																				"unprognostic (2.28e-1)"				"unprognostic (7.35e-2)"			"unprognostic (1.90e-1)"		"unprognostic (1.66e-1)"	"unprognostic (3.35e-2)"		"unprognostic (2.06e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"		0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.3	0.0	2.0	0.0	0.1	0.0	0.1	29.8	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.0	0.1	0.0	0.3	0.0	0.1	0.1	0.3	63.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.6	0.0	0.2	0.5	0.0	0.0	0.3	0.3	0.1	0.5	0.0	0.2	0.4	0.2	0.3	0.2	0.2	1.1	0.2	0.1	0.3	0.4	0.2	0.1	0.3	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206904386-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 51.7;U-266/70: 26.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 99.6;T-cells: 60.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"	2400000	2400000	"Focal adhesion sites, Cytosol"	"Focal adhesion sites, Cytosol"	"HPA003910: AB_1078798"	"prognostic favourable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	15.5	0.6	0.5	42.9	0.5	2.9	1.5	0.4	0.4	0.8	2.5	0.4	0.3	1.2	1.2	0.8	3.4	1.3	2.6	1.0	0.5	0.5	2.4	1.5	3.9	77.2	0.5	0.0	1.3	0.7	0.0	0.9	0.8	0.2	1.4	2.3	1.3	10.1	0.3	1.9	0.6	30.1	0.4	0.6	78.8	2.8	0.5	0.0	51.8	1.8	1.2	84.9	8.5	1.2	99.6	1.4	5.3	0.4	18.4	60.0	28.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.1	0.0	0.0	3.3	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	7.2	0.0	0.1	1.0	0.1	0.0	0.0	1.6	0.2	51.7	0.0	0.1	0.0	0.0	1.0	0.2	4.8	0.1	0.0	0.2	0.0	0.2	0.0	0.0	26.1	1.9	7.2	0.3	0.0	0.2	0.5	0.2	0.2	20.3	0.4	26.4	80.3	28.1	26.2	0.2	99.6	49.5	33.3	5.3	18.4	0.3	1.4	60.0	28.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.2	0.0
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1"	"Cell line enhanced"	"Detected in some"		"RH-30: 5.2;THP-1: 3.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	22	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	22	"B-cells: 2.2"									HPA012836	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012836: "	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.2	0.5	0.4	1.2	1.2	3.0	0.1	3.3	0.8	0.0	0.0			0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.6	0.6	0.4	0.1	0.4	0.4	0.3		0.0	0.2	0.0	0.4	0.1		0.2	0.1		0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.2	3.1			0.2		0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.6	1.0	0.0	1.5	0.0	0.6	0.0	0.1	0.3	0.0	2.0	0.9	0.1	0.1	0.6	0.0	0.1	1.9	1.3	0.7	1.0	0.9	0.0	2.1	1.6	0.0	0.7	0.2	0.0	0.0	1.2	1.7	0.3	0.1	0.3	0.9	0.0	0.7	0.6	5.2	0.7	0.1	0.6	0.7	0.4	0.5	0.1	0.2	0.4	3.7	0.4	1.7	1.5	0.6	1.3	1.3	1.3	0.7	0.3	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770526	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 128.2;lymphoid tissue: 32.2"	"Cell line enriched"	"Detected in some"	18	"U-937: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 128.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 128.2"									HPA029154	Approved									"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	7.9	1.1	0.6	30.7	2.1	8.7	0.8	0.4	1.9	0.6	0.8	0.8	0.0	0.4	0.6	0.2	1.0	2.6	3.3	5.0	1.9	0.6	1.3	2.4	17.3	32.2	2.8	0.0	1.6	1.1	0.0	1.1	4.4	2.3	0.6	0.1	1.1	1.0	0.0	1.1	0.4	1.1	3.3	3.0	29.1	1.2	2.5	1.6	0.8	1.0	0.9	0.3	4.4	2.2	0.0	1.7	128.2	12.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.8	25.4	0.0	0.4	12.7	0.6	0.0	11.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	128.2	0.0	7.5	0.3	0.0	3.9	0.6	2.1	0.4	1.9	1.9	0.6	2.8	0.0	2.3	1.6
GBP6	DKFZp686G0786	ENSG00000183347	"Guanylate binding protein family member 6"	Q6ZN66	1	89364058-89386461	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 106.5;lymphoid tissue: 60.5;tongue: 61.3"	"Group enriched"	"Detected in some"	9	"A-431: 7.8;HaCaT: 17.3"	"Group enriched"	"Detected in many"	7	"cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;T-cells: 2.7"									HPA027744	Enhanced									"HPA027744: AB_10602809"	"unprognostic (7.60e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-3)"	"unprognostic (5.85e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.04e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.91e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.1	0.0	106.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	15.6	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	61.3	60.5	0.1	6.8	0.6	0.6	3.4	0.6	0.3	2.7	0.4	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.0	17.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.4	0.7	0.2	1.2	0.6	0.9	1.2	0.4	0.4	0.7	0.7	3.4	0.3	0.4	0.6	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 41.1;neutrophil: 112.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 112.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"		890000	890000	Cytosol	Cytosol	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	13.1	6.8	13.4	24.8	21.3	116.0	7.8	6.9	15.8	6.0	7.7	15.3	3.2	8.2	4.6	11.0	5.0	7.2	9.7	11.2	15.9	13.0	8.5	7.6	15.6	51.8	26.0	9.7	4.4	11.5	4.8	8.1	10.6	24.6	5.7	8.6	3.7	6.9	4.9	2.2	3.7	7.8	7.7	30.2	50.0	10.3	10.7	20.8	5.8	7.4	2.5	10.3	10.0	6.3	3.1	8.9	112.7	18.2	0.3	1.3	8.4	1.3	2.1	5.8	0.0	1.4	1.2	0.2	2.1	6.1	3.4	6.2	4.8	16.3	1.9	15.0	0.1	0.8	2.2	6.9	4.2	9.1	9.2	17.1	1.5	9.1	1.7	21.4	5.0	1.5	2.4	3.1	0.7	0.4	0.3	6.6	0.2	16.8	0.4	12.4	3.7	8.3	7.4	1.4	9.6	17.9	9.6	3.8	6.5	2.8	12.6	10.6	8.6	9.6	0.4	0.8	6.2	9.7	3.2	6.3	11.7	0.3	5.3	8.4	4.0	4.4	18.2	41.1	0.4	10.7	0.5	3.0	0.6	0.6	8.9	3.1	1.1	0.7	112.7	0.3	8.0	2.2	1.3	8.4	13.4	21.3	6.9	15.8	15.9	13.0	26.0	9.7	24.6	20.8
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 43.5;hTCEpi: 32.4;RT4: 50.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.3	43.5	0.0	0.2	0.0	8.6	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.4	0.5	6.0	0.0	0.0	3.2	0.0	0.4	0.3	0.0	0.1	4.3	0.0	0.0	2.4	0.0	50.5	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.2	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 77.0;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		1500000	1500000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favourable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	22.6	6.1	7.3	29.6	7.4	80.9	16.8	2.2	4.8	6.0	8.8	4.0	1.7	5.3	4.4	9.4	6.4	7.3	8.7	7.5	6.0	4.9	9.4	9.7	28.5	42.2	8.6	2.3	4.7	3.6	1.1	3.1	18.0	5.8	6.1	7.9	4.9	8.1	2.3	5.4	4.2	17.8	6.8	8.2	86.0	5.9	2.9	5.6	109.5	9.8	7.0	37.1	11.1	7.5	39.1	57.2	276.5	79.4	41.6	88.0	106.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.8	33.5	0.3	0.0	0.2	0.0	0.1	0.1	11.3	0.0	36.5	0.0	0.5	0.6	39.0	77.0	0.1	0.0	0.0	0.1	2.0	1.3	59.8	0.3	0.0	35.5	43.6	0.0	0.0	49.0	0.4	21.9	0.0	5.2	0.1	0.0	0.1	0.2	0.2	0.1	76.8	20.0	0.0	0.4	0.1	0.1	3.4	11.6	38.3	0.2	52.7	0.3	185.2	79.4	178.1	37.7	72.3	40.0	39.1	56.7	46.6	57.2	35.0	55.9	46.4	276.5	41.6	78.9	22.2	88.0	106.7	7.3	7.4	2.2	4.8	6.0	4.9	8.6	2.3	5.8	5.6
GNGT2	GNG9	ENSG00000167083	"G protein subunit gamma transducin 2"	O14610	17	49202791-49210574	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"blood: 29.1;lymphoid tissue: 21.1;retina: 46.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 35.6;HDLM-2: 30.6;HUVEC TERT2: 9.2;RH-30: 11.3;TIME: 8.9;U-698: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 29.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA043381	Enhanced									"HPA043381: AB_2678455"	"unprognostic (9.11e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.99e-2)"	"unprognostic (4.62e-5)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.23e-1)"	2.7	2.1	2.7	9.4	3.7	1.3	1.8	0.7	2.2	2.1	2.3	2.0	0.4	2.6	1.6	1.2	1.8	1.7	3.3	2.4	2.5	1.9	3.0	2.6	6.2	12.2	3.2	0.4	1.7	1.2	0.1	1.4	1.9	2.2	2.2	3.3	46.7	1.6	1.1	0.6	0.6	4.9	2.9	4.5	21.1	1.7	0.8	2.5	6.0	2.5	1.4	16.6	3.6	5.1	2.0	9.7	0.9	29.1	10.6	14.4	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.6	0.5	0.0	0.0	35.6	0.3	0.1	0.0	0.0	0.0	2.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.2	0.0	0.2	0.8	0.0	2.7	2.1	0.3	0.0	6.9	11.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.0	5.7	0.0	0.0	0.1	1.6	10.9	0.1	0.1	0.0	0.0	4.3	0.4	14.4	21.5	12.6	1.9	2.4	10.2	9.7	2.0	1.5	5.9	0.9	10.6	29.1	0.8	1.8	5.4	2.7	3.7	0.7	2.2	2.5	1.9	3.2	0.4	2.2	2.5
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet alpha subunit"	P07359	17	4932297-4935030	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 37.8"	"Cell line enriched"	"Detected in some"	24	"HEL: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	7	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported					2000000000	2000000000			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.7	0.1	0.4	15.8	1.2	5.3	0.7	1.9	0.7	0.7	1.0	0.2	0.2	1.5	0.6	0.7	5.7	0.8	0.3	4.2	0.5	0.4	1.0	1.6	3.5	37.8	0.4	0.2	0.7	0.4	0.0	0.4	1.1	0.4	0.7	0.6	0.3	7.7	0.2	3.0	4.6	3.7	0.2	0.4	13.0	0.9	0.6	0.2	2.0	0.8	0.8	17.6	0.9	1.1	0.0	0.3	7.5	0.2	0.0	0.2	3.6	0.0	1.3	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.1	1.2	0.4	0.0	1.3	0.0	0.0	0.0	0.4	1.0	39.3	0.5	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.3	0.2	0.1	0.2	0.6	0.3	0.2	0.0	0.7	0.0	0.2	0.5	0.0	0.2	1.6	0.7	0.1	0.2	0.2	0.8	0.1	0.7	0.2	0.9	0.6	0.6	0.4	7.5	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.3	0.0	3.6	0.4	1.2	1.9	0.4	0.5	0.4	0.4	0.2	0.4	0.2
GPC2	"cerebroglycan, DKFZp547M109, FLJ38962"	ENSG00000213420	"Glypican 2"	Q8N158	7	100169606-100177372	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 34.3;skin 1: 9.4;testis: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 23.7;AN3-CA: 9.5;BEWO: 8.4;SH-SY5Y: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025423	Uncertain				"Intracellular and membrane"					"CAB025423: "	"unprognostic (4.33e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-4)"	"unprognostic (7.25e-4)"	"unprognostic (1.67e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (9.94e-4)"	0.5	0.5	3.2	3.5	1.9	1.9	0.6	2.2	4.3	0.8	0.9	2.1	0.0	0.5	2.6	0.3	0.2	0.4	0.4	0.3	2.9	1.6	0.2	0.1	0.5	2.2	2.0	0.9	0.8	0.3	0.5	0.7	0.3	1.5	0.5	0.8	0.5	1.7	0.4	0.8	9.4	0.7	0.8	3.3	1.4	0.3	16.7	2.0	34.3	0.3	0.7	2.0	0.6	1.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.1	23.7	9.5	0.0	0.0	8.4	0.7	0.0	0.1	0.2	0.0	0.3	2.0	0.5	0.2	0.8	0.8	0.3	0.0	0.0	0.7	0.2	0.3	0.0	0.4	0.5	3.6	0.8	0.4	0.5	0.0	1.1	0.9	0.0	0.6	0.3	5.4	0.6	4.1	1.3	6.2	1.6	0.0	0.1	0.4	6.3	26.2	0.5	0.6	0.8	0.4	0.4	0.9	0.2	3.8	0.5	0.1	0.8	0.2	2.8	0.2	1.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.3	3.2	1.9	2.2	1.7	2.9	1.6	2.0	0.9	1.5	2.0
GPR182	"ADMR, AM-R, G10D, hrhAMR"	ENSG00000166856	"G protein-coupled receptor 182"	O15218	12	56994446-56998441	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"liver: 9.5;lymphoid tissue: 29.1;testis: 12.9"	"Cell line enhanced"	"Detected in some"		"A549: 2.2;RH-30: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027037	Enhanced									"HPA027037: AB_1844622"	"unprognostic (6.13e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.10e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.94e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.34e-3)"	0.4	3.2	0.0	0.8	0.0	0.0	0.6	0.1	0.3	0.7	0.4	0.0	0.6	0.0	1.2	0.7	1.3	0.7	0.1	0.3	0.0	0.0	1.3	9.5	1.9	7.5	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.1	0.3	0.3	0.7	0.0	29.1	0.2	12.9	0.0	0.2	1.4	0.3	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	1.3	1.0	0.7	0.0	0.0	0.3	6.2	0.0	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.4	0.3	0.0	0.4	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2-related adaptor protein 2"	O75791	22	39901082-39973721	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 138.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdTCR: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 22.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		260000	260000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.6	0.4	0.3	7.7	0.7	7.6	1.5	0.3	0.4	1.1	2.3	0.6	0.4	2.9	2.3	1.6	1.6	1.2	3.5	2.8	0.6	0.4	1.2	1.8	6.4	12.6	0.9	0.4	1.0	0.8	0.0	0.6	1.1	0.6	2.4	1.9	1.2	2.4	1.2	0.5	1.4	6.2	2.0	2.2	13.2	2.9	2.4	0.3	138.0	1.3	1.5	11.3	3.0	1.9	2.1	0.4	2.5	0.2	1.7	22.5	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	18.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.2	0.0	19.5	0.1	14.4	1.0	14.4	21.1	0.4	2.1	12.2	22.5	2.5	1.7	0.1	0.3	12.0	25.9	0.3	0.7	0.3	0.4	0.6	0.4	0.9	0.4	0.6	0.3
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102648-55110252	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 92.3;intestine: 31.0;lymphoid tissue: 40.9"	"Cell line enriched"	"Detected in some"	4	"HL-60: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"gdTCR: 92.3;MAIT T-cell: 90.8;memory CD4 T-cell: 25.4;memory CD8 T-cell: 89.3;naive CD8 T-cell: 50.5;NK-cell: 61.9"	"Group enriched"	"Detected in many"	38	"NK-cells: 61.9;T-cells: 92.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054134	Approved				"Secreted to blood"					"HPA054134: AB_2682395"	"prognostic favourable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favourable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	4.3	1.8	1.1	16.3	1.2	10.0	2.5	0.7	0.8	3.9	12.5	0.9	1.3	10.3	5.2	2.9	2.9	2.9	9.6	4.5	1.1	1.1	4.6	5.2	11.8	20.3	1.7	0.9	3.0	5.8	0.0	1.9	5.8	1.5	3.4	6.3	4.5	5.1	1.3	2.6	1.2	31.0	2.5	2.6	40.9	3.9	1.1	0.6	1.9	3.1	4.2	11.1	6.6	2.9	0.2	0.2	2.0	0.3	61.9	92.3	52.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	92.3	0.2	90.8	0.2	25.4	89.3	0.2	0.1	5.2	50.5	2.0	61.9	0.3	0.2	2.9	52.0	1.1	1.2	0.7	0.8	1.1	1.1	1.7	0.9	1.5	0.6
H2AFX	H2AX	ENSG00000188486	"H2A histone family member X"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 135.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: "	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	5.9	10.1	10.7	17.9	9.4	24.0	4.2	9.4	13.9	5.0	12.0	15.2	2.5	15.4	5.7	2.8	9.8	5.5	4.0	4.7	10.6	10.1	6.4	5.0	7.1	17.0	13.3	5.3	8.0	9.2	3.8	8.1	12.8	9.3	6.4	5.4	6.3	5.8	6.3	7.2	10.8	13.7	4.2	13.6	11.1	12.6	28.3	9.5	135.1	5.9	11.3	23.2	4.8	6.6	2.0	3.4	7.4	2.4	3.8	3.4	1.8	26.1	15.8	25.0	14.9	2.3	1.7	26.4	29.8	9.1	16.8	14.8	25.0	11.3	18.0	18.0	6.8	27.2	11.8	8.5	4.5	26.5	33.1	36.4	4.3	25.7	2.4	17.9	22.7	1.4	1.8	7.1	4.4	8.4	29.4	29.6	8.0	66.7	40.9	53.6	18.2	33.5	40.0	29.5	8.4	7.6	11.4	26.7	31.7	23.6	13.8	4.1	20.6	13.6	10.3	16.3	43.1	13.2	22.1	8.1	7.9	18.2	3.7	29.2	31.8	7.0	2.4	7.4	3.4	1.1	1.8	2.0	3.4	3.4	3.4	1.8	2.3	2.0	1.2	3.8	1.5	1.5	2.8	1.8	10.7	9.4	9.4	13.9	10.6	10.1	13.3	5.3	9.3	9.5
HIST1H1D	"H1.3, H1d, H1F3, H1s-2"	ENSG00000124575	"Histone cluster 1 H1 family member d"	P16402	6	26234268-26234933	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 182.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.4;MOLT-4: 13.3;NB-4: 6.1;REH: 5.5;SiHa: 5.4;U-266/70: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA055907	Supported									"HPA055907: AB_2682966"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.61e-8)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-2)"	3.2	1.1	0.4	14.7	0.9	37.5	5.0	2.8	0.9	4.1	5.2	0.1	2.0	1.0	3.9	4.8	10.7	1.3	3.7	2.5	0.8	0.8	1.5	1.1	9.9	21.2	0.6	0.0	3.4	0.9	0.9	0.6	2.3	0.1	3.7	2.4	1.4	1.8	1.0	0.9	6.1	4.9	1.2	4.4	14.2	1.6	4.6	0.0	182.1	1.7	4.5	17.6	8.3	9.2	26.3	17.9	8.6	3.8	12.5	21.2	8.0	1.0	0.7	0.2	0.0	0.4	0.0	8.4	0.4	0.3	1.1	0.8	0.2	0.9	0.0	0.2	0.1	1.0	0.3	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.2	0.3	0.4	2.3	2.3	0.1	0.0	13.3	6.1	0.7	2.5	5.5	0.1	3.1	0.0	0.0	2.8	0.4	5.4	2.3	0.0	1.1	1.3	0.0	0.4	0.0	0.2	0.9	6.9	3.4	0.4	1.0	1.8	0.7	8.6	3.8	3.2	17.7	2.4	12.6	16.5	16.3	12.0	9.5	26.3	21.2	16.4	1.4	12.5	3.4	17.9	12.1	8.0	0.4	0.9	2.8	0.8	0.8	0.8	0.6	0.0	0.1	0.0
HIST1H1E	"H1.4, H1e, H1F4, H1s-4"	ENSG00000168298	"Histone cluster 1 H1 family member e"	P10412	6	26156354-26157107	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 9.7;U-266/70: 11.8;U-266/84: 13.2;U-87 MG: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"CAB011506: AB_470256, HPA055907: AB_2682966"	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	6.7	3.6	3.1	14.3	3.5	102.3	10.3	8.1	9.0	10.7	7.7	4.7	4.2	4.1	6.8	7.5	13.7	4.0	11.3	7.4	4.0	3.5	6.6	6.7	13.1	18.4	3.4	2.4	19.3	17.1	3.7	9.0	7.3	3.5	10.2	4.4	9.8	10.0	4.0	4.1	14.4	9.0	7.4	6.8	14.6	5.3	5.9	0.7	123.9	4.6	10.0	18.4	14.3	10.7	39.6	14.6	56.4	12.9	19.2	24.4	9.4	2.4	0.3	0.4	5.2	0.1	0.0	6.3	0.0	0.4	1.1	0.8	0.1	1.5	1.2	0.7	0.1	1.1	0.3	0.7	0.5	1.7	1.5	0.8	0.5	0.4	0.1	0.7	1.0	0.1	0.3	0.3	0.5	0.5	3.9	6.7	0.1	0.5	7.7	7.1	1.8	0.8	3.6	1.2	9.7	0.3	0.0	3.8	0.9	3.1	0.8	1.1	1.0	2.5	0.4	2.4	3.6	1.4	2.4	11.8	13.2	5.3	12.1	2.1	1.1	56.4	12.7	30.0	21.1	12.9	24.4	21.4	16.7	19.2	14.3	39.6	12.7	11.6	18.6	19.2	10.9	14.6	16.4	9.4	3.1	3.5	8.1	9.0	4.0	3.5	3.4	2.4	3.5	0.7
HIST1H4A	H4FA	ENSG00000278637	"Histone cluster 1 H4 family member a"	P62805	6	26021679-26021990	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 87.7"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.6;NB-4: 9.9;REH: 12.4"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	4	"neutrophil: 14.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.0"									"CAB021887, HPA042201"	Supported					30000000	30000000			"CAB021887: AB_2279758, HPA042201: AB_2677898"	"unprognostic (5.71e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.23e-1)"		"unprognostic (1.23e-3)"				"unprognostic (9.76e-2)"	"unprognostic (5.99e-2)"		"unprognostic (6.42e-2)"	0.5	0.5	0.0	5.2	0.0	7.1	2.1	16.7	3.2	0.6	1.5	0.0	0.0	5.2	1.5	1.8	3.7	0.3	1.2	3.2	0.0		0.5	0.1	2.0	3.5	0.0	1.8	1.4	0.8	0.1	0.0	0.8	0.2	0.4	1.0	1.6	0.8	1.0	0.8	0.9	1.1	3.6	0.1	2.5	0.7	2.6	0.0	87.7	2.5	3.6	9.6	2.0	0.0	0.8	0.9	14.0	1.0	1.2	1.4	0.2	3.7	1.7	3.5	0.0	0.8	0.0	0.0	0.3	1.3	1.6	2.3	0.0	5.6	2.6	0.9	0.0	4.9	2.6	0.0	0.5	0.4	1.8	2.5	1.5	0.0	0.0	0.6	6.0	0.0	0.0	0.5	0.0	1.6	1.3	4.1	0.0	1.5	13.6	9.9	2.3	0.0	12.4	2.2	2.2	0.0	0.4	4.2	1.8	1.6	6.1	0.1	3.2	2.7	0.0	3.0	7.7	3.0	3.0	1.5	2.4	0.0	1.4	4.1	5.8	0.0	1.0	3.4	1.3	0.8	0.2	0.4	1.1	0.3	0.9	0.8	0.4	0.3	14.0	1.2	0.2	0.4	1.4	0.2										
HIST1H4C	"dJ221C16.1, H4/g, H4FG"	ENSG00000197061	"Histone cluster 1 H4 family member c"	P62805	6	26103876-26104310	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 172.4;lymphoid tissue: 88.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 26.1;PC-3: 14.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-4)"	"unprognostic (6.95e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (5.74e-6)"	"unprognostic (2.42e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.79e-3)"	4.8	4.3	6.9	13.2	6.2	23.5	4.6	12.5	8.8	4.6	6.9	0.9	6.4	3.9	4.8	4.2	6.5	4.8	5.0	3.4	6.2	5.6	6.6	6.4	4.2	12.0	5.5	7.9	4.5	19.4	2.3	5.2	5.9	4.3	3.8	7.5	5.2	11.1	5.0	3.6	4.5	5.4	3.5	6.4	7.0	4.8	25.5	4.4	88.7	8.0	12.4	9.9	8.0	5.2	54.3	26.9	45.5	25.4	25.4	46.6	172.4	1.4	1.4	0.5	2.2	0.0	0.2	0.0	0.7	0.6	0.4	0.7	2.0	0.3	0.5	0.7	0.2	0.8	1.6	0.5	0.4	1.2	26.1	0.9	2.7	3.1	0.7	1.1	0.9	1.1	0.0	0.3	0.0	0.6	1.4	1.1	0.4	0.2	5.7	2.9	1.4	14.1	1.7	0.8	2.4	0.9	0.1	1.5	1.0	0.7	1.0	0.6	0.7	3.7	0.4	1.6	1.6	0.7	1.2	2.1	2.0	2.4	1.0	2.1	0.8	39.9	25.4	17.8	31.4	10.2	30.0	54.3	40.5	25.6	18.5	48.6	46.6	35.1	45.5	25.4	10.2	26.9	26.7	172.4	6.9	6.2	12.5	8.8	6.2	5.6	5.5	7.9	4.3	4.4
HIST2H2BF		ENSG00000203814	"Histone cluster 2 H2B family member f"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 117.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 21.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 21.7"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: , HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	5.6	17.7	3.9	14.9	3.5	3.7	7.1	8.5	5.6	17.4	3.8	3.7	3.2	1.5	5.6	6.2	7.1	7.9	3.6	12.1	3.4	2.4	5.0	4.2	14.6	27.5	3.2	3.8	24.2	6.2	2.6	4.4	5.1	3.2	16.7	2.5	3.5	3.7	5.5	1.2	10.9	3.4	6.0	7.7	12.7	7.9	5.9	3.1	117.6	4.4	6.3	16.7	6.1	21.5	2.0	0.8	21.7	1.1	0.6	0.8	0.2	0.4	0.6	0.5	0.6	4.5	3.0	0.3	7.7	4.0	5.9	5.2	0.3	2.2	0.4	0.6	4.4	1.3	0.1	0.5	4.6	1.2	0.9	0.4	1.5	0.0	6.6	0.2	1.7	5.4	0.0	7.6	1.9	3.3	1.2	2.3	0.8	0.9	3.1	3.7	0.4	1.0	0.3	1.1	0.7	2.8	0.4	2.6	7.2	4.1	3.5	0.3	1.3	9.6	1.4	1.5	0.0	11.2	2.0	31.4	1.0	1.3	5.2	0.3	3.3	0.0	1.0	0.2	0.6	0.8	0.7	0.6	0.8	0.3	0.8	2.0	0.4	0.3	21.7	0.6	1.1	0.8	0.2	0.2	3.9	3.5	8.5	5.6	3.4	2.4	3.2	3.8	3.2	3.1
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122612628-122621069	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"HeLa: 4.2;Karpas-707: 1.1;SiHa: 3.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"memory CD4 T-cell: 2.2;T-reg: 1.0"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"													"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	3.5			0.1		7.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1										
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5"	"Group enriched"	"Detected in some"	15	"HL-60: 2.8;U-937: 4.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"					"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.1	0.0	0.1	2.5	0.1	0.0	6.9	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	2.0	0.1	0.1	0.1	0.1	0.0	0.1	11.5	0.1	0.2	0.5	0.1	0.1	0.1	0.1	1.4	1.5	0.1	0.1	1.9	0.3	0.1	0.1	0.1	0.1	0.1	6.2	0.8	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 115.3;lymphoid tissue: 169.3"	"Cell line enriched"	"Detected in some"	6	"Karpas-707: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA046641, HPA049691"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA046641: AB_2679733, HPA049691: AB_2680851"	"unprognostic (2.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.73e-4)"	"unprognostic (8.25e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (2.28e-7)"	"unprognostic (1.73e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.54e-2)"	5.8	1.3	1.4	39.5	1.4	12.8	3.6	0.8	0.9	2.9	16.6	0.9	0.9	8.2	3.0	2.1	5.3	3.1	5.3	2.6	1.4	1.5	3.7	4.7	13.6	70.4	1.8	0.6	2.9	1.5	0.0	1.2	5.3	1.5	3.2	20.8	2.9	10.4	1.8	1.6	2.7	28.6	1.5	2.9	58.7	6.0	2.0	0.9	169.3	3.3	4.2	61.4	7.6	3.1	51.9	30.6	65.6	19.7	94.6	115.3	99.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	17.2	1.2	0.0	0.1	0.0	0.0	0.0	14.4	0.0	2.2	0.0	0.0	0.0	8.9	0.4	0.0	0.0	0.0	0.0	0.0	3.8	220.5	0.0	0.0	31.9	17.4	0.0	0.0	7.3	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	12.6	22.2	11.1	0.2	37.0	0.0	35.2	8.5	13.4	107.2	19.7	105.6	51.9	97.7	110.4	20.3	51.6	68.0	84.9	65.6	94.6	13.5	30.6	115.3	99.0	1.4	1.4	0.8	0.9	1.4	1.5	1.8	0.6	1.5	0.9
IL7R	CD127	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1"	"Cell line enhanced"	"Detected in many"		"BJ: 21.7;fHDF/TERT166: 40.7;HBF TERT88: 37.4;REH: 84.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1"	"Group enriched"	"Detected in many"	33	"NK-cells: 19.1;T-cells: 70.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB010215			Supported	"Plasma membrane,Centriolar satellite"	"Intracellular and membrane"	180000	180000	"Plasma membrane, Centriolar satellite"	"Plasma membrane, Centriolar satellite"	"CAB010215: AB_673727"	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"	6.7	3.6	0.7	34.0	0.7	3.1	4.8	0.5	0.6	4.8	20.6	0.3	0.9	3.5	1.8	2.9	6.6	3.7	8.5	1.9	0.7	0.7	7.0	2.7	52.6	133.1	0.8	0.1	2.5	1.7	0.0	1.5	1.2	0.8	3.3	5.4	1.7	13.2	1.8	0.9	1.8	34.0	1.2	1.5	32.3	7.8	3.0	0.4	130.9	5.1	5.3	42.9	12.6	4.6	0.4	0.3	1.3	0.2	19.1	70.3	12.7	0.1	0.0	0.1	0.1	0.1	0.1	0.2	21.7	11.0	19.6	11.6	0.1	0.1	2.1	0.0	40.7	3.5	0.0	1.3	37.4	1.8	0.2	0.6	2.3	0.0	0.3	0.1	1.5	0.3	0.0	4.2	0.9	0.5	0.1	0.3	15.4	0.0	0.5	0.2	0.1	1.0	84.6	1.1	0.1	0.0	1.2	0.0	0.0	3.6	0.3	0.0	0.1	0.0	1.5	7.7	13.1	3.3	2.8	0.1	0.0	2.4	3.9	2.0	5.9	0.5	0.2	0.1	19.2	0.2	70.3	0.2	39.9	28.0	0.1	0.4	34.5	22.5	1.3	19.1	0.2	0.3	6.7	12.7	0.7	0.7	0.5	0.6	0.7	0.7	0.8	0.1	0.8	0.4
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255191	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 28.0;lymphoid tissue: 60.5"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	28	"gdTCR: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1"	"Group enriched"	"Detected in many"	29	"NK-cells: 9.2;T-cells: 28.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"														"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	2.3	0.7	0.5	12.2	0.6	2.5	1.3	1.9	0.5	1.4	3.3	0.0	0.0	0.5	1.2	1.1	1.8	1.4	4.3	0.9	0.5	0.5	1.4	1.2	6.6	60.5	0.9	0.0	0.7	0.7	0.0	0.9	0.1	0.3	1.1	1.3	1.5	3.5	1.1	0.5	1.0	8.9	0.4	1.2	10.7	2.3	1.4	0.0	60.3	1.6	2.7	24.3	4.1	1.3	0.0	0.0	0.4	0.6	9.2	28.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	3.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	9.1	0.0	19.5	18.9	0.0	0.0	28.0	22.8	0.4	9.2	0.6	0.0	23.1	13.6	0.5	0.6	1.9	0.5	0.5	0.5	0.9	0.0	0.3	0.0
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876539-160885170	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.3;HHSteC: 1.9;HL-60: 3.1;RPMI-8226: 1.7;U-937: 11.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.9;non-classical monocyte: 17.3"	"Lineage enriched"	"Detected in many"	15	"monocytes: 17.3"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	160000000	160000000			"CAB012652: , HPA063275: AB_2684974, HPA067326: "	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	119.2	0.0	0.2	40.1	0.2	0.0	0.2	0.2	0.2	0.4	52.5	0.2	1.0	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0.0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0.0	0.4	0.4	0.3	3.0	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0.0	1.1	0.1	17.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	1.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	11.9	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.3	0.2
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110675033	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 59.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.4;Karpas-707: 25.6;U-266/70: 18.5;U-266/84: 16.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 3.3;T-cells: 11.5"	"Low region specificity"	"Detected in all"							HPA016625	Approved									"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	1.9	1.3	4.0	7.8	5.7	5.6	1.3	5.0	5.6	1.7	3.1	0.5	0.0	3.2	1.1	0.4	1.1	1.3	2.3	1.4	3.5	4.3	1.5	1.3	7.8	14.5	1.5	3.1	1.3	0.9	0.4	1.8	0.9	3.1	1.1	2.6	0.5	3.7	0.3	0.5	0.8	5.9	0.7	1.9	7.7	5.3	1.4	1.5	59.4	2.1	0.3	10.9	5.8	1.3	3.3	1.0	0.0	0.7	0.9	11.5	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	5.3	0.0	0.5	0.0	0.0	0.0	5.1	0.0	0.0	3.6	0.3	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	18.5	16.6	6.4	0.0	1.5	0.0	0.0	0.7	0.0	7.2	0.0	8.2	2.3	10.8	11.5	1.0	3.3	8.5	6.4	0.0	0.9	0.1	0.5	9.5	2.9	4.0	5.7	5.0	5.6	3.5	4.3	1.5	3.1	3.1	1.5
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92593286-92655395	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 74.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"				Cytosol	Cytosol	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (8.19e-7)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	2.3	1.6	1.0	20.2	2.6	14.3	1.6	0.7	1.5	2.4	4.6	0.7	0.5	3.7	1.4	1.9	11.5	0.8	2.6	2.0	1.1	1.2	1.1	1.1	2.8	12.1	1.0	1.0	1.1	1.1	0.5	0.7	3.1	1.4	1.0	5.4	0.5	2.7	0.2	0.6	4.2	4.4	1.6	1.8	5.2	2.7	10.5	1.1	74.2	1.2	7.5	13.4	2.2	3.8	2.4	0.9	2.5	1.2	3.5	3.9	1.0	30.6	13.7	31.0	28.8	2.2	3.4	7.7	22.1	19.3	24.6	24.4	12.0	20.4	33.9	11.4	10.3	22.2	22.1	11.3	28.9	20.2	12.7	21.2	13.1	12.5	0.4	34.1	19.8	1.1	1.0	19.0	17.7	15.2	15.0	39.7	18.5	12.3	29.0	19.2	12.3	9.5	31.3	30.7	12.0	6.4	9.0	9.5	13.6	17.3	7.8	9.0	21.2	10.9	8.6	11.2	16.2	11.4	29.0	11.1	17.0	34.9	9.1	24.7	15.2	2.5	0.5	0.5	0.4	1.2	1.1	2.4	1.4	1.9	0.9	1.0	0.5	0.7	1.4	3.5	0.4	0.4	3.9	1.0	1.0	2.6	0.7	1.5	1.1	1.2	1.0	1.0	1.4	1.1
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620734	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 9.0;lymphoid tissue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"				Cytosol	Cytosol	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.4	0.6	0.2	2.7	0.4	9.0	2.6	0.3	0.3	0.7	2.0	0.4	0.2	1.8	0.4	0.5	3.8	0.2	0.2	0.5	0.3	0.3	0.4	0.8	1.2	4.7	0.2	0.2	0.3	0.3	0.0	0.2	2.8	0.6	0.6	1.8	0.4	0.9	0.2	0.2	1.4	2.4	0.8	0.6	2.0	1.1	4.5	0.2	34.4	0.3	0.6	4.9	0.8	1.3	0.5	0.1	2.4	0.2	0.7	1.9	0.2	15.5	9.2	14.6	8.1	0.4	1.7	8.1	10.7	6.3	10.3	9.3	5.5	8.1	9.4	3.8	5.1	12.4	11.6	7.1	14.8	11.5	6.1	15.1	13.1	5.4	0.0	23.6	8.6	0.3	0.3	11.4	9.8	7.2	22.6	12.3	12.7	6.3	13.8	7.4	12.3	8.1	12.7	19.3	12.0	3.4	4.4	6.9	7.7	15.1	5.2	6.2	7.0	6.1	5.9	8.1	9.7	8.8	18.6	4.5	4.5	13.8	4.7	12.7	16.5	2.4	0.1	0.1	0.1	0.2	0.1	0.5	0.5	0.4	0.0	0.4	0.2	0.1	0.5	0.7	0.1	0.1	1.9	0.2	0.2	0.4	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2
KIR2DL4	"103AS, 15.212, CD158D"	ENSG00000189013	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4"	Q99706	19	54803535-54814517	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 5.6;intestine: 7.3;lymphoid tissue: 13.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	56	"NK-cell: 5.6"	"Lineage enriched"	"Detected in single"	56	"NK-cells: 5.6"														"Intracellular and membrane"						"unprognostic (1.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (5.95e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-5)"	"unprognostic (5.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.53e-8)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.10e-4)"	"unprognostic (3.59e-3)"	0.2	0.3	0.0	2.8	0.0	0.3	0.1	0.0	0.2	0.1	3.8	0.0	0.0	0.1	1.4	0.2	0.2	0.2	0.3	0.9	0.1	0.0	0.2	0.3	1.2	0.3	0.0	0.0	1.1	0.1	0.1	0.1	1.7	0.0	0.2	0.3	0.0	0.1	0.8	0.1	0.1	7.3	0.1	0.0	13.9	0.3	0.3	0.0	0.4	0.5	0.0	1.5	0.8	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821410-52834295	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 11.3;skin 1: 34.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 97.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 0.2;hippocampal formation: 0.3;olfactory region: 0.5"	HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		950000000	950000000	"Nucleoplasm, Nuclear membrane, Cytosol"	"Nucleoplasm, Nuclear membrane, Cytosol"	"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	4.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	34.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	11.3	0.1	0.1	0.2	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	97.6	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LCE3A	LEP13	ENSG00000185962	"Late cornified envelope 3A"	Q5TA76	1	152622834-152623103	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 50.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.0;LHCN-M2: 3.5;U-138 MG: 4.0;U-87 MG: 1.4"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 26.6;melanoma: 9.8"					"Cell type enriched"	"Detected in single"	33	"plasmacytoid DC: 3.3"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 3.3"																					"unprognostic (7.47e-2)"				"unprognostic (1.00e-1)"									"unprognostic (1.11e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2			0.0		50.6	0.0	10.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0										
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 231.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 103.2;REH: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 42.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 42.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favourable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	0.9	13.5	3.5	9.3	5.4	7.6	2.0	1.6	3.4	3.6	1.0	2.9	0.8	0.4	6.0	3.5	3.4	5.0	2.8	0.5	4.7	5.2	2.7	0.3	2.4	25.3	4.9	1.9	1.8	0.8	0.0	1.1	7.8	3.1	2.8	1.0	1.6	3.1	0.7	0.5	2.4	3.9	2.9	4.4	7.0	0.9	8.2	2.3	231.5	2.7	1.3	20.6	4.8	3.2	0.3	0.1	0.5	0.0	8.9	42.2	9.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.8	4.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	3.2	1.2	0.0	0.0	0.0	4.0	0.6	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.5	0.1	103.2	0.0	0.3	0.2	79.7	1.5	0.0	0.4	0.2	0.5	0.9	0.0	0.0	15.2	0.4	0.0	0.0	2.2	1.8	0.0	2.6	6.7	2.8	18.3	1.3	0.0	8.8	0.0	0.0	0.0	2.6	0.0	0.5	0.1	19.7	8.8	0.0	0.3	42.2	29.2	0.5	8.9	0.0	0.1	25.7	9.5	3.5	5.4	1.6	3.4	4.7	5.2	4.9	1.9	3.1	2.3
LIMD2	MGC10986	ENSG00000136490	"LIM domain containing 2"	Q9BT23	17	63695902-63701172	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 175.1;lymphoid tissue: 98.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 53.5;NB-4: 37.3;SH-SY5Y: 37.3;U-698: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062432, HPA075172"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA062432: , HPA075172: "	"unprognostic (2.90e-3)"	"unprognostic (2.89e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (5.36e-11)"	"unprognostic (1.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.08e-2)"	3.6	2.0	6.5	54.8	14.8	28.7	2.3	1.2	8.5	2.7	2.9	3.0	1.3	3.9	2.6	3.2	3.0	2.6	5.1	2.7	9.6	3.3	3.7	5.1	8.1	63.5	3.6	3.7	2.8	1.7	0.8	3.5	6.4	2.8	4.1	2.8	5.0	11.3	1.7	1.1	1.8	12.9	2.6	3.0	51.1	5.5	6.1	1.7	98.4	2.5	2.2	79.7	7.4	2.6	81.9	55.1	175.1	65.1	46.6	67.5	73.0	0.1	1.7	21.1	5.1	0.2	0.5	0.5	0.5	0.3	2.1	1.4	0.9	0.4	53.5	4.7	2.5	0.8	4.6	0.2	0.6	18.4	1.9	15.9	0.3	4.5	4.1	20.6	1.7	5.3	0.2	2.1	0.0	5.7	1.4	3.1	2.4	0.2	18.2	37.3	11.4	1.0	7.5	8.5	9.4	2.9	0.2	25.5	37.3	2.6	0.0	4.9	0.1	28.0	7.1	2.9	6.5	0.1	0.7	0.6	0.2	55.8	0.3	2.9	5.1	175.1	54.6	122.9	35.7	63.3	35.1	64.6	49.4	41.5	55.1	81.9	67.5	48.1	112.7	46.6	65.1	20.8	58.1	73.0	6.5	14.8	1.2	8.5	9.6	3.3	3.6	3.7	2.8	1.7
LRRC55	FLJ45686	ENSG00000183908	"Leucine rich repeat containing 55"	Q6ZSA7	11	57181747-57191717	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 9.2;lymphoid tissue: 24.4"	"Cell line enriched"	"Detected in some"	4	"AF22: 20.5"	"Group enriched"	"Detected in some"	9	"glioma: 9.0;ovarian cancer: 2.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Low region specificity"	"Detected in many"							HPA014053	Uncertain									"HPA014053: AB_2137630"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.17e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.79e-2)"	0.8	1.0	2.2	3.4	2.3	0.0	0.1	0.8	9.2	0.1	0.9	0.4	0.1	0.6	3.1	0.1	1.2	0.7	0.6	0.5	2.7	7.3	0.6	2.5	1.5	24.4	6.9	0.5	0.6	0.4	0.0	0.1	2.9	1.7	0.1	1.0	0.1	3.4	0.1	0.6	0.1	0.9	2.2	7.3	2.6	0.1	0.2	0.1	2.2	0.2	2.1	1.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	2.3	0.8	3.7	2.7	7.3	6.9	0.5	1.7	0.1
LRTM1	HT017	ENSG00000144771	"Leucine rich repeats and transmembrane domains 1"	Q9HBL6	3	54918237-54967088	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"								"unprognostic (9.56e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.87e-3)"	0.3	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.3	3.6	0.1	0.4	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.1	0.4	2.9	1.2	0.0	18.8	2.1	0.4	22.5	0.1	0.3	0.0	1.0	12.2	0.1	0.3	0.0	0.0	0.1	15.3	0.5	0.1	0.1	0.7	1.0	2.3	1.9	0.7	0.9	0.5	0.5	0.3	1.7	0.2	0.2	0.0	1.7	0.0	0.5	0.9	1.6	0.3	1.3	0.0	0.8	0.8	1.0	0.4	1.5	0.5	1.0	0.2	4.2	1.1	0.9	0.2	0.4	1.1	1.8	0.4	0.7	0.2	0.1	0.1	1.6	0.3	0.1	0.4	2.3	1.5	0.5	0.1	0.3	1.3	0.2	0.7	0.4	0.7	0.5	2.2	0.3	1.2	0.3	0.0	0.7	0.9	0.7	0.1	0.0	1.0	0.1	0.4	0.6	0.9	2.3	0.5	0.6	0.7	0.6	0.9	0.7	0.6	0.3	1.0	0.3	0.8	0.6	1.5	0.7	1.9	0.6	0.7	0.5	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0.0	2.9	0.0
LST1	"B144, D6S49E, LST-1"	ENSG00000204482	"Leukocyte specific transcript 1"	O00453	6	31586124-31588909	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 115.3;bone marrow: 60.9;lymphoid tissue: 72.4"	"Cell line enhanced"	"Detected in some"		"HEL: 11.6;HMC-1: 22.7;MOLT-4: 11.5;NB-4: 23.7;THP-1: 56.8;U-937: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 38.4;eosinophil: 60.8;intermediate monocyte: 95.8;myeloid DC: 34.1;neutrophil: 99.1;non-classical monocyte: 115.3"	"Group enriched"	"Detected in all"	12	"dendritic cells: 34.1;granulocytes: 99.1;monocytes: 115.3"																				"unprognostic (1.08e-2)"	"prognostic favourable (7.89e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.65e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (5.97e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (7.62e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.95e-1)"	4.6	3.1	5.2	14.9	7.3	60.9	2.4	1.0	4.0	1.5	3.3	7.7	0.2	4.2	1.3	3.9	1.9	2.2	2.8	3.2	4.9	5.4	2.8	11.9	16.2	25.7	9.7	1.9	2.3	1.6	0.7	2.2	7.0	6.2	2.7	2.6	2.6	3.0	1.7	1.0	2.3	4.1	4.2	13.6	72.4	2.8	0.9	6.6	12.6	1.5	1.2	5.8	4.1	1.7	1.9	34.1	99.1	115.3	1.6	7.0	35.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.1	0.1	0.1	3.7	0.0	11.6	0.0	0.0	0.2	8.5	22.7	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	11.5	23.7	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	30.2	0.0	8.6	38.4	60.8	0.8	95.8	7.0	1.9	1.3	1.7	34.1	1.8	0.9	0.8	99.1	1.6	115.3	6.0	0.9	35.7	5.2	7.3	1.0	4.0	4.9	5.4	9.7	1.9	6.2	6.6
MUC21	"bCX31G15.2, C6orf205"	ENSG00000204544	"Mucin 21, cell surface associated"	Q5SSG8	6	30983718-30989903	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 251.5;lymphoid tissue: 126.1"	"Cell line enriched"	"Detected in single"	14	"Karpas-707: 4.2"	"Group enriched"	"Detected in many"	9	"cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"									HPA052028	Enhanced									"HPA052028: AB_2681700"	"unprognostic (2.27e-2)"	"unprognostic (4.85e-3)"		"unprognostic (5.24e-3)"		"unprognostic (1.68e-2)"		"unprognostic (2.68e-2)"		"unprognostic (2.98e-3)"	"unprognostic (1.32e-4)"			"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	34.7	0.2	0.0	0.0	0.2	1.3	0.2	251.5	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.2	33.7	126.1	0.2	33.2	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520790-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.2;HL-60: 15.0;HMC-1: 26.5;NB-4: 59.1;THP-1: 44.0;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055242	Enhanced					8800	8800			"HPA055242: AB_2682754"	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	7.6	3.7	4.8	22.9	9.1	50.6	3.6	1.0	4.6	2.2	4.3	7.5	0.4	4.6	2.1	4.7	2.7	5.4	6.5	4.0	5.2	3.1	3.7	6.2	17.1	24.8	9.0	1.7	2.5	2.3	0.6	2.3	4.8	6.9	3.3	2.3	3.5	3.3	1.3	1.2	1.8	8.5	3.9	9.9	56.1	3.9	1.3	7.0	4.2	2.7	1.8	11.1	6.8	2.5	1.5	15.4	64.9	23.7	7.5	14.9	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.0	0.0	15.2	0.0	10.9	0.0	0.0	0.0	15.0	26.5	0.1	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	0.0	59.1	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	44.0	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	24.3	0.0	14.4	23.7	24.5	14.9	19.6	11.6	1.5	5.9	10.2	15.4	0.7	0.4	4.6	64.9	7.5	22.4	1.9	8.1	18.6	4.8	9.1	1.0	4.6	5.2	3.1	9.0	1.7	6.9	7.0
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 84.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	Cytosol	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavourable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	6.8	8.8	6.5	24.6	12.7	16.7	7.7	7.7	9.0	8.0	11.3	16.2	7.0	10.6	11.5	8.8	17.7	8.1	6.5	6.2	7.5	5.4	7.0	5.1	7.7	20.4	16.5	6.2	7.7	7.2	9.6	6.3	13.9	8.7	8.2	12.4	8.1	10.5	8.3	7.0	14.8	13.0	8.2	12.7	16.4	9.9	17.2	11.4	84.1	11.4	12.4	24.3	10.9	9.5	5.0	4.8	7.2	2.8	7.8	7.4	3.2	21.9	20.4	21.9	15.8	5.7	6.0	25.6	15.1	12.2	24.6	19.9	18.3	23.3	23.1	4.5	9.9	19.4	36.0	17.7	47.0	41.8	20.2	21.1	23.3	10.4	2.4	26.2	15.3	3.8	6.6	19.2	19.6	16.2	13.4	9.4	21.7	10.9	29.6	17.2	34.2	15.9	25.3	49.8	12.2	8.2	12.3	9.0	9.5	22.6	10.7	8.1	4.7	16.5	10.1	16.2	26.6	10.9	29.4	7.4	9.9	32.9	9.5	15.2	20.0	7.2	2.0	3.6	6.3	2.8	5.6	5.0	6.2	7.3	3.0	3.8	7.4	7.2	1.9	7.8	1.9	4.8	7.2	3.2	6.5	12.7	7.7	9.0	7.5	5.4	16.5	6.2	8.7	11.4
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810902-17844862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 65.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039613	Uncertain									"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavourable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	1.4	1.1	0.3	18.0	0.4	12.5	2.5	0.7	0.5	1.4	2.9	0.3	0.2	3.7	0.8	1.2	7.1	0.3	0.7	1.6	0.4	0.7	0.9	1.1	1.8	8.3	2.0	0.3	0.6	0.5	0.0	0.4	3.7	0.5	0.7	2.4	0.3	1.6	0.9	0.6	3.4	3.3	0.7	1.0	6.4	1.9	11.8	0.3	65.4	0.5	6.7	8.6	1.6	2.0	0.5	0.5	0.0	0.4	0.3	2.9	1.7	16.2	10.5	24.0	15.7	1.5	3.0	8.8	21.1	8.3	20.8	21.4	13.3	10.0	24.3	4.3	5.9	7.4	20.3	8.1	28.7	11.0	10.0	19.3	14.3	10.7	0.1	13.6	7.6	0.5	0.5	15.4	7.1	10.4	18.9	27.8	20.6	4.8	15.5	13.2	12.3	10.3	15.4	21.7	10.2	6.3	5.1	18.9	11.2	19.0	4.1	6.0	9.5	7.7	8.5	20.0	9.1	11.3	28.7	8.7	8.1	20.7	8.3	14.2	13.2	0.0	0.0	0.0	0.5	0.2	0.0	0.5	1.0	0.6	0.5	0.2	0.1	0.7	0.0	0.3	0.4	0.0	2.9	1.7	0.3	0.4	0.7	0.5	0.4	0.7	2.0	0.3	0.5	0.3
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335787-96373845	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6;T-reg: 8.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.6;T-cells: 8.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavourable (9.53e-6)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.3	1.1	0.8	13.2	0.9	17.2	1.7	0.7	1.2	1.5	3.9	0.7	0.4	2.9	0.7	1.1	7.4	0.4	1.0	0.8	0.8	0.7	0.9	0.9	1.5	10.6	1.0	0.6	0.8	0.6	0.1	0.5	3.4	1.0	0.7	5.1	0.6	1.9	0.4	0.6	2.7	3.5	1.4	1.2	6.7	2.1	60.4	0.8	41.3	0.6	6.4	12.2	1.7	2.2	1.3	0.5	5.6	1.0	0.1	8.7	0.8	30.9	11.8	29.9	15.5	1.1	1.6	19.8	14.7	10.3	28.4	30.0	21.8	17.4	28.9	10.4	6.4	14.0	25.6	10.0	30.5	25.4	17.0	29.8	12.3	19.6	0.2	27.5	25.5	0.5	1.1	22.0	9.3	11.2	20.6	21.5	13.4	14.6	40.4	28.7	21.4	14.9	31.4	27.2	23.5	5.6	12.0	17.8	13.6	8.5	12.0	5.2	8.8	20.4	6.5	21.0	32.1	19.6	23.7	11.5	16.3	30.8	9.1	27.6	23.7	5.6	0.0	0.3	1.3	1.0	0.2	1.3	1.9	1.5	0.5	0.9	0.0	0.7	0.3	0.1	0.0	0.0	8.7	0.8	0.8	0.9	0.7	1.2	0.8	0.7	1.0	0.6	1.0	0.8
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878015	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0"	"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 86.9;NB-4: 30.8;REH: 15.8;RPMI-8226: 30.6;THP-1: 29.0;U-937: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 130.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol				Cytosol	Cytosol	"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: "	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	10.4	5.8	4.4	24.8	5.6	69.0	5.6	0.7	2.8	3.4	7.4	2.5	1.2	5.0	2.2	8.1	4.4	5.9	7.2	8.0	3.9	2.2	4.4	4.2	17.5	21.2	8.0	1.0	3.3	2.1	0.6	2.6	10.3	4.6	5.1	5.3	4.2	6.5	2.2	2.6	2.3	16.0	4.3	7.7	66.0	3.9	3.0	5.4	5.0	3.5	2.8	22.2	9.0	7.1	12.6	10.0	130.3	19.5	0.4	10.8	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	18.2	0.0	0.0	0.0	2.6	86.9	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	30.8	0.0	0.0	15.8	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	16.1	0.0	58.0	19.5	76.4	0.2	9.6	1.1	12.6	3.9	0.8	9.1	8.9	0.2	0.2	130.3	0.4	6.4	10.0	10.8	10.2	4.4	5.6	0.7	2.8	3.9	2.2	8.0	1.0	4.6	5.4
NFATC3	"NFAT4, NFATX"	ENSG00000072736	"Nuclear factor of activated T cells 3"	Q12968	16	68084751-68229259	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 129.5"	"Cell line enhanced"	"Detected in all"		"HMC-1: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050665			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA050665: AB_2681210"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-1)"	9.6	6.8	4.3	16.0	6.6	12.0	7.8	7.5	5.8	9.8	11.0	9.7	7.6	7.1	12.2	6.5	7.7	8.3	7.6	7.0	4.7	4.0	8.2	12.1	11.3	14.2	8.7	3.5	10.0	7.0	18.7	6.8	6.6	5.1	10.5	6.1	11.1	7.9	7.6	27.1	14.0	12.0	9.0	6.7	12.3	6.2	25.9	5.8	129.5	11.0	8.1	16.0	10.2	14.1	6.7	3.1	12.0	7.1	13.4	15.6	9.0	4.9	5.8	9.4	10.3	8.4	5.4	8.6	3.2	4.0	9.1	7.9	8.4	4.4	16.5	4.9	5.3	7.4	11.7	5.5	8.9	3.4	7.6	16.2	6.1	18.9	5.6	14.5	42.7	4.1	7.1	9.2	5.0	7.6	20.9	4.7	6.7	9.9	22.3	19.7	6.1	3.1	12.7	9.0	17.0	3.9	5.7	7.1	7.6	24.0	6.1	3.1	8.4	11.0	4.8	4.7	5.1	5.4	4.8	6.5	11.2	30.0	3.6	13.5	6.5	12.0	2.4	5.3	15.6	3.7	14.8	5.2	8.9	15.2	2.9	6.7	9.1	14.0	3.3	13.4	7.1	3.1	6.0	9.0	4.3	6.6	7.5	5.8	4.7	4.0	8.7	3.5	5.1	5.8
NOX5	"NOX5A, NOX5B"	ENSG00000255346	"NADPH oxidase 5"	Q96PH1	15	68930525-69062743	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 19.1;placenta: 11.1;testis: 43.7"	"Cell line enhanced"	"Detected in some"		"BJ: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.5;EFO-21: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"														"unprognostic (2.33e-1)"	"unprognostic (1.63e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.21e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.71e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	1.5	1.0	0.8	0.4	2.3	0.4	1.5	0.8	1.2	3.0	0.9	0.9	5.3	0.4	1.5	2.5	1.1	1.1	1.1	1.6	0.8	0.9	1.4	0.5	0.6	1.1	1.3	0.1	1.2	0.6	0.5	1.9	11.1	2.7	2.1	0.9	1.1	0.6	2.3	0.9	0.8	1.0	2.3	1.3	19.1	0.9	43.7	0.5	0.2	1.4	0.2	0.6	1.5	1.0	0.4	0.1	0.4	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.6	1.9	2.5	1.3	1.5	0.0	3.1	0.4	0.0	0.0	0.1	1.6	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.5	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.7	1.1	0.0	0.0	0.7	1.5	0.0	0.1	0.3	1.2	0.0	1.6	0.0	0.1	0.6	1.9	0.9	0.3	0.0	0.1	0.2	0.2	0.4	0.1	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	2.3	0.8	1.2	0.8	0.9	1.3	0.1	2.7	0.5
NUSAP1	"ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41332694-41381050	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 38.3;lymphoid tissue: 123.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.3"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042904, HPA074847"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavourable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	3.2	12.9	0.7	20.3	1.3	38.3	3.8	0.7	0.9	2.9	5.4	1.1	4.4	5.8	1.5	2.8	16.1	0.9	2.5	2.7	0.7	0.7	2.5	4.2	5.7	16.5	0.9	0.5	4.2	3.0	0.0	0.6	9.2	0.9	1.8	6.5	0.8	3.6	5.6	4.4	6.0	6.3	2.2	1.2	7.4	4.1	8.6	0.6	123.4	0.8	9.7	19.4	2.9	5.3	2.7	3.1	6.4	1.4	1.7	16.3	3.1	37.0	12.4	41.3	19.6	2.2	3.6	13.7	29.6	17.5	32.7	31.7	16.8	19.3	19.2	16.5	11.1	35.7	31.8	14.5	31.4	34.4	15.6	48.7	30.9	15.8	0.6	31.0	21.9	1.0	1.7	17.4	13.4	19.6	26.7	65.4	25.3	9.8	38.3	20.8	21.2	15.4	41.4	44.1	20.7	11.7	11.6	29.9	20.5	40.8	24.0	8.5	36.1	23.0	11.8	25.4	31.9	28.7	52.1	24.3	47.1	61.4	13.3	46.6	43.6	6.4	1.4	4.4	0.7	0.9	0.4	2.7	3.5	2.6	3.1	2.1	0.2	1.9	0.8	1.7	1.2	2.9	16.3	3.1	0.7	1.3	0.7	0.9	0.7	0.7	0.9	0.5	0.9	0.6
OR3A2	"OLFRA04, OR17-228, OR228"	ENSG00000221882	"Olfactory receptor family 3 subfamily A member 2"	P47893	17	3276942-3386317	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 15.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (7.58e-2)"				"unprognostic (5.10e-2)"						"unprognostic (6.89e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.32e-1)"			0.5	0.5	2.2	0.5	8.6	0.5	0.6	0.4	2.8	0.6	0.4	1.2	0.0	0.4	0.5	1.5	0.4	0.3	0.2	0.4	2.5	1.2	0.5	0.3	0.8	6.5	1.4	0.6	1.0	0.4	0.2	5.5	1.0	2.7	0.7	0.4	1.3	0.3	0.5	0.8	0.6	0.5	0.4	1.9	0.9	0.4	10.9	2.1	2.3	0.3	0.0	0.7	0.6	0.4	3.0	3.4	3.6	0.6	0.7	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.6	0.7	0.9	0.3	1.6	3.0	1.2	0.3	0.8	0.8	1.2	1.8	1.6	0.7	0.4	3.4	0.5	0.8	2.2	8.6	0.4	2.8	2.5	1.2	1.4	0.6	2.7	2.1
OR4C6		ENSG00000181903	"Olfactory receptor family 4 subfamily C member 6"	Q8NH72	11	55662201-55666195	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 1.8;lymphoid tissue: 1.7"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 7.9;Karpas-707: 8.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"memory B-cell: 1.8"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.8"																																					0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3			0.0		1.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73981077-73982124	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 18.3;neutrophil: 16.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"					"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.7	0.4	0.2	0.7	0.9	46.8	0.8	0.2	0.3	0.3	1.1	0.0	0.0	0.1	0.2	0.4	0.2	0.5	0.8	46.0	0.8	0.3	0.5	1.7	9.1	3.3	2.6	0.3	3.0	0.4	0.1	0.4	4.8	1.9	0.2	0.9	1.0	0.4	0.2	1.0	0.2	0.3	0.2	0.9	42.6	0.9	0.6	0.0	0.0	1.8	0.9	0.1	1.0	3.0	0.3	1.9	18.3	1.4	0.0	0.3	50.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.7	0.0	0.0	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.4	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.3	0.2	0.1	16.5	0.0	1.1	1.9	0.2	50.5	0.2	0.9	0.2	0.3	0.8	0.3	2.6	0.3	1.9	0.0
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 39.9"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 13.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.6;dendritic cells: 3.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted - unknown location"						"prognostic favourable (4.35e-4)"	"prognostic favourable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favourable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.4	0.3	0.3	38.8	0.3	0.0	0.4	0.3	0.3	0.3	0.9	0.0	0.0	0.3	0.3	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.4	0.4	1.0	39.9	0.3	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.4	1.2	0.1	5.0	0.3	0.3	0.3	7.7	0.0	0.3	18.1	0.6	0.3	0.0	6.6	0.7	0.5	33.0	2.5	0.3	6.6	3.4	1.0	0.2	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.3	0.1	2.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	0.2	0.1	0.1	0.1	6.6	0.1	0.1	0.1	5.6	0.1	0.1	0.4	0.3	0.1	3.4	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225261-37244448	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 166.3;bone marrow: 66.3;lymphoid tissue: 169.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 75.8;HMC-1: 155.5;Karpas-707: 73.8;U-87 MG: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022946, HPA047820"	Enhanced					34000000	34000000			"CAB022946: , HPA047820: AB_2680167"	"prognostic favourable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavourable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"	17.4	2.6	2.0	79.2	4.1	66.3	8.3	0.9	2.0	3.3	7.5	1.5	1.2	6.0	3.2	3.5	7.8	4.7	11.2	5.6	1.7	1.9	4.8	5.3	29.6	89.3	3.0	0.2	4.9	2.3	0.0	1.8	3.5	2.2	6.2	5.9	3.3	16.9	2.2	1.4	2.9	29.4	3.2	4.1	102.8	7.0	2.5	2.0	169.1	3.6	3.6	74.2	11.2	4.0	85.3	79.1	166.3	88.3	98.4	121.7	130.9	14.0	0.0	0.0	0.0	1.5	14.5	0.0	1.9	4.4	1.5	3.1	0.0	4.7	17.4	2.1	5.5	3.5	0.1	24.5	1.7	54.2	0.0	21.8	0.4	0.0	3.9	75.8	155.5	10.6	3.5	2.7	9.2	25.6	5.1	73.8	0.2	0.0	22.3	30.0	0.3	9.3	7.5	0.0	19.9	2.4	0.0	0.2	0.0	0.0	2.4	0.3	1.0	40.9	27.5	0.0	2.5	0.1	0.2	33.4	17.2	18.4	67.7	33.0	3.7	115.0	53.8	166.3	111.5	73.2	84.4	85.3	89.3	97.9	53.4	70.9	69.5	88.6	146.6	98.4	88.3	79.1	121.7	130.9	2.0	4.1	0.9	2.0	1.7	1.9	3.0	0.2	2.2	2.0
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46247688-46278473	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 41.9;testis: 56.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favourable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	1.9	0.6	1.5	12.9	4.7	9.4	1.3	3.0	1.9	1.1	4.8	0.7	0.5	2.8	1.2	2.1	5.2	0.3	1.2	1.5	1.8	1.5	1.4	0.5	1.5	6.0	1.9	0.7	0.8	1.4	0.6	0.5	4.2	0.9	1.1	5.8	0.6	1.4	1.0	1.4	3.0	3.6	1.8	3.2	4.1	1.7	56.6	0.6	41.9	1.7	3.8	9.6	1.0	1.7	0.5	0.3	0.0	0.1	0.9	4.1	0.7	9.0	6.7	20.4	12.5	1.5	1.0	19.0	10.7	4.7	18.0	18.5	14.4	5.9	17.7	8.1	4.5	9.4	18.8	6.0	15.9	9.6	19.0	21.7	18.1	14.3	0.0	21.6	12.7	0.6	0.4	17.9	5.3	5.6	15.5	18.1	9.8	8.5	26.9	24.1	18.2	11.2	21.6	11.4	7.7	4.4	7.7	9.7	7.0	7.8	10.7	2.6	3.8	15.8	2.4	19.4	11.6	10.0	17.9	7.6	4.4	19.1	5.2	14.4	7.8	0.0	0.1	0.0	1.2	0.1	0.2	0.5	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.9	0.1	0.0	4.1	0.7	1.5	4.7	3.0	1.9	1.8	1.5	1.9	0.7	0.9	0.6
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 48.8;NB-4: 38.4;THP-1: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA056384: AB_2732602, HPA069984: AB_2732145"	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	7.0	4.8	6.0	19.0	7.5	36.7	12.7	2.5	5.0	3.3	3.5	6.8	1.9	5.5	2.9	2.9	4.4	4.1	4.5	5.1	5.4	4.9	4.0	7.2	10.4	27.2	9.1	2.6	2.7	3.9	0.8	2.6	5.6	5.7	3.9	1.8	2.2	6.1	2.2	1.6	4.3	10.6	3.2	7.1	43.1	5.7	2.8	7.2	15.2	3.7	1.2	19.5	6.1	3.6	17.3	29.9	95.0	55.5	9.1	13.8	22.0	4.8	7.4	2.1	3.8	0.9	1.6	3.6	3.0	2.1	6.4	2.6	10.9	6.7	8.5	8.5	1.9	4.7	2.1	3.9	1.5	4.1	4.1	12.1	3.8	4.4	1.2	24.7	48.8	1.0	2.4	2.7	0.9	4.1	4.6	4.5	1.9	8.6	18.2	38.4	2.2	9.4	15.3	1.2	6.1	1.8	2.4	4.1	3.8	3.1	1.9	4.0	2.6	32.6	4.3	6.0	3.0	1.0	2.9	2.8	2.2	10.3	3.3	18.9	3.9	33.1	35.5	95.0	13.4	50.4	13.8	17.3	12.7	12.7	29.9	17.1	8.9	9.2	79.6	9.1	55.5	17.1	13.5	22.0	6.0	7.5	2.5	5.0	5.4	4.9	9.1	2.6	5.7	7.2
RPTN	FLJ39117	ENSG00000215853	Repetin	Q6XPR3	1	152153595-152159228	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 33.2;skin 1: 19.5;tongue: 71.0"	"Group enriched"	"Detected in some"	7	"HaCaT: 3.6;hTCEpi: 1.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA030483, HPA030485"	Enhanced				"Secreted to extracellular matrix"					"HPA030483: AB_2673495, HPA030485: AB_10601159"		"unprognostic (1.37e-2)"				"unprognostic (5.06e-2)"		"unprognostic (2.35e-1)"	"unprognostic (4.54e-2)"		"unprognostic (4.00e-2)"						"unprognostic (5.23e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	71.0	33.2	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A12	"CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6"	ENSG00000163221	"S100 calcium binding protein A12"	P80511	1	153373706-153375649	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 139.8;bone marrow: 329.6;lymphoid tissue: 94.7"	"Group enriched"	"Detected in some"	7	"hTCEpi: 6.4;SK-BR-3: 2.1;THP-1: 4.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 51.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"classical monocyte: 91.9;neutrophil: 139.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 139.8;monocytes: 91.9"					"Not detected"	"Not detected"			"HPA002881, CAB025872"	Enhanced				"Secreted to blood"	6200000	6200000			"CAB025872: , HPA002881: AB_1848175"	"unprognostic (1.33e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (9.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (5.03e-4)"	"unprognostic (3.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.70e-2)"	6.7	0.5	0.9	8.9	1.7	329.6	0.8	0.3	1.0	3.5	1.1	0.2	0.0	0.6	0.5	0.4	9.2	3.3	1.1	41.2	0.7	0.8	1.6	4.0	34.4	27.4	3.3	0.0	1.5	5.0	0.4	0.7	3.9	2.8	0.8	0.4	0.7	1.9	0.4	1.3	0.8	0.5	4.4	0.8	94.7	1.4	3.4	0.5	3.9	4.5	15.3	4.9	1.7	36.0	0.2	9.6	139.8	91.9	0.0	0.1	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	2.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	91.9	0.3	0.1	3.3	0.0	0.2	0.0	0.1	9.6	0.0	0.0	0.0	139.8	0.0	0.7	0.6	0.1	59.2	0.9	1.7	0.3	1.0	0.7	0.8	3.3	0.0	2.8	0.5
SATB2	"FLJ21474, KIAA1034"	ENSG00000119042	"SATB homeobox 2"	Q9UPW6	2	199269500-199471266	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.1;intestine: 33.2;lymphoid tissue: 11.0"	"Cell line enhanced"	"Detected in many"		"HEL: 19.4;K-562: 21.2;THP-1: 28.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"amygdala: 7.9;cerebral cortex: 29.7;hippocampal formation: 19.7"	"Group enriched"	"Detected in many"	10	"cerebral cortex: 52.6;hippocampal formation: 45.2"	"HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB023669: AB_1129287, CAB062562: , CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737"	"unprognostic (1.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.53e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.54e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.37e-8)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.95e-6)"	"unprognostic (1.08e-3)"	2.4	5.0	4.5	11.0	10.0	0.5	2.0	0.5	26.1	2.3	27.9	0.4	0.4	1.4	1.7	1.1	0.9	1.1	1.4	0.7	5.6	1.6	3.6	2.8	0.8	0.6	2.3	15.5	1.9	3.4	3.1	1.1	0.8	4.6	1.9	33.2	0.1	1.5	2.6	2.1	1.7	5.0	2.9	4.9	0.7	1.0	2.4	0.0	0.0	1.6	2.4	1.0	1.6	3.1	0.2	0.0	0.0	0.7	0.0	0.5	0.1	1.2	0.8	8.7	4.0	4.2	5.1	0.6	3.0	4.4	2.2	2.9	0.1	2.8	0.4	0.1	6.5	0.2	6.9	1.8	3.5	4.4	6.0	19.4	1.6	2.3	0.9	8.8	8.6	2.4	3.2	4.3	2.8	0.2	21.2	0.0	6.3	0.4	0.4	11.0	1.6	1.4	0.8	3.0	0.1	3.3	0.3	1.9	0.0	1.5	0.0	4.5	1.8	28.9	3.0	15.9	3.0	5.0	8.0	1.3	4.1	12.7	11.0	7.1	12.5	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	4.5	10.0	0.5	26.1	5.6	1.6	2.3	15.5	4.6	0.0
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690667-169711698	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 227.5;lymphoid tissue: 77.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.3;EFO-21: 7.1;MOLT-4: 13.4;U-266/70: 25.2;U-698: 11.7;U-937: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol		8100000000	8100000000	Cytosol	Cytosol	"CAB002144: AB_563862, HPA051972: AB_2797242"	"prognostic favourable (3.76e-4)"	"prognostic favourable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favourable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favourable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavourable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	6.9	0.9	2.0	25.1	4.6	30.3	1.5	1.1	2.5	0.9	1.4	1.1	0.0	0.4	1.0	1.1	4.2	3.2	5.4	4.1	2.5	2.2	2.3	2.5	11.4	77.8	5.2	0.2	0.8	1.0	10.7	7.9	3.4	2.7	1.2	1.3	3.8	12.1	0.1	0.9	0.8	8.8	2.9	5.2	67.7	1.7	1.0	2.3	43.8	1.9	1.3	64.0	8.1	6.1	40.4	40.7	227.5	49.7	130.8	69.5	90.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	7.3	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.0	0.9	0.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.8	13.4	0.1	0.0	0.2	5.1	0.1	0.3	4.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	25.2	0.0	11.7	1.3	7.3	0.1	170.8	49.7	88.6	16.5	11.2	4.5	33.8	30.7	17.0	40.7	40.4	69.5	39.6	227.5	130.8	4.5	32.8	52.7	90.1	2.0	4.6	1.1	2.5	2.5	2.2	5.2	0.2	2.7	2.3
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 46.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7"									HPA014377	Uncertain					18000000	18000000			"HPA014377: AB_2189277"	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	1.6	1.6	0.6	13.0	0.5	13.3	0.5	0.0	0.3	0.6	0.6			0.0	0.4	0.0	0.2	1.7	1.0	0.8	0.6	0.6	0.4	1.4	5.1	6.2	1.3		0.1	0.3	0.0	0.1	0.9		0.4	0.4		0.7	0.1	0.0	0.0	4.0	0.9	1.9	21.6	0.7	1.3			0.2		7.0	2.2	0.2	4.9	15.9	48.7	29.7	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	3.6	25.8	0.4	0.0	29.7	0.0	4.9	0.0	0.0	15.9	4.8	0.0	0.0	48.7	0.1	21.3	2.9	0.0	7.6										
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357079-100422059	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;RPTEC TERT1: 1.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB079058		Supported								"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.1	0.3	2.0	0.1	3.7	0.1	0.1	0.0	10.7	0.1	1.1	0.0	0.0	1.8	0.4	0.2	0.1	1.0	0.1	0.1	6.9	2.2	0.3	1.2	0.2	0.1	0.8	1.0	0.2	0.2	0.1	0.4	1.0	3.6	0.1	1.0	1.7	0.1	0.1	0.1	0.1	12.4	0.1	0.5	0.1	0.2	0.4	0.1	3.9	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.0	3.7	0.0	10.7	6.9	2.2	0.8	1.0	3.6	0.1
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 1.8;NB-4: 1.5;RPMI-8226: 7.5"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036055	Approved									"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	0.3	0.3	0.3	42.8	0.3	0.0	6.1	0.3	0.3	0.4	110.1	0.2	0.3	58.4	0.3	1.2	0.3	0.6	53.5	0.3	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.3	0.0	0.3	0.2	0.2	0.5	92.7	0.2	0.3	14.4	0.3	0.3	106.5	1.2	0.3	0.3	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.3;hTCEpi: 2.2;MCF7: 3.8;RT4: 2.6;T-47d: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"	5400000	5400000			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SNX20	"SLIC-1, SLIC1"	ENSG00000167208	"Sorting nexin 20"	Q7Z614	16	50666300-50681353	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 58.5;lymphoid tissue: 42.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.0;HMC-1: 36.3;NB-4: 21.2;RPMI-8226: 9.0;THP-1: 9.5;U-266/70: 11.8;U-937: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043649	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043649: AB_10965697"	"unprognostic (1.53e-2)"	"prognostic favourable (9.07e-4)"	"unprognostic (5.58e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.03e-2)"	"prognostic favourable (6.56e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (6.00e-6)"	"unprognostic (3.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	2.0	1.4	2.5	12.7	5.7	10.7	1.3	1.2	2.7	1.3	1.7	1.4	0.1	1.8	1.2	2.4	1.7	1.7	3.1	2.7	1.5	1.5	1.9	1.5	5.7	21.1	2.6	0.2	1.1	1.0	0.1	1.1	1.8	3.1	1.8	2.3	1.3	3.0	0.2	0.7	1.4	7.4	1.6	3.0	23.6	2.1	0.6	3.3	42.5	1.5	0.8	22.3	4.7	1.2	5.5	27.9	58.5	30.7	11.1	30.1	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	13.0	0.0	2.3	0.0	0.0	0.0	3.2	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	1.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.0	0.0	0.0	11.8	6.1	2.9	0.0	12.6	0.0	58.5	15.1	45.5	10.1	26.6	12.6	5.5	18.0	12.2	27.9	5.2	14.0	9.5	14.1	11.1	30.7	7.7	30.1	15.8	2.5	5.7	1.2	2.7	1.5	1.5	2.6	0.2	3.1	3.3
SPRR2A		ENSG00000241794	"Small proline rich protein 2A"	P35326	1	153056113-153057537	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 393.4;lymphoid tissue: 173.5;tongue: 572.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.6;hTCEpi: 8.2;hTERT-HME1: 10.9;Karpas-707: 13.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 743.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-3)"		"unprognostic (1.64e-2)"		"unprognostic (6.80e-3)"	"unprognostic (3.51e-1)"		"unprognostic (3.36e-3)"			"unprognostic (4.53e-2)"			"prognostic unfavourable (1.37e-5)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	82.8	0.2	0.0	0.0	0.2	3.0	0.2	393.4	0.2	0.7	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	58.3	0.2	0.2	1.3	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	572.8	173.5	0.3	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	10.9	0.0	0.8	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.3	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRR2B		ENSG00000196805	"Small proline rich protein 2B"	P35325	1	153070224-153070840	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"esophagus: 22.3;lymphoid tissue: 11.7;skin 1: 11.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;SiHa: 1.2;U-2197: 1.2"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 77.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.52e-1)"				"unprognostic (1.44e-2)"			"unprognostic (3.62e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0			0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0		0.0	0.0		3.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	3.2			0.0		11.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SRY	TDF	ENSG00000184895	"Sex determining region Y"	Q05066	Y	2786855-2787699	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 2.5;lymphoid tissue: 7.2;skin 1: 3.7;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.7;NTERA-2: 1.4;RT4: 6.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (1.34e-1)"	"unprognostic (5.53e-4)"									"unprognostic (1.61e-1)"			0.3	0.7	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.6	0.9	0.1	0.0	0.1	0.8	2.5	0.0	0.1	0.1	0.3	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.1	0.0	5.5	0.1	7.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.3	0.5	0.1	0.1	0.4	0.1
TESPA1	KIAA0748	ENSG00000135426	"Thymocyte expressed, positive selection associated 1"	A2RU30	12	54948018-54984746	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 45.1;brain: 56.9;lymphoid tissue: 27.8"	"Group enriched"	"Detected in some"	6	"HEL: 66.4;HMC-1: 54.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 56.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 45.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA058823	Approved									"HPA058823: AB_2683828"	"unprognostic (1.98e-5)"	"unprognostic (3.70e-4)"	"unprognostic (3.87e-4)"	"unprognostic (1.13e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.55e-4)"	"unprognostic (2.29e-3)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-4)"	"unprognostic (1.35e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	1.4	0.8	2.9	9.2	25.0	8.2	1.1	0.7	56.9	1.3	2.3	0.2	0.0	2.0	1.6	3.0	1.3	1.3	3.3	1.0	4.5	1.6	1.3	1.1	3.8	23.4	2.1	13.3	5.2	0.9	0.6	0.9	0.2	0.5	1.5	3.3	0.0	1.1	0.6	0.9	1.2	4.8	1.4	0.9	8.7	2.6	0.9	4.0	27.8	1.4	0.0	23.1	3.2	1.4	4.3	3.9	9.3	0.4	13.5	45.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	66.4	0.1	0.0	0.0	3.7	54.7	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	10.5	0.3	0.1	0.0	2.5	0.0	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	3.1	0.4	1.2	0.0	9.3	0.4	0.4	9.8	0.3	11.5	4.3	31.8	14.7	3.9	3.9	45.1	24.9	0.7	13.5	0.3	1.4	21.2	14.8	2.9	25.0	0.7	56.9	4.5	1.6	2.1	13.3	0.5	4.0
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.8;HaCaT: 17.6;HeLa: 11.5;MCF7: 12.6;SK-BR-3: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171"	Enhanced					430000	430000			"CAB015159: AB_2202870, HPA040171: AB_2676869"	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	12.8	0.3	0.2	0.7	1.2	0.9	1.3	0.7	1.7	0.9	17.6	2.1	1.4	0.5	1.4	2.4	1.0	11.5	4.0	0.6	0.6	1.1	1.1	7.0	0.4	1.5	0.5	0.7	0.7	0.5	12.6	0.5	1.3	0.2	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.1	0.2	15.7	0.0	1.1	0.8	0.6	0.8	3.7	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TIGIT	"DKFZp667A205, FLJ39873, VSIG9, VSTM3"	ENSG00000181847	"T cell immunoreceptor with Ig and ITIM domains"	Q495A1	3	114276913-114310288	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 49.8;lymphoid tissue: 25.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.8;Karpas-707: 1.6;NTERA-2: 1.8;U-266/84: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 49.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 49.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.24e-2)"	"prognostic favourable (5.43e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.22e-6)"	"unprognostic (9.84e-2)"	"prognostic favourable (3.96e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.50e-4)"	"unprognostic (3.51e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.18e-3)"	1.4	0.3	0.4	20.2	0.7	0.9	1.1	0.2	0.3	0.5	1.2	0.2	1.2	0.8	1.4	1.1	1.1	0.9	3.8	0.8	0.4	0.7	1.3	1.6	5.0	25.9	0.6	0.3	0.4	0.3	0.0	0.6	0.5	0.4	1.0	1.4	1.1	4.4	1.9	0.6	0.6	8.0	0.3	1.5	13.4	2.0	0.6	0.1	4.3	1.6	1.7	20.2	4.1	1.0	0.4	0.2	0.2	0.0	4.4	49.8	5.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.5	0.3	0.0	0.0	0.1	0.0	0.5	4.8	0.0	0.1	0.9	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	1.8	0.0	0.1	1.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.5	0.1	0.1	1.3	1.8	0.0	0.9	0.3	0.0	0.0	0.0	0.0	8.5	0.0	0.9	0.4	13.6	25.0	0.0	0.2	1.5	11.4	0.2	4.4	0.0	0.2	49.8	5.4	0.4	0.7	0.2	0.3	0.4	0.7	0.6	0.3	0.4	0.1
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.92e-6)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	33.7	44.9	57.2	26.1	2.8	5.8	12.7	46.4	25.0	42.7	37.9	21.0	25.9	54.5	23.6	15.7	53.8	43.9	18.5	57.4	29.1	29.3	36.0	28.7	35.1	0.2	50.4	38.3	1.2	1.5	30.0	30.6	22.4	38.9	37.4	46.1	11.7	58.4	33.9	23.7	17.9	49.6	88.8	22.6	10.3	21.6	33.8	24.3	37.4	46.7	14.7	39.2	23.2	14.7	28.2	39.7	32.5	44.5	21.5	24.3	47.6	15.9	34.8	46.9	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell line enriched"	"Detected in single"	166	"HEL: 37.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced					94000000	94000000			"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.2	28.8	52.0	24.9	1.4	3.2	29.9	31.2	15.8	51.4	36.9	94.6	45.4	41.6	30.6	14.8	38.8	0.2	33.4	52.5	17.7	27.4	12.8	22.1	24.8	0.4	18.3	32.2	1.0	3.6	34.8	34.1	25.0	0.2	35.4	42.3	64.6	30.2	5.2	31.2	69.0	32.1	47.1	0.2	17.3	13.6	30.0	25.0	49.1	36.0	19.7	36.3	27.0	9.1	46.1	40.3	31.3	60.3	11.2	0.3	46.4	28.0	13.1	43.7	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 62.6;REH: 142.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.6	11.3	17.2	12.2	0.5	2.0	2.7	12.7	6.1	13.3	12.9	13.5	7.9	8.9	3.1	5.6	7.8	11.8	6.9	9.4	14.4	13.4	7.7	10.6	14.4	0.2	18.9	11.7	0.9	0.5	7.2	1.8	3.9	11.0	10.3	7.9	12.2	62.6	11.6	7.7	12.3	142.1	38.3	6.5	3.6	11.5	12.7	10.1	10.0	5.5	1.7	9.9	18.1	4.9	14.1	11.5	18.2	15.3	4.4	4.5	26.2	8.1	18.4	17.9	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9										
UMODL1		ENSG00000177398	"Uromodulin like 1"	Q5DID0	21	42062959-42143453	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 22.7"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 3.6;U-266/70: 8.9"	"Group enriched"	"Detected in some"	7	"lung cancer: 0.6;testis cancer: 2.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067245	Uncertain									"HPA067245: AB_2685810"	"unprognostic (4.70e-3)"	"unprognostic (3.75e-5)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.72e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.47e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.82e-1)"	"unprognostic (9.24e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-4)"	"unprognostic (2.68e-1)"	0.6	0.1	0.4	3.6	0.1	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	4.9	0.0	0.2	0.2	0.3	0.4	0.4	0.6	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.1	0.8	0.2	3.8	0.0	22.7	0.1	0.0	2.0	0.1	0.0	0.5	0.1	0.3	0.5	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.5	0.5	0.0	0.1	0.3	0.7	0.6	0.0	0.0	0.5	0.0	1.0	0.2	0.4	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 69.6;lymphoid tissue: 129.2"	"Group enriched"	"Detected in some"	5	"HHSteC: 56.9;HSkMC: 38.0"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"gdTCR: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Approved	"Cell Junctions"		960000000	960000000	"Cell Junctions"	"Cell Junctions"	"CAB000154: , HPA034796: AB_2674333, HPA069867: "	"unprognostic (2.96e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	10.9	18.1	1.5	20.2	3.2	1.3	5.2	0.9	1.1	3.7	5.0	3.3	1.4	3.3	4.9	4.5	5.3	4.9	6.8	7.2	1.7	2.3	69.6	11.8	9.8	26.8	2.8	1.7	11.1	6.6	10.6	3.5	10.9	4.2	8.3	5.5	15.3	4.9	1.1	4.7	1.8	6.3	4.2	3.7	129.2	3.0	2.5	1.6	13.3	3.5	2.8	20.9	8.2	2.8	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.2	0.1	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.2	0.0	0.0	0.0	0.0	56.9	0.0	0.0	38.0	0.0	10.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	3.2	0.9	1.1	1.7	2.3	2.8	1.7	4.2	1.6
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 85.2;lung: 36.4;lymphoid tissue: 43.6"	"Cell line enriched"	"Detected in some"	8	"Daudi: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 85.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 85.2"					"Low region specificity"	"Detected in single"									270000	270000				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	10.1	1.4	1.1	9.5	1.1	10.8	1.4	1.4	1.4	1.8	1.9	0.8	0.0	0.7	0.9	3.1	2.1	4.3	10.2	10.5	1.1	1.1	2.8	5.6	36.4	39.8	3.8	0.3	2.1	2.4	0.0	1.2	8.6	1.5	2.4	0.9	1.8	1.3	0.2	1.0	0.7	3.6	2.4	2.2	43.6	2.8	3.6	0.6	3.4	1.4	0.7	17.7	7.3	10.9	6.4	2.2	85.2	10.9	5.8	6.7	5.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.9	0.0	0.0	1.5	10.9	0.0	4.2	2.4	1.7	6.4	1.4	4.9	2.2	5.5	4.5	6.7	85.2	5.8	1.5	0.4	0.9	5.7	1.1	1.1	1.4	1.4	1.1	1.1	3.8	0.3	1.5	0.6
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 7.0;T-47d: 12.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060453: AB_2684280, HPA066745: AB_2685712"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.1	9.8	0.1	0.0	2.0	0.1	0.6	0.0	70.9	0.0	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	72.9	2.6	0.2	4.9	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	37.6	52.2	0.1	10.8	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.4	0.1	0.6	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.4	1.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.8	0.8	0.2	0.2	7.0	0.0	0.0	1.2	0.0	0.8	0.2	0.0	0.0	0.6	2.0	0.0	0.6	0.0	0.1	0.9	0.7	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.0	12.8	0.0	0.1	0.0	0.2	1.1	0.0	1.7	1.1	0.1	0.8	0.2	0.4	0.0	0.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485061	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 38.1"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 26.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Nucleoplasm, Cytoplasmic bodies"	"Nucleoplasm, Cytoplasmic bodies"	"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	3.3	0.8	0.5	33.4	1.0	3.4	1.2	0.7	0.6	0.8	3.0	0.1	1.0	3.0	0.6	1.2	0.8	0.8	0.9	0.6	0.5	0.7	1.3	0.8	2.0	10.6	0.5	0.0	0.4	0.7	0.0	0.6	0.8	0.5	0.7	1.5	0.9	2.0	0.2	0.4	1.1	7.7	0.4	0.7	9.5	0.7	0.7	0.4	4.8	0.9	1.6	38.1	1.7	0.6	3.2	1.7	1.3	2.7	0.7	7.2	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	6.2	0.1	0.0	0.1	0.0	0.0	0.1	26.4	0.2	0.2	0.8	2.1	0.0	2.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	1.9	0.0	0.0	5.4	0.0	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	3.5	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.3	0.3	2.0	0.1	1.3	1.8	0.4	0.3	1.0	0.5	3.1	3.2	1.5	1.7	3.2	2.0	0.5	1.3	0.7	2.7	1.0	7.2	1.5	0.5	1.0	0.7	0.6	0.5	0.7	0.5	0.0	0.5	0.4
AC119396.1		ENSG00000263264		I3L1I5	19	7348943-7383385	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 61.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.2;HL-60: 12.1;HMC-1: 7.7;MOLT-4: 11.7;REH: 10.8;THP-1: 11.7;U-698: 18.3;U-937: 9.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA049151	Uncertain									"HPA049151: AB_2680654"	"unprognostic (7.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-5)"	"unprognostic (7.56e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.55e-2)"	0.5	2.8	0.2	26.7	0.2	13.3	0.4	0.2	0.2	0.7	6.1	0.1	0.0	0.4	6.1	0.3	1.7	0.8	1.9	0.3	0.2	0.2	0.7	0.4	2.0	28.7	0.3	0.5	0.3	0.3	0.0	0.3	0.4	0.1	0.4	0.4	0.4	7.8	0.5	0.3	0.2	9.3	4.0	0.2	21.0	2.9	0.4	0.1	61.5	0.7	0.6	25.9	1.9	0.4	12.1	1.8	15.1	3.9	0.8	4.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	12.1	7.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	1.7	0.0	0.0	10.8	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.3	0.0	9.6	0.0	1.2	2.4	15.1	2.7	3.0	2.0	7.3	3.8	2.7	1.3	12.1	4.7	3.1	9.9	0.8	3.9	1.8	3.4	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.5	0.1	0.1
AC233755.1		ENSG00000275063	"Immunoglobulin heavy variable 4-38-2 "	P0DP08	Unmapped	41444-41876	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 75.1;intestine: 32.1;lymphoid tissue: 37.1;urinary bladder: 45.9"	"Cell line enriched"	"Detected in some"	8	"REH: 54.7"									"Group enriched"	"Detected in some"	363	"memory B-cell: 75.1;naive B-cell: 42.7"	"Lineage enriched"	"Detected in single"	463	"B-cells: 75.1"														"Secreted to blood"																							0.8	0.0		14.4		2.6	2.8		0.0	10.9	32.1			24.1	0.0	0.0	4.3	0.0	1.0	0.0			0.0	0.0	0.7	5.5			0.0	0.0	0.0		0.0		0.0	11.1		11.1	0.0	0.0	0.0	6.4	0.6		9.4	11.7	0.0			0.0		37.1	45.9		75.1	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.1	0.1	0.0	54.7	0.6	1.2	0.0	0.0	0.0	3.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	42.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0										
ADGRG5	"GPR114, PGR27"	ENSG00000159618	"Adhesion G protein-coupled receptor G5"	Q8IZF4	16	57542421-57591681	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 37.7;lymphoid tissue: 25.6"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.7"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 0.4"	"Low region specificity"	"Detected in single"			HPA007133	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"	"Nuclear membrane, Vesicles"	"HPA007133: AB_1849253"	"unprognostic (6.11e-3)"	"prognostic favourable (4.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.09e-4)"	"unprognostic (3.80e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.69e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.32e-3)"	0.7	0.6	2.4	20.2	2.7	1.4	0.8	0.6	2.1	0.6	2.1	2.5	0.0	4.3	0.5	0.2	1.7	0.8	0.8	0.5	1.6	1.1	0.5	0.6	2.9	12.1	2.6	0.9	0.5	0.4	0.2	0.8	0.0	2.9	1.2	1.7	0.5	4.6	0.8	0.4	0.7	7.5	0.3	3.5	12.8	0.5	1.2	3.5	3.4	1.1	0.2	25.6	2.8	0.9	4.0	21.9	37.7	0.0	8.8	11.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.4	2.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	37.7	11.1	0.0	5.6	4.0	1.6	6.4	0.7	2.8	0.4	4.0	0.1	8.8	0.0	21.9	0.0	2.3	2.4	2.7	0.6	2.1	1.6	1.1	2.6	0.9	2.9	3.5
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.9;lymphoid tissue: 18.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 17.6;Karpas-707: 17.2;RH-30: 43.0"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Group enriched"	"Detected in many"	4	"amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	3.8	1.8	34.3	11.8	40.2	8.1	0.7	48.2	55.9	0.6	2.1	1.2	0.0	2.0	1.5	0.9	1.6	0.8	2.8	4.3	37.6	8.9	1.2	0.8	2.2	13.5	6.3	3.1	1.2	2.4	1.7	1.2	1.7	2.5	1.0	1.2	0.7	4.5	0.9	8.3	2.1	2.2	0.8	2.1	10.0	2.1	0.9	0.7	18.8	0.9	1.5	16.6	2.9	0.6	1.9	1.4	6.3	1.2	2.3	6.3	1.7	3.0	4.4	8.6	2.5	0.0	0.0	4.9	2.0	0.4	0.0	0.2	0.5	2.8	7.7	0.6	0.0	1.9	0.0	0.0	0.0	8.4	1.3	8.5	0.7	1.4	0.0	8.7	17.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	5.2	15.4	5.6	1.4	4.6	6.4	43.0	5.5	0.0	2.5	2.4	8.9	1.1	1.5	1.8	1.1	6.2	4.7	2.4	4.0	4.5	1.5	7.3	4.3	3.9	4.3	5.8	4.0	6.0	0.8	1.0	4.8	1.2	5.1	1.9	4.8	5.1	1.4	1.6	2.0	3.0	6.3	2.3	0.7	1.2	6.3	1.7	34.3	40.2	48.2	35.4	37.6	8.9	6.3	3.1	2.5	0.7
ASF1B	FLJ10604	ENSG00000105011	"Anti-silencing function 1B histone chaperone"	Q9NVP2	19	14119509-14136956	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 39.2;lymphoid tissue: 45.1;testis: 45.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 39.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054036, HPA069385"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA054036: AB_2682350, HPA069385: "	"unprognostic (3.14e-1)"	"prognostic favourable (4.45e-5)"	"unprognostic (2.41e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (8.48e-3)"	"prognostic unfavourable (2.22e-16)"	"prognostic favourable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.31e-2)"	1.3	1.6	0.7	15.1	1.3	10.0	0.9	0.3	0.8	2.0	7.2	0.8	1.1	4.9	0.9	1.9	9.3	0.7	3.0	1.2	0.6	0.4	1.5	1.4	3.1	11.5	0.9	0.3	1.0	0.8	0.0	0.9	3.8	0.9	0.9	7.6	0.7	2.0	0.3	0.7	2.9	5.2	1.5	1.0	6.4	3.1	45.2	0.6	45.1	0.7	6.4	14.0	1.9	2.9	0.8	0.8	39.2	5.2	1.0	3.3	2.0	28.5	11.1	17.4	13.3	1.7	1.6	7.6	15.2	12.5	28.5	36.1	11.5	14.0	27.3	14.0	7.6	17.6	18.6	10.5	22.4	24.2	13.4	25.9	23.4	8.0	0.1	17.3	16.1	0.3	0.7	16.0	5.5	11.0	22.2	38.3	14.0	32.4	35.2	14.7	7.9	27.0	33.9	25.8	22.5	8.8	12.3	21.4	7.8	18.0	13.2	7.6	9.9	17.9	5.3	16.6	10.3	41.8	25.1	20.6	20.7	34.8	13.1	31.8	16.1	0.4	4.0	1.0	1.4	5.2	0.8	0.8	1.2	1.5	0.8	0.8	0.7	1.3	39.2	1.0	5.1	0.3	3.3	2.0	0.7	1.3	0.3	0.8	0.6	0.4	0.9	0.3	0.9	0.6
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"	"Nucleoplasm, Centrosome, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	32.5	24.0	16.1	11.3	0.9	2.1	20.4	26.7	12.5	64.7	27.3	67.2	22.8	10.7	18.4	10.9	26.3	28.5	17.9	69.0	9.6	10.9	19.0	24.6	41.8	0.5	25.4	26.8	1.0	1.9	22.4	20.1	15.1	21.5	8.5	27.5	33.2	15.2	19.7	14.7	24.8	11.6	31.1	11.8	10.3	8.6	13.9	7.5	37.3	43.0	17.9	25.5	15.9	8.6	28.1	27.9	15.5	37.6	11.9	13.8	18.5	15.2	14.8	23.2	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 59.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033311, HPA068414"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB033311: AB_781574, HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	7.7	0.0	1.9	0.0	59.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	7.3	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2
BHLHE23	"bA305P22.3, Beta4, BHLHB4, bHLHe23"	ENSG00000125533	"Basic helix-loop-helix family member e23"	Q8NDY6	20	63005927-63007035	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.0;lymphoid tissue: 4.1;retina: 1.3;testis: 1.8"	"Cell line enriched"	"Detected in single"	23	"MOLT-4: 16.5"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 3.0"	HPA030575	Uncertain									"HPA030575: AB_10601459"															"unprognostic (1.74e-1)"			0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025669	Supported				"Secreted in other tissues"	1200000	1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.9	25.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HEL: 40.0;HMC-1: 144.1;U-937: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		610000	610000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	16.0	144.1	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	11.2	0.2	0.0	12.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	13.7	0.0	20.9	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3
C17orf53	MGC3130	ENSG00000125319	"Chromosome 17 open reading frame 53"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavourable (3.46e-4)"	"prognostic unfavourable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	2.0	0.7	0.5	3.5	0.4	13.4	2.0	2.8	1.4	1.2	1.5	0.6	0.5	1.4	1.3	1.1	4.0	0.9	1.4	1.9	0.8	0.7	0.8	0.8	1.3	2.4	0.5	0.2	1.3	1.2	0.7	0.7	2.3	1.0	1.0	1.7	0.6	1.1	1.1	1.8	2.4	2.2	1.1	0.5	1.9	1.0	32.1	0.4	8.2	0.5	1.5	4.8	0.8	1.7	1.4	3.7	0.9	1.1	0.3	2.0	0.6	7.5	9.5	7.5	6.7	0.6	2.1	8.9	6.0	5.2	11.5	12.7	9.7	4.7	8.1	5.3	5.2	6.6	9.7	9.4	10.2	9.1	12.3	5.2	8.7	6.5	0.3	5.7	6.6	1.8	1.4	14.3	7.1	4.8	11.8	10.7	5.6	5.6	13.5	8.5	5.1	9.4	8.6	12.0	10.0	2.7	6.1	4.7	2.8	3.6	3.6	2.9	7.2	6.6	2.2	11.2	8.8	7.5	8.6	6.1	10.3	7.0	5.2	4.4	6.3	0.0	1.1	0.9	1.1	0.8	0.4	0.8	0.8	0.2	0.4	1.4	0.6	0.4	0.0	0.3	0.4	3.7	2.0	0.6	0.5	0.4	2.8	1.4	0.8	0.7	0.5	0.2	1.0	0.4
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710124	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 430.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.6;HL-60: 2.3;K-562: 3.8;RH-30: 2.4;U-937: 1.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB005067, HPA051210"	Enhanced				"Secreted to blood"	770000	770000			"CAB005067: AB_2071925, HPA051210: AB_2681390"	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	24.4	6.5	0.3	83.5	0.4	0.0	18.0	0.3	0.4	13.6	25.5	0.4	5.9	3.7	26.8	23.7	80.1	23.0	23.2	18.8	0.3	0.0	19.6	11.0	30.5	430.9	0.3	0.3	13.8	3.3	0.0	0.4	7.4	0.5	9.4	11.9	0.7	96.9	4.1	4.7	7.6	71.2	10.6	0.3	35.9	10.7	5.5	0.3	2.3	91.0	44.8	181.2	15.7	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.9	2.4	0.6	0.0	0.0	0.3	0.5	1.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.5	0.0	0.8	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103590-36105621	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 69.3;lung: 23.1;lymphoid tissue: 20.8"	"Group enriched"	"Detected in some"	23	"Karpas-707: 5.1;U-266/70: 11.2;U-266/84: 5.4"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	5	"gdTCR: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5"	"Lineage enriched"	"Detected in many"	17	"T-cells: 69.3"									CAB007805	Approved				"Secreted to blood"					"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favourable (3.54e-4)"	"prognostic favourable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	2.3	2.6	0.0	3.7	0.4	9.3	5.7	0.1	3.6	0.9	2.9	1.4	0.5	0.2	1.6	0.8	1.7	1.6	4.4	3.8	0.0		1.3	5.7	23.1	20.8	1.1	0.0	3.4	0.9	0.0	0.2	4.3	0.9	1.1	1.0	3.9	1.6	1.6	0.5	0.0	0.9	1.4	1.5	10.4	2.3	0.3	0.0	1.0	1.6	2.0	4.3	1.9	0.8	1.8	0.4	4.0	0.6	3.0	69.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	5.4	0.3	0.0	0.0	0.0	1.7	0.2	4.0	69.3	0.0	21.8	0.9	7.7	40.6	0.1	1.8	2.3	30.5	1.6	3.0	0.6	0.4	0.0	11.6										
CD200R1	"CD200R, HCRTR2, MOX2R, OX2R"	ENSG00000163606	"CD200 receptor 1"	Q8TD46	3	112921209-112975122	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 46.7;lymphoid tissue: 21.2"	"Cell line enriched"	"Detected in some"	8	"HEL: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 46.7;eosinophil: 12.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 46.7"									HPA068512			Supported	"Plasma membrane"	"Intracellular and membrane"	1500000	1500000	"Plasma membrane"	"Plasma membrane"	"HPA068512: AB_2732784"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-3)"	3.6	1.6	1.0	9.5	1.4	1.8	3.8	0.8	1.4	5.0	3.5	0.3	1.5	2.0	3.9	5.4	7.5	1.3	2.7	5.8	1.0	1.2	1.4	3.4	4.3	9.0	1.0	0.0	1.0	1.1	0.5	1.0	7.8	0.4	4.2	3.5	2.4	2.5	1.6	0.9	3.4	3.3	1.7	0.9	21.2	1.7	2.5	0.5	15.8	2.0	3.9	17.0	3.8	2.0	2.3	5.8	46.7	0.8	0.6	3.7	1.3	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.2	25.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.0	46.7	0.8	12.7	1.0	0.4	1.8	2.3	3.7	2.1	5.8	1.2	3.6	1.7	0.2	0.6	0.1	0.1	1.0	1.3	1.0	1.4	0.8	1.4	1.0	1.2	1.0	0.0	0.4	0.5
CD300LB	"CLM7, TREM5"	ENSG00000178789	"CD300 molecule like family member b"	A8K4G0	17	74521174-74531474	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9"	"Group enriched"	"Detected in some"	6	"HL-60: 4.5;NB-4: 5.9;THP-1: 4.6;U-937: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 30.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0"																				"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.49e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.01e-2)"	20.7	0.9	0.2	10.9	0.5	8.8	2.0	0.4	0.5	0.6	0.8	0.3	0.1	0.7	0.7	1.0	1.1	1.2	2.8	1.6	1.5	0.4	1.2	1.0	4.4	6.5	1.2	0.1	2.0	2.3	0.0	0.7	1.1	1.0	0.8	1.1	1.6	1.2	0.1	0.3	0.4	2.0	2.2	0.6	6.6	0.7	0.7	0.1	0.9	0.6	0.1	2.2	2.6	0.7	0.0	10.5	30.7	13.0	0.3	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	2.7	0.0	0.6	13.0	30.7	0.0	5.6	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.1	13.8	0.3	0.7	6.6	0.0	4.2	0.2	0.5	0.4	0.5	1.5	0.4	1.2	0.1	1.0	0.1
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 187.6"	"Cell line enriched"	"Detected in single"	78	"MOLT-4: 64.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	30	"gdTCR: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2"	"Lineage enriched"	"Detected in many"	37	"T-cells: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favourable (6.33e-4)"	"prognostic favourable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	1.1	0.6	0.4	7.1	0.4	0.5	0.8	0.3	0.3	0.7	2.3	0.4	0.4	2.0	0.9	0.6	1.5	1.1	1.9	0.6	0.4	0.4	1.2	0.9	2.4	17.2	0.5	0.2	0.7	0.7	0.0	0.5	0.4	0.3	1.0	1.6	0.9	2.9	0.3	5.9	0.6	8.1	0.2	0.8	11.5	2.4	0.5	0.2	187.6	1.4	1.7	19.2	2.5	1.1	0.1	0.2	1.2	0.2	0.2	46.7	14.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	64.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.2	0.2	43.5	0.1	25.6	0.1	36.1	37.1	0.1	0.1	37.6	46.7	1.2	0.2	0.1	0.2	34.2	14.1	0.4	0.4	0.3	0.3	0.4	0.4	0.5	0.2	0.3	0.2
CD5	"LEU1, T1"	ENSG00000110448	"CD5 molecule"	P06127	11	61102395-61127852	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.3;lymphoid tissue: 96.2"	"Cell line enriched"	"Detected in single"	99	"MOLT-4: 38.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"gdTCR: 12.9;MAIT T-cell: 9.3;memory CD4 T-cell: 31.2;memory CD8 T-cell: 20.6;naive CD4 T-cell: 25.9;naive CD8 T-cell: 19.5;T-reg: 36.3"	"Lineage enriched"	"Detected in many"	32	"T-cells: 36.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB015392, CAB020308, HPA043416, HPA060839"	Enhanced									"CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376"	"prognostic favourable (4.05e-4)"	"prognostic favourable (9.16e-5)"	"unprognostic (2.33e-1)"	"prognostic favourable (9.00e-5)"	"unprognostic (1.02e-2)"	"prognostic favourable (7.41e-6)"	"unprognostic (2.45e-3)"	"unprognostic (1.37e-2)"	"prognostic favourable (3.93e-4)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (8.94e-5)"	"unprognostic (4.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.06e-1)"	2.1	0.6	0.5	19.4	0.4	6.5	1.3	0.3	0.6	1.6	2.5	0.3	0.3	1.7	1.1	1.7	1.9	1.4	3.9	0.8	0.6	1.3	1.9	1.1	7.1	28.8	0.4	0.1	1.1	0.9	0.0	0.8	0.4	0.3	1.4	1.5	1.6	15.5	1.3	0.6	1.3	10.2	0.4	0.7	13.8	4.8	1.3	0.1	96.2	1.7	2.4	42.2	5.4	1.5	1.1	1.1	0.4	0.7	0.1	36.3	14.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.9	0.1	9.3	0.4	31.2	20.6	0.9	1.1	25.9	19.5	0.4	0.1	0.7	1.1	36.3	14.6	0.5	0.4	0.3	0.6	0.6	1.3	0.4	0.1	0.3	0.1
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932354	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 138.8;lymphoid tissue: 56.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 114.9;REH: 37.8;U-698: 157.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 100.6;naive B-cell: 138.8"	"Lineage enriched"	"Detected in many"	6	"B-cells: 138.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751"	Enhanced									"CAB009751: AB_2275844, HPA009178: AB_1078483"	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"	1.7	0.7	0.4	50.6	0.4	11.1	1.2	0.3	0.4	0.6	1.7	0.3	0.3	0.7	0.6	0.5	2.6	0.6	1.4	3.4	0.4	0.2	2.3	1.7	1.3	56.6	0.4	0.3	0.6	1.6	0.0	9.0	0.5	0.3	1.0	1.3	0.8	8.9	0.9	1.2	0.9	22.4	0.5	0.4	56.0	1.8	0.6	0.3	3.7	1.4	1.7	46.6	4.5	0.9	138.8	4.2	0.5	25.0	3.4	9.2	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.3	0.0	0.0	0.0	2.4	0.0	0.0	37.8	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.0	0.4	0.0	0.0	5.8	5.6	157.4	0.0	0.2	0.0	0.5	1.1	0.0	4.2	16.5	4.8	100.6	5.4	2.8	4.2	138.8	3.7	2.2	0.5	3.4	25.0	0.6	9.2	9.0	0.4	0.4	0.3	0.4	0.4	0.2	0.4	0.3	0.3	0.3
CD96	TACTILE	ENSG00000153283	"CD96 molecule"	P40200	3	111292719-111665750	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 32.0;lymphoid tissue: 82.4"	"Cell line enhanced"	"Detected in some"		"HEL: 6.7;MOLT-4: 29.2;RT4: 27.1;U-937: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 20.0;T-cells: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066754	Enhanced					37000	37000			"HPA066754: AB_2685714"	"unprognostic (1.06e-3)"	"unprognostic (3.95e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.91e-5)"	"unprognostic (4.72e-3)"	"prognostic favourable (5.52e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.06e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (2.02e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-2)"	"prognostic favourable (5.23e-5)"	5.7	0.9	0.4	18.6	0.5	8.6	3.1	0.6	0.4	2.2	7.1	0.6	0.5	3.6	1.7	1.8	3.4	2.1	3.5	1.3	0.4	0.5	2.3	2.7	9.7	21.9	1.5	0.2	1.4	0.8	0.0	1.1	1.1	1.0	2.6	3.7	2.5	4.0	1.6	0.6	1.3	13.4	1.4	2.0	14.2	3.5	1.0	0.4	82.4	4.8	2.3	23.9	9.9	3.2	5.5	0.1	3.8	0.2	20.0	32.0	11.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	6.7	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	29.2	0.1	0.3	0.0	0.0	0.9	0.2	0.2	27.1	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	2.6	0.8	0.0	0.1	24.2	5.2	0.5	0.1	3.8	20.2	0.0	32.0	2.8	18.6	23.5	0.1	5.5	19.4	23.6	0.8	20.0	0.2	0.1	11.8	11.2	0.4	0.5	0.6	0.4	0.4	0.5	1.5	0.2	1.0	0.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285265-138338355	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 23.3;testis: 22.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003800, HPA066991"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favourable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.03e-6)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	1.1	0.6	0.3	6.7	0.4	5.2	1.1	0.4	0.6	0.6	3.3	0.1	0.7	3.0	0.3	0.6	2.5	0.2	0.4	0.7	0.4	0.4	0.4	0.6	0.7	2.6	0.4	0.3	0.3	0.3	0.0	0.4	1.9	0.3	0.4	4.0	0.0	1.2	0.7	0.2	1.1	3.7	0.5	0.3	1.7	1.2	22.3	0.2	23.3	0.3	1.8	5.0	0.6	0.9	1.0	0.1	0.7	0.0	2.1	2.7	0.5	13.5	5.6	19.0	14.6	0.4	1.9	4.8	8.1	8.8	18.6	25.7	13.6	26.3	6.3	6.9	4.9	7.3	15.6	12.5	18.0	5.2	10.7	4.8	7.7	10.1	0.1	3.2	4.9	0.4	0.5	11.0	9.0	11.9	7.0	12.4	11.3	7.4	8.8	8.1	4.9	6.2	5.8	17.3	7.3	3.2	4.1	9.6	5.9	18.3	5.6	8.7	9.3	6.7	3.6	10.3	8.7	7.1	13.0	7.6	6.2	6.2	4.1	6.9	7.8	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	2.1	0.0	0.1	2.7	0.5	0.3	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.2
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"NK-cell: 5.8;T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.8;T-cells: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023691	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA023691: AB_1846392"	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.3	1.3	1.1	12.3	1.1	27.4	4.3	1.0	2.8	1.6	3.8	0.6	0.0	3.3	0.9	1.4	7.9	0.7	1.4	1.3	1.1	0.9	1.3	1.3	1.9	9.5	1.1	0.5	0.8	0.7	0.2	0.7	5.5	1.3	0.9	4.7	0.1	1.5	0.1	0.7	2.4	3.6	1.7	0.7	5.7	2.1	27.9	0.2	39.9	0.7	6.6	9.9	1.5	2.3	1.2	0.8	0.3	0.5	5.8	4.2	1.4	30.7	17.6	16.9	14.3	1.1	1.8	14.1	22.0	9.2	25.8	20.6	18.0	18.7	28.0	12.7	7.1	21.3	27.3	12.1	25.2	28.0	11.9	25.2	12.8	15.1	0.1	26.8	20.4	0.6	1.1	24.1	11.2	7.8	28.5	51.8	15.7	25.5	37.8	27.7	26.6	21.4	33.2	18.6	26.7	5.3	11.8	22.0	16.5	14.1	20.2	14.9	26.0	13.2	4.9	23.4	24.2	24.6	24.4	26.2	41.5	45.6	9.4	16.5	24.1	0.0	0.2	0.3	0.8	0.0	0.1	0.7	1.1	0.6	0.8	1.2	0.1	0.8	0.1	5.8	0.5	0.7	4.2	1.4	1.1	1.1	1.0	2.8	1.1	0.9	1.1	0.5	1.3	0.2
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 8.3;olfactory region: 21.4"	"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.1	0.6	1.2	28.0	1.5	9.7	1.8	0.5	1.4	8.3	12.3	2.8	2.6	14.9	7.9	1.7	12.9	2.3	6.6	0.9	2.0	1.4	0.8	0.4	1.3	17.2	1.3	2.2	1.1	2.9	0.0	0.4	7.3	3.4	3.2	14.8	1.1	3.3	0.6	4.3	8.3	16.4	1.5	2.0	2.9	7.6	8.1	2.0	71.4	0.9	10.5	24.0	2.3	8.0	2.6	4.2	0.3	0.7	3.6	9.4	2.7	9.8	7.6	17.9	19.4	0.8	3.3	18.7	5.9	2.1	14.2	16.0	11.7	12.5	27.6	7.6	3.6	10.3	28.3	10.7	20.7	13.2	15.6	6.2	5.5	14.8	0.9	40.3	5.9	2.7	0.9	7.7	6.4	6.4	14.9	6.3	4.1	7.9	61.8	40.7	21.1	5.3	43.7	13.6	17.5	6.8	8.7	5.2	9.2	9.3	3.1	5.0	0.0	15.9	2.9	9.3	4.0	3.0	10.9	1.7	3.7	38.7	5.8	22.5	7.8	0.0	0.7	0.0	1.4	0.0	0.5	2.6	3.9	7.6	4.2	0.3	0.3	1.4	0.3	3.6	0.0	0.6	9.4	2.7	1.2	1.5	0.5	1.4	2.0	1.4	1.3	2.2	3.4	2.0
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692418-37709719	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Cytokinetic bridge"				Nucleoli	Nucleoli	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.2	1.4	0.9	12.9	1.7	19.0	1.7	0.8	1.6	1.8	6.0	1.1	0.7	5.3	1.4	1.3	9.6	0.7	2.4	0.8	0.9	0.9	1.3	1.5	2.0	12.2	1.8	1.3	0.9	1.0	0.1	0.8	3.7	1.3	1.0	7.7	0.7	2.1	1.0	0.9	4.0	5.4	1.6	1.2	5.4	3.5	44.7	1.7	51.6	0.9	6.5	14.6	1.6	2.9	2.8	1.8	4.5	5.0	6.3	8.9	2.5	28.0	12.3	23.2	16.7	1.0	2.0	15.6	21.2	10.7	37.5	26.6	19.1	21.1	34.1	8.6	13.5	16.0	26.6	14.1	39.9	22.7	11.9	30.7	13.1	15.1	0.2	29.5	15.9	0.7	1.0	21.1	18.7	16.5	25.9	36.7	27.0	12.5	27.2	18.1	26.8	17.0	26.5	31.7	19.5	8.5	11.8	20.7	9.1	23.3	11.0	14.3	16.1	11.2	9.9	18.5	19.6	10.5	33.1	25.0	32.4	46.5	8.7	27.5	21.1	0.0	1.1	1.8	2.5	2.2	4.5	2.8	5.7	3.3	1.0	2.5	1.9	3.8	4.5	6.3	5.0	1.8	8.9	2.5	0.9	1.7	0.8	1.6	0.9	0.9	1.8	1.3	1.3	1.7
CEP128	"C14orf145, C14orf61"	ENSG00000100629	"Centrosomal protein 128"	Q6ZU80	14	80476983-80959517	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 61.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 25.2;MOLT-4: 21.6;U-266/70: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.6;T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000602, HPA001116, HPA018498"	Uncertain		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite"	"Centriolar satellite"	"HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560"	"unprognostic (6.13e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.48e-1)"	3.8	2.0	5.2	6.5	7.6	10.5	7.5	13.6	5.4	3.4	3.6	4.2	2.7	3.2	4.0	2.2	4.4	4.8	2.0	3.1	3.8	2.5	2.4	2.0	3.8	8.1	6.9	3.1	4.4	2.1	4.2	8.6	2.3	4.5	2.9	3.3	2.3	4.5	3.2	3.1	5.1	3.0	4.0	5.5	6.3	3.1	9.0	6.8	61.2	5.7	3.1	9.1	6.0	4.4	2.2	8.6	1.7	0.8	1.1	9.6	0.8	5.9	3.1	2.8	2.3	0.6	1.1	1.5	6.7	2.0	3.9	3.9	2.1	3.4	13.7	1.2	1.9	3.2	3.0	1.9	7.5	7.7	1.9	2.6	3.9	1.1	0.3	2.7	3.5	0.2	0.5	5.6	3.0	2.9	3.3	25.2	3.7	3.7	21.6	1.4	2.1	3.9	3.9	6.9	10.7	0.8	3.1	3.6	1.7	5.4	2.2	1.1	2.5	2.0	2.7	8.6	4.7	2.3	6.5	45.6	1.8	6.1	2.4	3.6	2.9	0.0	0.8	1.7	2.9	0.3	2.3	2.2	3.2	2.2	2.5	0.9	2.8	1.3	0.1	1.1	0.5	8.6	9.6	0.8	5.2	7.6	13.6	5.4	3.8	2.5	6.9	3.1	4.5	6.8
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624119-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7"	"Group enriched"	"Detected in some"	16	"SCLC-21H: 20.2;SH-SY5Y: 26.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6"	"Not detected"	"Not detected"			HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.2	6.6	2.7	3.9	0.8	0.7	0.2	0.5	0.4	0.6	2.3	0.2	0.0	0.2	0.8	0.7	1.4	0.1	0.1	0.8	1.0	0.3	0.5	0.1	0.1	2.9	0.2	0.0	0.3	0.2	0.0	1.6	0.0	1.3	0.2	1.1	10.6	2.2	2.4	0.6	0.3	1.0	0.9	1.0	1.0	0.8	10.7	0.1	18.5	0.4	0.3	1.1	0.5	0.5	1.5	0.4	1.4	0.8	1.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.2	26.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.3	0.5	0.2	0.6	0.9	0.5	0.6	0.2	1.5	0.8	0.8	1.4	1.0	0.4	0.4	0.3	0.0	2.7	0.8	0.5	0.4	1.0	0.3	0.2	0.0	1.3	0.1
CLEC2D	"CLAX, LLT1, OCIL"	ENSG00000069493	"C-type lectin domain family 2 member D"	Q9UHP7	12	9664969-9699555	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 45.6;lymphoid tissue: 47.5"	"Group enriched"	"Detected in some"	4	"Daudi: 27.2;HDLM-2: 21.2;Karpas-707: 12.9;U-698: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"gdTCR: 37.8;MAIT T-cell: 23.0;memory B-cell: 15.9;memory CD4 T-cell: 37.3;memory CD8 T-cell: 41.3;naive B-cell: 24.6;naive CD4 T-cell: 39.4;naive CD8 T-cell: 45.6;T-reg: 31.5"	"Group enriched"	"Detected in many"	11	"B-cells: 24.6;T-cells: 45.6"									"HPA017649, HPA047584"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA017649: AB_1846912, HPA047584: "	"unprognostic (1.09e-3)"	"prognostic favourable (1.37e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (5.85e-11)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.44e-1)"	"prognostic favourable (1.68e-7)"	3.8	1.0	1.1	47.5	1.1	7.8	3.7	0.8	1.0	2.9	6.0	0.6	1.4	1.7	3.0	7.0	3.6	3.2	3.0	3.3	1.2	1.1	2.6	1.3	10.4	28.3	1.7	1.2	4.0	1.5	0.2	1.3	1.7	1.1	4.5	2.1	2.5	9.8	3.2	1.2	2.4	11.2	3.2	2.5	21.3	2.7	5.7	1.0	44.7	2.8	2.7	29.4	8.2	2.5	24.6	0.4	1.1	0.4	3.1	45.6	19.2	0.4	1.0	1.5	0.1	0.2	0.6	1.6	0.7	1.0	0.3	0.9	0.7	0.9	27.2	0.1	0.7	0.3	0.5	0.0	0.5	21.2	0.4	0.8	0.6	1.2	2.4	0.6	0.7	0.9	0.7	0.2	0.9	0.0	0.2	12.9	0.6	1.8	0.3	2.4	1.3	0.2	5.9	0.6	0.8	1.4	1.5	0.2	0.5	0.3	1.1	1.1	0.2	0.7	0.2	0.5	0.7	0.4	0.4	1.8	0.4	41.8	1.2	1.2	0.8	1.1	0.4	0.2	37.8	0.2	23.0	15.9	37.3	41.3	0.4	24.6	39.4	45.6	1.1	3.1	0.2	0.3	31.5	19.2	1.1	1.1	0.8	1.0	1.2	1.1	1.7	1.2	1.1	1.0
CLEC4D	"CD368, CLECSF8, Dectin-3, MCL, Mpcl"	ENSG00000166527	"C-type lectin domain family 4 member D"	Q8WXI8	12	8509475-8522366	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 35.0;bone marrow: 38.4;lymphoid tissue: 15.0"	"Group enriched"	"Detected in some"	4	"NB-4: 3.3;NTERA-2: 13.0;U-937: 7.5"	"Cancer enriched"	"Detected in single"	50	"testis cancer: 11.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	18	"classical monocyte: 20.9;neutrophil: 35.0"	"Group enriched"	"Detected in many"	32	"granulocytes: 35.0;monocytes: 20.9"	"Not detected"	"Not detected"							HPA004906	Approved									"HPA004906: AB_1078535"	"unprognostic (1.10e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.81e-1)"	"unprognostic (7.91e-5)"	"unprognostic (1.12e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.18e-1)"	1.7	0.2	0.1	4.8	0.6	38.4	0.4	0.1	1.8	2.2	0.3	0.1	0.0	0.0	0.2	0.3	0.3	1.4	0.3	3.6	1.1	0.2	0.4	0.7	6.7	10.4	0.6	0.0	0.4	0.3	0.0	0.4	0.4	0.7	0.2	0.0	0.1	0.3	0.0	1.3	0.1	0.5	0.5	0.5	15.0	0.5	0.5	0.4	0.1	0.7	0.4	0.4	0.5	4.2	0.1	0.8	35.0	20.9	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	13.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.3	20.9	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	35.0	0.0	0.3	0.2	0.0	4.4	0.1	0.6	0.1	1.8	1.1	0.2	0.6	0.0	0.7	0.4
CLEC4G	"LSECtin, UNQ431"	ENSG00000182566	"C-type lectin domain family 4 member G"	Q6UXB4	19	7728957-7733906	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 63.1;lymphoid tissue: 53.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;hTEC/SVTERT24-B: 1.0;RPMI-8226: 1.2;RT4: 1.2;TIME: 2.6;U-937: 2.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.8"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 13.9;myeloid DC: 11.9"	"Group enriched"	"Detected in many"	19	"B-cells: 4.1;dendritic cells: 11.9;monocytes: 13.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003789, HPA014044"	Enhanced									"CAB003789: , HPA014044: AB_1846916"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.13e-8)"	"unprognostic (5.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.65e-2)"	11.2	0.1	0.9	1.5	1.2	0.9	2.6	11.8	1.6	0.2	1.5	0.2	0.2	0.4	0.2	1.3	5.2	2.7	1.0	7.3	2.6	1.0	0.3	63.1	0.5	53.5	0.8	0.2	0.5	0.8	0.0	0.2	0.8	0.2	0.8	0.7	0.3	4.9	0.5	0.2	0.4	0.7	0.7	0.2	1.3	0.3	0.7	0.2	0.3	0.5	0.6	0.2	2.0	0.6	4.1	11.9	0.5	13.9	0.4	0.1	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.6	0.7	2.6	0.0	0.1	0.7	0.0	0.1	0.0	0.2	0.0	2.2	0.1	0.0	13.9	0.0	0.0	3.3	0.0	0.3	0.0	0.0	11.9	4.1	0.1	0.0	0.5	0.4	0.4	0.6	0.0	2.8	0.9	1.2	11.8	1.6	2.6	1.0	0.8	0.2	0.2	0.2
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 53.9;bone marrow: 43.9;brain: 18.7;lung: 32.8;lymphoid tissue: 28.8"	"Group enriched"	"Detected in some"	16	"Karpas-707: 59.3;U-266/84: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 53.9"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"														"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"	7.1	5.0	6.3	27.7	7.4	43.9	3.7	0.9	3.4	3.9	4.5	9.5	0.5	3.7	3.2	8.9	8.7	5.3	7.4	5.2	6.2	4.2	8.7	6.9	32.8	24.2	8.9	4.3	2.4	2.8	1.6	2.6	7.8	8.6	2.7	5.0	6.4	6.5	2.4	1.2	3.2	6.5	5.7	18.7	28.8	3.1	1.6	7.3	5.1	2.3	3.2	9.1	5.5	3.8	0.1	13.1	53.9	30.1	0.1	0.1	7.4	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.3	46.2	0.0	0.1	0.3	0.0	0.2	26.4	0.4	0.0	29.5	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	53.9	0.1	30.1	0.2	0.0	7.4	6.3	7.4	0.9	3.4	6.2	4.2	8.9	4.3	8.6	7.3
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769967	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	12	"basal ganglia: 7.0"	"Low region specificity"	"Detected in all"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favourable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	1.5	0.8	0.9	11.5	1.0	12.6	1.7	0.3	3.6	0.9	2.1	0.1	0.0	1.0	0.5	0.9	2.9	0.5	2.8	0.6	1.1	0.6	1.0	0.7	1.9	6.0	0.6	0.1	0.5	0.5	0.3	0.4	4.3	0.7	0.5	2.7	1.9	1.0	0.0	0.4	1.2	3.4	1.0	0.8	4.4	1.1	10.0	0.5	30.4	0.5	4.2	6.6	0.9	1.2	0.9	0.9	3.4	1.1	1.3	1.6	1.1	8.5	7.1	15.7	8.2	1.1	2.0	5.9	17.7	5.0	13.0	17.4	11.4	8.0	18.4	5.8	4.7	8.7	15.2	6.1	20.4	12.6	6.9	25.9	15.7	5.0	0.0	21.2	15.3	0.4	0.2	22.4	1.6	7.0	17.4	12.8	12.4	5.6	22.2	4.8	14.8	5.1	14.2	23.7	5.5	2.7	14.3	5.8	6.8	15.4	4.7	3.1	4.1	8.3	5.0	18.7	14.2	11.5	19.7	4.6	11.3	19.4	5.9	15.2	15.1	1.6	1.1	1.1	1.6	0.5	0.5	0.4	1.0	0.8	0.9	0.9	0.4	0.8	3.4	1.3	0.7	0.8	1.3	1.1	0.9	1.0	0.3	3.6	1.1	0.6	0.6	0.1	0.7	0.5
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390287	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 268.7;lymphoid tissue: 276.3;tongue: 323.6;vagina: 85.7"	"Cell line enhanced"	"Detected in many"		"A549: 14.4;HEK 293: 20.7;MCF7: 9.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"memory B-cell: 25.1;naive B-cell: 27.5"	"Lineage enriched"	"Detected in many"	11	"B-cells: 27.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"				Microtubules	Microtubules	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favourable (4.02e-5)"	"unprognostic (2.45e-1)"	0.4	0.3	0.2	0.2	0.8	0.2	2.5	0.2	0.2	58.9	0.5	0.2	0.2	0.2	4.4	1.4	268.7	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.3	0.2	39.0	0.3	0.5	37.3	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.9	0.2	323.6	276.3	0.2	85.7	27.5	2.4	0.5	2.0	0.0	0.7	1.0	4.6	14.4	0.3	1.3	0.7	0.7	0.2	0.8	0.3	0.3	0.3	0.8	1.2	4.0	6.5	0.2	1.9	1.2	1.8	0.1	0.0	20.7	0.3	5.4	1.5	0.0	0.0	0.0	1.5	3.2	0.8	0.0	0.0	0.8	0.2	0.0	9.8	0.0	0.1	5.3	4.3	1.7	0.2	2.2	1.4	1.8	2.2	6.3	2.7	4.0	1.9	4.9	2.0	0.0	0.0	4.4	0.1	0.0	4.7	5.6	2.6	0.0	1.7	0.2	0.0	2.0	0.0	0.7	1.5	0.2	25.1	0.5	0.5	2.4	27.5	0.2	0.4	0.5	0.0	0.3	0.5	0.0	1.0	0.2	0.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866571-70209976	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.5;RH-30: 14.2;SCLC-21H: 4.0;SK-MEL-30: 11.9;WM-115: 10.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 14.4"	"Group enriched"	"Detected in some"	156	"memory B-cell: 7.9;naive B-cell: 23.1"	"Lineage enriched"	"Detected in single"	232	"B-cells: 23.1"	"Low region specificity"	"Detected in many"							HPA042422	Uncertain				"Secreted to extracellular matrix"					"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	4.2	0.7	1.1	18.8	2.7	1.1	0.5	14.4	4.1	0.5	1.6	0.0	0.0	0.8	0.5	0.2	0.6	0.7	0.6	2.6	6.0	1.0	4.5	0.6	0.6	7.3	0.7	1.1	0.5	0.9	0.2	4.2	0.4	0.7	5.2	2.2	0.0	0.8	0.4	3.7	0.5	2.3	37.8	0.6	4.2	4.4	1.5	0.0	1.3	0.6	0.0	8.8	12.4	2.3	23.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.2	0.0	0.0	0.0	4.0	2.9	0.0	0.0	11.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	2.7	14.4	4.1	6.0	1.0	0.7	1.1	0.7	0.0
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7"	"Group enriched"	"Detected in some"	18	"BEWO: 34.1;NB-4: 9.2;THP-1: 22.4;U-937: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 167.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 167.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"					"CAB017116: , HPA048086: AB_2680257"	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	8.5	1.5	2.9	39.5	3.2	88.9	2.4	0.7	2.9	1.1	1.1	4.2	0.4	0.6	0.7	1.1	1.2	6.9	4.3	5.6	2.6	2.0	1.7	4.5	26.9	27.5	7.2	1.1	1.1	1.3	0.3	1.1	152.7	3.8	1.3	0.5	2.1	1.6	0.5	0.6	0.3	1.6	3.1	7.1	71.4	2.2	1.4	3.3	1.1	1.0	0.4	0.9	4.6	3.9	0.0	8.2	167.3	22.1	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.6	0.0	0.0	22.1	0.6	0.0	4.8	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	167.3	0.2	1.8	0.2	0.0	10.3	2.9	3.2	0.7	2.9	2.6	2.0	7.2	1.1	3.8	3.3
DEFB4A	"DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1"	ENSG00000171711	"Defensin beta 4A"	O15263	8	7894629-7896711	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 44.1;lymphoid tissue: 15.7;tongue: 50.4"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.7;NTERA-2: 2.5"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 32.2;melanoma: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"							"unprognostic (6.96e-2)"		"unprognostic (1.17e-2)"		"unprognostic (2.72e-2)"		"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"				"unprognostic (2.75e-1)"				0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.0	0.3	0.2	44.1	0.0	8.6	0.2	0.2	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	7.3	0.2	0.2	1.3	0.2	0.2	0.2	0.2	2.9	0.2	0.2	0.2	0.2	50.4	15.7	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"	"Centriolar satellite, Cytosol"	"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.52e-6)"	"prognostic unfavourable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavourable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.0	14.7	38.8	17.4	0.9	3.9	12.0	21.5	14.2	31.9	30.4	12.0	20.5	21.6	11.9	12.5	23.1	24.8	17.3	41.9	25.9	12.2	22.1	13.8	10.3	0.1	21.6	13.6	0.7	0.6	14.9	7.2	35.1	17.9	21.6	29.6	17.8	27.3	11.1	20.0	15.4	21.3	37.5	9.9	10.4	12.1	19.8	11.1	22.9	8.6	8.5	19.3	8.1	13.6	14.3	37.4	13.8	24.7	5.3	11.5	28.6	10.0	15.4	22.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2
E2F2	E2F-2	ENSG00000007968	"E2F transcription factor 2"	Q14209	1	23506430-23531220	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 22.8;lymphoid tissue: 69.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.6;Karpas-707: 20.3;U-266/84: 18.1;U-698: 19.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB016313	Uncertain									"CAB016313: AB_2096794"	"unprognostic (3.14e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.18e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.43e-6)"	"unprognostic (7.83e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.00e-3)"	"unprognostic (2.82e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.84e-1)"	0.4	0.2	0.1	6.1	0.2	22.8	1.0	0.1	0.2	1.1	3.5	0.2	0.0	1.6	0.1	0.2	11.2	0.1	0.2	1.5	0.0	0.0	0.4	0.7	1.2	3.3	0.2	0.0	0.2	0.6	0.0	0.0	2.2	0.2	0.3	2.3	0.3	1.2	0.0	0.0	4.4	3.4	0.4	0.2	6.8	0.9	4.4	0.1	69.7	0.3	3.9	6.1	0.5	2.3	0.9	1.1	6.7	2.0	0.2	2.8	0.4	2.7	2.0	3.3	5.3	0.1	0.1	2.3	1.3	0.6	1.2	1.6	1.2	1.6	23.6	1.6	0.6	5.5	6.7	0.3	1.1	5.9	2.1	3.7	5.0	1.4	0.0	2.7	4.9	0.0	0.0	0.9	0.1	0.4	2.8	20.3	0.5	1.6	12.0	2.5	0.7	1.0	13.3	7.2	8.0	0.5	0.7	4.4	6.1	2.2	2.8	0.6	2.1	2.0	0.2	1.1	3.3	3.6	1.8	15.0	18.1	19.5	1.1	2.9	2.2	6.7	0.6	1.7	0.2	1.5	0.1	0.9	0.7	0.5	1.1	0.6	0.1	0.2	0.4	0.2	2.0	0.9	2.8	0.4	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1
EPHA8	"EEK, Hek3"	ENSG00000070886	"EPH receptor A8"	P29322	1	22563564-22603594	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5"	"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 36.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 25.0"	"CAB009660, HPA031433"	Uncertain				"Intracellular and membrane"					"CAB009660: AB_2099696, HPA031433: AB_10601371"	"unprognostic (8.58e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.69e-4)"	"unprognostic (3.58e-1)"		"unprognostic (7.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.84e-14)"	"unprognostic (2.14e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.68e-2)"	0.2	9.4	1.6	0.2	3.1	0.2	0.1	1.8	3.9	0.2	0.2	2.2	0.0	1.7	0.1	0.3	0.2	0.1	0.2	0.2	2.0	2.6	0.1	0.1	0.2	0.2	2.1	4.1	0.1	8.3	0.2	1.7	0.1	5.3	0.2	0.2	1.6	0.8	0.2	0.3	0.4	0.2	0.1	1.3	10.3	0.2	3.5	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	36.4	2.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.9	2.0	2.6	2.1	4.1	5.3	0.6
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	1.0	1.7	0.5	7.1	0.5	5.5	1.0	0.4	0.6	1.2	9.6	0.1	0.5	11.9	0.6	1.0	5.0	0.3	1.8	1.1	0.7	0.5	1.6	1.4	1.1	4.2	0.5	0.6	0.6	1.0	0.3	0.3	1.5	0.5	0.5	4.5	0.1	1.4	1.4	0.4	1.1	23.2	0.4	0.8	4.7	2.4	10.3	0.2	39.8	0.5	5.3	5.7	1.0	1.8	1.3	1.9	0.8	1.5	0.9	4.6	0.8	24.8	18.9	8.5	10.3	1.1	1.8	4.7	15.0	6.3	13.9	15.9	6.7	4.9	9.2	7.9	3.9	13.8	10.3	4.1	21.2	7.1	4.4	10.9	8.5	7.0	0.1	5.5	10.2	0.3	0.4	8.1	2.0	5.1	8.7	14.1	8.0	4.8	22.3	2.5	5.7	6.4	9.9	25.4	6.7	4.5	15.1	3.7	5.4	7.5	9.1	3.8	6.2	6.1	2.2	8.6	17.8	17.3	11.7	1.9	5.0	11.4	4.7	9.3	11.9	0.1	0.7	0.4	0.3	1.5	0.1	1.3	0.7	1.0	1.9	0.1	0.5	0.4	0.8	0.9	0.4	0.2	4.6	0.8	0.5	0.5	0.4	0.6	0.7	0.5	0.5	0.6	0.5	0.2
FCHO1	KIAA0290	ENSG00000130475	"FCH domain only 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.9;RPMI-8226: 19.2;U-937: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	2.3	13.6	13.7	18.9	18.9	1.9	11.4	15.2	1.1	2.7	30.2	0.0	3.7	1.8	1.8	1.5	1.9	4.5	1.1	17.8	11.7	1.0	2.7	3.4	22.6	23.0	10.0	2.2	0.9	0.8	2.6	1.4	10.8	1.4	2.6	0.6	2.7	1.2	0.9	13.4	4.0	2.1	15.9	13.7	3.5	4.3	23.3	16.4	1.2	0.0	17.3	5.1	1.0	9.9	10.4	25.7	9.5	4.1	5.7	4.4	0.4	5.4	3.5	2.5	0.1	0.1	3.5	0.5	0.1	0.1	0.2	0.7	0.6	27.9	8.0	0.2	1.1	1.7	1.0	0.1	12.3	0.9	2.2	0.7	2.8	0.3	6.9	4.7	0.0	0.1	0.1	0.2	0.7	10.9	13.4	0.0	7.7	15.8	12.4	1.7	13.3	13.5	0.1	19.2	0.1	0.5	0.6	1.3	0.1	2.8	0.4	2.7	6.9	0.5	0.1	2.0	0.5	0.2	8.5	3.8	15.1	0.4	17.2	0.3	6.9	6.6	6.5	5.2	9.5	4.5	8.8	5.7	4.5	9.7	9.9	5.5	4.4	25.7	4.1	7.2	10.4	5.2	4.4	13.6	18.9	11.4	15.2	17.8	11.7	23.0	10.0	10.8	23.3
FCRL1	"CD307a, FCRH1, IFGP1, IRTA5"	ENSG00000163534	"Fc receptor like 1"	Q96LA6	1	157794403-157820105	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 31.6;lymphoid tissue: 55.1"	"Group enriched"	"Detected in some"	33	"Daudi: 5.6;U-698: 18.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	51	"memory B-cell: 16.8;naive B-cell: 31.6"	"Lineage enriched"	"Detected in single"	66	"B-cells: 31.6"					"Low region specificity"	"Detected in all"			HPA013323	Enhanced					120000	120000			"HPA013323: AB_1848480"	"unprognostic (6.52e-4)"	"unprognostic (3.49e-3)"	"unprognostic (8.68e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-5)"	"unprognostic (1.47e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.74e-2)"	0.5	0.2	0.2	55.1	0.2	6.2	0.3	0.2	0.2	0.2	0.7	0.0	0.0	0.0	0.2	0.1	2.4	0.3	0.2	0.3	0.2	0.2	0.7	0.5	1.9	19.2	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.5	0.3	0.3	5.4	0.7	0.2	0.2	10.1	0.0	0.2	25.3	0.4	0.2	0.0	1.1	0.7	0.4	49.0	4.5	0.8	31.6	0.0	0.4	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.8	0.0	0.0	0.0	31.6	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FCRL4	"CD307d, FCRH4, IGFP2, IRTA1"	ENSG00000163518	"Fc receptor like 4"	Q96PJ5	1	157573749-157598080	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 5.4;lymphoid tissue: 15.6"	"Cell line enriched"	"Detected in single"	102	"U-266/70: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"					"Low region specificity"	"Detected in many"			HPA054030	Approved									"HPA054030: "	"unprognostic (6.06e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.57e-1)"	"unprognostic (5.08e-2)"		"unprognostic (4.69e-4)"		"unprognostic (2.06e-2)"			"unprognostic (6.38e-2)"			"unprognostic (1.99e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-1)"	"unprognostic (6.77e-2)"	0.1	0.1	0.1	15.6	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	2.5	0.0	0.1	0.1	5.4	0.0	0.1	2.2	0.3	0.1	0.0	1.1	0.1	1.9	14.9	0.4	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0
FCRLA	"FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595"	ENSG00000132185	"Fc receptor like A"	Q7L513	1	161706972-161714352	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 66.3;lymphoid tissue: 51.8"	"Group enriched"	"Detected in some"	6	"Daudi: 91.8;SK-MEL-30: 37.8;U-698: 50.9"	"Cancer enriched"	"Detected in many"	21	"melanoma: 38.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"memory B-cell: 66.3;naive B-cell: 61.9"	"Lineage enriched"	"Detected in many"	9	"B-cells: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016545	Enhanced				"Intracellular and membrane"					"CAB016545: AB_2247037"	"unprognostic (5.46e-4)"	"unprognostic (7.19e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.48e-4)"	"unprognostic (1.45e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.66e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.84e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-2)"	0.4	0.2	0.6	31.7	0.7	1.3	0.3	0.2	0.3	0.2	0.9	0.2	0.0	0.2	0.2	0.0	2.4	0.2	0.2	0.6	0.5	0.3	0.6	0.4	0.4	26.3	0.4	0.0	0.2	0.2	0.0	0.2	0.1	0.2	0.5	0.9	0.6	4.8	0.0	0.4	0.6	13.9	0.0	0.7	42.4	1.3	0.2	0.1	2.0	0.5	0.3	51.8	1.9	0.4	66.3	6.9	0.0	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.1	0.0	0.0	91.8	0.0	1.3	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.5	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	10.6	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	50.9	0.5	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	66.3	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	6.9	0.0	2.7	0.6	0.7	0.2	0.3	0.5	0.3	0.4	0.0	0.2	0.1
FOXD4L6		ENSG00000273514	"Forkhead box D4 like 6"	Q3SYB3	9	41126430-41128463	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 1.8;lymphoid tissue: 1.5"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012836: "		"unprognostic (2.41e-1)"			"unprognostic (3.41e-1)"									"unprognostic (3.61e-1)"				0.0	0.0		1.5		0.0	0.0		1.8	0.0	0.0			0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.2	0.1	0.3			0.0	0.2	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.8	0.2	0.3			0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.7	0.2	0.0	0.5	1.0	0.0	0.1	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.1	1.0	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.0	0.0	0.1	0.4	0.6	0.2	0.5	0.5	0.3	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.7	0.3	0.0	0.8	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXE3	"FKHL12, FREAC8"	ENSG00000186790	"Forkhead box E3"	Q13461	1	47416072-47418052	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 2.9;lymphoid tissue: 4.6;testis: 2.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.0;SCLC-21H: 1.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.9;cerebellum: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.11e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-7)"	"unprognostic (2.41e-1)"	"unprognostic (5.46e-2)"		"unprognostic (3.60e-1)"	0.2	0.1	0.2	0.1	2.9	0.1	0.1	1.6	0.4	0.8	0.7	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.0	2.9	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.7	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.6	0.4	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	1.6	0.4	0.3	0.2	0.1	0.1	0.1	0.1
FUT7		ENSG00000180549	"Fucosyltransferase 7"	Q11130	9	137030174-137033010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 40.4;lymphoid tissue: 10.5"	"Group enriched"	"Detected in some"	10	"NB-4: 14.1;THP-1: 18.1;U-937: 10.1"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 40.4"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA042780			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA042780: AB_2678162"	"unprognostic (1.33e-2)"	"unprognostic (4.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (2.50e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.75e-4)"	"unprognostic (4.68e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.69e-6)"	"unprognostic (3.99e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.75e-2)"	0.4	0.1	0.2	2.5	0.2	5.9	0.2	3.2	0.3	0.2	0.2	0.2	0.2	0.0	1.4	0.2	0.4	0.5	4.4	0.2	0.3	0.3	0.2	0.2	1.5	6.2	1.7	0.2	0.2	0.2	0.0	0.4	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.6	0.2	0.4	10.5	0.3	0.2	0.2	0.2	0.3	0.2	4.6	0.5	0.2	4.2	40.4	18.3	1.5	22.1	16.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.1	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.3	1.5	0.3	2.1	0.3	10.5	4.2	10.3	5.7	4.4	1.2	0.2	0.8	18.3	22.1	0.0	40.4	16.3	3.4	0.2	0.2	3.2	0.3	0.3	0.3	1.7	0.2	0.9	0.2
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060767-129062406	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 8.8;neutrophil: 7.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced					68000000	68000000			"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.2	0.1	0.1	0.1	0.1	10.0	0.1	0.0	0.6	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.1	5.0	0.8	0.1	0.1	0.4	4.8	0.0	0.8	0.2	0.5	0.1	0.0	0.3	1.5	0.4	0.1	0.4	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	24.5	0.3	2.2	0.0	0.0	0.6	0.6	0.0	0.6	3.0	0.1	1.5	8.8	0.6	0.0	0.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.6	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	7.5	0.0	0.0	1.5	0.0	27.1	0.1	0.1	0.0	0.6	0.8	0.1	0.8	0.2	0.4	0.0
GPR15		ENSG00000154165	"G protein-coupled receptor 15"	P49685	3	98531899-98533150	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.9;intestine: 27.1;lymphoid tissue: 26.3;urinary bladder: 9.4"	"Group enriched"	"Detected in some"	22	"HDLM-2: 10.9;U-266/70: 4.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 4.4;memory CD4 T-cell: 12.9;memory CD8 T-cell: 6.1;T-reg: 12.9"	"Group enriched"	"Detected in many"	30	"B-cells: 4.4;T-cells: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA013775	Approved									"HPA013775: AB_1849264"	"unprognostic (8.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.66e-2)"	"unprognostic (9.48e-3)"	"unprognostic (5.60e-5)"	"unprognostic (5.17e-1)"	"unprognostic (6.77e-3)"	"unprognostic (3.96e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	0.9	0.1	0.1	13.4	0.1	0.0	2.5	0.1	0.2	1.1	15.3	0.1	0.1	1.8	0.1	0.1	2.6	0.2	2.1	0.2	0.1	0.1	0.3	0.4	1.9	24.9	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.3	1.4	27.1	0.3	4.6	0.7	0.1	0.4	11.8	1.5	0.2	4.3	1.1	0.2	0.1	3.6	0.7	2.0	26.3	9.4	2.4	4.4	0.2	0.2	0.0	0.0	12.9	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.4	4.4	12.9	6.1	0.0	0.7	0.6	1.0	0.2	0.0	0.0	0.2	12.9	2.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.3	0.1
H2BFS		ENSG00000234289	"H2B histone family member S"	P57053	21	43565189-43565648	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.0"	"Cell line enhanced"	"Detected in many"		"K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				1.1	0.9	0.2	7.4	0.3	1.8	2.6	0.3	0.8	1.8	1.7	0.4	1.1	2.3	2.4	4.3	4.9	4.2	4.2	4.9	0.5		0.5	4.0	3.3	12.2	0.1	0.5	2.2	4.2	0.0	0.0	4.5	0.4	5.3	1.8	0.8	3.0	2.1	1.0	0.4	3.0	1.8	0.7	5.7	2.0	7.9	0.0	65.0	2.6	7.1	6.1	2.1	1.3	7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.0	3.2	0.6	0.9	2.2	0.8	2.3	2.5	1.3	3.2	1.9	4.5	1.0	0.5	8.6	0.8	2.4	0.2	0.7	0.9	2.1	3.5	0.5	4.9	0.2	0.3	0.9	4.4	2.4	0.4	0.6	0.0	0.3	23.2	2.7	0.8	6.0	1.0	2.2	0.3	2.6	0.8	0.5	8.5	0.6	0.7	3.4	2.4	10.2	3.1	2.0	10.9	1.4	0.9	1.7	22.9	1.1	0.6	7.4	23.3	4.9	1.1	11.6	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2										
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 107.1;lymphoid tissue: 72.6"	"Group enriched"	"Detected in some"	8	"THP-1: 22.6;U-937: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005195, HPA063768"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB005195: AB_631619, HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	12.3	5.8	5.9	40.8	13.1	20.8	4.0	1.8	5.3	3.0	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6.0	3.7	4.0	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8.0	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73.0	107.1	1.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	22.6	0.0	0.0	0.1	0.0	0.0	0.6	0.1	3.3	0.0	64.8	0.0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0.0	73.0	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6.0	3.7	11.2	1.2	8.0	8.2
HES3	bHLHb43	ENSG00000173673	"Hes family bHLH transcription factor 3"	Q5TGS1	1	6244192-6245578	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 6.8"	"Cell line enriched"	"Detected in some"	7	"NTERA-2: 15.7"	"Cancer enriched"	"Detected in single"	28	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	30	"cerebellum: 39.0"	"Low region specificity"	"Detected in many"			"HPA047927, HPA072697"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047927: AB_2680213, HPA072697: "															"unprognostic (7.42e-2)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0
HIST1H2AC	H2AFL	ENSG00000180573	"Histone cluster 1 H2A family member c"	Q93077	6	26124145-26139116	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 116.1;lymphoid tissue: 202.5"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.7;SiHa: 27.2;U-2 OS: 27.4;U-266/84: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 116.1"	"Lineage enriched"	"Detected in all"	17	"granulocytes: 116.1"					"Low region specificity"	"Detected in all"			HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (4.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.89e-3)"	13.6	14.5	13.6	22.5	16.4	19.0	29.9	7.3	9.8	35.6	21.0	12.2	17.9	18.1	13.2	32.8	27.5	23.6	13.9	12.6	18.5	12.4	21.4	34.1	29.2	28.5	18.6	8.5	23.8	15.7	3.7	13.4	26.2	8.5	37.2	15.0	21.1	10.4	17.0	17.5	15.4	21.6	14.4	27.0	26.4	26.9	16.3	10.4	202.5	24.5	9.2	34.9	29.6	25.8	6.6	4.5	116.1	3.6	1.9	2.1	48.3	5.6	1.6	1.9	0.6	16.2	8.9	0.8	2.8	1.8	8.6	7.4	2.1	1.4	0.2	14.0	5.6	6.7	1.6	2.9	6.2	5.3	0.9	0.9	0.7	0.3	12.8	0.9	6.5	31.7	5.0	1.8	5.6	0.5	14.0	10.3	3.8	4.6	0.9	1.0	2.3	0.5	0.6	1.0	16.5	8.2	0.6	3.0	1.2	27.2	5.8	8.8	13.2	1.4	1.9	5.3	27.4	2.3	1.2	13.4	27.2	1.5	1.9	14.2	2.2	36.0	2.0	24.4	1.4	1.5	1.2	3.3	1.5	1.0	1.4	6.6	2.1	1.1	116.1	1.9	3.6	4.5	2.0	48.3	13.6	16.4	7.3	9.8	18.5	12.4	18.6	8.5	8.5	10.4
HIST1H2AE	"H2A.1, H2A/a, H2AFA"	ENSG00000277075	"Histone cluster 1 H2A family member e"	P04908	6	26216975-26217483	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 139.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 26.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB012242: AB_470265, HPA041189: AB_2677357"	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	0.3	1.8	0.9	19.1	0.9	13.5	33.8	4.9	6.2	3.7	3.8	0.2	3.2	2.8	2.2	13.6	7.2	3.0	2.4	2.2	0.5		0.8	1.5	1.9	11.4	0.0	3.0	2.0	1.1	0.4	0.0	2.9	0.5	10.6	1.6	1.4	2.7	2.5	0.1	2.4	3.4	2.0	3.5	5.9	2.0	5.1	0.0	139.6	2.0	7.4	11.4	2.3	0.0	6.1	15.4	11.4	2.1	4.0	4.2	10.1	2.8	0.0	2.1	0.0	3.5	0.7	0.5	0.9	1.4	3.1	2.1	1.4	2.3	0.1	7.7	0.3	2.3	1.0	1.4	1.2	3.0	2.5	1.8	4.1	1.7	0.6	0.2	2.9	6.1	0.7	1.3	0.1	1.5	7.6	2.1	0.2	5.1	6.2	5.4	2.5	2.6	5.0	1.7	9.8	1.3	1.6	8.5	3.6	7.6	2.6	1.7	10.5	2.8	0.0	0.1	0.6	1.3	1.2	26.4	0.0	0.0	1.1	3.7	1.8	11.4	2.0	6.3	2.7	2.1	3.8	4.3	3.0	4.2	5.0	6.1	1.6	2.1	9.4	4.0	1.2	15.4	3.6	10.1										
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.9;U-2 OS: 23.0;U-266/70: 19.0;U-266/84: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	2.9	1.7	0.9	0.9	0.9	0.5	1.1	2.9	1.1	2.0	1.6	2.4	1.8	1.1	5.6	1.0	2.2	1.2	1.2	1.0	2.6	1.0	0.9	2.7	4.1	1.1	1.4	3.7	12.3	0.7	0.8	0.5	0.7	16.6	9.3	3.8	3.3	3.1	3.0	0.9	5.4	1.4	1.3	6.9	3.4	0.7	4.2	1.3	32.9	2.5	1.1	14.0	1.3	2.4	2.4	23.0	1.5	1.2	19.0	23.3	5.5	1.0	3.6	1.6	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5
HIST1H2BD	"H2B/b, H2BFB"	ENSG00000158373	"Histone cluster 1 H2B family member d"	P58876	6	26158146-26171349	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 174.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 36.8;U-266/84: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	7.9	6.6	6.0	33.2	9.0	36.4	17.3	14.0	8.9	33.6	17.0	2.9	13.2	8.2	9.5	21.4	18.2	17.4	11.1	17.4	7.5	4.2	19.9	25.3	13.8	32.3	7.7	7.1	33.1	21.7	2.2	11.5	10.1	7.4	43.4	12.9	8.3	13.0	14.7	12.0	14.7	9.5	13.0	18.7	11.0	18.8	7.1	5.6	174.9	9.5	23.9	18.9	13.2	32.7	15.6	12.9	19.3	4.5	6.8	9.6	2.0	5.3	12.1	3.7	2.1	29.0	2.6	1.1	4.7	2.7	6.1	3.8	4.0	4.4	2.4	29.8	5.6	8.5	2.0	2.0	2.9	10.9	5.2	1.6	9.7	4.2	3.1	2.1	4.6	19.0	3.2	1.7	2.4	1.5	16.7	13.4	1.1	19.1	4.8	5.4	3.9	5.6	1.9	2.3	15.8	5.8	3.8	11.9	5.0	29.6	7.8	4.6	19.6	0.7	0.9	7.7	19.9	3.1	1.0	36.8	38.8	6.1	0.9	9.9	1.5	19.3	1.5	10.5	5.8	3.4	7.4	8.4	8.9	9.6	3.7	15.6	8.4	5.7	16.6	6.8	4.5	12.9	5.8	2.0	6.0	9.0	14.0	8.9	7.5	4.2	7.7	7.1	7.4	5.6
HIST1H2BJ	"H2B/r, H2BFR"	ENSG00000124635	"Histone cluster 1 H2B family member j"	P06899	6	27125897-27132750	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 124.3"	"Cell line enhanced"	"Detected in many"		"K-562: 41.2;Karpas-707: 24.3;SiHa: 37.1;U-2 OS: 41.1;U-266/70: 35.0;U-266/84: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favourable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.1	2.2	1.5	30.0	2.4	10.7	11.3	0.9	1.9	12.8	6.2	1.6	3.9	2.1	3.1	5.9	12.8	5.1	2.8	6.0	2.5	1.7	1.9	3.9	7.3	12.0	3.2	0.9	1.3	5.1	0.6	1.2	5.1	2.9	8.0	3.0	0.5	4.0	4.8	5.9	2.9	2.8	2.8	5.9	12.0	5.1	30.5	2.2	124.3	2.7	10.1	22.3	5.2	9.4	2.2	1.0	13.6	0.6	0.7	2.4	14.7	3.7	4.7	1.4	1.3	7.1	0.5	1.8	2.1	1.2	8.3	3.6	4.0	2.2	0.6	6.7	2.2	2.7	2.0	1.8	4.6	4.4	3.5	1.1	5.3	0.2	0.6	0.4	3.0	3.4	0.2	1.7	0.8	0.4	41.2	24.3	2.2	2.0	1.7	2.4	1.7	4.4	0.9	1.2	3.7	1.0	1.4	9.2	1.0	37.1	2.5	1.0	0.1	1.5	1.0	2.1	41.1	1.6	0.9	35.0	43.1	9.9	0.5	11.6	1.0	1.8	0.6	0.7	0.5	0.5	0.8	1.6	0.7	0.3	0.4	2.2	0.4	0.5	13.6	0.7	0.2	1.0	2.4	14.7	1.5	2.4	0.9	1.9	2.5	1.7	3.2	0.9	2.9	2.2
HIST1H2BK	"H2BFAiii, H2BFT"	ENSG00000197903	"Histone cluster 1 H2B family member k"	O60814	6	27146418-27146798	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 243.8"	"Cell line enhanced"	"Detected in many"		"K-562: 115.0;U-2 OS: 104.9;U-266/84: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	9.4	6.0	3.0	39.8	4.1	7.8	8.6	2.4	3.6	14.9	11.0	2.5	10.5	8.4	8.0	14.6	19.1	13.5	10.5	9.8	4.3	3.7	4.0	19.3	12.7	25.9	3.6	2.3	8.5	17.4	0.6	5.9	18.7	2.0	16.0	5.3	3.5	11.3	10.7	3.7	6.3	10.3	6.9	7.6	28.0	13.7	30.6	1.9	243.8	8.9	32.3	26.4	11.5	16.7	26.5	22.1	60.7	16.2	5.0	11.5	12.5	6.1	15.9	2.5	4.4	11.5	4.3	8.8	10.1	7.3	14.7	9.5	14.4	8.1	2.0	34.4	5.8	8.1	3.1	3.1	2.2	9.1	15.4	3.4	10.0	0.4	5.0	2.7	20.9	20.6	2.7	2.5	2.8	3.0	115.0	23.3	6.6	16.8	4.9	4.9	2.3	6.9	3.2	1.7	25.9	5.5	2.7	12.9	7.4	60.5	20.8	5.5	53.7	3.1	3.3	6.6	104.9	6.1	1.7	32.0	137.9	18.3	3.8	27.4	3.7	33.8	9.4	60.7	4.1	8.3	3.9	20.3	4.2	4.1	9.6	26.5	5.0	3.9	60.1	5.0	16.2	22.1	11.5	12.5	3.0	4.1	2.4	3.6	4.3	3.7	3.6	2.3	2.0	1.9
HIST1H4E	"H4/j, H4FJ"	ENSG00000276966	"Histone cluster 1 H4 family member e"	P62805	6	26204552-26206038	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.4;U-266/70: 14.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (8.62e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.08e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (2.00e-6)"	"unprognostic (1.28e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	2.2	4.8	2.4	5.4	6.8	13.0	4.6	15.1	17.3	7.3	4.7	5.2	5.1	7.4	4.9	6.6	5.2	6.5	5.0	5.1	2.0		3.0	1.9	2.6	5.1	1.3	5.7	11.2	1.6	2.5	2.6	4.7	2.4	10.5	5.0	6.7	7.5	4.6	1.8	2.2	4.6	6.5	2.0	4.9	4.8	7.7	1.8	71.9	6.5	2.7	7.7	7.8	0.0	10.4	5.1	4.8	8.0	3.7	5.9	2.1	1.3	0.9	1.7	3.9	0.6	0.0	0.9	1.5	0.4	0.7	0.5	0.5	1.4	0.5	2.0	0.4	2.4	0.8	0.1	1.0	1.1	1.0	0.4	1.6	0.8	0.0	0.6	1.6	0.4	0.1	0.6	0.4	0.5	2.8	3.3	0.2	0.5	7.4	3.5	1.6	1.3	3.3	1.8	3.3	0.6	0.5	4.8	1.2	1.1	1.6	0.5	1.5	0.7	0.7	2.0	2.7	0.6	1.2	14.6	5.6	2.1	0.4	1.4	1.4	3.2	3.7	2.9	3.8	3.1	5.3	3.9	5.5	3.6	5.1	10.4	5.9	4.5	4.8	3.7	8.0	4.7	3.3	2.1										
HIST2H2AC	"H2A, H2A/q, H2AFQ"	ENSG00000184260	"Histone cluster 2 H2A family member c"	Q16777	1	149886975-149887364	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 47.7;bone marrow: 86.5;lymphoid tissue: 80.6"	"Cell line enriched"	"Detected in many"	4	"MCF7: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (5.50e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavourable (1.20e-10)"	"unprognostic (1.42e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.89e-2)"	"prognostic favourable (7.86e-5)"	10.5	8.5	4.2	6.5	4.2	86.5	8.6	3.1	4.1	13.8	7.5	2.8	5.4	4.6	8.1	6.0	10.9	6.4	8.1	13.2	3.9	3.1	8.2	6.1	10.5	12.5	2.9	3.7	15.3	15.8	3.6	7.6	8.4	2.3	10.6	4.3	13.8	6.0	10.1	7.2	10.1	6.4	9.7	7.6	10.7	5.8	4.9	2.4	80.6	6.0	8.1	10.5	16.2	8.9	15.8	11.6	47.7	15.9	7.9	11.0	10.8	2.5	3.2	3.6	11.0	0.0	0.6	5.3	0.7	0.9	1.8	2.6	1.9	0.7	5.4	0.1	0.2	1.2	0.2	1.2	0.0	0.3	4.3	1.3	0.4	9.2	0.0	3.1	2.8	0.7	0.2	0.1	0.4	1.3	1.1	6.6	0.4	44.3	3.7	3.1	4.7	7.6	1.1	1.5	1.0	0.7	1.9	1.1	5.1	1.5	0.8	2.5	0.4	3.1	1.0	0.8	7.3	1.3	1.9	3.0	1.9	2.8	2.0	4.3	1.6	17.0	15.9	8.1	11.0	10.6	10.0	6.2	9.7	8.7	8.1	15.8	6.8	6.7	47.7	7.9	10.6	11.6	7.3	10.8	4.2	4.2	3.1	4.1	3.9	3.1	2.9	3.7	2.3	2.4
HIST3H2BB		ENSG00000196890	"Histone cluster 3 H2B family member b"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 56.0"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	2.0	4.7	1.2	12.1	3.1	2.8	1.3	12.8	3.2	8.9	1.3	1.1	0.6	2.1	1.4	2.0	4.1	6.2	1.7	2.2	1.5	2.2	1.3	0.9	2.1	5.4	1.2	1.5	1.6	1.7	1.7	2.0	1.5	4.1	2.2	1.5	3.4	2.0	2.0	1.8	4.8	1.7	1.2	6.2	4.5	2.4	2.1	0.7	56.0	1.7	5.9	11.8	2.0	7.9	1.5	1.1	3.4	1.5	1.1	0.9	0.5	0.2	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.5	1.0	0.1	0.1	0.0	2.5	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.3	0.4	0.1	0.4	0.2	0.0	0.0	0.8	0.0	0.2	1.4	0.5	0.9	0.4	0.3	3.7	0.1	0.1	0.0	0.0	0.5	0.1	18.1	4.3	0.0	0.2	0.1	0.1	1.7	1.0	0.5	0.5	0.5	0.7	1.3	0.8	0.9	0.2	1.5	0.9	0.7	3.4	1.1	1.5	1.1	0.7	0.5	1.2	3.1	12.8	3.1	1.5	2.2	1.2	1.5	4.1	0.7
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"					"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.37e-5)"	"prognostic unfavourable (2.46e-4)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavourable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.0	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.6	5.3	2.9	10.1	19.9	18.0	13.2	24.4	12.5	6.7	20.5	18.5	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	11.4	17.4	13.3	33.6	17.2	23.7	18.6	19.2	16.0	18.3	33.8	9.4	9.4	10.3	13.0	8.1	14.7	11.2	10.5	8.4	13.1	8.3	19.8	21.5	14.5	27.6	12.7	10.0	21.4	11.8	12.5	49.2	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	380000	380000	Nucleoplasm	Nucleoplasm	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109"	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.3	8.2	70.9	31.6	8.8	8.8	27.2	25.6	19.5	28.2	25.3	23.3	48.0	116.2	5.8	14.3	13.4	46.5	14.0	44.2	71.1	21.7	127.7	20.9	34.1	8.6	112.9	49.3	8.5	4.3	14.1	32.2	29.0	48.1	163.7	25.9	28.7	168.3	104.8	25.8	14.3	85.1	36.4	43.1	16.3	14.7	61.4	55.4	25.9	15.0	11.5	20.8	82.4	16.6	12.7	37.6	15.7	38.4	52.9	29.6	133.0	10.8	82.6	33.0	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301083-14349404	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6"	"Cell line enhanced"	"Detected in many"		"AF22: 15.2;BEWO: 10.9;Hep G2: 13.2;HSkMC: 15.1;U-251 MG: 13.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;pons and medulla: 6.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 20.6;T-cells: 14.7"									HPA064126			Approved	Vesicles				Vesicles	Vesicles	"HPA064126: AB_2685194"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	1.4	1.4	0.6	8.7	0.8	1.3	3.0	0.9	2.7	3.8	1.8	0.0	0.8	1.4	1.0	0.3	2.8	1.7	2.6	2.0	0.6	0.7	3.6	29.1	3.7	26.6	0.6	0.0	4.7	1.3	0.4	1.4	33.5	6.0	2.4	1.9	5.3	12.6	2.5	1.8	2.2	2.5	0.6	2.9	4.9	1.4	0.7	0.0	13.2	1.5	2.5	5.9	1.5	5.3	0.4	20.6	0.5	0.4	3.8	14.7	2.7	0.0	0.3	15.2	0.0	4.6	5.2	10.9	4.3	6.3	3.9	4.1	0.0	0.1	0.0	0.0	5.9	0.0	0.4	2.4	2.0	1.2	3.1	0.3	2.0	13.2	6.0	0.5	2.3	15.1	0.8	1.3	3.6	0.0	4.5	0.0	3.1	0.8	0.7	0.6	0.5	0.4	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	3.8	0.0	0.0	13.9	0.0	0.0	0.0	3.0	0.0	0.9	0.1	0.2	0.0	6.3	0.4	5.0	0.4	7.6	4.9	0.4	0.4	7.7	7.5	0.5	3.8	0.4	20.6	14.7	2.7	0.6	0.8	0.9	2.7	0.6	0.7	0.6	0.0	6.0	0.0
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936748-203961577	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8"	"Group enriched"	"Detected in some"	100	"HEL: 5.9;MOLT-4: 15.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 18.4"	"Lineage enriched"	"Detected in single"	58	"T-cells: 18.4"	"Low region specificity"	"Detected in single"							"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	1.5	0.3	0.2	15.6	0.2	13.8	0.7	0.2	0.2	0.8	1.2	0.0	0.2	0.5	1.2	0.5	1.1	1.2	1.6	0.5	0.2	0.2	1.0	0.8	4.0	19.4	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.7	1.1	0.7	2.9	0.0	0.2	0.6	6.2	0.3	0.4	6.1	1.0	0.6	0.0	51.8	1.4	2.4	28.9	3.0	0.9	0.0	0.0	0.0	0.0	0.3	18.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.9	0.0	10.5	4.6	0.0	0.0	11.0	5.0	0.0	0.3	0.0	0.0	18.4	3.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.1	0.0
IGFLR1	"FLJ22573, TMEM149, U2AF1L4"	ENSG00000126246	"IGF like family receptor 1"	Q9H665	19	35738801-35742453	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 121.2;liver: 46.2;lymphoid tissue: 40.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 21.9;Karpas-707: 16.7;U-266/70: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 121.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 121.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012369	Uncertain		Approved	"Focal adhesion sites"	"Intracellular and membrane"			"Focal adhesion sites"	"Focal adhesion sites"	"HPA012369: AB_1858095"	"unprognostic (5.97e-3)"	"prognostic favourable (6.55e-4)"	"unprognostic (1.94e-1)"	"unprognostic (5.42e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.34e-4)"	"unprognostic (6.71e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-2)"	"prognostic favourable (1.59e-5)"	"unprognostic (1.44e-3)"	"unprognostic (3.52e-1)"	"unprognostic (8.72e-12)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-3)"	5.3	7.3	4.5	17.8	7.6	10.1	4.1	2.0	5.3	3.1	5.0	3.8	0.0	5.6	2.6	4.7	3.4	4.5	5.9	5.8	4.5	3.1	17.0	46.2	8.5	40.7	7.7	1.6	4.5	6.9	1.1	3.4	3.8	5.6	4.0	5.4	2.2	7.4	1.8	3.9	4.6	8.4	3.5	5.4	20.2	6.3	3.5	4.5	14.6	10.0	3.2	19.3	8.0	4.9	22.3	121.2	28.6	26.5	18.1	17.4	16.3	1.3	6.4	2.2	5.3	0.7	1.1	1.3	1.5	0.7	1.2	3.1	1.9	1.5	2.8	2.1	0.4	1.0	1.3	1.3	0.6	2.0	3.2	9.8	2.6	6.7	1.9	1.3	21.9	1.8	0.8	2.2	0.5	1.2	3.0	16.7	0.3	5.4	3.1	10.3	1.6	1.7	3.8	2.1	5.1	1.0	2.3	1.6	3.0	2.1	1.5	1.1	2.3	5.3	0.3	2.7	1.3	1.7	2.4	22.1	4.6	1.7	3.2	3.8	2.1	16.2	26.5	23.6	13.3	22.2	15.2	22.3	15.4	12.6	33.9	21.8	13.9	11.1	28.6	18.1	15.5	121.2	17.4	16.3	4.5	7.6	2.0	5.3	4.5	3.1	7.7	1.6	5.6	4.5
IGSF6	DORA	ENSG00000140749	"Immunoglobulin superfamily member 6"	O95976	16	21639537-21652660	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 96.8;lymphoid tissue: 49.7"	"Cell line enhanced"	"Detected in some"		"THP-1: 2.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 96.8"	"Lineage enhanced"	"Detected in many"		"granulocytes: 96.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041023, HPA041072"	Uncertain									"HPA041023: AB_10794434, HPA041072: AB_10794262"	"unprognostic (7.94e-2)"	"prognostic favourable (4.92e-4)"	"unprognostic (1.18e-2)"	"prognostic favourable (1.54e-5)"	"unprognostic (3.27e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.02e-1)"	17.8	3.9	5.0	16.7	7.7	2.0	2.0	0.9	5.1	2.3	5.8	3.8	0.0	4.1	1.1	2.7	1.2	2.1	1.3	3.6	4.7	2.7	1.7	8.5	16.2	30.2	6.5	0.2	3.5	1.4	0.8	1.1	6.5	5.9	2.1	1.6	0.8	3.6	2.1	0.7	0.9	3.5	1.3	10.6	49.7	2.4	0.6	6.2	3.4	1.2	0.9	2.1	1.5	1.0	0.2	18.7	96.8	28.5	0.2	0.1	12.7	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.6	1.6	0.1	0.1	0.4	0.1	0.1	0.1	1.0	0.0	0.4	0.0	0.7	0.0	1.5	1.1	0.1	0.0	0.1	0.0	0.2	0.5	0.4	0.1	0.5	0.7	0.8	0.6	0.0	1.7	0.0	0.6	0.3	0.8	0.5	0.3	0.3	0.1	0.2	0.3	2.0	0.4	1.7	0.1	0.1	0.9	0.8	0.4	1.3	0.6	0.8	0.3	0.0	23.7	3.4	0.0	28.5	0.0	0.2	0.0	0.0	18.7	0.0	0.0	0.1	96.8	0.2	18.6	4.0	0.0	12.7	5.0	7.7	0.9	5.1	4.7	2.7	6.5	0.2	5.9	6.2
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 16.5;blood: 55.4;lymphoid tissue: 56.7"	"Cell line enriched"	"Detected in some"	59	"HDLM-2: 153.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	6	"basophil: 30.3;T-reg: 55.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 30.3;T-cells: 55.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002419, HPA054622"	Enhanced					110000	110000			"CAB002419: AB_563538, HPA054622: AB_2682546"	"unprognostic (2.82e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.08e-9)"	"unprognostic (2.10e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.10e-2)"	16.5	2.5	0.3	10.9	0.6	0.1	1.4	0.3	0.3	0.6	3.1	0.1	0.0	1.3	0.8	4.9	1.9	0.8	2.2	1.9	0.4	0.5	2.6	1.3	4.0	50.4	0.5	0.0	0.6	1.0	0.0	1.8	1.8	2.4	1.1	1.6	3.4	2.2	0.5	0.8	0.6	10.3	3.5	2.2	56.7	1.4	0.4	0.0	4.5	4.2	2.0	16.8	5.0	0.6	3.6	0.0	30.3	0.0	2.9	55.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	153.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	30.3	0.0	4.5	0.1	0.0	0.5	3.6	6.8	0.7	0.0	1.5	0.5	0.0	0.2	2.9	0.0	0.0	55.4	0.7	0.3	0.6	0.3	0.3	0.4	0.5	0.5	0.0	2.4	0.0
IL36B	"FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882"	ENSG00000136696	"Interleukin 36 beta"	Q9NZH7	2	113022091-113052867	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 3.6;lymphoid tissue: 6.3;skin 1: 11.7"	"Cell line enriched"	"Detected in some"	21	"U-87 MG: 40.6"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035664	Uncertain				"Secreted to blood"					"HPA035664: AB_10669672"		"unprognostic (8.45e-2)"			"unprognostic (1.62e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.06e-1)"	"unprognostic (3.77e-2)"		"unprognostic (2.40e-3)"			"unprognostic (2.05e-1)"			"unprognostic (7.10e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 68.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.1;HEL: 9.0;HMC-1: 9.2;Karpas-707: 23.5;U-266/70: 9.1;U-266/84: 13.5;U-937: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favourable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.8	1.7	4.0	24.5	8.5	12.0	2.7	2.4	3.1	1.9	2.3	1.0	0.0	2.2	1.7	2.0	2.5	3.5	3.6	4.3	2.7	2.8	3.8	2.0	8.4	68.3	7.5	0.0	11.0	2.0	0.4	2.3	4.1	5.3	3.0	2.4	1.6	6.1	1.5	0.7	1.3	9.5	2.5	8.4	36.1	3.2	1.8	5.8	20.9	3.4	1.7	28.8	5.3	2.4	7.4	4.5	16.9	9.6	8.4	15.0	6.8	0.1	0.3	0.3	1.0	0.4	1.4	0.2	0.5	0.0	0.0	0.1	0.0	0.9	0.4	1.9	0.4	0.1	0.0	0.2	0.0	20.1	0.0	9.0	0.0	0.8	0.7	0.0	9.2	5.0	0.2	0.0	0.0	0.2	0.0	23.5	0.0	0.4	3.6	0.0	0.1	0.7	4.6	0.0	0.4	0.5	0.0	0.0	0.3	0.1	0.2	0.0	2.0	1.3	0.4	0.0	0.4	0.0	0.0	9.1	13.5	2.5	0.1	13.7	0.2	1.2	4.9	0.2	12.6	9.6	14.5	6.5	15.0	13.1	4.5	7.4	14.9	13.0	16.9	8.4	8.8	3.7	11.8	6.8	4.0	8.5	2.4	3.1	2.7	2.8	7.5	0.0	5.3	5.8
KLRD1	CD94	ENSG00000134539	"Killer cell lectin like receptor D1"	Q13241	12	10226058-10329600	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 85.5;lymphoid tissue: 31.0;pituitary gland: 44.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdTCR: 67.2;memory CD8 T-cell: 28.0;naive CD8 T-cell: 30.3;NK-cell: 85.5"	"Group enriched"	"Detected in many"	63	"NK-cells: 85.5;T-cells: 67.2"	"Not detected"	"Not detected"							HPA069688	Uncertain									"HPA069688: AB_2686170"	"unprognostic (3.75e-2)"	"unprognostic (2.15e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.53e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.37e-2)"	5.2	1.3	0.9	6.4	1.1	6.9	1.7	0.8	0.9	1.4	2.7	0.6	0.2	1.5	3.3	1.9	2.0	1.1	1.5	1.7	1.0	1.0	1.5	3.7	12.3	10.2	3.8	0.7	0.9	1.9	0.0	44.6	2.3	0.8	2.0	0.9	2.1	1.2	0.5	1.1	0.8	10.6	0.5	2.6	31.0	1.8	1.4	0.4	2.2	1.3	0.3	3.6	6.3	1.3	0.1	0.2	1.2	0.2	85.5	67.2	16.2	0.9	0.7	1.1	1.5	1.5	0.6	0.9	2.3	0.1	0.2	0.7	1.4	1.0	1.3	1.1	1.8	1.1	0.5	1.3	0.2	2.2	2.8	1.7	2.6	0.6	2.7	1.0	2.1	0.7	1.7	0.4	1.2	0.3	1.0	4.9	0.3	1.9	1.0	1.3	1.7	1.4	0.6	1.6	1.2	0.7	2.1	2.4	1.2	1.1	2.2	0.5	0.8	2.0	1.7	1.7	3.1	1.5	0.7	2.0	1.8	1.1	2.6	1.6	1.6	0.1	0.1	0.1	67.2	0.2	7.6	0.1	0.4	28.0	0.2	0.1	0.1	30.3	1.2	85.5	0.1	0.2	0.1	16.2	0.9	1.1	0.8	0.9	1.0	1.0	3.8	0.7	0.8	0.4
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin/SPAG5 binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"				"Mitotic spindle, Centriolar satellite"	"Mitotic spindle, Centriolar satellite"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	5.5	4.4	6.7	5.5	6.3	7.3	9.0	8.1	7.0	3.3	4.5	4.0	8.0	5.3	3.9	7.8	6.2	3.4	2.5	4.1	6.0	5.3	4.2	7.0	4.1	8.0	4.6	7.1	3.4	3.5	6.0	4.2	7.4	6.8	4.4	6.3	2.5	6.4	5.0	7.5	4.2	4.1	5.9	4.3	4.8	6.2	40.1	4.5	18.4	59.8	6.0	9.1	3.8	3.7	5.9	11.0	10.0	26.2	5.5	5.5	4.0	31.1	14.7	29.3	19.2	6.5	10.1	15.3	21.7	16.9	44.8	39.6	31.4	13.8	12.1	11.1	14.5	36.1	31.2	20.1	40.6	21.4	15.2	35.8	33.0	19.8	6.1	19.2	18.7	5.2	11.6	22.6	22.6	25.1	25.8	21.0	37.6	15.8	16.6	15.5	18.4	22.3	17.1	22.1	14.0	15.6	13.0	28.6	19.9	18.1	19.9	4.8	20.9	13.8	12.8	21.6	22.2	22.0	29.9	18.0	29.1	21.7	13.4	25.7	17.6	4.8	10.3	10.0	4.8	14.5	4.4	5.9	3.6	4.4	11.0	5.4	3.5	3.6	5.9	5.5	26.2	7.5	5.5	4.0	6.7	6.3	8.1	7.0	6.0	5.3	4.6	7.1	6.8	4.5
KRT78	K5B	ENSG00000170423	"Keratin 78"	Q8N1N4	12	52837804-52849092	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 166.3;lymphoid tissue: 128.7;tongue: 53.1"	"Group enriched"	"Detected in some"	7	"EFO-21: 9.7;RT4: 2.7;SK-BR-3: 6.8;U-87 MG: 5.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.0"					"Not detected"	"Not detected"			HPA039724	Enhanced					71000000	71000000			"HPA039724: AB_10795255"		"unprognostic (5.36e-2)"		"unprognostic (5.89e-2)"		"unprognostic (2.95e-2)"		"unprognostic (3.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.01e-3)"		"unprognostic (8.88e-16)"	"unprognostic (3.50e-2)"	"unprognostic (6.92e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.25e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.1	26.8	0.1	0.1	0.1	0.0	0.6	0.1	166.3	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	18.3	0.1	0.3	15.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	53.1	128.7	0.2	25.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	9.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.7	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LAIR2	CD306	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5"	"Group enriched"	"Detected in some"	5	"BEWO: 6.8;Hep G2: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"T-reg: 12.8"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.8"														"Secreted - unknown location"						"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.86e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.68e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.40e-5)"	"unprognostic (6.71e-2)"	0.9	0.5	0.6	5.9	1.7	1.6	0.5	0.2	1.3	0.4	0.6	1.3	0.0	0.4	0.5	1.3	0.7	0.5	1.3	0.4	1.4	3.0	0.6	0.8	3.2	12.3	0.6	0.5	0.2	0.9	0.1	7.1	15.5	1.3	0.8	1.3	0.4	0.5	0.4	0.6	0.5	1.2	0.5	1.5	6.6	1.0	1.2	0.4	19.6	0.5	0.0	2.0	0.3	0.3	0.0	0.0	0.1	0.1	0.6	12.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.0	2.0	0.0	0.0	0.8	2.7	0.1	0.6	0.1	0.0	12.8	1.8	0.6	1.7	0.2	1.3	1.4	3.0	0.6	0.5	1.3	0.4
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 21.6;bone marrow: 21.7;lymphoid tissue: 39.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.5;REH: 2.9;THP-1: 5.9;U-937: 13.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 21.6;monocytes: 7.1"														"Secreted to blood"	130000000	130000000				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	2.8	1.5	1.4	4.7	1.1	21.7	0.9	0.1	2.0	0.6	0.8	3.0	0.0	0.6	0.5	1.0	0.5	2.3	1.0	3.7	1.1	1.1	1.2	3.8	6.8	14.6	2.9	0.4	1.1	0.6	0.5	0.4	1.7	1.4	0.6	0.6	1.1	0.8	0.5	0.6	0.7	0.7	1.0	3.7	39.9	0.7	0.7	2.3	0.7	0.6	0.0	0.8	0.9	1.8	0.2	2.1	21.6	7.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	2.5	0.0	0.0	2.9	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	5.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	13.3	0.1	2.4	4.9	1.8	0.1	7.1	0.0	0.1	0.1	0.1	2.1	0.2	0.1	0.1	21.6	0.3	6.8	0.4	0.0	3.0	1.4	1.1	0.1	2.0	1.1	1.1	2.9	0.4	1.4	2.3
LIME1	"dJ583P15.4, FLJ20406, LIME"	ENSG00000203896	"Lck interacting transmembrane adaptor 1"	Q9H400	20	63736283-63739103	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 87.5;liver: 43.7;lymphoid tissue: 80.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 13.1;MOLT-4: 13.7;RPMI-8226: 50.3;U-266/70: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdTCR: 39.4;MAIT T-cell: 35.4;memory CD4 T-cell: 54.9;memory CD8 T-cell: 51.2;naive CD4 T-cell: 37.5;naive CD8 T-cell: 40.6;plasmacytoid DC: 87.5;T-reg: 77.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 87.5;T-cells: 77.8"									CAB015363	Approved				"Intracellular and membrane"					"CAB015363: AB_629890"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.51e-3)"	"prognostic unfavourable (5.04e-5)"	"unprognostic (2.39e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.67e-1)"	"prognostic favourable (6.92e-6)"	1.9	0.6	2.1	17.9	4.9	4.0	0.7	4.4	2.1	2.0	5.2	0.4	0.5	2.2	0.9	0.3	4.2	0.7	8.4	0.8	2.0	1.8	13.6	43.7	5.0	20.3	1.4	1.1	1.2	0.5	0.4	1.8	0.6	0.4	2.3	0.6	1.1	9.9	0.7	0.9	4.9	3.7	0.7	1.7	10.0	16.9	0.7	0.5	80.4	1.6	2.4	22.8	2.5	1.1	9.6	87.5	1.3	0.1	9.2	77.8	22.3	0.7	0.2	0.0	0.1	0.0	0.0	1.8	0.9	0.0	0.1	0.0	0.4	0.7	2.1	1.4	0.0	1.8	0.0	0.1	0.1	0.9	1.7	0.4	0.7	8.4	0.0	0.6	0.7	0.1	0.2	0.0	0.0	0.0	0.7	13.1	0.0	0.4	13.7	3.8	0.7	2.4	9.5	0.3	50.3	0.1	0.1	0.7	1.1	0.4	0.5	0.9	0.4	0.3	0.2	0.7	1.0	0.7	0.5	27.2	1.0	4.3	0.5	0.4	0.2	0.1	0.1	0.2	39.4	0.1	35.4	9.6	54.9	51.2	0.2	3.7	37.5	40.6	1.3	9.2	0.1	87.5	77.8	22.3	2.1	4.9	4.4	2.1	2.0	1.8	1.4	1.1	0.4	0.5
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 25.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.9;U-266/84: 1.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"					"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.4	0.1	0.2	25.3	0.6	1.1	0.1	1.3	0.2	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.1	0.3	0.4	2.0	7.2	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.0	0.6	0.4	0.2	2.4	0.5	0.3	0.2	2.8	0.2	0.3	10.0	0.4	6.0	0.0	11.2	0.2	0.5	17.5	0.7	0.1	0.2	0.0	0.5	0.6	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.5	0.1	0.6	0.0	0.1	0.0	0.2	0.6	1.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0
LY75	"CD205, CLEC13B, DEC-205"	ENSG00000054219	"Lymphocyte antigen 75"	O60449	2	159803355-159904749	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 28.8;lymphoid tissue: 61.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.3;HDLM-2: 9.7;Karpas-707: 41.3;RT4: 14.0;THP-1: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB001450, HPA049108, HPA054073"	Enhanced		Approved	"Golgi apparatus"		960000	960000	"Golgi apparatus"	"Golgi apparatus"	"CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: "	"unprognostic (7.29e-3)"	"unprognostic (1.92e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (2.39e-5)"	"unprognostic (2.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.94e-2)"	"prognostic favourable (3.86e-4)"	3.5	1.8	1.9	21.4	2.6	4.9	6.1	1.2	1.8	4.5	9.3	2.0	1.0	10.8	2.1	1.9	4.5	5.0	10.7	2.8	1.8	1.7	2.8	1.2	10.3	33.9	2.5	1.1	1.6	2.3	0.2	1.9	0.8	2.4	2.0	7.2	1.3	7.2	1.3	0.8	6.5	28.8	1.3	3.4	17.2	3.8	1.1	3.0	61.9	10.7	3.6	17.1	6.9	3.8	5.8	4.3	5.9	2.6	7.5	8.0	2.3	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	10.3	7.1	0.3	0.0	0.2	0.0	0.0	0.0	9.7	0.0	2.0	0.0	0.0	0.2	1.6	0.0	0.1	0.0	0.2	0.1	5.3	0.0	41.3	0.0	0.0	0.0	2.6	0.2	0.0	2.7	0.0	1.7	3.1	14.0	0.0	0.0	3.3	2.4	0.0	0.0	10.4	7.9	0.0	0.0	0.0	0.0	6.3	1.0	1.4	0.0	3.6	0.0	3.4	2.0	3.5	6.5	2.6	7.1	5.8	5.9	7.5	4.3	4.5	6.7	8.0	5.9	7.5	1.0	1.5	4.3	2.3	1.9	2.6	1.2	1.8	1.8	1.7	2.5	1.1	2.4	3.0
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.8;intestine: 11.3;lymphoid tissue: 43.7;urinary bladder: 28.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;Karpas-707: 14.6;U-266/70: 37.2;U-266/84: 14.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 30.6;MAIT T-cell: 30.7;memory B-cell: 15.2;memory CD4 T-cell: 26.8;memory CD8 T-cell: 29.6;naive B-cell: 13.9;naive CD4 T-cell: 30.5;naive CD8 T-cell: 30.8;plasmacytoid DC: 18.6;T-reg: 19.7"	"Group enriched"	"Detected in many"	4	"B-cells: 15.2;dendritic cells: 18.6;T-cells: 30.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA050917	Approved					23000	23000			"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.8	0.5	0.4	20.9	0.4	6.9	2.7	0.4	0.4	1.4	3.7	0.2	0.4	2.4	0.9	0.8	3.5	1.0	2.0	0.9	0.4	0.4	1.7	1.3	6.1	35.3	0.4	0.0	1.1	0.5	0.0	0.5	0.2	0.1	1.0	2.3	1.0	6.5	0.4	0.4	0.8	11.3	0.1	0.7	25.3	3.4	1.1	0.0	35.7	1.6	1.8	43.7	28.6	1.2	15.2	18.6	0.6	0.2	5.2	30.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	1.1	0.2	0.0	0.0	0.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	37.2	14.3	0.1	0.0	2.0	0.0	0.2	0.2	0.1	30.6	0.2	30.7	15.2	26.8	29.6	1.3	13.9	30.5	30.8	0.6	5.2	0.2	18.6	19.7	12.9	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.1	0.0
MS4A7	"CD20L4, CFFM4, MS4A8"	ENSG00000166927	"Membrane spanning 4-domains A7"	Q9GZW8	11	60378482-60395951	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in all"	4	"blood: 132.8;lymphoid tissue: 126.7"	"Cell line enriched"	"Detected in some"	24	"THP-1: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 71.2;non-classical monocyte: 132.8"	"Lineage enriched"	"Detected in many"	11	"monocytes: 132.8"					"Low region specificity"	"Detected in all"			"HPA017418, CAB026387"	Approved									"CAB026387: , HPA017418: AB_1854137"	"unprognostic (1.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.24e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	24.2	11.9	4.4	15.1	4.9	2.0	9.7	1.3	3.5	5.9	7.4	4.2	2.9	5.2	4.2	11.0	4.0	4.8	15.2	11.3	5.1	3.9	6.8	22.3	29.7	19.1	4.6	1.3	3.2	3.4	2.3	6.2	13.3	5.0	5.9	7.5	8.4	5.3	3.4	2.2	2.3	8.1	4.8	9.9	126.7	4.3	6.0	3.5	7.0	3.3	2.3	5.6	9.7	3.9	2.0	11.9	0.9	132.8	0.1	0.1	10.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.2	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	1.2	0.0	1.6	0.0	0.5	18.8	0.2	0.1	71.2	0.1	2.0	0.0	0.0	11.9	1.8	0.0	0.0	0.9	0.1	132.8	0.3	0.0	10.9	4.4	4.9	1.3	3.5	5.1	3.9	4.6	1.3	5.0	3.5
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387480-139390081	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 97.7;lymphoid tissue: 152.6"	"Group enriched"	"Detected in some"	5	"Karpas-707: 64.6;RPMI-8226: 228.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 29.5;plasmacytoid DC: 97.7"	"Group enriched"	"Detected in many"	115	"B-cells: 29.5;dendritic cells: 97.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced				"Secreted to blood"	670000	670000			"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favourable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	2.2	1.9	0.6	37.8	0.6	6.2	4.4	0.5	0.6	5.7	25.5	0.4	0.3	21.6	1.2	0.6	13.6	2.9	5.6	0.8	0.6	0.6	4.2	2.6	6.7	54.7	0.6	0.3	1.7	2.1	0.0	0.8	0.4	0.4	2.4	9.8	2.0	30.2	7.1	0.7	0.7	13.3	0.5	0.6	92.6	15.0	3.7	0.3	152.6	3.3	3.1	54.3	26.6	2.0	29.5	97.7	0.5	0.0	0.3	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	25.0	0.2	0.0	0.0	10.3	0.0	228.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	31.0	1.7	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	29.5	0.1	0.1	0.0	11.0	0.0	0.0	0.5	0.3	0.0	97.7	0.0	4.5	0.6	0.6	0.5	0.6	0.6	0.6	0.6	0.3	0.4	0.3
NCF1	"NCF1A, NOXO2, p47phox, SH3PXD1A"	ENSG00000158517	"Neutrophil cytosolic factor 1"	P14598	7	74773962-74789315	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 166.6;lymphoid tissue: 42.1"	"Group enriched"	"Detected in some"	6	"Daudi: 35.3;HMC-1: 50.5"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	5	"basophil: 75.1;classical monocyte: 49.6;eosinophil: 106.8;neutrophil: 166.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 166.6;monocytes: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004524, HPA047836, HPA052095"	Enhanced									"CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: "	"unprognostic (4.93e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.55e-3)"	"unprognostic (7.60e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.23e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-1)"	2.4	0.9	0.7	11.9	0.5	25.9	0.7	0.0	0.2	0.4	2.0			1.9	0.3	0.0	1.2	1.2	1.2	0.7	0.7	0.8	1.3	1.4	6.6	17.1	1.3		0.2	0.3	0.0	0.4	1.0		0.7	0.9		1.3	0.0	0.1	0.1	10.0	0.7	2.5	42.1	1.4	0.0			0.9		11.8	3.2	0.6	21.2	21.2	166.6	49.6	0.7	1.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	1.0	0.3	0.3	0.0	0.3	50.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.1	0.1	0.0	0.5	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.0	0.1	2.9	0.0	75.1	49.6	106.8	0.3	18.6	0.7	18.2	0.7	0.4	5.9	21.2	1.0	0.6	166.6	0.7	4.1	21.2	0.7	29.3										
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in many"		"A-431: 13.1;HMC-1: 11.4;hTERT-HME1: 27.4;U-2 OS: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Cytosol	"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	7.4	0.0	9.7	1.6	8.2	0.0	0.0	3.3	3.0	0.0	1.0	11.4	0.0	2.1	1.7	27.4	0.0	0.0	2.9	3.0	0.1	0.1	0.5	0.2	0.7	3.5	1.1	9.9	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.4	4.6	0.6	0.0	26.6	0.0	2.4	0.5	0.7	0.2	0.2	5.2	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301121	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2"	"Group enriched"	"Detected in some"	4	"HEL: 83.6;K-562: 36.2;NB-4: 25.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 119.7;neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 119.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"	"Nucleoplasm, Actin filaments"	"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	2.3	0.3	0.9	3.5	1.5	54.3	0.5	0.4	1.7	0.9	0.4	0.2	0.0	0.5	0.4	0.4	0.7	2.0	0.9	7.8	1.5	0.4	0.9	2.6	9.6	20.9	5.2	0.2	1.2	0.6	1.2	0.8	15.9	1.2	1.0	0.3	1.2	0.5	0.2	1.0	2.9	0.5	1.1	1.0	32.2	0.7	0.9	0.7	1.8	1.7	0.2	0.5	1.2	8.1	0.0	15.2	119.7	23.1	0.0	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	1.5	0.1	0.2	1.1	2.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	83.6	0.2	1.9	0.0	1.2	11.0	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	3.3	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	4.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	119.7	23.1	21.7	0.0	6.4	0.1	0.0	0.0	0.0	15.2	0.0	0.1	0.0	80.0	0.0	3.8	0.2	0.0	12.9	0.9	1.5	0.4	1.7	1.5	0.4	5.2	0.2	1.2	0.7
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577400	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"				Cytosol	Cytosol	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	0.2	0.4	0.0	20.1	0.1	2.8	0.0	0.0	0.2	0.4	1.3	0.0	0.2	1.2	1.0	0.1	1.0	0.0	1.8	0.8	0.0		0.6	0.5	6.0	11.2	0.2	0.0	0.1	1.5	0.0	0.0	0.6	0.2	0.9	0.7	0.9	2.7	0.2	0.5	0.0	2.4	0.1	0.0	10.5	1.4	0.0	0.0	27.0	0.4	1.1	18.1	1.6	1.0	1.0	0.0	2.6	0.0	4.7	4.1	3.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.2	0.1	0.0	0.0	12.9	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	5.4	13.8	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	3.3	0.4	0.2	0.0	0.2	0.1	0.3	0.0	19.9	0.1	9.7	0.0	2.6	0.0	0.0	3.7	0.0	4.1	1.0	2.7	3.8	0.0	0.8	2.1	2.0	0.0	4.7	0.0	0.0	3.1	3.3										
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793603-53824394	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5"	"Group enriched"	"Detected in some"	4	"HMC-1: 7.5;THP-1: 6.6;U-87 MG: 7.2;U-937: 6.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 22.8;neutrophil: 15.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.8;monocytes: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042099, HPA042981"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"HPA042099: , HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	1.9	0.3	0.2	4.2	0.6	11.0	0.4	0.2	0.2	0.9	0.3	0.1	0.9	0.3	0.7	0.7	0.6	1.0	0.5	3.3	0.2	0.2	0.5	0.5	6.5	13.5	0.6	0.3	1.0	0.3	0.1	0.2	1.1	0.8	0.3	0.1	0.5	1.7	0.0	0.2	0.2	0.3	1.4	0.5	10.2	0.4	1.0	0.6	0.3	0.3	0.4	0.2	1.1	1.4	0.0	3.6	22.8	8.7	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.6	7.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	6.0	0.0	22.8	8.7	11.0	0.0	2.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	15.0	0.0	1.5	0.0	0.0	2.1	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.3	0.8	0.6
NLRP4	"CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2"	ENSG00000160505	"NLR family pyrin domain containing 4"	Q96MN2	19	55836578-55881854	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 9.4;lymphoid tissue: 9.0;testis: 12.1"	"Cell line enriched"	"Detected in some"	8	"Daudi: 41.8"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.4"									HPA062128			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA062128: "	"unprognostic (2.48e-1)"			"unprognostic (7.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"		0.2	0.2	1.9	1.0	1.8	0.0	0.2	0.2	2.9	0.2	0.2	2.7	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.2	1.0	0.3	0.2	0.2	0.2	2.8	5.1	0.6	0.4	0.2	0.1	0.3	0.0	2.9	0.2	0.1	0.0	0.8	0.0	0.2	0.2	0.3	0.1	9.4	0.3	0.2	12.1	2.2	0.0	0.2	0.4	9.0	0.2	0.2	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	41.8	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	1.8	0.2	2.9	1.0	0.3	5.1	0.6	2.9	2.2
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371181	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"lymphoid tissue: 20.4;testis: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"			"Nuclear membrane"	"Nuclear membrane"	"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	6.8	5.3	3.9	6.5	5.9	11.2	7.3	6.9	7.5	6.4	5.1	5.9	3.4	4.4	9.7	3.7	6.9	5.0	3.7	4.7	3.9	4.1	4.4	5.3	5.1	8.1	3.8	4.2	7.9	5.5	8.1	7.0	8.4	5.2	5.5	6.3	5.9	6.0	5.9	6.1	8.1	5.0	5.9	3.9	7.2	4.9	70.1	2.5	20.4	5.4	4.8	9.8	5.8	6.0	7.3	4.9	7.1	7.1	7.7	10.0	4.4	13.6	10.8	11.8	17.4	3.7	5.5	42.5	11.1	5.9	15.2	11.2	15.9	11.2	15.5	5.1	7.1	11.1	19.9	10.9	23.9	10.2	11.2	12.0	39.6	7.4	4.7	20.0	8.5	4.0	4.6	23.4	11.9	8.0	21.8	8.3	10.1	6.7	10.7	5.4	11.2	9.9	12.9	37.3	12.3	3.5	13.1	14.3	9.8	25.5	11.0	6.4	13.5	8.0	6.9	18.3	15.4	13.8	16.8	9.4	15.7	20.8	8.5	18.1	13.8	7.1	3.4	5.8	6.1	7.1	10.0	7.3	5.7	5.3	4.9	5.8	5.8	6.5	1.3	7.7	5.0	3.4	4.1	4.4	3.9	5.9	6.9	7.5	3.9	4.1	3.8	4.2	5.2	2.5
OR4D1	"OR4D3, TPCR16"	ENSG00000141194	"Olfactory receptor family 4 subfamily D member 1"	Q15615	17	58148449-58159555	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 4.4;bone marrow: 2.2;lymphoid tissue: 1.8;testis: 1.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 2.0;NK-cells: 4.4;T-cells: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.1	0.1	0.1	0.5	0.1	2.2	0.1	0.1	0.6	0.2	0.1			0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.8	0.1		0.1	0.1	0.0	0.1	0.0		0.1	0.0		0.2	0.0	0.3	0.3	0.1	0.0	0.1	1.3	0.1	1.5			0.1		0.9	0.5	0.1	0.2	0.4	2.0	0.1	4.4	3.7	0.9	0.2	0.3	0.1	0.7	0.0	0.3	3.7	0.2	0.0	0.1	0.3	0.4	0.6	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.4	1.1	0.2	0.4	0.3	0.2	0.5	0.3	0.0	0.4	0.4	0.3	0.1	0.5	1.0	0.0	0.4	0.3	0.7	1.9	0.4	0.2	0.1	0.5	0.1	0.5	0.7	0.6	0.3	0.8	0.0	0.3	0.8	0.0	0.4	1.1	0.5	0.3	0.4	0.4	0.5	0.5	1.0	0.5	2.0	0.1	0.8	2.3	0.1	2.4	0.2	2.2	2.1	0.1	0.2	3.4	3.7	0.8	4.4	0.1	0.4	0.5	0.9										
OSCAR		ENSG00000170909	"Osteoclast associated, immunoglobulin-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.3;HHSteC: 9.1;hTERT-HME1: 4.7;NB-4: 5.3;U-937: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	34	"classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2"	"Group enriched"	"Detected in many"	75	"dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	72000000	72000000	"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	4.5	1.0	1.4	3.8	2.8	18.9	1.4	0.4	1.5	1.3	0.9	3.5	0.0	0.4	0.7	1.3	1.2	2.2	2.3	1.1	3.8	1.9	1.0	1.7	40.4	4.7	3.5	0.4	1.2	0.7	0.3	0.5	2.2	4.0	0.8	0.7	1.0	1.3	0.8	0.7	1.9	1.0	2.8	5.6	20.2	1.3	0.6	2.4	1.7	1.0	0.0	1.2	1.7	3.1	0.0	9.4	18.3	20.6	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.4	0.0	13.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.1	0.7	0.0	0.0	0.2	0.6	4.7	0.0	0.0	0.4	0.1	0.1	0.0	5.3	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.8	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.5	0.5	16.5	0.0	0.0	20.6	11.7	0.1	12.8	0.0	0.0	0.1	0.2	9.4	0.0	0.0	0.0	18.3	0.0	11.2	0.4	0.1	7.0	1.4	2.8	0.4	1.4	3.8	1.9	3.5	0.4	4.0	2.4
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696404	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;Karpas-707: 15.5;RPMI-8226: 27.0;U-698: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"memory B-cell: 28.1;naive B-cell: 30.4"	"Lineage enriched"	"Detected in many"	19	"B-cells: 30.4"									"HPA021948, HPA067827"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.6	0.3	2.2	32.0	4.9	4.8	0.5	4.1	5.1	0.3	1.4	0.0	0.4	0.9	0.2	0.2	2.4	0.2	0.8	4.9	1.8	3.0	0.8	0.4	1.0	39.1	1.5	2.1	0.2	0.8	0.1	1.2	0.2	1.7	0.5	1.2	0.0	5.4	0.1	11.4	0.2	12.0	0.4	0.6	29.6	1.8	0.6	0.2	9.3	0.5	1.9	27.6	2.2	0.3	30.4	0.1	0.7	0.0	0.0	1.6	1.6	3.8	3.2	0.0	0.0	0.1	0.6	0.0	4.0	1.8	0.4	1.3	2.4	4.7	24.0	2.4	1.9	2.0	8.6	0.0	0.8	0.4	1.5	1.2	8.5	2.9	0.6	1.6	2.1	1.0	0.9	0.1	5.6	0.0	0.2	15.5	8.7	0.0	10.8	3.6	2.4	9.7	0.4	0.0	27.0	0.1	2.9	2.0	0.0	3.3	1.1	1.8	1.0	1.5	0.0	0.0	2.2	0.1	0.7	5.5	11.7	22.3	0.0	2.3	0.2	0.0	0.0	0.7	1.1	0.0	1.6	28.1	1.0	0.8	0.1	30.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.6	2.2	4.9	4.1	5.1	1.8	3.0	1.5	2.1	1.7	0.2
P2RY10	P2Y10	ENSG00000078589	"P2Y receptor family member 10"	O00398	X	78945332-78961954	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 51.6;lymphoid tissue: 47.0"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 52.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 51.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036757, HPA065766"	Enhanced									"HPA036757: AB_10696786, HPA065766: AB_2685556"	"unprognostic (3.02e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-6)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-4)"	"unprognostic (3.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.99e-2)"	1.9	0.5	0.4	19.1	0.5	5.7	1.0	0.4	0.4	1.4	3.8	0.0	0.1	1.7	1.0	0.5	2.6	0.8	2.2	0.8	0.5	0.5	1.4	1.0	6.2	47.0	0.5	0.0	1.1	0.5	0.0	0.6	0.1	0.1	0.9	2.5	0.8	3.9	0.3	0.5	0.8	11.0	0.4	0.7	31.2	2.3	0.5	0.0	23.3	1.5	1.8	30.0	9.9	1.3	19.3	0.9	51.6	2.3	4.0	9.7	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.6	0.0	0.1	0.0	51.6	0.0	36.8	3.2	0.2	2.9	17.8	7.3	6.4	0.9	19.3	6.8	5.0	6.8	4.0	2.3	0.7	9.7	3.2	0.4	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.1	0.0
P2RY13	"FKSG77, GPR86, GPR94, P2Y13"	ENSG00000181631	"Purinergic receptor P2Y13"	Q9BPV8	3	151326312-151329548	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 88.4;lymphoid tissue: 44.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.1;U-937: 1.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 88.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 88.4;monocytes: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049047	Enhanced									"HPA049047: AB_2680611"	"unprognostic (1.09e-3)"	"unprognostic (7.51e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (7.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.46e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.78e-1)"	4.0	2.6	5.1	13.4	6.1	15.1	2.7	1.7	8.2	1.7	2.8	13.8	0.1	3.0	1.5	2.2	2.1	2.1	2.5	1.7	4.9	4.7	1.8	5.1	5.0	35.1	7.1	3.4	1.3	2.1	1.0	1.7	3.2	8.1	2.1	4.2	2.0	1.9	2.1	1.3	1.6	7.4	3.5	8.2	44.1	1.8	1.2	5.1	2.0	1.5	1.1	5.5	3.8	1.5	0.2	10.1	88.4	26.1	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.2	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.2	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	1.1	0.1	0.1	23.6	20.3	0.0	23.5	0.0	0.2	0.0	0.0	10.1	0.0	0.0	0.0	88.4	0.0	26.1	0.1	0.0	10.2	5.1	6.1	1.7	8.2	4.9	4.7	7.1	3.4	8.1	5.1
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 48.2;bone marrow: 54.8;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HEL: 4.1;NB-4: 1.6;RPMI-8226: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 17.0;classical monocyte: 18.6;eosinophil: 24.6;neutrophil: 48.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 48.2;monocytes: 18.6"	"Not detected"	"Not detected"							"HPA017007, HPA042825"	Enhanced					12000	12000			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.2	0.2	0.3	0.5	0.2	54.8	0.2	0.1	0.8	0.2	0.2	0.5	0.0	0.2	0.2	0.1	0.4	0.9	0.4	9.8	0.6	0.1	0.3	1.2	9.7	5.2	1.8	0.0	0.9	0.3	0.1	0.6	4.1	0.6	0.1	0.2	0.9	0.5	0.1	0.2	0.2	0.2	0.4	0.2	24.2	0.3	1.0	0.3	2.6	0.6	0.2	0.2	0.4	7.5	0.4	3.6	48.2	18.6	1.1	1.2	8.1	0.2	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	4.1	0.1	0.4	0.0	0.4	0.5	0.0	0.5	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	1.6	0.2	0.2	0.2	0.0	4.8	0.0	0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	17.0	18.6	24.6	0.1	1.4	0.0	0.2	0.1	0.2	3.6	0.4	0.7	1.2	48.2	1.1	0.4	1.6	0.1	8.1	0.3	0.2	0.1	0.8	0.6	0.1	1.8	0.0	0.6	0.3
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HMC-1: 15.2;Karpas-707: 12.6;MOLT-4: 23.0;U-266/70: 30.9;U-937: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA069976: AB_2686224"	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	5.0	1.8	2.2	16.0	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0.0	2.8	1.7	2.0	2.0	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3.0	1.0	1.7	1.5	0.6	1.4	2.0	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3.0	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.0	11.9	15.2	0.0	0.0	0.0	0.0	4.7	8.5	12.6	0.0	0.0	23.0	4.6	0.0	0.0	6.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.1	0.0	0.0	30.9	0.0	11.5	0.0	21.8	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3.0	1.0	2.5	3.0
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444415-6451469	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.3"	"Cell line enhanced"	"Detected in many"		"AF22: 49.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	1.9	4.5	1.2	1.6	1.1	3.1	2.2	1.0	0.8	1.3	4.7	0.6	0.4	4.3	1.6	1.7	6.0	0.3	2.5	1.6	0.5	0.5	0.8	0.9	2.1	1.7	0.6	0.4	1.6	0.4	0.0	1.0	0.9	1.2	0.8	6.2	0.4	1.3	0.4	0.4	3.7	4.5	2.7	1.0	9.5	1.8	1.0	0.4	27.3	0.4	3.9	3.6	2.3	2.0	0.4	0.0	0.8	0.4	3.3	1.5	1.2	12.4	16.8	49.8	22.3	0.4	1.4	3.9	14.6	9.0	24.0	16.2	9.9	5.4	0.0	5.8	11.8	9.1	25.1	6.5	12.9	19.2	10.0	0.0	10.0	12.0	0.0	0.5	15.2	0.7	0.4	9.9	3.9	7.5	2.9	7.1	15.0	8.9	2.7	0.1	21.8	11.0	22.3	20.0	8.7	3.9	1.9	11.3	15.9	12.6	13.2	12.3	6.1	1.2	3.5	18.8	15.3	11.0	23.8	2.5	9.0	0.0	7.3	6.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.0	0.4	0.2	0.7	0.8	3.3	0.4	0.0	1.3	1.2	1.2	1.1	1.0	0.7	0.5	0.5	0.6	0.4	1.2	0.4
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (8.33e-4)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	0.9	0.7	0.7	9.4	0.6	19.5	1.3	2.6	0.8	1.3	2.9	0.3	0.5	1.9	0.8	1.5	7.2	0.2	1.5	1.4	0.7	0.7	0.8	1.0	1.3	6.2	0.8	0.2	0.3	1.3	0.0	0.7	4.3	0.4	0.6	0.8	0.3	1.3	0.2	1.6	3.4	3.2	0.6	1.0	4.4	2.7	61.4	0.2	42.8	0.3	9.2	12.7	0.7	2.0	0.8	0.4	0.3	0.5	0.4	4.4	1.0	24.6	17.3	6.8	9.7	0.1	0.3	18.3	19.2	4.6	12.2	11.7	13.4	14.7	15.4	8.6	2.1	31.7	4.7	6.1	2.2	19.8	15.6	7.8	15.6	11.7	0.0	8.7	22.3	0.2	0.5	7.2	1.9	2.5	22.4	27.4	3.9	37.0	24.4	24.2	11.1	9.2	26.6	15.1	29.8	2.3	5.4	12.9	13.6	9.3	24.2	7.2	13.8	17.4	2.3	16.4	20.8	23.9	20.0	20.8	15.4	26.5	6.2	11.7	19.0	0.0	0.4	0.3	0.3	0.3	0.0	0.8	0.5	0.5	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.1	4.4	1.0	0.7	0.6	2.6	0.8	0.7	0.7	0.8	0.2	0.4	0.2
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.1;Daudi: 38.2;hTEC/SVTERT24-B: 15.0;U-266/70: 26.6;U-266/84: 25.7;U-698: 30.3;U-87 MG: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 33.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404"	Enhanced		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB002513: AB_442118, HPA049056: , HPA062096: AB_2684681, HPA064404: AB_2685259"	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavourable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	1.9	2.0	5.6	43.1	7.4	4.8	1.2	12.0	5.7	0.9	3.2	2.5	0.0	2.1	0.9	1.7	1.4	1.5	2.3	4.8	5.7	5.9	1.6	1.4	3.1	31.4	6.8	1.5	0.7	1.6	0.4	2.1	2.5	6.6	2.5	2.1	1.4	2.1	2.3	0.7	1.2	10.8	1.9	6.5	22.7	3.1	6.0	6.2	1.9	1.3	0.6	30.0	4.3	1.0	13.9	8.0	1.7	33.1	0.6	2.7	4.5	0.3	0.5	0.6	0.0	0.0	1.0	0.1	2.8	18.1	1.8	3.5	0.1	0.5	38.2	1.0	1.0	0.3	0.2	2.9	8.2	0.1	0.1	0.9	0.1	0.0	0.2	0.3	0.7	0.8	0.5	15.0	1.0	1.1	0.4	8.8	0.4	0.2	0.1	2.0	0.1	0.2	0.4	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.2	0.0	4.8	1.4	7.8	0.8	0.0	0.3	26.6	25.7	30.3	14.6	0.9	1.0	1.0	10.7	0.1	1.2	19.3	1.1	11.0	1.8	1.6	8.0	13.9	0.9	1.3	1.7	0.6	33.1	1.3	2.7	4.5	5.6	7.4	12.0	5.7	5.7	5.9	6.8	1.5	6.6	6.2
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4"	"Cell line enhanced"	"Detected in some"		"HEL: 30.9;MOLT-4: 23.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdTCR: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 6.5;T-cells: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		200000	200000	"Centriolar satellite"	"Centriolar satellite"	"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (3.51e-2)"	0.9	0.7	3.6	9.4	4.3	3.1	0.8	0.9	5.2	1.3	1.1	7.4	0.1	1.2	1.8	5.4	1.6	2.6	1.3	0.5	4.4	4.0	4.6	0.9	3.3	6.6	4.0	2.2	1.1	7.7	0.3	1.0	0.4	2.7	1.4	1.3	5.4	2.8	1.0	63.4	0.6	2.5	0.8	3.6	3.4	1.4	0.9	4.5	32.1	9.1	7.5	6.8	1.9	0.8	0.0	0.1	1.1	0.2	6.5	19.7	5.2	0.0	2.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.2	1.8	0.2	0.0	0.0	0.0	1.8	3.3	0.0	0.0	2.1	30.9	0.0	0.2	0.4	1.5	0.3	0.1	2.0	0.1	0.1	0.3	6.7	0.0	0.0	0.0	23.2	4.3	3.2	0.0	4.5	0.7	0.0	6.5	1.6	0.2	1.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.1	0.1	0.1	12.7	0.2	9.8	0.0	13.5	13.2	0.1	0.0	10.7	10.0	0.8	6.5	0.0	0.0	19.7	5.2	3.6	4.3	0.9	5.2	4.4	4.0	4.0	2.2	2.7	4.5
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase, receptor type C"		1	198638457-198757476	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"blood: 116.9;lymphoid tissue: 172.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 51.0;HEL: 28.8;HL-60: 26.0;MOLT-4: 38.5;THP-1: 21.4;U-266/70: 23.9;U-266/84: 21.6;U-698: 30.6;U-937: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: , HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	9.8	2.9	3.4	48.0	6.2	36.1	4.3	1.3	3.5	3.1	5.6	2.8	0.5	4.9	2.9	3.9	4.8	5.6	8.8	4.9	3.9	4.5	4.4	5.2	27.5	93.2	7.9	1.3	2.9	2.1	0.3	2.5	4.5	5.3	4.2	5.8	3.3	10.7	1.0	1.7	2.5	22.2	4.5	13.2	89.3	6.5	2.3	5.3	172.5	4.6	3.9	53.2	13.1	3.7	28.5	42.8	94.7	103.8	53.7	76.1	116.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	51.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	28.8	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	38.5	15.7	0.1	0.1	1.1	0.1	0.1	0.0	0.0	0.3	0.4	0.0	0.1	0.1	0.0	21.4	0.3	0.0	0.2	0.1	0.1	23.9	21.6	30.6	0.0	23.3	0.1	20.8	52.0	56.3	76.1	99.7	64.5	28.5	52.9	72.7	42.8	26.8	60.2	60.3	94.7	53.7	103.8	6.4	54.6	116.9	3.4	6.2	1.3	3.5	3.9	4.5	7.9	1.3	5.3	5.3
PTPRH	SAP-1	ENSG00000080031	"Protein tyrosine phosphatase, receptor type H"	Q9HD43	19	55181248-55209506	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.0;HHSteC: 10.4;K-562: 12.1;PC-3: 8.2;SK-MEL-30: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042300			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA042300: "	"unprognostic (1.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.57e-3)"	"unprognostic (5.01e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-11)"	"unprognostic (4.08e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.57e-1)"	0.5	8.9	0.5	5.2	0.7	0.0	0.5	0.5	1.0	0.7	39.9	0.6	0.5	30.1	0.5	0.5	0.6	0.0	29.6	0.5	1.3	1.6	0.6	7.8	0.6	0.5	3.0	0.5	0.6	2.8	0.0	3.0	0.6	0.5	1.0	9.6	0.6	0.5	0.5	0.5	0.0	84.3	0.7	6.9	21.2	10.2	0.5	0.5	0.5	0.5	1.0	0.8	1.1	2.4	0.0	0.7	0.0	1.5	0.0	0.0	0.0	5.6	3.5	0.0	1.4	1.1	3.1	0.1	0.1	3.0	0.6	1.2	1.5	8.0	0.0	0.3	0.5	0.0	0.0	0.0	0.7	0.0	0.1	0.4	0.1	4.0	10.4	0.0	4.1	0.8	2.5	2.0	3.1	0.1	12.1	0.5	0.0	0.0	0.0	0.2	0.0	8.2	0.0	0.0	0.4	0.0	0.0	0.3	0.8	0.0	3.6	18.2	0.0	1.6	0.0	0.8	1.2	0.4	0.0	0.0	3.0	0.0	0.9	0.1	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.7	0.5	0.5	1.3	1.6	3.0	0.5	0.5	0.5
PVRIG	"C7orf15, CD112R, MGC2463"	ENSG00000213413	"PVR related immunoglobulin domain containing"	Q6DKI7	7	100218241-100221490	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 51.7;lymphoid tissue: 21.0"	"Group enriched"	"Detected in some"	28	"Daudi: 37.2;MOLT-4: 40.5;U-698: 12.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	32	"gdTCR: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8"	"Group enriched"	"Detected in many"	37	"B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7"					"Low region specificity"	"Detected in all"			HPA047497	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum"				"Nucleoli, Endoplasmic reticulum"	"Nucleoli, Endoplasmic reticulum"	"HPA047497: AB_2680069"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.13e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.71e-3)"	0.5	0.1	0.4	5.6	0.7	1.2	0.4	0.4	1.1	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.0	0.5	0.9	0.9	15.9	0.4	0.4	0.6	0.5	0.0	0.4	0.4	0.8	0.4	0.0	0.4	0.7	0.4	2.0	0.0	8.9	0.4	0.4	21.0	1.4	0.6	0.4	18.0	0.5	0.4	4.2	1.0	0.4	24.8	0.2	1.0	0.1	42.9	51.7	17.5	0.1	0.8	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	40.5	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.1	0.0	43.5	0.1	51.7	24.8	28.9	42.9	0.1	19.3	32.6	32.2	1.0	42.9	0.1	0.2	22.8	17.5	0.4	0.7	0.4	0.4	0.4	0.0	0.4	0.4	0.8	0.4
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.1;lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.8;MOLT-4: 27.2;REH: 7.6;U-698: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA039389: AB_2732481"	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"	1.7	1.0	5.7	9.9	17.0	7.8	1.9	33.1	18.5	1.4	1.6	0.8	0.0	2.5	1.6	1.6	6.7	4.7	2.7	1.6	6.1	3.2	5.9	1.2	4.2	20.0	3.0	6.2	0.8	2.0	0.3	1.2	4.9	22.3	1.0	2.3	1.4	2.5	1.0	0.8	7.3	3.7	0.7	1.6	8.6	4.8	2.2	1.1	55.8	1.2	1.6	16.3	4.3	2.4	1.2	0.0	0.8	0.0	2.4	10.4	1.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	2.2	0.7	1.1	0.9	2.4	0.0	6.1	0.5	0.1	0.1	1.3	0.0	1.0	28.8	1.2	0.4	0.2	0.0	0.3	0.2	0.4	0.0	0.1	0.6	0.0	0.0	0.2	1.9	0.0	0.9	27.2	0.0	0.4	0.0	7.6	0.1	0.0	1.1	0.0	2.6	0.9	1.4	0.1	0.1	0.6	0.0	0.1	0.2	0.9	3.1	0.4	4.8	2.3	7.3	0.1	0.0	0.3	0.0	0.0	0.8	5.7	0.0	4.2	1.2	6.4	5.7	0.0	0.7	6.0	6.0	0.3	2.4	0.0	0.0	10.4	1.4	5.7	17.0	33.1	11.7	6.1	3.2	3.0	6.2	22.3	1.1
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA046368: AB_2679640"															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2										
RNF138	"NARF, STRIN"	ENSG00000134758	"Ring finger protein 138"	Q8WVD3	18	32091855-32131561	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041101			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA041101: AB_10805837"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.90e-1)"	8.2	5.0	6.5	11.0	7.4	40.4	7.7	9.9	7.1	6.5	11.0	9.0	5.8	8.0	7.5	6.3	7.4	9.7	7.1	5.0	6.8	6.4	5.9	10.1	7.6	17.9	10.6	6.3	9.0	7.8	5.6	8.7	7.2	6.7	6.5	10.0	4.5	6.9	4.9	5.1	5.6	11.2	5.6	9.1	14.3	6.6	73.4	8.1	28.3	7.0	5.7	9.9	6.1	6.8	14.4	24.3	25.7	24.9	16.4	43.8	24.2	8.9	5.3	22.0	10.9	2.8	6.0	12.5	9.2	5.2	11.5	13.4	6.2	6.3	21.6	11.5	6.0	9.4	11.5	10.4	15.7	12.0	19.2	17.0	6.9	7.6	11.3	46.8	15.1	5.8	10.4	12.7	18.1	11.7	23.4	8.9	7.4	8.5	31.6	21.0	24.6	7.4	32.7	13.8	12.4	10.5	6.7	25.0	12.5	12.3	7.1	9.5	4.6	19.8	9.0	13.9	10.2	3.4	10.2	14.8	19.5	37.5	7.6	26.2	13.6	8.0	24.9	24.0	10.5	18.6	13.4	14.0	22.9	14.8	24.3	14.4	43.8	27.9	25.7	16.4	15.3	10.5	16.7	24.2	6.5	7.4	9.9	7.1	6.8	6.4	10.6	6.3	6.7	8.1
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"									HPA056994	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.1	17.7	25.0	17.1	2.2	4.1	24.8	47.7	23.6	34.1	37.1	29.5	14.0	26.8	6.6	14.9	14.3	40.5	24.6	41.8	60.0	15.6	51.6	17.0	26.0	0.1	38.2	24.8	1.4	0.5	41.7	3.5	27.5	21.6	79.5	42.4	22.0	42.2	20.5	20.2	20.7	31.8	54.6	18.4	16.7	22.2	24.8	20.4	39.2	27.9	4.8	15.0	6.9	9.6	26.1	38.0	19.5	66.8	51.6	40.5	54.7	18.5	32.4	37.5	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0
S1PR4	EDG6	ENSG00000125910	"Sphingosine-1-phosphate receptor 4"	O95977	19	3172346-3180332	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.8;HL-60: 14.4;NB-4: 14.2;REH: 40.1;U-937: 13.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA060601, HPA067232"			Supported	Mitochondria				Mitochondria	Mitochondria	"HPA060601: AB_2797261, HPA067232: AB_2797271"	"prognostic favourable (3.13e-4)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.58e-2)"	"prognostic favourable (2.22e-4)"	"unprognostic (2.98e-2)"	"prognostic favourable (1.45e-6)"	"unprognostic (1.27e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (6.64e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.15e-3)"	2.0	0.5	0.7	8.3	0.3	14.9	1.3	0.6	0.7	0.5	0.9	0.4	0.2	0.8	0.7	0.7	1.2	1.4	0.7	2.1	0.3	0.2	1.2	1.4	6.4	35.9	0.3	0.4	0.7	0.3	0.0	0.2	1.7	0.6	0.7	0.0	1.0	1.3	0.2	1.1	0.4	7.1	0.2	0.5	34.2	3.9	0.3	0.3	10.2	1.5	0.2	10.7	1.9	0.6	14.1	7.3	44.2	15.3	5.4	23.1	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.0	0.1	0.0	0.0	0.0	10.8	0.0	4.6	0.1	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	40.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	13.7	0.0	16.4	10.4	27.4	11.8	11.6	10.5	11.3	14.7	11.4	7.3	14.1	12.4	11.9	44.2	5.4	15.3	6.6	23.1	7.2	0.7	0.3	0.6	0.7	0.3	0.2	0.3	0.4	0.6	0.3
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186292	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 40.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA035501: AB_2732469, HPA069302: , HPA069857: "	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.6	0.6	0.4	9.1	0.4	8.9	1.0	0.4	1.5	0.9	3.4	0.3	0.6	2.7	0.8	0.5	4.0	0.3	1.7	0.4	0.3	0.4	0.8	1.0	0.9	6.9	0.4	0.1	0.5	0.5	0.0	0.4	3.7	0.2	0.6	3.5	0.1	1.0	0.1	0.3	1.1	3.4	0.8	0.4	4.9	1.5	8.6	0.2	40.1	0.5	2.4	7.4	1.2	1.5	9.0	4.5	8.3	0.2	0.3	2.7	0.6	9.4	10.8	14.7	9.0	0.7	1.3	10.0	10.2	5.2	14.9	16.3	7.6	11.7	14.5	5.1	4.2	5.5	13.9	5.6	18.8	18.4	9.2	16.4	7.4	6.1	0.1	14.9	14.2	0.1	0.4	16.3	6.9	8.8	14.0	25.9	12.3	9.3	23.4	8.4	15.7	8.2	15.0	18.9	8.4	3.7	6.9	7.3	7.7	11.2	13.9	6.7	9.0	10.5	2.4	11.3	13.5	10.0	20.3	11.1	25.9	16.8	6.2	15.1	16.9	8.3	0.1	1.5	0.3	0.2	0.1	8.6	0.7	0.8	0.4	9.0	0.2	0.4	1.6	0.3	0.2	4.5	2.7	0.6	0.4	0.4	0.4	1.5	0.3	0.4	0.4	0.1	0.2	0.2
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200583782	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.6;lymphoid tissue: 25.7;testis: 27.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	5.3	1.7	1.5	8.6	2.3	5.3	3.5	4.0	3.1	1.6	2.7	0.7	0.3	2.1	1.6	1.0	3.7	1.6	1.3	1.4	1.9	1.5	1.8	1.0	1.9	6.5	2.7	3.7	2.2	1.2	1.1	0.9	2.2	3.2	1.4	2.9	0.1	1.7	1.5	1.0	2.0	2.8	1.7	3.5	3.9	1.7	27.9	2.3	25.7	1.5	4.1	7.0	2.0	1.8	3.8	2.1	12.6	1.9	2.4	4.2	1.4	15.5	7.3	17.6	7.9	2.4	3.9	10.9	17.9	7.5	15.4	15.5	11.2	10.5	10.1	8.3	8.5	11.6	15.5	9.3	26.4	20.3	7.7	19.1	10.5	8.0	0.7	19.9	15.5	1.5	1.1	15.5	8.0	13.6	14.7	15.0	29.1	6.9	16.0	8.2	12.5	18.2	12.7	23.3	9.3	6.4	6.1	10.3	7.1	13.1	6.4	7.8	6.8	11.7	8.2	16.2	16.1	14.8	15.6	6.8	14.2	22.1	10.2	13.4	23.1	12.6	1.8	5.1	2.8	1.7	1.9	3.0	3.2	2.8	1.0	3.8	2.4	3.0	1.3	2.4	1.9	2.1	4.2	1.4	1.5	2.3	4.0	3.1	1.9	1.5	2.7	3.7	3.2	2.3
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 163.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 23.7;Karpas-707: 53.2;MOLT-4: 63.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	53	"gdTCR: 27.3;MAIT T-cell: 36.5;memory CD4 T-cell: 20.6;memory CD8 T-cell: 40.1;naive CD4 T-cell: 21.0;naive CD8 T-cell: 25.2;NK-cell: 31.7;T-reg: 25.3"	"Group enriched"	"Detected in many"	67	"NK-cells: 31.7;T-cells: 40.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"prognostic favourable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"	2.5	0.5	0.4	5.8	0.6	2.5	1.0	0.2	0.3	0.8	1.0	0.4	0.5	0.6	0.7	0.8	0.9	0.6	2.6	0.6	0.5	0.4	1.1	1.7	4.1	21.3	0.6	0.2	0.6	0.3	0.0	0.4	0.4	0.3	1.0	0.7	0.7	1.9	0.3	0.3	0.4	4.0	0.3	1.0	12.2	1.3	0.4	0.3	163.1	1.3	0.7	10.2	4.2	1.1	0.2	0.1	0.5	0.2	31.7	40.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.2	0.0	0.0	63.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	8.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	27.3	0.1	36.5	0.2	20.6	40.1	0.1	0.0	21.0	25.2	0.5	31.7	0.2	0.1	25.3	17.2	0.4	0.6	0.2	0.3	0.5	0.4	0.6	0.2	0.3	0.3
SIGLEC12	"S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG"	ENSG00000254521	"Sialic acid binding Ig like lectin 12 (gene/pseudogene)"	Q96PQ1	19	51491357-51501789	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"liver: 13.1;lymphoid tissue: 29.6"	"Group enriched"	"Detected in some"	10	"HMC-1: 52.8;U-937: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"																						"unprognostic (1.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.58e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.79e-2)"	"unprognostic (9.21e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-1)"	2.8	1.0	0.2	6.2	1.2	1.3	0.3	0.1	0.3	0.3	1.5	0.2	0.6	0.4	0.4	0.5	0.6	0.4	1.6	0.7	0.2	0.2	0.4	13.1	5.3	3.9	0.2	0.0	0.3	0.3	0.0	0.2	0.0	0.3	0.5	2.6	0.6	1.2	0.0	0.2	0.2	2.5	3.4	0.3	29.6	0.5	1.4	0.0	2.4	0.2	1.0	1.7	0.6	0.3	0.7	0.8	3.0	2.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	2.0	3.0	0.0	0.9	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	1.2	0.1	0.3	0.2	0.2	0.2	0.0	0.3	0.0
SIGLEC7	"CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2"	ENSG00000168995	"Sialic acid binding Ig like lectin 7"	Q9Y286	19	51142299-51153526	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 51.5;lymphoid tissue: 29.4"	"Group enriched"	"Detected in some"	9	"Karpas-707: 30.8;RPMI-8226: 17.9;U-937: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.5"	"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"	1100000	1100000				"unprognostic (3.14e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.27e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.26e-2)"	6.9	3.7	1.6	10.0	5.8	3.7	3.0	0.3	2.2	0.9	1.6	1.0	0.6	1.4	0.9	2.1	1.1	1.8	2.4	1.9	0.8	1.0	2.8	9.8	4.7	18.4	3.3	0.0	1.3	0.9	0.2	0.9	5.9	2.9	1.0	2.3	0.7	2.3	0.2	0.4	0.5	2.3	3.5	3.3	29.4	1.1	1.8	2.5	0.7	1.0	0.0	2.1	3.2	1.7	0.6	14.9	51.5	32.0	20.0	4.4	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	18.9	0.0	0.5	32.0	51.5	2.5	23.0	4.4	0.6	0.0	1.1	14.9	0.0	0.0	1.0	26.8	20.0	9.1	0.6	0.0	15.8	1.6	5.8	0.3	2.2	0.8	1.0	3.3	0.0	2.9	2.5
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176602	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 41.6;testis: 12.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Enhanced	"Microtubules,Mitotic spindle,Centrosome,Cytosol"				Microtubules	Microtubules	"HPA039272: AB_10805359, HPA039356: , HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.8	0.6	0.6	6.4	0.6	6.2	0.9	0.4	1.6	0.8	2.8	0.3	0.0	1.1	1.0	0.8	5.1	0.2	0.3	0.4	0.8	0.5	0.8	0.5	1.0	6.1	0.6	0.3	0.5	0.4	0.0	0.6	2.6	0.8	0.4	4.0	0.2	0.9	0.0	0.5	2.4	3.1	1.1	0.5	2.6	1.4	12.6	0.3	41.6	0.3	5.7	6.4	0.5	1.4	0.4	0.2	0.3	0.3	1.9	2.3	0.6	11.2	5.9	10.7	9.1	0.0	2.3	8.4	15.2	6.4	19.2	13.1	9.8	12.1	15.4	4.5	8.4	10.6	14.3	6.2	21.0	13.1	7.3	20.5	3.9	5.5	0.0	15.8	7.9	0.4	0.4	15.4	5.1	9.4	10.6	6.6	12.7	8.7	24.0	14.2	12.4	11.1	15.8	23.0	7.1	4.3	4.4	13.7	5.0	5.0	7.9	3.2	7.1	12.2	3.7	7.6	11.0	7.1	18.2	4.0	8.4	15.4	1.8	12.4	21.8	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.8	1.4	0.2	0.0	0.8	0.3	0.0	1.9	0.3	0.0	2.3	0.6	0.6	0.6	0.4	1.6	0.8	0.5	0.6	0.3	0.8	0.3
SLA	"hSLAP, SLA1, SLAP, SLAP-1"	ENSG00000155926	"Src like adaptor"	Q13239	8	133036724-133103054	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 61.6;lymphoid tissue: 152.5"	"Group enriched"	"Detected in some"	4	"HMC-1: 17.2;Karpas-707: 46.3;MOLT-4: 12.2;U-266/84: 26.0;U-937: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 14.8;basal ganglia: 9.9;cerebellum: 44.5;cerebral cortex: 11.2;hippocampal formation: 11.6"	"Low region specificity"	"Detected in all"			HPA012296	Approved									"HPA012296: AB_1856946"	"unprognostic (1.19e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.73e-3)"	"unprognostic (6.07e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.65e-1)"	6.8	3.6	2.5	21.3	2.7	24.0	2.6	1.6	3.3	2.7	2.2	1.5	1.7	1.6	2.1	1.6	2.4	3.2	5.3	2.6	2.8	1.7	3.2	3.5	11.2	18.2	2.5	2.7	1.7	1.4	0.0	1.4	3.4	2.0	2.1	1.7	1.5	4.0	1.4	1.6	1.3	8.4	2.8	4.1	33.3	2.5	1.6	1.4	152.5	9.2	2.1	18.3	4.3	1.6	11.2	18.4	61.6	31.7	29.2	27.5	29.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.0	2.1	17.2	0.2	0.0	0.2	0.0	0.0	0.0	46.3	0.0	0.0	12.2	2.9	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	2.4	26.0	0.0	0.2	18.2	0.0	0.1	24.3	45.0	21.2	28.1	26.7	9.5	19.5	21.1	18.4	11.2	18.6	18.9	61.6	29.2	31.7	1.4	27.5	29.6	2.5	2.7	1.6	3.3	2.8	1.7	2.5	2.7	2.0	1.4
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608100-160647295	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 97.8"	"Cell line enriched"	"Detected in single"	111	"HDLM-2: 57.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 24.1"	"Group enriched"	"Detected in many"	10	"B-cells: 8.8;T-cells: 24.1"									"CAB002438, HPA069319"	Enhanced				"Secreted to blood"	590000	590000			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (2.99e-3)"	"unprognostic (3.33e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.38e-4)"	"unprognostic (5.87e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.74e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-7)"	"unprognostic (2.46e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-2)"	2.5	0.3	0.3	14.2	0.3	4.4	1.4	0.2	0.3	1.2	2.3	0.4	0.5	2.2	0.5	1.2	2.2	0.8	2.3	1.3	0.2	0.2	2.0	1.0	4.0	14.8	0.2	0.1	0.6	0.9	0.0	0.5	2.3	0.3	1.1	2.1	0.6	4.1	0.6	0.8	1.1	7.6	1.0	0.5	10.6	2.4	0.4	0.2	97.8	1.5	1.9	26.3	3.5	1.1	8.8	1.6	0.2	0.1	0.0	24.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.1	0.0	4.2	0.0	24.1	6.2	17.2	12.1	0.1	8.8	6.6	1.6	0.2	0.0	0.0	1.6	21.5	3.5	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.1	0.3	0.2
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925582-70931125	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 45.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HAP1: 24.5;MOLT-4: 9.6;NTERA-2: 50.3;REH: 10.5"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.7"	"Cell type enriched"	"Detected in single"	16	"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003629	Approved									"HPA003629: AB_2190964"	"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.1	0.0	1.0	0.1	1.0	1.3	1.4	0.1	2.1	2.0	0.1	1.1	0.8	0.1	9.1	6.2	0.7	2.7	0.1	0.0	1.2	6.7	0.2	0.0	0.1	0.5	0.5	0.5	1.7	0.0	0.0	0.6	0.0	1.2	10.4	0.0	0.5	0.2	9.4	0.0	0.0	0.3	4.6	0.2	0.1	5.6	2.4	0.4	45.5	0.0	0.2	0.5	4.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	50.3	0.0	10.5	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.0	0.1	2.1	1.2	6.7	0.5	0.5	1.2	0.4
SNTG1	"G1SYN, SYN4"	ENSG00000147481	"Syntrophin gamma 1"	Q9NSN8	8	49909789-50796691	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 22.7;lymphoid tissue: 7.8;pituitary gland: 10.4"	"Cell line enriched"	"Detected in some"	8	"RH-30: 10.6"	"Cancer enhanced"	"Detected in single"		"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072282	Enhanced									"HPA072282: AB_2686506"					"unprognostic (4.60e-2)"		"unprognostic (1.72e-2)"		"unprognostic (2.47e-1)"		"unprognostic (1.05e-2)"			"unprognostic (6.94e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.16e-3)"	0.7	1.9	7.4	0.6	13.3	1.6	0.7	2.4	22.7	0.7	0.8	1.1	0.0	0.7	0.7	2.0	0.6	0.9	0.8	0.5	11.9	4.7	1.6	1.9	0.8	0.8	3.3	9.1	0.7	1.4	0.6	10.4	0.7	3.3	0.8	1.0	0.0	0.8	1.0	0.6	1.1	0.7	0.8	2.1	7.8	0.8	3.1	3.8	0.0	0.8	0.0	0.6	2.3	0.3	1.3	0.8	2.3	1.2	0.5	1.0	0.5	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.3	0.0	0.2	0.2	1.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.5	0.4	0.1	0.3	1.4	0.0	0.2	0.8	0.1	0.0	0.1	10.6	0.0	0.4	0.3	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.2	0.4	0.1	0.2	2.3	0.5	0.5	0.7	0.5	0.7	1.3	0.8	0.8	0.3	1.3	1.0	0.8	1.1	0.5	1.2	0.8	1.0	0.5	7.4	13.3	2.4	22.7	11.9	4.7	3.3	9.1	3.3	3.8
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Group enriched"	"Detected in some"	7	"A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	40.8	1.0	0.6	0.3	0.0	0.1	3.2	0.4	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	45.9	0.0	18.3	0.1	1.1	1.2	0.1	0.5	0.1	0.0	0.0	0.9	0.0	18.2	0.2	4.1	0.0	0.9	0.3	0.0	0.3	0.2	0.5	1.2	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.4	0.5	1.5	0.5	1.0	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0
SPC25	"AD024, MGC22228, SPBC25"	ENSG00000152253	"SPC25, NDC80 kinetochore complex component"	Q9HBM1	2	168834132-168913371	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 38.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.1;T-cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047144, HPA050544"	Enhanced		Enhanced	Cytosol				Cytosol	Cytosol	"HPA047144: AB_2679952, HPA050544: "	"unprognostic (3.52e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (4.74e-6)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (1.84e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.11e-16)"	"unprognostic (9.91e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.57e-1)"	0.9	1.6	3.6	7.2	2.2	6.7	2.1	0.4	3.5	1.3	4.0	0.9	0.0	6.8	1.3	1.5	8.5	0.6	1.0	1.1	2.7	1.6	1.5	1.6	1.9	7.5	1.2	2.5	1.2	2.6	0.7	0.2	3.3	1.1	0.8	3.1	1.3	2.1	0.0	0.7	2.1	3.8	1.8	0.7	4.1	3.0	5.9	1.1	38.0	0.6	5.6	8.0	1.5	2.7	1.1	0.0	0.4	0.1	0.0	2.5	0.4	1.0	8.4	19.5	10.9	0.9	0.9	7.0	11.2	4.3	11.3	9.1	4.3	7.8	6.9	4.9	1.8	10.4	7.5	0.0	10.1	4.7	11.5	13.9	5.3	1.9	0.0	10.3	4.2	0.0	0.5	7.2	0.1	5.7	1.1	7.9	3.2	5.1	7.5	12.5	0.6	11.2	13.5	19.4	3.1	4.5	6.6	14.6	0.9	10.0	6.8	1.8	0.5	7.3	1.6	1.7	20.6	6.6	9.4	15.2	26.5	6.9	2.2	1.6	6.6	0.0	0.1	0.2	0.0	0.1	0.0	0.9	0.4	0.0	0.0	1.1	0.2	0.5	0.4	0.0	0.0	0.0	2.5	0.4	3.6	2.2	0.4	3.5	2.7	1.6	1.2	2.5	1.1	1.1
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Group enriched"	"Detected in some"	5	"Daudi: 62.1;U-698: 27.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	7.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	8.9	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 109.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.8;MOLT-4: 29.3;RPMI-8226: 12.5;U-266/70: 5.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.1"	"Group enriched"	"Detected in many"	23	"gdTCR: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2"	"Lineage enriched"	"Detected in single"	88	"T-cells: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031422, HPA031425"	Enhanced									"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	1.4	0.6	1.9	9.6	0.8	2.4	0.8	0.2	7.1	1.0	2.8	0.1	0.5	2.2	0.9	0.9	1.2	0.8	2.4	0.5	1.8	0.6	0.9	0.9	3.6	13.2	1.1	0.1	0.9	0.6	0.0	0.4	0.2	0.5	0.9	1.3	0.8	5.2	0.9	0.3	0.5	5.0	0.8	1.5	5.8	2.0	0.4	0.4	109.6	1.3	1.6	10.4	2.3	1.2	0.0	0.0	0.2	0.0	0.0	25.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	14.5	0.0	14.5	20.5	0.0	0.0	13.1	25.2	0.2	0.0	0.0	0.0	0.7	7.4	1.9	0.8	0.2	7.1	1.8	0.6	1.1	0.1	0.5	0.4
TMEM156	FLJ23235	ENSG00000121895	"Transmembrane protein 156"	Q8N614	4	38966744-39032922	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 30.6;brain: 12.7;intestine: 8.3;lymphoid tissue: 23.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 16.1;HBEC3-KT: 34.4;hTERT-HME1: 27.1;NB-4: 14.0;PC-3: 15.3;U-698: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 30.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"prognostic favourable (4.09e-4)"	"unprognostic (7.36e-3)"	"unprognostic (3.31e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.17e-2)"	"unprognostic (8.73e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.92e-4)"	"unprognostic (9.06e-2)"	0.9	1.7	5.8	11.8	6.6	1.7	1.1	0.7	4.1	0.6	1.7	6.1	0.0	1.7	0.6	0.3	2.0	1.0	1.9	0.6	4.1	2.6	1.4	2.6	1.6	20.2	6.2	0.8	0.5	0.8	0.3	0.7	0.2	5.3	0.9	2.0	0.0	2.0	0.6	0.6	0.5	8.3	0.5	12.7	17.3	2.3	0.6	4.2	7.4	1.0	0.3	23.7	4.5	0.8	30.6	5.0	18.8	0.3	4.8	9.0	3.6	0.9	9.7	0.1	0.1	0.0	0.3	0.1	0.0	2.6	0.0	0.0	0.1	0.1	16.1	0.1	0.0	0.1	0.1	34.4	0.1	0.2	0.0	0.9	3.3	0.2	5.7	6.6	0.1	0.0	1.8	0.7	27.1	3.0	2.3	0.1	1.2	0.1	1.2	14.0	0.0	15.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	7.3	1.2	0.2	0.0	0.3	0.0	0.0	18.4	2.1	6.2	0.0	5.4	0.3	18.8	5.2	0.1	6.1	30.6	9.0	5.2	3.3	21.9	3.5	4.6	0.8	4.8	0.1	5.0	6.0	3.6	5.8	6.6	0.7	4.1	4.1	2.6	6.2	0.8	5.3	4.2
TMEM26	"Em:AC068892.1, MGC35010"	ENSG00000196932	"Transmembrane protein 26"	Q6ZUK4	10	61406643-61453450	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 30.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.1;fHDF/TERT166: 2.2;HSkMC: 3.9;HUVEC TERT2: 2.9;MOLT-4: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 2.7"	"Low region specificity"	"Detected in many"														"unprognostic (1.21e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.34e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.29e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.95e-1)"	1.3	1.2	3.7	1.0	2.1	0.0	7.4	0.3	2.0	3.2	1.1	0.9	1.1	1.8	5.6	0.9	0.6	0.8	1.2	0.6	0.9	1.0	3.6	4.5	1.8	5.8	1.5	1.3	2.1	0.4	5.6	0.7	1.8	1.1	3.5	1.1	3.6	0.5	3.2	0.7	0.3	1.9	2.5	0.9	30.2	0.5	4.4	1.2	6.2	0.7	0.2	0.1	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.2	0.0	9.1	1.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.9	0.0	1.0	0.0	2.9	0.0	0.0	0.3	0.0	4.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	2.1	0.3	2.0	0.9	1.0	1.5	1.3	1.1	1.2
TMPRSS11D		ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884032	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1"	"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052834	Uncertain				"Intracellular and membrane"					"HPA052834: AB_2681969"	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	67.6	20.3	0.4	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 76.5;lymphoid tissue: 39.6"	"Cell line enriched"	"Detected in some"	7	"U-937: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009188	Enhanced				"Secreted to blood"	530000	530000			"CAB009188: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	7.2	8.2	3.0	18.5	8.2	13.2	3.4	1.4	5.2	1.6	4.2	2.1	1.0	7.8	1.2	6.5	3.5	2.9	9.4	9.4	5.7	2.9	3.1	5.0	13.2	39.6	7.2	2.6	2.9	2.7	0.5	2.1	6.4	5.7	3.7	6.4	2.6	5.4	1.8	1.6	1.6	6.8	3.5	11.6	23.5	3.4	1.0	4.9	7.2	5.1	1.7	12.7	8.5	3.8	1.0	31.0	76.5	53.7	0.6	5.3	20.8	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.2	0.7	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.3	0.1	0.0	0.1	3.5	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.1	0.0	7.9	0.0	0.1	0.0	0.0	0.1	3.7	0.1	0.0	3.8	59.5	0.6	1.2	53.7	14.4	0.8	39.8	5.3	0.6	3.5	0.7	31.0	1.0	1.7	0.5	76.5	0.6	31.7	11.5	2.8	20.8	3.0	8.2	1.4	5.2	5.7	2.9	7.2	2.6	5.7	4.9
TOX	"KIAA0808, TOX1"	ENSG00000198846	"Thymocyte selection associated high mobility group box"	O94900	8	58805418-59119208	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 88.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 9.8;MOLT-4: 53.9;SH-SY5Y: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018322, HPA073241"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA018322: AB_1858199, HPA073241: AB_2686584"	"unprognostic (7.60e-4)"	"unprognostic (6.16e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.73e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (1.90e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	1.3	1.2	10.5	15.7	6.3	2.8	1.5	1.9	15.6	2.1	13.4	1.5	1.2	10.0	1.5	1.1	3.7	1.1	5.0	0.9	6.3	9.8	3.2	1.7	4.9	17.7	4.8	12.0	6.6	2.4	2.9	3.7	1.5	2.2	2.4	9.3	2.6	1.8	1.3	0.5	1.0	10.7	2.8	2.3	5.7	10.0	6.5	2.5	88.8	1.5	0.8	19.4	2.6	2.3	3.4	0.8	10.2	0.1	10.4	21.0	3.1	0.3	0.0	6.0	0.0	0.6	1.4	0.0	1.2	2.8	0.7	0.1	0.0	0.0	0.0	0.0	5.4	0.4	1.4	0.0	0.1	0.2	0.5	0.0	1.1	0.0	5.0	1.0	0.2	0.7	0.2	0.9	1.1	9.8	0.0	0.0	0.4	0.0	53.9	0.0	1.0	0.1	1.1	4.1	0.0	0.1	0.1	5.5	16.9	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.7	4.9	1.6	0.0	0.0	3.7	0.2	0.0	1.0	10.2	0.1	1.8	7.5	0.0	3.4	3.4	5.5	11.3	0.8	0.6	2.1	6.3	0.2	10.4	0.0	0.0	21.0	3.1	10.5	6.3	1.9	15.6	6.3	9.8	4.8	12.0	2.2	2.5
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2, microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 92.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"				Nucleoplasm	Nucleoplasm	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (8.07e-7)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.8	1.7	1.0	13.4	2.0	21.7	1.2	2.2	1.7	2.2	5.7	0.5	0.3	4.6	1.2	2.3	13.3	0.5	1.9	1.5	0.8	0.7	1.2	2.7	2.6	12.9	0.7	1.1	0.8	0.5	0.0	0.7	6.6	0.9	0.7	7.4	0.5	2.3	0.5	2.2	5.9	4.7	3.2	0.9	5.9	3.2	22.0	0.6	92.7	0.7	11.0	16.2	2.2	3.8	1.0	1.4	4.0	0.1	4.8	10.4	1.3	69.6	23.4	28.3	22.1	2.2	4.2	27.3	29.3	16.6	42.6	32.2	49.6	30.1	32.8	17.3	16.3	36.8	32.3	26.6	48.6	14.1	12.5	64.3	22.4	33.8	0.7	24.6	16.6	1.4	1.4	26.7	19.5	22.9	47.5	30.0	33.3	28.6	41.2	19.2	31.5	25.3	23.4	76.4	19.8	11.4	11.4	20.6	13.8	44.8	17.0	13.2	29.5	15.0	15.4	47.8	29.4	21.9	44.9	12.0	20.7	29.4	14.9	87.9	31.0	4.0	0.0	0.5	0.6	0.0	0.3	1.0	1.9	2.3	0.6	0.4	0.4	0.7	0.4	4.8	0.1	1.4	10.4	1.3	1.0	2.0	2.2	1.7	0.8	0.7	0.7	1.1	0.9	0.6
TRABD2A	"C2orf89, TIKI1"	ENSG00000186854	"TraB domain containing 2A"	Q86V40	2	84821650-84907008	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 29.3;intestine: 26.6;lymphoid tissue: 24.7;ovary: 23.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HDLM-2: 18.3;HSkMC: 13.0;hTEC/SVTERT24-B: 10.7;SiHa: 10.4"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 14.4;stomach cancer: 3.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 29.3"	"Lineage enriched"	"Detected in many"	17	"T-cells: 29.3"									HPA045817	Approved				"Intracellular and membrane"					"HPA045817: AB_2679460"	"unprognostic (7.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-5)"	"unprognostic (2.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.47e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.37e-1)"	1.8	0.5	0.7	24.7	1.6	2.1	6.3	0.6	3.7	0.5	23.2	0.9	0.0	2.4	0.5	0.4	0.5	1.3	0.2	0.7	0.9	0.8	0.9	0.9	3.0	11.3	0.9	3.1	23.7	0.4	0.4	0.6	2.0	0.2	0.5	26.6	1.2	3.3	0.0	0.3	1.2	9.3	1.8	0.9	3.1	0.6	0.6	0.0	6.4	0.7	0.0	6.3	0.7	0.7	1.7	0.6	0.5	0.1	1.3	29.3	5.3	0.7	0.6	0.2	0.1	7.2	7.8	24.3	1.2	1.9	3.5	6.4	0.3	2.7	0.0	0.3	3.8	0.0	1.7	0.3	5.2	18.3	0.4	0.0	5.1	0.0	0.8	0.0	0.0	13.0	0.0	10.7	4.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.1	0.0	0.1	0.2	3.4	0.4	0.0	1.2	2.2	0.0	0.0	3.0	2.0	0.0	0.0	0.1	0.0	3.3	0.1	4.0	0.3	13.1	5.0	0.6	1.7	29.3	18.2	0.5	1.3	0.0	0.6	8.5	5.3	0.7	1.6	0.6	3.7	0.9	0.8	0.9	3.1	0.2	0.0
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974667-73983307	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 219.1;lymphoid tissue: 144.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 66.9;SK-BR-3: 86.1;U-698: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"CAB025583: , HPA075202: AB_2732284"	"unprognostic (1.13e-1)"	"prognostic favourable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	19.8	9.8	5.3	40.4	9.5	24.5	15.9	1.1	4.9	8.1	7.7	10.2	20.3	11.4	4.2	12.0	4.5	37.9	13.1	11.5	4.4	5.5	12.8	10.6	20.2	85.6	7.8	2.4	7.2	4.7	1.2	6.2	8.7	6.5	6.5	8.9	14.2	17.4	17.2	45.3	4.3	24.7	6.4	9.0	91.1	12.3	5.5	5.9	144.8	17.9	19.3	55.7	19.4	2.9	141.6	219.1	101.8	135.3	119.8	180.2	172.1	0.1	14.1	3.2	9.6	1.8	0.0	2.4	2.3	1.6	9.7	2.8	24.7	12.0	66.9	33.5	3.6	0.6	2.3	0.0	4.5	16.9	0.8	39.0	5.9	5.1	5.8	20.5	16.4	2.1	0.0	9.1	0.0	1.2	17.9	27.3	1.9	24.1	21.2	11.1	2.6	2.8	19.6	22.3	37.9	27.0	39.9	4.9	6.0	12.6	86.1	4.8	25.4	18.3	1.8	0.0	12.4	2.8	4.6	9.4	4.4	55.7	1.7	8.1	0.1	45.7	81.5	101.8	112.6	135.3	69.9	141.6	92.3	95.0	88.4	134.2	86.9	91.1	11.4	119.8	111.3	219.1	180.2	172.1	5.3	9.5	1.1	4.9	4.4	5.5	7.8	2.4	6.5	5.9
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 19.7;EFO-21: 13.7;HaCaT: 19.0;HBEC3-KT: 42.6;RPTEC TERT1: 28.4"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.1	13.7	0.0	19.0	0.0	42.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598366-184939492	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 31.6;lymphoid tissue: 9.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.4;RH-30: 14.0;THP-1: 10.3;U-698: 15.2"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.6"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA029195: "	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.4	1.0	4.3	9.6	7.2	1.8	0.4	31.6	10.7	0.6	0.8	0.1	0.8	1.5	0.4	0.3	0.6	0.4	4.8	0.3	5.2	7.3	1.8	0.6	1.2	2.7	2.2	3.0	0.8	0.3	0.2	0.4	0.5	5.4	4.1	1.1	2.4	1.1	4.4	0.3	0.3	3.3	0.5	1.5	1.8	1.2	0.9	0.4	0.0	4.4	0.0	2.9	1.8	2.1	2.0	1.2	1.0	1.7	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	4.8	1.6	1.5	0.0	0.0	20.4	0.0	0.0	0.0	0.3	0.0	3.6	0.1	0.0	5.4	0.8	0.1	8.0	5.1	0.0	2.5	0.0	0.0	1.3	3.8	0.0	0.9	0.0	0.0	0.0	4.8	0.0	3.3	0.0	14.0	0.8	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	10.3	0.0	5.1	0.1	0.2	2.0	2.2	0.0	15.2	5.9	1.5	1.7	0.0	1.1	0.0	0.0	1.7	0.0	2.0	0.0	0.0	1.2	0.3	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.3	4.3	7.2	31.6	7.5	5.2	7.3	2.2	3.0	5.4	0.4
A2ML1	"CPAMD9, FLJ25179, p170"	ENSG00000166535	"Alpha-2-macroglobulin like 1"	A8K2U0	12	8822472-8887001	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 131.6;lymphoid tissue: 67.9;tongue: 54.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 12.1;hTCEpi: 6.0;SK-BR-3: 15.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 39.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038847, HPA038848"	Enhanced				"Secreted in other tissues"	34000000	34000000			"HPA038847: AB_2676236, HPA038848: AB_10672654"	"unprognostic (1.13e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.42e-2)"	0.1	0.1	0.1	0.1	0.2	0.1	1.2	0.1	0.6	31.3	0.1	0.1	0.1	0.0	0.6	0.2	131.6	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	1.3	0.1	0.2	0.1	0.1	17.3	0.1	0.1	18.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	1.2	0.1	54.7	67.9	0.3	28.7	1.0	1.2	1.8	2.0	1.5	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.0	2.7	12.1	0.0	6.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.8	0.7	0.4	0.9	1.0	0.7	0.9	0.4	0.4	0.3	1.0	0.5	0.6	1.7	1.5	2.0	1.2	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647496	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.5;LHCN-M2: 3.6;U-2 OS: 10.2;U-266/84: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063601			Approved	Vesicles,Centrosome,Cytosol				Vesicles	Vesicles	"HPA063601: AB_2685057"	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.2	0.1	0.3	1.0	35.4	0.7	0.0	1.1	1.2	0.3	0.4	0.0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0.0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0.0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0.0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	1.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.5	1.2	2.1	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.1	2.1	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.6	10.2	0.4	1.5	3.0	4.1	0.0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1.0	0.3	0.6	0.1	0.2	0.1	1.0	0.0	1.1	1.8	0.2	0.1	0.0	0.4	0.0
ABHD17B	"C9orf77, CGI-67, FAM108B1"	ENSG00000107362	"Abhydrolase domain containing 17B"	Q5VST6	9	71862452-71910931	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 46.2"	"Cell line enhanced"	"Detected in many"		"REH: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047862	Uncertain									"HPA047862: AB_10959595"	"unprognostic (7.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.03e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.57e-2)"	"unprognostic (8.53e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.74e-1)"	"prognostic favourable (2.59e-4)"	"unprognostic (4.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.34e-2)"	7.7	6.6	16.5	6.9	25.0	18.0	8.2	14.4	21.6	9.0	12.0	43.3	2.3	18.1	9.5	4.6	13.5	9.6	9.1	5.8	23.6	13.8	13.4	13.6	7.5	10.8	44.0	13.6	7.6	6.4	12.7	5.8	7.8	24.3	11.0	11.2	9.0	9.4	5.1	13.6	11.2	14.9	9.4	30.4	8.9	8.9	11.1	38.2	46.2	8.8	3.6	10.7	11.8	8.8	7.2	5.7	8.1	3.8	6.6	4.9	1.7	6.4	6.2	14.2	8.2	7.4	4.6	12.5	7.1	7.8	6.2	5.3	1.8	4.0	15.6	6.6	4.8	12.8	13.8	4.7	7.2	8.1	8.2	9.1	10.5	6.0	5.2	10.7	14.9	5.7	6.6	5.5	5.0	8.0	7.4	7.1	5.2	2.9	27.8	8.6	21.5	8.8	37.3	10.9	0.1	7.1	13.0	9.5	11.0	7.5	8.1	6.1	2.6	7.8	6.4	6.0	7.8	11.1	5.7	7.0	8.2	12.3	4.7	7.7	3.0	8.1	3.8	4.1	3.1	1.4	3.0	4.2	3.8	4.3	4.8	7.2	3.2	4.5	2.9	6.6	1.3	5.7	4.9	1.7	16.5	25.0	14.4	20.8	23.6	13.8	44.0	13.6	24.3	38.2
ABI3	"NESH, SSH3BP3"	ENSG00000108798	"ABI family member 3"	Q9P2A4	17	49210227-49223225	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 84.6;lymphoid tissue: 50.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 19.0;HDLM-2: 10.9;HUVEC TERT2: 32.3;TIME: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 84.4;non-classical monocyte: 84.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 29.5;monocytes: 84.6;T-cells: 36.5"	"Low region specificity"	"Detected in many"							"HPA017345, HPA064805"	Enhanced									"HPA017345: AB_2669592, HPA064805: "	"unprognostic (1.24e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.18e-2)"	"prognostic favourable (7.13e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.29e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.24e-3)"	"unprognostic (4.16e-2)"	"unprognostic (2.40e-1)"	6.4	6.1	8.1	16.2	15.7	3.8	5.7	1.1	8.5	4.9	5.4	9.1	1.2	6.9	7.4	2.7	4.0	5.6	6.0	5.7	7.8	3.9	6.4	7.8	12.0	18.7	14.8	1.6	3.5	3.4	1.8	3.7	4.6	12.1	6.0	6.0	3.8	4.3	2.9	2.5	3.5	12.0	6.0	18.0	50.6	5.3	1.4	13.4	9.2	6.7	3.2	21.0	6.4	4.9	4.4	29.5	2.2	84.6	12.5	36.5	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	1.2	2.1	0.2	0.0	19.0	0.2	0.0	0.0	0.0	0.0	2.2	10.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	32.3	0.0	0.0	0.2	0.0	3.9	3.0	1.2	0.0	3.2	7.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	4.5	0.0	0.0	0.3	1.0	3.3	0.0	0.2	0.0	0.1	14.4	0.3	36.5	84.4	17.9	4.4	6.8	23.6	29.5	3.4	4.1	18.5	2.2	12.5	84.6	1.2	3.6	22.5	8.1	15.7	1.1	8.5	7.8	3.9	14.8	1.6	12.1	13.4
AC008878.3		ENSG00000268861			19	7382834-7472477	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 7.7;bone marrow: 7.1;lymphoid tissue: 8.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.9;HL-60: 8.1;MOLT-4: 11.5;REH: 9.4;THP-1: 13.5;U-698: 10.7;U-937: 8.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042689, HPA071867"	Supported		Uncertain	Cytosol				Cytosol	Cytosol	"HPA042689: AB_10794385, HPA071867: AB_2686466"	"unprognostic (1.46e-1)"							"unprognostic (2.47e-2)"			"unprognostic (2.97e-1)"		"unprognostic (1.20e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.45e-4)"			0.0	1.2		4.3		7.1	0.0		0.0	0.0	0.5			0.0	0.9	0.1	1.5	0.0	2.1	0.0			0.2	0.0	1.0	8.6			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.6	0.0	2.3		4.9	0.0	0.0			0.7		4.8	2.4		7.4	1.4	7.7	3.3	0.1	4.2	1.4	0.0	0.2	0.5	0.0	1.3	0.3	0.0	0.0	1.1	0.0	0.3	0.0	0.0	17.9	0.0	4.4	0.0	2.4	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.3	8.1	7.2	2.7	0.1	0.1	2.2	1.0	0.0	0.0	3.6	0.0	11.5	3.0	0.0	0.0	9.4	0.1	3.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	10.7	0.3	8.4	0.0	0.9	1.7	7.7	2.7	1.9	1.5	7.4	3.6	1.8	1.1	6.7	4.2	1.4	4.3	0.1	3.3	1.4	1.7	1.4										
AC009086.2		ENSG00000277669			16	29663279-29695144	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"lung: 17.3;lymphoid tissue: 55.9"	"Group enriched"	"Detected in some"	5	"BEWO: 18.9;EFO-21: 50.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 4.0;intermediate monocyte: 4.5;myeloid DC: 5.3;non-classical monocyte: 7.2;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.3;monocytes: 7.2"									HPA011887	Uncertain									"HPA011887: AB_2668555"																		3.4	0.4	0.3	8.5	1.3	1.9	0.4	0.0	0.5	0.4	9.5	1.2	0.0	6.8	0.4	0.4	0.7	0.4	1.4	2.2	0.1		0.4	0.5	17.3	12.5	2.0	0.0	0.4	0.5	0.4	0.0	0.4	1.0	0.4	0.4	0.5	3.1	0.4	0.4	0.4	2.5	0.4	2.7	8.3	1.5	0.4	0.7	55.9	0.4	0.6	11.7	0.4	0.0	0.0	5.3	0.0	7.2	0.1	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	3.6	0.0	0.0	2.0	7.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.7	0.0	0.3	0.0	0.0	4.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.1	7.2	2.8	0.7	1.5										
AC011530.1		ENSG00000268434			19	45779437-45785973	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"epididymis: 4.2;lymphoid tissue: 3.1;skeletal muscle: 3.4"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.6;HBEC3-KT: 4.1;HBF TERT88: 1.7;T-47d: 2.1;U-87 MG: 1.7;U-937: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"																										"unprognostic (3.77e-2)"					"unprognostic (2.87e-1)"		"unprognostic (2.00e-1)"		"unprognostic (1.29e-1)"				0.1	0.8	0.0	3.1	0.1	0.0	0.0	0.1	0.5	0.3	0.9			0.0	0.8	4.2	0.0	0.4	0.0	2.4	0.0	0.0	0.2	0.2	0.9	0.3	0.0		0.2	0.1	0.0	0.0	0.9		0.4	0.0		0.0	0.0	3.4	0.0	0.2	0.0	0.1	0.0	0.4	0.8			0.0		0.7	0.3	0.2	0.1	0.3	0.0	0.0	0.0	1.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.8	0.4	4.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.0	0.0	1.1	0.0	1.4	0.3	1.7	2.8	1.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.3	0.1	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.3										
AC013394.1		ENSG00000279765			15	92883413-92949230	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 28.4;lymphoid tissue: 23.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (7.26e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.46e-6)"	"unprognostic (2.74e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.12e-2)"	2.2	2.7	2.7	1.7	4.2	28.4	6.3	3.6	7.3	3.4	3.9	3.1	0.5	1.8	3.3	3.7	2.9	2.8	2.9	5.3	5.8		3.9	2.5	4.6	3.8	2.2	6.2	4.3	6.8	3.5	4.2	3.5	4.8	3.9	3.5	2.4	3.1	3.5	4.9	2.8	4.0	2.9	1.1	23.7	2.1	20.7	3.1	1.0	7.2	2.1	3.6	2.8	0.5	11.4	4.8	8.8	1.5	2.6	4.3	0.8	10.6	8.4	31.8	20.4	9.9	13.0	23.3	10.6	19.1	17.0	12.8	8.5	25.0	11.4	10.6	13.6	16.7	13.3	10.8	17.1	0.0	13.1	19.9	16.7	8.1	20.7	10.5	13.3	13.8	16.1	6.3	32.2	16.0	20.5	33.1	18.7	11.4	12.2	16.4	27.8	7.1	17.5	16.0	24.3	24.0	20.8	16.9	19.3	22.7	16.5	38.3	38.0	24.2	11.0	12.7	9.8	9.8	23.1	24.1	28.6	24.1	9.9	20.2	14.6	8.6	1.1	3.5	3.2	0.9	2.8	11.4	3.4	3.1	1.0	5.0	4.3	3.1	8.8	2.6	1.5	4.8	3.7	0.8										
AC020909.1		ENSG00000142539			19	50415799-50428409	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 5.3;intestine: 2.6;lymphoid tissue: 6.0"	"Cell line enhanced"	"Detected in some"		"REH: 6.8;U-2 OS: 2.6;U-266/70: 3.7;U-698: 5.5"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"memory B-cell: 2.5;naive B-cell: 1.3;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	21	"B-cells: 2.5;dendritic cells: 5.3"									HPA018523	Uncertain									"HPA018523: AB_1857443"																		0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0			2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		1.2	0.0	0.0	0.0	1.1	0.0	0.0	6.0	0.1	0.1			0.0		0.0	0.0	0.0	2.5	5.3	0.1	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.6	0.4	0.0	3.7	0.6	5.5	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.7										
AC068775.1		ENSG00000255641			12	10412312-10436001	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 43.7;brain: 11.4;lymphoid tissue: 9.2"	"Cell line enriched"	"Detected in some"	6	"HeLa: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 43.7"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 43.7"									HPA062570	Uncertain									"HPA062570: AB_2684795"					"unprognostic (6.09e-2)"													0.3	0.5	7.0	0.8	4.5	3.0	0.6	1.0	11.4	0.3	1.4	2.0	0.0	0.8	1.0	0.8	0.3	0.3	0.4	0.6	6.8	4.9	0.2	1.1	1.5	1.3	5.7	2.4	0.4	0.3	0.1	0.0	0.5	3.4	0.3	1.0	0.0	1.0	0.1	0.1	0.2	1.6	0.4	3.9	9.2	1.0	0.5	1.5	2.0	0.1	0.0	1.0	1.0	0.0	0.0	0.0	0.3	0.0	43.7	7.6	2.6	0.0	0.8	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.9	13.6	0.4	0.1	0.0	0.0	2.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	7.6	0.3	43.7	0.0	0.0	0.0	2.6	7.0	4.5	1.0	3.3	6.8	4.9	5.7	2.4	3.4	1.5
AC069368.1		ENSG00000249240			15	64841883-64930920	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 23.8"	"Cell line enhanced"	"Detected in many"		"U-266/84: 21.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in many"																						"unprognostic (2.49e-1)"	"unprognostic (1.95e-2)"			"unprognostic (3.20e-2)"	"unprognostic (1.22e-2)"		"unprognostic (3.28e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.97e-1)"	9.5	10.5	5.8	13.5	7.5	1.2	4.1	5.1	11.7	2.8	5.8	4.4	1.4	9.5	5.2	5.3	4.1	3.0	6.3	3.9	5.3	3.4	3.5	4.2	8.7	7.5	3.9	3.1	3.9	2.2	1.2	2.4	9.8	7.2	4.0	3.1	7.1	2.9	1.2	3.1	2.8	3.4	7.0	5.9	23.8	7.7	2.6	4.4	1.4	7.6	2.1	4.0	6.7	5.7	0.5	0.8	0.4	1.2	0.0	2.6	0.1	2.2	0.0	0.5	0.7	0.6	2.7	0.7	9.0	3.9	0.5	1.5	0.7	0.0	7.6	3.4	2.2	0.2	0.0	0.0	1.4	8.6	0.0	7.0	2.0	0.0	1.1	9.3	4.5	0.9	0.4	0.5	0.0	0.0	1.9	8.8	0.0	0.2	1.0	0.1	1.3	0.0	1.4	7.3	2.5	0.0	1.7	0.0	2.5	2.3	0.0	1.3	0.3	0.9	9.2	2.6	2.4	2.7	2.1	4.4	21.8	2.3	3.5	4.7	0.3	0.0	0.5	0.0	1.2	1.2	0.8	0.5	0.3	2.6	0.8	0.2	0.1	0.1	0.4	0.0	0.5	0.0	1.5	0.1	5.8	7.5	5.1	5.6	5.3	3.4	3.9	3.1	7.2	4.4
AC091057.5		ENSG00000284906	"Rho GTPase-activating protein 11B "	Q3KRB8	15	30624548-30685606	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA064479	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA064479: AB_2685272"																		0.2	0.1	0.8	10.3	1.8	7.1	0.5	0.7	0.9	0.1	5.1	0.6	0.0	1.1	0.8	0.2	1.8	0.2	0.3	0.2	1.0		0.0	0.1	0.9	2.8	0.1	0.0	0.1	0.0	0.0	0.4	0.7	0.6	0.0	1.2	0.3	0.1	0.1	0.4	0.9	1.5	0.8	1.9	1.4	1.0	5.8	2.1	14.4	0.0	1.4	5.7	0.5	0.0	1.0	1.0	1.6	0.3	0.0	0.8	0.0	4.3	2.9	5.0	2.5	0.1	0.6	2.8	4.6	1.8	3.2	3.7	3.0	3.7	2.8	1.8	1.9	4.0	2.5	1.6	2.8	6.1	3.0	7.4	9.9	1.3	0.0	4.7	5.3	0.2	0.2	2.1	1.6	2.2	4.4	8.6	2.2	2.1	3.6	4.0	1.5	1.5	5.1	5.1	1.3	0.9	2.8	2.4	2.2	5.4	2.0	1.0	2.5	2.4	2.5	5.0	4.2	2.4	3.9	3.0	3.2	6.1	1.7	5.3	4.0	1.6	0.3	0.2	0.4	0.0	0.0	0.6	0.8	0.6	0.1	1.0	0.1	0.1	0.1	0.0	0.1	1.0	0.6	0.0										
AC099489.1		ENSG00000188897			16	11359845-11523588	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 7.2;lymphoid tissue: 9.9;skin 1: 6.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;HDLM-2: 7.0;U-266/70: 3.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"					"Low region specificity"	"Detected in single"			HPA042154	Uncertain									"HPA042154: AB_2677877"	"unprognostic (4.69e-2)"	"unprognostic (3.80e-2)"	"unprognostic (7.24e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.91e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.04e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.72e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.33e-5)"	1.5	0.0	0.3	6.4	0.2	2.0	0.8	0.1	0.1	0.5	0.1			0.0	0.5	0.2	0.1	1.6	0.6	0.7	0.4	0.1	1.1	1.1	2.4	0.9	0.5		0.3	0.5	0.0	0.3	0.3		1.0	0.0		5.0	0.6	1.3	6.2	0.3	0.0	0.5	9.9	0.7	2.8			0.3		0.2	0.7	0.3	0.2	0.0	7.2	0.0	0.0	0.5	0.0	0.1	0.8	0.8	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.8	6.5	2.3	0.0	0.0	0.0	0.0	0.0	7.0	0.5	0.0	0.4	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.5	0.8	0.0	0.2	0.2	2.1	0.7	0.0	0.6	0.3	2.3	0.0	0.4	0.7	0.4	0.0	0.9	0.9	0.0	0.2	0.3	0.1	0.1	0.3	0.0	3.6	0.2	0.2	0.0	0.7	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.3	7.2	0.0	0.0	0.0	0.1	0.0										
AC136428.1		ENSG00000259680			16	33844784-33845229	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.6;naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	40	"B-cells: 4.0"																				"unprognostic (1.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.32e-2)"			"prognostic favourable (6.96e-5)"		"unprognostic (1.81e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"		"unprognostic (2.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.58e-1)"	0.6	0.4	0.4	5.0	0.4	1.8	1.6	0.4	0.4	2.7	7.0	0.5	0.2	5.9	0.5	0.2	2.3	1.1	0.2	1.1	0.4	0.4	0.9	0.5	2.0	0.2	0.4	0.2	0.4	0.4	0.0	0.4	0.2	0.2	0.5	3.7	0.5	3.4	0.2	0.4	0.4	5.7	0.2	0.4	6.8	6.9	0.5	0.2	0.2	0.5	0.2	15.7	6.3	1.0	4.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.2	0.2	0.2
AC136616.3		ENSG00000278782			Unmapped	1157687-1240349	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 6.6;breast: 4.8;cervix, uterine: 6.8;intestine: 5.2;lymphoid tissue: 7.7"	"Cell line enriched"	"Detected in single"	16	"U-251 MG: 1.6"									"Cell type enriched"	"Detected in some"	6	"naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	66	"B-cells: 6.6"																																					0.0	0.0		0.1		0.4	4.8		0.0	6.8	2.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.5		1.6	0.0	0.0	0.0	5.2	0.0		2.0	0.0	0.0			0.0		7.7	3.6		6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
AC141272.1		ENSG00000277836			Unmapped	1270984-1271271	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 15.4;intestine: 16.4;lymphoid tissue: 22.4;urinary bladder: 14.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;K-562: 2.1;RH-30: 1.7;RPMI-8226: 5.9;SCLC-21H: 1.6"									"Group enriched"	"Detected in some"	113	"memory B-cell: 15.4;naive B-cell: 7.0"	"Lineage enriched"	"Detected in single"	155	"B-cells: 15.4"																																					0.0	0.0		6.5		1.5	1.0		0.0	2.9	16.2			16.4	0.0	0.0	1.3	0.0	0.0	0.0			0.0	0.0	0.0	3.2			0.0	0.0	0.0		0.0		0.0	5.2		10.9	0.0	0.0	0.0	8.3	0.0		4.3	11.6	0.0			0.0		22.4	14.5		15.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.9	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6										
AC233755.2		ENSG00000277856			Unmapped	26241-26534	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 20.4;intestine: 14.5;lymphoid tissue: 33.2;stomach 1: 13.5"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 11.9;REH: 3.7;RH-30: 1.9;SH-SY5Y: 4.0;TIME: 2.6"									"Group enriched"	"Detected in some"	180	"memory B-cell: 15.5;naive B-cell: 20.4"	"Lineage enriched"	"Detected in single"	205	"B-cells: 20.4"																																					0.3	0.0		4.2		2.9	1.1		0.0	0.7	14.5			14.1	0.0	0.0	1.9	0.0	0.0	0.0			0.0	0.0	0.0	11.8			0.0	0.0	0.0		0.0		0.0	2.4		5.5	0.0	0.0	0.0	4.2	0.0		4.7	13.5	0.0			0.0		33.2	11.3		20.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.9	0.7	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.7	4.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6										
AC243756.1		ENSG00000270339			1	146344131-146344790	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.1;endometrium 1: 1.0;lymphoid tissue: 1.7"	"Cell line enriched"	"Detected in single"	15	"THP-1: 5.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA058345	Uncertain									"HPA058345: AB_2683685"	"unprognostic (1.35e-1)"				"unprognostic (2.13e-3)"			"unprognostic (2.34e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.34e-1)"				"unprognostic (2.84e-2)"				0.0	0.0		0.0		0.0	0.0		0.0	0.2	0.0			0.0	1.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.3		0.0	0.3	0.0	0.3	0.0	0.0		1.7	0.0	0.3			0.0		0.5	0.0		0.4	0.7	0.2	0.2	0.3	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.0	0.1	1.1	0.4	0.8	0.5	0.4	0.4	0.5	1.0	0.2	0.3	0.1	0.7	0.3	0.3										
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.4;bone marrow: 30.3;lymphoid tissue: 51.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.5;HDLM-2: 24.4;Karpas-707: 24.1;NB-4: 29.8;REH: 11.9;U-937: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075570	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favourable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favourable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	2.6	0.6	0.6	31.4	1.3	30.3	1.1	1.0	1.2	1.4	4.5	0.4	0.4	3.2	0.9	1.5	3.3	2.0	3.1	1.4	0.6	0.6	2.9	2.3	7.3	29.3	2.7	0.1	1.0	0.7	0.0	0.8	0.5	1.2	1.8	1.5	1.7	9.6	1.3	0.5	1.2	19.2	0.8	1.3	44.9	3.7	1.4	0.9	51.5	2.5	1.0	33.9	3.7	1.8	17.8	13.3	22.4	5.9	23.7	29.4	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	18.5	0.1	0.0	0.0	0.0	0.0	0.0	24.4	0.0	7.0	0.1	0.0	0.0	9.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	11.2	29.8	0.3	0.0	11.9	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	7.5	6.3	8.4	0.1	19.7	0.0	17.0	5.9	22.4	24.6	1.8	27.5	16.6	25.8	26.1	10.5	17.8	22.7	22.4	17.7	23.7	0.2	13.3	29.4	16.1	0.6	1.3	1.0	1.2	0.6	0.6	2.7	0.1	1.2	0.9
ACOD1	"CAD, IRG1"	ENSG00000102794	"Aconitate decarboxylase 1"	A6NK06	13	76948497-76958642	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 3.0;lymphoid tissue: 5.8"	"Group enriched"	"Detected in some"	6	"PC-3: 1.1;U-87 MG: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040143	Uncertain									"HPA040143: AB_10793916"	"unprognostic (2.39e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.37e-1)"			"unprognostic (3.54e-2)"		"unprognostic (3.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.30e-2)"			"unprognostic (1.64e-5)"	"unprognostic (7.70e-2)"	"unprognostic (3.68e-2)"		"unprognostic (6.51e-3)"	1.4	0.1	0.0	5.8	0.0	0.6	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.1	0.0	0.0	0.3	3.0	1.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.8	0.3	0.0	0.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSM4		ENSG00000215009	"Acyl-CoA synthetase medium chain family member 4"	P0C7M7	12	7304284-7328724	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.0;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.8;Karpas-707: 2.5;NB-4: 3.9;SH-SY5Y: 4.6;U-87 MG: 6.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in all"			HPA049895	Uncertain									"HPA049895: AB_2680940"	"unprognostic (9.50e-5)"	"unprognostic (5.45e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.06e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.31e-3)"	"unprognostic (3.85e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.45e-9)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.73e-1)"	0.2	0.5	0.1	0.7	0.1	0.0	0.1	0.1	0.6	0.1	0.1			0.9	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1		0.1	0.1	0.0	0.1	0.0		0.1	0.0		0.1	0.0	0.1	0.1	1.3	0.0	0.1	2.0	0.1	3.6			0.1		0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.5	0.4	0.3	0.0	0.0	0.7	4.6	0.7	1.1	0.0	0.0	1.4	1.0	0.5	0.4	0.1	0.0	0.1	0.1	0.0	6.6	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ACSM6	"bA310E22.3, C10orf129"	ENSG00000173124	"Acyl-CoA synthetase medium chain family member 6"	Q6P461	10	95194200-95228928	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.3;pancreas: 7.3;stomach 1: 6.2"	"Cell line enriched"	"Detected in single"	30	"RT4: 9.0"	"Cancer enriched"	"Detected in single"	7	"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"											HPA044593	Uncertain									"HPA044593: AB_10960261"	"unprognostic (2.91e-2)"				"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.48e-2)"		"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.71e-4)"	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.8	0.4	0.0	6.2	0.3	0.0	16.3	0.8	0.0	0.0	2.5	1.9	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17221989	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.0;EFO-21: 11.5;HUVEC TERT2: 12.4;Karpas-707: 22.1;MOLT-4: 20.5;U-266/70: 12.6;U-937: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	50000000	50000000			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favourable (9.26e-4)"	"prognostic favourable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	24.7	6.6	6.9	15.3	7.5	8.7	6.3	9.7	9.2	7.8	9.8	17.3	3.9	7.0	9.6	7.0	6.9	18.2	12.4	15.9	6.4	8.8	15.2	8.5	28.6	24.3	9.2	5.8	8.9	6.7	0.6	13.7	8.4	14.5	7.4	12.3	15.3	6.9	6.3	2.5	2.5	12.6	7.9	18.2	45.0	7.2	9.7	5.3	63.0	7.5	2.9	22.6	18.0	4.1	6.1	29.8	2.6	46.4	9.5	7.9	28.3	0.0	0.0	3.4	0.0	0.0	0.6	0.1	1.2	0.1	0.0	0.0	0.0	13.0	2.9	11.5	3.6	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.1	6.2	0.0	0.1	0.0	12.4	0.1	22.1	0.5	0.0	20.5	1.5	10.2	0.0	0.4	0.0	3.2	0.0	3.9	5.8	0.1	0.0	0.1	0.0	0.0	5.8	1.4	0.0	0.1	0.1	0.0	12.6	1.1	0.7	0.1	20.7	0.1	2.6	44.1	2.4	7.9	46.4	6.3	6.1	6.4	7.9	29.8	5.0	7.6	7.8	2.1	9.5	35.2	14.7	3.6	28.3	6.9	7.5	9.7	9.2	6.4	8.8	9.2	5.8	14.5	5.3
ADAM19	MLTNB	ENSG00000135074	"ADAM metallopeptidase domain 19"	Q9H013	5	157395534-157575775	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.4;smooth muscle: 46.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.1;U-251 MG: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5"	"Group enriched"	"Detected in many"	5	"B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055537			Approved	Vesicles				Vesicles	Vesicles	"HPA055537: AB_2797253"	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.90e-12)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-2)"	3.7	2.5	1.3	49.4	1.5	4.8	2.8	6.9	2.4	4.4	15.1	1.1	3.6	3.9	8.6	5.9	4.6	5.9	14.7	18.9	1.6	1.7	1.6	4.3	9.1	19.2	1.6	1.0	3.0	0.5	0.0	1.4	33.0	3.4	5.9	4.9	5.0	6.8	4.6	3.9	0.8	14.0	46.1	2.8	16.8	7.7	1.3	0.5	5.6	3.1	3.3	29.4	17.0	3.9	15.8	18.5	37.5	3.9	0.1	4.4	2.2	10.9	1.7	3.4	0.0	0.2	0.2	21.9	13.1	4.7	8.2	6.1	5.7	9.0	5.7	0.7	6.7	9.3	0.5	0.8	7.5	31.1	0.3	0.0	0.9	0.7	2.0	0.0	0.0	1.5	0.0	6.4	1.3	9.2	1.6	0.8	17.4	0.0	0.0	0.0	3.6	5.7	0.1	19.6	4.8	0.8	0.1	1.5	1.0	0.0	4.7	0.6	0.0	0.1	14.1	8.9	9.6	2.0	59.2	3.5	0.1	20.5	2.0	0.0	3.9	32.3	3.9	37.5	0.4	0.3	1.0	14.1	4.4	1.0	1.1	15.8	0.1	0.1	20.1	0.1	0.0	18.5	4.4	2.2	1.3	1.5	6.9	2.3	1.6	1.7	1.6	1.0	3.4	0.5
ADAM8	"CD156, CD156a, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262403-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.8;bone marrow: 37.1;lymphoid tissue: 28.3"	"Cell line enhanced"	"Detected in some"		"A-431: 22.3;BEWO: 32.2;CAPAN-2: 27.3;HaCaT: 26.8;HDLM-2: 17.2;U-87 MG: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 20.7;eosinophil: 56.8;neutrophil: 32.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 56.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"					"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	4.8	1.0	0.7	18.0	1.6	37.1	3.1	1.7	1.2	3.8	4.8	0.9	0.2	3.5	1.8	1.6	2.8	3.6	10.1	4.1	0.8	1.1	2.8	4.3	13.0	25.0	1.0	0.2	1.7	2.4	0.1	2.0	7.5	1.6	2.9	0.9	2.9	5.5	0.7	1.5	1.9	6.0	1.6	1.5	28.3	6.9	2.3	0.5	6.6	2.0	1.8	19.7	12.0	2.8	2.5	8.6	56.8	5.4	5.5	5.5	4.6	22.3	0.6	0.2	0.3	0.1	0.0	32.2	0.2	0.5	0.1	0.1	1.7	27.3	0.4	0.6	0.0	26.8	0.0	4.6	0.0	17.2	0.3	0.3	0.1	0.0	0.2	1.3	6.3	0.1	0.4	0.2	0.4	0.0	1.2	0.9	0.0	1.8	0.0	7.6	0.1	0.6	0.1	0.2	2.4	0.3	0.5	0.0	0.3	0.1	0.1	0.4	0.4	0.7	0.6	0.0	0.6	0.2	0.3	1.3	0.8	0.2	13.7	0.7	0.1	20.7	5.4	56.8	5.5	2.1	4.0	2.5	3.7	5.2	8.6	1.5	1.4	2.0	32.9	5.5	2.0	0.1	3.8	4.6	0.7	1.6	1.7	1.2	0.8	1.1	1.0	0.2	1.6	0.5
ADAMTS17	"FLJ16363, FLJ32769"	ENSG00000140470	"ADAM metallopeptidase with thrombospondin type 1 motif 17"	Q8TE56	15	99971589-100342005	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 12.0;RPMI-8226: 4.5;SK-BR-3: 4.6;SK-MEL-30: 5.9;WM-115: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA062487			Approved	Nucleoplasm	"Secreted to extracellular matrix"			Nucleoplasm	Nucleoplasm	"HPA062487: AB_2684780"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.43e-2)"	1.2	2.0	3.6	2.7	3.1	1.5	1.9	0.7	4.5	1.9	2.1	2.9	6.4	2.5	4.9	1.9	5.1	2.9	1.9	2.2	3.4	1.6	2.2	15.7	10.5	2.0	1.6	1.0	3.0	12.2	0.3	3.5	1.6	1.7	1.9	2.1	2.7	8.3	4.7	13.5	5.0	2.8	6.6	2.1	2.5	3.6	4.0	2.0	20.1	1.9	2.7	2.1	2.7	2.1	0.1	0.0	1.4	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.2	2.2	0.4	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	1.0	3.6	0.7	0.4	1.8	0.0	1.1	4.5	0.0	0.4	3.8	0.8	0.5	4.6	5.9	0.0	0.6	0.7	0.0	1.6	1.1	0.1	0.7	0.0	0.0	0.0	0.9	5.5	1.4	0.0	0.0	0.1	0.0	0.5	0.0	0.8	0.2	0.0	0.1	0.5	0.5	0.4	0.2	0.1	0.0	0.0	0.1	3.6	3.1	0.7	4.5	3.4	1.6	1.6	1.0	1.7	2.0
ADCYAP1	PACAP	ENSG00000141433	"Adenylate cyclase activating polypeptide 1"	P18509	18	904943-912172	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;lymphoid tissue: 16.5"	"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 19.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065887	Supported	Supported			"Secreted in other tissues"					"HPA065887: "	"unprognostic (2.68e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.87e-4)"	"unprognostic (9.58e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (2.91e-6)"	"unprognostic (2.24e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-4)"	2.1	0.5	2.5	16.5	7.7	0.1	1.6	2.1	12.5	3.4	2.6	0.8	0.0	0.1	4.0	0.1	2.2	0.5	12.3	1.0	1.2	18.4	0.6	0.3	1.7	1.6	2.8	6.2	0.2	7.7	0.1	4.5	0.3	33.8	1.4	1.4	2.5	2.2	1.0	0.3	0.9	1.3	1.5	5.9	0.2	1.8	3.6	0.2	0.1	0.3	0.0	1.4	3.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.7	2.1	12.1	1.2	18.4	2.8	6.2	33.8	0.2
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732393-14778541	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;lymphoid tissue: 38.9"	"Cell line enhanced"	"Detected in some"		"HEL: 10.1;HMC-1: 16.3;NB-4: 9.8;RPMI-8226: 7.2;U-937: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 24.2;monocytes: 28.7"									HPA055200			Uncertain	Vesicles,Cytosol				Vesicles	Vesicles	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	6.3	3.1	1.7	22.9	1.9	7.2	4.4	1.0	1.3	14.9	8.1	2.5	0.9	2.4	12.0	1.0	1.9	2.3	3.3	7.3	2.0	1.8	3.4	4.3	15.6	37.4	2.2	0.0	5.3	3.5	0.7	1.6	10.9	2.4	3.8	2.5	3.2	2.4	3.9	3.5	3.0	3.0	2.0	3.1	38.9	2.0	2.2	1.4	2.8	3.4	5.2	2.8	7.5	2.1	0.1	3.1	24.2	28.7	1.2	0.0	1.8	0.2	1.0	0.1	0.2	0.1	0.3	1.1	0.8	1.1	0.0	0.0	0.2	0.2	0.2	0.1	0.6	1.7	0.3	0.1	0.0	0.2	0.2	10.1	3.2	0.2	0.5	3.7	16.3	0.8	1.4	3.6	0.6	0.1	2.3	0.4	1.2	0.5	1.3	9.8	0.4	0.2	0.1	1.4	7.2	0.0	0.3	0.1	0.2	2.1	1.7	0.4	0.3	4.7	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.2	1.0	12.9	0.5	19.6	4.4	24.2	0.0	15.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	19.1	1.2	28.7	0.6	0.0	1.8	1.7	1.9	1.0	1.3	2.0	1.8	2.2	0.0	2.4	1.4
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.4;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA035507	Uncertain									"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.4	1.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	6.0	4.2	0.0	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.6	0.3	0.2	0.0	0.0	0.4	0.0	4.7	6.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	5.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.3	0.0
ADGRG3	"GPR97, Pb99, PGR26"	ENSG00000182885	"Adhesion G protein-coupled receptor G3"	Q86Y34	16	57668187-57689378	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;bone marrow: 62.7;lymphoid tissue: 26.4"	"Group enriched"	"Detected in some"	6	"NB-4: 8.5;SK-MEL-30: 4.7;U-937: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"eosinophil: 33.3;neutrophil: 42.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 42.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040469	Uncertain									"HPA040469: "	"unprognostic (4.41e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-4)"	"unprognostic (5.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.75e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.90e-1)"	4.6	0.4	0.3	7.2	0.9	62.7	1.6	0.2	0.5	1.1	4.1	0.0	0.0	1.4	1.4	2.0	2.9	3.4	1.6	7.7	0.2	0.3	0.7	2.7	11.0	26.4	2.0	0.0	1.7	0.6	0.2	0.3	1.7	0.6	1.6	0.9	1.2	0.4	0.3	2.3	0.7	3.9	1.5	0.3	25.4	1.2	1.7	0.3	1.1	6.5	1.2	0.8	3.4	7.2	0.0	0.0	42.8	0.0	8.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	15.6	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	8.8	0.0	0.0	0.0	0.1	0.3	0.9	0.2	0.5	0.2	0.3	2.0	0.0	0.6	0.3
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159972544	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.6;liver: 20.3;lymphoid tissue: 17.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.0;HaCaT: 6.6;TIME: 11.0;U-2 OS: 9.2;U-251 MG: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074416			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA074416: AB_2686688"	"unprognostic (4.93e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (6.00e-5)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.12e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (1.40e-6)"	"unprognostic (5.24e-4)"	"unprognostic (2.54e-1)"	"prognostic favourable (3.19e-5)"	"unprognostic (1.59e-2)"	5.3	2.9	5.3	0.9	9.0	0.4	2.3	1.3	21.6	0.9	1.2	0.7	0.8	1.2	1.5	3.6	1.1	3.6	1.3	3.3	6.2	5.8	7.4	20.3	4.7	2.3	1.2	13.9	6.2	0.8	1.0	0.8	1.1	5.2	1.6	1.1	0.9	1.0	1.9	1.6	1.3	1.7	1.2	0.9	17.4	0.9	0.8	0.5	0.0	2.0	0.0	1.1	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.3	0.0	2.4	0.9	0.1	0.5	0.2	0.6	0.3	0.0	4.2	0.0	13.0	3.8	6.6	0.0	0.5	0.3	0.0	0.3	0.0	1.6	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.6	0.0	0.7	0.0	4.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.0	11.0	0.1	9.2	0.0	7.0	0.0	0.0	0.0	3.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	9.0	1.3	21.6	6.2	5.8	1.2	13.9	5.2	0.5
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100142739	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.3;T-47d: 11.7;U-698: 34.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	16	"B-cells: 27.5;dendritic cells: 12.8"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.2	2.4	6.0	40.2	6.1	10.3	16.6	20.5	9.9	4.2	4.2	1.8	0.8	1.2	8.9	1.7	4.1	4.1	2.3	4.9	6.3	6.2	1.8	2.4	7.6	23.3	5.4	6.8	7.5	1.1	0.3	5.2	6.9	4.4	18.9	2.3	5.5	6.6	3.3	1.0	1.0	5.9	8.6	6.6	43.6	4.8	6.0	2.5	34.7	1.7	0.7	42.0	7.4	2.7	27.5	12.8	0.2	0.2	0.9	1.2	0.4	0.1	0.0	9.8	3.4	0.0	0.4	0.0	1.3	0.3	2.9	1.0	0.0	0.0	23.3	0.1	1.5	0.1	0.2	0.0	1.7	5.9	2.8	0.0	0.1	0.0	0.2	0.1	6.7	0.6	0.0	6.1	0.1	0.0	0.1	0.0	0.0	0.1	1.9	0.3	1.3	1.6	3.2	0.0	0.1	0.0	0.0	9.7	3.4	0.1	0.1	6.3	11.7	10.7	3.9	9.3	2.5	0.3	1.5	0.2	0.0	34.5	8.7	0.8	0.7	0.2	0.2	0.0	0.0	0.2	0.2	16.2	0.1	0.0	2.9	27.5	1.2	0.0	0.1	0.9	0.2	12.8	0.0	0.4	6.0	6.1	20.5	9.9	6.3	6.2	5.4	6.8	4.4	2.5
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602166-8612871	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.6;lymphoid tissue: 22.3"	"Group enriched"	"Detected in some"	6	"Daudi: 48.4;U-698: 40.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.6"	"Group enriched"	"Detected in many"	6	"B-cells: 6.6;granulocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	1.3	0.1	0.1	22.3	0.1	0.4	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.9	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.2	0.1	0.5	15.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	1.8	0.1	1.1	0.5	3.9	0.1	0.1	1.7	0.2	0.2	0.1	0.6	0.3	0.1	12.2	0.1	0.7	6.6	0.7	1.6	0.7	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.6	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	40.4	0.0	0.1	0.0	1.0	0.7	0.4	0.4	0.3	0.2	4.3	0.4	0.2	0.4	6.6	0.4	0.4	1.6	0.5	0.4	0.7	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615184-31617021	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.2;lymphoid tissue: 99.3"	"Cell line enhanced"	"Detected in some"		"HEL: 25.4;HMC-1: 36.6;NB-4: 58.2;THP-1: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2"	"Group enriched"	"Detected in many"	33	"dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol				Cytosol	Cytosol	"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	13.5	9.5	13.0	27.7	23.8	39.8	7.8	1.8	10.0	5.2	8.0	17.0	0.1	6.1	3.2	8.3	3.6	5.6	9.8	5.8	10.2	10.2	15.4	12.6	19.9	40.5	16.9	3.1	4.9	3.4	2.0	4.9	17.0	12.8	6.1	9.7	4.6	5.7	4.3	3.5	2.9	10.8	11.1	28.5	99.3	4.8	2.6	16.2	71.7	3.6	1.7	9.8	11.2	3.5	0.7	35.9	51.7	119.2	0.3	2.1	59.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	58.2	0.1	0.0	9.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.2	0.0	0.5	67.4	3.2	0.2	104.8	0.2	0.7	0.3	0.3	35.9	0.1	2.1	1.7	51.7	0.3	119.2	3.3	0.1	59.6	13.0	23.8	1.8	10.0	10.2	10.2	16.9	3.1	12.8	16.2
AIF1L	"C9orf58, FLJ12783, IBA2"	ENSG00000126878	"Allograft inflammatory factor 1 like"	Q9BQI0	9	131096476-131123152	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 128.9;lymphoid tissue: 92.1"	"Cell line enhanced"	"Detected in many"		"AF22: 34.8;MCF7: 22.9;NTERA-2: 26.2;RPTEC TERT1: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020522, HPA056852"	Enhanced									"HPA020522: AB_2670463, HPA056852: AB_2683256"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.68e-1)"	"prognostic favourable (5.54e-6)"	"unprognostic (2.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.20e-2)"	20.5	3.1	31.4	3.3	35.4	2.2	17.4	7.7	24.9	7.6	3.6	42.9	42.1	1.9	5.5	6.1	28.2	6.3	5.1	10.4	36.9	22.4	128.9	1.9	7.0	2.0	45.3	12.4	2.9	3.4	13.2	5.5	12.4	27.3	3.4	4.0	5.9	15.2	39.4	7.4	7.4	2.6	6.1	59.9	92.1	2.8	4.2	25.4	0.0	45.0	7.7	5.2	5.8	6.9	0.1	0.0	0.0	0.0	1.8	0.4	0.2	0.1	0.5	34.8	6.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	6.2	2.7	0.0	15.8	0.0	3.3	5.1	0.3	0.2	0.0	6.7	3.5	1.8	12.3	0.0	0.0	1.8	0.3	1.6	0.1	0.1	1.6	2.3	0.0	0.0	22.9	2.1	0.4	26.2	2.4	0.0	0.4	9.6	75.1	2.0	13.2	2.1	1.8	14.8	4.9	14.0	0.2	0.2	0.9	2.6	0.1	7.1	0.1	0.1	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	31.4	35.4	7.7	24.9	36.9	22.4	45.3	12.4	27.3	25.4
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 44.7;lymphoid tissue: 43.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.1;HDLM-2: 43.3;Karpas-707: 17.2;U-266/70: 14.5;U-266/84: 10.9;U-87 MG: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"memory B-cell: 44.7;naive B-cell: 14.3"	"Lineage enriched"	"Detected in many"	9	"B-cells: 44.7"	"Low region specificity"	"Detected in all"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	0.7	0.3	1.3	28.2	0.9	0.4	0.6	0.5	0.6	0.4	1.9	0.1	0.0	0.7	0.2	0.2	4.1	0.5	1.1	0.5	1.2	0.6	0.9	0.8	2.0	24.1	0.5	0.2	0.6	0.3	0.0	8.8	0.4	0.5	0.7	1.0	0.5	1.9	0.0	0.2	0.3	12.8	0.2	2.6	43.8	1.3	1.4	1.4	1.4	0.7	0.6	25.9	4.0	0.5	44.7	1.2	4.7	2.4	0.0	3.3	1.4	5.2	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.5	0.4	0.3	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.3	43.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	2.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	14.5	10.9	0.2	13.4	1.1	2.2	4.2	2.4	0.0	0.6	2.1	1.7	44.7	1.6	1.1	1.2	14.3	0.1	0.4	4.7	0.0	2.2	0.0	3.3	1.4	1.3	0.9	0.5	0.6	1.2	0.6	0.5	0.2	0.5	1.4
AIRE	"APECED, APS1, PGA1"	ENSG00000160224	"Autoimmune regulator"	O43918	21	44285838-44298648	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 5.3;lymphoid tissue: 8.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;NTERA-2: 1.1;U-87 MG: 1.3"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 6.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038267	Uncertain									"HPA038267: AB_10697247"	"unprognostic (3.24e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.69e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.29e-7)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.57e-2)"	0.3	0.3	1.4	0.9	3.4	1.3	1.2	0.2	3.5	0.5	0.3	1.0	0.0	0.0	0.4	0.8	0.4	0.3	0.2	0.5	1.0	5.3	0.4	0.2	0.6	2.3	1.1	1.8	0.3	1.1	0.0	0.3	0.1	3.6	0.4	0.0	0.2	2.2	1.2	0.5	0.3	0.8	0.1	1.3	0.5	0.8	0.4	0.4	8.3	0.3	0.0	0.2	0.2	0.2	0.4	0.3	1.3	0.3	0.3	0.6	0.2	0.1	0.0	0.4	0.1	0.3	0.2	0.0	0.5	0.0	0.0	0.1	0.3	0.3	0.1	0.3	0.0	0.3	0.2	0.6	0.0	0.3	0.3	0.0	0.6	0.3	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.3	0.0	0.3	1.1	0.0	0.1	0.0	0.5	0.0	0.7	0.3	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.3	0.3	0.3	0.8	0.0	0.3	1.3	0.2	0.3	0.8	0.3	0.1	0.5	0.3	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.6	1.3	0.3	0.2	0.3	0.2	0.2	1.4	3.4	0.2	3.5	1.0	5.3	1.1	1.8	3.6	0.4
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 71.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;MOLT-4: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA052367: AB_2681801, HPA063993: AB_2685169"	"unprognostic (5.19e-3)"	"prognostic favourable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favourable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favourable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favourable (2.29e-4)"	7.2	2.8	4.6	41.8	4.9	17.5	6.1	2.0	4.5	13.9	7.3	5.9	2.4	5.7	13.4	4.5	3.3	11.4	12.9	2.8	4.9	3.8	3.9	5.6	11.2	30.4	4.9	3.3	9.9	3.4	0.8	3.6	2.8	4.9	5.3	4.7	7.1	10.2	4.2	1.6	2.5	18.4	8.8	3.6	43.1	7.3	3.9	4.8	71.2	4.0	4.5	42.9	6.1	6.4	7.2	8.8	16.6	6.1	11.9	16.6	6.4	1.4	1.5	1.8	1.3	12.7	1.4	7.9	1.5	1.9	1.5	1.2	2.7	1.6	17.2	1.6	1.4	3.3	1.2	0.4	0.5	31.6	0.7	1.8	0.7	1.7	15.1	16.7	18.9	2.5	2.8	1.3	1.4	2.7	1.6	20.8	0.6	2.4	30.0	21.7	6.8	1.7	18.6	0.3	3.9	14.4	0.8	0.9	1.7	0.4	1.4	4.6	3.9	9.2	4.3	0.8	1.7	0.3	1.4	4.4	4.8	14.6	1.0	8.5	0.7	8.0	6.1	9.6	16.6	4.6	13.1	6.5	8.9	14.1	4.1	7.2	7.9	10.6	16.6	11.9	4.1	8.8	7.0	6.4	4.6	4.9	2.0	4.5	4.9	3.8	4.9	3.3	4.9	4.8
AL049634.2		ENSG00000260861			20	1540144-1620009	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.0;blood: 36.1;lymphoid tissue: 21.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 5.2;HMC-1: 11.1;NB-4: 3.6;THP-1: 4.2;U-937: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 22.5;neutrophil: 36.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 36.1;monocytes: 11.3"																																					18.0	2.4	0.9	6.0	3.8	6.4	0.8	0.7	7.5	0.8	0.8	1.1	0.0	0.6	0.9	1.0	0.8	0.7	0.9	5.2	1.4	1.1	0.8	5.4	14.7	14.8	4.7	0.1	1.0	1.0	0.0	0.7	2.5	2.4	0.8	0.3	0.9	0.9	1.0	0.9	0.8	1.5	1.4	5.2	21.9	0.8	4.6	2.6	1.5	0.8	0.0	1.8	1.6	1.0	0.0	3.8	36.1	11.3	0.0	0.2	5.9	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.2	11.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	4.2	1.4	0.0	0.0	0.3	1.6	0.1	0.0	0.1	0.1	3.1	0.1	0.2	11.1	22.5	0.2	8.2	0.1	0.0	0.0	0.1	3.8	0.0	0.0	0.0	36.1	0.0	11.3	3.4	0.0	5.9	0.9	3.8	0.7	2.0	1.4	1.1	4.7	0.1	2.4	2.6
AL121845.3		ENSG00000273154			20	63708864-63739103	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.2;blood: 2.4;lymphoid tissue: 2.2"	"Cell line enhanced"	"Detected in many"		"U-698: 4.8"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (3.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.29e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.18e-4)"	"unprognostic (3.37e-4)"	"unprognostic (1.84e-7)"	"unprognostic (7.09e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-3)"	0.0	3.2		2.2		0.0	0.0		0.0	0.0	0.7			1.6	0.7	0.0	0.0	0.0	0.0	0.0			0.6	0.4	0.1	0.0			1.0	2.0	0.0		0.5		0.8	0.0		1.0	0.0	0.2	0.0	0.6	0.0		0.0	0.3	0.0			0.0		0.0	0.0		0.0	0.6	0.1	0.1	1.8	2.4	0.4	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	3.0	2.2	0.1	2.3	0.0	0.8	0.5	0.6	0.0	0.7	0.0	0.0	2.4	0.0	1.8	1.2	0.3	1.2	1.5	0.8	0.0	0.4	0.0	0.6	0.0	1.2	0.0	2.4	0.4	0.0	1.6	0.0	0.0	0.0	2.0	0.7	1.9	0.0	0.0	0.2	1.4	3.5	0.0	3.3	1.3	1.3	0.7	0.4	3.6	4.8	0.0	1.2	0.3	0.0	0.0	0.1	0.9	0.1	0.6	0.0	1.1	2.4	0.0	0.0	1.0	0.7	0.0	1.8	0.0	0.6	1.5	0.4										
AL160272.2		ENSG00000285082			9	117704157-117877478	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.0"	"Cell line enhanced"	"Detected in many"		"A549: 5.0"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																																							12.0	3.8	7.2	3.0	4.9	10.1	10.7	4.0	4.5	2.0	2.3	4.7	0.6	2.1	2.5	3.7	1.5	1.6	3.0	4.8	9.6		3.8	2.7	5.3	15.4	5.6	5.1	2.0	6.0	4.5	0.4	4.2	4.6	2.0	2.6	2.9	4.5	1.5	3.0	4.4	3.7	1.8	4.9	21.0	3.4	2.5	5.9	0.0	2.7	2.0	2.1	3.4	7.6	2.0	1.7	4.2	1.9	0.6	1.1	0.5	0.4	5.0	2.0	0.5	0.0	1.6	1.3	0.6	0.4	0.1	0.3	3.3	1.2	0.9	0.5	0.5	1.3	0.2	0.6	0.7	1.0	0.3	1.8	1.7	0.7	0.0	2.5	0.6	0.7	0.4	1.4	0.6	0.7	0.4	3.0	1.2	1.7	0.8	1.9	0.8	1.1	0.5	0.5	0.8	0.4	2.0	0.9	1.3	1.3	1.9	0.6	0.7	0.7	2.0	1.3	0.4	1.5	0.6	2.2	2.3	1.3	1.3	1.3	0.8	4.2	1.9	1.3	0.7	0.9	0.7	0.9	0.7	0.6	0.6	2.0	0.9	1.1	3.8	0.6	1.2	1.7	0.5	0.5										
AL512428.1		ENSG00000282804			6	24797373-24809798	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.2;lymphoid tissue: 2.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HEK 293: 1.1;HeLa: 1.3;U-138 MG: 1.1;U-251 MG: 1.0;U-266/70: 1.0"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																																							0.1	0.0		2.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.5	0.0	1.1			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.0	0.0	0.5		0.6	0.7	1.1			0.1		0.9	0.2		0.8	2.1	3.2	0.6	0.0	1.7	0.1	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	1.0	0.0	0.0	0.5	0.0	0.0	0.9	0.5	0.8	1.7	0.6	1.7	0.4	0.4	0.8	0.3	0.8	1.4	1.7	3.2	0.0	0.0	2.1	0.9	0.1										
AL645941.2		ENSG00000248993			6	32937364-32953122	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"lung: 18.7;lymphoid tissue: 19.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.9;SK-MEL-30: 1.4;U-698: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 1.3;intermediate monocyte: 1.5;memory B-cell: 2.6;myeloid DC: 1.7;naive B-cell: 1.0;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	8	"B-cells: 2.6;dendritic cells: 1.7;monocytes: 1.5"									HPA012298	Uncertain									"HPA012298: AB_1853927"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.56e-4)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"		"unprognostic (1.08e-1)"		"unprognostic (1.93e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.18e-2)"		"unprognostic (4.73e-2)"		10.0	2.9	1.7	12.1	2.8	2.3	2.4	1.6	2.0	3.0	5.6	3.7	1.7	4.0	2.8	5.5	1.8	1.7	4.3	5.3	1.8	1.8	8.3	1.7	18.7	10.8	3.8	0.0	2.4	5.0	1.7	2.1	1.9	3.6	2.6	2.0	3.0	7.3	3.8	2.8	2.0	12.7	1.9	5.5	13.2	3.5	1.8	2.7	7.3	7.1	4.7	19.3	2.1	1.9	2.6	1.7	0.2	1.5	0.0	0.2	0.6	0.0	0.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	1.4	0.1	0.4	0.0	0.2	0.6	0.0	0.0	0.5	0.4	1.3	0.2	0.2	0.2	0.0	1.3	0.2	0.0	1.5	0.0	2.6	0.0	0.1	1.7	1.0	0.0	0.0	0.1	0.0	0.2	1.1	0.2	0.6	1.7	2.8	1.6	1.6	1.8	1.8	3.8	0.0	3.6	2.7
AL669918.1		ENSG00000250264			6	32813767-32838822	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 25.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.8;HDLM-2: 11.2;HEL: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA001312	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"				"Nuclear speckles, Endoplasmic reticulum"	"Nuclear speckles, Endoplasmic reticulum"	"HPA001312: AB_1080206"	"unprognostic (6.13e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.62e-1)"		"unprognostic (9.88e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	6.5	3.6	2.8	25.5	3.1	3.8	3.6	3.1	3.3	4.8	7.7	3.5	1.0	5.7	4.6	2.5	4.8	3.6	5.7	3.5	2.1	2.6	5.3	10.0	8.5	12.6	3.2	2.8	4.7	2.1	1.7	5.0	2.4	3.6	3.8	3.1	3.6	7.0	1.4	2.5	3.3	15.1	2.7	2.8	18.1	12.3	2.5	3.1	14.0	7.5	3.2	10.6	3.8	3.9	8.6	5.5	8.1	4.8	2.3	4.6	5.1	2.0	3.1	0.0	0.7	1.6	1.7	0.5	0.6	0.3	0.0	0.6	0.0	3.2	16.8	2.0	0.2	7.6	1.6	1.7	0.6	11.2	0.2	12.2	2.1	0.3	0.5	0.0	0.5	0.0	0.9	0.5	0.2	0.0	3.0	2.8	0.2	0.6	1.4	0.9	0.2	2.8	5.9	0.6	5.4	0.0	0.0	0.3	0.3	0.5	5.2	1.3	5.0	1.3	0.0	1.2	1.9	0.4	0.6	1.4	2.8	7.5	0.7	3.6	0.4	1.6	3.1	6.1	3.5	3.2	3.4	8.0	2.8	3.9	5.5	8.6	2.1	4.6	8.1	2.3	4.8	5.2	4.2	5.1	2.8	3.1	3.1	3.3	2.1	2.6	3.2	2.8	3.6	3.1
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell line enriched"	"Detected in some"	20	"A549: 321.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: "	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favourable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	321.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	16.1	0.0	0.1	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Group enriched"	"Detected in some"	5	"MCF7: 30.9;SK-BR-3: 32.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA045132	Approved									"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	30.9	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	32.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ALG1L2		ENSG00000251287	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2"	C9J202	3	130081831-130113227	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 4.0;lymphoid tissue: 3.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5;HDLM-2: 1.9;HEL: 1.7;Karpas-707: 1.3;REH: 2.8"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 4.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 4.0"									HPA060392	Uncertain		Uncertain	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA060392: AB_2684273"	"unprognostic (1.05e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.44e-3)"	"unprognostic (8.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.38e-1)"	"unprognostic (3.91e-1)"	"prognostic favourable (7.75e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.28e-3)"	0.0	0.0		0.8		1.2	0.0		0.0	0.0	0.0			0.8	0.0	0.0	0.3	0.3	0.0	0.0			0.0	0.0	0.0	0.0			0.2	0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0	0.9	0.0	0.0		3.5	0.3	0.0			0.0		0.0	0.1		0.7	4.0	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.5	0.1	0.0	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.6	0.3	0.3	0.4	0.1	0.0	0.0	0.0	4.0	0.9	0.1										
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;Daudi: 21.8;HMC-1: 15.6;Karpas-707: 6.9;RT4: 10.2;U-266/70: 10.3;U-698: 7.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavourable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (7.18e-4)"	7.4	3.9	2.9	18.3	7.4	39.9	5.8	13.2	3.2	3.4	6.5	6.4	1.0	4.5	3.2	4.7	4.9	5.4	8.0	6.1	3.9	2.6	4.8	2.6	34.7	36.9	9.0	1.7	2.6	10.0	1.3	1.7	11.2	6.1	7.8	3.4	3.2	6.6	3.4	1.1	2.9	14.4	7.8	8.4	41.8	4.5	2.0	6.2	2.4	3.0	1.4	16.7	27.2	10.5	14.8	11.1	45.2	21.3	0.0	0.5	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	6.0	21.8	0.7	0.0	0.3	0.2	0.0	0.0	0.4	0.2	4.2	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.2	10.2	0.5	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.0	10.3	1.9	7.2	0.0	0.1	0.0	36.7	21.3	27.0	0.0	20.0	0.1	14.8	0.5	0.2	11.1	10.4	0.0	0.0	45.2	0.0	19.6	0.3	0.1	9.5	2.9	7.4	13.2	3.2	3.9	2.6	9.0	1.7	6.1	6.2
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.2;HL-60: 13.3;NB-4: 17.0;U-937: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3"					"Low region specificity"	"Detected in many"			"HPA026789, HPA073498"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA026789: , HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavourable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.6	0.5	1.0	12.9	3.1	22.6	0.6	8.3	1.4	0.7	0.7	0.6	0.2	0.3	0.9	1.3	0.5	0.8	0.5	0.2	1.0	1.2	0.5	0.5	1.3	3.7	1.6	0.7	1.7	0.2	0.6	0.9	1.1	1.4	1.0	0.5	0.4	0.7	0.6	0.9	1.4	1.2	0.9	1.2	5.7	0.3	1.0	0.5	8.9	0.6	0.2	5.3	1.0	0.7	3.0	2.2	0.7	4.3	0.0	0.4	0.8	0.1	0.3	1.5	0.7	0.0	0.3	1.4	0.5	0.1	0.3	0.2	6.9	0.4	30.2	0.3	0.1	0.6	11.7	0.1	0.2	9.1	1.5	12.3	4.8	0.0	0.1	13.3	5.1	0.1	0.4	1.2	0.0	0.2	1.6	3.6	0.1	0.2	9.1	17.0	3.7	1.0	7.3	0.0	3.1	0.1	0.1	0.4	2.7	2.9	0.2	0.2	0.0	8.7	0.5	0.1	0.5	0.5	0.3	0.3	0.3	10.7	0.1	23.7	0.6	0.0	1.8	0.7	0.0	4.3	0.0	3.0	0.0	0.4	2.2	1.7	0.1	0.0	0.0	0.0	3.1	1.1	0.0	0.8	1.0	3.1	8.3	1.4	1.0	1.2	1.6	0.7	1.4	0.5
ANKRD44	PP6-ARS-B	ENSG00000065413	"Ankyrin repeat domain 44"	Q8N8A2	2	196967017-197311173	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 34.7;lymphoid tissue: 38.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.1;HMC-1: 20.3;Karpas-707: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030122, HPA056549"	Approved		Approved	"Nuclear speckles,Mitochondria"				Mitochondria	Mitochondria	"HPA030122: AB_10600980, HPA056549: AB_2683170"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.67e-2)"	6.0	6.0	4.9	29.4	8.8	12.5	4.3	3.7	5.1	8.6	6.7	10.8	3.9	3.2	6.5	3.9	4.3	4.9	7.6	6.4	6.4	4.7	5.6	4.5	15.4	36.7	9.4	4.7	5.1	3.5	6.0	6.1	6.4	6.4	5.0	4.8	7.4	8.0	4.7	2.9	3.0	12.6	9.6	8.0	17.8	5.6	7.1	8.9	38.2	5.1	3.0	27.0	9.0	9.8	15.7	9.4	34.7	11.4	12.0	13.4	6.3	1.0	0.6	1.6	1.7	3.8	1.5	0.3	2.4	1.1	1.3	1.2	0.4	0.5	8.8	1.1	2.0	0.1	0.5	0.5	1.0	26.1	2.2	0.3	3.1	0.1	0.2	6.4	20.3	0.8	0.3	1.3	0.1	1.7	1.4	14.7	1.9	1.5	3.1	5.2	0.2	1.6	5.6	1.8	12.0	3.1	0.8	1.6	7.2	0.8	0.6	6.9	0.9	6.3	9.1	4.5	2.5	1.3	1.8	3.7	4.3	11.2	3.1	8.0	2.6	21.8	9.5	21.0	13.1	9.8	12.4	11.6	9.8	11.1	9.4	15.7	11.3	13.4	34.7	12.0	11.4	6.2	9.3	6.3	4.9	8.8	3.7	5.1	6.4	4.7	9.4	4.7	6.4	8.9
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389806-36453791	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.4;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 98.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody				Nucleoplasm	Nucleoplasm	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: "	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (5.97e-7)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavourable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.7	0.6	13.9	7.2	10.5	20.9	1.3	1.8	36.7	1.9	3.9	1.6	0.0	2.9	1.3	2.4	12.8	0.6	1.4	0.6	24.0	12.1	0.7	0.8	3.3	4.2	30.5	2.5	0.9	0.4	0.3	0.3	12.9	9.7	0.7	5.5	0.0	0.9	0.3	0.4	8.9	3.4	9.4	63.4	1.6	3.3	9.2	12.5	32.7	0.6	17.7	6.7	2.6	1.3	0.0	0.3	0.6	0.9	0.0	1.7	2.0	67.1	14.1	11.7	8.9	1.6	4.1	12.7	42.4	24.8	51.2	38.4	9.6	20.8	3.4	12.3	21.4	34.6	9.2	24.8	98.4	2.2	6.7	4.6	15.9	8.0	0.2	6.6	5.4	0.9	1.1	33.3	22.0	15.9	9.7	7.1	41.7	10.1	5.6	7.7	13.0	15.0	4.1	35.3	2.2	11.3	11.0	5.0	5.9	22.3	25.9	3.9	17.5	7.6	15.1	32.1	36.1	18.9	49.5	3.0	4.7	6.2	10.9	10.7	67.3	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.9	0.5	0.3	0.0	0.6	0.0	0.6	0.0	0.3	0.2	1.7	2.0	13.9	10.5	1.8	7.7	24.0	12.1	30.5	2.5	9.7	12.5
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039081-43043170	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 28.9;lymphoid tissue: 25.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 10.0;MOLT-4: 10.7;REH: 11.2;U-937: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Nucleoplasm	Nucleoplasm	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavourable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	5.5	1.6	1.3	8.8	4.1	13.1	8.6	1.0	1.5	5.7	4.1	2.0	1.8	2.5	3.6	3.9	4.6	3.7	2.9	2.2	1.7	1.3	2.4	1.4	7.2	19.0	2.6	0.5	2.0	1.1	0.7	1.8	2.6	1.4	5.7	2.2	2.1	2.9	1.9	4.4	2.2	7.5	3.2	1.9	14.9	2.4	2.3	2.0	25.1	3.1	1.8	13.4	5.2	5.6	8.9	1.4	1.5	2.1	6.5	28.9	7.7	0.7	0.7	0.6	0.4	1.1	2.9	0.2	0.2	0.1	0.1	0.3	1.4	0.9	2.7	2.4	0.5	0.3	1.8	0.2	0.1	4.5	1.4	0.9	1.9	0.6	1.5	1.0	0.4	10.0	0.1	0.8	0.1	5.6	0.5	3.6	0.7	1.0	10.7	1.4	0.0	5.4	11.2	1.4	1.6	0.3	0.4	2.2	0.0	1.0	0.2	0.2	0.3	1.9	3.5	0.2	0.0	0.3	0.9	1.6	2.3	1.1	1.3	41.5	0.5	1.5	1.1	0.5	16.0	0.7	18.6	8.7	16.6	17.5	1.0	8.9	28.9	21.2	0.9	6.5	2.1	1.4	17.7	7.7	1.3	4.1	1.0	1.5	1.7	1.3	2.6	0.5	1.4	2.0
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512949-36724549	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 57.4"	"Group enriched"	"Detected in some"	5	"NB-4: 20.9;THP-1: 16.0;U-937: 7.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 54.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021666, HPA026716"	Approved				"Secreted to blood"					"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	8.4	3.4	5.2	17.2	4.9	19.3	2.8	1.9	3.6	3.1	5.3	7.4	0.2	4.9	3.9	7.2	2.5	3.1	8.4	3.4	4.8	3.8	3.1	6.8	9.4	23.2	6.9	2.0	2.1	2.3	0.6	2.4	5.7	5.8	3.8	7.3	3.8	4.5	1.4	1.5	1.6	7.6	4.7	12.6	57.4	3.3	1.4	6.8	14.0	2.9	0.4	10.9	7.2	2.8	0.3	34.8	18.7	54.6	19.2	8.8	31.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	20.9	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.3	54.6	17.6	8.8	47.9	1.8	0.3	0.4	6.1	34.8	0.0	1.0	7.8	18.7	19.2	20.2	0.5	0.1	31.0	5.2	4.9	1.9	3.6	4.8	3.8	6.9	2.0	5.8	6.8
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438203-26567803	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.2;lymphoid tissue: 100.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.2;MOLT-4: 21.6;REH: 48.6;U-698: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA017009: AB_2669505, HPA063903: AB_2685147"	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favourable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	18.3	3.9	7.9	27.7	14.2	25.8	10.1	1.2	7.3	2.6	3.9	16.6	0.0	4.5	2.0	1.5	2.9	4.9	7.5	4.8	7.3	4.9	4.8	25.4	11.1	28.2	14.5	3.2	1.5	3.0	1.3	2.7	5.5	11.1	2.5	4.5	1.6	4.0	1.6	1.5	2.8	12.0	4.7	21.9	41.5	5.4	1.3	12.1	100.5	3.0	0.7	26.2	8.0	3.9	11.0	14.8	54.2	10.3	5.3	9.5	3.5	0.0	0.4	0.0	0.0	3.4	5.6	2.9	9.4	1.8	5.4	5.2	0.0	0.0	25.2	0.1	6.2	0.0	0.0	0.0	7.5	0.0	0.0	18.2	0.0	0.0	0.0	3.4	0.0	8.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	21.6	4.8	0.0	0.0	48.6	0.0	17.8	1.5	0.0	0.0	0.0	0.8	0.1	0.0	0.0	11.9	0.0	0.0	0.1	1.7	0.0	4.4	0.0	51.7	4.4	17.8	0.0	19.0	7.1	16.1	9.5	6.9	7.7	9.5	8.1	7.9	4.4	11.0	9.3	9.0	54.2	5.3	10.3	14.8	7.6	3.5	7.9	14.2	1.2	7.3	7.3	4.9	14.5	3.2	11.1	12.1
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 113.5;bone marrow: 42.7;lymphoid tissue: 31.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 113.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 113.5"									"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: "	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	4.3	0.2	0.3	11.0	0.4	42.7	0.5	0.2	0.7	1.7	0.8	0.2	0.0	0.6	1.3	1.4	7.2	3.3	3.4	0.9	0.2	0.3	0.7	1.3	16.0	15.8	1.9	0.5	0.7	0.7	0.1	0.3	4.9	0.7	0.3	0.2	2.0	5.9	0.0	1.2	0.3	0.8	0.8	1.7	31.5	0.8	0.4	0.2	1.4	0.7	22.3	29.0	2.7	6.4	0.2	1.2	15.3	113.5	0.1	0.1	15.2	0.7	0.3	0.5	2.5	0.2	0.4	1.1	0.3	0.0	0.0	0.1	0.2	1.6	0.5	1.7	0.2	2.1	0.6	0.4	0.0	0.8	0.2	0.2	1.6	0.2	0.2	0.3	1.1	0.2	0.8	0.3	0.2	0.1	0.3	3.4	0.1	1.2	0.5	0.5	1.1	0.2	0.8	0.5	0.6	0.6	1.3	1.2	0.5	0.4	1.4	0.2	1.1	0.1	1.5	1.0	0.9	0.3	0.4	0.5	0.8	1.0	1.4	2.5	1.2	3.5	26.8	0.9	0.0	113.5	0.1	0.2	0.0	0.0	1.2	0.1	0.0	0.0	15.3	0.1	31.1	0.1	0.1	15.2	0.3	0.4	0.2	0.7	0.2	0.3	1.9	0.5	0.7	0.2
APOBEC3D	"APOBEC3DE, APOBEC3E, ARP6"	ENSG00000243811	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3D"	Q96AK3	22	39021113-39033276	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 17.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.0;Karpas-707: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA055116	Approved									"HPA055116: AB_2682701"	"prognostic favourable (2.51e-5)"	"prognostic favourable (1.31e-4)"	"unprognostic (2.69e-2)"	"prognostic favourable (4.47e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (3.76e-7)"	"unprognostic (4.76e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.06e-2)"	"prognostic favourable (3.01e-4)"	2.5	3.5	1.3	6.5	2.5	1.6	2.8	1.5	1.4	4.1	3.1	0.8	5.8	3.0	4.6	2.7	3.1	4.3	3.3	1.9	1.2	0.7	3.0	1.5	3.8	11.6	1.3	1.5	5.2	3.4	1.1	1.9	3.4	1.6	7.0	3.4	6.2	2.5	3.3	1.8	1.3	7.1	3.8	1.2	17.4	4.2	3.0	1.1	9.2	2.8	1.1	13.7	4.4	3.9	8.9	6.5	5.0	7.2	5.8	10.5	3.5	0.3	0.0	0.2	1.4	2.1	3.7	1.3	0.2	2.1	2.6	3.0	0.6	3.4	3.8	0.6	2.8	0.4	0.2	0.0	0.8	7.1	0.8	6.9	0.0	0.0	5.4	1.0	8.0	2.5	0.3	4.2	0.0	1.9	1.7	30.8	0.1	0.0	3.3	2.2	0.5	0.3	2.8	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	1.0	0.1	0.3	0.7	0.1	0.8	0.4	0.0	2.0	2.4	0.5	1.1	2.2	1.0	5.0	1.7	4.0	10.5	4.4	6.7	7.9	7.6	9.7	1.0	8.9	3.8	4.8	2.4	5.8	7.2	6.5	7.0	3.5	1.3	2.5	1.5	1.4	1.2	0.7	1.3	1.5	1.6	1.1
APOBR	"APOB100R, APOB48R"	ENSG00000184730	"Apolipoprotein B receptor"	Q0VD83	16	28494649-28498970	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.2"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HMC-1: 50.0;NB-4: 13.7;THP-1: 9.9;U-937: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA041667, HPA042093"	Enhanced					400000	400000			"HPA041667: AB_10793972, HPA042093: AB_10795393"	"unprognostic (3.16e-1)"	"unprognostic (8.01e-3)"	"unprognostic (6.19e-3)"	"prognostic favourable (3.26e-4)"	"unprognostic (5.48e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.60e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-2)"	11.5	2.5	1.7	15.1	3.7	24.2	1.9	0.9	2.7	1.4	18.9	2.8	16.0	4.8	1.5	6.9	2.1	3.1	2.8	1.7	2.7	1.7	2.6	3.0	18.9	15.4	4.7	0.4	1.4	1.8	0.4	1.3	4.4	4.0	2.9	12.9	1.2	2.7	22.6	1.0	2.5	8.6	2.2	7.7	34.2	3.1	1.6	4.1	6.3	1.8	2.1	6.4	6.0	4.5	0.1	4.0	14.1	4.9	6.1	2.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.1	0.2	0.0	5.8	50.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.5	13.7	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.5	9.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.0	12.0	0.0	7.0	4.9	12.5	2.1	2.3	2.0	0.0	1.2	2.0	4.0	0.1	0.3	1.0	14.1	6.1	1.9	0.8	0.3	1.5	1.7	3.7	0.9	2.7	2.7	1.7	4.7	0.4	4.0	4.1
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favourable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.5	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	28.0	1.3	0.1	0.0	13.3	1.3	0.9	50.9	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.1	14.3	13.0	1.5	6.2	12.7	4.9	1.1	0.1	0.2	21.2	2.3	0.2	47.4	0.4	1.0	7.1	32.8	0.0	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.0	44.0	3.1	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639949	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;lymphoid tissue: 35.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040419, HPA040830"	Enhanced		Approved	Nucleoli,Cytosol				Cytosol	Cytosol	"HPA040419: AB_10796121, HPA040830: AB_10805830"	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.05e-4)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.9	1.5	2.0	17.2	2.9	16.4	3.3	1.1	3.9	1.6	5.4	1.6	0.5	4.3	2.3	0.5	7.5	0.5	4.1	1.4	2.2	1.9	0.8	1.2	2.0	9.4	4.4	0.8	0.8	3.1	0.9	1.0	4.7	2.0	1.2	6.7	0.8	2.0	0.5	1.7	3.2	9.6	3.3	8.9	5.0	2.6	6.4	1.9	35.0	1.0	5.3	10.3	2.6	2.7	0.9	1.7	2.6	1.8	0.5	3.8	1.1	23.3	25.1	20.2	13.3	1.4	3.7	12.0	23.7	13.7	22.6	17.5	17.3	11.9	13.5	7.5	13.9	17.4	14.2	12.4	30.5	26.7	8.2	43.0	22.7	8.8	0.5	31.9	17.3	1.2	1.5	18.2	14.4	16.6	29.8	32.3	26.1	9.5	16.8	10.7	12.6	14.8	19.9	45.1	10.6	8.0	12.4	19.4	13.4	24.8	12.9	5.4	18.3	30.7	12.8	30.5	22.6	12.8	25.2	11.8	18.6	37.4	13.1	38.1	26.6	0.1	1.1	2.6	2.3	1.8	0.9	0.9	3.8	3.3	1.7	0.7	1.5	2.0	0.0	0.5	0.3	0.6	2.8	1.1	2.0	2.9	1.1	3.9	2.2	1.9	4.4	0.8	2.0	1.9
ARHGAP19	"FLJ00194, MGC14258"	ENSG00000213390	"Rho GTPase activating protein 19"	Q14CB8	10	97222173-97292673	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 30.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035777, HPA043231"	Uncertain		Enhanced	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA035777: AB_2674777, HPA043231: AB_10796791"	"unprognostic (5.88e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (7.47e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.29e-2)"	5.6	3.7	5.6	8.8	7.6	18.3	8.6	7.2	5.3	7.4	5.1	11.7	3.2	4.1	6.9	3.4	6.1	6.0	4.0	4.9	5.7	4.6	4.6	3.2	5.5	14.1	10.9	3.6	11.4	3.4	8.0	7.3	6.0	7.4	5.8	5.3	7.3	6.4	3.7	4.0	6.0	6.6	5.3	14.2	12.0	4.3	20.1	7.0	30.4	4.4	5.5	14.3	6.7	5.9	5.5	5.3	15.5	7.3	4.1	6.0	5.1	8.2	2.7	14.9	26.0	1.0	3.9	4.6	4.1	4.2	6.6	4.6	5.3	7.5	18.5	3.5	2.8	5.6	12.5	5.1	8.4	9.2	6.8	12.1	3.4	3.5	0.9	18.7	13.0	2.0	1.8	4.6	10.6	8.9	12.0	9.8	5.7	4.1	16.9	4.0	8.0	2.5	20.4	12.7	5.2	2.0	3.7	1.1	6.9	3.0	1.5	6.8	9.2	9.8	4.1	2.7	3.2	4.1	10.6	8.8	9.0	25.0	3.4	22.1	2.9	15.3	7.3	10.2	5.2	6.6	4.9	5.5	5.1	4.8	5.3	5.5	6.0	5.3	15.5	4.1	5.7	3.0	5.9	5.1	5.6	7.6	7.2	5.3	5.7	4.6	10.9	3.6	7.4	7.0
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;lymphoid tissue: 45.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.0;HL-60: 23.9;HMC-1: 33.7;Karpas-707: 25.0;THP-1: 23.8;U-266/70: 37.7;U-266/84: 24.9;U-698: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles				Vesicles	Vesicles	"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	6.1	3.0	2.6	23.3	3.9	20.4	3.1	0.6	2.4	2.2	3.9	3.5	1.4	3.5	2.0	3.7	8.0	3.3	5.9	4.1	1.9	1.7	3.0	3.3	11.3	27.9	4.3	0.7	1.8	1.8	0.3	1.5	2.5	3.4	2.3	3.2	2.6	6.1	1.8	0.9	11.2	13.7	2.9	4.3	45.9	4.1	1.4	4.5	38.1	2.0	2.4	33.2	5.6	3.8	8.3	12.3	27.1	24.0	10.2	19.7	14.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	31.0	0.1	0.0	0.6	0.0	0.0	0.0	14.4	0.0	10.3	0.0	0.0	0.0	23.9	33.7	0.0	0.3	0.0	0.0	0.0	0.0	25.0	0.0	0.2	19.3	5.5	0.0	0.0	12.2	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	23.8	0.2	0.0	0.1	0.0	0.1	37.7	24.9	26.5	0.1	19.1	0.0	3.3	15.5	17.6	19.7	18.3	15.1	7.1	13.2	16.1	12.3	8.3	11.0	14.7	27.1	10.2	24.0	8.4	13.2	14.7	2.6	3.9	0.6	2.4	1.9	1.7	4.3	0.7	3.4	4.5
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.8;lymphoid tissue: 48.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.7;Karpas-707: 26.4;MOLT-4: 24.8;RPMI-8226: 48.8;THP-1: 23.8;U-698: 22.7;U-937: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001012, HPA001083"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favourable (3.94e-5)"	"prognostic unfavourable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favourable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	7.0	4.8	5.3	24.3	5.8	44.8	5.0	4.5	3.2	3.1	6.5	5.2	2.1	6.0	3.9	7.0	4.4	5.2	6.5	4.2	4.5	3.2	7.4	4.9	13.4	29.1	5.2	0.9	2.6	2.3	0.9	3.5	9.0	4.8	4.2	3.0	5.7	7.5	1.8	1.6	1.8	18.0	3.9	5.9	48.4	4.9	3.6	4.2	43.2	4.2	1.6	29.0	7.1	3.6	10.8	17.7	18.7	30.5	8.5	15.7	12.6	0.4	0.1	0.2	1.7	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.1	12.3	25.7	1.5	0.0	0.2	1.3	0.0	0.0	6.9	1.0	9.9	0.1	0.4	1.0	18.2	16.9	0.0	0.1	0.0	0.1	2.6	0.0	26.4	0.1	1.3	24.8	0.3	0.8	0.0	11.8	3.5	48.8	0.1	0.2	2.4	3.5	0.2	0.6	0.2	5.7	23.8	0.5	0.1	0.3	0.2	0.1	16.0	13.6	22.7	0.2	21.3	0.0	5.1	14.1	18.7	15.7	23.1	10.9	10.8	11.2	12.4	14.1	10.4	10.1	10.1	12.0	8.5	30.5	17.7	12.6	12.6	5.3	5.8	4.5	3.2	4.5	3.2	5.2	0.9	4.8	4.2
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472255-57488814	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4"	"Cell line enhanced"	"Detected in some"		"HEL: 11.0;HMC-1: 49.0;THP-1: 14.1;U-937: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 76.9"					"Low region specificity"	"Detected in many"														"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favourable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	5.1	2.5	5.1	33.0	8.0	48.1	4.4	3.7	4.8	1.8	5.4	2.5	0.5	3.6	1.6	1.7	2.7	4.4	4.8	2.4	4.2	1.8	3.5	3.8	11.2	24.1	8.1	0.6	1.2	2.2	0.3	1.5	2.3	5.8	2.5	5.1	2.4	6.0	1.3	0.9	1.4	18.6	2.6	8.5	50.4	3.9	8.8	6.4	19.0	2.6	3.2	28.5	4.7	2.2	8.9	18.9	76.9	17.0	13.1	13.3	11.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.8	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	11.0	0.0	0.0	0.4	6.4	49.0	0.2	0.0	0.0	0.1	0.0	0.2	3.2	0.0	0.0	8.7	8.7	0.4	0.0	3.6	4.2	1.7	0.0	0.0	1.6	1.3	0.0	0.0	0.1	0.0	14.1	0.3	0.0	0.1	0.0	0.0	4.0	2.6	5.3	0.1	11.1	0.2	8.4	16.6	45.1	9.0	17.0	6.2	7.1	9.9	8.1	13.9	8.9	13.3	9.6	76.9	13.1	12.8	18.9	12.1	11.8	5.1	8.0	3.7	4.8	4.2	1.8	8.1	0.6	5.8	6.4
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883161-41930150	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 61.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favourable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavourable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	15.5	8.4	10.7	40.1	16.5	50.0	13.8	8.7	13.8	11.7	14.1	23.3	9.7	13.7	12.7	9.6	12.2	13.0	14.1	9.3	10.6	6.2	12.4	10.4	23.7	57.8	18.1	8.5	12.5	10.8	7.0	11.8	9.6	11.8	11.4	5.8	12.1	13.1	9.2	5.2	12.9	29.3	9.0	12.2	61.0	17.0	3.7	15.6	43.6	13.4	8.6	40.8	12.4	11.7	11.1	10.8	13.7	26.9	15.4	26.3	14.3	19.9	24.3	5.6	7.0	8.0	8.4	6.6	10.6	16.2	13.4	11.8	7.4	17.3	26.8	19.5	9.6	11.8	7.2	16.4	4.2	25.1	8.3	21.6	10.5	9.7	11.7	23.1	35.7	10.1	10.9	13.0	8.5	12.8	8.5	16.5	7.7	13.8	16.1	17.9	6.4	18.9	24.4	10.5	15.8	8.2	11.0	3.7	15.7	14.8	6.6	12.1	7.7	39.5	17.2	17.9	12.0	9.5	16.3	22.5	14.3	23.2	14.6	36.7	28.2	5.1	9.4	13.7	25.1	19.8	20.3	10.8	19.1	26.3	10.8	11.1	20.0	20.4	13.7	15.4	26.9	5.8	19.4	14.3	10.7	16.5	8.7	13.8	10.6	6.2	18.1	8.5	11.8	15.6
ARHGEF39	"C9orf100, FLJ14642"	ENSG00000137135	"Rho guanine nucleotide exchange factor 39"	Q8N4T4	9	35658875-35675866	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 2.4"	"Low region specificity"	"Detected in all"			HPA061299	Uncertain									"HPA061299: AB_2684473"	"unprognostic (2.93e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (8.55e-2)"	"prognostic favourable (4.48e-4)"	"unprognostic (1.14e-1)"	"unprognostic (9.75e-2)"	"unprognostic (6.04e-9)"	"unprognostic (3.31e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.46e-1)"	1.6	1.4	0.6	10.0	0.6	3.3	1.3	1.7	0.6	1.4	3.7	0.3	0.7	4.1	2.1	1.6	5.6	0.5	3.6	0.9	1.0	0.6	0.9	1.0	1.4	3.7	0.6	0.0	0.8	1.6	0.0	0.6	2.8	0.6	0.8	2.1	0.4	1.4	0.7	0.6	2.0	5.5	1.4	0.6	2.0	2.7	2.9	0.1	18.0	0.5	1.7	7.1	0.9	1.7	1.8	0.9	1.4	1.2	1.7	3.6	0.7	5.2	8.1	7.7	3.8	0.1	0.3	5.2	3.9	1.4	3.4	3.1	9.0	4.2	3.2	2.3	0.6	4.1	3.8	2.2	1.3	9.6	6.1	5.3	10.5	3.3	0.0	4.4	8.0	0.3	0.2	1.6	1.0	1.3	3.6	3.0	1.5	2.7	1.1	2.4	4.9	2.6	4.4	6.0	1.9	1.3	2.3	5.5	2.2	1.9	4.3	1.2	6.3	2.6	0.7	2.5	8.1	2.9	2.8	3.0	3.6	1.5	1.5	2.4	5.4	1.2	1.0	0.8	2.4	0.7	3.6	0.9	1.7	2.4	0.9	1.8	0.6	1.6	1.4	1.7	1.2	0.8	1.9	0.7	0.6	0.6	1.7	0.6	1.0	0.6	0.6	0.0	0.6	0.1
ARL11	"ARLTS1, FLJ33930"	ENSG00000152213	"ADP ribosylation factor like GTPase 11"	Q969Q4	13	49628299-49633872	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.5;lymphoid tissue: 18.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;HMC-1: 10.1;NB-4: 10.0;THP-1: 13.2;U-698: 6.0;U-937: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040855, HPA040887"	Uncertain									"HPA040855: AB_10793864, HPA040887: AB_10796229"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.72e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.14e-2)"	4.8	2.1	1.7	14.9	4.1	5.4	1.5	0.6	2.5	2.1	1.6	2.1	0.0	2.0	1.3	1.4	3.1	1.3	2.0	1.1	1.4	1.1	1.2	1.1	6.1	13.8	2.9	0.2	0.7	3.3	0.4	1.5	3.8	2.5	1.1	2.6	1.5	2.2	0.4	0.7	1.2	4.1	1.2	3.3	18.3	1.1	1.0	2.4	6.4	1.2	0.0	9.6	2.8	2.5	5.7	4.7	21.5	9.7	0.4	0.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	7.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.6	0.0	4.6	10.1	0.1	0.1	0.0	0.0	0.4	0.2	0.1	0.0	1.2	4.3	10.0	0.1	0.0	4.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.2	13.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	6.0	0.0	5.8	0.0	10.6	8.7	8.8	0.1	9.7	0.1	4.4	0.2	0.2	4.5	5.7	0.5	0.2	21.5	0.4	7.0	4.7	0.1	2.3	1.7	4.1	0.6	2.5	1.4	1.1	2.9	0.2	2.5	2.4
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497053	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 74.3;U-2197: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavourable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (6.99e-5)"	9.3	6.8	11.1	17.7	9.6	30.3	12.8	19.2	21.2	6.4	6.2	4.9	3.1	3.9	3.6	9.4	13.9	7.6	19.2	3.6	9.1	16.5	8.5	7.9	9.9	28.9	9.4	11.8	2.6	3.6	0.8	5.4	16.8	23.9	6.7	7.4	5.9	14.2	3.6	1.7	15.1	8.1	3.6	5.3	28.0	7.9	1.9	1.8	44.7	2.5	4.4	20.1	14.0	10.8	5.9	17.8	18.7	0.5	18.2	29.7	8.7	7.4	23.0	3.0	0.3	2.7	0.8	7.6	0.7	3.4	0.9	1.7	10.6	14.6	0.0	1.9	1.9	5.6	3.0	15.9	1.1	6.9	1.0	0.0	0.1	0.1	2.8	0.0	0.6	1.7	10.6	9.0	5.5	1.5	0.1	24.7	4.2	1.0	21.4	0.0	3.0	5.2	0.0	13.2	4.2	74.3	8.3	10.8	1.9	0.2	1.7	1.1	0.2	0.4	3.4	14.9	5.7	40.7	14.3	12.3	4.4	0.3	25.5	0.0	7.7	18.7	0.4	8.4	29.7	0.5	29.2	5.9	20.7	23.5	3.2	5.7	18.7	20.9	0.7	18.2	0.2	17.8	25.8	8.7	11.1	9.6	19.2	21.2	9.1	16.5	9.4	11.8	23.9	1.8
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710489-4721499	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.8;lymphoid tissue: 66.6"	"Cell line enhanced"	"Detected in all"		"HMC-1: 70.2;NB-4: 42.1;U-937: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065681			Supported	Vesicles				Vesicles	Vesicles	"HPA065681: AB_2685529"	"unprognostic (1.12e-1)"	"prognostic favourable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavourable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	21.6	15.6	23.7	47.8	18.3	102.8	10.0	28.1	26.3	8.7	16.1	20.4	1.9	23.0	7.4	7.8	7.1	10.8	14.8	10.2	27.3	20.9	10.5	15.6	35.0	31.3	20.1	19.6	8.7	8.3	6.6	10.2	16.0	19.7	7.4	13.2	10.7	8.7	6.2	5.5	5.8	21.0	13.7	21.7	66.6	12.5	5.0	18.3	23.5	6.4	3.2	17.0	15.7	7.1	2.2	18.0	52.9	32.8	5.9	11.4	16.0	3.6	19.5	7.7	7.3	1.5	2.1	4.0	2.9	3.9	8.6	10.7	6.7	3.1	10.2	2.6	2.2	6.2	12.7	4.0	8.9	24.3	18.4	41.5	9.9	11.8	2.3	18.5	70.2	2.0	5.2	10.5	4.2	6.5	2.7	10.3	1.9	6.5	18.5	42.1	4.1	4.1	21.7	6.8	11.3	2.9	2.0	8.0	11.0	6.5	11.2	5.0	5.4	8.7	5.6	3.2	6.4	5.5	10.9	4.3	5.8	5.8	8.5	60.1	4.7	22.6	30.4	52.5	11.0	31.5	7.8	2.2	7.1	11.4	18.0	1.9	6.8	9.0	52.9	5.9	32.8	4.4	6.0	16.0	23.7	18.3	28.1	26.3	27.3	20.9	20.1	19.6	19.7	18.3
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;HEL: 10.0;Hep G2: 6.0;HUVEC TERT2: 22.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in many"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	11000000	11000000	"Rods & Rings"	"Rods & Rings"	"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	6.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family, AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB056158: AB_2665580, HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	4.1	4.9	4.6	12.6	9.2	22.8	7.2	5.6	6.9	14.0	8.6	1.5	13.4	5.3	4.7	5.0	10.7	4.7	3.5	13.7	4.2	6.3	2.2	10.1	9.8	13.7	4.0	4.3	9.9	3.9	3.5	18.7	5.2	4.0	11.4	7.5	2.4	6.8	15.4	13.8	7.2	6.6	5.5	4.1	8.8	6.9	20.2	3.4	53.8	4.8	6.3	12.7	9.9	5.9	4.3	2.3	7.2	2.8	4.0	7.4	1.8	25.0	9.8	13.9	4.7	2.5	3.2	6.1	19.7	6.8	17.0	19.0	7.4	10.9	16.4	6.0	6.2	12.0	18.6	6.3	27.3	22.8	9.9	29.5	10.5	15.0	1.0	10.8	14.6	1.0	0.9	16.1	5.4	5.2	13.8	16.8	12.6	26.0	30.9	8.1	2.5	9.8	16.2	16.6	8.9	6.0	11.5	17.9	7.8	28.5	74.4	5.0	15.1	10.2	3.2	12.9	17.8	10.2	23.6	5.4	9.6	15.2	8.4	18.1	10.1	7.2	1.5	5.4	2.9	1.3	4.0	4.3	4.2	4.8	2.3	2.8	2.8	3.0	0.4	4.0	2.8	0.3	7.4	1.8	4.6	9.2	5.6	6.9	4.2	6.3	4.0	4.3	4.0	3.4
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family, AAA domain containing 5"	Q96QE3	17	30831970-30895869	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.0;lymphoid tissue: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	2.0	1.2	1.1	8.1	3.8	19.0	2.4	9.6	3.2	2.7	3.3	1.2	0.7	2.8	2.1	2.5	4.0	2.0	1.7	1.4	1.8	1.3	1.9	1.4	2.3	6.4	1.9	2.7	3.0	1.7	1.3	3.1	5.3	2.3	1.8	3.1	0.6	2.1	1.2	1.3	4.5	3.4	1.5	1.5	6.3	2.2	4.0	2.6	29.9	1.8	2.7	5.3	1.8	2.7	2.3	2.1	3.1	1.3	3.0	1.6	0.3	4.8	4.0	9.5	9.0	0.2	1.0	3.8	4.2	2.1	4.7	6.8	4.4	3.4	12.9	4.1	1.9	8.8	6.1	3.2	8.6	2.9	5.3	7.8	5.2	3.0	0.1	15.1	6.3	0.4	0.4	6.9	2.4	2.4	12.1	10.8	3.1	2.8	16.8	7.5	5.6	1.9	11.6	18.1	6.1	1.2	5.1	5.6	5.0	4.7	2.7	2.5	5.1	6.7	1.9	5.9	7.9	8.2	7.5	3.6	3.7	16.2	2.5	7.2	5.7	1.2	1.0	1.4	1.6	1.3	0.9	1.2	0.9	1.2	0.7	2.3	1.1	1.2	3.1	3.0	0.6	2.1	1.4	0.3	1.1	3.8	9.6	3.2	1.8	1.3	1.9	2.7	2.3	2.6
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814308-72843674	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.9;lymphoid tissue: 52.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 28.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favourable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	7.8	6.6	7.1	20.7	8.0	60.9	7.2	7.4	6.2	9.5	9.7	10.5	7.6	5.5	11.9	7.5	10.2	8.3	11.6	5.8	7.4	4.8	7.2	6.5	16.3	16.4	10.7	7.0	10.1	8.0	5.7	11.5	5.2	8.6	7.3	8.9	11.3	10.1	5.5	3.6	35.7	13.1	10.4	7.9	52.0	6.6	2.6	8.3	3.2	6.5	8.0	19.6	8.5	8.5	2.0	4.7	28.5	7.1	2.4	2.6	1.4	1.5	1.4	4.3	3.3	5.0	4.2	2.6	3.3	3.3	1.6	2.5	1.7	3.6	9.9	2.2	4.2	3.0	0.5	11.1	2.8	7.8	1.7	7.7	7.0	2.7	3.7	10.1	32.2	4.0	1.5	3.7	4.6	5.0	1.0	13.6	1.9	4.9	11.6	17.4	0.6	1.6	5.7	3.0	4.3	5.4	5.0	3.1	2.5	1.4	7.4	3.0	3.7	13.9	7.0	4.5	1.7	8.2	2.5	6.1	1.5	4.3	2.0	9.0	2.5	2.4	7.1	18.1	1.3	3.9	1.3	1.2	1.9	2.6	4.7	2.0	1.0	1.2	28.5	2.4	4.7	0.8	1.7	1.4	7.1	8.0	7.4	6.2	7.4	4.8	10.7	7.0	8.6	8.3
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;HEL: 3.2;NTERA-2: 1.0;U-266/84: 2.8;U-937: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved									"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.3	0.0	0.5	1.2	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.8	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.4;salivary gland: 88.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 57.9;Karpas-707: 25.3;MOLT-4: 51.8;SK-BR-3: 42.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.9;midbrain: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	15	"cerebellum: 75.4"	"Low region specificity"	"Detected in many"			"HPA007180, CAB010882"	Approved					100000000	100000000			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favourable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	2.1	4.9	0.9	36.9	1.6	24.3	2.7	10.9	1.7	2.3	15.4	1.8	48.8	8.1	3.4	2.8	4.5	2.2	16.0	2.6	0.9	0.7	3.4	1.6	7.8	25.6	4.1	1.4	2.1	20.2	0.0	0.8	1.7	1.4	7.4	9.0	8.7	88.1	47.3	0.9	9.4	26.1	3.0	1.0	36.4	25.5	1.6	1.2	82.4	4.2	6.0	47.5	5.4	2.6	8.3	10.8	21.1	1.0	2.5	7.8	3.9	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.3	39.1	2.4	0.1	0.1	0.6	0.0	0.0	4.8	0.4	20.4	1.2	0.0	0.3	22.2	57.9	0.0	0.0	0.1	0.0	0.0	4.1	25.3	0.0	24.3	51.8	23.9	0.2	0.3	5.7	0.0	9.0	0.0	0.7	2.5	0.7	0.3	42.1	0.0	2.6	5.5	0.1	0.0	0.4	0.1	0.0	9.4	2.8	13.8	0.5	15.9	0.0	9.1	1.0	21.1	7.8	0.6	6.1	6.9	4.8	7.2	1.0	8.3	3.6	4.4	9.0	2.5	0.3	10.8	4.2	3.9	0.9	1.6	10.9	1.7	0.9	0.7	4.1	1.4	1.4	1.2
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000163635	"Ataxin 7"	O15265	3	63898399-64003453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in many"											HPA034989			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA034989: "	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favourable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	8.8	6.4	4.9	14.5	7.4	19.7	8.9	10.2	6.5	9.5	10.7	4.9	6.7	8.0	10.9	9.2	9.2	7.5	11.4	7.5	5.0	4.3	6.3	8.2	10.2	19.9	6.1	3.1	12.4	21.7	15.3	10.9	15.1	6.0	8.2	8.1	15.1	12.2	7.8	9.6	10.6	12.5	9.2	5.7	11.1	7.2	14.6	6.7	55.4	8.8	8.5	24.2	8.4	10.2	0.9	0.5	11.1	0.5	2.6	5.9	1.1	5.9	4.8	5.0	4.0	5.7	6.5	6.5	3.5	6.4	7.4	6.0	6.8	5.8	5.7	2.1	6.7	3.9	6.3	6.5	7.9	15.0	2.6	10.0	5.7	2.0	2.9	4.2	12.1	6.2	3.5	11.0	12.2	5.5	3.7	17.5	4.6	14.2	8.8	3.4	3.4	2.2	3.8	4.5	6.9	3.6	7.1	2.0	3.7	7.7	5.2	7.0	3.6	6.0	7.6	6.4	8.7	9.3	8.0	7.9	7.9	6.4	7.6	7.0	6.1	11.1	0.3	0.9	3.2	0.5	2.6	0.0	5.9	3.4	0.1	0.9	5.7	3.7	1.2	2.6	0.1	0.5	4.7	1.1	4.9	7.4	10.2	6.5	5.0	4.3	6.1	3.1	6.0	6.7
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"	"Nucleoplasm, Midbody"	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.0	28.2	42.0	20.2	0.9	1.4	16.1	19.7	10.6	40.8	37.7	36.5	12.4	41.0	10.2	7.8	30.2	30.5	13.5	33.8	18.0	50.1	24.4	16.1	30.8	0.1	12.9	24.0	0.7	0.6	23.9	15.0	18.8	15.2	15.9	17.9	19.5	46.8	18.3	26.1	12.6	31.7	38.7	17.0	8.9	8.1	9.1	13.0	17.5	7.9	13.4	13.8	8.7	7.3	16.4	16.9	14.7	51.2	11.6	7.7	30.8	7.9	19.6	33.1	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.1;RPTEC TERT1: 21.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 15.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054092, HPA054684"	Approved				"Intracellular and membrane"					"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.1	0.3	0.5	3.1	15.8	0.1	1.8	0.3	1.5	3.0	16.2	0.6	0.0	19.4	1.4	1.6	2.3	1.0	12.9	0.2	1.3	1.5	0.6	0.3	0.2	0.1	0.7	0.1	0.7	6.2	0.1	7.9	0.7	2.2	1.0	27.1	2.2	5.5	0.1	0.2	1.1	23.4	0.7	2.0	0.2	3.8	0.6	3.6	1.8	1.1	0.8	14.8	1.1	5.9	0.2	0.2	1.0	0.2	0.3	0.2	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.9	0.5	0.0	2.1	0.1	21.5	1.3	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.1	0.8	0.0	0.0	0.0	0.9	0.0	0.2	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.3	0.0	0.2	0.0	0.0	0.5	15.8	0.3	1.5	1.3	1.5	0.7	0.1	2.2	3.6
B4GALNT2	"Cad, GALGT2, Sda"	ENSG00000167080	"Beta-1,4-N-acetyl-galactosaminyltransferase 2"	Q8NHY0	17	49132460-49176840	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.6;lymphoid tissue: 30.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA015721	Approved									"HPA015721: AB_1845245"	"unprognostic (4.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.03e-4)"		"unprognostic (1.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.67e-2)"	"unprognostic (4.06e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-1)"	"prognostic favourable (1.29e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.15e-1)"	0.3	0.8	0.4	30.9	0.5	2.2	0.4	0.3	0.5	0.3	19.6	0.3	0.3	0.7	0.3	0.3	0.5	0.4	4.0	0.3	0.3	0.3	8.3	0.3	1.1	0.8	0.3	0.3	0.3	0.5	0.0	0.4	0.7	0.6	0.3	7.9	0.4	1.7	0.3	0.3	1.8	11.9	1.3	1.1	0.8	5.3	0.7	0.3	0.3	10.3	0.3	0.8	0.3	1.4	2.0	1.2	2.3	0.6	0.6	1.6	0.2	1.5	2.9	2.9	5.1	0.1	0.1	1.5	2.2	1.6	0.1	0.2	6.0	2.4	3.5	3.5	0.1	1.6	1.1	0.1	0.4	3.0	3.2	3.8	7.2	3.5	0.1	1.9	6.1	0.3	2.1	0.6	0.3	0.0	2.1	5.8	0.1	1.8	2.5	2.6	3.6	1.5	4.2	1.3	1.1	8.2	2.4	2.7	2.6	1.0	1.3	1.1	3.1	2.5	1.1	3.7	2.3	2.3	1.1	4.4	1.4	3.7	1.3	2.6	1.5	2.3	0.6	0.9	1.1	0.5	0.6	1.3	1.2	0.8	0.5	2.0	1.6	1.5	1.2	0.6	0.3	1.2	0.6	0.2	0.4	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.6	0.3
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926529-90296908	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Group enriched"	"Detected in some"	6	"Daudi: 51.5;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 15.4"	"Lineage enriched"	"Detected in many"	4	"B-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1.0	1.3	6.8	2.1	1.9	3.0	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4.0	6.3	4.0	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2.0	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0.0	1.5	3.7	0.4	0.3	0.0	1.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	51.5	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	1.1	0.0	2.0	4.5	0.0	0.1	1.0	0.0	0.5	0.4	7.0	1.3	0.9	0.0	0.1	1.7	4.8	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.4	0.1	30.2	0.2	0.5	0.3	1.8	0.0	0.7	0.4	0.0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0.0	1.5	0.0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4.0	4.9	6.9
BATF	"B-ATF, BATF1, SFA-2"	ENSG00000156127	"Basic leucine zipper ATF-like transcription factor"	Q16520	14	75522425-75547015	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.1;lymphoid tissue: 26.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 81.1;MCF7: 30.5;RT4: 19.1;SK-BR-3: 15.6;U-937: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"T-cells: 41.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA059588, HPA064962"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059588: AB_2684074, HPA064962: AB_2685392"	"unprognostic (3.33e-3)"	"unprognostic (4.87e-3)"	"prognostic unfavourable (8.30e-4)"	"prognostic favourable (5.35e-6)"	"unprognostic (3.02e-2)"	"prognostic favourable (7.91e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavourable (3.74e-9)"	"unprognostic (4.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (4.30e-4)"	4.9	1.3	0.9	15.8	4.7	13.8	7.6	0.2	1.9	2.8	2.8	0.2	1.0	2.0	1.3	1.4	2.6	1.9	7.0	3.1	1.0	0.7	1.9	3.0	7.9	20.2	2.1	0.2	1.6	1.6	0.5	1.2	3.7	1.9	5.2	1.1	1.0	6.0	8.3	0.9	2.8	8.0	2.6	2.7	26.6	5.7	0.7	1.9	6.2	2.7	3.4	23.1	10.4	7.3	7.1	9.0	5.0	8.9	6.4	41.1	8.4	1.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.1	0.0	1.8	0.0	0.3	2.7	2.2	8.4	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	30.5	1.0	6.6	0.0	0.0	0.2	0.0	1.4	0.0	19.1	0.0	0.0	0.0	15.6	0.6	1.4	4.2	0.0	0.0	0.0	1.0	0.0	7.6	8.0	0.0	0.0	22.5	0.0	1.2	8.9	2.7	19.6	4.9	15.4	7.1	21.4	25.1	9.0	5.2	8.6	18.1	5.0	6.4	4.2	1.0	41.1	8.4	0.9	4.7	0.2	1.9	1.0	0.7	2.1	0.2	1.9	1.9
BCAS4	"CNOL, FLJ20495"	ENSG00000124243	"Breast carcinoma amplified sequence 4"	Q8TDM0	20	50794894-50882676	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.9;lymphoid tissue: 31.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;U-698: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.9;naive B-cell: 28.7"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA038812	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"	"Intermediate filaments, Cytosol"	"HPA038812: AB_10795141"	"unprognostic (3.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.30e-2)"	1.8	2.3	7.3	29.1	12.9	3.9	4.5	6.2	12.8	4.8	4.2	2.3	4.2	2.4	5.4	7.2	4.7	3.6	3.8	3.1	13.8	7.5	7.0	1.4	3.8	28.5	7.1	9.2	3.0	3.6	9.2	5.4	5.0	5.2	7.7	1.9	8.8	4.9	7.1	2.1	2.1	8.6	6.0	2.0	12.2	4.5	5.1	2.2	9.2	5.9	0.0	31.6	7.6	5.3	28.9	7.0	0.6	0.1	6.9	12.9	5.3	4.8	8.7	0.7	3.8	1.4	3.6	1.5	6.3	5.7	4.6	3.2	4.1	2.9	38.1	2.4	2.6	7.2	4.3	9.1	2.6	2.4	3.8	0.2	3.4	3.4	1.9	0.0	0.2	1.2	5.3	3.5	1.7	0.2	0.1	0.2	1.6	17.0	1.4	0.1	3.1	7.1	11.9	1.1	0.3	2.1	4.4	3.9	4.1	9.8	9.4	0.2	18.6	0.4	0.2	4.9	7.2	4.9	1.5	0.6	2.8	33.9	2.0	0.3	0.4	0.6	0.1	0.1	6.2	0.1	3.5	28.9	3.8	7.5	0.1	28.7	12.9	10.3	0.6	6.9	0.1	7.0	3.1	5.3	7.3	12.9	6.2	12.8	13.8	7.5	7.1	9.2	5.2	2.2
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"B cell CLL/lymphoma 11B"	Q9C0K0	14	99169287-99271524	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 32.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 13.7"	"Group enriched"	"Detected in many"	8	"gdTCR: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favourable (7.48e-4)"	0.3	0.4	4.4	6.6	13.7	5.2	1.3	0.3	3.8	0.8	1.3	0.1	0.0	2.3	1.9	0.8	3.9	0.3	3.0	0.8	4.8	1.0	0.3	0.5	1.1	10.8	0.8	2.6	0.2	0.1	0.0	0.1	0.0	0.6	0.6	1.7	0.3	5.0	0.7	0.1	17.6	3.0	0.2	0.7	4.9	2.1	0.4	1.6	25.4	0.9	1.5	8.8	2.0	2.3	0.0	0.0	0.1	0.0	0.5	7.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	3.0	0.0	1.8	32.6	0.5	0.3	0.0	5.1	0.0	0.0	0.0	1.8	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.1	3.3	0.0	3.0	0.0	4.5	3.7	0.0	0.0	7.4	4.9	0.0	0.5	0.0	0.0	3.0	1.1	4.4	13.7	0.3	3.8	4.8	1.0	0.8	2.6	0.6	1.6
BDKRB1	"B1BKR, BKR1, bradyb1"	ENSG00000100739	"Bradykinin receptor B1"	P46663	14	96255824-96268967	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 16.1;lymphoid tissue: 17.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.6;HHSteC: 11.9;hTEC/SVTERT24-B: 11.1;U-2197: 12.3;U-87 MG: 40.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Cell type enriched"	"Detected in single"	19	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.8"	"Low region specificity"	"Detected in single"							HPA002935	Approved									"HPA002935: AB_1078274"	"unprognostic (6.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.96e-6)"	"unprognostic (2.33e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.66e-2)"	7.3	0.0	0.2	17.1	0.2	0.0	0.8	2.1	0.6	5.4	3.7	0.2	0.2	1.8	0.7	2.8	10.4	4.8	16.1	2.3	0.2	0.0	2.4	0.6	3.7	0.2	0.2	0.2	4.5	7.9	0.0	0.2	3.0	0.4	2.2	2.8	0.7	1.5	1.1	0.4	2.4	3.7	5.7	0.2	0.6	3.3	2.3	0.2	0.2	0.8	4.6	2.0	13.7	5.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.6	0.0	0.4	1.1	3.9	0.0	1.0	11.6	1.2	0.2	0.0	0.2	0.0	0.0	6.7	1.1	0.0	0.1	1.9	0.1	0.0	0.0	1.1	0.0	11.9	0.0	0.0	0.4	0.9	11.1	0.2	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.1	0.0	0.4	0.0	3.2	1.1	0.0	0.0	0.0	0.0	4.4	0.2	12.3	0.6	2.1	4.0	0.0	40.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.2	2.1	0.6	0.2	0.0	0.2	0.2	0.4	0.2
BIK	NBK	ENSG00000100290	"BCL2 interacting killer"	Q13323	22	43110748-43129712	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 28.8;lymphoid tissue: 26.4"	"Cell line enhanced"	"Detected in many"		"A-431: 28.8;CAPAN-2: 14.7;Daudi: 14.4;U-698: 55.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"eosinophil: 28.8;memory B-cell: 7.8;plasmacytoid DC: 24.0"	"Group enriched"	"Detected in many"	5	"B-cells: 7.8;dendritic cells: 24.0;granulocytes: 28.8"									HPA051360	Approved									"HPA051360: AB_2681453"	"unprognostic (1.18e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.86e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (7.45e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.04e-1)"	0.2	2.2	0.1	23.0	0.9	3.5	4.7	0.1	0.7	3.1	7.7	0.3	8.6	3.5	0.7	2.0	10.5	3.0	19.1	0.6	0.5	0.2	4.2	0.7	2.8	11.1	0.4	0.1	1.8	3.1	0.6	1.1	0.6	0.5	11.9	5.3	0.9	20.9	4.8	0.1	3.1	6.7	0.6	0.6	3.6	13.2	3.0	0.1	4.3	1.8	5.2	26.4	2.7	5.0	7.8	24.0	28.8	1.2	0.3	4.2	2.6	28.8	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.4	14.7	14.4	1.4	0.0	6.4	1.6	0.6	0.0	0.2	2.2	0.0	0.1	1.5	0.2	6.8	1.4	0.0	3.0	0.0	0.0	0.0	0.1	0.6	0.0	7.3	5.3	9.3	2.2	2.4	0.0	0.0	6.6	0.3	0.8	0.5	0.0	1.0	2.7	2.0	0.5	9.4	0.2	0.0	0.8	0.0	0.3	3.5	5.4	55.8	0.0	0.7	0.0	0.7	1.2	28.8	1.2	0.3	1.9	7.8	4.2	1.8	4.3	3.4	2.8	1.5	4.8	0.3	0.3	24.0	2.8	2.6	0.1	0.9	0.1	0.7	0.5	0.2	0.4	0.1	0.5	0.1
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;Daudi: 33.0;HDLM-2: 31.2;hTERT-HME1: 32.8;U-266/70: 22.0;U-266/84: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA002317: AB_1846748"	"prognostic favourable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.3	5.1	0.0	0.1	0.1	0.7	0.6	0.5	4.3	0.6	0.7	0.9	37.5	33.0	17.0	0.3	3.6	0.0	0.9	2.1	31.2	0.1	0.1	1.5	0.2	6.5	0.5	0.7	0.7	4.6	2.1	32.8	0.1	0.1	0.0	0.8	0.0	2.2	0.3	0.1	0.2	0.0	0.3	1.6	8.5	3.3	0.0	0.1	0.5	0.5	0.3	1.6	0.3	1.7	7.2	0.7	0.4	6.5	22.0	18.8	11.6	1.3	1.8	0.8	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.6;testis: 51.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 14.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"				"Cytokinetic bridge"	"Cytokinetic bridge"	"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (5.28e-6)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	2.3	1.5	0.4	14.1	0.7	20.8	5.3	0.7	0.6	1.9	4.8	0.3	0.2	4.6	0.9	1.4	13.4	0.4	2.2	2.4	0.5	0.4	1.3	2.2	2.4	9.7	0.6	0.2	0.9	0.8	0.0	0.4	6.1	0.5	0.9	5.2	0.2	2.1	0.2	0.6	3.5	4.7	2.4	0.7	6.3	3.2	51.4	0.3	61.6	0.5	14.4	11.7	2.0	3.2	2.5	0.8	0.5	0.0	2.2	14.0	3.0	31.6	29.6	26.7	28.9	1.7	2.8	9.8	24.4	13.7	34.8	22.9	24.2	12.5	32.6	9.9	14.1	16.9	27.0	15.6	30.5	11.0	37.5	21.5	17.5	28.4	0.2	20.7	16.2	0.9	1.1	19.3	14.3	24.6	26.9	27.6	26.7	18.3	44.0	19.8	19.9	52.1	23.0	43.4	25.2	8.2	11.7	33.0	22.8	18.7	21.2	16.6	28.0	19.6	9.2	42.2	37.4	18.2	34.6	20.0	16.1	37.7	15.4	8.7	36.6	0.0	0.0	0.0	0.7	0.0	0.2	2.5	4.3	2.8	0.8	0.3	0.0	0.4	0.5	2.2	0.0	0.3	14.0	3.0	0.4	0.7	0.7	0.6	0.5	0.4	0.6	0.2	0.5	0.3
BLNK	"BASH, bca, BLNK-s, Ly57, SLP-65, SLP65"	ENSG00000095585	"B cell linker"	Q8WV28	10	96191702-96271587	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.7;lymphoid tissue: 47.1"	"Group enriched"	"Detected in some"	6	"Daudi: 17.9;REH: 43.3;RPMI-8226: 23.9;U-698: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 35.9;naive B-cell: 31.0;plasmacytoid DC: 50.7"	"Group enriched"	"Detected in many"	117	"B-cells: 35.9;dendritic cells: 50.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009333, CAB016291, HPA038309, HPA038310"	Enhanced		Supported	"Plasma membrane,Cytoplasmic bodies"				"Plasma membrane, Cytoplasmic bodies"	"Plasma membrane, Cytoplasmic bodies"	"CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: "	"unprognostic (4.86e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.46e-3)"	"prognostic favourable (2.67e-6)"	2.3	2.0	6.9	22.1	8.9	4.2	3.0	1.3	4.8	6.2	15.0	13.7	9.8	17.7	1.9	15.3	31.1	2.7	9.9	1.5	6.4	3.6	18.9	29.5	3.2	24.4	8.9	4.4	1.4	10.4	9.3	2.4	5.0	9.2	5.4	8.5	2.4	9.5	11.5	1.2	6.3	20.6	1.2	16.7	41.7	13.3	1.4	8.7	3.6	6.4	12.8	47.1	6.8	11.8	35.9	50.7	0.2	0.3	0.3	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.1	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	43.3	0.0	23.9	0.2	3.3	0.0	0.0	0.0	4.1	0.0	6.1	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	65.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	35.9	0.0	0.0	4.4	31.0	0.0	0.0	0.2	0.3	0.0	50.7	0.0	1.8	6.9	8.9	1.3	4.8	6.4	3.6	8.9	4.4	9.2	8.7
BMF	FLJ00065	ENSG00000104081	"Bcl2 modifying factor"	Q96LC9	15	40087890-40108892	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 81.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.4;HMC-1: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010120	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA010120: AB_1845385"	"unprognostic (2.94e-1)"	"unprognostic (4.92e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.83e-4)"	"prognostic unfavourable (6.32e-4)"	"unprognostic (1.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.35e-2)"	5.3	2.9	1.3	13.5	1.9	15.8	6.1	2.3	2.0	10.9	9.9	2.1	13.0	11.9	12.4	4.7	2.8	8.3	6.7	3.4	1.3	1.6	6.5	3.9	7.7	18.4	2.8	0.9	8.9	8.1	1.8	2.8	5.7	2.5	7.0	4.5	7.2	9.2	10.8	4.6	4.0	23.2	5.8	3.0	18.1	6.7	4.1	2.1	81.0	18.6	3.1	15.0	7.5	3.7	5.1	3.3	5.2	6.0	0.0	1.4	0.9	0.5	0.7	12.5	2.7	0.3	0.5	8.5	0.0	1.9	0.2	0.6	12.5	0.9	3.6	4.0	0.5	2.6	3.0	0.1	0.0	8.6	2.5	1.8	21.4	2.8	1.2	0.3	24.3	6.3	0.7	0.2	0.2	3.2	0.9	1.6	1.1	0.6	1.2	9.2	3.3	0.4	2.3	2.8	10.4	0.5	2.9	6.6	5.4	2.4	6.3	5.6	3.7	7.3	2.5	0.4	1.8	0.4	0.1	15.5	14.4	2.2	0.9	1.7	1.5	0.1	4.2	3.6	0.2	4.9	0.4	5.1	0.4	1.4	2.7	1.8	0.7	0.1	5.2	0.0	6.0	3.3	1.2	0.9	1.3	1.9	2.3	2.0	1.3	1.6	2.8	0.9	2.5	2.1
BORA	"C13orf34, FLJ22624"	ENSG00000136122	"Bora, aurora kinase A activator"	Q6PGQ7	13	72727749-72756198	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040866	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA040866: AB_10794868"	"unprognostic (9.93e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.32e-12)"	"unprognostic (7.04e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.28e-2)"	3.7	3.0	2.3	10.9	3.2	10.9	6.8	5.8	4.2	3.3	9.0	1.8	6.3	6.9	3.1	5.9	7.1	3.2	3.2	2.3	2.6	2.2	4.3	4.3	7.7	11.8	4.3	1.5	3.1	5.6	0.8	6.3	6.8	4.4	4.0	9.1	2.2	4.6	6.7	2.1	6.1	10.6	3.5	5.3	8.9	5.5	7.0	4.6	26.5	5.0	5.8	12.4	5.6	4.5	5.0	5.7	7.2	5.4	4.6	8.3	3.7	22.6	3.9	12.9	8.7	1.6	1.6	9.1	7.6	6.8	12.0	13.1	10.4	13.1	14.8	4.3	4.3	9.7	11.6	7.5	15.9	13.7	6.4	18.2	6.3	8.5	1.5	34.4	11.8	1.3	1.9	5.3	11.7	9.9	8.3	6.4	8.6	5.3	15.4	10.0	5.7	4.7	11.3	7.6	6.5	4.0	5.9	3.4	4.1	7.6	7.4	5.5	5.0	12.6	3.6	3.3	7.6	5.8	9.7	5.5	5.0	10.6	9.4	16.3	8.3	7.2	3.1	1.6	6.6	5.4	5.8	4.6	5.7	6.4	5.7	5.0	4.7	8.3	0.7	4.6	3.3	3.2	5.9	3.7	2.3	3.2	5.8	4.2	2.6	2.2	4.3	1.5	4.4	4.6
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309878	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HMC-1: 2.0;RT4: 4.1;SK-BR-3: 8.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 6.2"	"Low region specificity"	"Detected in all"			HPA024256	Enhanced				"Secreted in other tissues"	7500000	7500000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	100.1	0.1	0.3	0.1	3.7	0.5	0.2	23.3	0.0	0.3	0.3	0.2	0.0	0.1	0.1	101.0	0.1	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.9	0.0	0.1	38.8	0.8	1.0	0.0	0.1	0.1	0.1	0.1	76.9	1.1	0.1	0.2	0.2	29.6	115.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.7	0.0	0.3	0.0	4.1	0.0	0.0	0.0	8.4	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2, DNA repair associated"	P51587	13	32315474-32400266	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 16.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026815	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	2.4	1.0	0.6	13.8	0.6	11.6	3.2	0.6	0.6	1.8	4.0	0.2	0.2	1.4	1.5	2.7	3.0	1.0	0.7	2.1	0.6	0.7	1.0	1.4	3.5	5.3	0.7	0.5	1.4	3.3	0.4	0.7	7.0	0.8	0.9	2.0	0.1	1.8	0.3	3.3	1.8	3.2	0.8	2.1	6.6	1.5	16.9	0.1	23.2	0.9	4.8	4.2	1.3	1.7	1.3	1.9	0.4	0.2	1.5	0.8	0.0	3.9	3.5	6.0	4.5	0.6	1.6	6.2	4.3	2.7	5.0	4.6	8.2	5.3	14.0	2.8	2.1	5.4	4.9	2.5	9.6	9.1	2.6	8.9	2.2	3.2	0.2	12.7	4.4	0.3	0.3	9.1	6.3	4.0	5.8	4.9	5.7	4.5	10.1	7.5	7.2	1.9	10.0	15.5	2.7	1.3	4.3	2.3	4.3	5.2	2.2	2.1	2.6	6.3	3.1	5.7	6.1	6.3	5.9	1.9	2.9	7.2	2.9	5.1	5.4	0.1	0.2	0.2	0.3	0.2	0.1	0.9	0.4	0.2	0.2	1.3	0.6	0.8	0.4	1.5	0.2	1.9	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.5	0.8	0.1
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61681266-61863521	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favourable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favourable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	1.0	0.9	0.7	6.3	3.5	9.1	1.1	0.6	1.4	1.4	2.6	0.2	0.6	2.8	1.5	1.2	3.7	0.8	1.8	0.4	0.5	0.5	0.6	2.3	1.3	4.0	0.5	0.9	2.1	1.3	0.1	0.4	1.7	0.7	1.0	2.8	0.4	1.4	0.0	0.4	2.7	5.5	1.0	0.5	2.3	1.3	10.8	0.4	30.1	0.4	2.0	6.6	1.3	1.7	2.2	0.5	2.1	0.3	0.6	3.7	0.5	12.3	4.2	12.2	6.9	0.4	1.1	2.7	11.4	6.7	12.2	15.8	4.3	3.9	7.3	2.6	2.4	4.5	6.3	2.3	16.4	1.8	7.7	7.5	6.7	5.3	0.1	9.6	4.4	0.2	0.1	9.7	2.6	2.6	5.2	5.0	7.6	41.4	15.2	3.3	2.6	3.6	9.5	23.4	3.5	1.6	5.6	4.9	12.7	4.4	1.5	1.8	4.1	3.7	2.2	18.0	13.1	6.6	13.1	3.1	6.0	7.9	3.7	4.6	4.5	2.1	0.3	1.5	0.5	0.2	0.6	2.2	1.2	0.6	0.4	1.8	1.8	0.9	1.0	0.6	0.2	0.5	3.7	0.5	0.7	3.5	0.6	1.4	0.5	0.5	0.5	0.9	0.7	0.4
BTG1	APRO2	ENSG00000133639	"BTG anti-proliferation factor 1"	P62324	12	92140278-92145897	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 190.7"	"Cell line enhanced"	"Detected in all"		"ASC TERT1: 49.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005972			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA005972: "	"prognostic favourable (4.36e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (1.95e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.81e-2)"	52.0	22.1	11.5	58.3	13.4	126.9	114.4	66.8	10.4	41.7	40.1	5.5	21.9	15.5	30.1	22.0	28.7	27.9	39.9	49.2	11.9	8.1	22.2	58.1	85.6	190.7	10.4	8.2	29.1	64.2	17.6	17.1	23.4	13.3	28.7	18.1	21.0	19.0	25.9	31.6	70.6	34.3	26.0	24.6	77.1	26.4	19.0	8.9	148.9	15.7	14.3	58.2	54.2	35.2	58.3	6.6	94.3	14.0	47.1	95.2	26.1	6.8	8.6	9.5	1.1	35.7	49.6	4.1	7.7	17.1	5.2	5.2	5.1	2.4	7.4	1.6	8.2	4.7	3.1	8.7	9.7	8.9	6.7	1.4	6.0	2.6	36.2	5.4	2.5	42.3	26.2	11.9	36.9	10.4	5.1	9.8	5.9	7.1	3.8	17.4	2.3	9.9	13.1	5.3	2.3	16.0	14.3	5.3	10.6	9.7	7.5	25.0	31.4	12.6	3.3	5.9	1.8	4.5	4.7	13.6	7.2	12.3	4.6	4.3	6.6	22.3	13.6	94.3	17.0	10.6	20.1	44.5	34.3	29.8	6.6	58.3	95.2	39.1	52.3	47.1	14.0	6.2	39.2	26.1	11.5	13.4	66.8	10.4	11.9	8.1	10.4	8.2	13.3	8.9
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221136	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.5;testis: 25.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.8;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008419			Supported	Cytosol				Cytosol	Cytosol	"HPA008419: "	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (7.43e-6)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	1.0	0.9	0.3	18.4	0.6	11.4	1.5	0.4	0.5	1.3	4.0	0.4	0.1	3.3	1.1	0.8	6.5	0.5	1.1	0.6	0.4	0.4	0.8	0.7	1.8	8.7	0.4	0.3	0.6	0.5	0.0	0.4	3.4	0.5	0.6	4.4	0.3	1.6	0.1	0.7	2.3	2.9	1.2	0.6	5.4	1.7	25.6	0.1	49.5	0.5	3.1	10.6	1.1	2.0	2.8	2.8	0.0	0.2	0.7	0.7	0.5	21.6	11.0	35.1	13.9	0.8	2.5	11.3	20.5	11.5	22.0	19.1	16.0	8.3	19.6	11.5	7.4	24.4	33.1	11.1	24.0	16.8	17.8	28.6	28.4	14.9	0.0	25.7	15.7	0.5	0.6	13.4	12.7	15.9	24.6	20.9	21.9	7.3	20.2	15.7	23.7	12.5	21.7	28.8	14.8	6.7	11.0	22.9	14.1	12.7	12.1	4.5	14.1	13.4	9.2	16.9	17.9	16.8	18.2	10.9	18.5	32.0	9.0	29.0	21.9	0.0	0.0	0.0	0.2	0.2	0.3	2.4	0.7	0.6	0.7	2.8	0.1	0.4	0.0	0.7	0.1	2.8	0.0	0.5	0.3	0.6	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.1
C10orf105	FLJ00245	ENSG00000214688	"Chromosome 10 open reading frame 105"	Q8TEF2	10	71711702-71737824	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 20.1;lymphoid tissue: 8.6"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 8.3"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.3;myeloid DC: 1.6;non-classical monocyte: 4.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;monocytes: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (2.60e-3)"	"unprognostic (6.76e-3)"	"unprognostic (5.45e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.37e-6)"	"unprognostic (5.25e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	1.2	0.7	6.8	2.8	8.8	1.8	0.5	0.7	5.6	0.7	0.8	20.1	0.0	1.0	0.8	0.3	0.9	0.8	1.2	0.6	8.9	10.6	0.4	0.7	1.1	3.7	11.7	5.2	1.0	0.3	0.4	0.1	0.8	13.7	0.6	0.7	0.0	0.6	0.4	0.8	1.9	1.3	0.6	4.2	8.6	0.5	3.0	8.7	0.5	0.4	0.0	2.0	1.2	0.2	0.0	1.6	0.7	4.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.2	0.9	0.0	0.0	0.1	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	4.3	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	4.8	0.0	0.0	0.3	6.8	8.8	0.7	4.9	8.9	10.6	11.7	5.2	13.7	8.7
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173738-84185294	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1"	"Cell line enriched"	"Detected in some"	5	"RT4: 31.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050920	Enhanced				"Secreted in other tissues"					"HPA050920: AB_2681274"		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.1	0.0	0.0	48.4	0.0	0.0	0.1	0.0	0.1	22.5	63.5	0.0	0.2	0.0	2.6	0.0	93.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	66.0	0.0	5.9	0.7	0.0	8.8	5.4	3.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	95.1	21.6	17.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C11orf16		ENSG00000176029	"Chromosome 11 open reading frame 16"	Q9NQ32	11	8920076-8933006	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 19.1;lymphoid tissue: 10.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;CACO-2: 1.5;EFO-21: 1.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.0;T-reg: 1.6"	"Group enriched"	"Detected in many"	9	"monocytes: 1.0;T-cells: 1.6"	"Low region specificity"	"Detected in some"																		"unprognostic (5.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.09e-3)"	"prognostic favourable (3.32e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.94e-5)"	"unprognostic (6.40e-4)"	"unprognostic (1.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.13e-3)"	0.0	0.2	0.5	0.0	0.8	0.0	0.2	0.0	0.3	2.3	0.0	0.7	0.0	0.1	0.6	3.1	0.0	19.1	0.0	0.0	0.8	1.3	0.4	0.0	5.2	0.0	0.0	0.0	2.8	0.0	0.0	1.6	0.0	2.9	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.7	0.0	10.8	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.0	0.1	1.6	0.0	0.9	1.3	1.2	0.5	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.5	0.2	0.1	1.5	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.0	0.7	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.6	0.9	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.4	0.0	0.7	1.0	0.5	0.3	0.2	0.0	0.3	0.0	0.2	0.6	1.1	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.5	0.8	0.0	0.3	0.8	1.3	0.0	0.0	2.9	0.0
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295645-2303049	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0"	"Cell line enhanced"	"Detected in some"		"HEL: 30.1;HL-60: 11.4;NB-4: 10.4;THP-1: 7.3;U-937: 12.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA037607	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.5	0.4	0.7	8.7	0.5	30.4	0.7	0.2	0.7	1.5	0.8	1.7	0.8	0.2	1.6	1.3	0.7	1.0	5.4	15.6	0.4	0.4	1.0	1.3	5.2	8.5	2.2	0.9	0.7	0.6	0.0	0.8	0.8	1.0	0.8	0.8	1.4	9.3	0.1	0.4	0.8	3.3	0.6	1.4	16.0	2.0	0.9	1.0	6.4	1.1	2.7	11.5	1.0	0.9	2.6	7.3	29.5	23.2	9.5	10.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	30.1	0.0	0.1	0.3	11.4	0.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	12.8	0.0	29.5	6.3	18.7	10.6	13.1	7.3	2.0	3.6	8.4	7.3	2.6	5.4	7.5	5.5	9.5	23.2	0.7	2.6	6.4	0.7	0.5	0.2	0.7	0.4	0.4	2.2	0.9	1.0	1.0
C12orf56		ENSG00000185306	"Chromosome 12 open reading frame 56"	Q8IXR9	12	64264762-64391192	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.9;testis: 15.0"	"Group enriched"	"Detected in some"	10	"hTEC/SVTERT24-B: 9.8;SCLC-21H: 8.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA056986	Enhanced									"HPA056986: AB_2683300"	"unprognostic (5.85e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.79e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.38e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.69e-2)"	0.3	0.1	0.1	0.0	0.5	0.2	0.1	1.3	0.2	1.8	0.4	0.9	1.0	0.0	0.1	0.0	1.8	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.4	0.2	0.1	2.7	0.5	0.0	0.0	1.6	0.1	0.0	0.1	0.2	0.1	15.0	0.0	8.9	0.0	0.6	0.9	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123232916-123257959	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favourable (7.82e-5)"	7.8	15.7	13.2	11.3	15.1	9.6	9.0	21.6	18.2	14.1	10.8	12.3	11.6	13.8	14.9	16.5	10.7	11.7	11.1	17.4	13.2	15.2	12.1	15.6	10.6	18.8	11.5	13.2	21.3	12.4	8.8	24.6	9.2	15.0	15.1	9.7	13.1	21.2	10.8	14.3	17.7	12.6	10.5	14.2	14.7	11.7	17.3	12.2	80.9	15.3	7.9	15.5	14.3	13.7	23.6	10.0	22.6	4.6	17.1	28.9	10.0	14.5	10.0	11.4	22.3	5.7	6.1	6.9	12.1	7.7	12.3	9.1	10.8	8.6	18.1	10.5	3.9	10.7	12.3	6.6	11.8	13.6	11.0	21.3	9.9	9.4	12.8	9.9	10.8	6.4	16.1	8.9	18.5	8.0	22.5	7.5	8.2	6.3	23.7	18.3	8.7	15.5	17.7	13.6	16.8	11.5	8.3	24.3	10.5	13.5	6.9	12.6	11.0	11.6	9.0	13.4	16.1	12.1	12.2	12.4	14.3	16.6	8.7	13.1	17.5	22.6	3.5	14.0	15.9	3.8	19.8	23.6	22.0	21.1	6.0	20.2	28.9	24.7	3.7	17.1	4.6	10.0	18.5	10.0	13.2	15.1	21.6	18.2	13.2	15.2	11.5	13.2	15.0	12.2
C12orf74		ENSG00000214215	"Chromosome 12 open reading frame 74"	Q32Q52	12	92702843-92708549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;RT4: 2.4;SK-BR-3: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"memory B-cell: 3.7;naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	21	"B-cells: 3.7"																				"unprognostic (2.75e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.28e-3)"	"unprognostic (4.55e-3)"		"unprognostic (7.95e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.57e-1)"		"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.83e-4)"	"unprognostic (3.03e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.42e-2)"	0.2	0.1	0.1	12.3	0.1	0.0	0.2	0.1	0.1	2.1	0.7	0.0	3.6	0.3	0.7	6.9	1.7	4.5	0.3	0.2	0.1	0.1	1.3	0.5	6.6	1.9	0.1	0.0	1.0	1.1	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.9	0.9	0.1	0.2	1.8	0.0	0.1	2.6	2.1	0.5	0.0	0.1	0.2	0.0	10.5	2.5	1.4	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	2.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
C15orf48	"MIR147BHG, NMES1"	ENSG00000166920	"Chromosome 15 open reading frame 48"	Q9C002	15	45430529-45448761	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 95.5;lymphoid tissue: 56.1;testis: 47.2"	"Cell line enhanced"	"Detected in some"		"A-431: 24.2;CAPAN-2: 45.6;HMC-1: 10.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.2;intermediate monocyte: 3.7;myeloid DC: 3.0;neutrophil: 2.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.0;granulocytes: 2.1;monocytes: 3.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012943	Enhanced									"HPA012943: AB_2668774"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.74e-3)"	"unprognostic (1.48e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.95e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-1)"	0.6	0.1	0.4	56.1	0.4	7.2	2.9	0.4	0.4	9.0	87.2	0.5	26.0	6.0	0.9	0.9	33.5	0.6	6.0	2.8	0.4	0.1	1.4	1.6	11.2	0.4	0.4	0.4	0.6	3.3	0.0	0.4	10.6	0.5	2.5	95.5	0.8	6.1	21.5	0.5	14.9	54.6	3.1	0.8	0.6	10.8	47.2	0.4	1.6	0.9	33.1	19.6	1.4	10.9	0.0	3.0	2.1	3.7	0.0	0.2	1.6	24.2	6.0	0.0	0.1	0.3	0.0	1.0	1.2	8.7	1.6	4.5	0.9	45.6	0.0	1.1	0.1	0.6	0.7	0.3	3.9	2.7	0.6	0.0	0.1	0.1	4.1	0.0	10.6	0.4	0.4	8.1	0.0	0.0	0.0	0.2	0.2	1.1	0.0	0.6	0.0	0.1	0.0	0.1	0.1	1.0	1.9	0.0	0.2	1.4	2.8	0.1	0.5	0.5	0.2	0.2	0.5	0.3	0.3	0.7	0.4	0.1	0.8	0.2	0.1	0.0	3.2	0.3	0.2	3.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	2.1	0.0	0.4	0.5	0.0	1.6	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.5	0.4
C15orf62	LOC643338	ENSG00000188277	"Chromosome 15 open reading frame 62"	A8K5M9	15	40770080-40772449	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 21.9;tongue: 18.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 19.5;SK-BR-3: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			HPA044636	Approved									"HPA044636: AB_10794052"	"unprognostic (9.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.40e-1)"	1.5	0.9	0.8	1.5	1.1	1.5	1.1	4.0	1.7	1.7	1.0	0.8	0.8	2.0	1.1	0.8	22.8	0.9	1.4	0.8	0.8	0.6	0.9	1.9	1.6	2.1	1.1	0.8	1.3	0.9	0.0	1.3	0.8	0.9	1.1	0.0	0.8	5.4	1.8	1.9	11.9	1.8	0.8	0.8	1.5	1.2	0.9	0.8	1.8	1.0	18.8	21.9	0.9	3.8	0.4	0.7	0.0	0.1	0.4	1.0	0.1	0.6	0.5	1.8	2.2	0.7	0.2	0.4	0.8	0.2	0.0	0.2	2.0	2.4	1.1	2.0	0.0	4.4	0.8	0.0	0.0	1.6	1.8	1.1	4.0	0.6	0.0	0.9	1.4	0.2	1.0	0.0	0.1	0.6	0.9	1.3	0.0	0.5	1.4	1.7	0.7	0.8	1.5	0.3	0.5	19.5	1.6	3.9	0.9	0.6	6.2	0.2	2.2	1.4	0.9	2.2	1.0	2.0	0.7	1.5	1.0	1.0	0.7	3.3	0.7	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.9	0.6	0.0	0.4	1.0	1.0	0.0	0.4	0.0	0.7	0.8	0.1	0.8	1.1	4.0	0.9	0.8	0.6	1.1	0.8	0.9	0.8
C16orf54	FLJ35681	ENSG00000185905	"Chromosome 16 open reading frame 54"	Q6UWD8	16	29742463-29746006	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.2;lymphoid tissue: 41.8"	"Cell line enhanced"	"Detected in some"		"HEL: 13.3;HL-60: 13.4;HMC-1: 8.8;MOLT-4: 11.0;NB-4: 9.1;THP-1: 15.9;U-937: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA060546	Uncertain									"HPA060546: AB_2684317"	"unprognostic (2.09e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.92e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-1)"	2.7	0.9	0.8	19.9	0.8	23.2	1.2	0.6	0.7	2.8	3.8	1.3	0.2	1.7	1.3	1.4	2.4	2.1	4.7	2.2	0.8	1.0	1.9	1.3	7.1	41.8	1.1	0.5	0.8	1.0	0.0	0.8	1.6	0.8	1.8	2.2	1.4	6.8	0.2	1.0	0.9	9.3	0.8	1.2	25.4	3.3	0.7	0.8	35.6	1.3	2.3	27.8	3.1	1.8	26.5	14.7	95.2	20.0	36.1	40.7	26.2	3.9	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.3	0.2	0.0	0.0	13.4	8.8	0.3	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.1	11.0	9.1	0.8	0.0	6.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	15.9	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.6	0.2	7.4	0.1	42.6	18.4	61.9	40.7	16.8	38.5	26.5	40.5	35.6	13.0	21.8	33.7	34.7	95.2	36.1	20.0	14.7	21.2	26.2	0.8	0.8	0.6	0.7	0.8	1.0	1.1	0.5	0.8	0.8
C1orf112	FLJ10706	ENSG00000000460	"Chromosome 1 open reading frame 112"	Q9NSG2	1	169662007-169854080	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 24.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023778, HPA024451"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA023778: AB_1848665, HPA024451: AB_1848667"	"unprognostic (4.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (9.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.65e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	3.4	3.1	3.3	7.4	4.9	10.1	5.0	8.4	3.6	5.2	3.2	5.0	2.2	1.5	4.8	3.5	4.0	2.2	1.8	2.3	2.7	2.4	2.6	5.2	2.6	7.4	5.0	1.5	3.3	2.6	20.1	3.7	4.2	4.5	3.2	5.3	4.9	3.3	4.9	1.9	3.1	3.3	3.6	3.6	4.2	3.0	19.7	5.9	24.6	3.2	2.9	9.5	4.0	3.3	2.9	2.7	4.3	4.9	4.9	1.6	1.6	16.3	8.8	11.6	5.9	1.8	2.6	17.1	10.9	5.6	16.0	16.3	9.8	14.4	14.7	4.9	3.5	13.5	14.4	7.6	18.3	8.6	8.5	13.8	11.9	7.1	0.6	18.0	6.2	0.8	1.1	11.8	2.8	6.7	22.3	25.0	12.9	4.0	15.6	5.0	15.3	6.3	11.9	13.0	9.9	2.1	8.3	8.5	8.9	6.8	11.5	3.6	10.9	9.4	4.9	12.9	10.3	9.4	14.7	6.8	10.1	15.6	4.8	13.4	12.5	4.3	1.8	2.2	1.3	4.5	1.0	2.9	1.6	1.4	2.7	2.8	0.6	1.4	0.3	4.9	4.9	0.7	1.6	1.6	3.3	4.9	8.4	3.6	2.7	2.4	5.0	1.5	4.5	5.9
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018521-207032756	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1"	"Cell line enhanced"	"Detected in some"		"A-431: 17.8;CAPAN-2: 31.8;HaCaT: 39.2;HBEC3-KT: 37.7;hTCEpi: 20.0;RPTEC TERT1: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		7900	7900	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favourable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.3	0.2	1.6	0.2	0.0	4.1	0.2	0.4	7.1	8.3	0.3	0.2	8.4	1.0	1.1	49.4	0.6	14.0	0.2	0.3	0.1	4.3	1.1	42.8	0.2	0.2	0.2	0.5	7.0	0.0	0.9	1.4	0.4	18.8	2.7	0.3	12.5	1.9	0.3	14.4	16.5	0.6	0.2	0.4	20.3	0.4	0.2	0.4	6.8	16.0	37.1	6.1	12.3	0.0	0.0	0.7	0.0	0.1	0.0	1.8	17.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	2.1	0.0	39.2	0.0	37.7	0.0	0.0	0.0	3.3	0.3	0.5	0.0	0.0	0.2	0.0	20.0	0.0	11.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	18.4	4.7	0.0	0.1	0.3	3.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.4	0.2
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.1;lymphoid tissue: 86.6"	"Group enriched"	"Detected in some"	7	"HDLM-2: 44.4;HL-60: 21.6;NB-4: 12.0;THP-1: 17.1;U-937: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA026988	Approved									"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	39.8	9.3	9.2	25.1	17.9	37.5	20.1	4.6	9.3	5.2	6.3	4.9	0.8	2.7	5.4	7.4	4.9	10.2	11.7	14.8	13.4	4.7	17.3	14.8	40.1	86.6	17.5	1.9	5.8	4.5	1.3	9.7	5.6	15.3	5.0	6.9	5.0	5.9	2.5	7.2	3.6	8.3	13.5	31.0	78.1	5.8	6.1	13.9	10.6	6.2	1.1	20.0	7.2	6.7	24.7	83.3	98.7	119.1	40.1	27.8	74.8	0.1	0.0	0.1	0.3	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.2	44.4	0.1	0.1	0.1	0.0	0.2	21.6	3.6	0.0	0.8	0.3	0.3	0.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	17.1	0.0	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.1	35.9	0.4	68.4	82.5	98.7	14.2	119.1	4.1	17.5	17.7	8.2	83.3	24.7	27.8	16.8	11.4	40.1	86.3	24.9	5.0	74.8	9.2	17.9	4.6	9.3	13.4	4.7	17.5	1.9	15.3	13.9
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636506-22639608	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 204.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 2.2;RPMI-8226: 11.5;SCLC-21H: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"intermediate monocyte: 50.3;non-classical monocyte: 37.5"	"Lineage enriched"	"Detected in single"	57	"monocytes: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	1100000000	1100000000			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	51.4	33.0	12.4	19.3	21.0	5.3	40.6	1.9	10.9	10.8	20.3	8.0	2.1	22.1	8.2	25.9	11.3	15.5	22.6	43.9	9.2	10.4	14.4	27.6	60.7	94.4	17.2	4.6	9.5	11.9	2.4	9.6	33.6	15.8	16.0	15.9	12.2	9.4	7.5	7.9	4.3	24.7	24.8	26.8	204.0	11.6	12.3	16.6	7.5	10.9	5.4	8.4	24.1	12.8	0.0	0.8	0.1	50.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.2	0.5	0.0	0.8	0.5	11.5	0.0	0.0	5.1	1.6	0.1	0.0	0.0	0.9	0.1	0.4	0.0	0.3	0.6	0.2	1.5	0.0	0.1	0.2	0.2	0.1	0.0	1.2	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	37.5	0.0	0.0	2.1	12.4	21.0	1.9	10.9	9.2	10.4	17.2	4.6	15.8	16.6
C1QB		ENSG00000173369	"Complement C1q B chain"	P02746	1	22652762-22661538	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 262.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 2.7;NB-4: 2.5;SH-SY5Y: 2.9;U-266/70: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	66	"intermediate monocyte: 41.9;non-classical monocyte: 26.9"	"Lineage enriched"	"Detected in single"	83	"monocytes: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"	4700000000	4700000000			"HPA052116: AB_2681735"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.20e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (9.58e-6)"	"unprognostic (4.14e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.35e-2)"	76.7	42.3	30.3	22.0	54.5	7.1	17.6	3.3	27.8	12.1	28.2	27.6	1.4	30.0	9.0	25.5	10.8	21.5	33.2	19.8	19.8	17.0	21.8	51.5	87.9	84.1	45.7	6.8	9.8	11.2	4.2	14.4	41.2	35.7	15.0	24.6	17.2	13.9	9.3	9.2	4.3	30.5	41.9	52.2	262.8	14.4	11.7	38.1	7.4	9.8	3.7	9.5	36.8	6.6	0.0	0.5	0.1	41.9	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.2	2.5	1.6	0.0	1.6	1.1	1.9	0.0	0.0	1.9	2.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.3	2.9	0.1	0.5	0.5	0.3	0.6	0.0	0.5	0.0	0.0	41.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	26.9	0.0	0.0	1.4	30.3	54.5	3.3	27.8	19.8	17.0	45.7	6.8	35.7	38.1
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643630-22648110	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 192.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;RPMI-8226: 6.6;SH-SY5Y: 2.0;U-266/70: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"intermediate monocyte: 28.4"	"Lineage enriched"	"Detected in single"	284	"monocytes: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	1300000000	1300000000			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	50.5	35.7	24.2	24.6	39.2	5.9	15.6	2.5	18.3	9.8	21.8	19.9	1.2	30.0	8.5	23.4	9.7	17.0	26.8	22.6	17.5	13.6	14.4	41.2	48.2	75.1	34.8	6.1	8.5	7.8	2.6	10.2	34.8	30.2	15.0	15.7	14.8	13.2	8.3	8.0	4.6	33.1	27.1	34.5	192.2	15.5	10.3	29.1	10.7	8.3	4.0	9.5	28.3	6.0	0.0	0.0	0.0	28.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.7	2.6	0.7	0.0	1.5	0.8	6.6	0.0	0.0	1.2	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.3	2.9	0.0	0.3	0.3	0.4	0.0	0.0	0.7	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	24.2	39.2	2.5	18.3	17.5	13.6	34.8	6.1	30.2	29.1
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell line enhanced"	"Detected in many"		"REH: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"											"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.2	5.6	14.9	9.3	1.5	2.0	8.3	7.6	2.8	5.3	5.2	2.6	9.0	8.9	1.9	2.1	9.9	4.0	3.2	1.6	9.2	8.7	14.3	14.7	1.4	0.3	4.0	8.2	0.9	0.7	3.8	0.9	3.3	8.1	23.7	4.3	5.0	19.9	5.5	6.4	2.8	29.6	6.7	7.9	1.6	2.3	12.3	7.7	5.7	4.1	1.8	10.0	8.1	2.3	3.3	9.4	3.2	4.5	9.6	4.2	4.2	5.8	17.7	8.5	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2
C2orf54	FLJ22671	ENSG00000172478	"Chromosome 2 open reading frame 54"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5"	"Group enriched"	"Detected in some"	6	"CACO-2: 21.1;HaCaT: 15.8;SK-BR-3: 56.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.4"	"Not detected"	"Not detected"							HPA052722			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.3	0.0	0.3	1.5	0.3	0.0	0.9	0.3	0.3	8.9	3.9	0.3	0.3	6.3	0.7	0.4	63.8	0.3	0.3	0.3	0.3	0.0	2.8	2.8	5.5	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.7	0.3	0.5	1.1	0.3	7.6	0.3	0.3	18.6	3.6	0.3	0.3	0.3	1.0	0.3	0.3	1.0	0.3	35.5	28.6	0.8	19.1	0.8	0.1	0.7	0.2	3.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.1	1.3	0.1	0.1	0.0	15.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.1	3.1	1.0	0.0	0.0	56.0	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.3	0.5	0.0	0.1	0.8	0.1	0.2	0.1	3.4	0.2	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
C4orf46	"LOC201725, RCDG1"	ENSG00000205208	"Chromosome 4 open reading frame 46"	Q504U0	4	158666679-158672255	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047287, HPA052670"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047287: AB_2680011, HPA052670: "	"unprognostic (2.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.06e-3)"	4.5	4.6	4.2	5.4	5.6	16.7	4.3	6.4	5.5	5.4	4.5	10.7	2.4	4.2	7.2	5.1	5.5	4.2	4.0	5.1	4.5	3.7	3.9	2.7	4.8	7.7	7.3	3.5	6.4	5.8	2.2	3.1	6.3	5.3	4.1	6.1	7.2	4.1	3.4	2.8	4.1	4.4	5.7	6.6	5.4	4.3	25.5	7.3	26.3	6.1	5.8	7.2	5.3	5.0	4.0	5.1	4.9	4.9	8.6	5.8	3.4	6.8	4.2	10.2	15.1	4.5	4.7	5.1	11.7	8.1	13.6	11.9	3.7	6.2	12.3	1.8	5.9	3.8	8.9	6.0	17.8	16.8	4.5	18.5	4.7	4.9	1.5	14.1	10.2	2.8	2.2	11.0	4.8	9.9	8.0	31.0	18.6	3.6	26.8	12.7	7.0	5.5	19.5	5.8	5.4	4.1	3.4	5.6	17.0	5.1	4.7	4.2	4.0	11.3	5.2	21.1	9.7	11.7	9.7	7.1	8.9	15.4	5.3	12.6	8.1	4.9	4.7	4.5	4.9	3.9	3.7	4.0	4.0	4.8	5.1	3.9	5.5	5.8	1.6	8.6	4.9	4.4	4.1	3.4	4.2	5.6	6.4	5.5	4.5	3.7	7.3	3.5	5.3	7.3
C5AR2	"C5L2, GPR77"	ENSG00000134830	"Complement component 5a receptor 2"	Q9P296	19	47332147-47347327	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.1;lymphoid tissue: 17.3"	"Group enriched"	"Detected in some"	5	"MCF7: 16.7;T-47d: 20.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 9.4;eosinophil: 7.0;neutrophil: 21.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 21.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA016629	Uncertain									"HPA016629: AB_1849312"	"unprognostic (5.00e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.00e-6)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.73e-5)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-3)"	7.2	1.7	1.1	7.4	1.6	9.2	4.7	0.3	3.5	2.0	1.9	1.7	0.0	0.9	1.5	4.1	3.3	2.8	2.9	3.2	3.6	1.0	2.4	3.1	7.5	6.8	1.3	2.2	2.0	1.4	0.4	1.4	3.9	2.9	0.8	0.9	1.9	1.9	0.6	0.8	2.2	2.0	1.8	4.5	17.3	1.6	3.8	0.3	0.0	1.4	4.4	13.6	5.6	2.0	0.3	0.4	21.1	2.7	0.2	0.4	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.1	3.9	0.1	0.0	0.7	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	16.7	0.0	1.9	0.2	0.0	0.2	0.2	2.2	0.1	0.3	0.2	0.1	0.0	0.1	0.0	20.7	0.2	0.1	0.7	0.2	0.4	0.1	0.3	0.2	0.7	0.7	1.2	0.1	9.4	1.7	7.0	0.2	1.5	0.2	0.2	0.1	0.1	0.4	0.3	0.1	0.1	21.1	0.2	2.7	0.2	0.4	0.4	1.1	1.6	0.3	3.5	3.6	1.0	1.3	2.2	2.9	0.3
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101118-42142619	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3"	"Cell line enhanced"	"Detected in many"		"A-431: 27.2;CACO-2: 24.8;CAPAN-2: 20.6;HaCaT: 18.4;SK-BR-3: 16.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	1.3	0.5	0.2	3.7	0.2	0.2	4.2	0.3	0.3	13.3	20.9	0.2	1.4	15.7	0.7	1.2	66.1	2.6	15.5	0.5	0.2	0.1	6.2	0.6	5.9	0.2	0.2	0.2	1.4	20.8	1.1	2.2	3.1	0.2	6.8	5.3	0.2	16.6	4.0	1.2	24.8	37.2	0.7	0.2	0.2	16.2	0.4	0.2	0.6	12.5	49.3	54.3	4.8	17.5	2.1	1.9	3.5	1.3	0.9	1.2	0.7	27.2	0.3	0.0	0.1	0.1	3.2	13.5	1.6	2.0	3.8	4.0	24.8	20.6	0.0	2.9	2.7	18.4	0.0	8.3	2.5	2.2	3.8	1.3	2.4	5.5	1.0	0.0	0.1	1.9	15.4	2.9	4.3	0.0	0.7	0.2	0.7	9.5	0.3	0.1	1.8	0.7	0.1	0.0	0.1	2.9	12.3	1.5	0.0	2.4	16.6	0.0	12.1	0.1	0.4	0.2	1.8	6.9	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.9	1.3	1.7	0.8	0.8	0.6	1.0	0.8	0.8	1.4	2.1	0.9	1.2	3.5	0.9	0.5	1.9	0.5	0.7	0.2	0.2	0.3	0.3	0.2	0.1	0.2	0.2	0.2	0.2
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689737	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	5	"SK-BR-3: 6.0;T-47d: 3.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 2.1"					"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.97e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.27e-4)"	0.0	4.6	3.4	1.9	5.8	1.3	0.2	8.1	7.5	0.0	0.2			0.2	0.0	0.0	0.1	0.0	0.4	0.0	5.0	3.6	0.0	0.0	0.2	4.3	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.1	0.9	0.0	0.4	1.3	0.5	1.1			4.1		1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	6.0	0.0	3.6	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.5	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.8	0.1										
CALHM1	FAM26C	ENSG00000185933	"Calcium homeostasis modulator 1"	Q8IU99	10	103453387-103458888	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 5.7;kidney: 2.4;lymphoid tissue: 2.0"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.1;U-266/70: 4.3;U-266/84: 4.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA061816	Enhanced									"HPA061816: "	"unprognostic (2.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.65e-3)"	"unprognostic (3.44e-2)"		"unprognostic (2.86e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-2)"	0.0	0.0	1.1	0.5	0.3	0.8	0.0	3.4	5.7	0.0	0.0			0.5	0.1	0.3	0.0	0.0	0.4	0.1	1.2	2.5	2.4	0.0	0.0	0.4	1.3		0.1	0.4	0.0	0.2	0.0		0.0	0.1		0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.3	0.1	0.2			0.0		2.0	0.2	0.0	1.0	1.6	0.8	1.6	1.3	1.0	0.2	0.4	0.3	0.3	0.4	0.1	0.0	0.5	0.3	0.1	0.1	0.2	0.0	0.2	0.3	0.2	0.0	0.4	0.0	0.3	0.3	0.4	0.7	0.3	0.9	0.2	0.0	0.0	0.4	0.2	0.2	0.1	0.4	0.0	0.2	1.1	0.3	0.5	0.0	0.8	0.4	0.5	0.4	0.3	4.1	0.3	0.5	0.6	0.3	0.2	1.0	0.1	0.0	0.0	1.0	0.4	0.3	0.2	0.4	4.3	4.9	0.6	0.5	1.1	0.1	0.6	0.6	0.4	1.0	1.6	0.2	0.5	0.4	1.0	1.6	1.0	0.4	0.9	0.8	1.3	1.4	0.3	0.3	0.2										
CALN1	CABP8	ENSG00000183166	"Calneuron 1"	Q9BXU9	7	71779491-72447151	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0"	"Cell line enriched"	"Detected in some"	6	"Karpas-707: 30.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036278, HPA036708"	Approved		Uncertain	"Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA036278: AB_10673125, HPA036708: "	"unprognostic (6.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.67e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.72e-4)"	"unprognostic (2.99e-1)"	0.8	16.0	10.8	0.8	17.7	1.5	1.0	48.5	39.1	2.3	0.9	5.1	0.0	0.9	1.4	0.8	0.8	1.0	1.3	0.8	9.5	4.4	0.8	1.0	0.9	0.8	6.8	7.3	1.0	1.9	0.8	0.3	0.8	18.6	1.0	0.9	0.0	0.8	2.4	0.9	4.2	0.8	0.9	8.4	0.8	0.8	11.3	3.3	20.0	0.9	0.0	0.8	0.9	1.9	0.3	1.3	0.6	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	30.7	0.0	0.0	0.0	0.0	4.1	0.0	4.7	0.0	0.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	4.9	4.7	0.0	0.2	0.0	0.0	0.6	0.4	0.3	0.2	0.1	0.1	0.2	0.2	0.2	1.3	0.3	0.2	0.2	0.5	0.3	0.1	0.4	0.1	0.1	10.8	17.7	48.5	11.6	9.5	4.4	6.8	7.3	18.6	3.3
CAMK4	CaMK-GR	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.9;lymphoid tissue: 71.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.2;MOLT-4: 12.6;SH-SY5Y: 16.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3"	"Lineage enriched"	"Detected in single"	26	"T-cells: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	1.1	6.5	9.5	6.4	34.2	4.6	1.0	48.9	16.5	1.8	2.3	1.0	0.0	2.4	1.3	0.8	1.4	0.9	2.7	0.9	5.9	3.2	1.4	2.5	1.9	12.0	2.3	6.8	1.4	0.9	0.3	1.3	0.6	3.4	5.8	2.5	0.1	1.7	2.6	0.8	0.9	3.8	1.5	2.0	4.2	2.6	13.8	6.6	71.7	1.0	0.0	8.1	2.8	1.1	0.7	0.0	0.4	0.0	0.6	19.8	3.4	0.0	0.0	1.4	1.0	0.3	1.1	0.0	0.3	3.2	3.8	3.7	0.0	0.0	0.0	2.0	0.1	0.1	3.1	0.3	2.8	41.2	2.6	0.6	1.3	0.0	0.1	0.2	0.1	0.1	0.0	8.0	0.8	0.6	0.0	1.5	0.2	0.0	12.6	0.0	1.9	0.1	1.9	2.4	0.1	1.4	0.0	9.1	16.1	0.5	0.0	2.7	0.0	0.2	0.0	7.8	4.6	0.0	6.9	1.3	0.1	0.0	3.8	0.0	3.0	0.0	0.0	0.0	2.8	0.0	14.1	0.7	10.3	7.8	0.0	0.2	19.8	10.9	0.4	0.6	0.0	0.0	11.3	3.4	9.5	34.2	48.9	15.1	5.9	3.2	2.3	6.8	3.4	6.6
CARD11	"BIMP3, CARMA1"	ENSG00000198286	"Caspase recruitment domain family member 11"	Q9BXL7	7	2906141-3043945	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.4;lymphoid tissue: 44.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.7;K-562: 15.8;RT4: 29.9;U-698: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052984	Approved									"HPA052984: AB_2682005"	"unprognostic (3.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.81e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (6.68e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.10e-4)"	1.2	1.7	1.4	44.7	1.0	9.0	0.9	0.7	1.4	1.7	1.4	1.2	0.6	1.9	0.8	0.5	2.7	1.2	11.4	0.8	1.4	2.3	1.9	1.4	3.8	25.0	2.1	0.5	0.9	1.4	0.1	1.0	0.5	1.1	2.8	1.2	1.2	6.7	1.0	0.3	0.5	14.2	1.4	2.9	27.4	3.9	1.4	1.5	22.8	1.3	1.7	28.6	9.4	5.2	4.6	21.4	0.3	0.0	3.3	5.5	1.8	5.3	0.8	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.2	0.0	10.5	11.7	39.7	9.9	0.0	8.9	0.0	0.1	0.1	13.5	0.3	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	7.6	15.8	0.0	0.0	0.1	1.5	0.0	15.0	0.0	1.9	0.0	9.9	3.8	29.9	0.1	0.5	0.0	0.0	0.0	0.0	0.8	5.0	0.0	4.0	0.0	0.0	4.1	0.0	35.4	0.0	0.0	0.0	0.3	0.0	0.0	5.5	0.0	5.2	3.8	3.2	3.6	0.6	4.6	2.1	3.8	0.1	3.3	0.0	21.4	2.2	1.8	1.4	1.0	0.7	1.4	1.4	2.3	2.1	0.5	1.1	1.5
CARD16	"COP, COP1, PSEUDO-ICE"	ENSG00000204397	"Caspase recruitment domain family member 16"	Q5EG05	11	105041326-105101431	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 126.3;lymphoid tissue: 52.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.9;HHSteC: 66.6;HUVEC TERT2: 30.5;TIME: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA053981, HPA062805"	Uncertain		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA053981: AB_2682332, HPA062805: AB_2684871"	"unprognostic (2.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.71e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.93e-7)"	"unprognostic (2.81e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.19e-1)"	11.4	4.0	3.8	21.9	6.8	20.9	8.1	2.3	4.3	5.5	13.3	1.7	4.2	16.3	4.4	4.9	9.0	5.4	11.1	6.4	4.7	2.6	8.1	7.3	30.2	14.5	6.4	3.0	7.6	7.2	0.0	3.2	28.5	6.2	8.2	11.8	4.1	5.8	4.4	4.1	5.6	20.2	5.6	9.2	52.1	7.5	2.1	6.2	6.2	5.5	7.4	11.5	10.9	12.8	23.4	57.8	126.3	110.3	19.4	47.9	68.9	0.2	0.0	0.0	37.9	1.0	5.2	0.2	0.8	2.6	0.1	0.7	0.2	0.0	3.9	5.3	2.3	2.7	0.3	5.5	0.0	16.1	0.0	0.8	0.7	0.4	66.6	5.2	0.0	9.4	2.9	3.9	2.6	30.5	0.0	0.0	0.0	0.0	1.7	4.5	0.0	0.1	4.3	0.1	5.0	0.1	2.4	0.0	0.0	6.0	0.8	18.9	0.8	12.6	27.9	2.6	0.3	1.7	0.1	0.0	0.8	0.0	3.1	17.5	0.6	44.0	85.3	61.6	26.4	110.3	25.1	23.4	24.1	25.3	57.8	17.9	14.3	21.8	126.3	19.4	97.2	6.7	47.9	68.9	3.8	6.8	2.3	4.3	4.7	2.6	6.4	3.0	6.2	6.2
CARD9		ENSG00000187796	"Caspase recruitment domain family member 9"	Q9H257	9	136361903-136373681	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;bone marrow: 19.4;lymphoid tissue: 15.9"	"Cell line enhanced"	"Detected in some"		"HEL: 9.6;HMC-1: 32.5;NB-4: 23.6;THP-1: 28.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 24.5;non-classical monocyte: 20.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059502	Enhanced									"HPA059502: AB_2684042"	"unprognostic (7.03e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.02e-6)"	"unprognostic (2.52e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-1)"	1.7	2.4	3.6	8.8	10.4	19.4	2.2	2.7	6.4	2.1	1.9	5.5	0.3	2.7	1.4	1.9	1.7	3.3	4.2	1.7	4.0	2.4	2.0	2.3	4.8	6.6	8.1	2.0	1.6	1.0	0.6	1.5	2.3	5.0	2.7	1.0	1.5	2.9	2.2	0.8	4.8	3.8	2.0	4.8	15.9	1.7	0.8	6.9	0.9	0.8	1.5	4.6	2.5	1.8	0.0	11.3	4.6	24.5	0.3	0.4	5.1	0.0	0.0	0.3	0.0	0.0	0.0	2.7	4.9	0.1	0.1	0.0	0.5	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.2	9.6	0.1	3.1	2.3	6.0	32.5	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	23.6	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.2	7.2	0.0	7.7	0.0	2.3	28.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	7.2	0.1	2.3	14.6	4.6	0.0	24.5	0.4	0.0	0.0	0.0	11.3	0.0	0.0	0.0	1.1	0.3	20.5	0.1	0.3	5.1	3.6	10.4	2.7	6.4	4.0	2.4	8.1	2.0	5.0	6.9
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.2;lymphoid tissue: 40.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.8;HBEC3-KT: 17.9;HHSteC: 20.3;U-937: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"olfactory region: 22.8"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	7.4	3.9	6.6	15.1	17.0	8.2	6.9	3.5	7.0	4.1	12.8	2.2	2.9	34.0	3.0	4.2	10.6	4.3	7.3	4.9	9.3	3.0	6.4	5.8	20.5	16.2	16.7	2.6	4.4	3.4	0.2	3.7	8.7	13.3	6.1	13.9	3.7	7.0	3.2	1.6	9.9	37.2	5.2	17.4	40.7	5.6	1.5	11.0	4.1	3.7	5.6	9.0	9.7	13.2	7.3	39.6	40.5	64.2	11.1	34.3	31.2	0.4	0.1	0.0	1.8	2.0	4.2	0.3	1.9	37.8	4.8	13.2	0.0	0.2	6.1	0.7	2.1	2.7	0.0	17.9	1.1	4.0	0.0	0.3	0.2	0.4	20.3	7.1	0.0	7.2	12.7	3.9	10.4	2.0	0.0	0.0	1.1	0.0	0.2	9.9	0.0	0.1	5.9	0.1	4.8	0.1	2.9	0.1	0.1	5.6	0.3	8.3	0.4	16.4	2.4	4.4	0.2	0.4	0.5	0.0	1.7	0.0	2.7	44.7	0.9	12.3	42.8	23.2	25.4	64.2	34.3	7.3	18.1	22.0	39.6	6.0	9.9	16.4	40.5	11.1	64.0	1.4	22.2	31.2	6.6	17.0	3.5	7.0	9.3	3.0	16.7	2.6	13.3	11.0
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favourable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavourable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favourable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.5	6.5	6.6	10.7	6.7	26.8	10.2	9.6	10.9	9.6	8.5	9.0	8.2	8.2	10.8	7.8	14.1	8.4	5.7	6.1	5.7	4.1	7.3	5.8	9.8	15.8	6.9	6.1	8.7	8.1	12.1	6.6	11.3	7.3	7.6	10.2	10.1	11.6	5.8	4.3	14.2	14.0	7.4	6.3	18.6	7.5	8.6	6.9	45.7	8.9	8.0	23.0	7.4	10.2	18.5	11.8	33.2	17.7	13.4	21.4	7.6	10.7	10.1	11.4	20.2	6.4	7.6	6.1	11.1	5.0	10.2	11.2	10.1	12.3	20.5	10.5	7.0	10.6	11.4	8.7	13.6	17.9	8.8	12.1	16.0	6.9	3.4	23.6	15.2	5.2	7.2	12.3	4.4	8.7	10.1	13.1	10.8	10.6	41.0	24.9	14.3	10.3	30.2	5.9	12.5	6.0	9.2	12.5	14.1	22.0	9.6	7.0	10.5	9.0	9.7	9.0	6.3	16.2	11.0	10.9	10.7	23.8	10.2	28.1	16.4	33.2	10.8	9.3	14.9	11.9	14.6	15.8	20.6	15.4	9.8	18.5	15.4	17.8	12.3	13.4	17.7	11.8	21.4	7.6	6.6	6.7	9.6	10.9	5.7	4.1	6.9	6.1	7.3	6.9
CBFA2T3	"ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4"	ENSG00000129993	"CBFA2/RUNX1 translocation partner 3"	O75081	16	88874858-88977204	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.9"	"Cell line enhanced"	"Detected in some"		"HEL: 21.0;K-562: 36.7;MCF7: 17.0;MOLT-4: 18.6;NB-4: 22.7;REH: 36.9;T-47d: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 26.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059931, HPA062423, HPA065890"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575"	"unprognostic (2.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.98e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.04e-5)"	"unprognostic (2.18e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.35e-3)"	10.0	1.7	3.6	11.3	7.4	8.2	6.1	26.0	5.4	2.3	3.9	1.3	1.4	3.9	3.2	2.1	2.1	1.9	2.5	6.2	3.0	3.0	0.7	2.0	6.4	9.5	2.0	3.8	0.9	24.9	0.7	2.7	3.8	2.3	3.7	1.5	3.1	4.5	2.9	14.2	2.6	5.5	1.5	1.2	14.7	3.5	3.2	2.2	75.9	2.4	2.0	10.3	3.6	4.8	3.7	11.6	3.6	4.9	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.0	0.0	0.0	0.0	5.5	10.4	0.0	0.0	0.0	0.0	0.0	36.7	0.1	0.0	17.0	18.6	22.7	0.4	0.0	36.9	0.2	3.7	0.0	0.0	7.2	1.6	0.8	0.1	0.1	16.8	5.8	0.1	0.0	0.1	0.1	0.0	0.1	0.1	12.2	0.0	6.4	0.0	1.1	2.7	2.7	0.0	3.2	0.0	3.7	0.0	0.0	7.1	2.1	0.0	0.0	3.6	0.1	4.9	11.6	0.0	1.7	3.6	7.4	26.0	5.4	3.0	3.0	2.0	3.8	2.3	2.2
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206276-119313926	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	9.9	5.5	9.1	17.0	11.1	11.1	8.8	10.7	12.0	6.2	7.5	8.7	3.0	5.7	9.9	5.3	7.5	7.4	6.3	5.9	8.0	9.6	5.5	4.0	10.3	16.3	8.1	6.9	6.3	5.6	16.6	4.1	9.1	9.3	5.3	7.5	6.4	5.4	7.1	3.9	7.4	8.6	10.6	8.9	13.3	7.3	32.3	5.1	40.9	6.0	5.5	15.6	7.6	7.7	1.8	3.3	11.8	3.7	0.6	1.9	1.0	6.3	4.8	16.8	10.5	5.0	6.0	9.9	6.8	7.1	6.6	6.6	10.2	7.8	15.0	6.2	8.6	9.3	11.5	5.8	14.5	8.5	2.7	15.4	3.6	3.1	6.2	17.9	17.6	5.2	6.5	16.9	18.2	16.3	12.4	6.3	11.9	6.8	9.5	10.0	8.7	5.3	10.3	8.4	2.8	5.9	5.1	2.3	7.0	12.7	5.5	4.5	5.8	15.1	13.6	10.3	7.3	7.2	8.9	2.1	3.1	12.2	4.2	15.5	7.3	0.8	3.2	2.4	1.3	3.7	1.1	1.8	1.6	1.3	3.3	1.8	1.8	1.9	11.8	0.6	3.1	1.8	1.4	1.0	9.1	11.1	10.7	12.0	8.0	9.6	8.1	6.9	9.3	5.1
CBX2	"CDCA6, MGC10561"	ENSG00000173894	"Chromobox 2"	Q14781	17	79778132-79787983	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.9;testis: 16.5"	"Cell line enhanced"	"Detected in many"		"REH: 31.5;SK-BR-3: 45.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023083	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA023083: AB_2671063"	"unprognostic (1.37e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.25e-11)"	"unprognostic (1.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-8)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.07e-1)"	2.1	0.6	1.6	1.3	2.5	3.4	8.1	0.5	1.5	1.7	0.8	0.6	2.9	0.6	4.0	3.4	6.0	1.7	1.1	3.3	0.8	0.7	1.3	0.9	2.2	2.2	1.8	1.1	4.1	2.2	0.4	0.5	3.9	1.3	1.3	0.4	1.0	2.1	1.5	1.3	3.4	1.0	1.2	0.8	2.5	0.9	16.5	1.8	17.9	1.7	6.8	2.4	1.5	3.5	0.8	0.4	0.0	0.6	0.0	0.4	0.2	2.4	6.8	12.6	22.8	0.1	0.2	4.5	0.9	0.4	0.4	0.8	7.0	0.5	9.8	2.0	0.1	1.2	14.5	0.4	0.3	1.4	7.8	0.5	7.3	4.6	0.5	2.9	2.1	0.2	0.9	0.2	0.6	2.5	6.7	0.7	0.4	10.2	15.2	7.2	12.5	7.9	31.5	9.4	5.9	0.5	3.5	15.4	23.9	3.9	45.7	2.6	8.3	4.4	1.8	4.5	13.5	1.3	1.7	3.0	1.5	6.0	0.1	7.9	5.3	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.6	0.4	0.0	0.2	1.6	2.5	0.5	1.5	0.8	0.7	1.8	1.1	1.3	1.8
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.2;testis: 19.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	1.9	1.3	2.2	2.5	3.9	3.2	5.2	1.2	2.4	1.6	2.2	2.2	0.3	1.3	2.2	2.9	2.4	2.1	1.5	0.9	1.9	1.2	1.2	2.4	2.6	2.0	1.6	0.8	1.7	2.3	1.7	3.8	1.6	1.6	3.0	1.6	1.5	7.7	2.2	0.8	3.7	1.8	1.2	3.3	2.5	1.5	19.4	2.3	16.2	1.3	2.6	2.9	2.6	2.2	1.5	1.1	6.7	1.7	2.3	3.9	1.3	4.7	0.9	6.4	0.0	0.5	1.8	0.0	5.2	6.4	4.9	6.1	0.1	4.0	5.6	4.6	1.8	3.8	2.7	3.5	8.9	4.7	1.1	6.9	0.8	1.5	0.2	2.0	4.0	0.4	2.5	10.2	5.1	3.7	4.6	5.8	10.3	1.0	4.2	2.3	1.5	5.9	5.3	11.7	1.8	0.7	2.0	3.6	3.2	3.0	0.3	1.3	7.3	1.8	2.6	10.1	2.3	4.4	6.4	1.4	1.5	4.9	1.4	11.3	6.7	6.7	1.3	1.7	2.4	1.7	2.5	0.8	2.2	3.9	0.4	1.5	3.1	3.4	0.8	2.3	1.7	1.1	3.7	1.3	2.2	3.9	1.2	2.4	1.9	1.2	1.6	0.8	1.6	2.3
CCDC18	NY-SAR-41	ENSG00000122483	"Coiled-coil domain containing 18"	Q5T9S5	1	93179919-93278730	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028035	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA028035: AB_10601795"	"unprognostic (8.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.49e-4)"	"unprognostic (4.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.64e-13)"	"unprognostic (4.94e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	3.8	2.3	2.7	20.0	4.3	13.4	4.6	3.7	2.7	2.2	3.2	0.4	2.9	2.5	1.8	4.0	3.2	1.8	1.7	2.6	3.4	1.9	2.0	3.0	3.8	11.9	1.7	1.8	2.8	1.5	0.7	4.8	1.9	2.6	1.9	4.1	1.3	2.0	3.1	6.2	3.1	3.4	2.3	3.8	6.0	2.3	12.6	2.5	15.8	2.1	2.8	8.2	2.9	3.3	12.2	11.9	6.0	3.9	1.1	2.7	0.5	15.5	5.2	12.2	3.8	3.0	3.1	6.4	9.7	5.1	10.0	10.1	2.7	5.4	20.2	5.4	5.2	7.4	5.3	7.6	14.5	9.9	7.0	13.8	11.1	4.7	1.1	14.3	6.4	2.1	0.6	7.5	7.4	6.4	14.7	15.6	13.2	2.2	6.8	5.8	11.2	6.5	8.8	14.6	5.9	4.9	7.0	5.4	3.4	13.7	7.0	4.0	3.3	8.4	4.9	11.7	8.3	7.5	11.0	6.7	8.7	12.1	2.4	12.8	3.1	3.4	3.8	5.3	2.4	3.9	2.7	8.8	2.2	2.1	1.6	12.2	1.7	2.0	6.0	1.1	3.5	11.9	2.2	0.5	2.7	4.3	3.7	2.7	3.4	1.9	1.7	1.8	2.6	2.5
CCDC195		ENSG00000283428	"Coiled-coil domain containing 195"	A0A1B0GUA6	2	224703764-224716365	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"kidney: 1.0;lymphoid tissue: 2.1;skeletal muscle: 1.8"	"Group enriched"	"Detected in some"	7	"Daudi: 6.8;RPMI-8226: 2.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.0	0.0	0.0	0.8			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.3	1.8	0.0	0.0	0.0		0.0	0.0	0.1			0.0		2.1	0.0		0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340223-64357534	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 39.8;Karpas-707: 10.4;THP-1: 15.8;U-937: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA026652	Approved		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"			Centrosome	Centrosome	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavourable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	3.5	2.5	5.2	29.5	5.4	32.5	2.7	23.7	2.8	2.6	6.1	4.5	6.9	3.2	2.0	1.3	4.2	2.5	8.5	2.3	4.1	2.6	2.0	1.6	11.4	18.6	8.6	2.2	1.3	2.1	0.7	1.6	1.4	6.5	2.9	2.9	1.7	7.5	8.9	0.8	1.9	11.1	1.3	7.2	26.6	3.3	7.3	6.5	16.8	1.9	2.7	20.8	4.1	2.8	3.0	3.5	11.3	6.5	7.1	4.6	1.6	0.1	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	1.5	9.0	1.4	0.5	0.7	0.0	0.2	0.0	9.8	0.0	6.8	1.8	0.5	0.4	4.2	39.8	0.0	0.0	0.1	0.0	0.2	0.2	10.4	0.3	0.4	5.7	3.5	0.3	0.2	5.4	0.1	8.4	0.1	0.1	2.2	0.0	0.0	0.2	0.4	1.2	15.8	0.0	0.0	0.3	0.0	0.1	2.2	0.7	7.3	0.5	11.5	0.2	3.6	6.5	7.6	4.6	4.7	1.4	2.2	2.7	3.8	2.1	3.0	2.6	3.2	11.3	7.1	3.1	3.5	0.8	1.6	5.2	5.4	23.7	2.8	4.1	2.6	8.6	2.2	6.5	6.5
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 23.9;U-266/70: 21.0;U-266/84: 29.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 18.7"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favourable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	3.6	0.9	2.7	31.1	18.7	15.0	6.9	0.9	2.3	3.0	8.9	1.8	15.5	9.6	4.7	4.0	8.9	9.7	11.8	2.2	2.0	2.4	5.0	2.6	11.1	34.5	2.0	0.3	2.0	14.8	6.7	4.0	1.8	1.6	6.4	4.7	4.1	12.1	11.7	1.5	4.5	9.6	6.0	2.9	14.5	8.1	4.8	3.7	18.5	2.5	6.0	27.6	7.1	5.3	2.3	1.8	5.2	3.2	3.1	11.0	2.8	3.1	2.9	3.4	3.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	3.0	4.7	13.5	2.5	0.0	0.1	4.8	2.7	0.0	11.4	1.8	3.6	2.0	4.2	0.3	7.0	3.0	0.0	4.0	0.0	0.0	3.7	4.1	17.0	0.0	10.3	7.1	9.3	3.3	4.4	5.9	0.1	4.5	0.8	4.5	23.9	5.3	2.0	6.9	1.6	3.8	6.5	1.1	0.0	0.0	0.0	0.0	21.0	29.5	6.9	0.0	6.4	0.0	5.2	3.2	1.3	9.0	1.8	8.7	2.3	6.1	9.3	1.8	1.9	3.9	5.8	2.6	3.1	2.5	1.5	11.0	2.8	2.7	18.7	0.9	2.3	2.0	2.4	2.0	0.3	1.6	3.7
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363231	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 7.7;lymphoid tissue: 6.7;tongue: 3.2"	"Cell line enriched"	"Detected in some"	41	"HMC-1: 125.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.0;intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	20	"monocytes: 2.0"					"Region enriched"	"Detected in some"	4	"hippocampal formation: 2.2"	HPA049861	Uncertain				"Secreted to blood"					"HPA049861: AB_2680919"		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.1	0.0	0.2	0.2	2.5	0.0	0.1	0.1	0.9	0.1	0.5	0.1	0.1	0.0	0.1	0.8	0.1	0.2	0.4	0.1	0.5	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	7.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.8	0.1	6.7	0.1	3.2	0.5	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	125.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	2.5	0.1	0.8	0.5	0.3	0.2	0.1	0.1	0.1
CCL11	"eotaxin, MGC22554, SCYA11"	ENSG00000172156	"C-C motif chemokine ligand 11"	P51671	17	34285668-34288334	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 31.0;intestine: 29.6;lymphoid tissue: 29.2"	"Cell line enriched"	"Detected in single"	21	"BJ hTERT+: 13.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (4.61e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (8.70e-4)"	"unprognostic (8.18e-2)"		"prognostic favourable (1.99e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.64e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	2.6	0.4	0.2	29.2	0.2	0.0	0.2	0.2	0.2	4.5	29.6	0.4	0.6	17.3	3.5	0.0	20.7	0.8	12.0	31.0	0.2	0.2	7.0	1.2	7.3	0.3	0.2	0.0	2.6	11.6	0.2	1.1	0.0	0.2	16.1	8.0	0.0	0.2	0.3	0.5	0.2	18.7	10.2	0.2	1.2	18.2	0.6	0.0	0.7	0.4	0.0	0.8	12.1	5.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	13.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983291-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 80.7;lymphoid tissue: 98.4"	"Cell line enriched"	"Detected in single"	52	"HUVEC TERT2: 35.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	19000000	19000000			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	56.3	5.1	0.0	5.9	0.0	0.0	80.7	0.0	0.0	37.6	8.4	0.0	16.6	0.0	37.6	11.1	20.9	9.1	17.3	27.5	0.0		8.7	34.2	26.4	39.1	0.0	0.0	12.4	0.8	2.0	6.5	0.0	0.0	23.5	0.7	4.1	6.5	11.4	21.9	7.5	3.9	19.1	0.0	98.4	0.2	15.0	0.0	1.3	17.6	16.7	6.2	25.3	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL17	"ABCD-2, SCYA17, TARC"	ENSG00000102970	"C-C motif chemokine ligand 17"	Q92583	16	57404767-57416062	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.0"	"Cell line enriched"	"Detected in single"	613	"HDLM-2: 226.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8;myeloid DC: 1.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB002583	Uncertain				"Secreted to blood"					"CAB002583: AB_564022"	"unprognostic (4.62e-3)"	"prognostic favourable (1.91e-5)"	"unprognostic (5.83e-2)"	"unprognostic (3.52e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.14e-3)"	"prognostic favourable (5.80e-4)"	0.9	0.2	0.3	8.7	0.3	0.0	2.0	0.3	0.4	1.3	1.2	0.3	0.3	0.0	0.5	0.8	4.8	0.4	3.0	1.5	0.3	0.2	1.7	0.6	9.7	8.6	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.5	0.6	3.2	0.5	7.4	0.3	0.3	3.3	6.7	2.5	0.3	1.4	0.7	0.9	0.3	39.0	2.0	1.3	6.2	4.5	1.5	1.8	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	226.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.3	0.5	0.3
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064280-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	940000	940000				"unprognostic (8.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.87e-2)"	18.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	3.1	0.0	0.0	1.6	0.0	5.8	3.2	0.0	0.4	41.4	0.0		0.0	1.3	77.9	61.9	0.0	0.0	3.7	0.3	0.0	0.0	5.9	0.0	0.2	2.5	0.0	0.2	0.0	0.0	0.3	3.4	4.1	0.0	3.7	0.3	1.6	0.0	43.8	2.2	4.3	16.7	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL20	"CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38"	ENSG00000115009	"C-C motif chemokine ligand 20"	P78556	2	227805739-227817564	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.5;lung: 36.8;lymphoid tissue: 50.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.5;NB-4: 17.7;RT4: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (2.40e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-2)"	"unprognostic (7.06e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (1.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-1)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.19e-8)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.82e-1)"	5.6	0.1	0.4	23.3	0.9	1.5	0.4	0.3	0.4	7.1	5.5	0.3	0.3	4.4	3.9	1.5	11.8	2.0	48.5	1.5	0.4	0.2	7.1	17.2	36.8	16.3	0.4	0.3	1.5	1.9	0.0	0.3	0.9	1.3	2.0	7.8	0.4	4.0	0.3	0.5	4.3	18.2	1.0	1.3	0.5	2.8	1.6	0.4	1.8	0.5	18.3	50.9	19.6	2.5	0.3	0.6	0.0	0.3	0.0	6.6	0.3	0.3	1.0	0.5	0.6	2.3	4.7	0.6	0.3	1.4	0.1	0.5	2.7	0.4	0.8	3.2	0.0	0.5	0.1	6.1	1.0	0.6	1.0	0.1	2.0	24.5	1.8	3.4	0.3	7.3	1.3	1.4	1.7	0.0	0.2	3.8	0.4	0.2	0.2	17.7	1.2	0.6	0.5	6.3	0.7	0.1	10.8	0.4	0.3	0.2	1.0	0.6	0.9	3.5	1.8	2.3	3.1	5.2	0.5	0.7	2.0	1.4	3.6	2.4	4.8	0.0	0.3	0.0	0.1	0.1	6.6	0.2	2.7	1.4	0.3	0.3	0.4	0.3	0.0	0.0	0.2	0.6	1.0	0.3	0.4	0.9	0.3	0.4	0.4	0.2	0.4	0.3	1.3	0.4
CCL24	"Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24"	ENSG00000106178	"C-C motif chemokine ligand 24"	O00175	7	75811665-75823356	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.8;EFO-21: 2.6;HMC-1: 2.7;RH-30: 3.4;U-2 OS: 9.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 67.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.3"	"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	8.2	0.5	0.3	5.7	0.3	0.0	0.8	0.3	0.3	0.6	12.2	0.3	0.2	9.4	0.4	0.6	1.0	0.4	1.1	0.5	0.3	0.3	0.6	3.8	23.3	21.2	0.3	0.2	0.6	0.4	0.0	0.4	0.3	0.3	0.5	33.1	0.6	0.6	0.5	0.4	0.7	26.8	0.5	0.3	63.3	1.0	1.0	0.2	1.2	0.5	0.9	2.8	13.4	0.7	0.0	0.6	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	8.8	0.2	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.7	0.2	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	9.3	0.0	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.2
CCL3	"G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3"	ENSG00000277632	"C-C motif chemokine ligand 3"	P10147	17	36088256-36090169	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;lymphoid tissue: 18.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.7;U-266/70: 45.9;U-266/84: 116.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdTCR: 10.2"	"Group enriched"	"Detected in many"	5	"B-cells: 4.5;granulocytes: 4.0;T-cells: 10.2"														"Secreted to blood"						"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.90e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.23e-2)"	5.3	4.3	0.0	5.7	1.6	35.7	2.4	0.5	6.0	0.9	0.9	11.6	0.0	0.8	0.7	1.4	0.4	0.4	3.5	3.4	0.0		0.5	7.9	15.1	5.8	0.0	0.0	2.0	0.4	1.8	0.0	5.7	3.7	0.5	0.9	1.7	1.0	0.2	1.2	0.0	0.8	1.1	0.0	18.0	0.2	3.7	0.0	1.8	0.8	0.5	1.8	2.3	0.0	4.5	0.2	4.0	0.8	1.1	10.2	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.1	45.9	116.1	0.0	0.2	0.0	0.0	0.1	0.8	4.0	10.2	0.5	0.3	1.4	0.3	2.8	0.2	4.5	0.0	3.0	4.0	1.1	0.5	0.0	0.0	4.6										
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffolding protein"	Q9NUG4	20	32010450-32032180	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.4;HUVEC TERT2: 12.2;NTERA-2: 6.6;RH-30: 4.6;SCLC-21H: 11.3;TIME: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA008434: AB_1845671, HPA071063: AB_2686339"	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	7.2	1.8	2.1	1.8	2.0	0.2	15.0	2.1	2.2	4.4	1.4	1.7	2.1	1.2	7.1	2.3	1.9	2.6	2.4	5.4	2.0	1.7	3.1	1.0	15.1	1.3	2.3	1.5	1.8	1.0	1.4	1.4	6.7	2.5	1.9	1.2	4.9	1.4	2.0	3.5	1.5	1.6	3.2	1.4	53.0	1.4	1.6	1.6	0.2	3.0	5.2	1.0	2.0	4.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	3.5	0.0	0.0	6.6	0.0	0.8	4.6	0.2	0.0	0.0	11.3	1.3	0.3	0.0	0.0	3.6	0.0	6.2	0.1	2.0	0.0	0.0	0.2	0.0	0.2	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.1	2.0	2.1	2.2	2.0	1.7	2.3	1.5	2.5	1.6
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167010-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 71.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol				Cytosol	Cytosol	"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.54e-7)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4.0	4.2	3.7	4.0	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2.0	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.7	40.7	55.8	49.6	2.9	5.0	131.9	26.0	19.5	68.7	58.1	60.1	55.4	36.1	31.7	24.0	37.1	56.1	56.9	77.1	35.4	27.8	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.4	27.5	36.6	27.7	28.7	55.9	55.9	27.3	23.8	31.1	25.8	28.7	40.3	37.0	25.1	21.7	28.4	17.9	44.8	21.1	19.3	40.3	20.9	15.4	15.3	49.8	27.6	65.0	14.4	26.6	50.4	21.2	35.0	47.0	2.4	1.8	1.2	2.8	4.1	4.0	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1.0	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4.0	4.2	11.5	1.3
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105078-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.2;testis: 73.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"T-reg: 17.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"				Cytosol	Cytosol	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (2.83e-4)"	"prognostic unfavourable (4.63e-4)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	2.0	1.1	0.4	21.0	0.4	24.7	2.5	0.3	0.6	1.8	5.5	0.5	0.2	5.2	1.0	1.5	11.3	0.5	1.6	1.2	0.4	0.4	1.0	1.0	1.9	12.0	0.4	0.3	0.8	0.7	0.0	0.4	6.7	0.4	1.1	6.3	0.4	2.1	0.6	0.4	3.6	5.1	2.0	1.3	5.2	3.0	73.9	0.2	70.2	0.8	10.3	16.0	1.8	3.4	1.8	2.3	0.7	0.1	3.0	17.8	1.8	28.4	25.1	41.3	10.2	1.8	3.8	21.9	23.6	15.2	36.6	30.1	40.6	17.6	26.5	17.1	15.2	35.2	39.0	20.1	34.6	27.5	20.9	34.3	29.4	23.0	0.5	25.5	22.1	1.4	2.7	15.7	20.1	24.8	34.6	42.6	27.6	20.7	29.1	37.2	30.5	14.9	34.0	58.4	26.9	11.5	20.2	25.7	17.4	32.4	17.6	21.3	30.5	25.5	12.9	18.2	31.0	20.1	44.9	19.0	28.4	47.1	11.9	58.4	25.7	0.0	0.1	0.6	0.1	0.0	0.2	1.8	3.9	4.1	2.3	0.9	0.0	0.1	0.7	3.0	0.0	0.1	17.8	1.8	0.4	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.2
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934933-42050357	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 129.2;lymphoid tissue: 142.5"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 92.5;REH: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA071369"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"CAB000116: , HPA071369: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (8.08e-6)"	"unprognostic (2.11e-1)"	20.2	39.8	16.1	28.9	17.5	74.7	36.0	13.3	19.8	13.3	17.3	11.3	14.1	16.0	10.8	10.4	13.5	13.4	19.0	16.3	15.4	14.5	13.7	8.0	32.1	83.8	14.1	15.5	11.1	10.9	5.0	10.1	21.9	9.3	14.2	11.4	10.2	18.1	14.4	6.5	14.6	22.0	11.7	11.5	51.2	18.0	7.4	10.0	142.5	26.8	9.3	32.8	13.0	16.6	24.1	42.4	129.2	45.8	39.0	52.8	66.2	9.0	33.1	3.5	7.7	6.3	12.9	40.2	10.6	6.1	11.0	8.1	6.2	4.1	39.0	18.0	7.1	5.6	9.2	13.0	5.7	6.6	6.0	61.8	14.8	5.0	13.9	10.1	54.6	12.3	8.5	10.6	4.0	13.5	31.1	3.8	15.7	12.2	92.5	48.5	1.5	7.1	87.9	13.5	4.3	25.4	6.1	11.8	3.1	9.0	11.6	5.2	7.1	39.5	22.5	12.2	6.7	10.6	11.9	2.5	1.9	60.9	7.1	21.3	7.4	129.2	30.5	87.7	52.8	35.1	37.0	16.4	36.4	42.5	42.4	24.1	42.8	45.0	42.8	39.0	45.8	27.8	23.2	66.2	16.1	17.5	13.3	19.8	15.4	14.5	14.1	15.5	9.3	10.0
CCNF	"FBX1, FBXO1"	ENSG00000162063	"Cyclin F"	P41002	16	2429394-2458854	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060596, HPA070495, HPA071600"	Enhanced		Supported	Centrosome				Centrosome	Centrosome	"HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424"	"unprognostic (3.87e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (7.46e-7)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.58e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-1)"	2.1	1.8	4.1	6.0	3.2	9.2	5.1	11.6	4.9	2.1	3.0	1.9	3.6	4.4	1.5	3.4	8.1	1.5	1.5	1.8	4.3	3.9	1.7	1.6	2.2	10.5	1.9	3.1	1.8	1.7	0.8	1.8	3.8	2.4	3.0	3.2	0.7	3.2	3.4	2.5	7.2	3.2	1.8	1.7	4.7	2.6	5.1	2.3	35.7	1.6	3.4	14.2	5.0	2.9	2.7	1.4	0.1	1.1	4.1	3.1	1.7	8.3	13.2	12.7	11.6	0.8	1.2	10.0	10.1	5.0	14.1	10.9	26.3	10.3	17.7	3.4	5.7	14.3	21.1	7.8	6.8	12.5	10.0	19.4	13.7	8.0	1.0	12.7	12.7	0.8	1.0	10.0	4.8	10.5	20.6	11.6	7.1	18.2	18.5	8.4	12.6	6.1	31.0	15.0	15.8	3.9	3.7	12.4	7.0	15.1	13.2	2.7	14.0	6.5	7.2	7.8	20.3	5.5	10.5	7.1	8.5	30.6	2.2	12.7	10.6	0.0	1.1	0.0	2.8	0.6	1.7	2.7	1.5	3.1	0.5	2.6	1.2	1.7	0.1	4.1	0.9	1.4	2.2	1.7	4.1	3.2	11.6	4.9	4.3	3.9	1.9	3.1	2.4	2.3
CCR1	"CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1"	ENSG00000163823	"C-C motif chemokine receptor 1"	P32246	3	46201709-46208396	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.0;lymphoid tissue: 40.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 76.5;RPMI-8226: 35.1;U-266/70: 13.4;U-266/84: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"														"unprognostic (3.95e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	21.2	6.0	5.1	23.8	8.4	11.2	4.9	1.0	3.7	1.9	2.9	7.2	0.5	3.9	2.0	5.1	2.0	4.5	6.7	4.1	5.4	3.2	4.4	9.6	11.6	26.3	9.0	1.6	2.8	2.3	1.0	2.6	14.9	6.9	2.3	4.1	2.9	3.3	1.3	1.4	1.4	4.5	8.5	11.6	40.2	2.9	1.2	8.7	2.2	1.8	1.0	5.5	6.9	1.5	0.9	15.3	32.5	34.0	22.1	15.3	11.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	76.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	35.1	0.0	1.2	0.0	0.0	0.0	0.1	0.3	0.0	8.0	0.0	0.2	0.0	0.0	0.0	13.4	39.6	0.0	6.8	6.0	0.1	21.5	34.0	6.8	3.1	21.4	15.3	0.9	0.0	2.5	15.3	0.0	0.0	0.4	32.5	22.1	13.1	5.5	0.0	11.8	5.1	8.4	1.0	3.3	5.4	3.2	9.0	1.6	6.9	8.7
CD160	"BY55, NK1, NK28"	ENSG00000117281	"CD160 molecule"	O95971	1	145719471-145739288	"CD markers, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.9;brain: 15.2;intestine: 19.9;lymphoid tissue: 17.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 15.2"	"Group enriched"	"Detected in many"	9	"gdTCR: 33.9;MAIT T-cell: 14.4;memory CD8 T-cell: 22.9;naive CD8 T-cell: 27.3;NK-cell: 23.2"	"Group enriched"	"Detected in many"	11	"NK-cells: 23.2;T-cells: 33.9"	"Not detected"	"Not detected"												"Intracellular and membrane"						"unprognostic (6.54e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.25e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.48e-5)"	"unprognostic (4.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-4)"	0.6	0.2	2.2	3.6	2.6	5.1	0.6	15.2	3.1	0.8	9.3	0.4	0.3	5.6	0.8	1.4	0.9	0.6	1.2	0.6	1.6	2.2	0.5	5.9	3.8	6.0	1.6	0.3	1.1	2.2	0.0	0.4	1.8	0.6	1.3	1.0	0.9	3.0	0.4	1.0	1.1	19.9	1.4	1.0	17.4	0.8	0.8	0.3	2.9	0.4	0.3	3.1	0.7	0.3	0.2	0.3	2.7	0.4	23.2	33.9	20.2	1.3	1.0	1.6	0.9	0.0	0.3	0.3	0.1	0.0	0.2	0.1	0.6	0.1	1.7	1.3	0.2	1.6	0.2	0.2	0.1	3.5	1.6	3.1	4.6	1.2	0.1	2.0	3.2	0.2	0.4	0.1	0.3	0.0	0.8	1.5	0.1	1.5	1.2	4.0	1.1	2.8	0.3	0.2	1.0	0.0	0.6	1.2	1.5	0.9	1.3	0.6	1.5	2.0	1.8	1.3	0.6	0.7	3.0	2.3	1.6	0.6	0.7	2.4	0.2	2.7	0.1	0.1	33.9	0.1	14.4	0.2	0.4	22.9	0.0	0.2	0.2	27.3	1.7	23.2	0.4	0.3	0.0	20.2	2.2	2.6	15.2	3.1	1.6	2.2	1.6	0.3	0.6	0.3
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470813-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;CACO-2: 1.9;HSkMC: 5.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 28.2;myeloid DC: 25.3"	"Group enriched"	"Detected in many"	40	"dendritic cells: 25.3;monocytes: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002432, HPA046404, HPA051974"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	1600000000	1600000000	"Plasma membrane"	"Plasma membrane"	"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	66.7	23.8	2.1	44.6	7.2	4.1	23.2	2.8	4.9	11.3	25.3	1.6	1.4	3.5	7.2	16.8	11.3	20.1	13.2	15.7	2.8	1.8	43.9	38.9	81.0	99.8	6.9	0.5	10.3	6.7	3.1	11.7	31.9	9.9	6.8	6.5	9.8	8.6	2.2	15.2	4.0	12.5	37.2	5.7	113.6	10.2	19.6	4.3	3.4	15.5	2.9	3.5	20.1	8.3	0.0	25.3	0.6	28.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.1	1.1	0.4	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.3	5.9	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.6	0.0	0.1	1.0	0.1	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.3	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.5	28.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	6.3	2.1	7.2	2.8	2.4	2.8	1.8	6.9	0.5	9.9	4.3
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.4;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;HUVEC TERT2: 8.8;TIME: 8.3;U-87 MG: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	170000	170000	"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	5.0	1.7	1.2	19.1	1.2	0.0	2.5	0.8	1.6	1.4	9.2	0.3	1.0	5.5	1.2	8.5	1.8	1.3	2.6	3.2	1.2	1.0	1.7	1.5	2.8	14.6	1.1	0.7	1.0	1.0	0.1	1.4	6.8	3.3	1.4	15.1	2.7	2.5	1.4	1.1	1.4	18.4	1.8	1.0	31.2	2.6	4.6	0.2	9.5	1.7	6.4	12.9	4.3	1.2	0.2	0.7	0.7	0.8	0.0	0.0	0.2	0.2	0.4	0.2	0.0	1.0	0.3	0.0	0.8	1.8	0.2	0.8	0.0	1.4	0.0	0.3	0.8	0.0	0.0	1.1	1.4	8.2	0.0	0.0	0.4	1.2	0.0	0.5	0.0	0.3	0.0	0.2	3.3	8.8	0.1	4.7	5.2	0.0	0.0	6.5	0.2	0.0	1.5	1.5	1.8	0.0	0.0	1.2	5.5	4.3	6.8	0.0	0.0	5.4	8.3	3.0	2.7	0.3	0.0	0.1	0.1	0.0	19.4	0.4	5.7	0.0	0.8	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.8	1.6	1.2	1.0	1.1	0.7	3.3	0.2
CD177	"HNA2A, NB1, PRV1"	ENSG00000204936	"CD177 molecule"		19	43353659-43363172	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 67.6;intestine: 43.5;lymphoid tissue: 33.9;vagina: 30.8"	"Cell line enriched"	"Detected in some"	24	"RPMI-8226: 44.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.6"					"Cell type enriched"	"Detected in some"	7	"neutrophil: 11.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 11.3"									"HPA041820, HPA046601"	Enhanced				"Intracellular and membrane"					"HPA041820: AB_2677691, HPA046601: AB_2679716"	"unprognostic (4.32e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.24e-1)"	1.0	0.0	0.0	8.3	0.0	67.6	0.7	0.0	0.9	2.3	39.5	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	17.3	0.0		0.0	2.1	16.6	26.6	0.1	0.0	2.0	1.0	0.0	0.0	0.4	1.9	17.3	43.5	0.9	0.0	0.0	0.0	0.0	0.0	0.6	4.8	33.9	0.0	1.1	0.0	2.0	1.3	7.2	2.3	0.8	30.8	0.0	0.0	11.3	1.6	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.3	0.3	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	44.9	0.7	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	1.6	0.0	0.9	0.0										
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.2;lymphoid tissue: 38.7"	"Group enriched"	"Detected in some"	10	"Daudi: 22.8;Karpas-707: 21.4;U-266/70: 17.4;U-266/84: 24.2;U-698: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.7;naive B-cell: 29.2"	"Group enriched"	"Detected in many"	23	"B-cells: 29.2;dendritic cells: 8.5;monocytes: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced									"HPA003740: AB_1078450"	"unprognostic (9.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.85e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	9.6	1.6	1.4	24.3	3.2	1.9	5.7	0.6	1.3	1.0	2.1	1.6	0.0	1.8	0.9	1.0	1.7	1.3	1.5	4.6	1.2	1.1	2.5	2.7	3.0	30.4	4.1	0.6	1.5	1.0	0.2	1.1	2.9	2.2	1.5	2.5	0.4	3.1	0.4	0.6	0.7	8.4	1.6	3.5	38.7	1.9	0.8	2.8	1.9	1.2	0.2	31.3	4.1	0.8	29.2	8.5	0.3	11.6	0.7	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.1	17.4	24.2	6.4	0.0	1.4	0.0	0.0	4.1	0.3	0.0	7.4	0.0	28.7	0.0	0.0	8.0	29.2	0.0	0.0	0.3	0.7	11.6	8.5	0.0	2.8	1.4	3.2	0.6	1.3	1.2	1.1	4.1	0.6	2.2	2.8
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158179947-158184896	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.5;lymphoid tissue: 17.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 9.1;HHSteC: 14.1;MOLT-4: 18.6;THP-1: 11.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 49.5;monocytes: 49.5"					"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"		720000	720000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB016107: AB_626960, HPA072662: AB_2686545"	"unprognostic (8.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (9.31e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.38e-1)"	1.5	1.2	0.0	8.6	0.0	2.6	1.2	0.0	0.0	0.8	2.5			9.5	1.5	0.0	0.4	1.4	2.0	1.4	0.0	0.1	1.6	10.5	2.3	5.5	0.2		0.3	0.7	0.0	0.6	0.0		1.4	3.7		0.7	0.3	0.6	0.0	12.2	2.2	0.4	17.8	1.4	1.4			1.8		3.4	1.6	0.5	6.3	49.5	2.5	49.5	0.1	0.1	23.5	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.2	0.0	4.8	0.0	9.1	0.0	0.0	0.1	0.2	0.0	0.0	14.1	0.1	0.0	5.3	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	18.6	1.8	0.8	0.0	0.0	0.0	0.0	0.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.5	0.0	5.2	0.7	0.0	49.5	0.1	0.0	22.4	0.1	6.3	0.0	0.0	49.5	4.7	0.0	0.0	2.5	0.1	3.6	0.5	0.0	23.5										
CD207	"CLEC4K, Langerin"	ENSG00000116031	"CD207 molecule"	Q9UJ71	2	70830214-70835822	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.5;skin 1: 42.3"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"myeloid DC: 4.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002222, HPA011216"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB002222: AB_563850, HPA011216: AB_1078453"	"unprognostic (1.45e-2)"	"unprognostic (8.28e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.92e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	0.5	0.1	0.1	1.8	0.1	0.0	1.4	0.1	0.1	2.4	1.7	0.1	0.1	1.6	1.1	0.4	9.7	0.3	2.9	0.3	0.1	0.1	0.2	0.9	3.7	0.2	0.1	0.1	0.2	0.2	0.0	1.1	0.1	0.1	1.0	1.1	0.4	1.2	0.2	0.1	42.3	2.6	0.1	0.1	1.5	0.4	0.4	0.1	3.3	0.2	11.3	16.5	0.3	1.9	0.0	4.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	13.7	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	1.9	0.0	0.0	0.0	2.4	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CD209	"CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1"	ENSG00000090659	"CD209 molecule"	Q9NNX6	19	7739994-7747564	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.9"	"Cell line enriched"	"Detected in single"	14	"THP-1: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.7;intermediate monocyte: 3.5;myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"											"CAB032436, CAB033831"	Supported				"Intracellular and membrane"	970000	970000			"CAB032436: AB_639039, CAB033831: AB_1121347"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.15e-5)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.09e-1)"	20.3	4.5	0.5	4.1	1.8	0.0	6.8	4.5	0.9	2.0	5.6	0.7	0.3	7.2	1.1	7.3	2.4	3.3	4.4	7.8	0.4	0.7	2.2	5.0	3.7	47.9	1.1	0.5	1.8	3.8	0.4	1.0	12.1	1.8	3.6	7.4	3.2	3.0	0.7	3.5	1.6	10.1	5.2	0.9	1.4	2.6	2.1	0.3	2.3	2.1	2.1	1.3	6.8	1.6	0.3	3.4	0.9	3.7	0.3	0.2	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.6	0.0	0.1	0.0	0.2	8.6	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	3.7	0.2	0.2	3.5	0.1	0.2	0.1	0.1	3.4	0.3	0.1	0.2	0.9	0.3	0.1	0.3	0.1	1.0	0.5	1.8	4.5	0.9	0.4	0.7	1.1	0.5	1.8	0.3
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347355	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.3;lymphoid tissue: 77.8;ovary: 35.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 68.2;REH: 20.2;U-698: 54.2;WM-115: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"memory B-cell: 29.8;naive B-cell: 39.3"	"Lineage enriched"	"Detected in many"	28	"B-cells: 39.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002418, HPA024353"	Enhanced									"CAB002418: AB_563529, HPA024353: AB_10600695"	"unprognostic (2.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (6.79e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.45e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	2.1	1.0	5.5	57.9	6.8	3.1	0.5	0.7	3.2	1.4	1.0	0.9	0.5	0.4	1.4	0.9	4.4	7.9	2.9	0.8	9.9	4.2	1.4	0.6	5.5	52.6	9.8	0.5	35.4	0.5	0.0	0.7	1.0	0.9	2.8	1.5	1.1	5.9	1.1	0.5	0.0	11.6	2.0	13.5	64.1	1.4	1.2	0.6	5.0	1.1	2.3	77.8	4.3	0.9	39.3	1.3	0.3	0.3	0.0	0.0	1.4	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.2	68.2	1.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	3.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	20.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	54.2	0.5	0.2	12.4	0.0	0.0	0.0	0.0	0.3	0.0	29.8	0.0	0.0	1.3	39.3	0.0	0.0	0.3	0.0	0.2	1.1	0.0	1.4	5.5	6.8	0.7	3.2	9.9	4.2	9.8	0.5	0.9	0.6
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.9;parathyroid gland: 82.5"	"Group enriched"	"Detected in some"	6	"HEL: 44.3;HMC-1: 19.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdTCR: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5"	"Group enriched"	"Detected in many"	11	"NK-cells: 14.0;T-cells: 19.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015715, HPA050348"	Supported		Uncertain	Midbody		27000000	27000000	Midbody	Midbody	"HPA015715: AB_1846278, HPA050348: AB_2732559"	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.2	0.6	1.0	7.5	2.0	1.7	0.8	0.7	0.9	1.5	2.9	0.3	0.1	1.1	1.0	1.4	0.8	0.8	1.4	0.9	1.9	1.3	1.3	3.1	5.2	14.0	1.7	0.0	1.0	0.6	82.5	2.4	0.6	1.3	0.9	1.2	2.4	5.4	0.6	1.1	0.4	6.0	1.3	4.2	31.9	1.4	1.8	0.5	6.4	1.8	2.6	10.1	2.0	1.6	0.4	1.5	0.9	0.6	14.0	19.4	6.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	2.3	0.0	44.3	0.1	0.0	0.0	0.3	19.7	0.0	0.5	0.1	0.3	0.0	0.1	4.5	0.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	5.4	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.5	19.4	0.4	7.3	0.4	16.1	11.8	1.5	0.1	9.0	9.7	0.9	14.0	0.6	0.1	5.5	6.6	1.0	2.0	0.7	0.9	1.9	1.3	1.7	0.0	1.3	0.5
CD27	"S152, TNFRSF7, Tp55"	ENSG00000139193	"CD27 molecule"	P26842	12	6444867-6451718	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 82.3;lymphoid tissue: 60.4"	"Group enriched"	"Detected in some"	141	"Daudi: 63.7;U-698: 35.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 82.3"	"Group enriched"	"Detected in many"	7	"B-cells: 41.8;T-cells: 82.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002420, HPA038936"	Enhanced					28000	28000			"CAB002420: AB_563539, HPA038936: AB_2676278"	"unprognostic (2.75e-3)"	"prognostic favourable (3.77e-5)"	"unprognostic (8.87e-3)"	"prognostic favourable (2.90e-4)"	"unprognostic (2.35e-1)"	"prognostic favourable (6.65e-7)"	"unprognostic (3.56e-2)"	"unprognostic (9.37e-2)"	"prognostic favourable (5.50e-4)"	"unprognostic (1.31e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.19e-6)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.35e-2)"	1.1	0.6	0.4	40.8	0.5	2.0	1.2	0.4	0.4	1.7	10.0	0.2	0.5	5.3	0.8	0.6	4.9	1.6	3.7	0.9	0.4	0.4	1.7	1.0	2.9	49.5	0.4	0.1	1.0	0.5	0.0	0.6	0.4	0.2	1.3	2.9	1.2	10.7	1.4	0.4	0.6	19.4	0.2	0.6	45.7	3.7	0.5	0.1	33.5	3.1	2.3	60.4	9.1	1.2	41.8	0.3	0.8	0.1	8.3	82.3	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.8	0.1	0.1	16.7	0.1	28.7	41.8	40.1	37.5	0.1	10.5	55.6	39.1	0.8	8.3	0.1	0.3	82.3	22.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.1
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.7;lymphoid tissue: 48.6"	"Group enriched"	"Detected in some"	14	"Karpas-707: 72.1;RPMI-8226: 33.0;U-266/70: 59.3;U-266/84: 53.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 32.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 32.7"	"Region enhanced"	"Detected in single"		"olfactory region: 1.3"	"Low region specificity"	"Detected in all"			HPA070003	Enhanced									"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"	5.1	0.6	0.4	14.2	0.5	1.9	3.3	0.3	0.4	1.1	1.6	0.4	0.2	0.6	1.1	2.3	1.5	2.1	3.0	4.5	0.4	0.5	1.7	1.5	3.8	23.3	0.5	0.2	1.4	0.6	0.0	0.6	11.0	0.2	1.2	1.3	1.2	3.1	0.8	0.7	1.0	7.2	0.9	0.8	9.0	1.6	0.9	0.0	48.6	1.5	0.8	29.9	4.5	1.4	0.1	0.0	5.1	0.2	0.0	32.7	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	72.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.3	53.0	0.5	0.0	0.0	0.0	0.5	0.2	0.3	3.0	0.1	18.2	0.1	19.4	9.5	0.0	0.1	17.0	6.5	5.1	0.0	0.1	0.0	32.7	4.7	0.4	0.5	0.3	0.4	0.4	0.5	0.5	0.2	0.2	0.0
CD300E	"CD300LE, CLM2, IREM2"	ENSG00000186407	"CD300e molecule"	Q496F6	17	74609887-74623738	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.5;bone marrow: 22.5;lymphoid tissue: 21.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;SCLC-21H: 1.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"classical monocyte: 22.7;intermediate monocyte: 36.5;non-classical monocyte: 36.3"	"Lineage enriched"	"Detected in many"	6	"monocytes: 36.5"	"Low region specificity"	"Detected in single"							HPA015570	Uncertain									"HPA015570: AB_1846294"	"unprognostic (1.70e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.80e-3)"	"unprognostic (4.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.19e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-4)"	"unprognostic (7.38e-3)"	"unprognostic (1.19e-1)"	8.5	0.7	0.5	21.0	0.6	22.5	0.7	1.2	1.0	0.5	1.2	0.3	0.0	0.0	0.7	3.0	0.9	1.5	1.9	2.0	0.5	0.5	2.5	1.1	14.3	9.4	0.5	0.2	1.0	0.8	0.0	0.5	1.7	0.7	0.6	0.2	1.1	0.6	1.6	1.6	0.6	0.7	5.3	0.9	14.3	0.8	0.7	0.3	0.2	1.2	0.8	0.8	1.8	0.6	0.0	5.9	0.5	36.5	0.0	0.0	11.6	0.2	0.0	1.1	0.1	0.0	0.1	0.2	0.2	0.2	0.0	0.1	1.1	0.0	0.5	0.2	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.0	1.7	0.8	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.2	0.8	0.5	0.4	0.2	0.0	0.2	0.1	0.6	1.5	0.5	0.3	0.0	0.1	0.6	0.0	0.0	0.5	0.7	0.7	0.2	0.9	0.0	0.1	0.0	0.6	0.5	0.0	22.7	0.1	0.0	36.5	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.5	0.0	36.3	0.1	0.0	11.6	0.5	0.6	1.2	1.0	0.5	0.5	0.5	0.2	0.7	0.3
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.3;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in some"		"HEL: 27.9;HL-60: 37.1;HMC-1: 27.8;NB-4: 17.7;RPMI-8226: 20.0;THP-1: 21.8;U-937: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 49.3;monocytes: 37.6"									"CAB011442, HPA035832, HPA064807"	Approved		Supported	"Nucleoplasm,Plasma membrane"		1400000	1400000	"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB011442: , HPA035832: AB_2674808, HPA064807: "	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	10.2	4.3	3.6	8.4	6.0	23.0	6.5	0.8	3.5	2.6	2.7	4.4	0.3	2.5	2.3	5.2	1.7	3.9	5.3	7.5	3.1	2.5	4.1	6.4	11.6	45.4	6.4	1.8	1.9	1.9	0.5	1.7	5.4	5.2	2.6	3.4	2.6	2.9	2.1	1.2	2.5	4.0	5.6	9.9	31.6	2.8	1.5	5.8	2.5	1.7	0.2	2.7	4.7	2.3	0.1	49.3	4.6	37.6	3.3	0.2	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	37.1	27.8	0.0	0.0	0.0	0.0	0.0	5.1	7.0	0.0	0.0	0.0	17.7	0.0	8.5	0.0	1.4	20.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.8	0.2	4.8	0.4	0.6	0.0	0.1	2.4	0.0	3.2	27.4	0.1	3.3	37.6	2.3	0.0	27.3	0.1	0.0	0.0	0.1	49.3	0.1	0.0	0.0	4.6	3.3	12.6	1.4	0.2	14.7	3.6	6.0	0.8	3.5	3.1	2.5	6.4	1.8	5.2	5.8
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.4;lymphoid tissue: 109.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 65.7;HMC-1: 65.1;RPMI-8226: 23.4;THP-1: 23.4;U-937: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002492, HPA032120, HPA032121"	Enhanced									"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favourable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	7.3	3.1	3.4	62.9	4.8	48.7	3.7	1.0	3.1	1.9	4.2	8.5	0.0	3.2	2.0	2.2	5.9	2.9	5.2	10.4	3.8	3.8	4.3	2.7	25.3	109.6	6.9	1.7	2.5	1.6	0.5	1.9	5.4	4.7	3.5	1.7	2.7	10.7	1.4	1.1	2.0	39.3	1.7	14.5	88.1	5.1	2.9	5.0	47.9	3.4	1.7	86.8	10.2	2.4	163.4	53.7	84.4	62.8	27.9	43.5	58.8	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.7	0.0	0.0	0.1	0.0	0.0	0.0	10.4	0.0	11.5	0.0	0.1	0.0	1.9	65.1	0.0	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.1	1.2	0.0	0.0	0.6	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	14.5	0.0	17.4	0.0	42.8	58.2	71.7	34.3	53.4	34.7	137.2	41.8	36.4	41.1	163.4	43.5	36.3	84.4	27.9	62.8	53.7	40.9	58.8	3.4	4.8	1.0	3.1	3.8	3.8	6.9	1.7	4.7	5.0
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820808	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 111.5;parathyroid gland: 78.4"	"Group enriched"	"Detected in some"	6	"HEL: 33.5;HL-60: 13.5;NB-4: 19.3;THP-1: 38.1;U-937: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4"	"Group enriched"	"Detected in many"	20	"dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1"	"Region enriched"	"Detected in single"	15	"basal ganglia: 41.4"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: "	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	13.8	5.4	6.1	16.0	5.8	4.4	5.6	1.2	4.3	4.5	5.1	8.6	1.8	3.6	3.5	8.3	3.0	5.5	7.3	5.4	4.9	4.4	6.1	32.2	24.0	30.8	6.3	3.1	3.0	3.1	78.4	3.4	10.9	6.2	4.1	6.5	5.7	5.4	3.9	1.9	3.5	9.5	5.2	10.2	49.1	3.9	2.8	5.7	111.5	3.9	4.1	18.6	8.6	3.2	0.1	46.7	1.9	42.5	0.3	29.1	33.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	33.5	0.0	0.2	3.7	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	19.3	0.3	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.1	42.2	0.3	0.3	42.5	1.1	0.0	29.1	0.1	29.3	0.1	24.8	0.1	1.9	0.3	33.3	46.7	26.4	33.6	6.1	5.8	1.2	4.3	4.9	4.4	6.3	3.1	6.2	5.7
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.0;HMC-1: 42.5;U-266/70: 90.0;U-266/84: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	2600000	2600000	"Plasma membrane"	"Plasma membrane"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favourable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favourable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.5	42.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	13.2	6.5	0.0	0.0	0.8	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.0	60.1	15.4	0.0	11.4	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110873154-110899928	"CD markers, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 146.7;lymphoid tissue: 103.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 85.8;HDLM-2: 36.9;HMC-1: 54.0;Karpas-707: 33.7;U-266/70: 46.6;U-698: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced									"HPA047216: AB_2679986"	"unprognostic (2.93e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (9.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.72e-2)"	29.7	8.1	6.1	50.6	10.3	20.4	6.6	1.6	5.8	4.5	9.6	7.6	1.2	6.7	4.3	6.0	5.5	9.9	11.0	6.4	6.4	5.9	9.6	8.8	28.9	93.8	13.3	2.7	4.7	3.8	0.8	3.1	10.6	8.5	5.2	10.5	4.5	10.1	2.3	2.3	2.2	35.2	10.0	14.9	103.0	7.5	4.8	10.0	37.2	4.6	4.1	82.1	15.2	4.0	97.5	74.6	138.0	97.0	59.2	91.8	146.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	4.5	0.0	0.0	0.0	10.3	54.0	0.0	0.0	0.0	0.0	0.0	1.9	33.7	0.0	0.0	17.4	12.2	0.0	0.0	16.9	0.1	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	3.0	0.0	0.0	0.0	0.0	46.6	21.1	26.6	0.2	11.9	0.6	138.0	87.0	54.1	91.8	93.3	82.8	97.5	67.5	80.8	74.6	83.3	49.2	70.8	136.2	59.2	97.0	61.4	85.0	146.7	6.1	10.3	1.6	5.8	6.4	5.9	13.3	2.7	8.5	10.0
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.0;lymphoid tissue: 58.1"	"Cell line enriched"	"Detected in some"	18	"MOLT-4: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	34	"gdTCR: 12.4;MAIT T-cell: 11.1;memory CD4 T-cell: 23.0;memory CD8 T-cell: 21.4;naive CD4 T-cell: 15.5;naive CD8 T-cell: 11.1;T-reg: 10.1"	"Lineage enriched"	"Detected in single"	52	"T-cells: 23.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	110000	110000			"CAB002489: AB_563605, CAB016252: AB_631163"	"prognostic favourable (1.95e-4)"	"prognostic favourable (1.57e-5)"	"unprognostic (4.47e-2)"	"prognostic favourable (2.41e-4)"	"unprognostic (2.06e-2)"	"prognostic favourable (5.10e-6)"	"unprognostic (8.45e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.87e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.35e-1)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.96e-2)"	1.5	0.5	0.8	26.4	0.4	5.5	0.9	0.5	1.4	1.3	3.3	0.6	0.8	2.2	1.4	1.5	1.9	1.3	5.0	1.3	0.7	1.8	1.6	1.1	6.9	25.6	1.7	0.5	0.7	0.8	0.0	0.6	0.6	0.4	1.2	1.6	1.2	7.0	0.3	0.3	0.9	13.0	0.7	0.9	18.4	3.4	0.9	0.1	58.1	1.6	1.9	42.0	3.7	1.3	0.4	0.1	0.3	0.0	0.0	23.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.6	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	0.0	11.1	0.4	23.0	21.4	0.1	0.4	15.5	11.1	0.3	0.0	0.0	0.0	10.1	5.1	0.8	0.4	0.5	1.4	0.7	1.8	1.7	0.5	0.4	0.1
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579467-7582113	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 179.1;lymphoid tissue: 139.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 73.3;U-87 MG: 115.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 68.4;monocytes: 179.1"	"Low region specificity"	"Detected in all"							"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: , HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	118.4	28.5	12.5	46.8	21.6	46.8	40.9	2.9	11.2	27.1	38.1	15.5	2.1	57.0	9.6	24.1	26.9	17.3	33.7	39.0	10.1	6.9	20.9	43.1	84.4	102.5	21.1	4.4	15.8	7.5	2.1	8.5	34.7	15.7	12.1	18.5	12.8	22.2	4.4	16.1	9.4	58.3	15.6	26.0	139.1	17.6	9.4	16.3	13.3	8.8	12.3	21.1	31.4	19.1	3.7	68.4	11.0	179.1	0.9	0.5	125.6	35.1	7.1	0.4	0.5	73.3	28.0	0.3	11.2	30.7	14.9	17.4	1.5	10.6	0.4	12.8	32.6	1.5	0.1	7.1	10.1	0.3	1.3	5.6	1.7	8.5	6.2	2.7	31.7	8.8	1.4	31.2	23.0	3.9	2.2	3.6	14.4	0.2	0.2	2.4	0.4	5.2	0.4	0.6	20.7	3.0	1.5	0.2	0.4	9.3	4.7	10.9	0.2	21.6	12.2	19.0	1.1	19.0	14.6	0.2	0.2	0.2	115.5	6.9	9.6	10.1	155.1	0.9	0.4	179.1	0.5	3.7	0.2	0.3	40.9	2.0	0.3	0.2	11.0	0.9	170.1	68.4	0.3	125.6	12.5	21.6	2.9	11.2	10.1	6.9	21.1	4.4	15.7	16.3
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;lymphoid tissue: 56.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 12.4;K-562: 24.0;MOLT-4: 8.6;U-266/70: 9.8;U-698: 11.1;U-937: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 14.8;T-cells: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced									"CAB002503: AB_563625, HPA050525: AB_2681157"	"prognostic favourable (3.31e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.10e-3)"	"unprognostic (4.76e-3)"	"unprognostic (9.53e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (7.87e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"	10.1	2.2	1.3	19.9	1.4	52.1	7.0	0.5	0.9	9.0	9.6	4.6	0.8	2.8	5.1	5.1	10.6	6.4	13.6	3.1	2.0	2.2	4.7	6.2	27.0	31.6	4.5	0.6	3.4	1.4	0.9	3.4	1.9	3.5	7.4	8.0	3.3	6.0	2.0	1.5	3.3	14.3	5.0	8.3	43.3	4.3	4.5	1.6	56.4	5.5	6.1	26.7	27.4	5.9	3.9	0.0	3.1	0.1	14.8	18.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	12.4	0.5	0.0	0.0	0.0	0.0	0.2	24.0	0.0	0.0	0.0	8.6	2.5	0.0	0.0	0.0	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	1.1	11.1	0.0	41.1	0.0	0.7	0.1	3.1	13.7	0.0	18.3	3.3	8.7	9.9	0.0	3.9	12.6	9.2	0.2	14.8	0.0	0.0	4.3	3.8	1.3	1.4	0.5	0.9	2.0	2.2	4.5	0.6	3.5	1.6
CD70	"CD27L, CD27LG, TNFSF7"	ENSG00000125726	"CD70 molecule"	P32970	19	6583183-6604103	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.3;lymphoid tissue: 12.7"	"Cell line enhanced"	"Detected in many"		"SiHa: 36.0;THP-1: 29.6;U-251 MG: 43.8;U-266/70: 78.0;U-266/84: 56.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 13.9;T-reg: 23.3"	"Group enriched"	"Detected in many"	38	"B-cells: 13.9;T-cells: 23.3"									HPA046582			Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046582: "	"unprognostic (8.71e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	5.3	0.2	0.2	9.3	0.2	1.4	2.2	0.9	0.9	1.4	4.1	0.2	0.1	1.0	0.4	1.8	4.0	0.7	0.8	0.4	0.2	0.2	1.7	0.4	1.9	6.1	0.4	0.1	0.3	0.4	0.0	0.3	0.3	0.2	0.9	3.1	0.2	3.1	1.2	1.2	3.3	5.2	0.7	0.5	11.8	1.7	1.9	0.1	3.2	0.8	1.8	12.7	3.1	1.1	13.9	0.1	0.2	0.0	0.4	23.3	0.9	0.2	7.4	0.0	14.5	0.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	13.9	0.8	0.0	10.1	8.9	0.7	0.0	0.0	0.3	0.0	11.0	0.0	0.0	0.0	0.4	0.1	0.0	8.5	6.1	0.0	0.2	0.4	0.2	0.0	0.2	17.5	0.1	13.4	3.7	0.0	3.0	4.7	0.0	0.0	0.0	36.0	0.0	0.1	0.1	29.6	0.2	0.1	6.5	0.0	43.8	78.0	56.4	25.1	8.0	4.4	2.8	0.2	0.0	0.0	1.9	0.0	4.8	13.9	3.2	5.0	0.0	4.0	0.4	1.3	0.1	0.4	0.0	0.1	23.3	0.9	0.2	0.2	0.9	0.9	0.2	0.2	0.4	0.1	0.2	0.1
CD80	"B7-1, B7.1, CD28LG, CD28LG1"	ENSG00000121594	"CD80 molecule"	P33681	3	119524293-119559602	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 17.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;HDLM-2: 28.3;Karpas-707: 11.8;U-266/70: 5.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.3;non-classical monocyte: 1.1;T-reg: 3.3"	"Group enriched"	"Detected in many"	24	"B-cells: 4.3;monocytes: 1.1;T-cells: 3.3"					"Low region specificity"	"Detected in all"			"CAB025368, HPA050092"	Enhanced				"Intracellular and membrane"					"CAB025368: , HPA050092: AB_2681012"	"unprognostic (2.36e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.03e-8)"	"unprognostic (3.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.94e-2)"	0.7	0.6	0.4	11.7	0.3	1.5	1.2	0.3	0.3	0.6	0.7	0.3	0.7	1.3	0.4	0.6	0.7	0.3	1.0	0.5	0.9	0.3	0.7	2.0	6.2	7.4	0.4	0.0	0.3	0.9	0.0	1.1	0.7	0.6	0.6	1.7	0.8	3.9	0.2	0.5	0.4	2.4	0.2	0.8	17.5	0.6	0.4	0.0	5.6	1.6	0.8	17.2	1.8	0.4	4.3	0.1	0.0	1.1	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	4.3	0.5	0.3	0.1	0.6	0.0	0.0	0.0	0.0	1.1	0.0	3.3	0.2	0.4	0.3	0.3	0.3	0.9	0.3	0.4	0.0	0.6	0.0
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.0;lymphoid tissue: 64.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 28.6;HDLM-2: 25.7;U-698: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454"	Enhanced									"CAB002509: AB_563641, HPA041454: AB_2677489"	"unprognostic (2.22e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.05e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.68e-2)"	"prognostic favourable (3.49e-4)"	"unprognostic (2.30e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.46e-2)"	14.0	8.3	6.1	64.5	5.7	70.0	7.5	14.2	11.8	17.0	2.0	24.7	3.4	1.8	3.7	8.3	3.6	1.8	9.9	2.6	7.3	12.7	9.7	6.0	29.0	19.5	7.8	2.2	9.7	1.6	2.2	4.1	3.4	10.8	5.2	3.8	3.5	16.4	7.8	1.8	2.6	6.9	2.7	11.1	16.5	2.2	4.0	2.8	33.8	2.3	6.2	57.5	16.4	9.8	19.1	5.2	1.3	15.4	2.6	3.6	2.3	6.5	0.3	4.9	6.8	7.2	1.6	0.1	1.8	6.7	3.2	5.6	0.5	4.3	28.6	5.5	0.5	0.7	1.8	2.0	10.6	25.7	2.7	3.9	8.5	0.7	0.2	5.7	6.3	1.9	0.9	3.0	1.0	0.1	0.8	0.0	0.3	2.4	4.5	10.8	2.0	1.3	4.4	10.7	4.0	2.3	6.5	1.0	1.9	0.4	0.2	4.9	1.1	4.6	0.1	4.9	3.1	0.7	4.4	0.3	0.0	44.0	1.0	7.8	7.4	0.0	1.7	1.1	2.7	10.7	2.9	11.5	2.5	2.2	5.2	19.1	1.8	2.1	1.3	2.6	15.4	1.8	3.6	2.3	6.1	5.7	14.2	11.8	7.3	12.7	7.8	2.2	10.8	2.8
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HEL: 23.7;HL-60: 6.7;HMC-1: 27.1;MOLT-4: 6.6;U-698: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		36000000	36000000	"Plasma membrane"	"Plasma membrane"	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	15.9	4.8	3.8	18.5	4.5	6.7	3.7	1.3	3.4	3.3	3.2	7.9	7.7	2.5	2.5	4.3	2.7	3.1	6.4	5.0	3.8	3.0	3.1	5.1	9.2	26.0	6.0	2.2	1.8	4.3	0.9	1.9	7.1	5.3	3.7	4.7	2.4	4.3	9.8	1.6	2.7	9.6	4.1	11.1	25.6	3.5	2.8	5.9	13.8	2.9	2.3	16.3	5.8	2.7	5.1	5.4	21.0	7.3	1.0	8.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	6.7	27.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	6.6	5.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	1.5	0.0	21.0	7.3	11.0	6.9	6.3	5.2	5.1	5.9	8.2	5.4	4.7	3.5	6.3	1.0	1.0	2.4	3.2	7.9	6.1	3.8	4.5	1.3	3.4	3.8	3.0	6.0	2.2	5.3	5.9
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: "	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	51.7	25.3	35.3	23.0	1.2	3.1	33.9	24.0	21.6	70.1	37.4	39.6	43.2	30.0	14.1	22.0	36.5	38.6	45.8	58.5	23.5	28.5	43.9	25.0	24.5	0.3	30.6	16.0	1.0	2.1	48.6	44.1	29.7	19.8	20.6	31.7	20.0	29.4	18.8	44.7	34.1	42.8	48.5	19.0	17.1	13.8	20.9	10.3	42.5	28.7	13.3	20.1	38.8	15.4	21.0	49.2	23.3	74.5	15.9	14.0	31.1	15.0	38.2	31.2	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188402	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005855			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA005855: AB_1846364"	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.8	1.2	1.1	5.5	1.1	13.0	0.8	0.7	1.2	1.1	3.3	0.6	1.0	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1.0	4.0	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23.0	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0.0	1.0	0.1	7.5	3.7	17.8	9.6	0.6	1.2	12.3	10.5	4.0	13.2	10.7	16.1	3.9	22.4	4.1	2.7	5.7	30.5	7.2	13.9	7.3	16.0	28.7	6.8	7.9	0.6	20.2	8.3	0.6	1.1	16.4	7.1	5.0	22.8	11.9	7.1	4.0	25.2	15.7	26.0	8.5	11.3	11.7	12.2	3.3	7.1	8.4	10.4	6.5	7.6	3.3	4.0	14.3	2.5	6.5	10.0	7.2	14.2	6.0	17.9	35.2	4.8	22.5	5.4	0.0	0.0	0.5	0.4	0.0	0.0	1.7	0.6	0.2	0.9	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell line enhanced"	"Detected in many"		"K-562: 86.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	Nucleoplasm	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.1	11.0	13.7	10.7	0.6	1.3	5.8	16.2	7.6	18.7	18.6	8.4	7.3	14.6	5.7	4.8	12.6	14.6	10.7	16.8	17.8	24.7	19.5	12.4	9.2	0.7	28.3	10.7	0.4	0.5	14.3	6.4	9.4	86.6	18.4	10.9	17.5	22.9	13.4	4.1	8.3	19.1	22.8	6.4	4.3	12.6	17.7	9.3	8.8	9.7	2.8	6.3	12.6	3.6	14.6	23.4	11.0	14.7	6.3	11.6	17.0	7.7	14.2	19.5	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.0	17.3	21.0	14.9	1.1	2.3	19.1	27.3	8.2	23.9	29.0	19.6	11.2	20.2	17.1	5.8	36.4	18.1	12.4	23.8	10.7	14.2	16.4	20.7	17.6	0.7	22.4	10.1	0.5	0.9	27.7	16.7	7.2	29.9	19.0	11.6	13.1	32.5	5.4	17.2	6.4	24.0	51.0	19.1	4.0	28.2	14.4	12.9	24.8	85.2	8.4	17.3	19.4	6.0	17.3	24.7	28.3	32.3	7.9	17.2	39.0	15.0	14.8	18.9	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2
CDCA3	"GRCC8, TOME-1"	ENSG00000111665	"Cell division cycle associated 3"	Q99618	12	6844793-6852066	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.6;lymphoid tissue: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.8"	"Cell type enhanced"	"Detected in many"		"T-reg: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026587			Approved	Cytosol				Cytosol	Cytosol	"HPA026587: AB_1846386"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (6.51e-5)"	"prognostic unfavourable (9.77e-5)"	"unprognostic (3.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-3)"	"unprognostic (8.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.94e-2)"	1.6	1.9	1.0	19.2	1.8	9.9	1.9	8.8	2.2	2.0	17.3	1.2	1.2	15.5	2.3	2.0	6.9	1.0	2.9	2.2	1.1	1.6	1.3	0.9	1.9	10.8	1.3	0.7	3.7	0.6	0.3	6.9	4.7	1.2	2.2	5.3	0.7	2.4	0.4	0.7	4.3	34.6	2.0	1.4	5.2	2.4	18.2	1.1	51.0	1.3	8.5	15.1	1.6	2.8	1.6	2.3	0.5	0.6	0.8	7.7	0.9	29.8	21.6	22.1	13.4	1.3	2.0	25.6	19.7	12.1	32.4	22.6	32.0	25.7	16.5	2.5	14.8	20.5	14.1	13.6	32.2	24.8	15.7	14.8	14.4	20.8	0.2	11.0	14.2	0.9	1.1	17.4	9.5	13.7	12.3	10.8	30.8	23.3	16.0	12.7	25.7	16.7	16.2	19.2	9.3	10.7	8.4	3.4	6.6	17.8	16.6	6.1	6.5	10.7	6.0	15.8	20.5	10.3	33.0	5.5	5.6	25.8	7.4	13.7	27.8	0.0	0.6	0.0	0.5	0.3	0.8	1.6	1.3	1.9	0.7	0.8	0.6	1.2	0.5	0.8	0.5	2.3	7.7	0.9	1.0	1.8	8.8	2.2	1.1	1.6	1.3	0.7	1.2	1.1
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900900-21946084	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"olfactory region: 22.0"	HPA027169	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA027169: AB_1856058"	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	6.2	1.2	3.7	19.9	9.6	24.2	8.0	6.5	4.2	8.4	9.0	7.8	3.9	5.2	11.1	3.6	6.0	7.0	5.4	12.5	3.9	2.5	2.7	4.5	7.3	18.7	6.2	4.0	13.9	17.4	1.0	1.6	2.2	3.7	7.6	10.2	5.8	10.5	8.0	2.7	13.6	8.7	6.6	3.0	9.3	12.7	12.6	5.3	47.9	20.0	5.1	16.5	6.0	9.4	38.5	21.8	11.8	1.3	0.8	9.7	3.3	19.6	6.7	6.3	0.1	3.5	4.4	0.0	16.1	13.9	12.5	17.8	2.5	17.9	41.0	5.3	13.8	12.1	10.0	16.5	25.4	0.0	6.6	9.8	20.0	1.6	4.5	25.8	0.1	8.3	3.0	9.7	28.4	24.7	13.5	0.0	9.7	7.3	32.5	9.3	36.3	8.4	32.7	22.8	27.4	3.5	3.7	23.3	19.0	7.3	4.5	7.3	10.9	11.7	10.4	13.7	16.9	23.8	19.4	21.1	14.5	53.0	13.1	34.8	13.4	0.3	0.6	11.8	0.6	0.9	0.1	28.6	1.9	0.9	4.3	38.5	9.7	3.9	1.1	0.8	1.3	21.8	2.7	3.3	3.7	9.6	6.5	4.2	3.9	2.5	6.2	4.0	3.7	5.3
CDCP2		ENSG00000157211	"CUB domain containing protein 2"	Q5VXM1	1	54132968-54153770	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.2"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.4"	HPA031143	Uncertain				"Secreted - unknown location"					"HPA031143: AB_10611819"	"unprognostic (1.08e-1)"	"unprognostic (5.16e-2)"		"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-2)"	"unprognostic (7.67e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.21e-2)"	0.5	0.3	0.1	0.1	0.5	0.3	0.9	0.1	0.6	1.1	0.2			0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.4	0.3	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.2	0.5	0.0	0.6	0.3	0.2	0.0	2.2	0.2	0.1			0.6		0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.7	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958427-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.1;prostate: 15.3"	"Cell line enriched"	"Detected in some"	6	"RT4: 33.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"				"Plasma membrane"	"Plasma membrane"	"HPA015722: AB_2077659, HPA047578: AB_2680091"	"unprognostic (2.42e-1)"	"prognostic favourable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.8	0.5	0.8	0.7	1.2	1.3	0.8	2.0	1.1	3.8	0.7	0.7	0.7	0.5	1.3	0.7	3.8	2.5	0.7	0.7	1.2	1.0	0.7	0.7	2.9	0.7	1.3	0.7	2.0	0.7	0.7	1.9	0.7	1.4	15.3	0.4	1.4	2.8	0.7	1.0	0.4	0.7	0.7	1.6	0.7	1.9	0.7	0.7	4.2	0.7	0.7	16.1	6.2	1.3	0.0	0.9	1.6	1.4	0.0	0.2	0.4	0.0	0.5	0.1	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.6	0.6	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.2	0.2	0.1	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.4	0.1	0.0	0.0	0.6	0.0	33.9	0.7	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	1.2	2.0	1.1	1.2	1.0	1.3	0.7	1.4	0.7
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell line enhanced"	"Detected in some"		"A-431: 24.4;HaCaT: 67.7;HBEC3-KT: 32.6;hTCEpi: 26.1;hTERT-HME1: 19.9;RPTEC TERT1: 29.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.4	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.6	9.1	0.0	0.1	0.0	67.7	0.6	32.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.1	0.0	19.9	0.0	0.0	0.0	0.0	12.7	0.0	0.0	1.2	2.0	0.0	0.0	0.0	29.3	11.0	0.1	0.0	0.2	0.0	11.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252426-61940617	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.9;hTERT-HME1: 10.4;U-2 OS: 14.2;U-251 MG: 24.7"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA015613: AB_2732414"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	1.0	1.2	17.4	0.7	15.8	0.9	0.9	1.3	13.6	0.9	0.7	4.0	0.0	0.8	0.9	0.7	1.4	2.6	0.9	1.0	10.2	6.9	0.8	0.9	1.0	0.9	2.8	11.8	6.2	2.0	0.7	0.5	0.9	3.3	0.8	0.7	0.6	1.5	3.6	9.8	2.7	0.8	0.7	1.6	10.2	0.8	1.9	3.1	0.0	1.7	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.9	7.9	0.0	0.1	0.5	0.1	2.2	0.0	4.0	0.4	0.2	0.0	0.0	0.2	2.6	2.9	0.0	4.3	1.6	0.2	0.0	0.0	0.1	0.1	5.5	0.0	0.1	0.8	1.0	0.8	10.4	0.8	0.0	0.0	1.6	0.3	0.1	0.0	0.9	0.0	0.0	0.0	1.1	2.5	0.0	0.7	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	14.2	0.1	24.7	4.6	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	17.4	15.8	1.3	13.6	10.2	6.9	2.8	11.8	3.3	3.1
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 91.7;REH: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavourable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.0	2.8	7.8	5.0	2.3	2.6	1.6	6.3	3.9	3.1	3.0	7.7	4.7	4.7	3.6	4.2	3.8	4.3	9.0	7.4	10.3	3.0	11.8	5.4	7.4	1.4	7.3	0.5	2.5	4.9	4.2	20.0	1.2	11.2	13.0	5.6	1.2	91.7	0.7	2.4	2.6	44.8	27.6	7.9	4.3	0.1	4.1	26.8	0.7	2.1	3.7	0.1	12.0	4.6	10.3	16.1	4.0	12.6	7.0	0.1	6.3	1.5	25.0	13.6	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"Carcinoembryonic antigen related cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 58.7;liver: 46.1;lymphoid tissue: 46.5"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 12.5;Hep G2: 35.4;RT4: 23.3;SK-MEL-30: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.6;neutrophil: 12.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.6"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	180000000	180000000			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favourable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	5.3	5.0	0.4	30.2	0.7	15.8	5.3	0.5	0.5	7.7	58.7	0.9	2.5	11.8	3.5	1.5	35.6	1.7	4.3	3.8	0.5	0.5	24.0	46.1	5.4	8.6	1.8	0.0	2.5	1.0	0.0	3.7	16.8	1.0	8.8	35.6	1.7	20.7	5.4	0.9	1.7	54.9	3.0	1.5	5.5	3.6	1.3	0.7	1.2	2.3	18.5	46.5	7.8	12.7	1.9	0.1	20.6	1.8	0.0	1.5	0.3	0.1	2.3	0.1	0.1	0.0	0.0	6.0	0.0	0.1	0.4	0.2	0.9	12.5	0.7	5.0	0.0	0.3	0.0	3.4	0.1	0.0	0.2	0.1	0.1	35.4	0.7	0.0	5.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.4	0.1	0.0	0.1	0.7	0.7	0.0	0.5	0.2	23.3	0.1	0.0	0.0	0.0	26.2	0.1	0.0	0.8	0.1	0.2	0.1	0.1	0.7	0.0	1.3	0.0	0.1	0.1	0.4	0.0	20.6	0.0	0.9	0.2	1.9	0.5	0.2	0.1	0.3	0.4	0.1	12.7	0.0	1.8	0.0	1.5	0.3	0.4	0.7	0.5	0.5	0.5	0.5	1.8	0.0	1.0	0.7
CEACAM16	DFNA4B	ENSG00000213892	"Carcinoembryonic antigen related cell adhesion molecule 16"	Q2WEN9	19	44699151-44710714	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.9;pancreas: 7.0"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;RH-30: 1.5;T-47d: 2.7;U-266/70: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045075	Uncertain				"Secreted in other tissues"					"HPA045075: AB_10959617"	"unprognostic (1.27e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.59e-2)"		"unprognostic (7.81e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.05e-1)"		"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"		"unprognostic (7.94e-2)"	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0		0.0	7.0	0.0	1.1	0.0		0.0	0.0		0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2			0.0		1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.7	0.0	0.0	0.0	0.0	5.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"Carcinoembryonic antigen related cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 19.1;bone marrow: 21.1;lymphoid tissue: 22.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.5;Karpas-707: 7.6;U-266/70: 8.4;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043411	Uncertain									"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favourable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.8	1.2	1.6	18.5	1.7	21.1	1.3	1.0	1.4	3.5	3.8	2.4	0.0	1.2	3.9	1.4	1.5	1.4	1.1	2.1	2.0	7.2	1.4	1.8	7.2	19.2	8.4	0.5	1.1	0.7	0.3	1.0	2.4	1.9	1.2	1.2	2.0	4.3	6.2	0.5	0.6	5.0	0.9	3.3	22.7	1.4	1.5	1.6	11.1	1.2	0.7	22.4	2.9	0.8	6.9	7.0	13.0	4.6	10.3	19.1	10.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	8.4	1.5	1.6	0.0	6.4	0.0	0.0	2.6	10.8	19.1	4.6	12.8	6.7	16.5	13.1	2.8	6.9	14.2	13.8	13.0	10.3	2.8	7.0	14.6	10.1	1.6	1.7	1.0	1.4	2.0	7.2	8.4	0.5	1.9	1.6
CEACAM5	"CD66e, CEA"	ENSG00000105388	"Carcinoembryonic antigen related cell adhesion molecule 5"	P06731	19	41708585-41729798	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 17.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	19000000	19000000	"Plasma membrane"	"Plasma membrane"	"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	0.1	0.1	0.1	78.8	0.1	0.0	0.1	0.1	0.2	12.5	117.1	0.2	0.1	2.5	0.9	0.1	103.5	0.3	1.2	0.1	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.5	0.1	0.3	118.2	0.2	6.8	0.1	0.1	0.6	12.8	3.3	0.1	0.1	20.1	0.2	0.1	0.6	0.2	29.4	100.6	2.0	14.1	0.6	0.6	1.8	0.7	0.6	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.1	0.0	17.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	0.4	1.4	0.3	0.0	0.1	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.1	0.1	0.2	1.2	0.3	0.8	0.3	0.2	0.1	0.5	0.2	0.3	0.6	0.6	0.4	0.5	1.8	0.6	0.7	0.5	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CEACAM7	"CEA, CGM2"	ENSG00000007306	"Carcinoembryonic antigen related cell adhesion molecule 7"	Q14002	19	41673307-41706976	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 100.5;lymphoid tissue: 60.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.8;U-2 OS: 1.4;U-266/84: 2.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 66.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA069621	Supported				"Intracellular and membrane"					"HPA069621: AB_2686162"	"unprognostic (5.24e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (6.03e-2)"		"unprognostic (2.07e-2)"		"unprognostic (4.30e-2)"			"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"		"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"		"unprognostic (3.14e-1)"	0.1	0.1	0.1	60.9	0.1	0.0	0.1	0.1	0.1	9.2	90.0	0.1	0.1	0.0	0.6	0.1	21.1	0.3	5.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.1	0.3	0.1	0.3	100.5	0.2	1.5	0.1	0.1	0.5	0.2	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	12.1	19.4	6.1	13.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.1	2.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105806-103198409	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.3;lymphoid tissue: 25.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042294	Enhanced		Approved	Nucleoplasm,Microtubules,Cytosol				"Microtubules, Cytosol"	"Microtubules, Cytosol"	"HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	2.7	0.9	0.6	9.4	1.5	11.3	0.7	0.2	1.3	1.0	2.1	0.5	0.0	1.9	0.7	1.9	5.9	0.5	0.8	2.5	2.0	0.8	1.3	0.6	1.4	7.3	1.9	0.6	0.7	0.5	0.1	0.4	3.1	1.4	0.7	2.7	0.2	2.2	0.8	0.4	2.2	2.4	1.4	1.3	3.3	1.6	6.6	0.6	25.1	0.6	5.9	6.4	1.5	1.9	0.6	0.5	5.7	3.0	0.8	1.4	0.2	20.6	5.9	21.6	10.4	1.5	3.3	4.2	18.8	9.4	14.0	9.4	9.3	11.2	14.0	4.8	6.9	9.2	15.4	7.6	22.2	17.5	5.7	16.5	12.4	6.7	0.2	19.5	9.6	1.0	0.5	11.3	9.5	11.8	17.0	16.8	18.1	7.5	15.3	8.8	6.9	9.3	10.3	20.2	4.6	3.9	4.1	10.0	5.9	16.7	11.6	4.5	6.6	6.9	12.8	13.6	14.3	14.1	19.2	8.2	14.0	14.5	7.5	10.9	14.4	5.7	0.1	0.7	0.2	0.6	0.0	0.6	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.8	3.0	0.5	1.4	0.2	0.6	1.5	0.2	1.3	2.0	0.8	1.9	0.6	1.4	0.6
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189548-69210357	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.8;testis: 37.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favourable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavourable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.0	1.9	2.9	15.2	3.1	19.1	5.5	2.1	3.0	3.9	4.7	1.2	0.7	4.2	2.9	3.1	7.7	2.5	2.8	4.4	2.7	2.1	1.9	2.2	3.6	11.1	2.6	3.7	3.6	1.6	1.6	2.7	6.8	1.8	2.4	5.5	1.6	3.0	1.5	3.6	6.0	4.0	2.4	2.6	6.2	2.5	37.3	1.8	31.8	1.8	10.2	12.2	3.1	4.3	12.1	6.1	2.5	3.6	7.5	9.8	4.2	18.1	5.6	26.4	20.6	1.7	5.5	14.0	8.9	9.6	20.0	21.7	7.7	23.2	39.1	10.8	5.3	13.6	17.2	20.7	25.7	11.8	11.9	9.1	9.6	7.6	0.6	13.1	9.4	2.1	4.3	13.0	14.4	6.7	16.1	15.6	15.4	10.1	42.2	18.8	22.9	4.9	26.3	34.8	30.1	6.3	6.7	18.2	24.3	9.8	6.7	7.9	9.3	8.9	3.2	10.0	16.8	13.2	22.2	19.3	29.1	31.3	15.3	26.6	18.8	0.6	1.8	2.5	4.5	3.0	7.3	11.8	7.6	5.7	2.8	12.1	9.8	8.3	0.4	7.5	3.6	6.1	8.7	4.2	2.9	3.1	2.1	3.0	2.7	2.1	2.6	3.7	1.8	1.8
CENPI	"CENP-I, FSHPRH1, LRPR1, Mis6"	ENSG00000102384	"Centromere protein I"	Q92674	X	101098218-101163681	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061297			Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nuclear bodies"	"HPA061297: AB_2684471"	"unprognostic (3.10e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.78e-6)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.62e-3)"	"unprognostic (1.20e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-13)"	"unprognostic (1.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-1)"	2.6	1.8	1.5	10.8	4.7	9.1	4.0	1.7	2.9	3.7	3.9	3.6	0.0	4.0	4.1	2.2	7.1	2.7	2.8	1.7	1.8	1.4	1.5	1.6	2.9	7.7	3.3	1.8	4.5	1.2	0.3	1.3	3.6	2.6	1.8	5.3	1.2	2.0	0.8	1.5	4.5	3.8	4.3	4.3	4.0	3.3	4.6	2.7	18.3	1.3	4.1	11.0	3.1	3.7	2.6	2.9	4.8	2.8	3.2	3.3	1.2	16.9	11.7	14.5	11.1	1.8	3.3	6.4	18.3	9.8	18.6	37.8	15.6	10.8	12.4	6.6	7.2	9.9	21.1	9.7	26.1	7.7	5.4	7.6	16.7	5.9	0.2	10.0	8.4	1.3	0.8	24.7	3.1	15.8	5.4	22.9	18.0	11.9	9.9	3.6	11.1	14.4	9.3	20.9	8.0	4.6	10.1	9.2	4.9	22.5	6.4	3.8	6.3	3.3	6.4	17.5	14.7	16.3	14.6	3.7	8.5	14.0	6.9	13.4	13.5	2.2	2.1	2.3	2.0	2.8	1.3	2.6	2.0	2.6	1.0	2.1	1.6	1.7	4.8	3.2	2.6	2.9	3.3	1.2	1.5	4.7	1.7	2.9	1.8	1.4	3.3	1.8	2.6	2.7
CENPK	"CENP-K, FKSG14, SOLT"	ENSG00000123219	"Centromere protein K"	Q9BS16	5	65517766-65563171	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.5;testis: 29.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (4.04e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.69e-4)"	"unprognostic (3.22e-3)"	"unprognostic (9.59e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.98e-2)"	"unprognostic (6.33e-15)"	"unprognostic (2.22e-1)"	"unprognostic (2.97e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.11e-1)"	1.8	1.5	1.9	22.8	2.9	16.1	2.5	2.7	2.4	2.0	6.2	0.6	1.0	5.8	3.0	3.3	9.8	2.2	2.0	1.7	1.3	1.0	1.8	1.6	3.2	9.7	1.1	1.2	1.8	1.2	0.6	0.9	3.7	1.4	1.7	8.8	0.8	2.7	0.2	0.6	6.6	6.9	2.1	1.3	7.0	3.7	29.0	2.0	35.5	1.4	8.8	11.2	2.1	4.1	3.4	1.0	2.0	0.6	5.5	18.3	7.7	22.3	14.6	30.7	10.4	1.6	4.5	14.6	24.5	9.4	21.1	26.7	12.2	34.4	13.6	9.1	8.2	14.0	11.7	12.4	33.6	15.5	10.1	14.6	18.4	11.6	0.6	17.1	13.2	2.0	1.8	20.4	9.8	19.9	10.7	20.5	20.9	7.4	28.8	19.3	14.7	6.0	18.0	29.3	15.1	13.7	12.1	12.9	10.4	18.9	7.9	9.6	14.4	12.7	6.9	16.3	16.8	11.1	28.3	10.8	17.5	28.5	15.2	25.6	17.6	2.0	0.4	1.3	6.1	0.6	9.0	2.4	13.2	7.7	1.0	3.4	18.3	13.5	1.1	5.5	0.6	0.9	12.8	7.7	1.9	2.9	2.7	2.4	1.3	1.0	1.1	1.2	1.4	2.0
CENPL	"C1orf155, dJ383J4.3, FLJ31044"	ENSG00000120334	"Centromere protein L"	Q8N0S6	1	173799550-173824720	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 29.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044520	Uncertain									"HPA044520: AB_10794500"	"unprognostic (8.72e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.34e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.88e-3)"	"unprognostic (6.43e-6)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (2.51e-4)"	"prognostic favourable (3.60e-4)"	"unprognostic (1.78e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.46e-10)"	"unprognostic (2.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.09e-1)"	4.0	2.7	3.1	3.8	3.7	10.9	3.1	5.0	3.8	3.6	3.0	2.8	1.7	3.0	2.5	1.5	4.2	1.8	2.0	2.2	3.0	2.5	2.1	1.4	2.6	7.8	3.9	1.7	2.6	1.4	1.5	2.3	3.8	4.0	2.3	3.9	1.8	2.9	1.8	2.8	3.2	2.9	3.0	2.9	6.6	2.6	13.7	4.5	29.5	2.3	1.9	7.2	3.2	3.7	6.0	5.3	4.2	1.4	10.6	8.4	3.2	16.1	4.4	8.3	10.9	2.5	4.2	6.2	14.5	8.5	14.9	10.5	5.7	8.6	11.5	6.9	7.4	10.7	8.6	6.8	16.6	10.6	4.3	8.9	4.9	3.3	1.3	13.2	9.0	2.1	2.3	10.5	8.5	8.6	15.0	17.4	13.6	3.7	10.7	5.9	8.6	24.4	11.3	10.4	10.0	5.2	4.5	8.3	7.0	11.3	14.0	9.4	10.0	10.7	5.4	18.2	12.3	9.2	16.5	9.6	16.7	19.1	5.9	9.6	16.1	4.2	1.3	2.7	6.1	1.4	6.9	4.3	5.6	6.8	1.2	6.0	7.1	7.6	1.0	10.6	0.9	5.3	8.4	3.2	3.1	3.7	5.0	3.8	3.0	2.5	3.9	1.7	4.0	4.5
CENPM	"C22orf18, CENP-M, MGC861, Pane1"	ENSG00000100162	"Centromere protein M"	Q9NSP4	22	41938721-41947164	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.3;lymphoid tissue: 41.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 19.5;T-reg: 23.3"	"Group enriched"	"Detected in many"	7	"B-cells: 19.5;T-cells: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042404, HPA056500"	Enhanced		Enhanced	Cytosol				Cytosol	Cytosol	"HPA042404: AB_2677981, HPA056500: AB_2683156"	"unprognostic (3.78e-2)"	"prognostic favourable (3.40e-5)"	"unprognostic (7.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (5.50e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (5.99e-7)"	"unprognostic (9.54e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.73e-2)"	"unprognostic (5.61e-2)"	1.6	1.4	1.1	31.9	0.9	18.2	3.8	1.9	1.2	1.7	6.9	1.1	0.4	6.0	1.4	2.2	8.9	9.6	4.3	3.2	1.0	0.8	2.1	1.4	4.2	17.0	1.0	0.4	1.4	0.6	0.0	0.4	3.4	0.8	1.2	3.7	1.1	3.3	0.9	0.5	6.3	7.2	1.1	0.9	9.7	4.5	13.5	0.4	41.5	0.9	5.5	18.8	3.2	3.3	19.5	0.3	0.8	0.1	2.9	23.3	4.0	22.1	22.8	12.7	8.4	1.0	0.9	5.4	10.9	5.7	19.3	19.7	26.4	11.9	28.8	8.2	5.7	8.5	9.6	11.2	4.8	8.2	40.0	13.5	24.4	18.3	1.0	25.5	15.3	0.8	0.8	12.3	5.8	7.2	10.2	27.9	11.2	34.2	25.4	26.7	6.9	16.9	24.5	12.7	30.0	7.8	13.3	14.6	2.8	16.9	10.1	5.7	9.6	16.6	3.6	18.7	28.0	12.3	18.1	14.9	10.3	26.6	6.5	21.3	20.4	0.8	0.1	0.0	3.2	0.0	4.3	13.1	9.4	4.1	0.3	19.5	1.8	2.4	0.5	2.9	0.0	0.2	23.3	4.0	1.1	0.9	1.9	1.2	1.0	0.8	1.0	0.4	0.8	0.4
CENPO	"CENP-O, MGC11266"	ENSG00000138092	"Centromere protein O"	Q9BU64	2	24793136-24822376	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.7;testis: 28.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046189			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA046189: AB_2679579"	"unprognostic (1.67e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavourable (1.73e-6)"	"unprognostic (5.56e-2)"	"unprognostic (4.02e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (5.71e-13)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	6.9	6.0	6.6	7.6	7.8	15.4	6.3	6.2	11.9	4.4	6.6	8.3	2.6	6.5	4.6	3.9	6.3	3.6	3.4	3.3	8.4	6.4	5.3	3.5	4.9	9.2	6.2	6.5	6.6	4.9	4.2	5.2	6.7	7.9	4.4	7.9	3.6	4.1	2.8	5.6	7.9	6.0	4.6	6.3	6.6	4.8	28.9	5.7	28.7	5.0	6.5	11.4	4.7	4.9	1.6	4.1	0.3	1.2	2.1	3.5	1.3	13.7	16.3	19.0	10.0	2.3	3.5	10.6	16.7	10.0	23.7	18.2	20.7	7.0	9.6	1.9	10.3	7.4	18.6	6.3	15.9	12.4	9.7	15.0	10.3	13.8	1.1	12.5	11.4	1.7	1.1	23.6	5.2	10.9	17.5	10.9	14.6	9.6	17.1	9.2	13.6	10.4	13.9	24.6	5.1	6.0	8.4	12.5	13.6	9.9	7.8	3.6	7.5	5.3	7.0	21.9	20.0	7.2	18.5	6.7	8.8	19.4	6.8	12.2	16.7	0.0	1.2	0.0	3.5	0.9	1.5	1.6	1.6	2.0	1.9	1.3	1.2	2.7	0.3	2.1	1.1	4.1	2.7	1.3	6.6	7.8	6.2	11.9	8.4	6.4	6.2	6.5	7.9	5.7
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694618-184734133	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 14.1;eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"				"Nucleoplasm, Centriolar satellite"	"Nucleoplasm, Centriolar satellite"	"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	2.7	1.7	1.4	7.8	1.0	30.7	3.1	1.2	1.3	2.8	4.4	1.2	2.9	2.8	1.4	3.2	11.2	0.9	1.7	1.0	1.2	0.6	1.4	2.3	2.0	9.5	1.3	0.2	1.1	1.3	0.7	0.6	7.0	1.0	2.0	5.1	0.9	3.5	0.5	1.2	7.1	5.2	1.5	1.0	5.8	2.3	50.2	0.6	30.0	0.9	7.3	9.1	1.6	4.5	0.8	1.7	14.3	2.8	3.0	2.5	0.7	23.0	6.5	28.0	14.1	1.5	2.4	14.8	13.9	6.2	11.4	7.9	7.7	13.3	19.2	1.3	6.5	9.2	23.0	14.2	11.7	9.3	9.2	16.5	5.9	3.9	0.2	29.1	11.5	1.2	0.7	14.0	2.6	11.9	18.1	57.7	21.3	15.3	37.4	18.6	14.8	8.7	29.7	9.1	5.6	6.3	8.9	19.8	21.1	10.1	12.9	10.5	17.7	16.0	7.1	10.2	13.3	10.5	16.0	8.5	8.6	15.7	14.3	22.6	33.4	14.1	0.7	14.3	0.6	1.9	0.4	0.8	1.0	1.0	0.5	0.8	0.6	0.8	0.1	3.0	2.8	1.7	2.5	0.7	1.4	1.0	1.2	1.3	1.2	0.6	1.3	0.2	1.0	0.6
CEP135	"CEP4, FLJ13621, KIAA0635"	ENSG00000174799	"Centrosomal protein 135"	Q66GS9	4	55948871-56033363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 27.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073950			Uncertain	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA073950: "	"unprognostic (2.75e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.89e-3)"	"unprognostic (9.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-9)"	"unprognostic (7.55e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (6.11e-5)"	5.5	3.0	2.9	13.8	6.0	12.8	5.2	5.1	5.3	8.5	4.6	3.1	7.5	4.3	12.8	4.5	4.7	7.4	4.5	3.4	5.3	3.4	5.7	2.9	7.0	13.0	5.8	3.9	9.6	4.5	4.1	6.9	8.1	4.5	4.4	4.6	2.5	3.7	5.9	2.3	5.4	6.2	7.1	5.5	11.1	3.6	9.3	4.6	27.1	5.0	4.5	10.1	4.8	5.6	9.2	8.7	11.9	4.4	7.1	7.5	2.0	6.9	3.8	10.6	9.9	2.2	4.2	4.5	6.9	4.8	6.3	7.4	4.2	7.2	18.6	5.2	3.1	3.3	11.0	4.3	12.0	5.1	7.0	6.5	5.6	3.7	2.4	11.7	10.3	3.2	3.3	8.0	5.7	5.2	11.9	9.0	6.4	4.1	16.4	7.3	6.7	4.1	12.0	5.0	3.8	4.5	5.1	7.7	8.0	6.1	4.2	5.0	5.6	7.6	5.1	8.6	14.1	10.2	12.0	4.9	3.4	12.7	4.3	9.3	10.5	11.9	3.4	4.2	4.7	4.1	4.3	4.6	6.0	4.5	2.1	9.2	7.5	4.8	7.0	7.1	4.4	8.7	3.7	2.0	2.9	6.0	5.1	5.3	5.3	3.4	5.8	3.9	4.5	4.6
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496632-93529092	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9;testis: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023430	Approved		Supported	"Plasma membrane,Midbody,Centriolar satellite"				"Plasma membrane, Centriolar satellite"	"Plasma membrane, Centriolar satellite"	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavourable (3.20e-9)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (0.00e+0)"	"prognostic favourable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	3.2	1.4	0.5	12.1	0.4	3.1	3.6	0.3	0.6	2.0	5.2	0.3	0.2	4.6	0.8	1.5	11.6	0.6	2.5	0.7	0.4	0.5	1.5	0.7	4.4	10.1	0.6	0.2	0.8	0.6	0.0	0.7	3.8	0.5	0.8	6.5	0.4	2.3	0.2	0.7	3.0	5.2	3.5	1.1	4.8	3.2	19.3	0.3	52.9	0.7	10.8	11.0	2.7	3.3	0.1	0.1	0.0	0.0	0.0	4.4	0.0	51.0	20.4	13.6	17.2	1.5	3.1	7.6	28.1	19.9	26.7	27.7	21.6	27.5	13.6	12.4	18.2	29.2	16.4	13.8	32.1	41.0	8.5	5.1	12.6	7.3	0.1	8.8	11.9	0.7	1.0	28.4	34.7	24.6	4.6	25.9	30.1	11.8	23.2	13.4	5.3	14.9	10.1	22.2	7.5	12.0	6.3	5.6	7.9	21.6	6.7	17.0	17.5	9.0	15.3	16.9	23.7	23.2	46.1	11.6	15.7	16.7	13.2	33.4	15.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.5	0.4	0.3	0.6	0.4	0.5	0.6	0.2	0.5	0.3
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961850-56983845	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.5;lymphoid tissue: 54.5"	"Cell line enhanced"	"Detected in some"		"HEL: 5.1;HUVEC TERT2: 8.6;TIME: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.1;plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"																"Secreted to blood"	380000000	380000000				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	16.0	1.9	0.6	4.8	1.0	2.0	4.8	0.3	0.7	0.3	0.9	0.3	0.2	0.3	0.3	0.7	1.3	0.3	1.8	3.1	0.7	0.5	4.1	23.5	2.9	54.5	0.7	0.7	0.6	0.6	0.3	3.0	17.7	0.9	0.7	0.1	9.7	7.7	0.5	0.4	0.5	1.7	0.2	0.7	36.7	0.5	0.4	0.0	3.7	4.6	0.1	3.4	0.7	0.3	1.7	5.8	0.3	5.1	4.2	0.2	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	0.9	1.0	1.6	0.0	0.1	0.0	0.1	0.0	0.0	8.6	0.0	0.8	0.1	0.0	0.0	1.7	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.4	0.0	0.6	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.9	0.0	0.2	1.2	0.0	1.7	0.0	0.0	0.7	0.3	0.1	0.0	0.3	4.2	5.1	5.8	0.1	2.3	0.6	1.0	0.3	0.7	0.7	0.5	0.7	0.7	0.9	0.0
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.7;HEL: 4.5;HMC-1: 5.1;NB-4: 9.9;U-937: 6.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6"	"Group enriched"	"Detected in many"	40	"dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	8500000000	8500000000				"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	3.3	1.0	0.7	10.3	0.9	39.4	1.6	0.7	0.6	0.6	2.0	0.2	0.6	0.5	0.7	3.1	1.8	2.5	2.1	4.3	0.6	0.6	1.3	21.6	8.7	41.3	0.4	0.0	0.7	0.4	0.0	0.7	1.6	0.3	0.8	0.4	1.2	3.1	0.6	1.4	1.0	2.1	2.6	0.4	39.3	1.1	0.8	0.0	6.0	0.9	1.3	5.6	2.1	0.9	0.4	86.2	64.3	106.7	1.1	2.1	70.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	4.5	0.1	0.0	0.1	1.1	5.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	9.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.5	0.1	0.4	0.3	0.1	0.1	6.9	0.0	9.0	102.4	3.2	0.2	106.7	0.2	0.4	1.4	0.1	86.2	0.1	2.1	0.7	64.3	1.1	70.6	2.7	1.1	70.7	0.7	0.9	0.7	0.6	0.6	0.6	0.4	0.0	0.3	0.0
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98928957	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavourable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	13.0	7.4	5.5	15.8	7.5	41.7	10.2	14.9	5.5	9.4	9.3	4.7	7.9	6.6	11.3	7.5	7.6	10.8	10.6	6.8	4.9	3.1	7.3	10.1	12.1	8.8	8.8	3.2	18.1	8.3	9.3	12.0	11.1	6.4	7.7	7.4	5.6	8.1	11.5	13.2	8.2	12.3	8.3	7.2	17.2	8.6	12.0	7.4	70.1	8.1	5.5	9.3	10.4	11.3	10.1	7.1	16.7	8.2	8.1	8.4	2.2	11.4	10.5	24.8	16.8	8.4	8.7	21.7	11.9	7.8	9.7	12.6	13.1	8.9	9.7	11.6	6.9	9.6	19.4	13.1	20.3	15.2	14.6	17.2	12.6	9.9	9.3	16.5	13.4	7.5	5.4	16.8	17.0	11.7	20.7	15.0	9.7	9.2	32.8	7.2	16.7	12.8	27.9	17.4	14.6	8.5	11.0	11.6	9.9	15.3	8.0	19.3	7.7	11.4	13.1	20.8	11.2	13.0	21.0	10.5	11.0	20.7	11.4	16.6	12.5	11.4	8.2	10.7	6.5	7.5	8.2	10.1	6.1	6.1	7.1	9.4	8.4	6.6	16.7	8.1	7.1	5.2	6.3	2.2	5.5	7.5	14.9	5.5	4.9	3.1	8.8	3.2	6.4	7.4
CHI3L2	"YKL-39, YKL39"	ENSG00000064886	"Chitinase 3 like 2"	Q15782	1	111200771-111243440	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.7;salivary gland: 47.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.5;MOLT-4: 83.0;U-698: 18.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 104.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 36.0"	"Group enriched"	"Detected in many"	4	"B-cells: 16.8;T-cells: 36.0"					"Low region specificity"	"Detected in all"			HPA005443	Approved				"Secreted to blood"	480000	480000			"HPA005443: AB_1078510"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (9.10e-5)"	"prognostic favourable (2.19e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (8.59e-7)"	"unprognostic (7.15e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.20e-1)"	8.3	0.9	3.9	38.7	11.9	0.9	13.4	0.3	11.9	0.7	2.5	5.9	0.3	0.4	0.6	3.7	2.2	0.7	4.4	20.8	8.3	8.3	3.0	0.3	21.0	19.1	5.6	1.2	1.4	0.3	0.1	1.6	5.8	7.3	3.9	1.0	4.2	47.2	0.3	3.0	3.2	2.6	1.2	28.4	18.4	2.5	4.4	2.1	86.7	4.2	4.2	39.4	19.3	1.7	16.8	0.5	0.9	1.2	6.4	36.0	10.1	0.0	0.0	0.1	0.1	23.5	4.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	6.8	0.0	0.0	0.1	0.3	0.3	0.0	0.4	5.6	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	83.0	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.1	1.3	0.1	18.5	5.8	0.1	0.5	0.3	1.2	0.1	8.7	0.3	2.2	14.3	6.1	14.3	0.3	16.8	36.0	13.6	0.9	6.4	0.2	0.5	3.6	10.1	3.9	11.9	0.3	5.4	8.3	8.3	5.6	1.2	7.3	2.1
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;LHCN-M2: 1.7;RH-30: 1.7;U-266/70: 2.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Supported				"Secreted to blood"	58000000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.2	0.0	1.7	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1
CHMP7	MGC29816	ENSG00000147457	"Charged multivesicular body protein 7"	Q8WUX9	8	23243637-23262000	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.1"	"Cell line enhanced"	"Detected in all"		"Daudi: 24.5;U-698: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 31.7"	"Group enriched"	"Detected in all"	12	"B-cells: 15.2;T-cells: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036119	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036119: AB_10673000"	"unprognostic (2.94e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.59e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.83e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.06e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.30e-1)"	6.4	12.7	7.3	29.2	7.4	15.4	11.0	10.5	9.2	7.5	9.2	5.6	6.4	8.1	10.0	4.5	7.5	7.3	7.6	9.8	6.3	8.0	6.9	7.4	7.2	48.8	7.8	5.8	8.1	12.4	4.4	7.0	5.3	7.3	7.4	7.3	4.1	12.5	7.9	13.8	7.5	13.7	9.8	6.5	26.2	10.5	7.0	6.8	76.1	7.7	5.9	43.3	9.3	13.7	15.2	1.3	1.8	1.9	1.8	31.7	11.8	3.8	5.3	2.8	4.8	2.6	2.7	3.3	3.2	2.3	4.7	3.9	6.0	3.0	24.5	3.8	2.3	3.7	2.7	3.9	1.8	6.6	4.9	5.1	6.8	3.1	2.4	1.3	7.4	2.2	2.7	4.5	1.3	3.8	5.7	3.3	2.6	3.8	4.3	5.7	4.7	4.1	1.8	2.3	3.4	2.4	5.0	3.7	3.5	2.4	3.6	1.4	4.0	2.7	4.2	5.7	3.8	4.1	2.5	9.7	5.1	29.4	4.4	4.1	4.3	0.4	1.9	1.8	2.5	1.7	5.2	14.6	16.6	7.7	1.3	15.2	31.7	17.9	1.7	1.8	1.2	1.1	17.3	11.8	7.3	7.4	10.5	9.2	6.3	8.0	7.8	5.8	7.3	6.8
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46385098-46386608	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 4.9;SCLC-21H: 14.2;U-2 OS: 4.1"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4"	"Group enriched"	"Detected in many"	7	"amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"CAB022444: , HPA072083: "	"unprognostic (7.11e-2)"	"unprognostic (3.79e-1)"	"unprognostic (5.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (4.08e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.08e-2)"	0.0	0.5	1.1	0.2	11.7	1.6	0.0	0.0	6.0	0.0	0.6			3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.0	0.2		0.0	0.2	0.0	0.5	0.0		0.0	0.1		0.0	0.0	0.0	1.2	8.0	0.1	0.0	17.2	0.8	4.1			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	3.0	0.0	0.1	0.2	0.1	1.4	0.2	0.3	0.3	0.0	0.1	1.8	0.1	0.0	2.1	0.3	0.5	0.2	0.0	0.2	0.5	0.6	0.0	0.0	0.1	0.1	0.1	0.6	0.2	0.0	1.0	0.2	0.2	0.6	0.2	0.0	4.9	0.0	0.0	0.1	14.2	0.3	0.4	0.1	0.1	0.1	2.4	0.0	0.4	4.1	0.0	0.1	0.7	0.5	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2										
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 22.8;REH: 40.0;U-698: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	8.0	5.9	4.6	47.7	7.1	4.3	6.8	1.5	5.5	6.3	3.7	10.6	4.2	10.4	8.1	10.4	4.8	5.2	8.1	4.9	4.7	3.5	8.8	2.9	15.0	27.0	9.4	1.1	2.5	3.5	1.9	4.0	1.2	6.6	5.5	4.3	5.5	13.3	4.3	2.9	4.4	17.4	3.7	15.6	25.9	6.2	1.5	7.4	12.6	6.1	5.2	67.2	6.3	6.8	27.3	19.0	6.5	11.9	0.7	0.5	1.7	0.1	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	5.5	5.0	0.8	0.0	0.9	0.0	0.0	0.1	22.8	0.2	2.9	1.0	0.6	0.0	0.4	0.4	1.0	0.0	0.1	0.0	0.0	0.3	2.0	0.1	0.3	0.2	0.4	0.1	0.1	40.0	0.3	3.5	0.0	1.6	0.9	0.1	0.9	0.3	0.9	0.5	1.6	0.3	2.1	0.3	0.6	0.2	8.4	0.6	11.8	7.5	0.5	6.8	0.2	11.9	6.5	0.3	9.5	0.1	17.9	0.1	0.5	17.7	27.3	0.1	0.2	2.8	0.7	10.0	19.0	0.4	1.7	4.6	7.1	1.5	5.5	4.7	3.5	9.4	1.1	6.6	7.4
CIP2A	KIAA1524	ENSG00000163507	"Cell proliferation regulating inhibitor of protein phosphatase 2A"	Q8TCG1	3	108549869-108589644	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	2.1	2.3	2.5	8.5	6.3	10.4	3.6	6.3	6.2	3.2	3.1	2.6	0.8	2.0	3.2	1.8	4.0	1.8	2.0	2.7	2.9	2.1	2.2	1.6	2.2	10.2	2.0	3.2	3.8	1.8	1.8	3.0	3.3	2.4	3.0	4.4	2.2	2.3	1.4	2.0	1.9	2.7	2.5	2.4	5.5	2.0	8.5	1.5	21.5	1.9	1.5	8.0	4.0	2.7	1.9	0.3	0.7	1.1	0.0	1.6	0.6	18.6	5.6	15.7	10.0	0.7	1.5	6.4	14.2	6.7	16.8	19.8	6.7	8.4	12.6	4.9	5.1	9.5	5.3	5.0	30.7	4.0	5.2	15.1	7.6	5.0	0.2	9.7	10.8	0.6	1.0	13.1	5.4	7.5	9.3	20.4	16.5	3.8	11.6	8.6	16.1	9.6	13.3	14.6	6.9	5.1	5.2	7.6	10.0	10.4	4.1	5.8	7.0	6.9	5.5	17.3	19.6	5.2	17.0	4.7	5.2	20.9	7.6	10.5	17.6	0.6	0.3	0.7	0.0	0.5	1.3	1.2	0.7	0.3	0.0	1.9	0.7	1.6	0.0	0.0	1.1	0.3	0.8	0.6	2.5	6.3	6.3	6.2	2.9	2.1	2.0	3.2	2.4	1.5
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3;lymphoid tissue: 49.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008410, HPA027821"	Enhanced		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"	"Microtubules, Cytosol"	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavourable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	4.6	9.2	7.1	12.1	12.2	42.3	4.4	16.4	9.9	4.3	6.7	1.9	2.3	9.0	4.2	5.2	14.7	3.0	4.1	5.3	5.8	7.8	5.0	3.2	5.0	13.5	5.9	5.8	3.5	2.4	3.4	10.9	10.2	16.1	4.6	7.4	1.4	6.7	3.6	5.8	10.4	7.0	6.5	5.5	12.4	4.2	22.1	5.2	49.2	5.0	10.3	14.8	8.1	6.6	15.2	16.1	30.4	12.8	2.5	15.7	4.2	19.2	10.4	41.8	20.6	5.4	5.4	10.5	31.7	18.7	37.0	23.9	15.0	24.4	36.9	5.1	23.6	22.6	28.8	16.1	51.7	25.0	23.7	33.3	11.7	10.6	2.3	33.1	13.6	3.9	6.7	17.3	22.8	22.4	14.0	15.3	40.8	9.0	22.7	16.3	24.7	11.0	21.9	23.9	16.1	11.3	10.5	12.8	16.7	17.9	13.2	9.8	14.5	15.9	14.7	10.7	16.6	16.7	31.7	9.0	13.3	45.6	7.5	17.3	28.2	30.4	7.2	10.4	5.4	10.4	4.8	12.2	8.2	6.4	7.5	15.2	6.5	5.5	2.2	2.5	12.8	16.1	15.7	4.2	7.1	12.2	16.4	9.9	5.8	7.8	5.9	5.8	16.1	5.2
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736607-112764677	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;lymphoid tissue: 38.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Mitotic spindle,Cytosol"				"Mitotic spindle"	"Mitotic spindle"	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	1.5	0.7	0.6	9.2	0.6	13.4	1.3	0.7	0.6	0.6	1.8	0.0	0.3	1.5	0.5	1.4	3.8	0.7	0.1	2.3	0.6	0.5	0.7	0.7	1.2	5.3	0.6	0.2	0.6	0.6	0.0	0.5	3.2	0.2	0.6	2.4	0.0	1.0	0.0	0.6	1.5	2.4	0.9	0.6	2.2	0.9	9.0	0.1	38.3	0.6	5.9	6.0	0.9	0.7	1.0	0.8	1.8	0.7	1.6	1.8	0.4	19.9	4.0	15.8	7.1	0.9	1.5	3.2	16.5	13.7	17.2	16.4	3.7	5.8	13.7	6.9	6.5	7.7	9.1	8.7	29.0	19.0	4.0	22.8	5.6	3.2	0.0	10.7	13.7	0.4	0.8	21.6	12.3	7.8	6.0	20.0	14.0	2.9	12.9	4.1	6.7	13.0	9.4	16.6	3.6	2.9	7.8	8.7	5.5	6.7	5.6	5.7	5.4	5.0	5.5	19.1	14.9	15.2	12.1	4.3	8.3	11.7	8.2	7.7	29.9	0.8	0.5	0.7	0.5	0.7	0.4	0.9	1.2	1.1	0.5	1.0	0.5	0.7	1.8	1.6	0.7	0.8	1.8	0.4	0.6	0.6	0.7	0.6	0.6	0.5	0.6	0.2	0.2	0.1
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell line enriched"	"Detected in some"	5	"hTCEpi: 67.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	66000	66000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	12.3	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	10.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	67.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 50.5;lymphoid tissue: 49.4;pancreas: 97.3;salivary gland: 70.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HEL: 5.4;HUVEC TERT2: 8.2;NTERA-2: 16.2;RPTEC TERT1: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.8"	"Low region specificity"	"Detected in all"							"CAB012969, HPA042348"	Enhanced									"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (2.13e-4)"	"unprognostic (4.75e-3)"	0.8	0.5	28.3	0.5	17.1	1.9	2.6	5.9	17.7	26.0	0.6	4.3	0.0	1.4	8.1	15.4	2.6	16.0	23.1	0.6	18.1	6.2	50.5	1.7	0.8	0.5	10.8	12.0	1.1	97.3	0.8	1.1	0.7	5.7	1.4	0.6	3.4	70.0	0.6	0.5	4.5	0.5	0.7	2.8	0.7	1.0	0.9	6.3	0.0	0.5	2.1	49.4	0.6	0.2	1.2	0.6	7.8	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	0.0	0.0	33.4	0.0	0.2	0.2	0.0	0.0	0.0	0.3	2.9	0.6	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.6	0.0	0.1	28.3	17.1	5.9	17.7	18.1	6.2	10.8	12.0	5.7	6.3
CLEC10A	"CD301, CLECSF13, CLECSF14, HML, HML2"	ENSG00000132514	"C-type lectin domain containing 10A"	Q8IUN9	17	7074537-7080307	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;lymphoid tissue: 49.3"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.6;NB-4: 4.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	12	"myeloid DC: 81.1"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 81.1"									HPA021937	Approved									"HPA021937: AB_1846905"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.54e-2)"	"prognostic favourable (1.26e-5)"	"unprognostic (1.07e-1)"	"prognostic favourable (9.24e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.65e-1)"	12.7	4.0	0.4	14.3	0.5	0.6	6.6	0.4	0.6	4.9	9.7	0.8	1.7	7.9	6.4	31.3	6.9	6.1	12.2	17.5	0.4	0.4	4.4	6.2	22.0	49.3	0.6	0.6	4.1	3.3	0.4	2.0	1.3	2.0	7.2	9.7	3.8	5.0	5.9	6.1	5.1	14.3	9.6	0.9	10.2	4.4	3.7	0.5	5.4	4.7	9.9	10.4	9.8	4.6	0.0	81.1	0.3	6.6	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.3	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.6	0.0	0.0	0.1	0.0	0.1	0.0	5.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.3	0.3	0.0	1.6	0.0	3.3	0.4	0.5	0.4	0.6	0.4	0.4	0.6	0.6	2.0	0.5
CLEC2B	"AICL, CLECSF2, HP10085"	ENSG00000110852	"C-type lectin domain family 2 member B"	Q92478	12	9852984-9870136	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;lymphoid tissue: 56.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.9;ASC TERT1: 26.6;HSkMC: 14.6;U-937: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.7"	"Low lineage specificity"	"Detected in all"											HPA008194	Enhanced				"Intracellular and membrane"					"HPA008194: AB_1078533"	"unprognostic (3.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (5.64e-13)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.79e-1)"	10.8	1.8	2.0	9.1	2.8	29.8	8.2	2.4	3.0	6.3	3.9	2.7	3.4	1.5	7.2	4.4	6.1	3.6	6.0	4.8	2.0	1.3	2.7	4.5	13.1	8.9	3.0	2.0	12.9	2.0	0.2	2.0	4.8	3.2	4.9	3.7	3.4	4.5	2.0	5.7	24.5	4.9	4.0	3.3	12.6	2.2	3.6	2.4	56.6	3.4	3.6	7.6	5.3	7.9	5.6	9.3	58.7	17.3	17.1	19.1	18.6	0.0	0.8	0.0	0.0	16.9	26.6	0.1	0.4	3.3	0.2	0.9	0.0	0.6	0.3	0.2	13.4	5.0	2.7	0.0	0.1	0.7	0.0	0.9	0.0	0.0	5.6	0.6	0.1	14.6	5.0	0.6	0.1	8.4	0.0	2.3	3.9	0.0	5.2	1.1	0.1	0.5	7.7	0.1	0.0	0.0	5.4	0.0	0.0	0.1	0.0	3.4	1.3	0.1	11.2	0.1	3.1	0.4	1.5	4.1	0.3	0.6	3.4	60.8	4.9	9.6	10.3	3.7	18.4	14.7	14.6	3.1	11.6	19.1	9.3	5.6	11.1	16.8	58.7	17.1	17.3	3.5	9.3	18.6	2.0	2.8	2.4	3.0	2.0	1.3	3.0	2.0	3.2	2.4
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540963	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2"	"Group enriched"	"Detected in some"	4	"NB-4: 5.7;RPTEC TERT1: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 22.8;neutrophil: 81.7"	"Group enriched"	"Detected in many"	17	"granulocytes: 81.7;monocytes: 22.8"	"Not detected"	"Not detected"							HPA004935	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	8.4	3.0	1.1	20.9	2.4	37.7	17.5	1.2	2.2	3.4	1.4	0.0	1.1	0.1	1.2	1.6	1.7	4.2	6.7	5.9	1.3	1.2	6.2	3.5	25.6	41.2	2.8	0.6	1.0	3.3	0.0	1.7	1.7	9.0	1.6	0.5	1.1	1.2	0.6	2.7	0.7	1.9	3.2	5.3	34.2	1.8	3.3	0.8	0.7	12.8	0.9	1.1	2.2	2.2	0.0	2.9	81.7	22.8	0.0	0.0	4.5	0.1	0.6	0.4	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.9	0.1	2.6	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.3	0.0	0.7	0.1	0.0	1.7	0.1	0.7	0.2	0.1	0.0	0.1	0.0	5.7	0.5	0.1	0.1	0.2	0.1	16.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.5	1.2	0.6	0.1	1.1	0.1	0.2	0.1	0.1	1.6	0.4	0.1	0.0	22.8	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	81.7	0.0	0.1	0.1	0.0	4.5	1.1	2.4	1.2	2.2	1.3	1.2	2.8	0.6	9.0	0.8
CLLU1OS		ENSG00000205057	"Chronic lymphocytic leukemia up-regulated 1 opposite strand"	Q5K130	12	92420094-92428148	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 4.0;lymphoid tissue: 2.9;salivary gland: 4.0"	"Cell line enriched"	"Detected in some"	8	"U-698: 11.7"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	31	"memory B-cell: 4.0;naive B-cell: 3.8;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	27	"B-cells: 4.0;dendritic cells: 1.3"																				"unprognostic (9.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.41e-1)"		"unprognostic (1.75e-2)"		"unprognostic (2.58e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.88e-1)"		"unprognostic (2.51e-1)"	0.4	0.0	0.0	0.7	0.0	1.4	0.5	0.0	0.0	0.1	0.2			0.1	0.0	0.0	1.1	0.0	0.3	0.5	0.0	0.0	0.4	0.2	0.5	2.8	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.1		4.0	0.0	0.3	0.2	0.6	0.0	0.1	2.9	0.2	0.1			0.0		2.9	2.4	0.3	4.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.5	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2										
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684865	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 10.9;lymphoid tissue: 10.8"	"Group enriched"	"Detected in some"	6	"HDLM-2: 9.0;U-937: 4.7"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.4	0.5	0.3	5.7	0.3	0.5	0.7	0.4	0.3	1.9	1.8	0.1	0.1	0.7	0.8	1.7	2.0	0.4	1.4	0.3	0.3	0.3	10.9	1.2	3.2	5.0	0.3	0.1	0.5	0.7	0.0	3.2	1.5	0.5	0.5	0.4	1.6	2.5	0.1	0.3	1.2	2.3	1.7	0.3	6.3	1.6	1.1	0.1	8.4	0.5	1.5	10.8	0.4	0.4	3.4	5.5	1.6	0.4	4.3	3.6	0.5	0.1	0.5	0.5	0.3	0.8	0.2	0.6	0.4	0.0	0.1	0.2	0.0	0.4	0.3	0.1	0.4	0.4	0.0	0.0	0.1	9.0	0.4	0.4	0.5	0.1	0.1	0.3	0.3	0.3	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.1	1.1	0.1	0.6	0.8	0.1	0.3	0.5	0.2	0.3	0.0	1.0	0.2	0.3	0.6	0.3	0.5	0.1	0.4	0.5	4.7	0.2	1.0	0.4	0.6	0.7	0.3	0.3	3.4	1.2	0.4	5.5	2.9	0.5	0.5	1.6	4.3	0.2	1.4	3.6	0.5	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.1	0.5	0.1
CMKLR1	RVER1	ENSG00000174600	"Chemerin chemokine-like receptor 1"	Q99788	12	108288044-108339341	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.8;ASC TERT1: 32.8;BJ hTERT+: 23.3;LHCN-M2: 7.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 11.9;plasmacytoid DC: 15.2"	"Group enriched"	"Detected in many"	31	"dendritic cells: 15.2;monocytes: 11.9;T-cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047865	Uncertain									"HPA047865: AB_2680191"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.14e-1)"	11.3	6.3	2.5	8.5	3.5	0.3	5.1	0.9	3.6	6.7	5.2	5.1	1.7	3.1	9.6	12.0	4.1	5.4	6.4	9.3	2.9	2.3	4.3	7.1	10.5	17.2	5.6	1.5	3.9	3.2	1.6	4.1	18.9	4.0	5.3	6.5	10.7	5.6	3.7	2.9	4.6	5.4	12.1	5.1	42.6	3.4	4.6	4.8	3.2	9.9	5.9	5.8	6.9	3.2	0.0	15.2	0.2	11.9	0.3	6.3	3.1	0.0	0.0	0.1	0.0	7.8	32.8	0.1	0.0	23.3	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.4	0.0	0.0	7.1	0.0	0.0	0.6	0.0	0.0	0.0	1.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	3.2	0.0	6.3	11.9	0.0	0.0	1.0	4.2	0.8	0.0	0.4	3.4	0.2	0.3	2.0	15.2	0.3	3.1	2.5	3.5	0.9	2.6	2.9	2.3	5.6	1.5	4.0	4.8
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 51.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	13.6	7.8	8.6	21.5	8.2	15.3	11.0	11.1	9.2	7.8	7.3	7.0	4.6	7.5	11.4	6.3	10.2	7.1	8.3	7.5	6.0	5.7	7.7	10.8	12.7	19.2	7.6	7.3	8.8	10.8	14.6	10.0	12.3	6.7	8.4	8.9	10.3	9.9	7.4	9.1	12.2	11.5	8.4	6.9	23.4	7.9	7.3	5.6	51.3	9.1	6.2	21.1	10.7	10.3	7.5	6.1	20.2	9.3	7.4	10.0	4.4	8.6	5.6	7.1	4.7	8.4	7.3	7.0	6.9	9.1	6.2	8.4	2.2	9.7	15.0	8.8	9.6	5.6	9.1	9.6	8.3	15.0	5.1	14.0	7.8	6.3	5.3	13.9	12.3	4.7	12.4	6.9	12.8	19.6	11.7	20.1	7.1	5.9	25.7	7.0	3.2	1.8	6.3	20.0	10.7	7.1	9.8	8.7	4.2	11.9	10.9	4.8	3.5	7.2	21.3	6.0	6.6	11.3	3.8	25.8	11.0	18.7	6.5	6.1	4.4	20.2	4.7	10.2	10.0	7.0	10.0	5.3	7.5	7.8	4.5	7.5	7.3	8.5	6.7	7.4	9.3	6.1	6.0	4.4	8.6	8.2	11.1	9.2	6.0	5.7	7.6	7.3	6.7	5.6
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Group enriched"	"Detected in some"	5	"BEWO: 16.9;HDLM-2: 5.5;U-937: 8.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"			"Plasma membrane"	"Plasma membrane"	"HPA045876: AB_2679479"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.1	1.4	1.0	16.9	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.2	0.2	0.3	0.4	0.5	5.5	1.2	0.6	0.7	0.1	0.2	0.4	1.1	0.8	0.4	0.8	0.3	0.3	0.0	0.5	0.8	0.3	0.6	1.8	0.2	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.7	0.2	0.1	0.4	1.2	0.8	0.1	0.1	1.0	1.8	0.6	1.6	1.5	0.1	0.1	8.5	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565594-84618077	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 206.6;lymphoid tissue: 103.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 110.8;eosinophil: 160.2;intermediate monocyte: 190.1;myeloid DC: 117.3;neutrophil: 86.8;non-classical monocyte: 206.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 117.3;granulocytes: 160.2;monocytes: 206.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008918, CAB062328"	Enhanced		Supported	Cytosol		28000000	28000000	Cytosol	Cytosol	"CAB062328: AB_2084785, HPA008918: AB_2668176"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	28.6	9.9	20.4	68.1	19.5	57.7	13.7	12.4	18.1	7.6	16.5	25.3	2.4	22.0	13.2	8.4	8.2	13.2	18.7	7.2	19.6	24.9	34.3	12.4	26.6	103.0	28.9	8.1	10.8	7.5	5.1	13.1	29.4	23.2	11.8	16.7	30.8	7.7	7.6	5.1	5.1	26.1	16.2	27.8	92.3	29.6	8.0	13.4	33.0	10.1	5.2	62.0	29.3	7.6	28.5	117.3	160.2	206.6	30.8	32.5	108.3	52.7	44.1	101.0	106.6	11.6	32.0	30.5	46.0	29.7	36.3	14.0	59.8	82.0	14.6	14.1	34.5	26.6	6.1	36.2	36.6	0.1	7.8	27.5	9.3	15.8	32.7	30.8	109.2	25.5	5.8	35.0	31.3	17.3	2.5	6.1	21.6	8.5	9.4	18.6	12.4	45.2	1.0	3.4	0.9	53.3	22.5	16.0	0.8	42.9	10.3	22.9	7.7	25.1	44.3	52.3	29.8	16.8	33.4	1.1	5.5	12.0	40.9	15.0	127.4	29.6	110.8	160.2	3.6	190.1	4.8	28.5	23.0	21.7	117.3	13.2	10.3	12.1	86.8	30.8	206.6	6.0	32.5	108.3	20.4	19.5	12.4	18.1	19.6	24.9	28.9	8.1	23.2	13.4
CPLX3	CPX-III	ENSG00000213578	"Complexin 3"	Q8WVH0	15	74826547-74831802	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.5;Karpas-707: 4.8;SK-BR-3: 2.7;U-266/84: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB079003		Supported								"CAB079003: "																		0.4	2.5	6.4	0.5	7.4	0.4	0.4	20.8	19.6	0.5	0.5	3.3	0.0	0.4	0.4	0.5	0.5	0.4	0.4	13.4	6.4	0.8	0.4	0.4	0.4	0.5	0.6	7.9	0.4	0.4	0.4	1.7	0.4	8.2	56.4	0.4	32.8	9.8	0.4	0.4	0.5	0.6	0.4	1.0	31.8	4.6	2.2	1.2	0.0	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.0	5.5	0.1	0.0	0.2	0.1	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.0	4.8	0.0	0.1	0.0	0.9	0.1	0.3	0.2	0.0	0.4	0.0	0.1	2.1	0.1	0.0	2.7	1.1	1.6	0.0	0.0	0.1	0.1	0.5	0.0	1.3	3.1	2.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	7.4	20.8	19.6	6.4	0.8	0.6	7.9	8.2	1.2
CPVL		ENSG00000106066	"Carboxypeptidase, vitellogenic like"	Q9H3G5	7	28995231-29195451	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.9;lymphoid tissue: 84.0"	"Cell line enriched"	"Detected in many"	4	"RPTEC TERT1: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 95.8;intermediate monocyte: 81.6;myeloid DC: 111.9"	"Group enriched"	"Detected in many"	52	"dendritic cells: 111.9;monocytes: 95.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	510000	510000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: "	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavourable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavourable (4.99e-4)"	19.0	6.2	4.0	15.0	9.1	11.9	7.7	11.6	3.4	9.1	10.0	7.7	4.2	7.6	6.9	20.4	6.4	7.2	10.2	30.2	6.1	4.4	39.1	12.3	13.5	30.5	6.6	2.3	10.1	8.5	0.2	6.1	31.3	20.1	8.4	6.0	15.8	3.5	5.2	7.9	5.1	13.3	8.1	9.7	84.0	4.7	10.6	4.2	29.7	51.9	5.0	8.1	11.0	15.7	0.1	111.9	1.9	95.8	0.5	0.3	74.4	0.2	0.0	3.2	0.0	0.0	0.0	30.9	0.0	0.0	0.3	0.0	9.3	0.0	0.0	14.7	0.1	0.5	8.2	0.6	0.1	0.0	7.6	10.4	0.1	22.3	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.1	6.9	0.0	0.2	0.0	9.6	0.0	5.0	2.5	0.0	0.0	0.0	129.2	3.5	1.9	1.5	8.5	20.2	15.6	2.4	7.7	0.0	0.0	0.1	0.0	1.8	2.8	31.1	0.1	0.0	3.9	3.3	1.0	95.8	0.4	0.2	81.6	0.3	0.1	0.1	0.1	111.9	0.1	0.1	0.1	1.9	0.5	26.0	2.9	0.1	74.4	4.0	9.1	11.6	3.4	6.1	4.4	6.6	2.3	20.1	4.2
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 42.3"	"Group enriched"	"Detected in some"	9	"HL-60: 8.8;HMC-1: 20.6;NB-4: 8.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 23.2;eosinophil: 9.4;neutrophil: 9.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.2"									"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					27000000	27000000			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: "	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	9.0	1.1	0.6	17.0	0.6	5.8	1.5	0.4	0.5	0.6	1.7	0.2	0.0	0.5	0.7	5.6	1.4	2.2	1.1	8.0	0.6	0.5	2.3	3.8	4.0	42.3	0.6	0.0	1.7	1.2	0.0	0.6	5.5	1.0	1.7	0.7	0.5	1.9	0.0	0.8	0.5	5.1	3.6	0.7	42.0	1.1	0.9	0.1	1.3	0.7	0.0	11.1	3.2	1.3	2.8	0.2	23.2	2.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.8	20.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.2	2.3	9.4	0.0	1.4	0.4	2.8	0.6	0.3	0.2	1.4	0.1	0.1	9.1	0.0	1.2	0.0	0.0	0.6	0.6	0.6	0.4	0.5	0.6	0.5	0.6	0.0	1.0	0.1
CRCT1	"C1orf42, NICE-1"	ENSG00000169509	"Cysteine rich C-terminal 1"	Q9UGL9	1	152514502-152516010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 212.8;lymphoid tissue: 82.6;tongue: 126.1;vagina: 69.4"	"Cell line enriched"	"Detected in single"	11	"CAPAN-2: 10.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 68.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.01e-2)"				"unprognostic (6.92e-2)"		"unprognostic (2.86e-2)"	"unprognostic (3.30e-1)"		"prognostic unfavourable (7.03e-4)"			"unprognostic (1.56e-2)"			"unprognostic (1.46e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.7	0.1	0.1	46.9	0.1	0.1	0.1	0.2	2.3	0.1	212.8	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.1	22.9	0.1	0.7	38.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	126.1	82.6	0.1	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CRNN	"C1orf10, SEP53"	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 459.6;lymphoid tissue: 187.9;tongue: 139.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HaCaT: 1.1;HL-60: 1.2;K-562: 2.0;TIME: 1.2;U-266/84: 1.0;U-698: 1.5;U-937: 1.7"	"Group enriched"	"Detected in many"	18	"cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024343, CAB026182"	Enhanced					36000	36000			"CAB026182: , HPA024343: AB_1847162"		"unprognostic (1.96e-2)"		"unprognostic (1.74e-6)"		"unprognostic (4.20e-2)"			"unprognostic (3.43e-1)"	"unprognostic (6.43e-3)"								0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	57.1	0.2	0.0	0.0	0.2	6.2	0.2	459.6	0.2	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	49.6	0.2	0.2	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.2	139.6	187.9	0.3	81.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	1.0	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYBA1	CRYB1	ENSG00000108255	"Crystallin beta A1"	P05813	17	29246863-29254494	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.4;bone marrow: 1.4;brain: 2.8;lymphoid tissue: 1.5"	"Group enriched"	"Detected in some"	8	"AF22: 6.7;BEWO: 8.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022016	Supported									"HPA022016: AB_2732426"	"unprognostic (2.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.60e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.09e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.84e-3)"	0.0	0.0	0.2	1.5	0.3	1.4	0.0	0.0	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.6	0.0	0.0	0.0	1.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.4	0.0	0.7	0.1	0.0	0.0	6.7	0.1	0.0	0.0	8.7	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.3	1.4	0.4	0.4	0.7	0.1	0.8	1.0	0.3	0.1	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.3	0.0	2.8	0.2	0.2	0.5	0.0	0.0	0.0
CSAG2	"CSAG3B, CT24.2, TRAG3"	ENSG00000268902	"CSAG family member 2"		X	152708261-152714549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.1;skin 1: 2.7;testis: 1.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 16.8;SK-BR-3: 6.9;U-266/70: 5.6;U-266/84: 6.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (5.87e-2)"				"unprognostic (3.82e-2)"		"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.81e-2)"				"unprognostic (3.35e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.50e-2)"	0.1	0.0		0.0		0.0	0.0		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.2			0.0	0.0	0.0	3.1			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.1	0.0	2.7	0.0	0.0		1.0	0.0	1.9			0.0		0.2	0.7		0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	2.4	0.0	0.0	1.4	3.0	0.0	6.9	2.9	0.0	0.3	0.1	0.1	2.4	0.6	0.2	5.6	6.9	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.5;lymphoid tissue: 82.6"	"Group enriched"	"Detected in some"	5	"BEWO: 50.6;SK-BR-3: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 60.7;non-classical monocyte: 82.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	1500000000	1500000000	"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6.0	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8.0	8.7	3.0	5.8	14.5	16.2	25.8	82.6	9.0	4.9	23.0	3.1	4.2	2.9	8.2	16.4	4.7	0.0	19.1	2.9	82.5	0.0	0.1	13.9	1.7	0.0	0.0	0.0	0.8	0.2	50.6	0.1	0.0	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	19.3	0.0	0.0	7.2	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	2.6	0.9	0.0	0.4	18.1	0.5	0.1	60.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	2.9	0.0	82.5	1.4	0.0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6.0	17.1	23.0
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Approved	Vesicles,Cytosol		1500000	1500000	"Vesicles, Cytosol"	"Vesicles, Cytosol"	"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favourable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favourable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (1.74e-4)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	9.3	8.0	9.5	39.3	11.0	19.9	12.6	18.7	13.4	12.1	13.5	11.8	7.3	16.1	13.9	6.4	33.3	10.6	11.2	14.0	9.8	8.5	8.0	20.9	15.6	67.2	11.1	7.4	10.5	6.7	6.6	10.4	8.8	12.2	9.8	8.9	9.8	13.2	7.0	8.7	14.9	26.2	8.5	10.9	62.7	13.1	8.1	10.6	62.7	8.1	9.5	47.4	17.4	13.2	35.6	22.8	49.6	46.8	16.3	30.7	19.9	12.7	18.0	8.8	14.5	8.4	6.5	7.6	8.6	8.2	16.3	11.6	16.4	11.8	57.1	11.4	7.7	13.3	18.5	17.3	4.6	27.6	22.8	48.3	6.6	16.5	11.7	25.2	61.6	9.2	8.5	11.6	10.4	12.3	13.9	19.9	9.7	21.5	18.1	14.9	10.9	12.9	20.1	7.6	41.6	7.5	28.4	14.7	10.2	11.1	23.4	14.8	16.1	37.2	10.6	19.8	10.4	15.5	14.8	10.7	21.5	58.3	10.2	48.2	13.3	20.7	19.7	49.6	23.4	42.4	20.0	29.4	20.3	23.1	22.8	35.6	15.7	18.4	39.1	16.3	46.8	13.2	30.7	19.9	9.5	11.0	18.7	13.4	9.8	8.5	11.1	7.4	12.2	10.6
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell line enhanced"	"Detected in all"		"RT4: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		6100000	6100000	Cytosol	Cytosol	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	57.8	17.5	5.8	7.3	30.9	25.4	14.4	12.5	14.5	7.9	7.9	13.5	32.5	4.7	9.7	19.5	10.4	13.3	14.0	5.0	19.4	15.8	13.1	13.5	15.6	27.6	3.2	10.9	26.9	14.6	21.8	10.8	11.0	9.7	25.8	11.6	14.6	4.1	10.1	14.0	30.2	6.8	3.3	53.1	22.7	90.4	5.5	4.9	16.5	8.8	35.2	8.2	8.1	16.9	13.2	6.9	12.3	7.9	6.4	11.2	8.7	57.4	15.2	9.2	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1
CTLA4	"CD, CD152, CELIAC3, GSE, IDDM12"	ENSG00000163599	"Cytotoxic T-lymphocyte associated protein 4"	P16410	2	203867786-203873960	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.8;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.8;U-266/70: 5.8;U-266/84: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	6	"T-reg: 24.8"	"Lineage enriched"	"Detected in single"	248	"T-cells: 24.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"						"unprognostic (1.92e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.47e-3)"	"unprognostic (9.89e-6)"	"unprognostic (1.86e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.76e-1)"	"unprognostic (9.86e-10)"	"unprognostic (4.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-2)"	1.6	0.2	0.2	24.1	0.3	2.9	1.3	0.2	0.6	0.8	1.6	0.1	0.6	0.2	1.1	0.1	2.0	1.2	3.6	0.5	0.3	0.5	1.6	0.6	5.8	27.9	0.3	0.3	0.7	0.3	0.1	0.6	0.1	1.7	1.1	1.7	0.8	1.4	0.6	0.2	1.0	10.3	0.3	1.5	6.7	1.2	1.7	0.1	14.2	1.9	3.3	31.2	4.6	1.3	0.0	0.0	0.0	0.0	0.0	24.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.5	0.0	0.3	0.0	5.8	16.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	24.8	0.4	0.2	0.3	0.2	0.6	0.3	0.5	0.3	0.3	1.7	0.1
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88293592-88337787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 218.6"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	19000000	19000000	Vesicles	Vesicles	"CAB025364: , HPA066610: AB_2685694, HPA068434: "	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favourable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	40.7	20.5	6.7	44.5	10.6	12.0	35.3	1.5	5.6	14.0	25.3	7.1	6.2	20.4	16.1	24.0	21.8	16.7	36.6	53.3	6.8	6.5	62.7	18.1	110.1	218.6	12.5	3.6	11.0	24.8	3.8	17.3	43.4	9.4	13.8	33.1	27.0	35.1	5.8	10.0	11.7	28.5	14.2	14.6	86.6	13.5	10.8	9.2	19.5	17.7	25.3	30.0	30.2	16.9	8.5	75.9	52.5	92.6	34.7	42.4	31.2	11.2	11.5	4.5	9.4	12.2	33.0	30.2	77.1	112.0	44.0	31.8	31.2	51.8	17.5	41.0	41.8	18.2	7.0	32.6	35.2	30.8	12.7	22.8	31.9	35.1	16.2	28.9	15.4	45.9	23.1	33.9	69.6	43.2	20.7	21.1	5.3	2.1	13.0	40.0	23.6	35.7	17.0	4.7	31.0	56.6	18.9	1.2	9.5	13.0	17.2	10.1	3.8	19.8	21.0	3.0	27.3	20.9	48.9	9.0	12.8	17.7	8.0	61.1	16.7	12.5	32.5	52.5	42.4	69.3	36.5	8.5	19.5	37.8	35.1	4.6	9.9	23.8	37.2	34.7	92.6	75.9	28.4	31.2	6.7	10.6	1.5	5.6	6.8	6.5	12.5	3.6	9.4	9.2
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730196-150765957	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 171.4;lymphoid tissue: 111.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.1;HMC-1: 50.3;U-698: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"	19000000	19000000	Vesicles	Vesicles	"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	41.6	9.3	6.8	32.3	10.3	30.3	9.7	1.9	6.2	4.7	32.9	6.6	5.6	19.6	3.7	12.9	8.8	10.7	15.9	17.3	6.4	5.1	9.6	21.5	55.8	99.5	12.6	2.3	7.6	6.4	0.4	3.4	14.4	9.3	7.5	33.4	6.5	12.9	3.3	3.5	3.8	38.0	6.8	17.1	111.4	13.8	3.8	9.5	12.9	7.6	4.6	22.8	21.5	5.3	11.1	43.5	94.5	171.4	3.3	5.6	145.4	1.0	3.2	0.0	0.0	0.4	0.3	0.3	0.0	3.2	0.2	0.6	0.0	21.1	14.5	1.6	0.1	0.4	0.0	0.1	0.0	8.1	0.0	6.4	0.1	0.0	0.0	8.7	50.3	0.6	0.0	1.8	0.1	1.2	0.6	12.7	0.4	0.0	0.0	6.2	0.0	0.0	3.6	1.2	17.8	3.9	3.1	0.0	0.1	0.2	0.9	0.3	0.0	17.8	1.7	1.3	0.2	0.0	0.2	8.8	0.8	106.9	7.4	9.4	0.8	1.2	171.4	16.5	3.2	151.2	3.9	11.1	3.9	3.8	43.5	10.2	3.9	3.6	94.5	3.3	138.5	9.4	5.6	145.4	6.8	10.3	1.9	6.2	6.4	5.1	12.6	2.3	9.3	9.5
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871242	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.8"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 78.9;EFO-21: 201.6;RPTEC TERT1: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	253	"neutrophil: 25.3"	"Lineage enriched"	"Detected in single"	253	"granulocytes: 25.3"														"Secreted to blood"						"prognostic favourable (7.83e-4)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	12.0	0.8	1.3	22.5	2.2	14.8	4.1	0.8	1.4	49.2	7.7	1.0	0.7	4.3	0.9	2.1	27.8	6.1	11.2	12.1	1.7	1.3	8.9	4.2	23.0	10.9	3.1	1.0	3.8	13.0	0.0	0.7	26.1	3.9	8.7	7.1	2.1	8.1	4.1	3.2	0.8	10.8	1.2	3.8	124.8	3.1	2.1	1.7	1.7	0.7	7.9	22.6	29.9	6.6	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	1.3	0.0	2.1	78.9	1.9	2.0	0.0	1.4	0.0	201.6	0.1	4.0	0.0	0.3	10.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.1	14.2	1.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	72.8	1.7	0.0	0.0	0.1	0.0	3.9	0.0	0.1	18.2	0.0	0.6	3.9	0.1	0.0	0.1	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	1.3	2.2	0.8	1.4	1.7	1.3	3.1	1.0	3.9	1.7
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;BJ hTERT+ SV40 Large T+: 3.6;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;Daudi: 3.1;RPMI-8226: 6.6;RT4: 3.7;THP-1: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favourable (1.12e-5)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.6	3.6	3.5	0.3	0.1	3.1	0.4	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.6	0.1	3.7	0.0	0.0	0.0	0.7	2.1	0.2	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.9	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998779	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2"	"Cell line enhanced"	"Detected in some"		"A549: 33.7;EFO-21: 28.4;HSkMC: 20.5;hTEC/SVTERT24-B: 14.7;RPTEC TERT1: 108.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"									HPA065474	Approved				"Secreted to blood"					"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	1.7	0.3	1.6	28.0	6.0	0.7	2.4	0.4	1.4	10.5	0.7	1.5	0.2	0.6	0.3	0.0	0.6	0.4	3.9	1.4	4.3	2.8	0.4	2.1	20.0	13.6	1.2	0.1	0.3	0.8	0.0	0.3	1.5	7.4	1.5	0.2	0.0	31.2	0.5	0.3	0.3	1.8	0.1	2.6	5.2	6.4	5.4	0.2	1.0	0.3	10.8	0.8	10.9	0.3	0.0	0.0	1.1	0.1	0.0	0.2	5.5	0.0	33.7	0.1	0.0	0.0	1.2	0.0	0.6	0.5	0.2	0.5	0.1	0.3	0.0	28.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	20.5	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	5.5	1.6	6.0	0.4	1.0	4.3	2.8	1.2	0.1	7.4	0.2
CXCL6	"CKA-3, GCP-2, SCYB6"	ENSG00000124875	"C-X-C motif chemokine ligand 6"	P80162	4	73836497-73849064	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 16.8;EFO-21: 40.5;HUVEC TERT2: 26.4;RPTEC TERT1: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	107	"neutrophil: 10.7"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.7"														"Secreted to blood"						"unprognostic (4.35e-4)"	"unprognostic (4.47e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	3.5	0.1	0.1	5.7	0.2	0.5	0.3	0.1	0.2	7.4	3.7	0.0	1.7	3.1	0.1	0.9	1.6	1.7	16.3	2.7	0.5	0.1	4.4	4.6	8.9	0.9	0.3	0.3	0.7	9.4	0.0	0.2	0.0	1.3	3.5	0.1	0.3	2.4	4.7	0.1	0.1	5.2	0.0	0.5	59.6	0.3	1.4	0.0	1.4	0.1	0.6	2.2	13.7	3.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.4	0.0	0.9	16.8	0.1	0.2	0.0	0.0	0.0	40.5	0.0	3.4	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.1	8.5	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	31.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.5	0.1	0.3	0.3	1.3	0.0
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007488	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.6;thyroid gland: 28.6"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.6"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in many"								"Secreted to blood"						"prognostic favourable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favourable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favourable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	6.3	0.4	0.5	30.8	0.8	0.0	4.4	0.4	0.4	6.0	2.4	0.4	1.0	0.5	1.1	3.6	2.5	0.5	2.1	5.3	0.5	0.4	9.9	5.9	16.4	70.6	0.3	0.5	4.5	1.0	0.0	1.5	2.1	1.3	5.0	7.3	2.9	4.9	0.6	7.0	2.2	6.6	3.4	2.6	18.6	4.1	1.9	0.4	17.3	28.6	3.5	15.7	4.3	1.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	4.8	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.8	0.4	0.4	0.5	0.4	0.3	0.5	1.3	0.4
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118165	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 149.9;lymphoid tissue: 186.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 75.5;Karpas-707: 40.5;MOLT-4: 68.5;REH: 36.3;U-266/70: 87.9;U-698: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (1.41e-7)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	15.4	26.5	3.0	39.1	3.4	149.9	9.7	0.8	2.1	7.7	8.7	6.8	1.5	1.6	8.3	3.8	16.4	9.1	12.0	5.4	4.1	4.7	8.2	7.1	29.3	94.5	6.5	1.3	6.3	3.1	0.7	8.1	7.8	6.1	6.8	7.0	10.0	10.6	2.2	3.2	2.3	57.8	3.8	22.9	82.4	8.0	7.2	3.4	186.3	9.2	4.6	97.5	50.0	6.6	47.3	16.8	37.8	7.2	4.0	32.0	11.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	75.5	0.2	0.0	0.0	0.2	0.0	0.0	3.8	0.9	4.5	12.0	0.0	0.0	10.4	8.2	0.0	0.0	0.0	0.0	7.2	0.1	40.5	0.0	0.2	68.5	9.3	1.2	0.3	36.3	8.4	13.2	0.6	0.0	4.2	3.5	0.0	0.2	0.0	0.0	20.5	1.0	0.0	0.2	0.0	0.0	87.9	14.8	88.4	0.0	17.2	0.0	17.9	7.2	29.6	22.9	3.8	18.7	30.1	21.1	21.7	6.6	47.3	32.0	30.1	37.8	4.0	2.1	16.8	18.9	11.9	3.0	3.4	0.8	2.1	4.1	4.7	6.5	1.3	6.1	3.4
CXorf21	FLJ11577	ENSG00000120280	"Chromosome X open reading frame 21"	Q9HAI6	X	30558824-30577844	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7"	"Cell line enriched"	"Detected in some"	7	"THP-1: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001185	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	6.5	2.1	4.6	9.8	4.0	16.0	2.0	0.8	4.4	1.4	3.0	2.3	0.2	4.3	1.2	2.4	1.4	1.5	3.6	1.5	5.0	2.1	1.9	2.8	6.1	12.9	6.3	0.0	1.0	2.0	0.7	1.5	2.7	5.1	1.5	3.1	1.1	3.3	0.5	0.8	1.1	5.3	1.8	9.9	16.7	3.1	0.8	5.2	9.1	1.4	1.2	9.3	4.8	1.4	11.1	21.9	14.9	18.9	3.2	1.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	7.4	0.0	0.0	7.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	0.0	5.4	0.5	2.6	0.0	8.3	0.0	3.4	10.3	11.4	0.8	9.6	0.1	11.1	1.0	0.5	12.0	10.8	1.0	0.7	14.9	3.2	18.9	21.9	1.6	3.5	4.6	4.0	0.8	4.4	5.0	2.1	6.3	0.0	5.1	5.2
CYBA	p22-PHOX	ENSG00000051523	"Cytochrome b-245 alpha chain"	P13498	16	88643283-88651152	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;lymphoid tissue: 129.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 138.7;THP-1: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 94.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009492	Enhanced									"CAB009492: AB_2090309"	"prognostic favourable (8.19e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (4.75e-5)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.63e-2)"	31.4	12.6	9.7	60.1	14.9	116.7	16.5	2.0	8.6	16.1	40.5	11.5	25.8	35.7	11.4	20.0	19.6	19.2	43.6	18.0	7.8	8.0	49.3	19.8	46.7	120.1	15.7	3.4	14.8	37.4	0.9	8.2	19.3	11.8	14.7	15.2	15.1	21.7	22.5	6.7	7.1	41.0	9.0	16.7	129.2	41.1	7.4	12.7	31.0	25.6	14.0	60.4	27.0	13.6	15.3	28.4	94.1	20.7	5.2	11.9	5.7	0.2	54.2	0.2	0.1	0.1	0.0	29.3	13.3	7.2	3.8	2.2	36.1	77.3	41.5	39.4	5.5	22.6	2.1	0.0	0.5	13.2	44.8	8.1	20.3	57.7	7.2	13.8	36.8	7.7	0.0	0.1	0.0	2.0	23.3	56.7	0.3	84.1	13.3	65.5	9.9	0.1	39.0	0.1	138.7	31.6	45.5	7.7	6.9	39.7	7.8	12.5	0.1	115.8	11.0	0.1	0.5	0.1	0.2	33.9	40.6	45.7	18.8	39.4	5.0	15.9	14.7	94.1	11.9	20.7	8.7	14.5	5.8	11.0	15.7	15.3	4.6	5.7	28.5	5.2	19.3	28.4	5.8	5.7	9.7	14.9	2.0	8.6	7.8	8.0	15.7	3.4	11.8	12.7
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780011-37813461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3;lung: 49.4;lymphoid tissue: 74.5"	"Group enriched"	"Detected in some"	5	"Daudi: 16.1;NB-4: 19.4;REH: 16.5;RPMI-8226: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 50.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA051227	Enhanced					640000	640000			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	16.4	11.0	9.7	44.2	13.2	42.6	8.1	2.5	6.7	3.7	6.0	10.4	0.2	5.2	3.4	6.3	3.2	6.0	7.5	10.1	6.8	6.5	6.2	11.8	49.4	74.5	12.6	2.9	5.3	4.5	1.4	4.9	16.1	10.3	4.8	8.9	4.5	6.0	2.7	2.5	2.2	16.1	15.3	20.3	49.9	4.9	2.3	10.3	5.4	3.4	3.5	20.2	13.9	3.1	8.1	17.5	20.0	50.3	0.1	0.1	22.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	16.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.4	0.0	0.1	16.5	0.0	63.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	2.7	0.0	0.3	45.5	20.0	0.0	50.3	0.1	8.1	0.0	0.0	12.1	7.2	0.0	0.0	3.7	0.1	42.7	17.5	0.1	22.0	9.7	13.2	2.5	6.7	6.8	6.5	12.6	2.9	10.3	10.3
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Group enriched"	"Detected in some"	16	"A549: 92.9;Hep G2: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	92.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0
CYP26C1		ENSG00000187553	"Cytochrome P450 family 26 subfamily C member 1"	Q6V0L0	10	93060808-93069536	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.3;lymphoid tissue: 2.0;testis: 1.8"	"Cell line enhanced"	"Detected in some"		"AF22: 2.0;SiHa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"														"unprognostic (8.39e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.88e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.74e-4)"	"unprognostic (8.59e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.17e-1)"	0.1	1.3	0.2	0.1	0.1	0.0	0.1	0.1	0.8	0.3	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	2.0	0.1	1.8	0.1	1.7	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.3	0.4	0.1	0.1	0.1
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128366	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 7.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	3.1	6.1	0.0	2.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315345	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.3;lymphoid tissue: 53.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.8;HMC-1: 49.7;THP-1: 32.5;U-266/70: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071573	Approved									"HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavourable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	13.6	6.6	7.0	32.0	9.2	24.2	7.6	1.5	4.2	2.9	5.0	7.0	0.9	4.1	3.9	6.5	3.2	5.5	8.3	9.2	4.7	3.7	5.1	4.5	14.8	27.4	10.3	2.6	2.5	3.1	1.1	3.7	13.5	6.9	4.0	4.8	4.6	10.3	2.1	2.1	3.0	13.2	6.0	9.9	53.9	5.4	2.3	7.5	12.9	3.6	2.9	22.9	12.0	3.2	8.0	27.2	52.3	31.4	11.4	15.1	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.1	0.0	0.0	0.0	0.2	0.0	1.8	0.0	3.4	0.0	0.0	0.0	11.8	49.7	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.1	4.4	0.0	0.3	0.4	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.1	0.0	0.0	0.0	0.0	10.1	1.3	1.5	6.8	4.0	0.1	3.7	15.6	21.6	15.1	26.4	10.6	7.8	8.3	11.9	12.4	8.0	8.0	10.6	52.3	11.4	31.4	27.2	7.5	16.1	7.0	9.2	1.5	4.2	4.7	3.7	10.3	2.6	6.9	7.5
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.4;lymphoid tissue: 92.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.3;Karpas-707: 39.0;RPMI-8226: 11.9;U-266/70: 66.4;U-266/84: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.4"	"Low region specificity"	"Detected in single"			HPA007191	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favourable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"	9.4	1.4	1.4	33.3	1.6	32.3	3.9	0.8	1.0	4.4	9.7	1.6	0.8	9.3	3.1	4.2	6.6	2.8	5.8	3.8	1.5	1.5	4.1	3.9	26.8	92.9	3.1	0.6	2.9	3.1	0.0	1.5	1.3	2.0	2.4	5.0	3.1	11.5	3.1	1.4	2.1	17.4	2.1	4.3	48.3	14.4	3.3	1.3	40.5	3.2	3.8	61.8	24.1	3.2	21.9	13.0	48.5	53.3	19.9	53.4	31.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	11.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	66.4	24.9	6.4	0.6	1.7	0.0	48.5	8.4	24.5	30.6	27.8	30.9	21.9	32.4	28.9	13.0	21.1	53.4	40.7	48.2	19.9	53.3	6.7	31.3	31.6	1.4	1.6	0.8	1.0	1.5	1.5	3.1	0.6	2.0	1.3
DAPP1	BAM32	ENSG00000070190	"Dual adaptor of phosphotyrosine and 3-phosphoinositides 1"	Q9UN19	4	99816833-99870154	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.0;lymphoid tissue: 45.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 31.7;RPMI-8226: 34.3;SK-BR-3: 14.8;U-698: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033822, HPA046074"	Approved					29000	29000			"CAB033822: AB_2245677, HPA046074: AB_2679525"	"unprognostic (9.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.60e-2)"	3.1	1.0	1.3	22.0	2.8	8.8	2.1	0.6	1.7	7.1	3.0	1.8	0.0	0.8	9.7	2.9	29.3	3.4	8.7	1.0	1.0	1.0	1.6	1.1	6.4	20.3	3.1	0.5	1.5	0.9	0.0	1.0	13.4	1.9	3.6	1.9	1.0	9.5	0.3	1.2	10.0	6.4	9.7	5.6	20.3	3.7	0.7	2.4	12.9	1.1	17.4	45.6	8.9	12.0	36.4	29.0	51.0	27.0	6.3	8.7	21.6	10.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	11.6	12.1	0.1	0.0	6.5	0.0	13.7	0.0	31.7	0.0	11.9	0.0	0.0	0.0	4.6	0.5	0.0	5.9	0.0	4.5	0.0	0.6	11.5	0.0	0.1	0.0	2.7	0.0	0.2	0.1	0.0	34.3	2.3	9.5	0.0	0.0	0.0	14.8	0.0	0.2	4.6	0.0	0.0	0.2	0.0	0.0	4.2	1.7	24.3	0.0	3.0	0.0	6.8	27.0	24.8	0.9	22.4	0.9	33.9	4.4	1.5	29.0	36.4	4.9	1.7	51.0	6.3	20.2	12.6	8.7	21.6	1.3	2.8	0.6	1.7	1.0	1.0	3.1	0.5	1.9	2.4
DCANP1	"C5orf20, DCNP1"	ENSG00000251380	"Dendritic cell associated nuclear protein"	Q8TF63	5	135444214-135447348	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.0;lymphoid tissue: 3.0;skin 1: 2.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 6.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in many"											HPA048308	Uncertain									"HPA048308: AB_2680349"																		0.2	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.6			0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.5	3.0	0.2		0.0	0.3	0.0	0.0	0.0		0.1	0.4		0.2	0.1	0.1	2.2	2.0	0.0	0.2	2.7	0.1	0.0			0.2		1.6	0.1	0.2	0.0	1.0	0.1	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.0	0.0										
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Cell line enhanced"	"Detected in all"		"Daudi: 59.7;U-698: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	8.0	8.3	11.9	30.9	16.8	17.2	6.9	11.4	14.8	5.6	8.6	10.4	2.6	7.6	7.5	4.4	8.8	5.5	6.1	5.5	12.3	13.1	5.8	4.8	9.7	42.8	11.7	10.3	6.0	5.0	3.6	4.2	7.9	11.1	5.9	10.4	6.4	6.3	4.0	6.8	7.9	12.4	7.5	17.6	17.5	8.2	5.6	8.6	80.9	8.3	3.8	39.9	9.5	6.5	27.9	34.2	17.5	12.7	18.5	24.9	25.1	6.6	4.4	9.7	5.7	3.0	5.3	5.6	17.2	6.4	13.6	11.4	2.9	14.5	59.7	7.4	7.1	3.9	8.6	5.4	18.4	12.6	5.3	12.3	5.1	4.5	3.1	24.6	15.9	2.7	6.6	8.3	5.0	7.7	4.9	22.7	15.5	3.8	30.4	9.7	4.7	5.4	25.8	19.7	4.7	6.8	4.6	8.6	9.2	6.4	12.7	7.5	5.7	12.9	6.2	15.4	11.6	12.9	9.2	8.6	5.6	48.4	10.7	15.4	11.4	13.1	10.7	17.5	16.2	12.7	20.3	27.9	21.8	20.0	14.3	26.4	23.4	23.5	5.4	18.5	12.1	34.2	24.9	25.1	11.9	16.8	11.4	14.8	12.3	13.1	11.7	10.3	11.1	8.6
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113020970	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 52.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"				"Nucleoplasm, Cytoplasmic bodies"	"Nucleoplasm, Cytoplasmic bodies"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavourable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	8.0	7.5	8.1	16.3	9.5	22.9	15.0	16.8	10.9	9.1	6.6	6.4	6.6	6.3	10.5	6.8	7.4	8.0	6.5	6.1	8.1	8.9	8.1	8.1	13.2	19.8	6.9	6.1	12.8	6.2	7.0	12.2	40.2	8.3	8.1	7.3	6.5	9.6	8.6	8.3	9.8	8.7	7.3	7.4	19.9	6.7	6.8	6.5	52.9	7.0	4.1	20.0	8.7	9.1	5.1	6.5	16.3	8.3	3.9	5.9	3.2	3.6	3.1	14.1	11.3	2.8	3.1	22.8	3.3	2.7	4.2	6.1	14.6	7.8	19.1	5.3	1.9	4.5	16.2	4.5	5.1	5.1	7.1	17.9	2.7	5.8	3.2	10.9	9.3	2.9	3.1	5.1	5.1	7.1	13.2	7.5	3.8	4.6	16.0	11.6	12.2	1.9	15.7	13.4	7.1	6.5	9.3	3.3	7.0	4.6	5.2	6.7	15.4	14.6	4.6	4.7	8.4	2.4	5.0	5.1	11.2	14.6	2.7	15.3	3.6	12.2	7.2	5.5	4.0	7.1	5.5	5.1	4.9	4.2	6.5	3.6	4.6	4.7	16.3	3.9	8.3	3.5	5.9	3.2	8.1	9.5	16.8	10.9	8.1	8.9	6.9	6.1	8.3	6.5
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.6;testis: 16.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA038540: AB_10672648, HPA038541: AB_2676071"	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	1.3	1.0	0.8	6.1	0.8	7.0	1.7	0.8	1.2	1.9	2.3	1.2	0.2	1.3	1.5	2.6	5.5	1.0	0.4	2.6	0.9	0.7	1.0	2.3	3.1	5.0	0.8	0.6	1.3	0.9	0.0	0.5	2.5	1.0	0.9	2.0	0.2	2.1	0.2	10.1	2.3	1.9	1.5	0.9	5.5	1.1	16.3	0.9	17.6	0.8	9.5	5.9	1.8	1.8	2.0	4.5	5.8	10.7	1.9	0.7	3.2	6.0	9.5	9.8	7.1	1.0	1.5	7.2	11.4	4.8	12.6	14.7	9.3	7.5	7.3	17.1	2.6	11.5	16.6	7.2	17.5	13.2	8.9	10.4	4.9	4.1	0.1	12.7	9.2	0.3	0.7	15.9	7.3	5.9	10.4	12.7	11.1	8.7	12.0	10.4	11.7	10.9	8.9	19.0	9.4	2.7	10.0	7.4	9.9	7.0	7.1	2.7	7.7	5.3	2.8	12.7	17.2	33.3	13.8	7.2	18.9	25.5	4.0	9.2	12.0	0.6	10.7	3.9	0.5	8.3	0.3	1.1	0.3	0.7	4.5	2.0	0.7	0.4	5.8	1.9	7.8	1.4	0.5	3.2	0.8	0.8	0.8	1.2	0.9	0.7	0.8	0.6	1.0	0.9
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6, guanine nucleotide exchange factor"	Q9H4E7	6	35297852-35321771	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 51.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.8;MOLT-4: 23.8;NB-4: 31.8;REH: 22.0;THP-1: 25.5;U-937: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favourable (3.02e-6)"	"prognostic favourable (1.08e-4)"	"prognostic unfavourable (1.71e-4)"	"prognostic favourable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavourable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	2.9	2.0	4.5	34.8	4.6	30.3	3.4	0.9	3.1	4.3	4.7	6.9	4.7	5.3	3.1	11.1	15.3	2.7	6.8	2.6	3.8	2.7	3.1	2.5	7.5	42.7	5.3	1.0	2.0	16.5	0.7	5.1	4.2	4.8	10.6	4.0	2.9	14.1	6.7	0.9	14.4	15.2	2.4	7.1	32.6	8.3	6.7	5.0	42.6	4.7	9.3	51.7	6.7	8.6	13.9	21.0	43.5	13.8	25.9	31.5	20.7	7.6	0.0	0.2	0.2	0.0	0.1	9.7	0.8	1.2	0.2	0.2	0.4	3.3	9.1	2.8	0.4	5.0	0.0	6.4	0.1	0.3	0.3	10.2	0.1	4.0	0.2	18.3	13.4	1.5	8.2	0.1	7.4	0.0	4.5	21.8	0.0	3.9	23.8	31.8	0.4	0.9	22.0	0.2	12.2	0.8	5.8	0.1	0.0	0.6	1.9	1.7	5.3	25.5	1.2	0.1	0.2	0.0	0.1	12.5	11.5	7.5	0.0	38.2	0.0	16.3	13.8	43.5	31.5	11.0	25.8	13.9	25.7	31.0	21.0	12.5	27.1	26.1	26.7	25.9	9.9	13.9	26.9	20.7	4.5	4.6	0.9	3.1	3.8	2.7	5.3	1.0	4.8	5.0
DEFB103A	"DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3"	ENSG00000176797	"Defensin beta 103A"	P81534	8	7881204-7882664	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.6;tongue: 16.7;vagina: 6.9"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.7;U-2 OS: 1.2;U-2197: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.3	0.0	0.1	0.1	0.1	0.0	1.0	0.1	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.5	3.3	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	16.7	6.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DEFB103B		ENSG00000177243	"Defensin beta 103B"	P81534	8	7428888-7430348	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 4.1;lymphoid tissue: 6.3"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.7;U-2 OS: 1.2;U-2197: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.1	0.0			0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.7;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.9;HEL: 8.6;HMC-1: 26.9;MOLT-4: 8.3;THP-1: 7.9;U-937: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Cytosol	Cytosol	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favourable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (8.95e-4)"	"prognostic favourable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favourable (5.62e-4)"	2.1	1.3	1.5	22.0	2.5	14.1	2.0	0.5	1.6	1.0	2.8	2.5	0.0	3.4	1.0	1.5	1.7	1.7	3.4	1.0	1.3	1.3	2.2	2.0	5.2	30.1	3.1	0.6	0.8	1.0	0.0	1.1	1.3	2.2	1.7	0.8	1.4	5.4	0.8	0.6	1.0	12.1	0.8	2.7	31.3	3.5	0.5	2.7	32.9	1.8	1.2	25.2	3.0	1.5	16.3	12.2	19.0	20.6	14.1	26.7	20.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	12.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	8.6	0.0	0.8	0.0	4.2	26.9	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	8.3	6.5	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.0	0.0	17.9	0.0	10.4	11.6	19.0	26.7	20.6	23.4	16.3	19.1	22.9	12.2	13.7	24.8	21.6	17.6	14.1	20.0	7.1	21.9	20.2	1.5	2.5	0.5	1.6	1.3	1.3	3.1	0.6	2.2	2.7
DENND2D	"FLJ22457, RP5-1180E21.2"	ENSG00000162777	"DENN domain containing 2D"	Q9H6A0	1	111187174-111204535	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 51.0;lymphoid tissue: 67.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.7;MOLT-4: 51.9;SK-BR-3: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdTCR: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7"	"Group enriched"	"Detected in all"	6	"NK-cells: 45.1;T-cells: 51.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043630, HPA048642"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043630: AB_2678589, HPA048642: AB_2680474"	"unprognostic (1.72e-3)"	"prognostic favourable (1.67e-4)"	"unprognostic (2.60e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (2.70e-4)"	"unprognostic (5.09e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (8.66e-5)"	8.9	11.1	0.9	42.9	2.6	3.5	6.5	0.8	1.6	4.9	10.4	1.4	4.9	6.4	2.4	5.9	19.5	6.4	9.9	2.5	1.0	1.0	11.4	9.3	11.5	42.0	2.6	0.8	3.0	7.5	8.8	8.0	20.2	1.9	9.2	6.9	3.7	21.1	4.7	1.3	7.9	13.8	1.3	3.2	33.8	9.0	5.1	1.8	39.2	8.0	7.0	67.6	15.7	8.2	8.2	3.2	3.5	3.5	45.1	51.0	29.6	10.2	0.4	0.0	0.0	2.5	1.0	0.1	0.6	0.0	1.1	0.2	3.1	5.0	10.9	3.7	1.5	3.2	0.0	0.5	1.1	20.7	0.0	3.2	0.7	0.0	3.8	0.0	3.4	3.0	2.3	0.3	0.0	0.1	0.0	3.4	0.3	8.7	51.9	0.3	0.0	1.4	1.2	0.0	15.8	3.6	11.1	3.7	0.0	3.7	33.7	1.2	9.9	10.3	0.0	0.0	0.0	0.0	0.0	3.1	1.2	8.2	0.0	9.2	0.0	0.8	3.5	2.3	44.8	2.5	38.2	7.2	32.5	45.6	3.2	8.2	51.0	48.4	3.5	45.1	1.8	2.4	13.7	29.6	0.9	2.6	0.8	1.6	1.0	1.0	2.6	0.8	1.9	1.8
DEPDC1	"DEP.8, DEPDC1A, FLJ20354, SDP35"	ENSG00000024526	"DEP domain containing 1"	Q5TB30	1	68474152-68497221	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6;testis: 19.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017845	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"CAB017845: "	"unprognostic (2.73e-1)"	"unprognostic (7.40e-2)"	"prognostic favourable (8.70e-5)"	"unprognostic (1.23e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.73e-3)"	"unprognostic (4.37e-6)"	"unprognostic (3.39e-3)"	"unprognostic (1.57e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.04e-6)"	"unprognostic (2.18e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-1)"	1.3	0.8	0.7	12.1	0.5	5.1	1.9	0.3	0.7	1.2	3.3	0.1	0.5	2.9	0.5	0.7	6.5	0.6	0.3	1.3	2.1	0.6	0.7	0.8	2.0	5.5	0.5	0.2	0.6	0.5	0.3	0.4	7.4	0.3	2.5	4.3	0.5	1.3	0.0	0.4	1.7	3.7	1.5	0.4	3.1	1.4	19.5	0.0	28.6	0.5	5.4	5.7	1.5	2.0	0.3	0.0	0.0	0.0	0.8	2.6	0.3	15.5	7.2	13.8	6.3	0.9	2.0	10.8	20.0	9.2	17.0	14.8	5.9	6.5	0.0	14.9	8.2	10.5	20.0	10.4	28.9	13.6	13.1	12.7	12.8	3.4	0.2	10.9	0.0	0.7	0.5	19.5	10.9	12.3	8.6	12.4	30.3	3.5	0.0	4.1	11.8	9.8	0.0	41.1	5.1	6.9	4.2	15.5	7.2	20.0	8.5	10.4	7.7	5.5	7.2	11.0	12.6	19.4	23.1	7.8	16.7	0.1	10.4	3.8	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.6	0.3	0.7	0.5	0.3	0.7	2.1	0.6	0.5	0.2	0.3	0.0
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6;placenta: 71.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA038255: , HPA072558: AB_2686534"	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favourable (2.42e-4)"	"prognostic unfavourable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (3.08e-4)"	"prognostic unfavourable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.6	0.6	0.6	3.7	1.5	7.9	0.6	0.8	1.4	1.2	3.3	0.6	0.1	4.8	0.9	0.5	5.2	0.4	19.0	0.4	0.8	0.8	3.3	0.9	1.0	6.9	2.3	0.7	0.6	0.5	0.0	0.3	71.5	1.4	0.5	4.6	0.4	1.3	0.1	0.2	2.1	5.1	0.5	3.2	3.3	2.0	17.0	1.2	21.6	1.5	2.3	7.6	0.9	2.2	1.0	0.6	3.3	0.3	1.4	6.4	0.9	23.7	8.1	24.7	15.1	0.5	0.8	27.1	6.4	4.4	11.4	14.8	13.4	15.1	13.6	15.9	1.9	8.0	19.8	14.5	15.3	19.3	14.3	16.9	9.3	16.7	0.4	14.2	16.6	0.5	1.5	3.7	5.3	10.5	12.1	18.6	10.0	14.9	23.0	12.4	18.2	13.2	25.6	20.1	11.6	9.2	11.9	13.8	6.3	15.1	5.4	7.1	10.1	11.3	4.8	4.8	14.3	3.9	16.3	9.4	16.5	26.8	6.0	21.0	13.4	3.3	0.3	1.7	0.5	0.0	0.4	1.0	2.2	1.5	0.6	0.1	0.3	0.3	0.0	1.4	0.0	0.1	6.4	0.9	0.6	1.5	0.8	1.4	0.8	0.8	2.3	0.7	1.4	1.2
DGKA	"DAGK, DAGK1, DGK-alpha"	ENSG00000065357	"Diacylglycerol kinase alpha"	P23743	12	55927319-55954027	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 42.2;hTERT-HME1: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041645, HPA045462"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria				Vesicles	Vesicles	"HPA041645: AB_2677595, HPA045462: AB_2679335"	"unprognostic (1.12e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (1.66e-5)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.02e-2)"	4.9	4.7	7.1	31.8	8.2	9.7	4.8	6.0	10.8	8.4	13.4	3.6	3.1	20.5	6.9	4.1	42.0	4.9	7.9	3.8	4.6	2.4	3.9	1.5	7.6	28.6	2.1	4.1	4.9	6.4	6.2	3.1	10.2	3.3	10.6	11.0	4.1	16.2	5.3	1.0	33.0	27.2	5.7	3.7	23.1	4.8	4.4	2.6	117.1	4.5	9.6	57.0	13.0	15.1	7.6	4.0	5.4	2.8	5.2	30.2	10.9	6.7	4.3	3.0	4.0	7.5	9.8	0.9	15.2	15.6	6.0	4.4	2.0	11.5	3.8	3.6	10.1	12.4	3.2	42.2	7.2	3.2	0.7	6.1	9.1	1.1	6.5	1.9	6.0	8.4	22.7	8.3	44.8	12.2	0.7	5.9	16.1	0.7	12.5	2.4	0.6	5.1	5.8	1.0	0.6	14.2	19.5	0.5	1.7	5.0	0.2	0.5	2.7	2.0	10.9	3.9	2.8	0.8	0.5	0.7	0.3	9.2	4.7	5.2	1.1	5.2	2.8	5.4	6.5	2.0	11.7	7.6	24.3	11.7	4.0	6.4	30.2	18.1	5.2	5.2	1.2	4.0	26.7	10.9	7.1	8.2	6.0	10.8	4.6	2.4	2.1	4.1	3.3	2.6
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000284934	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207662-122227534	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8"	"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 20.8"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA001825	Uncertain		Approved	Mitochondria		21000	21000	Mitochondria	Mitochondria	"HPA001825: AB_1857247"																		0.1	8.7	0.0	3.8	0.0	0.0	0.0	0.0	0.5	0.2	5.3	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0		0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.9	2.4	0.0	1.2	0.6	1.1	0.6	0.6	2.3	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.5	0.4	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.1	0.7	0.0	0.4	1.8	20.8	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.5	0.3	1.4	0.6	1.0	0.3	1.0	2.3	0.6	1.2	0.3	1.3	1.1	0.6	0.2	0.4	2.2	0.5										
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163987	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.2;testis: 19.6"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA032151			Supported	"Plasma membrane,Microtubules"				"Plasma membrane, Microtubules"	"Plasma membrane, Microtubules"	"HPA032151: AB_2674181"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favourable (9.04e-4)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	1.8	0.4	1.7	11.5	1.8	6.7	1.6	0.1	1.4	0.9	4.7	0.2	0.4	2.0	1.4	1.1	7.1	0.3	2.5	1.1	1.0	1.6	1.7	0.4	4.1	2.9	1.0	0.0	0.4	0.4	0.5	0.2	9.4	0.2	0.4	2.3	0.0	1.6	0.0	0.1	1.8	4.3	2.7	0.3	2.5	3.1	19.6	0.0	35.2	0.2	5.3	5.9	0.8	1.5	0.4	2.0	0.4	0.2	0.0	0.5	0.2	17.9	6.0	6.2	3.5	1.1	2.9	10.6	25.2	11.2	25.5	22.3	15.9	12.2	6.0	2.0	12.9	12.3	10.1	9.9	38.9	6.8	7.0	8.6	15.4	3.6	1.6	11.7	6.9	1.1	0.2	15.5	10.5	11.4	6.6	8.6	24.2	2.6	10.4	5.0	5.8	3.5	7.1	15.4	4.9	8.3	3.7	3.3	5.7	12.8	8.9	3.9	6.5	6.4	11.3	16.2	10.4	5.4	20.8	5.8	6.3	9.4	4.3	5.8	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	2.0	0.5	0.2	1.7	1.8	0.1	1.4	1.0	1.6	1.0	0.0	0.2	0.0
DLL1		ENSG00000198719	"Delta like canonical Notch ligand 1"	O00548	6	170282206-170306565	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.8;HBEC3-KT: 10.5;NB-4: 17.4;THP-1: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 7.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078298			Uncertain	Nucleoplasm		210000	210000	Nucleoplasm	Nucleoplasm	"HPA078298: "	"unprognostic (1.03e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.66e-1)"	8.9	5.7	4.1	5.5	9.0	3.2	8.6	2.5	13.8	7.4	10.3	18.5	2.6	8.1	6.0	3.0	11.1	5.7	11.4	7.2	5.2	4.0	5.8	13.5	6.8	5.6	5.5	5.2	2.5	13.8	2.2	3.1	5.0	10.0	14.5	5.2	14.3	8.9	7.1	3.8	14.3	13.1	3.9	4.6	36.9	5.9	1.6	7.3	0.9	6.1	5.3	6.3	4.5	11.0	0.0	0.0	0.1	0.9	7.3	0.5	0.2	0.9	0.1	4.2	2.6	0.3	0.2	2.2	0.2	0.6	0.3	0.5	1.0	0.1	0.0	0.2	0.1	6.8	2.6	10.5	0.0	0.2	0.9	0.0	0.0	0.0	0.2	0.0	3.0	0.1	2.0	0.0	1.1	1.1	0.0	0.0	0.4	2.9	0.0	17.4	0.6	0.0	0.8	4.2	0.1	0.0	1.3	1.8	0.1	0.2	0.0	0.0	0.7	14.3	0.4	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.8	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.3	0.1	7.3	0.9	0.0	0.0	0.2	4.1	9.0	2.5	11.2	5.2	4.0	5.5	5.2	10.0	7.3
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.2;RPMI-8226: 19.3;SK-MEL-30: 5.3;THP-1: 3.7;WM-115: 3.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	9	"cerebral cortex: 2.3;hippocampal formation: 0.9"	HPA029297	Uncertain									"HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	3.8	0.5	1.9	0.5	6.5	0.4	4.5	0.5	4.5	0.5	1.6	11.0	2.6	0.4	0.5	1.3	0.6	0.6	0.4	0.5	3.2	1.3	27.3	0.4	2.4	0.6	7.0	2.5	0.4	0.4	52.9	0.7	0.6	3.6	0.6	1.1	0.0	1.4	1.5	9.0	0.6	0.4	0.5	3.0	0.4	0.4	0.9	6.2	18.4	0.4	6.6	0.5	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.2	19.3	0.0	0.8	3.0	0.0	0.0	0.0	5.3	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.5	0.5	4.5	3.2	1.3	7.0	2.5	3.6	6.2
DNASE1L3	"DNAS1L3, LSD"	ENSG00000163687	"Deoxyribonuclease 1 like 3"	Q13609	3	58192257-58214697	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.1;liver: 72.3;lymphoid tissue: 46.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;Karpas-707: 3.1;RPMI-8226: 5.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"plasmacytoid DC: 78.1"	"Lineage enriched"	"Detected in many"	20	"dendritic cells: 78.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019955	Approved				"Secreted to blood"					"HPA019955: "	"unprognostic (7.49e-3)"	"unprognostic (3.08e-3)"	"unprognostic (9.75e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.01e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (4.74e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (6.95e-2)"	"prognostic favourable (1.06e-7)"	"unprognostic (7.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.64e-3)"	3.5	7.2	0.5	27.8	0.5	0.1	3.8	0.6	0.5	2.7	6.1	0.5	1.1	6.1	0.9	1.1	4.2	0.8	1.7	3.4	0.5	0.5	14.3	72.3	5.7	38.5	0.5	0.1	1.5	0.8	0.0	6.0	2.0	0.4	1.4	9.2	12.0	3.3	1.2	0.9	1.8	14.0	0.4	1.3	46.9	0.8	1.5	0.0	11.0	3.9	20.1	17.0	3.6	3.2	3.8	78.1	0.1	0.0	0.1	0.0	0.6	0.2	0.8	0.5	0.3	0.1	0.1	5.3	0.3	0.2	0.3	0.1	1.0	0.3	0.5	0.3	0.0	1.5	0.1	0.0	0.1	0.2	0.1	0.5	0.8	2.1	0.2	1.1	1.2	0.2	1.1	0.5	0.7	1.0	0.5	3.1	0.0	0.7	0.3	1.2	0.5	0.4	0.5	0.7	5.5	0.1	0.3	0.8	0.5	0.3	0.4	0.6	0.4	0.6	0.9	0.7	0.3	0.4	0.3	0.8	0.5	0.7	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	6.1	3.8	0.0	0.0	0.1	0.1	0.0	78.1	0.0	0.6	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.1	0.4	0.0
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7;testis: 23.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 55.9;CACO-2: 21.0;HEL: 22.0;K-562: 21.1;NB-4: 18.6;NTERA-2: 75.5"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	1.1	0.8	0.9	2.5	0.9	4.7	2.4	4.5	1.4	1.6	2.1	0.7	0.5	0.9	1.3	4.7	1.6	1.1	1.6	1.8	0.8	0.7	2.7	1.2	1.2	1.9	0.9	0.5	1.2	7.5	2.5	1.1	2.8	0.8	1.1	0.8	1.2	3.5	1.6	0.5	5.5	0.8	1.0	0.5	1.3	1.1	23.3	0.8	17.7	2.6	1.7	2.5	2.7	2.2	0.7	1.0	0.0	0.2	0.9	1.3	0.1	0.8	1.1	6.1	1.4	0.1	0.5	55.9	0.7	0.5	0.8	0.8	21.0	0.9	2.2	2.2	0.3	0.5	3.9	0.3	0.6	0.2	3.1	22.0	0.7	4.0	0.2	0.9	2.2	0.5	0.4	1.2	0.2	1.4	21.1	0.6	0.3	3.4	3.3	18.6	75.5	0.7	3.3	1.0	0.5	2.0	0.9	1.9	1.3	1.3	1.9	0.5	1.3	1.2	0.3	1.2	2.8	0.6	0.5	1.3	0.6	0.8	0.6	6.0	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.7	0.2	0.0	1.0	0.0	1.3	0.0	0.0	0.9	0.1	0.9	0.0	0.1	0.9	0.9	4.5	1.4	0.8	0.7	0.9	0.5	0.8	0.8
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042445	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;lymphoid tissue: 27.6"	"Cell line enhanced"	"Detected in many"		"BJ: 20.0;HDLM-2: 22.7;TIME: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.2	7.6	17.1	16.7	28.8	8.8	4.0	3.0	18.4	9.5	5.9	27.6	0.0	4.1	3.4	1.4	3.4	2.5	6.4	1.8	24.3	14.7	2.9	5.4	7.3	23.9	33.3	9.6	15.9	1.8	1.9	1.4	2.5	23.2	2.0	6.7	1.1	4.1	2.0	1.3	5.0	8.5	4.4	37.7	26.5	6.1	2.3	35.5	27.6	2.7	1.3	18.4	6.6	3.7	6.8	6.2	2.6	9.6	12.8	10.5	4.0	0.0	9.4	3.0	0.0	3.9	8.3	0.0	20.0	16.4	9.6	7.2	0.0	0.0	0.2	0.0	12.6	0.2	0.0	0.0	7.7	22.7	0.0	0.2	2.0	0.0	0.1	1.9	0.9	1.9	0.2	13.9	5.4	9.5	0.0	18.8	16.2	0.9	3.4	2.6	1.1	2.2	4.5	4.4	2.7	0.5	0.0	0.1	2.5	0.0	0.0	2.0	0.6	8.7	21.2	10.4	2.5	4.9	6.8	0.0	0.0	0.0	14.7	12.9	4.5	2.6	2.8	0.2	6.2	8.2	6.4	6.8	10.5	8.8	6.2	3.8	10.4	9.0	0.1	12.8	9.6	2.6	7.5	4.0	17.1	28.8	3.0	18.4	24.3	14.7	33.3	9.6	23.2	35.5
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637247-170083382	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.0;bone marrow: 29.8;lymphoid tissue: 50.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.9;HDLM-2: 40.1;HL-60: 31.8;HMC-1: 37.0;MOLT-4: 24.2;U-698: 28.2;U-937: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036469	Enhanced									"HPA036469: AB_2675140"	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.3	3.1	2.9	30.7	4.8	29.8	4.1	1.0	2.7	2.2	3.5	5.8	1.2	2.6	2.9	2.7	2.4	2.9	4.9	2.7	3.4	2.5	3.1	2.9	12.6	22.6	4.8	1.3	1.9	1.9	0.7	2.2	3.8	4.1	3.3	4.5	2.6	6.6	1.2	1.3	2.0	13.7	3.6	8.5	28.0	3.6	1.8	3.7	50.3	2.8	1.7	31.5	6.2	2.5	6.4	14.0	12.7	31.0	6.6	6.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	3.2	0.0	0.0	31.9	0.6	2.5	0.0	0.0	0.0	4.0	40.1	0.0	17.7	0.3	0.0	0.0	31.8	37.0	0.0	0.0	0.7	0.0	0.0	0.3	16.0	0.8	0.0	24.2	8.2	0.0	0.0	15.1	0.5	12.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.1	0.3	1.0	0.4	0.7	5.0	7.8	28.2	0.6	22.1	0.0	6.2	12.7	10.0	6.4	23.0	6.6	6.4	5.9	6.3	14.0	5.3	4.3	5.0	12.7	6.6	31.0	4.8	5.3	9.4	2.9	4.8	1.0	2.7	3.4	2.5	4.8	1.3	4.1	3.7
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 40.5;lymphoid tissue: 61.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.0;HL-60: 16.8;MOLT-4: 15.7;NB-4: 26.6;REH: 19.8;RT4: 17.5;THP-1: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003218	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol				Centrosome	Centrosome	"HPA003218: AB_1078695"	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favourable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favourable (6.89e-6)"	6.7	12.9	5.6	27.4	8.4	20.8	6.1	1.2	4.1	3.1	3.9	9.2	0.9	3.9	3.0	4.3	6.0	4.1	8.2	2.9	6.3	3.3	7.5	3.9	16.8	35.3	10.2	2.3	2.5	6.4	7.6	3.5	10.4	8.1	4.9	4.1	4.4	10.5	2.4	1.7	3.3	15.0	3.4	13.6	43.5	4.9	7.2	8.9	61.0	5.1	3.0	27.1	10.5	4.0	7.3	15.4	40.5	21.5	6.6	5.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.4	17.0	1.2	0.0	0.7	0.2	0.1	0.0	5.8	0.6	0.0	0.0	0.0	0.0	16.8	2.3	0.0	3.1	0.0	0.0	0.0	3.7	8.6	0.0	1.0	15.7	26.6	0.0	0.2	19.8	0.0	6.5	0.0	17.5	0.0	0.0	0.0	0.2	1.1	0.4	50.6	3.3	0.0	0.1	0.2	0.0	3.4	0.0	0.0	0.0	10.6	0.3	14.2	14.7	16.7	4.6	15.1	3.8	7.3	5.5	4.8	15.4	6.8	4.4	4.2	40.5	6.6	21.5	4.4	5.3	6.4	5.6	8.4	1.2	4.1	6.3	3.3	10.2	2.3	8.1	8.9
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.3;lymphoid tissue: 35.8"	"Group enriched"	"Detected in some"	5	"HAP1: 22.7;NTERA-2: 83.5"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 10.3"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 10.3"									"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB020678: , HPA035249: AB_2674535, HPA035250: "	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.1	0.1	0.2	0.3	1.0	8.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.1	0.2	1.3	0.6	0.8	0.3	0.0	0.0	0.0	0.0	2.2	4.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	8.1	0.0	35.8	0.1	0.0	1.0	0.4	0.1	0.9	10.3	0.0	0.0	0.7	0.2	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.7	0.0	10.3	0.0	0.1	0.2	1.0	0.1	0.3	0.6	0.1	0.3	0.0	0.4	0.0
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102415	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 127.5;lymphoid tissue: 68.2;tongue: 163.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.8;CAPAN-2: 20.5;HaCaT: 29.6;hTCEpi: 32.0;SK-BR-3: 18.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.4;neutrophil: 5.7"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 20.4"	"Not detected"	"Not detected"							"HPA011911, HPA012615"	Enhanced					14000000	14000000			"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (3.01e-4)"	3.3	1.1	1.1	9.8	1.1	0.0	6.3	0.7	0.9	38.1	23.6	0.6	0.2	12.1	3.0	2.4	127.5	1.5	1.1	9.5	1.0	0.9	4.7	4.3	3.3	6.3	1.1	0.6	1.0	3.8	11.8	0.7	20.0	1.1	4.5	13.3	1.3	22.4	0.0	0.7	4.4	33.5	0.8	1.7	6.1	12.6	0.9	0.7	4.8	2.5	163.9	68.2	1.0	39.6	0.0	0.0	20.4	1.5	0.0	0.0	0.3	7.3	0.7	1.2	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	3.8	20.5	0.0	0.3	0.0	29.6	4.9	2.1	0.0	0.0	2.9	11.0	3.6	6.6	0.1	0.0	0.2	0.1	32.0	0.0	3.1	0.0	5.3	0.0	0.0	5.9	0.0	0.4	4.8	7.3	5.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	18.8	0.0	5.0	7.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	20.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.3	1.1	1.1	0.7	0.9	1.0	0.9	1.1	0.6	1.1	0.7
DSCC1	"DCC1, hDCC1, MGC5528"	ENSG00000136982	"DNA replication and sister chromatid cohesion 1"	Q9BVC3	8	119833976-119856010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 34.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA023780, HPA024401"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA023780: AB_2671311, HPA024401: AB_2671557"	"unprognostic (7.36e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.91e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (3.92e-6)"	"prognostic unfavourable (3.93e-4)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.12e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.32e-9)"	"unprognostic (2.75e-2)"	"unprognostic (5.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (8.18e-2)"	4.3	4.7	3.6	8.5	3.9	9.2	5.4	9.4	5.0	5.1	4.6	3.3	3.5	4.1	6.2	2.4	5.8	3.0	4.7	3.4	3.9	2.6	2.1	2.5	3.3	11.5	4.0	2.0	4.1	7.0	1.3	1.6	4.0	5.3	4.1	6.4	2.1	11.4	4.3	3.9	4.5	4.0	4.9	4.2	4.1	4.0	4.8	5.1	34.2	2.4	5.7	9.5	3.4	5.1	1.4	0.8	0.2	0.2	2.4	3.3	0.9	12.1	6.0	11.9	10.8	1.7	3.2	5.1	8.4	1.7	6.1	6.4	5.4	7.5	22.1	7.4	2.5	9.0	13.5	5.2	6.6	15.0	12.2	28.2	6.1	6.3	0.5	11.0	9.9	1.4	0.8	7.5	3.6	1.7	9.5	9.9	7.3	12.0	28.9	6.8	17.5	15.0	10.4	11.3	10.6	4.7	7.7	10.7	6.6	4.5	35.9	5.6	6.7	6.1	1.1	6.6	18.1	6.4	12.2	13.6	20.3	23.5	3.4	17.7	9.6	0.0	0.2	0.2	3.3	0.0	2.5	1.4	0.7	1.6	0.2	0.6	0.4	1.4	0.0	2.4	0.0	0.8	1.1	0.9	3.6	3.9	9.4	5.0	3.9	2.6	4.0	2.0	5.3	5.1
DSG3	CDHF6	ENSG00000134757	"Desmoglein 3"	P32926	18	31447795-31478702	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 156.7;lymphoid tissue: 50.7;tongue: 158.9"	"Group enriched"	"Detected in some"	7	"HaCaT: 41.1;hTCEpi: 101.8"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.0;head and neck cancer: 183.9;lung cancer: 36.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046864, HPA056863, CAB069880"	Enhanced									"CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260"	"unprognostic (5.76e-3)"	"unprognostic (6.99e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.79e-2)"		"unprognostic (1.00e-2)"		"unprognostic (4.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavourable (1.43e-5)"	"unprognostic (8.26e-2)"	"unprognostic (8.35e-7)"	"unprognostic (8.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (9.90e-4)"	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.1	35.9	1.1	0.0	0.0	1.6	2.3	0.0	156.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	10.6	0.0	0.0	10.2	1.8	0.1	0.0	0.0	0.0	0.1	0.0	3.2	0.0	158.9	50.7	0.4	24.8	0.2	0.1	9.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.8	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.7;lymphoid tissue: 13.3"	"Group enriched"	"Detected in some"	12	"Daudi: 40.0;REH: 16.4;U-698: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA051249: , HPA055275: AB_2682769"	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.7	2.3	6.1	8.9	7.0	3.2	3.9	7.3	8.3	0.8	0.7	1.1	0.5	1.6	2.0	0.5	1.2	1.7	1.0	2.7	5.4	5.9	1.7	6.4	0.5	13.3	3.7	4.2	0.5	2.0	0.0	2.2	0.9	4.6	0.8	0.2	1.4	3.2	0.5	0.5	0.5	2.2	0.5	1.1	9.8	1.0	4.9	0.5	0.5	1.3	0.5	8.1	0.5	0.5	2.3	0.0	0.0	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.7	0.0	16.4	0.0	0.9	0.0	0.0	1.0	2.7	0.1	0.1	0.9	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.2	0.0	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.2	6.1	7.0	7.3	7.1	5.4	5.9	3.7	4.2	4.6	0.5
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Enhanced	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: "	"unprognostic (7.46e-2)"	"prognostic favourable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	15.9	15.5	18.0	14.0	1.8	1.3	13.7	15.3	7.4	19.6	16.5	27.4	16.5	29.4	15.5	6.8	12.0	8.7	8.1	8.8	8.8	12.5	24.0	23.1	15.9	0.1	11.2	15.2	1.0	0.5	10.7	1.9	5.0	6.3	20.8	12.1	14.1	23.8	23.8	5.4	22.3	23.8	49.1	12.1	3.3	9.8	26.9	18.9	18.6	13.0	7.6	16.3	14.2	2.7	22.9	13.4	15.8	21.7	20.3	13.7	24.2	19.0	6.7	13.5	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	1.0	0.4	0.4	7.2	0.2	11.5	0.3	0.2	0.4	1.6	3.6	0.2	0.2	3.3	1.2	1.4	8.2	0.9	2.0	3.4	0.2	0.2	0.4	0.5	0.8	6.1	0.2	0.2	0.7	0.3	0.0	0.2	4.0	0.2	0.6	4.8	1.2	1.8	0.9	11.5	2.6	4.6	0.7	0.2	2.4	5.1	4.7	0.2	30.3	0.3	8.0	12.5	3.4	2.1	0.0	0.1	0.0	0.0	0.0	2.9	0.4	14.2	4.3	4.4	6.1	0.2	0.6	18.9	7.9	2.2	9.3	10.1	14.7	4.7	14.1	3.3	2.5	12.6	10.8	1.0	8.5	9.5	8.7	4.9	2.4	4.0	0.0	7.5	11.9	0.2	0.0	1.9	0.6	13.1	10.3	13.7	3.7	6.9	14.6	9.3	4.1	6.0	15.9	8.3	9.6	4.0	9.7	3.8	4.3	3.5	7.0	0.8	4.8	8.0	2.5	4.5	5.6	11.0	7.1	4.7	9.5	17.9	5.7	14.7	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.4	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"Early B cell factor 3"	Q9H4W6	10	129835283-129963841	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 25.8;lymphoid tissue: 29.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.9;HAP1: 11.6;LHCN-M2: 18.5;NB-4: 23.3;RH-30: 10.1;SCLC-21H: 23.9;THP-1: 9.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	20.0	0.9	0.3	3.4	0.4	0.1	25.8	0.7	0.5	7.3	3.6	0.2	2.5	0.2	5.4	4.9	4.3	3.8	4.3	10.5	0.3	2.5	0.6	0.4	1.0	29.9	5.0	0.3	1.0	1.2	3.6	0.9	3.8	4.8	4.6	0.8	2.0	3.6	2.2	10.9	2.8	1.0	6.3	9.3	0.2	1.6	4.6	0.1	0.5	6.7	6.3	2.4	4.7	16.9	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	9.9	7.6	0.1	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	11.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	2.3	0.0	0.0	0.0	0.0	18.5	0.1	0.0	23.3	0.1	0.0	0.3	10.1	0.0	0.0	0.1	23.9	0.3	0.0	0.0	0.0	0.0	9.8	0.0	0.0	1.2	6.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.5	0.3	2.5	5.0	0.3	4.8	0.1
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 76.4;BJ hTERT+: 53.2;fHDF/TERT166: 50.1;hTEC/SVTERT24-B: 36.0;LHCN-M2: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA027241	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	12000000000	12000000000	Cytosol	Cytosol	"HPA027241: AB_1847976"	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.1	0.6	2.3	0.0	13.8	76.4	2.1	22.4	53.2	14.0	18.3	0.3	3.4	0.1	0.2	50.1	12.9	0.0	2.6	14.7	0.1	0.1	0.9	0.7	0.1	3.8	0.0	23.2	6.7	0.1	36.0	1.3	3.9	4.8	0.1	39.0	0.0	0.0	0.7	0.2	0.7	0.3	16.8	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.1	0.0	5.9	1.0	29.7	4.4	3.3	4.8	0.1	0.1	0.2	15.6	2.0	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (6.82e-6)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	6.4	6.0	5.4	9.9	7.2	16.3	7.4	11.1	7.6	9.0	11.0	2.6	2.1	9.1	4.6	2.8	14.9	3.2	6.6	4.2	5.4	5.0	10.1	4.3	8.9	9.6	6.7	5.8	3.2	4.1	4.0	6.1	11.1	10.2	4.1	16.1	2.4	9.0	2.7	2.9	7.0	7.6	7.2	8.4	8.7	9.2	14.7	6.8	50.8	5.7	9.3	10.8	8.0	6.5	2.8	2.6	10.4	3.2	1.3	3.6	1.0	46.0	32.9	25.9	13.4	2.7	5.6	13.0	20.4	16.8	30.7	29.8	18.2	48.9	11.4	31.1	11.9	20.3	20.9	13.1	42.0	16.3	11.5	7.1	18.0	9.3	1.1	11.0	8.3	1.8	2.2	18.2	18.7	13.2	7.4	16.8	24.2	16.3	11.2	8.3	21.2	17.9	8.1	25.5	14.7	23.3	10.8	17.4	11.1	25.8	29.4	10.4	48.9	8.2	11.4	14.9	14.3	20.0	42.4	8.3	11.1	21.6	13.2	9.7	19.4	6.8	3.2	1.3	1.8	2.8	1.9	2.2	2.4	1.6	2.4	2.8	1.2	1.8	10.4	1.3	1.2	2.6	3.6	1.0	5.4	7.2	11.1	7.6	5.4	5.0	6.7	5.8	10.2	6.8
EDAR	"DL, ED1R, ED3, ED5, EDA1R, EDA3, Edar"	ENSG00000135960	"Ectodysplasin A receptor"	Q9UNE0	2	108894471-108989372	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.2;esophagus: 9.2;lymphoid tissue: 11.3"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.5;HaCaT: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 10.2;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	102	"T-cells: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042292	Approved									"HPA042292: AB_10794648"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.83e-7)"	"unprognostic (9.21e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.03e-3)"	0.3	0.2	0.3	1.9	0.4	0.5	1.8	0.4	0.3	2.8	2.9	0.1	0.0	2.2	1.1	2.6	9.2	0.4	6.8	0.5	0.3	0.4	1.9	1.9	2.4	6.6	0.3	0.0	0.3	0.5	0.0	0.2	0.2	0.3	1.6	4.5	0.1	3.2	0.1	0.3	3.5	2.5	1.3	1.2	0.5	1.8	0.6	0.2	3.2	0.3	1.7	11.3	4.6	3.5	0.0	0.0	0.0	0.0	0.0	10.2	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.5	0.0	14.0	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.2	4.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.4	0.4	0.3	0.3	0.4	0.3	0.0	0.3	0.2
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219957	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.5;lymphoid tissue: 89.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9;U-698: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	6.5	7.6	5.3	13.1	6.7	26.3	7.0	4.8	6.3	6.7	7.6	4.5	5.1	5.9	8.4	6.4	10.5	7.0	6.2	4.8	4.3	3.1	6.6	57.5	14.2	16.9	3.9	5.0	8.6	20.3	10.2	6.5	14.2	4.2	6.6	7.6	5.5	9.7	5.7	3.7	10.1	11.8	5.4	3.7	15.4	7.8	7.8	4.0	89.4	7.8	5.5	23.5	8.8	8.1	9.9	10.3	4.3	5.8	2.9	8.9	2.8	4.7	4.8	3.0	3.0	4.0	9.0	9.7	7.8	10.6	5.4	7.1	2.2	6.3	25.5	4.2	7.7	3.8	3.3	10.7	8.3	48.9	1.9	8.7	4.5	4.9	18.8	10.2	25.5	8.1	13.1	11.5	12.7	10.7	2.2	35.3	6.6	2.8	20.5	3.9	1.5	3.6	29.9	5.4	23.5	6.2	10.0	0.4	4.0	5.6	8.1	11.5	4.1	32.9	10.4	10.4	7.3	8.8	8.9	20.8	12.6	43.9	17.3	9.9	8.6	3.5	3.8	4.0	5.8	5.0	8.4	9.9	8.8	6.5	4.6	6.8	7.9	6.2	4.3	2.9	5.8	10.3	8.9	2.8	5.3	6.7	4.8	6.3	4.3	3.1	3.9	5.0	4.2	4.0
ELF1		ENSG00000120690	"E74 like ETS transcription factor 1"	P32519	13	40932028-41061440	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 129.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001755, CAB005172"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB005172: AB_631428, HPA001755: AB_1078732"	"unprognostic (1.21e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.20e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.72e-2)"	27.7	11.5	6.0	37.9	12.5	51.4	22.6	3.4	7.7	19.9	23.4	9.0	12.0	14.5	20.9	15.6	25.1	17.0	19.3	15.8	7.0	4.5	16.6	13.8	28.0	34.8	14.9	3.4	16.7	20.0	12.7	13.9	15.9	11.1	17.4	14.0	10.9	22.0	16.8	13.0	23.8	34.6	14.8	15.1	44.8	15.2	8.5	11.1	129.5	19.4	18.6	44.4	26.7	23.4	20.1	17.1	64.6	26.3	20.7	27.2	20.6	7.9	4.7	3.6	3.5	16.6	17.5	13.5	8.2	20.0	11.5	13.3	11.8	21.1	45.9	5.2	13.8	18.2	0.7	10.4	7.3	10.1	5.5	41.0	3.9	8.0	12.5	23.3	64.6	18.1	18.3	7.8	15.0	16.2	10.0	12.1	7.6	7.2	30.3	13.5	2.8	3.7	40.7	6.0	13.1	12.0	12.5	1.3	5.0	7.1	7.1	14.5	5.1	30.2	14.4	5.0	3.0	4.1	2.9	5.6	3.2	30.2	6.9	14.9	10.6	64.6	17.7	38.1	21.9	19.5	23.1	19.1	25.1	24.2	17.1	20.1	27.2	24.0	28.8	20.7	26.3	11.3	24.7	20.6	6.0	12.5	3.4	7.7	7.0	4.5	14.9	3.4	11.1	11.1
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772600-43777543	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.3;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;U-698: 18.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.3;naive B-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.5"	"Region enriched"	"Detected in single"	11	"olfactory region: 2.4"	"Low region specificity"	"Detected in all"			HPA028938	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA028938: AB_10795352"	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.7	1.1	1.0	24.2	0.6	0.4	2.5	4.7	0.6	2.3	10.6	0.5	1.6	4.8	1.0	1.0	5.5	1.3	0.9	0.6	1.0	0.6	1.8	0.5	0.9	7.5	1.3	0.0	1.3	0.7	0.6	1.2	0.8	2.6	2.1	1.8	0.8	2.0	0.7	1.0	7.0	13.3	0.9	0.6	1.5	1.1	12.3	0.5	0.8	1.1	2.8	16.7	1.3	1.7	8.5	1.0	0.1	0.1	0.1	1.2	0.6	0.6	0.1	0.6	0.2	1.6	0.1	0.1	0.2	0.5	0.8	1.2	0.1	0.5	7.8	0.1	0.7	2.8	0.3	0.0	0.5	0.7	3.3	0.3	2.6	0.8	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.2	0.8	0.0	0.8	0.8	0.1	0.1	0.2	0.0	3.5	0.2	0.3	1.5	0.3	3.5	0.2	0.1	0.2	0.0	0.3	0.2	0.0	0.0	18.8	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	5.3	0.5	0.2	0.0	8.5	1.2	0.3	0.1	0.1	0.0	1.0	0.3	0.6	1.0	0.6	4.7	0.6	1.0	0.6	1.3	0.0	2.6	0.5
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914812-79947580	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 92.6;skin 1: 41.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 19.1"	"Lineage enriched"	"Detected in single"	191	"T-cells: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.27e-4)"	1.2	2.6	6.0	1.6	8.8	0.6	4.7	16.0	15.5	2.2	1.4	2.3	0.2	1.1	2.8	1.6	11.0	0.9	2.2	0.9	8.4	10.4	1.9	0.6	0.7	0.9	6.3	4.8	2.3	1.0	10.7	7.6	2.2	19.3	4.7	1.6	15.5	3.0	2.3	0.7	41.9	1.3	3.2	3.5	1.0	1.0	5.8	2.3	92.6	2.0	4.4	2.2	1.8	2.6	0.0	0.0	0.0	0.0	0.0	19.1	0.6	0.0	0.6	7.5	8.3	6.3	6.1	1.1	3.8	4.2	3.3	7.2	1.0	0.0	0.0	0.7	5.2	0.7	9.7	5.4	2.4	0.0	12.6	0.3	1.6	0.0	5.8	2.9	1.2	4.9	2.0	3.3	3.4	5.3	0.0	0.0	6.9	1.3	21.5	0.0	7.2	3.9	0.0	10.8	0.0	0.1	0.0	9.9	2.9	4.1	6.6	1.1	2.6	0.2	0.5	1.5	2.9	2.2	2.9	5.0	10.0	0.0	3.5	0.0	2.2	0.0	0.0	0.0	1.8	0.0	19.1	0.0	2.6	3.1	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.2	0.6	6.0	8.8	16.0	13.5	8.4	10.4	6.3	4.8	19.3	2.3
EMB	MGC71745	ENSG00000170571	Embigin	Q6PCB8	5	50396192-50443248	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;intestine: 42.2;lymphoid tissue: 44.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 68.9;U-937: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.01e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.86e-3)"	15.0	16.4	1.7	21.7	2.0	43.3	8.4	1.1	2.9	2.7	18.9	1.4	0.5	21.7	1.6	5.6	6.5	4.7	6.1	16.7	2.2	4.7	4.2	1.9	10.6	44.1	3.8	1.4	2.7	1.8	15.2	8.0	6.6	4.5	9.5	3.6	4.0	7.4	6.9	2.7	15.9	42.2	2.5	3.3	20.6	3.7	10.5	1.8	15.9	13.7	3.6	17.0	5.3	2.9	9.9	11.4	16.4	14.7	16.4	26.1	16.1	8.4	0.7	1.6	0.0	0.7	2.3	0.1	0.4	0.0	0.7	0.0	0.0	22.3	16.9	0.4	0.8	12.9	3.8	10.9	0.1	5.2	8.6	8.0	2.7	0.0	0.1	16.0	0.0	0.1	6.0	1.8	7.3	0.0	0.0	22.6	13.3	9.8	9.9	9.5	6.4	4.3	15.8	0.0	22.1	0.0	7.6	5.1	4.6	0.0	2.5	0.2	1.0	68.9	0.0	0.0	8.2	0.0	0.0	0.2	0.0	14.0	0.0	29.9	2.0	3.7	14.7	16.4	21.5	1.9	26.1	9.9	19.4	19.3	9.7	6.5	11.5	15.5	13.7	16.4	0.6	11.4	23.4	16.1	1.7	2.0	1.1	2.9	2.2	4.7	3.8	1.4	4.5	1.8
EMID1	"EMI5, EMU1, hEmu1"	ENSG00000186998	"EMI domain containing 1"	Q96A84	22	29205851-29259597	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.0"	"Group enriched"	"Detected in some"	4	"HEL: 12.9;NB-4: 44.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 23.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 2.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000592	Uncertain				"Secreted in other tissues"					"HPA000592: AB_1078737"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-1)"	2.6	19.3	17.8	3.6	12.7	11.7	2.4	3.5	17.9	2.9	5.4	14.2	2.2	4.8	10.5	2.5	0.9	10.4	4.8	1.3	12.6	6.1	7.7	2.1	7.0	13.3	5.6	14.7	4.8	12.7	4.5	1.2	4.7	3.8	5.2	3.4	2.9	4.7	4.2	0.7	3.6	7.4	2.3	2.6	31.0	7.0	2.1	6.9	4.6	8.4	0.5	2.2	5.0	1.4	0.1	0.0	0.0	0.0	2.3	0.3	0.1	0.0	0.1	2.2	4.8	0.0	0.0	0.3	0.0	0.0	0.2	0.1	2.6	0.3	0.0	2.2	0.0	0.0	1.1	0.0	0.0	5.1	4.0	12.9	0.0	0.5	0.3	1.8	1.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	3.5	0.0	44.9	0.5	0.2	0.0	0.1	4.9	0.0	0.0	6.1	3.0	0.2	0.0	0.0	1.9	2.4	0.0	0.0	3.8	0.0	0.0	0.2	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	17.8	12.7	3.5	17.9	12.6	6.1	5.6	14.7	3.8	6.9
EML6	FLJ42562	ENSG00000214595	"Echinoderm microtubule associated protein like 6"	Q6ZMW3	2	54723499-54972025	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2;lymphoid tissue: 11.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;SCLC-21H: 20.1;U-698: 22.8"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.5"	"Lineage enriched"	"Detected in single"	26	"B-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062808, HPA068759"	Uncertain		Approved	Vesicles,Mitochondria				Mitochondria	Mitochondria	"HPA062808: AB_2684872, HPA068759: AB_2686027"	"unprognostic (1.06e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (9.96e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.26e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.85e-6)"	"unprognostic (5.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.13e-3)"	0.1	3.3	1.8	4.0	2.8	0.0	0.2	7.2	4.2	0.0	0.6			0.6	0.0	1.3	0.3	0.4	0.1	0.0	1.9	2.1	1.3	0.2	0.1	7.9	1.5		0.0	0.5	3.0	3.4	1.4		0.4	0.8		0.1	0.4	0.6	0.8	1.8	0.3	0.5	2.7	0.4	1.5			3.1		11.9	0.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.1	0.7	0.2	1.5	0.1	0.2	0.2	0.2	0.6	0.2	7.2	0.1	0.4	0.2	1.0	0.3	0.3	0.7	0.3	0.4	0.5	2.7	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.0	1.1	0.0	0.7	1.4	0.2	0.3	1.1	0.6	0.5	0.6	0.0	0.7	20.1	2.7	0.3	0.0	0.0	0.0	0.0	0.2	0.3	1.6	0.4	0.4	4.9	1.2	22.8	1.2	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EMP1	"CL-20, TMP"	ENSG00000134531	"Epithelial membrane protein 1"	P54849	12	13196716-13219939	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 240.9;lymphoid tissue: 129.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 129.3;fHDF/TERT166: 89.9;HaCaT: 80.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 28.6"	"Cell type enriched"	"Detected in some"	7	"myeloid DC: 7.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051931, HPA056250"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051931: , HPA056250: "	"unprognostic (1.40e-2)"	"unprognostic (7.30e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	"prognostic unfavourable (2.26e-8)"	"prognostic unfavourable (7.46e-4)"	"unprognostic (2.98e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.25e-1)"	"prognostic unfavourable (9.69e-8)"	63.3	5.0	2.7	8.0	10.4	2.1	20.8	0.8	3.9	51.3	11.6	5.5	4.0	4.6	14.0	10.4	240.9	9.9	25.2	16.1	7.3	2.8	8.9	4.4	18.1	5.9	5.3	0.9	5.7	10.2	2.9	2.8	10.6	28.6	6.3	6.9	17.8	45.4	2.8	12.0	16.8	10.7	17.6	9.7	8.5	6.0	5.2	3.0	0.6	22.5	99.1	129.3	14.1	80.6	0.0	7.0	0.0	0.5	0.1	0.1	0.0	38.1	2.0	0.9	0.2	61.8	129.3	0.1	28.3	51.9	14.6	18.7	0.2	64.6	0.2	20.2	89.9	80.4	1.1	3.7	19.8	0.7	0.0	0.1	6.7	0.0	14.9	0.2	0.2	40.5	5.4	46.4	13.6	33.3	0.2	0.6	34.3	0.1	0.0	0.8	0.7	6.5	0.1	3.9	0.3	42.6	0.4	0.0	0.0	12.6	1.8	21.0	0.3	0.2	36.5	32.8	11.5	30.8	15.2	0.1	0.4	0.2	47.8	0.2	38.5	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	2.7	10.4	0.8	3.9	7.3	2.8	5.3	0.9	28.6	3.0
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.9;brain: 22.6;lymphoid tissue: 21.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.6;MCF7: 3.4;SCLC-21H: 6.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in some"	20	"cerebellum: 22.6"	"Group enriched"	"Detected in many"	7	"gdTCR: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9"	"Group enriched"	"Detected in many"	102	"NK-cells: 17.9;T-cells: 16.5"	"Region enriched"	"Detected in some"	8	"olfactory region: 95.2"	"Group enriched"	"Detected in some"	13	"cerebellum: 44.2;olfactory region: 21.9"	"HPA028896, HPA077118"	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA028896: AB_10601370, HPA077118: "	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.4	0.7	0.5	6.8	0.4	1.6	1.6	22.6	0.4	1.8	0.8	0.0	0.0	0.3	3.2	0.9	1.4	0.6	5.0	0.7	0.4	0.7	1.0	4.9	10.1	15.6	0.5	0.3	1.3	0.9	0.0	0.6	1.6	1.1	2.1	0.9	3.3	2.2	0.1	0.4	0.4	1.8	0.7	0.9	21.4	1.4	0.5	0.0	1.8	1.1	0.9	11.2	3.3	0.8	0.0	0.0	0.1	0.0	17.9	16.5	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	2.2	0.0	11.6	1.7	0.0	0.1	0.9	0.0	1.4	0.0	0.1	1.4	0.0	1.6	0.0	0.3	0.0	0.0	3.4	3.1	0.0	0.4	1.4	2.1	0.0	0.0	1.1	0.0	6.5	0.0	0.0	0.0	1.3	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	10.0	0.0	16.5	0.0	1.9	12.0	0.0	0.0	0.1	7.5	0.1	17.9	0.0	0.0	0.0	1.4	0.5	0.4	22.6	0.4	0.4	0.7	0.5	0.3	1.1	0.0
EPHB6	HEP	ENSG00000106123	"EPH receptor B6"		7	142855061-142871094	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1"	"Group enriched"	"Detected in some"	6	"MOLT-4: 17.8;RT4: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035784			Approved	"Nuclear speckles"	"Intracellular and membrane"			"Nuclear speckles"	"Nuclear speckles"	"HPA035784: AB_2674781"	"unprognostic (1.90e-2)"	"prognostic favourable (1.80e-4)"	"unprognostic (7.08e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavourable (4.10e-4)"	"unprognostic (2.53e-3)"	"unprognostic (3.15e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.16e-1)"	"prognostic favourable (4.68e-5)"	3.3	1.7	7.4	3.0	30.1	3.3	2.6	3.1	29.3	9.0	1.5	0.8	3.4	0.9	3.0	4.5	7.5	6.4	2.8	1.4	5.4	4.2	1.7	1.3	2.4	3.6	3.3	14.4	3.9	7.8	0.8	1.1	2.9	1.7	6.8	0.9	1.5	4.7	8.1	1.8	32.1	1.6	2.0	1.4	2.6	3.3	3.8	3.6	26.7	6.6	2.5	3.3	5.1	6.5	4.1	0.9	1.0	1.3	0.0	3.1	1.4	0.1	0.0	0.0	0.4	1.9	1.0	0.0	0.2	0.4	0.1	0.0	0.5	1.3	0.0	0.0	0.1	4.4	0.2	0.0	0.0	1.0	0.1	0.3	0.0	0.2	0.6	4.2	0.1	0.3	0.0	1.1	0.0	0.2	0.6	0.0	0.0	0.0	17.8	3.2	3.0	1.3	0.4	0.0	0.0	0.0	33.8	0.0	0.0	1.2	0.8	0.0	2.8	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	1.3	0.5	0.1	1.0	0.6	4.1	2.5	1.4	0.9	1.0	3.1	1.5	1.0	0.0	0.4	0.1	1.9	1.4	7.4	30.1	3.1	29.3	5.4	4.2	3.3	14.4	1.7	3.6
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;NTERA-2: 5.9;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.8;monocytes: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favourable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.2	0.1	0.1	0.2	0.3	0.1	1.0	0.1	0.3	12.5	0.2	0.2	0.4	0.1	0.9	0.3	34.8	1.1	1.7	0.1	0.5	0.1	1.6	0.2	1.6	0.0	0.2	0.0	0.6	0.0	2.2	2.4	0.2	0.4	1.5	0.1	0.6	3.4	0.6	0.2	33.1	0.2	0.2	0.2	1.2	0.5	2.7	0.2	2.4	0.2	39.6	29.6	2.8	13.6	0.0	2.8	0.2	4.9	0.0	0.0	0.5	0.2	0.6	1.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.7	0.8	0.5	6.3	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.3	0.4	0.0	1.0	0.1	0.8	5.9	0.8	0.0	0.0	0.1	0.2	1.3	2.6	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.8	0.1	0.3	0.1	0.6	0.8	0.1	0.2	0.2	0.0	1.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	4.9	2.8	0.0	0.5	0.1	0.3	0.1	0.3	0.5	0.1	0.2	0.0	0.4	0.2
EPSTI1	"BRESI1, MGC29634"	ENSG00000133106	"Epithelial stromal interaction 1"	Q96J88	13	42886388-42992271	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 42.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 36.1;BJ hTERT+ SV40 Large T+ RasG12V: 37.8;HDLM-2: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017362	Approved									"HPA017362: AB_1848226"	"unprognostic (2.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (7.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.13e-2)"	22.4	11.9	3.9	42.2	5.5	18.2	7.1	1.4	3.7	6.5	14.1	5.1	5.9	20.3	7.0	9.7	6.8	5.4	11.2	7.5	3.8	3.9	14.8	7.9	14.6	18.7	5.4	3.9	5.4	2.9	5.1	4.7	18.1	6.4	6.5	6.8	6.6	10.5	16.8	3.0	2.7	22.2	5.8	7.4	28.3	9.2	5.8	4.0	28.5	7.6	4.3	18.0	10.1	5.4	12.7	14.4	19.3	26.8	10.2	26.4	9.7	1.0	0.0	0.0	0.0	0.0	2.0	1.1	0.8	9.6	36.1	37.8	8.4	2.1	1.3	0.3	1.2	4.2	0.0	1.4	4.6	26.6	0.0	4.2	0.0	0.0	8.8	0.0	0.7	6.7	1.9	2.9	0.2	0.5	0.0	6.7	0.9	0.0	6.7	1.0	0.2	0.0	0.0	0.0	12.7	6.0	0.2	0.7	0.0	0.1	0.0	0.6	0.2	0.7	1.4	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.7	0.0	0.3	19.3	16.2	13.0	5.5	26.8	5.7	12.7	11.1	6.0	14.4	10.9	5.3	4.0	7.8	10.2	16.6	1.7	26.4	9.7	3.9	5.5	1.4	3.7	3.8	3.9	5.4	3.9	6.4	4.0
EPX	"EPO, EPP, EPX-PEN"	ENSG00000121053	"Eosinophil peroxidase"	P11678	17	58192737-58205174	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 27.2;lymphoid tissue: 15.5"	"Cell line enriched"	"Detected in some"	69	"NB-4: 72.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	41	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 5.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076792	Enhanced									"HPA076792: "	"unprognostic (5.67e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-3)"	"unprognostic (4.83e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.73e-1)"	0.1	0.1	0.3	0.2	0.8	27.2	0.1	2.0	0.6	0.1	0.1	0.5	0.1	0.1	0.4	0.1	0.1	0.2	0.1	1.4	0.3	0.3	0.1	0.2	4.2	0.4	0.2	0.1	0.2	0.1	0.0	0.3	0.2	0.6	0.1	0.0	0.1	0.3	0.1	0.1	0.5	0.1	0.1	0.2	4.5	0.1	0.1	0.1	15.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	2.0	0.6	0.3	0.3	0.2	0.1	0.6	0.1
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239047	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Centrosome	Centrosome	"HPA050492: AB_2681145"	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.4	0.5	0.2	3.1	0.2	6.0	3.0	0.9	0.8	1.5	2.2	0.2	0.2	1.5	0.9	0.8	4.6	0.6	1.0	0.2	0.2	0.3	0.5	0.5	0.8	4.7	0.7	0.2	1.2	0.5	0.0	0.6	0.9	0.9	0.7	2.5	0.2	1.1	0.2	2.6	1.3	2.1	0.5	1.3	4.0	1.5	2.0	0.2	13.1	0.5	2.8	5.6	0.7	1.6	0.5	0.3	0.5	0.2	5.3	1.1	0.4	10.9	9.6	8.9	5.6	0.6	1.1	4.9	11.8	5.4	10.4	10.9	7.8	6.9	17.8	4.5	4.2	9.1	16.6	8.8	18.5	10.1	12.1	6.1	3.3	4.6	0.0	11.9	8.6	0.1	0.5	14.4	2.7	5.7	8.0	4.4	10.5	8.6	11.3	7.0	16.1	14.9	9.5	15.9	3.1	2.6	6.8	7.3	5.2	8.7	5.9	2.2	4.5	2.6	3.5	7.0	11.3	13.2	7.7	3.4	5.3	15.3	4.9	8.3	7.0	0.0	0.2	0.5	0.1	0.1	0.6	0.2	0.5	0.1	0.1	0.5	0.4	1.1	0.3	5.3	0.2	0.3	1.1	0.4	0.2	0.2	0.9	0.8	0.2	0.3	0.7	0.2	0.9	0.2
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.9;lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (2.01e-5)"	"prognostic unfavourable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favourable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.7	0.4	0.2	7.1	0.4	7.2	0.3	0.2	0.5	3.9	2.3	0.4	0.8	4.2	0.6	0.7	17.9	0.2	0.5	1.0	1.1	0.1	1.0	0.9	0.7	4.1	0.2	0.2	0.3	0.2	0.0	0.2	3.0	0.6	0.4	1.5	0.6	2.6	0.2	0.2	2.7	4.4	0.5	0.2	3.0	0.8	10.9	0.3	30.3	0.3	2.5	7.8	0.7	6.2	0.0	0.0	0.4	0.1	0.0	1.8	0.0	12.4	12.7	13.7	11.2	0.3	1.2	8.4	8.2	4.2	14.1	9.0	6.9	11.0	22.5	4.6	3.3	10.4	15.8	4.8	7.4	7.0	16.0	15.1	11.5	5.3	0.0	9.4	12.5	0.4	0.3	8.2	4.0	7.2	20.2	20.4	4.2	13.0	14.8	8.1	11.0	6.9	13.9	14.6	9.3	2.0	5.2	9.8	7.6	6.9	10.2	5.3	16.8	6.3	3.3	7.1	13.8	6.0	11.2	15.1	14.0	15.2	4.1	8.9	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.8	0.0	0.2	0.4	0.2	0.5	1.1	0.1	0.2	0.2	0.6	0.3
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 122.5"	"Cell line enhanced"	"Detected in many"		"HEL: 60.8;U-698: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	33.2	6.3	4.1	45.9	4.7	6.4	24.0	1.6	3.3	13.3	15.0	3.1	4.9	5.3	18.0	9.3	12.6	8.1	13.6	19.1	4.2	3.7	12.4	9.9	36.7	53.9	4.7	2.9	14.1	6.2	6.7	4.1	11.6	4.2	11.7	6.6	12.7	11.7	5.7	12.9	7.5	19.1	7.9	4.3	68.0	8.8	6.0	2.3	122.5	16.7	9.2	51.4	17.5	18.8	6.0	3.0	20.5	0.4	12.5	17.3	4.7	14.9	2.7	13.0	0.0	5.6	9.1	0.0	11.5	24.8	14.5	14.0	0.8	16.2	53.9	11.8	19.1	5.2	1.2	33.3	30.7	11.4	0.2	60.8	1.1	0.0	15.1	6.2	0.7	17.8	2.7	12.4	45.8	12.0	0.1	11.2	17.4	0.0	31.3	4.6	4.8	9.7	8.6	21.2	4.2	11.5	16.7	0.1	0.9	6.0	0.1	12.7	0.0	3.0	22.0	32.7	10.2	6.3	18.9	8.4	1.5	81.3	5.8	11.8	28.7	20.5	0.0	3.0	10.4	0.1	14.6	6.0	14.0	12.6	0.1	4.9	17.3	13.5	0.5	12.5	0.4	3.0	15.5	4.7	4.1	4.7	1.6	3.3	4.2	3.7	4.7	2.9	4.2	2.3
ETV3L	FLJ16478	ENSG00000253831	"ETS variant 3 like"	Q6ZN32	1	157092044-157099808	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.8;breast: 4.4;lymphoid tissue: 5.7"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.8;pons and medulla: 7.8"	"Group enriched"	"Detected in some"	13	"classical monocyte: 1.5;intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"					"Not detected"	"Not detected"														"unprognostic (7.39e-4)"	"unprognostic (1.53e-1)"			"unprognostic (3.22e-2)"	"unprognostic (1.79e-5)"		"unprognostic (2.25e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.57e-2)"			"unprognostic (3.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.37e-1)"		0.1	0.0	0.9	2.0	3.8	0.1	4.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.3	0.3	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.0	1.8	0.1	7.8	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.1	0.0	5.0	0.1	0.1	0.1	0.0	5.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.8	0.0	0.7	0.5	0.3	1.1	0.0	7.8	0.0
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303766-31314112	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 133.6;lymphoid tissue: 72.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;HL-60: 26.7;HMC-1: 37.7;Karpas-707: 26.7;NB-4: 21.1;RPMI-8226: 39.0;THP-1: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 133.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 133.6;monocytes: 34.3"					"Low region specificity"	"Detected in all"			HPA007436	Enhanced									"HPA007436: AB_1848307"	"unprognostic (1.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.73e-2)"	15.0	3.6	4.4	37.7	5.8	44.0	4.2	1.7	4.4	3.7	10.7	6.5	0.3	6.0	2.8	4.8	7.1	4.7	8.1	6.7	6.4	4.4	7.8	7.1	38.5	37.5	10.2	2.6	3.8	2.7	0.4	2.1	4.8	7.8	5.3	8.1	2.5	6.6	1.5	2.3	2.4	23.3	4.2	22.0	72.8	8.0	3.7	6.7	26.1	4.0	3.0	43.0	13.0	7.6	18.6	14.6	133.6	34.3	4.1	16.4	19.8	0.1	0.1	0.0	0.0	1.9	2.5	0.0	0.2	1.6	1.9	3.7	0.0	0.9	23.7	0.0	1.5	0.1	0.0	0.3	2.2	0.0	0.0	0.5	0.0	0.0	19.5	26.7	37.7	4.5	0.0	1.1	1.5	1.9	0.3	26.7	5.6	0.0	7.8	21.1	0.0	0.0	13.6	0.1	39.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	33.7	2.0	0.5	0.0	0.2	1.9	5.1	0.2	5.1	2.4	9.2	0.6	78.9	30.5	74.5	8.2	23.2	7.9	18.6	12.6	10.6	14.6	14.3	9.7	9.1	133.6	4.1	34.3	8.4	16.4	19.8	4.4	5.8	1.7	4.4	6.4	4.4	10.2	2.6	7.8	6.7
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 98.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favourable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavourable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	14.5	15.0	50.9	37.0	57.8	19.9	28.5	57.4	66.2	11.8	12.4	20.7	10.7	12.7	23.6	25.1	11.2	18.0	20.1	19.7	42.4	43.3	12.4	24.4	28.4	63.5	34.8	31.4	23.3	17.1	9.8	28.6	13.5	26.2	16.4	12.0	24.2	20.0	16.5	12.8	15.6	18.7	29.4	23.1	44.2	15.2	13.2	20.3	98.2	11.0	7.5	55.8	18.3	9.3	7.8	2.5	14.2	8.7	9.3	20.6	5.4	4.0	3.6	27.4	8.2	5.5	15.9	15.8	5.4	6.8	3.5	4.8	0.2	2.8	7.7	7.1	4.9	0.1	12.9	9.3	4.4	8.3	8.2	12.7	2.9	2.1	4.6	3.8	30.2	8.4	4.8	2.4	9.3	9.5	6.3	0.5	3.8	5.6	70.9	20.3	5.7	5.4	17.1	14.2	1.3	4.5	0.1	33.3	19.5	3.8	5.9	1.6	4.5	11.2	5.8	2.9	4.6	17.9	2.9	14.5	10.9	21.8	3.8	6.4	4.7	1.5	1.5	14.2	11.6	7.6	8.9	6.2	13.6	11.0	2.5	7.8	16.5	14.6	0.3	9.3	8.7	0.4	20.6	5.4	50.9	57.8	57.4	66.2	42.4	43.3	34.8	31.4	26.2	20.3
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027452	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 24.1;MCF7: 15.8;RT4: 34.9;SK-BR-3: 17.4;T-47d: 22.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments"	"Intermediate filaments"	"CAB002220: AB_563701, HPA053969: AB_2682326"	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	0.2	0.0	0.0	2.3	0.1	1.1	1.2	0.0	0.3	11.6	5.7	0.1	2.8	4.8	1.9	1.3	69.9	0.9	4.1	0.0	0.0	0.0	4.8	0.0	5.7	0.2	0.0	0.0	0.4	2.4	1.8	1.1	2.3	0.1	3.2	0.7	0.7	10.9	4.5	0.5	43.7	7.8	2.1	0.2	0.1	1.9	0.3	0.1	0.4	6.3	43.1	46.1	5.0	21.6	0.4	1.7	1.9	0.3	1.6	1.4	0.0	11.0	9.3	0.0	0.1	0.1	0.0	3.9	0.1	0.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	24.1	0.0	3.1	0.0	0.0	0.0	0.2	6.9	7.0	0.0	0.0	1.7	0.0	5.0	0.1	0.0	0.0	0.0	0.4	0.0	15.8	0.4	1.5	0.0	4.2	4.5	0.0	0.1	7.3	34.9	0.4	0.0	4.6	17.4	0.0	22.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.0	1.0	0.3	0.7	0.6	0.3	0.7	0.2	0.2	0.5	0.1	0.4	1.4	0.6	1.9	1.6	0.2	1.7	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1
EVPLL		ENSG00000214860	"Envoplakin like"	A8MZ36	17	18377662-18389647	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.2;lymphoid tissue: 10.4"	"Cell line enhanced"	"Detected in some"		"A-431: 1.9;HeLa: 3.2;hTCEpi: 11.3;RT4: 3.9;SiHa: 2.1;T-47d: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045728	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA045728: AB_10960394"	"unprognostic (1.34e-1)"	"unprognostic (4.88e-2)"				"unprognostic (2.06e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.08e-2)"		"unprognostic (1.64e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.60e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.06e-2)"	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	3.3	0.5	0.0	0.7	0.4	0.8	0.9	22.2	0.4	0.8	0.0	0.0	0.0	0.9	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.7	0.2	0.0	2.1	3.1	0.1	7.8	0.4	1.4	0.0	0.1	1.7	2.5	0.0	0.1	2.2	9.5	10.4	3.5	7.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	2.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavourable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavourable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	2.1	1.0	0.9	10.3	1.0	15.6	1.0	0.3	1.3	1.3	3.1	0.3	0.1	2.9	0.7	0.8	6.2	0.4	1.3	1.5	0.7	0.6	0.9	1.3	1.5	5.6	0.6	0.3	1.3	1.3	1.8	0.4	4.6	0.7	0.7	3.9	0.3	1.4	0.1	1.0	1.7	4.2	1.0	0.6	5.7	1.5	14.8	0.1	31.3	0.6	4.0	8.1	1.6	2.0	1.4	0.6	2.9	0.7	0.9	3.3	1.0	15.0	10.0	16.5	10.9	1.0	2.7	14.0	20.0	6.7	17.9	19.6	12.5	8.5	16.4	9.8	4.6	15.0	20.9	8.3	21.3	25.4	18.3	15.2	10.7	6.3	0.3	21.7	11.3	0.6	0.4	17.9	4.8	5.5	30.5	21.7	14.3	6.9	23.4	12.3	22.6	9.9	17.0	15.5	17.5	3.7	9.6	18.5	23.5	13.1	10.6	7.1	9.8	13.5	2.0	17.4	15.3	16.3	27.0	16.0	21.1	26.4	6.0	17.7	20.8	2.9	0.7	0.0	1.1	0.0	0.0	1.4	1.1	1.1	0.6	1.3	0.6	0.2	0.3	0.9	0.0	0.1	3.3	1.0	0.9	1.0	0.3	1.3	0.7	0.6	0.6	0.3	0.7	0.1
EXOC3L1	"EXOC3L, FLJ35539, FLJ35587"	ENSG00000179044	"Exocyst complex component 3 like 1"	Q86VI1	16	67184366-67190204	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.0;TIME: 3.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA029574	Uncertain		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA029574: AB_10602495"	"unprognostic (1.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.64e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.35e-1)"	4.5	2.4	0.3	1.8	0.9	0.0	2.4	0.4	1.2	1.4	0.6	0.3	0.3	0.8	3.6	0.8	1.2	0.9	1.5	4.5	1.3	0.2	3.3	1.4	8.7	1.8	0.3	0.8	2.0	1.0	0.4	1.1	6.0	1.0	1.6	0.3	2.4	1.1	0.5	1.8	0.7	1.0	0.8	1.0	26.6	0.7	1.0	0.3	0.3	4.1	1.0	0.5	1.0	0.5	0.0	0.7	1.8	2.0	0.0	0.0	0.3	0.2	0.1	1.2	0.4	0.0	0.1	3.1	0.4	0.0	0.0	0.0	1.4	0.3	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.8	0.5	0.0	0.1	0.2	0.3	0.1	0.5	0.6	1.3	1.2	0.2	0.0	0.2	11.0	1.3	1.4	0.3	0.1	1.0	0.1	3.9	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.8	0.0	0.3	0.0	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.3	0.3	0.9	0.4	1.2	1.3	0.2	0.3	0.8	1.0	0.3
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavourable (8.18e-12)"	"prognostic favourable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	16.9	7.9	27.1	18.0	0.8	1.4	14.8	13.2	5.3	10.9	11.0	11.9	19.6	29.9	6.4	4.9	10.4	13.9	4.5	13.9	42.8	13.9	12.7	9.8	9.2	2.2	28.4	10.5	1.2	2.6	8.1	4.3	6.4	27.1	19.9	9.7	19.2	55.1	23.7	21.5	10.7	34.1	15.2	18.5	5.0	8.1	25.9	16.5	16.6	12.6	4.3	9.2	12.2	3.9	11.6	5.4	23.1	23.6	17.9	19.4	30.1	10.6	19.4	22.7	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3
F2R	"CF2R, PAR-1, PAR1, TR"	ENSG00000181104	"Coagulation factor II thrombin receptor"	P25116	5	76716043-76735781	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.5"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 71.1;WM-115: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdTCR: 17.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 17.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008973, CAB012962"	Approved									"CAB008973: , CAB012962: AB_2533198"	"unprognostic (3.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.55e-2)"	"unprognostic (7.76e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (2.21e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.74e-3)"	12.3	11.2	1.5	7.5	2.2	1.1	8.9	0.8	3.5	11.7	14.0	3.3	20.1	5.9	17.6	8.6	9.3	3.5	20.8	19.2	1.4	1.7	19.5	22.6	24.4	10.4	1.5	1.8	6.2	4.0	1.6	4.7	32.0	2.5	9.6	5.1	9.6	26.4	14.0	7.2	23.7	15.5	8.4	3.5	67.5	4.5	16.6	1.4	4.0	9.1	11.4	13.5	10.7	4.7	0.4	0.2	0.8	0.3	4.2	17.6	6.4	1.0	3.3	10.4	1.7	19.8	34.6	0.5	5.8	19.9	3.8	13.9	0.7	9.1	0.0	9.9	2.4	2.5	4.4	3.5	7.3	0.8	3.7	22.7	0.7	2.8	29.9	0.1	0.9	19.5	11.8	7.3	2.0	71.1	4.2	4.3	7.8	0.4	1.7	0.0	3.3	18.2	3.2	6.2	0.8	18.0	0.1	1.2	5.6	1.7	0.0	8.5	0.1	0.2	32.5	24.2	5.4	0.2	10.7	11.6	3.4	0.0	6.4	0.4	67.0	0.5	0.2	0.3	17.6	0.3	4.4	0.4	4.1	12.1	0.0	0.1	0.7	9.1	0.8	4.2	0.1	0.2	0.4	6.4	1.5	2.2	0.8	2.1	1.4	1.7	1.5	1.8	2.5	1.4
FAM111A	"FLJ22794, KIAA1895"	ENSG00000166801	"Family with sequence similarity 111 member A"	Q96PZ2	11	59142748-59155039	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 73.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039529, HPA040176"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA039529: AB_10795149, HPA040176: AB_10793958"	"unprognostic (4.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (1.15e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.76e-2)"	"prognostic favourable (4.39e-4)"	16.3	13.7	4.8	28.1	6.7	9.9	14.5	3.3	4.8	14.7	14.2	8.3	13.2	12.8	18.1	16.8	10.2	11.3	15.9	6.7	5.5	3.9	14.5	11.7	17.5	19.6	7.4	3.8	11.2	10.7	17.8	17.4	10.8	8.1	22.5	11.7	13.2	13.4	13.0	5.6	11.0	19.3	14.0	12.3	29.5	12.9	5.9	6.5	73.4	19.5	12.9	21.3	10.9	13.2	4.6	6.5	7.7	6.3	6.9	8.6	2.4	21.0	5.5	2.7	2.5	6.0	7.3	1.8	30.2	16.4	13.0	19.2	8.2	19.8	30.9	12.7	9.7	7.4	9.0	13.1	16.4	27.5	0.4	11.6	6.9	2.5	6.2	18.5	15.8	5.1	3.3	12.1	3.9	12.0	1.4	25.5	14.0	6.0	27.8	12.4	1.2	5.9	19.2	9.7	7.2	8.7	18.8	0.0	0.7	15.5	13.0	5.9	26.6	8.3	11.6	21.2	19.1	14.4	14.0	13.1	13.6	5.0	11.6	13.2	25.5	6.2	6.3	6.7	6.6	5.4	8.6	4.2	4.5	4.8	6.5	4.6	4.4	3.7	7.7	6.9	2.6	1.8	4.6	2.4	4.8	6.7	3.3	4.8	5.5	3.9	7.4	3.8	8.1	6.5
FAM153A	NY-REN-7	ENSG00000170074	"Family with sequence similarity 153 member A"	Q9UHL3	5	177707981-177783398	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.6;lymphoid tissue: 8.9;testis: 15.2"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;Daudi: 1.0;K-562: 1.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 5.1"									"HPA042585, HPA044022, HPA046691, HPA052337, HPA055498"	Uncertain									"HPA042585: AB_2678063, HPA044022: , HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836"	"unprognostic (5.92e-5)"	"unprognostic (1.41e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.58e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.11e-1)"	0.5	0.3	1.3	0.5	3.5	1.1	0.2	10.6	4.3	1.3	0.2			0.6	0.4	0.4	0.4	1.2	0.5	0.3	2.0	1.5	0.3	0.3	0.5	1.2	0.0		5.3	0.5	0.3	5.2	0.2		3.9	0.3		0.3	0.5	0.5	1.5	0.5	0.2	0.0	8.9	0.3	15.2			1.3		1.4	0.2	0.6	0.3	0.1	0.0	0.0	0.0	5.1	0.2	0.0	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.3	5.1	2.2	0.0	0.0	0.0	0.1	0.0	0.2										
FAM163A	"C1orf76, MGC16664, NDSP"	ENSG00000143340	"Family with sequence similarity 163 member A"	Q96GL9	1	179743163-179816198	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 19.2;lymphoid tissue: 25.5;pituitary gland: 24.2"	"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 50.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	9	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (8.74e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.67e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	0.2	10.9	0.7	2.1	1.5	0.0	0.0	0.4	2.1	0.0	1.3	0.7	0.0	1.9	0.1	1.7	0.0	0.6	5.5	0.3	0.4	0.8	0.1	0.4	0.0	1.0	1.2	1.0	0.4	0.6	0.0	24.2	0.4	19.2	0.4	0.9	0.2	0.0	0.1	0.1	0.1	1.3	0.6	0.2	0.4	1.7	9.0	0.0	25.5	1.5	0.0	1.2	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	50.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.7	1.5	0.4	2.1	0.4	0.8	1.2	1.0	19.2	0.0
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986592	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5"	"Cell line enhanced"	"Detected in some"		"K-562: 17.1;RH-30: 4.7;RPMI-8226: 18.7;WM-115: 18.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.2;naive CD4 T-cell: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Nuclear speckles"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	0.8	0.0	2.4	0.6	3.8	18.2	0.6	1.0	1.5	0.6	1.0	0.6	0.6	0.1	0.7	6.8	0.6	1.5	0.6	0.6	3.4	1.9	0.6	0.6	0.6	0.6	5.3	0.6	0.6	0.6	0.0	0.6	1.1	0.6	0.6	0.2	1.0	0.6	1.0	0.6	1.2	0.6	0.6	8.5	13.3	0.0	29.5	0.6	0.6	0.6	0.6	0.6	1.0	0.6	0.0	0.8	0.0	0.0	0.1	2.6	0.6	4.1	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.4	1.7	0.0	0.0	0.1	0.0	0.0	4.7	18.7	0.0	0.0	0.6	0.0	0.0	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	18.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	1.7	0.0	0.1	0.0	0.8	0.0	0.6	2.4	3.8	1.0	1.5	3.4	1.9	5.3	0.6	0.6	0.6
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.5;lymphoid tissue: 9.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.3"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	Vesicles	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	1.0	0.8	1.3	4.1	1.0	6.5	0.6	5.1	1.0	0.5	1.0			1.3	0.4	0.2	3.0	0.5	1.0	0.2	1.6	0.9	0.3	0.4	0.8	9.3	1.4		0.4	0.1	1.5	0.1	1.4		0.2	1.3		0.5	0.0	0.0	2.1	1.3	0.7	1.4	3.2	0.9	3.6			0.2		7.9	0.9	0.9	0.8	3.3	0.1	2.4	0.8	1.4	1.1	11.9	4.4	7.4	3.6	0.7	1.1	5.8	6.4	2.7	7.5	6.3	0.1	6.3	26.6	8.9	1.2	7.5	10.1	3.6	11.6	17.6	7.5	11.5	4.9	5.3	0.4	19.9	10.3	0.6	0.4	5.9	12.0	4.5	15.0	16.4	5.4	5.0	10.0	16.4	13.9	9.1	15.0	15.8	12.1	2.9	1.4	8.0	4.6	4.8	3.7	3.7	5.0	15.6	1.5	6.2	10.5	12.0	11.2	14.6	18.1	26.3	5.5	21.7	14.3	0.0	2.4	0.0	0.0	0.9	0.0	0.8	0.4	0.5	3.3	0.3	0.0	0.1	0.1	0.8	1.1	0.4	1.4	1.1										
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6;lymphoid tissue: 6.4"	"Cell line enhanced"	"Detected in many"		"U-266/84: 29.0"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	Vesicles	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.1	0.0		1.6		3.6	0.0		0.0	0.0	0.2			0.5	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.0	6.1			0.0	0.0	0.0		0.3		0.0	0.6		0.0	0.0	0.0	1.5	0.0	0.1		0.5	0.1	1.9			0.0		6.4	0.4		1.1	0.4	0.0	1.0	1.7	2.2	0.6	8.5	5.0	6.1	2.7	0.3	0.8	5.8	4.3	1.4	5.7	4.4	0.7	10.3	20.4	5.6	0.5	8.3	8.1	2.6	6.3	7.0	4.8	8.8	4.4	1.5	0.3	17.9	8.0	0.1	0.0	4.5	11.8	2.5	15.4	9.6	0.3	0.6	10.6	13.9	4.8	3.2	13.5	4.3	14.5	1.0	1.1	3.0	5.5	4.1	2.4	2.3	5.9	15.4	1.7	4.6	7.6	6.0	9.3	20.1	29.0	12.1	2.4	11.2	2.9	0.0	1.0	0.0	0.1	0.3	0.0	1.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	1.7	0.6	0.1	2.2	0.6										
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145096000-145112696	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	Vesicles	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	1.1	0.7	0.8	7.2	0.8	5.5	0.7	4.0	0.9	0.6	1.1	0.6	0.4	1.4	0.8	0.4	4.4	0.2	0.5	0.4	1.0	0.7	0.5	0.4	1.3	7.6	1.0	0.4	0.4	0.4	0.3	0.4	1.5	0.8	0.4	1.6	0.4	0.6	0.4	0.4	2.9	2.0	0.5	1.1	3.3	0.8	6.7	0.4	17.7	0.4	2.7	7.4	1.1	2.5	0.1	0.7	0.1	1.7	0.0	1.0	0.5	8.3	5.1	6.0	2.4	0.2	0.5	6.6	4.8	1.4	6.1	3.8	3.4	7.6	13.7	4.9	0.7	8.9	7.3	1.4	7.2	11.0	7.3	6.8	2.5	5.0	0.1	12.2	7.7	0.3	0.5	4.8	9.3	2.7	13.6	19.2	4.0	6.3	8.2	11.9	11.4	7.1	7.3	7.6	16.2	2.1	1.1	5.9	5.0	3.6	3.3	2.2	9.3	7.9	1.2	4.5	5.0	3.8	8.6	14.5	22.8	21.3	0.0	9.7	5.1	0.0	1.2	0.0	0.0	1.7	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.0	0.5	0.8	0.8	4.0	0.9	1.0	0.7	1.0	0.4	0.8	0.4
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276547	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.7;skeletal muscle: 32.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.1;HEL: 17.1;HL-60: 16.9;NB-4: 26.6;THP-1: 23.8;U-937: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favourable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	4.9	1.5	2.9	9.3	4.6	12.4	2.5	1.1	4.3	1.0	1.6	3.4	0.8	1.8	1.2	1.1	1.1	1.1	2.0	19.2	3.8	2.0	2.1	2.5	8.0	18.4	4.3	1.0	1.8	0.8	0.8	1.0	5.8	3.2	1.3	1.1	5.4	2.7	0.7	32.3	0.8	6.1	1.2	3.6	15.9	2.3	20.1	2.4	23.7	1.5	1.8	15.0	3.1	0.8	14.4	5.2	14.5	10.9	2.5	10.5	6.9	0.3	0.1	1.1	2.5	0.8	0.2	18.1	0.2	0.1	0.2	0.1	0.1	0.1	7.5	0.1	0.1	0.0	7.3	0.1	0.0	1.9	0.6	17.1	0.2	0.1	0.3	16.9	0.7	0.2	0.3	0.0	0.0	10.0	6.0	2.1	0.2	2.6	0.7	26.6	1.2	0.2	1.8	1.0	10.5	0.1	0.0	0.7	0.9	1.0	0.3	1.0	0.6	23.8	0.2	1.0	1.1	0.6	0.0	1.6	0.8	4.4	0.1	15.9	0.2	0.4	8.6	14.5	8.6	10.9	6.8	12.5	8.3	9.3	5.2	14.4	10.5	8.7	8.8	2.5	8.1	2.4	8.2	6.9	2.9	4.6	1.1	4.3	3.8	2.0	4.3	1.0	3.2	2.4
FAM83A	"BJ-TSA-9, MGC14128"	ENSG00000147689	"Family with sequence similarity 83 member A"	Q86UY5	8	123178960-123210079	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.8;lymphoid tissue: 28.6"	"Group enriched"	"Detected in some"	5	"A-431: 23.7;HBEC3-KT: 37.0;hTCEpi: 19.9;K-562: 58.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 52.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052615			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA052615: AB_2797244"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (3.85e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (2.98e-9)"	"unprognostic (2.62e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (4.99e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.07e-2)"	0.1	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.6	0.4	0.0	8.3	0.6	0.8	2.0	44.8	2.8	1.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	2.7	0.0	1.3	0.0	0.0	3.1	13.6	0.1	4.4	2.5	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.3	13.4	28.6	3.1	18.4	0.4	0.3	0.7	0.2	0.3	0.4	0.0	23.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	3.2	0.0	7.6	0.0	37.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	19.9	0.0	5.1	0.0	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	4.2	2.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.4	0.1	0.3	0.1	0.2	0.1	0.0	0.4	0.1	0.2	0.7	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292401	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 24.0;lymphoid tissue: 12.1;skin 1: 29.7;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;Hep G2: 1.0;U-87 MG: 1.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain									"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.0	0.1	29.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	22.3	12.1	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.2	0.4	0.2	0.3	2.0	0.0	0.5	0.0	0.0	0.4	0.2	0.5	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.1	0.8	0.1	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM83H	FLJ46072	ENSG00000180921	"Family with sequence similarity 83 member H"	Q6ZRV2	8	143723933-143733801	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.2;lymphoid tissue: 30.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 19.5;MCF7: 26.8;RT4: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024505, HPA024604"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA024505: AB_1848417, HPA024604: AB_1848418"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (9.69e-3)"	"prognostic favourable (4.42e-4)"	"unprognostic (5.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	0.8	1.9	1.2	4.1	1.0	0.2	2.9	0.2	1.6	8.8	12.5	0.9	6.1	6.3	1.1	3.0	42.2	3.0	17.7	0.3	1.1	0.4	5.0	10.4	3.9	0.5	0.3	0.6	1.3	6.7	5.9	2.8	8.9	0.9	5.6	2.7	2.6	8.3	2.9	0.1	17.7	17.9	1.8	0.7	0.7	9.1	1.3	0.2	1.1	6.9	27.9	30.7	5.1	9.5	0.3	0.2	0.5	0.3	0.1	0.2	0.0	13.7	6.5	0.0	0.0	0.0	0.0	12.1	0.9	0.0	0.4	0.1	5.9	12.4	0.0	10.0	0.2	19.5	0.8	12.0	0.2	1.0	2.1	0.3	12.9	4.1	1.0	0.3	0.9	0.7	14.2	0.0	3.6	0.0	7.2	0.0	0.0	26.8	0.2	0.0	2.5	5.9	0.0	0.0	1.3	3.8	16.1	3.7	0.0	10.8	12.6	2.1	13.6	1.8	0.0	0.0	3.9	0.9	0.0	1.9	2.0	0.0	0.0	0.0	0.6	0.3	0.3	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	1.2	1.0	0.2	1.6	1.1	0.4	0.3	0.6	0.9	0.2
FANCA	"FA-H, FAA, FACA, FAH, FANCH"	ENSG00000187741	"Fanconi anemia complementation group A"	O15360	16	89737549-89816657	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6;testis: 28.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063236			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063236: AB_2684966"	"unprognostic (5.99e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-4)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.48e-4)"	"unprognostic (7.82e-10)"	"unprognostic (3.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.62e-1)"	2.1	2.0	2.2	16.5	3.7	17.1	1.7	5.7	6.6	1.7	5.1	1.1	0.6	5.0	1.7	3.1	6.6	1.9	1.6	1.7	1.8	1.4	2.1	5.8	3.3	11.1	1.3	2.7	1.6	1.8	2.3	1.9	11.2	2.4	1.7	6.3	1.5	2.2	0.5	0.7	5.0	5.4	2.0	1.6	6.9	3.5	28.8	0.8	20.6	1.7	4.6	17.6	2.9	2.5	7.4	6.5	9.9	9.2	7.5	9.5	4.2	9.2	14.2	17.0	14.9	1.1	2.2	13.0	11.5	6.3	19.5	8.2	12.4	15.4	22.7	5.4	3.9	14.2	11.4	8.6	20.6	5.3	19.2	6.7	18.2	25.4	0.7	6.8	7.4	0.7	0.9	15.8	5.0	6.1	16.1	7.0	10.1	21.4	13.6	29.5	11.0	8.9	24.8	13.7	4.1	4.8	8.7	15.3	8.3	17.2	5.1	2.2	9.3	12.3	4.5	15.7	16.5	8.7	12.0	6.3	7.3	22.6	7.4	15.3	14.8	2.6	7.9	9.9	4.7	8.8	3.3	7.4	2.8	4.1	6.5	5.5	0.7	3.0	9.8	7.5	9.2	0.4	9.5	4.2	2.2	3.7	5.7	6.6	1.8	1.4	1.3	2.7	2.4	0.8
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				Nucleoplasm	Nucleoplasm	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavourable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.5	9.1	17.5	4.9	0.9	1.3	45.3	7.9	3.5	11.4	9.3	6.8	8.5	16.8	3.7	2.6	7.5	18.0	6.1	11.4	8.0	12.2	23.0	14.0	6.5	0.1	17.0	14.4	0.4	1.0	12.8	7.1	6.8	14.0	19.3	8.5	9.9	14.2	6.5	21.1	6.4	15.5	14.2	11.9	3.9	9.7	4.9	9.6	9.7	7.6	3.1	11.6	10.8	3.9	9.4	10.8	5.7	11.4	8.2	16.0	28.5	5.4	17.5	16.1	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"Fanconi anemia complementation group I"	Q9NVI1	15	89243949-89317261	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.4;testis: 28.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA039972: AB_10673265, HPA040379: AB_2676951"	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.7	3.2	1.7	11.1	3.3	16.5	3.3	1.8	5.6	3.8	5.9	3.0	2.7	3.3	3.3	3.3	10.7	2.1	1.8	2.8	2.5	1.5	2.4	2.0	3.5	13.4	5.0	2.6	3.1	2.3	1.8	1.5	7.1	2.9	2.8	7.6	2.3	4.0	1.7	1.3	5.4	4.9	3.8	2.8	6.7	4.6	28.3	3.2	44.4	1.7	9.2	15.4	3.9	4.6	3.8	3.9	17.7	3.8	4.6	10.6	3.0	24.2	27.9	29.9	20.1	2.6	3.8	18.4	23.3	13.5	29.2	35.8	22.0	22.1	44.9	12.7	7.7	33.3	45.5	15.8	27.5	28.6	28.5	44.5	41.0	10.3	0.4	32.1	22.7	2.1	1.6	20.5	10.5	11.9	30.7	33.1	19.4	13.8	33.5	11.1	23.4	10.3	29.2	43.4	19.3	6.7	44.8	22.2	19.0	24.0	17.1	10.8	18.9	14.6	8.1	24.3	24.7	22.2	35.3	22.0	45.7	34.6	9.1	28.6	24.3	17.7	2.4	2.8	5.2	3.0	2.9	3.5	5.0	6.8	2.1	3.8	4.1	6.0	3.7	4.6	3.8	3.9	10.6	3.0	1.7	3.3	1.8	5.6	2.5	1.5	5.0	2.6	2.9	3.2
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659018-172666874	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.6;lymphoid tissue: 13.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;LHCN-M2: 2.4;NB-4: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"gdTCR: 25.6"	"Group enriched"	"Detected in many"	12	"NK-cells: 16.0;T-cells: 25.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054959	Approved				"Secreted to blood"					"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.9	1.1	0.5	1.9	0.7	3.6	1.8	0.5	0.8	0.7	2.6	0.6	0.0	3.0	3.9	1.2	1.0	0.8	1.6	1.2	0.5	0.5	1.2	2.2	6.8	7.7	1.4	0.0	1.5	0.6	0.0	0.7	2.4	0.6	4.7	1.2	2.8	1.9	0.3	0.4	0.5	3.8	1.9	1.7	13.4	2.1	0.4	0.0	1.2	1.1	0.0	10.1	1.4	0.9	0.0	0.0	1.6	0.0	16.0	25.6	5.5	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.5	0.5	0.1	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.7	0.0	0.2	0.6	2.4	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.7	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	25.6	0.0	15.8	0.0	5.4	13.7	0.0	0.0	1.1	11.7	0.8	16.0	0.0	0.0	0.1	5.5	0.5	0.7	0.5	0.8	0.5	0.5	1.4	0.0	0.6	0.0
FBXL12	"Fbl12, FLJ20188"	ENSG00000127452	"F-box and leucine rich repeat protein 12"	Q9NXK8	19	9810267-9827816	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002843			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA002843: AB_2666679"	"unprognostic (7.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.21e-2)"	"prognostic favourable (3.21e-4)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (1.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (4.07e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.77e-3)"	14.3	10.4	6.6	12.4	9.8	25.1	16.3	12.2	12.6	14.7	16.8	10.5	8.6	16.2	18.6	18.7	13.2	17.0	15.6	12.1	6.9	7.1	12.0	15.3	14.8	14.1	8.8	8.7	19.3	12.4	8.2	13.4	16.3	10.5	16.5	11.7	10.0	9.9	17.8	17.3	11.3	18.6	14.5	6.7	13.9	12.9	11.8	7.6	87.9	13.5	9.2	12.7	17.8	13.4	19.0	17.1	27.3	14.7	22.5	18.4	11.6	9.5	4.8	11.3	10.8	12.8	11.4	12.8	10.4	10.7	11.4	13.5	14.7	6.4	9.0	16.8	10.4	9.1	8.4	9.1	9.1	8.9	16.3	17.3	9.7	14.6	16.6	12.4	10.7	16.3	6.2	10.9	9.7	8.1	13.0	18.8	5.9	7.6	18.4	38.7	12.8	9.1	10.8	8.3	16.2	8.1	13.0	6.9	9.5	7.6	5.7	11.8	7.8	14.9	9.2	15.6	7.6	20.8	10.2	25.3	9.8	14.0	6.6	11.4	7.4	20.8	14.7	27.3	15.9	12.1	18.2	13.6	15.6	18.3	16.6	19.0	18.4	14.5	10.9	22.5	11.3	17.1	16.5	11.6	6.6	9.8	12.2	12.6	6.9	7.1	8.8	8.7	10.5	7.6
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874248-54890472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.6;neutrophil: 6.1"	"Group enriched"	"Detected in many"	44	"granulocytes: 6.1;monocytes: 2.6"					"Low region specificity"	"Detected in many"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.0	0.6	0.4	1.5	4.4	28.1	0.8	0.1	1.0	0.6	0.6	0.7	0.0	0.6	0.6	0.6	0.6	3.8	0.6	8.2	2.0	0.4	0.6	1.8	19.5	15.9	1.2	0.0	2.2	0.6	0.6	0.3	1.5	4.3	0.6	0.6	0.9	0.6	0.6	0.6	0.6	0.6	0.7	2.7	14.9	0.9	2.1	0.0	1.0	0.6	0.3	0.6	4.4	4.8	0.0	0.0	6.1	2.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.7	0.4	4.4	0.1	1.0	2.0	0.4	1.2	0.0	4.3	0.0
FCER1G		ENSG00000158869	"Fc fragment of IgE receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 262.7;lymphoid tissue: 176.3"	"Cell line enhanced"	"Detected in some"		"HEL: 17.1;HMC-1: 70.0;THP-1: 61.6;U-266/84: 18.9;U-937: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 262.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported					9800000	9800000			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.67e-2)"	"prognostic unfavourable (1.83e-6)"	"unprognostic (1.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.87e-2)"	62.6	20.5	12.1	49.5	22.4	71.5	17.6	2.4	10.8	10.6	14.6	14.1	1.3	8.0	7.2	15.9	6.9	20.5	18.8	21.2	15.3	11.2	18.9	35.9	71.2	124.8	23.4	4.5	11.4	7.4	2.9	7.9	38.1	17.0	9.7	21.3	9.7	12.8	7.4	11.9	5.7	13.6	28.5	33.3	176.3	10.9	11.6	16.0	6.5	11.5	6.7	14.7	22.4	10.5	0.9	135.4	73.5	262.7	66.6	2.0	132.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	17.1	0.1	3.3	0.0	3.5	70.0	1.4	0.7	0.5	0.0	0.1	0.0	1.6	0.5	0.1	0.3	8.3	0.3	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.6	0.0	61.6	0.1	0.4	0.1	0.2	0.2	0.7	18.9	0.2	0.4	19.3	0.1	64.3	129.8	12.1	0.5	210.3	0.6	0.9	0.4	0.4	97.1	0.3	0.7	2.0	73.5	66.6	262.7	135.4	0.8	132.1	12.1	22.4	2.4	10.8	15.3	11.2	23.4	4.5	17.0	16.0
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 223.6;lymphoid tissue: 60.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 109.4;non-classical monocyte: 223.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 73.0;monocytes: 223.6"									"CAB032435, HPA055431"	Supported				"Secreted to blood"	2500000000	2500000000			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	11.9	9.7	7.5	20.5	12.4	4.4	4.1	1.6	7.0	1.9	2.1	5.5	0.8	0.8	1.1	2.4	1.0	2.4	5.1	6.4	6.3	7.3	2.6	22.5	43.2	8.0	12.7	1.9	1.4	2.9	1.8	3.9	14.6	6.8	2.6	2.3	2.2	2.7	1.3	1.3	0.3	1.2	14.3	25.7	60.8	1.3	1.2	8.0	1.4	1.8	1.3	1.3	6.3	2.3	0.1	11.7	73.0	223.6	7.9	33.9	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.5	0.5	0.0	0.8	0.5	0.4	0.0	0.0	0.5	1.3	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.5	33.9	109.4	0.3	0.1	0.3	13.2	11.7	0.0	0.2	12.2	73.0	7.9	223.6	0.2	0.1	35.8	7.5	12.4	1.6	7.0	6.3	7.3	12.7	1.9	6.8	8.0
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700857	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;lymphoid tissue: 32.2"	"Cell line enriched"	"Detected in some"	7	"Daudi: 14.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 20.3"	"Group enriched"	"Detected in many"	56	"B-cells: 20.3;NK-cells: 10.7;T-cells: 10.8"					"Low region specificity"	"Detected in all"			HPA048022	Enhanced									"HPA048022: AB_2732541"	"unprognostic (6.73e-3)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.74e-5)"	"unprognostic (1.09e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.46e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.69e-2)"	0.4	0.2	0.2	29.4	0.2	0.4	0.3	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.5	0.2	1.5	0.3	0.6	0.3	0.2	0.2	0.5	0.6	0.9	26.4	0.4	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.5	0.6	0.2	5.6	0.0	0.4	0.2	8.7	0.1	0.2	22.4	0.6	0.2	0.0	5.2	0.6	0.6	32.2	1.2	0.3	20.3	0.0	0.2	0.0	10.7	10.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	1.0	16.1	1.4	7.2	0.0	20.3	0.1	4.7	0.2	10.7	0.0	0.0	5.6	3.5	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.0	0.0
FCRL5	"BXMAS1, CD307e, FCRH5, IRTA2"	ENSG00000143297	"Fc receptor like 5"	Q96RD9	1	157513377-157552520	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.3;lymphoid tissue: 39.1;salivary gland: 12.4"	"Group enriched"	"Detected in some"	5	"U-266/70: 5.6;U-698: 12.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 11.4;naive B-cell: 13.3"	"Lineage enriched"	"Detected in single"	19	"B-cells: 13.3"														"Secreted to blood"	36000000	36000000				"unprognostic (1.30e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.32e-5)"	"unprognostic (2.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.51e-10)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.78e-1)"	0.7	0.4	0.3	33.9	0.3	1.1	1.3	0.3	0.3	1.6	7.4	0.1	0.0	3.6	0.5	0.1	4.6	0.8	0.8	0.4	0.3	0.3	1.6	0.8	1.6	17.4	0.3	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.5	2.7	1.0	12.4	0.8	0.3	0.3	6.4	0.1	0.3	29.5	2.5	0.9	0.0	3.1	1.1	0.7	39.1	5.3	0.6	13.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
FCRL6	"FcRH6, FLJ16056, IFGP6"	ENSG00000181036	"Fc receptor like 6"	Q6DN72	1	159800511-159816251	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.4;lymphoid tissue: 15.5"	"Cell line enhanced"	"Detected in some"		"HSkMC: 2.3;hTCEpi: 2.6;Karpas-707: 1.7;U-937: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdTCR: 39.4;memory CD8 T-cell: 36.0;naive CD8 T-cell: 29.2;NK-cell: 13.2"	"Group enriched"	"Detected in many"	27	"NK-cells: 13.2;T-cells: 39.4"					"Low region specificity"	"Detected in all"														"unprognostic (2.64e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.18e-2)"	2.2	1.5	0.6	7.0	0.6	6.8	1.6	1.1	0.8	1.3	0.7	0.7	0.0	0.8	4.6	2.4	0.8	1.2	7.2	3.6	0.6	0.6	1.5	4.0	7.5	9.0	0.7	2.4	1.4	0.9	0.0	0.9	1.3	1.0	3.2	0.3	2.7	2.8	0.1	1.1	0.9	2.5	0.7	1.8	15.5	1.1	1.2	0.0	3.2	1.3	1.2	3.4	2.0	1.0	0.0	0.9	0.3	0.3	13.2	39.4	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.2	0.4	0.0	0.0	2.3	2.6	0.0	0.5	0.1	0.0	1.7	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.2	0.0	0.3	0.0	0.4	0.2	0.0	0.2	1.7	0.8	0.0	0.0	0.0	39.4	0.0	0.8	0.0	7.3	36.0	0.9	0.0	3.3	29.2	0.3	13.2	0.3	0.0	0.0	11.1	0.6	0.6	1.1	0.8	0.6	0.6	0.7	2.4	1.0	0.0
FCRLB	"FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2"	ENSG00000162746	"Fc receptor like B"	Q6BAA4	1	161721563-161728143	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.9;lymphoid tissue: 5.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.0;Daudi: 7.3;fHDF/TERT166: 10.7;HMC-1: 9.3;PC-3: 5.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 7.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"basophil: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB026139	Uncertain		Supported	Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"CAB026139: "	"unprognostic (1.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (5.77e-3)"	"unprognostic (7.49e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.14e-2)"	0.5	0.2	0.2	3.4	0.3	0.0	0.3	1.0	0.8	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	1.4	0.6	0.3	2.4	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	1.2	0.0	0.2	0.7	2.7	0.2	0.3	0.8	0.2	0.4	1.5	0.2	0.2	0.2	0.2	0.3	0.2	5.0	0.8	0.2	4.9	0.6	8.9	0.2	5.3	2.7	0.6	0.7	0.1	0.0	0.3	0.5	0.7	0.0	4.5	6.0	1.5	1.5	0.1	0.2	7.3	0.2	10.7	0.1	0.2	0.4	3.9	0.1	0.3	0.2	0.1	0.2	0.2	0.0	9.3	1.4	0.0	2.7	0.2	1.3	0.3	0.3	0.2	0.4	0.0	2.5	0.2	5.4	0.0	0.5	0.3	0.2	0.2	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.8	1.6	0.7	1.7	0.8	0.0	0.0	2.9	3.2	0.4	0.8	8.9	0.1	2.4	2.7	0.1	1.0	4.6	1.6	1.5	0.6	4.9	0.8	1.2	1.5	5.3	0.2	0.0	0.0	0.6	0.2	0.3	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		38000	38000	Nucleoplasm	Nucleoplasm	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favourable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavourable (5.73e-6)"	"prognostic favourable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.0	28.6	31.4	16.9	3.1	3.9	20.0	27.5	15.7	33.7	38.4	25.0	23.4	44.9	21.5	11.7	32.9	44.2	24.1	34.6	23.6	24.3	23.7	39.1	25.4	2.4	36.8	24.5	2.7	3.3	31.1	8.3	13.1	35.8	32.5	28.0	39.1	51.2	33.1	34.5	28.1	35.2	36.4	46.3	13.4	29.5	35.8	29.7	18.3	24.1	15.8	34.9	25.9	8.8	30.0	37.9	38.2	27.7	25.7	39.9	46.6	20.9	24.7	25.8	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223886	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.4;bone marrow: 57.6;lymphoid tissue: 52.7"	"Cell line enhanced"	"Detected in many"		"HEL: 61.5;HL-60: 26.9;HMC-1: 65.8;Karpas-707: 26.5;NB-4: 34.6;U-937: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065231			Approved	Vesicles		450000000	450000000	Vesicles	Vesicles	"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favourable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	20.0	5.6	3.1	29.4	5.5	57.6	5.6	0.9	3.2	3.4	8.8	3.4	0.7	8.1	3.4	6.0	3.6	5.8	6.5	7.2	2.2	2.4	5.3	5.5	17.8	39.1	6.3	0.8	4.9	2.8	0.2	2.6	7.5	3.7	4.2	3.0	5.6	8.9	2.9	3.2	2.8	12.4	3.3	4.8	52.7	10.6	2.5	4.3	51.2	4.0	2.4	29.6	6.2	2.9	13.7	47.3	54.7	49.5	22.6	30.6	59.4	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.4	6.5	0.6	1.2	0.5	0.2	0.1	0.1	16.7	0.1	61.5	0.2	0.0	2.3	26.9	65.8	0.2	0.2	1.0	0.0	16.7	1.4	26.5	1.7	0.7	23.9	34.6	0.2	0.4	14.5	1.8	0.1	0.0	0.1	0.3	0.1	0.1	0.9	0.3	0.4	18.7	1.5	0.2	0.5	0.3	0.1	0.3	0.6	11.8	4.1	27.9	17.7	40.6	49.5	54.7	30.6	46.3	29.4	13.7	24.4	28.4	39.0	13.4	16.1	21.1	45.0	22.6	33.5	47.3	28.3	59.4	3.1	5.5	0.9	3.2	2.2	2.4	6.3	0.8	3.7	4.3
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.8;lymphoid tissue: 49.7"	"Cell line enhanced"	"Detected in many"		"HEL: 20.9;HL-60: 18.6;HMC-1: 39.8;NB-4: 24.4;THP-1: 36.6;U-937: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	14.9	3.4	4.8	9.7	4.1	38.3	12.7	2.4	5.7	6.8	5.4	3.2	4.7	3.0	7.4	5.6	4.9	7.6	7.3	7.9	4.2	2.2	5.2	11.8	12.7	23.3	3.7	0.9	6.4	3.7	1.8	2.7	8.1	7.2	7.7	2.4	5.3	33.8	6.3	3.4	3.5	5.2	5.4	6.9	49.7	4.3	3.2	4.7	3.1	7.2	4.1	4.5	7.2	9.4	1.1	32.6	60.8	30.5	9.3	0.1	13.8	0.1	0.2	0.3	3.5	1.0	3.1	6.0	0.9	0.0	1.7	1.0	0.8	0.0	2.2	0.1	2.0	0.5	0.6	0.1	0.5	1.1	0.3	20.9	0.0	3.7	2.0	18.6	39.8	3.0	0.0	2.6	0.0	10.5	0.6	0.0	0.0	6.8	0.5	24.4	1.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.0	36.6	8.3	0.0	3.6	0.1	0.0	0.0	2.6	0.8	0.1	15.8	0.8	10.4	30.5	60.8	0.1	17.6	0.0	1.1	0.0	0.0	32.6	0.9	0.0	0.0	20.0	9.3	7.3	12.9	0.0	13.8	4.8	4.1	2.4	5.7	4.2	2.2	3.7	0.9	7.2	4.7
FFAR2	"FFA2R, GPR43"	ENSG00000126262	"Free fatty acid receptor 2"	O15552	19	35443907-35451767	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.2;lymphoid tissue: 22.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.8;SK-BR-3: 2.5;THP-1: 2.8;U-937: 3.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Region enhanced"	"Detected in many"		"midbrain: 7.0"	"Group enriched"	"Detected in some"	27	"eosinophil: 18.9;neutrophil: 60.2"	"Lineage enriched"	"Detected in many"	42	"granulocytes: 60.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023985	Approved									"HPA023985: "	"unprognostic (7.75e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.17e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.03e-2)"	4.3	0.3	1.1	16.5	0.8	16.7	9.2	0.3	1.8	0.4	1.6	0.2	0.0	3.0	0.5	0.9	1.5	1.3	1.2	1.4	0.9	0.3	0.5	1.6	8.9	15.2	7.0	0.5	0.8	0.4	0.3	0.3	1.9	1.3	1.1	0.5	0.8	0.7	0.0	0.3	0.8	4.1	1.0	1.2	22.9	1.0	0.9	0.3	0.8	0.6	1.2	0.7	2.3	4.6	0.0	0.2	60.2	1.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.3	0.1	8.8	0.2	0.3	0.1	0.0	0.0	0.2	0.4	0.0	1.8	0.0	1.3	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.7	0.1	0.0	2.5	0.1	0.3	2.8	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	3.5	0.0	0.6	0.4	18.9	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	60.2	0.0	1.4	0.0	0.0	0.1	1.1	0.8	0.3	1.8	0.9	0.3	7.0	0.5	1.3	0.3
FFAR3	"FFA3R, GPR41"	ENSG00000185897	"Free fatty acid receptor 3"	O14843	19	35358460-35360485	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.5;blood: 5.6;lymphoid tissue: 6.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 1.1;HHSteC: 3.8;HSkMC: 3.3;U-937: 1.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 4.7;neutrophil: 5.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.6"									HPA044681	Uncertain									"HPA044681: AB_2679043"	"unprognostic (1.15e-1)"		"unprognostic (5.16e-3)"		"unprognostic (1.45e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.22e-2)"	6.5	0.0	0.1	6.1	0.3	1.7	3.8	0.0	0.2	0.0	2.1			0.7	0.0	0.0	0.0	0.5	1.1	0.2	0.4	0.2	0.0	0.5	0.6	0.4	0.5		0.3	1.0	0.4	0.5	0.9		0.2	0.1		0.0	0.0	0.0	0.0	0.9	3.7	1.5	2.4	1.3	0.0			0.9		0.0	0.7	0.0	0.0	0.1	5.6	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.4	0.0	0.1	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.2										
FGD2	ZFYVE4	ENSG00000146192	"FYVE, RhoGEF and PH domain containing 2"	Q7Z6J4	6	37005646-37029070	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.5;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.0;Daudi: 12.4;HDLM-2: 12.1;U-698: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"classical monocyte: 8.8;intermediate monocyte: 25.4;memory B-cell: 9.3;myeloid DC: 13.7;naive B-cell: 7.8;non-classical monocyte: 25.5;plasmacytoid DC: 10.8"	"Group enriched"	"Detected in many"	19	"B-cells: 9.3;dendritic cells: 13.7;monocytes: 25.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA029145, HPA049692"	Approved									"HPA029145: AB_10601321, HPA049692: AB_2680852"	"unprognostic (3.54e-2)"	"unprognostic (1.40e-4)"	"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.10e-2)"	11.3	4.3	6.7	21.8	10.3	5.4	3.3	1.0	4.6	2.4	3.4	5.9	1.3	3.8	2.2	7.6	3.0	4.1	4.3	2.6	7.2	2.4	3.0	3.3	8.7	21.7	10.3	1.4	1.8	2.3	0.3	2.1	2.8	7.4	2.4	2.9	2.5	4.2	2.2	1.5	3.0	11.2	4.6	8.3	43.1	3.8	1.2	9.2	3.0	3.5	1.8	18.9	5.1	2.5	9.3	13.7	0.8	25.5	0.1	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	12.4	0.0	0.0	0.4	0.0	0.0	0.3	12.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	8.8	0.8	0.0	25.4	0.0	9.3	0.0	0.0	13.7	7.8	0.0	0.0	0.1	0.1	25.5	10.8	0.0	2.1	6.7	10.3	1.0	4.6	7.2	2.4	10.3	1.4	7.4	9.2
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947451-93036236	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.2;lymphoid tissue: 48.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 20.7;Karpas-707: 28.7;RT4: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favourable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	3.1	1.5	2.3	20.5	2.5	23.4	3.5	0.5	1.6	1.8	3.1	3.1	1.6	1.9	2.8	2.5	2.8	2.5	3.1	1.5	2.2	2.0	4.6	2.1	7.5	30.5	3.3	1.0	1.1	5.7	0.1	1.0	2.6	2.6	3.2	1.4	2.2	6.6	1.0	0.7	3.1	10.1	1.5	6.3	28.1	2.6	3.9	2.5	48.1	3.5	2.1	25.8	7.7	3.2	11.3	10.3	49.2	24.7	10.5	15.7	17.1	6.3	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.9	4.4	5.1	0.2	0.0	4.1	0.3	0.0	0.0	8.8	0.0	8.1	0.0	0.3	0.0	2.1	20.7	0.0	0.1	0.0	0.0	0.0	0.3	28.7	0.0	10.6	9.4	9.0	0.2	0.5	9.4	0.0	7.2	0.0	16.3	0.6	0.2	0.0	7.0	0.2	2.7	9.5	0.0	0.0	0.3	0.0	0.0	2.9	2.9	2.4	1.5	4.5	0.0	34.0	13.4	36.7	15.1	17.3	15.5	8.5	15.6	14.1	10.3	11.3	15.7	13.3	49.2	10.5	24.7	4.7	13.5	17.1	2.3	2.5	0.5	1.6	2.2	2.0	3.3	1.0	2.6	2.5
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935569-15938740	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 106.6;lymphoid tissue: 56.8;tongue: 133.1"	"Group enriched"	"Detected in some"	4	"HaCaT: 77.2;HBEC3-KT: 133.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"					"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.2	0.0	0.2	0.6	0.2	0.0	4.1	0.2	0.2	27.1	5.1	0.2	0.2	0.4	1.1	0.2	106.6	0.1	0.3	0.2	0.2	0.0	0.3	0.2	1.9	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.7	0.2	0.3	4.6	0.4	14.1	0.2	0.2	14.6	1.3	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.3	133.1	56.8	1.8	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	1.5	0.0	77.2	0.0	133.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	13.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247658	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.0;skeletal muscle: 61.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol		2500000	2500000	Cytosol	Cytosol	"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	8.3	7.5	2.5	5.1	4.4	2.9	7.9	4.7	2.8	4.2	5.3	2.5	3.8	3.3	3.9	4.7	2.5	3.4	5.6	3.7	2.3	1.3	4.8	2.3	12.5	4.4	4.0	0.7	12.9	3.4	2.5	2.5	5.8	4.2	4.2	2.6	4.0	5.7	4.0	61.1	2.5	3.9	3.5	5.6	38.0	2.9	2.2	3.0	2.7	8.2	11.1	5.8	2.6	3.5	0.5	2.0	2.2	3.0	1.3	1.4	2.1	4.3	11.9	4.4	3.6	18.1	10.9	15.0	9.2	7.6	10.6	10.3	8.2	5.7	5.2	6.7	6.7	5.3	5.2	7.5	5.3	4.1	8.3	23.2	4.6	8.9	4.8	9.5	42.6	13.5	0.9	16.2	1.5	16.4	12.0	3.2	6.6	14.9	6.4	17.1	6.7	3.8	7.4	10.0	12.3	3.3	1.7	1.4	7.4	14.5	8.3	8.4	8.9	7.6	19.0	14.4	8.4	8.8	7.4	11.1	11.3	7.6	29.6	9.0	13.1	1.5	3.0	0.5	1.1	1.2	1.4	0.1	1.3	1.0	2.0	0.5	0.8	0.6	2.2	1.3	1.0	1.2	1.2	2.1	2.5	4.4	4.7	2.8	2.3	1.3	4.0	0.7	4.2	3.0
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.2"	"Cell line enhanced"	"Detected in many"		"HEL: 40.2;HUVEC TERT2: 22.3;REH: 18.8;TIME: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073099			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	14.7	2.5	3.5	15.8	4.4	10.6	9.9	1.4	3.2	6.7	5.1	3.8	2.1	3.3	7.8	6.5	4.8	5.3	6.0	7.5	3.8	3.1	4.2	3.6	17.4	24.4	6.2	1.6	4.0	3.2	2.5	2.0	11.4	3.8	4.3	3.1	4.8	4.2	3.3	5.2	3.2	6.9	5.7	6.6	40.2	4.1	2.7	4.6	26.8	5.7	2.8	17.9	6.2	6.7	4.5	13.1	20.1	12.0	7.8	8.8	11.6	0.0	0.0	2.0	0.0	0.2	0.4	0.0	1.2	3.4	1.4	1.2	0.0	0.0	6.8	12.2	4.0	0.0	0.3	5.0	1.6	3.2	0.1	40.2	0.2	0.0	2.4	4.8	5.7	0.3	0.4	2.9	6.8	22.3	0.0	8.8	0.3	0.0	4.8	2.7	0.6	1.2	18.8	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	23.1	0.2	0.0	0.1	1.2	2.8	5.9	5.9	0.0	11.7	1.8	20.1	9.5	16.1	7.2	10.3	8.8	4.5	6.2	5.8	13.1	3.6	2.6	5.6	7.8	7.8	12.0	2.2	7.4	11.6	3.5	4.4	1.4	3.2	3.8	3.1	6.2	1.6	3.8	4.6
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;brain: 19.3;lymphoid tissue: 15.0"	"Group enriched"	"Detected in some"	11	"REH: 27.8;THP-1: 17.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.3"	"Group enriched"	"Detected in some"	11	"myeloid DC: 29.9;plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		180000	180000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1.0	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15.0	1.8	1.1	0.5	5.7	0.0	0.4	0.0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3.0	1.3	4.4	8.8	0.9	1.2	0.0	8.2	0.6	0.0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.5	0.0	27.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	1.4	0.0	0.3	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.8	0.0	12.1	0.0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0.0
FLT3LG		ENSG00000090554	"Fms related tyrosine kinase 3 ligand"	P49771	19	49474207-49486231	"Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.6;U-266/70: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 18.2;MAIT T-cell: 33.7;memory CD4 T-cell: 37.3;memory CD8 T-cell: 23.7;naive CD4 T-cell: 41.1;naive CD8 T-cell: 32.0;T-reg: 35.9"	"Lineage enriched"	"Detected in all"	7	"T-cells: 41.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (1.29e-3)"	"prognostic favourable (2.17e-5)"	"unprognostic (2.12e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.78e-6)"	"unprognostic (2.17e-1)"	"unprognostic (5.25e-2)"	"unprognostic (8.22e-3)"	"unprognostic (5.68e-2)"	12.8	5.9	4.5	21.0	6.7	14.0	11.1	1.9	4.0	14.1	12.4	5.1	6.6	9.4	12.1	8.0	11.3	9.2	14.8	6.8	3.4	2.7	8.6	4.8	10.5	32.7	4.3	2.6	16.3	4.5	2.2	5.7	3.5	4.7	12.9	3.4	6.6	9.6	7.7	7.1	8.8	11.0	10.8	4.9	17.0	8.1	5.5	6.3	49.8	8.5	9.0	32.7	11.6	16.0	3.1	1.2	4.9	6.0	6.0	41.1	10.4	4.2	0.4	0.6	1.5	7.1	11.7	0.4	3.2	6.7	6.9	11.5	0.3	4.6	4.1	1.7	4.5	4.6	1.1	3.7	1.7	17.6	1.7	3.0	1.7	1.6	12.4	2.7	10.4	7.9	0.5	4.7	0.9	2.3	1.3	13.9	2.0	2.6	2.8	4.4	0.2	0.8	2.2	2.1	4.7	1.0	2.6	0.3	1.0	1.0	1.2	1.9	1.7	2.1	2.0	8.7	1.9	5.1	4.7	17.6	5.4	1.7	4.3	5.7	2.4	1.1	1.6	4.9	18.2	4.5	33.7	3.1	37.3	23.7	1.2	2.6	41.1	32.0	1.7	6.0	6.0	0.5	35.9	10.4	4.5	6.7	1.9	4.0	3.4	2.7	4.3	2.6	4.7	6.3
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247320	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.4;lymphoid tissue: 56.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 49.5;MOLT-4: 33.9;U-266/70: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavourable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	8.6	3.8	10.7	29.7	9.6	107.4	7.5	8.1	16.1	4.6	5.2	4.2	0.8	5.8	2.6	5.8	4.5	6.1	9.1	5.8	13.4	6.0	4.2	3.6	22.2	38.1	6.1	6.4	3.1	3.6	3.6	7.4	7.4	7.2	4.3	4.1	3.3	8.4	2.3	2.5	4.2	14.9	4.3	6.2	45.9	6.6	2.7	3.3	56.6	3.9	4.1	22.8	11.3	4.6	3.5	4.3	22.3	5.6	5.4	7.6	3.5	4.1	8.1	0.0	0.4	0.0	1.8	0.4	0.5	1.1	3.1	2.3	0.3	1.8	12.8	4.2	0.1	0.7	0.0	0.1	1.0	22.5	1.1	7.4	12.1	0.6	8.7	19.3	26.3	1.4	0.3	4.0	1.7	0.0	0.6	49.5	2.2	2.7	33.9	20.0	0.4	0.2	21.5	2.9	22.9	0.8	0.5	2.6	1.2	2.5	0.4	0.9	2.3	15.8	1.0	0.1	2.9	0.4	18.2	41.3	18.2	13.1	0.3	15.8	0.6	6.8	5.1	8.2	7.0	5.6	4.7	3.5	5.5	7.6	4.3	3.3	3.6	4.8	22.3	5.4	4.2	2.5	6.0	3.5	10.7	9.6	8.1	16.1	13.4	6.0	6.1	6.4	7.2	3.3
FOLR3	FR-G	ENSG00000110203	"Folate receptor 3"	P41439	11	72114869-72139892	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.4;bone marrow: 43.4;lymphoid tissue: 22.6"	"Group enriched"	"Detected in some"	5	"hTERT-HME1: 34.8;U-2197: 30.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 5.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"classical monocyte: 52.9;neutrophil: 73.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 73.4;monocytes: 52.9"														"Secreted to blood"	9600000	9600000				"unprognostic (1.47e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.90e-2)"	"unprognostic (8.39e-2)"	"unprognostic (9.99e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.03e-6)"	"unprognostic (4.17e-1)"	2.9	0.3	0.1	4.8	0.2	43.4	4.2	0.1	0.8	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.4	1.0	0.1	1.7	0.2	0.1	2.7	0.6	14.4	8.2	0.2	0.0	0.1	1.7	0.0	0.1	4.5	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.2	0.1	22.6	0.4	0.7	0.2	0.3	0.9	0.4	0.4	0.2	7.5	0.0	5.1	73.4	52.9	0.0	0.2	29.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.8	6.1	1.8	4.4	0.0	0.0	0.0	0.6	0.9	0.4	0.0	3.3	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	2.5	34.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.1	30.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	52.9	4.3	0.0	3.5	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	73.4	0.0	0.1	0.9	0.0	29.5	0.1	0.2	0.1	0.8	0.2	0.1	0.2	0.0	0.2	0.2
FOXD4L3	FOXD6	ENSG00000187559	"Forkhead box D4 like 3"	Q6VB84	9	68302867-68304905	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.0"									HPA012836	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012836: "		"unprognostic (7.93e-4)"			"unprognostic (8.71e-2)"					"unprognostic (7.04e-2)"				"unprognostic (4.75e-2)"				0.0	0.1	0.7	1.4	1.3	0.0	0.0	2.1	2.3	0.3	0.1			0.0	0.0	0.0	0.0	2.4	0.4	0.0	2.6	0.7	0.0	0.0	0.0	1.6	0.5		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.3	0.0	0.0	0.4	0.0	0.0	0.1	2.0	0.0	0.9			0.0		0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.3	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.2	0.5	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.6	0.1	0.8	0.5	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857681-2877155	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.5;testis: 40.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB017832	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (1.95e-6)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.7	1.7	1.0	9.3	0.9	13.8	2.4	0.4	1.2	2.0	6.5	0.4	1.1	6.0	1.2	2.1	13.5	0.4	4.1	1.2	0.8	0.6	1.3	1.6	2.8	6.6	0.8	0.3	0.8	0.6	0.0	0.5	3.9	0.9	0.9	8.2	0.6	2.6	1.1	0.7	3.7	7.1	4.4	1.2	5.0	3.2	40.1	0.4	47.5	0.6	11.4	11.6	2.0	3.7	0.7	0.6	1.0	0.6	0.4	1.9	0.1	28.6	29.1	22.6	20.7	3.4	4.5	28.8	18.7	18.5	38.1	34.5	36.7	25.7	18.5	4.0	26.8	22.3	33.8	17.2	37.3	34.6	18.1	20.9	27.9	15.7	0.5	16.8	17.1	2.3	1.9	35.3	24.9	26.8	11.7	41.7	29.9	26.9	22.8	8.0	49.8	21.7	16.6	34.3	9.7	9.0	18.4	12.7	20.2	24.0	20.1	11.0	19.7	18.8	10.7	30.9	47.0	36.1	65.0	5.5	9.1	26.8	14.3	16.1	32.7	0.4	0.6	0.1	0.4	0.2	0.4	0.7	0.5	0.4	0.2	0.7	0.9	0.3	1.0	0.4	0.1	0.6	1.9	0.1	1.0	0.9	0.4	1.2	0.8	0.6	0.8	0.3	0.9	0.4
FOXN1	"FKHL20, RONU, WHN"	ENSG00000109101	"Forkhead box N1"	O15353	17	28506243-28538896	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 15.1;lymphoid tissue: 37.0;skin 1: 27.9;tongue: 18.4"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 15.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 7.0;head and neck cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.60e-1)"	"prognostic favourable (6.43e-4)"	"unprognostic (2.68e-3)"	"unprognostic (5.98e-6)"		"prognostic favourable (5.00e-4)"		"unprognostic (2.85e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.6	0.0	15.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	1.6	0.2	0.1	27.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	37.0	0.1	18.4	11.3	0.7	6.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.9	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FOXO6		ENSG00000204060	"Forkhead box O6"	A8MYZ6	1	41361922-41383590	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.2;placenta: 8.4"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.8"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (3.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.35e-2)"	"prognostic unfavourable (7.65e-6)"	"unprognostic (5.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.55e-9)"	"unprognostic (4.35e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.10e-2)"	1.1	0.6	0.7	0.6	3.0	0.7	1.0	0.1	4.5	1.0	0.6	1.9	0.0	1.4	0.6	0.6	0.6	0.6	0.9	0.6	4.9		0.7	0.8	0.9	0.7	0.1	1.9	4.8	2.3	0.6	3.6	8.4	0.7	0.6	0.6	1.3	0.6	0.6	1.3	0.6	0.6	0.6	0.0	1.0	0.6	1.2	1.6	7.2	0.6	3.5	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250436-49264826	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.9;lymphoid tissue: 23.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 8.1;SiHa: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	11	"T-reg: 25.9"	"Lineage enriched"	"Detected in single"	260	"T-cells: 25.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB026301: , HPA045943: AB_2679508"	"unprognostic (2.46e-2)"	"prognostic favourable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favourable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favourable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.4	0.4	1.4	20.2	1.3	1.4	0.6	2.2	1.2	0.7	0.8	0.5	1.0	0.6	1.1	7.2	2.6	0.3	3.3	0.4	1.3	1.0	1.1	4.7	1.9	23.3	0.9	0.4	0.6	0.4	0.1	1.2	0.4	0.4	0.9	0.6	0.6	4.0	0.6	0.4	2.5	4.0	0.4	0.7	4.7	1.8	2.7	0.4	23.3	0.8	1.8	20.6	4.9	0.6	0.0	0.0	0.0	0.0	0.0	25.9	0.4	0.3	0.5	0.5	1.2	0.2	0.0	1.5	0.3	0.0	0.4	0.1	0.4	0.3	0.9	0.4	0.4	0.4	0.9	0.0	0.3	3.0	0.4	0.4	0.6	0.1	0.7	0.7	0.9	0.3	0.5	0.7	0.8	0.0	1.5	0.8	0.1	8.1	0.3	0.6	1.2	0.8	0.6	0.3	0.6	0.4	0.5	0.7	0.4	4.8	0.5	3.0	1.8	0.7	0.1	0.1	1.6	0.8	0.2	0.8	1.6	1.0	0.5	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	25.9	0.4	1.4	1.3	2.2	1.2	1.3	1.0	0.9	0.4	0.4	0.4
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.3;lymphoid tissue: 64.4"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 34.2"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 213.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 213.3"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	22.6	3.7	5.2	52.2	12.4	54.5	2.9	1.1	6.3	2.6	2.4	5.9	0.0	1.1	2.3	2.3	3.3	8.4	9.6	11.2	15.7	4.3	6.0	7.5	28.8	58.4	15.5	0.8	1.9	3.5	0.8	2.3	13.0	9.7	1.8	1.2	2.4	2.4	0.9	3.2	1.1	2.2	12.8	14.3	64.4	3.2	2.9	10.1	0.9	2.7	0.7	3.2	7.9	4.6	0.0	8.9	213.3	36.3	0.0	0.0	16.9	0.3	0.5	0.2	0.3	0.4	1.1	0.3	0.2	0.0	0.3	1.0	0.2	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.6	2.7	0.2	0.4	2.4	0.1	0.8	0.8	0.0	0.1	0.3	6.9	0.5	0.1	0.2	0.2	0.4	0.2	0.4	0.0	0.6	0.3	0.1	0.2	0.4	0.0	0.3	0.6	0.6	0.5	1.1	0.2	0.0	1.6	0.1	0.0	0.3	34.2	0.8	0.1	13.0	36.3	10.0	0.0	15.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	213.3	0.0	9.5	0.3	0.0	16.9	5.2	12.4	1.1	6.3	15.7	4.3	15.5	0.8	9.7	10.1
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.8;lymphoid tissue: 29.4"	"Group enriched"	"Detected in some"	8	"K-562: 4.6;RPMI-8226: 7.3"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"				"Actin filaments"	"Actin filaments"	"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			6.4	0.1	0.0	6.0	0.2	0.0	10.8	0.2	0.1	0.2	9.8	0.0	0.0	2.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	5.6	0.2	0.1	0.0	1.5	0.2	0.2	0.2	0.0	0.1	0.3	0.6	0.1	6.8	1.1	1.7	0.0	2.6	0.2	4.5	0.1	1.0	2.9	7.5	8.1	0.0	29.4	0.1	1.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.2	0.6	0.0
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	4	"A-431: 30.2;RH-30: 10.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"											HPA046966	Supported									"HPA046966: AB_2679879"	"prognostic unfavourable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.2	0.1	0.2	14.5	0.2	0.0	0.4	0.2	0.2	10.9	40.4	0.2	32.5	18.8	0.4	0.5	53.6	0.7	21.5	0.1	0.2	0.2	3.8	0.9	5.1	0.1	0.2	0.1	0.5	4.7	0.0	0.3	0.6	0.1	1.0	18.1	0.2	27.5	31.6	0.1	1.0	49.3	1.0	0.2	0.1	8.1	1.3	0.1	0.3	0.1	14.9	38.4	2.9	16.1	0.2	1.6	0.8	0.6	0.0	0.5	0.0	30.2	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.2	1.0	0.0	0.5	0.0	0.1	0.0	4.8	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.8	0.0	0.0	1.6	0.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830610-5839731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0"	"Group enriched"	"Detected in some"	7	"Hep G2: 14.6;RPMI-8226: 5.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.7;NK-cells: 2.1"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favourable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.2	0.2	0.2	7.2	0.2	0.1	0.8	0.2	0.2	9.2	26.4	0.0	9.5	15.6	0.7	7.6	40.8	0.6	25.4	0.2	0.2	0.2	27.2	6.5	1.3	0.2	0.2	0.0	0.2	2.2	0.0	0.8	0.0	0.0	0.3	6.9	0.0	37.0	19.1	0.2	0.2	44.4	0.2	0.2	0.2	2.8	0.3	0.0	0.0	0.2	16.4	33.9	0.2	12.4	0.4	0.3	3.7	0.3	2.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.2	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	5.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.1	3.7	0.3	0.4	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.3	0.2	1.2	2.1	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105255-39274528	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 153.7;lymphoid tissue: 63.5"	"Group enriched"	"Detected in some"	4	"HEL: 18.4;MOLT-4: 62.6;REH: 18.4;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025336, HPA026796"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		6600000	6600000	"Plasma membrane"	"Plasma membrane"	"CAB025336: , HPA026796: AB_10964126"	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"	7.0	3.5	6.3	36.0	18.3	22.1	3.9	1.8	10.1	3.5	4.4	8.3	0.3	4.1	2.7	6.5	4.9	4.2	7.9	3.5	6.8	6.6	5.7	6.2	13.8	35.5	15.5	2.7	2.6	2.5	1.3	3.5	8.7	11.7	3.8	5.3	3.0	5.4	1.5	1.9	2.4	11.7	5.6	29.4	41.5	5.2	3.5	12.2	63.5	4.1	1.8	28.0	10.1	3.6	0.1	11.9	153.7	41.3	8.6	28.7	30.8	0.0	1.3	0.0	0.0	0.1	0.0	7.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	18.4	0.0	0.0	0.0	6.9	5.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	62.6	3.9	0.0	0.0	18.4	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.1	1.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	24.3	0.0	11.9	33.8	32.3	7.9	38.6	5.5	0.1	22.5	13.8	11.9	0.1	28.7	17.3	153.7	8.6	41.3	3.0	21.7	30.8	6.3	18.3	1.8	10.1	6.8	6.6	15.5	2.7	11.7	12.2
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.9;lymphoid tissue: 18.6"	"Group enriched"	"Detected in some"	4	"AF22: 8.4;BEWO: 9.7;hTCEpi: 5.6;RPTEC TERT1: 2.9;RT4: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"thalamus: 7.6"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favourable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	1.1	0.4	1.0	0.5	1.9	0.2	1.5	5.4	2.1	11.6	0.6	2.1	1.6	0.4	5.1	3.4	26.9	2.2	7.1	0.5	1.0	1.0	0.4	0.2	2.0	0.9	1.6	1.2	3.4	1.1	0.2	1.4	9.2	1.9	3.7	0.6	3.0	5.4	3.1	1.2	10.2	0.7	0.9	1.2	0.3	1.0	0.7	2.0	0.6	1.7	9.0	18.6	5.1	7.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	1.5	0.7	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.9	4.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	1.9	5.4	2.1	1.0	1.0	1.6	1.2	1.9	2.0
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor pi subunit"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.0;lymphoid tissue: 57.7"	"Cell line enhanced"	"Detected in many"		"A-431: 44.6;EFO-21: 52.2;HeLa: 31.3;PC-3: 71.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 10.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 10.1;monocytes: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB014883	Uncertain									"CAB014883: "	"unprognostic (3.98e-3)"	"prognostic favourable (3.37e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.92e-3)"	"unprognostic (6.52e-3)"	1.5	0.5	0.5	1.3	0.5	1.1	31.6	0.5	1.1	18.5	1.7	0.6	2.6	2.6	30.4	9.9	37.0	2.2	8.6	1.0	0.5	0.4	6.9	3.8	2.5	0.5	0.5	0.5	1.1	4.3	0.0	2.4	5.5	0.6	6.8	0.4	0.8	25.5	3.2	2.0	10.0	3.9	0.5	0.5	0.8	5.0	1.0	0.5	2.5	0.6	3.1	57.7	1.2	20.0	0.9	1.1	10.1	6.1	0.2	1.3	3.1	44.6	2.0	2.2	1.5	0.1	0.9	5.2	0.8	0.3	0.1	0.1	8.0	5.1	0.7	52.2	0.2	16.2	1.3	0.1	0.1	0.7	1.6	2.9	31.3	1.1	0.1	1.0	2.5	0.3	0.6	0.6	0.4	0.3	12.0	5.7	0.1	1.4	1.9	1.0	18.4	71.4	2.8	1.4	1.7	3.0	2.4	1.8	0.8	16.5	0.8	0.5	0.9	0.5	1.9	4.1	15.2	3.4	3.3	2.2	1.3	1.3	0.5	2.9	0.6	10.1	2.3	6.8	0.5	1.7	1.3	0.3	0.5	0.4	0.7	0.9	0.7	0.6	5.4	0.2	6.1	1.1	0.7	3.1	0.5	0.5	0.5	0.6	0.5	0.4	0.5	0.5	0.6	0.5
GAL3ST2	GP3ST	ENSG00000154252	"Galactose-3-O-sulfotransferase 2"	Q9H3Q3	2	241776825-241804208	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 8.6;intestine: 16.0;lymphoid tissue: 11.6"	"Group enriched"	"Detected in some"	7	"CACO-2: 1.8;Hep G2: 6.4;HMC-1: 2.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071809	Enhanced				"Intracellular and membrane"					"HPA071809: AB_2686450"	"unprognostic (5.22e-3)"	"unprognostic (6.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.04e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.87e-11)"	"unprognostic (4.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.49e-1)"	1.0	0.6	0.5	11.6	0.7	0.1	0.1	0.1	0.5	1.9	16.0	0.0	0.0	0.1	0.1	0.1	0.1	1.0	8.6	0.1	0.4	0.6	0.4	0.9	1.3	0.1	0.2	0.0	1.7	0.1	0.1	0.4	0.1	0.0	0.3	6.6	0.0	3.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.2	0.1	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.5	0.4	0.6	0.2	0.0	0.0	0.0
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168750	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.5;HSkMC: 8.6;WM-115: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 4.3;T-cells: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	3.9	5.4	8.4	4.2	9.4	1.0	4.1	1.5	10.9	7.8	6.5	18.6	0.4	4.1	9.0	3.7	8.4	6.3	5.9	4.9	8.0	3.8	1.8	1.0	5.3	2.9	11.9	4.7	7.6	1.5	1.6	4.6	9.8	8.1	6.5	7.0	4.2	24.9	4.3	1.9	27.8	8.9	10.6	14.9	2.7	2.8	4.4	10.2	37.8	2.0	2.4	3.9	7.3	10.6	0.1	4.3	0.3	0.1	0.2	15.0	2.2	0.0	0.6	4.0	1.8	3.6	7.0	7.5	2.1	2.2	1.3	1.7	0.4	0.2	0.7	0.5	7.3	8.5	0.2	1.2	0.4	0.0	0.4	0.2	0.1	0.2	2.4	0.4	2.4	8.6	3.3	3.9	0.4	2.5	1.1	0.1	2.3	0.2	2.7	0.1	1.3	0.9	2.1	1.8	0.1	0.0	0.3	0.2	1.7	0.6	0.0	4.5	0.0	0.2	2.2	0.2	1.2	0.3	0.1	0.1	0.1	1.6	1.4	0.4	29.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	4.4	0.3	0.0	0.1	15.0	4.5	0.3	0.2	0.1	4.3	1.1	2.2	8.4	9.4	1.5	10.9	8.0	3.8	11.9	4.7	8.1	10.2
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168753-173323967	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		5000000	5000000	"Golgi apparatus"	"Golgi apparatus"	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favourable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	3.7	4.4	8.4	7.4	8.4	5.0	12.0	27.6	8.0	13.4	23.3	9.4	2.8	14.1	9.3	5.5	12.0	4.9	9.5	3.5	6.5	5.2	4.9	1.2	4.5	5.2	10.8	7.0	7.2	14.9	5.3	5.6	6.3	11.2	20.3	26.7	6.2	20.1	4.2	1.4	3.1	16.2	8.4	16.3	5.7	32.8	6.4	8.8	67.4	6.6	4.4	9.6	9.4	4.8	5.0	9.8	16.8	11.4	5.5	6.8	4.7	20.1	10.6	10.4	3.3	5.6	8.3	14.9	5.3	6.0	5.0	6.9	3.3	32.0	11.2	3.9	4.7	17.2	4.4	9.3	6.8	43.5	8.5	13.6	21.9	0.1	3.7	20.1	9.7	5.3	8.5	11.1	5.6	32.9	9.1	17.5	25.2	6.6	14.7	11.1	10.2	7.0	14.8	9.6	2.9	36.6	9.5	8.4	6.4	2.5	14.8	7.3	5.9	6.0	39.3	3.6	15.9	0.1	11.4	5.1	0.0	6.0	14.6	12.1	12.8	9.6	11.4	14.6	4.3	6.0	6.2	5.0	4.9	4.6	9.8	3.1	3.9	3.0	16.8	5.5	6.1	4.1	6.8	4.7	8.4	8.4	27.6	8.0	6.5	5.2	10.8	7.0	11.2	8.8
GALNTL6	"GalNAc-T6L, GALNT17"	ENSG00000174473	"Polypeptide N-acetylgalactosaminyltransferase like 6"	Q49A17	4	171812254-173041559	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 7.3;testis: 6.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;SCLC-21H: 2.4;SK-MEL-30: 1.9;U-266/70: 2.8;WM-115: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.5;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	8	"B-cells: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031019	Uncertain				"Intracellular and membrane"					"HPA031019: AB_10601653"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.73e-2)"	0.2	0.7	3.9	1.2	8.3	1.1	0.7	1.0	9.5	3.3	1.0	0.6	0.0	0.7	0.3	0.3	0.2	0.3	0.5	0.5	3.6	4.1	0.3	0.5	0.5	1.3	7.6	2.4	0.1	0.5	0.1	0.0	0.1	1.8	2.2	0.7	1.3	0.3	0.2	0.5	0.6	1.2	0.3	0.5	7.3	2.9	6.4	1.2	0.0	0.5	1.1	0.4	0.5	0.6	4.5	0.5	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.5	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.7	1.2	0.0	1.3	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.7	2.3	0.2	1.1	0.3	0.6	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.0	0.0	0.5	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.1	2.8	0.0	0.0	0.3	0.1	1.7	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.3	1.0	5.9	3.6	4.1	7.6	2.4	1.8	1.2
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Group enriched"	"Detected in some"	10	"Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favourable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	40.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	2.0	0.0	0.5	11.7	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.4	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 29.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.0;NB-4: 7.3;U-266/70: 15.9;U-937: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028656	Supported									"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favourable (9.54e-4)"	"prognostic favourable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favourable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavourable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.3	1.5	1.0	29.1	1.5	12.1	1.7	0.7	0.8	2.3	4.4	0.7	0.2	2.0	2.4	3.0	2.6	3.3	4.5	1.5	1.0	1.0	2.6	4.0	14.0	26.2	2.8	0.8	3.4	1.3	0.0	1.5	2.6	1.9	3.8	3.0	3.3	2.4	1.2	0.9	1.2	7.6	2.0	2.9	27.6	3.2	4.5	1.0	7.8	3.6	1.3	24.9	6.8	1.7	1.5	1.5	23.0	9.4	11.6	54.6	7.3	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.9	1.0	0.0	0.1	0.1	5.0	4.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.4	2.4	0.2	0.0	0.0	7.3	1.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.5	1.5	0.1	0.0	3.0	0.1	0.4	0.4	0.0	1.6	15.9	0.3	0.1	0.2	23.4	0.0	0.1	3.5	0.2	23.5	8.7	36.8	1.1	15.5	21.4	1.5	1.5	5.8	9.0	23.0	11.6	9.4	0.1	54.6	7.3	1.0	1.5	0.7	0.8	1.0	1.0	2.8	0.8	1.9	1.0
GCSAM	"GCET2, HGAL, MGC40441"	ENSG00000174500	"Germinal center associated signaling and motility"	Q8N6F7	3	112120841-112133305	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.7;skin 1: 15.4"	"Group enriched"	"Detected in some"	7	"Daudi: 49.5;U-698: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002473	Approved									"HPA002473: AB_1078960"	"unprognostic (8.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.17e-3)"	"unprognostic (9.20e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.38e-2)"	0.8	0.2	0.1	29.0	0.3	1.2	0.6	0.1	0.3	0.6	1.6	0.3	0.7	1.3	0.3	0.5	3.2	0.5	1.0	0.8	0.1	0.0	1.0	1.1	2.4	16.4	0.3	0.1	0.5	4.4	0.0	0.8	0.1	0.3	1.0	0.6	0.4	3.0	0.4	0.6	15.4	4.0	0.5	0.2	11.1	2.7	0.4	0.2	59.7	3.4	1.3	24.6	1.8	1.0	10.8	5.7	5.9	0.1	0.5	10.1	3.1	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.3	0.0	49.5	0.0	0.0	1.1	0.0	0.9	0.0	0.9	0.3	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.9	0.0	0.0	4.6	0.0	0.3	0.2	5.4	0.4	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.1	0.5	0.0	0.3	0.4	0.2	0.0	0.0	0.2	0.0	28.3	0.0	0.0	0.1	5.9	0.0	0.0	2.0	0.1	0.4	9.0	10.1	5.2	5.7	10.8	9.5	5.1	0.3	0.5	0.0	3.1	1.5	3.1	0.1	0.3	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.2
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689782-7695776	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 6.4;lymphoid tissue: 6.6"	"Cell line enriched"	"Detected in some"	13	"NTERA-2: 99.7"	"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"					"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	1.3	1.1	0.0	1.1	0.7	0.0	6.4	0.0	0.0	0.5	0.2	0.0	0.0	0.4	0.5	1.5	0.4	1.4	0.9	2.2	0.0	0.0	4.7	0.5	0.5	0.9	0.0	0.0	1.7	0.0	0.1	2.0	0.0	0.0	0.7	0.1	0.6	0.2	1.9	0.2	0.3	1.4	0.7	0.0	6.6	0.2	1.8	0.0	0.0	1.2	1.0	0.3	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	99.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2"	"Group enriched"	"Detected in some"	7	"AF22: 9.2;NTERA-2: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.4	0.4	6.8	0.6	5.7	0.4	1.0	1.1	4.0	0.3	13.0	8.2	8.3	8.0	0.4	22.5	0.4	0.5	0.5	0.8	7.6	4.0	0.6	0.3	0.4	0.4	4.3	5.6	0.4	0.4	0.3	2.6	0.4	8.4	0.3	3.0	0.2	1.1	0.6	0.6	33.2	19.5	0.4	1.5	37.5	1.6	0.3	4.9	0.0	0.4	0.6	0.3	1.0	0.3	0.4	0.1	1.4	0.2	0.1	0.2	0.0	0.0	0.0	9.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	19.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.0	6.8	5.7	1.1	4.0	7.6	4.0	4.3	5.6	8.4	4.9
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113856	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6"	"Group enriched"	"Detected in many"	6	"MCF7: 13.7;SK-BR-3: 48.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"eosinophil: 1.6;neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.1"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	"Not detected"	"Not detected"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	3.0	0.9	1.2	10.5	1.2	0.5	2.5	5.7	1.3	9.4	11.3	1.2	1.2	4.0	2.8	3.4	30.8	2.1	3.6	1.7	1.2	0.7	5.9	1.2	3.7	2.3	1.2	1.2	3.3	1.2	0.4	2.3	12.9	2.5	2.4	7.4	1.2	4.9	1.2	1.3	5.3	8.6	2.4	1.2	4.1	8.3	1.2	1.2	1.9	2.3	36.6	40.8	2.7	9.2	0.1	0.0	5.1	0.2	0.0	0.2	0.0	5.3	0.0	1.8	0.5	0.5	2.8	1.6	0.5	0.4	0.5	0.6	0.6	3.7	0.6	0.7	0.3	0.5	0.5	0.2	0.5	1.0	1.5	0.1	0.8	2.5	0.5	0.2	0.4	0.1	0.7	1.5	0.1	2.1	0.4	0.9	0.7	13.7	0.4	0.9	1.1	0.2	2.5	0.6	2.9	1.1	2.4	0.5	0.9	0.0	48.5	0.3	0.9	1.0	1.5	0.5	0.5	1.1	0.5	1.6	0.3	0.6	1.4	0.8	0.3	0.1	0.0	1.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	5.1	0.0	0.1	0.0	0.1	0.0	1.2	1.2	5.7	1.3	1.2	0.7	1.2	1.2	2.5	1.2
GDPD5	"GDE2, PP1665"	ENSG00000158555	"Glycerophosphodiester phosphodiesterase domain containing 5"	Q8WTR4	11	75434640-75525903	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.2;placenta: 41.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 17.0;fHDF/TERT166: 16.2;HDLM-2: 33.2;U-2 OS: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.3;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065257, HPA066762, HPA069281"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.12e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.59e-9)"	"unprognostic (8.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.65e-1)"	16.5	6.0	3.3	3.3	4.6	7.8	8.0	23.2	7.9	3.3	3.0	3.3	1.6	2.0	6.4	3.1	1.6	3.2	3.6	2.8	3.0	1.8	2.3	2.7	5.4	4.3	3.0	2.6	2.9	13.4	0.4	7.0	41.7	4.2	3.1	1.3	18.8	15.5	4.1	5.9	2.3	3.2	4.9	3.4	37.2	1.4	11.9	5.5	2.0	2.6	1.4	3.4	3.5	11.5	1.1	1.1	9.3	1.2	0.0	3.1	0.7	1.0	3.8	1.6	1.9	1.1	0.6	5.7	1.2	1.6	0.5	0.4	5.0	2.2	7.1	17.0	16.2	2.3	2.0	1.9	0.3	33.2	1.5	1.3	5.8	10.3	1.7	0.8	5.6	1.3	1.0	0.4	0.8	13.6	2.3	3.2	0.7	2.2	1.9	3.5	2.9	5.4	2.2	0.4	1.9	0.4	1.8	0.9	0.6	2.4	9.3	4.5	1.3	3.1	4.0	3.9	15.8	3.0	1.2	0.8	0.1	1.3	0.9	4.2	0.4	9.3	1.2	0.7	2.0	0.6	2.9	1.1	2.3	1.6	0.3	0.4	1.2	1.5	0.1	0.0	0.0	1.1	3.1	0.7	3.3	4.6	23.2	7.9	3.0	1.8	3.0	2.6	4.2	5.5
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92474762-92486876	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.9;lymphoid tissue: 56.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 16.3;HMC-1: 13.1;NB-4: 16.9;THP-1: 34.0;U-937: 70.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdTCR: 4.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain									"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favourable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.2	0.4	0.1	3.6	0.3	31.9	0.7	0.2	0.3	1.1	3.9	0.1	0.1	3.0	0.7	0.7	1.2	1.0	2.6	0.6	0.2	0.1	1.0	0.9	3.4	5.4	0.5	0.3	0.5	12.4	0.0	0.7	0.7	0.5	1.1	3.1	0.9	1.2	1.3	0.7	0.4	6.8	0.6	0.8	8.9	1.8	1.1	0.2	56.1	1.2	0.5	5.0	1.9	0.8	0.0	1.6	0.8	0.0	0.3	4.9	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	1.3	0.0	16.3	13.1	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.5	10.2	16.9	0.0	0.0	2.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.4	0.0	0.0	6.1	0.4	1.1	0.0	70.3	0.0	0.0	0.0	0.8	4.9	0.0	2.2	0.0	2.1	3.0	0.0	0.0	0.8	4.5	0.1	0.3	0.0	1.6	0.7	0.5	0.1	0.3	0.2	0.3	0.2	0.1	0.5	0.3	0.5	0.2
GIMAP2	"DKFZp586D0824, HIMAP2, IAN12, IMAP2"	ENSG00000106560	"GTPase, IMAP family member 2"	Q9UG22	7	150685697-150693641	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.8;lymphoid tissue: 38.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 27.8;MOLT-4: 33.5;REH: 14.6;U-937: 14.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA013589	Approved									"HPA013589: AB_1849666"	"prognostic favourable (3.50e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.91e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.08e-2)"	13.0	7.3	4.8	21.3	7.1	4.6	8.3	2.6	4.2	7.6	7.8	3.3	4.0	5.7	7.8	7.1	5.5	4.5	8.1	7.8	6.7	4.2	6.6	7.7	14.9	35.4	7.3	3.3	8.7	2.7	0.9	3.3	9.2	6.2	6.5	7.6	4.6	7.7	3.0	3.9	2.9	12.7	5.4	12.3	38.1	5.3	2.5	6.5	26.7	6.3	4.4	26.7	9.4	9.6	3.9	11.6	10.0	28.3	31.4	44.8	28.0	0.7	0.0	0.0	0.0	0.3	0.3	0.3	0.0	8.0	1.0	2.3	0.0	10.5	1.8	0.1	0.6	0.4	0.0	0.4	0.1	8.4	0.0	5.5	0.0	0.2	1.3	4.2	5.7	3.1	0.8	0.7	0.0	27.8	0.1	2.2	0.4	0.0	33.5	10.6	0.0	0.0	14.6	0.3	4.2	0.0	2.6	0.0	0.0	0.0	0.0	2.6	0.4	10.9	6.2	0.4	0.1	0.1	0.0	2.5	2.3	0.0	1.0	14.1	1.5	2.7	20.7	1.7	24.6	28.3	31.0	3.8	32.2	29.7	11.6	3.9	44.8	32.6	10.0	31.4	27.6	1.4	25.6	28.0	4.8	7.1	2.6	4.2	6.7	4.2	7.3	3.3	6.2	6.5
GIMAP5	"HIMAP3, IAN4L1, IAN5"	ENSG00000196329	"GTPase, IMAP family member 5"	Q96F15	7	150722253-150750033	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 61.0;lymphoid tissue: 58.3"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 24.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 17.3;T-cells: 61.0"																				"unprognostic (6.77e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.13e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.47e-2)"	26.8	6.6	4.7	23.3	5.8	1.7	26.6	1.9	4.3	9.3	9.2	3.4	4.5	2.4	15.2	12.0	7.1	8.7	7.9	12.4	5.5	3.7	8.2	9.2	25.8	58.3	5.2	2.1	4.1	5.2	2.0	3.8	10.3	6.1	7.0	7.9	8.4	9.1	4.2	8.7	5.6	11.7	14.2	5.7	28.7	6.6	3.3	5.6	5.5	12.8	9.2	30.7	10.4	10.2	0.1	0.4	0.7	9.5	17.3	61.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.4	4.7	0.1	30.2	9.5	37.9	0.1	52.1	35.0	0.4	0.0	61.0	30.8	0.7	17.3	3.0	0.1	17.1	51.1	4.7	5.8	1.9	4.3	5.5	3.7	5.2	2.1	6.1	5.6
GINS1	"KIAA0186, PSF1"	ENSG00000101003	"GINS complex subunit 1"	Q14691	20	25407727-25452628	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA051185	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051185: AB_2681378"	"unprognostic (6.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (4.61e-7)"	"unprognostic (5.86e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (5.42e-11)"	"unprognostic (5.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.55e-1)"	1.5	1.9	4.1	11.7	4.2	4.5	2.2	7.4	4.3	2.2	4.5	1.3	0.0	4.3	2.2	1.0	8.5	1.4	2.3	1.0	2.2	2.2	2.2	2.0	1.4	7.2	1.9	2.1	1.7	1.8	1.1	0.8	5.5	2.2	1.4	5.9	1.3	2.1	0.7	0.7	5.3	4.1	2.8	1.8	3.4	2.9	21.4	0.9	20.1	1.0	6.4	10.5	2.6	3.2	2.6	2.3	1.3	1.0	1.9	3.5	0.9	17.7	16.2	19.9	12.9	1.1	1.5	20.1	7.9	3.9	15.3	16.2	14.0	17.8	22.0	9.1	3.3	20.7	17.3	14.6	17.8	5.8	6.0	15.1	5.9	16.9	0.4	19.7	6.9	0.7	0.8	14.5	3.0	8.1	14.5	14.5	9.1	19.2	30.2	14.8	13.5	8.5	21.7	22.9	14.8	5.8	12.0	8.3	8.7	8.0	19.3	6.8	18.3	9.9	3.6	12.0	13.0	7.7	14.4	5.8	16.5	17.4	3.2	19.3	13.5	0.8	0.8	0.5	1.5	1.0	0.9	2.6	1.1	0.5	2.1	1.7	0.8	1.4	1.3	1.9	1.0	2.3	3.5	0.9	4.1	4.2	7.4	4.3	2.2	2.2	1.9	2.1	2.2	0.9
GINS2	"Pfs2, PSF2"	ENSG00000131153	"GINS complex subunit 2"	Q9Y248	16	85676198-85690073	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.2;testis: 21.3"	"Cell line enhanced"	"Detected in many"		"U-698: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA057285	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA057285: AB_2683398"	"unprognostic (3.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.70e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.60e-1)"	0.9	1.5	3.5	15.9	3.7	13.2	3.6	3.8	2.1	1.9	6.5	1.9	1.5	4.7	1.8	2.6	7.1	0.9	2.2	1.6	4.8	1.5	1.3	3.3	1.4	8.7	2.2	1.5	1.9	4.4	2.6	1.4	4.6	1.6	2.6	7.4	1.9	2.0	0.7	3.2	3.1	5.9	1.5	2.3	7.6	2.1	21.3	1.8	25.2	1.8	8.0	13.3	1.9	3.0	1.4	1.7	1.5	3.3	4.3	11.1	2.4	13.2	9.5	18.6	7.8	0.5	1.8	4.9	9.1	3.6	13.5	8.3	12.5	8.8	15.6	5.0	3.1	10.1	19.6	7.4	13.1	5.4	17.0	7.7	7.3	14.1	0.1	5.3	4.3	0.5	0.9	8.1	3.1	5.7	21.0	3.7	7.7	27.6	18.7	20.1	10.4	7.3	26.3	11.3	8.6	4.3	5.5	25.7	8.1	13.1	2.7	2.6	27.1	7.3	3.4	8.8	11.8	8.3	10.4	7.0	12.3	70.7	5.1	11.3	10.0	0.7	0.3	1.5	1.4	1.3	0.2	1.4	4.7	3.1	1.7	1.0	2.2	1.6	1.2	4.3	3.3	1.0	11.1	2.4	3.5	3.7	3.8	2.1	4.8	1.5	2.2	1.5	1.6	1.8
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"	"Vesicles, Cell Junctions"	"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	3.5	0.0	30.0	0.0	25.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.1	0.0	10.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	6.7	0.0	0.0	0.0	12.5	9.9	0.0	0.0	3.9	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.7;HaCaT: 31.1;HBEC3-KT: 13.9;hTCEpi: 51.5;RT4: 17.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain									"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.0	0.1	0.7	0.0	0.5	0.1	2.6	0.6	2.3	7.5	0.1	0.0	0.5	0.0	0.1	2.1	39.0	0.4	3.3	0.1	0.8	0.1	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.6	0.0	0.4	7.0	0.2	3.0	0.1	0.0	5.6	2.1	0.2	37.7	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.6	0.6	28.0	26.1	3.4	11.7	0.0	0.0	0.0	0.8	0.0	0.1	0.8	9.7	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	31.1	0.0	13.9	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	51.5	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	1.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.7	0.5	0.6	2.3	0.8	0.1	0.2	0.5	0.2	0.0
GJD3	"Cx30.2, CX31.9, GJA11, GJC1"	ENSG00000183153	"Gap junction protein delta 3"	Q8N144	17	40362931-40363815	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;HaCaT: 11.6;HEK 293: 9.6;MCF7: 9.8;T-47d: 9.7"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"					"Cell type enriched"	"Detected in single"	8	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"															"unprognostic (5.54e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.75e-3)"		"unprognostic (7.89e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.43e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.73e-4)"	1.9	0.6	0.1	1.2	0.2	0.0	0.8	0.1	0.2	1.1	3.4			1.8	1.3	0.0	2.1	0.5	0.0	0.7	0.1	0.3	1.6	1.0	1.8	0.3	0.1		0.2	0.8	0.0	0.4	0.3		1.7	0.0		1.3	1.1	2.0	2.7	2.2	0.0	0.0	7.2	4.0	0.4			1.7		0.0	2.2	1.1	0.0	0.0	0.0	0.1	1.4	0.1	0.0	3.5	7.5	0.1	1.5	0.0	0.0	13.1	3.9	0.0	0.1	0.0	0.3	0.9	0.0	3.8	0.0	11.6	0.0	0.0	0.0	4.2	9.6	0.7	0.8	6.1	3.2	1.6	5.4	0.2	0.0	0.0	0.0	0.0	7.3	0.0	0.0	9.8	0.7	3.2	0.9	2.6	4.9	0.0	0.3	0.0	7.4	0.5	3.3	5.0	0.0	1.6	9.7	2.6	3.8	0.0	0.1	2.9	0.0	1.5	0.0	1.5	0.7	0.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0										
GLCCI1	"FAM117C, GIG18, TSSN1"	ENSG00000106415	"Glucocorticoid induced 1"	Q86VQ1	7	7968794-8094272	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.4;U-266/70: 40.5;U-698: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001674, HPA005987"	Approved		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA001674: AB_1078971, HPA005987: AB_1078970"	"unprognostic (6.12e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.20e-3)"	4.6	4.3	5.6	19.1	12.5	7.6	4.1	26.6	8.0	5.4	4.9	3.4	0.9	5.7	3.4	1.8	3.0	2.8	3.9	2.2	3.7	4.1	3.9	3.8	18.4	13.8	3.1	5.6	5.1	2.3	8.0	6.5	9.3	4.4	3.2	4.7	3.1	6.3	2.0	3.0	7.5	5.6	2.5	3.2	9.2	6.4	14.2	3.7	55.7	20.7	1.9	15.9	7.7	3.3	3.1	2.4	3.7	0.4	4.7	4.5	0.7	2.3	0.3	3.9	0.9	1.2	1.7	0.8	2.0	2.8	1.2	1.1	1.2	0.8	6.4	0.5	1.6	0.4	3.5	1.0	1.5	3.2	2.7	1.9	4.9	0.8	1.9	3.0	2.8	0.8	1.3	0.7	2.6	1.0	6.9	17.4	2.0	1.3	1.3	3.0	9.6	2.3	6.8	2.9	3.4	1.1	2.7	6.4	12.6	3.0	3.8	0.2	4.5	7.8	0.8	2.2	0.9	1.9	1.0	40.5	12.9	18.3	2.3	3.2	1.6	3.7	0.1	1.5	2.7	0.4	2.5	1.8	2.8	2.0	0.1	3.1	1.6	1.8	1.2	4.7	0.1	2.4	4.5	0.7	5.6	12.5	26.6	8.0	3.7	4.1	3.1	5.6	4.4	3.7
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850943-109880488	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056461	Approved		Supported	Cytosol		280000	280000	Cytosol	Cytosol	"HPA056461: AB_2683138"	"unprognostic (1.18e-1)"	"prognostic favourable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (4.17e-6)"	"unprognostic (3.28e-2)"	7.0	5.8	11.4	6.1	16.4	6.6	10.5	4.7	19.3	21.8	13.2	31.3	6.6	5.4	5.4	13.4	82.0	4.9	5.4	6.4	15.9	9.7	13.7	4.5	9.2	7.0	22.4	8.9	5.9	7.7	5.7	3.4	7.9	14.8	8.0	11.8	4.0	21.2	8.0	6.1	84.3	8.2	7.1	48.7	7.4	7.6	4.0	24.7	6.2	8.9	60.6	78.0	10.8	38.5	11.8	23.2	16.7	32.3	21.2	26.7	17.2	14.0	10.0	5.8	6.2	13.9	16.0	4.3	17.4	21.7	13.6	11.4	4.0	5.4	12.4	9.4	21.4	17.3	9.0	20.6	19.3	12.6	8.0	8.1	6.1	6.0	12.2	8.6	9.6	11.8	25.9	24.2	17.2	22.7	3.7	8.6	19.8	19.5	11.7	7.1	10.5	13.6	10.5	13.8	13.0	7.6	42.3	7.4	7.4	11.0	28.6	9.3	13.3	3.1	31.0	15.5	8.3	22.8	13.1	11.4	9.4	8.5	31.3	9.1	9.6	16.7	32.3	16.5	26.7	30.8	16.2	11.8	16.1	23.3	23.2	11.4	10.5	18.8	15.8	21.2	24.8	3.7	17.6	17.2	11.4	16.4	4.7	19.3	15.9	9.7	22.4	8.9	14.8	24.7
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.8;BJ hTERT+ SV40 Large T+ RasG12V: 4.1;HAP1: 6.5;SK-BR-3: 15.5;U-2197: 7.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 16.7;endometrial cancer: 15.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"					"Not detected"	"Not detected"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favourable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.4	0.0	0.4	0.1	0.2	0.0	11.2	0.1	0.3	18.8	0.1	0.1	0.1	0.1	1.2	0.1	0.8	0.1	6.6	0.2	0.3	0.4	0.1	0.1	0.6	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.0	0.1	25.8	0.1	0.1	1.2	0.1	0.1	1.5	1.1	0.1	0.1	0.1	0.1	0.1	4.4	9.9	0.1	0.3	0.4	0.1	2.1	0.4	0.2	0.2	0.9	0.0	0.0	0.5	0.0	0.9	3.0	0.0	1.9	5.8	2.5	4.1	0.0	0.0	0.2	0.0	1.6	0.5	6.5	0.0	2.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	15.5	0.0	0.0	0.0	0.0	2.1	0.1	7.5	2.2	0.0	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.1	2.1	0.2	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.3	0.3	0.4	0.6	0.1	0.1	0.1
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643667	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavourable (3.97e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (5.15e-4)"	6.1	2.8	3.5	20.3	4.9	31.0	4.0	0.9	4.1	2.9	6.9	4.3	2.7	7.0	2.7	3.2	6.2	4.4	7.9	3.3	4.3	3.4	4.2	3.9	11.7	28.0	4.2	2.5	2.4	4.6	10.6	3.0	3.9	3.4	4.1	4.6	2.7	6.0	4.5	1.5	4.9	15.3	2.9	4.9	40.0	11.1	2.2	3.1	26.8	6.2	2.7	23.2	6.1	4.5	6.6	6.7	32.7	13.9	4.2	6.4	4.6	4.4	2.0	2.7	3.0	3.0	1.6	11.0	2.8	2.4	1.7	1.6	1.6	5.9	10.8	5.7	1.9	5.3	1.7	3.0	1.1	3.7	2.8	3.4	3.2	1.7	0.9	9.6	43.0	2.0	2.1	1.8	0.9	3.8	2.3	3.9	1.8	6.5	6.0	15.9	1.6	3.7	10.4	1.2	6.2	3.2	10.5	2.3	7.1	3.8	4.0	1.6	3.7	13.8	6.8	3.1	1.8	3.5	2.0	2.0	0.8	8.9	2.0	12.6	2.1	2.9	8.3	21.5	6.4	10.6	5.9	5.9	4.0	5.7	6.7	6.6	4.5	4.6	32.7	4.2	13.9	6.1	4.5	4.6	3.5	4.9	0.9	4.1	4.3	3.4	4.2	2.5	3.4	3.1
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136193-3163769	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4;esophagus: 46.0;lymphoid tissue: 42.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 19.4;HMC-1: 45.9;MOLT-4: 45.9;NB-4: 17.2;REH: 34.3;THP-1: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 31.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043113	Approved									"HPA043113: AB_10967343"	"prognostic favourable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	4.9	1.7	1.6	7.2	2.3	37.4	3.9	1.1	2.0	7.9	1.3	1.6	1.0	1.0	0.8	1.8	46.0	1.3	2.8	2.6	1.6	1.1	1.3	1.2	7.6	3.7	3.1	1.3	1.0	0.7	0.2	0.8	4.5	2.7	5.9	1.1	1.3	9.2	1.7	0.8	20.0	1.1	1.8	2.8	5.6	2.5	1.1	2.2	42.2	0.7	29.0	25.3	10.4	16.2	0.0	31.0	6.2	12.6	2.1	3.9	5.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	10.7	0.0	19.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	7.8	45.9	0.0	12.1	0.0	8.0	0.0	0.0	0.1	0.0	0.0	45.9	17.2	0.0	0.0	34.3	0.0	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	5.8	12.6	6.2	0.0	9.7	0.5	0.0	1.0	0.1	13.0	0.0	0.0	0.0	3.1	2.1	6.5	31.0	3.9	5.1	1.6	2.3	1.1	2.0	1.6	1.1	3.1	1.3	2.7	2.2
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.7"	"Cell line enriched"	"Detected in some"	9	"HEL: 18.6"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA072646			Uncertain	Cytosol		400000000	400000000	Cytosol	Cytosol	"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.3	0.0	0.4	2.1	0.5	1.6	0.3	0.3	0.3	0.6	0.3	0.3	0.3	0.0	0.3	0.3	0.3	2.5	0.3	0.3	0.4	0.6	0.3	0.6	0.9	3.7	0.3	0.3	0.8	0.3	0.0	0.4	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.3	1.7	0.2	0.3	0.3	0.3	1.0	0.3	1.9	0.3	0.5	0.1	1.1	0.2	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.4	0.1	0.1	2.0	2.2	0.1	0.0	0.0	1.1	0.0	0.4	0.4	0.5	0.3	0.3	0.4	0.6	0.3	0.3	0.3	0.3
GP6	GPVI	ENSG00000088053	"Glycoprotein VI platelet"	Q9HCN6	19	55013705-55038264	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	12	"HEL: 13.5;K-562: 5.8;U-2 OS: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"											HPA066482	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	28000000	28000000	Nucleoplasm	Nucleoplasm	"HPA066482: AB_2685674"	"unprognostic (3.06e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.44e-3)"	"unprognostic (2.70e-2)"	0.3	0.3	0.8	0.4	1.4	4.4	0.9	4.6	1.6	1.3	0.4	0.3	0.3	0.1	1.1	0.3	2.1	0.5	0.5	5.4	0.7	0.9	0.4	1.5	1.4	0.3	0.3	0.3	0.6	0.3	0.6	0.3	2.8	0.3	0.6	0.4	2.0	0.7	3.0	0.3	3.2	0.3	0.3	0.3	8.9	0.1	4.2	1.0	0.3	0.6	0.3	0.3	0.7	1.8	0.0	0.3	1.3	0.2	0.0	0.1	4.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.5	13.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	5.8	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.2	0.1	0.4	0.2	0.2	0.1	3.9	0.1	0.0	0.3	0.0	0.4	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	4.0	0.8	1.4	4.6	1.6	0.7	0.9	0.3	0.3	0.3	1.0
GPR132	G2A	ENSG00000183484	"G protein-coupled receptor 132"	Q9UNW8	14	105049389-105065445	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 14.0;lymphoid tissue: 20.2"	"Group enriched"	"Detected in some"	6	"HDLM-2: 19.8;Karpas-707: 20.5;THP-1: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA029694, HPA029695"	Supported									"HPA029694: AB_10600213, HPA029695: AB_10601984"	"unprognostic (2.71e-3)"	"prognostic favourable (3.21e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.44e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.18e-1)"	"prognostic unfavourable (1.71e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.72e-1)"	2.9	1.2	1.8	11.5	2.7	9.3	1.5	0.7	1.8	1.5	2.4	3.3	0.0	1.3	1.0	1.6	1.4	3.0	2.9	1.4	1.6	1.2	4.5	0.8	5.9	20.2	3.3	1.0	1.1	0.8	0.4	0.9	2.0	2.2	1.4	1.2	1.5	3.0	0.7	0.8	3.5	6.6	1.0	3.7	15.4	2.1	0.6	2.5	4.3	6.5	0.7	17.4	3.1	1.9	8.6	9.1	9.8	14.0	9.3	10.6	6.6	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.5	0.0	0.6	0.0	0.0	0.0	19.8	0.3	0.5	0.1	0.0	0.0	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.5	0.0	1.9	0.1	0.0	1.5	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	6.2	0.3	0.0	0.1	0.0	0.2	0.5	1.9	0.2	0.0	1.8	0.0	9.8	9.0	8.6	10.6	12.5	9.9	7.2	8.2	9.2	9.1	8.6	8.6	8.9	7.9	9.3	14.0	5.2	5.8	6.6	1.8	2.7	0.7	1.8	1.6	1.2	3.3	1.0	2.2	2.5
GPR142	PGR2	ENSG00000257008	"G protein-coupled receptor 142"	Q7Z601	17	74367407-74372622	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.3;lymphoid tissue: 1.3"	"Cell line enhanced"	"Detected in single"		"U-937: 1.1"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031392	Uncertain		Uncertain	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA031392: AB_10601935"	"unprognostic (6.81e-2)"		"unprognostic (1.75e-1)"			"unprognostic (1.98e-1)"		"unprognostic (1.34e-1)"		"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-7)"	"unprognostic (3.95e-2)"	"unprognostic (7.72e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-3)"	0.2	0.0	0.0	1.3	0.1	0.0	0.1	1.3	0.2	0.3	0.1			0.8	0.6	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.2	0.0		0.1	0.8	0.0	0.0	0.1		0.2	0.1		0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR152	PGR5	ENSG00000175514	"G protein-coupled receptor 152"	Q8TDT2	11	67451301-67452729	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.7;lymphoid tissue: 1.6"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 3.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035078	Uncertain									"HPA035078: AB_10670286"								"unprognostic (3.81e-2)"		"unprognostic (1.69e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.76e-3)"				0.1	0.0	0.0	0.6	0.0	0.6	0.0	0.1	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.6	0.0		0.0	0.0	0.3	0.0	0.0		0.1	0.0		0.2	0.0	0.3	0.1	1.7	0.0	0.1	1.6	0.7	0.0			0.0		0.0	0.1	0.0	0.2	0.1	1.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.5	0.0	1.0	0.0	0.3	0.0	0.0	0.0										
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203201	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.2;intestine: 19.5;lymphoid tissue: 33.0"	"Cell line enriched"	"Detected in single"	26	"U-266/70: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 45.2"	"Lineage enriched"	"Detected in many"	18	"T-cells: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062429	Approved									"HPA062429: AB_2684760"	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	4.1	0.9	0.4	15.1	0.4	0.4	1.6	0.3	0.3	4.0	6.8	0.3	0.6	3.5	1.4	1.6	2.7	3.9	4.6	1.3	0.4	0.4	4.3	2.7	10.7	33.0	0.7	0.5	1.9	1.0	0.0	0.7	0.8	1.5	2.2	3.8	1.7	2.4	1.2	1.0	1.1	19.5	1.1	2.7	20.7	4.0	1.0	0.5	19.9	2.2	1.8	8.5	7.0	2.4	0.1	0.8	1.0	0.1	2.5	45.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	11.6	0.0	45.2	0.0	16.2	21.5	0.8	0.1	9.9	8.4	0.3	2.5	0.1	0.7	8.0	3.4	0.4	0.4	0.3	0.3	0.4	0.4	0.7	0.5	1.5	0.5
GPR18		ENSG00000125245	"G protein-coupled receptor 18"	Q14330	13	99254714-99261744	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 25.4;lymphoid tissue: 25.1;testis: 15.0"	"Group enriched"	"Detected in some"	4	"Daudi: 8.4;THP-1: 19.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 25.4;NK-cells: 19.6;T-cells: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013873	Enhanced									"HPA013873: AB_1849285"	"unprognostic (3.87e-6)"	"unprognostic (1.31e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.31e-6)"	"unprognostic (2.89e-1)"	"unprognostic (7.55e-4)"	"unprognostic (4.27e-5)"	"unprognostic (3.45e-3)"	"unprognostic (2.31e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.20e-6)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.92e-3)"	0.7	0.3	0.3	13.2	0.3	6.0	0.4	0.3	0.2	0.5	1.2	0.0	0.0	0.4	0.4	0.4	0.8	0.3	0.7	0.6	0.3	0.3	0.6	0.9	1.9	25.1	0.3	0.0	0.4	0.4	0.0	0.5	0.5	0.4	1.0	0.5	0.2	2.8	0.0	0.3	0.5	5.3	0.0	0.5	24.0	0.8	15.0	0.0	14.4	0.7	0.3	20.6	4.0	0.7	25.4	4.8	0.9	2.0	19.6	17.6	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	1.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	19.8	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	3.3	0.0	0.1	0.7	0.2	10.0	2.0	16.9	25.4	9.0	13.8	4.7	21.4	17.6	15.6	0.9	19.6	1.9	4.8	2.3	5.0	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.0	0.4	0.0
GPR25		ENSG00000170128	"G protein-coupled receptor 25"	O00155	1	200872955-200874178	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 22.9;lymphoid tissue: 11.6;stomach 1: 7.3"	"Cell line enriched"	"Detected in single"	6	"U-266/70: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 15.1;T-reg: 22.9"	"Group enriched"	"Detected in many"	63	"B-cells: 8.1;T-cells: 22.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (2.80e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-4)"	"unprognostic (2.21e-3)"	"unprognostic (4.49e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-6)"	"unprognostic (1.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.22e-6)"	0.2	0.2	0.1	3.4	0.9	0.2	0.1	0.1	0.7	0.2	0.6	0.4	0.0	0.5	0.7	0.1	2.6	0.8	0.2	1.6	0.1	0.4	0.2	0.1	1.7	1.7	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.3	0.1	0.0	5.2	0.1	0.3	0.1	1.9	0.1	0.1	2.9	7.3	1.5	0.0	1.0	0.3	1.5	11.6	0.9	0.5	8.1	0.0	0.1	0.0	0.2	22.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	6.1	8.1	15.1	4.8	0.0	0.7	0.4	1.3	0.1	0.2	0.0	0.0	22.9	3.1	0.1	0.9	0.1	0.7	0.1	0.4	0.0	0.0	0.2	0.0
GPR31	"12-HETER, HETER1"	ENSG00000120436	"G protein-coupled receptor 31"	O00270	6	167156271-167158329	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.7;epididymis: 2.5;lymphoid tissue: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	28	"myeloid DC: 2.7"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.7"	"Not detected"	"Not detected"							"HPA014014, HPA027108"	Uncertain									"HPA014014: AB_1849292, HPA027108: AB_10601474"	"unprognostic (9.92e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-3)"		"unprognostic (2.20e-3)"	"unprognostic (5.95e-3)"	"unprognostic (4.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.10e-4)"	"unprognostic (2.45e-1)"	"unprognostic (6.01e-2)"	0.0	0.0	0.1	0.9	0.1	0.2	0.1	0.0	0.1	0.1	0.1			0.5	0.0	2.5	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	4.5	0.2		0.0	0.0	0.0	0.1	0.0		0.0	0.1		0.1	0.0	0.0	0.0	0.9	0.0	0.2	2.1	0.3	1.1			0.1		1.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR55		ENSG00000135898	"G protein-coupled receptor 55"	Q9Y2T6	2	230907318-230961066	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 7.8;intestine: 8.2;lymphoid tissue: 13.2;testis: 7.7"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 26.4"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (9.88e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.24e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.26e-1)"	0.4	0.1	0.4	6.9	7.8	0.2	0.7	0.1	1.2	0.6	4.8	0.7	0.1	2.1	0.9	0.5	0.8	0.2	1.6	0.1	0.5	0.7	0.9	0.1	0.8	8.8	0.2	0.1	0.1	0.1	0.1	0.5	0.1	0.3	1.2	1.5	0.1	1.9	2.1	0.1	0.6	8.2	0.1	0.3	6.6	0.9	7.7	0.1	7.0	0.4	1.2	13.2	2.2	0.4	3.0	1.9	0.5	0.2	2.2	3.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.6	26.4	0.0	0.0	0.2	0.7	0.5	0.8	0.0	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	4.8	0.0	1.8	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.1	0.0	0.0	0.1	0.3	1.2	1.2	0.9	0.4	3.0	0.5	2.3	0.5	2.2	0.2	1.9	3.1	4.6	0.4	7.8	0.1	1.2	0.5	0.7	0.2	0.1	0.3	0.1
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005124-88014811	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.4;lymphoid tissue: 40.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.1;HEL: 6.6;HL-60: 7.9;HMC-1: 10.2;RH-30: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol				Vesicles	Vesicles	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	9.8	3.1	1.8	12.1	6.4	15.2	2.3	0.7	3.0	1.9	2.4	0.9	0.9	2.3	2.2	2.2	2.3	2.2	4.1	2.3	6.0	2.1	4.0	6.9	10.6	13.1	8.2	0.0	1.7	1.8	0.8	6.2	3.6	6.3	2.9	2.3	1.2	2.6	0.9	0.9	1.2	7.7	3.3	15.7	40.8	2.5	1.5	6.2	12.5	1.8	2.3	8.9	4.8	2.3	4.3	5.9	19.1	13.7	21.3	30.4	9.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.3	7.9	10.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	14.6	9.1	19.1	16.5	12.8	30.4	4.3	8.4	12.6	5.9	4.0	4.4	9.7	6.9	21.3	13.7	2.7	4.0	9.4	1.8	6.4	0.7	3.0	6.0	2.1	8.2	0.0	6.3	6.2
GPR82		ENSG00000171657	"G protein-coupled receptor 82"	Q96P67	X	41724155-41730135	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 12.0"	"Cell line enriched"	"Detected in single"	16	"HMC-1: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"eosinophil: 23.2;NK-cell: 6.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 23.2;NK-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035914	Approved									"HPA035914: AB_10670671"	"unprognostic (5.62e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.41e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-1)"	1.2	2.2	1.6	3.9	5.9	0.2	1.1	0.6	1.5	0.9	2.7	0.3	0.0	3.0	0.8	1.1	1.1	1.1	1.1	0.7	2.5	1.1	4.7	5.0	10.0	9.0	2.5	0.1	0.7	1.5	0.1	1.1	0.3	3.2	1.1	2.1	0.8	0.8	0.7	0.4	0.7	5.2	0.6	7.3	3.6	1.6	0.4	2.3	1.6	0.8	0.6	12.0	2.4	0.9	0.1	0.2	23.2	1.6	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	23.2	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	6.6	1.4	0.0	0.0	0.1	1.6	5.9	0.6	1.5	2.5	1.1	2.5	0.1	3.2	2.3
GPSM3	"AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1"	ENSG00000213654	"G protein signaling modulator 3"	Q9Y4H4	6	32190766-32195523	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;lymphoid tissue: 66.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 25.9;NB-4: 14.3;THP-1: 15.0;U-937: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									160000	160000				"unprognostic (2.93e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.02e-2)"	"prognostic favourable (5.98e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.61e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (6.92e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.87e-2)"	7.1	3.3	3.4	28.8	5.3	20.6	4.4	1.3	3.6	2.3	3.9	5.2	0.4	3.4	2.2	4.2	4.1	4.2	5.5	4.7	3.6	3.0	5.2	5.1	17.3	32.2	5.3	1.0	2.1	1.9	0.8	2.5	6.1	4.7	4.0	4.0	4.7	7.2	1.8	1.2	2.5	18.4	2.2	9.1	66.2	4.8	2.0	4.6	53.0	3.4	1.5	33.3	8.1	3.4	5.7	6.3	29.9	6.6	3.4	7.4	4.6	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.4	1.6	0.6	0.9	0.1	0.6	4.3	2.0	0.7	0.1	0.0	1.1	0.7	5.4	0.1	6.1	0.0	0.2	1.8	0.0	25.9	0.4	0.0	0.2	0.9	3.0	2.9	7.2	0.1	0.0	3.0	14.3	0.0	0.0	2.5	0.3	6.6	0.3	0.0	0.0	0.2	0.0	0.0	0.9	0.1	15.0	2.8	0.3	1.2	0.0	0.3	0.3	0.3	4.7	0.1	8.8	1.6	4.6	6.5	19.2	5.2	6.6	4.8	5.7	6.9	6.0	6.3	5.3	7.4	5.6	29.9	3.4	6.4	4.4	4.7	4.6	3.4	5.3	1.3	3.6	3.6	3.0	5.3	1.0	4.7	4.6
GRAP		ENSG00000154016	"GRB2-related adaptor protein"	Q13588	17	19020673-19047637	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.3;lymphoid tissue: 20.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.7;HUVEC TERT2: 13.1;REH: 16.6;TIME: 25.7;U-698: 22.3"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 28.2;T-cells: 37.3"									"HPA046595, HPA066654"	Uncertain		Approved	Centrosome				Centrosome	Centrosome	"HPA046595: AB_10966385, HPA066654: AB_2685699"	"unprognostic (3.02e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.86e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-3)"	2.8	1.4	0.7	5.7	0.9	2.4	2.8	0.1	0.4	1.4	0.6			0.3	1.4	0.0	0.5	1.9	2.1	0.6	0.8	0.6	2.2	2.7	3.5	15.8	1.0		0.6	0.1	0.0	0.7	2.5		1.0	0.4		0.4	1.6	0.3	0.8	7.7	1.1	1.0	20.9	0.5	2.5			2.7		14.2	1.7	0.8	28.2	2.7	5.6	2.5	4.9	37.3	13.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	0.0	0.0	6.5	0.5	0.3	0.0	16.6	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	25.7	0.0	0.0	3.1	0.0	0.0	0.0	22.3	0.0	0.0	0.1	5.6	2.5	0.3	5.9	1.3	5.9	28.2	18.5	7.7	2.7	22.8	37.3	17.9	0.7	4.9	0.1	2.0	15.4	13.0										
GRAPL		ENSG00000189152	"GRB2 related adaptor protein like"	Q8TC17	17	19127469-19159176	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	7	"Daudi: 21.7;HUVEC TERT2: 9.0;TIME: 24.0;U-698: 20.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 10.8"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.8"									"HPA051796, HPA066654"	Uncertain		Approved	Centrosome				Centrosome	Centrosome	"HPA051796: AB_2681613, HPA066654: AB_2685699"	"unprognostic (2.85e-1)"		"unprognostic (3.37e-1)"		"unprognostic (5.09e-4)"	"unprognostic (4.49e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	4.6	1.6	0.7	9.5	1.7	1.0	1.7	0.4	2.0	1.5	1.3	0.1	2.9	0.7	3.6	1.9	2.5	1.6	2.2	3.4	1.7	0.8	2.8	1.8	4.6	15.6	1.1	1.2	1.1	0.4	0.0	1.0	1.7	1.0	1.4	1.3	1.0	1.4	1.3	2.3	0.7	9.7	1.9	0.9	20.6	0.8	1.1	0.5	7.7	2.7	1.7	17.0	1.7	2.3	10.8	0.1	0.0	0.0	0.0	2.2	0.7	0.0	1.2	1.5	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.3	21.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	2.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	24.0	0.0	0.2	1.1	0.0	0.0	0.0	20.1	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	10.8	1.4	0.3	0.1	4.1	2.2	0.7	0.0	0.0	0.0	0.0	0.9	0.7	0.7	1.7	0.4	2.0	1.7	0.8	1.1	1.2	1.0	0.5
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319322-24364482	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.5;HaCaT: 16.9;MCF7: 26.0;RT4: 29.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 28.9"	"Region enhanced"	"Detected in some"		"pons and medulla: 3.6"	"Group enriched"	"Detected in some"	12	"eosinophil: 1.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.1	0.1	0.1	0.1	0.9	0.0	1.0	0.2	0.9	9.0	0.1	0.2	0.0	0.2	0.6	0.8	59.0	0.2	0.6	0.1	1.1	0.3	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.1	1.1	3.6	3.6	0.1	0.0	5.9	0.9	0.2	21.7	0.1	0.5	3.0	0.0	0.2	1.1	0.1	0.5	0.1	51.5	60.1	12.3	11.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	1.2	0.4	0.0	0.0	0.0	21.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	1.5	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.3	0.0	0.1	0.0	0.0	26.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	2.1	29.7	0.1	0.0	0.0	2.9	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.2	0.1	1.1	0.3	0.1	0.0	3.6	0.1
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786888	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2"	"Cell line enhanced"	"Detected in some"		"A-431: 8.2;HaCaT: 5.8;hTCEpi: 3.0;HUVEC TERT2: 3.2;TIME: 8.5"	"Group enriched"	"Detected in many"	6	"cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA023670, HPA024767, HPA026317"	Supported		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA023670: , HPA024767: , HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.2	25.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.4	0.0	0.0	14.1	0.0	0.0	0.2	25.0	0.0	0.0	0.0	0.1	0.1	19.2	17.5	1.4	5.9	0.3	0.3	1.2	0.1	0.4	0.3	0.0	8.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296741-46330810	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0;testis: 22.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"				Centrosome	Centrosome	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (1.90e-10)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	1.1	1.3	0.3	10.4	0.8	10.2	1.3	1.0	1.1	1.2	2.5	0.7	0.1	4.1	1.1	1.3	6.6	0.4	0.4	0.8	1.0	0.3	0.9	0.9	1.3	9.0	0.6	0.4	0.9	0.5	0.0	0.9	2.8	1.8	0.6	2.6	0.7	1.5	0.1	0.3	2.4	3.3	1.0	0.6	4.6	2.4	22.3	0.3	20.0	0.5	5.8	8.8	1.1	2.1	1.4	1.9	3.0	0.2	1.8	1.6	0.9	21.5	10.2	20.2	15.9	0.4	1.2	9.7	18.7	8.8	27.4	22.6	10.7	8.2	20.4	5.0	7.2	11.3	18.1	4.7	17.6	12.2	19.5	13.6	14.4	8.2	0.0	24.4	16.7	0.2	0.3	11.7	6.0	11.8	10.4	25.7	16.3	12.0	21.8	12.0	14.1	11.6	21.7	22.7	13.4	4.5	3.9	10.5	14.3	17.9	11.7	8.2	9.9	9.4	9.3	15.6	29.6	12.7	19.6	14.7	7.0	20.7	9.9	11.8	22.7	0.1	0.2	1.5	1.3	0.1	0.4	1.4	0.6	0.6	0.3	0.6	0.4	0.3	3.0	1.8	0.1	1.9	1.6	0.9	0.3	0.8	1.0	1.1	1.0	0.3	0.6	0.4	1.8	0.3
GYPE	"GPE, MNS"	ENSG00000197465	"Glycophorin E (MNS blood group)"	P15421	4	143870867-143905563	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 14.5;lymphoid tissue: 6.9"	"Group enriched"	"Detected in some"	11	"HEL: 49.7;K-562: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5"	"Group enriched"	"Detected in many"	12	"B-cells: 3.5;NK-cells: 2.1;T-cells: 1.3"																				"unprognostic (2.17e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.10e-4)"	"unprognostic (7.81e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.49e-2)"	2.7	0.2	1.2	1.5	0.5	14.5	1.2	0.5	1.2	0.9	0.5	0.5	0.5	0.0	0.5	0.8	0.5	0.1	0.7	2.6	1.1	0.3	0.7	0.5	3.7	1.0	0.5	0.5	1.5	0.5	0.0	0.5	5.7	1.1	0.5	0.4	0.5	0.5	0.6	0.5	0.5	1.7	0.5	0.7	6.9	0.4	0.8	0.5	1.5	1.4	0.5	3.1	0.9	0.5	3.5	0.1	0.0	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	2.9	2.9	0.0	1.2	2.7	0.6	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	49.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.5	0.0	0.0	0.0	1.1	0.8	0.6	0.0	2.1	0.0	0.1	0.0	0.0	1.2	0.5	0.5	1.2	1.1	0.3	0.5	0.5	1.1	0.5
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.2;lymphoid tissue: 28.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.2;HDLM-2: 4.2;HMC-1: 5.3;MOLT-4: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdTCR: 79.2"	"Group enriched"	"Detected in many"	31	"NK-cells: 22.7;T-cells: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015624	Enhanced				"Secreted to blood"					"HPA015624: AB_2669245"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"	1.8	1.0	0.7	13.6	0.9	15.6	1.0	4.3	1.4	1.0	3.5	0.2	0.1	1.8	1.0	2.9	2.0	1.1	4.7	1.6	0.7	0.6	1.1	2.6	4.8	15.1	0.7	0.4	0.8	0.4	0.0	0.9	1.6	0.5	1.7	0.1	1.5	12.0	0.3	0.8	0.7	5.1	0.5	1.1	21.1	3.0	1.5	0.4	28.6	1.4	1.1	10.9	1.1	1.2	0.4	0.4	1.6	0.2	22.7	79.2	27.0	0.1	0.7	0.1	0.3	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.6	0.2	0.1	5.2	0.0	0.1	0.0	0.0	0.0	4.2	0.4	0.0	0.6	0.2	0.6	0.4	5.3	0.2	0.0	0.1	0.0	0.1	1.6	0.3	0.0	1.2	3.4	1.4	0.9	0.8	0.3	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.8	0.9	0.0	1.1	0.4	1.1	0.3	0.8	0.3	0.8	0.1	0.1	79.2	0.2	49.8	0.1	26.4	63.6	0.1	0.4	25.8	53.1	1.6	22.7	0.2	0.4	12.2	27.0	0.7	0.9	4.3	1.4	0.7	0.6	0.7	0.4	0.5	0.4
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877288-88895626	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.4;lymphoid tissue: 23.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.6;U-2 OS: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1.0	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6.0	4.7	9.8	3.2	1.0	3.0	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6.0	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6.0	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.3	0.9	9.6	2.7	3.0	3.0	2.6	0.6	1.0	1.3	2.7	4.0	0.0	7.6	3.3	1.0	9.1	1.2	0.0	20.6	8.0	3.0	0.2	0.0	0.4	0.0	0.1	1.1	0.5	1.9	0.1	4.5	0.0	5.9	0.4	0.1	0.0	0.0	7.1	0.1	0.0	0.4	7.2	1.8	0.1	0.1	2.6	0.5	0.5	3.6	0.0	0.3	0.8	6.9	20.6	5.2	0.4	0.9	0.0	0.0	2.5	0.0	5.9	0.7	0.6	0.0	0.6	0.3	3.0	0.1	10.0	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1.0	2.3	3.2	1.0	3.1	0.9	3.6	1.8
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 49.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	11.7	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	49.8	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.7;lymphoid tissue: 110.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 42.3;HMC-1: 60.1;THP-1: 41.9;U-266/70: 59.5;U-698: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		200000	200000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	24.7	10.7	7.8	44.9	14.7	35.5	9.1	1.3	7.4	6.3	10.4	8.5	2.2	5.5	5.6	8.2	4.8	9.1	10.1	7.5	6.7	5.0	10.5	10.1	18.7	59.4	12.9	3.2	4.6	5.1	1.4	6.1	15.4	10.9	6.1	8.6	4.9	7.4	3.1	7.0	4.6	23.0	8.9	15.1	110.1	7.1	3.6	11.6	41.0	6.1	4.4	61.5	12.5	5.6	33.4	59.6	149.7	84.9	24.3	44.1	103.5	0.1	0.0	0.0	0.0	3.5	1.9	0.9	0.6	0.6	0.1	0.2	0.0	0.0	42.3	20.6	0.0	0.0	1.1	1.6	0.1	18.8	0.0	27.4	0.0	0.0	1.9	30.1	60.1	0.3	0.0	0.0	0.3	24.9	5.4	39.1	0.0	0.0	21.3	25.4	0.0	0.7	21.6	0.0	40.2	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.0	41.9	32.5	0.0	0.3	0.0	0.1	59.5	18.1	59.5	0.3	29.0	0.0	26.6	64.1	104.2	40.2	80.6	32.9	33.4	33.3	36.8	59.6	29.4	28.5	33.0	149.7	24.3	84.9	18.5	44.1	103.5	7.8	14.7	1.3	7.4	6.7	5.0	12.9	3.2	10.9	11.6
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902480-35904377	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1"	"Cell line enhanced"	"Detected in some"		"HEL: 51.7;HL-60: 29.8;HMC-1: 34.5;THP-1: 39.1;U-937: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"				"Plasma membrane"	"Plasma membrane"	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	29.4	4.0	6.5	19.9	5.2	84.0	5.9	1.4	3.1	3.9	4.9	4.8	0.5	4.5	5.4	6.0	3.0	4.5	6.3	7.3	5.7	5.9	5.6	6.9	38.4	79.1	7.7	2.2	3.4	2.9	0.7	4.3	10.6	4.9	5.5	3.6	7.1	6.2	3.7	2.4	2.8	10.9	4.5	12.7	49.5	5.6	1.7	4.4	56.8	3.4	3.3	26.7	5.2	3.6	6.1	66.6	15.9	57.0	96.4	134.0	89.5	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.2	5.6	0.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	51.7	0.1	0.1	0.1	29.8	34.5	0.3	0.0	0.0	0.0	0.0	0.4	7.4	0.1	0.0	3.4	11.6	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.1	39.1	0.1	0.3	0.4	0.0	0.0	0.3	0.2	8.5	0.3	58.7	0.0	7.3	57.0	7.9	134.0	42.0	99.3	6.1	57.4	108.5	32.6	3.7	48.3	96.4	15.9	96.4	23.0	66.6	48.5	89.5	6.5	5.2	1.4	3.1	5.7	5.9	7.7	2.2	4.9	4.4
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 85.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol				Cytosol	Cytosol	"HPA004775: "	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (4.65e-4)"	26.0	21.6	8.2	22.7	10.8	17.3	24.4	8.4	10.7	28.2	20.7	8.7	15.4	8.0	27.9	21.5	19.2	25.2	22.1	16.5	10.3	4.3	17.7	5.1	27.6	21.1	8.2	8.0	25.4	8.9	23.7	11.5	17.5	10.0	20.1	4.1	17.6	16.3	18.9	12.5	19.7	13.9	24.9	10.3	23.1	14.9	9.5	11.5	85.8	20.9	12.9	21.0	24.8	25.0	1.4	0.6	10.5	1.9	1.7	1.5	1.8	14.0	9.6	10.0	16.3	7.8	21.9	9.0	13.9	10.8	10.1	6.6	12.8	13.4	28.3	46.2	12.6	13.1	2.3	10.8	3.7	13.2	4.8	9.6	9.4	2.9	8.5	3.0	0.4	14.3	3.8	10.0	5.4	20.8	10.2	11.6	6.4	6.1	27.8	7.5	14.0	10.7	21.4	5.3	10.2	4.3	9.2	2.8	6.8	10.6	4.9	5.0	4.6	4.1	23.5	20.7	22.5	16.8	9.8	26.2	19.0	22.5	8.5	14.3	6.7	0.0	1.9	0.0	1.5	0.8	1.5	1.4	1.3	1.1	0.6	1.1	1.5	1.0	10.5	1.7	0.7	0.5	0.6	1.8	8.2	10.8	8.4	10.7	10.3	4.3	8.2	8.0	10.0	11.5
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.4"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	Nucleoplasm	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favourable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.4	2.0	1.2	28.8	1.5	14.8	3.0	11.9	3.2	4.2	5.0	0.7	3.3	3.5	5.8	6.0	8.6	2.5	3.6	2.1	1.3	2.0	3.9	2.0	2.5	11.9	1.4	1.7	4.3	1.9	2.7	4.7	9.0	1.3	3.4	5.5	3.3	2.8	2.0	0.6	5.2	5.3	2.1	1.7	8.3	3.6	18.7	0.7	46.4	1.7	8.1	15.1	3.6	4.4	13.6	22.0	0.7	0.8	5.6	10.9	1.5	19.7	19.5	25.2	31.9	1.0	2.3	13.7	15.1	9.7	12.6	20.0	25.7	16.0	24.4	6.0	5.0	19.9	14.4	12.1	18.1	23.6	16.6	13.0	19.8	20.6	0.6	24.4	11.7	1.3	0.7	15.1	7.2	8.7	7.0	15.6	14.9	19.8	25.7	12.2	26.1	8.7	24.0	22.5	5.6	8.6	25.5	10.1	8.2	17.9	5.1	2.6	21.9	7.9	6.1	13.9	7.0	12.6	18.1	8.1	15.4	26.1	6.9	15.1	6.3	0.1	0.5	0.0	4.4	0.8	1.5	10.9	7.2	6.2	1.3	13.6	3.5	5.0	0.7	5.6	0.6	22.0	10.9	1.5	1.2	1.5	11.9	3.2	1.3	2.0	1.4	1.7	1.3	0.7
HESX1	"ANF, RPX"	ENSG00000163666	"HESX homeobox 1"	Q9UBX0	3	57197843-57226521	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"ductus deferens: 14.7;lymphoid tissue: 15.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 39.5;U-266/84: 12.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.0;plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024187	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA024187: AB_1850620"	"unprognostic (6.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.96e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.14e-1)"	1.5	2.6	2.1	1.4	2.0	4.2	3.5	1.4	2.3	1.4	1.4	1.4	14.7	1.0	1.4	5.7	1.4	1.2	2.1	1.4	2.2	2.3	2.7	4.8	1.5	15.2	3.3	2.4	2.1	2.5	3.4	2.6	3.4	1.4	1.9	0.8	2.3	1.5	7.0	1.4	5.7	1.4	1.4	5.1	4.6	2.1	8.7	2.0	3.0	3.3	1.4	1.8	1.4	1.4	1.5	4.6	0.3	4.0	1.1	0.3	0.5	0.7	0.5	1.4	2.6	0.2	1.0	0.4	0.0	0.2	0.4	0.8	0.2	2.4	1.9	0.4	0.0	0.1	0.7	0.7	0.5	1.0	1.4	2.7	0.7	0.1	1.7	1.0	0.2	2.5	0.7	0.2	1.5	0.3	0.4	2.4	0.1	0.1	1.1	4.9	39.5	0.5	0.4	0.9	1.0	1.9	0.2	0.6	1.9	0.6	0.8	1.5	0.6	4.0	0.3	1.8	0.7	0.6	0.8	7.3	12.2	5.9	0.7	1.7	1.0	0.0	2.1	0.3	0.3	4.0	0.0	1.5	0.1	0.0	1.1	1.1	0.2	0.0	0.3	1.1	0.3	4.6	0.0	0.5	2.1	2.0	1.4	2.3	2.2	2.3	3.3	2.4	1.4	2.0
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell line enhanced"	"Detected in many"		"K-562: 48.9;SiHa: 46.5;U-2 OS: 91.7;U-266/70: 101.7;U-266/84: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	Nucleoplasm,Nucleoli		1800000	1800000	"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.7	4.2	3.1	3.3	8.0	1.6	0.1	2.9	4.8	13.8	14.7	2.2	4.2	0.4	16.8	3.8	2.5	1.0	2.2	3.9	5.6	3.6	2.4	4.6	2.5	2.3	1.1	5.8	11.2	3.1	1.8	3.0	2.1	48.9	36.8	6.8	2.6	2.9	2.6	1.7	6.4	1.5	1.4	18.7	8.1	4.2	8.0	2.7	46.5	8.0	3.2	9.9	1.7	0.9	6.3	91.7	1.8	1.3	101.7	96.6	4.4	4.6	38.1	2.1	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4
HIST1H2BG	"H2B.1A, H2B/a, H2BFA"	ENSG00000273802	"Histone cluster 1 H2B family member g"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 8.8;T-47d: 17.8;U-266/70: 16.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	0.4	1.5	0.7	16.5	1.2	8.9	20.2	5.1	3.4	4.3	2.9	0.5	5.1	1.8	2.8	4.0	6.6	2.1	1.8	1.7	0.2		1.2	0.6	2.0	7.2	0.1	2.0	1.3	1.9	0.4	0.5	1.6	0.7	10.3	3.0	1.2	5.0	5.8	0.3	1.6	2.2	2.8	4.7	3.1	2.9	6.7	0.3	75.2	1.0	6.9	8.3	4.3	0.0	5.8	14.6	12.0	1.6	1.3	6.2	2.0	2.4	0.1	1.2	0.0	3.8	0.2	0.3	3.1	0.2	2.0	0.8	0.3	2.1	0.0	3.1	0.3	2.6	1.1	1.0	1.1	2.1	1.3	0.7	1.2	1.1	0.6	0.2	2.0	1.4	0.5	0.6	0.0	0.4	7.6	0.1	0.0	1.8	2.2	1.7	1.2	1.6	1.4	0.7	4.3	1.1	0.6	7.2	1.1	8.8	3.2	1.0	17.8	0.8	0.2	0.0	1.0	0.3	0.4	16.7	0.1	0.0	0.3	1.0	0.5	12.0	1.2	2.5	2.0	0.9	6.2	3.7	3.1	3.8	4.4	5.8	1.5	1.3	5.6	1.3	1.6	14.6	2.7	2.0										
HIST1H3A	"H3/A, H3FA"	ENSG00000275714	"Histone cluster 1 H3 family member a"	P68431	6	26020490-26020900	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.1;testis: 78.7"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 8.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (3.07e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.36e-5)"	"unprognostic (2.85e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.21e-2)"	1.6	2.1	0.8	6.3	0.5	23.5	1.2	8.0	7.2	2.1	1.2	0.0	1.2	0.9	1.9	4.8	3.0	1.5	2.1	2.5	0.9		1.8	1.1	2.1	2.6	0.0	2.5	1.6	2.9	0.9	1.1	1.2	2.4	1.4	1.8	1.6	1.2	1.0	0.9	1.3	1.5	2.3	0.8	2.6	1.3	78.7	0.0	40.1	1.6	4.1	8.4	0.9	0.0	3.9	5.2	14.6	1.6	8.8	3.9	1.5	1.5	0.0	1.7	0.0	1.5	0.6	0.0	2.3	0.0	2.0	4.2	0.0	0.8	1.4	0.8	0.0	0.0	2.5	0.6	3.9	0.8	3.1	2.4	0.8	0.0	0.0	0.3	2.2	0.0	0.0	0.4	0.0	2.0	0.2	0.2	0.0	5.5	3.9	1.8	2.2	2.5	2.6	1.2	0.0	0.5	1.2	1.2	2.5	1.8	3.2	0.5	0.2	2.0	0.0	0.0	8.8	0.8	1.0	0.5	0.4	0.0	1.1	3.0	2.8	11.1	1.5	4.3	3.9	1.6	3.3	2.1	2.8	2.3	3.0	3.9	2.2	1.7	14.6	8.8	0.9	5.2	3.8	1.5										
HIST1H3E	"H3.1, H3/d, H3FD"	ENSG00000274750	"Histone cluster 1 H3 family member e"	P68431	6	26224199-26227473	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.4;testis: 19.9;tongue: 25.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;SCLC-21H: 13.5;T-47d: 8.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (2.42e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-2)"	0.6	4.8	0.0	2.8	1.2	0.2	2.6	2.4	1.2	2.6	3.6	1.9	5.2	6.1	2.5	6.9	14.5	1.6	3.0	7.4	0.0		0.7	0.9	2.1	4.1	4.1	0.0	2.5	0.6	2.5	0.5	2.9	1.8	4.6	2.4	0.5	4.4	1.8	6.1	1.3	6.1	2.5	1.8	2.3	3.5	19.9	3.2	22.4	3.6	25.6	8.8	2.7	0.3	2.6	3.9	6.5	1.8	0.5	3.1	1.4	2.0	2.2	3.2	1.4	3.8	1.8	0.2	1.5	1.7	0.8	0.6	0.7	1.2	0.0	12.0	0.6	2.5	0.0	0.4	0.7	3.1	2.8	0.4	1.0	0.7	1.2	0.2	1.9	2.7	2.7	0.3	0.8	1.2	0.3	2.5	2.2	1.9	0.4	0.1	0.2	2.2	1.5	0.6	0.3	6.5	1.2	13.5	1.6	2.1	3.3	3.7	8.2	1.3	0.6	1.5	0.5	0.4	0.3	0.9	0.3	0.2	0.7	0.1	0.8	0.4	1.8	0.0	1.3	1.5	1.7	1.4	1.8	1.7	1.2	2.6	1.7	1.8	6.5	0.5	1.3	3.9	3.1	1.4										
HIST1H4B	"H4/I, H4FI"	ENSG00000278705	"Histone cluster 1 H4 family member b"	P62805	6	26026815-26027252	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 102.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	6	"neutrophil: 25.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.8"									HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (1.16e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.58e-2)"	2.6	1.0	0.3	6.2	0.4	11.3	2.3	6.2	1.0	4.0	3.2	0.0	4.2	1.8	5.7	1.8	5.7	3.3	2.0	1.6	0.2		5.0	1.7	3.0	4.7	0.2	0.0	8.6	19.9	1.0	0.5	2.4	0.4	3.6	1.4	6.0	4.0	3.5	2.3	1.6	2.7	2.0	0.0	6.3	2.2	10.5	0.2	102.5	8.0	3.0	8.9	3.5	4.3	4.3	1.3	25.8	1.2	0.2	1.0	0.3	1.7	0.0	0.2	3.7	0.0	0.0	0.0	2.7	0.3	1.7	1.1	0.7	0.5	1.4	0.6	0.5	0.5	0.8	0.0	1.0	0.6	3.8	4.7	1.8	2.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.8	5.3	0.5	2.8	4.7	3.7	0.8	0.6	3.4	1.7	2.9	0.0	1.3	1.0	0.7	0.4	2.0	0.0	0.5	2.4	0.0	1.1	2.5	2.0	3.6	3.0	2.8	2.2	1.4	1.4	1.9	0.0	0.5	0.7	0.9	0.6	0.9	1.7	1.0	0.8	0.4	4.3	0.8	0.4	25.8	0.2	1.2	1.3	0.7	0.3										
HIST1H4H	"H4/h, H4FH"	ENSG00000158406	"Histone cluster 1 H4 family member h"	P62805	6	26277609-26285638	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 119.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 6.0;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 17.5"									HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (4.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (6.18e-6)"	"unprognostic (7.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.55e-2)"	"unprognostic (6.36e-2)"	6.2	3.6	4.4	10.6	4.4	5.2	23.0	6.4	4.6	7.0	6.6	1.2	5.6	6.5	4.5	6.8	13.9	4.0	5.5	8.3	5.2	5.2	5.2	3.3	5.5	4.1	7.1	2.8	9.4	2.8	1.2	4.0	9.0	2.5	16.7	4.0	3.8	3.9	4.5	30.9	3.7	9.9	7.6	10.9	10.9	3.8	11.0	1.9	119.1	9.5	10.3	23.1	7.3	7.3	1.6	1.1	17.5	1.0	0.2	0.8	4.4	2.4	2.4	0.6	0.3	5.9	0.3	1.5	3.8	0.4	1.1	0.3	2.4	0.7	1.1	6.4	1.0	1.7	0.3	0.4	0.3	3.6	1.1	2.3	4.5	2.3	2.5	0.9	2.0	5.8	0.4	1.2	0.9	2.0	7.2	7.2	2.0	3.0	9.3	6.0	1.1	3.4	6.4	1.4	4.1	0.8	2.5	4.2	0.8	7.7	4.3	2.9	6.3	3.2	0.6	1.4	12.1	1.2	4.2	9.0	36.6	2.2	0.7	8.5	2.0	1.9	0.6	6.0	0.5	1.0	0.3	0.7	0.4	0.6	0.5	1.6	0.4	0.6	17.5	0.2	0.3	1.1	0.8	4.4	4.4	4.4	6.4	4.6	5.2	5.2	7.1	2.8	2.5	1.9
HIST1H4J	"H4/e, H4F2iv, H4FE"	ENSG00000197238	"Histone cluster 1 H4 family member j"	P62805	6	27824108-27824480	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.9;lymphoid tissue: 68.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 31.4;MCF7: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 58.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.9"									HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (3.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-3)"	5.9	9.4	2.9	15.6	4.1	25.9	4.0	3.7	15.5	5.3	9.9	0.2	6.8	7.9	4.4	4.7	7.6	5.6	6.2	7.5	5.9	1.9	4.0	18.1	8.3	26.7	2.2	7.1	5.2	4.1	0.6	4.5	3.2	2.3	8.0	4.6	0.7	2.0	3.7	0.7	2.7	7.6	3.8	6.0	13.9	7.5	19.3	0.8	68.3	8.6	8.0	10.8	5.4	4.9	12.0	7.7	58.9	10.8	10.6	13.2	10.8	3.8	4.7	10.6	17.9	6.4	2.7	6.2	4.4	2.3	4.4	2.8	8.7	1.3	6.2	7.9	1.8	9.2	0.2	6.6	1.4	8.8	1.6	4.1	9.4	31.4	3.8	6.0	5.3	8.4	1.8	2.8	1.5	4.1	7.8	13.1	0.0	31.5	10.7	6.1	6.7	10.4	4.4	0.7	4.4	0.6	1.7	5.8	8.0	7.5	4.4	7.0	5.7	3.0	3.9	2.1	10.6	1.1	0.0	8.4	8.0	10.8	2.7	7.6	4.2	58.9	3.4	14.8	11.7	8.5	8.9	11.0	11.5	12.7	5.2	12.0	6.6	8.3	6.9	10.6	10.8	7.7	13.2	10.8	2.9	4.1	3.7	15.5	5.9	1.9	2.2	7.1	2.3	0.8
HIST1H4K	"dJ160A22.1, H4/d, H4F2iii, H4FD"	ENSG00000273542	"Histone cluster 1 H4 family member k"	P62805	6	27831216-27831527	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lung: 2.9;lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	5	"HHSteC: 2.8;LHCN-M2: 2.8;RT4: 1.6;U-87 MG: 1.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (3.19e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.84e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.02e-1)"	0.7	0.0	1.0	3.1	3.4	0.0	0.0	0.7	2.0	0.4	0.6	0.3	0.0	0.0	0.0	0.5	2.1	0.0	1.3	0.0	0.3		0.1	0.0	2.9	2.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	1.6	0.0	0.7	1.1	0.0	0.9	0.0	2.1	0.5	2.0	0.0	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0										
HIST2H2BE	"H2B, H2B.1, H2B/q, H2BFQ"	ENSG00000184678	"Histone cluster 2 H2B family member e"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.8;U-266/70: 39.7;U-266/84: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	14.3	16.2	9.8	22.2	10.0	19.4	16.9	17.2	14.0	31.3	9.0	11.2	10.5	6.4	18.5	24.9	25.5	13.3	9.6	51.1	13.1	10.1	12.5	10.2	27.5	24.5	12.4	8.7	28.0	13.4	5.8	15.4	17.2	8.5	72.8	7.6	19.4	24.1	15.3	43.1	33.5	8.6	18.8	18.2	22.0	17.5	9.3	11.6	198.1	12.1	12.4	25.3	27.2	33.8	2.3	4.5	29.9	5.5	0.7	1.2	5.1	1.1	1.1	1.9	0.4	10.1	2.7	0.9	4.0	2.7	1.7	0.5	0.4	1.8	0.2	1.1	3.5	4.5	1.5	0.7	0.9	1.4	1.2	0.3	4.5	0.8	3.2	0.3	5.3	9.2	3.3	0.7	2.8	0.5	4.8	23.8	2.1	6.8	1.2	2.0	1.2	2.4	1.4	0.7	5.4	1.6	0.9	12.8	2.0	13.8	1.9	1.0	9.8	0.9	0.7	1.3	14.4	0.9	0.3	39.7	21.2	1.0	1.7	1.4	0.7	8.4	2.1	3.8	0.7	3.2	1.2	0.8	0.9	1.1	1.6	2.3	1.2	1.1	29.9	0.7	5.5	4.5	1.0	5.1	9.8	10.0	17.2	8.5	13.1	10.1	12.4	8.7	8.5	11.6
HIST2H3D		ENSG00000183598	"Histone cluster 2 H3 family member d"	Q71DI3	1	149813271-149813681	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;bone marrow: 9.3;lymphoid tissue: 10.2"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 21.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.6"	"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (3.35e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.27e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-4)"	"unprognostic (6.95e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.48e-3)"	1.1	1.2	1.5	1.7	1.4	9.3	5.7	2.6	2.0	1.1	0.9	0.6	0.6	0.5	0.6	0.6	3.8	1.2	3.1	1.9	0.6	0.5	0.6	1.4	1.9	2.9	0.6	0.6	2.4	1.1	0.0	0.6	0.6	1.2	1.9	0.1	0.6	0.6	0.6	0.6	1.1	1.6	0.6	2.3	2.2	2.6	2.3	1.3	10.2	0.7	2.2	1.1	2.7	1.3	6.9	2.7	12.6	1.8	0.4	2.4	0.5	0.8	0.0	0.2	2.3	0.4	0.0	0.5	1.3	0.0	0.0	0.1	0.4	0.2	0.6	0.2	0.0	1.1	0.0	0.0	0.0	1.3	0.7	0.2	3.4	0.1	0.4	0.0	1.9	0.8	0.0	0.5	0.3	0.0	1.8	2.0	0.0	1.5	2.2	5.4	2.1	4.0	1.2	0.4	1.6	0.0	1.1	0.5	0.3	1.3	0.0	0.1	0.4	0.6	0.5	1.2	0.0	1.0	0.0	21.7	2.2	1.4	0.2	0.4	0.8	0.0	1.3	0.5	1.2	1.8	2.4	1.3	1.6	1.8	1.2	6.9	0.6	0.4	12.6	0.4	0.6	2.7	0.2	0.5	1.5	1.4	2.6	1.1	0.6	0.5	0.6	0.6	1.2	1.3
HIST2H3PS2	p06	ENSG00000203818	"Histone cluster 2 H3 pseudogene 2"		1	143905556-143905966	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adrenal gland: 9.1;lymphoid tissue: 7.0;ovary: 8.9"	"Cell line enhanced"	"Detected in some"		"BJ: 8.4;NB-4: 9.6;SH-SY5Y: 10.2;THP-1: 9.8;U-2197: 7.2;U-87 MG: 5.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"																		0.6	9.1	0.5	0.6	0.5	0.0	0.2	1.4	0.3	0.2	0.1			0.1	0.7	0.0	1.4	1.1	1.1	0.3	0.5	0.7	0.0	0.0	0.5	1.3	0.7		8.9	0.7	0.3	0.3	0.0		2.3	0.0		0.5	0.4	0.0	0.3	0.2	1.4	1.5	7.0	4.7	0.9			1.0		0.4	2.4	0.2	1.5	1.0	0.1	3.5	2.4	0.3	0.8	0.0	0.0	0.0	0.0	3.4	0.8	0.0	8.4	1.9	1.7	1.5	0.0	1.2	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	2.1	0.0	3.3	0.0	1.9	0.3	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.2	0.0	3.0	0.0	0.0	9.8	0.0	1.0	0.0	7.2	0.4	0.2	0.0	0.0	5.4	0.0	0.2	0.0	1.2	0.0	0.0	1.7	0.0	0.7	0.1	0.3	1.0	1.5	0.0	0.1	0.1	2.4	3.5	0.6	0.0	0.8										
HIST3H2A	MGC3165	ENSG00000181218	"Histone cluster 3 H2A"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 35.8;lymphoid tissue: 62.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.4;U-266/70: 18.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 35.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favourable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	2.5	20.5	4.3	7.0	8.3	11.1	5.8	35.8	8.1	9.9	3.8	2.4	2.0	7.7	5.0	4.4	7.0	4.2	3.8	4.9	5.4	4.6	1.6	1.0	2.5	5.1	5.6	5.3	8.3	4.5	3.5	5.0	3.4	6.5	7.0	2.8	13.9	6.6	3.9	1.0	6.4	4.2	1.5	5.2	6.6	4.7	3.5	4.8	62.3	1.9	5.6	9.3	2.9	9.3	3.4	3.4	5.1	7.1	6.8	11.7	4.3	3.5	1.9	2.5	3.4	2.1	2.1	3.0	1.7	1.7	5.1	3.6	1.8	2.9	1.6	2.1	0.4	8.7	1.8	0.8	1.2	2.5	18.4	2.5	2.5	0.0	4.9	1.7	5.1	4.7	5.2	0.9	2.2	2.1	8.8	0.0	0.0	5.0	2.3	0.0	3.8	4.7	0.0	0.0	13.3	0.8	2.1	15.5	10.9	6.2	5.5	11.9	9.8	1.3	0.8	0.0	0.0	6.8	1.5	18.5	13.1	0.0	1.8	1.8	1.3	5.1	1.7	0.0	7.1	3.1	5.1	3.4	6.8	5.3	3.4	2.0	5.3	5.2	0.7	6.8	7.1	0.6	11.7	4.3	4.3	8.3	35.8	5.9	5.4	4.6	5.6	5.3	6.5	4.8
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"Human immunodeficiency virus type I enhancer binding protein 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3;lymphoid tissue: 16.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.5;hTEC/SVTERT24-B: 9.1;Karpas-707: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	4.2	1.5	7.5	5.4	5.7	3.8	3.6	20.3	11.7	1.2	1.4	5.1	0.0	1.2	1.1	1.1	3.2	1.3	2.0	2.1	6.1	3.0	1.4	1.2	4.6	4.1	4.8	4.7	1.6	2.4	2.3	8.3	1.8	6.5	2.2	1.5	0.5	3.7	1.1	1.6	11.7	1.3	2.2	5.0	2.9	1.9	1.4	5.1	16.6	2.9	1.8	5.4	1.9	1.6	1.0	1.5	0.1	3.7	0.2	2.1	1.1	1.8	0.6	0.2	1.7	2.2	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	3.8	0.6	0.9	2.5	0.4	0.4	3.0	17.5	0.5	0.2	0.8	0.0	0.4	0.3	0.3	5.5	0.4	9.1	1.0	0.5	0.0	10.6	1.7	1.1	2.8	0.7	0.5	2.2	1.8	2.7	2.0	1.4	0.3	2.0	0.6	2.5	0.6	0.5	0.8	3.2	3.2	2.0	2.1	0.6	4.3	3.2	1.3	2.5	7.9	0.2	7.1	0.1	1.7	0.0	2.1	3.7	0.5	0.6	0.9	1.0	1.5	1.0	0.2	0.8	0.1	0.2	3.1	0.3	0.3	1.1	7.5	5.7	20.3	11.7	6.1	3.0	4.8	4.7	6.5	5.1
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899332	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6"	"Cell line enriched"	"Detected in some"	4	"U-937: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 76.2"	"Group enriched"	"Detected in many"	11	"granulocytes: 76.2;monocytes: 31.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					1700000	1700000			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavourable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	9.2	2.6	0.6	8.5	1.0	55.0	1.3	0.3	1.2	0.4	1.7	0.3	0.0	0.9	0.8	2.6	1.9	3.0	0.9	5.4	0.6	0.3	1.6	4.1	16.3	24.1	1.2	0.5	1.2	1.0	0.0	0.4	2.9	0.5	0.9	0.6	0.9	0.9	0.1	0.8	0.3	1.6	3.4	0.6	40.6	1.2	0.6	0.2	1.3	1.5	0.2	1.2	1.8	5.3	0.0	5.1	76.2	31.4	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	20.8	0.0	76.2	15.4	32.9	0.0	29.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.4	0.0	31.4	0.2	0.0	6.0	0.6	1.0	0.3	1.2	0.6	0.3	1.2	0.5	0.5	0.2
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004178-33009612	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 30.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.3;HDLM-2: 4.5;REH: 20.2;U-698: 4.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.1;naive B-cell: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 11.2;dendritic cells: 9.1;monocytes: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045038	Enhanced									"HPA045038: AB_10959457"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"	5.7	5.7	2.2	18.4	3.9	2.0	5.1	1.5	2.1	4.5	4.0	8.3	2.2	5.1	4.6	6.0	2.7	4.6	4.8	9.3	2.8	3.1	10.0	3.4	18.1	24.7	5.5	2.0	5.7	2.9	3.3	3.3	1.0	5.4	5.4	4.7	4.0	4.5	3.2	1.2	2.5	12.3	2.4	9.6	25.5	4.5	1.2	3.9	14.7	3.8	3.2	30.6	3.4	3.1	11.2	9.1	0.3	4.4	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	7.4	0.0	0.3	9.1	11.2	0.1	0.9	0.3	0.1	2.0	2.8	0.7	1.4	2.2	3.9	1.5	2.1	2.8	3.1	5.5	2.0	5.4	3.9
HLA-DOB		ENSG00000241106	"Major histocompatibility complex, class II, DO beta"	P13765	6	32812763-32817048	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.1;lymphoid tissue: 33.0"	"Group enriched"	"Detected in some"	5	"Daudi: 32.7;U-698: 11.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 42.0;naive B-cell: 51.1"	"Lineage enriched"	"Detected in many"	19	"B-cells: 51.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013846	Enhanced									"HPA013846: AB_1853928"	"prognostic favourable (4.29e-4)"	"unprognostic (3.84e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.26e-3)"	"unprognostic (6.95e-2)"	"prognostic favourable (4.17e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.46e-1)"	0.7	0.4	0.3	28.8	0.3	2.7	1.4	0.7	0.3	1.2	2.7	0.4	0.0	1.7	0.7	0.5	1.3	0.5	1.4	2.2	0.2	0.4	1.8	0.7	3.3	33.0	0.4	0.2	0.5	0.2	0.0	1.8	0.5	0.8	0.7	2.4	0.7	3.8	0.9	0.4	1.0	12.2	0.2	0.7	28.5	1.4	1.7	0.1	5.8	1.1	0.9	29.8	5.5	0.8	51.1	2.6	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	1.6	32.7	0.1	0.0	0.2	0.9	1.7	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.1	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.6	0.3	11.5	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	2.6	51.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.3	0.3	0.7	0.3	0.2	0.4	0.4	0.2	0.8	0.1
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075926-33087201	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.4"	"Group enriched"	"Detected in some"	6	"HDLM-2: 46.1;REH: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 90.1"	"Group enriched"	"Detected in all"	8	"B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6"									"HPA011078, HPA058509"	Approved		Approved	"Nucleoplasm,Cell Junctions"		730000	730000	"Cell Junctions"	"Cell Junctions"	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favourable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	29.6	31.9	9.8	52.8	15.1	6.9	22.0	6.1	7.7	15.5	11.8	14.9	6.9	14.4	15.3	23.4	9.8	11.0	26.6	29.6	9.7	10.4	25.5	12.4	79.9	99.4	23.5	6.0	10.8	10.5	4.3	11.5	6.2	19.6	19.4	6.6	22.2	25.0	15.4	6.1	14.8	33.7	8.9	35.3	88.8	15.8	4.3	16.2	51.9	14.2	20.7	69.3	35.5	11.9	57.8	90.1	1.1	40.6	2.8	7.6	23.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.2	0.0	0.0	0.0	0.0	46.1	2.1	1.2	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	22.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	5.8	0.1	3.8	0.0	0.0	0.0	0.2	18.7	1.1	5.3	40.6	0.7	57.8	1.9	7.6	90.1	56.9	0.7	4.2	0.4	2.8	17.0	25.7	7.2	23.5	9.8	15.1	6.1	7.7	9.7	10.4	23.5	6.0	19.6	16.2
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 91.5;lymphoid tissue: 113.3"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 91.5"	"Group enriched"	"Detected in many"	19	"B-cells: 43.3;dendritic cells: 91.5;monocytes: 32.1"									HPA012315	Enhanced									"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	44.6	8.9	3.9	63.5	6.9	0.7	14.8	1.2	3.1	11.4	13.6	7.4	6.1	0.0	10.6	45.5	8.1	6.1	23.7	4.4	3.8	4.9	23.8	17.2	69.0	48.2	8.7	2.6	16.4	5.1	0.0	6.5	3.7	8.9	5.8	22.1	14.8	11.4	1.2	7.6	11.3	26.1	4.2	19.5	97.0	17.3	2.1	6.7	113.3	8.5	0.5	63.6	42.3	6.6	43.3	91.5	0.4	32.1	1.0	2.9	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.1	0.0	0.0	0.0	0.0	0.0	172.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.0	0.1	19.1	3.1	0.0	0.0	0.1	14.8	0.0	0.3	32.1	0.1	42.8	0.4	2.3	91.5	43.3	0.0	0.6	0.4	1.0	8.1	22.7	2.9	15.8	3.9	6.9	1.2	3.1	3.8	4.9	8.7	2.6	8.9	6.7
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741342-32747215	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.7;lymphoid tissue: 51.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	6.1	2.7	0.5	1.5	0.5	1.5	3.6	0.0	1.5	6.3	1.8	2.1	0.0	1.5	3.8	1.5	2.5	1.9	27.2	16.5	1.0	0.9	12.5	3.5	37.7	43.6	1.3	0.6	1.5	1.5	1.5	1.5	1.9	3.0	7.9	1.5	6.5	19.9	2.5	1.5	4.7	11.7	1.5	5.9	35.5	2.3	1.5	0.0	40.5	3.5	6.7	51.1	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.2	1.0	0.9	1.3	0.6	3.0	0.0
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 74.6"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4"	"Group enriched"	"Detected in all"	6	"B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"				"Rods & Rings"	"Rods & Rings"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	23.9	10.0	3.5	40.4	3.0	9.0	17.0	1.0	4.9	11.0	18.8	8.8	4.5	0.0	9.9	42.6	9.6	8.0	21.7	12.7	4.1	5.3	35.4	9.9	61.2	61.1	6.1	4.2	6.3	4.0	0.0	9.2	4.0	7.9	11.3	10.7	13.5	11.8	5.6	7.8	12.4	27.6	4.6	15.5	74.5	32.7	4.6	2.9	63.5	13.3	7.9	74.6	37.9	7.4	35.6	68.2	4.6	27.8	1.5	7.1	31.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.4	0.0	3.6	0.0	3.6	0.0	111.8	2.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.6	2.0	0.0	0.0	0.1	0.1	0.0	13.4	0.3	12.3	9.3	0.0	0.0	0.0	27.8	4.6	2.4	24.1	1.1	30.9	1.2	3.7	68.2	35.6	0.0	1.1	1.9	1.5	6.6	21.4	7.1	31.9	3.5	3.0	1.0	4.9	4.1	5.3	6.1	4.2	7.9	2.9
HLA-DQB2	HLA-DXB	ENSG00000232629	"Major histocompatibility complex, class II, DQ beta 2"	P05538	6	32756098-32763534	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6;skin 1: 25.8"	"Group enriched"	"Detected in some"	4	"Daudi: 1.0;HDLM-2: 3.6;U-266/70: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Group enriched"	"Detected in many"	7	"B-cells: 3.0;dendritic cells: 3.1;monocytes: 1.2"									HPA073187	Enhanced									"HPA073187: "	"prognostic favourable (5.55e-4)"	"unprognostic (3.75e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.92e-2)"	2.1	0.9	0.4	3.5	0.4	0.3	2.0	0.4	0.3	2.1	0.5	0.6	0.2	0.4	0.3	1.8	5.5	0.6	0.8	0.3	0.3	0.2	1.2	0.4	9.7	3.0	1.3	0.2	0.9	0.2	0.0	0.8	0.2	0.8	0.6	1.1	0.8	2.7	0.8	0.5	25.8	3.1	0.2	1.4	7.2	2.2	0.5	0.3	25.6	1.0	11.3	17.8	1.1	2.3	3.0	3.1	0.3	1.2	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.2	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.4	0.2	0.1	0.2	0.8	0.1	0.1	1.2	0.0	2.8	0.0	0.1	3.1	3.0	0.1	0.1	0.3	0.3	0.4	0.5	0.2	1.2	0.4	0.4	0.4	0.3	0.3	0.2	1.3	0.2	0.8	0.3
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439842-32445046	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 211.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 55.4;HDLM-2: 98.7;REH: 40.2;U-266/70: 24.3;U-698: 56.9;U-87 MG: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.8;intermediate monocyte: 46.8;memory B-cell: 59.4;naive B-cell: 61.7;non-classical monocyte: 28.0;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in all"	5	"B-cells: 61.7;dendritic cells: 29.6;monocytes: 46.8"					"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced					1600000	1600000			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (1.20e-3)"	"unprognostic (4.70e-3)"	"prognostic favourable (5.30e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.52e-2)"	51.8	33.5	14.1	79.1	20.2	1.8	37.3	2.3	10.1	21.1	38.9	21.5	10.9	30.8	16.5	76.8	15.9	33.9	21.8	34.7	13.1	16.2	60.9	17.8	147.2	211.6	27.3	7.4	14.7	10.0	1.7	14.7	9.7	23.5	21.9	33.8	23.5	21.6	12.6	12.9	27.6	86.2	9.0	52.8	127.3	68.7	7.2	21.6	53.7	18.6	25.9	151.6	53.5	15.1	61.7	29.6	9.3	46.8	1.8	2.7	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.4	0.0	0.0	0.0	0.0	0.0	98.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	24.3	0.0	56.9	39.6	0.0	0.0	0.6	29.8	9.3	0.3	46.8	0.1	59.4	0.3	1.7	0.5	61.7	0.2	0.3	2.2	1.8	28.0	29.6	2.7	29.9	14.1	20.2	2.3	10.1	13.1	16.2	27.3	7.4	23.5	21.6
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517343-32530287	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 71.8;lymphoid tissue: 64.8"	"Group enriched"	"Detected in some"	5	"HDLM-2: 109.4;HMC-1: 27.7;U-698: 32.7;U-87 MG: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 26.4"	"Group enriched"	"Detected in many"	10	"B-cells: 13.3;dendritic cells: 26.4;monocytes: 16.0"									HPA043151	Supported									"HPA043151: AB_2678342"	"unprognostic (1.97e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.30e-2)"	"prognostic favourable (7.89e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.68e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.60e-3)"	"unprognostic (9.72e-2)"	"unprognostic (5.48e-2)"	21.8	14.2	2.9	22.1	3.9	3.7	16.2	2.0	3.2	16.7	21.7	7.0	6.4	2.3	8.7	22.1	9.5	12.6	6.6	9.1	4.3	4.0	32.2	9.3	71.8	60.4	7.3	0.8	4.9	4.9	0.0	6.0	4.9	5.4	9.5	10.2	11.2	9.0	2.7	7.4	8.8	34.7	4.7	12.2	64.8	40.3	4.6	4.5	15.3	9.5	11.2	27.6	21.8	6.5	13.3	26.4	1.5	16.0	0.9	1.8	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	109.4	1.1	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	9.6	0.0	0.6	0.1	0.3	0.0	7.4	0.1	32.7	43.2	0.3	0.0	0.0	10.1	1.5	0.4	16.0	0.0	10.5	0.4	1.1	26.4	13.3	0.0	0.5	0.3	0.9	8.1	5.9	1.8	15.4	2.9	3.9	2.0	3.2	4.3	4.0	7.3	0.8	5.4	4.5
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB032200, HPA065612, HPA068442"	Enhanced		Approved	Nucleoplasm,Nucleoli		18000	18000	Nucleoplasm	Nucleoplasm	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (1.29e-6)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	15.8	3.5	14.8	35.7	13.5	55.4	13.0	13.8	19.0	26.1	22.0	5.9	7.7	42.3	8.6	7.2	79.4	15.1	17.8	13.0	11.7	12.6	14.6	6.9	16.0	46.1	10.7	8.7	3.9	13.0	4.1	5.1	31.8	12.5	8.7	21.2	9.9	22.0	6.9	33.7	38.3	36.0	3.8	8.4	31.6	24.2	32.6	7.2	107.3	12.5	39.6	72.7	13.0	29.6	26.6	33.4	12.8	10.1	7.3	22.4	11.0	120.4	47.7	24.5	17.1	11.4	84.6	107.0	48.7	55.7	37.8	21.1	31.2	84.5	56.8	24.6	19.9	25.9	28.8	86.9	30.1	12.4	19.3	17.4	16.1	41.7	24.2	62.2	20.1	36.2	9.7	68.4	35.8	114.1	70.1	2.9	52.6	12.2	53.9	76.6	119.2	80.9	80.2	0.5	62.7	25.6	11.1	42.8	18.1	5.1	24.7	45.0	9.9	66.8	98.9	19.7	62.2	28.6	45.6	23.4	36.2	73.4	41.7	26.0	98.3	6.2	10.1	12.8	10.2	10.1	13.3	26.6	18.7	16.0	30.7	16.4	22.4	17.7	2.6	7.3	9.4	33.4	21.0	11.0	14.8	13.5	13.8	19.0	11.7	12.6	10.7	8.7	12.5	7.2
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol				Microtubules	Microtubules	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (5.52e-4)"	"prognostic unfavourable (1.93e-7)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.1	14.5	1.4	2.6	20.2	20.1	9.8	25.2	22.9	27.0	40.8	35.1	19.2	6.2	24.4	31.3	19.0	43.0	31.8	9.7	21.0	9.5	13.1	0.4	18.6	19.4	0.7	1.1	23.6	18.5	14.3	19.8	28.8	26.2	7.7	19.6	10.6	23.4	14.5	21.4	36.3	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	27.6	14.9	9.3	18.1	15.3	14.4	26.9	15.5	25.9	28.3	11.9	28.8	17.3	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 209.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 110.9;U-138 MG: 64.7;U-87 MG: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4"	"Lineage enriched"	"Detected in many"	6	"monocytes: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		17000	17000	"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	28.4	10.3	4.1	12.5	8.7	16.3	13.8	0.8	20.6	5.7	12.0	6.1	0.6	22.0	2.5	8.5	8.8	9.8	9.8	10.2	4.1	3.1	23.0	63.7	54.0	76.3	12.5	1.3	28.6	8.8	0.5	2.7	21.1	7.5	3.6	4.9	3.3	3.5	0.8	21.9	13.8	22.8	6.9	11.2	209.8	4.6	5.9	7.6	3.6	4.2	7.3	8.3	6.7	10.2	4.8	7.9	8.4	53.4	1.1	0.3	10.1	1.4	22.6	0.2	4.6	18.5	5.4	110.9	10.4	6.2	4.9	5.3	10.0	1.4	0.0	2.3	8.5	1.2	1.3	0.2	1.5	37.3	1.1	0.5	6.9	20.4	25.7	1.4	7.0	17.0	0.4	32.3	2.1	14.7	0.0	10.8	15.6	1.1	0.0	0.5	2.2	2.5	0.1	1.9	3.4	3.5	12.1	0.3	0.3	26.9	2.4	1.8	1.0	0.3	5.5	64.7	2.9	10.5	10.1	6.8	8.7	1.0	62.8	0.6	1.0	2.0	17.7	1.2	0.2	40.5	0.0	4.8	0.1	0.3	7.9	0.5	0.0	0.0	8.4	1.1	53.4	0.2	0.2	10.1	4.1	8.7	0.8	4.8	4.1	3.1	12.5	1.3	7.5	7.6
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffolding protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 61.2;THP-1: 73.6;U-266/84: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 14.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.1;monocytes: 14.7"	"Region enriched"	"Detected in many"	6	"cerebellum: 212.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	Cytosol	"CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	11.4	8.3	11.1	6.5	16.0	12.4	31.0	42.3	12.2	8.7	6.7	17.6	2.1	4.9	8.2	5.2	7.6	4.8	10.9	11.9	15.8	9.0	21.2	4.1	7.0	5.5	19.4	7.2	8.2	5.3	13.6	2.4	9.7	15.5	8.1	4.5	15.4	8.4	7.0	49.2	10.9	5.5	7.6	24.2	64.8	6.5	3.4	14.6	2.2	19.6	7.8	3.3	12.3	16.8	2.4	1.2	5.1	14.7	0.0	0.7	3.6	19.3	5.0	9.6	7.9	8.9	9.0	4.7	19.2	17.0	19.3	9.8	2.5	7.4	0.1	9.1	21.5	12.1	3.3	24.9	10.8	0.6	2.0	0.0	1.6	4.7	8.3	3.7	0.3	7.3	16.1	10.7	14.5	23.4	0.5	5.1	14.0	5.2	0.3	61.2	4.9	20.7	9.5	2.9	9.0	6.9	5.0	0.0	8.1	4.7	5.6	13.5	2.5	73.6	18.6	17.2	7.7	20.7	23.0	49.9	63.2	16.1	27.1	47.3	12.4	0.1	14.7	2.6	0.1	5.1	0.0	2.4	0.7	0.3	1.2	1.7	0.1	0.0	5.1	0.0	1.4	0.2	0.7	3.6	11.1	16.0	42.3	12.2	15.8	9.0	19.4	7.2	15.5	14.6
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954834-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.0;lymphoid tissue: 8.1;skin 1: 6.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 21.8;K-562: 6.0;SiHa: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain									"HPA055632: AB_2682867"	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HRK	DP5	ENSG00000135116	"Harakiri, BCL2 interacting protein"	O00198	12	116856144-116881441	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.3;lymphoid tissue: 12.9;thyroid gland: 8.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;SCLC-21H: 6.5;SH-SY5Y: 5.6;SK-MEL-30: 14.9;U-698: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"eosinophil: 2.2;memory B-cell: 6.7;naive B-cell: 5.5"	"Group enriched"	"Detected in many"	45	"B-cells: 6.7;granulocytes: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB025973	Uncertain									"CAB025973: "	"unprognostic (9.38e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.42e-2)"	0.5	1.9	10.1	1.2	3.2	1.7	2.9	0.5	17.3	0.4	0.6	1.3	0.0	0.4	0.5	0.4	0.5	1.4	0.4	0.6	12.1	3.6	0.4	0.3	0.6	1.9	1.8	4.1	0.4	0.6	0.3	5.0	0.4	2.6	0.4	0.7	0.0	1.0	0.3	1.3	0.6	0.5	0.4	1.1	0.8	0.4	1.4	0.6	12.9	8.1	0.0	1.8	0.4	0.2	6.7	0.0	2.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.0	3.1	1.7	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.7	0.1	0.7	0.0	1.0	0.1	0.0	6.5	5.6	0.4	0.0	14.9	0.4	0.1	0.0	0.0	1.3	0.2	0.0	0.7	0.3	25.8	0.0	0.3	0.0	0.1	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	10.1	3.2	0.5	8.5	12.1	3.6	1.8	4.1	2.6	0.6
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.4;lymphoid tissue: 33.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 18.5;NB-4: 43.6;RPMI-8226: 19.6;U-937: 42.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 47.4"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA036616: "	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (3.47e-5)"	1.2	1.1	1.2	31.5	1.1	19.2	1.2	1.1	1.1	1.4	8.9	0.0	5.2	5.5	1.1	6.2	2.0	1.5	10.3	1.2	1.1	1.1	1.3	1.5	6.0	16.7	1.0	0.0	1.1	4.8	0.9	3.7	2.3	0.3	2.2	4.0	1.0	8.8	5.2	1.1	1.1	12.1	0.7	1.1	21.8	5.4	1.1	0.0	8.5	1.7	2.4	33.8	4.7	1.1	14.5	6.0	47.4	8.4	19.0	4.3	3.6	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	6.8	12.9	0.2	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.2	0.1	0.8	0.0	13.4	18.5	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	2.8	0.0	43.6	0.0	0.0	0.9	0.0	19.6	0.1	1.8	0.0	0.0	0.0	0.4	0.1	0.1	5.0	0.0	0.0	0.0	0.0	0.0	1.9	12.6	7.1	0.0	42.8	0.0	47.4	3.7	23.0	4.3	5.0	3.9	14.5	1.9	2.8	6.0	8.6	1.8	2.3	43.7	19.0	8.4	1.8	2.9	3.6	1.2	1.1	1.1	1.1	1.1	1.1	1.0	0.0	0.3	0.0
HTR3A	"5-HT3A, 5-HT3R, HTR3"	ENSG00000166736	"5-hydroxytryptamine receptor 3A"	P46098	11	113974881-113990313	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 11.1;lymphoid tissue: 12.0;salivary gland: 8.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.1;Daudi: 5.9;NTERA-2: 3.7;SCLC-21H: 19.6"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 15.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"memory B-cell: 4.1;naive B-cell: 9.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	104	"B-cells: 9.7;dendritic cells: 11.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"amygdala: 3.3;cerebral cortex: 4.0;hippocampal formation: 4.2"	HPA069442	Supported									"HPA069442: AB_2732132"	"unprognostic (6.46e-3)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (3.36e-3)"	"unprognostic (8.36e-3)"	"unprognostic (1.65e-5)"	"unprognostic (1.46e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.40e-2)"	0.3	0.5	2.2	4.4	3.9	0.0	0.3	0.3	0.9	0.3	2.5	0.3	0.3	1.0	0.3	0.3	0.8	0.0	0.3	0.3	2.1	0.0	0.3	0.3	0.3	9.7	0.3	0.3	0.3	3.7	0.0	0.3	0.3	0.3	0.3	0.6	0.3	8.6	0.3	0.3	0.6	2.0	1.0	0.3	3.0	0.9	0.3	0.3	0.7	0.3	0.3	12.0	0.3	0.3	9.7	11.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.6	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.6	9.7	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.2	2.2	3.9	0.3	0.9	2.1	0.0	0.3	0.3	0.3	0.3
HVCN1	"Hv1, MGC15619, VSOP"	ENSG00000122986	"Hydrogen voltage gated channel 1"	Q96D96	12	110627841-110704950	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 99.8;lymphoid tissue: 40.6"	"Group enriched"	"Detected in some"	4	"NB-4: 76.4;U-698: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 99.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039329	Enhanced									"HPA039329: AB_10674284"	"unprognostic (3.43e-2)"	"unprognostic (6.32e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.85e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-1)"	4.8	3.3	7.6	17.6	12.2	3.8	3.3	4.7	7.4	5.6	3.9	20.4	3.2	3.0	6.4	7.0	2.9	5.8	5.0	13.8	9.7	11.3	2.6	2.6	8.0	34.6	26.9	5.0	8.6	1.5	1.5	2.0	4.8	36.7	5.9	4.1	14.2	2.6	5.5	4.6	1.9	10.8	6.1	9.4	25.6	4.3	24.5	8.2	5.0	2.5	2.8	40.6	7.5	5.3	99.8	15.4	75.6	24.2	19.8	3.3	18.8	0.0	0.2	0.8	0.0	1.3	1.3	0.4	0.2	0.3	0.7	0.3	0.1	0.0	0.7	0.7	1.3	0.1	0.9	0.0	1.0	0.0	0.2	0.0	0.0	0.2	1.1	11.7	0.8	1.7	0.1	0.6	0.0	1.7	0.5	0.7	1.2	0.0	1.7	76.4	0.9	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.5	0.0	0.0	0.1	0.0	7.5	0.9	23.9	0.0	0.6	0.0	39.8	24.2	75.6	1.7	23.0	0.9	63.0	1.6	2.8	10.4	99.8	3.2	2.1	38.4	19.8	19.9	15.4	3.3	18.8	7.6	12.2	4.7	7.4	9.7	11.3	26.9	5.0	36.7	8.2
HYAL2	"LuCa-2, LUCA2"	ENSG00000068001	"Hyaluronoglucosaminidase 2"	Q12891	3	50317790-50322906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.0"	"Group enriched"	"Detected in all"	4	"HUVEC TERT2: 67.2;TIME: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036436	Uncertain									"HPA036436: AB_10670104"	"unprognostic (9.97e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-3)"	"unprognostic (3.44e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.93e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (7.36e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.62e-2)"	46.5	16.4	5.4	11.0	13.9	1.2	52.1	3.5	7.6	16.0	9.5	6.6	9.0	7.3	18.8	11.3	16.0	16.5	19.9	33.6	11.1	6.0	35.7	20.2	61.1	25.6	7.5	4.0	13.6	11.2	7.9	11.9	34.4	16.3	10.3	4.8	20.4	10.9	9.7	11.6	9.7	9.9	15.1	8.0	107.0	10.2	8.6	5.5	1.1	23.2	16.0	8.3	14.8	20.2	0.9	4.4	8.6	11.3	2.0	3.4	2.6	4.8	7.1	11.7	12.0	7.3	6.3	7.7	5.8	7.6	7.9	6.1	8.2	14.3	1.2	19.7	7.8	5.1	4.4	10.7	2.1	2.6	3.9	1.7	6.6	12.4	6.3	1.4	4.7	9.9	9.0	7.9	2.5	67.2	3.2	1.5	6.4	6.6	3.1	2.9	13.7	11.0	2.8	2.3	4.7	9.7	4.3	3.2	10.2	5.7	5.8	5.8	6.5	3.7	91.9	9.5	9.7	6.4	8.6	2.7	4.3	3.9	5.6	4.6	13.7	0.0	8.0	8.6	1.3	11.3	2.8	0.9	1.1	3.4	4.4	0.9	0.4	0.6	7.6	2.0	10.4	3.3	1.4	2.6	5.4	13.9	3.5	7.6	11.1	6.0	7.5	4.0	16.3	5.5
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 74.5;lymphoid tissue: 63.9"	"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 163.3;TIME: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071155			Approved	"Plasma membrane,Cytosol"		1200000000	1200000000	"Plasma membrane"	"Plasma membrane"	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	36.0	3.6	8.4	13.0	11.5	8.3	34.1	3.5	7.7	9.4	9.7	5.6	2.8	6.4	9.8	5.2	9.5	7.4	8.8	22.8	9.5	8.9	10.5	8.7	27.9	24.0	12.3	3.1	6.3	7.4	3.1	4.5	36.8	9.1	7.9	8.5	8.1	8.8	4.3	17.1	5.5	10.8	13.9	10.5	63.9	8.0	4.0	7.4	14.3	11.6	9.0	18.0	12.8	23.6	49.0	30.9	56.5	74.5	26.0	65.3	67.5	0.0	0.0	0.0	0.0	1.3	1.5	0.4	0.1	0.1	0.0	0.1	0.3	6.8	11.5	2.1	0.0	0.0	0.1	0.0	0.2	2.5	0.0	10.3	0.6	1.2	0.2	1.7	0.0	0.0	0.0	0.1	0.0	163.3	8.4	6.7	0.0	0.0	12.8	1.5	0.0	0.0	7.8	0.0	15.9	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	41.2	0.0	0.1	0.8	0.0	6.4	2.2	10.2	0.0	2.1	0.0	56.5	30.0	8.9	45.8	66.5	52.8	36.5	60.1	42.8	30.9	49.0	65.3	40.7	3.6	26.0	74.5	10.0	64.5	67.5	8.4	11.5	3.5	7.7	9.5	8.9	12.3	3.1	9.1	7.4
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339823	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;NB-4: 41.4;RPMI-8226: 48.2;U-266/84: 34.1;U-937: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 172.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 172.3"									"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		370000000	370000000	Mitochondria	Mitochondria	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	6.8	2.8	1.7	23.5	1.9	51.5	5.5	0.6	1.5	3.0	6.8	1.1	1.2	4.3	1.7	3.0	4.0	2.9	7.2	6.4	1.1	0.9	5.1	28.7	13.2	68.5	1.8	1.4	1.7	6.8	0.2	0.4	4.8	1.5	2.8	3.3	2.4	10.3	1.3	5.0	1.6	11.9	1.8	1.0	39.4	5.4	1.4	1.0	47.6	3.0	5.7	38.4	4.5	4.9	25.5	28.4	172.3	33.5	31.0	41.0	43.1	2.6	1.3	0.9	2.9	1.6	1.3	1.6	1.6	1.1	1.4	1.2	1.1	1.8	0.0	5.7	1.4	1.1	0.0	1.2	0.4	19.8	0.8	5.0	1.2	5.0	0.8	18.3	20.7	1.1	1.0	1.6	0.5	0.6	2.7	64.3	1.5	5.4	2.4	41.4	0.7	9.0	1.5	0.6	48.2	1.4	2.3	0.3	1.2	1.4	4.5	3.6	3.9	5.2	1.1	6.3	0.5	7.0	1.6	3.1	34.1	7.6	4.5	33.8	4.9	15.3	33.1	72.0	33.8	24.4	41.0	25.5	32.7	31.2	28.4	23.9	29.3	27.4	172.3	31.0	33.5	4.8	36.9	43.1	1.7	1.9	0.6	1.5	1.1	0.9	1.8	1.4	1.5	1.0
IFNA2	"IFN-alphaA, IFNA"	ENSG00000188379	"Interferon alpha 2"	P01563	9	21384254-21385388	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.6;brain: 1.3;lymphoid tissue: 1.1"	"Cell line enriched"	"Detected in single"	11	"HeLa: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"									HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.1	0.0	0.8	0.1	1.3	0.8	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	1.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.3	0.4	1.0	0.4	0.6	0.1	0.1	0.1
IFNA21	IFN-alphaI	ENSG00000137080	"Interferon alpha 21"	P01568	9	21165637-21166660	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.2;brain: 2.1;lymphoid tissue: 1.4"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"									HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.0	0.4	0.3	0.3	0.9	0.0	0.0	2.1	0.9	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.3	1.3	0.0	0.0	0.1	1.4	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.3	0.0	0.2	0.2	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IGLL5		ENSG00000254709	"Immunoglobulin lambda like polypeptide 5"	B9A064	22	22887780-22896107	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 87.9;lymphoid tissue: 102.9"	"Group enriched"	"Detected in some"	7	"Daudi: 101.1;U-266/70: 72.4;U-698: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	230	"memory B-cell: 87.9;naive B-cell: 72.8"	"Lineage enriched"	"Detected in single"	252	"B-cells: 87.9"														"Secreted to blood"	120000000000	120000000000				"prognostic favourable (6.10e-4)"	"unprognostic (7.64e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"prognostic favourable (3.41e-5)"	"unprognostic (1.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (5.94e-8)"	"unprognostic (1.85e-1)"	"unprognostic (4.63e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.50e-2)"	3.5	1.8	1.3	82.6	1.5	6.5	12.3	1.3	1.5	3.3	37.7	1.4	1.3	39.0	1.5	1.7	7.5	4.3	5.8	1.3	1.3	0.3	4.6	3.6	10.8	22.8	1.5	1.3	2.1	1.3	0.0	1.3	1.5	1.7	2.1	23.3	3.3	42.9	2.8	1.5	0.6	25.2	1.3	1.3	102.9	27.7	3.1	1.3	5.8	5.8	2.9	69.8	38.2	2.6	87.9	0.3	0.1	0.0	0.0	0.0	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	101.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	72.4	11.7	68.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.9	0.0	0.0	0.1	72.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	10.7	1.3	1.5	1.3	1.5	1.3	0.3	1.5	1.3	1.7	1.3
IGSF21	"MGC15730, RP11-121A23.1"	ENSG00000117154	"Immunoglobin superfamily member 21"	Q96ID5	1	18107746-18378483	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.5;lymphoid tissue: 16.5"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	7900	7900				"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.85e-4)"	"unprognostic (3.76e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	3.1	9.0	14.1	1.7	12.3	1.6	6.0	48.5	32.7	3.0	1.8	7.2	0.0	0.9	1.9	1.8	2.6	1.8	2.4	1.8	21.1	10.4	1.7	1.7	2.5	1.3	10.9	13.9	2.0	4.1	1.8	1.1	3.3	10.1	4.5	1.5	5.5	1.9	3.0	1.4	1.5	1.2	2.7	6.5	16.5	1.6	1.8	4.5	0.0	1.4	0.0	2.1	4.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	12.3	48.5	27.4	21.1	10.4	10.9	13.9	10.1	4.5
IHH	"BDA1, HHG2"	ENSG00000163501	"Indian hedgehog"	Q14623	2	219054420-219060467	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.1;intestine: 42.8;lymphoid tissue: 20.2"	"Cell line enriched"	"Detected in some"	10	"CACO-2: 20.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	13000000	13000000				"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.63e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.81e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.91e-2)"	0.1	0.1	0.1	20.2	0.1	0.0	0.1	0.3	0.2	4.5	33.1	0.1	0.7	10.7	14.3	10.3	0.7	0.7	19.1	0.1	0.1	0.2	3.7	3.4	3.3	0.1	0.1	0.1	0.7	0.1	0.0	0.6	0.2	0.1	2.3	11.4	8.2	0.1	1.1	0.1	0.1	42.8	0.5	0.1	0.1	11.6	0.3	0.1	0.1	1.1	0.1	0.1	0.9	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.8;lymphoid tissue: 19.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 25.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol				Cytosol	Cytosol	"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.1	0.9	1.0	17.3	3.4	4.3	1.4	1.1	1.7	2.2	4.8	1.5	1.7	3.9	2.0	3.9	6.1	1.2	3.6	1.1	2.9		1.5	0.6	3.7	13.6	2.1	0.7	1.0	1.5	0.0	0.8	2.5	1.9	1.8	4.3	1.5	8.3	2.9	0.1	8.9	4.2	1.0	2.9	12.8	4.0	0.0	2.4	18.8	2.6	4.4	19.5	4.4	0.4	12.9	4.6	4.2	15.9	10.8	24.8	12.3	8.8	7.0	1.9	0.2	3.5	5.0	2.0	3.6	11.3	4.9	5.5	5.5	14.4	17.5	9.7	7.2	12.0	0.0	9.1	1.0	2.8	1.7	2.4	4.2	3.8	4.6	14.9	8.0	6.5	1.6	4.0	0.8	7.1	1.1	5.4	5.1	1.8	9.5	25.1	2.8	5.4	5.1	2.1	14.0	5.8	15.1	0.0	0.0	1.5	12.0	2.2	7.2	10.6	13.7	4.9	3.0	3.5	4.0	1.8	0.8	11.4	9.2	12.5	2.0	4.2	15.9	0.3	10.5	11.2	7.5	12.9	16.7	15.2	4.6	7.4	13.3	13.6	1.1	10.8	6.4	1.5	24.8	12.3										
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 26.6;HDLM-2: 45.2;HMC-1: 42.4;MOLT-4: 33.1;REH: 35.8;U-698: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced									"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favourable (4.28e-4)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favourable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	3.5	1.5	2.9	25.5	3.8	55.2	2.3	0.7	1.8	1.6	3.6	2.8	0.8	2.4	1.6	2.1	2.2	2.4	2.9	1.6	3.4	1.8	2.5	2.3	8.3	44.4	5.9	1.1	1.1	1.3	0.2	1.2	1.2	3.4	2.2	2.5	1.5	5.2	0.7	0.9	1.9	14.5	1.4	5.1	31.0	3.7	1.1	4.1	86.7	2.4	1.2	26.3	4.5	2.9	24.0	12.6	12.8	23.6	12.8	28.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.0	9.1	0.0	0.0	0.0	16.1	42.4	0.0	0.0	0.0	0.0	0.0	11.7	3.1	0.0	0.0	33.1	16.0	0.4	0.0	35.8	0.0	7.5	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.0	22.2	0.0	0.0	0.3	0.0	0.0	14.5	7.4	68.0	0.1	17.5	0.1	10.2	7.7	12.8	20.4	23.6	17.0	24.0	21.2	19.9	8.2	21.3	28.7	20.7	11.2	12.8	22.3	12.6	17.1	12.7	2.9	3.8	0.7	1.8	3.4	1.8	5.9	1.1	3.4	4.1
IKZF2	"Helios, ZNFN1A2"	ENSG00000030419	"IKAROS family zinc finger 2"	Q9UKS7	2	212999691-213152427	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 19.2;RT4: 18.3;U-698: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059142	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA059142: AB_2683923"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.93e-3)"	"unprognostic (7.09e-2)"	3.4	2.4	6.1	4.1	12.4	5.9	4.0	8.0	8.6	4.9	2.6	5.3	7.6	1.0	2.3	3.9	24.8	3.4	3.6	2.8	6.3	2.6	2.1	2.1	3.7	7.4	11.8	3.4	2.5	3.0	9.7	6.9	3.2	8.6	5.4	2.0	2.3	13.5	9.2	4.3	10.4	2.5	1.2	9.1	5.9	5.2	2.8	13.4	55.8	9.2	5.5	7.5	11.9	11.6	1.5	0.7	5.7	0.0	7.2	7.1	0.3	1.8	0.6	3.5	0.2	11.5	11.6	2.2	2.2	2.5	0.5	1.1	0.9	3.0	2.3	2.9	1.3	4.2	0.0	1.1	1.8	0.0	0.6	1.2	2.3	0.3	0.1	5.5	0.4	11.3	1.0	0.0	0.3	0.0	0.7	2.0	1.0	3.3	19.2	5.6	0.7	0.5	11.4	2.3	0.0	1.0	18.3	1.1	0.6	0.0	2.3	0.0	3.1	0.6	5.9	3.3	2.5	1.5	0.4	3.9	1.2	13.2	1.6	0.0	0.7	4.1	0.0	5.7	2.5	0.0	6.5	0.2	0.8	1.9	0.0	1.5	0.4	1.9	0.0	7.2	0.0	0.7	7.1	0.3	6.1	12.4	8.0	8.6	6.3	2.6	11.8	3.4	8.6	13.4
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757715-39864188	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.7;lymphoid tissue: 55.1"	"Group enriched"	"Detected in some"	4	"Daudi: 26.5;Karpas-707: 14.0;U-266/70: 16.9;U-266/84: 18.8;U-698: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 8.3;T-cells: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024377, HPA073266"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favourable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favourable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favourable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.7	0.7	0.5	41.7	0.5	3.1	1.0	0.5	0.5	1.1	4.5	0.0	0.6	1.8	1.2	0.6	3.6	1.2	2.4	0.9	0.6	0.6	1.5	1.4	5.3	30.5	0.6	0.0	0.9	0.9	0.0	0.7	0.4	0.1	1.5	1.7	1.2	5.5	1.3	0.6	0.8	11.3	1.2	0.9	41.0	3.3	2.6	0.1	55.1	1.6	1.8	54.1	4.0	1.3	8.3	0.3	0.7	0.1	2.6	17.7	4.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.1	1.6	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	14.0	0.0	0.1	2.3	0.9	0.1	0.0	0.1	0.1	4.8	0.0	1.6	0.1	0.1	0.5	0.2	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.0	16.9	18.8	43.1	0.0	0.1	0.0	0.5	0.1	0.4	16.3	0.1	17.7	8.3	6.7	12.1	0.0	7.7	2.8	7.5	0.7	2.6	0.1	0.3	10.6	4.1	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.0	0.1	0.1
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206772494	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.3"	"Group enriched"	"Detected in some"	8	"HMC-1: 18.2;U-266/70: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;intermediate monocyte: 4.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB013120, HPA071391"	Approved				"Secreted to blood"					"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	10.9	3.1	1.1	10.7	1.2	4.1	2.1	0.3	1.3	1.6	1.8	2.1	0.5	0.8	1.0	1.9	1.7	4.0	5.2	3.9	0.8	0.9	1.3	3.1	4.3	9.2	1.8	0.9	1.5	1.2	0.4	2.3	3.6	2.3	1.7	1.8	2.1	1.6	0.8	0.9	0.7	2.1	4.6	2.2	28.3	2.0	1.6	1.4	2.2	2.4	0.9	3.5	4.1	1.0	0.2	0.5	0.5	5.4	0.1	1.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	9.3	0.3	0.3	0.0	0.1	0.0	0.5	5.4	0.1	0.2	4.0	0.0	0.1	0.2	1.0	0.5	0.2	0.1	0.1	0.3	0.1	1.4	0.1	0.9	1.0	1.1	1.2	0.3	1.3	0.8	0.9	1.8	0.9	2.3	1.4
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986348-118003037	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.5;HDLM-2: 36.2;Karpas-707: 13.6;RPMI-8226: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.27e-2)"	"prognostic favourable (4.47e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.70e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (1.45e-5)"	"unprognostic (1.82e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-1)"	11.3	6.5	2.9	29.6	3.5	27.2	7.2	1.1	3.0	3.4	7.9	4.7	0.5	3.8	5.5	11.0	4.3	4.9	9.7	7.6	3.0	3.6	5.0	6.4	13.6	49.8	4.7	1.4	3.4	3.6	1.3	3.4	6.9	4.5	5.8	7.5	6.4	7.9	1.9	2.6	3.0	17.6	5.0	8.0	56.2	4.9	3.1	3.5	9.6	3.6	3.9	32.2	9.5	3.4	4.6	15.4	1.2	23.9	23.7	30.7	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.1	0.0	0.0	0.2	0.0	0.0	36.2	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	2.6	13.6	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	3.8	0.0	5.4	0.0	1.1	15.8	0.8	19.7	23.9	14.2	4.6	19.0	22.7	15.4	2.3	6.9	12.3	1.2	23.7	18.8	6.0	30.7	22.8	2.9	3.5	1.1	3.0	3.0	3.6	4.7	1.4	4.5	3.5
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314783-159330887	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 10.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;NB-4: 2.7;SCLC-21H: 3.6"	"Cancer enriched"	"Detected in single"	20	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"					"HPA040970: AB_10796234"	"unprognostic (5.96e-5)"	"unprognostic (4.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.40e-1)"		"unprognostic (9.13e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-2)"	0.2	0.2	0.2	0.7	0.2	1.4	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	1.2	0.4	0.2	0.7	0.2	0.2	0.2	0.6	0.3	0.9	1.8	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	0.2	0.6	0.2	0.7	0.2	0.2	1.3	0.5	0.2	0.2	1.8	0.9	0.5	0.2	10.8	0.4	0.2	0.9	0.3	0.2	1.1	0.3	2.9	0.5	1.0	0.2	0.0	0.3	0.4	0.6	0.7	0.1	0.0	0.2	0.5	0.0	0.0	0.5	0.5	0.9	0.5	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.8	0.1	1.4	0.2	0.1	0.4	1.1	0.3	0.3	0.1	0.0	0.1	0.2	2.9	0.0	0.2	0.5	2.7	0.6	0.4	0.5	0.7	1.8	0.0	0.2	3.6	0.2	0.3	0.3	0.0	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.2	0.1	0.2	0.7	0.5	0.2	1.7	0.5	0.2	0.2	0.1	0.1	1.1	0.2	0.1	0.1	0.3	0.2	0.2	2.9	1.0	0.1	0.3	0.1	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2
IL12RB1	"CD212, IL12RB"	ENSG00000096996	"Interleukin 12 receptor subunit beta 1"	P42701	19	18058995-18098944	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.6;lymphoid tissue: 21.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.4;HDLM-2: 17.6;Karpas-707: 30.1;U-698: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA074414			Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA074414: AB_2686687"	"unprognostic (7.70e-3)"	"prognostic favourable (3.41e-4)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavourable (5.90e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.93e-2)"	1.9	1.5	1.3	17.5	2.1	5.6	1.2	0.5	1.0	0.9	3.4	2.4	1.1	2.9	1.0	2.4	1.3	1.5	2.5	1.4	1.3	1.2	1.8	1.8	5.0	16.0	2.0	0.2	1.1	1.3	1.2	1.1	2.4	1.4	1.7	2.0	1.1	6.6	0.2	0.9	1.0	8.0	1.0	2.4	21.4	2.3	0.7	2.2	10.1	1.3	0.7	16.9	3.8	1.0	4.9	5.9	6.2	14.0	16.2	28.6	9.0	0.2	0.1	0.1	0.2	0.0	0.1	0.5	0.1	0.1	0.2	0.6	0.2	1.0	10.4	0.1	0.1	0.2	0.1	0.0	0.0	17.6	0.2	1.2	0.3	0.2	0.4	0.7	1.7	0.0	0.0	0.3	0.1	0.0	0.2	30.1	0.0	0.1	4.9	0.2	0.1	0.1	3.5	0.1	0.4	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.2	5.7	0.2	0.3	0.3	0.1	0.1	3.6	5.4	8.8	0.4	6.0	0.7	3.3	5.1	3.6	22.8	14.0	28.6	4.9	15.5	18.3	5.9	3.7	8.7	15.2	6.2	16.2	13.2	3.5	20.5	9.0	1.3	2.1	0.5	1.0	1.3	1.2	2.0	0.2	1.4	2.2
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.7;lymphoid tissue: 97.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HEL: 12.9;HMC-1: 23.3;RPMI-8226: 22.1;U-266/70: 27.7;U-698: 11.4;U-937: 15.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 40.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"cerebellum: 61.1;hippocampal formation: 29.7"	"Region enriched"	"Detected in single"	38	"cerebellum: 96.7"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Midbody ring,Cytosol"	"Secreted to blood"	14000	14000	"Nuclear speckles"	"Nuclear speckles"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	8.8	2.4	4.1	48.0	5.8	19.5	7.8	40.1	4.3	4.7	4.8	4.6	0.9	3.8	5.4	2.9	3.4	9.7	5.6	5.1	4.9	2.1	2.5	3.9	14.7	58.0	5.8	2.3	3.7	1.7	0.7	1.4	3.0	6.7	3.5	5.9	3.4	13.5	1.5	1.8	6.1	19.2	3.3	7.8	38.2	5.0	2.2	5.5	97.9	3.7	2.4	54.8	8.7	5.4	43.3	37.1	75.7	35.0	49.3	60.5	66.5	0.0	0.0	0.0	0.0	8.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.0	0.4	9.1	23.3	0.4	0.0	0.0	0.2	0.1	1.3	4.9	0.0	0.0	0.7	9.7	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	2.0	0.1	0.1	0.1	0.4	0.0	27.7	2.3	11.4	0.8	15.5	0.7	52.7	27.4	75.7	43.1	35.0	48.6	43.3	45.1	47.1	37.1	39.9	60.5	48.6	69.1	49.3	33.7	28.0	47.0	66.5	4.1	5.8	40.1	4.3	4.9	2.1	5.8	2.3	6.7	5.5
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 27.0;NB-4: 23.7;THP-1: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	20000	20000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favourable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	17.7	7.6	6.5	13.6	13.8	40.5	24.7	4.0	6.7	8.6	8.1	7.7	4.6	6.2	7.4	9.4	6.8	7.8	7.4	8.8	6.1	4.9	8.3	11.6	16.8	39.2	10.3	2.0	7.7	7.7	6.9	5.4	6.2	8.3	6.9	5.7	5.3	7.0	5.3	5.3	8.6	9.1	8.3	11.2	23.4	7.3	5.3	9.7	50.0	7.9	3.2	11.0	6.3	12.8	0.5	3.6	15.6	6.9	1.4	2.4	2.0	3.6	2.1	1.9	2.4	3.8	2.2	2.4	5.3	3.5	2.5	3.2	2.0	2.4	3.3	2.2	5.3	5.8	2.6	2.5	1.8	5.3	3.1	0.0	1.2	1.2	4.4	27.0	8.4	3.3	3.7	2.2	1.7	2.7	1.4	3.4	2.5	3.0	3.2	23.7	1.0	2.0	0.7	0.4	0.6	2.4	2.7	1.3	0.0	3.7	3.2	2.6	2.5	34.1	7.4	2.0	2.8	2.9	1.9	2.8	1.5	1.6	2.8	13.1	2.1	6.7	6.9	6.1	1.1	3.2	0.9	0.4	1.5	1.1	3.6	0.5	2.4	1.8	15.6	1.4	2.9	1.7	0.9	2.0	6.5	13.8	4.0	6.7	6.1	4.9	10.3	2.0	8.3	9.7
IL17REL	FLJ41993	ENSG00000188263	"Interleukin 17 receptor E like"	Q6ZVW7	22	49994513-50012659	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.7;stomach 1: 4.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;SK-BR-3: 3.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.9;hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045546	Supported									"HPA045546: AB_10963836"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.65e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-2)"	0.1	0.1	0.3	11.7	0.3	0.0	0.1	0.2	1.9	0.3	0.4	0.0	0.0	1.7	0.2	0.9	0.2	0.3	0.0	0.1	0.2	1.4	0.1	0.1	0.8	3.9	0.4	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.3	0.5	0.0	2.0	0.0	0.1	0.3	3.3	0.0	0.1	1.9	4.6	0.6	0.0	8.1	0.2	0.6	8.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	3.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.9	0.2	1.4	0.4	0.0	0.0	0.0
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	14000000	14000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.6	6.2	3.5	1.3	1.9	7.0	3.3	1.9	3.2	4.5	13.0	2.5	1.2	2.6	1.6	5.0	3.7	2.7	2.6	2.9	4.3	5.2	7.0	3.7	1.4	3.0	12.4	2.9	3.1	3.0	1.6	6.3	8.8	2.2	1.8	3.4	3.8	6.4	4.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.7	4.2	4.9	4.2	2.7	13.7	5.3	4.1	6.1	2.1	3.6	2.1	2.5	2.3	10.9	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 34.6;bone marrow: 50.2;lymphoid tissue: 29.8"	"Cell line enriched"	"Detected in some"	10	"U-937: 34.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 34.6"	"Group enriched"	"Detected in many"	108	"granulocytes: 22.5;NK-cells: 34.6;T-cells: 22.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced									"CAB025270: "	"unprognostic (1.73e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.07e-3)"	"unprognostic (4.64e-6)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.86e-5)"	"unprognostic (5.09e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.73e-2)"	3.6	0.3	0.2	6.1	0.5	50.2	0.9	0.3	0.4	1.2	4.8	0.5	0.0	1.2	1.2	2.1	0.8	3.8	3.0	2.1	0.2	0.2	0.9	2.6	9.6	16.4	0.9	0.0	1.1	0.4	0.0	0.9	0.8	0.2	0.6	0.9	1.5	0.8	0.3	0.6	0.2	8.1	1.0	1.0	29.8	1.5	1.3	0.0	1.3	0.8	0.9	3.5	2.5	1.3	0.0	0.2	22.5	0.0	34.6	22.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.2	0.0	0.0	6.1	15.7	0.0	22.1	0.0	2.0	4.2	0.1	0.0	0.0	0.5	22.5	34.6	0.0	0.2	0.1	2.0	0.2	0.5	0.3	0.4	0.2	0.2	0.9	0.0	0.2	0.0
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773915-112784590	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 84.8;hTCEpi: 41.9;hTERT-HME1: 55.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.41e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.7	0.3	0.7	1.2	1.4	0.8	0.3	0.2	1.2	5.8	0.3	2.3	0.5	0.0	2.6	0.7	17.6	0.3	2.4	0.3	3.1	0.8	0.2	0.2	3.7	0.2	1.2	0.1	0.3	0.2	0.3	0.4	3.1	2.1	0.3	0.1	0.0	1.9	1.2	0.2	1.2	0.3	0.0	1.8	0.5	0.2	10.9	1.2	0.0	0.2	17.9	22.2	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.1	0.0	10.2	0.0	0.6	0.0	84.8	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	41.9	0.7	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.2	0.9	3.1	0.8	1.2	0.1	2.1	1.2
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836903	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.3;lymphoid tissue: 35.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 92.5;HBEC3-KT: 42.0;HMC-1: 34.3;hTEC/SVTERT24-B: 46.3;U-87 MG: 84.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 34.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.4"	"Low region specificity"	"Detected in some"												"Secreted to blood"						"unprognostic (1.55e-3)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavourable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	19.6	3.3	4.2	20.4	15.3	62.3	0.8	1.1	10.8	1.6	3.2	12.7	0.2	1.2	3.0	1.5	3.5	3.4	7.5	3.7	19.0	3.6	1.7	4.0	17.3	5.0	5.9	0.3	3.4	2.4	2.4	3.0	10.3	24.9	2.6	2.6	1.0	2.2	0.8	0.4	0.9	3.7	3.5	29.7	35.4	20.9	1.6	5.8	0.8	1.1	13.5	14.0	10.4	1.2	0.0	6.9	34.4	7.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.5	0.4	1.0	0.0	0.0	0.0	2.6	0.0	2.1	0.0	42.0	5.7	0.0	0.0	4.1	0.0	0.0	0.3	0.0	34.3	0.1	1.3	46.3	15.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	3.5	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	84.5	1.9	3.2	0.5	4.2	1.5	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	34.4	0.0	2.7	0.0	0.0	1.0	4.2	15.3	1.1	10.8	19.0	3.6	5.9	0.3	24.9	5.8
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991844-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.2;lymphoid tissue: 74.1"	"Cell line enriched"	"Detected in some"	19	"HDLM-2: 100.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.2"	"Cell type enriched"	"Detected in some"	25	"neutrophil: 73.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 73.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	21000000	21000000			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	9.1	3.2	1.2	16.4	1.9	22.3	1.6	1.2	1.9	6.4	13.4	0.4	0.1	0.1	1.3	1.3	20.4	9.7	3.4	15.1	1.2	0.5	5.8	8.2	25.5	74.1	9.2	0.2	2.5	1.4	0.0	2.4	24.9	2.2	1.1	20.0	1.8	4.3	0.8	2.8	14.1	2.2	1.3	4.4	47.5	14.6	1.6	1.1	1.6	1.8	8.5	25.1	3.2	9.1	0.0	2.8	73.2	0.8	0.0	1.1	0.2	1.5	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.6	0.0	0.1	0.0	100.0	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	73.2	0.0	0.0	0.0	1.1	0.2	1.2	1.9	1.2	1.9	1.2	0.5	9.2	0.2	2.2	1.1
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell line enhanced"	"Detected in some"		"A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"			Nucleoplasm	Nucleoplasm	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavourable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	40.8	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.1	7.7	0.0	5.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	0.3	0.0	0.0	11.5	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.0	3.9	4.6	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.4;lymphoid tissue: 1.9"	"Cell line enriched"	"Detected in single"	23	"MOLT-4: 2.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB010310	Uncertain				"Secreted to blood"					"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.6	0.0	0.0	0.6	0.0	0.4	0.5	0.0	0.0	0.9	0.3			0.5	0.1	0.0	0.8	0.6	0.5	0.0	0.0	0.0	0.2	0.3	0.7	1.1	0.0		0.1	0.0	0.0	0.0	0.0		0.4	1.9		0.1	0.0	0.0	0.4	2.4	0.0	0.2	0.8	0.3	0.0			0.4		1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL22	"IL-21, IL-22, IL-D110, IL-TIF, ILTIF, MGC79382, MGC79384, TIFa, TIFIL-23, zcyto18"	ENSG00000127318	"Interleukin 22"	Q9GZX6	12	68248242-68253607	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.8;urinary bladder: 3.6"	"Cell line enhanced"	"Detected in single"		"hTERT-HME1: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted to blood"								"unprognostic (2.57e-1)"											"unprognostic (4.24e-2)"				0.2	0.0	0.0	2.8	0.0	0.1	0.0	1.0	0.0	0.0	0.2			0.5	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.5	0.0	0.0	0.0	1.5	0.8	0.0	0.1	0.0	0.7			0.0		0.6	3.6	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.0;lymphoid tissue: 15.2;testis: 12.1"	"Cell line enhanced"	"Detected in some"		"A-431: 9.2;CAPAN-2: 16.1;U-266/70: 27.0;U-266/84: 12.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"MAIT T-cell: 8.4;memory B-cell: 10.6;memory CD4 T-cell: 15.5;memory CD8 T-cell: 7.4;naive B-cell: 10.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 10.6;T-reg: 8.4"	"Group enriched"	"Detected in many"	14	"B-cells: 10.6;T-cells: 17.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"			Cytosol	Cytosol	"HPA001554: AB_1079135"	"unprognostic (2.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.03e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.50e-3)"	0.7	0.5	0.4	3.9	0.5	3.6	0.4	0.3	0.3	0.5	0.6	0.3	0.3	0.0	1.3	0.8	6.0	0.5	2.0	0.3	0.4	0.5	1.3	1.4	1.2	7.5	0.4	0.3	0.3	1.1	0.0	1.1	0.6	0.3	1.0	0.2	0.3	1.8	0.3	0.3	0.8	2.5	1.0	0.4	2.8	0.7	12.1	0.3	12.9	0.6	10.4	15.2	7.4	0.6	10.6	0.5	0.1	0.2	1.0	17.0	5.9	9.2	0.2	0.3	0.3	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.4	16.1	0.5	4.8	0.0	0.8	0.0	1.6	0.0	0.6	0.3	0.2	0.1	0.7	0.0	0.2	0.5	0.1	0.0	0.0	0.4	0.0	0.4	4.0	0.0	0.4	0.3	0.5	1.4	0.2	0.2	0.1	0.4	5.5	4.6	0.3	0.4	0.2	0.2	0.8	0.1	4.3	0.3	0.3	0.3	0.3	1.1	27.0	12.1	1.2	0.3	2.3	0.2	0.0	0.2	0.0	1.7	0.0	8.4	10.6	15.5	7.4	0.5	10.6	17.0	10.6	0.1	1.0	0.0	0.0	8.4	5.9	0.4	0.5	0.3	0.3	0.4	0.5	0.4	0.3	0.3	0.3
IL23R	IL-23R	ENSG00000162594	"Interleukin 23 receptor"	Q5VWK5	1	67138907-67259979	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 18.1;lymphoid tissue: 11.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.6;HMC-1: 10.5;K-562: 3.9;U-2197: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 18.1"	"Lineage enriched"	"Detected in single"	35	"T-cells: 18.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056427	Uncertain									"HPA056427: AB_2683129"	"unprognostic (4.01e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.41e-3)"	0.2	4.8	0.2	11.0	0.3	0.0	0.2	0.2	0.2	0.2	2.4	0.2	0.0	0.9	0.3	1.0	0.3	0.2	0.6	0.2	0.2	0.2	0.3	0.5	0.5	4.8	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.2	2.6	0.6	2.3	0.0	0.2	0.2	2.7	0.0	0.2	3.3	1.3	4.1	0.0	1.2	0.2	1.4	7.6	0.9	0.3	0.0	0.0	0.0	0.0	0.5	18.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	2.6	10.5	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	15.8	0.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	18.1	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
IL24	"C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16"	ENSG00000162892	"Interleukin 24"	Q13007	1	206897443-206904139	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.7;lymphoid tissue: 22.5"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 62.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 18.7;T-cells: 12.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.9"	CAB025972	Uncertain				"Secreted to blood"					"CAB025972: "	"prognostic favourable (5.09e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.09e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.43e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.33e-2)"	5.3	0.0	0.2	9.2	0.2	1.6	0.2	0.2	0.4	0.2	1.3	0.2	0.2	0.3	0.9	0.7	0.9	1.4	1.7	0.8	0.2	0.0	0.6	2.4	2.5	22.5	0.2	0.2	0.9	0.2	0.0	0.2	1.1	1.3	1.3	0.0	0.2	0.2	0.2	3.9	0.2	1.3	0.2	0.2	19.6	0.9	0.5	0.2	0.4	0.2	0.9	2.7	3.3	0.3	18.7	0.4	0.7	0.0	3.4	12.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.9	7.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.1	5.0	0.0	0.0	0.0	0.8	0.4	2.7	0.1	3.3	0.2	0.5	0.5	0.0	0.1	0.4	0.0	0.0	4.3	0.0	6.2	18.7	6.8	6.4	0.0	18.6	11.8	6.5	0.7	3.4	0.0	0.4	12.0	3.6	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.2	1.3	0.2
IL26	"AK155, IL-26"	ENSG00000111536	"Interleukin 26"	Q9NPH9	12	68201351-68225821	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.0;tongue: 5.4;urinary bladder: 4.4"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 2.2;memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;T-reg: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"					"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (2.71e-1)"	"unprognostic (8.87e-2)"			"unprognostic (3.26e-5)"		"unprognostic (7.10e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.96e-1)"		"unprognostic (3.69e-5)"	"unprognostic (3.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.79e-2)"	0.1	0.0	0.5	6.0	0.2	0.0	0.0	0.7	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.1	0.5	0.3	1.0	0.2	0.1	0.1	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	2.3	0.0	0.0	0.5	1.4	0.0	0.1	1.1	0.3	0.3	0.0	0.5	0.1	5.4	3.5	4.4	0.3	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	1.5	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.5	0.2	0.7	0.1	1.0	0.2	0.1	0.0	0.0	0.0
IL27RA	"CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1"	ENSG00000104998	"Interleukin 27 receptor subunit alpha"	Q6UWB1	19	14031748-14053216	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 25.2;lymphoid tissue: 32.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA073441			Approved	Vesicles		4100000	4100000	Vesicles	Vesicles	"HPA073441: "	"prognostic favourable (1.74e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (2.58e-10)"	"unprognostic (5.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.87e-3)"	8.4	2.1	2.8	26.0	2.7	3.5	20.6	3.0	3.5	3.5	3.9	1.1	2.7	3.6	3.6	2.0	3.4	4.2	4.1	5.8	3.8	3.6	4.8	2.1	11.8	25.3	2.6	2.3	2.3	3.5	8.1	1.1	2.0	2.5	5.0	3.4	1.2	7.4	2.1	2.8	2.6	9.0	3.0	2.5	18.0	4.1	2.4	1.6	32.3	4.9	2.2	28.3	6.0	6.8	14.6	18.2	5.3	19.7	19.1	25.2	16.9	8.1	3.5	3.6	4.8	0.3	1.9	1.5	3.8	8.0	7.0	10.1	1.7	6.7	0.1	4.1	3.4	1.6	5.6	2.2	5.5	15.7	3.9	19.9	0.8	2.9	0.6	9.5	0.3	1.8	0.9	3.3	0.7	2.8	13.7	14.9	0.3	11.4	7.1	20.7	4.7	2.5	6.2	2.1	7.6	4.3	1.9	3.2	1.7	4.9	0.3	5.5	6.2	5.8	4.4	0.7	8.8	7.1	4.1	15.5	7.4	7.2	0.6	19.4	4.6	5.3	19.7	0.5	22.9	16.3	20.2	14.6	22.7	18.9	18.2	12.8	25.2	19.4	1.5	19.1	7.5	6.8	19.9	16.9	2.8	2.7	3.0	3.5	3.8	3.6	2.6	2.3	2.5	1.6
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125838-37175054	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 104.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdTCR: 14.7;NK-cell: 51.6"	"Group enriched"	"Detected in many"	32	"NK-cells: 51.6;T-cells: 14.7"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Low region specificity"	"Detected in all"			HPA062657	Enhanced									"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favourable (6.76e-4)"	"prognostic favourable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	2.2	1.0	0.8	20.5	0.8	12.3	1.6	0.6	0.7	1.3	5.5	0.6	1.4	1.8	4.3	2.8	2.6	1.8	5.8	3.7	0.7	0.8	1.9	6.0	7.4	20.8	0.8	0.2	1.5	1.0	0.0	1.1	58.5	0.7	3.5	1.8	2.9	3.7	2.1	0.9	4.0	7.3	0.6	1.1	35.0	2.3	1.1	0.2	21.0	2.1	1.8	28.7	4.0	1.5	0.3	0.0	1.0	0.1	51.6	14.7	7.9	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	104.1	0.1	0.2	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.1	7.5	12.8	0.0	0.1	0.0	0.1	1.0	0.0	0.1	14.7	0.1	8.1	0.1	3.3	8.2	0.0	0.3	1.1	4.3	0.3	51.6	0.1	0.0	6.8	7.9	0.8	0.8	0.6	0.7	0.7	0.8	0.8	0.2	0.7	0.2
IL3	"IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF"	ENSG00000164399	"Interleukin 3"	P08700	5	132060529-132063204	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;lymphoid tissue: 2.8"	"Cell line enriched"	"Detected in single"	16	"HMC-1: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"																				"unprognostic (9.74e-2)"			0.1	0.1	0.0	0.3	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.0	2.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
IL34	"C16orf77, IL-34, MGC34647"	ENSG00000157368	"Interleukin 34"	Q6ZMJ4	16	70579895-70660682	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 65.1;skin 1: 31.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.7;Hep G2: 4.4;HSkMC: 4.2;NTERA-2: 9.3;U-138 MG: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.76e-3)"	"prognostic favourable (7.41e-4)"	"unprognostic (5.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-2)"	"prognostic favourable (9.69e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavourable (3.52e-8)"	"unprognostic (6.47e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.37e-2)"	3.3	10.8	13.4	3.3	13.1	0.6	5.3	5.4	17.7	3.8	2.7	2.7	2.7	4.6	2.2	1.8	10.1	2.8	4.9	3.4	8.6	6.6	2.6	1.6	7.6	5.6	3.9	9.5	1.6	1.5	1.5	5.5	0.9	4.8	2.6	2.2	9.8	6.7	3.4	3.4	31.9	5.1	2.3	1.7	65.1	1.9	2.7	3.0	0.3	2.3	5.0	4.3	3.7	6.1	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.4	3.7	0.4	0.2	3.3	0.3	0.3	0.7	0.1	0.0	0.5	0.5	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.0	4.4	1.6	0.0	2.8	4.2	0.2	0.4	0.0	0.8	0.0	0.0	1.1	0.0	0.1	0.1	9.3	0.0	0.2	3.1	0.0	0.0	0.0	0.3	0.8	0.2	0.3	0.1	0.0	0.0	0.0	6.1	0.3	0.3	0.4	0.4	0.0	0.0	0.7	1.8	0.1	1.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.1	5.4	17.7	8.6	6.6	3.9	9.5	4.8	3.0
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985665	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 31.5;skin 1: 22.1;tongue: 94.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;BJ hTERT+: 1.9;HaCaT: 3.4;HMC-1: 3.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"						"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	10.9	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	2.8	0.1	0.1	22.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	94.1	31.5	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	2.5	0.0	0.0	0.0	0.7	0.0	1.9	0.1	1.3	0.0	0.0	0.0	0.8	0.0	3.4	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.6	0.3	0.0	0.1	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.6	0.4	0.0	1.2	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IL36RN	"FIL1, FIL1(DELTA), FIL1D, IL-1F5, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, MGC29840"	ENSG00000136695	"Interleukin 36 receptor antagonist"	Q9UBH0	2	113058638-113065382	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 26.7;skin 1: 31.9;tongue: 68.9"	"Group enriched"	"Detected in some"	17	"BEWO: 21.5;U-87 MG: 16.6"	"Cancer enriched"	"Detected in some"	7	"head and neck cancer: 25.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (3.88e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"		"unprognostic (4.29e-1)"	"unprognostic (8.68e-3)"		"unprognostic (9.80e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"		"unprognostic (3.99e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.23e-3)"	0.1	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	8.4	0.1	0.0	0.0	0.0	2.3	0.0	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	68.9	26.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.1;lymphoid tissue: 48.0"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8"	"Group enriched"	"Detected in some"	70	"memory B-cell: 6.1;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	77	"B-cells: 7.7"					"Not detected"	"Not detected"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	60.1	5.6	1.4	48.0	10.0	15.3	11.5	0.7	4.4	2.9	8.1	1.2	0.4	0.7	2.1	4.6	14.3	7.8	16.1	21.6	3.9	1.5	1.3	5.2	34.9	3.0	1.8	0.2	5.3	8.3	5.7	14.2	4.5	12.8	6.5	7.5	3.3	3.1	0.8	6.9	2.8	4.5	8.2	7.0	3.5	6.5	3.2	1.2	0.1	4.5	12.7	3.5	34.9	8.4	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.8	221.9	4.2	14.2	0.0	0.0	0.0	7.3	1.4	0.1	0.0	0.0	5.6	8.7	0.0	0.0	0.3	0.0	4.7	0.0	0.0	0.5	0.0	42.4	6.1	1.5	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	1.3	1.4	0.1	2.6	0.4	0.0	2.5	0.0	10.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	10.0	0.7	4.4	3.9	1.5	1.8	0.2	12.8	1.2
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.5;lymphoid tissue: 26.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.8;HDLM-2: 12.9;HEL: 13.7;HMC-1: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 10.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA019590	Approved				"Secreted to blood"					"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	6.8	1.9	1.3	13.4	1.8	1.8	2.2	1.7	1.7	2.6	9.5	0.4	1.3	7.0	1.9	5.0	5.0	5.2	8.2	1.5	1.0	0.9	5.6	8.9	6.5	26.3	0.8	0.1	2.4	2.6	0.0	1.3	1.0	1.0	5.0	4.8	1.1	7.9	2.0	0.9	9.6	20.5	2.4	1.2	8.6	4.4	3.0	0.9	2.0	4.1	4.4	10.4	3.9	3.3	10.9	2.4	5.4	0.8	0.5	7.5	0.6	0.2	0.0	0.1	0.0	0.3	0.3	0.0	1.1	1.1	1.0	1.5	0.0	5.8	0.1	0.0	3.3	3.3	0.1	0.0	0.0	12.9	0.0	13.7	0.3	1.7	0.0	0.1	20.3	1.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	4.2	2.3	0.0	1.9	2.0	0.2	0.1	0.1	0.0	0.2	0.7	0.8	0.0	1.5	0.2	0.0	0.0	2.7	0.0	1.5	5.4	0.3	0.0	0.4	0.2	0.0	10.9	1.1	1.1	2.4	8.2	0.3	0.3	0.0	0.5	0.8	0.3	7.5	0.6	1.3	1.8	1.7	1.7	1.0	0.9	0.8	0.1	1.0	0.9
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123973-62153163	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;NK-cell: 4.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.9;NK-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Midbody"				"Nucleoplasm, Nuclear bodies, Midbody"	"Nucleoplasm, Nuclear bodies, Midbody"	"CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: "	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.25e-4)"	"prognostic unfavourable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	5.1	5.0	6.9	9.2	8.2	23.8	7.7	19.3	13.6	6.9	6.5	5.7	2.8	9.5	5.7	11.7	22.2	5.3	4.7	4.1	5.9	5.0	3.9	3.8	5.0	14.1	6.9	7.9	5.3	5.4	6.0	3.1	5.7	6.9	4.2	5.3	4.9	10.6	4.6	6.7	9.8	7.5	4.9	5.1	7.5	6.4	12.3	6.4	36.1	8.5	8.5	13.2	5.9	8.6	0.2	0.0	2.9	0.3	4.0	0.5	0.0	26.9	25.8	19.6	16.7	2.6	3.1	10.5	16.9	7.4	15.8	10.1	13.6	18.3	25.0	14.0	5.8	26.4	19.4	10.2	12.4	22.1	13.5	16.3	25.4	11.0	1.0	18.7	23.3	1.6	2.2	15.2	8.8	9.5	17.2	20.8	8.7	21.9	30.1	15.3	21.1	12.6	28.3	24.7	18.8	4.5	13.6	15.0	16.2	17.0	11.1	10.5	17.3	6.8	10.6	15.6	19.9	22.3	18.0	11.2	17.1	28.0	8.7	12.4	18.7	2.9	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.2	4.0	0.1	0.0	0.0	0.0	6.9	8.2	19.3	13.6	5.9	5.0	6.9	7.9	6.9	6.4
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in many"		"HEL: 31.2;HMC-1: 32.8;hTCEpi: 30.0;NB-4: 29.3;THP-1: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016300, HPA070455"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	7.1	3.1	7.2	33.0	10.7	24.6	4.7	1.7	6.9	3.6	3.7	12.5	0.7	3.5	4.1	2.9	3.3	3.3	6.7	3.2	6.6	9.1	5.1	3.3	8.0	26.1	8.8	2.6	1.9	2.1	1.6	3.4	7.4	7.6	4.5	4.5	3.3	18.8	3.0	1.9	3.4	15.8	3.4	17.6	40.9	4.1	2.4	9.5	16.7	3.1	3.4	32.3	6.2	3.5	14.5	12.0	10.5	18.2	11.9	16.7	14.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.4	5.9	0.0	0.0	0.0	0.0	15.1	0.0	5.0	0.0	31.2	0.0	2.9	0.2	9.4	32.8	0.6	30.0	0.1	3.3	4.3	0.1	2.7	0.1	0.0	4.3	29.3	1.0	0.0	9.1	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	20.9	3.6	0.0	0.5	0.0	0.0	0.0	1.6	9.0	0.0	12.1	0.0	9.8	9.8	10.5	16.7	15.8	11.4	14.5	7.5	12.3	12.0	13.9	6.3	8.8	9.9	11.9	18.2	6.0	10.2	14.0	7.2	10.7	1.7	6.9	6.6	9.1	8.8	2.6	7.6	9.5
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391739-411447	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 49.1;Karpas-707: 45.6;RPMI-8226: 44.1;U-266/70: 41.3;U-266/84: 30.7;WM-115: 25.0"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8"	"Group enriched"	"Detected in many"	5	"B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favourable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	7.1	0.5	0.4	36.6	0.4	18.4	4.0	0.4	0.4	17.4	13.9	0.1	0.4	5.0	2.2	0.7	6.4	1.2	4.1	1.6	0.4	0.5	1.4	5.6	4.2	31.5	0.5	0.0	1.9	0.7	0.0	0.7	0.5	0.1	1.5	4.8	15.8	21.3	1.9	0.7	4.5	11.1	0.3	0.6	33.8	4.6	1.7	0.1	15.2	1.3	2.4	48.7	8.4	4.2	9.7	10.4	0.0	1.6	0.2	4.8	1.3	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	45.6	0.0	0.0	0.0	0.0	0.2	0.0	5.8	0.0	44.1	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	30.7	13.4	0.0	0.0	25.0	0.0	1.6	0.0	0.6	1.2	0.0	9.5	0.9	0.9	9.0	9.7	1.6	0.7	0.0	0.2	1.2	10.4	4.8	1.3	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.0	0.1	0.1
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85898803-85922609	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 197.4;lymphoid tissue: 64.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 34.7;THP-1: 58.7;U-698: 137.6;U-937: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 197.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	12.4	4.0	6.8	36.1	8.8	19.2	6.7	2.6	5.3	2.3	7.8	8.3	6.8	12.3	2.3	3.0	3.7	2.9	5.6	2.9	5.8	3.3	5.6	9.9	11.7	60.4	9.3	3.1	2.1	3.1	0.2	2.2	2.7	6.7	3.3	10.0	2.2	6.1	8.9	1.5	2.6	36.4	3.6	10.9	64.4	6.5	2.2	8.8	18.4	3.6	2.3	63.3	8.3	2.1	31.8	197.4	0.7	10.8	8.9	0.3	9.8	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.7	0.0	34.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.7	0.0	0.0	1.6	0.0	0.1	0.0	0.0	137.6	0.0	19.4	0.0	0.5	10.7	0.2	0.2	10.8	0.3	29.3	0.1	0.1	23.7	31.8	0.3	0.2	0.7	8.9	7.2	197.4	0.0	9.8	6.8	8.8	2.6	5.3	5.8	3.3	9.3	3.1	6.7	8.8
ISG20	"CD25, HEM45"	ENSG00000172183	"Interferon stimulated exonuclease gene 20"	Q96AZ6	15	88636153-88656483	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 116.8;lymphoid tissue: 56.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 35.8;Karpas-707: 21.2;SK-MEL-30: 119.1;U-698: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Not detected"	"Not detected"														"unprognostic (2.55e-3)"	"unprognostic (1.19e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (6.51e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.35e-3)"	"prognostic favourable (1.85e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (4.86e-8)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.58e-2)"	8.4	2.4	2.2	39.6	3.6	12.1	7.3	0.8	3.1	4.1	18.3	1.9	8.3	25.9	2.7	8.2	9.9	3.9	36.6	4.9	2.4	2.6	6.1	9.9	26.0	56.6	3.2	1.8	6.8	6.4	0.2	10.1	4.6	3.2	6.0	3.0	2.2	13.2	8.1	4.1	3.4	39.4	1.2	3.6	53.8	21.9	2.5	1.8	29.1	14.5	6.1	41.4	10.7	4.2	99.2	12.3	116.8	5.1	31.0	104.4	29.7	1.5	2.4	0.0	0.0	0.0	0.0	0.4	0.0	1.1	7.4	10.1	0.7	3.5	35.8	1.8	0.1	0.5	0.1	0.8	0.2	11.3	0.1	0.1	1.2	1.5	4.9	0.0	0.0	0.6	1.4	2.5	1.6	1.1	0.1	21.2	0.0	2.6	0.1	0.2	0.3	5.4	1.4	0.1	6.6	0.5	0.3	0.1	0.1	0.2	14.2	119.1	0.4	0.8	1.4	0.2	0.8	0.0	0.5	15.1	4.0	21.3	0.3	0.5	1.5	8.4	3.0	6.2	27.7	5.1	36.6	94.6	47.9	39.7	2.6	99.2	35.5	37.2	116.8	31.0	3.8	12.3	104.4	29.7	2.2	3.6	0.8	3.1	2.4	2.6	3.2	1.8	3.2	1.8
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389505	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8"	"Group enriched"	"Detected in some"	13	"HEL: 69.4;HMC-1: 118.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 28.5"	"Low region specificity"	"Detected in single"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		1100000000	1100000000	"Plasma membrane"	"Plasma membrane"	"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.7	0.2	1.4	0.4	1.0	15.2	0.6	3.8	2.4	1.2	0.9	0.4	0.4	0.1	1.1	25.2	0.7	1.9	1.4	10.6	0.9	1.6	1.0	0.4	6.5	0.5	0.7	0.8	2.1	2.5	0.1	2.5	1.9	1.1	0.6	0.3	0.6	0.4	1.6	0.8	0.1	0.6	0.4	0.8	22.8	0.2	3.0	0.4	0.4	5.2	1.0	0.6	0.7	1.9	0.0	0.5	28.5	0.2	0.0	0.2	11.1	0.0	0.1	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	69.4	0.0	0.6	0.0	0.0	118.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	28.5	0.2	2.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	11.1	1.4	1.0	3.8	2.4	0.9	1.6	0.7	0.8	1.1	0.4
ITGA4	CD49d	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181536187	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.4;lymphoid tissue: 101.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.7;HEL: 61.5;MOLT-4: 71.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 26.0"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	100000	100000	"Plasma membrane"	"Plasma membrane"	"HPA074961: AB_2732273"	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favourable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"	3.8	1.7	1.3	39.7	1.1	19.2	3.2	2.4	1.9	6.7	4.8	0.5	1.1	3.8	3.0	3.1	2.9	2.1	6.9	1.7	2.9	1.3	3.0	2.5	13.6	33.7	1.2	0.5	1.8	1.6	0.0	1.3	7.1	0.9	3.8	4.9	2.9	7.5	2.0	1.0	1.5	11.6	2.4	1.6	36.0	4.4	1.2	0.2	101.6	2.6	1.5	14.3	6.0	4.1	11.0	19.1	38.4	38.3	8.8	15.9	16.2	0.0	0.2	1.0	0.0	9.1	13.8	0.0	8.9	11.2	4.8	10.1	0.0	0.0	7.1	0.0	38.7	5.3	3.1	0.1	5.8	0.0	0.7	61.5	0.2	0.0	0.9	27.2	1.5	9.8	0.0	0.3	0.0	0.4	0.0	10.4	3.0	0.0	71.7	19.1	0.8	0.0	15.7	4.5	1.0	0.0	0.0	1.6	0.6	0.0	0.0	0.3	0.0	18.0	4.8	1.5	0.9	0.1	1.8	20.4	15.1	4.0	0.8	13.5	20.6	6.7	16.2	38.4	12.9	38.3	9.7	11.0	14.6	15.9	19.1	10.0	8.5	10.4	2.1	8.8	37.5	5.0	3.7	16.2	1.3	1.1	2.4	1.9	2.9	1.3	1.2	0.5	0.9	0.2
ITGAE	"CD103, HUMINAE"	ENSG00000083457	"Integrin subunit alpha E"	P38570	17	3714628-3801243	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.2;lung: 25.9;lymphoid tissue: 13.0"	"Cell line enriched"	"Detected in single"	21	"MOLT-4: 15.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.1;memory CD8 T-cell: 7.4;T-reg: 1.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB026461, HPA036313"	Approved					13000	13000			"CAB026461: , HPA036313: AB_10795355"	"unprognostic (9.81e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.86e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (5.78e-4)"	"unprognostic (3.34e-2)"	"prognostic unfavourable (1.13e-8)"	"unprognostic (8.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (3.56e-4)"	3.6	0.2	0.3	13.0	0.6	8.0	0.9	0.2	0.2	0.6	9.6	0.2	0.0	4.9	0.4	0.4	2.0	1.5	2.7	0.2	0.5	0.4	0.3	0.3	25.9	8.1	0.3	0.0	0.9	1.2	0.5	0.4	0.1	0.2	1.2	2.0	0.2	1.8	3.9	0.3	0.6	20.2	2.0	0.7	1.4	3.6	1.6	0.1	3.1	1.0	1.5	5.3	1.9	2.5	0.2	0.1	0.0	1.0	0.0	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	15.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	1.0	3.1	0.2	1.0	7.4	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.9	0.9	0.3	0.6	0.2	0.2	0.5	0.4	0.3	0.0	0.2	0.1
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523185	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.7;lymphoid tissue: 74.6"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced				"Intracellular and membrane"	1100000	1100000			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favourable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favourable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favourable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"	2.8	1.1	1.8	29.8	2.0	15.1	1.8	0.6	1.5	1.3	3.0	2.7	0.5	2.4	1.7	1.4	2.2	2.6	4.9	1.4	1.3	1.3	2.6	6.7	16.2	29.0	3.1	1.4	1.4	1.2	0.0	1.4	1.7	1.7	2.0	3.4	1.9	6.6	0.7	0.8	1.0	12.7	1.4	4.7	44.1	3.5	0.8	2.7	74.6	2.8	2.0	41.8	4.4	1.9	2.1	7.5	7.2	36.7	9.5	22.5	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	119.0	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	7.9	0.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	4.2	0.0	0.0	0.0	0.0	0.0	7.5	2.5	0.0	0.1	0.8	0.0	3.1	8.4	6.5	22.5	16.9	11.2	2.1	8.8	16.2	7.5	1.3	4.9	11.4	7.2	9.5	36.7	3.0	6.3	11.5	1.8	2.0	0.6	1.5	1.3	1.3	3.1	1.4	1.7	2.7
ITGAX	CD11c	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382997	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004458, HPA004723, CAB072871"	Enhanced									"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	47.9	1.9	4.4	28.1	5.7	28.6	2.9	1.4	4.4	1.8	2.1	17.1	0.6	1.7	2.1	2.5	1.9	4.3	7.7	2.5	5.3	4.6	2.3	4.6	33.2	24.4	13.6	3.8	3.0	2.1	0.8	2.4	3.3	8.1	2.5	3.2	2.5	4.3	1.3	1.1	1.6	3.8	3.3	15.6	46.3	3.3	0.9	7.5	3.8	2.2	0.9	9.7	5.1	1.9	0.8	12.4	31.7	20.3	14.9	1.8	3.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.1	0.1	0.0	0.4	48.1	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.1	3.9	10.1	9.2	1.8	18.1	0.1	0.8	0.0	0.3	12.4	0.4	0.0	0.2	31.7	14.9	20.3	0.2	0.0	3.2	4.4	5.7	1.4	4.4	5.3	4.6	13.6	3.8	8.1	7.5
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6"	"Group enriched"	"Detected in some"	5	"THP-1: 114.8;U-937: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		2500000	2500000	"Plasma membrane"	"Plasma membrane"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	59.1	9.8	9.0	47.5	16.8	91.4	8.4	1.7	8.0	5.6	7.4	12.2	1.2	6.3	4.9	9.0	4.8	10.7	10.3	9.7	7.2	6.4	8.1	7.0	32.9	73.8	14.3	2.9	6.6	5.1	1.1	3.3	12.7	12.1	6.9	4.2	5.2	8.8	2.7	3.0	4.1	13.2	12.3	18.3	75.6	7.6	4.2	12.2	53.5	4.5	2.2	29.0	15.7	4.2	9.5	76.0	104.6	122.9	41.0	57.4	159.7	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.3	0.0	0.4	0.0	15.0	3.9	0.2	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.5	17.0	18.0	0.0	0.3	0.2	3.5	9.3	0.7	0.0	0.0	0.2	0.5	0.3	0.3	0.0	114.8	0.3	0.0	1.0	0.0	0.5	0.1	0.8	0.4	0.0	85.3	0.1	10.5	122.9	85.7	57.4	84.1	25.8	6.7	28.4	39.5	76.0	9.5	19.1	32.0	104.6	41.0	81.0	11.6	20.7	159.7	9.0	16.8	1.7	8.0	7.2	6.4	14.3	2.9	12.1	12.2
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191318-53207307	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.3;lymphoid tissue: 37.6"	"Group enriched"	"Detected in some"	99	"Karpas-707: 288.3;RPMI-8226: 225.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA042277			Uncertain	"Plasma membrane,Cytosol"		42000	42000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.8	1.4	1.4	29.1	1.8	7.5	1.5	0.6	1.2	1.8	8.7	2.9	0.8	6.7	2.3	2.8	6.6	2.0	5.6	1.4	1.5	1.0	5.4	5.1	4.9	26.4	1.9	1.0	1.1	1.3	0.7	1.7	1.8	2.4	2.7	5.6	2.1	10.7	2.2	1.0	6.4	15.1	1.5	2.0	26.7	4.3	0.9	2.0	7.8	3.6	4.4	37.6	4.6	3.0	10.1	15.4	31.3	1.9	7.5	23.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	288.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	225.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.2	0.2	0.1	0.0	22.6	1.9	31.3	19.3	0.5	14.3	10.1	19.4	23.0	15.4	8.3	16.3	17.1	0.5	7.5	0.1	4.2	22.7	5.2	1.4	1.8	0.6	1.2	1.5	1.0	1.9	1.0	2.4	2.0
ITIH6	"ITIH5L, UNQ6369"	ENSG00000102313	"Inter-alpha-trypsin inhibitor heavy chain family member 6"	Q6UXX5	X	54748899-54798240	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.8;salivary gland: 3.5;skeletal muscle: 5.0"	"Cell line enriched"	"Detected in some"	19	"WM-115: 33.3"	"Cancer enriched"	"Detected in some"	7	"melanoma: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000506	Uncertain				"Secreted to blood"					"HPA000506: AB_2666007"	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.73e-3)"	"unprognostic (7.24e-2)"		"unprognostic (2.83e-1)"		"unprognostic (5.38e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"		"unprognostic (2.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITM2A	"BRICD2A, E25A"	ENSG00000078596	"Integral membrane protein 2A"	O43736	X	79360384-79367667	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 100.7"	"Cell line enriched"	"Detected in some"	8	"MOLT-4: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 26.5;eosinophil: 16.8;gdTCR: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000296			Approved	"Golgi apparatus,Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA000296: "	"unprognostic (1.05e-2)"	"unprognostic (5.22e-3)"	"unprognostic (2.77e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-3)"	"prognostic favourable (3.66e-6)"	"unprognostic (1.57e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.30e-1)"	27.2	4.1	27.0	9.1	37.8	13.6	27.4	7.8	25.8	21.8	11.0	16.1	6.5	5.4	16.4	19.4	14.8	15.3	10.6	42.1	33.6	22.5	7.7	2.2	19.0	28.5	34.8	19.5	69.6	6.3	2.7	9.3	10.6	25.8	16.7	11.9	16.2	28.2	8.8	13.2	10.3	8.8	20.9	33.9	8.4	9.6	8.0	12.5	100.7	31.1	14.1	16.5	14.7	16.6	4.7	1.1	26.5	0.2	25.2	48.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.3	0.0	0.4	0.0	7.6	0.0	0.0	0.0	12.2	14.2	2.3	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	187.9	8.5	2.8	0.0	0.0	0.0	0.0	7.3	0.0	0.0	2.1	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.1	23.7	0.0	0.0	0.0	0.0	0.9	26.5	0.1	16.8	23.2	0.2	17.0	4.6	44.6	36.5	0.1	4.7	48.0	22.6	0.8	25.2	0.2	1.1	32.4	22.6	27.0	37.8	7.8	25.8	33.6	22.5	34.8	19.5	25.8	12.5
IZUMO1R	"Folbp3, FOLR4, JUNO"	ENSG00000183560	"IZUMO1 receptor, JUNO"	A6ND01	11	94305592-94307721	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.0;lymphoid tissue: 2.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.0;CACO-2: 2.1;HBEC3-KT: 2.2;U-266/84: 3.0;WM-115: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (5.56e-3)"									"unprognostic (1.37e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.08e-2)"	"unprognostic (8.61e-2)"		0.2	3.0	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.9	0.1			0.1	0.3	0.0	0.0	0.4	0.5	1.2	0.0	0.0	1.3	0.2	0.0	2.4	0.0		1.3	0.0	0.0	0.6	0.0		0.3	1.1		0.3	0.0	0.0	0.0	0.3	0.3	0.1	0.6	0.0	0.4			0.9		1.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 158.7;Karpas-707: 84.7;RPMI-8226: 168.2;U-266/70: 358.1;U-266/84: 139.0;U-698: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	118	"memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7"	"Group enriched"	"Detected in many"	142	"B-cells: 213.0;dendritic cells: 160.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	4200000000	4200000000			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favourable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	4.4	1.6	0.9	209.3	0.9	0.4	69.6	0.9	0.9	27.2	403.3	2.1	0.7	132.7	1.7	1.5	29.2	9.8	79.4	2.4	0.9	1.0	19.9	12.7	62.8	111.7	0.9	0.6	14.0	8.6	0.0	1.4	0.7	0.8	5.7	142.5	8.2	220.1	30.1	1.1	1.7	361.5	4.0	1.0	161.3	124.6	7.0	0.7	8.0	7.1	36.8	96.7	42.1	5.9	213.0	160.7	1.3	0.3	0.2	0.9	52.6	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	158.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	84.7	0.0	0.0	0.2	0.5	0.1	0.0	0.2	0.1	168.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.2	358.1	139.0	206.4	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	0.9	213.0	0.1	0.2	0.3	91.6	0.1	0.1	1.3	0.2	0.1	160.7	0.1	52.6	0.9	0.9	0.9	0.9	0.9	1.0	0.9	0.6	0.8	0.7
KAZALD1	"FKSG28, FKSG40"	ENSG00000107821	"Kazal type serine peptidase inhibitor domain 1"	Q96I82	10	101061841-101068131	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6;prostate: 24.0;retina: 22.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.3;T-47d: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011800	Uncertain				"Secreted to extracellular matrix"					"HPA011800: AB_1852082"	"unprognostic (3.34e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (2.11e-1)"	2.6	0.6	0.8	3.2	0.5	0.1	2.6	0.3	1.0	10.3	2.3	0.4	2.9	3.3	5.2	10.6	1.6	2.0	3.0	7.7	1.0	0.4	1.9	0.4	2.4	2.8	0.6	0.3	1.9	1.1	1.6	3.6	1.1	1.5	24.0	2.0	22.5	8.3	3.0	4.8	1.7	3.7	5.6	0.5	20.6	8.7	1.8	0.3	0.6	2.5	5.7	2.3	3.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	1.7	22.3	1.9	6.7	1.7	4.1	4.7	1.1	1.0	4.9	1.8	0.2	2.4	4.1	0.4	1.5	0.0	0.2	2.6	0.8	0.3	4.9	4.7	0.4	0.3	2.0	0.9	0.3	0.1	0.8	0.1	0.6	2.4	0.7	3.7	0.1	1.4	0.5	9.1	9.5	8.3	0.3	0.4	1.1	0.3	1.0	0.5	0.7	1.3	28.5	0.6	0.1	0.6	1.9	0.3	1.1	0.7	2.1	2.0	1.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	1.0	1.0	0.4	0.6	0.3	1.5	0.3
KAZN	"FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.7;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 6.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 6.9"									"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA032095: AB_2674146, HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	8.0	11.0	13.4	3.0	17.4	1.2	7.6	41.1	21.9	8.0	3.8	27.5	5.7	4.6	3.1	11.1	18.8	11.0	7.0	4.1	12.4	12.4	13.2	5.2	8.5	1.5	25.1	12.1	10.4	8.0	22.9	2.7	11.0	15.0	4.1	4.0	10.5	16.8	7.2	1.7	14.2	4.9	3.7	25.0	64.9	4.9	4.1	18.9	0.0	6.6	7.0	6.3	7.9	9.4	0.3	0.0	6.9	0.0	0.0	0.0	0.0	7.8	1.4	8.6	39.7	3.8	3.9	2.9	3.8	3.2	7.1	5.1	1.8	4.2	0.0	9.9	8.1	2.8	1.9	6.2	3.5	0.2	3.9	4.5	4.7	11.8	2.8	0.0	2.3	5.5	8.3	1.6	1.1	0.0	1.8	9.2	5.6	5.7	0.0	0.4	2.4	1.2	2.7	0.2	4.8	11.9	2.4	4.6	3.3	0.6	21.6	14.8	1.2	3.0	0.0	5.8	5.5	9.2	4.5	1.5	1.3	0.0	5.4	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	13.4	17.4	41.1	21.4	12.4	12.4	25.1	12.1	15.0	18.9
KBTBD8	"KIAA1842, TA-KRP"	ENSG00000163376	"Kelch repeat and BTB domain containing 8"	Q8NFY9	3	66998307-67011210	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 31.2;Karpas-707: 14.6;U-698: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041285, HPA069190"	Approved									"HPA041285: AB_10796341, HPA069190: AB_2686101"	"unprognostic (2.62e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-4)"	"unprognostic (1.99e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.54e-1)"	1.6	1.4	3.4	7.3	10.3	12.5	1.2	5.1	4.7	0.9	2.5	1.0	0.0	1.9	0.9	0.3	2.3	1.0	2.0	4.4	3.6	2.5	1.2	2.2	2.9	19.8	2.5	0.6	0.8	2.0	0.4	3.5	3.7	3.6	2.6	2.2	0.5	1.9	0.5	3.5	1.1	7.0	5.9	2.8	9.9	2.2	7.9	3.0	5.4	1.4	0.4	20.7	4.1	2.1	8.9	3.2	0.5	3.8	1.5	3.0	1.6	0.5	0.7	1.2	1.5	0.9	0.5	2.7	1.6	0.6	1.2	0.8	2.8	0.3	31.2	0.4	0.4	0.8	7.4	1.7	1.8	5.2	2.4	11.4	0.3	1.4	1.1	7.3	12.4	1.0	0.7	2.4	2.1	0.8	2.7	14.6	0.8	1.2	5.8	1.2	5.4	0.5	3.3	1.3	4.2	0.3	0.9	4.5	1.6	0.6	0.5	1.1	0.3	2.1	2.4	4.0	0.9	8.6	3.0	8.5	13.1	21.7	1.1	5.8	1.3	0.0	1.5	0.5	1.5	3.8	0.9	8.9	1.8	1.6	3.2	8.8	1.8	1.2	0.0	1.5	3.2	0.4	3.0	1.6	3.4	10.3	5.1	4.7	3.6	2.5	2.5	0.6	3.6	3.0
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"				"Plasma membrane"	"Plasma membrane"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4
KHDC1L	RP11-257K9.7	ENSG00000256980	"KH domain containing 1 like"	Q5JSQ8	6	73223544-73225770	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 8.9;lymphoid tissue: 4.1;testis: 7.7"	"Cell line enriched"	"Detected in some"	4	"BEWO: 33.0"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 33.6"	"Region enriched"	"Detected in some"	5	"basal ganglia: 8.9"	"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"																				"unprognostic (1.18e-1)"	"unprognostic (6.11e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-2)"		"unprognostic (9.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.01e-2)"		"unprognostic (1.31e-2)"	"unprognostic (4.13e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.17e-3)"	0.3	0.2	1.1	0.3	8.9	0.5	0.3	1.6	1.4	0.3	0.3	0.3	0.3	0.2	0.5	0.3	0.3	0.0	0.3	0.3	0.5	0.4	0.3	0.3	2.1	0.3	0.7	0.3	0.4	0.3	0.0	1.4	2.0	0.3	0.4	0.0	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3	0.0	7.7	0.3	4.1	0.3	0.3	1.5	0.3	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.1	0.0	0.3	0.0	0.0	33.0	0.1	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	8.9	1.6	0.7	0.5	0.4	0.7	0.3	0.3	0.3
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Intermediate filaments,Cytosol"				Nucleoli	Nucleoli	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.9	5.3	9.2	3.5	4.2	5.0	13.7	3.6	3.6	2.6	2.8	20.0	19.6	14.3	9.0	3.0	4.0	12.6	2.4	3.7	10.5	1.7	20.0	2.6	2.6	8.2	14.4	32.4	2.7	3.7	2.9	4.8	20.2	11.4	22.8	2.7	1.4	20.2	6.0	19.6	2.2	9.4	8.8	6.2	2.6	5.5	3.7	3.3	4.7	2.4	2.5	8.4	16.0	12.7	2.7	4.4	4.7	3.8	13.9	14.7	17.6	1.5	8.1	3.0	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9
KIF15	"HKLP2, KNSL7, NY-BR-62"	ENSG00000163808	"Kinesin family member 15"	Q9NS87	3	44761717-44873376	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 33.5;testis: 13.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035516, HPA035517"	Approved									"HPA035516: AB_2674664, HPA035517: AB_10671935"	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.12e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.17e-3)"	"unprognostic (6.68e-7)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.14e-4)"	"unprognostic (2.72e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.58e-1)"	0.4	0.3	0.4	4.4	0.4	6.5	0.4	0.4	0.9	0.8	2.0	0.1	0.5	1.9	0.4	0.7	2.6	0.3	0.3	0.6	0.4	0.3	0.3	0.3	0.5	3.2	0.4	0.0	0.3	0.2	0.0	0.3	0.9	0.2	0.3	2.4	0.3	0.6	0.0	0.3	1.1	1.9	0.3	0.3	1.9	0.8	13.0	0.0	33.5	0.3	2.4	3.2	0.6	0.9	0.9	0.0	0.0	0.4	0.0	2.0	0.4	5.4	2.9	12.7	9.4	0.9	1.0	2.9	6.3	3.8	7.6	6.6	4.7	5.4	9.4	2.1	2.1	4.7	7.2	3.3	9.3	8.4	2.1	10.4	6.0	5.9	0.1	10.5	4.8	0.2	0.1	5.2	5.1	6.0	6.6	12.2	6.1	3.0	20.6	4.0	13.4	5.0	8.1	14.0	5.7	1.7	3.6	6.2	5.6	10.1	3.3	2.1	5.4	8.2	3.4	8.0	6.5	6.2	8.5	5.4	8.8	12.4	4.1	12.2	7.5	0.0	0.0	0.0	0.5	0.4	0.0	0.9	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.4	0.4	0.4	0.4	0.9	0.4	0.3	0.4	0.0	0.2	0.0
KIF18A	"DKFZP434G2226, PPP1R99"	ENSG00000121621	"Kinesin family member 18A"	Q8NI77	11	28020620-28108308	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.3;testis: 16.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA039312, HPA039484"	Approved		Supported	"Microtubules,Cytokinetic bridge"				"Microtubules, Cytokinetic bridge"	"Microtubules, Cytokinetic bridge"	"HPA039312: AB_10794087, HPA039484: AB_10795252"	"unprognostic (3.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.09e-3)"	"unprognostic (3.80e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.72e-4)"	"unprognostic (4.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-1)"	0.9	0.5	0.6	3.9	0.8	7.9	0.6	0.9	0.9	0.8	2.1	0.3	0.0	1.5	0.5	0.8	3.1	0.5	0.4	0.5	0.7	0.5	1.8	0.5	1.5	4.8	0.5	0.0	0.6	0.5	0.0	0.6	3.4	0.8	0.5	2.2	1.3	0.9	1.6	0.8	1.3	1.9	0.6	0.9	2.7	1.0	16.9	0.2	31.3	2.8	2.0	4.9	1.0	1.2	2.3	0.7	6.4	0.4	2.8	2.2	0.4	12.3	12.3	12.5	8.7	0.4	1.8	4.2	12.8	6.0	20.5	21.5	4.1	5.0	10.4	4.6	6.6	12.4	10.7	5.0	28.8	10.3	6.5	6.7	8.4	5.2	1.0	9.9	6.2	3.2	0.6	7.1	8.5	7.8	10.7	9.2	11.5	6.5	10.0	7.4	6.1	5.1	7.8	30.0	5.1	5.7	3.6	7.6	5.8	10.7	5.1	3.5	10.9	3.0	4.5	16.4	12.8	15.3	16.7	3.7	8.5	10.5	9.8	7.4	11.5	6.4	0.0	0.8	0.2	0.4	0.8	2.3	0.9	0.5	0.7	1.0	0.8	0.3	0.0	2.8	0.1	0.6	2.2	0.4	0.6	0.8	0.9	0.9	0.7	0.5	0.5	0.0	0.8	0.2
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187715	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.7;testis: 18.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 10.0;T-reg: 3.2"	"Group enriched"	"Detected in many"	64	"NK-cells: 10.0;T-cells: 3.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036909, HPA036910"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cleavage furrow"				"Nucleoplasm, Cleavage furrow"	"Nucleoplasm, Cleavage furrow"	"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (2.14e-12)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	2.3	1.7	0.3	3.6	0.4	10.4	0.7	0.3	0.7	1.7	2.7	0.4	0.3	2.7	1.6	2.2	10.7	0.3	0.3	0.8	0.3	0.3	1.2	1.2	2.3	6.7	0.6	0.4	0.8	0.5	0.0	0.3	6.6	0.5	1.0	4.2	0.4	2.0	0.3	0.5	3.5	2.7	4.4	0.5	3.8	2.1	18.2	0.3	47.7	0.5	6.1	11.7	1.8	3.0	0.1	0.0	0.0	0.0	10.0	3.2	0.4	22.3	15.1	33.5	22.2	1.7	3.3	14.4	19.4	17.8	42.5	32.1	28.4	20.9	9.7	10.5	24.4	22.2	31.3	36.4	42.5	14.1	14.8	14.3	27.0	18.1	0.1	7.0	6.6	1.2	0.6	22.6	13.0	27.4	6.0	18.5	29.3	20.6	11.7	6.9	21.1	16.5	12.8	33.6	10.0	11.6	11.1	10.0	9.9	36.8	12.5	8.5	16.0	7.3	13.0	11.1	16.5	10.0	32.4	9.6	9.2	10.8	7.1	20.7	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.2	0.4	0.3	0.4	0.3	0.7	0.3	0.3	0.6	0.4	0.5	0.3
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701610-89774939	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031263, HPA050214"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"				"Nucleoplasm, Cytokinetic bridge"	"Nucleoplasm, Cytokinetic bridge"	"HPA031263: AB_10602610, HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	3.9	2.3	1.3	5.9	6.6	11.1	3.2	12.8	3.0	4.1	3.8	0.7	1.1	4.3	3.4	2.2	7.0	3.3	1.5	2.2	2.1	1.3	2.4	3.2	2.8	9.5	1.6	2.6	4.3	2.0	2.1	3.2	4.0	3.6	2.3	5.1	1.5	3.4	2.0	2.1	4.9	5.5	3.0	3.0	8.0	3.0	10.2	2.6	26.2	2.8	3.9	9.1	2.8	3.8	13.3	4.8	8.3	3.9	2.4	8.6	1.9	35.5	7.3	10.7	9.4	2.1	3.6	8.9	14.6	13.4	15.3	16.2	9.6	16.5	13.8	4.6	7.4	18.1	11.8	8.2	20.7	16.6	8.1	14.0	12.7	8.2	0.6	23.8	11.6	1.5	1.2	14.8	15.2	9.8	13.3	15.9	13.6	6.1	13.9	4.6	10.9	7.0	9.7	21.0	6.0	4.8	4.8	3.4	6.1	10.5	4.8	5.5	12.4	6.9	7.7	9.9	9.9	12.8	23.4	4.4	12.0	18.6	9.3	21.2	7.3	8.3	2.3	3.7	5.5	3.9	6.7	11.5	7.4	5.9	1.2	13.3	8.6	8.0	0.1	2.4	3.8	4.8	8.6	1.9	1.3	6.6	12.8	3.0	2.1	1.3	1.6	2.6	3.6	2.6
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805385	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041076, HPA048213"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA041076: AB_10794540, HPA048213: AB_2680316"	"unprognostic (3.71e-2)"	"prognostic favourable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	5.6	4.3	8.5	21.7	11.2	38.9	7.0	6.4	10.9	5.1	12.5	8.8	3.0	8.4	5.1	10.1	13.6	6.5	6.0	5.6	6.2	5.9	7.2	4.5	5.8	16.1	6.3	6.2	5.8	3.9	18.6	5.7	22.1	5.8	13.2	10.7	8.9	6.3	9.6	4.0	16.7	9.6	4.1	5.8	11.6	5.9	17.9	5.9	78.2	16.8	13.1	19.0	6.5	7.6	13.6	6.6	19.7	9.1	13.3	25.0	17.1	21.5	23.1	30.5	22.0	2.1	3.1	26.8	16.3	13.1	31.4	29.4	22.2	25.8	31.4	15.3	8.4	22.5	29.8	16.8	14.7	20.5	23.9	17.4	25.1	28.1	0.7	18.9	19.3	1.7	4.5	17.4	13.1	16.9	25.4	26.3	16.4	43.8	41.3	47.6	25.7	14.3	57.8	27.1	30.0	11.3	10.1	25.5	16.5	11.9	23.8	8.3	21.4	25.7	7.4	16.4	17.3	14.5	17.6	24.6	24.3	33.9	10.7	31.3	20.9	19.7	6.4	17.0	23.6	9.1	17.6	13.6	23.7	25.0	6.6	11.3	19.5	18.5	2.8	13.3	7.7	4.2	24.0	17.1	8.5	11.2	6.4	10.9	6.2	5.9	6.3	6.2	5.8	5.9
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.8;testis: 20.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 7.7"	"Group enriched"	"Detected in many"	12	"granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"				Nucleoplasm	Nucleoplasm	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: "	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavourable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavourable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.8	2.6	1.8	12.7	1.3	16.3	3.2	0.3	0.9	2.2	3.3	0.3	1.4	3.5	3.3	1.2	8.8	1.8	2.4	2.2	0.7	0.5	4.9	0.8	2.5	6.7	0.9	0.5	1.6	0.9	0.0	0.3	10.8	1.3	1.9	4.3	0.6	2.1	0.9	0.3	3.0	3.9	3.4	1.4	4.5	3.1	20.4	0.2	41.8	0.6	6.3	8.8	1.8	3.3	0.3	0.1	7.7	2.2	0.1	2.1	0.6	24.8	21.6	16.0	15.3	1.0	1.9	9.8	27.3	14.8	39.6	30.9	13.1	19.5	14.6	8.3	14.1	28.8	33.1	10.2	40.3	13.5	15.5	13.7	20.3	8.1	0.6	14.1	12.7	0.9	1.0	18.9	16.0	13.4	9.1	18.3	24.9	11.0	7.9	7.6	19.9	8.7	9.0	35.8	8.1	10.4	12.9	8.2	6.8	31.7	13.9	12.0	13.3	6.4	8.7	24.0	31.9	16.6	40.1	7.1	19.2	13.1	8.4	19.1	21.1	0.0	2.2	7.7	0.0	1.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.1	1.0	0.1	2.1	0.6	1.8	1.3	0.3	0.9	0.7	0.5	0.9	0.5	1.3	0.2
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006219			Supported	Nucleoplasm,Midbody,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA006219: AB_2667540"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	28.7	11.2	25.0	20.0	1.3	2.9	16.8	21.6	15.4	44.2	38.6	18.9	20.8	33.1	10.4	10.6	13.7	25.4	14.5	40.5	21.4	10.9	39.2	19.8	15.7	0.1	28.9	18.2	0.7	1.4	31.5	15.4	14.2	30.9	28.4	27.9	11.2	30.4	17.5	24.4	14.1	24.4	37.8	20.8	7.4	10.4	17.2	12.3	28.7	20.5	18.1	11.8	22.0	8.4	16.1	31.9	17.4	37.8	15.1	15.3	47.8	10.3	28.2	30.9	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290090-70420832	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;lymphoid tissue: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"									"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"	"Nucleoplasm, Midbody"	"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.9	0.6	0.8	3.3	1.0	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2.0	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0.0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2.0	0.7	0.0	0.0	0.2	0.2	3.2	0.3	22.4	15.7	23.8	11.7	1.1	2.0	9.4	17.1	9.2	23.4	20.4	17.6	13.2	13.8	10.8	8.4	13.5	25.7	9.3	26.4	15.8	12.9	15.6	19.2	12.5	0.2	17.3	10.9	0.6	0.5	19.4	11.1	14.3	19.8	30.8	22.0	14.4	15.8	8.6	24.0	16.7	17.6	32.1	13.0	5.6	8.9	15.7	13.1	27.9	11.8	7.3	9.5	6.8	9.9	15.5	20.2	16.6	20.3	8.9	15.2	20.0	8.2	19.1	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	3.2	0.3	0.8	1.0	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1
KIR2DL1	"47.11, CD158A, cl-42, nkat1, p58.1"	ENSG00000125498	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1"	P43626	19	54769811-54784322	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.8;lung: 4.0;lymphoid tissue: 4.5"	"Cell line enriched"	"Detected in single"	25	"U-266/84: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"																				"unprognostic (2.14e-1)"	"unprognostic (9.82e-2)"		"unprognostic (8.18e-2)"		"unprognostic (2.19e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.19e-4)"	"unprognostic (4.11e-2)"	"unprognostic (6.87e-2)"		"unprognostic (1.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.61e-2)"		0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.0	0.1	2.8	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	2.2	4.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.8	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.8	4.5	0.4	1.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
KIR2DL3	"CD158B2, cl-6, nkat2, nkat2a, nkat2b, p58"	ENSG00000243772	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3"	P43628	19	54738515-54753052	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 3.0;lymphoid tissue: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (7.37e-2)"	"unprognostic (2.35e-2)"		"unprognostic (2.23e-1)"		"unprognostic (6.88e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.41e-2)"		"unprognostic (2.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-2)"	0.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.1	2.1	0.1	0.1	0.2	0.1	2.2	0.0	0.0	0.1	0.4	3.0	2.4	0.0	0.0	1.0	0.1	0.1	0.0	0.8	0.1	1.3	0.1	1.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	5.6	0.1	0.1	0.8	0.6	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8
KIR3DL1	"AMB11, CD158E1, CD158e1/2, CD158e2, cl-11, cl-2, KIR, nkat3, NKB1, NKB1B"	ENSG00000167633	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1"	P43629	19	54816468-54830778	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.4;bone marrow: 2.0;lymphoid tissue: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	4	"gdTCR: 5.4"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.4"																				"unprognostic (3.18e-1)"	"unprognostic (8.01e-2)"		"unprognostic (3.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (5.18e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.19e-2)"	0.1	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.1	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	5.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.5										
KIR3DL2	"CD158K, cl-5, nkat4, nkat4a, nkat4b"	ENSG00000240403	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2"	P43630	19	54850443-54867207	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.0;lymphoid tissue: 5.3;salivary gland: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"																				"unprognostic (6.99e-2)"	"unprognostic (1.83e-1)"		"unprognostic (3.64e-1)"		"unprognostic (4.56e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.39e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.62e-2)"	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIR3DX1	"FLJ00060, LENG12"	ENSG00000104970	"Killer cell immunoglobulin like receptor, three Ig domains X1"		19	54532692-54545771	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 3.9;heart muscle: 3.6;lymphoid tissue: 4.6"	"Cell line enriched"	"Detected in some"	6	"U-266/84: 9.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA052110	Uncertain				"Secreted - unknown location"					"HPA052110: AB_2681731"	"unprognostic (5.85e-3)"	"unprognostic (4.13e-3)"	"unprognostic (8.47e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.22e-4)"	"unprognostic (1.36e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.73e-9)"	"unprognostic (1.09e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.20e-3)"	1.9	0.0	0.0	1.3	0.6	2.2	0.3	0.0	1.2	0.6	0.2	3.9	0.0	0.0	1.0	0.0	0.5	0.1	0.4	3.6	0.1		0.1	0.2	2.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.5	0.6	4.6	0.0	0.5	0.1	0.0	0.2	0.0	2.7	0.0	0.0	0.4	0.3	1.7	0.2	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	9.7	0.0	0.0	0.8	0.0	1.7	0.2	0.0	1.1	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.1	0.2	0.6	1.2	0.0	0.3	0.3	0.0										
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921015	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;lymphoid tissue: 12.4"	"Cell line enhanced"	"Detected in some"		"K-562: 10.5;RPMI-8226: 25.7;SCLC-21H: 5.4;SH-SY5Y: 14.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;neutrophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavourable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.2	0.2	2.1	2.1	4.1	0.2	0.3	0.1	4.7	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.2	0.1	0.1	1.0	6.8	1.4	0.1	0.3	12.4	1.1	0.1	0.4	3.6	0.1	2.0	1.0	0.8	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.7	0.5	1.0	2.4	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.6	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	2.8	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.7	0.0	25.7	0.0	0.0	5.4	14.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.7	0.0	0.0	0.1	2.0	0.6	1.8	0.0	0.0	0.0	0.1	0.0	2.1	4.1	0.1	1.5	1.0	6.8	1.1	0.1	0.8	0.1
KLF1	EKLF	ENSG00000105610	"Kruppel like factor 1"	Q13351	19	12884422-12887199	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0"	"Group enriched"	"Detected in some"	28	"HEL: 22.6;K-562: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051850	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051850: AB_2616460"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.44e-1)"	0.0	0.0	0.5	0.0	0.3	30.6	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	1.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.2	9.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	7.0	0.0	0.1	0.0	0.0	0.8	1.2	0.0	0.6	0.0	0.3	0.5	0.5	4.7	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.6	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.2	4.7	0.0	0.3	0.0	0.1	0.5	0.1	0.1	0.2	0.5	0.0	2.9	0.0	0.0	1.6	0.5	0.3	0.1	0.4	0.2	0.1	0.2	0.0	0.3	0.0
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487531-183555689	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.0;U-266/70: 30.9;U-266/84: 16.0;U-698: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"				"Centriolar satellite"	"Centriolar satellite"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	4.4	1.2	1.4	43.2	3.3	2.9	2.2	0.5	1.8	1.7	4.1	2.4	0.5	2.3	1.1	0.3	1.7	4.2	2.3	1.9	1.8	1.3	1.4	1.4	8.0	23.8	4.4	0.0	0.7	0.8	0.2	1.0	1.8	2.8	1.4	2.2	0.8	4.6	0.6	0.7	0.8	9.9	0.7	8.8	15.1	3.5	0.7	2.3	21.4	1.6	0.5	34.5	2.8	2.7	4.4	5.2	13.3	3.3	2.8	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	9.6	0.0	0.0	0.0	2.6	10.1	0.0	0.0	0.0	0.0	1.7	0.1	6.9	0.0	0.0	3.1	1.4	0.0	0.0	5.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.0	30.9	16.0	45.3	0.0	2.9	0.0	7.1	3.3	13.3	0.8	2.7	0.9	4.4	3.0	1.3	2.3	3.3	3.6	2.2	3.1	2.8	3.0	5.2	4.8	2.7	1.4	3.3	0.5	1.8	1.8	1.3	4.4	0.0	2.8	2.3
KLK10	"NES1, PRSSL1"	ENSG00000129451	"Kallikrein related peptidase 10"	O43240	19	51012739-51020175	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 52.5;HaCaT: 79.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	670000	670000				"prognostic favourable (8.32e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-6)"	"unprognostic (9.34e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.52e-2)"	1.5	0.5	0.2	1.7	0.3	0.3	2.4	0.7	0.4	20.8	0.9	0.3	0.5	0.2	2.9	0.8	78.6	7.8	36.0	0.7	0.2	0.5	0.2	0.3	4.3	0.2	0.2	0.3	7.2	0.2	0.0	0.2	0.8	0.6	1.6	0.4	0.3	11.0	0.6	0.4	17.7	0.4	0.4	0.4	0.2	0.5	1.6	0.2	1.0	0.3	136.3	58.6	0.5	33.4	0.4	0.5	2.1	0.4	0.4	0.3	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.5	0.0	2.9	0.0	79.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	2.1	0.4	0.4	0.5	0.3	0.1	0.2	0.3	0.7	0.4	0.2	0.5	0.2	0.3	0.6	0.2
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 9.4;HaCaT: 29.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"pons and medulla: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	320000	320000			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	5.5	0.0	0.2	1.1	0.2	0.0	4.9	0.2	0.6	24.5	1.7	2.0	0.4	0.0	5.1	2.7	103.4	9.7	61.8	0.4	0.9	0.0	0.2	0.6	12.3	0.2	0.2	0.2	2.3	25.0	0.0	2.1	0.4	10.7	18.8	0.0	5.1	96.5	1.6	0.3	49.8	0.6	0.3	0.2	0.2	18.7	7.7	0.2	0.9	0.2	65.2	88.5	0.7	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	9.4	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.9	0.0	0.2	0.2	10.7	0.2
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HaCaT: 2.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"					"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favourable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	2.0	0.0	0.0	3.6	1.2	0.2	53.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.7	0.0	16.6	0.0	0.0	0.4	4.3	0.1	0.2	0.0	0.4	0.5	0.0	0.2	0.0	33.3	24.7	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412312-10420595	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 28.5;brain: 9.7;lymphoid tissue: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.5;HEL: 2.2;HeLa: 11.8;HSkMC: 2.2;U-698: 3.2"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"					"Cell type enriched"	"Detected in some"	5	"NK-cell: 28.5"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 28.5"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.1	0.0	4.6	0.2	2.4	2.5	0.0	0.2	9.7	0.0	0.6			1.2	0.7	0.0	0.1	0.3	0.9	0.0	3.7	2.9	0.0	0.6	0.8	2.7	3.0		0.0	0.0	0.0	0.0	0.0		0.0	0.5		0.0	0.0	0.0	0.0	1.9	0.0	2.1	6.9	0.7	0.1			0.1		1.0	0.1	0.0	0.0	0.0	0.3	0.0	28.5	5.6	1.5	0.0	0.0	0.2	0.7	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.2	11.8	0.1	0.0	0.3	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.2	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	4.4	0.3	28.5	0.0	0.0	0.0	1.5										
KLRC4	NKG2-F	ENSG00000183542	"Killer cell lectin like receptor C4"	O43908	12	10407382-10409757	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 9.3;lymphoid tissue: 11.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 9.8;HSkMC: 1.9;U-698: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"gdTCR: 9.3;memory CD8 T-cell: 6.5;naive CD8 T-cell: 7.5;NK-cell: 5.4"	"Group enriched"	"Detected in many"	67	"NK-cells: 5.4;T-cells: 9.3"																				"unprognostic (3.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.60e-1)"		"unprognostic (7.00e-2)"	"unprognostic (1.55e-4)"		"unprognostic (1.89e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.51e-3)"	1.6	0.8	2.3	2.5	1.6	1.6	1.7	1.3	3.9	5.0	2.6	0.6	0.6	1.4	0.9	0.6	0.8	1.0	2.8	0.6	2.6	1.5	3.7	1.9	3.5	5.6	1.9	0.6	0.6	0.6	0.0	0.6	1.3	1.5	1.1	1.6	2.1	1.2	3.8	0.6	0.3	4.2	0.6	2.0	11.8	2.6	0.6	0.6	1.2	1.5	0.6	6.9	2.1	1.1	0.0	0.0	0.1	0.0	5.4	9.3	1.5	0.0	0.2	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	9.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.3	0.0	0.0	6.5	0.0	0.0	0.0	7.5	0.1	5.4	0.0	0.0	0.0	1.5	2.3	1.6	1.3	1.4	2.6	1.5	1.9	0.6	1.5	0.6
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.8;lymphoid tissue: 30.7"	"Cell line enriched"	"Detected in some"	8	"U-698: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	39	"gdTCR: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8"	"Group enriched"	"Detected in many"	47	"NK-cells: 50.8;T-cells: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		33000	33000	"Plasma membrane"	"Plasma membrane"	"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	4.1	0.9	1.3	18.3	1.1	10.6	2.1	0.4	0.8	2.8	4.5	1.2	0.6	2.0	2.4	2.7	3.1	2.0	7.7	1.3	1.3	1.1	2.4	3.6	13.6	22.2	2.1	0.1	1.5	3.3	0.0	1.2	1.6	1.2	2.2	2.1	2.4	7.0	0.6	0.5	1.1	13.1	1.3	2.1	30.7	3.3	1.9	0.6	6.0	2.9	2.8	11.4	11.3	2.5	1.0	0.2	0.8	0.1	50.8	49.4	16.7	0.2	0.0	0.4	1.8	0.1	4.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	36.0	0.1	0.0	0.2	0.0	0.0	0.0	49.4	0.1	18.5	0.8	0.3	44.0	0.1	1.0	0.4	44.3	0.8	50.8	0.1	0.2	0.1	16.7	1.3	1.1	0.4	0.8	1.3	1.1	2.1	0.1	1.2	0.6
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favourable (8.69e-4)"	"prognostic unfavourable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	5.6	5.6	4.5	15.3	5.4	28.9	5.8	7.5	5.6	5.2	6.4	2.7	3.9	7.0	5.4	5.5	9.6	4.9	2.9	2.9	4.6	1.8	4.9	4.5	5.8	11.8	4.0	3.8	6.7	4.9	3.5	5.9	8.1	3.6	5.3	9.7	3.9	6.1	2.8	1.6	11.7	10.9	7.7	3.1	14.1	5.5	23.2	2.8	39.6	4.0	7.0	15.6	4.4	6.6	4.8	2.1	5.0	2.6	2.2	3.6	0.8	13.0	10.9	31.5	7.2	2.5	4.5	14.2	12.1	7.9	12.0	11.4	10.3	11.0	15.6	6.3	5.8	18.0	13.6	7.6	16.0	11.1	9.4	19.2	20.4	10.5	0.8	18.9	13.3	2.4	1.7	12.4	8.3	8.1	19.2	11.8	9.0	9.7	15.6	43.8	15.9	13.8	21.4	15.3	17.3	7.2	14.0	9.8	12.6	22.0	4.7	6.5	17.8	10.9	5.9	13.8	13.2	13.4	14.1	15.9	16.0	24.1	8.2	12.3	15.7	5.0	1.4	4.6	2.0	1.9	1.8	4.8	3.3	3.6	1.3	3.0	2.5	2.9	4.4	2.2	2.6	2.1	1.4	0.8	4.5	5.4	7.5	5.6	4.6	1.8	4.0	3.8	3.6	2.8
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2963944-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1;skin 1: 12.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 19.9;MCF7: 10.0;RPMI-8226: 18.7;T-47d: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.2;monocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"			Nucleoli	Nucleoli	"HPA003223: "	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavourable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.2	0.1	1.6	2.0	0.7	1.7	0.2	0.2	3.0	1.8	0.4	0.2	4.5	0.3	0.3	0.8	3.8	0.6	0.3	0.2	1.9	0.3	0.2	0.2	0.2	0.8	0.7	0.2	0.2	0.4	0.0	0.2	0.2	0.3	1.6	0.0	1.9	1.6	0.2	0.6	12.5	0.6	0.2	1.7	0.9	0.5	2.1	0.2	13.1	0.2	1.8	6.8	0.2	0.6	3.2	0.3	0.0	1.4	0.0	0.0	0.0	1.2	0.8	0.3	7.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.9	1.1	5.2	1.4	0.0	5.9	0.9	0.5	0.0	0.8	0.8	0.3	1.7	1.7	0.0	0.4	19.9	0.2	0.0	0.0	0.1	0.0	2.1	2.1	0.0	10.0	1.2	2.3	2.0	1.5	3.1	8.2	18.7	0.0	0.2	2.1	1.2	1.4	3.2	3.2	10.1	1.9	0.1	0.6	8.7	0.7	0.4	3.7	0.8	3.1	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.7	0.2	2.3	1.9	0.3	0.7	0.2	0.3	0.2
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8"	"Group enriched"	"Detected in some"	100	"A-431: 211.8;HaCaT: 141.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		1100000000	1100000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	0.3	0.3	0.0	0.3	0.0	0.5	0.3	0.0	0.3	250.9	0.3	0.0	0.0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0.0	0.3	0.3	0.4	0.0	0.6	0.3	499.8	404.8	14.9	222.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.7	0.2	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192000	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8"	"Cell line enhanced"	"Detected in many"		"A-431: 44.0;MCF7: 62.9;SK-BR-3: 29.1;U-2 OS: 40.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"Low region specificity"	"Detected in all"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"		290000000	290000000	"Intermediate filaments"	"Intermediate filaments"	"HPA077836: AB_2686857, HPA077918: AB_2686871"	"prognostic unfavourable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.2	1.9	0.1	0.0	0.2	0.0	3.9	0.0	0.1	5.7	0.5	0.0	1.5	0.0	0.5	4.2	20.4	1.4	1.8	0.2	0.0	0.1	2.7	0.2	1.5	0.0	0.0	0.0	0.6	9.0	7.3	0.2	17.5	0.0	1.8	0.0	0.1	22.1	1.6	0.9	64.0	0.5	0.0	0.1	0.1	0.2	0.5	0.0	0.8	0.4	41.8	43.9	3.2	10.7	0.1	0.9	0.3	0.9	0.0	0.1	0.0	44.0	14.8	0.0	0.0	0.0	0.0	12.4	0.6	0.4	3.5	1.0	1.0	19.3	0.0	21.7	0.5	22.0	0.0	0.2	1.2	0.0	0.0	0.0	23.1	0.5	2.3	0.0	0.0	0.2	2.7	0.7	5.3	5.2	0.0	0.0	1.2	62.9	0.0	0.0	0.0	2.2	0.0	18.1	0.6	19.8	7.9	5.6	0.3	11.2	29.1	0.2	5.4	0.2	3.0	0.0	40.8	0.0	15.8	0.0	0.0	0.1	4.1	1.6	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
KRTAP29-1	KAP29.2	ENSG00000212658	"Keratin associated protein 29-1"	A8MX34	17	41301826-41302851	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.5;lymphoid tissue: 1.3;skin 1: 5.9"	"Cell line enriched"	"Detected in single"	21	"HDLM-2: 6.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																			"unprognostic (1.15e-2)"						"unprognostic (2.18e-3)"									"unprognostic (9.76e-2)"	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.0	0.1			0.0		1.3	0.2	0.0	0.9	0.0	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.5	0.2	0.0	0.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.3										
L1TD1	"ECAT11, FLJ10884"	ENSG00000240563	"LINE1 type transposase domain containing 1"	Q5T7N2	1	62194831-62212328	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.2;placenta: 34.0"	"Cell line enriched"	"Detected in some"	25	"NTERA-2: 75.0"	"Cancer enriched"	"Detected in some"	14	"testis cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 8.1"	"Lineage enriched"	"Detected in single"	17	"monocytes: 8.1"																				"unprognostic (2.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.95e-1)"	0.6	0.8	0.2	18.2	0.4	0.0	0.7	0.4	0.2	1.6	6.9	0.0	0.3	0.1	0.3	0.4	0.4	0.4	0.3	0.3	0.2	0.2	0.4	0.2	3.1	1.6	0.2	0.1	1.3	0.3	0.0	0.4	34.0	0.7	2.4	1.6	1.5	0.7	0.1	0.6	0.3	0.6	0.5	0.2	2.9	0.4	8.5	0.0	0.4	2.4	0.1	0.1	1.6	1.3	0.4	0.3	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.1	0.7	0.0
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.1;ovary: 28.4"	"Cell line enriched"	"Detected in single"	144	"HDLM-2: 55.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.7"	"Cell type enhanced"	"Detected in many"		"gdTCR: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0"	"Lineage enriched"	"Detected in single"	56	"T-cells: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Secreted - unknown location"					"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favourable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavourable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"	1.7	0.4	0.3	33.2	0.3	1.0	1.0	0.8	0.7	7.7	4.4	0.5	2.7	2.9	6.4	3.3	2.4	3.8	3.0	2.2	0.3	0.4	1.2	5.9	3.8	12.4	0.4	0.0	28.4	0.4	0.1	1.0	1.3	2.7	2.8	1.8	1.1	2.0	6.8	0.8	0.6	9.6	1.7	0.9	58.1	2.0	6.1	0.1	4.1	1.0	1.3	23.5	2.6	3.6	0.0	0.2	0.0	0.0	0.0	11.3	0.8	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	55.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	9.2	0.0	2.2	10.0	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.2	1.7	0.8	0.3	0.3	0.8	0.7	0.3	0.4	0.4	0.0	2.7	0.1
LAIR1	CD305	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.0"	"Group enriched"	"Detected in some"	5	"HMC-1: 6.5;Karpas-707: 16.7;THP-1: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA011155	Enhanced		Supported	"Plasma membrane"		130000	130000	"Plasma membrane"	"Plasma membrane"	"HPA011155: AB_1852685"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (5.01e-5)"	"unprognostic (1.72e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.52e-2)"	"unprognostic (5.22e-2)"	12.7	7.0	4.5	10.9	9.9	13.5	6.9	0.5	4.5	2.7	5.1	6.7	0.2	2.7	2.2	6.8	2.5	3.6	4.4	3.9	5.2	4.2	3.8	2.9	16.5	33.1	10.2	1.9	2.0	2.4	1.4	2.8	7.0	7.0	3.0	2.0	3.1	3.9	2.2	2.3	2.3	7.6	7.8	11.9	28.6	2.9	3.1	7.4	39.0	2.0	0.5	6.1	3.7	1.7	6.0	10.3	12.4	8.8	5.8	8.0	5.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	2.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	2.1	1.5	0.0	0.0	2.1	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	2.6	0.2	12.4	4.2	10.0	8.0	8.3	4.6	2.3	2.4	4.3	0.1	6.0	3.8	4.9	0.6	5.8	8.8	10.3	1.6	5.7	4.5	9.9	0.5	4.5	5.2	4.2	10.2	1.9	7.0	7.4
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757820	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 46.0;HEL: 87.3;HL-60: 55.3;HMC-1: 206.8;REH: 64.8;U-698: 75.1;U-937: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favourable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	56.0	15.5	11.5	59.1	17.8	157.5	15.0	2.2	10.4	8.2	11.2	20.7	1.8	9.5	7.5	6.8	8.3	13.7	19.9	9.2	11.2	12.7	14.0	18.2	60.8	144.5	19.0	3.3	7.7	6.3	2.0	6.8	20.1	14.6	8.2	13.2	7.4	11.7	4.7	4.0	5.5	37.1	12.9	33.8	130.9	9.5	6.7	15.8	75.2	10.1	5.2	91.2	21.4	6.4	98.2	69.1	145.1	109.3	26.0	55.4	166.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	46.0	4.8	0.1	0.1	0.0	0.0	0.0	5.1	0.0	87.3	0.0	0.1	0.0	55.3	206.8	0.0	0.1	0.0	0.3	10.5	1.1	2.9	0.7	0.0	9.5	11.6	0.0	0.0	64.8	8.6	32.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	35.2	12.2	0.0	0.2	0.0	0.2	0.2	0.0	75.1	0.2	45.2	0.1	73.5	109.3	115.3	47.7	87.9	55.4	70.2	43.7	44.6	69.1	98.2	44.2	43.1	145.1	26.0	83.9	33.2	53.7	166.6	11.5	17.8	2.2	10.1	11.2	12.7	19.0	3.3	14.6	15.8
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 98.4;lymphoid tissue: 36.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 45.6;REH: 51.8;RPMI-8226: 18.5;THP-1: 46.9;U-937: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 98.4"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	4.6	3.7	10.3	21.4	19.3	32.8	2.5	2.7	9.6	2.8	3.9	11.6	0.5	3.3	2.5	2.4	2.5	3.8	5.9	2.4	8.8	6.5	3.0	3.8	11.6	29.3	21.9	2.5	1.4	2.8	1.0	2.8	4.4	15.7	4.5	4.7	2.3	3.6	2.2	2.7	1.8	9.9	5.0	19.3	36.7	3.6	1.6	17.6	3.2	2.4	1.0	32.7	5.8	4.6	26.8	32.5	98.4	39.5	10.0	1.3	24.7	0.4	0.2	0.2	0.8	0.0	0.0	0.2	0.3	0.3	0.2	0.2	0.4	7.9	5.2	0.1	0.1	0.2	0.0	0.3	0.1	8.3	0.3	2.0	0.3	0.3	0.0	15.2	15.2	0.1	0.2	0.5	0.1	0.0	0.3	2.4	0.1	0.3	0.2	45.6	0.2	0.5	51.8	0.2	18.5	0.0	0.4	0.2	0.2	0.1	0.3	0.2	0.2	46.9	0.6	0.6	5.5	0.2	0.4	0.2	1.5	8.1	2.6	45.8	0.3	98.4	39.5	5.9	1.3	22.3	0.1	24.4	0.3	0.1	32.5	26.8	0.1	0.4	69.1	10.0	12.4	1.2	0.6	24.7	10.3	19.3	2.7	9.6	8.8	6.5	21.9	2.5	15.7	17.6
LAX1	"FLJ20340, LAX"	ENSG00000122188	"Lymphocyte transmembrane adaptor 1"	Q8IWV1	1	203765176-203776233	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 11.4;U-266/70: 14.1;U-266/84: 31.7;U-698: 12.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdTCR: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0"	"Group enriched"	"Detected in many"	19	"B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9"					"Low region specificity"	"Detected in all"			"HPA002461, HPA003887, CAB025358"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240"	"unprognostic (2.85e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.90e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.23e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	1.6	0.6	0.4	19.9	0.4	1.3	1.3	0.4	0.4	1.8	3.4	0.0	0.2	2.1	1.2	1.1	4.5	1.1	3.8	0.6	0.4	0.4	1.0	0.8	6.3	17.4	0.4	0.0	0.7	0.6	0.0	0.5	0.1	0.0	2.2	2.6	1.1	5.7	1.5	0.5	1.0	5.5	1.1	0.5	11.7	3.4	1.0	0.0	22.7	1.1	0.7	26.7	6.3	2.8	6.5	0.0	0.3	0.0	4.6	9.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	11.4	0.0	0.0	3.7	0.0	0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	31.7	12.1	0.0	0.9	0.0	0.0	0.0	0.3	9.9	0.0	7.4	6.5	5.7	7.3	0.0	1.5	4.5	5.9	0.0	4.6	0.0	0.0	6.0	2.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049840, HPA062236"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA049840: AB_2680908, HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	16.7	4.2	5.6	22.9	7.8	37.0	14.6	5.5	7.2	23.4	37.7	14.5	10.8	16.8	31.4	19.5	17.2	21.8	11.1	7.2	6.5	6.1	15.4	18.9	12.3	31.0	9.9	4.2	14.3	11.8	2.4	5.0	11.2	9.4	19.6	19.7	6.2	8.2	16.6	6.8	7.3	20.4	32.8	9.9	25.4	21.5	8.0	8.9	88.7	8.7	6.9	28.1	28.8	16.2	14.1	13.1	70.9	15.0	12.2	19.9	20.2	24.7	9.7	32.9	14.6	13.8	8.6	16.6	6.5	8.2	13.6	14.7	19.5	42.7	51.0	14.6	6.8	18.9	23.5	6.9	20.7	29.7	24.4	12.7	9.5	16.6	8.6	55.1	22.5	7.5	4.5	12.4	11.0	17.3	38.5	34.7	9.1	3.4	50.5	31.1	29.7	3.3	34.1	30.0	47.5	15.6	11.6	8.8	11.7	11.1	8.2	5.4	11.3	36.4	11.3	3.8	19.7	10.5	23.4	12.5	17.0	57.0	5.1	24.9	12.8	22.2	15.0	21.1	15.3	10.1	17.1	13.8	14.6	16.2	13.1	14.1	14.7	17.4	70.9	12.2	7.8	6.6	19.9	20.2	5.6	7.8	5.5	7.2	6.5	6.1	9.9	4.2	9.4	8.9
LCE3D	"LEP16, SPRL6A, SPRL6B"	ENSG00000163202	"Late cornified envelope 3D"	Q9BYE3	1	152579381-152580504	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 53.2;lymphoid tissue: 48.6;tongue: 96.6;vagina: 48.5"	"Group enriched"	"Detected in some"	6	"hTCEpi: 8.5;hTERT-HME1: 7.9"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 126.9;melanoma: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.34e-1)"				"unprognostic (1.09e-1)"			"unprognostic (2.87e-1)"									0.3	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	53.2	0.1	0.1	0.1	0.0	3.7	0.1	7.8	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	8.5	0.1	0.1	17.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.9	0.1	96.6	48.6	0.1	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	7.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LCE3E	LEP17	ENSG00000185966	"Late cornified envelope 3E"	Q5T5B0	1	152565654-152566772	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 35.6;lymphoid tissue: 21.3;tongue: 38.9;vagina: 19.8"	"Cell line enriched"	"Detected in single"	6	"hTCEpi: 4.9"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 40.7;melanoma: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.33e-1)"				"unprognostic (7.76e-2)"			"unprognostic (2.51e-1)"									0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.9	0.1	9.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	3.5	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	38.9	21.3	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 271.0;EFO-21: 111.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	870000000	870000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favourable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.5	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.0	0.0	111.0	0.0	17.7	0.0	0.5	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	4.9	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 188.6;lymphoid tissue: 118.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 82.6;HDLM-2: 75.5;HL-60: 80.2;HMC-1: 85.1;THP-1: 74.8;U-698: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		2200000000	2200000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	57.1	10.0	5.6	44.3	9.4	71.2	8.7	3.9	4.6	3.6	6.2	4.5	5.0	4.5	5.3	43.1	6.2	8.3	8.9	5.5	4.3	3.8	7.2	12.2	33.7	59.1	12.0	1.0	5.7	3.9	0.1	2.8	24.7	7.7	21.5	8.1	5.5	9.5	2.5	3.5	6.8	21.7	6.5	11.9	112.9	6.1	8.2	9.2	118.2	4.5	4.1	68.7	14.0	7.1	25.4	79.3	133.5	127.6	43.2	67.2	188.6	3.3	0.0	0.1	0.0	0.0	0.0	40.1	0.0	0.1	0.3	0.2	22.1	0.1	82.6	17.6	0.0	0.1	0.0	0.0	0.3	75.5	19.6	17.8	0.0	0.0	0.0	80.2	85.1	0.2	0.0	0.1	0.1	0.0	9.3	55.0	0.0	0.1	56.8	55.5	0.0	0.8	42.3	0.1	59.0	0.0	22.8	0.1	0.7	0.1	8.8	0.6	0.4	74.8	0.2	2.1	1.3	0.1	2.4	13.1	27.3	106.3	1.6	48.9	0.3	57.1	96.6	54.3	67.2	127.6	60.8	25.4	40.4	55.5	79.3	18.3	25.2	42.3	133.5	43.2	118.1	20.8	40.5	188.6	5.6	9.4	3.9	4.6	4.3	3.8	12.0	1.0	7.7	9.2
LCP2	"SLP-76, SLP76"	ENSG00000043462	"Lymphocyte cytosolic protein 2"	Q13094	5	170246237-170298227	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1;lymphoid tissue: 95.2"	"Cell line enhanced"	"Detected in some"		"HEL: 33.6;HL-60: 34.5;HMC-1: 89.1;Karpas-707: 19.1;MOLT-4: 20.7;THP-1: 18.4;U-937: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004574, HPA036396, HPA036397"	Enhanced					3600000	3600000			"CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436"	"unprognostic (1.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.52e-3)"	"prognostic favourable (5.08e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.10e-1)"	"prognostic unfavourable (6.22e-5)"	"unprognostic (1.87e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.07e-1)"	18.9	5.8	4.6	26.6	5.8	51.1	6.8	1.2	6.3	5.4	7.5	5.2	0.7	5.7	4.2	5.0	3.6	5.4	10.8	4.3	3.7	3.6	5.4	9.4	22.0	25.3	8.4	1.7	3.6	3.0	0.9	3.3	8.0	5.6	7.3	6.1	4.6	5.3	2.3	2.7	4.0	14.3	5.9	7.9	46.8	6.1	4.0	6.7	95.2	4.6	2.4	25.8	9.7	4.3	1.3	11.3	31.1	26.1	18.0	18.4	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	33.6	0.0	0.0	0.0	34.5	89.1	0.0	0.0	0.0	0.0	0.0	0.2	19.1	0.0	0.0	20.7	11.8	0.1	0.0	3.2	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	22.7	0.4	23.2	8.6	31.1	18.3	18.4	18.4	1.3	15.0	17.5	11.3	0.4	14.2	14.5	30.6	18.0	26.1	2.3	16.8	8.7	4.6	5.8	1.2	6.3	3.7	3.6	8.4	1.7	5.6	6.7
LDLRAD4	C18orf1	ENSG00000168675	"Low density lipoprotein receptor class A domain containing 4"	O15165	18	13217498-13652755	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.4;lymphoid tissue: 49.2"	"Cell line enhanced"	"Detected in many"		"HEL: 15.5;MOLT-4: 47.4;REH: 14.3;U-698: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047633, HPA065246"	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA047633: , HPA065246: AB_2685444"	"unprognostic (2.52e-1)"	"unprognostic (4.31e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.94e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.18e-2)"	8.3	6.6	9.6	11.5	22.0	11.9	7.5	10.3	22.9	8.6	6.1	45.4	4.3	9.8	12.9	5.2	5.6	11.0	7.8	17.8	14.6	10.7	3.9	10.4	5.9	11.6	19.9	12.5	3.6	6.2	4.6	8.3	8.0	23.5	10.4	3.3	3.7	4.8	8.3	19.0	4.8	10.9	7.5	30.7	8.9	7.6	8.9	21.2	49.2	5.2	2.5	8.5	7.9	6.7	8.2	8.2	17.2	11.0	12.5	14.5	6.2	0.1	0.2	0.9	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.2	0.0	0.0	0.0	7.7	0.8	15.5	3.2	0.2	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.0	1.2	47.4	0.6	1.2	5.4	14.3	0.1	0.6	0.0	0.8	1.1	1.6	0.2	1.0	0.0	2.1	4.7	1.4	0.8	5.5	0.1	1.0	2.2	0.2	11.9	0.0	3.5	3.1	12.7	10.3	3.4	10.2	10.3	8.9	7.2	9.7	8.8	5.1	8.2	14.5	12.6	17.2	12.5	11.0	8.2	5.2	6.2	9.6	22.0	10.3	20.6	14.6	10.7	19.9	12.5	23.5	21.2
LGALS9	LGALS9A	ENSG00000168961	"Galectin 9"	O00182	17	27629798-27649560	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 11.1;HMC-1: 29.1;MOLT-4: 14.4;REH: 10.2;THP-1: 26.0;U-937: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA046876, HPA047218"	Approved		Approved	Cytosol	"Secreted to blood"			Cytosol	Cytosol	"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (2.62e-2)"	"prognostic favourable (2.35e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (1.52e-5)"	"unprognostic (4.76e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	25.7	3.9	6.4	15.6	11.2	22.2	6.1	2.0	5.3	5.7	26.9	12.6	0.2	8.6	4.3	6.1	6.0	8.5	13.9	4.6	5.6	3.4	5.0	9.0	14.7	29.6	9.7	2.7	5.9	6.0	0.5	2.9	8.5	8.7	4.2	26.0	10.9	5.7	2.1	2.5	3.7	15.0	5.1	13.2	48.9	20.2	2.2	7.9	22.1	3.8	2.0	17.1	14.8	3.6	6.6	28.7	12.0	35.2	4.2	7.0	10.9	0.4	0.3	0.2	0.1	0.0	0.1	0.5	0.2	0.4	3.3	11.1	0.0	2.2	0.4	2.5	0.5	1.1	0.1	0.0	0.2	3.4	0.4	3.6	0.4	0.0	0.1	7.3	29.1	0.1	0.0	0.2	0.0	3.9	0.2	0.2	0.0	0.0	14.4	3.5	0.1	0.0	10.2	0.0	0.2	1.6	0.3	0.1	0.3	0.0	1.0	0.0	0.1	26.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	22.3	0.1	5.6	16.4	12.0	1.0	35.2	0.6	4.5	2.6	1.3	28.7	6.6	1.5	0.7	7.2	4.2	31.2	4.5	7.0	10.9	6.4	11.2	2.0	5.3	5.6	3.4	9.7	2.7	8.7	7.9
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 8.9;esophagus: 15.8;intestine: 8.3;lymphoid tissue: 8.5;stomach 1: 15.4"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;CAPAN-2: 2.9;Daudi: 1.0;Karpas-707: 2.8;RPMI-8226: 1.5;U-937: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 3.2;NK-cell: 8.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 8.9"									"HPA046876, HPA047218"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	2.1	8.3	0.2	0.0	1.6	0.0	0.0	15.8	0.0	4.7	1.0	0.0	0.0	0.0	0.8	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.9	0.0	1.6	1.0	0.0	0.2	5.1	0.1	0.0	1.5	15.4	0.0	0.0	0.4	0.0	3.0	7.5	0.0	2.1	0.0	0.4	3.2	1.2	8.9	0.6	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.9	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.5	0.5	0.6	1.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.2	3.2	8.9	1.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 23.3;U-266/70: 7.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 9.5;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 9.9"	"Group enriched"	"Detected in some"	32	"basal ganglia: 15.3;hypothalamus: 4.4"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.0	3.9	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.3	0.0	0.5	4.9	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.2	0.0	0.0	7.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.5	0.0	1.1	0.0	0.6	0.0	3.3
LILRA5	"CD85, CD85f, ILT11, LILRB7, LIR9"	ENSG00000187116	"Leukocyte immunoglobulin like receptor A5"	A6NI73	19	54307070-54313139	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.2;lymphoid tissue: 67.3"	"Cell line enriched"	"Detected in single"	11	"RPMI-8226: 4.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"classical monocyte: 10.6;intermediate monocyte: 27.0;neutrophil: 14.5;non-classical monocyte: 30.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.5;monocytes: 30.2"														"Secreted to blood"	370000	370000				"unprognostic (8.52e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (7.78e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.51e-3)"	"unprognostic (4.68e-2)"	"unprognostic (6.21e-2)"	3.4	0.6	0.3	9.9	0.3	19.1	0.7	0.1	0.3	0.4	0.6	0.1	0.0	0.8	0.4	2.0	0.6	2.0	0.9	7.0	0.2	0.2	1.7	10.8	14.4	24.2	0.5	0.0	1.5	0.4	0.1	0.4	1.3	0.6	0.6	0.7	0.6	0.5	0.3	0.9	0.1	1.8	1.3	0.7	67.3	1.0	0.6	0.0	0.1	1.4	0.4	0.4	2.7	2.8	0.0	2.6	14.5	30.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.6	0.0	0.0	27.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	14.5	0.0	30.2	2.1	0.0	5.1	0.3	0.3	0.1	0.3	0.2	0.2	0.5	0.0	0.6	0.0
LILRA6	"CD85b, ILT8, LILRB6"	ENSG00000244482	"Leukocyte immunoglobulin like receptor A6"	Q6PI73	19	54236592-54242791	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.4;lymphoid tissue: 16.0"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.5;neutrophil: 9.4"	"Group enriched"	"Detected in many"	23	"granulocytes: 9.4;monocytes: 4.5"															18000000	18000000				"unprognostic (1.00e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.47e-5)"	"unprognostic (7.76e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-2)"	4.9	1.1	0.2	4.0	0.2	4.4	0.8	0.2	0.6	0.2	0.5	0.2	0.2	0.3	0.2	2.2	1.9	1.3	1.4	0.8	0.2	0.0	0.4	5.5	6.0	0.2	0.2	0.2	1.1	0.2	0.0	0.2	1.9	0.7	1.1	0.0	0.2	0.8	0.2	0.8	0.1	1.1	4.0	0.2	16.0	0.5	0.8	0.2	0.2	0.6	0.2	0.2	1.3	0.2	0.0	0.3	9.4	4.5	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.5	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.4	0.0	1.0	0.0	0.0	1.2	0.2	0.2	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.2
LILRB2	"CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10"	ENSG00000131042	"Leukocyte immunoglobulin like receptor B2"	Q8N423	19	54273821-54281184	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.9;bone marrow: 30.3;lymphoid tissue: 31.9"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;intermediate monocyte: 33.8;neutrophil: 16.7;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.7;monocytes: 37.9"															52000000	52000000				"unprognostic (1.23e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.45e-7)"	"unprognostic (1.90e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.72e-1)"	"unprognostic (9.73e-2)"	3.2	1.4	0.4	6.8	0.6	30.3	1.0	0.3	1.9	0.5	1.1	0.6	0.4	3.3	0.6	0.9	0.5	2.3	6.6	1.5	1.6	0.4	1.5	3.6	18.4	4.9	2.6	0.0	0.4	0.7	0.2	0.7	0.7	1.8	0.9	1.0	1.1	7.4	2.6	0.5	0.4	1.5	0.6	3.4	31.9	1.0	0.3	0.8	0.8	0.6	5.0	0.7	0.6	1.9	0.0	5.3	16.7	37.9	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.9	4.2	0.0	33.8	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	16.7	0.0	37.9	2.2	0.1	8.1	0.4	0.6	0.3	1.9	1.6	0.4	2.6	0.0	1.8	0.8
LILRB3	"CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB"	ENSG00000204577	"Leukocyte immunoglobulin like receptor B3"	O75022	19	54216278-54223506	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.4;bone marrow: 15.3;lymphoid tissue: 23.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.8;HEK 293: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 24.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 24.4;monocytes: 9.4"																				"unprognostic (7.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.83e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-8)"	"unprognostic (2.18e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-1)"	5.1	0.8	0.4	8.9	1.0	15.3	0.8	0.4	0.5	0.7	1.6	0.0	0.2	0.2	0.6	2.5	0.7	1.3	1.1	7.8	1.5	0.6	0.7	1.5	10.9	19.7	0.5	0.0	3.0	1.7	0.0	0.5	2.0	0.6	0.9	0.0	1.0	0.8	0.0	1.7	0.6	0.9	0.9	2.2	23.4	0.8	0.7	0.0	0.3	1.5	0.0	0.1	6.4	1.1	0.1	4.0	24.4	9.4	0.0	0.1	4.5	1.5	0.6	0.4	0.8	0.0	0.0	0.5	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.4	2.5	1.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	0.5	0.6	0.2	0.0	0.0	0.9	1.6	0.0	0.0	0.6	0.1	1.5	0.0	0.0	0.7	0.8	0.0	0.0	0.5	0.3	0.0	0.3	0.9	0.0	0.4	9.4	0.3	0.0	7.5	0.1	0.1	0.1	0.0	4.0	0.1	0.0	0.0	24.4	0.0	3.3	0.4	0.0	4.5	0.4	1.0	0.4	0.5	1.5	0.6	0.5	0.0	0.6	0.0
LILRB4	"CD85k, HM18, ILT3, LIR-5, LIR5"	ENSG00000186818	"Leukocyte immunoglobulin like receptor B4"	Q8NHJ6	19	54643889-54670359	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.8;lymphoid tissue: 33.1"	"Cell line enriched"	"Detected in some"	35	"Karpas-707: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 22.8"	"Group enriched"	"Detected in many"	69	"dendritic cells: 22.8;monocytes: 6.2"									HPA052807	Approved					9900	9900			"HPA052807: AB_2681958"	"unprognostic (4.09e-2)"	"unprognostic (5.75e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	15.4	4.3	5.1	20.1	7.4	4.5	3.1	0.8	5.9	1.6	3.6	12.8	0.0	4.0	1.0	4.7	2.1	4.2	4.4	3.9	5.3	5.3	3.1	3.9	12.3	33.1	10.8	1.9	1.7	1.6	1.5	2.4	4.2	6.6	1.7	5.5	2.9	3.8	1.4	0.8	0.9	5.4	2.1	15.1	18.0	2.8	1.3	6.9	3.1	2.3	0.7	6.1	13.8	0.8	0.2	22.8	0.1	6.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	6.2	0.0	0.1	0.0	0.0	7.0	0.2	0.0	0.0	0.1	0.1	4.8	22.8	0.0	1.8	5.1	7.4	0.8	4.5	5.3	5.3	10.8	1.9	6.6	6.9
LILRB5	"CD85c, LIR-8, LIR8"	ENSG00000105609	"Leukocyte immunoglobulin like receptor B5"	O75023	19	54249431-54257301	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 31.0;lymphoid tissue: 35.1"	"Cell line enhanced"	"Detected in some"		"SiHa: 2.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA012069	Approved					36000000	36000000			"HPA012069: AB_1852873"	"unprognostic (3.55e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.86e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.02e-5)"	"unprognostic (6.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	23.6	8.3	0.7	5.4	0.8	0.8	31.0	0.6	0.6	2.1	11.9	0.5	1.6	5.2	1.2	16.2	5.8	4.9	6.2	10.0	0.7	0.8	2.1	22.8	8.6	13.3	0.8	0.0	4.1	2.7	0.7	1.0	5.6	0.7	4.0	5.5	3.6	2.9	1.1	6.1	2.0	9.0	5.9	0.9	35.1	2.4	3.9	0.0	1.2	2.6	4.9	1.3	10.6	1.8	0.9	0.7	3.1	0.9	0.9	0.5	0.3	0.4	0.0	0.8	0.5	0.1	0.1	1.0	1.0	0.3	0.4	0.0	0.3	0.6	0.2	0.4	0.1	1.4	0.3	0.5	0.0	0.5	0.9	1.1	1.7	0.4	0.5	0.6	0.6	0.5	0.3	0.1	0.3	0.5	0.6	1.0	0.2	0.0	0.3	0.3	0.6	0.0	0.6	0.7	0.6	0.2	0.8	0.5	0.9	2.3	0.8	0.7	0.7	0.0	0.3	0.8	0.7	0.5	0.6	0.3	1.1	0.1	0.4	0.3	0.2	3.1	0.9	0.4	0.4	0.6	0.3	0.4	0.5	0.3	0.3	0.9	0.4	0.4	2.3	0.9	0.8	0.7	0.3	0.3	0.7	0.8	0.6	0.6	0.7	0.8	0.8	0.0	0.7	0.0
LINGO3	"LERN2, LRRN6B"	ENSG00000220008	"Leucine rich repeat and Ig domain containing 3"	P0C6S8	19	2289784-2292024	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.9;brain: 15.7;lymphoid tissue: 7.1"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 19.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"					"Cell type enhanced"	"Detected in some"		"eosinophil: 6.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 6.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5"	"HPA043781, HPA059558"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA043781: AB_2678668, HPA059558: AB_2684062"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.16e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.53e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.03e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	0.1	0.2	2.2	3.1	15.7	2.8	0.0	4.6	2.9	0.0	0.4			0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.2	2.7	1.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.3	0.1	1.2	0.0	0.4	7.1	1.2	0.1			0.0		0.0	0.0	0.0	1.0	0.1	6.9	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	2.1	19.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	2.5	0.2	0.1	1.8	0.0	4.7	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	1.9	0.1	6.9	0.4	0.0	0.4	0.5	0.0	0.2	0.1	1.0	0.1	0.0	2.9	0.3	0.1	0.0	0.6	0.0										
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 93.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 23.4;pons and medulla: 6.3"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757"	Supported		Enhanced	"Nuclear membrane"		3300000	3300000	"Nuclear membrane"	"Nuclear membrane"	"CAB005269: AB_648156, CAB079757: AB_2665863, HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	3.9	2.0	2.5	36.8	3.5	21.1	7.0	23.4	2.5	3.1	10.6	0.5	3.9	8.2	2.2	3.2	15.8	2.4	4.3	3.3	3.0	2.7	2.4	5.0	9.7	25.4	2.1	1.7	2.9	2.9	1.0	3.4	5.2	6.3	1.9	9.9	1.7	4.1	5.7	1.8	6.2	11.1	2.6	8.8	15.3	5.7	2.5	2.3	93.1	2.0	9.3	20.3	4.1	5.1	3.8	13.2	8.5	12.2	1.9	10.5	4.9	24.9	8.3	25.9	24.7	0.6	1.8	33.6	11.7	3.4	13.0	14.1	21.6	20.9	43.5	20.4	4.0	14.0	17.7	8.0	14.4	30.5	21.7	27.9	9.9	12.7	0.2	33.1	18.9	0.5	0.1	6.8	3.2	10.7	16.1	17.0	9.0	20.6	59.9	65.8	19.5	11.7	28.7	51.3	17.6	7.1	11.4	30.0	15.8	19.0	8.2	7.1	14.9	38.4	9.0	9.7	26.5	7.1	25.0	11.2	8.5	38.2	5.0	47.1	14.4	1.2	12.2	4.0	1.9	5.0	1.5	3.8	4.0	2.5	13.2	2.9	2.9	2.6	8.5	1.9	1.2	4.0	10.5	4.9	2.5	3.5	23.4	2.5	3.0	2.7	2.1	1.7	6.3	2.3
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.0;lymphoid tissue: 75.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.3;HMC-1: 65.8;Karpas-707: 56.4;U-2197: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"				"Focal adhesion sites"	"Focal adhesion sites"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	16.3	5.6	5.1	34.2	4.7	4.2	5.1	3.5	4.9	4.4	6.7	9.0	4.1	5.1	6.5	5.9	3.8	4.7	7.2	3.9	5.2	5.1	6.3	7.1	19.7	37.2	6.3	2.5	6.6	5.6	3.9	4.8	2.6	5.0	5.7	9.6	6.2	7.6	5.1	2.1	3.7	16.0	4.7	11.4	32.2	5.7	5.9	4.9	75.1	6.8	4.4	52.9	11.2	3.9	19.9	36.5	3.8	19.1	20.1	42.0	20.9	0.3	0.4	0.4	0.7	1.5	1.9	0.2	9.8	39.3	2.4	4.4	0.0	1.0	28.7	0.4	11.9	0.3	0.3	26.7	10.3	12.4	0.1	1.3	0.2	0.1	2.6	7.7	65.8	1.4	0.6	33.9	4.4	15.8	0.3	56.4	19.9	0.2	27.1	9.7	0.3	8.9	0.4	0.5	24.7	1.6	13.7	0.2	0.3	0.4	0.6	3.9	0.5	2.2	15.4	6.2	1.8	39.6	8.8	3.6	3.5	28.2	14.3	7.0	14.0	1.7	19.1	3.1	28.2	11.0	42.0	19.9	29.0	32.4	36.5	11.5	22.6	26.8	3.8	20.1	5.6	33.1	38.7	20.9	5.1	4.7	3.5	4.9	5.2	5.1	6.3	2.5	5.0	4.9
LRMP	JAW1	ENSG00000118308	"Lymphoid restricted membrane protein"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;lymphoid tissue: 69.5"	"Group enriched"	"Detected in some"	6	"Daudi: 94.1;REH: 32.7;U-698: 107.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA002967, HPA018505"	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol				Vesicles	Vesicles	"HPA002967: AB_1079161, HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	5.5	1.4	15.1	51.7	2.9	19.2	4.6	0.4	5.6	1.9	3.6	2.1	0.9	3.2	1.4	1.8	3.9	2.3	3.0	1.7	8.1	1.8	5.5	2.3	5.6	57.8	3.5	4.7	2.3	15.1	0.4	2.1	1.7	7.4	2.8	3.5	1.3	4.1	2.1	0.8	2.7	13.2	1.8	5.3	27.6	3.6	0.7	2.8	67.0	3.6	1.7	69.5	10.4	5.7	17.4	5.7	51.8	12.2	12.0	7.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.1	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	5.6	0.0	0.0	0.0	7.2	8.3	0.0	0.0	0.1	0.0	0.0	1.1	6.3	0.0	0.0	7.9	13.4	0.0	0.0	32.7	0.0	9.3	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	0.0	0.0	6.2	1.1	107.6	0.0	3.2	0.0	17.0	5.4	51.8	6.5	10.5	5.4	17.4	4.1	6.6	5.7	13.3	7.1	6.9	39.3	12.0	12.2	5.4	0.7	4.7	15.1	2.9	0.4	5.6	8.1	1.8	3.5	4.7	7.4	2.8
LRRC25	"FLJ38116, MAPA"	ENSG00000175489	"Leucine rich repeat containing 25"	Q8N386	19	18391144-18397617	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.9;lymphoid tissue: 50.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.1;THP-1: 4.7;U-937: 3.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"classical monocyte: 37.6;eosinophil: 41.2;intermediate monocyte: 61.8;myeloid DC: 27.9;neutrophil: 70.3;non-classical monocyte: 79.9"	"Group enriched"	"Detected in many"	50	"dendritic cells: 27.9;granulocytes: 70.3;monocytes: 79.9"					"Low region specificity"	"Detected in all"			HPA029459	Approved					250000	250000			"HPA029459: AB_10610005"	"unprognostic (2.72e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-2)"	"unprognostic (9.15e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-3)"	"unprognostic (5.77e-2)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.14e-1)"	12.7	7.0	2.1	14.6	3.0	19.5	5.2	0.6	1.2	1.6	3.4	2.7	0.4	2.3	1.6	5.4	1.5	3.4	3.5	6.4	1.6	1.3	4.1	10.0	10.5	30.7	2.6	0.4	3.2	1.7	0.1	1.3	5.5	2.5	3.5	1.7	2.7	2.5	0.6	2.0	1.1	3.9	4.3	2.7	50.7	2.1	2.2	1.7	2.5	1.4	0.6	3.0	4.5	2.8	1.1	27.9	70.3	79.9	0.6	0.2	21.2	0.2	0.0	0.3	0.4	0.1	0.2	0.7	0.3	0.3	0.1	0.3	0.4	0.5	0.5	0.2	0.0	0.3	0.3	0.1	0.2	0.1	0.2	2.0	0.8	2.5	2.5	1.1	5.1	1.5	0.1	0.0	0.1	0.0	0.2	1.3	0.0	0.5	0.0	1.2	0.6	0.1	0.2	0.1	1.3	0.3	0.1	0.2	0.2	0.0	0.1	0.3	0.5	4.7	1.1	0.6	0.4	0.4	0.3	0.3	0.1	0.2	0.6	3.9	0.2	5.8	37.6	41.2	0.1	61.8	0.2	0.9	0.0	0.1	27.9	1.1	0.0	0.0	70.3	0.6	79.9	3.9	0.1	21.2	2.1	3.0	0.6	1.2	1.6	1.3	2.6	0.4	2.5	1.7
LRRC61	"FLJ31392, HSPC295, MGC3036"	ENSG00000127399	"Leucine rich repeat containing 61"	Q9BV99	7	150322639-150338150	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;Hep G2: 20.5;NTERA-2: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019355	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA019355: AB_1853339"	"unprognostic (4.05e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.91e-3)"	"prognostic unfavourable (1.11e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (2.85e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.69e-3)"	2.8	14.7	6.7	9.0	9.3	2.3	4.1	7.5	7.3	6.7	6.0	3.5	4.5	5.8	7.0	4.0	6.4	20.8	8.0	3.3	5.4	13.1	10.8	18.3	4.8	9.1	5.0	3.4	18.5	12.7	12.2	10.9	7.3	5.1	6.4	2.9	10.6	6.2	6.7	3.0	5.4	7.9	3.8	3.0	10.1	6.6	6.6	3.9	41.0	16.4	3.0	11.8	4.2	9.0	9.5	15.1	11.6	2.4	6.5	10.5	4.2	7.8	0.2	0.2	0.0	0.0	0.0	3.6	0.0	0.0	1.0	3.1	14.7	7.7	2.4	3.3	0.1	7.0	0.0	0.0	0.5	30.8	10.1	2.8	9.4	20.5	5.7	0.0	1.5	0.6	3.1	0.0	0.0	0.0	9.7	4.5	0.0	14.1	14.2	1.2	27.1	0.0	0.0	0.0	6.4	2.2	5.1	14.0	13.6	13.1	2.8	5.4	2.2	1.7	0.0	0.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	0.0	0.0	2.3	2.4	6.7	9.5	1.0	7.6	8.0	6.8	7.3	2.6	9.5	6.7	7.7	11.6	6.5	1.0	15.1	10.5	4.2	6.7	9.3	7.5	7.3	5.4	13.1	5.0	3.4	5.1	3.9
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	"Leucine rich repeat kinase 1"	Q38SD2	15	100919215-101078254	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.1;Karpas-707: 17.0;U-266/84: 15.4;U-698: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010537	Uncertain		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA010537: AB_1079283"	"unprognostic (3.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (5.71e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.25e-2)"	6.1	1.9	4.5	26.3	3.9	6.5	5.0	2.1	8.1	6.4	8.0	5.9	2.2	2.9	7.9	6.0	5.4	7.1	4.2	3.4	4.0	1.5	2.7	1.0	4.7	15.0	4.5	4.0	6.3	5.3	2.8	2.3	4.4	2.5	7.1	6.5	2.8	7.7	6.8	1.6	7.3	8.5	5.7	3.7	11.1	3.9	5.1	3.4	1.2	3.5	2.1	17.4	7.5	6.7	2.3	3.3	3.2	1.1	0.0	0.0	0.1	0.8	4.7	0.0	0.0	7.3	7.5	0.0	2.8	2.1	2.6	1.8	0.8	2.1	23.1	1.0	7.7	4.7	0.6	0.5	1.3	0.4	1.1	7.0	1.0	0.0	0.5	3.7	5.4	5.9	1.0	1.7	1.5	4.7	1.1	17.0	0.5	0.0	0.0	2.3	0.2	2.0	1.6	0.4	6.3	0.0	0.0	0.0	1.6	1.8	2.7	5.3	0.3	4.5	5.4	0.0	0.8	1.0	0.0	8.7	15.4	15.0	0.3	0.5	4.3	0.0	0.7	3.2	0.0	0.3	0.0	2.3	0.0	0.0	0.9	1.5	0.0	0.0	0.8	0.0	1.1	3.3	0.0	0.1	4.5	3.9	2.1	8.1	4.0	1.5	4.5	4.0	2.5	3.4
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;lymphoid tissue: 81.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;Daudi: 19.4;HDLM-2: 10.9;NB-4: 12.6;REH: 11.9;U-698: 14.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048884	Approved		Approved	Centrosome				Centrosome	Centrosome	"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favourable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favourable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	1.0	0.2	0.2	35.9	0.2	3.4	0.5	0.1	0.1	0.2	1.5	0.0	0.0	1.3	0.2	0.3	2.7	0.4	0.7	1.9	0.2	0.1	4.2	1.3	4.2	27.8	0.2	0.0	0.5	0.8	0.0	0.2	0.3	0.1	0.7	0.6	0.5	6.1	0.3	0.1	0.6	18.0	0.3	0.3	69.7	2.0	0.2	0.0	81.5	1.1	0.8	41.6	1.6	0.5	44.1	15.6	17.8	3.6	5.2	39.3	10.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	19.4	0.2	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	12.6	0.0	0.0	11.9	0.0	2.7	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	2.5	0.4	17.8	3.7	2.0	26.8	42.5	39.3	17.3	0.6	44.1	33.5	14.2	14.5	5.2	3.6	15.6	22.2	10.7	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.0
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	1.5	1.2	0.4	1.8	0.5	4.8	1.1	0.4	0.6	7.9	0.4	0.6	0.8	2.4	1.0	4.7	38.9	0.8	0.7	0.4	0.5	0.1	6.1	0.5	1.1	1.8	0.4	0.7	0.7	0.5	0.3	0.7	0.8	0.5	1.8	0.3	0.5	4.7	1.1	0.9	21.4	1.8	0.4	0.4	3.5	1.0	1.4	0.4	3.1	0.9	43.6	26.8	0.6	9.0	0.3	2.2	1.4	2.0	0.9	2.7	1.1	2.4	4.3	1.8	1.8	0.4	0.6	7.6	0.9	0.4	1.3	0.9	3.4	1.5	3.2	1.6	0.6	15.7	1.3	2.7	0.9	3.9	4.8	2.2	3.5	1.6	0.5	3.6	4.1	0.5	3.6	1.9	2.3	0.6	2.7	3.5	0.6	4.8	1.9	3.8	1.0	5.4	7.8	1.7	1.8	0.4	3.1	3.4	1.6	1.6	2.0	1.3	3.7	2.7	1.6	2.6	3.2	4.0	1.3	7.9	2.2	5.2	0.5	6.0	2.0	0.0	2.0	1.4	2.7	1.6	1.6	0.1	2.2	2.0	2.2	0.3	1.7	0.9	1.3	0.9	0.8	0.6	0.4	1.1	0.4	0.5	0.4	0.6	0.5	0.1	0.4	0.7	0.5	0.4
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706885-31710595	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3"	"Cell line enriched"	"Detected in single"	138	"HEL: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"									HPA008053	Uncertain					12000000	12000000			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	1.1	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
LY75-CD302		ENSG00000248672	"LY75-CD302 readthrough"		2	159771851-159904710	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"intestine: 17.0;lymphoid tissue: 37.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6;HDLM-2: 5.8;Karpas-707: 22.2;RT4: 9.4;TIME: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA049108	Uncertain									"HPA049108: AB_2680635"	"unprognostic (2.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.33e-1)"			"unprognostic (1.86e-1)"		"unprognostic (9.04e-2)"			"unprognostic (1.68e-4)"		"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.88e-1)"	1.1	1.2	0.9	12.5	1.0	5.9	2.1	1.0	1.0	1.1	5.0	0.5	0.0	4.5	0.9	0.4	1.3	1.1	5.8	1.1	1.0	1.1	1.0	1.0	5.6	20.2	0.9	0.0	1.0	1.1	0.0	1.0	0.4	0.7	1.0	3.6	0.0	2.7	0.0	1.0	1.3	17.0	0.2	1.2	9.9	1.1	1.0	1.1	37.5	4.6	1.5	9.8	1.5	1.2	1.7	10.0	6.9	4.2	0.9	2.7	3.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.6	2.6	0.7	0.2	0.1	0.0	0.0	0.0	0.0	5.8	0.0	3.3	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.3	0.0	2.6	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	9.4	0.0	0.0	2.4	0.5	0.0	0.0	0.7	5.3	0.0	0.0	0.0	0.0	1.9	0.4	0.7	0.0	1.3	0.0	3.0	3.7	4.4	1.7	4.2	2.7	1.5	1.6	2.0	10.0	1.7	1.9	1.4	6.9	0.9	1.8	2.0	1.8	3.1	0.9	1.0	1.0	1.0	1.0	1.1	0.9	0.0	0.7	1.1
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;lymphoid tissue: 44.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.4;NB-4: 11.0;RPMI-8226: 66.3;THP-1: 26.6;U-937: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 58.2;myeloid DC: 58.7"	"Group enriched"	"Detected in many"	43	"B-cells: 47.7;dendritic cells: 58.7;monocytes: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	83000	83000			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	10.2	5.0	9.9	18.2	12.9	11.5	2.9	1.6	5.3	3.9	3.2	15.4	0.0	1.5	1.8	1.5	2.0	2.8	7.4	2.5	8.9	7.0	2.8	5.2	13.3	31.2	16.5	4.1	2.1	2.0	0.8	2.8	6.3	9.3	2.5	4.3	2.3	4.5	3.0	0.9	1.5	13.0	4.6	19.9	44.6	2.5	1.1	12.7	2.9	1.7	0.3	32.7	8.4	1.7	47.7	58.7	1.2	58.2	0.7	0.7	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	2.3	0.0	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	12.5	0.0	0.5	58.2	0.4	0.1	32.1	0.1	47.7	0.1	0.1	58.7	35.6	0.7	0.4	1.2	0.7	11.6	2.3	0.2	25.7	9.9	12.9	1.6	5.3	8.9	7.0	16.5	4.1	9.3	12.7
LYL1	bHLHa18	ENSG00000104903	"LYL1, basic helix-loop-helix family member"	P12980	19	13099033-13103161	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4;lymphoid tissue: 25.4"	"Cell line enhanced"	"Detected in some"		"HEL: 32.3;HL-60: 22.6;HMC-1: 54.5;K-562: 25.3;NB-4: 33.1;REH: 24.3;THP-1: 21.9;U-937: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA075004			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA075004: AB_2686728"	"unprognostic (8.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (3.89e-4)"	"unprognostic (1.18e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.28e-1)"	6.3	3.0	3.4	19.9	5.8	37.4	8.0	1.1	3.8	4.0	3.7	5.5	1.3	3.0	5.3	3.9	5.9	3.8	3.5	4.9	4.5	2.9	3.9	2.0	8.1	24.0	7.1	1.6	3.2	1.6	0.8	1.7	8.0	5.1	6.2	1.4	4.4	6.4	2.4	3.5	2.0	8.8	3.3	6.0	25.4	4.2	11.9	4.1	3.6	3.5	1.4	18.9	3.3	7.0	4.6	1.4	8.8	3.6	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	6.3	2.2	0.0	0.0	0.1	0.0	0.0	3.7	0.0	32.3	0.0	0.3	0.3	22.6	54.5	0.1	0.0	0.0	0.0	8.3	25.3	1.1	0.0	0.0	0.1	33.1	0.0	0.8	24.3	0.0	2.7	0.0	0.0	0.0	2.4	0.7	0.0	1.5	0.0	21.9	13.3	0.0	0.0	0.9	0.0	0.0	0.0	5.1	0.0	21.8	0.0	2.5	2.3	8.8	0.1	2.9	0.2	2.8	0.3	0.2	1.4	4.6	0.2	0.2	3.6	0.0	3.6	0.4	0.5	0.6	3.4	5.8	1.1	3.7	4.5	2.9	7.1	1.6	5.1	4.1
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.9"	"Cell line enhanced"	"Detected in many"		"HEL: 56.8;HMC-1: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		11000000	11000000	"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	8.8	6.8	4.5	34.0	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.6	7.5	1.7	0.3	0.1	0.0	13.7	9.7	14.2	6.1	4.3	5.2	4.4	12.2	4.3	3.8	5.9	7.1	7.2	5.2	19.8	7.1	56.8	2.3	1.8	1.9	5.7	57.7	0.3	2.5	0.1	4.4	8.2	30.0	26.5	0.9	0.7	0.0	6.0	10.9	0.8	0.9	2.8	1.5	3.9	6.0	1.1	22.0	4.8	0.0	2.0	1.1	13.4	9.6	0.0	2.8	0.0	4.4	8.9	3.2	27.6	0.6	11.3	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0.0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465660	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.5;HaCaT: 29.4;MCF7: 32.8;RT4: 31.5;SK-BR-3: 47.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 235.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		9700000	9700000	"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	0.3	0.4	0.3	0.4	0.3	0.8	5.8	0.3	0.3	28.0	0.3	0.3	0.3	0.0	2.1	0.7	110.5	0.5	0.3	0.3	0.3	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.0	0.3	7.4	0.3	1.4	0.0	0.5	21.7	0.3	0.6	86.4	0.4	0.8	0.3	0.3	0.1	0.3	0.3	1.9	0.3	70.6	75.2	4.1	48.3	0.2	3.5	3.0	0.4	0.1	7.9	1.9	11.0	0.1	0.0	0.2	0.1	0.0	4.6	0.4	1.1	0.4	0.5	0.1	12.5	0.0	0.5	0.3	29.4	0.0	1.3	0.2	0.0	0.0	0.2	1.5	0.2	0.1	0.0	0.2	0.5	11.1	0.0	0.1	0.0	0.0	0.0	0.0	32.8	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.3	31.5	0.0	0.0	0.1	47.3	0.5	5.2	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	1.6	0.2	4.2	1.6	3.5	0.0	7.9	6.7	3.0	0.1	0.0	0.4	1.2	1.9	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.4;SK-MEL-30: 12.4;THP-1: 43.9;U-937: 16.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.0;monocytes: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"				Nucleoplasm	Nucleoplasm	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	10.3	5.2	6.4	9.0	8.8	31.3	10.6	10.5	7.1	8.8	5.3	3.8	3.4	3.4	6.8	4.3	6.6	5.6	5.8	4.7	4.3	2.4	5.0	6.1	10.9	7.8	4.2	6.0	6.2	5.0	9.1	12.6	5.5	5.3	6.0	5.0	9.6	8.2	4.8	3.9	11.7	6.3	9.8	9.2	11.3	8.4	6.4	6.3	38.8	8.5	4.0	7.6	9.3	10.6	1.6	1.7	13.0	5.9	1.7	1.0	0.7	3.7	0.8	0.4	0.9	5.9	6.8	0.6	1.4	5.6	1.5	1.4	0.0	1.0	0.5	0.5	3.0	1.8	0.5	0.7	1.3	13.4	1.2	1.2	0.8	0.3	1.0	1.8	1.6	2.2	3.6	1.8	4.6	1.2	0.1	0.8	1.1	0.1	2.3	3.8	0.1	0.4	0.1	0.5	0.0	4.3	4.1	2.4	0.5	1.5	0.0	12.4	0.5	43.9	2.6	1.1	0.5	1.2	1.2	0.9	0.0	0.0	1.9	16.8	3.1	0.4	3.1	5.7	0.6	3.5	1.0	1.1	0.3	0.7	1.7	1.6	0.2	0.5	13.0	1.7	5.9	0.2	0.2	0.7	6.4	8.8	10.5	7.1	4.3	2.4	4.2	6.0	5.3	6.3
LYVE1	"LYVE-1, XLKD1"	ENSG00000133800	"Lymphatic vessel endothelial hyaluronan receptor 1"	Q9Y5Y7	11	10556966-10611689	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 87.6"	"Cell line enriched"	"Detected in some"	12	"HUVEC TERT2: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.0;neutrophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025860, HPA042953"	Supported					3000000000	3000000000			"CAB025860: , HPA042953: AB_2678238"	"unprognostic (9.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (1.07e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (6.98e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	51.8	28.6	3.3	7.4	4.2	0.4	23.0	2.8	2.8	7.9	26.4	2.4	2.9	5.3	5.3	20.8	17.7	17.2	8.0	19.8	3.8	2.0	18.0	31.1	15.7	47.7	3.2	1.6	11.0	5.4	1.6	3.6	56.6	6.2	15.2	8.0	6.0	4.8	4.7	15.4	5.1	17.8	25.5	2.9	87.6	8.4	11.9	2.5	0.0	21.4	9.1	2.7	25.9	10.9	0.7	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	42.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.3	4.2	2.8	1.8	3.8	2.0	3.2	1.6	6.2	2.5
LZTFL1	BBS17	ENSG00000163818	"Leucine zipper transcription factor like 1"	Q9NQ48	3	45823316-45916042	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043466, HPA048447"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA043466: AB_2678491, HPA048447: AB_2680398"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.27e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.19e-1)"	5.8	7.2	12.3	5.0	14.9	4.8	13.6	9.3	21.6	14.5	6.9	4.4	10.4	6.0	14.4	16.6	6.1	20.8	7.3	5.3	10.2	11.6	12.9	10.1	9.7	4.4	6.9	13.4	12.8	8.6	14.6	30.7	6.2	10.1	9.0	6.8	5.6	7.5	10.4	3.6	6.4	6.8	8.7	6.1	5.8	6.3	27.7	5.6	55.7	20.4	4.3	5.7	7.3	6.4	7.2	4.6	1.9	2.5	2.3	4.0	2.7	6.7	3.5	5.5	3.5	5.2	12.5	2.6	3.6	6.0	7.5	9.8	1.0	5.1	2.0	2.2	4.5	3.2	5.9	6.0	10.5	0.0	4.2	1.3	4.9	2.9	6.8	6.6	1.9	6.7	20.9	9.3	6.1	4.2	6.2	4.3	4.1	1.0	18.1	6.3	5.7	2.9	2.5	0.5	7.1	10.3	2.6	3.7	7.7	4.4	4.1	8.8	4.9	11.6	6.8	3.2	2.2	8.5	4.7	12.3	6.4	0.0	10.1	7.8	2.6	0.0	1.9	0.7	2.8	2.5	3.9	7.2	2.5	2.4	4.6	3.7	4.0	3.3	1.9	2.3	1.6	4.5	3.5	2.7	12.3	14.9	9.3	21.6	10.2	11.6	6.9	13.4	10.1	5.6
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055608-120067074	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavourable (5.15e-5)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavourable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	1.4	1.8	2.4	4.2	5.7	10.3	2.4	4.4	4.1	1.9	4.4	1.2	0.3	3.8	1.7	1.4	6.5	2.9	1.1	1.7	2.7	2.7	1.2	1.2	1.5	7.6	2.3	3.6	1.7	1.2	0.7	1.0	3.5	2.4	1.6	5.5	0.7	2.4	1.2	1.2	2.3	4.2	1.8	2.8	3.8	1.9	13.7	1.2	27.3	1.2	8.2	7.3	2.1	2.4	1.8	2.2	2.0	0.8	2.5	3.9	1.7	14.4	6.4	15.0	9.7	1.6	2.0	6.4	11.5	6.5	12.1	9.3	8.5	8.9	21.3	3.8	4.2	3.9	14.9	8.8	16.9	10.1	10.4	11.8	6.2	8.0	0.5	19.2	6.8	1.1	1.3	8.2	5.1	6.9	14.1	12.3	6.3	6.4	18.4	8.4	10.2	7.2	9.5	20.1	8.8	4.9	5.6	15.9	11.3	5.7	7.1	3.5	4.7	7.1	4.3	8.1	9.2	8.2	14.5	11.5	12.2	14.0	7.5	10.0	10.6	2.0	0.5	0.4	1.6	0.5	2.1	1.8	3.8	3.0	0.4	1.4	3.5	3.5	1.3	2.5	0.8	2.2	3.9	1.7	2.4	5.7	4.4	4.1	2.7	2.7	2.3	3.6	2.4	1.2
MADCAM1	MACAM1	ENSG00000099866	"Mucosal vascular addressin cell adhesion molecule 1"	Q13477	19	489176-505342	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.9;lymphoid tissue: 27.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.6;Hep G2: 4.3;U-266/70: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 10.3"									CAB075699	Enhanced					41000000	41000000			"CAB075699: "	"unprognostic (2.30e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.56e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.17e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.42e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.07e-2)"	1.4	0.9	4.6	27.2	5.2	0.9	1.1	6.8	6.3	0.7	5.6	0.9	1.2	5.1	0.9	3.3	1.6	0.6	19.9	0.7	3.6	2.9	0.7	0.9	0.8	3.2	2.4	3.1	0.7	3.3	2.9	2.9	0.9	2.7	0.9	5.0	0.5	1.3	0.7	1.5	0.9	12.1	0.8	2.4	13.7	5.0	1.6	3.2	1.0	2.3	0.0	0.8	0.7	1.5	1.0	0.4	10.3	0.4	0.4	1.2	0.1	0.8	0.1	0.3	1.2	1.1	0.1	1.4	0.3	0.2	0.4	0.1	0.8	0.5	0.5	2.4	0.2	1.3	0.2	0.0	0.1	2.8	3.6	0.0	2.2	4.3	0.1	0.1	2.7	1.2	0.2	0.3	0.0	0.0	0.7	1.9	0.4	2.6	0.2	1.3	0.4	2.0	0.7	0.0	0.2	0.0	0.6	1.7	0.4	0.2	0.3	0.1	0.1	0.0	0.0	1.4	0.3	1.0	0.2	4.8	1.7	0.9	0.2	1.2	0.1	0.0	0.4	1.0	0.5	0.4	0.6	0.6	0.4	0.3	0.1	1.0	1.2	1.2	10.3	0.4	0.3	0.4	0.0	0.1	4.6	5.2	6.8	6.3	3.6	2.9	2.4	3.1	2.7	3.2
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.6;parathyroid gland: 154.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 15.8;hTCEpi: 33.3;SCLC-21H: 9.1;SiHa: 8.2;U-138 MG: 9.0;U-2197: 13.1;U-87 MG: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 27.4;non-classical monocyte: 36.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	38.3	7.9	3.2	13.0	4.0	17.0	19.5	1.0	9.7	10.6	6.9	3.0	1.2	3.3	5.6	8.9	16.8	7.0	9.2	12.4	3.6	2.3	10.9	14.0	21.9	28.9	4.7	3.4	7.0	6.1	154.1	2.3	9.4	5.0	7.6	3.3	5.6	10.4	2.7	11.0	41.6	7.6	5.5	7.7	87.6	4.7	7.5	3.8	6.9	18.2	20.5	11.4	8.2	10.9	0.0	2.5	0.7	36.7	0.0	0.0	2.5	0.0	0.0	0.0	1.4	0.8	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.0	0.2	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.5	0.0	0.1	15.8	33.3	0.1	1.1	0.2	0.0	0.0	0.0	0.5	0.1	3.8	1.4	0.0	0.0	0.0	0.0	0.3	0.2	9.1	0.7	8.2	0.8	2.0	0.8	0.1	0.2	9.0	0.1	13.1	0.0	0.0	0.0	0.0	8.7	0.3	0.0	0.1	7.3	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.7	0.0	36.7	0.0	0.0	2.5	3.2	4.0	1.0	9.7	3.6	2.3	4.7	3.4	5.0	3.8
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.5;HDLM-2: 20.3;Karpas-707: 21.1;REH: 11.2;RPMI-8226: 12.7;U-266/70: 16.6;U-266/84: 16.3;U-698: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007419, CAB007754"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favourable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favourable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	1.6	0.9	1.2	31.4	2.3	6.3	1.1	1.0	1.2	1.0	3.1	1.7	0.1	2.1	0.9	1.4	2.6	1.2	2.9	0.9	1.1	1.4	2.2	1.6	3.9	23.0	2.3	0.7	0.8	1.2	0.2	1.2	1.4	2.1	1.6	1.9	2.0	4.4	0.8	0.5	1.2	16.9	0.7	3.4	34.4	2.3	0.9	1.3	19.1	1.9	1.4	39.2	3.1	1.3	16.2	15.9	1.3	6.2	3.7	14.6	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.3	0.0	0.0	0.0	0.0	0.0	20.3	0.1	4.3	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	21.1	0.0	0.1	4.9	5.1	0.6	0.0	11.2	0.0	12.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.0	0.1	0.0	0.0	16.6	16.3	25.8	0.0	5.8	0.0	1.3	3.2	1.2	13.4	6.2	12.4	16.2	11.2	14.0	15.9	10.7	6.2	8.7	0.3	3.7	3.4	14.0	14.6	7.3	1.2	2.3	1.0	1.2	1.1	1.4	2.3	0.7	2.1	1.3
MARCH1	"FLJ20668, MARCH-I, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.4;lymphoid tissue: 32.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 9.4;U-266/70: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	95	"classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014600	Uncertain		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA014600: AB_1853573"	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	7.7	4.2	11.6	20.5	19.7	3.9	4.0	3.1	14.5	3.7	3.9	8.5	0.1	4.4	3.9	4.6	3.6	4.2	5.9	2.6	12.6	10.1	3.0	4.5	8.3	28.5	17.3	6.3	4.2	4.1	1.5	4.1	10.2	13.5	3.5	5.1	2.4	4.6	1.8	1.6	4.9	9.0	6.5	24.4	32.4	4.1	2.3	17.9	2.6	3.2	1.4	24.6	9.0	4.2	18.5	18.1	9.9	17.2	0.1	0.0	6.6	0.8	0.7	2.9	1.7	0.0	0.0	1.8	1.2	0.1	0.0	0.0	1.6	3.3	9.4	3.5	0.0	1.4	0.0	0.0	0.0	1.0	1.0	6.7	3.7	0.6	0.0	4.1	2.2	0.0	0.0	0.0	0.2	0.0	2.5	4.9	3.3	1.0	2.3	2.6	3.6	1.3	2.6	0.5	0.7	0.1	1.5	1.5	1.3	0.9	1.4	0.5	4.0	0.7	3.1	1.1	2.0	0.7	2.3	9.7	3.2	2.6	1.3	2.1	1.5	0.0	16.8	9.9	0.0	17.0	0.0	18.5	0.0	0.0	18.1	15.7	0.0	0.0	0.1	0.1	17.2	6.8	0.0	6.6	11.6	19.7	3.1	12.5	12.6	10.1	17.3	6.3	13.5	17.9
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942166-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.3;lung: 65.6;lymphoid tissue: 58.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.9;THP-1: 5.6;U-2 OS: 6.0;U-266/70: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 15.8;intermediate monocyte: 26.7"	"Lineage enriched"	"Detected in many"	5	"monocytes: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		24000000	24000000	"Golgi apparatus"	"Golgi apparatus"	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	22.8	11.7	0.8	29.6	1.1	0.9	3.3	2.3	1.3	0.3	2.8	0.9	0.0	0.6	0.3	12.9	5.2	13.8	0.8	10.8	0.6	0.4	1.6	66.3	65.6	29.3	1.3	3.1	4.7	0.4	0.2	0.8	2.3	2.7	4.5	0.7	1.0	2.9	0.8	6.8	1.1	1.3	9.6	1.7	58.7	2.2	2.8	0.6	0.0	3.0	0.5	0.4	8.8	1.1	0.0	5.0	0.3	26.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.6	0.0	0.0	6.0	0.9	0.0	3.6	0.0	0.2	0.0	1.3	0.0	0.0	15.8	0.0	0.0	26.7	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.3	0.0	3.2	0.4	0.0	3.4	0.8	1.1	2.3	1.3	0.6	0.4	1.3	3.1	2.7	0.6
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161554-13211104	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 31.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	3.0	0.5	0.3	5.6	0.3	10.8	2.1	0.3	0.5	1.4	2.6	0.4	0.3	1.8	1.1	0.6	5.9	0.2	0.7	0.7	0.3	0.3	0.6	0.9	1.4	6.0	0.3	0.6	0.7	0.3	0.3	0.4	3.6	0.5	0.6	2.9	0.4	1.1	0.3	1.5	1.3	1.8	0.9	0.7	2.9	1.1	4.3	0.3	31.4	0.9	3.3	6.9	0.9	1.8	0.5	1.0	1.5	0.4	0.8	3.4	1.5	13.5	15.3	18.2	13.7	0.6	1.1	7.9	14.2	2.2	16.0	16.7	14.9	9.7	20.4	6.5	3.6	15.9	25.5	8.3	14.8	10.6	12.1	25.5	6.8	9.9	0.0	13.0	11.6	0.2	0.3	16.2	1.5	5.2	30.0	14.0	8.6	12.2	30.9	5.6	10.7	3.8	24.5	16.1	12.6	3.6	5.0	3.6	13.8	11.5	8.2	2.1	10.3	9.0	3.1	10.2	19.2	15.3	15.3	4.4	16.9	26.9	6.5	14.4	7.9	0.2	0.3	0.2	1.1	0.1	0.2	0.5	1.6	3.4	1.0	0.4	0.4	2.8	1.5	0.8	0.4	0.2	1.6	1.5	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.6	0.5	0.3
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598223-127622436	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 69.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000303, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		8600	8600	Nucleoplasm	Nucleoplasm	"CAB000303: AB_322519, HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favourable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	2.9	3.7	2.1	24.3	4.0	32.5	3.5	6.7	3.2	4.7	7.1	3.3	2.2	4.7	4.7	5.9	11.2	4.8	5.4	3.6	2.0	2.3	3.9	3.4	3.4	14.6	2.2	3.5	5.1	3.0	2.4	2.4	26.4	3.0	3.2	6.0	2.5	4.7	1.9	7.0	6.0	7.1	2.9	2.9	13.3	3.8	20.3	3.9	69.9	4.1	16.6	20.7	3.4	5.1	10.4	3.6	0.9	1.4	5.8	10.6	3.4	24.8	21.2	23.2	20.3	1.4	3.0	22.7	13.1	8.4	26.3	28.7	35.1	16.5	26.8	12.8	6.4	20.0	41.5	15.0	16.4	22.1	25.9	44.3	28.4	25.5	0.9	41.4	19.4	1.6	1.7	17.8	2.7	8.2	22.1	24.6	9.6	33.0	38.3	30.4	34.0	18.7	43.1	33.3	38.4	5.4	19.3	28.9	21.9	33.5	10.0	3.4	21.4	32.5	4.2	20.5	17.5	25.2	17.6	25.5	28.9	66.6	14.2	31.4	7.8	0.0	0.6	0.2	4.7	1.4	5.9	10.4	4.1	5.5	2.8	9.2	3.9	5.0	0.9	5.8	0.3	3.6	10.6	3.4	2.1	4.0	6.7	3.2	2.0	2.3	2.2	3.5	3.0	3.9
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264009-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 82.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Enhanced	Nucleoplasm		29000	29000	Nucleoplasm	Nucleoplasm	"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.13e-5)"	"unprognostic (1.34e-2)"	17.3	10.9	8.5	29.7	10.5	22.3	15.3	10.7	9.7	15.9	17.2	9.5	20.2	9.0	21.2	13.0	21.7	15.5	15.8	15.4	7.4	6.6	16.1	12.6	13.7	30.1	8.9	5.8	20.0	13.8	16.0	7.4	24.7	10.0	15.9	19.2	12.7	12.6	23.4	12.1	15.0	17.8	17.7	9.5	23.2	15.3	16.1	10.5	82.5	12.9	20.1	35.7	19.1	15.3	21.1	12.9	11.4	13.3	22.2	29.4	18.6	30.2	20.1	35.1	33.1	7.6	6.9	23.1	22.5	17.3	38.4	39.5	41.2	16.5	33.1	22.6	13.1	24.1	46.3	27.5	38.9	37.2	43.8	62.5	40.5	58.0	2.0	61.3	25.6	4.1	6.4	28.2	7.9	19.6	50.8	76.3	19.8	20.0	61.7	47.4	29.1	14.2	54.8	53.8	44.2	17.0	32.2	35.7	27.3	23.6	13.6	20.4	26.8	43.5	10.0	26.3	28.3	27.1	33.6	22.6	25.8	58.9	22.6	53.2	30.7	11.1	8.0	11.4	22.9	13.3	19.7	21.1	23.3	23.0	12.9	19.2	22.6	24.0	1.1	22.2	7.4	8.3	29.4	18.6	8.5	10.5	10.7	9.7	7.4	6.6	8.9	5.8	10.0	10.5
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favourable (2.19e-4)"	"prognostic unfavourable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	4.9	8.7	6.7	18.4	12.6	33.1	9.3	13.9	14.8	6.7	11.9	6.9	3.6	8.3	4.7	7.8	21.6	5.9	6.8	8.3	6.6	7.1	8.0	6.6	4.4	20.3	5.9	7.7	5.3	5.5	4.3	4.1	29.2	7.7	4.2	13.2	5.3	9.0	3.1	8.7	16.2	10.3	5.9	6.4	10.1	6.3	39.0	4.1	56.6	4.0	21.8	23.7	8.0	9.5	5.1	4.9	3.4	4.3	4.9	12.9	4.5	34.1	21.2	39.4	14.4	3.9	6.8	17.4	26.0	17.1	32.8	37.2	22.5	31.0	37.0	14.6	12.9	25.2	49.6	21.1	37.1	11.6	32.8	63.4	25.5	24.9	1.0	33.8	13.9	4.1	4.2	26.1	9.3	11.5	34.9	30.8	22.6	21.1	74.8	24.7	42.7	9.2	47.6	30.9	24.1	11.9	30.6	37.8	18.2	52.7	22.0	7.8	26.3	17.8	7.7	25.1	24.4	28.1	23.8	10.1	24.2	75.5	20.1	31.4	22.4	3.4	2.1	1.5	5.5	3.7	2.7	5.1	5.0	6.8	4.9	2.1	4.6	3.4	0.1	4.9	4.3	1.7	12.9	4.5	6.7	12.6	13.9	14.8	6.6	7.1	5.9	7.7	7.7	4.1
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400063-35425430	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.0;lymphoid tissue: 60.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favourable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.78e-4)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	12.1	4.9	6.1	27.5	9.0	57.0	9.1	6.7	5.7	10.4	11.5	12.3	5.0	9.5	10.8	10.8	15.8	8.7	9.4	5.2	4.4	3.4	6.8	8.0	9.3	31.1	8.8	3.7	17.9	10.8	6.2	3.6	19.3	5.8	7.2	8.3	6.5	8.9	5.1	8.8	10.3	16.7	6.0	7.8	31.2	8.4	16.4	8.8	60.6	9.0	17.7	33.0	8.7	9.6	46.8	30.9	19.0	26.0	21.3	32.9	24.0	38.9	28.3	22.4	22.8	2.1	4.4	19.6	26.0	13.8	38.9	37.0	18.8	19.4	25.8	15.1	13.2	19.4	22.3	20.6	12.5	20.8	41.0	36.8	28.4	37.5	0.7	75.9	33.3	2.4	1.9	23.2	6.3	17.2	22.7	38.6	14.7	32.1	61.8	25.3	29.7	16.8	70.0	31.7	32.5	7.7	22.6	17.3	18.4	35.8	14.4	8.0	15.0	29.0	10.1	39.3	29.9	24.4	26.8	21.5	26.4	48.5	25.4	28.7	30.0	19.0	20.7	14.5	18.4	24.1	13.1	46.8	16.1	19.4	27.1	37.0	13.1	14.8	9.9	21.3	26.0	30.9	32.9	24.0	6.1	9.0	6.7	5.7	4.4	3.4	8.8	3.7	5.8	8.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876426	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 66.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	11.3	6.3	7.2	17.7	8.4	23.1	9.5	12.3	9.4	9.1	11.9	5.1	2.9	8.7	10.4	8.8	12.6	8.7	7.6	6.0	5.0	5.5	6.8	7.0	8.5	23.9	4.9	8.0	10.9	4.3	6.2	3.4	10.9	5.9	8.6	12.2	6.2	6.9	6.7	8.2	8.9	16.7	10.4	7.2	14.1	8.0	13.2	3.7	66.3	5.1	11.4	27.5	10.8	9.8	5.5	9.4	5.3	4.0	7.0	13.9	5.6	23.0	14.2	31.0	19.7	6.7	8.7	12.2	16.8	12.8	19.6	21.9	29.0	17.7	40.4	12.4	12.2	13.7	31.3	15.4	21.0	20.7	21.6	40.1	21.1	9.1	3.1	48.1	17.9	5.1	2.0	14.3	4.4	13.3	28.6	34.2	14.4	23.6	58.7	35.4	27.9	14.3	29.1	37.1	37.0	9.8	20.4	19.5	16.6	22.2	10.6	10.6	12.2	30.3	6.5	13.7	11.4	14.7	12.7	20.5	33.4	53.2	19.1	36.8	16.2	5.3	1.4	0.9	7.6	4.0	7.1	5.5	10.5	9.2	4.6	3.2	9.6	11.8	0.8	7.0	3.6	9.4	13.9	5.6	7.2	8.4	12.3	9.4	5.0	5.5	4.9	8.0	5.9	3.7
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 13.8;HAP1: 9.9;HDLM-2: 16.4;THP-1: 19.7;U-698: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			"HPA019114, HPA048999"	Uncertain		Supported	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA019114: AB_1853645, HPA048999: AB_2680592"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	2.9	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	13.8	0.4	0.0	0.1	9.9	1.2	1.1	16.4	7.3	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.0	0.3	0.2	0.4	0.2	0.1	1.1	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.1	1.7	19.7	0.1	0.9	1.5	0.1	2.6	0.1	0.0	12.3	0.8	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.6"	"Cell line enhanced"	"Detected in many"		"HEL: 14.2;HMC-1: 11.7;U-698: 15.5;U-87 MG: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	5.3	4.1	0.8	19.7	1.7	12.6	2.7	0.7	1.5	5.4	12.3	0.0	6.9	5.6	4.0	9.5	5.7	4.5	10.3	4.6	1.0	2.2	3.6	2.3	12.4	18.4	2.5	0.8	3.8	10.0	5.3	24.4	17.1	0.6	6.8	10.2	2.5	16.8	9.6	0.8	4.0	10.9	4.0	0.9	41.6	3.7	1.7	0.4	3.0	8.7	4.1	12.9	6.2	14.8	2.7	0.1	21.2	0.5	6.8	4.4	1.1	2.4	0.0	0.0	0.0	0.0	0.0	1.7	1.3	0.8	0.2	0.1	1.6	3.1	7.1	0.3	0.0	5.6	0.1	4.6	0.0	1.3	0.5	14.2	1.9	0.8	1.0	2.9	11.7	0.8	5.7	0.1	5.8	0.0	0.5	4.0	0.0	0.0	1.3	7.9	0.5	2.6	3.2	0.1	2.7	0.3	7.4	1.4	0.3	0.1	2.4	0.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.6	0.1	15.5	17.7	7.7	0.8	3.2	0.5	7.7	4.4	0.1	2.1	2.2	1.2	1.9	0.0	2.7	0.5	1.9	21.2	6.8	0.5	0.1	0.0	1.1	0.8	1.7	0.7	1.5	1.0	2.2	2.5	0.8	0.6	0.4
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative beta subunit"	Q9NWR8	4	109560205-109688726	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 39.3;lymphoid tissue: 45.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria				"Nucleoplasm, Vesicles, Mitochondria"	"Nucleoplasm, Vesicles, Mitochondria"	"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavourable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	11.6	2.2	4.1	21.0	3.2	8.3	16.6	0.4	3.7	8.2	4.9	4.6	1.4	3.5	12.3	5.5	9.2	6.3	7.3	14.9	4.5	4.7	3.9	2.1	7.8	44.2	3.5	2.6	7.5	2.1	2.3	5.1	9.9	6.5	5.4	6.1	4.1	6.5	2.2	4.3	7.6	8.8	8.4	8.5	13.8	4.2	3.6	1.9	45.3	4.7	9.5	24.8	7.3	9.0	14.0	15.7	1.1	16.0	20.0	39.3	25.7	10.3	4.4	2.4	12.6	2.7	7.3	9.5	8.9	5.4	9.8	8.7	0.2	8.3	36.1	1.8	7.6	2.9	9.3	5.4	8.6	23.0	7.3	4.4	4.9	0.6	4.8	8.8	0.1	4.6	1.5	5.9	5.1	13.0	1.2	23.0	7.4	12.6	20.1	0.1	11.4	6.4	7.7	19.1	4.0	11.4	4.6	10.2	4.4	9.5	28.5	2.9	3.5	0.4	9.2	3.9	5.0	20.3	15.4	8.9	6.2	8.7	11.8	1.9	2.6	0.0	16.0	0.2	6.3	9.7	9.0	13.5	26.7	19.0	15.7	14.0	39.3	22.2	1.1	20.0	7.2	11.0	22.4	25.7	4.1	3.2	0.4	3.7	4.5	4.7	3.5	2.6	6.5	1.9
MEFV	"FMF, MEF, TRIM20"	ENSG00000103313	"MEFV, pyrin innate immunity regulator"	O15553	16	3242028-3256627	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell line enriched"	"Detected in some"	6	"THP-1: 11.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"											HPA077497			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA077497: "	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.58e-7)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	4.2	1.2	0.5	9.8	1.0	9.7	0.9	0.4	0.9	1.1	1.4	0.3	0.0	1.0	0.6	2.7	1.2	1.6	1.8	4.2	0.5	0.5	1.3	1.5	11.4	14.8	2.8	0.1	1.2	1.8	0.2	0.7	1.8	0.8	0.9	0.6	1.7	0.8	0.7	1.7	0.6	1.3	1.6	2.2	23.3	1.0	2.2	1.3	1.2	1.7	0.2	1.4	2.7	4.1	0.4	2.1	10.0	6.5	0.5	0.3	1.3	0.1	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.1	11.8	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.2	0.4	2.0	0.0	2.5	3.8	0.2	0.1	4.2	0.1	0.2	0.2	0.1	2.1	0.4	0.1	0.3	10.0	0.5	6.5	0.3	0.1	1.3	0.5	1.0	0.4	0.9	0.5	0.5	2.8	0.1	0.8	1.3
MEI1	"MGC40042, SPATA38"	ENSG00000167077	"Meiotic double-stranded break formation protein 1"	Q5TIA1	22	41699499-41799456	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 26.8;lymphoid tissue: 20.3;testis: 34.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.8;HMC-1: 6.3;Karpas-707: 20.9;U-266/70: 22.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"amygdala: 1.6;basal ganglia: 1.7;cerebral cortex: 2.6;hippocampal formation: 1.7;olfactory region: 1.9"	"Low region specificity"	"Detected in many"			HPA049240	Approved				"Secreted in male reproductive system"					"HPA049240: AB_2680689"	"unprognostic (1.95e-3)"	"prognostic favourable (1.59e-6)"	"unprognostic (6.13e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.45e-10)"	"unprognostic (2.82e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.39e-2)"	2.1	0.9	1.4	7.7	1.4	12.4	3.1	1.7	3.3	1.6	6.3	0.5	0.9	2.6	0.8	3.6	1.6	1.2	1.9	1.5	1.2	1.8	2.2	1.3	3.5	20.3	1.1	0.4	0.9	1.0	0.0	1.0	1.6	1.6	1.2	3.3	3.3	6.0	1.0	0.7	1.1	6.5	0.6	1.1	15.5	4.5	34.7	0.3	3.8	1.9	1.8	17.1	4.0	1.3	11.0	3.2	7.3	3.7	7.8	26.8	8.8	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	1.6	0.0	0.2	0.4	0.1	0.3	0.4	0.1	0.1	0.0	0.0	0.0	4.9	0.0	1.3	7.8	0.9	1.3	0.9	6.3	0.1	0.1	0.0	0.0	0.3	0.2	20.9	0.0	0.0	0.0	4.6	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.7	0.4	0.0	0.0	0.0	22.2	3.5	0.9	0.3	2.0	0.1	6.2	3.7	7.3	15.8	2.7	15.2	11.0	15.8	13.3	3.2	7.3	11.7	12.8	0.7	7.8	1.1	1.2	26.8	8.8	1.4	1.4	1.7	3.3	1.2	1.8	1.1	0.4	1.6	0.3
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 4.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017214	Uncertain									"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (2.91e-7)"	"prognostic unfavourable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2.0	8.3	0.4	0.1	0.7	0.8	0.0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1.0	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1.0	0.1	0.4	4.8	0.5	35.4	18.2	24.6	14.5	3.4	5.9	14.3	26.3	18.6	36.9	45.6	14.0	14.0	11.9	8.5	12.9	12.2	21.4	16.5	40.8	32.3	8.5	9.3	21.7	13.9	1.3	14.4	11.8	2.1	3.0	28.5	16.2	18.6	11.9	19.0	30.2	11.8	17.9	6.8	19.6	14.3	16.6	16.6	7.6	11.3	12.0	16.7	12.4	14.0	13.5	8.5	11.3	6.9	9.1	19.9	25.2	16.8	23.9	3.7	13.5	17.8	12.6	10.7	27.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.7;lymphoid tissue: 42.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 32.2;HL-60: 40.5;HMC-1: 53.7;HUVEC TERT2: 43.3;U-698: 31.1;U-937: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"	28000	28000	Vesicles	Vesicles	"HPA048936: AB_2680564, HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavourable (5.12e-4)"	"prognostic favourable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	10.0	4.5	2.6	16.6	5.1	14.4	13.4	1.0	3.3	6.0	6.5	3.0	2.0	3.7	6.5	3.5	4.4	7.1	6.3	6.7	2.8	2.6	6.1	5.6	14.9	42.1	5.6	1.2	3.6	3.7	0.8	2.2	14.0	8.3	5.6	3.7	4.4	5.7	2.5	3.4	3.0	14.1	5.1	4.4	37.6	4.1	2.6	3.6	33.9	6.3	4.5	19.3	8.8	4.2	24.1	40.5	72.7	40.8	40.9	53.3	53.2	1.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.6	32.2	0.1	0.0	2.3	9.4	1.8	0.0	12.7	0.2	24.8	0.1	0.3	0.1	40.5	53.7	0.0	0.5	0.3	0.7	43.3	0.1	15.3	0.0	0.1	4.6	0.5	0.1	0.1	11.9	0.4	24.2	0.1	0.0	19.4	0.1	0.1	0.0	0.0	0.2	2.8	24.1	0.0	1.2	4.8	0.1	0.0	0.1	31.1	0.2	36.4	0.5	36.8	40.1	72.7	41.3	38.8	45.1	21.8	48.0	43.3	40.5	24.1	52.9	45.5	25.5	40.9	40.8	10.1	53.3	53.2	2.6	5.1	1.0	3.3	2.8	2.6	5.6	1.2	8.3	3.6
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227054	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 23.9;lymphoid tissue: 8.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;Hep G2: 13.2;U-698: 3.5"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Group enriched"	"Detected in some"	5	"cerebellum: 5.1;cerebral cortex: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA005662			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.6	0.2	0.6	8.9	0.4	0.3	0.3	5.1	1.8	0.7	1.4	0.4	0.0	2.7	0.4	0.1	0.6	0.3	0.2	0.4	0.6	0.6	0.3	0.6	0.5	8.2	0.6	0.0	1.2	0.2	2.3	0.3	0.3	0.6	1.0	1.1	0.2	4.9	0.4	0.2	0.3	1.3	0.0	0.5	7.8	1.4	2.2	0.0	1.0	0.4	0.7	7.0	2.6	0.3	7.5	7.7	23.9	12.2	14.6	9.5	4.0	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.3	0.1	0.1	2.7	0.0	0.2	0.0	0.1	0.2	0.2	13.2	0.6	0.0	0.1	0.2	0.1	0.7	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	23.9	4.7	8.4	4.8	7.1	9.5	7.5	5.6	5.4	4.8	7.2	7.4	7.3	12.9	14.6	12.2	7.7	7.1	4.0	0.6	0.4	5.1	1.8	0.6	0.6	0.6	0.0	0.6	0.0
MKI67	"MIB-, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2;lymphoid tissue: 81.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.4;T-reg: 1.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 1.1;T-cells: 1.4"									"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	1.8	1.2	0.2	9.9	0.5	25.2	1.8	0.3	0.5	1.5	5.0	0.6	0.2	3.6	0.7	1.4	13.4	0.3	1.2	1.3	0.2	0.2	1.2	1.0	1.9	8.8	0.2	0.2	0.5	0.4	0.0	0.4	2.9	0.5	0.7	5.8	0.5	2.2	0.6	0.5	3.9	6.2	1.3	0.8	6.5	3.5	2.5	0.2	81.5	0.4	5.2	10.0	1.3	3.5	0.0	0.0	0.0	0.0	1.1	1.4	0.4	47.3	24.1	25.1	17.8	1.0	2.1	7.8	18.0	13.3	17.1	15.3	19.7	19.7	35.7	5.2	12.3	28.9	26.3	13.5	25.8	37.6	12.7	30.6	17.8	12.3	0.0	43.0	16.6	0.5	0.6	17.6	18.0	16.7	14.0	34.4	16.9	18.8	25.6	13.1	10.0	11.0	19.1	32.9	4.7	6.2	13.3	8.7	9.5	25.5	9.2	4.4	7.5	9.2	15.4	9.1	18.2	12.8	48.6	15.7	12.4	43.3	7.5	19.7	7.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.4	1.0	0.0	1.1	0.0	0.0	1.3	0.4	0.2	0.5	0.3	0.5	0.2	0.2	0.2	0.2	0.5	0.2
MMP12	HME	ENSG00000262406	"Matrix metallopeptidase 12"	P39900	11	102862736-102875034	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 42.4;urinary bladder: 13.2"	"Group enriched"	"Detected in some"	12	"BJ: 4.1;fHDF/TERT166: 14.3;hTEC/SVTERT24-B: 8.2"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (1.69e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.05e-6)"	"unprognostic (1.08e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.92e-2)"	2.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.3	6.9	0.0	0.0	3.3	0.0	5.9	0.0	0.0	1.0	0.0	0.0		0.0	0.4	0.6	18.9	0.0	0.0	0.1	0.0	0.0	0.0	9.7	0.0	0.3	8.4	0.0	0.9	0.0	0.0	0.0	3.8	4.6	0.0	42.4	1.3	0.1	0.0	5.5	0.0	1.5	9.9	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	14.3	0.5	0.0	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MMP20		ENSG00000137674	"Matrix metallopeptidase 20"	O60882	11	102576835-102625332	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.0;testis: 3.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;Hep G2: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"						"unprognostic (4.62e-3)"		"unprognostic (2.61e-2)"	"unprognostic (1.68e-3)"		"unprognostic (1.75e-1)"		"unprognostic (2.13e-1)"		"unprognostic (3.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.58e-5)"	"unprognostic (6.10e-2)"		"unprognostic (2.35e-1)"		0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046681-3060726	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 49.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB025177	Uncertain				"Secreted to blood"					"CAB025177: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favourable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	4.0	0.3	0.6	12.3	0.4	25.6	0.8	0.5	0.6	0.8	1.1	0.2	0.0	1.0	0.4	0.5	0.8	3.8	1.1	2.8	0.5	0.4	0.7	2.5	10.7	54.1	1.8	0.0	0.6	0.8	0.0	0.5	2.0	1.1	0.6	1.0	1.0	0.9	0.0	2.4	0.6	1.8	0.5	0.4	43.9	1.1	0.7	0.5	4.1	0.7	0.9	4.2	1.5	2.5	0.0	0.3	17.6	0.2	1.7	0.5	0.1	0.2	0.1	0.6	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.3	0.0	0.0	3.9	0.8	0.1	0.1	0.0	0.0	0.1	49.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	3.0	1.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	3.5	0.1	0.1	0.4	0.1	0.0	1.2	0.1	0.1	0.0	0.9	0.1	10.2	0.2	6.0	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.3	0.2	17.6	1.7	0.0	0.3	0.3	0.1	0.6	0.4	0.5	0.6	0.5	0.4	1.8	0.0	1.1	0.5
MMS22L	"C6orf167, dJ39B17.2"	ENSG00000146263	"MMS22 like, DNA repair protein"	Q6ZRQ5	6	97142161-97283217	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067042			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA067042: AB_2685768"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-5)"	"unprognostic (9.63e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.21e-3)"	"unprognostic (9.39e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	3.1	3.3	3.0	8.0	4.6	12.7	7.1	2.0	3.2	4.2	3.4	5.5	3.6	2.7	5.2	2.8	4.9	3.1	3.0	3.7	3.6	3.3	2.7	2.1	6.0	11.0	5.1	1.8	3.7	3.2	5.0	4.3	4.1	4.0	4.6	5.0	4.6	3.9	3.5	1.6	5.9	5.1	3.9	8.1	4.5	2.8	13.1	3.1	21.4	2.5	4.0	6.8	3.5	4.0	3.0	4.1	3.1	4.8	2.1	3.9	1.4	4.9	5.5	9.3	10.1	1.5	2.9	7.3	10.1	4.7	9.6	14.0	7.6	5.8	10.8	6.2	3.8	9.0	11.7	5.6	19.1	9.3	8.7	11.0	8.1	4.8	0.9	16.8	7.8	1.5	2.9	13.4	6.3	4.1	14.9	17.5	8.9	5.9	6.1	6.9	3.5	4.2	10.4	8.8	3.8	4.1	6.5	5.3	4.6	6.6	3.3	2.8	5.2	10.4	3.0	9.7	9.3	8.1	13.8	2.2	6.6	12.3	5.5	10.7	10.6	1.6	1.5	3.1	2.4	2.4	3.6	1.8	3.2	3.5	3.6	3.0	3.0	3.9	1.5	2.1	4.8	4.1	2.8	1.4	3.0	4.6	2.0	3.2	3.6	3.3	5.1	1.8	4.0	3.1
MND1	GAJ	ENSG00000121211	"Meiotic nuclear divisions 1"	Q9BWT6	4	153344649-153415118	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.5;testis: 15.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5;T-reg: 4.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.5;NK-cells: 1.2;T-cells: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA043499	Enhanced									"HPA043499: AB_2732506"	"unprognostic (2.21e-2)"	"unprognostic (6.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (6.21e-3)"	"prognostic unfavourable (3.40e-4)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.71e-8)"	"unprognostic (7.65e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.84e-2)"	"unprognostic (7.64e-2)"	0.8	0.9	1.5	10.5	1.4	9.4	3.0	0.9	1.3	1.0	3.6	0.4	0.3	2.5	1.2	1.0	5.3	0.3	0.9	1.1	1.8	1.7	1.0	0.9	1.2	9.5	1.8	0.6	1.0	2.0	0.0	0.7	3.7	0.8	0.9	4.4	0.3	1.4	0.6	1.5	1.5	2.3	1.3	1.9	4.0	1.7	15.7	0.3	28.5	0.7	4.2	11.1	1.4	1.7	0.6	3.5	0.0	0.0	1.2	4.4	0.6	11.5	5.4	17.7	10.1	0.2	2.3	6.5	11.1	4.7	9.8	8.0	10.3	8.5	22.6	2.2	2.8	4.8	17.9	5.0	12.7	14.5	6.6	12.1	5.2	12.6	0.4	26.7	6.0	0.7	1.1	7.7	6.6	3.3	21.1	29.6	8.2	6.3	37.5	34.6	12.2	5.5	23.5	6.0	10.8	6.6	2.9	8.6	7.7	5.0	5.7	9.1	4.5	21.8	0.8	7.7	11.3	8.7	10.4	25.0	28.8	18.7	7.8	21.2	9.4	0.0	0.0	0.0	0.5	0.0	0.0	0.6	1.6	0.1	3.5	0.1	1.4	0.1	0.0	1.2	0.0	0.3	4.4	0.6	1.5	1.4	0.9	1.3	1.8	1.7	1.8	0.6	0.8	0.3
MPEG1	MPG1	ENSG00000197629	"Macrophage expressed 1"	Q2M385	11	59208510-59212951	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.3;lymphoid tissue: 108.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HMC-1: 1.3;THP-1: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 47.3;intermediate monocyte: 38.9;myeloid DC: 26.6;non-classical monocyte: 41.6;plasmacytoid DC: 38.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 38.3;monocytes: 47.3"									HPA046801	Approved									"HPA046801: AB_2679814"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	17.6	6.4	2.2	27.7	2.1	3.6	5.9	1.3	1.8	3.3	9.5	4.9	0.9	9.0	3.2	13.2	3.7	4.9	8.2	7.7	2.2	2.3	7.0	17.3	13.1	51.3	2.6	1.0	4.2	2.7	0.8	2.3	13.4	2.5	5.6	10.0	8.9	7.5	2.4	2.9	2.6	20.6	6.0	3.9	108.6	4.0	3.2	1.7	18.5	3.7	5.5	23.0	11.0	2.7	2.9	38.3	7.0	47.3	0.2	0.1	29.1	0.0	0.0	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.5	0.5	0.0	0.5	0.4	0.7	0.0	0.5	0.3	0.5	0.2	0.0	0.0	0.0	3.7	0.4	0.0	0.2	0.4	0.0	0.9	0.1	0.5	0.0	0.2	0.1	0.0	47.3	1.4	0.1	38.9	0.1	2.4	0.0	0.0	26.6	2.9	0.0	0.0	7.0	0.2	41.6	38.3	0.1	29.1	2.2	2.1	1.3	1.8	2.2	2.3	2.6	1.0	2.5	1.7
MPHOSPH9	MPP9	ENSG00000051825	"M-phase phosphoprotein 9"	Q99550	12	123152320-123244014	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037485	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA037485: AB_10672792"	"unprognostic (2.98e-2)"	"unprognostic (5.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.17e-1)"	5.3	9.8	11.0	10.5	14.6	24.8	5.6	21.6	14.9	5.5	6.7	7.7	4.9	7.9	6.4	12.8	5.9	6.1	4.0	8.8	8.8	6.0	7.1	12.7	6.1	12.0	7.1	8.0	6.9	6.3	9.9	20.4	5.7	9.9	5.8	7.6	7.7	5.9	5.2	7.2	5.4	8.0	5.9	9.1	10.2	5.9	14.4	11.0	48.9	6.2	3.2	10.8	5.5	5.0	6.2	4.9	8.3	3.7	8.5	12.1	3.0	8.7	9.3	14.9	16.8	6.7	6.3	5.6	9.0	4.6	11.3	9.1	8.8	4.2	17.2	6.7	5.9	6.3	19.3	7.3	15.9	11.0	12.5	17.5	10.3	8.6	5.1	16.3	15.2	6.8	2.8	10.8	10.8	11.6	12.1	7.6	10.3	7.3	18.5	25.7	10.2	10.2	16.6	15.0	11.1	8.8	8.6	19.2	9.0	14.0	5.6	8.8	10.5	12.3	6.5	9.3	13.4	10.8	12.8	11.9	19.1	14.3	7.4	15.7	19.2	8.3	3.7	5.1	10.9	3.6	7.7	5.6	8.6	9.8	3.5	6.2	12.1	11.8	0.7	8.5	3.1	4.9	7.4	3.0	11.0	14.6	21.6	14.9	8.8	6.0	7.1	8.0	9.9	11.0
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.2"	"Cell line enriched"	"Detected in single"	17	"HEL: 11.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.0;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.8;NK-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	7400000	7400000	"Endoplasmic reticulum, Golgi apparatus"	"Endoplasmic reticulum, Golgi apparatus"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.8	0.2	0.0	1.2	0.5	5.3	0.7	0.1	0.4	1.0	0.9	0.0	0.0	0.9	1.0	0.8	2.0	0.7	1.5	7.4	0.2	0.0	0.4	0.5	7.6	2.8	1.0	0.0	2.7	0.2	0.2	0.2	1.4	0.7	0.9	0.2	1.1	1.8	0.3	1.2	10.5	0.8	1.9	0.6	33.2	0.4	2.7	0.1	1.2	1.0	1.4	0.8	1.6	1.6	0.2	1.8	0.5	0.1	3.0	0.1	5.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.5	3.0	0.1	1.8	0.0	5.7	0.0	0.5	0.1	0.4	0.2	0.0	1.0	0.0	0.7	0.1
MPL	"CD110, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337849-43352772	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.6"	"Cell line enriched"	"Detected in single"	78	"HEL: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Low region specificity"	"Detected in all"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA007619: "	"unprognostic (2.74e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.42e-1)"	1.1	0.3	0.9	0.5	0.8	2.0	0.9	0.5	2.2	0.6	0.6	0.5	0.5	0.3	0.9	1.7	0.9	2.1	0.5	3.9	0.8	0.6	0.5	0.5	2.0	0.5	0.9	0.5	6.6	1.1	0.6	0.6	2.2	0.5	1.5	0.7	0.5	0.5	0.7	0.6	0.4	1.2	2.1	2.5	8.6	0.5	2.1	0.5	0.5	2.2	2.4	0.5	0.9	0.5	0.0	0.0	1.6	0.3	0.0	0.0	4.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	40.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.0	0.9	0.8	0.5	2.2	0.8	0.6	0.9	0.5	0.5	0.5
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809344-17911170	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 44.8;lymphoid tissue: 37.8"	"Group enriched"	"Detected in some"	19	"MOLT-4: 17.2;TIME: 16.0"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	15	"myeloid DC: 8.2"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA004114, HPA045134, CAB068203"	Enhanced					130000000	130000000			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	34.8	8.3	0.3	6.2	1.2	0.0	19.8	0.7	0.6	5.2	11.2	0.6	0.9	2.2	4.5	10.4	4.2	1.3	7.9	13.4	0.9		12.4	16.4	44.8	37.8	1.0	0.0	3.6	5.1	1.8	2.4	15.4	3.1	5.5	5.1	7.0	0.7	1.9	5.1	0.0	6.5	8.2	1.4	30.6	2.2	7.1	0.8	0.8	6.5	3.5	0.7	7.5	5.1	0.0	8.2	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.2										
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 79.3;testis: 53.6"	"Cell line enriched"	"Detected in single"	24	"THP-1: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.8;non-classical monocyte: 9.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 9.2"									HPA058973			Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	14.5	4.4	2.0	4.6	2.3	1.5	5.4	0.8	1.5	2.4	3.9	1.9	1.1	1.5	1.9	6.4	1.8	1.3	2.3	6.4	2.5	2.3	3.5	13.3	18.0	11.3	2.4	0.1	1.3	1.5	1.2	3.2	6.0	2.4	3.0	2.2	4.5	2.1	1.6	1.3	1.3	4.0	2.4	5.5	79.3	1.5	53.6	1.5	3.7	1.7	0.7	3.0	2.4	1.7	0.5	1.8	0.1	9.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	4.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.9	2.0	2.3	0.8	1.5	2.5	2.3	2.4	0.1	2.4	1.5
MS4A6A	"CD20L3, MS4A6"	ENSG00000110077	"Membrane spanning 4-domains A6A"	Q9H2W1	11	60172014-60184666	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 112.4;lymphoid tissue: 89.5"	"Cell line enriched"	"Detected in some"	9	"THP-1: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3"	"Group enriched"	"Detected in many"	96	"dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4"									HPA011391	Approved									"HPA011391: AB_10603876"	"unprognostic (1.17e-1)"	"prognostic favourable (6.33e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.97e-2)"	29.3	17.8	12.3	18.3	26.7	9.1	18.1	2.8	14.6	10.2	14.9	4.7	4.0	9.0	7.0	28.3	8.7	11.3	21.0	23.1	10.7	6.9	18.0	35.6	23.0	89.5	22.2	2.4	7.7	6.0	2.4	8.8	21.5	20.5	9.6	19.0	10.2	11.8	6.3	6.0	5.1	20.4	17.2	32.0	78.1	8.5	8.3	19.4	8.5	7.0	6.7	15.4	21.5	6.3	0.7	65.3	32.4	112.4	0.2	0.3	61.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.8	3.7	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	32.4	112.4	0.7	0.1	35.6	0.3	0.7	0.2	0.1	65.3	0.1	0.1	0.1	7.4	0.2	2.3	46.3	0.1	61.3	12.3	26.7	2.8	14.6	10.7	6.9	22.2	2.4	20.5	19.4
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	8.8	35.0	19.2	16.7	21.0	1.6	14.6	11.4	23.7	14.5	12.5	10.2	16.8	9.0	17.2	25.0	16.7	14.1	11.3	11.1	18.3	14.0	14.5	7.6	8.3	11.5	12.3	14.6	33.3	15.0	18.3	15.8	16.1	12.5	15.0	14.1	12.6	10.6	20.8	9.8	15.4	8.7	14.3	10.4	6.4	12.5	21.0	9.3	74.3	13.0	7.7	15.0	13.5	13.4	2.9	3.2	7.7	1.9	3.3	8.8	3.3	7.7	8.1	12.1	7.3	9.7	13.6	24.0	4.8	8.7	10.9	9.3	10.2	13.4	25.3	8.4	10.5	4.8	25.6	11.5	16.0	9.3	8.7	4.5	4.7	16.0	10.5	2.7	15.5	14.3	12.9	7.4	7.9	14.6	8.2	2.9	11.9	11.4	17.6	8.5	43.2	4.9	10.2	10.6	0.0	10.9	6.3	6.4	20.9	7.5	23.5	9.9	12.7	3.5	9.1	5.2	8.6	3.9	4.7	6.1	2.8	37.1	6.9	2.8	6.7	7.7	1.9	0.0	4.1	0.7	5.7	2.5	4.4	6.2	3.2	2.9	8.8	5.9	0.3	3.3	1.2	1.0	2.2	3.3	19.2	21.0	11.4	23.7	18.3	14.0	12.3	14.6	12.5	9.3
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139081	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.4"	"Cell line enhanced"	"Detected in all"		"U-698: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA069047: AB_2686073, HPA069066: AB_2686078"	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavourable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavourable (1.05e-4)"	"prognostic unfavourable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	6.8	8.0	8.5	19.7	18.4	21.9	10.3	24.3	12.2	9.8	8.0	8.6	4.9	8.0	9.0	8.5	7.2	7.6	7.4	5.3	9.0	8.2	7.6	7.3	8.6	19.9	8.1	9.8	12.0	7.0	6.7	13.9	13.0	9.2	7.0	8.4	6.7	6.7	6.8	7.1	8.1	9.5	6.8	8.5	12.7	7.2	17.3	9.2	43.4	9.6	7.1	19.4	7.9	8.3	11.7	12.0	14.7	10.6	13.0	14.3	6.2	7.3	3.5	12.3	8.1	2.1	2.1	14.3	4.7	3.8	8.2	10.3	6.0	4.1	23.8	8.7	3.0	4.0	11.3	4.9	12.1	9.1	8.3	16.4	5.5	8.1	3.2	21.3	7.0	2.6	2.7	7.7	4.7	7.8	18.5	7.5	5.1	3.1	30.6	17.8	21.0	4.8	24.9	15.3	6.4	7.6	8.0	7.7	9.3	7.8	9.3	9.5	5.5	15.1	4.4	5.5	8.2	5.2	7.0	5.9	6.6	42.3	1.0	12.8	3.5	9.4	9.4	14.7	11.3	10.6	12.9	10.0	11.7	14.3	12.0	11.7	13.9	12.4	7.2	13.0	6.3	11.4	12.9	6.2	8.5	18.4	24.3	12.2	9.0	8.2	8.1	9.8	9.2	9.2
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavourable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	1.7	0.9	0.6	5.1	1.5	15.2	0.9	0.9	1.1	0.8	2.9	0.8	0.4	2.8	0.7	0.9	4.5	0.5	1.7	1.0	0.6	0.6	2.5	0.7	1.5	6.4	0.8	0.4	0.9	0.7	0.0	0.7	3.2	1.2	0.7	4.1	0.6	1.3	0.4	1.4	1.9	3.2	0.9	1.1	3.8	1.9	13.5	0.4	16.8	0.4	3.2	5.8	1.1	1.4	1.6	3.0	0.1	2.9	0.0	2.6	1.1	7.1	5.6	4.8	8.9	0.8	1.4	8.6	9.5	6.6	11.3	15.9	9.9	5.9	18.7	5.8	3.8	11.2	10.8	7.0	16.9	10.4	8.3	14.7	4.1	9.0	0.5	26.9	13.9	1.1	1.5	12.6	8.1	6.1	15.8	14.6	8.4	9.6	15.1	22.6	4.8	6.9	13.9	7.7	9.4	4.8	5.6	3.8	3.8	6.0	10.6	5.4	4.4	18.6	3.3	5.6	5.9	19.8	14.5	5.5	13.0	12.4	3.2	18.4	8.6	0.0	0.6	0.0	1.2	2.9	0.4	1.6	1.6	2.6	3.0	1.3	0.2	1.3	0.1	0.0	2.3	2.2	2.2	1.1	0.6	1.5	0.9	1.1	0.6	0.6	0.8	0.4	1.2	0.4
MTNR1B		ENSG00000134640	"Melatonin receptor 1B"	P49286	11	92969720-92985066	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.0;lymphoid tissue: 1.9;placenta: 4.5;testis: 2.0"	"Group enriched"	"Detected in some"	8	"AF22: 1.1;U-138 MG: 1.4;WM-115: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"midbrain: 0.8;pons and medulla: 1.2"	HPA074024	Supported									"HPA074024: "					"unprognostic (3.61e-1)"												"unprognostic (1.43e-1)"	0.1	0.0	0.3	0.0	3.0	0.0	0.0	0.1	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.1		0.0	0.0	0.0	0.0	4.5		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0			0.0		1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195812277	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.5;lymphoid tissue: 57.2"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA005895, CAB013536"	Approved				"Secreted in other tissues"					"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.4	0.4	0.0	28.7	0.0	0.4	0.4	0.0	0.4	13.4	21.5	0.0	0.0	0.4	1.4	0.4	13.0	1.7	0.4	0.4	0.0	0.0	0.4	0.4	10.3	0.4	0.0	0.0	0.5	0.4	0.4	0.0	6.2	0.2	10.0	1.9	0.0	5.5	0.4	0.4	0.4	1.7	0.4	0.0	0.4	2.4	0.5	0.0	0.5	0.4	6.1	57.2	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8"	"Cell line enriched"	"Detected in some"	7	"PC-3: 51.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	590000	590000	Vesicles	Vesicles	"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.1	0.1	0.7	0.1	0.0	0.2	0.1	0.1	67.4	8.4	0.0	0.0	0.0	1.9	0.0	11.6	0.2	301.7	0.1	0.1	0.1	0.1	0.6	2.0	0.0	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.1	4.6	0.0	192.8	0.0	0.7	0.1	0.3	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.1	31.6	155.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361943-41409390	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.2;lymphoid tissue: 35.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 42.2;BJ hTERT+ SV40 Large T+ RasG12V: 41.2;MOLT-4: 26.3;U-266/84: 43.8;U-937: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 61.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.2"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain									"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	21.6	1.4	1.6	14.3	7.6	12.5	11.5	0.7	2.3	9.2	4.7	3.0	2.5	5.5	9.2	7.4	5.7	5.6	12.4	7.1	2.3	2.2	4.9	3.0	6.1	34.7	2.2	2.8	3.9	2.8	0.2	1.7	5.7	6.1	4.4	2.8	5.7	6.7	1.8	4.5	4.8	8.9	4.9	5.5	24.3	11.2	3.9	2.1	35.9	4.6	2.4	14.9	12.3	6.7	5.2	7.4	61.2	11.7	2.5	8.3	6.3	0.2	0.0	0.0	0.0	0.9	2.3	0.0	0.0	5.8	42.2	41.2	0.0	14.3	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.5	0.0	17.4	0.0	7.5	0.3	0.3	0.0	3.4	0.0	0.8	0.0	0.0	0.7	8.9	0.0	0.0	26.3	10.5	16.5	0.2	3.8	0.0	1.3	0.0	1.1	0.0	0.0	0.9	0.0	1.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.6	1.3	45.2	4.5	2.3	10.5	9.0	4.4	11.7	5.7	5.2	7.1	5.2	7.4	4.7	8.3	5.4	61.2	2.5	10.3	4.2	4.8	6.3	1.6	7.6	0.7	2.3	2.3	2.2	2.2	2.8	6.1	2.1
MXD3	"bHLHc13, MAD3"	ENSG00000213347	"MAX dimerization protein 3"	Q9BW11	5	177301461-177312757	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.1;lymphoid tissue: 59.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.1;monocytes: 8.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA070111			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA070111: AB_2686228"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.18e-3)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.33e-16)"	"unprognostic (8.55e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-3)"	2.5	1.8	1.3	28.2	1.9	32.1	5.4	1.2	3.4	2.4	6.8	1.2	2.8	6.9	2.7	6.2	6.6	3.6	2.8	2.4	1.6	0.8	2.7	6.6	5.4	7.3	2.2	1.2	2.6	5.8	0.7	4.3	4.5	2.1	5.0	0.9	1.1	4.7	2.1	3.6	10.3	5.6	1.4	1.3	10.3	3.8	3.1	2.9	59.4	3.5	3.7	13.5	2.7	3.6	2.0	1.6	14.1	8.7	0.7	0.8	1.1	8.0	5.6	3.4	9.4	0.2	0.4	5.7	10.6	3.5	4.8	4.6	3.6	8.4	4.3	4.4	1.4	4.0	0.4	1.2	0.2	58.7	7.1	2.4	8.0	5.3	0.5	2.3	7.4	0.3	0.6	0.3	0.2	4.4	1.4	13.5	0.9	10.3	21.4	6.4	1.2	9.7	10.5	10.7	6.1	1.0	1.1	8.5	7.0	6.8	6.9	3.6	10.8	6.1	3.2	5.8	14.9	4.5	5.6	17.9	5.9	4.7	4.5	8.1	3.3	3.5	2.6	7.7	0.7	7.2	0.0	1.6	0.1	0.1	1.6	2.0	0.0	0.3	14.1	0.7	8.7	1.0	0.8	1.1	1.3	1.9	1.2	3.4	1.6	0.8	2.2	1.2	2.1	2.9
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 28.6;BJ hTERT+ SV40 Large T+ RasG12V: 24.2;Daudi: 29.1;HBF TERT88: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 4.9;MAIT T-cell: 3.5"	"Group enriched"	"Detected in many"	32	"NK-cells: 1.4;T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008791	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavourable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	2.1	1.1	2.6	25.6	5.1	2.5	2.2	6.5	3.8	1.6	2.1	4.0	2.6	1.7	1.6	2.9	1.5	1.8	3.3	3.9	3.4	2.2	1.4	2.4	4.5	21.7	6.4	2.8	1.2	0.7	1.3	1.2	4.1	6.3	2.6	1.9	1.8	1.2	2.2	1.3	1.6	3.9	2.7	6.5	11.0	2.2	12.7	4.4	4.7	1.5	1.0	18.0	2.2	1.9	0.0	0.0	0.0	0.0	1.4	4.9	0.3	11.6	4.0	1.3	3.4	0.3	0.7	0.9	16.1	7.4	28.6	24.2	0.5	11.8	29.1	1.4	13.5	3.3	1.1	1.3	39.5	3.5	1.8	0.6	4.4	0.5	0.0	0.2	1.1	0.2	0.1	7.8	6.6	0.9	0.1	9.7	17.4	1.0	1.9	0.4	0.9	5.4	0.6	4.8	0.7	6.7	0.4	2.8	1.1	2.8	1.0	2.9	17.3	0.7	4.9	17.2	3.9	3.8	14.7	2.8	3.9	8.6	4.5	1.7	6.8	0.0	0.0	0.0	4.9	0.0	3.5	0.0	0.9	2.0	0.0	0.0	0.1	0.8	0.0	1.4	0.0	0.0	0.0	0.3	2.6	5.1	6.5	3.8	3.4	2.2	6.4	2.8	6.3	4.4
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716496	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 101.9"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	30	"plasmacytoid DC: 35.9"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB017114: , HPA030530: AB_2673515, HPA055416: "	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.7	0.7	0.2	48.3	0.2	33.0	1.0	0.2	0.2	1.0	4.4	0.2	0.1	2.7	1.1	1.1	8.4	0.3	1.7	0.9	0.2	0.2	1.0	1.2	1.8	22.3	0.3	0.1	0.8	9.4	0.0	0.4	4.0	0.2	0.7	2.7	0.3	2.9	0.1	0.3	1.8	6.4	0.6	0.3	43.9	2.9	12.6	0.1	49.2	0.6	6.4	33.8	1.9	2.1	1.1	35.9	0.0	0.0	0.0	0.4	0.3	25.8	16.5	14.6	15.1	0.1	0.5	19.0	11.7	4.0	37.1	27.4	80.9	16.3	52.3	6.8	5.1	15.8	26.4	8.1	13.9	9.8	16.9	24.5	16.5	21.8	0.0	22.3	17.0	0.3	0.7	14.1	3.2	9.9	24.4	65.1	3.2	101.9	45.3	31.4	16.8	14.5	31.6	30.1	30.0	6.8	5.3	13.5	19.6	34.8	35.0	3.5	23.1	24.5	4.6	2.3	37.4	16.4	20.1	22.6	46.5	82.3	4.8	19.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	35.9	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979098	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.9;HEL: 25.3;HL-60: 14.4;MOLT-4: 32.0;NB-4: 13.5;THP-1: 28.4;U-937: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced					120000	120000			"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favourable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.5	1.2	1.6	11.0	3.0	27.4	1.5	0.4	2.0	1.0	1.9	0.7	0.0	1.8	1.2	2.1	2.4	1.9	3.6	3.2	1.0	0.9	1.9	1.9	13.0	18.6	4.5	0.0	0.9	0.8	0.0	0.9	1.5	2.7	1.5	1.1	1.5	5.8	0.5	0.6	1.2	8.3	1.9	2.6	22.3	2.1	0.9	1.8	46.8	2.1	2.2	26.6	4.7	1.3	9.9	14.0	9.4	37.9	6.7	24.4	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	25.3	0.8	0.0	0.0	14.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	13.5	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	20.9	0.0	9.4	17.0	5.2	19.9	29.6	12.6	9.9	12.7	17.4	14.0	6.6	4.6	9.0	1.7	6.7	37.9	1.2	24.4	19.3	1.6	3.0	0.4	2.0	1.0	0.9	4.5	0.0	2.7	1.8
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056826-40158252	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	3.5	3.1	3.4	7.4	5.1	7.0	5.8	6.1	3.2	5.5	4.3	1.2	7.1	4.7	7.0	6.6	5.2	4.8	3.8	3.5	2.5	3.6	3.2	11.3	7.5	9.2	1.9	1.6	7.0	13.1	2.5	14.3	11.9	2.8	4.9	4.5	4.3	10.7	11.0	2.9	5.4	5.3	3.2	3.1	4.3	3.8	3.5	2.1	35.6	7.2	3.5	7.8	5.6	5.2	2.4	8.1	5.7	1.2	10.6	4.5	1.2	1.5	1.6	9.3	1.5	0.6	3.1	7.6	1.7	1.9	1.0	2.2	2.9	3.1	8.2	3.4	1.6	1.1	5.9	1.9	2.4	2.6	1.9	3.7	1.4	1.4	1.6	9.9	8.8	3.4	2.7	1.7	3.7	2.7	8.1	3.6	2.0	1.5	20.0	4.3	4.6	1.3	11.7	11.0	1.9	0.8	3.6	3.8	6.6	1.6	1.3	1.5	1.1	2.7	3.6	1.1	5.9	0.7	1.3	5.9	5.9	5.6	1.1	3.6	2.3	5.7	1.1	0.5	2.3	1.2	2.4	1.7	3.0	1.7	1.7	2.4	4.5	2.5	0.3	10.6	1.0	8.1	1.3	1.2	3.4	5.1	6.1	3.2	2.5	3.6	1.9	1.6	2.8	2.1
NABP1	"DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2"	ENSG00000173559	"Nucleic acid binding protein 1"	Q96AH0	2	191678068-191696659	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054978, HPA067802"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA054978: AB_2682660, HPA067802: AB_2685899"	"unprognostic (5.43e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.07e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (8.20e-7)"	"unprognostic (5.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.02e-2)"	20.8	4.9	2.4	26.0	2.3	4.2	22.2	1.1	2.1	4.4	14.1	1.9	1.6	13.3	6.7	9.2	12.1	4.9	8.1	6.9	4.7	2.0	8.8	8.7	18.6	39.6	3.9	1.3	4.9	6.3	0.8	4.4	28.0	6.1	4.7	5.2	2.6	6.2	3.9	3.1	4.3	30.6	4.7	5.3	40.0	4.6	18.4	1.5	7.4	3.6	12.1	23.0	8.7	8.8	3.8	2.2	18.6	7.7	1.6	14.2	1.9	14.7	2.3	0.3	0.4	11.2	13.6	3.9	23.0	18.9	14.3	8.6	12.2	8.3	0.8	18.3	13.8	4.2	2.1	9.8	15.8	7.7	1.9	7.3	4.7	3.1	8.2	3.4	8.4	17.8	12.3	20.5	14.7	5.4	10.3	32.6	22.3	1.2	1.1	3.9	1.3	11.6	2.5	2.5	6.9	21.4	10.9	0.5	0.1	7.9	2.7	6.4	0.7	2.2	13.6	12.0	10.1	6.3	14.4	10.7	4.4	3.0	9.9	4.1	2.1	2.5	4.0	1.9	6.4	6.7	8.7	3.8	8.6	6.6	2.2	0.6	2.2	3.8	18.6	1.6	7.7	1.4	14.2	1.9	2.4	2.3	1.1	1.9	4.7	2.0	3.9	1.3	6.1	1.5
NAIP	"BIRC1, NLRB1"	ENSG00000249437	"NLR family apoptosis inhibitory protein"	Q13075	5	70968483-71025114	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.1;lymphoid tissue: 17.5"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 7.8;SiHa: 4.5;T-47d: 4.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.4"	"Group enriched"	"Detected in some"	10	"classical monocyte: 8.1;intermediate monocyte: 2.9;myeloid DC: 6.9;neutrophil: 5.9"	"Group enriched"	"Detected in many"	14	"dendritic cells: 6.9;granulocytes: 5.9;monocytes: 8.1"									HPA042438	Approved									"HPA042438: AB_10796578"	"unprognostic (9.03e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.96e-2)"	2.4	1.0	0.8	4.7	0.8	2.4	0.8	0.8	2.6	0.8	0.8	0.8	0.8	0.1	0.9	1.2	0.8	1.6	1.6	0.8	0.8	0.6	0.8	0.8	3.9	3.4	1.2	0.8	0.8	0.8	0.2	0.8	0.8	6.4	0.8	0.7	0.8	0.8	0.8	1.0	0.4	2.3	1.1	2.3	17.5	3.0	0.8	0.8	0.8	0.9	0.8	0.8	3.6	0.8	0.3	6.9	5.9	8.1	0.4	0.2	2.0	0.0	0.0	1.1	0.4	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.8	0.7	1.6	0.2	1.5	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.2	0.0	7.8	0.0	0.1	0.0	0.1	0.0	1.7	0.3	0.1	0.3	0.0	4.5	0.0	0.3	4.9	0.0	0.0	1.2	0.3	0.2	0.0	0.9	0.0	0.6	0.1	0.1	0.8	0.2	8.1	0.0	0.2	2.9	0.1	0.1	0.0	0.1	6.9	0.3	0.2	0.1	5.9	0.4	0.5	0.3	0.1	2.0	0.8	0.8	0.8	2.6	0.8	0.6	1.2	0.8	6.4	0.8
NAT14	KLP1	ENSG00000090971	"N-acetyltransferase 14 (putative)"	Q8WUY8	19	55485004-55487568	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 42.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047187			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA047187: AB_2679974"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (7.00e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.58e-1)"	3.6	10.1	15.8	5.7	19.6	4.5	5.5	25.8	25.8	8.2	7.0	8.9	3.1	3.5	12.6	10.1	2.9	24.1	6.5	5.9	15.4	16.7	9.2	2.5	7.8	4.6	10.8	15.5	14.1	5.6	11.2	19.2	8.5	10.6	6.8	3.1	7.8	5.0	10.5	2.9	4.1	3.4	11.1	6.5	3.7	5.6	4.9	9.5	42.2	9.8	1.3	3.8	6.0	4.3	1.8	1.8	2.3	0.3	0.3	1.0	0.6	2.4	8.8	9.7	17.9	4.1	5.0	6.1	9.1	10.6	10.0	14.2	3.0	7.8	1.0	3.2	5.8	3.2	6.3	5.6	6.2	9.8	54.7	7.9	11.8	6.7	7.3	5.9	8.0	7.2	2.1	7.3	1.9	7.2	9.8	2.7	5.8	2.9	9.8	8.9	13.8	4.9	9.7	6.2	3.5	22.8	4.6	29.9	20.4	3.6	5.3	8.0	4.3	5.6	8.7	3.7	10.1	0.5	7.3	5.7	2.2	4.2	8.1	1.0	9.1	0.0	0.3	0.2	0.5	0.3	1.0	0.6	0.4	0.3	0.0	1.8	0.7	0.7	2.3	0.3	0.3	1.8	0.0	0.6	15.8	19.6	25.8	25.8	15.4	16.7	10.8	15.5	10.6	9.5
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631311-158704829	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.91e-4)"	"prognostic unfavourable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	5.9	4.0	4.4	8.6	4.2	20.1	5.4	9.0	5.1	4.4	6.6	5.8	3.5	4.2	5.1	5.1	9.9	3.7	3.1	4.0	4.3	3.5	3.3	3.9	4.4	11.4	6.2	4.2	4.4	4.4	6.0	5.8	6.9	4.9	4.5	7.7	3.9	5.3	4.2	4.5	6.5	5.5	4.6	6.2	6.1	5.3	14.6	5.1	39.1	3.6	7.6	13.0	4.8	5.5	1.8	2.8	6.9	5.4	6.1	9.3	2.5	29.7	15.8	19.3	12.4	2.9	4.7	7.7	21.8	14.1	27.0	30.3	14.0	15.6	18.4	13.6	8.9	15.3	16.0	10.0	36.1	19.6	11.9	16.6	19.7	11.0	1.3	20.5	18.8	2.0	1.1	22.0	6.3	15.0	20.3	27.7	24.8	31.6	34.0	13.9	19.0	12.8	20.0	20.3	17.5	6.7	13.4	21.1	16.3	26.9	10.5	5.9	9.5	13.4	7.8	18.5	14.1	49.9	34.9	18.3	13.5	22.4	19.6	26.2	35.1	6.9	1.0	1.2	6.5	1.4	9.3	1.8	6.6	4.5	2.8	1.2	2.2	2.4	0.6	6.1	5.4	1.4	8.3	2.5	4.4	4.2	9.0	5.1	4.3	3.5	6.2	4.2	4.9	5.1
NCCRP1	"FBXO50, LOC342897, NCCRP-1"	ENSG00000188505	"Non-specific cytotoxic cell receptor protein 1 homolog (zebrafish)"	Q6ZVX7	19	39196961-39201884	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 101.7;lymphoid tissue: 113.1;skin 1: 49.6"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"olfactory region: 2.0"	"Not detected"	"Not detected"			HPA052812	Approved					1200000	1200000			"HPA052812: AB_2681960"	"unprognostic (3.56e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (4.59e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.37e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	0.1	0.1	0.0	3.1	0.0	0.3	2.1	0.0	0.4	21.5	0.8	0.0	0.4	0.6	2.1	0.3	101.7	0.4	0.3	0.1	0.0	0.0	0.9	0.1	0.8	2.4	0.0	0.0	0.1	2.9	0.1	0.0	7.5	0.0	0.4	0.6	20.2	10.5	0.4	0.3	49.6	2.4	0.2	0.0	0.4	0.1	0.1	0.0	4.3	0.2	42.7	113.1	1.2	31.2	0.7	0.8	3.4	0.6	0.9	0.6	0.1	0.2	0.2	1.0	0.2	0.1	0.7	2.1	0.1	0.0	0.1	0.1	0.5	0.5	0.6	2.0	0.4	0.9	1.4	0.5	0.4	0.0	0.4	0.2	0.8	0.2	0.1	0.4	0.3	0.5	0.4	0.0	0.3	0.2	0.3	0.3	0.3	0.1	0.2	0.1	0.6	0.2	0.2	0.4	0.4	0.1	0.5	0.6	1.0	2.5	26.2	0.2	0.3	0.9	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.5	0.2	0.5	3.4	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.3	0.2	0.7	0.5	0.4	2.0	0.9	0.5	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
NCKAP1L	HEM1	ENSG00000123338	"NCK associated protein 1 like"	P55160	12	54497711-54548238	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.1;lymphoid tissue: 56.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 32.9;HMC-1: 34.8;NB-4: 24.2;REH: 17.4;THP-1: 36.1;U-937: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039490, HPA040772"	Approved		Uncertain	"Plasma membrane,Cytosol"		52000	52000	Cytosol	Cytosol	"HPA039490: AB_2676540, HPA040772: AB_2677129"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.63e-2)"	"unprognostic (4.74e-2)"	18.1	5.0	5.9	22.0	10.5	16.9	7.2	1.2	5.8	3.1	15.0	8.1	0.6	4.0	3.1	4.3	4.8	4.0	5.1	6.5	4.1	3.5	3.9	6.5	19.7	56.7	9.3	2.5	2.2	2.4	4.4	2.3	7.3	6.6	4.8	6.9	3.0	4.3	4.0	1.5	2.8	15.4	7.0	13.9	44.7	4.7	1.7	7.9	47.2	2.8	1.8	30.0	22.2	3.3	11.2	25.4	18.4	39.1	12.3	15.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	11.9	0.1	14.2	0.0	0.0	0.0	32.9	34.8	0.0	0.0	0.0	0.0	0.2	2.2	13.3	0.0	0.0	13.8	24.2	0.0	0.0	17.4	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.7	0.8	11.6	0.0	21.1	0.0	8.6	23.3	18.4	11.9	36.4	9.8	11.2	10.7	12.1	25.4	11.0	6.9	10.0	5.9	12.3	39.1	14.4	15.2	19.2	5.9	10.5	1.2	5.8	4.1	3.5	9.3	2.5	6.6	7.9
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906150-54916140	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 5.5;lymphoid tissue: 13.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049311			Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA049311: AB_2680707"	"unprognostic (3.92e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.87e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.32e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.05e-3)"	1.4	0.2	0.1	3.7	0.4	2.1	0.3	0.1	0.3	0.3	2.1	0.0	0.5	0.1	1.2	1.3	0.3	0.2	2.1	1.9	0.2	0.2	0.3	2.5	5.5	3.8	0.2	0.0	0.2	0.1	0.1	0.2	0.4	0.0	0.6	0.2	1.0	0.4	0.1	0.3	0.5	3.4	1.2	0.2	13.9	0.3	0.4	0.0	2.0	0.3	0.1	2.6	0.7	0.3	0.2	0.2	1.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.3	0.2	0.2	0.2	0.0	0.0	0.0
NCR2	"CD336, LY95, NK-p44"	ENSG00000096264	"Natural cytotoxicity triggering receptor 2"	O95944	6	41335655-41350887	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.5;intestine: 3.3;lymphoid tissue: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;MOLT-4: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"NK-cell: 2.5;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 8.5;NK-cells: 2.5"									HPA067249	Uncertain									"HPA067249: AB_2685811"		"unprognostic (5.81e-2)"				"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"		"unprognostic (2.12e-2)"				"unprognostic (1.65e-1)"				0.1	0.1	0.1	1.9	0.1	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	2.8	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.2	0.0	0.1	2.5	0.1	0.0	0.6	0.1	0.3	0.0	1.2	0.1	1.7	3.7	0.0	0.1	0.0	8.5	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	8.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31592985	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 28.5;lymphoid tissue: 18.5"	"Cell line enriched"	"Detected in some"	4	"NB-4: 9.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 28.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 28.5"																				"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"	1.8	0.1	0.2	10.5	0.2	4.3	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.2	0.3	0.5	0.9	0.2	0.3	1.2	0.6	0.1	0.5	1.3	3.9	11.4	0.2	0.0	0.5	1.1	0.0	0.1	0.8	0.1	0.3	0.3	0.1	8.4	0.4	0.1	0.3	5.8	0.2	0.2	18.5	0.4	0.8	0.0	3.6	0.4	0.1	12.8	1.0	0.3	6.1	0.0	0.1	0.2	6.4	28.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	10.5	0.0	28.5	6.1	1.2	5.2	0.0	4.4	0.5	3.3	0.1	6.4	0.2	0.0	1.7	2.5	0.2	0.2	0.1	0.1	0.6	0.1	0.2	0.0	0.1	0.0
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80, kinetochore complex component"	O14777	18	2571511-2616635	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 51.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066330			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Nucleoplasm	"HPA066330: AB_2685661"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	2.9	1.3	0.8	15.3	0.8	14.6	0.9	0.7	0.9	2.9	3.8	0.8	0.6	2.7	4.2	3.8	8.3	1.3	1.8	2.7	0.6	0.4	1.6	1.4	2.9	10.1	0.6	0.8	1.2	0.8	0.0	0.6	6.0	1.1	4.3	5.1	0.8	1.9	7.6	0.6	4.0	4.8	2.2	0.6	7.9	3.0	15.9	0.6	51.3	0.9	8.1	9.9	2.2	6.7	7.9	1.6	9.3	0.7	2.2	11.5	1.4	21.5	4.9	24.5	10.8	1.3	2.9	12.6	25.4	13.6	33.3	28.4	13.4	12.3	23.6	11.5	9.8	13.4	27.3	11.0	35.3	8.8	6.9	18.6	14.0	10.3	0.4	35.6	15.7	1.5	1.0	19.1	13.6	15.1	15.1	30.1	29.0	9.7	17.3	15.5	12.6	7.2	19.2	25.0	18.9	8.7	10.5	19.8	8.9	23.2	6.1	9.2	10.3	14.2	9.2	21.7	48.4	17.1	33.4	13.2	20.8	31.7	9.6	16.5	18.3	3.7	0.7	2.8	2.2	0.6	2.0	7.9	3.7	4.3	0.3	5.7	2.4	2.4	9.3	2.2	0.5	1.6	11.5	1.4	0.8	0.8	0.7	0.9	0.6	0.4	0.6	0.8	1.1	0.6
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258648	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6"	"Cell line enriched"	"Detected in single"	19	"MOLT-4: 18.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain									"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.3	2.0	3.2	0.3	17.0	0.6	0.3	22.2	6.9	2.1	0.4	0.0	0.0	0.3	0.4	0.2	0.3	1.3	0.4	0.3	2.3	2.0	0.9	4.6	0.4	0.6	0.9	1.7	0.6	0.2	0.2	7.6	0.4	1.7	0.5	0.4	1.3	0.2	1.2	0.3	0.4	0.4	0.4	0.6	6.8	1.0	0.5	2.4	6.8	0.6	0.0	0.4	0.3	0.3	0.3	0.4	1.3	0.2	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.9	1.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.3	0.4	0.1	0.4	0.0	0.0	3.2	17.0	22.2	5.7	2.3	2.0	0.9	1.7	1.7	2.4
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (9.47e-6)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.3	21.9	16.8	12.0	1.0	1.7	18.5	11.7	11.0	20.7	17.8	11.7	29.8	16.1	5.7	9.0	16.3	14.5	8.8	26.1	24.6	12.1	7.7	19.1	15.7	0.1	15.2	10.5	0.5	1.0	15.9	17.2	13.2	21.1	28.4	20.7	8.4	16.5	10.3	15.9	11.2	16.4	25.7	24.5	7.2	8.7	15.2	16.9	16.9	19.0	14.7	29.2	9.1	6.9	10.3	20.5	20.3	31.4	11.8	21.7	21.3	9.0	11.7	17.1	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4
NEMP2	TMEM194B	ENSG00000189362	"Nuclear envelope integral membrane protein 2"	A6NFY4	2	190504342-190534722	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 27.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA057719			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA057719: AB_2683510"	"unprognostic (3.51e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.65e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (5.82e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.32e-1)"	7.8	4.9	2.9	14.5	2.9	4.5	4.3	7.5	3.6	6.0	3.6	4.3	2.2	2.5	8.5	6.8	4.4	3.3	3.0	4.3	3.5	2.9	5.7	5.7	9.3	11.3	3.8	3.2	5.6	3.2	2.6	4.0	3.7	3.4	3.9	2.6	6.6	9.3	4.8	1.7	5.1	4.5	3.4	3.4	12.3	5.1	8.1	2.4	27.3	5.4	3.5	15.8	4.4	4.3	3.6	3.4	0.2	0.8	2.4	5.6	2.2	5.1	2.8	1.9	2.4	1.1	3.0	5.1	3.7	3.2	3.7	4.7	4.2	7.2	7.5	2.4	1.9	9.2	3.0	8.0	7.5	5.6	2.6	5.4	2.8	2.8	2.8	5.8	1.9	3.0	3.4	17.1	4.5	1.7	4.7	8.9	7.2	2.4	6.4	2.8	2.0	3.1	2.7	4.2	3.5	3.4	3.9	3.5	2.9	5.9	0.6	5.6	1.5	6.3	3.0	8.4	6.5	1.6	4.1	4.9	5.3	4.0	6.5	6.1	6.0	0.1	0.8	0.1	3.0	0.7	3.9	2.7	3.3	2.7	0.9	3.6	5.4	4.6	0.2	2.4	0.6	3.4	5.6	2.2	2.9	2.9	7.5	3.6	3.5	2.9	3.8	3.2	3.4	2.4
NETO2	"FLJ10430, NEOT2"	ENSG00000171208	"Neuropilin and tolloid like 2"	Q8NC67	16	47077703-47143997	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.6;lymphoid tissue: 23.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013180	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA013180: AB_1854383"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavourable (5.53e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.32e-1)"	3.3	6.7	6.9	6.9	23.6	2.4	3.4	11.8	15.8	1.8	9.5	2.1	0.6	1.9	2.8	0.9	5.6	1.1	5.5	2.4	8.3	5.9	2.5	0.9	5.3	6.6	4.9	7.1	2.0	9.8	11.6	1.4	3.8	13.5	1.4	2.8	10.1	2.6	1.6	4.5	1.7	2.7	1.9	2.5	23.8	1.9	8.6	4.7	1.9	10.0	3.1	6.8	4.2	2.5	1.0	2.1	0.9	3.3	0.3	2.2	0.7	24.7	27.6	40.0	0.1	5.9	34.5	6.6	24.6	3.9	21.9	11.9	5.7	15.9	6.1	15.2	5.2	11.1	25.5	24.5	27.0	0.0	16.4	4.9	9.8	6.1	7.3	15.8	13.1	20.7	16.4	8.8	12.4	14.5	7.3	7.6	14.0	6.7	9.0	8.6	19.2	20.3	0.0	7.8	12.4	15.4	5.3	26.3	19.1	32.5	2.5	3.6	0.5	11.6	7.0	0.0	0.0	0.0	0.1	8.2	6.7	13.6	17.8	11.2	17.6	0.9	3.3	0.1	0.1	1.6	1.3	1.0	1.3	0.1	2.1	0.4	0.0	0.1	0.9	0.3	1.5	0.2	2.2	0.7	6.9	23.6	11.8	15.8	8.3	5.9	4.9	7.1	13.5	4.7
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380410-42432395	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.0;bone marrow: 28.0;lymphoid tissue: 35.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 34.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 34.0;monocytes: 17.5"					"Group enriched"	"Detected in many"	4	"basal ganglia: 2.9;hypothalamus: 3.7;midbrain: 7.4;pons and medulla: 7.8;thalamus: 8.3"	HPA031812	Uncertain									"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	10.9	3.1	1.7	12.3	3.1	28.0	2.0	0.9	1.9	2.2	1.8	4.0	0.7	1.5	1.4	4.2	2.0	3.3	2.8	4.8	1.8	2.2	2.5	9.9	12.1	35.2	2.4	0.6	1.5	1.7	0.4	1.3	4.4	2.7	2.5	1.4	2.4	2.0	1.8	1.1	1.6	3.3	3.0	4.8	27.7	1.7	1.4	2.5	2.8	1.5	1.2	3.7	3.1	1.5	0.0	6.1	34.0	17.5	0.0	0.1	7.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.4	0.2	0.0	0.1	0.0	0.0	0.3	0.1	4.4	0.0	0.0	0.1	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.1	17.5	0.9	0.0	12.2	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.0	34.0	0.0	10.6	0.1	0.0	7.3	1.7	3.1	0.9	1.9	1.8	2.2	2.4	0.6	2.7	2.5
NFATC2	"NF-ATP, NFAT1, NFATp"	ENSG00000101096	"Nuclear factor of activated T cells 2"	Q13469	20	51386957-51562831	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.2;HMC-1: 16.3;WM-115: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008789, CAB018567, HPA024369"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413"	"unprognostic (2.69e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.59e-2)"	8.6	2.4	4.1	44.6	8.2	4.4	9.8	1.1	5.1	8.4	7.8	6.8	3.9	8.4	7.0	7.6	4.0	5.6	19.4	8.5	4.1	3.3	3.4	6.7	6.1	25.2	8.4	0.7	5.0	8.7	3.9	3.7	8.1	10.4	5.4	4.1	6.2	7.9	7.2	5.4	7.0	11.7	5.9	6.5	16.0	11.0	4.5	6.5	8.6	7.0	13.2	18.7	4.5	4.9	1.6	1.7	3.8	0.7	7.6	7.7	1.6	1.5	1.7	0.0	2.1	0.0	0.0	4.5	0.2	1.1	0.7	0.3	8.2	1.5	10.9	1.3	0.5	0.0	0.5	0.0	0.6	14.2	0.2	4.6	1.2	2.1	0.0	1.3	16.3	0.0	0.0	0.6	0.0	5.0	4.5	7.3	0.0	1.8	1.9	7.7	0.1	3.9	0.8	0.0	4.8	0.2	0.0	0.1	0.0	5.1	1.2	11.9	2.0	3.1	0.5	1.0	1.9	2.5	0.1	6.2	4.0	11.2	1.0	5.1	24.5	0.3	0.0	3.8	7.7	0.7	3.2	1.6	4.3	6.1	1.7	1.6	2.4	4.4	0.2	7.6	0.2	0.6	2.3	1.6	4.1	8.2	1.1	5.1	4.1	3.3	8.4	0.7	10.4	6.5
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532933-99536524	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;NB-4: 4.7;REH: 6.0;THP-1: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.3"	HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA047561: AB_2680088"		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	0.8	0.0	0.1	17.2	0.1	0.0	0.1	0.1	0.1	0.3	21.6	0.1	0.1	10.4	0.2	0.1	0.5	0.0	12.5	0.1	0.1	0.0	0.1	0.2	0.1	1.1	0.1	0.1	0.1	6.4	0.0	0.1	0.1	0.1	0.1	4.6	0.1	9.0	0.5	0.1	0.0	19.1	3.1	0.1	36.8	1.8	0.1	0.1	0.2	1.0	0.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	6.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NKX2-6	"CSX2, NKX4-2"	ENSG00000180053	"NK2 homeobox 6"	A6NCS4	8	23702451-23706598	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.4;heart muscle: 2.7;lymphoid tissue: 3.0;salivary gland: 4.3"	"Group enriched"	"Detected in some"	8	"hTEC/SVTERT24-B: 8.9;LHCN-M2: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																									"unprognostic (1.86e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX3-2	"BAPX1, NKX3.2, NKX3B"	ENSG00000109705	"NK3 homeobox 2"	P78367	4	13540830-13545050	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 18.3;lymphoid tissue: 6.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.5;NB-4: 12.4;NTERA-2: 7.1;THP-1: 7.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027564	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027564: AB_10601973"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.24e-5)"	"unprognostic (3.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.93e-8)"	"unprognostic (5.81e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	1.7	0.0	0.1	6.5	0.1	0.0	0.1	0.1	0.1	1.1	18.3	0.1	0.1	1.6	0.9	0.1	2.3	0.2	0.4	1.8	0.1	0.0	0.4	0.1	0.1	2.0	0.1	0.1	2.9	0.2	0.0	0.9	0.1	0.1	0.6	2.4	0.1	1.5	0.6	0.1	0.1	2.0	3.2	0.1	5.3	2.8	0.9	0.1	0.1	0.3	0.9	0.1	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	1.9	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	2.5	0.6	1.6	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.3	12.4	7.1	0.5	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.0	7.4	0.0	0.5	2.9	0.1	0.5	2.2	0.0	0.0	0.4	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4, X-linked"	Q8N0W4	X	5840637-6228863	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.3"	"Group enriched"	"Detected in some"	4	"AF22: 30.9;NTERA-2: 24.4"	"Cancer enhanced"	"Detected in many"		"glioma: 8.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	6	"B-cells: 1.5"									HPA001651	Approved									"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	4.9	2.3	8.3	2.8	10.7	0.3	3.4	12.2	19.2	8.2	3.6	3.7	0.4	2.1	3.7	1.0	1.3	3.4	4.0	5.4	7.9	9.9	0.8	2.2	1.9	1.7	5.6	6.4	16.8	0.9	12.3	2.6	5.4	5.7	2.0	3.2	2.1	1.5	3.3	0.7	1.2	2.9	5.6	4.3	3.2	1.9	3.9	3.9	56.3	1.0	0.0	1.1	3.6	1.8	1.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	3.9	0.0	24.4	0.0	0.0	0.0	0.0	2.2	6.2	1.5	1.9	0.0	0.0	0.0	3.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	10.7	12.2	14.7	7.9	9.9	5.6	6.4	5.7	3.9
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265854	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.8;lymphoid tissue: 22.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 19.8;intermediate monocyte: 23.8;myeloid DC: 13.3;neutrophil: 9.7;non-classical monocyte: 17.6"	"Group enriched"	"Detected in many"	35	"dendritic cells: 13.3;granulocytes: 9.7;monocytes: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA006592	Uncertain									"HPA006592: AB_2667620"	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	8.4	2.4	2.2	11.7	5.2	11.2	1.3	1.3	3.7	0.8	1.1	2.0	0.3	1.1	0.9	1.4	0.8	1.7	2.0	2.7	2.1	1.4	1.7	2.2	8.3	16.2	5.4	0.8	1.0	1.5	0.0	1.2	2.8	3.0	0.9	1.1	1.2	1.1	0.2	1.5	0.6	1.7	2.9	5.5	22.4	1.2	1.0	3.6	1.7	0.9	0.0	1.5	2.7	2.3	0.4	13.3	9.7	23.8	0.1	0.1	6.5	0.6	0.6	0.9	1.7	0.2	0.0	1.1	0.8	0.0	0.0	0.0	0.6	0.8	0.9	0.7	0.0	0.8	0.0	0.0	0.0	2.0	0.7	1.3	0.3	0.9	0.0	6.9	1.2	0.0	1.0	0.0	3.5	0.0	0.7	1.1	0.0	0.1	0.4	3.2	0.5	0.5	0.3	1.0	1.1	0.0	0.8	0.8	1.6	0.5	0.6	2.8	0.3	3.3	0.2	0.8	0.8	0.7	1.0	1.4	1.9	3.0	1.4	3.0	1.0	0.1	19.8	2.3	0.0	23.8	0.1	0.2	0.0	0.0	13.3	0.4	0.0	0.0	9.7	0.1	17.6	0.1	0.0	6.5	2.2	5.2	1.3	3.7	2.1	1.4	5.4	0.8	3.0	3.6
NLRP11	"CLR19.6, NALP11, NOD17, PAN10, PYPAF6"	ENSG00000179873	"NLR family pyrin domain containing 11"	P59045	19	55785397-55836800	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;RPMI-8226: 21.5;U-266/70: 38.0;U-266/84: 16.4;U-698: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			"HPA046402, HPA078027"	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA046402: AB_10962951, HPA078027: AB_2732369"	"unprognostic (2.36e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.95e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.61e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	4.0	0.1	0.3	0.2	0.1	0.1	0.0	0.7	3.3	0.1	0.6	0.1	0.1	0.9	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.3	0.5	3.6	0.1	0.1	0.1	0.1	4.5	0.1	0.1	1.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.7	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	38.0	16.4	27.6	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		35000	35000	Mitochondria	Mitochondria	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favourable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	4.8	6.1	1.9	3.3	3.7	3.6	3.6	2.5	4.9	8.9	5.1	2.9	8.0	2.9	5.6	5.3	34.9	6.7	4.9	8.7	2.9	1.6	4.3	4.4	3.4	3.4	1.8	2.7	2.9	6.2	5.6	2.5	3.3	3.0	4.4	2.0	5.4	5.6	4.8	14.3	11.6	3.2	4.6	2.4	4.5	4.0	3.2	1.3	3.8	4.3	38.9	37.5	5.3	8.5	0.6	2.0	14.3	3.3	1.3	1.3	1.9	4.0	12.0	1.3	9.6	4.1	4.8	1.9	5.4	6.3	2.7	4.7	0.6	10.1	7.3	16.7	6.9	10.2	3.7	3.1	0.9	9.4	3.9	9.6	4.1	6.5	6.3	3.3	5.6	5.3	13.0	3.5	6.9	5.5	0.1	4.9	2.8	10.8	5.6	8.1	5.9	6.8	11.1	1.6	2.4	6.5	5.2	1.8	6.3	8.0	4.3	3.5	13.9	9.9	6.4	5.4	4.9	4.8	2.8	1.7	1.9	2.4	0.8	10.3	3.8	2.8	3.3	14.3	0.9	1.5	1.0	0.6	0.8	1.3	2.0	0.4	1.0	1.1	8.1	1.3	1.3	0.9	1.3	1.9	1.9	3.7	2.5	4.9	2.9	1.6	1.8	2.7	3.0	1.3
NOS2	"HEP-NOS, iNOS, NOS, NOS2A"	ENSG00000007171	"Nitric oxide synthase 2"	P35228	17	27756766-27800499	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.8;lymphoid tissue: 15.6"	"Group enriched"	"Detected in some"	8	"CACO-2: 16.6;SCLC-21H: 13.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 16.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB002014	Enhanced									"CAB002014: "	"unprognostic (1.95e-3)"	"unprognostic (3.08e-3)"	"unprognostic (4.75e-3)"	"unprognostic (4.42e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.13e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.03e-2)"	1.0	0.7	1.6	15.6	1.6	0.0	0.5	1.5	7.3	0.4	6.8	0.0	0.0	11.8	0.4	0.0	1.0	0.5	0.4	0.7	1.3	1.1	1.7	0.2	3.8	1.8	1.0	2.2	1.0	0.3	0.1	2.1	3.4	0.4	0.9	9.0	1.2	0.2	0.2	0.7	0.4	20.8	1.7	0.8	0.2	0.3	0.4	0.2	0.2	0.5	5.3	1.7	5.4	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	1.5	7.3	1.3	1.1	1.0	2.2	0.4	0.2
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150990995-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.2;HUVEC TERT2: 21.5;K-562: 7.6;TIME: 39.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 32.4;cerebral cortex: 12.4;hippocampal formation: 18.8;pons and medulla: 35.3"	"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced									"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	11.4	4.5	3.1	7.5	32.4	1.9	25.6	1.8	12.4	4.6	3.2	1.7	1.0	4.0	8.3	2.5	4.7	5.0	6.6	35.2	18.8	3.4	5.5	5.4	14.0	10.3	4.7	1.7	4.5	4.1	2.7	4.8	11.5	35.3	5.2	2.5	5.2	3.0	3.2	6.0	4.9	4.0	5.4	25.9	70.6	3.6	4.5	1.6	0.0	5.9	2.1	2.4	5.1	7.3	1.1	0.5	0.7	0.4	0.5	5.3	1.2	0.2	0.0	0.6	1.9	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.1	1.0	0.2	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.1	2.9	0.3	0.2	5.0	0.0	0.1	0.0	0.0	21.5	7.6	1.8	0.0	0.0	0.1	0.2	0.8	0.0	1.4	0.0	0.8	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.1	0.6	39.2	0.1	0.4	0.1	0.0	1.2	4.0	1.0	0.0	3.5	0.0	0.3	0.3	0.2	2.5	0.4	1.5	0.8	3.9	2.2	0.5	1.1	5.3	2.1	0.7	0.5	0.4	0.5	4.4	1.2	3.1	32.4	1.8	12.4	18.8	3.4	4.7	1.7	35.3	1.6
NOXO1	"P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28"	ENSG00000196408	"NADPH oxidase organizer 1"	Q8NFA2	16	1978917-1984192	"FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.0;intestine: 10.5;lymphoid tissue: 10.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.6;HaCaT: 3.8;MOLT-4: 3.3;SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA071540	Enhanced									"HPA071540: AB_2686415"			"unprognostic (3.74e-1)"							"unprognostic (1.10e-1)"				"unprognostic (1.73e-2)"				0.5	0.0	1.1	10.6	3.1	0.3	0.5	7.0	2.0	0.9	10.5	0.5	0.5	4.6	0.5	1.5	2.2	0.2	2.8	0.5	1.0	0.9	0.5	2.2	1.0	0.5	0.6	0.5	0.5	0.5	0.3	0.8	0.5	0.5	0.5	8.6	0.5	4.9	0.5	0.5	0.6	4.2	0.6	0.5	0.5	0.3	4.8	0.5	1.4	0.5	0.5	4.1	1.1	0.5	0.7	0.2	1.3	0.0	0.0	0.3	0.0	0.4	1.0	1.1	0.3	0.6	0.0	0.0	0.1	0.3	0.9	0.5	0.8	6.6	0.6	0.5	0.0	3.8	0.0	0.3	0.0	1.2	0.0	0.0	1.9	0.0	0.1	0.0	0.6	1.1	0.2	1.0	0.4	0.0	0.3	0.0	0.0	0.3	3.3	0.1	0.0	0.0	0.5	1.0	0.1	0.8	0.0	3.5	0.0	1.4	1.3	0.2	2.6	1.0	0.0	0.7	0.1	0.0	1.6	0.2	0.6	1.5	0.6	0.1	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	1.1	3.1	7.0	2.0	1.0	0.9	0.6	0.5	0.5	0.5
NPFFR2	"GPR74, NPFF2, NPGPR"	ENSG00000056291	"Neuropeptide FF receptor 2"	Q9Y5X5	4	72031804-72148067	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;seminal vesicle: 10.1"	"Group enriched"	"Detected in some"	10	"NTERA-2: 8.8;RPTEC TERT1: 11.4;SH-SY5Y: 13.5;U-2 OS: 13.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"olfactory region: 5.3"	"Low region specificity"	"Detected in many"			HPA026825			Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA026825: "	"unprognostic (1.28e-1)"		"unprognostic (1.05e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.40e-5)"	"unprognostic (5.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-1)"	0.9	0.2	5.5	0.7	2.6	0.2	1.4	0.2	3.5	0.5	0.5	0.0	0.0	0.5	0.1	2.8	0.3	0.8	0.4	0.4	0.9	2.9	0.6	0.2	0.2	0.6	0.5	4.0	0.3	1.2	0.1	1.0	4.6	1.5	3.2	0.9	1.4	0.3	10.1	0.3	0.7	0.5	0.2	0.6	0.5	0.4	1.6	0.0	15.4	1.2	0.0	0.6	2.5	0.7	0.6	0.3	2.3	0.3	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	11.4	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.2	1.1	0.8	0.3	0.3	0.2	0.1	5.5	2.6	0.2	3.5	0.9	2.9	0.5	4.0	1.5	0.0
NPY1R	NPYR	ENSG00000164128	"Neuropeptide Y receptor Y1"	P25929	4	163323961-163344832	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.2"	"Cell line enriched"	"Detected in some"	18	"HEL: 50.2"	"Cancer enriched"	"Detected in many"	13	"breast cancer: 65.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029903			Approved	Nucleoplasm,Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA029903: AB_10601276"	"prognostic favourable (7.68e-5)"	"unprognostic (9.14e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.21e-1)"	18.0	15.9	5.2	1.5	17.1	0.2	17.5	0.9	11.4	6.2	3.1	0.7	3.9	0.7	5.0	5.4	2.3	4.3	2.4	2.6	7.1	4.2	16.6	8.3	1.2	7.2	1.5	5.8	1.8	14.5	1.1	3.9	2.7	3.5	1.9	2.4	2.0	11.0	4.5	1.5	5.0	0.9	3.1	3.7	55.2	1.2	2.7	6.0	0.0	4.4	1.4	0.6	3.4	3.3	0.5	0.3	1.2	0.4	0.3	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.9	0.7	0.4	1.2	0.5	0.1	0.6	0.4	0.7	0.9	0.0	0.5	0.7	1.2	1.1	0.3	0.2	0.3	0.3	0.0	5.2	17.1	0.9	11.4	7.1	4.2	1.5	5.8	3.5	6.0
NPY5R	NPYR5	ENSG00000164129	"Neuropeptide Y receptor Y5"	Q15761	4	163343939-163351934	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 12.2;lymphoid tissue: 13.6"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;RPTEC TERT1: 3.5;T-47d: 1.3"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (4.63e-6)"		"unprognostic (3.00e-1)"		"unprognostic (2.79e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"			"unprognostic (3.74e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-1)"	10.6	5.7	3.6	1.6	12.2	0.1	3.2	0.3	6.2	1.5	0.7	0.1	0.3	0.2	2.2	1.9	0.6	1.4	1.0	1.3	4.5	3.1	7.8	1.8	0.7	6.6	1.3	4.6	0.5	1.8	0.8	0.6	4.9	2.3	0.5	0.6	1.1	6.1	1.7	0.4	1.4	0.3	1.5	4.2	13.6	0.5	9.1	2.2	0.0	1.3	0.4	0.3	0.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	12.2	0.3	6.2	4.5	3.1	1.3	4.6	2.3	2.2
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507430	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.7;lymphoid tissue: 50.8"	"Cell line enhanced"	"Detected in some"		"HEL: 38.2;Hep G2: 24.7;K-562: 9.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Region enriched"	"Detected in single"	20	"hypothalamus: 6.1"	"Not detected"	"Not detected"														"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.2	47.7	0.2	0.2	0.5	0.0	0.2	0.2	0.4	0.2	0.2	1.3	0.2	0.0	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	13.1	0.2	0.0	5.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.8	0.0	9.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	24.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2
NTN4		ENSG00000074527	"Netrin 4"	Q9HB63	12	95657807-95791152	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 92.6;hTERT-HME1: 38.3;PC-3: 35.0;TIME: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	49	"T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049832	Approved				"Secreted to extracellular matrix"					"HPA049832: AB_2680905"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (2.85e-1)"	"prognostic favourable (8.12e-9)"	"unprognostic (3.52e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.93e-1)"	"prognostic favourable (6.67e-5)"	11.1	8.5	4.0	4.4	6.3	0.0	22.8	1.2	9.0	9.9	8.9	2.5	7.3	3.4	8.2	11.9	10.7	10.7	13.0	27.2	3.9	2.4	35.8	13.6	21.7	0.7	4.1	6.1	28.5	18.2	6.6	4.5	7.7	2.8	24.1	5.4	8.4	14.7	19.6	7.2	3.8	8.7	7.2	2.2	76.9	14.5	6.5	2.2	1.5	6.7	9.7	4.2	14.1	11.9	0.0	0.0	0.0	0.0	0.0	4.9	0.0	4.7	13.0	0.3	0.0	5.3	8.5	0.5	9.1	92.6	12.3	14.8	10.2	9.0	0.0	0.6	19.1	7.6	0.1	2.7	6.3	0.0	0.8	0.4	2.4	1.9	0.3	0.0	0.0	0.2	7.9	14.2	38.3	24.2	0.0	0.0	4.6	3.5	0.0	0.0	0.2	35.0	0.0	0.1	0.0	12.0	24.4	0.0	0.1	11.0	14.1	0.2	4.1	0.0	52.6	4.8	1.8	18.8	0.9	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.3	1.2	9.0	3.9	2.4	4.1	6.1	2.8	2.2
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2, NDC80 kinetochore complex component"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.6;testis: 29.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059692, HPA076604"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (1.04e-5)"	"prognostic unfavourable (9.16e-4)"	"prognostic unfavourable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavourable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	1.3	0.9	0.8	9.8	0.9	14.1	0.6	0.5	0.9	1.4	2.5	0.6	0.9	2.3	0.6	2.1	6.1	0.5	0.7	1.5	0.8	0.6	0.7	0.6	1.9	9.9	0.8	0.6	0.7	0.4	0.3	0.4	3.6	0.7	0.6	2.9	0.8	1.3	0.0	0.5	2.2	3.2	1.0	1.4	4.4	1.6	29.0	0.3	38.6	0.5	5.1	9.2	1.5	1.8	1.4	0.6	2.6	0.2	3.0	7.7	1.0	25.9	9.0	24.1	10.1	0.7	2.5	13.1	16.4	11.6	26.8	23.5	6.9	23.0	22.4	13.7	6.6	15.2	14.7	6.2	33.9	23.3	10.5	8.7	10.4	9.9	0.0	15.1	18.1	0.3	0.6	13.5	9.6	12.1	16.4	31.0	25.3	5.0	27.5	20.2	13.1	14.0	18.7	21.1	19.8	7.5	3.6	18.0	20.8	8.8	9.6	9.1	14.7	31.6	8.5	20.0	22.5	15.0	33.1	22.3	31.3	42.6	6.6	12.4	22.1	2.6	0.2	2.5	2.4	0.1	1.0	1.2	3.6	2.4	0.5	1.4	2.5	2.1	0.9	3.0	0.2	0.6	7.7	1.0	0.8	0.9	0.5	0.9	0.8	0.6	0.8	0.6	0.7	0.3
NUGGC	"C8orf80, HMFN0672, SLIP-GC"	ENSG00000189233	"Nuclear GTPase, germinal center associated"	Q68CJ6	8	28021964-28083871	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"liver: 21.1;lymphoid tissue: 32.2"	"Group enriched"	"Detected in some"	5	"Daudi: 44.6;Karpas-707: 15.3;U-698: 32.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (6.23e-2)"	"unprognostic (2.17e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.83e-4)"	"unprognostic (2.08e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.14e-2)"	0.8	0.3	0.3	32.2	0.4	0.5	0.4	0.3	0.3	0.3	4.9	0.1	0.4	1.1	0.3	0.4	1.6	0.5	0.4	0.5	0.3	0.3	4.1	21.1	1.1	12.9	0.3	0.0	0.9	0.3	0.0	0.3	0.0	0.0	0.5	0.8	0.3	3.6	2.7	0.3	0.3	4.6	0.0	0.3	5.2	1.6	0.5	0.0	0.1	2.3	1.4	23.2	1.8	0.4	3.3	1.2	2.5	1.1	1.2	7.8	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	44.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	15.3	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	6.0	0.5	32.9	0.1	0.1	0.0	1.8	1.1	0.5	7.8	0.7	1.0	3.3	3.4	4.9	0.3	1.9	0.7	2.1	2.5	1.2	0.4	1.2	0.2	0.9	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420309	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.0;lymphoid tissue: 44.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 46.4;U-266/84: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					28000	28000			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavourable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	1.6	4.1	4.0	25.6	5.2	31.0	3.7	12.6	6.7	1.7	4.2	8.0	3.3	4.9	1.8	7.0	5.6	2.9	4.0	2.0	4.1	5.3	6.8	13.8	5.3	25.6	4.9	3.5	1.4	11.4	7.2	10.9	4.3	4.5	4.2	3.9	6.3	6.8	4.4	7.2	3.8	16.4	1.6	3.6	25.3	5.6	6.6	6.1	44.2	6.5	3.1	23.1	5.6	1.8	6.7	6.8	1.0	3.9	6.2	9.3	3.6	8.3	14.7	7.3	18.9	0.0	0.0	29.1	0.1	0.0	1.8	0.0	7.5	13.7	33.9	11.7	0.0	4.9	16.1	0.0	0.6	27.2	12.0	13.1	16.7	7.9	0.0	42.0	4.8	0.0	0.0	0.0	0.0	0.0	20.3	36.5	0.0	20.9	22.3	16.7	8.4	3.0	0.0	0.0	46.4	3.5	7.8	8.4	8.4	10.5	14.1	4.4	13.5	35.0	0.1	0.0	2.5	0.0	6.4	37.1	51.4	29.6	0.0	23.5	0.0	0.0	2.9	1.0	9.3	3.9	7.4	6.7	6.7	9.0	6.4	4.5	5.6	7.3	0.1	6.2	2.4	6.8	5.6	3.6	4.0	5.2	12.6	6.7	4.1	5.3	4.9	3.5	4.5	6.1
OC90	PLA2L	ENSG00000253117	"Otoconin 90"	Q02509	8	132024220-132059380	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9"	"Cell line enriched"	"Detected in single"	46	"SK-MEL-30: 4.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"														"unprognostic (1.92e-1)"						"unprognostic (2.93e-1)"			0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.2	0.7	1.5	0.0	0.0	0.0
OCM	OCM1	ENSG00000122543	Oncomodulin	P0CE72	7	5879827-5886362	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;brain: 9.5;lymphoid tissue: 5.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.1;PC-3: 1.9;THP-1: 1.4;U-937: 2.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"											HPA046422	Uncertain									"HPA046422: AB_2679659"	"unprognostic (1.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.90e-4)"	0.1	0.5	9.5	0.7	1.7	1.8	1.6	3.1	1.4	0.2	0.5			0.0	0.2	2.7	0.3	0.3	0.5	0.0	2.0	1.8	0.3	0.1	0.1	5.5	0.9		0.5	0.3	0.0	0.2	0.0		0.2	0.6		0.9	0.8	0.0	2.0	0.7	0.2	0.8	1.4	0.1	2.3			0.6		2.3	0.3	0.1	2.1	0.1	2.0	0.8	0.0	5.7	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.8	0.4	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.5	0.1	0.0	1.4	0.0	0.0	0.2	0.4	0.4	0.3	0.3	0.1	0.0	2.1	0.0	0.0	0.8	2.0	1.1	0.5	0.4	0.9	2.8	0.8	0.1	2.1	3.7	1.0	1.6	0.0	0.4	0.0	5.7	1.3										
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309268-41332621	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.7;testis: 41.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"				"Nuclear speckles, Vesicles"	"Nuclear speckles, Vesicles"	"HPA052271: AB_2681780, HPA059602: AB_2684079"	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.79e-4)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	1.3	2.1	0.5	3.8	0.8	7.5	0.7	1.5	1.1	1.1	3.4	0.7	2.3	3.0	0.6	0.6	4.6	0.6	1.3	1.9	0.9	0.4	1.1	1.1	1.0	4.3	0.6	0.4	1.2	0.6	0.0	0.3	1.6	0.5	0.5	3.1	0.2	1.2	1.3	8.3	2.5	3.1	0.6	0.8	2.7	1.4	41.7	0.7	16.7	0.5	6.3	4.0	0.7	1.5	2.5	7.7	1.1	1.3	1.9	5.9	1.7	13.3	7.1	14.0	10.2	0.7	0.9	13.4	8.2	3.8	9.9	10.7	12.6	6.6	7.9	7.2	3.0	20.8	14.2	6.3	7.8	17.1	16.4	16.8	20.7	13.1	0.1	18.3	9.5	0.3	1.3	5.6	5.9	8.4	23.0	15.4	6.6	6.4	10.7	13.7	12.7	15.5	13.3	11.7	12.0	4.4	6.1	22.3	7.4	13.6	13.9	3.8	13.8	10.5	4.1	10.2	15.8	10.1	14.6	7.3	32.2	28.2	2.9	22.4	14.6	0.0	0.8	1.1	0.6	1.3	1.5	2.1	1.8	1.6	1.4	2.5	2.6	1.7	0.0	1.9	0.8	7.7	5.9	1.7	0.5	0.8	1.5	1.1	0.9	0.4	0.6	0.4	0.5	0.7
OPN1MW	"CBBM, CBD, COD5, GCP, OPN1MW1"	ENSG00000268221	"Opsin 1, medium wave sensitive"	P04001	X	154182596-154196135	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.5"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.6		1.5		0.0	0.7		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.4	0.3		0.1	0.0	0.1			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
OR10G2		ENSG00000255582	"Olfactory receptor family 10 subfamily G member 2"	Q8NGC3	14	21633836-21634940	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																									"unprognostic (7.80e-3)"						0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.0		0.0	0.0	0.0	0.6	0.0		0.5	0.0		0.1	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.2	0.2			0.1		0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.2										
OR13A1		ENSG00000256574	"Olfactory receptor family 13 subfamily A member 1"	Q8NGR1	10	45302298-45315608	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.3;urinary bladder: 4.2"	"Group enriched"	"Detected in some"	34	"Daudi: 13.2;U-698: 12.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"					"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA057237	Uncertain									"HPA057237: AB_2683378"	"unprognostic (7.88e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.33e-5)"	"unprognostic (6.43e-3)"	"unprognostic (6.04e-2)"		"unprognostic (8.65e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-15)"	"unprognostic (6.54e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.09e-3)"	0.0	0.0	0.1	0.4	0.2	0.5	0.1	1.9	0.1	0.0	0.2			0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.4	2.2	0.2		0.1	0.2	0.0	0.0	0.0		0.9	0.3		0.5	0.0	0.3	0.0	1.6	0.0	0.4	2.3	0.2	0.3			0.0		2.0	4.2	0.3	2.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.9	0.0	0.0	0.0										
OR1L8		ENSG00000171496	"Olfactory receptor family 1 subfamily L member 8"	Q8NGR8	9	122567117-122583384	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.7"	"Cell line enriched"	"Detected in some"	5	"RT4: 10.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																		"unprognostic (9.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.68e-1)"		"unprognostic (4.94e-3)"		"unprognostic (1.36e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-4)"	"unprognostic (9.82e-3)"	"unprognostic (3.33e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.06e-1)"	0.9	0.1	0.3	0.0	0.6	0.1	1.0	0.3	0.7	0.8	0.4			0.1	1.4	0.7	0.2	0.9	0.8	0.9	0.7	0.9	0.7	0.6	0.8	0.5	0.5		0.4	0.1	0.0	0.6	0.5		0.6	0.2		0.8	0.4	0.7	0.6	0.3	0.4	0.9	3.7	0.3	2.0			0.7		0.2	1.1	0.5	0.6	0.2	1.6	0.2	1.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	10.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.4	0.2	0.0	0.1	0.1	0.2	0.2	0.0	0.6	1.2	0.8	0.6	1.1	0.0	0.2	0.0	0.0										
OR2AJ1	"OR2AJ1P, OR2AJ1Q"	ENSG00000177275	"Olfactory receptor family 2 subfamily AJ member 1"	Q8NGZ0	1	247924889-247935339	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.5;thyroid gland: 1.1"	"Cell line enhanced"	"Detected in single"		"HEL: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.3	0.0	0.3	0.6	0.0	0.0	0.6	0.2	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.1			1.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52N4		ENSG00000181074	"Olfactory receptor family 52 subfamily N member 4 (gene/pseudogene)"	Q8NGI2	11	5754243-5755905	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 5.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.8;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;HSkMC: 1.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3;T-reg: 3.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.3;T-cells: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.44e-2)"	"unprognostic (2.59e-3)"		"unprognostic (4.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.86e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.41e-2)"	1.3	0.4	0.1	1.1	0.1	0.8	1.4	0.0	0.4	0.8	0.6			0.0	1.4	3.4	0.7	1.6	0.5	0.7	0.2	0.1	1.1	0.3	1.3	2.9	0.2		3.5	0.0	0.0	0.9	0.0		1.2	0.6		0.6	1.8	0.2	0.6	3.6	0.1	0.5	5.7	0.4	0.6			0.6		2.9	0.5	1.4	2.3	0.4	0.0	0.1	0.0	3.1	0.3	0.0	0.0	0.4	0.0	0.0	1.8	0.3	0.0	0.3	0.2	1.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.0	2.3	0.4	0.6	0.0	0.0	0.1	0.4	3.1	0.3										
OR56B1	OR56B1P	ENSG00000181023	"Olfactory receptor family 56 subfamily B member 1"	Q8NGI3	11	5736448-5738522	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA045043	Uncertain									"HPA045043: AB_10794296"																		0.2	0.0	0.0	1.2	0.0	0.3	0.3	0.0	0.2	0.9	0.1			0.0	0.3	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.5	1.3	0.0		0.8	0.0	0.7	0.1	0.0		0.3	0.1		0.2	0.5	0.0	0.0	0.7	0.0	0.0	1.4	0.0	0.2			0.1		0.9	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5B12	"OR5B12P, OR5B16, OST743"	ENSG00000172362	"Olfactory receptor family 5 subfamily B member 12"	Q96R08	11	58439077-58442758	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.2"	"Cell line enhanced"	"Detected in single"		"BJ hTERT+: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.5	0.6	0.3	0.0			0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.4	0.0	0.3	1.2	0.1		0.4	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.0	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.6			0.0		0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.3	0.6	0.7	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.4	0.0										
OR6S1	OR6S1Q	ENSG00000181803	"Olfactory receptor family 6 subfamily S member 1"	Q8NH40	14	20640696-20641691	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Cell line enriched"	"Detected in single"	28	"HDLM-2: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (2.62e-2)"				0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.1	0.5			0.0		0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR9G4		ENSG00000172457	"Olfactory receptor family 9 subfamily G member 4"	Q8NGQ1	11	56741223-56748697	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404459	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.9;lymphoid tissue: 29.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favourable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.9	1.2	0.2	9.9	0.4	22.9	0.8	1.4	1.1	1.1	3.4	0.4	0.1	1.4	0.6	1.5	5.3	0.5	0.8	0.9	0.3	0.4	1.0	1.1	1.4	5.7	0.3	0.4	1.0	0.7	0.2	0.9	1.6	0.9	0.8	3.8	0.5	1.4	0.8	0.9	2.0	3.0	0.7	0.4	4.2	1.2	8.7	0.5	29.1	0.5	8.0	11.3	1.0	1.7	1.0	1.3	0.7	0.4	7.5	2.3	0.7	7.3	8.1	13.1	8.6	0.3	1.1	12.7	5.3	4.8	15.5	16.1	9.9	4.2	16.9	4.6	3.3	10.2	19.2	6.6	13.6	7.2	11.0	20.3	12.0	9.8	0.0	27.2	11.7	0.6	0.3	15.2	1.7	4.6	23.6	8.3	5.0	5.5	21.3	12.9	29.0	11.6	23.0	20.4	16.6	2.7	9.7	7.4	6.2	12.1	7.4	4.1	4.0	11.0	2.1	6.3	9.1	9.9	13.0	4.3	11.5	21.0	6.3	20.3	7.6	0.1	0.2	0.0	0.5	0.3	0.6	0.4	0.8	0.8	1.3	1.0	0.3	0.7	0.7	7.5	0.4	0.1	2.3	0.7	0.2	0.4	1.4	1.1	0.3	0.4	0.3	0.4	0.9	0.5
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (3.53e-4)"	"prognostic favourable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.8	1.4	4.1	8.9	7.0	14.2	1.1	3.8	6.1	1.3	2.8	1.2	1.4	2.7	1.5	1.9	6.7	0.9	1.2	2.3	4.4	3.5	0.8	1.6	1.5	10.6	3.1	4.5	0.9	0.6	0.3	1.2	5.2	2.4	0.8	3.1	0.5	1.4	0.6	0.4	1.9	2.7	1.7	2.9	4.1	1.5	23.1	1.4	12.8	0.9	4.2	10.7	2.6	2.0	4.1	3.4	1.0	2.6	2.8	4.1	2.5	10.7	10.0	15.9	12.4	2.0	2.5	11.8	19.3	7.2	21.3	11.2	14.0	6.6	12.5	10.1	3.6	11.0	20.4	5.3	18.1	6.4	16.5	10.4	5.3	14.1	2.4	16.9	10.9	0.7	0.9	11.6	6.1	7.0	12.5	6.4	12.9	9.5	22.7	21.2	17.6	27.4	27.4	29.2	12.7	5.2	3.7	19.1	11.3	9.8	10.9	6.7	5.8	13.4	4.2	19.7	13.3	12.4	18.1	4.9	6.6	43.6	8.3	11.1	15.2	0.0	1.1	1.0	3.5	2.6	1.4	2.7	2.0	2.0	2.2	4.1	2.9	1.4	0.5	2.8	2.5	3.4	4.1	2.5	4.1	7.0	3.8	6.1	4.4	3.5	3.1	4.5	2.4	1.4
P2RY8	P2Y8	ENSG00000182162	"P2Y receptor family member 8"	Q86VZ1	X	1462572-1537107	"Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.7;lymphoid tissue: 19.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 33.2;RPMI-8226: 20.4;THP-1: 20.4;U-266/70: 27.9;U-698: 54.3;U-937: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA003631	Enhanced									"HPA003631: AB_1079543"	"unprognostic (4.32e-2)"	"unprognostic (3.22e-5)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.80e-5)"	"prognostic favourable (1.73e-4)"	"unprognostic (5.27e-3)"	"unprognostic (5.76e-3)"	"unprognostic (5.52e-3)"	"prognostic favourable (6.54e-4)"	"unprognostic (4.29e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.80e-1)"	2.9	4.8	0.5	8.9	2.2	13.9	8.2	0.9	1.8	4.7	1.6	0.5	0.5	1.3	7.1	0.5	0.8	0.8	1.6	11.8	0.9	0.2	13.5	0.8	2.1	19.0	3.6	1.7	5.8	1.1	1.0	6.9	3.4	2.7	1.6	1.3	0.5	1.6	0.5	1.1	0.4	7.8	0.5	3.9	16.6	2.0	0.5	2.0	0.5	8.1	0.5	16.7	2.7	2.8	18.5	5.8	17.8	7.3	15.6	26.7	18.3	0.1	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	33.2	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.3	0.3	1.6	0.0	14.5	3.5	0.0	0.0	0.0	0.0	0.0	0.3	14.0	0.0	0.0	16.4	16.4	0.2	0.3	14.8	0.1	20.4	0.0	0.2	0.0	0.2	0.1	0.3	0.1	0.1	20.4	0.0	0.3	0.3	0.1	0.0	27.9	5.2	54.3	0.0	16.9	0.0	17.8	7.3	12.4	26.7	5.5	24.6	15.4	20.2	25.1	5.8	18.5	16.1	16.5	4.7	15.6	2.2	1.5	15.9	18.3	0.5	2.2	0.9	1.8	0.9	0.2	3.6	1.7	2.7	2.0
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205126-17246005	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 48.7;lymphoid tissue: 60.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.3;EFO-21: 4.5;HaCaT: 2.8;LHCN-M2: 3.6;RPTEC TERT1: 4.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Low region specificity"	"Detected in some"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.3	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.1	0.0	4.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	60.2	1.3	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.1	9.3	0.0	4.5	0.4	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PARP15	"FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577602-122639047	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.9;lymphoid tissue: 40.4"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;REH: 5.0;THP-1: 5.1;TIME: 12.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5"	"Group enriched"	"Detected in many"	6	"B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3"					"Low region specificity"	"Detected in many"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	2.4	0.9	0.5	24.5	0.4	9.8	1.3	0.3	0.8	1.2	2.8	1.2	0.5	1.0	1.5	2.3	1.9	1.4	2.8	1.5	0.6	0.5	1.5	1.9	5.6	20.3	0.6	0.6	1.1	2.7	0.0	1.0	1.0	0.6	1.3	2.1	1.8	5.5	0.2	2.6	0.7	22.9	0.9	0.9	40.4	1.7	1.7	0.4	9.4	1.9	1.7	34.8	3.6	1.2	11.9	1.2	1.3	0.6	5.2	9.3	2.7	0.6	0.2	0.5	0.5	0.2	0.3	0.6	0.3	0.2	0.1	0.1	0.3	1.0	0.8	0.6	0.2	0.6	0.1	0.0	0.0	1.9	0.2	10.7	0.8	0.5	0.2	0.7	0.5	2.2	0.1	0.4	0.2	2.4	0.3	2.1	0.0	0.5	3.2	0.7	0.7	0.3	5.0	0.4	0.6	0.0	1.0	0.8	0.5	0.3	0.2	0.3	0.8	5.1	12.7	0.4	1.1	0.5	0.4	1.0	0.7	2.4	0.7	0.3	0.2	1.3	0.2	0.1	9.3	0.5	6.5	11.2	5.0	6.4	0.9	11.9	4.3	5.9	0.7	5.2	0.6	1.2	4.5	2.7	0.5	0.4	0.3	0.8	0.6	0.5	0.6	0.6	0.6	0.4
PARPBP	"C12orf48, FLJ20641, PARI"	ENSG00000185480	"PARP1 binding protein"	Q9NWS1	12	102120185-102197520	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA039677	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA039677: AB_10673426"	"unprognostic (7.84e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.54e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.52e-3)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.83e-1)"	"unprognostic (5.61e-8)"	"unprognostic (3.50e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.16e-3)"	"unprognostic (6.14e-2)"	1.8	1.5	1.7	6.3	1.9	11.0	2.4	2.0	2.8	1.8	4.0	1.0	1.4	3.3	2.4	1.9	6.7	0.9	1.4	2.4	1.6	4.8	3.1	1.0	1.8	5.4	1.8	2.2	1.8	1.1	0.3	1.0	4.1	4.4	2.9	5.5	0.4	2.2	1.1	1.2	2.6	3.7	2.2	1.7	5.6	2.4	14.5	0.4	26.6	1.4	5.9	6.7	3.3	2.7	3.0	1.9	6.2	1.5	1.2	4.5	1.9	7.2	15.6	13.2	7.5	2.2	2.0	9.3	11.3	6.2	18.1	16.1	8.1	5.5	13.5	6.5	4.0	8.0	21.5	6.4	19.2	13.9	12.8	17.3	9.3	7.3	0.6	18.2	5.2	1.8	1.4	12.6	7.7	11.9	15.9	8.4	11.7	5.7	16.2	16.7	17.5	14.5	10.9	21.5	8.8	5.6	11.4	8.9	8.6	7.5	9.1	6.4	14.9	6.5	4.6	9.3	9.1	11.5	13.8	6.5	12.9	12.1	6.4	18.5	12.1	6.2	1.2	2.4	1.6	1.5	0.4	3.0	2.5	2.2	1.9	1.5	1.4	1.6	0.0	1.2	1.2	1.7	4.5	1.9	1.7	1.9	2.0	2.8	1.6	4.8	1.8	2.2	4.4	0.4
PARVG		ENSG00000138964	"Parvin gamma"	Q9HBI0	22	44172956-44219533	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.4;bone marrow: 31.2;lymphoid tissue: 27.7"	"Group enriched"	"Detected in some"	4	"HL-60: 43.8;NB-4: 16.9;THP-1: 24.8;U-937: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031833, HPA031834"	Uncertain									"HPA031833: AB_2674063, HPA031834: AB_10601242"	"unprognostic (9.83e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (4.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (3.43e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.89e-2)"	8.0	2.9	3.5	22.2	6.9	31.2	2.7	1.2	3.1	3.5	3.5	4.9	0.8	2.7	1.9	2.7	1.9	3.1	4.5	3.5	4.2	3.3	3.1	3.1	13.1	20.3	8.9	1.5	1.6	2.0	0.5	2.1	2.3	5.4	2.6	2.7	2.5	5.2	1.0	1.0	1.7	10.1	2.2	10.8	27.7	3.1	1.7	5.6	19.7	2.4	0.0	18.8	4.5	5.9	8.4	18.5	27.4	23.6	4.8	6.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	43.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	16.9	0.0	0.0	3.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	24.8	0.0	0.0	4.7	0.1	0.0	0.1	0.0	0.1	0.0	20.6	0.7	3.6	23.6	25.3	5.5	21.3	5.5	8.3	3.3	6.0	18.5	8.4	3.7	4.2	27.4	4.8	22.6	12.6	4.4	14.2	3.5	6.9	1.2	3.1	4.2	3.3	8.9	1.5	5.4	5.6
PATL2	Pat1a	ENSG00000229474	"PAT1 homolog 2"	C9JE40	15	44665732-44711316	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.7;lymphoid tissue: 13.1"	"Cell line enriched"	"Detected in some"	28	"U-266/70: 53.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdTCR: 16.7"	"Lineage enriched"	"Detected in many"	7	"T-cells: 16.7"	"Low region specificity"	"Detected in some"																		"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (3.30e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-4)"	1.4	2.3	0.6	5.6	1.3	5.2	1.1	0.4	1.2	0.9	1.3	0.4	0.4	1.5	1.1	1.4	2.1	1.3	5.1	1.6	1.1	0.5	1.4	1.5	4.7	12.7	2.0	1.3	1.3	0.7	0.0	1.7	1.0	1.0	1.7	1.7	1.2	4.8	0.4	1.0	1.8	6.5	0.4	1.8	13.1	2.0	1.0	1.5	0.9	1.4	0.4	8.4	2.2	0.9	2.5	0.5	1.7	0.4	1.7	16.7	2.2	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.1	0.3	0.4	0.2	0.5	0.3	0.0	0.1	0.5	0.0	0.1	0.2	0.8	0.0	0.5	0.0	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.1	0.0	0.0	1.8	0.1	0.1	0.0	0.5	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.2	0.1	0.0	0.3	0.0	53.0	1.6	0.1	0.5	1.2	0.1	1.0	0.2	1.7	16.7	0.4	2.4	2.5	4.7	13.0	0.5	2.4	2.8	10.1	1.1	1.7	0.3	0.4	0.6	2.2	0.6	1.3	0.4	1.2	1.1	0.5	2.0	1.3	1.0	1.5
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833275-37034185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 21.6;lymphoid tissue: 33.4"	"Group enriched"	"Detected in some"	8	"Daudi: 21.0;REH: 61.0;U-698: 27.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 1.6"	"Group enriched"	"Detected in some"	209	"memory B-cell: 20.1;naive B-cell: 21.6"	"Lineage enriched"	"Detected in single"	216	"B-cells: 21.6"	"Region enriched"	"Detected in single"	11	"midbrain: 4.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2"	"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	Nucleoplasm	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.4	0.2	0.2	33.4	0.2	5.5	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.5	0.3	0.3	23.2	1.6	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.3	0.3	0.4	2.5	0.0	0.6	0.2	8.7	0.0	0.3	16.5	0.7	0.9	0.0	2.3	0.4	0.2	30.1	1.3	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.1	61.0	0.1	0.1	0.0	0.0	4.3	1.0	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	0.0	0.2	0.0
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631810-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		31000	31000	Cytosol	Cytosol	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	2.0	2.4	8.0	2.1	11.2	0.3	0.9	4.6	18.2	2.9	1.2	6.2	0.3	1.1	2.6	1.3	1.7	2.5	3.6	2.3	6.5	12.1	1.6	1.4	13.5	0.9	7.4	4.8	0.8	6.2	2.0	1.0	4.7	4.4	1.2	1.2	1.1	1.0	1.1	1.8	0.6	0.7	2.6	4.4	32.7	1.8	8.9	7.7	0.0	3.4	0.4	0.8	3.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.7	0.0	0.0	1.8	0.0	0.0	0.0	9.9	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	1.0	0.0	0.0	0.0	6.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	11.2	4.6	7.8	6.5	12.1	7.4	4.8	4.4	7.7
PCED1B	"FAM113B, MGC16044"	ENSG00000179715	"PC-esterase domain containing 1B"	Q96HM7	12	47079603-47236662	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 40.2"	"Cell line enhanced"	"Detected in many"		"A549: 32.0;K-562: 23.9;SK-BR-3: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043901	Approved		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA043901: AB_10959888"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavourable (4.55e-6)"	"unprognostic (4.79e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.74e-2)"	"prognostic favourable (5.36e-5)"	5.7	28.4	4.1	25.9	3.9	7.1	4.4	0.6	3.6	5.1	6.4	5.7	1.2	1.8	7.6	4.6	4.5	6.9	5.8	2.4	2.8	2.3	4.1	2.7	7.8	25.6	3.8	2.9	19.6	2.1	0.6	2.0	3.2	3.7	6.0	2.3	3.3	6.5	2.8	1.0	2.0	8.5	11.7	7.7	20.8	2.9	9.1	3.3	5.7	2.6	1.3	40.2	10.0	4.2	16.5	12.5	1.5	0.8	9.1	32.1	10.9	1.7	32.0	0.8	0.0	0.2	0.0	1.5	1.0	1.7	0.4	0.1	1.6	6.3	5.7	1.8	3.2	4.6	0.0	4.7	0.0	6.6	0.0	0.2	0.3	0.6	0.6	1.3	0.2	0.1	2.1	0.5	3.7	1.4	23.9	5.4	2.2	0.7	0.3	1.1	5.5	0.4	0.1	0.8	4.0	4.9	2.6	0.2	0.0	2.9	15.9	0.0	2.9	2.0	0.4	0.1	0.4	0.0	1.1	5.9	4.1	10.4	1.5	4.4	0.1	0.4	0.3	0.8	14.9	0.7	16.9	16.5	17.9	18.8	2.1	10.1	32.1	29.1	1.5	9.1	0.8	12.5	18.9	10.9	4.1	3.9	0.6	3.6	2.8	2.3	3.8	2.9	3.7	3.3
PCLAF	"KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15"	ENSG00000166803	"PCNA clamp associated factor"	Q15004	15	64364311-64387687	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.1;lymphoid tissue: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"T-reg: 24.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 24.2"									HPA047929			Supported	Centrosome				Centrosome	Centrosome	"HPA047929: AB_2680215"	"unprognostic (5.34e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (4.38e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (9.77e-15)"	"unprognostic (5.59e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.22e-1)"	2.1	1.8	0.7	24.5	0.8	42.1	2.6	0.4	0.8	1.8	7.7	0.6	1.0	4.6	1.6	2.8	18.8	0.6	4.0	2.2	0.8	1.0	2.5	3.0	4.0	21.8	1.4	0.4	0.9	1.4	0.1	0.6	5.1	0.7	1.6	10.1	0.5	3.1	0.4	0.9	2.8	8.1	1.6	1.9	10.9	4.9	3.0	0.5	78.3	1.2	18.0	20.7	4.3	5.7	2.2	3.2	2.0	0.4	5.2	24.2	2.7	30.4	35.2	30.0	19.1	3.1	11.3	21.9	23.5	20.9	45.3	65.8	39.5	29.0	58.5	8.4	11.9	22.9	74.7	18.2	51.3	37.1	26.8	57.3	37.1	34.0	0.3	37.7	21.2	3.8	1.9	35.8	7.2	34.4	35.2	21.5	52.1	35.1	45.6	84.6	11.1	15.3	59.6	56.8	38.4	21.5	31.5	2.9	15.4	18.6	14.8	10.8	20.9	52.4	4.8	22.5	47.2	27.2	62.7	11.7	40.6	36.6	9.3	83.2	15.1	2.0	0.2	1.2	1.6	0.1	0.2	2.2	4.8	4.5	3.2	0.5	0.4	0.8	1.6	5.2	0.4	0.2	24.2	2.7	0.7	0.8	0.4	0.8	0.8	1.0	1.4	0.4	0.7	0.5
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 115.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favourable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavourable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	13.9	21.4	11.1	31.8	15.8	87.2	13.7	17.2	14.6	13.7	23.1	15.6	13.7	18.9	15.7	13.7	36.0	12.7	17.5	13.6	11.6	9.8	21.7	14.9	17.8	41.6	18.8	10.8	14.4	14.3	14.0	13.9	24.0	14.3	10.8	26.1	18.7	17.7	15.6	11.0	16.5	20.5	12.8	16.1	24.5	15.7	40.5	17.4	115.8	18.1	40.7	38.7	17.3	17.2	16.9	16.0	8.7	11.6	19.6	24.4	16.9	73.2	57.7	58.6	25.2	13.9	13.0	41.1	48.3	28.5	45.5	64.7	45.0	58.6	74.5	15.7	17.2	55.1	34.6	58.2	41.7	22.1	38.2	52.3	22.2	104.8	5.9	71.6	23.5	9.4	13.8	38.7	9.2	25.9	46.5	63.0	44.3	26.5	136.8	79.2	43.8	32.0	75.6	51.5	60.1	20.6	42.8	50.3	34.2	33.8	52.3	33.1	36.9	36.5	17.3	32.9	37.8	46.2	55.1	32.0	91.3	126.2	14.8	68.2	42.1	2.4	11.6	8.7	19.2	10.9	23.8	16.9	24.4	19.3	16.0	13.6	22.4	20.1	3.8	19.6	11.4	14.7	23.3	16.9	11.1	15.8	17.2	14.6	11.6	9.8	18.8	10.8	14.3	17.4
PCSK6	"PACE4, SPC4"	ENSG00000140479	"Proprotein convertase subtilisin/kexin type 6"	P29122	15	101297142-101525202	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.3;liver: 76.0;lymphoid tissue: 37.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 26.1;CACO-2: 18.3;HEK 293: 27.5;Hep G2: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004774	Uncertain				"Secreted to extracellular matrix"	38000	38000			"HPA004774: AB_1079583"	"prognostic favourable (9.99e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (7.06e-7)"	"unprognostic (2.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	3.0	1.5	5.1	1.5	25.1	0.9	6.1	4.5	11.5	1.5	8.4	41.9	0.0	3.6	1.4	2.5	4.8	1.9	1.9	10.1	8.9	5.7	1.7	76.0	2.3	4.6	38.8	8.4	4.0	1.7	0.5	3.1	16.5	29.0	1.9	8.2	0.7	1.5	0.7	3.5	4.0	4.8	1.9	69.3	37.4	5.3	6.6	24.5	3.7	1.4	3.5	1.3	1.6	1.6	2.6	0.7	1.9	2.4	7.5	1.4	2.5	8.6	7.0	1.3	0.9	0.1	0.1	26.1	0.5	1.3	0.0	0.1	18.3	4.0	0.2	1.2	0.2	5.9	7.0	0.7	0.1	1.2	27.5	15.0	3.6	24.6	0.8	2.1	0.3	0.4	4.8	0.1	0.2	0.0	11.5	0.2	0.0	4.2	0.1	1.9	3.7	3.0	0.2	0.2	1.9	2.3	12.2	3.5	3.8	12.1	0.9	3.9	1.0	9.5	0.1	0.1	0.7	0.2	0.0	0.3	0.3	0.3	0.1	0.3	3.4	1.3	0.6	1.9	0.6	0.8	0.7	1.1	1.0	0.5	0.2	2.6	1.4	1.3	1.1	7.5	2.4	0.7	0.2	2.5	5.1	25.1	4.5	10.4	8.9	5.7	38.8	8.4	29.0	24.5
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849881-241858908	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.6;lymphoid tissue: 21.5"	"Group enriched"	"Detected in some"	14	"MOLT-4: 9.3;RPMI-8226: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 4.1;MAIT T-cell: 3.9;memory CD4 T-cell: 6.8;memory CD8 T-cell: 11.6;T-reg: 3.5"	"Lineage enriched"	"Detected in single"	93	"T-cells: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced									"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (2.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (7.78e-2)"	"prognostic favourable (9.44e-5)"	"unprognostic (7.18e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.82e-3)"	"unprognostic (3.75e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.94e-1)"	"prognostic unfavourable (3.48e-7)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (5.06e-3)"	1.4	0.4	0.0	21.5	0.7	3.0	0.5	0.1	0.3	1.2	1.9	0.0	0.0	0.4	0.5	1.6	2.0	0.8	1.7	9.2	0.2	0.5	1.3	0.5	5.6	16.6	0.1	0.3	0.7	1.0	0.2	1.9	0.3	0.4	1.3	0.2	1.2	3.0	0.5	0.2	0.2	4.9	0.4	0.3	9.5	1.9	0.4	0.2	16.6	1.9	3.0	20.1	1.3	0.8	0.1	0.0	0.0	0.0	0.0	11.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	9.3	0.0	0.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.9	0.1	6.8	11.6	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	3.5	1.5	0.0	0.7	0.1	0.1	0.2	0.5	0.1	0.3	0.4	0.2
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0;lymphoid tissue: 65.4"	"Cell line enriched"	"Detected in some"	8	"HeLa: 105.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.7;T-cells: 9.6"					"Group enriched"	"Detected in many"	5	"amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"CAB009752: AB_2268159, HPA031192: AB_2673781"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favourable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	27.8	18.4	30.4	3.0	34.2	2.5	25.4	1.0	48.0	8.9	7.7	3.8	1.9	3.5	9.4	4.9	10.2	11.6	12.0	11.3	18.0	6.1	7.0	10.4	5.1	3.8	3.8	27.0	3.4	2.4	4.4	3.4	6.6	6.7	4.8	5.2	3.0	2.3	6.3	6.6	4.8	4.2	10.3	2.1	65.4	4.2	2.9	7.4	0.1	7.0	3.9	2.2	8.3	11.2	3.7	1.2	0.2	1.0	0.1	9.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	105.0	0.1	0.2	0.0	1.6	0.0	0.2	0.5	4.3	2.3	0.1	0.1	0.0	0.0	0.0	0.0	1.5	2.9	0.0	0.0	0.2	0.0	0.0	9.4	0.5	0.0	0.0	0.4	0.0	0.0	13.4	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	9.6	1.0	5.6	3.7	5.7	5.6	1.2	2.5	3.7	3.0	0.2	0.1	0.5	0.0	2.3	1.9	30.4	34.2	1.0	48.0	18.0	6.1	3.8	27.0	6.7	7.4
PDE7A	HCP1	ENSG00000205268	"Phosphodiesterase 7A"	Q13946	8	65717510-65842322	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.5;skeletal muscle: 48.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.1;MOLT-4: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018770, HPA027340"	Approved									"CAB018770: AB_677329, HPA027340: AB_1855127"	"unprognostic (2.76e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (1.44e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.03e-2)"	6.9	1.4	4.4	22.7	4.6	12.3	10.0	7.3	4.3	7.1	4.1	5.8	5.9	5.6	3.6	8.2	3.6	3.8	6.1	21.0	4.3	3.6	13.4	2.7	10.1	27.7	4.3	2.7	3.4	9.2	1.4	7.5	4.0	4.6	7.3	5.0	3.3	11.7	12.6	48.3	4.3	13.6	4.0	3.4	16.3	6.2	4.8	5.5	87.5	13.0	25.4	22.4	5.4	4.7	7.7	2.2	5.3	0.7	2.1	12.6	1.8	4.0	3.6	15.9	7.4	2.3	2.0	6.7	3.0	2.6	3.9	3.7	4.4	2.7	11.4	0.7	1.9	4.5	5.8	6.4	4.1	13.4	3.0	8.3	5.7	3.1	1.1	6.6	3.3	2.9	10.8	2.5	7.6	3.8	6.1	32.1	2.6	2.3	53.5	8.2	16.9	1.6	20.0	2.4	2.9	2.6	8.1	7.9	9.0	3.2	1.6	1.6	8.7	17.1	2.4	5.4	6.7	3.8	2.4	15.7	6.7	19.8	5.5	13.9	2.9	0.2	0.7	5.3	3.7	0.6	6.0	6.7	5.7	3.7	1.5	7.7	12.6	9.6	2.6	2.1	0.1	2.2	4.5	1.8	4.4	4.6	7.3	4.3	4.3	3.6	4.3	2.7	4.6	5.5
PDLIM2		ENSG00000120913	"PDZ and LIM domain 2"	Q96JY6	8	22578279-22598025	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 81.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003880	Approved		Supported	"Actin filaments,Focal adhesion sites"				"Actin filaments, Focal adhesion sites"	"Actin filaments, Focal adhesion sites"	"HPA003880: AB_1855149"	"unprognostic (1.04e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-3)"	"unprognostic (9.33e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (1.37e-7)"	"unprognostic (6.14e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.08e-3)"	10.4	7.0	5.4	10.9	5.9	6.0	10.4	16.2	7.9	19.8	27.6	8.4	7.7	17.8	11.1	11.0	41.1	9.0	19.9	10.1	6.3	5.0	20.9	16.4	26.5	17.2	6.9	7.1	13.1	15.6	2.2	5.7	42.3	10.8	11.2	3.2	11.3	12.4	10.0	53.5	48.8	32.2	16.2	10.1	81.6	5.6	8.5	5.0	7.5	5.5	23.4	21.0	12.7	23.2	9.6	12.4	49.3	20.2	8.7	16.4	10.2	22.6	14.0	9.5	16.6	18.7	32.1	10.7	35.8	26.8	25.8	26.1	16.0	3.8	9.3	10.1	32.3	11.6	5.3	24.4	5.0	0.0	3.6	2.9	9.1	11.5	23.8	3.2	22.7	34.2	3.0	12.6	3.5	14.1	0.8	6.1	17.4	11.9	4.1	3.8	7.8	1.4	3.3	1.8	1.0	4.5	4.6	2.9	7.1	7.5	20.5	32.4	7.2	6.6	17.5	28.1	29.0	33.5	16.4	0.1	0.2	3.0	28.9	13.0	20.6	22.7	15.5	49.3	16.4	20.2	14.6	8.4	12.4	16.1	12.4	9.6	8.6	12.2	32.9	8.7	19.4	8.0	12.8	10.2	5.4	5.9	16.2	7.9	6.3	5.0	6.9	7.1	10.8	5.0
PDSS1	"COQ1, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697659-26746798	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 22.4;lymphoid tissue: 31.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA038032: AB_10670650, HPA042741: AB_2678139"	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	3.1	2.6	2.4	7.0	3.1	5.6	3.5	5.6	5.1	3.1	18.2	1.5	1.2	20.6	3.8	2.1	8.3	3.4	3.7	4.2	2.2	2.2	8.6	7.2	4.0	7.8	2.1	2.3	2.8	3.8	1.7	2.5	2.8	2.9	2.3	17.0	3.2	3.5	1.8	10.4	2.7	22.4	3.6	3.1	5.7	3.8	3.0	1.6	31.8	2.1	4.7	5.0	2.9	4.0	3.2	5.2	0.9	5.3	0.8	3.4	1.3	7.5	5.9	4.5	8.2	1.5	2.8	6.2	7.0	1.8	10.2	7.0	9.0	4.2	17.3	3.7	3.4	9.6	14.3	10.7	8.7	7.2	12.0	14.9	5.1	6.5	2.2	9.9	5.9	3.5	4.6	9.5	2.5	5.3	13.7	4.6	7.1	11.9	31.2	7.0	9.0	5.7	14.5	12.9	12.5	6.0	3.6	13.2	8.1	6.8	14.0	7.6	4.9	11.6	3.4	5.7	9.1	11.7	11.1	1.8	6.7	12.6	5.6	25.2	4.4	0.0	5.3	0.9	0.9	4.1	2.1	0.5	1.8	1.3	5.2	3.2	3.4	1.5	0.3	0.8	2.1	1.4	0.1	1.3	2.4	3.1	5.6	5.1	2.2	2.2	2.1	2.3	2.9	1.6
PEAK3	"C19orf35, FLJ45778"	ENSG00000188305	"PEAK family member 3"	Q6ZS72	19	2274622-2282176	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;lymphoid tissue: 19.1"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 16.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 24.5"					"Group enriched"	"Detected in some"	5	"basal ganglia: 6.4;cerebellum: 6.0"	HPA057806	Uncertain									"HPA057806: AB_2683534"	"unprognostic (9.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.40e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.90e-1)"	1.9	1.3	1.4	4.7	3.3	8.2	0.9	0.8	2.0	1.3	1.7	2.1	0.1	1.1	0.7	1.0	0.8	1.6	0.9	2.1	2.0	0.9	3.8	2.0	4.4	14.3	3.3	0.9	1.0	0.8	0.6	1.2	0.8	2.3	1.0	1.1	0.7	0.8	0.6	1.5	1.0	2.5	0.9	4.0	19.1	1.1	0.6	1.7	0.6	0.8	0.0	2.7	0.9	1.9	0.2	1.1	24.5	3.4	2.8	1.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.1	0.2	0.5	0.1	16.5	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	5.3	2.7	6.6	1.0	3.4	0.1	0.1	0.1	0.1	1.1	0.2	0.0	0.2	24.5	2.8	1.1	0.1	0.0	0.5	1.4	3.3	0.8	2.0	2.0	0.9	3.3	0.9	2.3	1.7
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853189-73854155	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;lymphoid tissue: 27.8"	"Cell line enhanced"	"Detected in some"		"BJ: 2.7;CAPAN-2: 3.5;EFO-21: 5.5;HHSteC: 2.2;HSkMC: 3.4;HUVEC TERT2: 1.8;RPTEC TERT1: 3.3;U-2197: 1.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	28	"basophil: 9.1;neutrophil: 11.2"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.2"									HPA052485	Supported				"Secreted to blood"	1400000000	1400000000			"HPA052485: AB_2681847"		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.3	0.2	0.1	0.9	0.4	2.8	0.6	0.2	0.5	0.8	0.7	0.0	0.7	4.8	0.1	1.1	0.6	0.5	0.5	8.7	0.4	0.6	2.0	1.9	2.6	0.9	0.4	0.3	7.4	0.4	0.1	0.4	2.0	1.2	1.0	0.7	0.2	1.5	4.0	0.1	0.2	3.2	0.0	0.6	27.8	0.2	0.3	0.0	0.1	0.2	1.1	0.2	5.0	1.0	0.1	0.3	11.2	0.2	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.7	0.6	0.3	2.7	0.4	0.0	0.0	0.0	3.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	11.2	0.0	0.1	0.3	0.0	12.6	0.1	0.4	0.2	0.5	0.4	0.6	0.4	0.3	1.2	0.0
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2a"	O14813	11	72239077-72245664	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7"	"Cell line enriched"	"Detected in single"	228	"SH-SY5Y: 112.7"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in single"	96	"pons and medulla: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"pons and medulla: 0.8"	"Low region specificity"	"Detected in some"			"HPA053810, HPA065621, HPA078004"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA053810: , HPA065621: AB_2685522, HPA078004: "			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	24.6	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.5	0.0	0.4	0.1	0.0	1.4	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	12.1	0.9	0.7	1.7	0.7	3.7	0.0	0.0	3.2	0.3	2.1	0.1	1.6	5.2	0.0	0.0	0.0	0.0	0.0	2.6	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	112.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Group enriched"	"Detected in some"	6	"EFO-21: 27.0;HaCaT: 32.8;PC-3: 55.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	2100000	2100000	"Plasma membrane"	"Plasma membrane"	"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favourable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.84e-6)"	"prognostic unfavourable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavourable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	27.0	0.0	32.8	0.0	6.7	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.4	5.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.3	0.0	6.4	0.1	0.0	0.0	4.6	0.6	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
PIDD1	"DKFZp434D229, LRDD, MGC16925, PIDD"	ENSG00000177595	"P53-induced death domain protein 1"	Q9HB75	11	799179-809753	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB012647, HPA055473"	Supported		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"CAB012647: , HPA055473: AB_2682827"	"unprognostic (1.38e-1)"	"prognostic favourable (8.19e-5)"	"unprognostic (5.07e-3)"	"prognostic favourable (3.32e-5)"	"unprognostic (7.25e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (8.17e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-2)"	3.4	3.0	3.3	6.7	3.7	15.0	3.9	7.7	10.0	4.4	4.3	2.2	0.4	7.1	3.2	4.1	6.8	3.3	3.0	2.2	4.7	2.9	2.9	5.6	3.1	7.0	4.4	10.9	2.9	5.6	3.0	2.8	10.1	3.2	5.2	2.0	2.7	6.1	3.5	7.1	7.9	6.5	2.0	5.9	5.3	5.9	5.0	1.9	21.9	3.9	4.3	9.2	3.3	2.8	1.9	3.1	0.1	1.8	0.4	3.3	1.2	4.1	4.8	2.3	4.9	0.5	1.8	21.3	5.9	1.6	2.2	2.9	4.4	8.0	3.4	1.8	0.8	6.2	1.7	2.3	0.4	6.9	9.8	2.9	3.3	9.0	5.6	3.2	7.5	6.9	4.2	1.1	0.3	3.9	3.4	2.6	0.9	1.9	9.1	5.4	3.2	3.4	14.9	3.3	6.6	0.8	1.4	4.0	5.4	2.5	6.5	1.6	4.8	5.6	2.2	2.8	6.2	2.0	3.8	8.4	4.7	6.6	3.5	2.7	4.4	0.0	1.7	0.1	1.9	1.8	1.8	1.5	1.4	1.5	3.1	1.9	1.7	1.7	0.0	0.4	1.6	0.8	3.3	1.2	3.3	3.7	7.7	10.0	4.7	2.9	4.4	10.9	3.2	1.9
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	1.8	1.1	0.6	12.9	0.6	6.0	0.6	0.6	1.2	1.2	5.2	0.6	0.6	3.3	2.0	1.3	4.6	0.8	1.4	0.9	0.6	1.8	0.7	0.6	1.9	7.5	0.9	0.6	0.6	0.6	0.0	0.6	1.4	1.0	2.5	1.8	0.9	0.8	1.2	0.6	1.6	3.7	2.1	0.6	7.0	2.7	3.3	0.6	14.3	0.6	5.1	6.0	1.8	1.9	0.7	0.3	0.0	0.0	0.0	3.2	0.4	5.1	6.0	14.7	5.9	2.6	3.1	5.4	5.1	2.7	5.1	4.0	9.5	8.6	6.2	2.1	2.5	14.3	15.1	4.3	1.9	9.9	5.5	7.2	16.9	6.8	1.3	2.9	5.9	1.7	0.0	2.2	1.8	5.2	4.7	12.5	4.8	4.5	3.0	12.0	12.0	4.2	6.4	4.9	8.7	2.8	2.9	6.1	3.9	3.9	4.3	2.3	4.8	3.1	3.5	3.1	16.1	4.9	9.3	10.1	9.3	5.9	2.9	12.7	4.4	0.0	0.0	0.0	1.5	0.0	0.5	0.7	0.1	1.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.3	3.2	0.4	0.6	0.6	0.6	1.2	0.6	1.8	0.9	0.6	1.0	0.6
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593312-96720514	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.1;NB-4: 17.4;REH: 51.7;THP-1: 26.4;U-698: 32.9;U-937: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9"	"Group enriched"	"Detected in all"	6	"B-cells: 17.5;monocytes: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	5.8	2.2	2.9	16.8	7.1	14.7	4.8	1.0	3.0	1.4	2.2	3.2	0.0	1.9	1.3	2.3	1.3	2.0	8.5	3.3	3.1	2.4	6.2	38.4	6.0	19.5	5.3	0.5	3.3	16.1	0.3	3.0	10.9	5.1	1.8	2.7	1.6	29.7	0.8	1.1	1.5	6.6	2.4	7.3	32.0	1.9	1.7	4.3	2.0	2.4	0.6	19.2	4.1	2.2	17.5	4.4	4.7	38.9	4.5	4.8	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.4	24.1	2.5	0.0	0.0	5.1	0.0	0.2	13.4	0.8	3.7	0.0	0.4	0.0	10.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	17.4	0.2	0.3	51.7	1.2	5.6	0.0	0.0	1.0	0.6	0.0	0.0	0.3	0.0	26.4	0.0	0.0	0.8	0.0	0.2	0.2	0.0	32.9	0.0	27.1	0.0	1.7	5.4	3.3	4.8	15.5	1.7	17.5	0.1	1.5	4.4	16.2	0.0	1.2	4.7	4.5	38.9	3.9	0.1	4.2	2.9	7.1	1.0	3.0	3.1	2.4	5.3	0.5	5.1	4.3
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651732-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5;NB-4: 21.8;REH: 22.7;THP-1: 22.0;U-937: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"				Vesicles	Vesicles	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	4.5	2.1	3.4	34.8	7.1	32.8	2.9	3.3	4.3	3.2	3.3	5.5	0.7	3.1	3.7	3.4	3.5	4.0	6.5	2.9	4.2	3.1	4.6	3.3	8.2	40.3	7.4	1.8	5.3	2.2	2.3	2.2	3.3	4.6	3.2	2.1	3.1	11.2	1.8	0.9	2.0	11.4	2.9	5.3	35.5	3.3	3.0	5.7	23.5	4.1	2.3	36.0	5.8	3.6	8.4	14.5	35.0	15.0	14.5	13.7	16.6	2.6	1.7	0.1	0.5	0.4	0.4	0.2	4.1	8.4	9.0	7.4	0.1	1.1	7.1	1.7	3.3	0.8	0.7	3.7	5.7	50.5	0.1	0.8	0.4	3.0	1.8	18.4	6.4	1.5	1.5	10.1	3.4	1.3	2.6	0.0	5.1	0.2	1.7	21.8	0.7	0.5	22.7	4.5	0.2	3.8	0.0	0.5	0.5	0.9	1.7	4.0	0.2	22.0	3.3	2.7	2.8	0.0	3.8	1.6	1.6	10.0	5.8	26.3	1.5	9.6	11.8	21.1	12.9	13.1	13.7	7.8	9.8	11.8	12.5	8.4	12.9	13.4	35.0	14.5	15.0	14.5	7.4	16.6	3.4	7.1	3.3	4.3	4.2	3.1	7.4	1.8	4.6	5.7
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802723-8867677	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 12.2"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 57.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in many"	4	"eosinophil: 32.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	2.2	0.0	2.1	12.2	5.4	5.3	1.0	0.0	3.7	1.5	1.9	2.5	1.4	3.5	2.6	2.3	1.2	0.4	6.6	2.6	3.1		0.0	0.6	3.4	4.4	2.5	0.0	0.3	0.8	0.3	0.0	1.4	3.2	2.4	1.5	1.4	0.9	0.7	1.0	1.8	5.2	2.2	3.1	6.3	2.3	1.1	2.7	6.9	0.0	0.8	6.4	3.0	3.3	1.3	4.9	32.1	4.3	0.5	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	7.3	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.7	3.4	32.1	0.2	4.3	0.2	1.3	0.0	0.1	4.9	0.1	0.0	0.1	0.5	0.5	3.3	0.0	0.0	1.4										
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 63.4;lymphoid tissue: 71.2"	"Group enriched"	"Detected in many"	5	"HDLM-2: 58.9;Karpas-707: 73.0;RPMI-8226: 71.9;U-266/70: 133.0;U-266/84: 117.5"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol				Cytosol	Cytosol	"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favourable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	3.6	3.4	4.3	37.2	7.2	30.4	3.4	7.1	7.9	4.5	13.4	2.1	2.2	29.5	2.8	4.3	10.0	5.6	8.3	3.1	5.6	6.7	5.2	5.4	10.6	59.7	3.8	4.6	5.4	3.0	1.0	4.9	2.4	6.7	3.6	17.7	6.1	16.9	4.9	1.5	3.0	19.2	2.2	3.1	71.2	14.7	5.7	1.3	39.4	4.8	3.6	47.9	24.6	3.3	26.0	2.9	46.9	3.0	17.0	63.4	13.2	1.8	1.5	0.8	1.6	0.3	0.2	1.2	1.1	1.4	1.6	1.4	1.4	1.3	7.8	0.5	0.5	1.1	2.6	1.0	1.5	58.9	2.1	9.4	1.6	1.4	0.7	2.2	6.4	0.6	0.9	1.6	1.0	0.5	10.0	73.0	0.9	1.3	0.8	4.7	17.8	2.4	1.0	0.5	71.9	1.6	0.2	0.5	0.8	1.2	0.8	0.8	2.0	3.1	0.3	0.3	0.2	0.3	1.1	133.0	117.5	15.0	1.5	2.0	0.3	46.9	1.5	14.3	12.5	1.9	21.2	26.0	34.4	17.6	2.5	15.9	36.9	23.0	38.3	17.0	3.0	2.9	63.4	13.2	4.3	7.2	7.1	7.9	5.6	6.7	3.8	4.6	6.7	1.3
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451264-6556494	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.1;HeLa: 8.6;hTCEpi: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"	1.1	2.4	17.9	1.2	18.8	0.5	1.7	18.7	23.0	2.4	4.5	0.7	3.4	1.5	1.9	3.4	9.4	4.3	3.8	0.8	7.2	5.2	1.5	1.6	3.1	0.6	2.9	11.9	24.2	0.9	1.9	0.7	0.6	2.5	2.7	3.6	2.3	1.9	8.3	1.1	14.3	1.4	3.8	0.9	43.3	3.2	2.4	1.5	0.0	2.4	0.7	2.1	1.3	2.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.4	0.5	0.4	0.2	0.0	0.1	0.4	0.4	0.1	0.5	0.3	0.3	3.9	0.1	2.1	0.1	11.1	0.2	2.3	0.2	0.2	0.4	0.1	8.6	0.1	0.6	0.2	0.3	0.1	32.3	0.6	1.8	0.3	0.1	0.0	0.3	0.5	0.0	0.1	0.6	1.6	0.1	1.2	0.0	0.8	0.1	0.3	0.3	5.0	2.4	0.1	0.8	0.0	0.2	0.3	2.1	0.4	1.3	0.3	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	17.9	18.8	18.7	23.0	7.2	5.2	2.9	11.9	2.5	1.5
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027735-135034813	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 39.6;HeLa: 32.4;K-562: 31.6;T-47d: 47.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA008743	Approved		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	0.3	0.3	0.0	4.7	0.0	0.3	0.2	0.0	0.2	14.8	2.8	0.0	0.0	5.6	0.5	1.2	119.4	0.3	1.9	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	32.9	1.3	1.0	8.8	1.1	10.8	33.0	0.2	8.6	0.5	3.2	18.6	0.0	0.2	7.4	0.4	0.0	0.0	0.4	58.8	60.8	18.2	28.9	0.3	0.3	1.4	0.4	0.4	1.1	0.2	16.9	10.4	0.0	14.0	0.5	0.2	4.3	3.4	4.9	1.6	0.6	39.6	10.0	19.0	5.4	0.2	5.7	2.3	8.1	0.1	0.2	14.8	4.7	32.4	10.9	5.1	1.7	0.0	0.4	5.9	0.0	1.9	0.0	31.6	0.0	0.5	5.2	0.1	3.8	0.0	9.3	5.6	0.3	0.3	0.2	5.3	6.5	0.0	14.8	8.0	0.0	47.1	1.1	0.6	1.8	4.7	1.0	5.2	0.0	0.0	12.5	2.4	0.1	0.0	1.4	0.3	0.1	0.9	0.3	0.5	0.3	0.6	1.1	0.2	0.3	0.3	1.0	0.7	0.4	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0
PKD1L3		ENSG00000277481	"Polycystin 1 like 3, transient receptor potential channel interacting"	Q7Z443	16	71929538-71999978	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9;smooth muscle: 2.9;testis: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.90e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-6)"	"unprognostic (6.71e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.93e-3)"	0.6	0.5	0.1	2.9	0.1	0.3	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.7	0.1	0.1	0.1	0.5	0.1	0.2	0.1		0.1	1.2	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	1.9	2.9	0.1	0.4	0.2	2.1	0.1	0.1	0.1	0.1	0.1	1.2	0.1	0.7	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.6	0.0	0.0	0.1	0.0										
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288154-100330486	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.2;lymphoid tissue: 12.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;NB-4: 1.7;PC-3: 1.9;RT4: 1.0;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.7;U-937: 1.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB022621	Uncertain									"CAB022621: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.3	0.3	0.4	0.6	3.7	1.3	1.4	0.1	6.2	0.1	1.5	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	2.0	0.3	0.5	2.7	4.0	2.3	0.5	4.0	0.2	0.2	0.0	0.2	0.7	1.3	0.4	2.2	1.0	0.3	0.0	0.1	0.1	0.8	0.0	1.5	12.0	0.1	2.3	0.0	0.3	0.1	0.0	2.9	0.4	0.1	0.2	0.3	0.6	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.7	0.0	1.9	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.7	0.0	0.0	1.3	0.0	0.0	2.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.6	0.0	2.3	0.0	0.0	0.4	0.4	3.7	0.1	6.2	2.0	0.3	0.5	4.0	1.3	0.0
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139326-20150386	"Enzymes, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.1;skin 1: 13.7;urinary bladder: 19.5"	"Cell line enriched"	"Detected in single"	67	"RT4: 54.8"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.3"	"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favourable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	7.7	0.0	0.0	0.0	0.0	0.0	13.7	0.1	6.5	0.0	0.0	0.3	0.1	0.0	2.8	0.0	6.3	11.1	19.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G4B	"cPLA2-beta, HsT16992"	ENSG00000243708	"Phospholipase A2 group IVB"	P0C869	15	41837775-41848147	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.0;skin 1: 32.8;tongue: 56.0"	"Cell line enhanced"	"Detected in many"		"RT4: 11.0;T-47d: 5.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 10.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"																						"unprognostic (6.16e-2)"	"unprognostic (6.48e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.14e-3)"	"unprognostic (3.26e-5)"	"unprognostic (4.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.97e-2)"	1.8	1.2	1.8	1.8	2.2	3.4	3.6	10.8	2.1	6.1	1.8	1.8	1.8	1.9	2.7	2.3	19.3	2.0	1.9	1.8	1.8	2.5	2.5	2.6	2.2	3.3	1.8	1.8	4.2	3.5	1.4	3.2	1.8	1.8	4.8	1.1	1.8	7.0	2.7	1.8	32.8	2.4	1.8	1.8	3.0	1.8	1.8	1.8	2.2	4.8	56.0	36.0	2.0	5.9	3.0	0.5	0.2	0.8	3.9	1.5	0.1	1.3	0.7	0.0	0.0	0.1	0.0	3.7	0.4	1.2	1.3	0.1	0.3	0.7	0.3	0.1	0.7	4.4	1.5	0.5	0.3	0.0	2.5	1.1	1.4	3.4	1.7	0.2	1.4	0.9	4.9	0.2	1.3	0.6	1.7	0.2	0.4	2.1	1.0	4.1	1.0	1.2	0.0	1.2	0.9	1.0	11.0	0.2	1.1	0.0	2.0	1.0	5.9	1.8	0.0	0.0	1.0	1.0	0.1	3.4	0.0	0.9	0.3	5.0	0.0	0.0	0.8	0.0	1.5	0.5	0.9	0.1	0.4	0.8	0.5	3.0	0.9	0.8	0.2	3.9	0.2	0.5	1.2	0.1	1.8	2.2	10.8	2.1	1.8	2.5	1.8	1.8	1.8	1.8
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 57.0;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.8;PC-3: 7.7;RT4: 3.5;U-2 OS: 3.7"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 24.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 7.9;monocytes: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	170000000	170000000				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	57.0	2.1	2.8	14.0	5.8	1.1	2.9	2.0	2.7	1.5	4.4	2.0	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2.0	2.1	1.7	1.0	4.3	19.0	22.2	3.2	1.8	4.0	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2.0	6.4	13.1	0.6	6.0	7.2	0.8	0.1	7.9	0.2	24.2	0.0	0.2	6.1	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.2	1.9	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.3	3.8	7.7	0.0	0.0	0.1	0.0	3.5	0.1	0.5	0.0	0.0	0.0	1.0	1.0	0.0	0.0	3.7	0.1	0.8	0.1	0.0	0.0	0.0	0.2	1.3	0.0	24.2	0.1	0.0	5.0	0.2	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	6.1	2.8	5.8	2.0	2.7	2.1	1.7	3.2	1.8	2.3	2.0
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta specific 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8"	"Cell line enhanced"	"Detected in many"		"A-431: 31.5;CAPAN-2: 91.0;HL-60: 56.4;NB-4: 27.7;RPMI-8226: 40.7;THP-1: 32.8;U-937: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 181.6"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	2.3	1.3	1.7	47.9	5.9	62.0	1.6	0.7	4.1	6.1	44.1	0.6	0.2	14.6	1.0	0.9	34.5	3.1	7.5	2.4	1.4	1.9	1.6	12.4	23.4	51.6	2.5	0.2	1.9	1.2	0.0	1.3	32.3	3.0	2.0	31.4	1.3	9.7	1.0	0.8	0.7	66.5	3.1	5.2	74.8	21.8	0.7	2.7	18.2	1.5	1.4	53.1	3.4	2.5	41.5	181.6	7.0	47.8	77.6	32.9	36.0	31.5	0.2	0.1	0.2	0.0	0.0	5.2	0.8	0.2	2.0	2.4	0.6	91.0	5.3	0.2	9.2	3.3	0.5	0.2	7.5	0.0	0.1	0.1	6.3	2.6	0.3	56.4	0.3	0.1	0.6	0.3	0.4	0.1	0.0	0.4	5.2	0.1	10.7	27.7	0.1	0.1	1.4	1.9	40.7	0.1	0.9	4.6	0.0	0.2	5.2	0.1	0.3	32.8	0.2	0.2	5.9	0.1	0.1	0.3	0.0	14.1	0.4	26.0	0.0	2.7	11.0	7.0	32.9	47.8	24.9	41.5	15.7	18.7	10.0	38.4	19.4	22.0	2.4	77.6	25.8	181.6	1.0	36.0	1.7	5.9	0.7	4.1	1.4	1.9	2.5	0.2	3.0	2.7
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.5;lymphoid tissue: 36.3"	"Cell line enhanced"	"Detected in some"		"HEL: 30.8;HMC-1: 38.5;THP-1: 11.1;U-937: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298"	Approved		Approved	Cytosol				Cytosol	Cytosol	"CAB009443: AB_632197, HPA041298: AB_2677395"	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	6.3	3.6	8.1	17.6	11.6	30.5	2.9	1.1	7.5	2.9	3.3	16.2	1.7	4.0	2.8	3.2	2.4	4.6	6.5	3.3	6.9	5.1	3.3	4.2	12.5	17.2	12.7	2.4	1.6	2.0	1.3	2.9	4.6	9.3	3.2	5.5	4.1	5.2	2.9	1.3	1.5	10.2	4.8	17.9	36.3	3.6	1.4	10.9	12.2	2.8	1.8	17.6	6.9	2.5	1.0	4.5	8.5	4.3	1.8	3.1	2.0	0.1	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	7.7	0.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	6.5	38.5	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	1.8	3.5	0.4	0.1	5.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.1	4.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.0	21.1	0.0	2.7	4.2	8.5	3.1	4.3	2.0	0.7	1.6	1.6	4.5	1.0	1.6	1.8	6.9	1.8	4.2	1.6	2.9	2.0	8.1	11.6	1.1	7.5	6.9	5.1	12.7	2.4	9.3	10.9
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962693	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.6;HMC-1: 19.0;U-698: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Vesicles		21000	21000	Vesicles	Vesicles	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favourable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	8.4	3.8	3.3	55.8	4.9	14.1	10.7	1.0	2.4	5.6	10.3	5.3	3.1	8.7	11.2	12.2	6.0	4.7	10.1	4.4	3.3	2.8	20.6	8.8	10.7	35.5	5.2	1.8	2.0	3.6	1.0	1.8	4.1	4.5	4.3	3.6	4.6	8.8	2.8	2.0	4.1	17.6	4.6	8.6	33.6	4.2	2.3	4.2	6.3	5.3	2.6	44.6	7.5	7.7	18.8	3.9	26.8	12.2	14.0	1.1	2.3	0.3	0.7	0.1	0.6	0.0	0.0	0.9	0.0	0.0	0.5	0.2	0.2	1.7	39.6	6.8	0.0	0.9	0.8	0.1	0.3	0.3	0.4	4.7	0.0	0.0	0.2	4.7	19.0	0.0	0.4	0.3	0.2	0.9	0.5	3.3	0.0	1.2	0.5	11.9	0.7	0.2	16.1	0.0	5.0	0.1	0.8	0.3	0.0	1.1	0.3	0.3	0.7	14.6	0.2	0.0	0.7	0.1	0.1	7.9	12.9	87.9	0.0	6.5	0.3	2.8	4.4	26.8	0.7	5.7	0.3	18.8	0.2	1.1	3.9	17.3	0.3	0.8	24.8	14.0	12.2	2.6	0.1	2.3	3.3	4.9	1.0	2.4	3.3	2.8	5.2	1.8	4.5	4.2
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365173-68397453	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0"	"Cell line enhanced"	"Detected in some"		"HEL: 91.5;HMC-1: 35.0;NB-4: 30.8;THP-1: 35.8;U-266/84: 23.8;U-698: 24.4;U-937: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		970000000	970000000	Nucleoli	Nucleoli	"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	27.8	3.6	3.0	21.7	7.7	120.1	4.6	1.0	3.0	1.8	4.2	7.0	0.4	2.4	2.4	7.5	3.5	5.5	4.9	4.9	2.6	2.4	3.8	6.5	17.0	36.6	6.4	0.8	4.3	2.8	0.7	2.0	8.5	5.0	4.0	4.5	2.7	3.5	0.8	2.3	1.7	8.0	5.0	8.6	51.0	3.2	5.7	3.7	8.2	3.8	2.7	25.7	7.3	2.0	22.9	66.9	80.4	50.8	33.2	44.7	65.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.5	0.0	0.0	0.0	20.6	35.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	30.8	0.0	0.0	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	1.3	23.8	24.4	0.0	56.8	0.0	24.8	39.7	57.2	44.7	49.2	23.5	22.9	8.2	32.2	32.1	13.5	2.3	25.3	80.4	33.2	50.8	66.9	0.8	65.9	3.0	7.7	1.0	3.0	2.6	2.4	6.4	0.8	5.0	3.7
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 18.1;Karpas-707: 16.1;U-698: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"memory B-cell: 14.7;naive B-cell: 15.9"	"Lineage enriched"	"Detected in single"	29	"B-cells: 15.9"	"Region enriched"	"Detected in many"	5	"thalamus: 56.1"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	27.5	2.2	7.3	10.6	7.3	2.3	10.0	2.4	7.1	8.3	5.8	10.1	4.8	4.8	7.8	14.1	9.6	8.9	8.1	5.9	7.7	6.7	4.5	5.1	12.1	13.5	10.5	3.0	4.7	2.8	8.2	5.1	13.9	11.1	4.1	6.2	3.4	3.5	5.4	6.4	8.9	6.0	5.7	19.6	28.9	4.5	7.3	7.7	39.7	6.0	5.8	13.3	7.4	8.5	15.9	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	12.2	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	6.8	3.0	4.8	4.7	0.0	1.7	18.1	1.6	0.0	7.6	2.0	0.3	0.9	0.0	0.0	0.0	1.3	0.8	4.6	0.0	0.1	7.5	0.0	16.1	0.0	0.2	1.5	0.0	0.9	0.5	0.8	0.0	0.0	3.6	8.0	0.3	0.1	0.0	2.1	1.5	0.0	0.0	7.6	0.0	1.7	0.0	3.3	0.0	0.0	11.2	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.5	14.7	0.3	0.4	0.0	15.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.4	7.3	7.3	2.4	7.1	7.7	6.7	10.5	3.0	11.1	7.7
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966497-975865	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2"	"Cell line enhanced"	"Detected in many"		"A-431: 11.1;HaCaT: 19.5;SK-BR-3: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	0.6	0.0	1.8	0.2	0.4	1.4	0.0	0.1	7.7	0.9	0.0	0.0	0.8	1.1	2.7	31.5	0.3	5.0	0.5	0.3	0.0	2.3	0.8	1.1	0.3	0.0	0.0	0.1	0.5	0.3	0.0	1.5	0.0	3.7	0.2	0.3	5.3	1.2	1.5	31.3	0.7	0.6	0.6	0.5	1.7	0.8	0.0	0.2	0.7	20.2	21.2	6.0	10.6	0.0	0.3	2.0	0.9	2.3	1.1	0.2	11.1	1.2	0.0	0.7	0.0	0.5	1.9	5.2	1.3	3.4	0.8	1.5	8.6	0.0	2.5	2.1	19.5	0.2	3.2	0.5	3.8	0.8	0.0	3.4	2.2	0.4	0.2	0.1	0.1	2.7	2.2	1.2	0.3	0.2	3.1	0.2	6.5	0.0	0.2	0.3	9.0	0.0	0.0	4.1	3.6	3.4	0.1	0.1	5.8	13.3	0.7	2.5	0.0	2.3	4.2	1.8	0.4	3.4	2.5	0.1	0.1	5.1	1.9	2.4	0.0	0.9	2.0	0.3	0.3	0.0	0.0	0.5	1.1	0.3	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
PLEKHO2	"DKFZp761K2312, PLEKHQ1, PP1628, pp9099"	ENSG00000241839	"Pleckstrin homology domain containing O2"	Q8TD55	15	64841883-64868007	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6"									HPA040055	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		450000	450000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA040055: AB_10793954"	"unprognostic (4.32e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.85e-3)"	22.1	17.4	12.9	19.9	16.6	29.4	12.4	6.2	9.9	10.3	12.2	11.5	5.2	6.8	11.9	13.3	10.7	13.0	17.4	9.3	13.3	8.0	8.1	8.2	22.4	19.6	10.1	8.7	10.4	5.7	5.1	6.4	22.6	17.2	10.5	5.6	17.0	6.1	10.2	5.9	6.0	9.4	16.9	14.5	57.9	10.2	7.0	11.3	5.1	18.6	6.6	13.8	17.1	14.1	4.0	10.4	30.2	26.6	2.7	5.4	10.3	2.7	1.8	3.4	3.4	30.8	17.7	8.1	8.0	12.0	8.5	8.8	2.1	1.7	7.3	4.2	16.2	0.9	3.9	3.2	5.0	11.2	1.2	7.3	0.8	2.5	23.7	8.1	10.9	12.8	2.9	10.6	3.4	11.8	2.1	26.1	11.3	0.8	1.7	8.8	6.6	1.6	6.3	8.3	5.2	1.3	1.9	0.2	3.0	3.3	1.1	10.9	1.2	11.1	15.2	6.6	6.1	6.2	3.3	9.7	15.2	2.5	7.1	10.6	3.8	7.0	14.3	9.2	5.4	20.4	5.0	4.0	3.1	5.0	10.4	2.6	1.3	2.7	30.2	2.7	26.6	1.2	4.1	10.3	12.9	16.6	6.2	9.9	13.3	8.0	10.1	8.7	17.2	11.3
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 83.9;testis: 32.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"T-reg: 9.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 9.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051638, HPA053229"	Approved									"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavourable (2.70e-7)"	"prognostic unfavourable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	2.9	1.1	1.1	14.2	1.5	15.9	1.7	2.1	1.1	1.5	7.1	0.7	0.5	6.0	1.1	0.9	10.4	0.7	1.5	1.0	1.0	0.8	1.3	1.2	2.6	15.2	0.8	0.6	1.2	0.7	0.0	0.8	6.8	0.7	0.9	5.9	0.5	1.7	0.8	0.8	2.9	5.9	2.0	0.7	8.3	3.6	32.4	0.5	83.9	0.6	6.6	20.4	2.1	2.6	1.9	0.5	0.7	0.1	1.3	9.0	2.3	43.1	45.0	37.2	20.2	1.1	2.6	20.9	24.7	16.3	38.7	28.9	39.3	28.5	21.6	12.9	16.6	24.8	50.7	20.3	46.6	30.7	28.6	27.4	35.5	53.7	0.3	31.6	30.1	1.0	1.1	27.4	28.3	28.3	42.6	29.8	29.8	39.4	29.7	31.6	42.5	22.9	46.5	25.3	34.3	11.0	9.4	21.0	14.6	28.2	19.8	12.8	25.2	19.5	14.3	18.4	23.6	18.0	42.1	21.2	33.0	37.4	15.6	27.5	30.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.4	0.5	0.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	9.0	2.3	1.1	1.5	2.1	1.1	1.0	0.8	0.8	0.6	0.7	0.5
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: "	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.6	5.5	20.7	10.6	0.7	2.0	9.4	11.4	8.1	15.2	15.8	7.7	12.0	15.7	4.2	6.3	7.7	14.6	9.1	23.5	12.2	6.0	14.2	8.8	7.2	0.2	20.0	16.9	0.6	0.9	13.9	6.4	11.7	16.5	21.0	12.8	8.1	30.8	9.0	9.6	6.3	16.1	14.5	5.4	5.0	7.4	11.5	9.4	7.2	6.6	3.5	5.3	8.7	5.0	12.0	11.6	8.1	14.2	10.9	11.9	22.4	6.1	15.3	13.2	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0
PLXNC1	"CD232, VESPR"	ENSG00000136040	"Plexin C1"	O60486	12	94148723-94307675	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.5;retina: 40.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.9;SK-MEL-30: 18.5;U-266/70: 29.4;U-266/84: 30.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 24.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.2;monocytes: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026155, HPA066899"	Uncertain		Approved	Mitochondria		82000	82000	Mitochondria	Mitochondria	"CAB026155: , HPA066899: AB_2685743"	"unprognostic (1.49e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.33e-3)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.48e-2)"	6.6	7.5	7.1	16.1	6.9	12.6	3.9	16.8	8.6	8.0	5.1	3.1	0.8	3.1	7.3	2.2	4.9	4.3	8.3	4.1	6.3	15.2	3.2	2.0	15.2	43.5	4.5	7.7	13.0	2.3	0.5	6.3	7.5	5.2	4.3	5.4	40.6	3.7	3.7	2.9	6.6	5.0	5.7	4.9	28.6	3.4	12.1	3.3	8.6	3.3	2.7	10.2	9.6	6.5	2.4	2.5	14.2	6.7	0.9	1.7	1.5	0.4	0.2	1.2	0.2	0.7	0.5	0.1	0.6	0.8	0.8	2.3	4.0	0.0	9.5	0.0	0.9	0.0	14.9	0.6	0.5	6.6	0.3	0.5	0.2	2.7	8.3	1.9	3.3	8.2	0.0	0.9	0.4	0.0	0.2	11.7	0.2	0.1	0.4	1.0	2.5	0.5	1.5	0.4	5.2	0.0	0.7	1.0	0.7	0.1	0.1	18.5	0.0	1.6	0.3	0.2	1.1	0.1	0.3	29.4	30.6	0.6	0.1	5.2	0.6	0.0	3.0	12.2	1.4	5.2	1.6	2.4	1.6	1.7	2.5	1.4	1.4	1.5	14.2	0.9	6.7	0.9	1.0	1.5	7.1	6.9	16.8	8.6	6.3	15.2	4.5	7.7	5.2	3.3
PNOC	"N/OFQ, NOP, PPNOC"	ENSG00000168081	Prepronociceptin	Q13519	8	28316986-28343355	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 47.9;brain: 22.6;lymphoid tissue: 18.1"	"Group enriched"	"Detected in some"	6	"Daudi: 24.0;Karpas-707: 18.9;RPMI-8226: 7.0;U-698: 14.5"	"Cancer enriched"	"Detected in many"	8	"ovarian cancer: 32.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory B-cell: 46.6;naive B-cell: 47.9;plasmacytoid DC: 33.7"	"Group enriched"	"Detected in many"	17	"B-cells: 47.9;dendritic cells: 33.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044507, HPA056724"	Enhanced				"Secreted to blood"					"HPA044507: AB_10795043, HPA056724: AB_2683216"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (2.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.57e-9)"	"unprognostic (2.19e-2)"	"unprognostic (5.45e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-1)"	0.4	0.6	4.0	7.2	7.4	2.0	0.5	0.9	22.6	0.3	2.3	1.0	0.0	3.3	0.2	0.0	1.2	13.5	0.9	0.3	3.1	8.4	1.2	0.4	0.9	18.1	5.9	3.2	2.2	0.2	0.1	0.2	0.0	7.5	0.3	1.3	0.0	2.5	0.1	0.2	0.2	6.5	0.4	4.3	16.9	2.4	0.7	0.0	0.6	0.6	0.0	18.1	5.2	0.4	47.9	33.7	0.4	2.4	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.6	2.6	14.5	0.1	0.1	0.0	0.0	2.4	0.4	0.0	1.5	0.0	46.6	0.0	0.0	0.2	47.9	0.0	0.0	0.2	0.2	0.6	33.7	0.1	2.4	4.0	7.4	0.9	15.7	3.1	8.4	5.9	3.2	7.5	0.0
POC1A	"DKFZP434C245, WDR51A"	ENSG00000164087	"POC1 centriolar protein A"	Q8NBT0	3	52075253-52154690	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.7;testis: 34.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040600	Approved									"HPA040600: AB_10672837"	"unprognostic (2.68e-1)"	"unprognostic (7.17e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (5.08e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavourable (9.43e-7)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.32e-2)"	2.2	4.6	1.3	5.5	1.6	9.2	1.8	1.0	2.2	1.3	5.5	1.5	1.5	4.4	1.0	2.8	5.0	1.4	2.8	1.7	1.8	1.4	1.8	5.2	2.2	4.6	1.5	0.6	1.1	0.9	0.5	0.7	5.9	1.3	1.4	5.9	0.9	1.5	1.5	1.5	2.2	3.5	2.5	1.4	3.1	2.7	34.3	1.1	19.7	1.1	5.5	6.9	1.8	1.8	2.2	3.9	1.1	4.5	2.8	5.5	2.2	13.5	11.6	11.8	15.6	2.4	3.2	16.0	13.8	13.4	29.8	23.3	10.2	14.4	14.2	4.1	10.9	8.5	17.7	15.7	21.8	11.7	7.4	9.7	12.3	10.8	0.6	11.0	6.1	1.7	3.4	23.4	12.4	13.5	8.4	15.5	17.6	10.8	20.2	20.0	8.9	19.2	8.8	9.3	13.6	6.7	9.6	5.5	7.9	11.1	11.0	8.4	13.6	20.8	4.4	13.6	13.3	21.8	22.3	13.2	21.5	12.0	9.1	19.3	13.6	0.0	3.4	0.0	2.8	4.5	0.3	2.2	2.0	0.9	3.9	1.1	1.6	1.1	1.1	2.8	3.2	3.9	5.5	2.2	1.3	1.6	1.0	2.2	1.8	1.4	1.5	0.6	1.3	1.1
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.6;lymphoid tissue: 17.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	3.3	2.2	1.5	11.6	2.8	17.6	3.4	1.7	1.6	4.4	4.2	1.1	1.5	2.6	2.8	3.5	9.0	2.4	2.3	1.6	1.0	1.2	2.5	5.1	2.2	5.3	1.1	0.3	2.7	5.0	1.4	2.5	4.1	1.4	2.1	5.2	2.6	2.6	0.7	1.1	3.7	7.7	2.9	2.7	5.4	3.0	5.3	2.4	17.6	1.6	10.3	8.4	2.1	4.2	1.2	0.9	0.7	0.0	3.2	2.7	0.5	17.1	8.8	16.7	7.7	0.8	4.9	8.5	9.8	5.0	15.6	18.1	8.8	13.5	10.7	5.6	5.5	10.6	16.7	6.0	18.5	12.5	9.2	15.9	9.7	10.9	0.4	18.9	6.9	1.4	0.4	8.5	1.4	9.0	13.9	6.9	15.6	15.0	19.2	12.4	9.8	20.6	16.4	15.4	9.7	5.6	9.7	12.0	6.9	9.9	5.8	3.1	11.7	6.7	3.2	2.5	18.6	10.4	7.7	5.0	10.2	24.7	4.7	14.0	10.0	0.0	0.0	0.7	0.9	0.0	0.7	1.2	0.9	1.7	0.6	1.2	0.1	0.8	0.0	3.2	0.0	0.9	2.7	0.5	1.5	2.8	1.7	1.6	1.0	1.2	1.1	0.3	1.4	2.4
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	"HPA048931, HPA053359"			Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA048931: , HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favourable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.3	9.1	7.8	5.5	0.7	0.9	7.1	6.3	2.4	7.5	10.1	7.2	5.0	15.9	2.9	3.4	10.6	9.2	4.1	12.8	4.6	5.0	10.2	5.6	4.5	0.0	11.0	9.3	0.1	0.3	6.8	4.2	3.7	6.7	12.1	7.8	5.2	9.9	6.4	7.4	4.4	8.4	9.4	5.6	2.4	7.7	4.3	3.8	7.3	4.0	2.6	3.7	10.9	2.8	6.6	8.7	2.6	8.2	6.1	4.9	16.5	3.2	8.2	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6
POU2AF1	"BOB1, OBF1"	ENSG00000110777	"POU class 2 associating factor 1"	Q16633	11	111352252-111455630	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.2;lymphoid tissue: 84.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 45.4;Karpas-707: 52.0;U-266/70: 50.7;U-266/84: 22.8;U-698: 93.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"memory B-cell: 19.9;naive B-cell: 14.2"	"Lineage enriched"	"Detected in many"	13	"B-cells: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011193	Enhanced									"CAB011193: AB_532299"	"prognostic favourable (1.68e-4)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.04e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.88e-1)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (3.63e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.81e-2)"	"unprognostic (8.51e-8)"	"unprognostic (2.35e-1)"	"unprognostic (3.90e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.23e-1)"	0.9	0.5	0.6	62.7	0.7	2.0	1.4	0.4	0.6	1.9	7.8	1.8	0.0	6.7	0.7	0.3	8.7	1.1	1.4	0.5	0.8	0.7	2.1	1.0	2.6	42.6	1.0	0.5	1.2	0.5	0.0	0.4	0.5	1.2	1.3	4.1	1.2	8.4	0.9	0.4	0.4	21.2	0.0	1.4	74.2	12.2	1.0	0.9	5.0	1.7	1.4	84.0	5.0	1.4	19.9	0.1	1.5	0.2	0.3	0.7	0.6	0.1	0.1	0.0	0.0	0.8	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	45.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.7	52.0	0.0	0.1	0.2	0.2	0.0	0.0	9.7	0.1	12.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.4	0.0	0.0	50.7	22.8	93.3	0.0	0.1	0.0	1.5	0.1	0.3	0.1	0.1	0.1	19.9	0.2	0.1	0.0	14.2	0.2	0.1	0.9	0.3	0.2	0.1	0.7	0.6	0.6	0.7	0.4	0.6	0.8	0.7	1.0	0.5	1.2	0.9
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73987038-73988197	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.0;HEL: 11.7;RPTEC TERT1: 2.7"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"basophil: 30.0;neutrophil: 18.4"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 30.0"					"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	3500000000	3500000000			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.4	0.6	0.4	0.6	1.7	67.0	0.6	0.2	0.4	0.5	0.2	0.1	0.0	0.1	0.3	0.5	0.5	0.8	0.9	35.7	0.3	0.3	0.5	1.9	13.3	0.1	1.6	0.0	6.0	0.4	0.1	0.5	8.7	1.3	0.6	0.2	0.4	0.5	0.1	1.0	0.3	0.2	0.2	1.3	60.0	0.3	0.5	0.0	0.0	2.2	0.9	0.1	1.7	11.0	0.3	2.6	30.0	1.8	0.2	0.5	206.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	30.0	1.8	1.1	0.2	0.6	0.3	0.1	0.1	0.0	1.0	0.3	0.5	0.1	18.4	0.2	0.5	2.6	0.2	206.7	0.4	1.7	0.2	0.4	0.3	0.3	1.6	0.0	1.3	0.0
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.6;HaCaT: 55.8;MCF7: 20.4;SiHa: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		310000	310000	"Plasma membrane"	"Plasma membrane"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	10.8	0.7	2.2	1.4	0.7	0.2	6.8	0.6	3.0	23.5	2.9	0.2	4.1	1.7	2.6	5.1	126.9	2.9	5.8	1.8	1.8	0.2	3.0	3.3	4.7	0.2	0.0	0.9	1.7	2.8	1.6	2.8	2.9	0.5	4.6	1.0	0.7	24.3	3.3	3.2	30.7	2.0	5.0	0.0	0.2	2.1	1.5	0.0	0.5	7.2	57.8	60.9	5.0	39.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.8	2.5	0.0	0.0	18.3	26.6	8.8	0.0	0.4	0.0	0.1	11.3	17.4	0.1	4.0	0.3	55.8	0.3	6.7	0.0	0.0	0.3	0.0	13.5	2.0	1.1	0.0	0.0	1.3	6.2	0.0	2.1	0.0	0.0	0.0	0.0	20.4	0.0	0.0	1.7	5.3	0.0	0.0	8.6	13.3	10.9	9.2	0.1	29.9	10.0	0.1	5.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.6	3.0	1.8	0.2	0.0	0.9	0.5	0.0
PPP1R16B	"ANKRD4, KIAA0823, TIMAP"	ENSG00000101445	"Protein phosphatase 1 regulatory subunit 16B"	Q96T49	20	38805705-38923024	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.4;lymphoid tissue: 35.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 22.2;HMC-1: 24.0;HUVEC TERT2: 14.1;U-266/70: 39.0;U-266/84: 15.6;U-698: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049571			Supported	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA049571: "	"unprognostic (2.62e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (2.67e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (7.87e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.90e-2)"	11.2	3.2	26.3	15.9	44.4	13.0	4.4	19.7	35.1	3.6	4.5	25.6	0.0	3.6	3.5	1.9	3.3	5.8	5.3	4.9	25.5	9.1	24.4	2.6	7.3	30.1	15.0	18.8	1.6	1.5	1.2	1.8	3.7	10.9	2.1	5.1	1.6	2.3	2.3	3.4	1.8	9.2	6.8	18.6	14.4	4.9	1.2	15.1	5.1	3.2	0.5	35.0	7.5	3.7	8.4	4.9	3.5	1.3	3.9	5.2	1.6	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	1.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	14.1	0.3	4.7	0.0	0.0	2.8	3.7	3.1	0.0	1.9	0.0	0.0	0.0	0.0	7.1	8.0	0.0	0.0	0.0	0.0	1.2	2.1	0.0	0.3	0.0	0.0	39.0	15.6	15.3	0.0	0.0	0.0	0.0	0.3	3.5	5.2	0.7	2.8	8.4	3.7	5.1	1.1	5.4	2.2	3.0	0.0	3.9	1.3	4.9	3.7	1.6	26.3	44.4	19.7	35.1	25.5	9.1	15.0	18.8	10.9	15.1
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966038-90995629	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 18.9;T-reg: 5.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 18.9;T-cells: 5.8"	"Low region specificity"	"Detected in single"							"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"				"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	3.2	2.8	3.5	13.0	3.8	43.3	3.6	12.5	5.8	3.4	9.3	1.6	0.2	6.1	3.5	4.7	15.0	2.6	2.8	3.5	5.1	4.9	2.3	1.9	5.8	9.2	3.4	4.7	3.6	3.8	1.6	1.5	10.4	5.2	2.4	9.9	2.7	3.9	1.0	2.5	9.9	6.6	5.4	3.5	5.8	5.0	44.3	0.8	44.5	1.8	15.3	16.5	3.5	4.9	0.9	2.0	18.9	0.4	2.0	5.8	0.7	32.4	39.7	33.2	22.6	3.5	6.0	17.8	46.8	27.7	51.9	39.7	26.5	31.7	12.4	18.6	29.8	44.3	37.8	20.0	49.1	22.9	41.9	25.6	51.9	24.3	0.8	12.6	22.2	1.5	2.6	29.4	30.2	29.0	21.3	26.6	48.2	28.2	12.9	19.3	13.0	17.0	13.6	41.5	16.6	23.1	24.7	30.3	24.0	44.5	24.8	16.1	29.7	25.0	17.3	34.3	30.3	28.3	67.4	8.6	22.8	15.3	15.0	31.4	52.3	18.9	0.4	2.0	0.5	0.0	0.3	0.9	1.0	1.0	1.8	0.4	0.9	0.4	0.2	2.0	0.2	2.0	5.8	0.7	3.5	3.8	12.5	5.8	5.1	4.9	3.4	4.7	5.2	0.8
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	106086320-106109939	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 66.9;RPMI-8226: 12.5;U-266/70: 25.1;U-266/84: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.6;gdTCR: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;T-cells: 19.3"	"Region enriched"	"Detected in single"	6	"olfactory region: 4.4"	"Low region specificity"	"Detected in all"			HPA030033	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA030033: AB_10601050"	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	11.6	1.5	1.6	26.3	3.2	10.4	7.0	5.3	1.6	14.0	16.5	1.9	1.4	5.4	11.6	2.2	33.4	3.8	8.1	2.3	1.9	2.0	3.1	2.4	18.8	33.3	2.1	0.5	4.2	1.8	1.2	2.1	9.0	4.9	3.6	11.0	4.3	10.6	3.0	2.0	8.9	18.2	3.4	7.4	24.2	8.6	3.0	1.5	3.1	7.7	35.7	49.9	12.8	18.0	1.5	0.2	6.8	0.6	2.5	19.3	1.3	0.4	0.1	0.3	0.0	0.5	0.6	0.0	2.3	7.0	0.7	1.3	0.4	2.7	0.5	0.1	4.5	0.1	0.0	1.0	0.8	6.3	0.0	0.1	1.4	0.0	1.1	0.2	0.5	0.7	3.5	1.0	3.0	0.8	0.4	66.9	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	12.5	0.6	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.7	0.4	1.1	0.6	0.6	2.1	25.1	16.2	1.4	1.5	0.4	0.6	1.2	0.4	5.6	12.6	0.6	19.3	1.5	12.0	11.6	0.2	0.5	1.1	6.8	6.8	2.5	0.1	0.2	15.4	1.3	1.6	3.2	5.3	1.6	1.9	2.0	2.1	0.5	4.9	1.5
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602775	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 100.3;lymphoid tissue: 38.7"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdTCR: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1"	"Group enriched"	"Detected in many"	48	"NK-cells: 65.1;T-cells: 100.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	960000	960000	Cytosol	Cytosol	"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favourable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	8.8	1.3	0.9	5.5	1.1	15.3	2.4	0.5	0.7	1.7	3.8	0.4	0.2	1.4	4.4	2.9	2.7	1.7	5.3	4.1	0.8	0.9	1.8	6.5	19.6	11.3	2.5	0.3	2.1	1.6	0.0	1.1	3.1	1.2	3.3	0.8	3.9	2.5	3.3	2.6	0.9	5.1	1.2	1.4	38.7	3.1	1.6	0.2	12.7	2.8	1.0	10.3	3.2	1.7	0.4	0.3	1.7	0.2	65.1	100.3	46.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.4	0.0	2.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	100.3	0.1	70.9	0.4	14.6	54.9	0.2	0.2	6.2	36.1	1.7	65.1	0.2	0.3	11.1	46.7	0.9	1.1	0.5	0.7	0.8	0.9	2.5	0.3	1.2	0.2
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646849	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.7;prostate: 22.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (3.00e-5)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavourable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	5.4	1.6	1.7	9.0	2.3	7.8	4.1	6.5	3.3	5.3	3.9	2.5	2.4	3.0	9.7	3.7	5.6	3.7	2.7	3.1	2.8		3.5	2.7	2.7	7.1	3.6	1.5	4.3	2.2	2.4	5.4	5.9	1.7	22.6	5.0	3.5	7.3	3.4	1.1	3.4	3.7	5.8	3.6	6.7	2.4	5.3	3.1	21.7	4.6	4.5	8.7	4.7	2.7	5.0	7.3	2.5	5.4	5.6	7.9	2.7	15.1	6.2	12.4	14.3	7.1	12.5	10.3	18.7	18.3	20.9	28.1	9.8	7.3	13.9	10.4	23.3	10.3	11.1	10.7	25.9	15.1	9.0	16.4	8.5	16.4	2.9	15.8	10.4	4.7	4.0	23.0	8.1	9.4	15.5	36.9	17.4	9.6	16.5	12.5	7.8	6.1	12.6	17.1	11.0	7.6	7.9	9.2	6.9	12.1	5.8	7.6	12.4	13.7	6.5	21.3	21.0	39.0	15.8	5.0	9.6	16.1	9.7	16.7	11.4	0.3	2.4	2.5	5.5	5.1	6.2	5.0	5.0	7.5	4.1	4.9	3.6	7.9	1.0	5.6	5.4	7.3	5.9	2.7										
PRKCB	"PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835946-24220611	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in some"		"HEL: 40.8;HMC-1: 40.9;K-562: 58.1;THP-1: 18.4;U-937: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		3400000	3400000	Nucleoplasm	Nucleoplasm	"CAB003843: AB_562197, HPA048321: , HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.0	1.9	13.9	20.8	55.6	20.4	1.8	14.1	57.2	4.1	4.7	4.4	0.6	4.9	3.5	1.2	3.2	2.6	3.9	1.5	23.4	7.8	1.8	3.7	5.4	31.0	11.0	20.4	1.2	1.4	0.9	1.4	2.5	8.3	6.2	4.4	3.5	1.9	8.4	1.2	4.6	9.1	5.8	7.3	31.2	3.8	6.4	6.4	24.1	3.9	0.0	27.7	7.6	1.7	23.6	18.5	21.8	14.6	20.1	19.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.8	40.8	1.9	0.0	0.0	5.9	40.9	0.0	0.1	0.0	0.0	0.0	58.1	0.1	0.0	0.0	12.9	12.9	0.3	0.0	12.3	0.1	2.3	0.1	3.6	7.1	0.0	0.0	0.0	0.6	0.0	18.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	16.4	0.0	17.5	7.6	14.4	14.5	10.7	6.7	23.6	9.5	17.2	6.2	22.1	7.8	19.0	21.8	20.1	14.6	18.5	6.7	7.5	13.9	55.6	14.1	57.2	23.4	7.8	11.0	20.4	8.3	6.4
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155499-59204705	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (1.35e-7)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	3.2	1.4	2.8	13.8	4.2	14.9	2.0	0.9	2.8	3.1	4.2	2.2	0.7	6.9	2.0	2.1	10.3	1.7	2.1	1.4	3.1	2.3	1.7	1.1	3.4	9.6	3.2	1.6	1.7	1.0	0.2	0.6	4.8	2.0	1.2	5.5	1.2	2.2	0.5	1.3	2.9	4.8	3.2	5.1	7.3	2.5	2.5	2.1	40.8	1.3	7.7	11.7	2.8	3.2	1.4	3.0	2.5	10.6	0.7	2.0	0.8	27.1	13.1	20.6	6.0	0.6	4.8	8.4	16.9	10.7	17.6	14.0	16.1	18.4	17.6	17.3	12.4	10.0	15.8	17.4	38.6	24.4	10.1	19.3	14.5	10.8	0.2	20.4	8.2	1.1	1.3	19.4	25.8	19.8	10.5	19.2	18.8	21.1	20.0	3.6	8.6	22.1	16.1	31.0	11.3	4.8	7.3	9.0	12.4	14.0	5.1	7.3	13.7	7.9	13.4	36.1	42.3	18.1	30.1	12.4	23.8	17.7	8.0	11.4	35.3	1.0	2.3	2.5	0.8	5.1	0.3	1.4	0.6	1.0	3.0	0.9	0.6	0.8	2.3	0.7	10.6	1.6	2.0	0.8	2.8	4.2	0.9	2.8	3.1	2.3	3.2	1.6	2.0	2.1
PRR5-ARHGAP8		ENSG00000248405	"PRR5-ARHGAP8 readthrough"		22	44702233-44862706	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.5;placenta: 17.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;CACO-2: 3.2;HEK 293: 5.3;MCF7: 3.5;U-266/70: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"																				"unprognostic (1.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.28e-8)"	"unprognostic (8.64e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.45e-1)"	1.5	0.5	0.8	2.0	0.8	0.9	3.9	0.6	0.9	4.8	3.1	0.0	1.4	2.3	2.6	7.7	3.7	2.8	2.5	0.5	0.7	0.8	5.7	0.9	1.9	10.6	0.6	0.0	2.6	3.1	3.6	4.2	17.9	0.6	3.4	1.5	4.0	4.9	4.1	0.5	1.6	4.9	0.7	0.6	17.5	1.6	4.3	0.2	3.8	5.6	4.3	7.5	1.8	6.2	0.0	0.0	0.0	0.1	0.0	2.4	0.0	2.1	0.0	0.0	0.1	0.0	0.0	4.9	0.0	2.1	0.0	0.0	3.2	0.5	0.0	0.2	0.0	1.1	0.7	2.3	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	1.8	0.0	0.0	0.0	0.8	0.2	1.2	0.4	0.0	0.0	1.4	0.0	2.0	0.0	0.0	0.0	0.6	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4	0.0	0.8	0.8	0.6	0.7	0.7	0.8	0.6	0.0	0.6	0.2
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.3;HMC-1: 27.1;hTERT-HME1: 28.2;SiHa: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"				"Cytokinetic bridge, Cytosol"	"Cytokinetic bridge, Cytosol"	"HPA070174: AB_2686231"	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favourable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (7.71e-8)"	"prognostic unfavourable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	2.9	1.5	4.2	8.1	15.5	3.1	2.4	1.7	9.5	9.5	25.7	34.1	1.1	2.5	2.6	1.6	1.4	4.9	5.3	1.6	7.2	5.1	3.8	2.3	10.4	6.2	24.9	3.8	11.4	2.0	1.0	2.7	2.8	16.6	2.3	21.4	3.3	6.3	1.6	0.7	1.6	9.3	4.8	22.8	26.1	2.6	1.2	19.7	1.1	3.0	0.2	2.6	3.6	3.6	1.1	4.2	16.9	12.3	4.6	20.1	7.2	0.0	2.8	4.9	0.1	0.7	0.0	0.0	5.9	4.6	12.6	13.0	0.0	0.0	0.0	1.9	7.3	0.2	0.9	3.0	6.1	2.3	1.7	0.6	16.3	0.0	1.6	0.0	27.1	2.0	4.3	1.2	28.2	5.2	0.0	0.0	6.4	1.5	0.3	0.0	0.3	1.1	1.7	0.5	0.5	12.8	3.0	0.0	0.2	18.6	0.0	1.1	0.0	0.2	3.6	10.7	3.3	0.0	7.4	0.1	0.0	0.0	4.6	0.6	3.2	16.9	1.1	13.3	20.1	11.8	4.6	0.0	7.2	16.8	1.3	1.1	1.6	10.8	6.5	4.6	12.3	4.2	0.0	7.2	4.2	15.5	1.7	9.5	7.2	5.1	24.9	3.8	16.6	19.7
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852727-2858170	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;MCF7: 12.4;RT4: 5.8;SK-BR-3: 13.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm	Nucleoplasm	"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.4	0.7	0.0	0.4	0.0	0.6	1.3	1.5	0.4	9.9	1.0	0.0	8.6	1.5	3.0	0.6	40.4	3.0	6.8	0.4	0.0	0.0	2.4	0.7	3.0	0.4	0.0	0.0	0.4	7.5	0.4	1.1	4.3	0.0	5.1	0.6	0.0	13.4	10.6	2.3	1.3	0.4	0.7	0.0	0.4	3.5	0.4	0.0	0.0	1.5	36.5	40.1	5.2	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	13.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712418-2720551	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;SK-BR-3: 21.8;T-47d: 12.8;U-266/70: 4.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"			Vesicles	Vesicles	"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	0.2	0.3	0.1	0.2	0.5	0.2	0.4	0.7	0.4	15.3	0.2	0.1	0.1	0.1	1.2	0.1	94.1	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.2	0.1	0.1	10.0	0.3	0.2	1.2	0.1	0.2	0.1	0.2	0.1	0.5	0.1	0.3	0.2	64.5	97.2	0.5	24.0	0.1	1.7	0.2	0.0	0.2	1.4	1.2	0.0	0.2	0.5	1.8	0.3	0.6	5.4	0.0	0.2	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.6	0.0	0.9	1.3	0.0	0.8	0.2	0.1	0.1	0.3	0.6	2.6	0.0	21.8	0.5	12.8	1.5	0.0	0.3	0.0	0.0	0.0	4.5	3.1	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	1.7	0.0	0.3	0.7	0.2	0.2	0.0	0.0	0.0	1.2	0.1	0.5	0.7	0.1	0.1	0.4	0.1	0.1	0.1	0.1
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome subunit beta 9"	P28065	6	32844136-32859585	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 69.1;lymphoid tissue: 54.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 29.1;REH: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		420000	420000	Cytosol	Cytosol	"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: "	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	13.3	9.7	5.0	30.0	7.9	10.7	11.6	1.6	5.3	7.6	16.5	6.0	3.4	15.7	8.8	7.1	10.8	7.4	10.8	8.9	5.1	4.7	12.2	12.2	17.7	32.7	7.3	3.7	9.2	5.4	1.2	4.5	5.5	6.3	12.5	5.8	7.7	9.0	3.5	6.2	7.6	36.1	5.7	9.8	54.9	11.2	3.0	6.7	35.4	14.4	9.3	35.2	15.9	8.8	31.8	17.2	69.1	30.5	23.4	31.1	45.7	0.0	1.4	0.0	0.1	1.1	2.9	2.0	0.2	3.2	4.2	9.7	0.0	9.1	29.1	0.4	2.6	5.9	0.4	6.2	0.5	16.4	0.0	17.7	0.5	1.1	15.7	3.1	1.3	1.3	0.2	2.6	0.4	1.5	0.7	5.4	1.4	0.4	13.4	4.1	0.0	0.9	21.5	0.0	6.9	2.8	0.5	0.0	0.0	2.7	1.7	1.9	2.3	6.5	1.5	4.5	0.4	8.5	2.5	10.1	15.3	9.3	4.6	11.8	3.8	21.9	22.4	39.3	28.7	30.5	23.8	31.8	23.3	27.5	17.2	23.4	17.5	22.9	69.1	23.4	29.4	12.7	31.1	45.7	5.0	7.9	1.6	5.3	5.1	4.7	7.3	3.7	6.3	6.7
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137536-31139350	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;skin 1: 58.0;tongue: 35.9"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;HaCaT: 1.6;SiHa: 1.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061228	Enhanced				"Secreted in other tissues"					"HPA061228: AB_2684455"	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	58.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	13.8	0.0	35.9	0.7	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037332	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.2;bone marrow: 41.0;lymphoid tissue: 29.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.9;HL-60: 6.8;NB-4: 11.5;THP-1: 7.8;U-937: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA010600	Enhanced									"HPA010600: AB_1855870"	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favourable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavourable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	1.9	1.7	29.3	1.7	41.0	2.7	0.4	0.9	2.4	3.8	0.6	0.1	2.0	3.6	4.1	3.3	2.2	7.2	3.8	2.0	1.4	2.8	2.2	10.6	28.1	1.8	0.0	1.8	1.2	0.4	1.1	2.3	1.0	2.5	0.9	2.1	7.6	2.6	2.3	1.2	6.6	1.9	2.4	24.5	2.5	2.3	0.9	15.7	2.1	2.4	18.6	2.8	2.0	6.4	23.0	34.2	27.9	15.4	17.3	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	28.9	0.0	0.0	0.0	1.7	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	11.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	31.2	0.0	1.8	27.9	26.7	17.3	12.7	13.3	5.5	11.6	14.2	23.0	6.4	6.4	9.9	34.2	15.4	13.0	1.9	10.3	14.8	1.7	1.7	0.4	0.9	2.0	1.4	1.8	0.0	1.0	0.9
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7"	"Cell line enhanced"	"Detected in many"		"HEL: 37.1;HMC-1: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 38.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		7100000	7100000	"Plasma membrane, Mitochondria"	"Plasma membrane, Mitochondria"	"HPA040923: , HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.6	3.3	1.8	6.1	3.1	36.9	4.9	0.6	2.1	3.4	3.4	0.9	2.7	2.0	2.7	2.8	4.4	2.9	4.4	4.0	4.5	1.2	3.3	8.6	7.4	11.5	3.4	0.4	3.1	3.9	2.2	3.9	11.6	3.5	5.8	3.0	3.5	4.5	8.8	16.6	5.9	3.1	4.1	4.6	46.7	4.3	1.9	3.2	3.0	1.8	6.5	5.6	4.6	3.0	0.0	8.9	38.1	12.4	0.9	3.9	6.3	1.0	0.0	1.4	0.0	0.3	2.6	7.8	5.5	2.7	2.0	1.7	4.2	1.5	0.0	0.3	1.8	13.5	7.6	10.4	2.5	0.0	1.2	37.1	1.8	0.0	2.2	2.1	41.2	1.9	13.0	1.9	6.2	3.9	8.8	0.0	8.6	1.3	0.3	0.0	0.8	0.0	0.0	2.8	1.8	4.2	13.6	0.1	0.8	0.9	3.8	0.1	12.2	4.3	2.8	0.2	3.1	0.3	0.0	0.0	0.1	0.0	0.5	0.0	0.1	20.7	9.0	38.1	3.9	12.4	1.3	0.0	2.3	2.8	8.9	0.0	2.8	3.3	4.9	0.9	11.9	0.3	1.4	6.3	1.8	3.1	0.6	2.1	4.5	1.2	3.4	0.4	3.5	3.2
PTGDR2	"CD294, CRTH2, DP2, GPR44"	ENSG00000183134	"Prostaglandin D2 receptor 2"	Q9Y5Y4	11	60850940-60855971	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;lymphoid tissue: 28.1"	"Cell line enhanced"	"Detected in some"		"HEL: 10.3;Hep G2: 5.0;HMC-1: 6.5;K-562: 4.2;NB-4: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 35.1;eosinophil: 51.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014259	Uncertain									"HPA014259: "	"unprognostic (9.77e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.30e-4)"	"unprognostic (2.61e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.99e-2)"	1.2	0.3	3.9	2.3	8.0	0.4	2.8	2.3	8.2	1.7	10.7	4.0	0.3	7.5	0.9	0.6	1.4	1.5	1.6	5.1	4.3	2.8	0.5	0.7	1.4	1.9	4.9	5.9	0.5	1.1	5.9	0.6	1.9	5.7	0.9	7.4	0.6	0.5	0.5	11.3	1.0	10.8	0.9	2.2	1.1	13.3	0.5	0.8	28.1	0.4	5.6	0.6	1.1	0.4	0.0	1.2	51.8	7.8	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	10.3	0.0	5.0	1.2	0.0	6.5	2.2	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.1	3.3	14.8	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.1	0.0	51.8	0.0	2.5	0.0	0.0	0.3	0.2	1.2	0.0	0.0	0.0	0.1	0.0	7.8	0.2	0.3	0.4	3.9	8.0	2.3	8.2	4.3	2.8	4.9	5.9	5.7	0.8
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 13.6;lymphoid tissue: 14.2"	"Cell line enhanced"	"Detected in some"		"HEL: 5.2;NB-4: 2.8;PC-3: 7.1;SH-SY5Y: 4.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.5;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.7	1.4	1.1	2.7	1.3	0.2	1.5	0.6	1.2	1.3	1.5	0.1	0.0	1.2	0.4	0.3	1.7	1.0	0.4	3.1	0.4	0.4	13.6	0.5	4.9	6.7	1.8	0.0	1.6	1.8	0.2	1.4	0.3	1.0	0.5	0.3	0.3	0.3	0.4	0.7	0.2	1.9	1.4	0.1	14.2	3.2	0.4	0.6	0.0	0.7	0.0	0.3	0.6	1.3	0.0	0.4	0.0	1.5	2.6	1.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	5.2	0.0	0.3	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.3	7.1	0.8	0.0	0.2	0.0	0.1	0.5	4.1	0.1	0.1	0.1	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.2	1.1	1.3	0.6	1.2	0.4	0.4	1.8	0.0	1.0	0.6
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.9;HL-60: 13.0;U-266/70: 14.2;U-698: 17.6;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	Nucleoplasm	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	32.9	0.0	0.1	0.0	0.0	0.0	0.2	3.1	0.0	4.6	0.0	0.0	0.1	13.0	10.3	2.9	0.0	1.4	0.1	5.1	0.0	7.5	5.0	0.1	9.2	7.4	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	2.3	7.8	0.1	0.1	0.2	14.2	3.0	17.6	5.4	13.4	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Cell line enhanced"	"Detected in many"		"HEL: 28.1;HL-60: 24.9;HMC-1: 110.1;THP-1: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		7400000	7400000	Nucleoplasm	Nucleoplasm	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favourable (1.87e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic favourable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favourable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.8	5.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.9	6.4	2.0	1.5	0.0	3.3	0.0	3.8	0.0	1.2	1.1	28.1	0.6	2.4	0.0	24.9	110.1	0.0	2.8	0.0	1.2	0.0	0.0	0.2	0.0	6.0	9.0	14.6	1.5	0.9	8.2	0.0	14.2	3.0	5.4	0.5	0.0	0.9	4.5	0.0	1.4	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.9	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Cell line enhanced"	"Detected in some"		"HEL: 16.4;HL-60: 35.6;HMC-1: 48.1;NB-4: 15.5;THP-1: 16.4;U-937: 25.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved									"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	16.4	0.0	0.0	0.0	35.6	48.1	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	4.8	15.5	0.0	0.0	0.7	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.4	0.0	0.0	0.1	0.0	0.0	7.2	1.8	10.3	0.0	25.7	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960435-37961125	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;MOLT-4: 3.0;U-698: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4;T-reg: 1.0"	"Low lineage specificity"	"Detected in many"											"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Cytosol	"HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	1.0	0.4	0.9	5.2	1.2	5.0	0.5	2.2	2.4	1.1	3.9	0.2	0.0	0.0	1.6	2.2	3.3	1.8	1.5	2.5	1.0	0.4	0.7	0.5	0.9	1.0	0.7	0.4	1.2	1.0	1.4	0.4	1.8	0.3	0.8	0.7	0.0	0.2	1.4	1.9	0.6	3.1	2.0	0.9	2.3	1.0	5.3	0.0	15.8	1.3	7.5	7.3	1.8	0.7	0.4	0.0	1.4	0.4	0.0	1.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.7	0.5	0.9	0.0	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	0.9	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	1.4	0.0	0.0	0.0	1.0	0.1	0.9	1.2	2.2	2.4	1.0	0.4	0.7	0.4	0.3	0.0
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977054	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.4;lymphoid tissue: 23.3"	"Cell line enriched"	"Detected in some"	6	"U-698: 32.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdTCR: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.4;T-cells: 33.4"									HPA051224	Enhanced									"HPA051224: AB_2681394"	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	4.0	0.6	0.5	20.1	0.5	3.9	2.1	0.4	0.4	2.0	2.7	0.2	0.3	1.2	2.2	1.4	1.7	1.6	3.2	1.2	0.6	0.5	1.8	2.6	11.7	18.8	0.7	0.0	1.6	0.8	0.0	0.8	1.7	0.4	2.6	1.8	1.2	3.4	1.2	0.7	0.9	7.8	0.4	1.3	20.7	2.0	1.0	0.0	6.6	2.5	1.9	23.3	5.7	1.6	4.9	0.1	1.2	0.1	11.4	33.4	6.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.6	0.0	32.3	0.0	5.0	0.0	0.4	0.1	0.1	33.4	0.1	19.1	4.9	14.2	25.2	0.1	2.4	4.8	16.0	1.2	11.4	0.1	0.1	21.0	6.0	0.5	0.5	0.4	0.4	0.6	0.5	0.7	0.0	0.4	0.0
RAB42	MGC45806	ENSG00000188060	"RAB42, member RAS oncogene family"	Q8N4Z0	1	28592200-28595443	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.4;Hep G2: 15.2;HSkMC: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA050290			Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA050290: AB_2681075"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.00e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.07e-3)"	4.3	1.2	0.8	1.8	1.6	0.4	3.2	0.8	1.6	3.7	2.3	0.8	0.8	1.8	3.1	4.1	1.5	1.4	2.4	1.3	1.6	0.5	1.5	3.2	3.4	14.3	1.2	0.8	1.4	0.8	5.0	0.8	6.2	1.2	3.3	2.5	1.7	4.2	0.8	1.5	0.9	2.3	1.8	5.5	5.9	1.6	3.0	0.8	3.4	1.0	0.8	4.4	4.1	1.8	0.7	0.7	1.2	0.9	2.4	0.5	0.1	0.1	1.2	1.0	0.0	4.5	10.4	0.0	0.7	4.3	4.6	5.9	2.2	1.5	0.2	2.9	5.0	0.1	4.5	0.0	2.9	0.1	0.1	0.4	7.0	15.2	1.8	1.2	0.0	10.8	0.2	2.7	0.0	1.4	0.2	0.1	0.9	0.0	0.2	2.3	5.3	0.0	8.4	0.0	1.8	1.8	0.0	0.3	2.0	4.2	0.1	0.0	0.1	1.9	0.7	0.0	1.4	4.5	0.1	0.4	2.7	0.2	0.2	4.4	0.1	1.2	0.9	0.2	0.3	0.4	0.3	0.6	0.2	0.2	0.7	0.7	0.5	0.4	0.9	2.4	0.8	0.4	0.1	0.1	0.8	1.6	0.8	1.6	1.6	0.5	1.2	0.8	1.2	0.8
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB025859: , HPA039427: AB_2676503, HPA043912: "	"prognostic unfavourable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavourable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	3.7	2.6	4.9	10.0	11.3	21.0	4.2	6.3	7.8	4.2	10.1	4.7	1.5	6.5	3.3	1.9	17.7	2.7	4.0	2.7	4.8	4.5	5.9	2.8	5.6	13.7	7.8	5.0	2.5	2.0	3.3	1.4	8.4	5.4	2.4	11.9	2.0	4.7	2.1	3.8	8.7	7.5	7.6	5.9	5.9	6.8	29.4	6.6	40.9	2.4	8.7	17.8	6.0	6.5	6.3	2.2	16.5	3.5	8.8	14.8	4.8	43.9	40.1	32.0	20.4	5.9	7.1	27.4	46.6	22.4	48.9	33.4	40.1	33.6	24.4	20.8	24.7	29.8	31.8	21.6	52.2	46.7	20.1	31.4	39.7	13.1	2.1	33.0	25.9	3.9	4.0	33.1	26.5	16.5	22.6	37.4	45.6	30.8	27.2	16.5	22.9	26.6	26.0	39.1	17.9	13.0	21.9	26.9	23.3	38.0	24.2	12.9	47.0	14.9	15.0	32.4	29.2	20.7	33.5	19.9	49.1	29.0	16.3	22.6	18.9	16.5	2.6	3.9	5.7	3.5	4.9	6.3	6.9	7.8	2.2	3.9	4.2	5.5	0.5	8.8	1.9	1.5	14.8	4.8	4.9	11.3	6.3	7.8	4.8	4.5	7.8	5.0	5.4	6.6
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.9;testis: 24.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB010381, HPA039310"	Enhanced		Supported	Nucleoli,Cytosol				Nucleoli	Nucleoli	"CAB010381: AB_2253533, HPA039310: AB_2676434"	"prognostic unfavourable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	1.0	0.9	0.4	6.6	0.9	5.3	1.0	0.7	0.9	1.1	5.7	0.4	0.3	1.7	0.8	2.0	4.9	0.5	1.7	1.8	0.5	0.5	1.0	1.0	1.9	7.4	0.5	0.3	0.9	0.7	0.0	0.4	6.2	0.7	0.8	7.6	0.4	1.4	0.3	1.3	2.1	2.6	1.2	1.1	5.0	1.5	24.0	0.5	27.9	0.6	3.7	9.7	1.0	1.9	3.1	1.7	2.7	2.2	2.2	8.8	1.7	12.5	5.6	13.4	5.0	1.4	3.6	12.1	22.3	6.1	19.8	19.9	13.1	8.6	7.1	11.0	7.9	26.7	25.2	10.4	19.3	14.8	8.6	17.8	10.9	10.0	0.1	14.4	12.2	0.5	1.8	13.3	5.9	10.7	23.3	20.0	17.1	11.0	20.5	13.3	15.3	7.0	23.5	18.9	11.9	7.2	17.0	6.0	11.2	9.8	17.3	3.5	10.5	12.0	4.5	14.3	9.1	20.0	11.4	5.0	24.9	23.7	6.2	30.1	12.5	2.0	0.9	2.7	4.1	2.0	0.8	3.1	4.3	5.5	1.7	1.6	1.2	2.1	1.3	2.2	2.2	1.2	8.8	1.7	0.4	0.9	0.7	0.9	0.5	0.5	0.5	0.3	0.7	0.5
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560048	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavourable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	3.0	2.0	1.7	9.2	3.6	15.4	2.7	4.5	2.6	1.8	5.4	1.4	3.8	5.4	1.5	3.2	7.6	1.1	2.2	1.9	1.5	1.2	1.7	1.7	2.6	8.8	2.1	1.7	1.5	1.2	0.5	1.2	4.2	1.8	1.7	7.1	1.5	2.8	1.0	1.2	3.2	6.2	1.9	2.9	5.8	2.9	9.2	2.5	29.8	1.4	4.7	8.2	2.1	3.1	4.5	9.7	0.9	3.1	1.9	1.5	0.9	12.8	4.5	16.2	8.0	0.9	2.1	19.0	16.9	7.5	18.9	25.0	12.3	12.5	16.8	2.5	3.6	8.1	11.2	5.0	29.0	13.2	9.5	21.1	7.8	8.5	0.2	19.2	10.7	0.4	0.5	11.3	11.0	7.5	13.2	19.4	11.9	4.6	15.6	7.0	39.4	5.1	15.8	19.4	6.6	5.7	6.4	5.4	6.0	12.6	9.8	4.0	4.0	11.3	3.3	12.8	13.2	13.9	18.0	2.9	3.3	32.2	4.8	13.8	10.4	0.0	0.8	0.9	0.2	3.1	0.8	4.2	0.6	1.5	0.6	4.5	0.2	0.4	0.0	1.9	2.7	9.7	1.4	0.9	1.7	3.6	4.5	2.6	1.5	1.2	2.1	1.7	1.8	2.5
RAD54B	RDH54	ENSG00000197275	"RAD54 homolog B (S. cerevisiae)"	Q9Y620	8	94371960-94475109	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdTCR: 1.4;MAIT T-cell: 4.4;memory B-cell: 1.7;memory CD4 T-cell: 2.4;memory CD8 T-cell: 1.3;naive B-cell: 2.6;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.6;T-reg: 1.4"	"Group enriched"	"Detected in many"	14	"B-cells: 2.6;T-cells: 4.4"									HPA007087	Uncertain									"HPA007087: AB_1856040"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.31e-2)"	"unprognostic (8.84e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.56e-8)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.04e-12)"	"unprognostic (5.86e-2)"	"unprognostic (5.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.68e-5)"	2.7	3.9	3.9	7.7	8.6	4.6	4.7	11.8	9.1	6.1	4.7	3.8	4.4	3.8	4.0	4.7	5.4	7.7	2.3	3.5	7.7	3.5	3.5	4.3	2.6	6.3	5.4	4.2	5.2	4.1	5.0	6.6	3.7	7.2	5.2	4.8	3.1	3.7	5.7	1.9	4.2	3.4	3.1	9.4	3.2	4.2	10.5	6.7	21.2	3.6	5.0	6.7	6.7	3.8	2.6	0.2	0.0	0.2	0.2	4.4	0.9	14.1	9.8	13.9	7.5	1.1	1.5	7.6	10.7	5.7	15.1	14.4	5.0	9.7	10.2	16.2	3.0	7.7	12.3	5.3	16.5	11.7	7.3	15.5	5.6	4.0	1.3	5.8	5.5	1.3	0.7	7.6	9.3	5.5	11.5	6.7	15.3	6.6	19.7	3.8	9.6	8.7	4.7	15.2	5.8	6.3	6.8	8.9	6.2	7.6	1.8	5.7	9.6	3.3	4.3	10.3	5.5	11.4	11.7	3.5	7.5	5.3	5.5	10.4	10.3	0.0	0.0	0.0	1.4	0.0	4.4	1.7	2.4	1.3	0.2	2.6	1.8	2.6	0.0	0.2	0.2	0.1	1.4	0.9	3.9	8.6	11.8	9.1	7.7	3.5	5.4	4.2	7.2	6.7
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.5;HeLa: 21.4;hTCEpi: 15.5;SiHa: 7.4;U-87 MG: 6.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"			"Focal adhesion sites"	"Focal adhesion sites"	"HPA054022: AB_2797250"	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	1.6	0.5	0.2	0.5	0.2	0.0	1.4	0.2	0.2	10.4	0.3	0.2	0.2	0.2	0.8	0.6	39.7	0.6	0.2	0.2	0.2	0.0	2.8	0.2	0.6	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.5	0.2	0.4	0.3	0.2	7.0	0.2	0.7	14.6	0.3	0.3	0.2	0.6	0.2	0.5	0.3	0.3	0.2	19.8	22.5	1.3	12.6	0.6	0.4	2.3	0.6	0.5	0.7	0.1	1.5	0.9	0.0	0.0	0.1	1.3	0.1	0.1	0.9	0.1	0.3	0.0	3.7	0.0	2.1	3.0	1.6	0.0	15.5	0.2	0.4	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.3	15.5	0.9	3.2	0.1	0.0	1.3	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.7	0.2	0.0	7.4	2.0	0.0	1.1	0.0	2.9	1.1	0.4	0.1	0.9	0.0	0.0	0.0	6.7	0.3	0.0	2.0	0.6	0.4	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.6	0.7	0.4	2.3	0.5	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3
RAET1L		ENSG00000155918	"Retinoic acid early transcript 1L"	Q5VY80	6	150018334-150025532	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 31.4;lymphoid tissue: 15.3;tongue: 25.1"	"Cell line enriched"	"Detected in some"	5	"HaCaT: 19.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.1"	"Region enriched"	"Detected in single"	4	"amygdala: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.51e-1)"		"prognostic unfavourable (4.09e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.43e-3)"	0.0	0.1	1.1	0.0	0.1	0.0	0.3	0.0	0.2	6.1	0.1	0.0	0.0	0.0	0.3	0.0	31.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.5	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	25.1	15.3	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.8	0.0	19.3	0.5	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.7	0.9	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464571	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 14.1;HEL: 11.7;HMC-1: 22.6;Karpas-707: 25.2;NB-4: 12.8;RPMI-8226: 10.6;TIME: 16.7;U-937: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favourable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favourable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favourable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	2.8	2.1	3.1	19.2	3.8	16.7	1.7	0.5	1.9	1.4	3.4	4.6	0.7	3.6	1.7	1.1	3.0	1.9	4.5	1.1	4.1	1.8	3.3	2.8	8.0	23.5	4.5	1.3	0.9	1.3	0.3	1.4	0.8	3.7	2.3	1.9	1.5	7.5	1.1	0.7	1.2	14.5	0.9	5.1	29.9	4.0	0.6	4.6	27.3	3.1	1.6	28.9	4.5	2.0	2.9	3.2	8.8	9.3	8.9	16.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	11.7	0.0	0.0	0.2	9.3	22.6	0.0	0.0	0.0	0.0	0.1	0.0	25.2	0.0	0.1	4.9	12.8	0.0	0.0	1.4	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	16.7	0.0	0.0	0.0	0.0	0.2	4.5	6.9	0.0	15.8	0.0	4.3	1.7	8.8	14.9	3.4	8.9	2.2	9.5	16.4	2.6	2.9	8.0	9.6	2.5	8.9	9.3	3.2	6.4	3.5	3.1	3.8	0.5	1.9	4.1	1.8	4.5	1.3	3.7	4.6
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.6;bone marrow: 63.9;lymphoid tissue: 47.6"	"Cell line enhanced"	"Detected in some"		"HEL: 22.5;HL-60: 40.7;NB-4: 77.3;REH: 23.1;THP-1: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015667	Approved					1900000	1900000			"HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	7.6	4.2	4.6	26.8	26.4	63.9	4.5	4.3	8.2	5.6	9.9	3.2	4.5	3.6	8.8	4.9	4.5	8.9	4.7	13.7	5.5	4.7	5.5	3.1	8.5	47.6	4.7	5.7	2.7	1.2	0.7	1.5	8.1	4.1	6.9	3.2	5.3	7.4	10.4	5.8	1.5	25.6	8.1	2.7	43.9	5.4	3.1	8.2	9.7	2.9	2.5	30.1	7.0	4.8	51.6	29.1	24.5	32.2	16.7	32.8	22.2	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.3	0.0	0.3	0.2	0.3	0.0	14.0	0.6	0.0	0.1	1.2	0.2	0.0	0.0	0.4	22.5	0.0	0.0	0.0	40.7	8.3	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.3	9.6	77.3	0.5	0.0	23.1	0.0	0.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	24.2	0.1	0.0	0.4	0.3	0.0	0.1	0.0	12.9	0.0	12.9	0.0	16.5	11.8	19.1	24.4	28.6	13.2	51.6	25.3	19.3	11.6	32.0	32.8	29.0	24.5	16.7	32.2	29.1	29.9	22.2	4.6	26.4	4.3	8.2	5.5	4.7	4.7	5.7	4.1	8.2
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	5	"HEL: 18.9;HMC-1: 18.9;U-937: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA041929: "	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	4.5	1.8	2.4	8.0	3.3	23.3	5.4	0.7	1.8	1.8	1.7	2.8	0.1	1.4	1.6	2.9	1.6	2.6	3.4	6.2	2.0	1.3	1.5	1.8	11.8	23.1	3.4	0.2	1.1	1.6	0.5	0.9	3.0	1.8	1.7	1.2	1.7	1.6	0.8	1.5	1.4	2.4	2.7	4.2	19.2	1.9	0.8	2.4	0.5	1.0	0.2	1.0	2.6	3.1	0.1	5.2	22.4	9.5	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.9	0.0	0.0	0.0	0.1	18.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	6.0	7.1	10.6	0.0	8.5	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	22.4	0.0	9.5	0.4	0.7	2.1	2.4	3.3	0.7	1.8	2.0	1.3	3.4	0.2	1.8	2.4
RASSF5	"Maxp1, NORE1, RAPL"	ENSG00000266094	"Ras association domain family member 5"	Q8WWW0	1	206507530-206589448	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.0;lymphoid tissue: 34.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 24.6;Karpas-707: 51.5;MOLT-4: 21.3;RPMI-8226: 55.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA070480	Approved									"HPA070480: AB_2686271"	"unprognostic (1.92e-3)"	"prognostic favourable (1.46e-4)"	"unprognostic (1.37e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.17e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavourable (1.22e-6)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.28e-3)"	1.7	3.5	1.5	14.1	1.7	29.2	1.6	0.0	6.2	1.9	2.1	2.0	7.8	2.2	1.0	1.7	13.7	2.8	8.5	1.6	1.6		0.5	4.9	8.8	17.8	0.2	1.8	1.7	7.2	2.6	3.1	1.0	2.8	2.7	2.4	1.8	12.3	12.6	1.6	5.2	2.7	2.0	1.3	23.9	4.9	0.5	0.6	34.1	1.1	8.7	24.6	7.4	4.4	7.0	10.3	61.0	18.2	29.2	29.1	30.1	2.6	1.1	0.0	0.4	0.9	0.5	0.0	0.1	1.3	0.5	0.6	0.1	5.3	8.4	0.7	0.5	4.0	0.9	0.6	0.4	5.7	3.3	9.1	0.2	0.0	0.3	15.1	24.6	0.6	2.5	0.6	0.7	0.1	3.6	51.5	0.2	0.2	21.3	9.7	0.4	1.0	10.1	1.2	55.9	0.0	3.9	1.2	0.0	4.6	0.4	0.1	1.0	9.7	0.0	0.1	1.8	2.3	0.5	18.3	13.2	7.8	0.8	8.9	0.2	41.0	9.1	61.0	27.7	12.5	25.1	7.0	20.9	29.1	10.3	6.4	29.0	26.8	37.1	29.2	18.2	8.1	17.9	30.1										
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 77.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.6;hTERT-HME1: 9.5;RPTEC TERT1: 10.1;RT4: 29.4;U-266/70: 8.7;U-698: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	8	"memory B-cell: 6.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 6.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.5	0.3	0.3	12.9	0.3	0.0	4.8	0.3	0.3	1.8	12.1	0.4	3.7	5.8	0.4	3.7	3.7	1.3	7.7	0.3	0.3	0.5	13.4	1.2	4.2	3.0	0.3	0.1	1.8	11.3	0.0	2.2	11.2	1.1	6.4	7.8	0.4	5.1	6.3	0.4	3.1	23.2	2.1	0.5	0.6	21.5	0.9	0.1	77.9	3.3	2.0	8.2	11.0	2.5	6.4	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	5.1	31.6	0.5	0.0	1.6	0.0	2.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	10.1	29.4	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	25.8	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	6.4	0.4	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.1	1.1	0.1
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167706249	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 47.6;REH: 47.7;RPMI-8226: 32.6;THP-1: 25.1;U-266/70: 31.9;U-698: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"		150000	150000	"Plasma membrane"	"Plasma membrane"	"HPA016597: AB_2669397, HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"	8.5	2.9	3.5	33.3	4.8	19.2	7.3	1.2	3.1	3.0	8.4	3.6	1.3	3.6	2.7	5.4	4.1	3.1	8.8	18.4	3.9	3.6	4.2	3.7	9.0	45.6	5.1	2.2	2.5	1.5	0.8	2.0	7.0	3.1	3.7	5.0	3.1	6.5	2.5	52.3	2.3	20.1	7.4	6.9	40.6	4.9	3.7	3.4	70.8	4.8	12.7	29.2	7.4	4.5	51.0	22.1	56.4	38.2	26.6	27.8	26.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.1	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.3	0.0	0.0	0.0	8.1	0.9	0.1	0.0	0.1	0.0	0.0	15.2	14.0	6.4	0.0	15.1	11.7	0.4	0.0	47.7	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.1	0.1	0.0	0.1	0.0	0.0	31.9	9.5	31.4	0.0	15.6	0.0	48.4	38.2	56.4	15.2	25.1	18.3	45.6	19.8	18.9	22.1	51.0	17.2	15.9	38.5	26.6	24.1	12.8	27.8	26.3	3.5	4.8	1.2	3.1	3.9	3.6	5.1	2.2	3.1	3.4
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;lymphoid tissue: 6.2;testis: 24.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.6;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 5.7"	"Group enriched"	"Detected in many"	14	"NK-cells: 1.5;T-cells: 5.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA024794: AB_1856039, HPA067546: AB_2732769"	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.0	0.0	0.9	0.9	1.2	0.6	0.0	0.0	1.8	0.0	0.9	0.1	0.0	1.3	0.2	0.7	0.3	0.1	0.3	0.0	1.0		0.1	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.7	0.0	0.0	0.0	0.0	1.1	1.5	0.1	0.2	0.1	1.1	24.0	0.0	6.2	0.3	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	1.5	5.7	0.3	6.0	7.1	1.3	2.5	0.1	0.0	2.1	1.4	0.1	0.8	1.3	10.6	6.0	6.6	2.9	0.4	0.9	4.1	1.7	4.1	1.5	8.3	4.2	1.8	0.0	0.0	0.2	3.0	0.0	0.8	0.5	0.4	0.1	1.8	0.0	0.6	2.4	2.3	2.3	0.9	2.6	0.8	0.0	0.0	1.6	3.4	4.8	0.8	1.9	1.8	2.6	17.4	0.4	0.0	0.1	2.1	0.0	0.4	5.5	2.0	2.3	3.4	2.4	1.1	0.0	0.0	0.0	1.4	0.0	2.3	0.1	1.6	5.7	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	1.5	0.3										
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"		8	144511288-144517845	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0;lymphoid tissue: 18.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"B-cells: 1.9;monocytes: 1.0;T-cells: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	2.0	1.6	2.6	12.3	5.6	21.0	2.8	11.5	3.7	1.8	4.3	1.5	1.6	5.6	2.5	4.9	9.4	1.5	1.9	1.9	2.3	1.7	1.6	1.9	1.6	5.9	1.5	2.2	1.9	3.5	0.3	2.4	2.7	2.2	7.7	1.5	1.4	5.4	0.9	2.1	9.4	4.8	1.1	1.7	4.7	3.0	18.1	1.8	18.9	2.5	5.3	8.0	1.6	1.8	1.9	0.1	0.0	1.0	0.0	1.6	0.2	10.3	18.5	8.7	18.2	0.5	0.8	15.2	10.5	1.9	7.8	6.6	18.2	15.3	7.1	7.0	1.7	12.6	5.7	4.5	2.1	12.4	21.8	25.5	31.7	13.5	0.1	6.4	21.2	1.1	0.6	8.7	1.7	2.1	25.3	9.2	2.6	32.0	23.5	17.5	6.0	22.2	24.6	6.8	11.8	2.1	11.2	17.1	10.3	14.2	11.9	3.7	14.5	14.2	2.9	12.6	38.3	15.1	19.3	5.1	5.4	11.9	7.3	20.0	12.6	0.0	0.1	0.0	1.1	1.0	0.0	1.9	0.5	1.1	0.1	0.0	0.9	1.6	0.0	0.0	0.0	0.1	0.0	0.2	2.6	5.6	11.5	3.7	2.3	1.7	1.5	2.2	2.2	1.8
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935263-153944691	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 32.7;lymphoid tissue: 36.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.9;HMC-1: 43.9;SK-MEL-30: 29.0;U-266/84: 25.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000428, HPA000522"	Enhanced					42000	42000			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	12.7	11.1	7.8	11.2	16.8	8.6	8.4	2.3	11.5	4.2	6.2	11.3	1.1	7.4	2.1	6.0	3.0	2.5	5.7	8.7	9.4	9.1	32.7	4.6	12.8	12.1	16.9	7.4	1.2	1.6	1.8	3.4	8.1	11.6	3.6	3.0	9.6	3.4	2.0	1.4	5.2	7.5	4.5	12.7	36.5	4.4	1.4	13.5	3.0	2.9	1.1	4.4	5.7	2.9	1.1	0.6	5.3	3.1	0.3	0.9	0.7	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.9	0.0	0.0	2.5	0.0	0.0	0.0	0.5	9.8	0.0	0.8	7.6	0.0	43.9	0.3	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.2	2.0	0.1	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	29.0	0.0	3.4	0.4	0.0	0.3	0.0	0.0	4.4	25.2	1.7	0.9	4.6	3.4	2.9	2.0	5.3	0.3	1.4	0.3	1.1	0.1	0.1	0.2	0.6	0.9	0.4	4.5	0.3	3.1	0.6	0.0	0.7	7.8	16.8	2.3	11.5	9.4	9.1	16.9	7.4	11.6	13.5
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669044-7670454	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 79.5;lymphoid tissue: 27.6"	"Group enriched"	"Detected in some"	11	"NB-4: 100.1;U-937: 46.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 4.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.5;myeloid DC: 30.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 30.3;monocytes: 45.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	350000	350000				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	1.3	0.4	0.0	1.9	0.6	79.5	0.6	0.4	0.9	0.1	0.2	0.1	0.7	2.3	0.3	0.1	0.2	1.3	0.2	21.9	0.0	0.0	0.9	1.6	17.3	7.5	1.3	0.0	0.8	1.6	0.1	0.4	1.1	0.2	0.2	0.1	0.7	0.7	0.1	0.6	0.2	0.3	1.5	0.4	27.6	0.4	0.4	0.5	2.7	0.8	0.0	0.4	0.2	2.3	0.0	30.3	3.4	45.5	0.0	2.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	100.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	45.5	0.0	0.1	21.7	0.3	0.0	0.5	0.4	30.3	0.0	1.1	2.4	3.4	0.0	11.1	1.2	0.0	14.0	0.0	0.6	0.4	0.9	0.0	0.0	1.3	0.0	0.2	0.5
RFX8	FLJ42986	ENSG00000196460	"RFX family member 8, lacking RFX DNA binding domain"	Q6ZV50	2	101397361-101474703	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;hTEC/SVTERT24-B: 15.4;LHCN-M2: 7.3;U-87 MG: 10.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	12	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059745			Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA059745: AB_2684120"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.56e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-5)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	2.1	0.6	0.4	0.8	0.7	10.0	7.5	0.2	2.3	0.9	0.5	0.8	1.3	0.4	0.7	1.7	0.7	0.2	1.0	0.8	0.4	0.9	0.6	0.7	0.7	0.9	0.7	1.6	0.7	0.6	1.0	2.2	0.9	1.6	0.5	0.1	0.8	0.9	0.1	0.5	1.4	0.3	0.8	0.8	0.4	0.4	2.6	0.0	7.8	1.5	0.0	0.3	0.6	2.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	2.0	1.4	1.3	1.4	0.0	3.1	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.0	0.0	15.4	0.1	0.0	0.0	0.0	7.3	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	1.9	2.8	0.0	0.0	0.0	10.1	4.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	2.3	0.4	0.9	0.7	1.6	1.6	0.0
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499828-119542708	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.9;lymphoid tissue: 96.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		1400000	1400000	"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favourable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favourable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	9.6	7.7	11.9	28.2	12.1	23.6	15.4	2.8	12.4	25.8	44.0	17.0	5.3	12.5	15.3	13.1	21.9	10.8	18.8	11.7	12.0	10.5	8.3	3.9	13.5	47.6	17.4	6.7	10.3	3.9	0.8	6.6	16.9	10.5	17.8	18.9	6.4	18.1	8.2	13.2	9.3	23.1	19.1	28.5	18.7	12.8	3.7	11.1	96.9	14.7	11.1	34.3	17.9	20.0	6.9	40.2	20.5	26.3	7.6	77.9	63.0	29.6	5.5	0.4	52.1	7.5	48.1	4.9	13.8	21.0	8.4	13.5	1.7	7.1	12.7	7.4	10.7	6.6	7.7	8.4	22.2	6.2	8.9	34.0	1.6	4.0	12.0	6.9	92.5	18.7	11.2	16.2	15.1	15.9	8.7	10.3	9.6	13.4	40.2	24.0	2.4	15.0	7.8	0.0	4.7	4.3	6.9	2.1	1.7	2.6	34.0	48.7	6.5	12.3	20.9	4.8	4.1	6.8	11.8	0.5	7.9	4.6	1.4	30.2	2.1	20.5	21.5	0.2	15.0	26.3	15.7	6.9	32.5	25.8	40.2	3.6	77.9	58.5	9.9	7.6	21.6	23.9	35.0	63.0	11.9	12.1	2.8	12.4	12.0	10.5	17.4	6.7	10.5	11.1
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660306	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.9"	"Cell line enriched"	"Detected in some"	17	"Daudi: 33.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	35	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 9.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA044952	Uncertain									"HPA044952: AB_10964914"	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	2.2	0.1	0.1	46.9	0.6	0.2	1.3	0.1	0.1	2.4	4.2	0.0	1.1	2.2	1.5	1.3	1.3	0.4	3.5	0.4	0.1	0.4	0.5	0.2	3.6	31.7	0.2	0.0	0.2	0.7	0.0	0.8	0.0	0.1	3.9	1.0	0.5	1.4	1.6	0.3	1.9	11.9	2.9	0.2	1.2	1.9	0.7	0.0	0.6	0.6	1.7	22.9	1.4	1.8	0.2	0.1	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0
RGS18	RGS13	ENSG00000150681	"Regulator of G protein signaling 18"	Q9NS28	1	192158457-192185815	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 66.0;lymphoid tissue: 37.3"	"Group enriched"	"Detected in some"	5	"HEL: 28.6;HL-60: 21.9;NB-4: 20.6;U-937: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 66.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 66.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028727, HPA045780"	Uncertain		Approved	"Golgi apparatus"		380000	380000	"Golgi apparatus"	"Golgi apparatus"	"HPA028727: AB_2797219, HPA045780: AB_10962728"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.81e-4)"	"unprognostic (1.73e-2)"	"unprognostic (9.91e-2)"	3.9	1.9	4.8	11.4	4.6	9.9	1.8	0.9	3.1	2.0	2.2	1.0	0.0	2.3	1.1	2.3	2.0	2.2	4.5	7.5	3.6	2.5	2.7	4.2	16.1	23.0	4.9	0.8	1.6	1.2	0.0	1.2	3.8	4.2	1.8	2.3	0.6	1.6	0.8	0.9	0.9	4.8	2.3	9.2	37.3	1.4	1.3	4.4	3.0	1.3	0.4	3.5	4.6	1.3	0.0	9.8	66.0	14.9	0.1	1.3	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	27.4	9.8	66.0	0.1	12.9	1.3	0.0	0.1	0.2	9.8	0.0	0.0	0.0	32.4	0.1	14.9	2.3	0.0	16.4	4.8	4.6	0.9	3.1	3.6	2.5	4.9	0.8	4.2	4.4
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496613	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.8;hTCEpi: 4.4;RT4: 4.4;SK-MEL-30: 2.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"olfactory region: 10.4"	"Low region specificity"	"Detected in many"			"HPA041874, HPA043317"	Enhanced									"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.0	0.5	60.6	0.2	0.0	0.0	0.2	4.4	0.2	304.0	0.3	0.3	0.3	0.2	0.0	8.6	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.1	37.3	0.3	0.2	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	115.4	185.9	0.5	91.8	0.6	0.3	0.0	0.2	0.0	0.6	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.6	1.6	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	4.4	0.3	0.3	0.8	0.0	2.7	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.6	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.0
RHOH	"ARHH, RhoH, TTF"	ENSG00000168421	"Ras homolog family member H"	Q15669	4	40191053-40246967	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.8;lymphoid tissue: 94.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 35.6;HMC-1: 27.4;MOLT-4: 49.6;U-266/70: 19.2;U-266/84: 15.4;U-698: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030345, HPA061314"	Uncertain		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA030345: AB_10601607, HPA061314: "	"unprognostic (4.00e-2)"	"unprognostic (1.83e-4)"	"unprognostic (1.24e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.31e-6)"	"unprognostic (2.96e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.44e-2)"	1.8	0.6	0.6	33.8	1.1	21.7	5.2	0.4	0.4	1.3	2.4	0.5	0.4	1.6	2.0	0.9	2.5	1.5	4.1	1.1	0.6	0.7	1.6	1.7	4.8	43.2	0.8	0.2	0.7	0.8	0.0	0.9	0.3	0.8	2.1	2.0	1.0	7.8	0.6	0.5	1.2	15.1	0.7	1.2	33.1	2.7	0.7	0.6	94.7	1.6	1.9	41.0	5.1	1.5	41.2	4.7	32.2	0.2	12.3	54.8	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.3	0.0	0.0	0.0	5.8	27.4	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	49.6	3.7	0.6	0.1	5.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.1	0.1	0.0	0.1	0.0	0.0	19.2	15.4	32.9	0.0	1.2	0.0	32.2	0.2	29.6	21.6	0.1	19.4	30.5	34.6	29.1	0.3	41.2	54.8	43.3	1.6	12.3	0.2	4.7	47.0	21.1	0.6	1.1	0.4	0.4	0.6	0.7	0.8	0.2	0.8	0.6
RIPOR2	"C6orf32, DIFF48, FAM65B, KIAA0386, MYONAP"	ENSG00000111913	"RHO family interacting cell polarization regulator 2"	Q9Y4F9	6	24804281-25042170	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 125.3;lymphoid tissue: 49.7"	"Cell line enhanced"	"Detected in some"		"AF22: 14.0;Daudi: 32.9;fHDF/TERT166: 32.1;U-266/70: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 125.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 125.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.05e-3)"	"unprognostic (1.34e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.89e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	8.2	2.5	6.7	38.0	14.9	14.7	4.7	1.8	11.4	8.6	2.5	1.9	1.4	1.9	33.8	4.2	3.4	8.8	5.5	7.3	6.1	6.2	2.7	2.8	13.2	49.7	3.6	9.1	2.5	1.8	0.8	16.9	17.8	2.9	4.4	2.7	3.3	12.5	3.0	12.9	4.0	11.9	10.7	2.2	39.1	3.8	4.1	2.4	21.5	2.5	1.2	42.7	7.7	5.4	25.8	9.1	125.3	21.1	15.8	24.6	18.1	0.4	0.0	14.0	0.2	0.1	0.1	5.1	3.6	6.9	1.6	2.4	0.1	0.2	32.9	0.9	32.1	0.3	0.0	0.0	0.3	3.3	0.1	7.9	0.5	0.1	0.2	0.1	0.6	1.4	0.1	0.0	0.1	0.0	0.4	5.6	0.1	0.1	7.3	0.3	1.0	0.9	7.8	1.3	0.3	0.0	0.1	0.7	0.1	0.2	0.1	2.5	0.1	0.2	0.1	0.3	1.5	0.3	0.4	11.9	0.2	1.0	0.3	0.4	2.2	43.1	12.9	41.8	18.1	16.7	19.1	25.8	18.5	18.9	9.1	25.0	24.6	19.1	125.3	15.8	21.1	7.5	15.9	18.1	6.7	14.9	1.8	11.4	6.1	6.2	3.6	9.1	2.9	2.4
RMI1	"BLAP75, C9orf76, FLJ12888"	ENSG00000178966	"RecQ mediated genome instability 1"	Q9H9A7	9	83980711-84004074	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021661			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA021661: "	"unprognostic (9.59e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.24e-2)"	9.3	9.9	6.2	16.6	7.5	3.9	5.1	13.1	6.1	5.7	7.6	2.9	5.9	7.6	4.1	6.3	7.7	7.5	3.5	3.8	5.3	8.5	5.5	6.3	7.0	13.2	7.4	3.5	5.4	10.0	9.1	7.5	11.0	9.6	6.6	9.1	3.9	7.7	6.3	6.4	5.4	10.5	4.0	8.1	21.0	7.1	11.7	4.8	35.7	7.3	6.3	11.4	5.6	4.5	4.3	9.8	14.4	8.1	5.1	3.9	3.7	13.8	9.5	20.1	7.0	3.1	4.9	18.9	13.9	7.9	12.7	11.7	4.6	9.4	29.3	5.0	6.8	20.2	13.4	6.7	14.8	16.8	3.4	12.3	7.7	5.8	4.5	22.7	12.7	4.3	4.3	10.1	7.5	6.0	9.2	15.1	13.2	9.8	28.3	7.9	17.2	9.1	26.2	19.7	10.9	5.8	5.9	17.2	10.6	13.0	9.9	5.4	10.6	10.1	4.2	13.2	8.6	13.0	11.0	6.6	13.8	11.2	8.4	9.9	14.2	14.4	6.1	11.2	2.8	7.3	3.3	4.3	3.3	2.9	9.8	4.0	3.2	3.7	10.6	5.1	8.1	2.8	3.9	3.7	6.2	7.5	13.1	6.1	5.3	8.5	7.4	3.5	9.6	4.8
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11351762	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.7;testis: 29.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;T-cells: 3.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favourable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.0	1.8	4.2	18.0	5.1	4.8	2.8	0.7	4.1	2.8	7.3	1.0	0.4	4.3	2.5	3.2	11.8	1.0	2.6	1.9	2.5	1.5	3.1	2.3	2.9	17.9	1.6	5.6	3.6	1.6	0.7	1.1	13.2	1.2	2.6	9.0	0.8	2.9	1.7	1.1	8.7	5.6	1.1	1.4	4.2	4.0	29.6	1.2	31.7	1.4	2.8	20.4	3.6	4.5	6.5	0.6	0.9	0.0	0.3	3.0	0.3	19.0	12.8	25.1	10.7	1.1	5.5	10.5	11.1	8.8	10.5	17.6	4.9	22.7	26.5	9.6	5.2	11.2	10.7	10.6	17.1	5.2	10.0	14.5	7.6	32.4	0.4	5.6	6.5	1.2	2.0	4.5	4.4	5.7	20.0	21.1	5.5	22.0	19.2	26.0	21.1	5.1	23.3	27.1	28.3	6.2	12.4	14.5	11.5	9.4	15.8	8.2	26.7	8.4	1.8	8.5	7.9	16.2	1.6	5.8	9.5	31.4	7.9	18.4	15.5	0.0	0.0	0.9	0.6	0.0	0.0	6.5	0.2	0.0	0.4	2.5	1.8	0.7	0.2	0.3	0.0	0.6	3.0	0.3	4.2	5.1	0.7	4.1	2.5	1.5	1.6	5.6	1.2	1.2
RNASE7	RAE1	ENSG00000165799	"Ribonuclease A family member 7"	Q9H1E1	14	21042226-21044234	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 38.3;lymphoid tissue: 41.0;tongue: 21.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.0;hTCEpi: 6.5;hTERT-HME1: 32.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA005690, CAB062560, CAB068225"	Enhanced				"Secreted in other tissues"					"CAB062560: AB_2665595, CAB068225: , HPA005690: AB_1079819"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.42e-1)"	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.3	38.3	0.0	4.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.5	0.2	0.0	3.5	0.2	0.2	14.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.1	21.4	41.0	0.6	7.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806556-12815201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042692: "	"unprognostic (6.74e-2)"	"prognostic favourable (1.18e-4)"	"prognostic favourable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favourable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavourable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	6.5	5.5	6.4	11.4	10.6	21.9	6.6	11.0	7.5	6.8	6.6	9.2	1.6	8.6	6.8	4.4	14.1	6.0	5.7	5.1	6.7	4.8	8.7	5.9	5.5	9.2	10.6	5.8	7.3	7.0	6.2	4.1	11.8	6.1	5.3	5.7	5.5	8.8	4.3	7.1	13.4	7.1	4.4	7.8	12.0	7.4	14.1	8.4	44.8	8.6	13.4	17.4	6.0	8.0	11.3	7.8	7.1	6.8	12.9	8.6	5.0	14.8	11.2	6.8	6.8	1.0	1.9	8.4	6.9	2.9	10.4	12.1	8.8	5.7	15.9	10.5	1.6	8.9	5.5	6.8	5.7	8.6	15.0	7.6	11.9	6.8	0.7	7.0	7.1	1.0	1.7	8.8	3.2	4.0	10.5	4.7	4.9	25.5	12.8	6.9	6.7	19.6	13.8	9.8	11.4	2.6	5.9	14.1	8.2	7.5	2.7	3.1	7.4	4.3	3.8	12.4	6.2	17.6	11.4	11.5	12.7	12.6	7.3	11.2	10.0	7.1	6.8	6.4	8.6	6.6	7.0	9.8	7.0	6.1	4.2	11.3	6.6	6.5	6.8	12.9	5.9	7.8	5.5	5.0	6.4	10.6	11.0	7.5	6.7	4.8	10.6	5.8	6.1	8.4
RNASEH2B	"AGS2, DLEU8, FLJ11712"	ENSG00000136104	"Ribonuclease H2 subunit B"	Q5TBB1	13	50909678-51024120	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 120.1"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 68.7;NB-4: 51.0;REH: 57.5;THP-1: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040084, HPA041469"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040084: AB_10697714, HPA041469: AB_2677496"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.50e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavourable (2.54e-8)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	11.9	10.5	11.3	20.2	14.1	28.3	10.9	11.3	10.9	14.0	15.2	9.4	12.9	8.9	20.0	12.6	11.6	15.8	11.6	14.7	10.0	8.8	9.1	7.9	14.3	25.7	11.8	9.9	14.0	18.0	6.3	12.0	10.6	8.5	15.4	12.4	9.6	12.7	12.9	15.8	8.5	13.9	15.5	10.0	18.5	11.5	16.4	11.3	120.1	15.8	11.0	20.4	15.1	12.2	34.2	31.3	5.5	13.9	12.0	34.5	16.9	8.0	6.6	3.6	7.3	4.8	9.5	8.6	5.8	6.6	8.3	7.0	8.6	12.5	22.9	3.7	5.9	7.7	11.3	5.3	10.0	8.4	9.3	20.5	4.7	5.1	6.6	37.5	13.6	3.8	6.8	7.3	6.5	7.4	11.3	10.9	11.3	3.8	68.7	51.0	11.7	5.2	57.5	10.7	15.4	6.4	4.7	8.0	11.8	6.9	2.5	7.4	3.9	51.2	5.2	7.5	6.3	8.8	12.8	14.7	9.7	27.1	1.9	28.1	8.7	0.9	12.6	5.5	11.1	13.9	12.7	34.2	22.1	18.2	18.2	29.0	19.9	18.5	2.1	12.0	11.9	31.3	34.5	16.9	11.3	14.1	11.3	10.9	10.0	8.8	11.8	9.9	8.5	11.3
RNASEK-C17orf49		ENSG00000161939	"RNASEK-C17orf49 readthrough"		17	7012635-7017520	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 5.2;THP-1: 6.1;U-87 MG: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA022961, HPA024457"	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (4.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.37e-5)"	"unprognostic (4.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.26e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-1)"	4.8	4.8	2.8	3.5	3.5	5.3	2.9	3.6	4.0	2.0	2.8	0.4	1.5	1.4	4.9	3.3	2.3	2.7	3.2	6.3	2.5	3.3	6.6	14.5	16.7	20.3	2.9	2.4	2.4	7.9	1.4	4.7	2.5	1.8	1.8	1.4	0.4	1.6	5.0	4.2	1.9	6.3	2.3	1.7	9.1	1.6	6.4	0.7	4.1	2.0	4.6	3.4	2.3	1.6	1.9	4.0	7.5	4.3	0.9	1.7	2.8	1.1	3.5	0.5	0.5	0.0	0.0	1.1	2.3	1.9	2.8	2.1	2.3	1.0	1.8	0.2	0.0	0.6	0.7	5.2	0.7	0.0	4.3	0.0	2.9	1.0	2.7	0.0	0.6	0.0	0.0	1.6	0.0	0.7	0.6	0.0	0.0	1.2	1.9	2.2	2.2	1.2	1.4	0.0	0.0	0.7	0.7	0.5	1.8	0.0	0.0	0.2	0.6	6.1	0.0	0.0	0.2	3.5	0.9	0.0	0.8	0.2	6.8	0.5	0.0	3.6	4.3	3.4	1.2	3.0	1.7	1.9	1.5	0.8	3.8	1.8	1.4	1.2	7.5	0.9	3.1	4.0	0.9	2.8	2.8	3.5	3.6	4.0	2.5	3.3	2.9	2.4	1.8	0.7
RNF222		ENSG00000189051	"Ring finger protein 222"	A6NCQ9	17	8390704-8397826	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 15.7;lymphoid tissue: 9.4;tongue: 13.6"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 12.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048916	Uncertain									"HPA048916: AB_2680555"	"unprognostic (2.49e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.19e-4)"	"unprognostic (2.81e-1)"	"unprognostic (5.30e-2)"		"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-3)"	"unprognostic (5.82e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.97e-2)"	0.1	0.0	0.1	0.1	0.1	1.8	0.5	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.6	0.1	15.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	1.8	0.1	0.1	6.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.6	9.4	0.1	5.5	0.4	0.5	2.0	0.5	0.2	1.0	0.1	1.1	0.0	0.0	0.2	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	12.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.6	0.5	1.0	0.3	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.6	1.0	2.0	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
RNF223		ENSG00000237330	"Ring finger protein 223"	E7ERA6	1	1070966-1074307	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"A-431: 11.7;CAPAN-2: 8.8;HaCaT: 5.5;MCF7: 18.7;SK-BR-3: 12.8;T-47d: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (4.71e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (8.08e-5)"	"unprognostic (3.50e-1)"	"unprognostic (6.50e-2)"		"unprognostic (1.43e-3)"	"unprognostic (3.91e-1)"	"unprognostic (5.09e-2)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-1)"	"unprognostic (9.52e-3)"	0.0	0.0	0.0	1.4	0.0	0.4	0.8	0.0	0.5	8.3	1.4	0.0	0.0	0.4	1.0	0.3	28.8	0.2	1.9	0.0	0.0	0.0	0.6	0.3	0.9	0.1	0.0	0.0	0.0	1.0	0.1	0.0	6.5	0.0	4.2	0.8	0.0	3.3	0.4	0.7	3.5	0.2	2.6	0.0	0.2	7.8	0.1	0.0	0.0	0.2	14.8	17.1	4.9	9.3	0.6	0.6	1.9	0.4	0.3	0.4	0.0	11.7	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	18.7	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	12.8	0.2	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.4	0.2	0.3	0.1	0.1	0.3	0.2	0.4	0.0	0.6	0.2	0.4	0.9	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF225		ENSG00000269855	"Ring finger protein 225"	M0QZC1	19	58396090-58397079	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 31.6;lymphoid tissue: 16.5;tongue: 21.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;SCLC-21H: 1.1;T-47d: 3.2;U-266/84: 1.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (3.07e-1)"	"unprognostic (6.94e-2)"				"unprognostic (3.68e-3)"		"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.75e-3)"		"unprognostic (1.40e-1)"		"unprognostic (3.42e-1)"	"unprognostic (9.18e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	4.0	0.0	0.0	3.1	0.0	0.0	0.1	31.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	1.4	0.0	0.0	1.9	2.1	0.0	6.2	0.0	0.4	0.0	0.1	0.1	1.1	0.0	0.0	0.2	21.8	16.5	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.3	0.9	1.1	0.3	0.0	0.6	0.0	3.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RORC	"NR1F3, RORG, RZRG, TOR"	ENSG00000143365	"RAR related orphan receptor C"	P51449	1	151806071-151831872	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.8;skeletal muscle: 63.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.1;Karpas-707: 11.0;MOLT-4: 5.6;RPMI-8226: 5.8;SK-BR-3: 5.0;T-47d: 8.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 7.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 28.3"	"Lineage enriched"	"Detected in single"	44	"T-cells: 28.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065620			Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA065620: AB_2685521"	"unprognostic (6.51e-2)"	"unprognostic (7.78e-2)"	"prognostic favourable (1.83e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-4)"	"unprognostic (6.29e-5)"	"unprognostic (1.13e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (2.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-2)"	1.3	1.6	0.4	3.4	0.9	0.0	3.3	7.0	0.3	2.7	10.0	0.7	19.8	4.2	1.2	6.7	3.4	8.7	3.5	4.8	0.4	0.5	13.3	30.8	8.7	0.7	0.9	0.3	1.3	30.3	8.5	9.4	0.2	2.4	7.0	4.0	2.8	27.8	33.4	63.8	9.8	10.3	0.8	0.3	0.7	7.7	6.4	1.1	69.8	15.6	11.1	4.0	2.4	1.7	0.0	0.1	0.0	0.0	0.6	28.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	2.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.0	0.2	0.1	5.0	0.0	8.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	0.0	28.3	0.0	4.4	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	3.0	0.6	0.4	0.9	7.0	0.3	0.4	0.5	0.9	0.3	2.4	1.1
RPL39	"L39, RPL39P42"	ENSG00000198918	"Ribosomal protein L39"	P62891	X	119786504-119791643	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 403.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047105	Uncertain									"HPA047105: AB_2679933"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.23e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (3.26e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.31e-3)"	78.3	56.7	39.3	73.7	42.7	121.2	154.3	48.9	52.9	73.4	68.8	17.1	67.4	44.3	50.3	83.0	80.3	61.3	55.6	149.7	32.5	27.7	50.8	74.6	159.8	403.2	40.3	42.5	139.3	190.8	9.0	31.1	41.7	38.8	54.7	65.2	33.7	68.3	63.6	86.9	104.5	59.5	97.6	56.8	84.3	57.0	31.5	33.5	87.2	72.7	125.9	97.1	65.7	71.9	224.4	140.6	53.6	118.6	94.2	236.1	246.4	145.0	92.1	132.9	107.6	227.1	292.3	126.7	136.5	155.3	156.4	139.6	94.2	109.5	227.4	142.9	134.1	120.1	204.7	176.5	159.2	81.2	319.9	108.6	136.3	135.1	192.5	189.3	90.0	279.6	315.0	120.7	226.7	176.7	133.0	161.6	141.4	195.8	130.2	343.6	210.0	206.7	122.8	174.2	280.0	175.5	115.9	79.1	162.3	175.4	158.7	231.9	83.5	205.1	137.8	57.3	57.0	154.1	218.1	102.7	173.8	242.7	85.5	273.8	67.9	53.6	118.6	38.7	91.9	82.0	146.2	224.4	202.4	138.0	126.3	208.8	236.1	183.4	28.0	94.2	73.6	140.6	128.7	246.4	39.3	42.7	48.9	52.9	32.5	27.7	40.3	42.5	38.8	33.5
RPLP1	LP1	ENSG00000137818	"Ribosomal protein lateral stalk subunit P1"	P05386	15	69452784-69456194	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1030.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003368			Supported	"Endoplasmic reticulum,Cytosol"		1000000	1000000	"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA003368: AB_1079845"	"unprognostic (5.04e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (2.30e-9)"	"unprognostic (7.75e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.83e-2)"	59.6	57.2	47.5	76.8	42.9	171.7	451.2	68.8	103.3	70.1	79.0	20.8	57.9	87.5	73.5	76.3	100.7	65.7	80.6	341.6	35.5	29.7	55.8	69.9	290.9	1030.2	42.4	33.3	134.3	209.0	8.6	36.0	52.3	45.6	71.0	33.3	61.3	102.8	60.7	262.9	155.2	74.3	128.2	38.8	77.4	77.1	45.7	32.7	73.0	50.8	146.9	71.8	72.3	95.5	329.0	226.3	79.6	176.1	169.8	267.2	368.8	82.7	84.7	38.0	87.6	54.5	65.8	81.7	72.9	43.3	40.8	32.7	85.9	84.4	115.9	109.0	38.3	113.3	58.5	57.3	8.9	116.2	179.0	97.6	97.3	83.8	95.5	86.4	89.2	82.7	100.5	29.7	55.7	49.2	91.8	98.9	28.8	77.6	94.2	254.8	142.1	81.7	96.7	124.2	169.6	39.3	89.7	60.9	118.7	73.2	90.6	297.4	74.7	199.0	86.3	59.2	132.5	70.6	118.3	202.7	323.2	98.3	70.9	220.7	48.8	79.6	176.1	60.4	119.5	124.7	220.2	329.0	247.2	162.7	215.0	278.5	267.2	223.0	26.2	169.8	70.2	226.3	202.7	368.8	47.5	42.9	68.8	103.3	35.5	29.7	42.4	33.3	45.6	32.7
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990755-153992155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 778.4;lymphoid tissue: 769.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA066851: AB_2685737"	"prognostic favourable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	120.7	72.5	74.9	188.7	118.6	186.7	268.2	51.3	91.4	172.5	114.2	35.9	136.4	58.1	169.0	135.6	107.5	129.0	144.1	176.5	59.6	50.1	98.6	102.5	167.8	769.0	92.1	76.0	317.8	227.2	44.6	91.5	67.5	71.2	117.6	113.6	63.5	248.2	116.1	243.8	160.1	115.9	254.3	65.6	159.3	111.5	119.0	81.9	118.2	113.0	224.0	270.9	162.9	286.0	720.2	296.5	132.9	139.9	324.1	750.5	778.4	104.0	122.0	161.3	87.8	379.9	374.5	100.0	126.2	302.5	170.0	153.7	244.4	115.1	236.9	106.0	182.0	104.8	142.1	208.9	143.7	115.1	183.2	93.3	161.8	158.5	251.8	207.4	123.1	363.6	410.9	135.2	249.1	139.3	113.9	128.9	161.3	261.5	223.2	131.3	195.4	178.0	143.0	118.2	184.3	157.0	210.8	85.8	191.2	72.3	254.7	219.3	141.9	416.9	82.3	58.8	97.3	93.6	126.1	258.9	263.9	287.2	102.0	116.5	80.6	132.9	139.9	68.1	393.0	138.9	473.7	720.2	594.4	502.0	179.5	637.3	750.5	579.6	32.4	324.1	127.0	296.5	397.8	778.4	74.9	118.6	51.3	91.4	59.6	50.1	92.1	76.0	71.2	81.9
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138876	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Enhanced	Cytosol		13000	13000	Cytosol	Cytosol	"CAB022093: , HPA057265: AB_2683386, HPA064297: "	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	13.9	25.3	8.0	15.2	12.2	18.5	14.4	18.0	12.6	15.7	15.9	11.1	11.5	11.9	13.0	9.8	25.4	10.7	8.7	11.9	7.9	9.0	9.2	13.1	11.0	20.2	9.0	10.3	13.6	10.7	24.2	11.2	22.7	18.4	14.0	18.9	12.0	15.4	10.7	28.3	26.8	12.5	17.5	10.7	12.4	13.8	10.5	9.1	78.6	9.8	28.0	27.1	17.5	18.5	5.6	4.3	3.3	8.3	5.7	24.3	6.0	45.4	24.7	40.5	23.5	6.2	12.4	15.7	41.9	20.8	47.7	49.2	22.2	34.6	49.2	10.2	20.9	36.6	37.5	30.1	56.5	24.2	39.8	25.0	37.1	17.3	2.5	42.8	18.4	5.8	8.1	26.1	18.8	22.8	32.6	23.3	39.7	20.6	50.3	9.3	25.6	25.1	40.8	31.7	17.6	13.1	12.9	34.7	19.0	36.9	22.3	6.7	22.0	15.0	13.0	44.9	23.5	44.4	30.7	15.2	21.1	53.8	24.9	28.7	27.8	3.3	2.5	2.6	7.7	6.5	13.3	5.6	14.2	10.7	4.3	3.5	11.3	9.2	0.0	5.7	8.3	2.7	24.3	6.0	8.0	12.2	18.0	12.6	7.9	9.0	9.0	10.3	18.4	9.1
RUBCNL	"C13orf18, FLJ21562, KIAA0226L"	ENSG00000102445	"RUN and cysteine rich domain containing beclin 1 interacting protein like"	Q9H714	13	46342000-46438190	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.1;lymphoid tissue: 24.0"	"Group enriched"	"Detected in some"	5	"Daudi: 39.1;U-698: 64.6"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"memory B-cell: 29.9;naive B-cell: 31.1;neutrophil: 31.1;plasmacytoid DC: 22.5"	"Group enriched"	"Detected in many"	17	"B-cells: 31.1;dendritic cells: 22.5;granulocytes: 31.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favourable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"	3.7	1.6	4.5	21.2	4.3	15.0	5.7	2.9	3.6	5.5	8.1	2.9	1.3	1.5	3.0	3.2	1.0	2.0	3.8	1.5	3.4	3.7	1.5	1.7	5.5	20.2	4.5	2.7	0.9	1.2	0.1	2.7	3.3	5.2	2.2	11.2	3.0	6.5	1.8	0.8	2.7	14.9	2.8	8.8	24.0	1.6	15.9	3.7	10.1	2.2	0.2	21.7	2.9	2.0	31.1	22.5	31.1	1.6	0.3	0.0	1.2	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	1.5	0.0	39.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.4	11.2	0.0	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.6	0.0	9.0	0.0	0.0	0.3	0.0	0.1	0.2	9.0	64.6	0.4	0.1	0.0	0.0	1.0	0.0	0.0	1.6	0.0	29.9	0.0	0.0	1.0	31.1	0.0	0.0	31.1	0.3	0.9	22.5	0.0	1.2	4.5	4.3	2.9	3.6	3.4	3.7	4.5	2.7	5.2	3.7
RUFY4	"FLJ46536, ZFYVE31"	ENSG00000188282	"RUN and FYVE domain containing 4"	Q6ZNE9	2	218034960-218090581	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 6.6;lymphoid tissue: 5.1"	"Cell line enriched"	"Detected in some"	13	"Karpas-707: 15.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037980	Uncertain									"HPA037980: AB_10672501"	"unprognostic (1.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.39e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.41e-14)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.43e-5)"	0.3	0.4	0.6	2.2	1.9	1.8	0.3	0.3	1.0	0.3	0.4	0.3	0.3	1.9	0.3	0.3	0.9	0.4	1.2	0.3	3.1	0.3	0.5	0.3	6.6	2.8	0.4	0.3	0.3	0.3	0.0	0.4	0.3	0.3	2.6	1.5	0.3	1.4	0.3	0.3	0.7	1.8	0.3	0.3	5.1	1.5	0.3	0.3	1.1	0.3	0.3	2.2	0.6	0.6	0.0	1.9	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.0	0.6	1.9	0.3	1.0	3.1	0.3	0.4	0.3	0.3	0.3
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"Runt related transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 54.3;lymphoid tissue: 58.6"	"Cell line enhanced"	"Detected in many"		"HEL: 65.0;HMC-1: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	11.5	3.2	5.2	14.8	7.3	29.8	54.3	1.0	4.3	12.5	4.7	3.8	4.0	3.8	2.9	7.4	6.5	4.6	12.4	7.6	6.1	2.0	4.2	6.7	17.9	13.9	8.5	1.1	6.5	5.8	1.6	5.5	6.4	6.0	9.9	5.1	3.5	29.8	8.8	14.4	8.3	5.1	6.8	12.3	10.6	12.7	2.9	6.6	58.6	4.6	5.7	14.2	11.0	9.1	3.2	3.4	17.0	3.9	1.3	4.8	2.0	13.0	1.0	0.0	0.1	3.4	4.4	8.6	7.4	7.5	4.1	3.1	0.6	10.0	6.4	0.5	6.5	11.8	0.8	8.8	6.0	9.9	1.0	65.0	2.6	3.0	6.3	7.5	39.2	8.5	5.3	12.5	12.4	2.3	4.4	3.8	8.7	2.8	30.3	11.9	0.6	3.8	30.7	22.8	3.9	5.5	5.2	0.3	0.0	7.6	1.9	2.7	3.9	17.6	9.7	6.8	8.8	10.1	11.1	12.5	5.1	6.1	8.5	16.5	9.9	17.0	3.2	6.3	3.4	1.4	3.3	3.2	3.1	3.2	0.9	3.1	4.8	3.8	3.5	1.3	3.9	3.4	4.0	2.0	5.2	7.3	1.0	4.3	6.1	2.0	8.5	1.1	6.0	6.6
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"Runt related transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.5;lymphoid tissue: 47.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 38.7;Karpas-707: 52.1;SK-MEL-30: 28.9;U-266/70: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	Nucleoplasm	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavourable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.0	1.1	0.9	25.4	1.1	31.5	3.4	0.5	1.0	11.9	8.0	1.2	0.3	2.5	1.7	1.4	3.5	1.7	6.2	1.3	0.9	1.1	2.2	2.3	11.7	28.8	2.8	0.7	1.3	1.0	0.0	1.0	1.3	1.8	2.3	2.3	2.8	6.5	2.2	2.2	9.5	13.7	1.3	1.8	30.6	2.7	2.1	0.8	14.2	1.8	3.1	47.6	8.9	2.2	4.5	1.0	4.3	4.6	18.1	15.1	3.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	6.2	6.1	5.3	0.1	3.6	0.0	0.2	38.7	0.6	0.1	0.6	0.0	0.0	1.4	13.4	0.0	0.0	0.0	0.3	0.0	0.0	52.1	0.0	0.0	0.4	12.0	0.2	1.0	0.0	0.0	7.3	0.0	0.1	1.2	0.0	2.4	0.0	28.9	0.0	8.3	0.0	0.0	0.5	0.0	0.1	18.1	12.5	5.9	0.0	13.5	1.4	0.4	0.7	4.3	15.1	3.0	8.1	4.5	5.7	13.2	0.9	3.8	2.8	10.3	0.9	18.1	4.6	1.0	5.7	3.1	0.9	1.1	0.5	1.0	0.9	1.1	2.8	0.7	1.8	0.8
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9"	"Group enriched"	"Detected in some"	5	"HaCaT: 7.3;SK-BR-3: 16.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"	17000000	17000000	Cytosol	Cytosol	"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	2.2	0.1	0.1	45.2	0.1	0.1	0.1	0.0	3.7	3.9	116.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	6.2	0.1	0.1	45.7	0.1	0.2	0.1	0.1	0.0	0.3	0.1	1.2	0.1	409.9	156.7	0.2	85.3	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	7.3	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.8	16.9	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
S100Z	"Gm625, S100-zeta"	ENSG00000171643	"S100 calcium binding protein Z"	Q8WXG8	5	76850001-76921650	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.7;lymphoid tissue: 9.5"	"Cell line enriched"	"Detected in some"	6	"U-698: 41.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 17.6;eosinophil: 15.0;intermediate monocyte: 15.9;myeloid DC: 9.5;neutrophil: 5.9;non-classical monocyte: 18.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.5;granulocytes: 15.0;monocytes: 18.7"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.6"	"Low region specificity"	"Detected in all"			HPA051929	Approved									"HPA051929: AB_2732571"	"unprognostic (4.17e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.47e-5)"	"unprognostic (3.39e-4)"	"unprognostic (8.94e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.62e-1)"	1.0	1.0	3.5	5.3	3.3	5.7	1.1	0.6	2.2	0.6	0.9	3.8	0.4	1.0	0.8	0.4	0.8	0.7	1.9	0.7	4.1	1.7	1.0	1.0	5.1	6.2	2.1	2.6	0.6	2.4	0.2	0.7	3.2	3.2	1.0	1.4	0.3	1.1	0.5	0.9	0.6	2.3	1.5	6.2	9.5	1.1	0.7	4.5	2.1	0.7	0.0	6.2	1.8	0.9	2.5	9.5	15.0	18.7	0.3	0.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	41.4	1.7	0.0	0.0	1.4	17.6	15.0	0.4	15.9	0.1	2.5	0.3	0.0	9.5	0.6	0.0	0.0	5.9	0.3	18.7	0.1	0.3	4.6	3.5	3.3	0.6	2.2	4.1	1.7	2.1	2.6	3.2	4.5
SAMD1		ENSG00000141858	"Sterile alpha motif domain containing 1"		19	14087840-14091036	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041662, HPA049059"	Uncertain		Approved	Mitochondria,Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"HPA041662: AB_2677605, HPA049059: AB_2680616"	"unprognostic (2.93e-2)"	"prognostic favourable (7.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (1.96e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.00e-1)"	"prognostic unfavourable (7.98e-5)"	"prognostic favourable (8.31e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.45e-1)"	16.0	9.5	23.5	17.4	20.2	19.6	47.9	17.2	21.2	15.3	21.3	19.7	12.2	20.6	14.7	9.8	18.2	14.0	12.8	16.8	21.2	17.9	13.1	11.1	15.9	20.1	20.9	10.3	14.5	20.3	7.2	7.3	11.3	16.5	12.7	15.5	7.8	15.4	16.1	27.2	25.9	21.5	12.4	21.3	18.0	16.7	11.4	16.1	79.1	14.8	10.8	17.9	12.9	20.5	3.5	2.3	4.5	2.9	8.0	2.7	1.5	22.6	17.3	15.2	21.5	9.6	9.8	23.2	12.5	3.0	12.7	10.3	13.0	11.2	39.5	17.0	8.1	18.4	16.6	9.3	6.5	26.4	13.7	17.2	22.9	23.4	8.6	10.1	10.8	6.8	15.5	8.8	3.0	7.5	20.9	10.8	7.4	34.1	21.5	39.9	31.3	15.3	29.3	13.5	28.3	10.8	11.0	28.0	28.0	11.0	15.0	8.3	9.4	21.8	8.1	22.4	20.6	22.4	15.7	20.5	17.6	32.6	13.4	27.7	9.0	0.3	2.9	4.5	1.7	0.9	2.0	3.5	1.9	2.0	2.3	2.1	2.7	2.0	0.5	8.0	1.0	1.8	2.1	1.5	23.5	20.2	17.2	19.6	21.2	17.9	20.9	10.3	16.5	16.1
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.6;lymphoid tissue: 35.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	9.6	4.0	2.3	9.2	2.4	5.2	2.6	1.0	1.6	9.3	6.8	0.6	0.9	4.3	2.8	3.0	34.6	2.7	4.3	2.5	1.3	1.5	6.3	3.5	7.8	10.8	2.5	1.1	6.3	2.3	0.1	6.4	11.3	3.1	5.3	7.0	0.7	5.7	1.6	2.4	1.5	12.7	2.2	2.5	21.7	6.3	2.5	1.7	35.4	3.3	9.9	9.5	4.8	9.7	5.5	3.0	15.6	9.8	7.4	7.6	2.6	12.2	1.6	0.4	0.1	5.5	7.0	0.1	4.8	20.1	23.0	30.5	0.1	13.6	5.1	7.6	11.8	14.5	0.0	4.4	7.8	17.4	0.6	7.4	8.2	0.0	2.5	8.3	10.4	3.1	6.4	7.6	2.1	3.4	0.5	12.8	4.8	0.0	12.3	6.8	0.0	3.5	4.1	4.1	5.8	0.1	1.5	2.0	0.2	3.7	1.4	3.9	0.4	4.1	14.8	5.4	1.9	16.1	2.6	7.6	1.4	4.7	5.6	4.9	5.3	15.6	3.6	12.7	7.6	7.0	7.3	5.0	5.9	6.5	3.0	5.5	6.3	5.7	15.5	7.4	9.8	2.1	7.2	2.6	2.3	2.4	1.0	1.6	1.3	1.5	2.5	1.1	3.1	1.7
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6"	"Group enriched"	"Detected in some"	4	"HEL: 59.5;K-562: 70.8;Karpas-707: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 53.6;eosinophil: 49.9"	"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	7	"olfactory region: 25.4"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	14.4	3.9	5.8	33.0	10.4	72.1	4.2	1.1	5.1	2.9	4.7	4.9	0.0	3.1	3.4	4.6	4.1	6.8	10.1	5.1	4.4	3.4	5.9	7.2	27.9	28.3	11.1	1.4	3.3	2.3	1.0	2.7	6.7	6.7	4.1	7.0	3.4	3.4	1.2	1.6	1.9	13.6	4.7	17.5	43.6	5.0	2.4	7.1	12.6	2.6	2.8	16.7	11.8	4.5	6.5	5.6	53.6	17.3	3.7	12.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	59.5	0.0	0.0	0.0	7.0	2.9	0.0	0.0	0.0	8.8	0.8	70.8	30.9	0.0	0.0	3.3	8.5	0.0	0.0	5.8	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.7	0.0	0.0	0.0	0.0	13.3	0.1	0.0	0.3	4.5	0.0	53.6	8.8	49.9	5.3	11.6	3.6	6.5	10.3	7.8	5.6	2.6	6.6	4.6	11.0	3.7	17.3	0.2	12.9	6.8	5.8	10.4	1.1	5.1	4.4	3.4	11.1	1.4	6.7	7.1
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779979-129795201	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 43.9;HL-60: 15.4;MOLT-4: 31.3;NB-4: 23.8;REH: 23.5;U-698: 40.0;U-937: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favourable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	7.8	3.4	2.8	34.6	5.2	33.2	2.7	0.7	2.2	2.0	3.3	4.0	0.2	3.9	1.9	2.1	2.9	3.4	3.6	2.0	3.3	2.4	3.3	3.0	10.6	38.2	5.2	1.1	1.3	1.8	0.2	1.8	2.5	4.2	2.7	3.5	1.6	7.8	0.8	0.9	1.1	18.8	2.4	6.2	55.7	4.2	0.8	4.0	85.3	2.5	2.0	38.6	7.0	2.0	22.0	27.6	53.7	44.2	33.4	46.9	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	31.3	23.8	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.0	8.9	40.0	0.0	31.1	0.0	7.9	29.4	53.7	46.9	44.1	38.7	19.1	26.7	43.1	27.6	22.0	19.3	30.0	29.1	33.4	44.2	12.7	32.3	61.8	2.8	5.2	0.7	2.2	3.3	2.4	5.2	1.1	4.2	4.0
SCAI	"C9orf126, FLJ36664, NET40"	ENSG00000173611	"Suppressor of cancer cell invasion"	Q8N9R8	9	124942608-125143506	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 34.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020632	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"HPA020632: AB_1845804"	"unprognostic (1.93e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-3)"	4.5	6.5	9.5	6.4	14.3	6.8	5.4	9.5	19.1	5.0	4.5	3.5	3.1	3.3	5.9	4.6	4.1	6.1	3.7	3.7	7.1	7.9	4.4	3.8	8.5	7.2	4.6	12.0	7.6	4.6	5.7	4.6	2.7	4.8	5.5	5.0	12.4	3.7	3.3	4.2	6.6	4.0	4.0	4.0	5.0	4.4	5.2	5.1	34.4	5.3	2.1	6.2	4.2	4.5	2.9	3.1	1.5	1.7	2.5	2.6	1.3	3.8	3.0	4.0	3.8	2.2	5.4	6.7	2.4	5.1	2.6	3.7	3.8	3.7	6.9	1.8	2.4	6.5	5.1	2.6	5.3	4.9	1.9	4.5	5.5	3.3	3.1	4.8	3.5	2.1	2.3	4.0	2.7	3.7	6.4	8.1	3.9	4.2	15.3	3.3	3.9	3.3	9.7	6.4	5.9	1.8	5.3	4.1	2.6	5.7	3.1	3.0	7.8	2.1	3.8	2.4	4.4	4.0	4.2	4.5	8.5	6.6	2.9	4.0	3.5	0.8	1.2	0.2	1.1	1.7	1.2	2.0	1.9	1.3	0.8	2.9	2.6	1.8	1.5	2.5	0.6	3.1	2.6	1.3	9.5	14.3	9.5	17.0	7.1	7.9	4.6	12.0	4.8	5.1
SCARF1	"KIAA0149, SREC, SREC1"	ENSG00000074660	"Scavenger receptor class F member 1"	Q14162	17	1633858-1645747	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.9"	"Cell line enhanced"	"Detected in some"		"HEL: 4.6;HUVEC TERT2: 15.5;REH: 7.9;TIME: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 8.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072936	Enhanced				"Intracellular and membrane"	940000	940000			"HPA072936: AB_2686559"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.39e-2)"	15.3	3.4	2.3	6.8	2.8	3.7	15.6	3.5	2.4	6.7	3.8	2.4	2.3	3.9	8.7	5.7	2.9	4.1	4.8	10.1	2.1	2.2	5.4	6.1	12.6	8.5	2.9	3.1	4.5	3.1	2.5	2.8	7.6	3.4	5.0	1.8	5.3	2.7	3.4	5.7	2.4	3.8	3.6	2.4	28.9	3.4	3.4	1.3	1.5	13.5	4.6	2.5	4.7	12.4	0.0	1.1	8.3	1.7	0.0	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.5	2.3	2.8	3.5	2.4	2.1	2.2	2.9	3.1	3.4	1.3
SCGB1D1	"LIPA, LPHA, MGC71958"	ENSG00000168515	"Secretoglobin family 1D member 1"	O95968	11	62190216-62193539	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 5.4;fallopian tube: 3.2;lymphoid tissue: 2.0"	"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 11.6"	"Group enriched"	"Detected in some"	40	"endometrial cancer: 23.3;ovarian cancer: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"									"unprognostic (6.95e-3)"						"unprognostic (9.01e-2)"								0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	5.4	0.1	0.1	0.1	0.0	1.1	0.1	1.4	3.2	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	2.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107704104-107824317	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.3;lymphoid tissue: 24.6"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 36.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"gdTCR: 19.5;MAIT T-cell: 18.0;memory CD4 T-cell: 27.3;memory CD8 T-cell: 24.3;naive CD4 T-cell: 26.9;naive CD8 T-cell: 23.9;NK-cell: 17.6"	"Group enriched"	"Detected in many"	5	"NK-cells: 17.6;T-cells: 27.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063326, HPA065958"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	1.3	0.6	0.5	13.9	0.6	2.7	1.4	0.3	0.5	1.2	5.4	0.3	0.3	10.1	0.9	4.9	1.3	1.2	2.4	0.6	1.7	0.9	1.7	2.7	3.2	24.6	0.4	0.0	0.7	1.4	0.0	3.9	0.3	0.5	1.2	2.1	1.6	5.7	0.0	0.3	0.9	12.4	0.4	0.9	11.5	2.4	10.4	0.2	23.9	1.5	1.3	24.5	2.3	1.3	4.5	0.3	3.6	0.1	17.6	27.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	2.1	19.5	0.0	18.0	4.5	27.3	24.3	0.0	3.5	26.9	23.9	3.6	17.6	0.1	0.3	2.6	9.4	0.5	0.6	0.3	0.5	1.7	0.9	0.4	0.0	0.5	0.2
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845769-38950561	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5;placenta: 5.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HDLM-2: 4.9;SCLC-21H: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"amygdala: 0.9;basal ganglia: 0.4;cerebral cortex: 0.6;hippocampal formation: 0.8"	"HPA036746, HPA036747"	Uncertain									"HPA036746: AB_10696785, HPA036747: AB_2675287"	"unprognostic (6.11e-2)"	"unprognostic (5.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.79e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.30e-4)"	0.9	0.2	0.8	0.5	0.8	0.0	0.6	0.1	0.3	0.0	1.1			0.4	0.0	1.4	0.0	0.1	0.1	0.0	0.4	0.5	0.4	0.3	0.0	0.2	0.4		0.0	0.1	0.0	0.4	5.2		0.1	1.3		0.0	0.0	0.1	0.8	1.0	0.5	0.6	7.5	0.0	2.6			0.1		0.1	3.4	0.1	0.2	0.4	0.9	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.1	4.9	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.5	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.9	0.1	0.1	0.4	0.0	0.0										
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108622277-108633959	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.9;lymphoid tissue: 60.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.0;HMC-1: 27.2;Karpas-707: 42.6;RPMI-8226: 59.2;U-266/70: 69.5;U-266/84: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB002431	Enhanced									"CAB002431: AB_563509"	"unprognostic (2.32e-2)"	"prognostic favourable (1.46e-4)"	"unprognostic (3.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.32e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (2.92e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.24e-1)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (5.88e-2)"	"unprognostic (2.37e-2)"	"prognostic favourable (2.74e-4)"	"unprognostic (5.44e-2)"	10.6	5.5	11.3	25.3	8.9	10.7	4.2	2.2	12.5	5.8	5.4	27.2	0.1	5.0	2.9	4.1	5.0	6.8	9.6	5.9	12.1	9.6	4.6	3.9	23.3	46.8	16.2	5.4	2.1	2.9	1.3	3.1	7.3	11.5	3.0	5.2	3.4	5.2	2.5	1.8	2.7	10.3	6.7	19.6	60.5	6.0	2.1	13.5	26.0	3.1	2.8	18.0	14.8	3.0	2.2	50.9	126.9	68.4	28.1	63.2	77.1	0.1	0.0	0.3	0.1	0.1	0.3	0.1	1.0	1.0	0.3	0.3	0.0	0.4	0.1	0.3	1.5	0.0	0.0	0.0	0.3	28.0	0.0	9.9	0.0	0.0	0.0	7.0	27.2	0.3	0.1	0.5	0.1	0.0	0.1	42.6	1.3	0.0	5.6	4.0	0.0	0.3	0.0	0.1	59.2	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	8.9	0.3	0.5	0.1	0.7	0.2	69.5	43.3	1.2	0.3	14.9	0.4	126.9	28.1	88.8	43.8	49.5	35.8	2.0	41.8	37.4	29.4	2.2	32.4	34.1	125.8	28.1	68.4	50.9	63.2	77.1	11.3	8.9	2.2	12.5	12.1	9.6	16.2	5.4	11.5	13.5
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.8;HaCaT: 17.1;TIME: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	77000	77000	"Golgi apparatus"	"Golgi apparatus"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.3	4.5	4.9	5.4	2.6	0.0	0.0	0.0	1.4	16.8	17.1	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	4.5	1.2	5.4	3.9	1.7	0.0	0.1	0.6	0.0	0.0	0.2	0.2	0.0	26.2	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 99.7;hTEC/SVTERT24-B: 39.1;U-251 MG: 57.5;U-87 MG: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 8.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles		29000000	29000000	Vesicles	Vesicles	"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.2	1.9	5.4	10.4	13.8	12.8	1.4	22.9	27.3	1.3	1.8	19.9	1.4	2.7	4.3	1.8	3.2	1.2	3.3	1.4	10.8	5.7	1.4	1.5	4.4	19.0	28.5	5.7	5.9	0.9	6.4	1.9	54.0	28.6	1.4	1.8	7.8	1.7	3.5	1.4	4.7	6.0	2.0	36.4	34.7	3.7	23.6	15.4	9.0	1.1	0.4	19.7	4.6	1.7	1.4	1.8	8.9	0.0	0.8	0.2	0.0	5.7	0.0	1.7	0.5	2.2	7.4	14.3	26.5	10.7	5.6	8.6	2.2	9.4	0.0	1.5	12.0	1.7	0.5	1.7	5.8	0.4	0.3	10.3	0.0	2.8	0.5	0.3	99.7	5.2	0.0	39.1	2.2	0.0	5.9	3.6	18.1	0.4	1.4	3.4	1.8	4.0	0.2	1.1	1.5	2.3	2.4	0.1	0.1	0.2	4.8	2.1	0.3	2.1	1.0	10.5	7.0	5.0	57.5	0.6	0.4	0.1	33.6	1.2	0.5	3.9	0.0	8.9	0.2	0.0	0.2	1.4	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.8	0.0	1.8	0.0	0.0	5.4	13.8	22.9	27.3	10.8	5.7	28.5	5.7	28.6	15.4
SEPT6	"KIAA0128, MGC16619, MGC20339, SEP2, SEPT2"	ENSG00000125354	"Septin 6"	Q14141	X	119615724-119693370	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 145.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 56.9;REH: 52.4;SH-SY5Y: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Supported		Approved	Cytosol		10000000	10000000	Cytosol	Cytosol	"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (6.35e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.60e-2)"	5.1	39.1	6.9	34.0	6.5	20.6	5.6	23.6	13.1	6.1	22.5	3.8	5.6	5.4	6.7	7.2	9.5	7.3	9.9	8.8	6.7	17.2	8.2	9.8	7.0	42.9	9.5	6.9	6.0	2.2	3.4	5.5	14.1	13.3	6.5	7.3	8.4	12.4	16.7	2.3	3.8	17.6	9.3	5.4	31.8	9.5	24.7	3.3	145.4	4.3	4.5	43.8	9.8	5.3	24.3	22.6	13.0	12.9	27.5	38.5	16.8	1.2	2.0	7.6	13.7	0.7	1.6	10.8	3.7	8.3	6.3	10.9	0.6	2.8	25.3	2.9	4.7	0.7	11.9	2.4	4.4	15.4	2.7	11.2	4.1	4.4	1.8	12.6	5.9	2.8	0.5	5.0	0.1	9.2	8.2	13.6	3.7	0.9	56.9	7.1	8.0	6.1	52.4	6.3	20.5	6.7	1.3	3.4	79.9	9.7	3.5	4.1	4.8	6.5	5.7	1.7	3.5	5.5	0.9	6.8	2.7	33.5	0.1	13.4	1.2	9.8	5.6	13.0	22.3	9.4	23.3	24.3	28.4	25.6	12.0	22.9	30.5	26.0	4.4	27.5	12.9	22.6	38.5	16.8	6.9	6.5	23.6	13.1	6.7	17.2	9.5	6.9	13.3	3.3
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2842006	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 119.2;lymphoid tissue: 108.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;U-937: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"		49000000	49000000	"Cytoplasmic bodies"	"Cytoplasmic bodies"	"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	11.4	15.1	3.5	13.4	7.0	75.8	6.4	2.9	3.3	25.1	23.6	5.7	5.3	26.0	6.6	8.6	119.2	7.6	18.1	8.3	3.5	3.9	11.4	36.9	32.6	37.4	7.5	1.8	7.8	66.7	8.3	10.4	11.9	6.2	6.5	16.7	6.7	23.5	3.6	21.8	4.4	49.2	5.6	6.8	34.8	18.0	3.9	5.3	9.4	14.0	98.9	108.0	7.2	20.8	12.8	38.3	48.5	49.6	21.7	16.7	38.7	12.9	15.1	0.8	0.1	3.3	7.0	13.1	3.8	10.9	4.5	8.2	14.2	37.5	0.1	27.5	8.0	8.2	1.5	3.4	3.4	18.5	2.7	22.8	5.1	10.9	12.0	4.0	14.7	8.7	5.9	2.3	1.0	14.8	8.1	3.1	4.0	6.0	0.5	10.5	1.5	7.2	1.2	0.1	13.2	15.5	2.8	2.9	1.6	8.7	3.4	18.9	1.7	12.9	9.1	1.5	3.6	3.2	1.1	0.0	0.6	0.1	5.5	42.6	0.7	27.1	49.6	28.5	16.1	25.7	14.5	12.8	15.6	14.8	38.3	9.6	16.1	16.1	48.5	21.7	19.5	14.8	16.7	38.7	3.5	7.0	2.9	3.3	3.5	3.9	7.5	1.8	6.2	5.3
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6"	"Cell line enhanced"	"Detected in some"		"BJ: 45.7;fHDF/TERT166: 32.2;HaCaT: 78.8;HBEC3-KT: 25.0;HBF TERT88: 43.8;hTERT-HME1: 25.5;U-138 MG: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.2	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	2.0	0.2	0.0	0.0	0.0	0.5	0.0	2.6	0.1	1.3	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	54.6	0.1	0.0	0.1	0.0	0.3	0.3	0.0	6.7	0.1	22.6	16.7	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.7	0.0	45.7	9.2	7.0	5.2	0.0	0.2	0.0	0.0	32.2	78.8	0.0	25.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.5	1.0	25.5	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	1.6	0.9	4.3	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887266-2903280	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.0;lymphoid tissue: 39.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 66.8;HUVEC TERT2: 14.6;TIME: 15.2;U-266/84: 13.7;U-698: 28.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		4900000	4900000	Nucleoplasm	Nucleoplasm	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavourable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	5.6	5.1	3.3	15.9	4.1	7.2	2.6	3.6	6.7	3.9	2.1	4.4	1.3	1.7	1.9	1.9	4.6	4.1	5.3	4.9	3.4	3.6	2.5	7.6	13.7	39.6	4.8	3.9	3.8	1.3	4.7	4.9	24.5	4.7	2.6	2.9	3.5	7.5	1.3	2.0	1.0	5.5	2.4	7.1	14.4	2.0	4.4	2.0	6.4	4.2	2.1	18.9	3.4	3.8	10.3	6.4	2.9	38.0	18.8	17.9	12.3	0.0	2.8	0.1	0.0	0.2	0.1	66.8	0.5	0.1	0.6	1.0	0.8	5.4	10.9	6.8	0.6	0.0	8.0	0.0	0.6	3.5	0.8	1.0	1.0	1.5	3.9	0.0	0.0	3.0	0.0	1.2	0.0	14.6	4.9	0.1	0.5	0.2	0.0	0.0	9.3	0.0	1.0	0.0	0.1	0.4	0.0	0.4	0.1	6.5	0.0	0.0	0.0	0.1	15.2	0.0	0.1	0.0	0.0	0.0	13.7	28.7	0.0	0.0	0.0	1.7	18.3	0.1	17.9	38.0	14.7	8.3	13.0	16.8	6.1	10.3	12.1	17.5	2.9	18.8	22.0	6.4	13.0	12.3	3.3	4.1	3.6	6.7	3.4	3.6	4.8	3.9	4.7	2.0
SERTAD2	"KIAA0127, Sei-2, TRIP-Br2"	ENSG00000179833	"SERTA domain containing 2"	Q14140	2	64631621-64751005	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019021, HPA020904"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA019021: AB_1856740, HPA020904: AB_1856741"	"unprognostic (1.40e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (2.15e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.55e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.21e-3)"	"unprognostic (6.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.84e-1)"	14.3	5.5	4.3	11.3	5.5	52.1	10.4	6.4	5.9	12.4	8.6	9.1	5.6	4.6	9.6	7.6	24.7	7.8	8.4	10.9	4.7	3.5	6.7	11.0	11.8	12.5	7.2	4.4	12.1	5.8	8.4	6.2	17.4	6.0	8.6	6.5	10.2	18.4	7.5	10.8	18.8	9.9	9.5	6.7	24.5	7.2	7.4	8.4	53.8	7.6	16.7	25.7	22.0	16.7	5.4	8.8	3.8	3.1	2.6	4.2	1.4	14.3	4.2	8.0	8.0	6.9	17.6	9.2	11.5	11.1	6.8	6.5	10.8	11.0	12.2	6.4	18.8	5.7	5.2	7.0	14.6	1.1	7.9	8.0	4.0	7.8	1.5	7.0	4.1	11.9	9.3	15.7	10.2	4.1	5.0	6.8	15.9	3.4	7.5	7.7	4.4	11.3	6.6	13.7	4.7	9.3	13.2	9.3	3.6	8.1	5.7	14.4	3.8	5.7	12.4	37.2	19.2	21.7	9.3	11.7	4.4	14.1	13.8	13.0	14.5	2.3	2.7	3.8	1.8	2.8	1.1	4.7	1.8	2.0	2.8	5.4	4.2	3.1	3.8	2.6	3.1	8.8	0.9	1.4	4.3	5.5	6.4	5.8	4.7	3.5	7.2	4.4	6.0	8.4
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Cell line enhanced"	"Detected in many"		"A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	Nucleoli,Cytosol	"Secreted in other tissues"	54000000	54000000	Cytosol	Cytosol	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	68.6	11.6	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	36.2	0.6	3.0	0.0	108.3	0.0	166.7	0.0	16.4	0.5	0.0	11.6	12.2	0.0	0.0	0.1	0.0	111.9	0.0	29.3	0.0	0.1	0.4	0.0	14.6	0.0	0.0	0.2	19.3	0.0	0.0	3.8	25.9	15.8	0.0	0.0	16.6	2.9	0.1	7.7	0.1	0.0	0.0	31.7	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4
SH2D2A	"F2771, TSAd"	ENSG00000027869	"SH2 domain containing 2A"	Q9NP31	1	156806243-156816862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.5;lymphoid tissue: 41.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.9;HMC-1: 15.8;Karpas-707: 38.0;RPMI-8226: 11.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdTCR: 26.5"	"Group enriched"	"Detected in many"	30	"NK-cells: 10.1;T-cells: 26.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"prognostic favourable (4.96e-4)"	"unprognostic (2.76e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (5.26e-12)"	"unprognostic (1.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.79e-1)"	"prognostic favourable (1.31e-4)"	4.1	1.4	0.6	14.3	2.3	4.3	2.0	0.8	1.8	2.6	2.6	1.1	0.5	3.0	2.1	3.8	1.8	2.0	6.2	3.4	0.7	0.8	2.6	2.9	10.3	14.1	1.3	0.4	1.7	1.5	0.0	2.6	1.0	1.4	3.5	2.6	3.1	3.1	2.4	1.3	0.6	9.1	2.0	1.6	20.5	3.4	0.6	1.0	41.2	2.2	2.5	16.0	5.2	1.8	0.3	0.0	0.6	0.0	10.1	26.5	5.9	1.2	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	3.2	0.0	0.0	0.1	0.6	0.0	20.9	0.0	3.1	0.3	0.4	0.1	0.2	15.8	0.2	0.0	0.1	1.6	0.1	0.8	38.0	0.0	0.1	2.6	0.3	2.3	3.9	0.4	0.0	11.0	0.0	0.1	3.6	0.0	0.7	0.4	0.3	0.1	0.6	1.0	0.0	0.0	0.1	0.2	5.5	7.3	3.8	0.0	3.1	0.1	0.3	0.0	0.0	26.5	0.0	24.8	0.3	11.2	16.2	0.0	0.1	4.3	11.1	0.6	10.1	0.0	0.0	12.8	5.9	0.6	2.3	0.8	1.8	0.7	0.8	1.3	0.4	1.4	1.0
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46580554-46621626	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA048876	Uncertain		Uncertain	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"				"Nuclear bodies"	"Nuclear bodies"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	1.5	0.8	1.0	17.3	3.0	18.9	0.9	2.4	1.3	0.8	2.2	0.6	0.3	1.3	1.5	2.0	5.7	0.4	1.1	1.5	1.0	0.7	5.0	0.3	1.7	11.2	0.7	0.7	1.2	0.3	0.2	0.8	2.8	0.7	0.9	2.5	0.3	2.6	0.3	1.4	3.8	2.3	1.9	1.1	9.9	1.4	14.1	0.9	22.9	0.6	3.0	12.9	2.0	1.6	4.6	2.0	1.8	5.4	0.3	3.4	2.1	15.2	16.2	6.1	7.4	1.3	3.1	8.5	31.0	12.2	30.4	14.1	7.7	10.0	13.3	14.0	14.1	10.1	13.4	10.1	37.6	8.5	9.0	14.6	12.2	13.1	0.0	12.8	18.7	0.6	0.6	22.3	9.0	15.9	6.0	14.1	32.9	10.1	11.5	10.7	4.8	17.3	21.0	41.1	21.3	6.2	4.7	2.6	3.3	21.4	11.4	4.9	6.2	10.5	9.1	22.3	14.4	21.4	24.6	11.2	14.8	21.4	10.2	13.9	22.4	0.3	0.8	1.8	0.5	1.3	0.1	4.6	0.8	0.4	1.2	1.9	0.1	0.3	0.8	0.3	5.4	2.0	3.4	2.1	1.0	3.0	2.4	1.3	1.0	0.7	0.7	0.7	0.7	0.9
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633344-52669683	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 10.8;lymphoid tissue: 25.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.3;Karpas-707: 12.7;NB-4: 3.6;RPMI-8226: 16.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.8;NK-cells: 5.7;T-cells: 7.9"	"Region enhanced"	"Detected in single"		"hypothalamus: 4.7"	"Low region specificity"	"Detected in many"			HPA030744	Uncertain									"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"	0.6	0.4	1.0	25.4	1.4	3.5	0.5	1.3	2.0	1.3	1.2	1.2	0.0	1.0	1.1	1.9	1.0	0.9	1.3	0.3	0.9	8.8	0.8	0.4	1.2	20.4	2.8	0.2	0.2	0.7	0.0	3.2	0.5	1.2	0.7	0.9	0.6	3.7	1.0	0.7	0.2	5.7	0.6	2.1	12.1	1.2	1.2	0.7	3.5	1.3	0.3	24.0	3.2	0.4	10.8	0.1	1.9	0.0	5.7	7.9	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	3.6	2.1	0.0	0.0	0.0	16.7	0.1	0.0	0.5	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	7.9	0.0	4.5	10.7	7.2	6.4	0.1	10.8	5.0	3.1	0.0	5.7	0.0	0.1	2.2	1.8	1.0	1.4	1.3	2.0	0.9	8.8	2.8	0.2	1.2	0.7
SIGLEC1	"CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN"	ENSG00000088827	"Sialic acid binding Ig like lectin 1"	Q9BZZ2	20	3686970-3707128	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.7"	"Cell line enriched"	"Detected in single"	18	"THP-1: 6.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 4.1;intermediate monocyte: 2.5;myeloid DC: 1.9;plasmacytoid DC: 1.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.9;monocytes: 4.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA053457	Supported				"Intracellular and membrane"	110000	110000			"HPA053457: AB_2682158"	"unprognostic (2.05e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.83e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (8.69e-5)"	"unprognostic (8.71e-2)"	"prognostic unfavourable (4.36e-4)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	11.6	8.0	1.5	4.5	2.0	7.0	4.7	1.5	1.9	1.5	4.4	1.5	1.5	2.9	1.5	1.5	3.1	4.2	5.3	3.5	1.5	0.1	2.9	4.9	9.7	35.7	2.1	1.5	1.6	1.5	0.0	1.5	12.2	3.0	1.5	4.1	1.8	6.3	1.5	3.2	1.5	5.9	4.6	1.5	12.0	2.9	1.5	1.5	2.8	1.9	3.4	1.8	4.8	1.7	0.0	1.9	0.0	4.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.2	1.5	2.0	1.5	1.9	1.5	0.1	2.1	1.5	3.0	1.5
SIGLEC9	CD329	ENSG00000129450	"Sialic acid binding Ig like lectin 9"	Q9Y336	19	51124908-51136651	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.7;lymphoid tissue: 25.1"	"Group enriched"	"Detected in some"	10	"Karpas-707: 20.7;RPMI-8226: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"classical monocyte: 40.6;intermediate monocyte: 36.5;myeloid DC: 34.1;neutrophil: 42.7;non-classical monocyte: 22.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 34.1;granulocytes: 42.7;monocytes: 40.6"									HPA010682	Uncertain					220000	220000			"HPA010682: AB_1079968"	"unprognostic (2.31e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.03e-3)"	"prognostic unfavourable (6.17e-5)"	"unprognostic (6.56e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-1)"	8.5	5.7	6.6	17.0	12.6	7.6	7.4	0.9	5.0	1.7	2.5	4.0	0.0	1.6	1.4	2.8	1.1	3.7	4.9	2.9	6.2	2.3	4.5	5.5	9.0	15.8	8.4	0.7	3.2	1.8	5.8	1.5	7.5	8.1	1.6	2.4	1.3	2.3	0.9	0.8	0.9	2.6	6.1	8.8	25.1	2.0	1.9	9.6	0.8	1.4	0.0	2.3	3.7	1.2	0.0	34.1	42.7	40.6	0.5	3.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.8	1.3	0.0	2.5	40.6	0.3	3.2	36.5	1.8	0.0	0.5	1.2	34.1	0.0	0.1	0.6	42.7	0.5	22.9	1.8	0.1	14.4	6.6	12.6	0.9	5.0	6.2	2.3	8.4	0.7	8.1	9.6
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"Single-minded family bHLH transcription factor 2"	Q14190	21	36699133-36749917	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 22.9;RPTEC TERT1: 28.8;RT4: 17.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.5"	"Group enriched"	"Detected in some"	4	"hypothalamus: 2.1;midbrain: 0.8"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (2.88e-4)"	0.5	0.3	0.8	0.1	2.3	0.0	0.1	2.4	2.3	2.8	0.2	0.2	0.0	0.1	0.3	1.5	31.3	0.3	0.2	0.1	2.5	1.1	16.1	0.1	0.1	0.1	1.4	0.7	0.1	0.1	1.2	1.7	0.1	0.3	6.8	0.0	0.2	0.4	0.0	15.7	0.3	0.1	0.0	0.4	0.1	5.5	0.2	1.3	0.0	0.2	11.0	28.7	1.5	0.4	0.3	0.7	0.0	0.0	0.0	0.8	0.0	3.2	5.0	0.2	0.2	0.0	0.0	5.0	0.1	0.0	0.4	0.0	2.6	7.6	0.1	4.6	0.1	1.7	2.5	0.0	0.2	3.9	7.9	0.1	7.2	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.4	0.0	0.1	0.0	8.3	1.9	0.0	0.0	0.2	22.9	0.0	0.1	0.1	28.8	17.3	0.2	0.3	8.2	0.0	0.7	2.1	0.2	0.3	0.0	1.4	0.5	0.2	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	2.3	2.4	2.3	2.5	1.1	1.4	0.7	0.3	1.3
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638097-65650930	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"				Nucleoli	Nucleoli	"CAB020833: , HPA039867: AB_2676716"	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	10.5	9.1	7.5	27.1	12.0	29.8	10.0	2.6	8.7	8.9	10.8	9.4	2.9	7.7	10.9	3.0	7.6	9.0	9.9	8.0	8.4	4.6	9.5	7.8	17.6	33.2	11.5	4.7	7.7	4.6	2.7	4.2	11.9	10.3	8.6	3.9	8.2	8.7	6.8	5.4	4.2	17.2	9.0	14.3	47.1	8.1	3.0	10.5	25.3	7.7	4.6	32.7	8.5	7.8	6.6	2.8	14.1	5.2	5.8	7.4	3.0	0.7	6.2	4.4	9.5	2.6	5.4	10.5	7.1	6.0	5.5	5.4	1.9	6.8	9.8	16.0	3.5	3.6	1.6	2.3	1.8	10.6	3.9	23.9	9.1	3.3	4.6	9.6	10.3	5.5	1.1	7.7	1.0	16.2	13.5	4.5	2.7	2.7	3.8	16.5	3.0	5.7	17.5	2.4	8.7	2.1	0.5	1.7	10.1	3.5	6.1	14.5	4.6	14.9	22.7	6.9	13.9	7.5	1.4	6.8	5.3	22.0	9.4	15.4	19.8	4.0	4.1	10.2	7.4	4.8	5.5	5.3	3.7	4.8	2.8	6.6	2.9	4.4	14.1	5.8	5.2	2.7	3.5	3.0	7.5	12.0	2.6	8.7	8.4	4.6	11.5	4.7	10.3	10.5
SIRPB2	"dJ776F14.2, PTPN1L, PTPNS1L3"	ENSG00000196209	"Signal regulatory protein beta 2"	Q5JXA9	20	1470741-1491587	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.5;lymphoid tissue: 21.2"	"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HBEC3-KT: 4.5;HMC-1: 9.1;hTCEpi: 9.8;HUVEC TERT2: 4.8;THP-1: 8.6;TIME: 4.3;U-937: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"classical monocyte: 19.8;eosinophil: 12.3;intermediate monocyte: 12.8;myeloid DC: 8.8;neutrophil: 29.5;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	194	"dendritic cells: 8.8;granulocytes: 29.5;monocytes: 19.8"					"Low region specificity"	"Detected in all"			"HPA011548, HPA048032"	Uncertain		Approved	"Nuclear bodies"		100000	100000	"Nuclear bodies"	"Nuclear bodies"	"HPA011548: AB_2668514, HPA048032: AB_2680236"	"unprognostic (3.22e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.50e-5)"	"unprognostic (3.59e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	8.1	4.2	5.8	15.8	11.0	8.1	5.2	0.8	6.5	2.8	2.4	3.3	0.0	1.3	1.9	4.5	2.6	3.1	5.2	2.7	5.9	3.1	2.6	2.5	9.5	17.3	9.2	1.7	1.4	1.6	0.7	1.4	10.0	7.9	1.8	2.5	2.4	2.8	1.0	1.2	1.5	3.3	5.5	13.1	21.2	2.0	1.8	9.1	1.0	1.7	0.3	4.3	6.4	3.9	0.0	8.8	29.5	19.8	0.0	0.0	6.4	5.2	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.3	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	9.1	0.0	9.8	0.0	0.2	4.8	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	8.6	4.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	9.2	0.1	1.2	19.8	12.3	0.0	12.8	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	29.5	0.0	9.7	0.3	0.0	6.4	5.8	11.0	0.8	6.5	5.9	3.1	9.2	1.7	7.9	9.1
SKA1	"C18orf24, MGC10200"	ENSG00000154839	"Spindle and kinetochore associated complex subunit 1"	Q96BD8	18	50374995-50394173	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.5;testis: 28.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA045495	Approved		Supported	Microtubules				Microtubules	Microtubules	"HPA045495: AB_10960405"	"unprognostic (2.18e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.66e-3)"	"unprognostic (5.93e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (9.60e-8)"	"unprognostic (1.03e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.91e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.50e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	1.3	1.5	0.3	6.3	0.3	12.1	1.5	2.2	0.5	1.2	1.9	0.1	0.0	1.7	0.5	0.8	6.1	0.3	1.1	0.4	0.5	0.4	0.6	0.8	1.3	5.2	0.5	0.4	0.4	2.8	0.1	0.3	3.3	0.4	0.4	2.8	0.2	1.2	0.0	0.6	1.5	2.0	1.4	1.0	4.4	1.5	28.0	0.0	27.5	0.4	5.9	8.7	0.9	1.6	2.1	0.6	2.5	0.9	1.7	1.9	1.1	9.8	3.9	6.3	6.1	0.5	0.9	3.8	10.9	4.6	12.8	12.7	6.4	3.5	8.8	2.9	3.4	8.8	9.0	4.5	12.1	12.4	3.0	10.6	3.1	6.7	1.1	16.8	10.6	0.5	0.4	11.0	6.5	7.2	13.4	30.8	10.5	3.5	11.8	3.8	4.7	3.1	5.8	8.1	8.6	2.5	1.1	5.4	3.4	6.6	3.5	5.1	5.0	5.8	3.9	12.8	7.1	4.4	11.7	13.3	21.4	15.0	5.6	13.7	10.9	1.9	0.9	0.5	0.9	0.4	0.6	1.7	1.2	1.9	0.5	2.1	0.7	0.8	2.5	1.7	0.5	0.6	1.5	1.1	0.3	0.3	2.2	0.5	0.5	0.4	0.5	0.4	0.4	0.0
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133440-48430275	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9;lymphoid tissue: 52.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.6;HDLM-2: 10.1;HMC-1: 8.6;Karpas-707: 10.7;RPMI-8226: 12.6;RPTEC TERT1: 15.6;U-266/70: 9.7;U-266/84: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favourable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (3.14e-4)"	1.9	9.4	0.5	28.0	0.6	2.9	4.5	0.4	0.6	5.9	3.8	0.6	10.9	1.1	2.2	10.6	2.1	8.0	6.2	2.1	1.3	1.1	12.9	2.0	5.2	20.0	0.7	0.4	2.4	2.8	11.6	17.5	0.7	1.2	3.0	2.4	1.6	10.2	7.4	0.5	1.2	6.1	1.2	1.9	11.7	2.2	7.8	0.6	52.1	1.8	1.3	27.7	5.1	4.3	11.9	0.1	2.1	0.2	22.3	50.9	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	19.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	15.6	0.0	0.0	0.0	1.0	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	9.7	6.9	0.0	0.0	0.0	0.0	2.1	0.1	0.3	35.9	0.0	30.1	2.8	29.6	32.2	0.1	11.9	26.1	28.9	0.7	22.3	0.2	0.1	50.9	22.3	0.5	0.6	0.4	0.6	1.3	1.1	0.7	0.4	1.2	0.6
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646216	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.7;lymphoid tissue: 36.5"	"Cell line enriched"	"Detected in some"	8	"HEL: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"gdTCR: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Nucleoplasm, Golgi apparatus, Vesicles"	"Nucleoplasm, Golgi apparatus, Vesicles"	"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favourable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	2.3	0.8	0.7	15.1	0.8	11.3	1.3	1.5	0.5	1.5	3.9	0.2	2.3	2.8	2.0	1.1	1.7	1.4	4.8	1.6	0.7	0.7	1.5	1.9	6.9	17.1	0.7	0.0	1.6	0.8	0.0	1.1	1.6	0.8	1.5	1.8	1.8	6.3	0.4	0.9	0.7	7.5	1.5	1.1	15.9	2.5	1.0	0.3	36.5	1.5	1.1	18.4	3.8	1.3	0.2	21.7	2.3	0.3	16.5	14.9	11.6	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.2	1.7	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.1	3.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.6	0.0	0.8	0.2	1.6	13.9	0.3	11.7	0.2	11.5	12.9	0.1	0.1	10.8	14.5	2.3	16.5	0.0	21.7	14.9	11.6	0.7	0.8	1.5	0.5	0.7	0.7	0.7	0.0	0.8	0.3
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.6;lymphoid tissue: 51.9"	"Group enriched"	"Detected in some"	5	"Daudi: 32.6;U-698: 48.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favourable (9.42e-4)"	"prognostic favourable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favourable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favourable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	3.9	0.8	0.4	21.0	0.4	1.2	1.0	0.4	0.4	1.1	3.8	0.3	0.4	1.1	1.0	0.6	2.3	1.6	2.8	1.2	0.4	0.4	2.1	1.6	4.7	51.9	0.6	0.4	0.6	0.8	0.0	0.6	1.7	0.7	1.4	1.5	1.5	5.6	1.0	0.5	0.7	11.9	0.4	0.8	29.6	2.3	0.9	0.2	12.9	1.8	0.6	30.4	4.1	1.3	15.2	0.3	8.4	1.0	15.9	28.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	48.1	0.0	0.2	0.0	2.5	0.1	8.4	22.9	0.3	15.8	14.7	14.6	28.6	0.1	15.2	8.2	16.4	1.0	15.9	1.0	0.3	16.8	7.4	0.4	0.4	0.4	0.4	0.4	0.4	0.6	0.4	0.7	0.2
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.9;lymphoid tissue: 45.0"	"Cell line enriched"	"Detected in some"	5	"U-266/70: 78.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles		620000	620000	Vesicles	Vesicles	"CAB015445: AB_1121905, HPA055945: , HPA061654: AB_2684576"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.46e-2)"	"prognostic favourable (3.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (8.57e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-2)"	5.5	1.0	0.7	28.6	0.7	2.3	3.4	0.6	0.7	4.1	11.9	0.2	0.4	11.1	1.9	1.3	6.7	1.6	6.2	1.0	0.7	0.7	2.4	3.1	10.2	24.6	0.8	0.4	2.5	2.2	0.0	0.9	1.3	0.6	1.8	10.2	2.9	15.1	4.8	0.9	2.0	15.8	0.8	1.2	45.0	11.0	1.5	0.4	5.9	2.1	4.2	38.7	11.5	2.6	3.7	27.4	1.1	14.9	17.3	32.9	8.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	2.1	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	78.8	6.7	0.0	2.2	0.0	0.0	0.0	1.6	0.3	32.9	11.0	25.4	3.7	3.5	22.4	7.2	0.6	1.1	13.6	1.1	17.3	14.9	27.4	0.0	8.7	0.7	0.7	0.6	0.7	0.7	0.7	0.8	0.4	0.6	0.4
SLAMF8	"BLAME, CD353, SBBI42"	ENSG00000158714	"SLAM family member 8"	Q9P0V8	1	159826750-159837249	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;HL-60: 3.5;U-138 MG: 4.9;U-87 MG: 2.7;U-937: 2.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 12.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA067601	Enhanced									"HPA067601: AB_2685870"	"unprognostic (1.04e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (5.42e-5)"	"unprognostic (3.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	16.9	4.6	1.5	20.1	3.4	0.4	5.4	8.2	1.6	3.1	6.0	1.4	0.6	4.6	1.8	4.2	3.1	3.6	6.1	7.1	5.2	1.7	7.8	2.2	19.6	44.1	4.1	0.7	3.8	2.0	0.1	4.2	5.4	5.0	2.7	7.1	3.0	4.2	1.0	2.2	3.1	7.0	5.4	4.1	22.7	3.1	2.4	2.7	9.7	4.8	3.0	12.7	8.6	2.8	0.0	12.1	0.5	6.6	8.1	3.8	2.8	0.0	0.1	0.0	0.0	0.5	4.1	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.8	0.0	0.1	1.8	0.0	0.0	0.0	3.5	0.6	1.4	0.0	0.3	0.1	0.0	0.0	0.8	0.2	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.6	0.0	4.9	0.2	0.0	0.9	0.0	0.0	0.0	2.7	2.5	0.0	0.0	5.1	0.0	3.2	6.6	0.2	0.0	1.1	3.8	12.1	0.0	0.2	2.6	0.5	8.1	0.4	0.1	0.0	2.8	1.5	3.4	8.2	1.6	5.2	1.7	4.1	0.7	5.0	2.7
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Cell line enhanced"	"Detected in some"		"HEL: 3.7;HMC-1: 3.6;NB-4: 3.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 0.8"	HPA029590	Uncertain									"HPA029590: AB_10794613"	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	0.9	2.1	0.2	0.2	0.0	0.8	0.0	0.0	0.0	0.7	0.1	3.7	0.6	0.7	0.1	0.0	3.6	0.3	0.1	0.0	0.2	0.0	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.3	1.0	0.2	0.7	0.4	0.2	0.0	0.3	0.3	0.6	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063067-125090312	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.2;salivary gland: 85.6"	"Cell line enhanced"	"Detected in some"		"A-431: 12.5;CAPAN-2: 26.6;hTCEpi: 12.0;hTERT-HME1: 28.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"classical monocyte: 8.0;intermediate monocyte: 9.9;myeloid DC: 3.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 3.7;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain									"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	7.1	26.4	1.0	47.2	1.4	0.0	3.4	0.4	1.0	2.5	3.6	3.5	0.5	3.7	0.7	2.0	7.2	1.0	2.4	2.3	1.3	0.7	1.0	2.7	7.2	6.4	1.5	0.3	1.8	0.7	0.0	0.6	3.2	1.5	2.0	4.6	2.4	85.6	0.6	0.4	16.3	4.6	1.3	1.7	10.2	0.8	0.7	1.2	1.4	0.6	3.3	3.1	6.6	6.5	0.1	3.7	0.6	11.9	0.0	0.0	3.1	12.5	0.0	0.2	0.0	0.2	0.4	0.0	0.4	1.2	0.3	1.2	0.1	26.6	0.0	3.8	0.1	6.6	0.2	7.1	1.8	0.3	0.2	2.8	0.2	0.6	0.0	0.0	0.1	0.3	12.0	1.2	28.6	0.7	0.1	0.1	1.2	0.0	0.0	0.6	0.3	0.2	0.0	0.9	0.2	0.3	6.4	0.0	0.1	2.3	0.0	0.8	0.0	0.5	1.4	20.4	0.0	0.2	0.5	0.3	0.4	0.0	0.7	0.7	1.6	0.0	8.0	0.0	0.0	9.9	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.6	0.0	11.9	0.0	0.0	3.1	1.0	1.4	0.4	1.0	1.3	0.7	1.5	0.3	1.5	1.2
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560579-189583758	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.4;lymphoid tissue: 170.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 91.2;CACO-2: 20.8;HEL: 73.9;HMC-1: 19.5;T-47d: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favourable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	18.2	126.4	3.9	10.1	5.5	3.9	47.4	1.8	3.5	20.0	25.7	3.7	13.9	34.4	24.7	24.3	6.3	25.9	25.2	37.1	4.1	4.3	14.4	42.1	45.9	170.2	5.1	1.9	50.9	24.0	4.6	9.8	51.3	6.4	18.4	15.8	11.6	10.2	16.6	12.3	4.9	44.7	13.6	5.8	76.4	11.3	16.2	3.5	17.0	20.8	6.4	8.8	11.1	20.4	0.1	22.7	64.7	20.8	0.8	17.3	20.1	0.0	1.2	0.1	0.0	91.2	0.6	4.4	0.0	1.1	0.3	0.5	20.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.3	73.9	0.3	7.6	0.3	0.2	19.5	6.4	0.0	0.2	0.0	2.2	7.5	0.2	1.1	0.0	3.0	4.8	0.2	0.3	0.0	0.8	0.4	0.9	3.0	0.1	0.9	0.1	6.1	0.0	36.0	1.0	0.0	0.1	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	20.8	32.9	0.4	4.7	0.6	0.0	11.3	1.0	22.7	0.1	17.3	3.7	64.7	0.8	0.4	3.7	1.0	20.1	3.9	5.5	1.8	3.5	4.1	4.3	5.1	1.9	6.4	3.5
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890913	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.1;U-2197: 1.0"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 17.0;intermediate monocyte: 8.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved									"HPA020098: AB_2670363"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.82e-2)"	0.2	0.1	0.1	0.5	0.1	0.0	1.0	1.1	0.5	17.7	0.1	0.0	21.1	0.0	3.6	10.4	1.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	17.1	1.9	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.8	0.0	0.1	0.4	9.9	0.1	22.3	0.2	0.6	0.2	1.0	0.1	1.5	0.0	31.8	0.1	0.0	0.3	5.4	0.7	0.0	3.8	0.2	17.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	6.5	0.1	0.0	4.1	0.1	0.1	1.1	0.5	0.1	0.3	0.1	0.2	0.0	0.0
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272190	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.5;lymphoid tissue: 14.5"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 8.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041004, HPA041329"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	1.7	1.7	2.9	1.1	8.8	0.5	1.1	13.5	8.6	0.9	1.4	0.5	3.6	1.3	1.1	3.2	0.6	0.6	1.9	2.3	2.9	3.6	1.1	0.6	2.9	2.1	2.1	2.3	1.4	1.5	0.5	0.6	1.7	4.3	1.0	1.1	0.5	1.0	2.5	1.7	4.2	0.9	0.6	2.7	14.5	0.8	3.3	1.2	0.0	1.0	0.0	1.3	1.6	0.4	1.5	0.8	1.0	0.5	0.6	0.9	0.1	0.5	4.1	3.7	1.2	6.8	4.7	0.4	1.3	5.8	3.4	3.1	0.2	2.9	0.0	0.8	1.6	0.2	1.0	0.7	1.3	1.2	1.2	3.2	0.3	0.9	0.8	1.4	6.7	5.3	1.4	1.9	0.4	0.7	0.7	1.9	2.2	2.3	0.1	0.3	2.5	0.4	0.0	0.8	0.9	0.6	0.7	2.1	0.9	3.5	0.2	1.8	1.4	0.3	1.0	8.8	1.4	1.6	0.6	3.6	0.9	1.8	6.3	0.7	2.2	0.0	0.4	0.0	0.0	0.0	0.6	1.5	0.4	0.9	0.1	0.0	0.4	0.4	1.0	0.6	0.5	0.8	0.0	0.1	2.9	8.8	13.5	8.6	2.9	3.6	2.1	2.3	4.3	1.2
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;NTERA-2: 5.9;RPMI-8226: 5.5;SCLC-21H: 6.4;U-266/70: 3.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	2.3	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	5.9	0.9	1.0	0.9	5.5	0.1	0.0	6.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.1	1.2	3.4	0.5	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0
SLFN12L		ENSG00000205045	"Schlafen family member 12 like"	Q6IEE8	17	35464249-35537861	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.4;Karpas-707: 13.7;U-266/70: 4.9;U-266/84: 4.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdTCR: 9.5;MAIT T-cell: 8.8;memory CD4 T-cell: 6.3;memory CD8 T-cell: 8.0;naive CD4 T-cell: 4.8;naive CD8 T-cell: 5.2;NK-cell: 6.8;T-reg: 4.7"	"Group enriched"	"Detected in many"	7	"NK-cells: 6.8;T-cells: 9.5"									HPA024447	Uncertain									"HPA024447: AB_1856614"	"unprognostic (1.93e-3)"	"unprognostic (2.10e-4)"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.18e-3)"	"unprognostic (2.98e-5)"	"unprognostic (4.59e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.25e-6)"	"unprognostic (2.30e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (8.88e-3)"	7.2	0.9	1.0	11.2	1.2	6.6	2.7	0.8	1.4	1.6	3.0	0.9	1.2	3.9	3.6	3.0	2.3	2.0	3.8	1.4	1.1	1.1	1.8	1.8	9.1	10.6	1.7	0.5	1.3	1.2	0.5	1.0	0.6	2.9	1.8	2.0	2.1	6.2	1.3	0.9	1.2	7.0	1.1	1.9	18.4	3.0	0.8	1.1	5.8	2.8	2.1	16.3	2.3	2.0	0.4	0.3	1.1	0.4	6.8	9.5	1.9	0.5	0.2	0.2	0.2	0.1	0.0	0.2	0.2	0.0	0.6	1.4	0.1	0.4	0.5	0.1	0.0	0.3	0.0	0.0	0.7	19.4	0.1	1.2	0.7	0.1	0.0	0.4	0.2	0.3	0.1	0.2	0.0	0.1	0.3	13.7	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.1	0.1	0.1	1.9	0.5	0.3	1.2	0.5	0.2	4.9	4.3	0.1	0.2	0.3	0.5	0.8	0.4	0.9	9.5	0.1	8.8	0.3	6.3	8.0	0.3	0.4	4.8	5.2	1.1	6.8	0.1	0.3	4.7	1.9	1.0	1.2	0.8	1.4	1.1	1.1	1.7	0.5	2.9	1.1
SLFN14		ENSG00000236320	"Schlafen family member 14"	P0C7P3	17	35548125-35558098	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.0;lymphoid tissue: 3.0"	"Cell line enriched"	"Detected in some"	6	"HEL: 21.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022994, HPA023065"	Uncertain					13000	13000			"HPA022994: AB_10670035, HPA023065: AB_2671055"	"unprognostic (4.27e-3)"	"unprognostic (4.72e-4)"		"unprognostic (1.21e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-1)"	"unprognostic (7.59e-8)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-3)"	0.2	0.0	0.0	0.5	0.0	9.0	0.1	0.0	0.0	0.1	0.1			0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.2	1.5	1.3	0.0		0.0	0.0	0.0	0.0	0.9		0.1	0.0		0.2	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.3	0.3			0.2		0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	2.2										
SLURP2		ENSG00000283992	"Secreted LY6/PLAUR domain containing 2"	P0DP57	8	142764338-142769844	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 112.1;lymphoid tissue: 60.7;tongue: 105.8"	"Cell line enriched"	"Detected in some"	4	"HaCaT: 24.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	112.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	105.8	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.1	5.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SMAP2	SMAP1L	ENSG00000084070	"Small ArfGAP2"	Q8WU79	1	40344850-40423326	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 90.9"	"Cell line enhanced"	"Detected in all"		"THP-1: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021466, HPA024424"	Approved									"HPA021466: AB_2239737, HPA024424: AB_1857259"	"unprognostic (1.65e-1)"	"prognostic favourable (6.55e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.32e-1)"	"prognostic favourable (5.34e-5)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.24e-1)"	24.3	9.4	21.3	47.3	25.9	26.1	12.7	17.0	35.1	17.8	12.2	12.4	2.7	6.6	6.8	5.8	10.0	11.8	17.7	6.6	20.0	19.1	8.2	26.3	21.6	90.9	15.7	15.6	6.9	8.9	9.5	16.0	13.9	18.2	7.2	12.5	9.1	11.4	7.7	12.0	11.4	34.3	15.0	14.2	79.2	15.0	6.2	13.8	35.1	7.0	4.3	70.0	16.7	6.9	14.4	11.7	47.4	42.7	6.9	8.4	10.5	6.0	2.2	5.5	5.5	8.0	15.5	3.0	9.4	8.6	9.8	9.6	2.8	4.1	22.5	4.6	8.4	2.5	10.1	7.2	13.5	42.4	8.5	12.4	3.6	6.1	7.2	12.9	38.7	13.3	6.1	12.6	5.5	5.5	22.4	23.8	11.6	4.0	18.7	12.2	3.3	20.6	7.2	5.1	23.0	4.7	7.0	9.3	4.3	4.4	11.5	7.1	3.7	73.4	3.0	10.8	4.4	10.0	7.2	7.8	8.6	18.5	9.8	12.9	6.9	2.7	21.1	23.2	3.7	36.8	4.6	10.6	5.9	5.5	11.7	14.4	8.4	7.7	47.4	6.9	42.7	2.2	8.1	10.5	21.3	25.9	17.0	35.1	20.0	19.1	15.7	15.6	18.2	13.8
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141417	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	7.4	6.1	6.6	10.1	10.5	15.2	6.1	8.1	9.1	7.9	7.5	4.0	5.1	7.0	6.1	5.2	11.4	5.1	3.6	7.1	6.5	6.8	8.6	5.7	5.5	14.2	8.2	5.2	6.0	4.1	5.2	6.5	7.5	10.7	5.2	8.5	3.0	5.9	4.7	4.2	6.8	6.9	5.4	8.6	13.7	5.9	12.3	8.7	56.1	7.2	12.9	14.7	6.1	6.3	8.9	5.1	12.0	8.3	8.0	7.4	2.8	18.1	14.0	15.8	14.6	3.3	4.9	14.8	16.8	8.0	15.1	12.8	12.1	14.1	34.7	8.2	8.6	30.8	22.9	10.9	20.5	22.0	9.6	20.9	22.5	7.8	0.9	12.6	21.1	3.2	2.2	20.4	8.3	10.6	16.8	28.6	13.6	8.8	32.9	6.5	13.7	11.0	22.1	45.3	13.0	6.5	6.6	15.0	11.6	20.0	9.4	4.9	18.9	8.6	8.4	18.4	19.4	25.4	21.0	10.5	35.2	20.4	11.9	18.6	22.2	12.0	2.8	2.8	6.2	7.1	7.0	8.5	5.7	6.2	3.0	8.9	6.7	7.4	0.4	8.0	8.3	5.1	6.9	2.8	6.6	10.5	8.1	9.1	6.5	6.8	8.2	5.2	10.7	8.7
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434962	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (4.20e-5)"	"prognostic unfavourable (9.00e-4)"	"prognostic unfavourable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	4.8	5.5	3.0	25.4	4.4	15.1	4.0	3.1	3.2	5.3	10.1	1.7	5.3	6.5	5.2	4.9	19.3	4.6	7.0	5.7	2.4	1.7	4.4	6.3	7.9	16.5	3.1	1.3	4.7	4.2	1.7	10.8	7.4	2.6	4.4	6.9	2.7	5.7	6.9	5.9	4.6	7.0	6.2	3.1	13.1	5.7	20.7	3.2	70.2	5.1	7.6	14.3	7.8	6.3	8.8	6.1	30.5	7.6	7.8	15.8	4.8	62.1	11.5	26.2	12.1	5.0	5.1	12.1	31.0	14.7	35.9	31.2	14.5	35.8	39.4	18.1	12.7	36.0	29.8	15.0	57.8	52.2	20.8	38.1	19.7	4.7	2.8	25.2	31.2	2.6	2.2	19.0	15.5	15.2	21.9	45.8	21.4	11.2	30.9	6.2	15.4	27.1	31.4	41.2	28.6	6.7	7.7	15.8	16.4	23.7	21.9	10.8	26.3	18.9	14.4	23.0	19.2	20.9	56.5	30.6	31.3	71.9	16.4	25.9	25.5	30.5	3.2	12.1	6.7	4.7	6.5	8.8	10.5	8.0	3.5	7.2	6.7	6.0	5.7	7.8	7.6	6.1	15.8	4.8	3.0	4.4	3.1	3.2	2.4	1.7	3.1	1.3	2.6	3.2
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358325-68448688	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.4;MOLT-4: 13.4;RPMI-8226: 11.1;SCLC-21H: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 44.5"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 44.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.1"	"Low region specificity"	"Detected in all"			"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favourable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	3.5	2.3	6.0	3.1	18.3	1.8	1.6	9.4	15.4	1.0	9.6	2.5	0.0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5.0	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3.0	18.6	4.2	4.4	73.0	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0.0	0.0	0.7	0.3	0.3	0.7	0.3	0.1	0.0	0.0	5.2	0.4	0.0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	1.1	0.0	0.0	0.1	0.3	0.7	0.1	2.1	0.3	0.0	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.3	0.2	13.4	2.5	0.6	0.1	0.6	0.2	11.1	0.0	0.1	12.9	2.5	0.4	1.5	0.6	1.0	0.8	0.0	0.4	0.8	1.4	0.1	2.1	1.1	0.2	0.2	0.8	0.2	1.0	0.0	6.1	0.7	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	44.5	0.5	0.3	6.0	18.3	9.4	15.4	8.7	3.6	2.5	5.0	3.9	4.4
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572882-100663415	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0"	"Cell line enriched"	"Detected in single"	50	"RT4: 41.9"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"thalamus: 2.9"	"Group enriched"	"Detected in some"	4	"basal ganglia: 0.8;olfactory region: 3.1"	"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1.0	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16.0	1.1	0.3	3.0	0.5	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3.0	1.6	0.0	0.3	0.0	0.0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254405-11256200	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.3;lymphoid tissue: 58.3"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 47.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 15.2"	"Cell type enhanced"	"Detected in many"		"basophil: 12.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	Nucleoplasm	"CAB010355: AB_2193144, HPA074108: AB_2686661"	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.9	2.8	0.7	19.2	1.5	13.9	37.9	15.2	1.1	15.8	6.3	0.3	2.2	3.3	4.9	7.6	5.6	4.2	11.0	3.6	0.6	1.0	11.1	42.3	9.6	25.8	0.8	0.0	9.3	3.8	0.7	16.8	9.3	2.4	5.3	1.8	3.2	3.7	3.9	2.3	6.0	11.0	6.5	1.1	14.7	6.6	7.1	0.4	58.3	5.1	4.8	14.7	5.4	8.3	4.4	1.3	12.9	0.1	5.5	2.7	0.4	1.2	0.2	0.5	0.1	1.6	0.2	1.8	1.0	7.3	0.4	0.6	0.3	0.2	2.8	2.2	0.4	0.5	0.2	0.1	0.1	47.2	0.3	0.7	0.0	3.8	0.6	0.0	8.7	0.6	0.1	1.0	0.0	0.1	6.3	0.8	0.0	1.1	3.1	1.8	5.3	0.8	0.3	0.3	0.3	0.5	0.2	0.7	0.1	0.2	1.7	0.5	0.0	0.4	0.0	0.6	3.1	0.4	0.6	0.2	0.2	4.4	1.2	0.3	0.6	12.9	0.1	8.8	2.2	0.0	2.0	1.4	2.5	2.7	0.0	4.4	2.7	2.5	0.3	5.5	0.0	1.3	2.6	0.4	0.7	1.5	15.2	0.6	0.6	1.0	0.8	0.0	2.4	0.4
SOWAHD	ANKRD58	ENSG00000187808	"Sosondowah ankyrin repeat domain family member D"	A6NJG2	X	119758613-119760164	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.1;lymphoid tissue: 12.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;NB-4: 3.8;SK-BR-3: 4.5;THP-1: 11.2;U-937: 10.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"			HPA065955	Uncertain									"HPA065955: AB_2685586"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.74e-3)"	0.7	0.9	1.0	3.9	2.5	4.2	0.5	0.7	2.1	0.6	1.8	4.0	2.0	4.6	0.4	0.0	0.6	0.8	1.5	1.1	0.9	0.9	1.3	0.8	3.5	6.7	2.5	1.1	0.8	2.2	0.3	0.5	9.6	1.5	0.9	1.1	0.9	5.0	1.0	0.4	0.6	6.7	0.2	3.0	12.6	1.8	8.0	2.0	0.7	0.4	1.1	3.2	0.8	0.5	11.1	2.3	3.7	3.6	0.3	1.9	0.7	0.6	0.0	0.2	0.1	0.0	0.0	6.0	0.1	0.0	0.6	0.9	1.2	0.2	0.3	0.8	0.0	0.1	0.0	0.0	0.1	1.0	0.7	0.1	0.1	1.6	0.3	1.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	1.1	0.1	0.6	0.0	3.8	1.3	0.4	3.3	0.1	0.2	0.1	0.2	0.4	0.2	1.3	4.5	0.2	0.7	11.2	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.0	10.0	0.1	0.0	3.4	1.9	0.1	3.6	0.0	9.0	0.5	0.4	2.3	11.1	1.9	1.0	3.7	0.3	3.0	1.1	0.0	0.7	1.0	2.5	0.7	2.1	0.9	0.9	2.5	1.1	1.5	2.0
SP140	"LYSP100-A, LYSP100-B"	ENSG00000079263	"SP140 nuclear body protein"	Q13342	2	230203110-230313215	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.2;lymphoid tissue: 46.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.6;HDLM-2: 29.4;Karpas-707: 14.7;RPMI-8226: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 36.2"	"Low lineage specificity"	"Detected in all"											"HPA006162, HPA067493"	Enhanced		Approved	"Nucleoli fibrillar center,Mitochondria"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA006162: AB_1857403, HPA067493: AB_2685851"	"unprognostic (8.15e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-3)"	"unprognostic (5.72e-4)"	"unprognostic (5.66e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.20e-9)"	"unprognostic (9.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.30e-3)"	1.9	0.8	0.9	39.1	1.1	2.9	1.1	0.5	0.7	0.7	2.3	0.5	0.0	1.4	0.6	0.9	3.5	0.8	1.4	0.8	0.9	1.0	1.1	1.1	6.3	26.9	1.4	0.0	0.7	0.4	0.0	0.9	0.6	0.6	1.0	2.0	1.0	8.9	0.1	0.3	0.7	13.1	0.3	2.0	34.9	2.3	1.3	0.7	4.0	1.3	1.7	46.8	4.8	0.9	36.2	3.0	12.6	3.6	5.1	10.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	17.6	0.0	0.0	0.0	0.0	0.0	1.1	29.4	0.0	0.0	0.0	0.3	0.1	2.5	0.1	0.3	0.0	0.3	0.4	0.0	0.0	14.7	0.3	0.0	0.0	0.8	0.8	0.0	0.0	1.6	9.1	5.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.8	0.0	0.0	5.4	2.2	0.6	1.3	0.4	0.0	0.0	1.3	4.1	9.0	2.6	10.0	36.2	9.0	9.7	3.0	25.1	4.6	6.1	12.6	5.1	3.6	0.2	7.8	3.6	0.9	1.1	0.5	0.7	0.9	1.0	1.4	0.0	0.6	0.7
SP7	"osterix, OSX"	ENSG00000170374	"Sp7 transcription factor"	Q8TDD2	12	53326575-53345315	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0;lymphoid tissue: 3.3;testis: 4.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;HSkMC: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory region: 34.5"	"Low region specificity"	"Detected in all"			HPA063202	Enhanced									"HPA063202: AB_2684961"	"unprognostic (6.02e-1)"	"unprognostic (6.28e-3)"		"unprognostic (6.37e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.75e-2)"		"unprognostic (3.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.02e-1)"	"unprognostic (3.93e-7)"	"unprognostic (6.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.95e-1)"	1.0	0.2	1.7	0.0	2.8	0.4	0.1	0.3	4.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.1	1.1	0.5	0.1	0.0	0.2	3.3	0.7	0.0	0.2	0.0	1.9	0.0	0.1	0.0	0.0	0.0	1.7	0.4	0.1	0.1	0.1	0.0	0.2	1.6	0.3	0.3	4.2	0.0	0.0	1.7	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.7	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.4	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.1	1.7	2.8	0.3	4.0	1.1	0.5	0.7	0.0	0.0	0.0
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599279	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.3;testis: 94.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 10.1;T-reg: 6.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 10.1;T-cells: 6.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA022008, HPA022479"	Approved									"HPA022008: AB_1853519, HPA022479: AB_1853521"	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavourable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.1	1.1	2.3	7.6	3.8	16.5	1.7	2.7	3.4	1.7	5.1	0.8	0.5	3.9	2.0	1.9	3.8	0.5	1.8	1.7	1.8	3.7	12.7	9.5	2.6	6.5	1.5	0.7	1.4	1.9	0.4	1.9	3.3	1.3	1.3	5.3	1.3	1.4	0.9	0.8	2.5	7.1	1.5	1.9	5.8	1.7	94.2	1.0	27.3	3.9	5.5	11.2	1.8	1.3	1.2	0.4	10.1	0.7	1.0	6.2	1.2	23.6	25.2	30.1	23.3	1.5	2.5	12.4	19.2	12.2	28.6	23.0	19.6	7.2	16.7	10.4	13.3	20.7	32.7	12.1	30.5	30.0	21.0	17.7	25.0	23.7	0.2	23.0	22.4	0.8	1.1	23.0	11.9	14.9	19.0	29.6	23.1	15.6	30.2	27.3	16.2	12.7	20.2	41.9	19.9	8.6	12.7	22.9	13.4	27.5	33.2	9.6	23.7	21.0	7.3	16.5	27.7	13.6	32.7	13.7	21.0	25.7	11.1	17.6	26.3	10.1	0.0	0.3	0.6	0.7	1.1	0.9	1.8	1.3	0.1	1.2	1.5	1.4	0.6	1.0	0.4	0.4	6.2	1.2	2.3	3.8	2.7	3.4	1.8	3.7	1.5	0.7	1.3	1.0
SPATA1	SP-2	ENSG00000122432	"Spermatogenesis associated 1"		1	84506300-84566194	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.6;testis: 6.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.7;REH: 2.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (6.00e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-2)"	"unprognostic (8.84e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.77e-3)"	"unprognostic (5.52e-4)"	"unprognostic (2.03e-1)"	"unprognostic (5.81e-8)"	"unprognostic (1.63e-1)"	"unprognostic (5.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.79e-4)"	0.0	0.0	0.7	4.6	3.5	0.9	0.1	0.0	0.6	1.2	0.0	0.7	0.0	0.0	0.6	0.9	0.0	0.1	0.0	0.5	0.0		2.0	0.9	1.9	0.3	0.0	0.9	0.8	0.8	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.2	6.9	0.0	0.9	0.8	0.0	0.8	0.5	0.0	0.7	0.3	2.6	0.3	0.0	0.4	0.1	0.3	0.0	0.6	0.6	0.3	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.0	0.9	0.1	1.3	0.2	1.2	0.1	0.3	0.4	0.2	0.4	1.7	0.7	0.2	0.1	0.9	0.3	0.6	2.2	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.8	0.5	0.1	0.5	1.2	1.0	0.0	0.6	0.3	0.0	0.0	0.0	0.4	1.0	0.1	0.6	0.3	0.0	0.1	0.3	0.0	0.7	0.1	0.0	0.1	0.5	0.1	0.1	2.6	0.0	0.0	0.3	0.4	0.1										
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24, NDC80 kinetochore complex component"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favourable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	2.8	3.2	1.1	9.0	1.0	19.4	3.8	0.4	1.9	2.8	4.0	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1.0	0.4	1.8	2.6	4.2	4.9	0.6	1.0	1.1	1.0	0.1	1.0	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4.0	13.3	0.7	58.0	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.0	9.8	13.6	11.1	1.9	3.6	6.2	15.3	5.7	14.5	16.5	10.3	8.9	20.7	17.5	6.8	14.2	10.6	10.9	10.8	10.9	9.1	27.8	22.9	15.3	0.4	19.4	12.5	0.7	0.4	10.3	4.8	12.8	14.8	43.7	10.1	17.2	26.6	11.8	9.6	15.9	21.3	20.9	6.7	4.3	8.6	14.3	10.3	13.4	8.4	3.5	8.2	7.1	12.0	13.8	14.6	18.4	18.3	26.7	13.7	19.9	10.1	19.3	11.1	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1.0	0.4	1.9	1.0	0.4	0.6	1.0	0.6	0.7
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378576	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 100.3;lymphoid tissue: 70.2"	"Cell line enhanced"	"Detected in some"		"HEL: 18.7;HL-60: 32.9;HMC-1: 61.4;NB-4: 55.5;THP-1: 43.2;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 45.4;neutrophil: 24.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	24.4	8.1	6.7	35.7	15.2	100.3	9.0	1.5	6.6	3.6	5.2	8.6	0.0	7.6	3.2	6.2	4.0	8.5	7.7	15.7	5.6	5.1	5.8	11.9	37.2	51.1	12.6	1.6	6.1	3.5	0.9	3.6	10.1	9.6	4.5	3.9	3.9	6.4	2.6	3.3	5.0	10.5	7.6	12.1	70.2	5.8	5.4	10.5	9.6	3.7	2.7	16.8	9.1	5.7	1.0	4.6	45.4	9.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	32.9	61.4	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	55.5	0.0	0.0	10.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	17.5	0.0	24.4	0.0	3.6	5.4	45.4	0.0	7.8	0.0	1.0	0.0	0.0	4.6	0.8	0.0	0.0	24.8	0.0	9.1	0.2	0.0	1.5	6.7	15.2	1.5	6.6	5.6	5.1	12.6	1.6	9.6	10.5
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor, Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 61.9"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in many"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"			"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	0.2	0.4	0.2	24.3	0.3	0.0	0.2	0.2	0.2	0.2	69.3	0.2	0.2	28.8	0.2	0.2	0.3	0.2	35.8	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.4	0.2	0.2	0.3	110.5	2.5	0.2	0.2	0.3	0.2	120.9	4.6	0.2	0.3	0.5	0.3	0.2	0.2	0.2	0.2	0.2	3.4	0.2	0.0	0.0	5.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	10.0	0.4	0.0	0.0	61.9	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	1.3	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	5.2	1.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.1	0.0	5.1	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
SPRR1B	"GADD33, SPRR1"	ENSG00000169469	"Small proline rich protein 1B"	P22528	1	153031202-153032900	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 264.7;lymphoid tissue: 188.6;tongue: 618.5"	"Cell line enriched"	"Detected in some"	9	"hTCEpi: 89.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 468.6;head and neck cancer: 1812.5;melanoma: 425.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.73e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.59e-2)"		"unprognostic (9.68e-2)"		"prognostic unfavourable (7.66e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (7.64e-5)"			"unprognostic (5.71e-2)"		"unprognostic (2.15e-1)"	"prognostic unfavourable (7.28e-4)"	0.1	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	94.9	0.1	0.1	0.1	0.1	9.5	0.2	264.7	0.2	2.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	48.7	0.1	0.2	33.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.9	0.1	618.5	188.6	0.2	113.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	9.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	89.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 855.8;lymphoid tissue: 537.4;tongue: 389.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.7;hTCEpi: 10.9;RT4: 13.9;TIME: 3.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 423.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044467	Enhanced					15000	15000			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavourable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	157.6	0.2	0.0	0.0	0.2	11.5	0.2	855.8	0.2	1.8	0.5	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	1.2	0.0	0.2	0.2	0.0	93.4	0.2	0.4	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.0	0.0	0.2	389.6	537.4	0.6	163.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	6.7	3.5	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	10.9	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	13.9	0.0	0.0	0.4	3.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSBP2	HSPC116	ENSG00000145687	"Single stranded DNA binding protein 2"	P81877	5	81413021-81751797	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 89.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 36.2;REH: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020834, HPA068605"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB020834: , HPA068605: AB_2732116"	"unprognostic (4.62e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.04e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.39e-3)"	18.9	11.5	16.3	11.1	24.3	11.0	20.0	49.8	21.3	26.5	18.8	13.6	11.1	5.2	27.0	27.2	21.3	26.4	14.2	26.3	16.1	22.8	10.3	3.2	11.3	15.4	19.9	16.2	33.1	8.7	42.4	31.0	11.7	20.9	16.1	11.7	20.0	14.6	19.5	16.3	19.6	10.3	26.1	20.6	8.9	13.6	6.9	21.5	89.9	12.8	11.7	19.9	19.0	18.5	16.2	8.1	26.2	12.2	25.6	15.2	7.9	1.0	1.9	24.7	14.0	14.2	21.7	1.5	5.1	4.7	4.8	4.9	0.0	2.0	17.0	0.3	6.0	0.1	6.7	2.7	4.6	7.2	2.9	3.5	4.1	0.0	8.0	1.7	9.5	22.2	23.9	0.8	4.6	2.0	2.3	8.4	5.1	2.4	36.2	2.9	3.4	1.0	54.5	5.6	13.0	2.5	0.9	12.8	11.6	5.4	6.1	1.8	8.9	5.0	1.3	1.9	3.1	3.5	1.3	8.8	6.8	28.5	6.4	3.1	1.2	20.7	8.6	26.2	2.4	7.6	3.8	9.9	7.7	4.3	8.1	16.2	15.2	5.3	12.5	25.6	12.2	2.6	3.4	7.9	16.3	24.3	49.8	21.3	16.1	22.8	19.9	16.2	20.9	21.5
SSTR3		ENSG00000278195	"Somatostatin receptor 3"	P32745	22	37204238-37212322	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 11.1;lymphoid tissue: 29.6;testis: 11.3"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 21.8;SCLC-21H: 8.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.9"					"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.9;naive CD8 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022647	Approved									"CAB022647: "	"unprognostic (1.63e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.26e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-2)"	0.1	0.8	2.8	1.9	1.9	0.9	0.1	2.7	11.1	0.0	0.5	0.2	0.0	2.6	1.9	0.2	0.1	0.1	0.1	0.0	5.6		0.1	0.0	0.1	3.5	0.0	7.9	5.8	3.9	0.0	6.4	0.0	7.9	0.2	0.6	0.0	0.6	0.1	0.0	0.0	1.0	2.2	4.3	1.2	0.5	11.3	0.1	29.6	0.0	0.0	2.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	8.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	3.9	3.0	0.1	0.0	0.0	0.1	0.3	0.8										
SSTR5		ENSG00000162009	"Somatostatin receptor 5"	P35346	16	1078781-1080142	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0"	"Group enriched"	"Detected in some"	15	"Hep G2: 9.2;PC-3: 34.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 4.2;hypothalamus: 2.7"	"Low region specificity"	"Detected in many"			HPA066503			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA066503: AB_2685679"		"unprognostic (2.16e-2)"	"unprognostic (7.31e-2)"		"unprognostic (3.69e-2)"	"unprognostic (2.39e-2)"		"unprognostic (2.14e-1)"			"unprognostic (9.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"		"unprognostic (4.09e-2)"	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.4	0.0	0.7	0.6	0.9	0.5	0.0	8.2	2.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	9.0	0.0	0.0	1.1	0.0	0.0	1.1	0.9	0.1	0.1	0.8	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	5.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	1.3	0.3	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806935-100903266	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.1;lymphoid tissue: 34.7"	"Cell line enhanced"	"Detected in many"		"AF22: 18.7;HDLM-2: 30.2;Karpas-707: 26.0;NB-4: 12.2;RPMI-8226: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	580000	580000	"Golgi apparatus"	"Golgi apparatus"	"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	11.7	2.7	4.3	16.7	4.3	8.2	6.5	1.3	4.2	3.4	5.3	2.6	0.3	4.0	2.3	4.2	4.3	3.5	6.5	4.7	4.0	8.0	2.6	3.3	17.5	27.9	5.1	1.7	2.5	2.1	1.5	2.4	13.7	11.6	3.4	5.6	2.7	4.0	1.3	2.0	2.1	7.7	3.6	8.0	31.6	3.7	1.6	4.3	34.7	4.9	0.8	13.8	7.4	3.5	4.7	4.9	37.1	8.9	4.0	6.9	4.4	0.0	2.7	18.7	0.0	1.2	1.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	30.2	0.0	1.1	0.2	0.0	0.0	5.6	2.3	1.5	0.0	0.0	0.0	3.4	0.0	26.0	1.1	0.2	7.9	12.2	0.1	0.1	4.5	0.3	19.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.1	1.2	0.2	0.1	0.0	0.2	8.5	8.7	1.7	0.4	7.0	2.3	18.8	7.5	8.9	5.7	8.8	4.3	4.7	3.8	4.7	4.9	3.6	2.4	4.5	37.1	4.0	8.9	1.5	6.9	4.4	4.3	4.3	1.3	4.2	4.0	8.0	5.1	1.7	11.6	4.3
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 90.8"	"Group enriched"	"Detected in some"	47	"HUVEC TERT2: 33.1;NB-4: 45.7;TIME: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	68	"classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8"	"Group enriched"	"Detected in many"	69	"dendritic cells: 2.8;monocytes: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		60000000	60000000	Cytosol	Cytosol	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	39.5	37.6	8.0	26.7	12.8	6.5	41.3	3.2	6.8	13.1	23.4	6.9	4.2	16.1	13.6	26.4	9.7	15.5	16.8	19.7	5.4	4.2	19.2	35.8	21.7	80.7	9.1	2.7	9.9	7.1	4.9	11.9	32.1	10.2	13.5	18.0	23.7	10.4	9.7	8.0	5.1	18.7	18.3	7.2	90.8	11.6	9.7	8.7	2.6	11.9	11.4	11.1	15.9	15.4	0.0	2.8	0.0	10.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	8.0	12.8	3.2	6.8	5.4	4.2	9.1	2.7	10.2	8.7
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL, centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.0;testis: 23.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046543			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA046543: AB_2679692"	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.2	1.4	1.3	10.8	2.4	11.0	2.9	1.4	2.2	1.2	4.1	0.9	2.5	3.6	1.5	2.2	5.8	0.9	1.7	2.0	1.4	1.2	1.5	1.6	1.7	5.0	1.3	1.5	1.2	1.5	0.9	0.9	5.5	1.1	1.7	6.4	0.8	3.6	0.5	0.8	4.2	4.0	1.3	1.2	3.4	2.2	23.8	1.0	36.0	1.1	3.5	7.1	1.3	2.1	1.9	1.6	5.4	0.7	3.3	1.2	0.5	16.9	9.1	13.1	11.7	0.9	2.3	8.3	15.0	7.2	16.8	17.7	9.8	8.4	20.0	7.1	7.4	11.3	15.3	7.8	18.1	14.9	6.9	22.5	11.3	8.6	0.5	18.1	11.5	0.8	1.3	14.4	9.4	11.1	15.9	19.0	12.6	7.7	17.6	5.7	15.8	7.5	11.5	21.3	9.6	4.7	10.2	11.7	7.0	16.1	11.9	7.7	7.7	10.4	6.5	15.8	16.1	11.4	20.2	6.3	13.0	19.6	7.4	13.9	14.7	4.3	0.7	1.1	1.1	0.4	0.5	1.7	1.2	1.0	0.5	1.9	0.8	0.8	5.4	3.3	0.3	1.6	1.1	0.5	1.3	2.4	1.4	2.2	1.4	1.2	1.3	1.5	1.1	1.0
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in all"		"WM-115: 51.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		24000	24000	"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favourable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.7	7.2	4.5	6.7	5.2	6.5	11.5	10.1	8.4	7.3	6.8	3.7	10.2	9.3	5.4	12.4	9.0	2.0	12.3	4.8	12.2	3.3	11.2	3.0	2.1	7.5	11.3	13.3	6.4	2.6	9.9	8.3	6.3	1.0	13.1	5.1	12.4	8.1	25.5	1.8	5.7	13.4	3.5	6.2	3.0	9.8	3.0	3.7	5.8	8.1	27.6	2.9	24.0	8.7	8.2	4.1	5.7	5.4	11.1	16.3	5.9	10.8	17.5	51.5	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA018138, HPA037979"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Nuclear speckles"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2.0	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11.0	9.0	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.5	5.7	5.2	3.5	6.5	8.6	2.1	16.5	17.8	9.0	9.2	4.9	3.3	7.3	26.0	13.7	9.4	3.9	21.9	12.6	18.0	4.4	6.5	4.3	6.1	4.8	11.2	4.4	7.0	25.8	11.9	10.9	16.8	7.6	25.2	10.3	2.1	18.2	5.2	8.0	18.7	6.3	3.3	14.5	15.7	3.4	2.8	6.3	7.4	3.4	4.8	4.0	5.7	16.8	19.6	7.5	11.6	18.4	15.3	7.6	10.6	19.9	9.9	31.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 35.5;HMC-1: 36.0;Karpas-707: 33.4;U-698: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.1	2.2	3.3	1.2	14.7	5.6	3.7	7.6	11.4	8.3	8.7	6.6	1.1	35.5	7.0	4.3	2.2	1.4	3.2	10.2	6.2	3.8	3.3	2.8	0.6	4.4	13.4	36.0	7.1	3.2	10.3	5.4	3.4	2.6	33.4	20.6	1.7	17.4	30.4	1.9	5.1	2.9	20.3	10.7	4.9	7.5	1.2	1.3	1.9	1.9	1.6	1.3	7.0	4.1	8.1	4.0	5.8	4.2	13.7	22.2	38.7	6.1	4.6	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051442-5500998	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.6;lymphoid tissue: 33.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 11.5;REH: 10.1;U-2197: 18.5;WM-115: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.3;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.3;dendritic cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058536			Approved	Vesicles,Microtubules				Microtubules	Microtubules	"HPA058536: AB_2683746"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favourable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	5.2	0.8	6.0	2.1	4.8	2.3	7.3	1.0	5.8	6.0	2.1	5.2	1.6	1.2	5.7	1.6	2.3	2.5	4.7	0.9	4.5	7.6	23.6	0.5	1.3	2.8	5.3	2.2	1.2	4.9	0.8	0.8	5.1	4.2	2.3	2.2	3.0	2.9	1.9	2.1	3.6	1.6	7.0	3.9	0.6	9.5	7.1	2.9	33.6	2.8	2.1	1.9	4.2	6.1	1.3	3.5	0.0	0.5	0.0	0.0	0.0	0.0	5.7	0.3	0.0	0.2	0.4	0.0	4.0	0.5	2.7	0.1	0.0	0.0	0.0	0.8	8.1	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	11.5	0.0	0.0	1.4	0.0	0.0	0.8	1.7	0.0	10.1	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	2.9	0.0	1.1	18.5	0.0	0.4	0.0	0.0	0.0	0.0	47.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.0	4.8	1.0	5.8	4.5	7.6	5.3	2.2	4.2	2.9
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 143.4;lymphoid tissue: 117.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 79.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 79.3;T-cells: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010107	Enhanced		Supported	Cytosol		210000	210000	Cytosol	Cytosol	"CAB010107: AB_628297"	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavourable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	7.3	13.2	91.7	17.5	47.4	40.7	10.9	54.1	124.8	6.2	16.7	47.0	2.5	12.7	24.7	7.8	13.0	7.3	9.4	9.5	67.9	88.4	13.2	6.4	11.0	42.8	86.5	58.0	33.6	3.5	4.6	12.1	21.7	43.4	5.2	20.7	7.7	5.3	6.3	3.8	9.5	15.9	18.8	143.4	10.9	9.7	58.2	27.1	117.1	6.1	7.2	43.1	13.0	8.1	8.6	79.3	4.0	1.5	10.1	26.2	9.3	67.5	15.2	151.7	60.6	9.1	8.8	15.4	52.7	41.9	75.3	72.9	10.4	69.5	83.1	29.6	38.4	20.7	42.0	30.5	113.3	25.1	20.8	51.5	26.9	36.3	3.6	64.8	36.8	5.4	4.5	30.3	34.6	56.6	69.5	82.9	97.5	17.6	213.2	95.3	93.0	20.5	126.2	118.3	49.3	36.4	6.1	102.8	89.2	47.9	24.0	42.0	34.4	82.6	27.2	50.6	60.1	43.8	43.9	48.9	77.6	103.2	24.9	126.8	54.5	2.0	0.7	4.0	10.4	1.5	6.3	6.4	9.3	13.1	4.2	8.6	15.3	13.7	0.3	10.1	0.7	79.3	26.2	9.3	91.7	47.4	54.1	124.8	67.9	88.4	86.5	58.0	43.4	27.1
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.5;lymphoid tissue: 101.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 55.2;U-937: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol		53000000	53000000	Cytosol	Cytosol	"HPA015564: AB_1857626, HPA063868: AB_2685136"	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (7.68e-4)"	"prognostic favourable (5.13e-6)"	7.2	7.9	5.5	17.9	9.9	49.5	9.9	2.0	5.8	6.5	17.7	5.4	15.9	19.0	3.0	10.4	23.4	9.6	14.3	18.4	5.2	2.0	20.2	19.0	46.4	61.5	12.2	1.3	4.6	28.0	10.9	9.8	24.9	5.8	16.4	10.5	8.7	24.6	9.7	1.5	15.3	32.0	3.7	16.9	101.5	20.6	22.5	8.0	73.4	19.5	5.4	17.8	11.4	18.0	6.7	30.2	45.6	101.5	9.0	9.9	31.9	24.0	8.5	0.2	0.1	0.0	0.2	16.9	3.1	0.3	0.6	1.6	20.1	15.3	6.4	12.4	2.4	16.6	0.9	14.7	0.6	26.5	10.3	27.5	10.2	11.8	14.7	17.7	55.2	1.0	15.1	3.0	8.6	12.9	17.1	21.9	0.0	15.2	8.6	41.1	6.3	15.1	8.9	0.0	24.4	12.3	27.9	2.6	0.1	7.4	11.0	0.5	13.7	45.8	13.5	0.1	5.0	0.3	0.1	24.4	12.0	8.2	0.2	48.4	0.6	25.5	58.1	35.5	9.6	73.1	7.7	6.3	7.3	8.6	30.2	6.7	5.2	6.2	45.6	9.0	101.5	11.5	9.9	31.9	5.5	9.9	2.0	5.8	5.2	2.0	12.2	1.3	5.8	8.0
SUCNR1	GPR91	ENSG00000198829	"Succinate receptor 1"	Q9BXA5	3	151873643-151884619	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.1;lymphoid tissue: 23.3"	"Group enriched"	"Detected in some"	5	"HEL: 27.4;NB-4: 15.8;U-937: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.0;intermediate monocyte: 1.0;non-classical monocyte: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.2;granulocytes: 2.0;monocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022745	Uncertain									"CAB022745: "	"unprognostic (1.54e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.58e-1)"	13.7	1.6	0.6	0.7	0.9	4.7	1.6	0.2	1.2	0.3	0.5	0.7	0.0	0.7	0.4	0.6	0.5	0.3	0.2	2.8	0.4	0.4	63.1	3.6	2.2	3.3	0.6	0.1	0.7	0.4	4.2	0.3	0.2	0.8	0.5	0.5	0.1	1.3	0.0	0.3	0.7	0.5	0.3	0.5	23.3	6.7	0.4	0.0	1.3	14.6	0.8	0.3	0.7	0.3	0.0	2.2	2.0	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	4.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.1	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.7	2.2	0.0	0.2	0.6	0.9	0.2	1.2	0.4	0.4	0.6	0.1	0.8	0.0
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;CAPAN-2: 34.1;MCF7: 20.9;T-47d: 17.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB033013, HPA041724, HPA043539"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"CAB033013: AB_661450, HPA041724: AB_2677638, HPA043539: AB_2678540"	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	5.6	7.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	34.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	20.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	2.9	0.1	17.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.7;HEL: 22.3;HL-60: 30.8;HMC-1: 20.5;REH: 25.8;THP-1: 23.7;U-698: 18.3;U-937: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		1000000	1000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.2	3.3	6.0	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5.0	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	38.7	1.1	0.0	6.0	0.8	3.2	0.0	0.0	5.3	22.3	0.0	0.0	0.0	30.8	20.5	0.0	4.4	0.0	0.4	0.0	0.6	3.1	0.0	4.7	0.0	13.5	0.2	0.0	25.8	0.0	10.6	0.8	5.8	2.0	1.8	0.0	2.7	0.0	2.5	23.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.3	0.0	21.7	0.0	1.4	21.4	23.3	0.1	19.0	0.1	23.1	0.0	0.0	24.9	17.5	0.0	0.0	32.8	8.7	16.4	18.5	0.0	10.2	6.0	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.1;HMC-1: 20.6;Karpas-707: 21.4;U-266/84: 9.6;U-698: 19.8;U-937: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	4.4	2.3	1.5	16.9	2.1	55.6	2.5	0.9	2.0	1.9	2.5	7.9	1.3	1.7	9.7	1.8	2.7	2.1	4.1	2.0	1.9	3.7	2.2	2.4	8.4	32.7	5.0	1.1	1.9	1.0	0.4	1.4	2.8	3.9	1.9	3.6	3.2	3.2	1.8	0.8	1.4	11.8	12.2	9.2	22.1	2.7	1.7	3.0	32.6	2.2	4.0	32.1	6.8	1.9	14.9	7.8	47.9	7.7	12.0	22.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.0	0.0	7.3	20.6	0.1	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	1.9	3.8	5.8	0.0	0.6	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	2.3	9.6	19.8	0.0	15.8	0.0	38.7	7.7	23.6	16.4	5.5	18.5	13.9	22.0	19.0	7.8	14.9	17.4	12.1	47.9	12.0	7.0	2.6	15.5	14.4	1.5	2.1	0.9	2.0	1.9	3.7	5.0	1.1	3.9	3.0
TARM1		ENSG00000248385	"T cell-interacting, activating receptor on myeloid cells 1"	B6A8C7	19	54069895-54081365	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;lymphoid tissue: 2.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"basophil: 2.8;neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"									"HPA051022, HPA054401"	Uncertain									"HPA051022: AB_2681315, HPA054401: AB_2682476"														"unprognostic (1.56e-1)"				0.1	0.7	0.1	0.0	0.1	1.2	0.2	0.1	0.4	0.0	0.1			0.0	0.4	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.1	0.2	0.6	0.0	0.1		0.1	0.5	0.0	0.1	0.0		0.1	0.0		0.4	0.1	0.1	0.1	0.1	0.0	0.1	2.4	0.2	0.7			0.7		0.1	0.0	0.1	0.5	0.3	3.1	0.5	0.6	0.3	0.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.3	0.3	0.0	0.0	0.6	1.1	0.4	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.4	0.8	0.7	1.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.0	1.0	0.2	0.8	0.4	0.4	0.2	0.0	0.0	0.6	0.2	1.4	0.4	1.1	0.2	0.0	0.6	0.0	0.9	0.2	0.1	1.1	0.1	1.1	0.4	0.3	0.0	0.9	0.2	2.8	0.5	0.6	0.3	0.4	0.2	0.1	0.2	0.1	0.2	0.5	0.1	0.3	3.1	0.6	0.3	0.3	0.1	0.2										
TBC1D3	"DKFZp434P2235, PRC17, TBC1D3A"	ENSG00000274611	"TBC1 domain family member 3"	Q8IZP1	17	38181659-38192541	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.0;REH: 5.6;U-138 MG: 7.8;U-266/70: 12.1;U-266/84: 4.7;U-698: 6.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.0	0.0		0.0	1.5	0.5			0.0	3.4	0.0	0.0	0.0	1.5	0.0			0.1	0.0	0.0	1.7			0.0	0.0	0.0		0.0		2.9	1.9		0.0	0.0	0.0	0.2	5.5	0.0		0.0	0.0	5.5			0.0		3.5	0.0		0.0	0.0	2.2	0.0	0.0	0.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	12.1	4.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0										
TBC1D31	"Gm85, MGC21654, WDR67"	ENSG00000156787	"TBC1 domain family member 31"	Q96DN5	8	123041968-123152153	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 29.0"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023710	Approved		Approved	Centrosome				Centrosome	Centrosome	"HPA023710: AB_1858819"	"unprognostic (1.39e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.21e-2)"	"unprognostic (3.18e-5)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (1.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.33e-1)"	3.8	4.4	6.7	9.7	10.9	7.3	3.6	13.5	7.7	3.2	5.2	4.5	5.2	6.9	3.8	2.4	4.6	7.5	3.6	5.3	7.2	5.7	4.4	3.8	3.9	11.0	5.5	5.6	2.9	5.4	5.5	8.4	2.7	7.5	3.4	6.3	5.6	3.6	4.1	3.7	4.7	5.9	4.8	4.7	7.4	3.9	9.2	4.7	29.0	5.1	5.2	10.3	5.2	4.1	2.4	2.6	3.0	3.3	9.5	16.8	4.0	10.7	4.5	8.1	6.4	2.8	3.1	4.0	5.8	3.5	7.7	7.1	4.3	4.7	5.0	4.5	2.5	7.0	7.8	3.8	10.9	10.3	7.7	11.8	4.9	3.7	4.4	5.4	8.4	2.5	2.3	6.4	6.6	5.5	9.8	12.0	5.5	8.7	16.8	3.6	6.3	7.9	8.2	7.3	5.2	5.2	2.9	7.6	5.9	13.0	39.0	3.9	6.2	4.5	2.9	6.1	12.5	5.0	8.6	9.4	13.6	6.0	5.0	9.8	9.1	2.7	3.1	3.0	8.3	3.3	16.8	2.4	3.8	6.3	2.6	2.3	4.7	5.3	1.6	9.5	1.4	1.6	3.0	4.0	6.7	10.9	13.5	7.7	7.2	5.7	5.5	5.6	7.5	4.7
TBC1D3K		ENSG00000273513	"TBC1 domain family member 3K"	A0A087X1G2	17	37924415-37935365	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2"	"Group enriched"	"Detected in some"	5	"SiHa: 2.2;T-47d: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.5	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	1.3			0.6	0.0	0.1		0.0		0.0	0.0		0.0	0.0	1.1	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box 21"	Q9UL17	17	47733244-47746119	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.5;bone marrow: 12.2;lymphoid tissue: 17.7"	"Cell line enriched"	"Detected in single"	113	"HDLM-2: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"gdTCR: 13.5;NK-cell: 10.8"	"Group enriched"	"Detected in many"	8	"NK-cells: 10.8;T-cells: 13.5"	"Region enriched"	"Detected in single"	27	"olfactory region: 27.1"	"Low region specificity"	"Detected in all"			"CAB009524, CAB030043"	Enhanced									"CAB009524: AB_2200557, CAB030043: AB_1595503"	"unprognostic (3.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.35e-6)"	"unprognostic (3.93e-1)"	"unprognostic (2.56e-4)"	"unprognostic (5.86e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.26e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.04e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (4.43e-3)"	2.9	0.6	0.5	5.7	0.5	12.2	0.9	0.4	0.4	2.3	4.3	0.9	0.4	1.3	2.0	1.7	1.4	1.0	1.8	0.9	0.5	0.5	1.3	1.9	11.1	9.3	2.6	0.3	1.2	0.6	0.0	0.6	0.2	0.7	3.3	0.7	2.2	3.0	0.4	1.5	0.5	2.7	1.4	0.8	17.7	1.6	0.7	0.4	4.1	1.4	1.6	8.1	2.6	1.8	1.5	0.0	0.2	0.0	10.8	13.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	3.1	1.5	2.8	7.4	0.0	0.4	0.4	7.1	0.2	10.8	0.0	0.0	0.1	1.6	0.5	0.5	0.4	0.4	0.5	0.5	2.6	0.3	0.7	0.4
TBX6		ENSG00000149922	"T-box 6"	O95947	16	30085793-30091887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8"	"Cell line enhanced"	"Detected in many"		"RT4: 10.0;U-266/70: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062498			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062498: AB_2732686"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.62e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.05e-3)"	"unprognostic (4.26e-2)"	1.2	1.4	1.4	1.0	1.5	0.6	0.9	0.9	1.5	2.7	1.2	0.9	0.9	1.8	0.9	1.0	22.8	1.6	1.3	0.9	1.5	1.0	1.8	1.2	1.2	1.2	1.7	0.9	1.9	19.8	3.2	2.3	0.9	2.1	3.2	0.3	2.3	3.9	2.2	2.8	5.0	1.7	0.9	1.5	1.8	7.8	2.4	1.2	1.6	2.3	5.1	16.3	5.5	8.6	4.4	1.3	3.3	2.6	1.3	1.9	1.1	0.9	1.1	0.6	1.2	1.5	0.8	0.8	0.3	0.2	0.0	0.2	1.3	4.3	1.9	2.3	0.2	1.3	0.5	0.9	0.0	1.4	0.8	1.2	1.7	1.0	1.1	0.2	2.6	0.3	1.2	0.3	0.5	0.6	0.1	4.3	0.1	3.7	0.7	0.5	0.9	0.9	2.8	0.1	3.2	0.0	10.0	1.4	2.1	0.2	0.9	1.2	1.8	1.7	0.5	1.2	0.7	0.6	0.0	10.5	2.4	0.3	1.2	1.8	0.4	3.1	2.6	0.8	1.8	2.3	1.2	1.3	0.9	1.3	1.3	4.4	1.9	1.7	3.3	1.3	0.8	1.1	1.8	1.1	1.4	1.5	0.9	1.4	1.5	1.0	1.7	0.9	2.1	1.2
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.1;lymphoid tissue: 51.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 34.7;PC-3: 11.1;RPTEC TERT1: 9.9;U-937: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"basophil: 38.1;classical monocyte: 44.5;eosinophil: 45.2;intermediate monocyte: 67.1;myeloid DC: 18.7;neutrophil: 38.8;non-classical monocyte: 56.4"	"Group enriched"	"Detected in all"	20	"dendritic cells: 18.7;granulocytes: 45.2;monocytes: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031257, HPA031258, HPA031259"	Enhanced					32000000	32000000			"HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.5	7.7	6.6	17.6	8.9	13.8	5.4	1.5	5.6	3.7	6.3	13.9	0.8	6.5	3.2	4.1	3.4	5.0	13.9	3.7	7.6	5.7	6.1	8.1	20.3	43.9	12.6	2.0	2.5	3.1	1.4	3.5	9.0	9.0	5.2	8.6	4.4	8.2	2.6	1.6	1.9	9.3	7.9	19.3	51.7	7.1	2.0	12.7	7.5	2.4	2.2	6.1	9.3	2.5	1.3	18.7	45.2	67.1	1.5	2.2	25.1	0.1	3.0	0.1	0.0	0.6	1.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	4.5	0.3	8.2	0.0	0.0	0.8	2.7	7.3	1.0	0.0	0.0	0.4	1.0	0.2	1.0	0.3	0.0	1.0	34.7	0.1	11.1	1.3	0.0	0.5	9.9	0.0	0.1	0.5	0.1	0.0	0.3	0.0	6.6	0.9	0.2	0.1	0.6	0.5	2.3	0.4	0.1	0.2	28.2	0.8	38.1	44.5	45.2	1.1	67.1	1.7	1.3	2.2	0.6	18.7	0.5	0.3	0.2	38.8	1.5	56.4	3.3	2.0	25.1	6.6	8.9	1.5	5.6	7.6	5.7	12.6	2.0	9.0	12.7
TCF12	"bHLHb20, HEB, HsT17266, HTF4"	ENSG00000140262	"Transcription factor 12"	Q99081	15	56918623-57299281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 89.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004432, HPA065827"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"	"Nucleoplasm, Nuclear speckles"	"CAB004432: AB_671267, HPA065827: AB_2685564"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (7.26e-3)"	"unprognostic (5.57e-3)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (2.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.41e-1)"	20.9	14.3	24.9	12.6	37.5	10.9	18.4	32.7	41.8	48.2	16.5	33.6	14.0	16.0	28.1	15.0	14.8	28.2	21.4	15.7	28.4	16.4	17.0	14.4	17.3	13.7	33.9	15.3	26.2	12.5	29.2	15.7	19.1	27.9	26.3	17.9	14.7	20.1	17.5	18.1	16.0	15.8	25.8	25.3	13.6	17.3	14.7	41.3	89.4	17.0	9.6	15.8	23.3	21.2	11.8	15.9	16.0	19.3	12.2	17.6	10.2	6.5	12.3	54.2	17.5	24.7	21.7	9.5	13.5	23.8	12.0	16.0	8.0	5.3	9.0	11.1	20.4	7.9	21.2	9.7	15.4	11.8	7.9	18.1	13.4	9.5	17.1	11.3	9.5	19.1	17.6	11.0	29.2	21.4	20.2	11.4	16.3	2.2	26.7	6.3	14.6	5.3	36.6	63.0	8.4	16.5	12.2	11.1	32.1	14.6	5.3	13.1	8.2	22.3	16.5	19.4	14.8	8.2	19.7	6.5	11.6	15.0	10.8	22.1	23.1	16.0	11.2	8.7	15.0	14.3	12.4	10.8	12.2	13.6	15.9	11.8	14.1	12.7	1.3	12.2	19.3	6.6	17.6	10.2	24.9	37.5	32.7	26.9	28.4	16.4	33.9	15.3	27.9	41.3
TCF19	SC1	ENSG00000137310	"Transcription factor 19"	Q9Y242	6	31158542-31167159	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.3"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;HEK 293: 19.1;Karpas-707: 16.5;SCLC-21H: 21.0;U-138 MG: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"														"unprognostic (1.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (5.66e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (3.54e-10)"	"unprognostic (3.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.21e-1)"	4.3	1.5	1.3	12.4	4.1	2.3	5.2	8.2	3.9	7.0	5.6	2.3	3.7	9.2	4.2	6.2	11.2	3.2	3.8	3.4	1.7	1.1	4.3	1.6	4.8	18.0	3.0	1.0	4.6	3.6	0.4	0.9	1.5	2.0	5.5	4.0	2.3	4.1	6.7	2.5	11.5	6.0	3.9	1.8	8.6	5.9	3.1	1.8	31.3	2.8	14.4	13.8	4.8	6.7	2.0	0.9	0.2	0.3	1.2	3.8	1.2	33.8	0.3	0.3	0.0	2.3	3.0	0.3	0.2	0.0	0.0	0.0	2.2	0.0	0.0	7.6	8.3	0.0	0.0	12.7	0.0	0.2	19.1	3.0	2.0	0.8	0.0	0.1	9.0	1.3	0.0	1.0	0.0	7.6	0.0	16.5	3.3	0.1	0.4	5.4	0.0	0.0	0.4	2.0	0.2	3.0	0.1	21.0	0.2	0.2	0.0	0.2	0.0	2.5	0.0	21.0	0.1	0.1	0.2	5.4	6.1	10.4	0.0	0.1	0.1	0.0	0.3	0.0	0.7	0.0	3.8	1.6	1.9	3.4	0.9	2.0	2.4	0.9	0.2	1.2	0.1	0.0	2.6	1.2	1.3	4.1	8.2	3.9	1.7	1.1	3.0	1.0	2.0	1.8
TCL1B	TML1	ENSG00000213231	"T cell leukemia/lymphoma 1B"	O95988	14	95686417-95692643	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3"	"Cell line enriched"	"Detected in some"	7	"U-698: 102.4"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"naive B-cell: 13.0;plasmacytoid DC: 5.9"	"Group enriched"	"Detected in many"	23	"B-cells: 13.0;dendritic cells: 5.9"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.2	0.1	0.9	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	1.4	0.4	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	5.3	0.1	0.0	0.2	0.1	0.0	0.1	12.7	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.1	1.8	0.1	7.3	0.0	0.0	0.1	0.0	5.4	0.1	0.1	13.0	5.9	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	102.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.3	0.4	0.0	5.9	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TDGF1	"CR, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582463	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 45.5"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 6.4;testis cancer: 27.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 12.5;pons and medulla: 9.1"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"			Vesicles	Vesicles	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.6	3.9	0.6	0.6	0.8	0.0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0.0	0.6	0.6	1.0	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0.0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1.0	0.0	0.6	0.8	1.0	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1.0	0.7	3.7	0.6	1.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	10.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1.0	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1.0	0.6	0.9	0.6	0.6	0.6
TEDC2	"C16orf59, FLJ13909"	ENSG00000162062	"Tubulin epsilon and delta complex 2"	Q7L2K0	16	2460080-2464963	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3;testis: 12.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051394, HPA055389"	Approved		Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"HPA051394: AB_2681465, HPA055389: AB_2732595"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.38e-3)"	"prognostic unfavourable (2.43e-5)"	"prognostic unfavourable (7.58e-4)"	"unprognostic (4.04e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.03e-1)"	0.8	1.8	2.3	6.2	4.1	9.3	1.1	2.8	4.6	1.2	2.6	0.8	0.0	4.3	1.2	1.4	4.5	1.2	1.4	1.3	2.3	2.7	2.2	1.7	1.0	5.6	2.1	1.9	1.0	1.9	0.3	2.4	3.8	2.0	1.3	2.2	1.0	1.3	0.8	1.0	2.6	3.8	1.1	1.4	2.5	2.2	12.5	0.8	15.3	0.9	4.2	3.9	0.6	2.2	1.2	1.4	0.0	1.0	0.0	2.1	0.7	5.2	16.6	9.5	11.1	0.1	0.6	9.6	4.2	2.5	6.8	6.6	11.4	4.3	7.3	6.9	1.7	8.1	6.9	4.2	1.6	8.1	9.2	6.5	11.7	11.7	0.2	6.3	8.9	0.6	0.5	6.0	1.6	3.1	11.2	2.8	2.3	10.0	11.1	11.8	21.1	6.0	27.1	8.2	16.4	1.4	2.2	9.0	14.8	4.8	5.1	3.6	7.6	7.4	1.1	7.2	10.5	6.9	9.4	6.2	10.1	14.6	3.7	6.4	9.8	0.0	0.0	0.0	0.1	0.1	0.0	0.6	2.1	0.0	0.3	1.2	0.7	1.3	0.0	0.0	1.0	1.4	1.9	0.7	2.3	4.1	2.8	4.6	2.3	2.7	2.1	1.9	2.0	0.8
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 140.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 80.4;REH: 42.8;U-698: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"				Nucleoplasm	Nucleoplasm	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favourable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	8.4	8.4	6.1	6.3	8.7	20.7	9.3	9.9	8.6	8.9	11.1	6.5	6.5	10.4	9.9	8.6	8.3	7.2	11.6	12.0	7.5	4.9	14.3	9.5	6.8	5.3	6.0	5.0	11.6	8.8	10.4	19.4	13.5	8.0	9.9	6.6	8.8	7.9	6.9	14.5	8.0	14.6	11.8	8.5	5.3	8.6	51.9	5.4	140.3	10.6	4.8	6.4	9.7	8.0	9.3	16.5	24.6	4.5	18.0	14.7	5.7	6.3	2.9	12.3	9.8	4.1	4.5	27.1	3.2	3.7	5.1	8.3	3.7	6.3	22.5	15.0	3.6	3.8	3.1	6.1	7.2	9.0	5.6	27.1	4.4	4.9	4.0	8.1	9.6	4.2	4.3	5.6	5.4	3.5	10.1	1.2	8.8	4.8	80.4	3.1	9.9	4.0	42.8	8.5	5.2	5.9	3.3	5.4	5.0	10.8	4.0	5.5	9.3	4.2	2.3	4.9	4.5	3.9	4.0	4.2	3.8	70.5	3.9	2.2	2.3	24.6	2.1	22.3	14.7	3.4	5.7	6.6	6.7	7.6	4.8	9.3	10.1	11.8	2.4	18.0	4.5	16.5	6.1	5.7	6.1	8.7	9.9	8.6	7.5	4.9	6.0	5.0	8.0	5.4
TGM5	TGX	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232595-43266857	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1"	"Cell line enriched"	"Detected in some"	7	"HEL: 19.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"cerebellum: 2.9"	"Not detected"	"Not detected"														"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.3	0.0	0.1	0.1	0.1	0.2	2.1	0.1	0.1	2.6	0.1	0.1	0.1	0.0	0.7	0.1	9.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.6	0.0	0.1	2.8	3.4	0.1	24.3	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.1	10.4	0.8	4.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.4	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TGM7	TGMZ	ENSG00000159495	"Transglutaminase 7"	Q96PF1	15	43276280-43302255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.9;testis: 2.9"	"Cell line enriched"	"Detected in single"	78	"EFO-21: 8.9"	"Cancer enriched"	"Detected in single"	13	"endometrial cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (2.45e-2)"		"unprognostic (2.04e-1)"		"unprognostic (2.82e-2)"				"unprognostic (1.71e-2)"		"unprognostic (1.07e-1)"			"unprognostic (2.01e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0			0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.2	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9			0.0		5.9	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0										
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 47.2;U-266/70: 36.7;U-937: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	13.4	5.2	4.3	27.2	7.2	72.3	5.8	0.9	4.6	3.6	7.2	10.7	0.3	4.1	3.0	6.6	4.6	5.4	9.5	6.5	7.1	4.6	5.9	7.5	22.1	39.0	11.5	2.7	3.8	2.7	1.0	2.7	7.1	7.8	2.8	4.2	6.0	6.0	1.8	2.3	2.3	12.7	6.0	16.4	73.0	4.8	9.9	6.7	12.5	5.3	1.1	25.2	7.8	3.3	6.5	43.6	72.0	62.6	8.5	11.3	40.5	3.1	0.1	1.2	0.2	4.0	5.6	0.5	0.6	6.9	10.1	14.3	0.4	0.8	4.4	0.4	2.2	0.4	1.8	0.4	1.6	0.6	0.4	6.2	0.1	0.9	8.0	7.6	10.1	2.8	0.1	5.2	0.0	3.8	8.6	47.2	0.7	2.1	0.3	6.7	4.1	0.7	1.3	4.5	7.7	3.0	0.1	0.0	1.8	0.0	0.2	8.8	0.1	6.8	2.4	0.6	0.0	1.9	0.1	36.7	2.1	0.3	11.4	21.4	0.1	4.4	54.1	47.1	11.3	62.6	10.3	6.5	8.2	9.1	43.6	2.9	7.1	7.3	72.0	8.5	60.9	17.7	7.9	40.5	4.3	7.2	0.9	4.6	7.1	4.6	11.5	2.7	7.8	6.7
TICRR	"C15orf42, FLJ41618, MGC45866, SLD3, Treslin"	ENSG00000140534	"TOPBP1 interacting checkpoint and replication regulator"	Q7Z2Z1	15	89575482-89631056	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.0;lymphoid tissue: 21.7;tongue: 9.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046746, HPA049454"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046746: AB_2732533, HPA049454: AB_2680773"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-5)"	"unprognostic (7.73e-3)"	"prognostic unfavourable (2.87e-6)"	"unprognostic (1.64e-1)"	"unprognostic (1.31e-4)"	"unprognostic (5.87e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.54e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.59e-2)"	0.9	0.4	0.3	3.5	0.4	6.9	0.6	0.1	0.4	1.0	2.5	0.1	0.1	2.2	1.0	0.1	9.0	0.7	0.5	0.3	0.2	0.3	0.3	0.2	0.7	2.9	0.4	0.1	0.9	0.1	0.0	0.3	3.9	0.1	0.5	2.6	0.2	1.2	0.1	0.1	1.0	3.2	0.4	0.2	2.9	0.9	7.7	0.1	21.7	0.4	9.5	12.2	0.8	2.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	7.0	9.7	12.6	7.2	0.5	1.0	7.1	5.2	2.4	7.3	7.7	10.5	5.5	9.4	2.8	1.7	14.1	17.3	4.6	6.7	4.7	16.6	14.0	9.4	5.5	0.0	9.9	5.1	0.3	0.3	6.0	4.4	3.6	13.3	11.0	4.2	6.6	8.7	8.4	8.4	5.0	12.5	11.4	7.5	1.7	10.0	5.4	5.3	12.3	7.0	2.1	5.2	6.7	2.1	8.0	10.0	16.2	10.5	2.6	4.9	8.1	2.7	8.5	4.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.4	0.1	0.3	0.2	0.3	0.4	0.1	0.1	0.1
TIFAB		ENSG00000255833	"TIFA inhibitor"	Q6ZNK6	5	135444218-135452399	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 13.9;lymphoid tissue: 15.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 13.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"myeloid DC: 4.5;plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049372	Uncertain									"HPA049372: AB_2680733"	"unprognostic (1.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-5)"	"unprognostic (3.87e-1)"	"unprognostic (3.25e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.01e-2)"	0.6	0.3	0.4	13.9	0.4	0.5	0.4	0.3	0.4	0.4	1.2	0.7	0.0	1.4	0.3	1.3	1.1	0.3	0.9	0.3	0.4	0.3	0.5	0.4	4.2	11.1	0.5	0.0	0.3	0.3	0.0	0.6	0.4	0.2	0.4	2.3	0.0	2.5	0.6	0.3	1.3	3.0	0.3	0.6	4.5	0.9	2.0	0.0	11.6	0.5	0.7	15.9	2.6	0.5	0.0	13.9	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.2	0.4	0.4	0.3	0.4	0.4	0.3	0.5	0.0	0.2	0.0
TIMP1	"CLGI, EPO, TIMP"	ENSG00000102265	"TIMP metallopeptidase inhibitor 1"	P01033	X	47582313-47586789	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 293.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 161.3;ASC TERT1: 216.0;HSkMC: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB022360, HPA053417"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	750000000	750000000	"Golgi apparatus"	"Golgi apparatus"	"CAB022360: , HPA053417: AB_2682142"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.24e-3)"	"unprognostic (9.12e-3)"	"unprognostic (9.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (2.90e-11)"	"unprognostic (1.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	80.2	82.3	6.3	154.0	12.8	9.2	31.8	3.3	8.4	63.5	29.1	6.5	27.2	6.1	48.9	109.6	34.9	53.5	110.9	105.7	9.2	5.5	71.2	115.9	144.8	293.3	8.4	4.8	149.3	22.2	41.8	48.7	125.5	29.5	62.9	19.0	33.4	45.9	42.0	26.1	11.6	13.2	64.5	14.6	69.3	19.3	71.9	4.6	8.8	98.6	14.6	34.8	121.0	46.8	2.3	56.8	57.1	91.5	9.4	26.4	39.7	9.4	15.8	7.7	91.3	161.3	216.0	1.9	102.5	84.8	32.0	25.9	6.2	17.8	0.1	13.5	131.9	9.4	4.2	43.5	20.7	19.1	10.0	9.7	11.5	9.6	107.4	6.5	124.3	148.0	11.1	97.4	20.7	14.3	15.0	7.2	52.9	18.4	0.1	25.0	8.6	33.2	0.1	15.9	8.4	51.5	6.6	0.1	0.4	60.8	0.4	12.9	0.8	12.6	13.8	47.9	50.5	56.5	10.0	3.0	6.4	0.3	139.3	15.7	31.1	29.5	54.6	0.8	16.2	91.5	16.0	2.3	26.4	14.3	56.8	1.2	8.6	7.7	57.1	9.4	83.6	1.6	10.7	39.7	6.3	12.8	3.3	5.3	9.2	5.5	8.4	4.8	29.5	4.6
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174075-78187233	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB004683	Enhanced									"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (6.87e-4)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	5.3	2.0	2.1	21.4	4.5	32.8	4.8	1.1	1.9	3.7	11.4	2.2	1.9	8.5	2.4	4.8	18.9	2.2	7.0	4.3	1.6	0.7	7.9	6.2	9.3	15.7	3.1	1.6	2.1	3.6	0.1	1.3	8.6	2.1	2.3	7.9	0.5	4.6	2.0	2.0	6.2	8.5	4.4	1.7	9.0	9.4	3.6	1.6	41.8	1.3	33.0	20.5	3.1	5.8	4.0	2.1	1.1	1.2	6.2	21.2	3.5	65.1	54.2	10.8	13.6	1.0	4.3	7.1	32.4	17.0	48.2	66.9	47.8	27.5	21.2	11.4	19.4	29.7	9.8	28.9	25.0	7.3	36.2	37.4	19.4	31.3	0.3	15.8	24.2	2.1	0.9	25.1	3.4	19.6	23.0	47.0	18.5	48.7	7.9	8.9	5.6	37.8	21.4	43.8	47.3	12.8	21.2	4.9	14.3	24.8	68.2	9.1	46.0	21.3	9.0	47.4	46.6	33.8	41.6	19.8	10.3	27.3	23.3	10.7	21.3	0.0	0.7	0.0	1.1	1.2	0.5	4.0	5.3	2.7	2.1	1.2	0.3	1.4	1.1	6.2	1.0	0.7	21.2	3.5	2.1	4.5	1.1	1.9	1.6	0.7	3.1	1.6	2.1	1.6
TLR1	"CD281, KIAA0012, rsc786"	ENSG00000174125	"Toll like receptor 1"	Q15399	4	38790677-38856817	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.3;lymphoid tissue: 40.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 9.4;HUVEC TERT2: 10.8;RPMI-8226: 11.7;U-698: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 43.3"	"Group enriched"	"Detected in all"	6	"granulocytes: 43.3;monocytes: 13.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (7.82e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.25e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.97e-2)"	10.9	4.6	7.1	17.9	11.4	21.0	5.4	2.0	6.0	3.4	3.7	5.9	0.5	4.2	5.8	3.9	3.2	5.3	6.5	4.0	6.5	3.4	4.6	5.8	9.8	26.4	12.9	2.6	7.4	7.7	1.0	4.2	6.6	10.6	3.9	4.6	2.2	11.0	2.5	1.7	3.1	6.7	6.5	19.4	40.4	4.2	1.6	10.9	10.1	2.4	1.7	13.1	6.3	2.8	2.3	4.5	43.3	13.1	1.8	1.1	2.4	0.2	1.7	0.1	0.0	0.2	1.3	0.0	0.0	0.4	0.1	1.0	0.2	4.6	9.4	1.0	0.0	0.2	0.1	1.1	0.2	1.1	0.5	1.2	0.4	0.0	0.0	1.8	0.5	0.4	0.2	0.4	0.0	10.8	1.3	2.8	1.4	0.0	0.4	3.8	0.0	0.0	6.3	0.1	11.7	1.1	0.0	0.0	1.3	0.0	0.1	0.4	0.1	2.3	2.8	0.9	0.4	0.1	0.6	1.0	0.1	17.5	2.5	6.5	0.3	0.0	6.8	2.6	1.0	10.4	0.8	2.3	1.1	0.8	4.5	2.0	1.1	0.6	43.3	1.8	13.1	1.5	0.4	2.4	7.1	11.4	2.0	6.0	6.5	3.4	12.9	2.6	10.6	10.9
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.2;brain: 16.0;lymphoid tissue: 16.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.0;RPMI-8226: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	2.9	2.7	6.1	10.7	7.9	6.4	2.1	2.0	3.9	1.8	1.6	2.6	0.2	1.7	1.4	2.0	1.8	1.9	3.9	1.5	4.5	1.7	1.7	2.1	5.0	11.2	10.6	1.9	1.6	1.2	0.7	1.9	2.8	7.2	1.6	2.4	0.9	4.3	0.5	0.9	1.7	7.8	2.1	16.0	16.2	2.1	0.8	6.8	1.8	1.5	1.1	14.8	5.8	1.9	1.8	1.8	14.2	2.6	0.3	0.4	0.6	1.5	6.0	0.2	0.1	0.3	6.9	0.0	1.6	7.1	0.7	2.4	0.0	13.0	7.1	2.8	0.3	0.7	0.1	1.3	1.1	0.0	0.5	3.3	7.2	0.2	0.5	3.6	5.4	2.9	1.3	2.9	1.6	1.4	3.6	2.3	3.3	0.0	0.0	6.3	0.2	1.0	3.5	3.2	10.2	0.4	0.1	0.0	0.1	0.2	0.0	1.0	0.3	1.9	2.0	2.3	7.8	0.9	2.5	0.1	0.0	6.0	5.3	4.3	1.7	0.0	2.6	0.7	0.2	2.4	0.0	1.8	0.1	0.1	1.8	1.2	0.3	0.2	14.2	0.3	1.2	1.3	0.4	0.6	6.1	7.9	2.0	3.9	4.5	1.7	10.6	1.9	7.2	6.8
TLR8	CD288	ENSG00000101916	"Toll like receptor 8"	Q9NR97	X	12906620-12923169	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.8;lymphoid tissue: 45.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;PC-3: 2.7;THP-1: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"classical monocyte: 10.0;intermediate monocyte: 9.6;myeloid DC: 5.3;neutrophil: 17.8;non-classical monocyte: 9.2"	"Group enriched"	"Detected in many"	100	"dendritic cells: 5.3;granulocytes: 17.8;monocytes: 10.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA001608	Enhanced									"HPA001608: AB_1080295"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.43e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	8.5	1.4	0.9	16.0	1.5	4.7	1.2	0.7	1.1	1.0	1.5	0.4	0.0	0.6	1.0	3.2	1.0	2.0	2.4	3.0	2.0	1.0	2.0	4.0	13.7	33.0	1.7	0.1	1.1	1.0	0.2	1.0	4.0	1.9	1.4	1.7	0.9	1.2	0.0	1.4	0.8	2.0	3.5	3.3	45.6	1.3	1.2	1.6	3.5	1.0	1.1	2.4	4.2	2.4	0.1	5.3	17.8	10.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.0	10.0	0.0	0.0	9.6	0.0	0.1	0.0	0.0	5.3	0.0	0.0	0.0	17.8	0.0	9.2	0.0	0.0	2.0	0.9	1.5	0.7	1.1	2.0	1.0	1.7	0.1	1.9	1.6
TMC6	"EVER1, EVIN1, LAK-4P"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78110458-78132407	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.6;brain: 43.1;lymphoid tissue: 41.4"	"Cell line enhanced"	"Detected in many"		"K-562: 33.7;SK-BR-3: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain									"HPA051430: AB_2681483"	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favourable (3.20e-4)"	10.5	3.5	7.5	26.1	25.5	39.6	8.3	2.1	12.8	4.1	8.8	33.5	5.6	13.5	3.1	1.7	9.5	5.6	6.5	8.1	12.5	8.1	6.9	3.7	14.4	39.2	43.1	4.6	1.7	6.4	1.8	2.4	6.6	20.3	7.5	4.7	3.6	12.7	7.2	2.3	6.5	17.5	2.7	31.4	41.4	9.1	1.6	31.2	12.1	5.0	2.7	24.8	7.3	6.5	13.5	8.3	9.8	26.7	15.6	27.2	13.2	5.4	4.3	2.4	1.9	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.8	6.2	6.2	7.7	0.0	9.7	0.3	1.8	0.0	0.6	3.5	12.8	1.1	9.6	0.6	11.7	21.9	0.3	5.2	0.0	0.4	4.7	33.7	23.4	0.0	11.0	5.7	20.0	1.9	1.6	2.6	0.2	18.1	3.6	20.3	0.6	1.5	1.8	38.5	10.4	21.9	17.8	1.6	0.0	3.0	0.0	0.1	18.5	8.1	3.9	0.0	19.0	0.3	6.4	4.9	9.8	27.2	16.9	23.7	13.5	20.1	21.9	8.3	10.2	18.1	18.7	6.9	15.6	26.7	2.5	17.0	13.2	7.5	25.5	2.1	12.8	12.5	8.1	43.1	4.6	20.3	31.2
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HL-60: 20.4;HMC-1: 41.5;Karpas-707: 35.2;RPMI-8226: 21.8;U-266/70: 17.1;U-937: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favourable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favourable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavourable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	3.6	1.6	2.3	30.1	4.6	33.6	1.9	0.7	2.3	1.7	4.4	3.5	0.1	4.2	2.5	2.1	2.5	2.1	6.2	1.5	2.3	1.7	3.4	3.1	10.7	38.7	4.0	0.8	0.9	1.2	0.1	1.3	1.5	2.8	2.4	1.9	2.6	10.2	1.0	0.6	1.7	23.2	1.0	5.1	52.9	4.1	0.7	3.7	49.7	3.1	1.8	36.6	3.9	2.5	5.0	2.1	5.5	6.6	6.7	13.1	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.4	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	20.4	41.5	0.0	0.0	0.0	0.0	0.0	1.3	35.2	0.0	0.4	7.0	0.9	0.0	0.1	0.4	0.1	21.8	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.0	17.1	0.7	1.5	0.0	17.3	0.0	2.3	1.8	5.5	13.1	3.1	9.4	5.0	10.5	12.9	2.1	5.0	9.4	8.4	3.0	6.7	6.6	1.9	5.7	4.2	2.3	4.6	0.7	2.3	2.3	1.7	4.0	0.8	2.8	3.7
TMEM106A	MGC20235	ENSG00000184988	"Transmembrane protein 106A"	Q96A25	17	43211835-43220041	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (9.71e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (4.95e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.30e-2)"	7.6	4.8	4.7	17.2	5.9	3.5	8.9	1.1	3.6	7.4	4.1	5.0	2.6	4.4	7.3	9.1	2.5	6.2	5.2	5.5	4.1	2.8	24.9	5.5	11.0	31.9	5.7	3.6	9.3	6.2	2.6	3.8	18.7	4.1	5.2	6.3	7.2	5.8	6.0	1.9	2.4	6.2	9.9	7.4	16.5	5.5	5.5	5.4	5.3	7.3	4.1	12.0	5.6	5.2	3.3	5.3	17.4	4.9	1.7	2.2	1.7	2.6	0.9	0.3	0.2	3.4	3.8	2.1	6.8	4.4	6.0	9.4	2.0	5.6	3.9	1.3	10.4	1.2	0.7	0.9	7.1	6.0	0.0	2.7	2.3	9.2	2.0	0.1	15.1	2.3	0.2	11.1	0.3	5.2	0.1	2.9	7.5	1.2	4.6	1.8	0.3	0.0	3.4	1.2	2.3	2.6	0.2	0.6	0.0	1.3	3.3	1.5	4.9	3.9	5.9	3.0	0.4	3.0	1.3	4.5	0.4	1.2	2.5	4.7	5.9	17.4	4.3	4.8	1.5	4.9	0.6	1.7	1.0	1.4	3.6	3.3	0.7	1.3	1.3	1.7	1.7	5.3	2.2	1.7	4.7	5.9	1.1	3.6	4.1	2.8	5.7	3.6	4.1	5.4
TMEM131L	"DKFZp586H1322, KIAA0922"	ENSG00000121210	"Transmembrane 131 like"	A2VDJ0	4	153466346-153636711	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 36.5;MOLT-4: 33.9;U-698: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043472, HPA048443"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles"				Vesicles	Vesicles	"HPA043472: AB_2678496, HPA048443: AB_2680395"	"unprognostic (1.12e-1)"	"prognostic favourable (6.69e-6)"	"unprognostic (1.71e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-2)"	7.5	1.9	2.1	37.9	6.0	27.3	6.6	0.5	3.0	6.5	5.6	2.3	3.5	1.5	11.9	7.9	6.6	5.0	4.3	5.6	2.5	1.6	3.4	13.0	6.1	27.6	2.2	1.6	4.9	23.0	0.8	6.4	2.5	2.1	5.3	3.1	5.3	10.3	3.2	17.5	5.2	10.0	8.1	3.0	26.5	6.0	3.2	3.9	69.4	4.1	5.5	36.8	7.1	5.8	18.5	13.3	13.6	23.7	14.9	17.9	10.3	2.0	1.3	5.6	5.9	3.3	2.9	0.1	2.9	1.4	2.0	2.6	9.0	1.3	36.5	0.7	3.8	2.0	4.3	5.0	3.1	3.3	3.1	7.1	2.5	2.3	2.2	7.8	0.4	2.7	3.1	2.6	2.5	5.1	6.7	0.1	2.0	3.7	33.9	5.7	5.0	1.9	11.8	5.4	2.3	1.3	0.8	4.2	3.3	2.3	5.1	3.0	1.9	5.8	4.0	2.7	4.9	3.2	2.4	4.0	4.1	43.3	0.8	4.7	2.2	6.1	12.4	13.1	8.5	23.7	11.2	18.5	10.7	7.9	13.3	17.3	17.9	12.0	13.6	14.9	18.6	1.3	12.9	10.3	2.1	6.0	0.5	3.0	2.5	1.6	2.2	1.6	2.1	3.9
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618632-152680165	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.3;HMC-1: 28.0;Karpas-707: 21.8;U-266/70: 27.3;U-937: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 75.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	1.4	0.7	0.8	12.5	0.8	8.3	2.0	0.7	0.7	5.0	1.4	1.3	0.9	1.0	1.1	1.2	36.1	1.1	2.4	1.7	0.8	0.8	1.0	4.8	7.9	20.4	1.3	0.1	0.7	0.8	0.1	3.5	3.5	0.8	3.9	1.1	0.5	16.1	2.5	1.3	28.7	3.0	2.2	1.2	16.2	2.7	0.6	0.1	8.2	1.5	26.0	38.0	7.1	6.3	8.3	2.9	75.4	6.0	0.1	3.4	2.2	12.0	0.0	0.1	0.0	0.2	3.5	5.5	3.0	11.3	3.3	6.4	0.1	1.6	12.4	1.3	2.8	8.8	0.0	24.3	6.2	0.0	0.0	0.6	0.1	0.0	3.6	9.5	28.0	3.3	11.7	10.7	9.3	8.3	0.0	21.8	0.2	0.8	3.7	2.9	0.6	2.9	0.4	0.0	0.0	19.2	7.4	0.0	0.5	0.7	2.4	0.4	0.3	6.7	3.3	0.4	2.0	0.3	4.2	27.3	9.2	6.8	4.6	21.7	2.5	49.8	5.8	44.8	0.8	5.9	1.5	8.3	1.8	1.3	2.9	7.2	1.8	1.2	75.4	0.1	6.0	0.3	3.4	2.2	0.8	0.8	0.7	0.7	0.8	0.8	1.3	0.1	0.8	0.1
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733525-12769457	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 72.0;hTCEpi: 16.2;hTERT-HME1: 20.5;RT4: 10.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044165	Enhanced		Approved	Cytosol		7000000	7000000	Cytosol	Cytosol	"HPA044165: AB_10961279"	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.0	0.0	0.0	0.0	0.2	1.4	1.8	0.0	0.0	11.7	0.0	0.0	0.4	0.0	0.9	0.6	62.9	1.6	0.1	1.6	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	53.6	0.1	2.3	0.0	0.0	6.6	1.4	0.4	24.0	0.0	0.7	0.0	1.1	0.0	0.4	0.0	0.4	0.0	40.5	41.8	10.6	18.6	0.0	0.5	4.5	0.6	0.0	0.3	21.1	7.2	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.3	0.4	0.2	1.1	0.0	0.0	0.0	2.1	0.0	72.0	1.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	16.2	0.0	20.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.4	10.1	0.0	0.0	0.0	9.0	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.0	0.0	0.5	0.0	21.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 65.7;lymphoid tissue: 31.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.0;HDLM-2: 32.3;Karpas-707: 6.9;U-937: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 65.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 65.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	4.2	1.1	1.4	8.2	1.5	20.8	5.4	0.7	1.2	2.5	9.9	0.8	0.4	1.2	1.0	2.0	4.8	1.9	4.1	25.5	1.8	1.2	1.9	2.3	8.3	20.9	2.2	0.8	1.9	2.9	0.0	1.4	1.0	1.7	2.2	2.2	5.8	5.8	1.3	1.3	1.3	7.2	2.2	4.2	18.2	2.9	0.9	1.4	31.3	2.2	2.5	10.6	7.0	2.8	1.4	8.2	65.7	13.5	2.9	14.8	8.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.7	8.0	0.3	0.5	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.2	0.9	32.3	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	1.2	0.6	0.0	6.9	1.4	0.0	1.6	1.2	0.7	0.2	0.1	1.1	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.5	0.7	3.3	0.0	1.6	0.0	5.7	19.1	2.4	12.5	13.5	23.9	8.0	3.9	14.8	1.4	5.9	5.6	8.2	1.3	9.0	6.5	65.7	2.9	3.2	0.2	0.7	8.4	1.4	1.5	0.7	1.2	1.8	1.2	2.2	0.8	1.7	1.4
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515512-98550379	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 130.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"CAB009847: AB_2205450, HPA008150: AB_1079235"	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavourable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	10.8	9.5	8.1	25.0	9.5	36.8	12.7	19.1	11.0	16.9	22.9	10.7	8.7	15.9	18.4	17.1	23.0	15.4	10.3	9.6	8.5	8.3	15.8	20.5	13.8	34.0	9.0	11.2	34.7	21.6	9.9	9.9	13.6	7.6	15.6	17.6	12.5	14.0	9.7	9.4	11.7	22.6	10.7	9.4	29.1	16.8	11.4	10.3	130.9	13.2	12.2	35.4	13.0	17.9	14.1	10.9	18.1	33.1	9.7	15.6	13.3	30.3	20.0	49.4	25.1	4.1	5.5	29.3	25.0	13.2	33.9	24.6	21.8	15.2	53.0	15.4	14.5	19.5	41.4	18.8	31.1	37.0	25.7	45.4	18.3	14.4	3.7	52.4	30.3	3.1	6.2	20.0	10.8	19.3	38.2	20.6	21.0	19.1	85.4	41.3	29.7	18.8	71.7	32.8	36.7	12.0	28.4	39.1	23.4	42.7	26.9	13.4	30.3	25.2	10.3	19.7	17.2	13.4	25.5	22.4	38.2	59.3	5.6	30.4	26.1	18.1	14.4	6.1	9.5	25.0	10.2	10.9	11.1	10.8	10.9	14.1	15.6	11.7	1.1	9.7	33.1	6.1	13.3	13.3	8.1	9.5	19.1	11.0	8.5	8.3	9.0	11.2	7.6	10.3
TMPRSS11A	ECRG1	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909385-67964140	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 19.5;esophagus: 48.4;lymphoid tissue: 18.7;tongue: 47.6"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.5"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	47.6	18.7	0.3	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11B		ENSG00000185873	"Transmembrane serine protease 11B"	Q86T26	4	68226653-68245720	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 138.8;lymphoid tissue: 57.0;tongue: 44.0"	"Low cell line specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (4.24e-2)"				"prognostic favourable (6.91e-4)"				"unprognostic (2.92e-1)"				"unprognostic (3.96e-1)"				0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	11.2	0.1	0.0	0.0	0.1	0.5	0.1	138.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	13.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	44.0	57.0	0.1	23.2	0.7	0.6	2.4	0.5	0.4	0.7	0.0	0.3	1.4	0.8	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.3	0.8	0.4	1.3	0.1	0.4	1.0	0.2	0.1	0.0	0.1	1.5	0.8	1.8	2.0	0.1	1.1	1.3	0.5	0.2	0.0	0.1	0.0	0.7	2.0	0.1	0.7	0.5	1.3	0.1	1.0	0.6	0.6	0.5	0.2	1.4	0.8	0.3	0.1	0.2	0.1	0.4	0.2	1.3	1.0	0.3	0.5	0.1	0.2	0.9	0.7	0.3	1.0	0.1	0.3	0.4	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.0	0.7	0.3	0.7	2.4	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447449-68497604	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6"	"Group enriched"	"Detected in some"	6	"HaCaT: 5.8;HBEC3-KT: 2.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051062	Enhanced				"Intracellular and membrane"					"HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavourable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.9	0.0	0.0	1.2	0.0	1.1	10.5	103.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.4	0.0	0.0	13.6	0.5	0.0	1.6	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	40.5	39.1	2.6	36.6	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	5.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11F	FLJ16046	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129880	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1"	"Group enriched"	"Detected in some"	8	"HEL: 2.4;K-562: 5.4;Karpas-707: 1.6;U-266/70: 1.6"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026911	Uncertain									"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	13.1	11.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 44.9;HaCaT: 19.2;RPTEC TERT1: 31.5;RT4: 39.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	44.9	0.0	1.7	0.0	19.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	31.5	39.3	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0
TMPRSS9		ENSG00000178297	"Transmembrane serine protease 9"	Q7Z410	19	2389771-2426239	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 6.3;lymphoid tissue: 4.6;testis: 5.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.1;SK-BR-3: 3.1;U-266/70: 5.4"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"eosinophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Low region specificity"	"Detected in all"			HPA051483	Uncertain									"HPA051483: AB_2681501"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.44e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.73e-2)"	0.1	1.1	0.9	0.4	0.2	2.0	1.3	0.0	0.2	0.0	0.4			0.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	6.3	0.0	0.1	0.0		0.2	1.2	0.0	0.2	0.1		0.1	0.0		0.5	0.0	1.5	1.8	0.4	0.0	0.0	4.6	0.1	5.9			0.0		0.0	0.0	0.0	0.0	0.9	2.4	0.0	0.0	0.0	0.1	1.7	0.3	0.2	0.6	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.6	0.5	0.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.2	2.1	2.3	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	1.0	6.1	0.0	1.2	0.1	0.4	0.5	0.8	1.1	0.0	0.8	0.0	0.3	0.1	0.2	0.2	3.1	0.1	0.4	1.6	0.4	1.1	0.8	1.1	0.7	5.4	1.3	1.5	0.2	0.9	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1										
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575567-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.6;lymphoid tissue: 28.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 10.0;HMC-1: 9.6;NB-4: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.5;monocytes: 10.8;T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	2.3	1.2	0.6	15.6	1.0	14.6	1.2	0.4	1.8	1.7	1.3	3.7	0.3	1.3	1.1	0.4	1.5	0.9	2.3	2.0	0.5	0.3	2.6	1.9	9.5	8.0	0.8	0.0	0.6	0.7	0.5	0.5	3.2	2.0	0.7	0.7	0.4	2.2	0.8	0.4	2.7	4.1	0.7	1.0	28.0	1.0	0.4	0.5	2.1	0.6	5.3	14.7	1.2	0.4	1.3	1.2	3.5	10.8	0.5	6.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	1.8	0.0	0.0	0.0	0.8	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	4.1	6.5	6.6	1.3	3.1	2.4	1.2	1.3	0.9	1.0	3.5	0.5	10.8	0.7	2.2	2.1	0.6	1.0	0.4	1.8	0.5	0.3	0.8	0.0	2.0	0.5
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 73.4;lymphoid tissue: 83.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm		270000	270000	Nucleoplasm	Nucleoplasm	"HPA054434: AB_2682487, HPA057089: AB_2683331"	"prognostic favourable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	21.1	2.1	1.6	49.9	3.0	17.8	18.9	1.5	1.7	11.3	8.0	1.6	4.7	4.3	9.7	9.2	15.0	4.6	9.7	8.5	1.8	1.7	8.7	8.4	22.0	71.3	2.9	1.8	4.2	12.5	5.2	1.7	36.1	12.2	11.8	5.5	4.2	13.7	5.8	2.2	14.4	21.4	6.9	3.6	37.5	13.1	4.7	2.2	83.1	9.3	8.6	41.1	12.7	12.8	50.3	25.2	73.4	19.7	19.7	54.4	36.5	7.5	5.3	2.8	4.6	6.0	5.0	25.8	4.1	11.3	3.1	6.6	2.9	8.8	14.1	1.3	4.7	10.7	2.3	12.7	4.5	15.4	4.9	22.3	11.8	4.8	2.9	26.9	24.8	5.6	12.0	9.5	4.6	4.3	8.6	44.1	4.3	2.9	22.8	35.1	4.3	2.5	7.0	12.5	20.4	12.7	15.1	1.4	2.2	15.7	3.0	1.5	2.7	30.7	2.1	5.7	2.2	4.0	4.9	21.7	23.8	28.3	6.7	28.8	3.4	73.4	18.6	55.3	22.6	19.7	43.9	50.3	45.5	33.2	25.2	44.2	54.4	34.9	10.6	19.7	14.8	12.1	34.8	36.5	1.6	3.0	1.5	1.7	1.8	1.7	2.9	1.8	12.2	2.2
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 45.1;lymphoid tissue: 44.6;skeletal muscle: 30.5"	"Group enriched"	"Detected in some"	8	"Karpas-707: 54.6;RPMI-8226: 34.3;U-266/70: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"memory B-cell: 45.1;naive B-cell: 13.1"	"Lineage enriched"	"Detected in single"	65	"B-cells: 45.1"					"Low region specificity"	"Detected in all"			HPA030453	Uncertain									"HPA030453: AB_10601700"	"unprognostic (3.94e-5)"	"unprognostic (1.11e-3)"	"unprognostic (4.88e-2)"	"unprognostic (4.30e-3)"		"unprognostic (1.23e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.61e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.59e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	0.5	0.3	0.4	17.6	0.3	0.2	0.5	0.2	0.3	0.7	3.0	0.1	0.0	1.9	0.3	0.0	2.7	0.5	0.5	2.5	0.3	0.3	0.6	0.5	1.2	12.5	0.3	0.2	0.3	0.3	0.0	0.3	0.0	0.1	0.9	1.2	0.6	9.0	1.1	30.5	0.3	14.8	0.0	0.4	44.6	2.4	0.3	0.1	0.9	0.6	0.9	37.8	2.3	0.4	45.1	0.0	0.1	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.1	0.1
TNFRSF13C	"BAFFR, CD268"	ENSG00000159958	"TNF receptor superfamily member 13C"	Q96RJ3	22	41922023-41926818	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;intestine: 18.9;lymphoid tissue: 69.1"	"Group enriched"	"Detected in some"	6	"REH: 19.9;U-698: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	51	"memory B-cell: 14.5;naive B-cell: 20.3"	"Lineage enriched"	"Detected in single"	59	"B-cells: 20.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA003246, CAB008380"	Enhanced									"CAB008380: AB_590602, HPA003246: AB_1078264"	"unprognostic (3.43e-4)"	"prognostic favourable (4.44e-7)"	"unprognostic (6.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.64e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-8)"	"unprognostic (2.21e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.44e-2)"	0.9	0.8	0.8	41.0	1.0	3.3	0.6	1.0	2.0	0.5	1.2	4.4	0.0	0.7	0.4	0.2	5.0	0.5	0.6	0.6	0.8	0.9	0.9	0.5	1.8	48.4	1.0	0.6	0.4	0.4	0.0	0.4	0.1	1.8	0.6	0.7	0.5	5.8	0.0	1.2	2.0	18.9	0.1	1.1	69.1	1.4	0.7	0.6	2.0	0.8	0.3	51.4	9.5	0.7	20.3	0.2	0.3	0.2	0.2	0.2	0.5	0.3	0.2	1.1	2.3	0.0	0.0	0.5	0.1	0.1	0.2	0.8	0.9	0.5	1.8	0.4	0.2	0.3	0.6	0.0	0.3	0.4	2.2	0.2	0.3	0.2	0.1	1.6	0.4	0.1	0.0	0.4	0.1	0.0	0.4	1.8	0.2	0.7	1.5	1.7	0.7	0.1	19.9	2.4	1.5	0.0	0.2	1.2	0.3	0.1	0.4	0.3	0.4	2.2	0.2	0.5	2.6	0.9	0.3	2.1	1.0	10.8	0.1	1.7	0.5	0.3	0.1	0.1	0.1	0.1	0.2	14.5	0.2	0.1	0.0	20.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.5	0.8	1.0	1.0	2.0	0.8	0.9	1.0	0.6	1.8	0.6
TNFRSF17	"BCM, BCMA, CD269, TNFRSF13A"	ENSG00000048462	"TNF receptor superfamily member 17"	Q02223	16	11965107-11968068	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.1;intestine: 17.8;lymphoid tissue: 28.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 25.3;RPMI-8226: 39.9;U-266/70: 118.6;U-266/84: 58.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"memory B-cell: 34.1;naive B-cell: 26.9;plasmacytoid DC: 27.9"	"Group enriched"	"Detected in many"	62	"B-cells: 34.1;dendritic cells: 27.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									2200000	2200000				"prognostic favourable (1.35e-5)"	"unprognostic (3.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.41e-2)"	"unprognostic (6.47e-2)"	"prognostic favourable (1.58e-6)"	"unprognostic (9.75e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.85e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.10e-1)"	0.6	0.4	0.4	24.0	0.9	0.3	5.4	0.5	0.4	1.5	17.8	0.2	0.2	12.3	0.5	0.2	3.7	1.1	4.9	0.7	0.4	0.4	1.3	0.8	3.0	22.4	0.4	0.2	0.9	3.1	0.0	0.5	0.3	0.2	1.0	9.4	0.6	14.2	0.2	0.4	0.4	11.7	0.2	0.4	22.2	9.4	2.2	0.3	3.1	1.1	1.4	28.8	7.6	0.7	34.1	27.9	0.5	0.1	0.2	0.1	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.6	58.9	9.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	34.1	0.0	0.0	0.0	26.9	0.0	0.0	0.5	0.2	0.0	27.9	0.0	3.7	0.4	0.9	0.5	0.4	0.4	0.4	0.4	0.2	0.2	0.3
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"			"Plasma membrane, Actin filaments, Focal adhesion sites"	"Plasma membrane, Actin filaments, Focal adhesion sites"	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.5	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.2	2.1	0.0	2.9	0.0	3.1	0.4	3.6	0.0	19.7	1.4	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.1	3.1	0.0	0.0	0.0	1.6	0.0	7.8	1.0	5.3	0.6	0.2	19.3	0.8	0.5	3.8	5.2	0.0	1.9	0.1	1.6	2.1	1.6	1.0	1.5	0.0	1.5	0.0	3.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8
TNFRSF4	"ACT35, CD134, OX40, TXGP1L"	ENSG00000186827	"TNF receptor superfamily member 4"	P43489	1	1211326-1214138	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.5;blood: 18.4;lymphoid tissue: 13.6"	"Group enriched"	"Detected in some"	9	"MOLT-4: 7.8;NB-4: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 15.9;T-reg: 18.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB016128	Enhanced									"CAB016128: AB_626897"	"unprognostic (2.24e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-1)"	"prognostic favourable (3.50e-6)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (4.52e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.91e-2)"	12.5	0.2	0.6	8.8	0.4	0.7	7.3	0.3	1.2	1.1	3.1	0.3	0.3	2.6	0.8	0.7	1.7	0.9	0.8	6.7	0.8	0.1	2.2	0.4	5.3	8.4	0.3	0.6	0.5	0.9	0.0	1.3	5.9	0.6	3.2	0.3	0.6	2.2	1.1	4.4	0.8	4.3	0.3	0.3	13.5	3.5	2.0	0.3	13.6	4.1	0.8	10.9	1.4	0.7	0.0	0.6	4.1	0.0	8.1	18.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	15.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.0	1.8	0.0	15.9	1.7	0.0	0.0	1.5	0.0	0.2	8.1	0.0	0.6	18.4	1.5	0.6	0.4	0.3	1.2	0.8	0.1	0.3	0.6	0.6	0.3
TNFRSF6B	"DcR3, M68, TR6"	ENSG00000243509	"TNF receptor superfamily member 6b"	O95407	20	63696651-63698684	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.4;lymphoid tissue: 56.3"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 11.4;RPTEC TERT1: 45.0;TIME: 27.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 17.4"					"Low region specificity"	"Detected in many"			HPA047154	Approved				"Secreted to blood"					"HPA047154: AB_2679959"																		11.8	2.0	10.0	39.2	17.6	2.5	7.0	5.4	8.1	4.5	6.0	2.1	0.0	2.0	3.0	2.0	6.6	2.5	3.6	2.0	11.6	6.6	4.4	2.5	39.4	9.8	5.9	0.0	3.6	2.2	2.0	4.2	2.1	23.6	2.7	2.3	0.0	2.9	2.0	10.0	4.8	3.8	4.6	13.0	56.3	10.0	2.1	5.3	2.7	6.5	3.3	12.1	11.6	2.3	0.0	17.4	0.0	0.9	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	27.8	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.9	17.4	0.0	0.1	10.0	17.6	5.4	8.1	11.6	6.6	5.9	0.0	23.6	5.3
TNFSF11	"CD254, ODF, OPGL, RANKL, TRANCE"	ENSG00000120659	"TNF superfamily member 11"	O14788	13	42562736-42608013	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 14.3;lymphoid tissue: 19.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;HSkMC: 5.2;NTERA-2: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 14.3"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009193, HPA045142"	Enhanced				"Secreted to blood"					"CAB009193: , HPA045142: AB_2679231"	"unprognostic (3.97e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.94e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.74e-2)"	0.5	0.2	0.2	19.5	0.2	0.0	4.6	0.1	0.2	0.8	0.8	0.1	2.4	0.2	0.2	0.1	3.7	0.2	1.3	0.3	0.1	0.7	0.6	5.3	0.4	19.8	0.1	0.1	0.1	0.6	0.0	0.3	0.3	0.4	0.5	2.2	0.1	1.6	1.0	0.2	0.5	6.0	0.1	0.1	0.8	0.3	3.3	0.1	2.8	0.4	0.1	5.2	2.3	0.7	0.0	0.1	1.8	0.0	14.3	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.6	0.0	0.1	5.2	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	7.4	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.7	0.1	0.1	0.4	0.1
TNFSF4	"CD252, gp34, OX-40L, TXGP1"	ENSG00000117586	"TNF superfamily member 4"	P23510	1	173183734-173207313	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.5;testis: 14.4"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 18.3;HHSteC: 7.9;HUVEC TERT2: 35.9;LHCN-M2: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA059579	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA059579: AB_2684071"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-7)"	"unprognostic (3.73e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.98e-2)"	2.1	4.0	1.7	8.2	2.3	0.9	3.7	4.5	3.4	1.7	1.8	1.0	0.8	0.3	1.5	1.5	1.6	1.4	2.1	2.1	3.0	2.0	1.5	1.6	2.5	11.5	1.9	0.8	2.7	2.1	1.0	3.3	1.2	1.2	2.8	2.5	1.0	0.8	1.0	0.8	0.3	2.5	1.6	1.9	9.7	1.4	14.4	1.2	9.3	0.8	0.8	3.7	1.6	1.6	1.3	2.6	1.7	0.2	3.4	1.2	6.5	0.0	0.0	0.2	0.5	1.2	6.5	0.0	1.8	0.4	0.1	0.1	0.0	0.0	0.0	0.3	18.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	7.9	0.1	0.0	2.8	0.1	0.9	0.1	35.9	0.0	0.2	29.9	0.0	0.3	0.1	0.1	0.3	0.8	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.4	0.5	0.1	0.1	3.3	1.9	0.0	0.2	0.3	1.1	0.1	0.8	1.1	0.7	0.9	0.8	1.3	1.2	1.1	1.7	3.4	0.1	2.6	0.9	6.5	1.7	2.3	4.5	3.4	3.0	2.0	1.9	0.8	1.2	1.2
TNFSF8	"CD153, CD30LG"	ENSG00000106952	"TNF superfamily member 8"	P32971	9	114893343-114930595	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.6;lymphoid tissue: 48.1"	"Group enriched"	"Detected in some"	111	"Daudi: 34.3;U-698: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (8.82e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.79e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.58e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.82e-1)"	3.6	1.7	1.1	12.0	1.7	12.7	1.8	0.5	0.9	1.6	2.4	1.4	0.6	0.3	1.1	2.5	1.4	1.5	4.6	2.8	1.1	1.2	1.8	1.4	4.9	48.1	1.6	0.6	0.9	1.1	0.0	0.8	2.2	1.0	1.3	1.9	1.4	3.7	0.9	0.7	1.0	7.0	1.3	2.8	14.9	1.7	1.1	1.0	45.6	1.6	0.8	18.5	3.2	1.3	1.7	7.3	3.9	14.1	1.0	18.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	28.1	0.0	0.0	0.0	0.0	14.1	0.0	4.1	7.3	13.8	1.0	16.4	9.8	7.3	1.7	18.6	13.5	3.9	1.0	0.9	4.0	5.9	8.7	1.1	1.7	0.5	0.9	1.1	1.2	1.6	0.6	1.0	1.0
TNIP3	"ABIN-3, FLJ21162, LIND"	ENSG00000050730	"TNFAIP3 interacting protein 3"	Q96KP6	4	121131408-121227466	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.2;lung: 8.5;lymphoid tissue: 15.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.6;hTEC/SVTERT24-B: 6.4;U-138 MG: 24.9;U-266/70: 7.0;U-266/84: 6.9;U-87 MG: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 9.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 9.2"					"Low region specificity"	"Detected in all"			HPA043063	Uncertain									"HPA043063: AB_10793989"	"unprognostic (2.89e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.23e-3)"	"unprognostic (8.75e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.84e-7)"	"unprognostic (3.35e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.78e-2)"	2.2	0.3	1.0	9.8	0.2	1.3	0.3	0.3	0.7	2.0	1.3	0.2	0.2	0.6	0.2	0.2	1.8	0.4	1.5	0.4	0.4	0.6	0.3	0.7	8.5	3.5	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.5	0.9	0.4	0.2	0.8	0.2	0.4	0.3	1.2	0.5	0.3	2.8	0.8	1.4	0.2	15.4	0.4	3.6	6.3	1.3	0.4	0.2	0.1	0.7	0.2	0.1	9.2	0.8	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.9	0.1	0.1	0.1	2.1	0.0	0.0	0.5	0.8	5.6	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	6.4	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	24.9	0.5	2.0	0.1	7.0	6.9	0.2	5.1	0.2	0.8	0.7	0.2	0.0	4.0	0.0	2.7	0.1	1.8	9.2	0.0	0.2	0.8	4.4	0.6	0.1	0.2	0.1	1.1	0.8	1.0	0.2	0.3	0.7	0.4	0.6	0.7	0.2	0.5	0.2
TOX2	"C20orf100, dJ1108D11.2, GCX-1"	ENSG00000124191	"TOX high mobility group box family member 2"	Q96NM4	20	43914864-44069616	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 77.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 45.3;PC-3: 20.3;U-266/70: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 9.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049900, HPA058396"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA049900: AB_2680942, HPA058396: AB_2683704"	"unprognostic (2.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.97e-3)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (7.45e-8)"	"unprognostic (1.60e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.60e-2)"	"unprognostic (3.12e-1)"	7.0	4.4	8.0	9.9	5.2	2.4	4.8	0.8	14.5	6.7	4.8	2.6	3.5	2.3	3.6	3.5	12.2	3.0	4.7	2.0	7.8	20.6	2.4	4.1	20.1	19.2	13.7	7.0	1.8	2.7	17.3	14.9	4.6	7.3	9.9	4.2	3.0	2.4	5.3	0.8	2.9	5.3	12.0	4.5	7.1	5.7	17.6	2.0	77.2	4.8	2.4	11.8	9.7	6.5	0.1	3.7	9.7	0.3	1.9	2.0	0.2	4.4	5.7	1.8	0.3	2.0	5.8	0.0	5.6	2.4	3.6	4.5	0.0	1.8	0.0	8.2	6.4	2.2	1.4	0.1	3.2	7.2	1.5	0.0	0.4	0.0	45.3	0.0	8.6	15.5	6.7	12.6	0.6	4.4	0.0	5.4	2.2	4.7	1.7	1.6	1.4	20.3	0.0	4.4	7.4	0.0	0.5	2.0	15.4	1.0	0.0	7.2	0.0	3.8	5.4	0.0	3.5	0.1	0.0	29.3	6.3	3.8	7.5	0.0	12.0	0.0	0.3	9.7	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.1	0.2	0.1	1.0	1.9	0.0	3.7	2.0	0.2	8.0	5.2	0.8	14.5	7.8	20.6	13.7	7.0	7.3	2.0
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687550	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: , HPA051244: , HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	18.5	11.1	6.0	28.6	6.8	9.0	17.5	2.5	7.3	18.5	14.6	6.8	8.3	9.7	20.3	15.0	25.3	16.7	22.6	8.1	5.0	3.8	10.6	20.8	11.2	26.0	6.6	3.1	33.8	13.8	4.9	6.0	22.8	6.9	16.5	14.5	9.9	15.3	16.1	12.5	24.6	14.0	12.8	6.2	24.2	12.0	14.1	6.9	102.6	13.2	23.5	31.2	16.9	15.0	15.2	19.6	2.2	14.1	11.0	11.3	8.2	19.2	35.6	19.4	14.0	9.1	10.8	20.6	6.9	15.6	19.2	24.3	1.0	9.9	45.3	31.5	13.6	42.5	28.2	19.1	18.0	10.1	18.9	18.3	20.0	16.9	27.4	0.4	9.5	13.7	22.2	9.3	25.7	18.8	0.9	1.7	9.8	34.2	30.7	22.4	19.6	0.7	59.7	13.7	15.7	14.3	21.3	11.6	20.0	22.8	15.4	5.9	26.7	1.7	24.3	23.0	7.6	0.3	11.6	11.9	8.7	19.5	6.0	2.3	19.4	0.8	13.3	2.2	9.1	14.1	11.1	15.2	9.4	10.2	19.6	14.5	9.9	10.8	1.7	11.0	11.9	17.9	11.3	8.2	6.0	6.8	2.5	6.4	5.0	3.8	6.6	3.1	6.9	6.9
TP53AIP1	p53AIP1	ENSG00000120471	"Tumor protein p53 regulated apoptosis inducing protein 1"	Q9HCN2	11	128934731-128943399	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 19.6;lymphoid tissue: 15.2;skin 1: 22.5;tongue: 31.5"	"Cell line enhanced"	"Detected in some"		"RT4: 3.4;SK-BR-3: 2.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.9"									"HPA044300, HPA048797"	Uncertain									"HPA044300: AB_2678888, HPA048797: AB_2680524"	"unprognostic (4.12e-7)"	"unprognostic (3.00e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.57e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.78e-2)"	0.1	0.3	0.3	0.1	0.3	0.2	1.6	0.3	0.3	4.6	0.1	0.2	4.2	0.0	0.4	8.9	19.6	3.2	0.1	0.1	0.3	0.6	0.5	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.1	1.2	0.1	0.1	3.0	1.2	0.9	22.5	0.2	0.1	0.1	0.1	0.2	0.6	0.1	15.2	0.1	31.5	6.7	0.2	11.0	0.4	0.1	1.9	0.2	0.2	0.3	0.1	0.4	0.0	0.2	0.5	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.2	0.0	0.4	0.4	0.5	0.0	0.1	1.6	0.0	0.1	1.0	0.0	0.8	0.6	0.0	0.4	0.0	0.0	3.4	1.1	0.1	0.0	2.3	0.0	0.7	0.0	0.0	0.7	0.7	0.5	0.4	0.0	0.0	0.4	0.0	0.2	0.1	1.3	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.4	0.2	0.1	1.9	0.2	0.1	0.1	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.6	0.1	0.1	0.1	0.1
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.3;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.5;HDLM-2: 12.2;Karpas-707: 6.2;T-47d: 5.5;U-266/70: 5.9;U-266/84: 4.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favourable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	16.1	1.0	0.3	0.9	0.8	0.0	14.4	1.7	0.8	19.7	1.2	0.1	1.0	0.0	5.0	1.6	43.3	5.2	1.6	2.4	0.2	0.2	0.6	5.1	2.7	0.3	0.3	0.5	1.9	0.3	0.0	0.8	1.0	0.5	2.5	0.0	0.8	3.7	0.7	5.0	14.5	0.5	1.9	0.3	0.7	0.4	2.6	0.3	7.9	0.8	25.5	32.9	2.3	17.8	0.2	0.7	1.3	2.3	0.0	6.3	1.3	1.2	0.2	0.5	0.1	2.8	2.3	0.0	0.0	0.0	0.1	0.1	1.4	2.9	1.8	4.5	0.2	0.3	0.0	0.1	0.0	12.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.0	6.2	0.2	0.5	0.0	0.0	0.9	0.4	0.0	0.0	2.2	0.1	2.4	0.0	0.0	0.3	0.7	0.0	5.5	0.8	0.1	0.2	0.4	0.0	0.4	5.9	4.6	0.5	0.1	0.1	0.1	0.0	2.3	0.0	6.0	1.8	0.9	0.2	4.9	6.3	0.7	0.0	1.0	2.5	1.3	0.0	1.6	0.1	5.4	1.3	0.3	0.8	1.7	0.8	0.2	0.2	0.3	0.5	0.5	0.3
TRAF3IP3	T3JAM	ENSG00000009790	"TRAF3 interacting protein 3"	Q9Y228	1	209756032-209782320	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 86.5;lymphoid tissue: 69.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 39.9;Karpas-707: 16.6;MOLT-4: 20.6;NB-4: 23.7;THP-1: 22.4;U-266/70: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040796	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA040796: AB_10794861"	"prognostic favourable (4.11e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.36e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-5)"	"unprognostic (3.83e-3)"	"prognostic favourable (8.15e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.08e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.21e-2)"	2.2	0.8	1.7	30.6	2.1	9.8	1.3	0.6	1.5	1.5	3.8	2.2	0.3	2.3	1.5	1.4	2.5	1.7	4.6	1.2	1.7	1.4	3.4	2.4	5.8	32.6	3.8	0.6	1.2	1.3	0.0	1.0	1.0	2.7	2.2	3.6	1.7	8.4	1.3	0.7	1.1	19.8	1.0	3.8	38.3	4.1	1.4	2.6	69.5	2.4	1.5	33.6	5.7	1.9	43.9	25.3	54.9	29.5	50.1	86.5	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	39.9	0.0	3.8	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	20.6	23.7	0.0	0.0	2.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	24.6	8.6	1.5	0.0	11.1	0.0	54.9	24.1	24.8	48.9	25.7	51.8	43.9	67.8	55.9	25.3	41.4	76.9	60.8	6.5	50.1	29.5	18.6	86.5	56.3	1.7	2.1	0.6	1.5	1.7	1.4	3.8	0.6	2.7	2.6
TRAPPC3L	"bA259P20.2, BET3L, FLJ11180"	ENSG00000173626	"Trafficking protein particle complex 3 like"	Q5T215	6	116494989-116545610	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.9;placenta: 9.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"														"unprognostic (1.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.09e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.47e-3)"	1.1	0.9	0.8	0.5	0.9	4.3	1.0	0.6	1.3	0.7	0.8	0.7	0.4	0.7	1.1	2.2	0.9	0.8	1.3	2.6	1.5	1.6	1.3	5.2	3.4	5.0	1.4	0.4	1.1	0.5	1.5	0.8	9.7	0.8	1.8	0.1	3.4	1.1	0.5	1.8	2.6	1.9	1.6	2.3	10.9	0.9	1.9	0.4	0.4	2.1	0.4	0.4	0.9	0.7	0.4	0.7	2.1	0.5	0.4	0.6	7.0	1.6	0.9	2.1	3.1	0.6	2.3	2.2	1.2	1.0	0.8	1.0	1.0	1.4	2.6	1.4	0.5	1.9	0.7	1.4	1.2	1.4	1.1	2.6	3.2	1.2	1.2	1.8	1.4	1.4	0.9	0.6	1.0	1.5	1.6	12.4	0.8	2.8	1.6	2.1	2.1	1.1	1.6	1.5	3.9	1.4	2.6	2.1	1.6	1.6	1.0	1.1	1.6	1.6	2.3	2.3	2.0	2.5	1.2	2.4	1.4	1.7	1.8	1.7	1.5	1.1	0.4	0.6	0.5	0.4	0.3	0.3	0.4	0.4	0.3	0.4	0.6	0.4	2.1	0.4	0.5	0.7	0.3	7.0	0.8	0.9	0.6	1.3	1.5	1.6	1.4	0.4	0.8	0.4
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 53.0;hTCEpi: 70.5;RT4: 27.9;SiHa: 39.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020053	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"				"Nucleoplasm, Intermediate filaments"	"Nucleoplasm, Intermediate filaments"	"HPA020053: AB_1858280"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.3	0.0	0.8	0.0	53.0	0.0	12.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	70.5	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.2	0.9	39.6	5.6	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113106	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;lymphoid tissue: 7.4;urinary bladder: 12.2"	"Cell line enriched"	"Detected in single"	490	"RT4: 79.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046400	Uncertain									"HPA046400: AB_2679652"	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.1	0.0	0.1	7.4	0.1	0.0	0.1	0.1	0.1	0.2	16.3	0.1	0.1	1.2	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.1	0.1	13.7	0.7	0.1	0.1	4.8	2.0	0.1	0.1	0.1	0.1	0.1	12.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TRIM59	"Mrf1, RNF104, TRIM57, TSBF1"	ENSG00000213186	"Tripartite motif containing 59"	Q8IWR1	3	160432445-160485773	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.6;lymphoid tissue: 24.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017750	Uncertain		Approved	"Rods & Rings"				"Rods & Rings"	"Rods & Rings"	"HPA017750: AB_1858312"	"unprognostic (3.74e-1)"	"prognostic favourable (4.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.00e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (1.15e-5)"	"unprognostic (1.02e-3)"	"unprognostic (2.44e-11)"	"unprognostic (7.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.91e-3)"	1.3	1.4	8.0	6.0	19.3	18.6	2.7	2.1	14.5	1.8	3.5	30.6	0.3	3.6	4.1	1.3	6.6	2.8	3.6	1.2	13.4	6.4	2.0	1.6	2.6	13.8	28.3	6.3	2.1	2.4	2.7	2.5	2.6	14.3	2.9	3.5	0.1	2.6	1.6	1.6	6.8	4.0	3.8	14.5	6.3	3.3	10.4	28.4	24.6	2.8	0.3	14.5	6.1	3.1	7.8	4.7	16.1	2.2	8.8	15.2	2.6	8.7	7.0	8.9	0.6	3.6	4.9	11.7	14.0	12.1	17.5	16.8	0.7	15.3	23.5	10.4	10.4	15.1	0.0	5.7	23.0	21.3	8.5	0.8	2.1	0.9	5.0	10.3	1.4	4.1	1.7	8.5	6.0	12.2	11.0	10.0	16.3	9.3	6.2	0.7	23.4	11.7	8.9	7.8	10.5	6.1	2.9	5.8	1.3	3.9	11.7	0.3	13.8	9.6	9.2	1.2	4.1	2.0	1.3	16.7	6.0	5.9	1.5	13.5	1.3	16.1	2.2	3.7	8.3	2.2	9.4	7.8	13.6	11.2	3.2	6.9	9.4	11.1	2.7	8.8	1.0	4.7	15.2	2.6	8.0	19.3	2.1	11.8	13.4	6.4	28.3	6.3	14.3	28.4
TRIP13	16E1BP	ENSG00000071539	"Thyroid hormone receptor interactor 13"	Q15645	5	892643-919357	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.4;testis: 52.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005727, HPA053093"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA005727: AB_10603220, HPA053093: AB_2682042"	"unprognostic (1.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (2.34e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.30e-6)"	"unprognostic (4.44e-3)"	"unprognostic (1.73e-3)"	"prognostic favourable (1.39e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.34e-1)"	1.5	0.9	1.7	8.6	1.2	3.4	1.7	0.6	1.6	1.6	2.7	0.4	1.4	2.4	1.6	1.9	5.3	4.9	2.4	1.2	1.4	1.7	1.3	0.8	1.5	4.7	0.6	0.6	2.1	1.0	0.0	1.9	2.8	1.0	1.0	4.5	0.4	1.3	1.0	0.6	1.4	2.5	2.5	0.7	3.8	1.4	52.9	0.3	16.4	0.5	8.8	6.3	1.1	1.8	2.7	2.3	0.0	0.3	3.3	4.8	0.9	19.3	22.5	14.6	20.6	1.3	3.3	15.3	20.5	10.3	32.6	30.6	21.1	13.4	17.5	14.7	12.1	14.2	30.9	14.6	40.7	26.1	24.1	12.2	42.2	15.3	0.3	19.8	7.3	1.4	1.0	27.1	11.9	15.9	17.9	15.5	22.2	13.2	19.2	16.4	16.0	19.6	11.5	27.1	32.6	8.7	10.4	14.5	14.9	31.1	11.3	6.0	21.7	9.3	8.1	17.4	21.6	14.1	22.8	9.1	19.9	19.0	10.3	22.7	18.9	0.0	0.1	0.0	1.0	0.1	0.5	2.7	1.4	1.9	0.3	2.1	0.6	0.2	0.0	3.3	0.3	2.3	4.8	0.9	1.7	1.2	0.6	1.6	1.4	1.7	0.6	0.6	1.0	0.3
TROAP	TASTIN	ENSG00000135451	"Trophinin associated protein"	Q12815	12	49323236-49331731	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.3;lymphoid tissue: 45.6;testis: 29.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044102	Uncertain									"HPA044102: AB_10963691"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (3.43e-3)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.17e-2)"	0.7	1.3	0.3	17.3	0.4	26.3	2.6	0.4	0.9	2.1	6.5	0.5	0.3	5.1	0.8	2.5	11.2	0.5	3.2	1.9	0.4	0.2	1.2	1.3	2.0	6.2	0.3	0.5	0.8	0.8	0.0	0.5	4.3	0.7	0.9	5.5	0.6	2.2	0.8	0.7	4.3	5.2	1.4	0.4	5.9	4.0	29.1	0.3	45.6	0.7	7.0	10.8	1.1	4.1	2.0	0.4	0.2	0.1	2.3	10.9	0.9	26.2	20.8	27.2	19.9	0.8	2.0	20.4	12.8	12.7	38.6	22.1	46.1	20.8	18.0	6.3	9.8	21.0	21.2	12.5	22.5	14.5	29.0	25.1	33.0	14.9	0.5	18.2	27.0	0.4	1.7	25.7	17.6	21.8	15.5	31.1	15.5	34.0	33.4	28.0	12.5	31.5	17.2	22.7	23.3	9.2	9.8	17.3	11.9	15.8	30.5	9.6	25.0	13.8	6.9	9.8	26.9	19.8	34.5	16.8	18.2	22.5	9.4	20.5	10.9	0.2	0.0	0.1	0.2	0.0	0.4	2.0	2.9	3.0	0.4	1.5	0.1	0.7	0.0	2.3	0.1	0.0	10.9	0.9	0.3	0.4	0.4	0.9	0.4	0.2	0.3	0.5	0.7	0.3
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318200	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5"	"Group enriched"	"Detected in some"	8	"HEL: 15.4;HL-60: 6.7;NB-4: 5.6;THP-1: 5.9;U-937: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA024135	Uncertain		Approved	Nucleoplasm		37000	37000	Nucleoplasm	Nucleoplasm	"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	1.2	0.4	0.3	6.3	0.5	17.5	0.5	0.4	1.0	1.3	1.3	2.1	0.0	0.2	1.6	1.6	0.9	0.6	1.4	11.9	0.3	0.4	0.9	0.8	3.1	5.1	0.5	0.3	0.8	0.4	0.0	0.4	0.9	0.5	1.2	0.1	1.7	5.6	0.9	0.3	0.5	1.1	1.8	0.8	5.8	1.4	0.4	1.1	7.4	0.5	2.1	11.5	1.0	0.8	1.1	14.9	17.9	19.3	25.3	13.2	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	15.4	0.0	0.1	0.7	6.7	1.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	9.4	0.0	17.9	15.2	2.0	13.0	17.9	8.1	1.1	4.7	11.1	14.9	0.6	3.7	13.2	8.4	25.3	19.3	0.7	5.8	9.5	0.3	0.5	0.4	1.0	0.3	0.4	0.5	0.3	0.5	1.1
TTC24		ENSG00000187862	"Tetratricopeptide repeat domain 24"	A2A3L6	1	156579727-156586770	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 13.3;lymphoid tissue: 8.4"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.1;REH: 15.5;U-698: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 13.3"	"Low lineage specificity"	"Detected in many"											HPA029799			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029799: AB_10601684"	"unprognostic (2.43e-3)"	"unprognostic (5.61e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-6)"	"unprognostic (6.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.87e-9)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.76e-4)"	0.2	0.0	0.2	2.7	0.3	2.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	8.4	0.2	0.2	0.2	0.2	0.0	3.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.6	0.0	2.6	0.2	0.2	5.1	0.4	0.2	0.2	1.4	0.2	0.2	7.5	0.2	0.2	2.2	13.3	0.3	0.0	3.8	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	1.1	0.1	2.2	0.2	1.9	0.3	3.8	0.0	13.3	0.0	0.6	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TTC7A	"KIAA1140, TTC7"	ENSG00000068724	"Tetratricopeptide repeat domain 7A"	Q9ULT0	2	46916157-47076137	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.0"	"Cell line enhanced"	"Detected in many"		"REH: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036781, HPA036782"	Enhanced									"HPA036781: AB_10673665, HPA036782: AB_10671711"	"unprognostic (2.51e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.51e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.36e-1)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (3.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-2)"	8.9	18.2	7.1	10.6	18.1	18.7	7.1	2.1	10.4	7.4	14.7	16.0	4.0	14.2	5.0	5.8	14.2	6.0	7.3	4.3	8.1	4.2	7.3	6.4	13.8	10.8	17.0	4.2	5.2	17.2	7.0	5.3	12.6	10.6	5.4	6.9	8.6	13.6	5.9	2.2	12.4	22.5	4.3	12.3	11.6	11.6	36.7	16.2	56.0	11.3	6.0	16.2	6.1	8.9	3.8	5.3	1.4	5.0	0.5	2.5	1.4	16.5	6.1	2.0	0.5	3.2	3.7	8.4	4.5	6.1	3.0	2.8	9.4	9.8	11.2	4.5	8.4	7.0	2.8	5.8	2.5	21.7	2.3	1.1	4.5	10.2	1.2	4.5	4.6	1.5	7.0	3.8	4.8	2.4	4.3	7.5	1.6	6.0	22.4	5.9	2.2	1.6	37.4	3.3	19.3	2.9	4.3	2.7	2.4	8.5	16.8	1.5	3.2	9.7	6.0	3.3	2.7	2.4	3.7	4.8	1.7	6.1	2.5	5.5	1.9	0.1	5.0	0.0	0.8	2.5	1.2	3.8	2.5	0.9	3.4	3.5	1.8	0.7	1.4	0.5	0.8	5.3	1.1	1.4	7.1	18.1	2.1	10.4	8.1	4.2	17.0	4.2	10.6	16.2
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.7	1.1	3.5	13.6	15.5	9.6	22.7	27.8	10.9	10.2	19.8	12.1	6.6	17.4	21.2	9.5	31.7	18.0	17.1	18.3	10.7	8.9	0.0	21.5	12.0	0.4	1.0	15.9	10.2	12.8	20.0	20.5	19.3	9.9	12.3	15.6	14.2	9.7	11.0	43.9	8.2	5.7	8.6	16.6	9.7	9.1	9.9	5.6	9.3	16.4	5.3	10.2	10.2	6.6	24.8	4.6	15.5	11.0	3.6	20.1	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30720201-30725426	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	Microtubules		510000000	510000000	Microtubules	Microtubules	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	51.6	27.7	30.0	31.8	33.2	78.8	30.0	30.9	57.2	43.3	37.0	24.3	18.7	10.8	58.5	39.7	39.9	41.0	29.6	33.1	23.7	48.2	31.4	74.1	32.7	62.1	27.8	24.0	81.5	27.0	15.3	16.3	41.1	39.9	32.2	34.2	30.6	27.9	24.3	29.6	37.6	24.3	37.6	27.4	47.7	29.1	19.7	14.4	198.7	26.9	36.8	91.5	39.7	34.3	15.4	17.5	8.6	15.4	12.3	18.2	19.8	41.9	15.5	60.6	26.3	17.1	29.7	0.5	0.0	0.0	0.0	0.0	29.6	16.1	21.0	26.0	19.4	14.5	48.9	44.0	0.0	11.8	30.9	0.5	0.0	16.9	8.2	57.2	28.2	22.0	10.3	0.0	0.5	21.3	16.5	0.0	26.6	30.3	41.3	0.2	0.0	18.3	0.0	0.6	12.3	35.4	23.9	10.5	35.4	22.8	10.1	0.4	26.4	5.2	13.1	63.8	28.4	0.0	0.2	19.6	37.6	48.6	12.6	56.9	80.6	4.9	7.7	8.6	15.5	12.2	18.2	15.4	12.1	17.6	6.2	10.0	12.3	12.2	4.3	12.3	15.4	17.5	14.2	19.8	30.0	33.2	30.9	57.2	23.7	48.2	27.8	24.0	39.9	14.4
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019254-59026654	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 58.6;lymphoid tissue: 28.2"	"Cell line enriched"	"Detected in some"	19	"HEL: 24.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"basophil: 8.7;neutrophil: 6.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB004286, HPA043640, HPA046280"	Approved					480000000	480000000			"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: "	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.6	0.3	0.2	0.4	0.6	12.2	0.2	0.7	0.7	0.2	0.2	0.1	0.0	0.2	0.2	0.9	0.2	0.5	0.6	10.8	0.2	0.2	0.2	1.0	8.3	0.4	0.2	0.4	0.8	0.4	0.0	0.7	3.2	0.6	0.3	0.0	0.5	0.2	0.6	0.6	0.2	0.5	0.0	0.6	28.2	0.3	1.8	0.0	0.0	0.5	0.3	0.2	0.4	1.8	0.1	0.6	8.7	0.5	0.0	0.1	58.6	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	24.4	0.6	1.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.3	0.2	0.0	0.3	0.2	0.1	0.2	0.0	0.2	0.3	0.2	0.1	0.5	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	8.7	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	6.5	0.0	0.0	0.6	0.1	58.6	0.2	0.6	0.7	0.7	0.2	0.2	0.2	0.4	0.6	0.0
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	"TXK tyrosine kinase"	P42681	4	48066393-48134256	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.7;HMC-1: 11.0;U-266/70: 5.4;U-266/84: 6.7;WM-115: 24.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 43.5"	"Group enriched"	"Detected in many"	26	"NK-cells: 43.5;T-cells: 17.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062482			Approved	Vesicles				Vesicles	Vesicles	"HPA062482: AB_2684778"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.04e-2)"	1.8	1.5	0.3	15.3	0.4	3.9	1.5	0.2	0.6	0.8	2.1	0.3	0.2	1.3	1.3	11.6	2.4	2.6	1.7	0.7	0.2	0.4	2.1	2.8	4.0	49.1	0.5	0.5	0.5	1.0	0.4	1.3	28.4	0.6	0.9	1.0	1.0	6.1	0.2	0.5	1.7	7.9	0.4	0.4	17.8	1.0	1.7	0.2	14.0	1.9	0.2	19.3	2.4	1.4	0.0	0.1	1.1	0.0	43.5	17.5	10.6	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.7	0.0	1.4	0.0	0.2	0.0	0.0	0.4	0.2	0.1	2.3	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.0	0.0	2.0	0.0	0.8	0.3	0.0	0.0	1.3	1.2	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.0	0.3	0.1	5.4	6.7	0.4	0.0	0.4	24.8	1.1	0.0	0.3	13.2	0.0	17.4	0.0	6.8	6.4	0.0	0.0	17.5	11.9	0.8	43.5	0.0	0.1	5.1	10.6	0.3	0.4	0.2	0.6	0.2	0.4	0.5	0.5	0.6	0.2
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530056	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.9;HHSteC: 39.3;Karpas-707: 38.0;U-266/70: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 23.0;eosinophil: 18.2;intermediate monocyte: 22.4;myeloid DC: 12.2;neutrophil: 6.7;non-classical monocyte: 15.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 12.2;granulocytes: 18.2;monocytes: 23.0"	"Low region specificity"	"Detected in some"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus"		16000000	16000000	"Nuclear bodies"	"Nuclear bodies"	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favourable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	25.2	7.9	2.8	41.6	8.4	12.1	19.0	1.5	4.4	10.7	10.7	3.8	2.3	10.4	4.4	15.7	22.0	13.7	9.6	15.0	7.0	2.6	18.6	38.1	28.8	57.8	6.5	0.4	7.5	5.8	1.7	3.9	11.5	9.1	7.9	4.9	5.4	16.5	3.8	10.0	8.8	13.9	7.3	15.2	43.9	12.4	3.0	5.0	13.3	12.5	25.5	28.8	12.4	9.4	0.9	12.2	18.2	23.0	0.8	0.9	2.6	6.5	0.7	0.0	0.1	0.9	1.2	0.6	1.1	0.1	2.4	5.3	0.0	15.9	0.5	0.8	2.7	5.8	0.2	0.2	0.0	2.8	1.4	0.3	1.1	0.4	39.3	0.1	7.6	2.4	2.4	3.2	0.0	0.0	0.2	38.0	0.2	0.1	0.0	1.0	0.0	2.1	0.2	0.0	7.6	0.0	0.0	0.0	1.4	6.1	8.3	0.5	0.6	4.8	1.5	0.0	0.6	0.1	0.2	18.2	3.7	0.4	0.2	0.1	0.2	2.5	23.0	18.2	0.3	22.4	0.2	0.8	0.3	0.2	12.2	0.9	0.2	0.1	6.7	0.8	15.9	1.1	0.9	2.6	2.8	8.4	1.5	4.4	7.0	2.6	6.5	0.4	9.1	5.0
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657604-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 75.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.8;T-cells: 13.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 6.7;olfactory region: 8.8"	CAB002784	Enhanced									"CAB002784: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	3.0	2.6	4.6	15.5	5.8	34.9	2.8	1.2	6.3	3.4	10.1	10.2	1.5	4.8	2.5	3.6	12.3	2.4	4.6	2.0	5.8	2.9	4.8	5.1	4.2	15.4	3.4	4.5	2.0	3.1	1.1	1.3	14.3	3.4	3.0	12.9	1.1	3.4	0.8	0.7	3.6	6.9	5.5	4.6	8.9	4.2	21.5	5.3	75.5	1.7	10.9	19.3	4.8	4.3	1.2	1.8	1.0	0.1	6.8	13.8	2.5	13.7	21.2	44.3	21.4	4.9	8.2	22.5	32.5	19.4	35.1	42.1	17.9	11.0	21.4	12.7	17.5	6.2	30.9	12.2	30.4	20.1	34.3	36.3	19.9	30.7	1.1	74.5	39.8	7.3	2.9	22.1	6.9	29.3	29.1	34.4	44.1	15.8	89.7	41.3	15.9	15.9	59.4	39.9	25.8	13.2	12.2	15.1	24.5	27.4	12.7	8.2	8.7	34.0	11.6	40.6	80.2	37.1	63.3	42.7	52.5	48.9	10.7	32.3	46.4	0.0	0.0	1.0	1.1	0.1	0.0	1.2	2.9	2.2	1.8	0.0	0.0	0.7	0.6	6.8	0.1	0.3	13.8	2.5	4.6	5.8	1.2	6.3	5.8	2.9	3.4	4.5	3.4	5.3
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"TYRO protein tyrosine kinase binding protein"	O43914	19	35904401-35908295	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 267.2;bone marrow: 125.7;lymphoid tissue: 123.6"	"Group enriched"	"Detected in some"	10	"HMC-1: 116.0;THP-1: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 267.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced									"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	76.0	21.4	13.3	54.9	20.7	125.7	16.4	2.8	11.3	11.9	14.3	24.0	2.3	17.1	8.1	19.3	7.2	14.0	25.7	17.5	12.9	14.2	17.6	29.8	75.3	80.0	20.8	5.6	11.7	8.7	1.8	9.0	32.0	17.2	14.9	12.3	15.0	12.4	7.2	7.3	6.7	18.9	16.0	36.3	123.6	10.4	7.3	18.6	8.5	6.7	6.6	10.3	22.3	8.4	0.7	79.3	267.2	190.6	62.8	20.3	162.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.1	5.3	116.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.8	0.0	32.8	190.6	100.9	20.3	134.4	10.6	0.7	0.4	2.8	79.3	0.3	0.5	2.3	267.2	62.8	130.3	68.5	0.3	162.3	13.3	20.7	2.8	11.3	12.9	14.2	20.8	5.6	17.2	18.6
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655675-122814473	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.5;lymphoid tissue: 27.7"	"Cell line enhanced"	"Detected in many"		"HEL: 41.7;HMC-1: 31.7;hTEC/SVTERT24-B: 25.9;REH: 24.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 32.5;pons and medulla: 21.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038607"	Approved		Approved	"Plasma membrane"		2200000	2200000	"Plasma membrane"	"Plasma membrane"	"HPA038605: AB_10669648, HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	4.3	1.3	2.8	5.5	4.0	7.2	1.5	32.5	4.9	4.0	1.5	0.7	0.0	1.7	1.3	0.3	1.8	1.1	2.4	1.3	3.4	3.5	1.5	1.7	5.5	10.9	5.1	1.9	0.8	1.2	0.6	0.9	16.8	21.2	1.3	1.8	0.9	1.3	0.9	1.8	4.1	2.4	2.3	2.1	27.7	1.7	2.1	0.2	23.9	2.9	1.7	3.8	3.4	1.3	1.0	1.7	9.8	11.0	6.5	4.9	1.8	4.4	10.9	2.0	2.6	0.8	1.6	10.3	15.8	8.8	6.4	5.0	4.3	2.4	1.8	1.2	8.4	2.2	0.0	5.6	10.3	0.0	0.3	41.7	0.3	3.6	2.4	5.0	31.7	1.4	0.3	25.9	9.6	4.3	0.0	0.0	6.2	0.1	6.1	3.2	0.8	2.6	24.9	1.2	0.2	10.2	3.8	4.5	0.1	4.2	0.3	3.5	0.0	1.3	11.2	8.4	4.5	4.9	6.5	0.3	0.0	5.3	4.4	7.1	15.2	0.0	1.3	9.8	2.0	6.5	2.2	0.3	2.6	1.8	1.7	1.0	3.0	1.6	2.8	6.5	11.0	0.2	4.9	1.8	2.8	4.0	32.5	4.9	3.4	3.5	5.1	1.9	21.2	0.2
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559925	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.2"	"Cell line enriched"	"Detected in some"	13	"RT4: 13.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favourable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	3.4	0.4	0.0	53.2	0.0	0.4	1.8	0.0	0.4	0.7	1.8	0.0	0.0	1.5	0.6	1.6	4.2	1.2	2.9	1.8	0.0	0.0	13.4	16.3	5.1	26.3	0.0	0.0	0.5	14.6	0.4	0.7	0.4	1.0	5.6	3.0	1.0	11.3	0.7	3.1	0.6	15.5	0.7	0.2	18.6	3.5	0.4	0.0	26.3	2.7	4.5	50.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	59.4	32.2	28.3	22.6	1.8	2.6	5.0	48.4	14.7	29.9	27.3	21.8	21.3	57.9	20.1	12.1	17.5	28.4	12.6	13.3	45.3	94.2	34.6	18.5	7.0	5.4	41.3	33.7	2.8	3.5	22.0	21.3	11.7	34.3	40.6	18.7	15.7	56.0	21.5	71.1	54.7	49.3	21.8	20.8	8.0	12.7	72.0	39.0	61.7	15.3	27.4	10.9	22.5	17.9	18.1	51.3	15.3	115.2	32.7	78.5	67.9	18.9	29.3	65.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA002831: "	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavourable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favourable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.3	29.0	43.2	20.4	4.0	7.4	24.7	33.2	18.6	38.0	26.8	20.6	37.3	35.4	13.2	12.1	24.8	39.9	19.5	34.3	32.1	22.8	21.6	15.8	23.5	1.8	25.9	26.4	2.6	4.7	29.9	12.4	22.0	27.3	29.3	29.7	28.3	46.3	33.0	16.7	14.8	35.9	46.0	30.8	14.5	14.6	34.0	34.7	23.2	28.6	11.1	30.1	16.4	10.8	17.1	27.4	29.9	39.4	14.9	29.0	45.1	17.0	27.0	35.5	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;T-47d: 5.7;THP-1: 12.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.4	5.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	4.0	0.0	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991104-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 30.6;RPMI-8226: 85.2;SK-BR-3: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: "	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	8.0	2.7	5.7	9.7	7.4	9.2	5.0	6.2	7.0	4.7	11.9	5.3	6.9	11.8	2.3	5.7	5.5	4.1	13.9	4.6	8.7	6.0	5.9	7.1	13.4	20.8	3.6	0.4	3.0	5.2	0.8	3.3	6.7	2.7	5.3	1.2	5.0	12.3	9.0	6.1	3.7	16.9	2.7	3.5	28.6	10.7	4.1	2.2	2.6	5.3	2.4	13.3	5.9	2.8	2.5	13.6	5.7	6.6	1.8	0.2	0.9	4.4	8.0	0.6	3.3	1.8	0.6	7.0	2.0	1.8	3.1	2.9	0.6	30.6	9.8	7.7	0.9	10.7	0.2	1.6	0.1	3.4	2.3	0.9	2.5	1.4	2.7	6.9	5.5	1.5	1.8	0.9	0.3	0.6	0.7	4.6	0.4	4.3	0.0	5.5	1.5	4.3	5.8	0.0	85.2	2.8	2.5	0.9	1.4	3.3	22.9	4.4	8.5	9.1	2.1	2.1	3.0	3.0	0.2	3.3	4.3	1.6	3.9	7.2	2.5	0.1	3.6	5.7	0.1	6.6	0.2	2.4	0.2	0.2	4.7	2.5	0.0	0.0	3.1	1.8	6.6	13.6	0.0	0.9	5.7	7.4	6.2	7.0	8.7	6.0	3.6	0.4	2.7	2.2
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510428-76516521	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;CAPAN-2: 27.8;HaCaT: 5.7;RT4: 19.0;T-47d: 15.9"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"									HPA010506	Approved									"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	28.5	0.3	0.0	7.1	0.0	0.4	0.3	0.0	0.3	1.5	6.9	0.1	0.0	0.3	0.8	7.9	40.2	2.8	3.0	9.4	0.0	0.0	0.3	0.4	34.1	0.4	0.0	0.0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0.0	0.2	0.3	6.1	25.0	20.5	2.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.8	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.2	2.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0
UPK3BL1	"UPK3BL, UPLP"	ENSG00000267368	"Uroplakin 3B like 1"	"B0FP48, E5RIL1"	7	102637025-102642791	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.1;lymphoid tissue: 34.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 47.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA011403	Supported									"HPA011403: AB_2668503"	"unprognostic (4.63e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.93e-2)"	3.0	2.2	2.1	3.3	2.7	7.9	3.0	4.5	2.1	6.5	2.9			3.6	3.4	1.7	45.1	3.7	1.0	2.2	3.0	1.9	4.6	4.0	3.4	7.1	2.1		3.7	3.8	3.4	4.3	1.7		5.9	1.5		7.7	23.7	6.5	5.1	4.6	0.9	2.0	8.8	3.0	1.3			13.1		34.6	11.8	15.1	5.3	6.8	13.6	5.9	7.1	9.6	4.7	7.2	5.7	3.7	1.6	1.5	0.2	5.1	0.0	0.8	0.8	2.1	0.9	4.0	1.1	1.4	0.9	47.8	1.1	5.3	0.6	6.5	8.4	1.1	2.4	1.7	0.5	1.9	1.9	3.2	6.9	0.0	1.3	6.7	2.8	4.0	2.4	16.6	2.9	15.9	1.7	1.7	2.9	2.0	6.0	6.8	5.8	2.5	5.8	9.9	2.6	2.4	0.8	2.9	2.3	14.2	6.1	5.0	2.8	4.2	1.9	0.6	3.0	4.4	2.3	13.6	5.9	8.5	9.6	5.2	4.4	5.3	5.0	4.7	6.8	4.9	6.3	4.8	7.1	7.1	1.7	6.8	7.9	4.7										
UPK3BL2		ENSG00000284981	"Uroplakin 3B like 2"	E5RIL1	7	102538417-102543849	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 12.2;lymphoid tissue: 12.8"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA011403	Approved									"HPA011403: AB_2668503"																		0.8	0.0		1.5		6.5	1.0		0.3	0.0	0.6			1.0	0.7	0.4	12.2	0.9	0.6	0.0			0.0	0.1	0.8	3.4			0.4	0.7	0.2		0.3		1.2	0.8		1.5	3.6	2.7	2.8	0.9	0.1		3.2	0.4	0.0			4.5		12.8	2.5		5.0	8.4	6.1	3.7	1.0	7.9	1.3	5.7	8.9	3.8	6.7	1.8	0.6	13.2	10.5	13.2	13.3	16.5	3.0	9.7	6.5	5.3	4.0	18.7	0.4	5.0	3.7	7.2	10.9	2.3	14.6	5.2	7.7	5.6	7.2	6.4	7.3	3.8	3.6	6.0	6.0	15.1	4.8	23.5	6.3	9.5	1.5	1.8	4.9	2.1	9.5	7.5	22.6	4.9	5.4	5.9	2.9	5.3	3.1	5.3	2.7	7.1	3.2	4.5	4.2	15.1	4.8	4.0	2.0	10.2	5.1	0.2	3.7	2.6	7.9	1.9	2.9	4.7	3.1	2.5	1.5	5.0	5.6	2.8	6.1	1.0	2.0	8.4	3.0	1.3										
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	11.6	9.0	11.3	17.2	10.7	29.3	15.9	20.6	14.2	19.2	13.3	7.8	8.0	10.8	15.1	12.0	15.6	13.8	8.9	9.0	11.5	9.6	11.8	9.3	11.7	19.2	14.2	9.6	26.7	12.7	14.8	18.4	13.6	10.9	14.8	13.9	7.6	12.7	13.5	11.7	12.3	13.3	15.8	15.5	18.1	11.6	31.6	11.8	70.6	15.0	13.3	20.1	16.5	16.5	14.7	11.8	23.4	12.4	15.5	16.3	9.2	22.0	6.5	27.4	14.8	6.2	7.4	15.2	21.2	14.5	26.4	29.0	11.0	10.8	39.9	15.4	11.9	12.8	22.5	14.6	37.0	19.9	16.2	32.7	22.6	11.5	6.7	35.0	16.5	3.9	9.6	23.9	18.0	12.4	23.7	34.9	18.6	9.8	35.9	13.5	24.1	13.5	34.1	46.5	24.7	9.9	16.5	28.4	15.9	24.0	19.6	23.2	11.2	21.4	8.6	20.4	22.2	29.8	29.7	13.9	19.3	45.8	13.8	28.0	18.2	17.4	9.5	23.4	12.6	9.6	16.3	14.7	15.0	12.7	11.4	10.7	14.3	11.9	16.9	15.5	12.4	11.8	13.6	9.2	11.3	10.7	20.6	14.2	11.5	9.6	14.2	9.6	10.9	11.8
UTY	"KDM6AL, KDM6C"	ENSG00000183878	"Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked"	O14607	Y	13248379-13480673	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.7"	"Cell line enhanced"	"Detected in many"		"HEL: 14.7;U-266/84: 11.3;U-698: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA000568, HPA001165"	Supported		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA000568: , HPA001165: AB_1080541"			"unprognostic (7.52e-2)"		"unprognostic (6.60e-2)"	"unprognostic (4.04e-6)"	"unprognostic (6.47e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-2)"		"unprognostic (9.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-2)"	5.3	5.1	3.0	15.4	10.3	9.0	5.1	6.1	11.0	0.4	8.4	18.0	18.4	4.3	0.4	16.5	7.2	0.4	6.5	4.7	3.5	3.4	5.0	6.9	11.9	19.0	3.3	0.0	0.5	15.1	0.4	6.3	5.9	13.0	14.0	10.6	16.8	10.9	16.1	9.3	7.4	10.1	18.6	4.8	17.4	5.7	6.7	0.0	37.7	6.3	10.3	22.0	7.2	0.0	6.1	4.8	6.6	3.8	9.9	6.7	1.3	0.0	1.8	0.0	0.0	0.0	0.0	6.5	3.3	5.6	3.7	5.6	0.0	0.0	8.9	0.0	3.7	0.0	0.0	0.0	5.2	4.9	0.0	14.7	0.1	0.0	4.9	0.0	0.0	5.9	5.9	0.0	0.0	0.0	0.0	0.0	4.1	0.0	5.0	0.1	0.0	0.0	0.0	2.3	3.9	4.0	6.0	3.7	0.0	0.0	0.0	10.5	0.0	3.2	4.3	6.5	0.0	0.0	2.3	10.0	11.3	14.7	0.6	0.0	0.0	1.8	2.8	5.8	4.7	3.4	6.7	5.0	4.6	3.6	3.0	6.1	6.5	4.7	6.6	9.9	3.8	4.8	5.3	1.3	3.0	10.3	6.1	11.0	3.5	3.4	3.3	0.0	13.0	0.0
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772714-6857366	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 30.9;Karpas-707: 35.3;MOLT-4: 33.5;REH: 22.2;THP-1: 26.0;U-266/84: 25.6;U-937: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001864	Enhanced		Approved	Cytosol		30000	30000	Cytosol	Cytosol	"HPA001864: AB_1858722"	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	5.1	3.0	3.1	19.0	5.6	25.7	2.3	0.7	2.2	1.7	3.5	4.0	0.3	2.8	1.9	2.6	2.6	2.6	3.1	3.3	2.5	3.0	2.7	2.6	8.5	25.1	5.3	1.2	2.0	1.5	5.2	1.8	4.4	3.5	3.2	3.7	2.3	5.8	1.1	0.8	1.4	10.7	2.6	8.7	37.1	2.5	1.5	4.8	43.1	2.0	1.2	20.0	6.1	2.4	9.3	10.5	25.7	22.8	11.5	14.7	10.5	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	15.2	4.6	0.0	0.0	0.0	0.0	0.0	6.4	0.5	18.3	0.0	0.0	0.0	17.8	30.9	0.0	0.0	0.0	0.0	0.0	0.6	35.3	0.0	2.5	33.5	10.2	0.0	0.0	22.2	0.0	12.0	0.6	0.0	0.0	0.0	0.0	5.1	0.0	2.2	26.0	0.0	0.0	0.4	0.0	0.0	21.2	25.6	17.2	0.0	28.1	0.0	0.9	11.5	11.9	14.7	18.8	10.5	9.3	10.7	12.7	10.5	9.2	11.8	10.6	25.7	11.5	22.8	9.0	8.5	10.5	3.1	5.6	0.7	2.2	2.5	3.0	5.3	1.2	3.5	4.8
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750798-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.5;lymphoid tissue: 64.7"	"Group enriched"	"Detected in some"	4	"HeLa: 2.1;SH-SY5Y: 6.8;TIME: 4.8;U-2 OS: 2.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	1.2	5.7	9.7	64.7	8.3	0.3	0.9	1.5	20.1	0.6	31.5	0.5	0.3	7.5	0.7	0.4	13.1	0.5	4.2	1.1	12.4	7.7	0.9	0.6	1.7	0.4	2.7	8.3	0.4	3.8	0.5	0.4	0.5	1.6	6.3	28.3	3.2	0.4	6.9	0.8	0.4	32.5	18.0	0.4	5.2	13.2	0.5	0.1	0.0	1.3	0.5	0.4	9.1	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.0	0.0	0.0	4.8	0.0	2.0	0.2	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.7	8.3	1.5	20.1	12.4	7.7	2.7	8.3	1.6	0.1
VPREB1	"CD179A, VpreB"	ENSG00000169575	"V-set pre-B cell surrogate light chain 1"	P12018	22	22244675-22245515	"CD markers, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.1;bone marrow: 23.8;lymphoid tissue: 4.8"	"Group enriched"	"Detected in some"	11	"Daudi: 8.4;MOLT-4: 17.8;RPMI-8226: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 5.8;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 8.1"					"Not detected"	"Not detected"			HPA055886	Uncertain				"Intracellular and membrane"					"HPA055886: AB_2682956"																		0.0	0.0	0.0	2.2	0.0	23.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	1.3	0.0	4.8	0.0	0.0	1.2	0.0	0.0	8.1	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VRTN	"C14orf115, FLJ10811, vertnin"	ENSG00000133980	"Vertebrae development associated"	Q9H8Y1	14	74303069-74360008	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.9;lymphoid tissue: 4.5;testis: 5.8"	"Cell line enriched"	"Detected in some"	9	"NTERA-2: 33.0"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001460	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA001460: AB_1078318"			"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"				"unprognostic (1.37e-1)"		"unprognostic (5.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.78e-2)"		"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"			0.1	0.1	0.1	2.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.5	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.2	0.2	5.8	0.0	0.0	0.1	0.0	1.9	0.1	0.1	0.8	1.2	1.4	0.5	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.5	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.8	0.3	0.4	1.4	0.8	0.5	1.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"Wiskott-Aldrich syndrome"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 55.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;HMC-1: 45.7;MOLT-4: 19.4;NB-4: 21.1;RPMI-8226: 26.0;U-266/70: 24.2;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		320000	320000	"Plasma membrane"	"Plasma membrane"	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favourable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favourable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavourable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	7.6	4.0	4.9	28.9	7.8	30.7	3.3	2.0	5.1	2.7	4.4	5.9	0.5	4.8	2.4	5.6	3.7	4.5	4.4	3.0	4.6	4.1	4.1	5.0	12.6	29.9	7.6	1.3	2.6	2.2	0.7	2.6	5.4	6.0	3.2	3.2	3.5	5.4	1.9	1.4	2.2	14.3	3.7	12.8	55.9	4.1	1.7	7.3	53.2	2.8	1.4	33.2	5.8	2.5	2.1	3.5	20.3	5.3	2.1	3.2	2.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	21.3	0.0	0.0	0.7	0.0	0.0	0.0	12.2	0.1	18.8	0.2	0.0	0.2	9.6	45.7	0.0	0.0	0.0	0.0	0.0	0.2	13.1	0.0	2.1	19.4	21.1	0.1	0.1	16.9	0.0	26.0	0.0	0.0	0.1	0.2	0.3	0.2	0.2	0.1	19.2	0.1	0.0	0.1	0.3	0.0	24.2	11.8	14.9	0.1	24.4	0.0	1.8	4.6	20.3	3.0	5.0	2.2	1.8	2.3	2.5	3.5	2.1	2.1	2.3	18.1	2.1	5.3	1.8	3.2	2.0	4.9	7.8	2.0	5.1	4.6	4.1	7.6	1.3	6.0	7.3
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.7;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 29.4;HDLM-2: 26.9;HL-60: 10.2;THP-1: 9.1;U-698: 12.5;U-937: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7"	"Group enriched"	"Detected in many"	7	"B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2"	"Low region specificity"	"Detected in many"							HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	2.7	1.5	3.6	31.2	5.4	8.6	1.5	0.9	2.7	1.2	1.6	5.2	0.0	1.1	1.2	1.5	1.5	1.5	2.6	1.4	3.1	1.9	1.7	1.2	9.4	20.8	5.3	0.6	1.1	1.1	0.2	1.1	0.8	3.7	1.2	1.5	1.2	5.7	0.4	0.9	2.0	10.2	1.3	7.3	19.1	1.6	1.5	4.4	4.1	1.6	0.9	26.6	3.0	1.2	12.5	19.7	6.2	1.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	3.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	12.1	0.0	0.0	1.7	0.0	0.0	1.6	0.0	8.9	0.0	0.1	6.7	12.5	0.0	0.0	6.2	0.0	0.8	19.7	0.0	0.6	3.6	5.4	0.9	2.7	3.1	1.9	5.3	0.6	3.7	4.4
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938950-55027105	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.1"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavourable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	5.0	2.8	6.3	6.6	7.5	10.8	3.8	7.2	4.6	3.7	4.9	2.7	0.6	3.2	4.2	2.9	7.0	4.0	2.3	2.3	3.2	2.3	2.8	2.1	2.9	8.9	3.3	2.5	4.1	2.0	3.0	1.9	6.0	4.4	2.1	7.3	2.6	3.0	2.2	2.0	4.5	3.6	4.6	2.8	4.6	2.8	8.8	3.5	21.1	2.1	6.4	11.2	3.6	4.3	4.8	1.8	4.3	0.9	4.3	4.6	1.6	15.8	10.2	20.2	8.9	2.0	4.8	11.8	15.4	6.6	12.4	15.3	6.7	10.6	18.1	7.9	4.4	13.5	30.1	8.8	26.2	12.1	5.2	11.9	10.0	6.5	0.8	22.5	9.1	2.5	1.6	15.3	6.0	8.0	14.9	9.1	11.9	8.7	21.1	4.4	16.0	10.7	19.8	29.2	6.9	3.5	10.6	11.8	8.3	16.3	4.1	5.3	11.1	4.5	5.2	15.8	18.8	11.5	13.0	2.7	5.6	24.2	7.2	11.1	12.4	4.3	0.8	1.4	2.3	0.6	3.2	3.0	2.7	3.3	1.4	4.8	3.3	4.6	1.2	4.3	0.9	1.8	3.9	1.6	6.3	7.5	7.2	4.6	3.2	2.3	3.3	2.5	4.4	3.5
WDR76	FLJ12973	ENSG00000092470	"WD repeat domain 76"	Q9H967	15	43826963-43868419	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039804, HPA040626"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA039804: AB_10795297, HPA040626: AB_10795527"	"unprognostic (2.26e-1)"	"unprognostic (7.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (6.98e-4)"	"prognostic unfavourable (8.02e-5)"	"unprognostic (4.24e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (1.91e-2)"	"prognostic unfavourable (1.35e-8)"	"unprognostic (7.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.28e-2)"	5.4	1.8	2.4	21.9	3.0	17.5	4.8	12.9	6.0	5.3	6.3	1.5	1.6	3.6	4.9	3.6	8.2	3.3	2.1	2.5	2.4	2.0	2.8	2.5	5.1	19.8	2.4	2.1	4.2	4.8	3.9	3.3	4.3	3.3	4.2	6.8	4.5	4.6	2.4	1.4	6.3	5.8	7.0	3.9	6.5	4.8	6.7	2.1	37.2	2.9	7.1	21.9	5.3	5.5	3.2	1.6	0.4	0.8	5.7	8.3	2.6	11.0	5.6	13.5	10.3	1.5	3.6	3.6	18.6	11.1	20.4	25.7	7.1	5.8	16.3	8.2	8.6	16.0	13.8	6.6	17.8	25.4	8.2	20.1	18.0	2.3	0.8	20.3	9.0	1.1	1.0	11.2	2.6	6.5	15.1	28.6	13.9	3.8	19.7	4.8	4.8	5.9	21.1	23.2	10.3	3.8	11.4	10.4	10.3	11.7	7.4	2.3	11.5	9.9	2.9	18.8	8.9	21.0	18.8	14.2	35.2	41.6	13.5	18.1	10.3	0.0	0.8	0.4	5.1	0.5	5.4	2.5	6.4	4.4	1.3	3.2	5.2	4.1	0.0	5.7	0.2	1.6	8.3	2.6	2.4	3.0	12.9	6.0	2.4	2.0	2.4	2.1	3.3	2.1
WFIKKN1	"C16orf12, RJD2, WFDC20A, WFIKKN"	ENSG00000127578	"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1"	Q96NZ8	16	629239-634116	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;lymphoid tissue: 5.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;Hep G2: 2.1;NTERA-2: 2.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (3.12e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (4.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.70e-5)"	0.7	0.2	1.3	0.3	2.4	0.4	0.3	5.8	1.9	0.7	1.4	0.3	0.3	0.2	1.3	0.3	0.3	0.2	0.3	0.3	1.0	0.2	1.3	0.6	1.3	0.3	0.4	2.3	0.5	1.2	0.2	1.5	0.5	0.3	0.6	0.2	0.3	0.5	0.3	1.0	0.7	0.4	0.3	0.3	1.6	1.2	1.0	0.3	5.1	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.6	0.7	0.0	0.0	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	2.9	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	1.3	2.4	5.8	1.9	1.0	0.2	0.4	2.3	0.3	0.3
WSCD1	KIAA0523	ENSG00000179314	"WSC domain containing 1"	Q658N2	17	6057807-6124427	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;lymphoid tissue: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 21.9;HUVEC TERT2: 13.3;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5"	"Group enriched"	"Detected in many"	7	"glioma: 18.8;renal cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015919	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA015919: AB_2216211"	"unprognostic (1.50e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	3.9	2.6	11.2	1.6	7.3	0.4	1.3	17.1	24.7	1.5	8.7	11.2	0.0	4.7	1.5	1.4	1.2	1.7	1.6	3.8	10.5	9.7	6.2	1.1	1.8	1.9	11.9	5.3	0.8	2.4	2.3	2.7	6.5	8.5	1.2	5.4	1.1	1.8	1.3	13.3	2.0	5.7	2.1	12.2	16.7	1.4	12.9	10.5	0.6	1.3	0.0	1.6	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	3.1	21.9	1.7	0.1	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	5.4	0.1	0.0	0.0	7.3	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.3	13.3	0.0	0.5	0.6	0.4	0.0	0.0	7.3	13.5	0.0	27.7	0.8	4.6	1.1	8.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.2	7.3	17.1	7.3	10.5	9.7	11.9	5.3	8.5	10.5
XCR1	"CCXCR1, GPR5"	ENSG00000173578	"X-C motif chemokine receptor 1"	P46094	3	46017024-46027742	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.5;RT4: 4.3;U-266/84: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 7.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013169	Uncertain									"HPA013169: AB_1846211"	"unprognostic (3.49e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.53e-6)"	"unprognostic (3.89e-6)"	"unprognostic (9.27e-3)"	"unprognostic (4.41e-3)"	"unprognostic (3.40e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-1)"	0.7	0.5	0.4	4.0	0.5	2.5	0.7	0.4	0.5	1.1	2.5	0.1	0.1	1.1	0.6	4.9	2.5	0.7	3.3	0.9	0.4	0.4	0.8	0.7	1.8	9.8	0.4	0.1	0.9	0.6	0.0	0.5	9.4	0.2	0.5	0.8	1.7	2.1	0.2	0.6	7.6	3.3	1.1	0.5	6.8	0.8	0.7	0.1	27.5	0.8	6.3	5.1	1.0	1.2	0.1	7.2	0.9	0.3	0.3	0.7	0.6	0.1	1.9	0.8	0.0	0.0	0.0	1.6	0.7	1.8	0.0	0.0	1.6	0.0	1.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.3	3.1	0.0	0.9	0.0	1.0	1.0	5.5	0.0	1.8	0.9	0.0	0.0	0.0	1.0	0.0	0.6	0.7	4.3	0.4	0.0	0.0	0.5	0.1	0.5	0.1	0.0	0.9	2.2	0.4	0.2	2.6	4.5	1.4	3.1	0.0	0.4	0.9	0.1	0.3	0.7	0.1	0.1	0.0	0.1	0.6	7.2	0.1	0.1	0.4	0.7	0.3	0.3	0.2	0.1	0.6	0.4	0.5	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1
XKR5		ENSG00000275591	"XK related 5"		8	6808517-6835644	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.5"	"Cell line enhanced"	"Detected in some"		"AF22: 5.9;NTERA-2: 3.9;SCLC-21H: 3.2;SH-SY5Y: 5.8;U-2 OS: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.73e-2)"		"unprognostic (9.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.91e-3)"	"unprognostic (3.13e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.06e-2)"	0.0	0.0	0.0	0.9	0.0	2.0	0.0	0.3	0.6	2.7	0.0	0.2	0.0	0.0	1.3	0.6	0.4	0.6	0.7	0.0	0.4		0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.1	0.5	0.0	0.0	1.8	0.0	9.5	0.0	0.0	0.5	0.0	0.0	0.2	1.2	0.4	0.1	0.1	0.1	0.0	0.0	0.0	5.9	1.1	0.0	0.0	0.0	2.0	0.9	1.1	1.7	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.9	0.0	0.0	0.1	0.0	0.0	0.5	3.2	5.8	0.4	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	1.2	0.0	0.0										
XRCC2	FANCU	ENSG00000196584	"X-ray repair cross complementing 2"	O43543	7	152644779-152676165	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 12.7;testis: 11.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065153			Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA065153: AB_2685422"	"unprognostic (9.31e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.36e-5)"	"unprognostic (9.98e-3)"	"unprognostic (5.82e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-15)"	"unprognostic (4.52e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.73e-2)"	1.3	1.3	3.4	4.5	2.0	5.4	2.4	4.4	2.6	1.6	1.5	2.5	0.6	1.1	1.9	2.2	2.6	1.3	0.6	2.5	3.3	1.1	1.1	1.3	1.4	3.0	1.9	1.9	2.0	1.2	0.4	1.3	7.2	2.7	1.5	2.9	0.6	1.5	1.3	1.1	1.6	1.9	1.3	1.8	1.8	1.5	11.7	2.2	12.7	1.2	1.1	3.6	1.3	1.6	1.8	1.0	3.1	1.1	1.1	1.6	0.6	7.4	4.5	6.6	7.1	0.8	0.7	7.6	5.4	1.9	4.7	4.6	5.6	6.5	10.6	4.2	2.1	5.4	5.3	4.4	8.5	5.0	5.5	7.6	6.0	3.1	0.3	11.3	3.7	0.5	0.4	7.6	2.0	1.6	15.7	9.1	2.7	5.2	10.4	2.7	8.7	4.0	8.4	8.8	5.9	1.4	4.9	6.3	6.0	6.0	2.6	1.1	2.2	2.4	3.1	6.2	2.8	5.8	9.9	3.3	6.4	9.3	3.3	6.1	8.1	2.0	0.9	1.5	1.6	0.6	1.1	1.3	1.3	1.1	0.3	1.8	1.6	0.8	3.1	1.1	1.1	1.0	1.5	0.6	3.4	2.0	4.4	2.6	3.3	1.1	1.9	1.9	2.7	2.2
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.8;U-2197: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	30000	30000	"Plasma membrane"	"Plasma membrane"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.6	0.0	18.8	11.7	3.2	8.4	4.3	0.9	0.4	0.1	0.2	2.0	0.0	10.1	0.2	0.0	1.7	1.5	4.0	0.2	2.5	0.0	0.0	0.2	3.6	3.4	4.3	0.2	5.4	0.8	0.0	0.3	7.9	0.9	0.3	0.0	3.9	2.8	0.0	1.2	0.0	0.4	0.0	3.8	0.7	5.1	0.6	2.6	0.5	0.6	2.3	0.0	8.8	1.0	19.3	0.0	8.8	0.5	3.8	9.8	4.1	7.4	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1
Z83844.3		ENSG00000285304			22	37639693-37666932	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.3"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA000757	Approved		Uncertain	Cytosol				Cytosol	Cytosol	"HPA000757: AB_1079951"																		2.4	0.1	1.8	12.3	2.7	8.5	1.0	2.4	3.5	3.7	7.5	2.0	0.9	8.4	1.3	2.0	11.6	1.9	2.4	1.0	1.5		0.3	1.0	3.7	8.2	1.7	1.5	2.5	0.9	2.8	0.0	6.0	1.8	3.5	5.7	1.4	4.4	2.8	0.0	2.2	12.5	2.6	2.5	13.4	1.6	0.9	2.4	10.5	0.3	10.4	16.3	4.6	2.0	1.6	3.6	0.1	2.7	1.7	2.6	1.5	9.1	1.6	5.3	3.3	1.5	4.6	5.8	2.7	8.4	10.1	10.6	7.4	2.3	6.7	1.1	3.0	8.0	5.7	13.8	3.2	6.9	5.1	14.0	0.2	7.4	3.0	21.3	19.2	5.4	6.6	11.8	1.1	0.6	4.0	5.0	0.4	11.2	0.9	2.0	5.4	1.3	8.7	3.6	5.4	1.1	3.2	3.0	5.5	0.7	3.5	6.1	4.6	10.7	1.2	1.5	5.5	0.7	0.0	9.1	3.4	6.1	3.5	14.7	10.1	0.0	2.7	0.1	2.2	1.3	1.8	1.6	1.4	2.1	3.6	0.9	2.6	1.6	0.0	1.7	2.7	2.2	2.5	1.5										
Z84488.2		ENSG00000285446			6	116399395-116463696	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.5;lymphoid tissue: 3.0"	"Cell line enhanced"	"Detected in some"		"BJ: 3.4;HDLM-2: 3.7;hTEC/SVTERT24-B: 2.8;Karpas-707: 4.3;RPMI-8226: 3.2;SiHa: 2.4"									"Cell type enriched"	"Detected in single"	6	"basophil: 3.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.5"																																					0.5	0.0		0.0		0.4	0.0		0.1	0.1	0.0			0.0	0.0	0.0	0.2	0.8	1.5	0.0			0.0	0.4	0.2	0.1			0.2	0.0	0.0		0.1		0.0	0.1		0.7	0.0	0.0	0.0	0.4	0.0		3.0	1.1	0.0			0.0		0.5	0.0		0.5	0.1	3.5	0.3	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	1.2	0.0	0.0	0.0	0.8	0.0	1.4	0.2	1.8	0.9	3.7	0.0	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.8	0.0	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	3.2	0.0	0.6	0.0	0.0	2.4	0.2	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.5	0.0	0.1	0.2	0.8	0.0	3.5	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4										
ZBP1	"C20orf183, DAI, dJ718J7.3, DLM-1, DLM1"	ENSG00000124256	"Z-DNA binding protein 1"	Q9H171	20	57603846-57620576	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 29.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.4;U-266/70: 12.0;U-266/84: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA041256	Enhanced									"HPA041256: AB_2677380"	"unprognostic (5.78e-3)"	"unprognostic (9.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.58e-8)"	"unprognostic (8.29e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	"unprognostic (9.79e-2)"	3.3	0.8	0.8	20.8	0.9	12.6	1.5	0.7	1.1	1.6	4.6	1.4	0.9	6.1	1.3	2.6	5.1	1.4	4.7	1.0	1.1	1.0	2.6	1.9	5.2	12.1	1.2	1.0	1.2	0.8	0.0	1.1	1.5	1.8	1.6	5.3	2.0	12.0	1.5	1.1	1.7	7.5	0.3	2.5	24.5	3.6	0.9	1.0	3.1	2.1	2.7	29.6	7.0	1.4	10.1	2.6	23.2	2.2	11.4	12.0	3.8	0.5	0.4	1.5	2.5	0.4	0.4	0.7	0.4	0.4	0.2	0.6	2.1	1.6	6.5	0.5	0.0	1.0	0.0	0.7	0.0	0.6	1.4	2.3	3.5	1.0	0.4	2.6	1.6	0.0	0.3	0.8	0.7	0.3	0.8	24.4	0.9	3.2	1.0	3.3	1.5	2.9	1.1	0.1	6.9	0.0	3.3	1.3	1.4	0.2	1.1	1.0	0.9	1.0	1.7	3.2	1.1	2.2	1.1	12.0	15.5	2.8	1.1	2.0	0.7	0.9	2.2	9.8	12.0	2.2	8.0	10.1	8.1	7.0	2.6	6.9	3.7	5.2	23.2	11.4	1.3	0.1	10.5	3.8	0.8	0.9	0.7	1.1	1.1	1.0	1.2	1.0	1.8	1.0
ZGRF1	"C4orf21, FLJ11331"	ENSG00000138658	"Zinc finger GRF-type containing 1"	Q86YA3	4	112539333-112636995	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA030704, HPA030706"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA030704: AB_2673577, HPA030706: AB_10601784"	"unprognostic (8.48e-2)"	"unprognostic (6.17e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.83e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.72e-3)"	"unprognostic (7.60e-10)"	"unprognostic (3.45e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-4)"	2.5	1.8	3.3	4.9	4.8	13.8	2.8	13.8	6.5	2.5	2.4	0.5	0.1	2.6	2.6	1.5	3.0	2.1	1.3	1.5	3.1	1.0	1.6	1.6	2.7	5.0	2.5	3.3	3.2	2.2	0.9	4.5	3.5	3.5	2.1	3.1	1.1	2.7	2.3	2.9	3.0	3.2	2.1	4.2	3.8	2.6	7.3	4.1	17.0	2.7	2.2	5.8	2.1	2.5	2.5	2.8	1.3	2.9	1.1	1.6	0.4	3.7	2.7	9.3	6.6	0.7	1.3	3.6	6.6	2.8	6.7	6.0	5.2	5.5	9.7	2.0	2.0	3.0	9.7	3.5	7.8	5.2	2.4	6.1	4.3	1.5	0.3	13.6	4.1	0.6	0.4	8.5	2.3	2.7	8.7	11.0	4.5	6.0	18.2	5.0	4.8	3.2	10.2	13.9	3.3	1.2	3.2	4.4	7.3	3.0	4.1	1.2	1.9	4.0	3.2	8.5	8.3	4.5	5.2	4.2	7.2	13.0	3.8	4.6	4.8	0.0	0.6	1.3	1.0	2.9	0.6	1.3	0.5	0.2	0.1	2.5	1.6	1.6	0.9	1.1	0.7	2.8	1.0	0.4	3.3	4.8	13.8	6.5	3.1	1.0	2.5	3.3	3.5	4.1
ZNF101	"DKFZp570I0164, HZF12"	ENSG00000181896	"Zinc finger protein 101"	Q8IZC7	19	19668796-19683509	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.4;lymphoid tissue: 37.9"	"Cell line enhanced"	"Detected in all"		"U-698: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 27.4"									"HPA023449, HPA055486"	Uncertain									"HPA023449: AB_2671211, HPA055486: AB_2682831"	"unprognostic (5.05e-2)"	"prognostic favourable (5.76e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.15e-4)"	"unprognostic (2.43e-1)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.62e-2)"	"prognostic favourable (2.26e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.84e-3)"	"prognostic favourable (1.11e-4)"	"unprognostic (3.15e-2)"	"unprognostic (7.02e-2)"	"prognostic favourable (4.37e-4)"	4.0	2.5	2.8	21.6	2.7	9.7	5.6	2.7	2.9	2.7	3.7	2.2	2.3	2.5	3.2	2.3	8.1	2.0	4.4	2.2	3.2	2.4	4.0	3.0	4.0	36.0	2.8	1.9	2.7	3.6	1.5	2.5	4.2	2.2	2.5	3.8	3.9	7.0	3.1	1.5	4.2	8.1	1.6	3.1	11.0	3.5	11.3	2.1	37.9	4.5	4.3	22.1	5.4	3.1	6.8	4.8	5.4	3.3	4.8	27.4	7.7	3.0	2.8	3.5	4.1	1.3	2.4	6.2	3.6	1.9	2.8	4.9	3.5	3.7	17.3	3.9	1.8	2.7	6.0	3.6	5.6	2.5	3.2	5.5	2.6	5.6	1.1	10.0	9.4	1.8	2.1	5.0	3.7	3.3	3.8	9.8	3.2	3.5	12.7	3.2	9.1	4.3	5.0	4.5	7.3	2.9	5.0	1.7	1.9	3.3	2.8	1.2	3.7	6.0	2.5	3.9	1.5	5.9	3.5	4.6	9.0	40.5	2.3	5.4	3.6	5.4	2.0	3.4	6.5	2.7	11.5	6.8	15.5	10.2	3.0	6.4	22.2	16.1	3.0	4.8	3.3	4.8	27.4	7.7	2.8	2.7	2.7	2.9	3.2	2.4	2.8	1.9	2.2	2.1
ZNF107	"smap-7, ZFD25, ZNF588"	ENSG00000196247	"Zinc finger protein 107"	Q9UII5	7	64666083-64711582	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 37.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 23.4;REH: 24.9;U-698: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavourable (2.62e-4)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.15e-3)"	5.6	8.6	3.7	16.2	6.6	9.6	19.3	8.6	5.0	9.5	3.6	5.8	2.7	3.5	4.1	3.4	5.9	4.2	3.9	3.2	4.2	3.2	4.0	3.0	4.7	19.7	7.8	3.2	6.3	4.0	2.9	9.3	4.5	5.8	6.0	4.8	2.4	10.3	6.1	2.2	9.6	14.6	3.3	8.2	17.8	4.8	4.2	7.7	37.4	7.0	4.2	18.9	8.4	7.2	10.1	2.7	13.5	1.6	2.5	6.2	1.6	3.4	2.0	6.0	10.3	1.4	1.5	4.5	2.6	1.7	4.0	5.2	3.2	3.3	20.2	4.8	1.7	2.7	6.6	2.6	6.0	4.8	4.5	3.9	3.1	1.8	0.7	7.4	7.0	2.5	1.8	3.3	1.9	1.9	6.8	10.6	3.5	2.8	23.4	8.1	11.6	2.3	24.9	5.0	4.5	2.1	6.8	6.7	5.4	4.1	4.2	2.6	6.6	5.1	1.6	6.6	2.6	2.6	3.8	5.0	4.4	26.3	1.5	5.2	4.3	8.6	0.7	1.4	3.5	1.6	3.7	8.4	4.7	4.7	1.0	10.1	6.2	5.7	13.5	2.5	1.1	2.7	3.9	1.6	3.7	6.6	8.6	5.0	4.2	3.2	7.8	3.2	5.8	7.7
ZNF215	"ZKSCAN11, ZSCAN43"	ENSG00000149054	"Zinc finger protein 215"	Q9UL58	11	6926404-7001004	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.6"	"Cell line enhanced"	"Detected in many"		"U-698: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA047243, HPA051010"	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA047243: , HPA051010: AB_2681308"	"unprognostic (2.18e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	1.2	1.4	1.5	9.0	1.8	1.4	2.7	0.7	4.0	1.9	4.2	0.3	0.9	4.6	2.3	5.2	2.8	1.4	1.1	1.4	1.2	2.2	2.9	1.6	1.5	6.7	0.7	1.4	1.9	10.4	0.0	0.8	0.7	1.9	2.7	5.5	1.2	4.2	2.0	0.9	1.6	5.5	0.9	1.1	4.8	1.6	6.1	0.0	6.5	2.7	2.1	11.6	3.3	2.2	2.5	2.9	4.0	1.8	1.5	1.4	0.8	2.6	1.2	1.7	0.6	1.3	1.6	5.7	6.1	5.2	3.2	6.3	0.2	0.1	8.5	2.0	3.2	3.0	5.0	6.0	6.0	0.0	6.9	0.1	0.8	0.1	1.2	5.3	0.4	2.8	2.9	0.1	6.5	5.0	10.0	3.0	1.3	0.1	0.2	0.2	8.4	1.7	0.2	0.1	1.0	0.2	4.7	0.1	0.2	0.0	2.1	0.2	0.2	2.1	2.4	2.0	5.7	2.3	0.1	0.4	0.1	17.8	4.5	0.3	1.7	4.0	1.8	0.6	0.8	1.0	0.3	2.5	0.6	1.4	1.7	2.5	1.4	0.8	2.7	1.5	0.5	2.9	0.7	0.8	1.5	1.8	0.7	4.0	1.2	2.2	0.7	1.4	1.9	0.0
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076588	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.8;lymphoid tissue: 26.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.3;SK-BR-3: 11.0;U-698: 19.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Nucleoplasm	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	1.4	0.8	2.4	22.8	3.4	10.5	7.3	6.6	1.4	3.0	7.1	0.4	3.2	6.4	1.0	1.2	11.3	1.4	4.0	1.4	2.0	1.7	1.4	1.0	3.4	15.9	1.1	0.1	0.6	2.7	0.3	3.5	0.7	0.8	2.4	1.0	0.8	13.8	3.4	0.8	6.2	10.1	0.6	1.3	16.9	5.5	2.6	0.6	4.3	1.7	9.5	26.2	2.0	2.7	29.8	26.7	14.7	6.2	14.7	3.5	2.6	3.0	2.1	0.0	0.4	0.0	0.2	1.7	0.5	0.0	0.2	0.2	3.4	1.2	16.3	1.9	0.1	5.7	0.8	1.3	0.0	3.4	4.3	4.8	0.9	3.3	0.9	2.7	5.1	0.7	0.6	0.7	0.0	0.4	3.4	5.8	0.0	4.6	0.2	4.5	1.9	4.3	9.1	0.0	9.8	0.4	1.1	3.1	0.3	2.0	11.0	0.1	2.4	5.4	1.1	0.0	1.7	0.1	0.0	6.0	6.0	19.1	0.1	3.4	0.1	14.7	3.6	5.7	3.0	6.2	3.5	29.8	1.6	3.3	8.8	22.4	0.7	1.7	1.8	14.7	5.8	26.7	1.4	2.6	2.4	3.4	6.6	1.4	2.0	1.7	1.1	0.1	0.8	0.6
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418329	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.8;lymphoid tissue: 21.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	7	"T-cells: 1.8"	"Low region specificity"	"Detected in all"							"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favourable (2.34e-4)"	"unprognostic (2.28e-1)"	2.7	1.2	2.1	8.9	4.6	23.8	4.4	2.9	3.9	2.2	4.9	2.9	1.7	3.2	1.3	2.1	4.5	1.3	3.0	4.6	2.5	2.1	3.3	12.0	2.6	4.7	4.4	2.0	2.2	1.8	3.9	0.6	3.7	3.8	1.4	3.8	2.1	3.2	0.6	3.9	3.9	3.2	2.6	4.3	3.4	2.4	9.6	4.3	21.5	1.3	6.5	5.0	2.1	2.5	0.1	0.2	0.1	0.2	0.1	1.8	0.7	13.2	5.5	5.4	4.8	2.1	3.0	7.3	18.5	11.0	9.3	11.1	3.4	9.4	10.1	7.9	8.8	16.3	6.2	6.7	11.0	11.0	5.4	7.3	10.5	2.8	0.0	10.2	9.0	0.5	0.4	7.5	3.8	3.4	6.7	24.7	11.7	8.8	15.6	8.4	3.7	9.0	8.0	27.3	6.1	2.6	9.0	9.6	6.6	8.1	9.8	5.6	5.1	9.1	3.0	15.3	8.7	14.0	14.0	9.6	16.2	4.1	9.2	9.0	12.8	0.0	0.0	0.1	1.2	0.0	0.8	0.0	0.8	1.2	0.2	0.1	1.1	1.3	0.0	0.1	0.2	0.1	1.8	0.7	2.1	4.6	2.9	3.9	2.5	2.1	4.4	2.0	3.8	4.3
ZNF492	"KIAA1473, ZNF115"	ENSG00000229676	"Zinc finger protein 492"	Q9P255	19	22634324-22667670	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.4;HAP1: 4.8;NB-4: 6.2;NTERA-2: 6.1;U-2197: 5.9"	"Group enriched"	"Detected in some"	6	"ovarian cancer: 0.6;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.08e-3)"	"unprognostic (5.63e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.93e-2)"	"unprognostic (6.04e-2)"	2.1	0.7	2.0	1.0	3.1	7.4	2.6	7.6	3.8	2.0	1.0	0.1	0.0	0.3	1.2	0.7	1.9	1.2	0.4	1.6	1.9	0.9	1.2	0.6	1.4	1.8	3.1	0.9	2.5	0.9	1.2	0.6	2.1	1.1	0.8	1.4	0.7	0.9	0.6	0.6	1.4	0.9	1.0	0.9	1.8	0.7	8.0	2.3	11.1	1.3	0.0	1.3	0.9	1.3	2.4	0.5	1.4	0.3	0.9	1.0	0.4	0.0	0.0	2.1	0.1	0.0	0.0	8.4	1.3	0.0	0.7	0.7	0.0	0.1	0.0	3.0	1.1	0.1	4.8	0.0	1.6	0.0	1.4	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.0	1.6	0.0	0.0	1.2	0.2	0.0	0.8	0.0	6.2	6.1	0.1	0.0	0.0	0.9	0.8	1.5	0.1	3.5	0.0	0.0	0.5	2.5	2.2	0.0	0.1	3.2	5.9	0.2	0.1	0.0	3.9	0.0	0.0	0.0	0.7	0.3	0.2	0.3	0.2	0.9	0.6	0.6	0.2	0.1	2.4	1.0	0.5	1.4	0.9	0.2	0.5	0.8	0.4	2.0	3.1	7.6	3.8	1.9	0.9	3.1	0.9	1.1	2.3
ZNF681	FLJ31526	ENSG00000196172	"Zinc finger protein 681"	Q96N22	19	23739195-23758891	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.48e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-3)"	"unprognostic (8.55e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.55e-2)"	3.3	3.6	6.4	5.9	4.9	1.7	5.1	15.8	9.5	4.0	4.0	1.0	2.2	2.6	2.9	4.4	5.1	3.6	1.9	2.0	5.7	5.5	2.2	1.2	2.4	6.7	4.1	6.8	5.6	4.9	1.9	5.4	3.1	8.3	3.1	5.1	1.1	3.0	2.1	1.1	5.8	3.2	2.3	4.7	7.2	2.8	6.1	4.6	17.7	5.0	0.6	5.7	6.6	3.9	3.7	1.5	0.6	0.6	1.8	7.0	1.8	0.7	0.0	4.7	9.1	0.3	0.0	2.5	0.5	0.1	1.4	1.5	1.2	2.4	1.2	4.3	0.8	2.2	4.3	0.2	2.4	14.5	1.6	2.3	0.0	0.0	0.7	0.0	0.4	1.1	0.8	0.6	0.6	0.0	6.2	0.0	2.4	2.0	7.8	2.1	6.8	2.1	6.1	3.3	9.5	1.2	4.5	0.4	4.9	0.0	0.0	0.8	4.9	0.3	0.0	0.9	0.1	2.9	3.3	0.1	8.4	7.2	0.0	0.0	0.0	0.3	0.6	0.1	2.0	0.4	3.2	2.4	3.4	2.8	1.0	3.7	7.0	5.8	0.6	1.8	0.4	1.5	3.4	1.8	6.4	4.9	15.8	9.5	5.7	5.5	4.1	6.8	8.3	4.6
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.3;testis: 8.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 5.1"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.2"									HPA024743	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.3	0.3	0.6	3.2	2.1	3.3	1.5	1.6	1.0	0.6	1.0	0.0	0.0	0.4	0.6	0.0	1.3	0.3	0.2	0.3	5.1	0.4	0.7	0.2	0.9	1.1	0.5	0.9	0.6	1.7	0.0	0.6	2.5	0.3	0.4	1.5	0.1	1.1	0.1	0.2	0.5	2.3	1.4	0.7	0.4	0.6	8.3	0.0	8.3	0.3	0.0	2.2	0.4	0.7	0.1	0.1	3.2	0.2	0.2	0.2	0.0	6.5	0.8	4.1	10.3	0.1	0.1	10.7	2.2	0.1	3.1	4.2	6.9	0.4	5.4	4.3	1.2	2.0	11.5	0.6	3.6	0.0	4.0	3.5	1.5	4.2	0.0	0.0	1.3	0.2	0.0	3.5	2.9	1.2	4.7	0.0	3.2	2.6	7.4	3.8	7.6	4.2	4.1	9.4	0.0	0.7	3.6	3.6	6.3	3.3	2.6	1.2	2.9	4.9	0.5	0.5	5.9	3.1	0.0	0.7	1.8	0.1	0.0	0.0	2.2	0.7	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	3.2	0.2	0.1	0.1	0.0	0.0	0.6	2.1	1.6	1.0	5.1	0.4	0.5	0.9	0.3	0.0
ZNF724	ZNF724P	ENSG00000196081	"Zinc finger protein 724"	A8MTY0	19	23221599-23250390	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.5"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (2.02e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.30e-2)"	2.6	1.8	3.0	7.5	4.0	8.1	2.2	5.3	4.4	2.1	1.9	0.8	0.5	1.2	2.0	2.2	8.7	1.3	1.5	2.7	1.8	2.4	2.4	1.7	2.2	5.5	2.5	2.6	2.0	1.7	1.5	1.3	2.4	3.4	2.8	2.5	0.5	2.4	1.8	2.1	2.6	2.1	1.7	5.7	7.1	6.5	6.1	3.7	16.5	2.1	0.9	3.3	2.1	2.5	5.1	3.2	5.9	1.6	4.6	2.6	0.4	3.5	2.3	5.9	7.3	0.5	0.8	7.1	1.7	1.5	4.5	5.3	3.5	1.2	3.7	4.3	1.7	2.3	6.4	2.8	8.1	0.5	7.0	3.7	1.3	1.5	0.2	0.1	3.6	0.4	0.4	5.4	3.7	0.2	5.4	0.3	2.7	5.3	8.9	2.1	14.1	4.7	5.0	7.9	2.7	0.6	4.3	3.6	3.5	0.0	0.1	0.8	2.1	2.1	0.1	1.7	0.2	5.2	4.8	0.0	1.5	7.8	0.0	1.0	1.4	4.0	1.6	0.7	2.5	1.4	1.3	3.9	1.7	1.9	1.2	5.1	2.1	2.6	5.9	4.6	1.1	3.2	1.0	0.4	3.0	4.0	5.3	4.4	1.8	2.4	2.5	2.6	3.4	3.7
ZNF730		ENSG00000183850	"Zinc finger protein 730"	Q6ZMV8	19	23075210-23147219	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.2"	"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BJ hTERT+ SV40 Large T+ RasG12V: 12.0;NTERA-2: 15.8;REH: 13.8;U-698: 12.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"																						"unprognostic (6.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.60e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.24e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.43e-2)"	0.9	0.7	3.4	3.6	3.0	2.5	2.0	2.5	3.6	1.2	0.9	1.9	1.1	0.1	2.5	2.7	1.2	1.9	1.5	1.1	2.2	3.1	0.9	0.7	1.3	3.2	2.2	3.5	5.1	0.8	2.3	1.8	6.3	7.2	3.2	1.4	3.5	0.8	0.8	0.7	0.9	0.8	1.9	4.1	0.9	0.8	9.9	1.0	25.2	2.0	0.2	3.7	1.1	1.3	0.9	1.5	0.3	0.4	0.2	0.5	0.3	0.0	0.0	11.6	8.3	0.5	0.9	2.5	3.4	0.0	7.0	12.0	0.0	0.0	0.0	4.3	2.1	0.0	1.2	0.4	10.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	1.4	0.0	3.2	1.0	0.0	4.0	0.0	6.2	1.6	10.3	3.2	15.8	2.0	13.8	7.0	0.7	0.9	7.7	0.0	6.7	0.0	0.0	0.0	5.5	3.7	0.1	0.1	0.6	2.3	3.4	0.0	2.4	12.6	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.4	0.0	0.6	0.3	0.3	0.6	0.9	0.0	0.1	0.0	0.2	0.0	1.5	0.0	0.3	3.4	3.0	2.5	2.3	2.2	3.1	2.2	3.5	7.2	1.0
ZNF750	"FLJ13841, Zfp750"	ENSG00000141579	"Zinc finger protein 750"	Q32MQ0	17	82829435-82840578	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.3;lymphoid tissue: 54.2;skeletal muscle: 84.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.0;hTCEpi: 6.3;MCF7: 4.5;SK-BR-3: 12.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021573, HPA023012"	Enhanced									"HPA021573: AB_1859438, HPA023012: AB_1859439"	"unprognostic (3.46e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.33e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.30e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.25e-2)"	0.4	0.1	0.1	0.1	0.1	0.1	3.0	0.1	0.1	14.0	0.1	0.0	9.0	0.2	0.9	3.8	59.3	0.4	0.2	0.2	0.1	0.1	0.2	0.1	2.3	0.1	0.1	0.0	0.1	0.1	0.6	2.2	19.5	0.0	3.2	0.1	0.0	38.3	13.2	84.2	46.2	0.1	0.4	0.1	0.1	0.1	0.2	0.0	3.4	6.7	44.1	54.2	3.2	16.8	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	1.1	1.0	0.0	12.7	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;pituitary gland: 6.6"	"Group enriched"	"Detected in some"	13	"Daudi: 9.1;HMC-1: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdTCR: 4.1;MAIT T-cell: 3.3;memory CD4 T-cell: 2.3;memory CD8 T-cell: 3.3;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.4;NK-cell: 2.3;T-reg: 4.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 2.3;T-cells: 4.2"	"Group enriched"	"Detected in many"	4	"amygdala: 5.3;basal ganglia: 4.3;cerebral cortex: 5.1;hippocampal formation: 6.0;olfactory region: 4.7"	"Group enriched"	"Detected in many"	26	"amygdala: 6.5;basal ganglia: 5.1;cerebral cortex: 4.5;hippocampal formation: 7.1;olfactory region: 11.1"	HPA016839	Uncertain									"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"	0.6	0.1	1.7	9.1	3.6	1.3	0.4	0.2	1.2	0.2	0.4	0.2	0.2	0.3	0.2	0.4	0.8	0.4	0.8	0.2	1.5	0.6	0.3	0.3	1.3	10.0	0.2	0.2	0.2	0.3	0.0	6.6	0.2	0.2	0.2	0.5	0.2	0.5	0.2	0.2	0.1	4.2	0.2	0.2	9.3	0.9	0.4	0.2	0.4	0.7	0.9	13.8	3.1	0.2	0.4	0.0	0.5	0.0	2.3	4.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	4.1	0.0	3.3	0.4	2.3	3.3	0.0	0.4	1.9	2.4	0.2	2.3	0.0	0.0	4.2	0.8	1.7	3.6	0.2	1.2	1.5	0.6	0.2	0.2	0.2	0.2
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981771-31991628	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.2"	"Cell line enriched"	"Detected in many"	4	"BEWO: 31.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	61	"memory B-cell: 9.1;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	71	"B-cells: 9.1"									HPA063386	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA063386: AB_2684999"	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"	2.0	1.0	0.7	11.2	1.0	0.1	2.8	0.8	1.5	4.3	1.1	0.0	1.7	0.3	4.1	4.9	6.2	1.9	3.6	1.3	0.6	1.6	7.2	0.4	3.7	8.3	1.6	0.6	1.8	0.6	0.1	5.5	8.1	1.1	6.0	1.6	1.6	5.6	2.6	0.4	2.3	3.7	6.7	0.5	9.6	1.1	2.2	0.0	0.5	1.8	4.2	20.2	6.4	3.6	9.1	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.6	0.0	1.6	0.0	0.0	31.3	0.2	0.1	0.2	0.2	2.0	2.4	2.2	2.3	0.0	1.9	0.7	3.0	0.2	0.0	0.3	0.0	3.1	1.0	0.0	0.0	0.0	0.1	1.3	0.2	6.0	0.6	0.0	0.0	0.2	1.7	0.0	0.0	0.8	3.3	0.0	0.0	0.1	7.1	0.8	0.2	0.0	0.5	3.7	0.0	2.9	0.0	1.2	0.2	2.6	0.0	0.2	0.0	0.0	3.5	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.0	0.8	1.5	0.6	1.6	1.6	0.6	1.1	0.0
ZNRF1	"DKFZp434E229, FLJ14846, nin283"	ENSG00000186187	"Zinc and ring finger 1"	Q8ND25	16	74999030-75110994	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 53.8;MOLT-4: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.5;T-reg: 5.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.5;monocytes: 1.4;T-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027470	Approved									"HPA027470: AB_10603108"	"unprognostic (2.78e-2)"	"prognostic favourable (9.90e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-2)"	10.0	9.5	13.4	8.1	13.7	5.2	16.6	6.3	16.5	13.2	12.5	8.1	6.7	8.3	10.7	9.1	28.2	10.0	11.3	9.1	11.6	14.6	5.6	12.8	12.8	8.7	9.1	9.4	10.1	6.1	12.2	6.2	9.7	7.8	9.1	10.8	7.2	7.5	7.5	58.6	14.5	11.2	10.1	8.8	2.8	11.8	21.6	4.9	80.1	21.4	16.9	13.3	14.0	15.5	0.2	0.8	4.5	1.4	0.0	5.2	0.3	3.1	4.6	8.0	8.2	8.6	6.7	27.7	3.8	5.4	5.3	5.2	7.4	9.9	0.8	3.0	8.3	7.6	3.9	5.3	4.2	7.7	2.2	16.5	1.5	13.6	6.8	7.9	53.8	6.0	4.4	5.5	4.5	8.6	7.9	2.6	4.1	30.2	38.5	29.1	11.1	5.0	17.1	3.0	5.0	7.5	9.0	10.7	11.5	6.1	8.1	2.2	21.5	7.5	5.8	3.7	6.4	6.5	2.3	15.4	15.6	9.1	4.8	8.8	3.7	4.5	1.4	0.9	0.2	1.1	1.3	0.2	1.5	0.2	0.8	0.0	0.0	0.2	1.2	0.0	1.1	0.0	5.2	0.3	13.4	13.7	6.3	16.5	11.6	14.6	9.1	9.4	7.8	4.9
ZP4	ZPB	ENSG00000116996	"Zona pellucida glycoprotein 4"	Q12836	1	237877864-237890922	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 8.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA008547	Supported				"Secreted in female reproductive system"					"HPA008547: AB_1080766"						"unprognostic (7.12e-2)"			"unprognostic (2.70e-1)"						"unprognostic (4.59e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		2.3	0.0	0.0	0.0	1.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357228-56361275	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.6;testis: 37.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	1.7	3.5	3.4	14.6	3.1	18.4	3.0	0.9	2.8	3.3	9.4	1.3	2.1	6.8	2.0	4.5	14.1	1.1	6.3	1.6	2.7	1.8	4.6	2.9	2.6	12.8	2.4	3.4	1.7	2.8	2.8	1.9	7.3	1.9	1.8	11.8	1.5	4.2	1.4	0.9	5.2	8.8	3.1	2.5	9.0	6.2	37.1	0.7	35.6	1.9	12.7	17.2	3.1	4.6	1.6	1.3	0.6	2.6	2.9	15.2	3.0	39.5	31.5	22.4	24.9	1.6	2.3	18.3	29.2	22.1	35.3	32.1	55.6	23.7	20.4	11.1	10.0	20.4	31.5	22.0	33.0	51.7	16.4	20.3	25.3	25.7	0.1	33.4	27.3	1.0	1.4	32.8	13.5	17.7	27.4	25.0	31.0	31.9	29.5	21.2	15.9	38.9	30.2	43.6	10.8	11.0	17.7	20.8	12.8	27.6	62.8	7.3	40.7	32.7	9.6	15.5	39.8	15.9	44.5	22.1	10.6	35.4	21.8	42.1	19.4	0.0	0.7	0.6	2.2	2.6	0.3	1.6	5.3	3.6	1.3	0.3	6.4	3.6	0.0	2.9	2.0	1.0	15.2	3.0	3.4	3.1	0.9	2.8	2.7	1.8	2.4	3.4	1.9	0.7
